,CompoundName,SMILES,Formula,ItemID
0,Prostaglandin A1,CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1CCCCCCC(=O)O,C20H32O4,10010.0
1,Ac-YVAD-CMK,CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)CCl)C(C)C,C24H33ClN4O8,10014.0
2,Ac-YVAD-CHO,CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C=O)CC(=O)O)C(C)C,C23H32N4O8,10016.0
3,DDMS,CS(=O)(=O)NC(=O)CCCCCCCCCC=C(Br)Br,C13H23Br2NO3S,10018.0
4,Prostaglandin A1 ethyl ester,CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1CCCCCCC(=O)OCC,C22H36O4,10020.0
5,F16,C[n+]1ccc(/C=C/c2c[nH]c3ccccc23)cc1.[I-],C16H15IN2,10022.0
6,(S)-AL 8810,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)C2Cc3ccccc3C2)[C@@H](F)C[C@@H]1O,C24H31FO4,10023.0
7,T0070907,O=C(Nc1ccncc1)c1cc([N+](=O)[O-])ccc1Cl,C12H8ClN3O3,10026.0
8,MK 571,CN(C)C(=O)CCSC(SCCC(=O)O)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,C26H27ClN2O3S2,10029.0
9,POV-PC,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCC=O,C29H56NO9P,10031.0
10,N-(.alpha.-Linolenoyl) Tyrosine,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O,C27H39NO4,10032.0
11,Lipoxin A4 methyl ester,CCCCC[C@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)CCCC(=O)OC,C21H34O5,10033.0
12,8-iso Prostaglandin A1,CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@H]1CCCCCCC(=O)O,C20H32O4,10035.0
13,TMS,COc1cc(/C=C/c2ccc(OC)cc2OC)cc(OC)c1,C18H20O4,10038.0
14,FR122047 (hydrochloride),COc1ccc(-c2nc(C(=O)N3CCN(C)CC3)sc2-c2ccc(OC)cc2)cc1.Cl,C23H26ClN3O3S,10039.0
15,15(R)-Iloprost,CC#CCC(C)[C@@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O,C22H32O4,10043.0
16,PGPC,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCC(=O)O,C29H56NO10P,10044.0
17,UCM707,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCc1ccoc1,C25H37NO2,10045.0
18,URB597,NC(=O)c1cccc(-c2cccc(OC(=O)NC3CCCCC3)c2)c1,C20H22N2O3,10046.0
19,6(S)-Lipoxin A4,CCCCC[C@H](O)/C=C/C=C\C=C\C=C\[C@H](O)[C@@H](O)CCCC(=O)O,C20H32O5,10049.0
20,"15-deoxy-.DELTA.12,14-Prostaglandin A1",CCCCC/C=C/C=C1/C=CC(=O)[C@@H]1CCCCCCC(=O)O,C20H30O3,10065.0
21,15-epi Prostaglandin A1,CCCCC[C@@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1CCCCCCC(=O)C(=O)O,C21H32O5,10070.0
22,(+)-Abscisic Acid,CC1=CC(=O)CC(C)(C)[C@@]1(O)/C=C/C(C)=C\C(=O)O,C15H20O4,10073.0
23,"16,16-dimethyl Prostaglandin A1",CCCCC(C)(C)[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1CCCCCCC(=O)O,C22H36O4,10080.0
24,SB-242084 (hydrochloride),Cc1cc2c(cc1Cl)N(C(=O)Nc1ccc(Oc3cccnc3C)nc1)CC2.Cl.Cl,C21H21Cl3N4O2,10096.0
25,EA4,CCN(CC)c1ccc(C2=C(Cl)C(=O)c3ncccc3C2=O)cc1,C19H17ClN2O2,10111.0
26,AL 8810 isopropyl ester,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@H](O)C2Cc3ccccc3C2)[C@@H](F)C[C@@H]1O,C27H37FO4,10113.0
27,N-Oleoyl Dopamine,CCCCCCCC/C=C\CCCCCCCC(=O)NCCc1ccc(O)c(O)c1,C26H43NO3,10115.0
28,15(R)-Prostaglandin D2,CCCCC[C@@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,10118.0
29,"CP 24,879 (hydrochloride)",CC(C)CCOc1ccc(N)cc1.Cl,C11H18ClNO,10120.0
30,5-trans Latanoprost (free acid),O=C(O)CCC/C=C/C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C23H34O5,10129.0
31,MK-886 (sodium salt),CC(C)c1ccc2c(c1)c(SC(C)(C)C)c(CC(C)(C)C(=O)[O-])n2Cc1ccc(Cl)cc1.[Na+],C27H33ClNNaO2S,10133.0
32,HQL-79,c1ccc(C(OC2CCN(CCCc3nnn[nH]3)CC2)c2ccccc2)cc1,C22H27N5O,10134.0
33,Icilin,O=C1NC(c2cccc([N+](=O)[O-])c2)=CCN1c1ccccc1O,C16H13N3O4,10137.0
34,Prostaglandin F2.alpha.-1-glyceryl ester,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OCC(O)CO)[C@@H](O)C[C@H]1O,C23H40O7,10139.0
35,Prostaglandin E2-1-glyceryl ester,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)OCC(O)CO,C23H38O7,10140.0
36,BM 567,CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1,C18H28N4O5S,10155.0
37,Ramatroban,O=C(O)CCn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2,C21H21FN2O4S,10156.0
38,APF,Nc1ccc(Oc2ccc3c(c2)Oc2cc(O)ccc2C32OC(=O)c3ccccc32)cc1,C26H17NO5,10157.0
39,HPF,O=C1OC2(c3ccc(O)cc3Oc3cc(Oc4ccc(O)cc4)ccc32)c2ccccc21,C26H16O6,10159.0
40,Treprostinil,CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O,C23H34O5,10162.0
41,D-erythro-MAPP,CCCCCCCCCCCCCC(=O)N[C@H](C)[C@@H](O)c1ccccc1,C23H39NO2,10165.0
42,Arachidonoyl p-Nitroaniline,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)Nc1ccc([N+](=O)[O-])cc1,C26H36N2O3,10168.0
43,15(S)-HETE Ethanolamide,CCCCC[C@H](O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO,C22H37NO3,10169.0
44,BEC,N[C@@H](CSCCB(O)O)C(=O)O,C5H12BNO4S,10170.0
45,OMDM-1,CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](CO)Cc1ccc(O)cc1,C27H45NO3,10171.0
46,1-Palmitoyl-2-hydroxy-sn-glycero-3-PC,CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C24H50NO7P,10172.0
47,OMDM-2,CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](CO)Cc1ccc(O)cc1,C27H45NO3,10179.0
48,Arachidonoyl Ethanolamide Phosphate,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCOP(=O)(O)O,C22H38NO5P,10180.0
49,4-oxo-2-Nonenal,CCCCCC(=O)/C=C/C=O,C9H14O2,10185.0
50,trans-trismethoxy Resveratrol,COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1,C17H18O3,10188.0
51,"2,4-Dichlorophenoxy Acetic Acid",O=C(O)COc1ccc(Cl)cc1Cl,C8H6Cl2O3,10190.0
52,Prostaglandin D2 serinol amide,CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)NC(CO)CO,C23H39NO6,10192.0
53,Prostaglandin E2 serinol amide,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)NC(CO)CO,C23H39NO6,10193.0
54,Prostaglandin F2.alpha. serinol amide,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)NC(CO)CO)[C@@H](O)C[C@H]1O,C23H41NO6,10194.0
55,13-epi-12-oxo Phytodienoic Acid,CC/C=C\C[C@H]1C(=O)C=C[C@@H]1CCCCCCCC(=O)O,C18H28O3,10195.0
56,Prostaglandin A2,CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H30O4,10210.0
57,IDFP,CCCCCCCCCCCCP(=O)(F)OC(C)C,C15H32FO2P,10215.0
58,8-iso Prostaglandin A2,CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@H]1C/C=C\CCCC(=O)O,C20H30O4,10235.0
59,"13,14-dihydro-15-keto Prostaglandin A2",CCCCCC(=O)CC[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H30O4,10260.0
60,"15-deoxy-.DELTA.12,14-Prostaglandin A2",CCCCC/C=C/C=C1/C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H28O3,10265.0
61,15(R)-15-methyl Prostaglandin A2,CCCCC[C@@](C)(O)/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C21H32O4,10270.0
62,Prostratin,CC(=O)O[C@@]12C[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C,C22H30O6,10272.0
63,ATB-337,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)Oc1ccc(-c2cc(=S)ss2)cc1,C23H15Cl2NO2S3,10277.0
64,"16,16-dimethyl Prostaglandin A2",CCCCC(C)(C)[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C22H34O4,10280.0
65,16-phenoxy tetranor Prostaglandin A2,O=C(O)CCC/C=C\C[C@H]1C(=O)C=C[C@@H]1/C=C/[C@@H](O)COc1ccccc1,C22H26O5,10285.0
66,17-phenyl trinor Prostaglandin A2,O=C(O)CCC/C=C\C[C@H]1C(=O)C=C[C@@H]1/C=C/[C@@H](O)CCc1ccccc1,C23H28O4,10288.0
67,"17-phenyl trinor-13,14-dihydro Prostaglandin A2",O=C(O)CCC/C=C\C[C@H]1C(=O)C=C[C@@H]1CC[C@@H](O)CCc1ccccc1,C23H30O4,10290.0
68,19(R)-hydroxy Prostaglandin A2,C[C@@H](O)CCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H30O5,10295.0
69,Prostaglandin A3,CC/C=C\C[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H28O4,10310.0
70,Prostaglandin E2 isopropyl ester,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)OC(C)C,C23H38O5,10384.0
71,?-hydroxy Midazolam,OCc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,C18H13ClFN3O,10385.0
72,?-hydroxy Midazolam (CRM),OCc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,C18H13ClFN3O,39954.0
73,1'.alpha.-Hydroxymidazolam .beta.-D-Glucuronide,O=C(O)[C@H]1O[C@@H](OCc2ncc3n2-c2ccc(Cl)cc2C(c2ccccc2F)=NC3)[C@H](O)[C@@H](O)[C@@H]1O,C24H21ClFN3O7,10386.0
74,PKC 412,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,C35H30N4O4,10459.0
75,Paclitaxel,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,C47H51NO14,10461.0
76,JWH 007-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1c(C)c(C(=O)c2cccc3ccccc23)c2ccccc21,C25H25NO,10486.0
77,Capecitabine,CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,C15H22FN3O6,10487.0
78,Bupropion (hydrochloride),CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1.Cl,C13H19Cl2NO,10488.0
79,Bupropion (hydrochloride) (CRM),CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1.Cl,C13H19Cl2NO,25576.0
80,(S)-AM1241,CN1CCCC[C@H]1Cn1cc(C(=O)c2cc([N+](=O)[O-])ccc2I)c2ccccc21,C22H22IN3O3,10490.0
81,(R)-AM1241,CN1CCCC[C@@H]1Cn1cc(C(=O)c2cc([N+](=O)[O-])ccc2I)c2ccccc21,C22H22IN3O3,10491.0
82,4-iodo-SAHA,O=C(CCCCCCC(=O)Nc1ccc(I)cc1)NO,C14H19IN2O3,10495.0
83,BayCysLT2,O=C(O)c1ccc(OCCCc2ccc(OCCCCOc3ccccc3)cc2)c(C(=O)NC2CCCC(C(=O)O)C2)c1,C34H39NO8,10532.0
84,"7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid",CC/C=C\C[C@H](O)/C=C/C=C\C/C=C\C=C\[C@@H](O)CCCCCC(=O)O,C22H34O4,10546.0
85,4-biphenylthio Carboxamide,NC(=S)c1ccc(-c2ccccc2)cc1,C13H11NS,10550.0
86,Pyrazine-2-thio Carboxamide,NC(=S)c1cnccn1,C5H5N3S,10551.0
87,4-methoxythio Benzamide,COc1ccc(C(N)=S)cc1,C8H9NOS,10552.0
88,3-methoxythio Benzamide,COc1cccc(C(N)=S)c1,C8H9NOS,10553.0
89,NG-amino-L-Arginine (hydrochloride),Cl.N=C(NN)NCCC[C@H](N)C(=O)O,C6H16ClN5O2,10554.0
90,7-hydroxycoumarinyl-.gamma.-Linolenate,CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)Oc1ccc2ccc(=O)oc2c1,C27H34O4,10556.0
91,MDA 19,CCCCCCN1C(=O)/C(=N\NC(=O)c2ccccc2)c2ccccc21,C21H23N3O2,10563.0
92,NVP-BEZ235,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,C30H23N5O,10565.0
93,Ellagic Acid,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,C14H6O8,10569.0
94,Scriptaid,O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO,C18H18N2O4,10572.0
95,Suberohydroxamic Acid,O=C(CCCCCCC(=O)NO)NO,C8H16N2O4,10574.0
96,HC Toxin,C[C@@H]1NC(=O)[C@H]2CCCN2C(=O)[C@H](CCCCCC(=O)[C@@H]2CO2)NC(=O)[C@@H](C)NC1=O,C21H32N4O6,10576.0
97,JWH 081,CCCCCn1cc(C(=O)c2ccc(OC)c3ccccc23)c2ccccc21,C25H25NO2,10579.0
98,JWH 081 (exempt preparation),CCCCCn1cc(C(=O)c2ccc(OC)c3ccccc23)c2ccccc21,C25H25NO2,15665.0
99,JWH 122,CCCCCn1cc(C(=O)c2ccc(C)c3ccccc23)c2ccccc21,C25H25NO,10591.0
100,JWH 122 (exempt preparation),CCCCCn1cc(C(=O)c2ccc(C)c3ccccc23)c2ccccc21,C25H25NO,15667.0
101,AS-1269574,Cc1cc(NCCO)nc(-c2ccc(Br)cc2)n1,C13H14BrN3O,10626.0
102,JWH 073 2-hydroxyindole metabolite,CCCCn1c(O)c(C(=O)c2cccc3ccccc23)c2ccccc21,C23H21NO2,10633.0
103,RCS-8,COc1ccccc1CC(=O)c1cn(CCC2CCCCC2)c2ccccc12,C25H29NO2,10636.0
104,RCS-8 (exempt preparation),COc1ccccc1CC(=O)c1cn(CCC2CCCCC2)c2ccccc12,C25H29NO2,15663.0
105,Niclosamide,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,C13H8Cl2N2O4,10649.0
106,ent-Corey PG-Lactone Diol,CCCCC[C@@H](O)/C=C/[C@H]1[C@@H]2CC(=O)O[C@@H]2C[C@@H]1O,C15H24O4,10653.0
107,JWH 200-d5 (exempt preparation),[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1cccc3ccccc13)c([2H])n2CCN1CCOCC1,C25H24N2O2,10682.0
108,JWH 200-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1cccc3ccccc13)c([2H])n2CCN1CCOCC1,C25H24N2O2,10903.0
109,"3,4-Methylenedioxy Pyrovalerone (hydrochloride)",CCCC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1.Cl,C16H22ClNO3,10684.0
110,"3,4-Methylenedioxy Pyrovalerone (hydrochloride) (CRM)",CCCC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1.Cl,C16H22ClNO3,31088.0
111,Prostaglandin B1,CCCCC[C@H](O)/C=C/C1=C(CCCCCCC(=O)O)C(=O)CC1,C20H32O4,11110.0
112,Prostaglandin B2,CCCCC[C@H](O)/C=C/C1=C(C/C=C\CCCC(=O)O)C(=O)CC1,C20H30O4,11210.0
113,Prostaglandin B3,CC/C=C\C[C@H](O)/C=C/C1=C(C/C=C\CCCC(=O)O)C(=O)CC1,C20H28O4,11990.0
114,Prostaglandin D1,CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1CCCCCCC(=O)O,C20H34O5,12000.0
115,Prostaglandin D1 Alcohol,CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1CCCCCCCO,C20H36O4,12002.0
116,Prostaglandin D2,CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,12010.0
117,Prostaglandin D2 Ethanolamide,CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)NCCO,C22H37NO5,12012.0
118,Prostaglandin D2-1-glyceryl ester,CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)OCC(O)CO,C23H38O7,12015.0
119,BW 245C,O=C(O)CCCCCC[C@H]1C(=O)NC(=O)N1CCC(O)C1CCCCC1,C19H32N2O5,12050.0
120,BW 246C,O=C(O)CCCCCC[C@@H]1C(=O)NC(=O)N1CCC(O)C1CCCCC1,C19H32N2O5,12055.0
121,BW A868C,O=C(O)CCCCCCC1C(=O)N(Cc2ccccc2)C(=O)N1NCC(O)C1CCCCC1,C25H37N3O5,12060.0
122,5-trans Prostaglandin D2,CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C/CCCC(=O)O,C20H32O5,12210.0
123,11-deoxy-11-methylene Prostaglandin D2,C=C1C[C@H](O)[C@H](C/C=C\CCCC(=O)O)[C@H]1/C=C/[C@@H](O)CCCCC,C21H34O4,12410.0
124,"13,14-dihydro-15-keto Prostaglandin D2",CCCCCC(=O)CC[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,12610.0
125,.DELTA.12-Prostaglandin D2,CCCCC[C@H](O)C/C=C1/C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,12650.0
126,"15-deoxy-.DELTA.12,14-Prostaglandin D2",CCCCC/C=C/C=C1/C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H30O4,12700.0
127,15(R)-15-methyl Prostaglandin D2,CCCCC[C@@](C)(O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C21H34O5,12720.0
128,15(S)-15-methyl Prostaglandin D2,CCCCC[C@](C)(O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C21H34O5,12730.0
129,"16,16-dimethyl Prostaglandin D2",CCCCC(C)(C)[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C22H36O5,12750.0
130,17-phenyl trinor Prostaglandin D2,O=C(O)CCC/C=C\C[C@H]1[C@@H](O)CC(=O)[C@@H]1/C=C/[C@@H](O)CCc1ccccc1,C23H30O5,12810.0
131,tetranor-PGDM,O=C(O)CCCCC(=O)CC[C@H]1C(=O)C[C@H](O)[C@@H]1CCC(=O)O,C16H24O7,12850.0
132,Prostaglandin D3,CC/C=C\C[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H30O5,12990.0
133,Pterostilbene,COc1cc(/C=C/c2ccc(O)cc2)cc(OC)c1,C16H16O3,13000.0
134,2-methyl Benzamideoxime,Cc1ccccc1/C(N)=N/O,C8H10N2O,13002.0
135,2-Pyridylamide oxime,N/C(=N\O)c1ccccn1,C6H7N3O,13003.0
136,3-Pyridylamide oxime,N/C(=N\O)c1cccnc1,C6H7N3O,13004.0
137,4-Pyridylamide oxime,N/C(=N\O)c1ccncc1,C6H7N3O,13005.0
138,3-methyl-2-Quinoxalinone,Cc1nc2ccccc2[nH]c1=O,C9H8N2O,13006.0
139,ethyl-2(2-pyridyl)-4-(bromomethyl)-Thiazole-5-Carboxylate,CCOC(=O)c1sc(-c2ccccn2)nc1CBr,C12H11BrN2O2S,13007.0
140,Disuccinimidyl Suberate,O=C(CCCCCCC(=O)ON1C(=O)CCC1=O)ON1C(=O)CCC1=O,C16H20N2O8,13008.0
141,GSK264220A,Cc1oc(S(=O)(=O)N2CCCCC2)cc1NC(=O)Nc1ccccc1,C17H21N3O4S,13009.0
142,Prostaglandin E1,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C20H34O5,13010.0
143,Prostaglandin E1 Ethanolamide,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)NCCO,C22H39NO5,13012.0
144,2-Hydroxyestradiol,C[C@]12CC[C@@H]3c4cc(O)c(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,C18H24O3,13019.0
145,Prostaglandin E1 Alcohol,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCCO,C20H36O4,13020.0
146,2-Methoxyestradiol,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,C19H26O3,13021.0
147,PD 173074,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,C28H41N7O3,13032.0
148,Valproic Acid (sodium salt),CCCC(CCC)C(=O)[O-].[Na+],C8H15NaO2,13033.0
149,PD 0325901,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,C16H14F3IN2O4,13034.0
150,2-(3-Pyridyl)-4-methyl-thiazole-5-Carboxylic Acid,Cc1nc(-c2cccnc2)sc1C(=O)O,C10H8N2O2S,13036.0
151,2-Pyridylthioamide,NC(=S)c1ccccn1,C6H6N2S,13043.0
152,Tranilast,COc1ccc(C=CC(=O)Nc2ccccc2C(=O)O)cc1OC,C18H17NO5,13044.0
153,ATB-343,COc1ccc2c(c1)c(CC(=O)Oc1ccc(-c3cc(=S)ss3)cc1)c(C)n2C(=O)c1ccc(Cl)cc1,C28H20ClNO4S3,13045.0
154,2-(2-Pyridyl)-4-methyl-thiazole-5-Carboxylic Acid,Cc1nc(-c2ccccn2)sc1C(=O)O,C10H8N2O2S,13047.0
155,2-(4-Pyridyl)-4-methyl-thiazole-5-Carboxylic Acid,Cc1nc(-c2ccncc2)sc1C(=O)O,C10H8N2O2S,13049.0
156,"1a,1b-dihomo Prostaglandin E1",CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCCCC(=O)O,C22H38O5,13050.0
157,2-(3-pyridyl)-Benzimidazole,c1cncc(-c2nc3ccccc3[nH]2)c1,C12H9N3,13054.0
158,Naphthofluorescein,O=C1OC2(c3ccccc31)c1ccc3cc(O)ccc3c1Oc1c2ccc2cc(O)ccc12,C28H16O5,13055.0
159,4-Pyridylthioamide,NC(=S)c1ccncc1,C6H6N2S,13056.0
160,3-methyl Benzamideoxime,Cc1cccc(/C(N)=N/O)c1,C8H10N2O,13057.0
161,N-Oleoyl-L-Serine,CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](CO)C(=O)O,C21H39NO4,13058.0
162,ethyl-2-amino-4-methyl-Thiazole-5-Carboxylate,CCOC(=O)c1sc(N)nc1C,C7H10N2O2S,13059.0
163,17(R)-Resolvin D1,CC/C=C\C[C@@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)C/C=C\CCC(=O)O,C22H32O5,13060.0
164,2-amino-5-methyl-4-phenyl-Thiazole,Cc1sc(N)nc1-c1ccccc1,C10H10N2S,13061.0
165,N-3-oxo-tetradecanoyl-L-Homoserine lactone,CCCCCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,C18H31NO4,13063.0
166,N-hexadecanoyl-L-Homoserine lactone,CCCCCCCCCCCCCCCC(=O)N[C@H]1CCOC1=O,C20H37NO3,13064.0
167,SB 203580,CS(=O)c1ccc(-c2nc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1,C21H16FN3OS,13067.0
168,Fucoxanthin,CC(=O)O[C@H]1CC(C)(C)C(=C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(\C)C(=O)C[C@@]23O[C@]2(C)C[C@@H](O)CC3(C)C)[C@](C)(O)C1,C42H58O6,13068.0
169,Tosyllysine Chloromethyl Ketone (hydrochloride),Cc1ccc(S(=O)(=O)N[C@@H](CCCCN)C(=O)CCl)cc1.Cl,C14H22Cl2N2O3S,13074.0
170,16(R)-Iloprost,CC#CC[C@@H](C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O,C22H32O4,13076.0
171,16(S)-Iloprost,CC#CC[C@H](C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O,C22H32O4,13077.0
172,Resorcinolnaphthalein,O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2cccc3cccc1c23,C24H14O5,13082.0
173,ThioFluor 623,COCCOCCOCCN(c1ccc(/C=C/C2=C(C#N)C(=C(C#N)C#N)OC2(C)C)cc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1[N+](=O)[O-],C31H30N6O10S,13083.0
174,STF-62247,Cc1cccc(Nc2nc(-c3ccncc3)cs2)c1,C15H13N3S,13084.0
175,Tenovin-1,CC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(C(C)(C)C)cc2)cc1,C20H23N3O2S,13085.0
176,Tenovin-6 (hydrochloride),CN(C)CCCCC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(C(C)(C)C)cc2)cc1.Cl,C25H35ClN4O2S,13086.0
177,Radicicol,C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,C18H17ClO6,13089.0
178,N-tridecanoyl-L-Homserine lactone,CCCCCCCCCCCCC(=O)N[C@H]1CCOC1=O,C17H31NO3,13093.0
179,N-pentadecanoyl-L-Homoserine lactone,CCCCCCCCCCCCCCC(=O)N[C@H]1CCOC1=O,C19H35NO3,13094.0
180,"13,14-dihydro-15-keto-tetranor Prostaglandin D2",CCCCCC(=O)CC[C@H]1C(=O)C[C@H](O)[C@@H]1CCC(=O)O,C16H26O5,13100.0
181,"13,14-dihydro-15-keto-tetranor Prostaglandin E2",CCCCCC(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCC(=O)O,C16H26O5,13101.0
182,"2,3-dinor Prostaglandin E1",CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCC(=O)O,C18H30O5,13120.0
183,Sodium Butyrate,CCCC(=O)[O-].[Na+],C4H7NaO2,13121.0
184,BIO,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,C16H10BrN3O2,13123.0
185,BIX01294 (hydrochloride hydrate),COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC.Cl.Cl.Cl,C28H41Cl3N6O2,13124.0
186,trans-trismethoxy Resveratrol-d4,[2H]c1c([2H])c(OC)c([2H])c([2H])c1/C=C/c1cc(OC)cc(OC)c1,C17H18O3,13129.0
187,trans-Resveratrol-d4,[2H]c1c([2H])c(/C=C/c2cc(O)cc(O)c2)c([2H])c([2H])c1O,C14H12O3,13130.0
188,VER-49009,CCNC(=O)c1[nH]nc(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1,C19H18ClN3O4,13131.0
189,VER-50589,CCNC(=O)c1noc(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1,C19H17ClN2O5,13132.0
190,N-acetyl-D-Glucosamine,CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO,C8H15NO6,13136.0
191,Imatinib (mesylate),CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,C30H35N7O4S,13139.0
192,4-(n-nonyl) Benzeneboronic Acid,CCCCCCCCCc1ccc(B(O)O)cc1,C15H25BO2,13140.0
193,CAY10587,Cc1ccccc1C#Cc1ccc(CCC(=O)O)cc1,C18H16O2,13143.0
194,Anacardic Acid,CCCCCCCCCCCCCCCc1cccc(O)c1C(=O)O,C22H36O3,13144.0
195,AGK2,N#C/C(=C\c1ccc(-c2cc(Cl)ccc2Cl)o1)C(=O)Nc1cccc2ncccc12,C23H13Cl2N3O2,13145.0
196,CAY10603,CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1,C22H30N4O6,13146.0
197,(E)-C-HDMAPP (ammonium salt),C/C(=C\CCP(=O)([O-])OP(=O)([O-])[O-])CO.[NH4+].[NH4+].[NH4+],C6H23N3O7P2,13151.0
198,JZL184,O=C(Oc1ccc([N+](=O)[O-])cc1)N1CCC(C(O)(c2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)CC1,C27H24N2O9,13158.0
199,Sunitinib (malate),CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O,C26H33FN4O7,13159.0
200,AT-56,C1=Cc2ccccc2C(=C2CCN(CCCCc3nnn[nH]3)CC2)c2ccccc21,C25H27N5,13160.0
201,7-epi Maresin 1,CC/C=C\C/C=C\C[C@H](O)/C=C\C=C\C=C\[C@@H](O)C/C=C\CCC(=O)O,C22H32O4,13161.0
202,CAY10589,CCCCCCC(Sc1nc(Cl)cc(NCc2ccc(-c3ccccc3)cc2)n1)C(=O)O,C25H28ClN3O2S,13164.0
203,(+)-Blebbistatin,Cc1ccc2c(c1)C(=O)[C@@]1(O)CCN(c3ccccc3)C1=N2,C18H16N2O2,13165.0
204,Iressa,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,C22H24ClFN4O3,13166.0
205,Splitomicin,O=C1CCc2c(ccc3ccccc23)O1,C13H10O2,13168.0
206,JWH 018 (exempt preparation),CCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,13169.0
207,JWH 018,CCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,10900.0
208,JWH 018 (CRM),CCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,27973.0
209,JWH 073 (exempt preparation),CCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C23H21NO,13170.0
210,JWH 073,CCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C23H21NO,10904.0
211,JWH 200 (exempt preparation),O=C(c1cccc2ccccc12)c1cn(CCN2CCOCC2)c2ccccc12,C25H24N2O2,13171.0
212,JWH 200,O=C(c1cccc2ccccc12)c1cn(CCN2CCOCC2)c2ccccc12,C25H24N2O2,10902.0
213,CBHA,O=C(/C=C/c1cccc(C(=O)NO)c1)NO,C10H10N2O4,13172.0
214,M 344,CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1,C16H25N3O3,13174.0
215,Farnesyl Thiosalicylic Acid Amide,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(N)=O,C22H31NOS,13175.0
216,Oxamflatin,O=C(/C=C/C#Cc1cccc(NS(=O)(=O)c2ccccc2)c1)NO,C17H14N2O4S,13176.0
217,Salermide,CC(C(=O)Nc1cccc(/N=C/c2c(O)ccc3ccccc23)c1)c1ccccc1,C26H22N2O2,13178.0
218,FKGK 11,O=C(CCCCc1ccccc1)C(F)(F)C(F)(F)F,C13H13F5O,13179.0
219,CAY10590,CCCC[C@H](CCC(=O)O)NC(=O)CCCCCCc1ccccc1,C21H33NO3,13181.0
220,"CP 80,633",COc1ccc(C2CNC(=O)NC2)cc1O[C@H]1C[C@@H]2CC[C@H]1C2,C18H24N2O3,13183.0
221,17(S)-HpDHA,CC/C=C\C[C@@H](/C=C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O)OO,C22H32O4,13185.0
222,Cardiogenol C (hydrochloride),COc1ccc(Nc2nccc(NCCO)n2)cc1.Cl,C13H17ClN4O2,13187.0
223,NSC 23766 (hydrochloride),CCN(CC)CCCC(C)Nc1nc(C)cc(Nc2ccc3nc(C)cc(N)c3c2)n1,C24H35N7,13196.0
224,DAPT,C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H](C(=O)OC(C)(C)C)c1ccccc1,C23H26F2N2O4,13197.0
225,PP2,CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21,C15H16ClN5,13198.0
226,cis-trismethoxy Resveratrol,COc1ccc(/C=C\c2cc(OC)cc(OC)c2)cc1,C17H18O3,13199.0
227,G-418 (sulfate),CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H]([C@@H](C)O)[C@@H](O)[C@H](O)[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.O=S(=O)(O)O.O=S(=O)(O)O,C20H44N4O18S2,13200.0
228,Agomelatine,COc1ccc2cccc(CCNC(C)=O)c2c1,C15H17NO2,13203.0
229,Halopemide,O=C(NCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1ccc(F)cc1,C21H22ClFN4O2,13205.0
230,CAY10594,O=C(NCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc2ccccc2c1,C26H28N4O2,13207.0
231,Mirin,N=C1NC(=O)/C(=C/c2ccc(O)cc2)S1,C10H8N2O2S,13208.0
232,N-octadecanoyl-L-Homoserine lactone,CCCCCCCCCCCCCCCCCC(=O)N[C@H]1CCOC1=O,C22H41NO3,13209.0
233,Pimelic Diphenylamide 106,Cc1ccc(NC(=O)CCCCCC(=O)Nc2ccccc2N)cc1,C20H25N3O2,13212.0
234,N-3-oxo-tetradec-7Z-enoyl-L-Homoserine lactone,CCCCCC/C=C\CCCC(=O)CC(=O)N[C@H]1CCOC1=O,C18H29NO4,13213.0
235,"(-)-CP 47,497 (exempt preparation)",CCCCCCC(C)(C)c1ccc([C@H]2CCC[C@@H](O)C2)c(O)c1,C21H34O2,13218.0
236,"(-)-CP 47,497",CCCCCCC(C)(C)c1ccc([C@H]2CCC[C@@H](O)C2)c(O)c1,C21H34O2,10917.0
237,"(+)-CP 47,497 (exempt preparation)",CCCCCCC(C)(C)c1ccc([C@@H]2CCC[C@H](O)C2)c(O)c1,C21H34O2,13219.0
238,"(+)-CP 47,497",CCCCCCC(C)(C)c1ccc([C@@H]2CCC[C@H](O)C2)c(O)c1,C21H34O2,10910.0
239,3-dodecanoyl-NBD Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CCCCCCCCCCCNc5ccc([N+](=O)[O-])c6nonc56)CC[C@]4(C)[C@H]3CC[C@]12C,C45H70N4O5,13220.0
240,3-hexanoyl-NBD Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CCCCCNc5ccc([N+](=O)[O-])c6nonc56)CC[C@]4(C)[C@H]3CC[C@]12C,C39H58N4O5,13221.0
241,2-Acetyl-5-tetrahydroxybutyl Imidazole,CC(=O)c1ncc([C@@H](O)[C@H](O)[C@H](O)CO)[nH]1,C9H14N2O5,13222.0
242,Neurodazine,COc1ccc(-c2nc(-c3ccc(-c4cccc(Cl)c4)o3)[nH]c2-c2ccc(OC)cc2)cc1,C27H21ClN2O3,13224.0
243,trans-Zeatin,C/C(=C\CNc1ncnc2[nH]cnc12)CO,C10H13N5O,13226.0
244,Fumonisin B2,CCCC[C@@H](C)[C@@H](OC(=O)C[C@@H](CC(=O)O)C(=O)O)[C@H](C[C@@H](C)CCCCCC[C@@H](O)C[C@H](O)[C@H](C)N)OC(=O)C[C@@H](CC(=O)O)C(=O)O,C34H59NO14,13227.0
245,thio-p-Toluamide,Cc1ccc(C(N)=S)cc1,C8H9NS,13229.0
246,4-Methylbenzamide oxime,Cc1ccc(/C(N)=N/O)cc1,C8H10N2O,13231.0
247,"Ethyl-2,4-Dimethylthiazole-5-Carboxylate",CCOC(=O)c1sc(C)nc1C,C8H11NO2S,13232.0
248,"2,4-Dimethylthiazole-5-Carboxylic Acid",Cc1nc(C)c(C(=O)O)s1,C6H7NO2S,13233.0
249,Thiamet G,CCNC1=N[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]2S1,C9H16N2O4S,13237.0
250,KH7,CC(Sc1nc2ccccc2[nH]1)C(=O)N/N=C/c1cc(Br)ccc1O,C17H15BrN4O2S,13243.0
251,Donepezil,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,C24H29NO3,13245.0
252,YM-58483,Cc1nnsc1C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1,C15H9F6N5OS,13246.0
253,L-DOPA,N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,C9H11NO4,13248.0
254,(-)-AS 115,CCCCOC[C@H]1CCCC[C@H]1COCCNC(=O)Oc1ccccc1F,C21H32FNO4,13250.0
255,DEPMPO-biotin,CCOP(=O)(OCC)C1(C)[C@H](COC(=O)NCCCNC(=O)CCCC[C@@H]2SC[C@H]3NC(=O)N[C@@H]23)CC=[N+]1[O-],C24H42N5O8PS,13251.0
256,S107,COc1ccc2c(c1)CN(C)CCS2,C11H15NOS,13253.0
257,Tamoxifen,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,C26H29NO,13258.0
258,6-keto Prostaglandin E1,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CC(=O)CCCCC(=O)O,C20H32O6,13260.0
259,URB447,Cc1c(C(=O)c2ccccc2)c(N)c(-c2ccccc2)n1Cc1ccc(Cl)cc1,C25H21ClN2O,13261.0
260,4-hydroxy Nonenal Alkyne,C#CCCCC(O)/C=C/C=O,C9H12O2,13265.0
261,Myristic Acid Alkyne,C#CCCCCCCCCCCCC(=O)O,C14H24O2,13267.0
262,Farnesyl Alcohol Azide,C/C(=C\CO)CC/C=C(\C)CC/C=C(\C)CN=[N+]=[N-],C15H25N3O,13269.0
263,ZLJ-6,CN1C(N)=NC(=O)/C1=C/c1ccc(S(C)(=O)=O)cc1.CS(=O)(=O)O,C13H17N3O6S2,13271.0
264,PF-3845,O=C(Nc1cccnc1)N1CCC(Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1,C24H23F3N4O2,13279.0
265,CAY10598,O=C1CC[C@H](/C=C/[C@@H](O)Cc2ccccc2)N1CCCCCCc1nnn[nH]1,C21H29N5O2,13281.0
266,CAY10599,CCCc1cc(C(=O)c2ccc(-c3ccccc3)cc2)ccc1OCCCN1CCCc2c(OC(C)(C)C(=O)O)cccc21,C38H41NO5,13282.0
267,MS-275,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,C21H20N4O3,13284.0
268,Cannabidiol dimethyl ether,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(OC)cc(CCCCC)cc1OC,C23H34O2,13285.0
269,FK-866,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,C24H29N3O2,13287.0
270,CB-86,CCCCCCC(C)(C)c1cc(O)cc(OCCCCCCCC(=O)NC2CC2)c1,C26H43NO3,13289.0
271,CAY10616,COc1cc(/C=C\c2ccc(OC)c(O)c2)cc(OC)c1,C17H18O4,13291.0
272,Rhapontigenin,COc1ccc(/C=C/c2cc(O)cc(O)c2)cc1O,C15H14O4,13293.0
273,Pyrrophenone,O=C1NC(=O)/C(=C/c2ccc(C(=O)NC[C@@H]3C[C@@H](SC(c4ccccc4)(c4ccccc4)c4ccccc4)CN3C(=O)c3ccccc3C(=O)c3ccc(F)cc3F)cc2)S1,C49H37F2N3O5S2,13294.0
274,HNHA,O=C(CCCCCCSc1ccc2ccccc2c1)NO,C17H21NO2S,13295.0
275,AG-126,N#CC(C#N)=Cc1ccc([N+](=O)[O-])c(O)c1,C10H5N3O3,13297.0
276,Bisindolylmaleimide I,CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,C25H24N4O2,13298.0
277,Bisindolylmaleimide IV,O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12,C20H13N3O2,13299.0
278,Bisindolylmaleimide V,CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O,C21H15N3O2,13300.0
279,RG108,O=C(O)[C@H](Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O,C19H14N2O4,13302.0
280,NSC 663284,O=C1C(Cl)=C(NCCN2CCOCC2)C(=O)c2ncccc21,C15H16ClN3O3,13303.0
281,Biotin-XX hydrazide,NNC(=O)CCCCCNC(=O)CCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C22H40N6O4S,13304.0
282,D 4476,NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1,C23H18N4O3,13305.0
283,NU7026,O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12,C17H15NO3,13308.0
284,H-9 (hydrochloride),Cl.Cl.NCCNS(=O)(=O)c1cccc2cnccc12,C11H15Cl2N3O2S,13312.0
285,Indirubin-3'-monoxime,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O,C16H11N3O2,13314.0
286,Biotin-NHS,O=C1N[C@H]2[C@H](CS[C@H]2CCCCC(=O)ON2C(=O)CCC2=O)N1,C14H19N3O5S,13315.0
287,Biotin-X-NHS,O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)NCCCCCC(=O)ON1C(=O)CCC1=O,C20H30N4O6S,13316.0
288,KN-62,CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12,C38H35N5O6S2,13318.0
289,KN-93,COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1,C26H29ClN2O4S,13319.0
290,MCI-186,CC1=NN(c2ccccc2)C(=O)C1,C10H10N2O,13320.0
291,ARP 100,CC(C)ON(CC(=O)NO)S(=O)(=O)c1ccc(-c2ccccc2)cc1,C17H20N2O5S,13321.0
292,CGP 57380,Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,C11H9FN6,13322.0
293,IM-54,CCCCCNC1=C(c2cn(C)c3ccccc23)C(=O)N(C)C1=O,C19H23N3O2,13323.0
294,Pifithrin-.alpha.,Br.Cc1ccc(C(=O)Cn2c3c(sc2=N)CCCC3)cc1,C16H19BrN2OS,13326.0
295,1-NM-PP1,CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,C20H21N5,13330.0
296,(S)-Glycyl-H-1152 (hydrochloride),Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@@H]3C)c12.Cl.Cl,C18H26Cl2N4O3S,13332.0
297,Bisindolylmaleimide VIII (acetate),CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21,C26H26N4O4,13333.0
298,Bisindolylmaleimide IX (mesylate),CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21,C26H27N5O5S2,13334.0
299,SB 225002,O=C(Nc1ccc([N+](=O)[O-])cc1O)Nc1ccccc1Br,C13H10BrN3O4,13336.0
300,ST638,CCOc1cc(/C=C(/C#N)C(N)=O)cc(CSc2ccccc2)c1O,C19H18N2O3S,13337.0
301,SU6656,CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2,C19H21N3O3S,13338.0
302,TPEN,c1ccc(CN(CCN(Cc2ccccn2)Cc2ccccn2)Cc2ccccn2)nc1,C26H28N6,13340.0
303,LY364947,c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,C17H12N4,13341.0
304,SU 5416,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,C15H14N2O,13342.0
305,SB 203580 (hydrochloride),CS(=O)c1ccc(-c2nc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1.Cl,C21H17ClFN3OS,13344.0
306,GYY 4137,C1COCC[NH2+]1.COc1ccc(P(=S)([S-])N2CCOCC2)cc1,C15H25N2O3PS2,13345.0
307,Rapamycin,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,C51H79NO13,13346.0
308,IBMX,CC(C)Cn1c(=O)n(C)c(=O)c2[nH]cnc21,C10H14N4O2,13347.0
309,Myristic Acid,CCCCCCCCCCCCCC(=O)O,C14H28O2,13351.0
310,Lignoceric Acid,CCCCCCCCCCCCCCCCCCCCCCCC(=O)O,C24H48O2,13353.0
311,Hexacosanoic Acid,CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O,C26H52O2,13354.0
312,Geldanamycin,COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,C29H40N2O9,13355.0
313,CAY10608,CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCc2ccc(Cl)c(Cl)c2)cc1,C18H22Cl2N2O4S,13358.0
314,8-iso Prostaglandin E1,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@H]1CCCCCCC(=O)O,C20H34O5,13360.0
315,Piroxicam,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,C15H13N3O4S,13368.0
316,CAY10621,CCCCCCCCCCCCCC#CC(=O)[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C,C26H45NO4,13371.0
317,"2',3',5'-triacetyl-5-Azacytidine",CC(=O)OC[C@H]1O[C@@H](n2cnc(N)nc2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O,C14H18N4O8,13373.0
318,Atrazine,CCNc1nc(Cl)nc(NC(C)C)n1,C8H14ClN5,13375.0
319,5-bromo-3-phenyl-Salicylic Acid,O=C(O)c1cc(Br)cc(-c2ccccc2)c1O,C13H9BrO3,13379.0
320,CAY10606,CCOC(=O)c1c(Cc2cccc(Cl)c2)[nH]c2c1cc(O)c1ccccc12,C22H18ClNO3,13381.0
321,DAz-2,[N-]=[N+]=NCCCC1CCC(=O)CC1=O,C9H13N3O2,13382.0
322,5-(2-Aminopyridyl)amide oxime,N/C(=N\O)c1ccc(N)nc1,C6H8N4O,13384.0
323,2-Methyl-4-phenylthiazole,Cc1nc(-c2ccccc2)cs1,C10H9NS,13386.0
324,Ethyl 2-Amino-4-phenyl-thiophene-3-Carboxylate,CCOC(=O)c1c(-c2ccccc2)csc1N,C13H13NO2S,13387.0
325,2-amino-4-phenyl Thiazole,Nc1nc(-c2ccccc2)cs1,C9H8N2S,13388.0
326,2-amino Pyridyl-5-thioamide,NC(=S)c1ccc(N)nc1,C6H7N3S,13389.0
327,N-methyl Leukotriene C4,CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](NC(=O)CC[C@H](NC)C(=O)O)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O,C31H49N3O9S,13390.0
328,11.beta.-Prostaglandin E1,CCCCC[C@H](O)/C=C/[C@H]1[C@@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C20H34O5,13450.0
329,AM3102,CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](C)CO,C21H41NO2,13452.0
330,11-deoxy Prostaglandin E1,CCCCC[C@H](O)/C=C/[C@H]1CCC(=O)[C@@H]1CCCCCCC(=O)O,C20H34O4,13510.0
331,PC190723,NC(=O)c1c(F)ccc(OCc2nc3cc(Cl)cnc3s2)c1F,C14H8ClF2N3O2S,13518.0
332,Celastramycin A,CCCCCCc1cc(Cl)c(O)c(C(=O)c2cc(Cl)c(Cl)[nH]2)c1O,C17H18Cl3NO3,13519.0
333,Oxalomalic Acid (sodium salt),O=C(O)C(=O)C(C(=O)O)C(O)C(=O)O.[NaH].[NaH].[NaH],C6H6Na3O8,13521.0
334,(+)-Warfarin,CC(=O)C[C@H](c1ccccc1)c1c(O)c2ccccc2oc1=O,C19H16O4,13526.0
335,Pseudolaric Acid B,COC(=O)C1=CC[C@@]23CC[C@@H]([C@@](C)(/C=C/C=C(\C)C(=O)O)OC2=O)[C@@]3(OC(C)=O)CC1,C23H28O8,13527.0
336,Bicyclo Prostaglandin E1,CCCCC1C(=O)CC[C@H]2[C@@H]1CC(=O)[C@@H]2CCCCCCC(=O)O,C20H32O4,13530.0
337,(-)-Warfarin,CC(=O)C[C@@H](c1ccccc1)c1c(O)c2ccccc2oc1=O,C19H16O4,13531.0
338,17-phenyl trinor Prostaglandin E2 ethyl amide,CCNC(=O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1ccccc1,C25H35NO4,13532.0
339,E-64d,CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C,C17H30N2O5,13533.0
340,FIPI,O=C(NCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1cc2cc(F)ccc2[nH]1,C23H24FN5O2,13563.0
341,N-Benzylacetamidine (hydrobromide),Br.CC(=N)NCc1ccccc1,C9H13BrN2,13570.0
342,3-bromo-5-phenyl-Salicylic Acid,O=C(O)c1cc(-c2ccccc2)cc(Br)c1O,C13H9BrO3,13574.0
343,YM-201636,Nc1ccc(C(=O)Nc2cccc(-c3nc(N4CCOCC4)c4oc5ncccc5c4n3)c2)cn1,C25H21N7O3,13576.0
344,SU 11652,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,C22H27ClN4O2,13577.0
345,Phosphine-biotin,COC(=O)c1ccc(C(=O)NCCCOCCOCCOCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)cc1P(c1ccccc1)c1ccccc1,C41H53N4O8PS,13581.0
346,XAV939,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,C14H11F3N2OS,13596.0
347,IWR-1-exo,O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@@H]3[C@H](C2=O)[C@H]2C=C[C@@H]3C2)cc1,C25H19N3O3,13598.0
348,MK-0457,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,C23H28N8OS,13600.0
349,ZM 447439,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,C29H31N5O4,13601.0
350,S-Adenosylhomocysteine,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC[C@H](N)C(=O)O)[C@@H](O)[C@H]1O,C14H20N6O5S,13603.0
351,"13,14-dihydro Prostaglandin E1",CCCCC[C@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C20H36O5,13610.0
352,CAY10614,CCCCCCCCCCCCCCOc1ccc(C[N+](C)(C)C2CCCC2)cc1OCCCCCCCCCCCCCC.[I-],C42H78INO2,13615.0
353,(R)-Lisofylline,C[C@@H](O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,C13H20N4O3,13616.0
354,(S)-Lisofylline,C[C@H](O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,C13H20N4O3,13617.0
355,Rivenprost,COCc1cccc(C[C@H](O)/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCSCCCC(=O)OC)c1,C24H34O6S,13618.0
356,ACS 67,O=C(CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O)Oc1ccc(-c2cc(=S)ss2)cc1,C32H38O5S3,13619.0
357,AL 6598,CC(C)OC(=O)COC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)C2CCCCC2)[C@H](O)C[C@H]1Cl,C23H39ClO5,13620.0
358,Pristimerin,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(O)=C5C)[C@]4(C)CC[C@@]3(C)C2C1,C30H40O4,13621.0
359,AS-041164,O=C1NC(=O)/C(=C/c2ccc3c(c2)OCO3)S1,C11H7NO4S,13622.0
360,Topiramate,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1,C12H21NO8S,13623.0
361,Icariin,COc1ccc(-c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)cc1,C33H40O15,13624.0
362,Lansoprazole,Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1,C16H14F3N3O2S,13627.0
363,Salidroside,OC[C@H]1O[C@@H](OCCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O,C14H20O7,13628.0
364,"13,14-dihydro-15(R)-Prostaglandin E1",CCCCC[C@@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C20H36O5,13630.0
365,UNC0224,COc1cc2c(NC3CCN(C)CC3)nc(N3CCCN(C)CC3)nc2cc1OCCCN(C)C,C26H43N7O2,13631.0
366,JWH 019,CCCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C25H25NO,13633.0
367,JWH 019 (exempt preparation),CCCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C25H25NO,15664.0
368,JWH 250,CCCCCn1cc(C(=O)Cc2ccccc2OC)c2ccccc21,C22H25NO2,13634.0
369,JWH 250 (exempt preparation),CCCCCn1cc(C(=O)Cc2ccccc2OC)c2ccccc21,C22H25NO2,15662.0
370,JWH 398,CCCCCn1cc(C(=O)c2ccc(Cl)c3ccccc23)c2ccccc21,C24H22ClNO,13636.0
371,JWH 398 (exempt preparation),CCCCCn1cc(C(=O)c2ccc(Cl)c3ccccc23)c2ccccc21,C24H22ClNO,15686.0
372,WZ811,c1ccc(NCc2ccc(CNc3ccccn3)cc2)nc1,C18H18N4,13639.0
373,NVP-AEW541 (hydrochloride),Cl.Cl.Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,C27H31Cl2N5O,13641.0
374,Alendronate (sodium hydrate),NCCCC(O)(P(=O)([O-])O)P(=O)(O)O.O.O.O.[Na+],C4H18NNaO10P2,13642.0
375,Aspalatone,CC(=O)Oc1ccccc1C(=O)Oc1c(C)occc1=O,C15H12O6,13644.0
376,Alfuzosin (hydrochloride),COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC.Cl,C19H28ClN5O4,13648.0
377,"13,14-dihydro-15-keto Prostaglandin E1",CCCCCC(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C20H34O5,13650.0
378,ABT-869,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,C21H18FN5O,13653.0
379,Adapalene,COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2,C28H28O3,13655.0
380,IWR-1-endo,O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@@H]3[C@H](C2=O)[C@@H]2C=C[C@H]3C2)cc1,C25H19N3O3,13659.0
381,"13,14-dihydro-19(R)-hydroxy Prostaglandin E1",C[C@@H](O)CCC[C@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C20H36O6,13660.0
382,YK-4-279,COc1ccc(C(=O)CC2(O)C(=O)Nc3c(Cl)ccc(Cl)c32)cc1,C17H13Cl2NO4,13661.0
383,Arecoline (hydrobromide),Br.COC(=O)C1=CCCN(C)C1,C8H14BrNO2,13662.0
384,Pregabalin,CC(C)C[C@H](CN)CC(=O)O,C8H17NO2,13663.0
385,Pregabalin (CRM),CC(C)C[C@H](CN)CC(=O)O,C8H17NO2,37861.0
386,S32826,CCCCCCCCCCCCCC(=O)Nc1ccc(CP(=O)(O)O)cc1,C21H36NO4P,13664.0
387,YS121,CCCCCCC(Sc1nc(Cl)cc(Nc2cccc(C)c2C)n1)C(=O)O,C20H26ClN3O2S,13665.0
388,Muscimol,NCc1cc(O)no1,C4H6N2O2,13667.0
389,Muscimol (CRM),NCc1cc(O)no1,C4H6N2O2,38030.0
390,JZL 195,O=C(Oc1ccc([N+](=O)[O-])cc1)N1CCN(Cc2cccc(Oc3ccccc3)c2)CC1,C24H23N3O5,13668.0
391,Wortmannin-Rapamycin Conjugate,COC[C@H]1OC(=O)/C(=C/N(C)CCCN(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](OC(=O)CCCCCCC(=O)O[C@@H]5CC[C@@H](C[C@@H](C)[C@@H]6CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)[C@@H](OC)C[C@@H]7CC[C@@H](C)[C@@](O)(O7)C(=O)C(=O)N7CCCC[C@H]7C(=O)O6)C[C@H]5OC)CC[C@@H]34)[C@]21C,C88H131N3O23,13671.0
392,ZK 118182 isopropyl ester,CC(C)OC(=O)COC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)C2CCCCC2)[C@H](O)C[C@H]1Cl,C23H37ClO5,13673.0
393,"13,14-epoxy Fluprostenol Isopropyl Ester",CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](C2OC2[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C26H35F3O7,13679.0
394,15-keto Prostaglandin E1,CCCCCC(=O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C20H32O5,13680.0
395,Chidamide,Nc1cc(F)ccc1NC(=O)c1ccc(CNC(=O)/C=C/c2cccnc2)cc1,C22H19FN4O2,13686.0
396,CAY10638,O=C1NC(=O)/C(=C/c2ccc(OCCc3cccs3)cc2)S1,C16H13NO3S2,13695.0
397,(R)-MG132,CC(C)C[C@@H](C=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,C26H41N3O5,13697.0
398,15(R)-Prostaglandin E1,CCCCC[C@@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C20H34O5,13710.0
399,15(S)-15-methyl Prostaglandin E1,CCCCC[C@](C)(O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C21H36O5,13730.0
400,Butaprost,CCCC1([C@@H](O)C/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)OC)CCC1,C24H40O5,13740.0
401,Butaprost (free acid),CCCC1([C@@H](O)C/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)CCC1,C23H38O5,13741.0
402,(R)-Butaprost,CCCC1([C@H](O)C/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)OC)CCC1,C24H40O5,13745.0
403,CAY10408,CCCC1([C@H](O)C/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2C/C=C\CCCC(=O)O)CCC1,C23H36O5,13747.0
404,"16,16-dimethyl Prostaglandin E1",CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C22H38O5,13750.0
405,OU749,COc1ccc(Cc2nnc(NS(=O)(=O)c3ccccc3)s2)cc1,C16H15N3O3S2,13804.0
406,Limaprost,CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)O,C22H36O5,13810.0
407,17.beta.-hydroxy Wortmannin,COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CC[C@H](O)[C@@]2(C)C[C@H]1OC(C)=O,C23H26O8,13812.0
408,Axitinib,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,C22H18N4OS,13813.0
409,Misoprostol,CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,C22H38O5,13820.0
410,11.beta.-Misoprostol,CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,C22H38O5,13825.0
411,Misoprostol (free acid),CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C21H36O5,13821.0
412,AX 048,CCCCCCCCCCCCCCC(=O)C(=O)NCCCC(=O)OCC,C22H41NO4,13823.0
413,trans-Resveratrol-3-O-.beta.-D-Glucuronide,O=C(O)[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,C20H20O9,13832.0
414,CAY10625,CCCCCCCCn1c2nc(=O)n(-c3ccccc3)c(=O)c-2cc2cc([N+](=O)[O-])ccc21,C25H26N4O4,13836.0
415,CAY10626,CN(C)CCN(C)C(=O)c1ccc(NC(=O)Nc2ccc(-c3nc(N4CCOCC4)c4ccn(CC(F)(F)F)c4n3)cc2)cc1,C31H35F3N8O3,13838.0
416,19(R)-hydroxy Prostaglandin E1,C[C@@H](O)CCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C20H34O6,13910.0
417,Prostaglandin E2,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,14010.0
418,Prostaglandin E2 methyl ester,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)OC,C21H34O5,14011.0
419,Prostaglandin E2 Ethanolamide,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)NCCO,C22H37NO5,14012.0
420,AH 6809,CC(C)Oc1ccc2c(=O)c3cc(C(=O)O)ccc3oc2c1,C17H14O5,14050.0
421,Prostaglandin E2 p-acetamidophenyl ester,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)Oc1ccc(NC(C)=O)cc1,C28H39NO6,14053.0
422,Prostaglandin E2 p-benzamidophenyl ester,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)Oc1ccc(NC(=O)c2ccccc2)cc1,C33H41NO6,14054.0
423,SC-19220,CC(=O)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,C16H14ClN3O3,14060.0
424,5-trans Prostaglandin E2,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C/CCCC(=O)O,C20H32O5,14210.0
425,8-iso Prostaglandin E2,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@H]1C/C=C\CCCC(=O)O,C20H32O5,14350.0
426,8-iso Prostaglandin E2 isopropyl ester,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@H]1C/C=C\CCCC(=O)OC(C)C,C23H38O5,14352.0
427,8-iso-15-keto Prostaglandin E2,CCCCCC(=O)/C=C/[C@H]1[C@H](O)CC(=O)[C@H]1C/C=C\CCCC(=O)O,C20H30O5,14390.0
428,9-deoxy-9-methylene Prostaglandin E2,C=C1C[C@@H](O)[C@H](/C=C/[C@@H](O)CCCCC)[C@H]1C/C=C\CCCC(=O)O,C21H34O4,14410.0
429,"9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2",C=C1C[C@@H](O)[C@H](/C=C/[C@@H](O)C(C)(C)CCCC)[C@H]1C/C=C\CCCC(=O)O,C23H38O4,14420.0
430,11.beta.-Prostaglandin E2,CCCCC[C@H](O)/C=C/[C@H]1[C@@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,14510.0
431,11-deoxy Prostaglandin E2,CCCCC[C@H](O)/C=C/[C@H]1CCC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O4,14520.0
432,Bicyclo Prostaglandin E2,CCCCC1C(=O)CC[C@H]2[C@@H]1CC(=O)[C@@H]2C/C=C\CCCC(=O)O,C20H30O4,14530.0
433,"11-deoxy-16,16-dimethyl Prostaglandin E2",CCCCC(C)(C)[C@H](O)/C=C/[C@H]1CCC(=O)[C@@H]1C/C=C\CCCC(=O)O,C22H36O4,14570.0
434,"13,14-dihydro-15-keto Prostaglandin E2",CCCCCC(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,14650.0
435,15(R)-Prostaglandin E2,CCCCC[C@@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,14710.0
436,15-keto Prostaglandin E2,CCCCCC(=O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H30O5,14720.0
437,15(R)-15-methyl Prostaglandin E2,CCCCC[C@@](C)(O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C21H34O5,14725.0
438,15(S)-15-methyl Prostaglandin E2,CCCCC[C@](C)(O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C21H34O5,14730.0
439,"16,16-dimethyl Prostaglandin E2",CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C22H36O5,14750.0
440,"16,16-dimethyl Prostaglandin E2 p-(p-acetamidobenzamido) phenyl ester",CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)Oc1ccc(NC(=O)c2ccc(NC(C)=O)cc2)cc1,C37H48N2O7,14753.0
441,16-phenoxy tetranor Prostaglandin E2,O=C(O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1ccccc1,C22H28O6,14760.0
442,Sulprostone,CS(=O)(=O)NC(=O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1ccccc1,C23H31NO7S,14765.0
443,17-phenyl trinor Prostaglandin E2,O=C(O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1ccccc1,C23H30O5,14810.0
444,tetranor-PGEM,O=C(O)CCCCC(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCC(=O)O,C16H24O7,14840.0
445,19(R)-hydroxy Prostaglandin E2,C[C@@H](O)CCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O6,14910.0
446,20-ethyl Prostaglandin E2,CCCCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C22H36O5,14940.0
447,20-hydroxy Prostaglandin E2,O=C(O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCCCCO,C20H32O6,14950.0
448,Prostaglandin E3,CC/C=C\C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H30O5,14990.0
449,17-trans Prostaglandin E3,CC/C=C/C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H30O5,14995.0
450,Prostaglandin F1.alpha.,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](CCCCCCC(=O)O)[C@@H](O)C[C@H]1O,C20H36O5,15010.0
451,Prostaglandin F1.alpha. Alcohol,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](CCCCCCCO)[C@@H](O)C[C@H]1O,C20H38O4,15020.0
452,3-methoxy Prostaglandin F1.alpha.,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](CCCCC(CC(=O)O)OC)[C@@H](O)C[C@H]1O,C21H38O6,15170.0
453,6-keto Prostaglandin F1.alpha.,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](CC(=O)CCCCC(=O)O)[C@@H](O)C[C@H]1O,C20H34O6,15210.0
454,.DELTA.17-6-keto Prostaglandin F1.alpha.,CC/C=C\C[C@H](O)/C=C/[C@@H]1[C@@H](CC(=O)CCCCC(=O)O)[C@@H](O)C[C@H]1O,C20H32O6,15230.0
455,"6,15-diketo-13,14-dihydro Prostaglandin F1.alpha.",CCCCCC(=O)CC[C@@H]1[C@@H](CC(=O)CCCCC(=O)O)[C@@H](O)C[C@H]1O,C20H34O6,15270.0
456,8-iso Prostaglandin F1.alpha.,CCCCC[C@H](O)/C=C/[C@@H]1[C@H](CCCCCCC(=O)O)[C@@H](O)C[C@H]1O,C20H36O5,15350.0
457,8-iso Prostaglandin F1.beta.,CCCCC[C@H](O)/C=C/[C@@H]1[C@H](CCCCCCC(=O)O)[C@H](O)C[C@H]1O,C20H36O5,15370.0
458,Prostaglandin F1.beta.,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](CCCCCCC(=O)O)[C@H](O)C[C@H]1O,C20H36O5,15410.0
459,11.beta.-Prostaglandin F1.beta.,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](CCCCCCC(=O)O)[C@H](O)C[C@@H]1O,C20H36O5,15450.0
460,11-deoxy Prostaglandin F1.beta.,CCCCC[C@H](O)/C=C/[C@H]1CC[C@@H](O)[C@@H]1CCCCCCC(=O)O,C20H36O4,15510.0
461,11-deoxy Prostaglandin F1.alpha.,CCCCC[C@H](O)/C=C/[C@H]1CC[C@H](O)[C@@H]1CCCCCCC(=O)O,C20H36O4,15512.0
462,"13,14-dihydro Prostaglandin F1.alpha.",CCCCC[C@H](O)CC[C@@H]1[C@@H](CCCCCCC(=O)O)[C@@H](O)C[C@H]1O,C20H38O5,15610.0
463,"13,14-dihydro-15-keto Prostaglandin F1.alpha.",CCCCCC(=O)CC[C@@H]1[C@@H](CCCCCCC(=O)O)[C@@H](O)C[C@H]1O,C20H36O5,15670.0
464,15-keto Prostaglandin F1.alpha.,CCCCCC(=O)/C=C/[C@@H]1[C@@H](CCCCCCC(=O)O)[C@@H](O)C[C@H]1O,C20H34O5,15710.0
465,"17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F1.alpha.",O=C(O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)CCc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C24H35F3O5,15895.0
466,19(R)-hydroxy Prostaglandin F1.alpha.,C[C@@H](O)CCC[C@H](O)/C=C/[C@@H]1[C@@H](CCCCCCC(=O)O)[C@@H](O)C[C@H]1O,C20H36O6,15910.0
467,Prostaglandin F2.alpha.,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H34O5,16010.0
468,Prostaglandin F2.alpha. methyl ester,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)[C@@H](O)C[C@H]1O,C21H36O5,16011.0
469,Prostaglandin F2.alpha. Alcohol,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCCO)[C@@H](O)C[C@H]1O,C20H36O4,16012.0
470,Prostaglandin F2.alpha. Ethanolamide,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)NCCO)[C@@H](O)C[C@H]1O,C22H39NO5,16013.0
471,Prostaglandin F2.alpha. Alcohol methyl ether,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCCOC)[C@@H](O)C[C@H]1O,C21H38O4,16014.0
472,Prostaglandin F2.alpha. ethyl amide,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)NCC)[C@@H](O)C[C@H]1O,C22H39NO4,16016.0
473,Prostaglandin F2.alpha. (tromethamine salt),CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)[O-])[C@@H](O)C[C@H]1O.[NH3+]C(CO)(CO)CO,C24H45NO8,16020.0
474,Prostaglandin F2.alpha. isopropyl ester,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC(C)C)[C@@H](O)C[C@H]1O,C23H40O5,16030.0
475,Prostaglandin F2.alpha. dimethyl amide,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)N(C)C)[C@@H](O)C[C@H]1O,C22H39NO4,16032.0
476,Prostaglandin F2.alpha. dimethyl amine,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCCN(C)C)[C@@H](O)C[C@H]1O,C22H41NO3,16033.0
477,"1a,1b-dihomo Prostaglandin F2.alpha.",CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCCCC(=O)O)[C@@H](O)C[C@H]1O,C22H38O5,16050.0
478,"Prostaglandin F2.alpha. 1,11-lactone",CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C=C\CCCC(=O)O[C@@H]1C[C@@H]2O,C20H32O4,16110.0
479,"Prostaglandin F2.alpha. 1,15-lactone",CCCCC[C@H]1/C=C/[C@@H]2[C@@H](C/C=C\CCCC(=O)O1)[C@@H](O)C[C@H]2O,C20H32O4,16120.0
480,"Prostaglandin F2.alpha. 1,9-lactone",CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C=C\CCCC(=O)O[C@H]2C[C@H]1O,C20H32O4,16130.0
481,5-trans Prostaglandin F2.alpha.,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C/CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H34O5,16210.0
482,5-trans Prostaglandin F2.alpha. (tromethamine salt),CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C/CCCC(=O)[O-])[C@@H](O)C[C@H]1O.[NH3+]C(CO)(CO)CO,C24H45NO8,16220.0
483,5-trans Prostaglandin F2.beta.,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C/CCCC(=O)O)[C@H](O)C[C@H]1O,C20H34O5,16250.0
484,"2,3-dinor-8-iso Prostaglandin F2.alpha.",CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CC(=O)O)[C@@H](O)C[C@H]1O,C18H30O5,16290.0
485,8-iso Prostaglandin F2.alpha.,CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H34O5,16350.0
486,8-iso Prostaglandin F2.beta.,CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@H](O)C[C@H]1O,C20H34O5,16370.0
487,"8-iso-13,14-dihydro-15-keto Prostaglandin F2.alpha.",CCCCCC(=O)CC[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H34O5,16380.0
488,8-iso-15-keto Prostaglandin F2.alpha.,CCCCCC(=O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H32O5,16390.0
489,Prostaglandin F2.beta.,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@H](O)C[C@H]1O,C20H34O5,16410.0
490,Prostaglandin F2.beta. (tromethamine salt),CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)[O-])[C@H](O)C[C@H]1O.[NH3+]C(CO)(CO)CO,C24H45NO8,16420.0
491,U-44069,CCCCC[C@H](O)/C=C/[C@H]1C2COC(C2)[C@@H]1C/C=C\CCCC(=O)O,C21H34O4,16440.0
492,5-trans U-44069,CCCCC[C@H](O)/C=C/[C@H]1C2COC(C2)[C@@H]1C/C=C/CCCC(=O)O,C21H34O4,16442.0
493,U-46619,CCCCC[C@H](O)/C=C/[C@H]1C2CC(CO2)[C@@H]1C/C=C\CCCC(=O)O,C21H34O4,16450.0
494,5-trans U-46619,CCCCC[C@H](O)/C=C/[C@H]1C2CC(CO2)[C@@H]1C/C=C/CCCC(=O)O,C21H34O4,16452.0
495,U-51605,CCCCCC/C=C/[C@H]1C2CC(N=N2)[C@@H]1C/C=C\CCCC(=O)O,C20H32N2O2,16465.0
496,11-deoxy Prostaglandin F2.alpha.,CCCCC[C@H](O)/C=C/[C@H]1CC[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H34O4,16500.0
497,11-deoxy Prostaglandin F2.beta.,CCCCC[C@H](O)/C=C/[C@H]1CC[C@@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H34O4,16510.0
498,11.beta.-Prostaglandin F2.alpha.,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@@H]1O,C20H34O5,16520.0
499,11.beta.-Prostaglandin F2.alpha. Ethanolamide,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)NCCO)[C@@H](O)C[C@@H]1O,C22H39NO5,16522.0
500,"2,3-dinor-11.beta.-Prostaglandin F2.alpha.",CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CC(=O)O)[C@@H](O)C[C@@H]1O,C18H30O5,16530.0
501,"11.beta.-13,14-dihydro-15-keto Prostaglandin F2.alpha.",CCCCCC(=O)CC[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@@H]1O,C20H34O5,16540.0
502,"13,14-dihydro Prostaglandin F2.alpha.",CCCCC[C@H](O)CC[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H36O5,16660.0
503,Unoprostone,CCCCCCCC(=O)CC[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C22H38O5,16680.0
504,Lumula,CCCCCCCC(=O)CC[C@@H]1[C@@H](C/C=C\CCCC(=O)NCC)[C@@H](O)C[C@H]1O,C24H43NO4,16685.0
505,15-keto Prostaglandin F2.alpha.,CCCCCC(=O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H32O5,16720.0
506,15(R)-15-methyl Prostaglandin F2.alpha.,CCCCC[C@@](C)(O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C21H36O5,16730.0
507,15(R)-15-methyl Prostaglandin F2.alpha. methyl ester,CCCCC[C@@](C)(O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)[C@@H](O)C[C@H]1O,C22H38O5,16734.0
508,AL 8810,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@H](O)C2Cc3ccccc3C2)[C@@H](F)C[C@@H]1O,C24H31FO4,16735.0
509,15(R)-Prostaglandin F2.alpha.,CCCCC[C@@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H34O5,16740.0
510,15(S)-15-methyl Prostaglandin F2.alpha.,CCCCC[C@](C)(O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C21H36O5,16743.0
511,15(S)-15-methyl Prostaglandin F2.alpha. methyl ester,CCCCC[C@](C)(O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)[C@@H](O)C[C@H]1O,C22H38O5,16744.0
512,"16,16-dimethyl Prostaglandin F2.alpha.",CCCCC(C)(C)[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C22H38O5,16750.0
513,16-phenoxy tetranor Prostaglandin F2.alpha.,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2ccccc2)[C@H](O)C[C@@H]1O,C22H30O6,16760.0
514,(+)-Cloprostenol,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,C22H29ClO6,16765.0
515,(+)-Cloprostenol (sodium salt),O=C([O-])CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O.[Na+],C22H28ClNaO6,16766.0
516,Fluprostenol,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C23H29F3O6,16768.0
517,(+)-Fluprostenol isopropyl ester,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C26H35F3O6,16769.0
518,16-phenyl tetranor Prostaglandin F2.alpha.,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)Cc2ccccc2)[C@H](O)C[C@@H]1O,C22H30O5,16770.0
519,5-trans Fluprostenol,O=C(O)CCC/C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C23H29F3O6,16776.0
520,5-trans Fluprostenol isopropyl ester,CC(C)OC(=O)CCC/C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C26H35F3O6,16777.0
521,9-keto Fluprostenol,O=C(O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1,C23H27F3O6,16781.0
522,9-keto Fluprostenol isopropyl ester,CC(C)OC(=O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1,C26H33F3O6,16782.0
523,11-keto Fluprostenol,O=C(O)CCC/C=C\C[C@H]1[C@@H](O)CC(=O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1,C23H27F3O6,16783.0
524,15-keto Fluprostenol isopropyl ester,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C(=O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C26H33F3O6,16786.0
525,15(S)-Fluprostenol,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C23H29F3O6,16787.0
526,15(S)-Fluprostenol isopropyl ester,CC.O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C25H35F3O6,16788.0
527,Bimatoprost (free acid),O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C23H32O5,16810.0
528,Latanoprost (free acid),O=C(O)CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C23H34O5,16811.0
529,Latanoprost,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C26H40O5,16812.0
530,5-trans Latanoprost,CC(C)OC(=O)CCC/C=C/C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C26H40O5,16813.0
531,15(R)-17-phenyl trinor Prostaglandin F2.alpha.,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C23H32O5,16814.0
532,15-keto Latanoprost (free acid),O=C(O)CCC/C=C\C[C@@H]1[C@@H](CCC(=O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C23H32O5,16815.0
533,15-keto Latanoprost,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](CCC(=O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C26H38O5,16816.0
534,15-keto-17-phenyl trinor Prostaglandin F2.alpha.,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C(=O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C23H30O5,16817.0
535,15(S)-Latanoprost,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](CC[C@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C26H40O5,16818.0
536,Bimatoprost,CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C25H37NO4,16820.0
537,Bimatoprost amide,NC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C23H33NO4,16821.0
538,Latanoprost ethyl amide,CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C25H39NO4,16822.0
539,Bimatoprost diethyl amide,CCN(CC)C(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C27H41NO4,16823.0
540,Bimatoprost isopropyl ester,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C26H38O5,16824.0
541,15(R)-17-phenyl trinor Prostaglandin F2.alpha. isopropyl ester,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C26H38O5,16825.0
542,N-undecanoyl-L-Homoserine lactone,CCCCCCCCCCC(=O)N[C@H]1CCOC1=O,C15H27NO3,16827.0
543,Lisinopril,NCCCCC(N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O,C21H31N3O5,16833.0
544,Hexadecanal-d5,[2H]C([2H])([2H])C([2H])([2H])CCCCCCCCCCCCCC=O,C16H32O,16834.0
545,CAY10580,CCCCCC(O)CCC1CCC(=O)N1CCCCCCC(=O)O,C19H35NO4,16835.0
546,.beta.-Carotene,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)C(C)(C)CCC1,C40H56,16837.0
547,CAY10581,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)[C@H](NCc2ccccc2)[C@@H]1O,C22H21NO4,16838.0
548,tetranor-PGFM,O=C(O)CCCCC(=O)CC[C@@H]1[C@@H](CCC(=O)O)[C@@H](O)C[C@H]1O,C16H26O7,16840.0
549,NBD-FTY720 phenoxy (hydrochloride),Cl.NC(CO)(CO)CCc1ccc(OCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1,C23H32ClN5O6,16841.0
550,LED209,O=S(=O)(Nc1ccccc1)c1ccc(NC(=S)Nc2ccccc2)cc1,C19H17N3O2S2,16844.0
551,"13,14-dihydro-15-keto-tetranor Prostaglandin F1.beta.",CCCCCC(=O)CC[C@@H]1[C@@H](CCC(=O)O)[C@H](O)C[C@H]1O,C16H28O5,16853.0
552,"Eicosadienoic Acid (8Z,14Z)",CCCCC/C=C\CCCC/C=C\CCCCCCC(=O)O,C20H36O2,16854.0
553,Swainsonine,O[C@H]1[C@H]2[C@H](O)CCCN2C[C@H]1O,C8H15NO3,16860.0
554,N-nonanoyl-L-Homoserine lactone,CCCCCCCCC(=O)N[C@H]1CCOC1=O,C13H23NO3,16868.0
555,17-trifluoromethylphenyl trinor Prostaglandin F2.alpha.,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C24H31F3O5,16890.0
556,"17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2.alpha.",O=C(O)CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C24H33F3O5,16895.0
557,19(R)-hydroxy Prostaglandin F2.alpha.,C[C@@H](O)CCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H34O6,16910.0
558,"15(R),19(R)-hydroxy Prostaglandin F2.alpha.",C[C@@H](O)CCC[C@@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H34O6,16920.0
559,20-ethyl Prostaglandin F2.alpha.,CCCCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C22H38O5,16940.0
560,20-hydroxy Prostaglandin F2.alpha.,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCCO)[C@H](O)C[C@@H]1O,C20H34O6,16950.0
561,Prostaglandin F3.alpha.,CC/C=C\C[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H32O5,16990.0
562,8-iso Prostaglandin F3.alpha.,CC/C=C\C[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H32O5,16992.0
563,17-trans Prostaglandin F3.alpha.,CC/C=C/C[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H32O5,16995.0
564,Prostaglandin G2,CCCCC[C@@H](/C=C/[C@H]1C2CC(OO2)[C@@H]1C/C=C\CCCC(=O)O)OO,C20H32O6,17010.0
565,Prostaglandin H1,CCCCC[C@H](O)/C=C/[C@H]1C2CC(OO2)[C@@H]1CCCCCCC(=O)O,C20H34O5,17015.0
566,Prostaglandin H2,CCCCC[C@H](O)/C=C/[C@H]1C2CC(OO2)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,17020.0
567,6.alpha.-Prostaglandin I1,CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C[C@@H](CCCCC(=O)O)O[C@H]2C[C@H]1O,C20H34O5,18110.0
568,YM-53601,Cl.F/C(COc1ccc2c(c1)[nH]c1ccccc12)=C1/CN2CCC1CC2,C21H22ClFN2O,18113.0
569,6.beta.-Prostaglandin I1,CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C[C@H](CCCCC(=O)O)O[C@H]2C[C@H]1O,C20H34O5,18120.0
570,Carbaprostacyclin,CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O,C21H34O4,18210.0
571,5-cis Carbaprostacyclin,CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C\CCCC(=O)O)C[C@H]2C[C@H]1O,C21H34O4,18211.0
572,"13,14-dehydro-15-cyclohexyl Carbaprostacyclin",O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](C#CC3(O)CCCCC3)[C@H]2C1,C21H30O4,18212.0
573,Iloprost,CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O,C22H32O4,18215.0
574,Ciprostene (calcium salt),CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@]2(C)C/C(=C\CCCC(=O)[O-])C[C@H]12.CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@]2(C)C/C(=C\CCCC(=O)[O-])C[C@H]12.[Ca+2],C44H70CaO8,18216.0
575,PHA-767491 (hydrochloride),Cl.O=C1NCCc2[nH]c(-c3ccncc3)cc21,C12H12ClN3O,18218.0
576,Prostaglandin I2 (sodium salt),CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)[O-])O[C@H]2C[C@H]1O.[Na+],C20H31NaO5,18220.0
577,Piriprost (potassium salt),CCCCC[C@H](O)/C=C/[C@@H]1c2cc(CCCCC(=O)[O-])n(-c3ccccc3)c2C[C@H]1O.[K+],C26H34KNO4,18228.0
578,Beraprost (sodium salt),CC#CCC(C)[C@H](O)/C=C/C1[C@H](O)C[C@@H]2Oc3c(CCCC(=O)[O-])cccc3[C@H]12.[Na+],C24H29NaO5,18230.0
579,Prostaglandin I3 (sodium salt),CC/C=C\C[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)[O-])O[C@H]2C[C@H]1O.[Na+],C20H29NaO5,18300.0
580,Prostaglandin J2,CCCCC[C@H](O)/C=C/[C@H]1C(=O)C=C[C@@H]1C/C=C\CCCC(=O)O,C20H30O4,18500.0
581,.DELTA.12-Prostaglandin J2,CCCCC[C@H](O)C/C=C1/C(=O)C=C[C@@H]1C/C=C\CCCC(=O)O,C20H30O4,18550.0
582,"15-deoxy-.DELTA.12,14-Prostaglandin J2",CCCCC/C=C/C=C1/C(=O)C=C[C@@H]1C/C=C\CCCC(=O)O,C20H28O3,18570.0
583,(-)-Nutlin-3,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,C30H30Cl2N4O4,18585.0
584,CAY10410,CCCCC/C=C\C=C1\C(=O)CC[C@@H]1C/C=C\CCCC(=O)O,C20H30O3,18590.0
585,Prostaglandin K1,CCCCC[C@H](O)/C=C/[C@H]1C(=O)CC(=O)[C@@H]1CCCCCCC(=O)O,C20H32O5,18800.0
586,Prostaglandin K2,CCCCC[C@H](O)/C=C/[C@H]1C(=O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H30O5,18900.0
587,Pinane Thromboxane A2,CCCCC[C@H](O)/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)C2(C)C,C24H40O3,19020.0
588,I-SAP,CC1(C)[C@H]2C[C@H](NS(=O)(=O)c3ccc(I)cc3)[C@@H](C/C=C\CCCC(=O)O)[C@@H]1C2,C22H30INO4S,19021.0
589,AH 23848 (calcium salt),O=C([O-])CC/C=C\CC[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC(=O)[C@@H]1N1CCOCC1.O=C([O-])CC/C=C\CC[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC(=O)[C@@H]1N1CCOCC1.[Ca+2],C58H68CaN2O10,19023.0
590,"SQ 29,548",O=C(O)CCC/C=C\CC1C2CCC(O2)C1CNNC(=O)Nc1ccccc1,C21H29N3O4,19025.0
591,Thromboxane B2,CCCCC[C@H](O)/C=C/[C@H]1OC(O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H34O6,19030.0
592,"2,3-dinor Thromboxane B2",CCCCC[C@H](O)/C=C/[C@H]1OC(O)C[C@H](O)[C@@H]1C/C=C\CC(=O)O,C18H30O6,19050.0
593,11-dehydro Thromboxane B2,CCCCC[C@H](O)/C=C/[C@H]1OC(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O6,19500.0
594,"11-dehydro-2,3-dinor Thromboxane B2",CCCCC[C@H](O)/C=C/[C@H]1OC(=O)C[C@H](O)[C@@H]1C/C=C\CC(=O)O,C18H28O6,19510.0
595,I-BOP,O=C(O)CCC/C=C\C[C@H]1C2CCC(O2)[C@@H]1/C=C/[C@@H](O)COc1ccc(I)cc1,C23H29IO5,19600.0
596,Leukotriene A3 methyl ester,CCCCCCCC/C=C\C=C\C=C\[C@@H]1O[C@H]1CCCC(=O)OC,C21H34O3,20009.0
597,Leukotriene A4 methyl ester,CCCCC/C=C\C/C=C\C=C\C=C\[C@@H]1O[C@H]1CCCC(=O)OC,C21H32O3,20010.0
598,Leukotriene B3,CCCCCCCC[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)O,C20H34O4,20109.0
599,Leukotriene B4,CCCCC/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)O,C20H32O4,20110.0
600,Leukotriene B4 Ethanolamide,CCCCC/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)NCCO,C22H37NO4,20112.0
601,Leukotriene B4-3-aminopropylamide,CCCCC/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)NCCCN,C23H40N2O3,20114.0
602,Leukotriene B4 dimethyl amide,CCCCC/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)N(C)C,C22H37NO3,20115.0
603,12-epi Leukotriene B4,CCCCC/C=C\C[C@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)O,C20H32O4,20135.0
604,12-oxo Leukotriene B4,CCCCC/C=C\CC(=O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)O,C20H30O4,20140.0
605,"14,15-dehydro Leukotriene B4",CCCCCC#CC[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)O,C20H30O4,20150.0
606,18-carboxy dinor Leukotriene B4,O=C(O)CC/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)O,C18H26O6,20170.0
607,20-carboxy Leukotriene B4,O=C(O)CCCC/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)O,C20H30O6,20180.0
608,20-hydroxy Leukotriene B4,O=C(O)CCC[C@H](O)/C=C\C=C\C=C\[C@H](O)C/C=C\CCCCCO,C20H32O5,20190.0
609,Leukotriene C4,CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O,C30H47N3O9S,20210.0
610,11-trans Leukotriene C4,CCCCC/C=C\C/C=C/C=C/C=C/[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O,C30H47N3O9S,20230.0
611,Leukotriene D4,CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](N)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O,C25H40N2O6S,20310.0
612,11-trans Leukotriene D4,CCCCC/C=C\C/C=C/C=C/C=C/[C@@H](SC[C@H](N)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O,C25H40N2O6S,20330.0
613,Leukotriene E4,CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](N)C(=O)O)[C@@H](O)CCCC(=O)O,C23H37NO5S,20410.0
614,N-acetyl Leukotriene E4,CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](NC(C)=O)C(=O)O)[C@@H](O)CCCC(=O)O,C25H39NO6S,20420.0
615,11-trans Leukotriene E4,CCCCC/C=C\C/C=C/C=C/C=C/[C@@H](SC[C@H](N)C(=O)O)[C@@H](O)CCCC(=O)O,C23H37NO5S,20430.0
616,Leukotriene F4,CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)O)[C@@H](O)CCCC(=O)O,C28H44N2O8S,20520.0
617,12(S)-hydroxy-16-Heptadecynoic Acid,C#CCCC[C@@H](O)CCCCCCCCCCC(=O)O,C17H30O3,31570.0
618,4-hydroxy Hexenal,CCC(O)/C=C/C=O,C6H10O2,32060.0
619,4-hydroxy Nonenal,CCCCCC(O)/C=C/C=O,C9H16O2,32100.0
620,4-hydroxy Nonenal Mercapturic Acid,CCCCCC1OC(O)CC1SC[C@H](NC(C)=O)C(=O)O,C14H25NO5S,32110.0
621,5(S)-HEPE,CC/C=C\C/C=C\C/C=C\C/C=C\C=C\[C@@H](O)CCCC(=O)O,C20H30O3,32210.0
622,8(S)-HEPE,CC/C=C\C/C=C\C/C=C\C=C\[C@@H](O)C/C=C\CCCC(=O)O,C20H30O3,32350.0
623,9(S)-HEPE,CC/C=C\C/C=C\C/C=C\C[C@H](O)/C=C/C=C\CCCC(=O)O,C20H30O3,32410.0
624,11(R)-HEPE,CC/C=C\C/C=C\C=C\[C@H](O)C/C=C\C/C=C\CCCC(=O)O,C20H30O3,32505.0
625,11(S)-HEPE,CC/C=C\C/C=C\C=C\[C@@H](O)C/C=C\C/C=C\CCCC(=O)O,C20H30O3,32510.0
626,12(R)-HEPE,CC/C=C\C/C=C\C[C@@H](O)/C=C/C=C\C/C=C\CCCC(=O)O,C20H30O3,32545.0
627,12(S)-HEPE,CC/C=C\C/C=C\C[C@H](O)/C=C/C=C\C/C=C\CCCC(=O)O,C20H30O3,32550.0
628,15(S)-HEPE,CC/C=C\C[C@H](O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H30O3,32710.0
629,5(R)-HETE,CCCCC/C=C\C/C=C\C/C=C\C=C\[C@H](O)CCCC(=O)O,C20H32O3,34225.0
630,5(S)-HETE,CCCCC/C=C\C/C=C\C/C=C\C=C\[C@@H](O)CCCC(=O)O,C20H32O3,34230.0
631,5(S)-HETE lactone,CCCCC/C=C\C/C=C\C/C=C\C=C\[C@@H]1CCCC(=O)O1,C20H30O2,34240.0
632,5-OxoETE,CCCCC/C=C\C/C=C\C/C=C\C=C\C(=O)CCCC(=O)O,C20H30O3,34250.0
633,8(R)-HETE,CCCCC/C=C\C/C=C\C=C\[C@H](O)C/C=C\CCCC(=O)O,C20H32O3,34350.0
634,8(S)-HETE,CCCCC/C=C\C/C=C\C=C\[C@@H](O)C/C=C\CCCC(=O)O,C20H32O3,34360.0
635,9(R)-HETE,CCCCC/C=C\C/C=C\C[C@@H](O)/C=C/C=C\CCCC(=O)O,C20H32O3,34405.0
636,9(S)-HETE,CCCCC/C=C\C/C=C\C[C@H](O)/C=C/C=C\CCCC(=O)O,C20H32O3,34410.0
637,11(R)-HETE,CCCCC/C=C\C=C\[C@H](O)C/C=C\C/C=C\CCCC(=O)O,C20H32O3,34505.0
638,11(S)-HETE,CCCCC/C=C\C=C\[C@@H](O)C/C=C\C/C=C\CCCC(=O)O,C20H32O3,34510.0
639,12(R)-HETE,CCCCC/C=C\C[C@@H](O)/C=C/C=C\C/C=C\CCCC(=O)O,C20H32O3,34560.0
640,tetranor-12(R)-HETE,CCCCC/C=C\C[C@@H](O)/C=C/C=C\CCC(=O)O,C16H26O3,34565.0
641,12(S)-HETE,CCCCC/C=C\C[C@H](O)/C=C/C=C\C/C=C\CCCC(=O)O,C20H32O3,34570.0
642,12-OxoETE,CCCCC/C=C\CC(=O)/C=C/C=C\C/C=C\CCCC(=O)O,C20H30O3,34580.0
643,12(S)-HHTrE,CCCCC[C@H](O)/C=C/C=C/C/C=C\CCCC(=O)O,C17H28O3,34590.0
644,15(R)-HETE,CCCCC[C@@H](O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O3,34710.0
645,15(R)-HEDE,CCCCC[C@@H](O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O3,37710.0
646,15(S)-HETE,CCCCC[C@H](O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O3,34720.0
647,15(S)-HETE-biotin,CCCCC[C@H](O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)NNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C30H48N4O4S,34722.0
648,15-OxoETE,CCCCCC(=O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H30O3,34730.0
649,"5(S),6(R)-DiHETE",CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)CCCC(=O)O,C20H32O4,35200.0
650,6-trans Leukotriene B4,CCCCC/C=C\C[C@@H](O)/C=C/C=C/C=C/[C@@H](O)CCCC(=O)O,C20H32O4,35250.0
651,6-trans-12-epi Leukotriene B4,CCCCC/C=C\C[C@H](O)/C=C/C=C/C=C/[C@@H](O)CCCC(=O)O,C20H32O4,35265.0
652,"5(S),15(S)-DiHETE",CCCCC[C@H](O)/C=C/C=C\C/C=C\C=C\[C@@H](O)CCCC(=O)O,C20H32O4,35280.0
653,"8(S),15(S)-DiHETE",CCCCC[C@H](O)/C=C/C=C\C=C\[C@@H](O)C/C=C\CCCC(=O)O,C20H32O4,35370.0
654,5(S)-HETrE,CCCCCCCC/C=C\C/C=C\C=C\[C@@H](O)CCCC(=O)O,C20H34O3,36230.0
655,8(S)-HETrE,CCCCC/C=C\C/C=C\C=C\[C@@H](O)CCCCCCC(=O)O,C20H34O3,36360.0
656,15(S)-HETrE,CCCCC[C@H](O)/C=C/C=C\C/C=C\CCCCCCC(=O)O,C20H34O3,36720.0
657,11(R)-HEDE,CCCCC/C=C\C=C\[C@H](O)CCCCCCCCCC(=O)O,C20H36O3,37505.0
658,11(S)-HEDE,CCCCC/C=C\C=C\[C@@H](O)CCCCCCCCCC(=O)O,C20H36O3,37510.0
659,15(S)-HEDE,CCCCC[C@H](O)/C=C/C=C\CCCCCCCCCC(=O)O,C20H36O3,37720.0
660,15-OxoEDE,CCCCCC(=O)/C=C/C=C\CCCCCCCCCC(=O)O,C20H34O3,37730.0
661,9(R)-HODE,CCCCC/C=C\C=C\[C@H](O)CCCCCCCC(=O)O,C18H32O3,38405.0
662,9(R)-HODE cholesteryl ester,CCCCC/C=C\C=C\[C@H](O)CCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C45H76O3,38406.0
663,9(S)-HODE,CCCCC/C=C\C=C\[C@@H](O)CCCCCCCC(=O)O,C18H32O3,38410.0
664,9(S)-HODE cholesteryl ester,CCCCC/C=C\C=C\[C@@H](O)CCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C45H76O3,38411.0
665,9-OxoODE,CCCCC/C=C\C=C\C(=O)CCCCCCCC(=O)O,C18H30O3,38420.0
666,13(R)-HODE,CCCCC[C@@H](O)/C=C/C=C\CCCCCCCC(=O)O,C18H32O3,38605.0
667,13(R)-HODE cholesteryl ester,CCCCC[C@@H](O)/C=C/C=C\CCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C45H76O3,38606.0
668,13(S)-HODE,CCCCC[C@H](O)/C=C/C=C\CCCCCCCC(=O)O,C18H32O3,38610.0
669,13(S)-HODE cholesteryl ester,CCCCC[C@H](O)/C=C/C=C\CCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C45H76O3,38611.0
670,13(S)-HODE-biotin,CCCCC[C@H](O)/C=C/C=C\CCCCCCCC(=O)NNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C28H48N4O4S,38612.0
671,13-OxoODE,CCCCCC(=O)/C=C/C=C\CCCCCCCC(=O)O,C18H30O3,38620.0
672,9(S)-HOTrE,CC/C=C\C/C=C\C=C\[C@@H](O)CCCCCCCC(=O)O,C18H30O3,39420.0
673,13(S)-HOTrE(.gamma.),CCCCC[C@H](O)/C=C/C=C\C/C=C\CCCCC(=O)O,C18H30O3,39610.0
674,13(S)-HOTrE,CC/C=C\C[C@H](O)/C=C/C=C\CCCCCCCC(=O)O,C18H30O3,39620.0
675,5(S)-HpEPE,CC/C=C\C/C=C\C/C=C\C/C=C\C=C\[C@H](CCCC(=O)O)OO,C20H30O4,42210.0
676,12(S)-HpEPE,CC/C=C\C/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)OO,C20H30O4,42550.0
677,15(S)-HpEPE,CC/C=C\C[C@@H](/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O)OO,C20H30O4,42710.0
678,5(S)-HpETE,CCCCC/C=C\C/C=C\C/C=C\C=C\[C@H](CCCC(=O)O)OO,C20H32O4,44230.0
679,12(S)-HpETE,CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)OO,C20H32O4,44570.0
680,15(S)-HpETE,CCCCC[C@@H](/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O)OO,C20H32O4,44720.0
681,9(S)-HpOTrE,CC/C=C\C/C=C\C=C\[C@H](CCCCCCCC(=O)O)OO,C18H30O4,45120.0
682,13(S)-HpOTrE(.gamma.),CCCCC[C@@H](/C=C/C=C\C/C=C\CCCCC(=O)O)OO,C18H30O4,45210.0
683,13(S)-HpOTrE,CC/C=C\C[C@@H](/C=C/C=C\CCCCCCCC(=O)O)OO,C18H30O4,45220.0
684,15(S)-HpEDE,CCCCC[C@@H](/C=C/C=C\CCCCCCCCCC(=O)O)OO,C20H36O4,47720.0
685,9(S)-HpODE,CCCCC/C=C\C=C\[C@H](CCCCCCCC(=O)O)OO,C18H32O4,48410.0
686,13(S)-HpODE,CCCCC[C@@H](/C=C/C=C\CCCCCCCC(=O)O)OO,C18H32O4,48610.0
687,PAF C-16,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(C)=O,C26H54NO7P,60900.0
688,1-O-hexadecyl-2-Dihomo-?-Linolenoyl-sn-glycero-3-PC,CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O[C@H](COCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C44H84NO7P,60901.0
689,2-O-methyl PAF C-16,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC,C25H54NO6P,60902.0
690,1-O-hexadecyl-2-Docosahexaenoyl-sn-glycero-3-PC,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C46H82NO7P,60903.0
691,1-O-hexadecyl-2-Arachidonoyl-sn-glycero-3-PC,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C44H82NO7P,60904.0
692,Hexanolamino PAF C-16,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCCCCCC[N+](C)(C)C)OC(C)=O,C30H62NO7P,60905.0
693,Lyso-PAF C-16,CCCCCCCCCCCCCCCCOC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C24H52NO6P,60906.0
694,1-O-hexadecyl-2-Eicosapentaenoyl-sn-glycero-3-PC,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C44H80NO7P,60907.0
695,Methylcarbamyl PAF C-16,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)NC,C26H55N2O7P,60908.0
696,Pyrrolidino PAF C-16,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+]1(C)CCCC1)OC(C)=O,C28H56NO7P,60909.0
697,PAF C-18,CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(C)=O,C28H58NO7P,60910.0
698,Lyso-PAF C-18,CCCCCCCCCCCCCCCCCCOC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C26H56NO6P,60916.0
699,Hexadecyl Acetyl Glycerol,CCCCCCCCCCCCCCCCOC[C@H](CO)OC(C)=O,C21H42O4,60920.0
700,Azelaoyl PAF,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC(=O)O,C33H66NO9P,60924.0
701,2-O-ethyl PAF C-16,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OCC,C26H56NO6P,60925.0
702,Butanoyl PAF,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC,C28H58NO7P,60928.0
703,Hexadecyl Methyl Glycerol,CCCCCCCCCCCCCCCCOC[C@H](CO)OC,C20H42O3,60930.0
704,2-thio PAF,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)SC(C)=O,C26H54NO6PS,60945.0
705,"D-myo-Inositol-1,4,5-triphosphate (potassium salt)",O=P([O-])(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(=O)([O-])O)[C@H](OP(=O)([O-])O)[C@H]1O.[K+].[K+].[K+],C6H12K3O15P3,60960.0
706,"D-myo-Inositol-1,3,4,5-tetraphosphate (sodium salt)",O=P([O-])([O-])O[C@H]1[C@H](O)[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)([O-])[O-])[C@@H](OP(=O)([O-])[O-])[C@H]1O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],C6H8Na8O18P4,60980.0
707,Arachidonyl Trifluoromethyl Ketone,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)C(F)(F)F,C21H31F3O,62120.0
708,1-Arachidonoyl Glycerol,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(O)CO,C23H38O4,62150.0
709,2-Arachidonoyl Glycerol,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC(CO)CO,C23H38O4,62160.0
710,2-Arachidonyl Glycerol ether,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCOC(CO)CO,C23H40O3,62165.0
711,Arachidonoyl Serinol,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NC(CO)CO,C23H39NO3,62170.0
712,Palmitoyl Serinol,CCCCCCCCCCCCCCCC(=O)NC(CO)CO,C19H39NO3,62175.0
713,"1,2-Didecanoyl-sn-glycerol",CCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCCC,C23H44O5,62210.0
714,1-Oleoyl-2-hydroxy-sn-glycero-3-PA (sodium salt),CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])O.[Na+],C21H40NaO7P,62215.0
715,"1,2-Dioctanoyl-sn-glycerol",CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC,C19H36O5,62225.0
716,"1,2-Dioleoyl-sn-glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC/C=C\CCCCCCCC,C39H72O5,62230.0
717,"1,2-bis(heptanoylthio) Glycerophosphocholine",CCCCCCC(=O)SC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)SC(=O)CCCCCC,C22H44NO6PS2,62235.0
718,DPPP,c1ccc(P(c2ccccc2)c2ccc3ccc4cccc5ccc2c3c45)cc1,C28H19P,62237.0
719,Arachidonoyl Thio-PC,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)S[C@H](COCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C44H82NO6PS,62240.0
720,10-Pyrene-PC,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCc1ccc2ccc3cccc4ccc1c2c34,C50H76NO8P,62245.0
721,2-Linoleoyl Glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(CO)CO,C21H38O4,62260.0
722,C2 Ceramide (d18:1/2:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(C)=O,C20H39NO3,62510.0
723,C6 Ceramide (d18:1/6:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCC,C24H47NO3,62525.0
724,C6 NBD Ceramide (d18:1/6:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCNc1ccc([N+](=O)[O-])c2nonc12,C30H49N5O6,62527.0
725,C24:1 Ceramide (d18:1/24:1(15Z)),CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCC,C42H81NO3,62530.0
726,C24 Ceramide (d18:1/24:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCC,C42H83NO3,62535.0
727,C8 Ceramide (d18:1/8:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCC,C26H51NO3,62540.0
728,C8 Ceramine (d18:1/8:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NCCCCCCCC,C26H53NO2,62545.0
729,C8 Ceramide-1-phosphate (d18:1/8:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)(O)O)NC(=O)CCCCCCC,C26H52NO6P,62547.0
730,Sphingosine-1-phosphate (d18:1),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)COP(=O)(O)O,C18H38NO5P,62570.0
731,"N,N-Dimethylsphingosine (d18:1)",CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C,C20H41NO2,62575.0
732,Fumonisin B1,CCCC[C@@H](C)[C@@H](OC(=O)C[C@@H](CC(=O)O)C(=O)O)[C@H](C[C@@H](C)C[C@H](O)CCCC[C@@H](O)C[C@H](O)[C@H](C)N)OC(=O)C[C@@H](CC(=O)O)C(=O)O,C34H59NO15,62580.0
733,PDMP (hydrochloride),CCCCCCCCCC(=O)NC(CN1CCOCC1)C(O)c1ccccc1.Cl,C23H39ClN2O3,62595.0
734,1-Oleoyl-2-acetyl-sn-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](CO)OC(C)=O,C23H42O5,62600.0
735,Oleyl Trifluoromethyl Ketone,CCCCCCCC/C=C\CCCCCCCC(=O)C(F)(F)F,C19H33F3O,62640.0
736,Palmityl Trifluoromethyl Ketone,CCCCCCCCCCCCCCCC(=O)C(F)(F)F,C17H31F3O,62650.0
737,1-Palmitoyl-2-Oleoyl-3-Linoleoyl-rac-glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C55H100O6,62660.0
738,Thioetheramide-PC,CCCCCCCCCCCCCCCCSC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCC,C40H83N2O5PS,62750.0
739,7-hydroxycoumarinyl Arachidonate,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)Oc1ccc2ccc(=O)oc2c1,C29H36O4,62910.0
740,PAz-PC,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC(=O)O,C33H64NO10P,62924.0
741,KDdiA-PC,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC(=O)/C=C/C(=O)O,C36H66NO11P,62935.0
742,KOdiA-PC,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCC(=O)/C=C/C(=O)O,C32H58NO11P,62945.0
743,Myriocin,CCCCCCC(=O)CCCCCC/C=C/C[C@@H](O)[C@H](O)[C@@](N)(CO)C(=O)O,C21H39NO6,63150.0
744,DMAPP (ammonium salt),CC(C)=CCOP(=O)([O-])OP(=O)([O-])[O-].[NH4+].[NH4+].[NH4+],C5H21N3O7P2,63180.0
745,S-Farnesyl Thioacetic Acid,CC(C)=CCC/C(C)=C/CCC(C)CCSCC(=O)O,C17H30O2S,63260.0
746,N-acetyl-S-farnesyl-L-Cysteine,CC(=O)N[C@@H](CSC/C=C(\C)CC/C=C(\C)CCC=C(C)C)C(=O)O,C20H33NO3S,63270.0
747,Miltefosine,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,C21H46NO4P,63280.0
748,N-acetyl-S-geranylgeranyl-L-Cysteine,CC(=O)N[C@@H](CSC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C)C(=O)O,C25H41NO3S,63340.0
749,.alpha.-hydroxy Farnesyl Phosphonic Acid,CC(C)=CCC/C(C)=C/CC/C(C)=C/C(O)P(=O)(O)O,C15H27O4P,63420.0
750,PRIMA-1,O=C1C2CCN(CC2)C1(CO)CO,C9H15NO3,63520.0
751,"PtdIns-(3,4,5)-P3 (1,2-dipalmitoyl) (sodium salt)",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])O[C@H]1[C@H](O)[C@@H](OP(=O)([O-])O)[C@H](OP(=O)([O-])O)[C@@H](OP(=O)([O-])O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCC.[Na+].[Na+].[Na+].[Na+],C41H78Na4O22P4,64920.0
752,2-Aminoethyl diphenylborinate,c1ccc([B-]2(c3ccccc3)[NH2+]CCO2)cc1,C14H16BNO,64970.0
753,Corey Lactone Aldehyde Benzoate,O=C[C@@H]1[C@H]2CC(=O)O[C@H]2C[C@H]1OC(=O)c1ccccc1,C15H14O5,70030.0
754,TBS-Corey Lactone Aldehyde,CC(C)(C)[Si](C)(C)O[C@@H]1C[C@@H]2OC(=O)C[C@@H]2[C@H]1C=O,C14H24O4Si,70031.0
755,Fluprostenol Lactone Diol,O=C1C[C@@H]2[C@@H](/C=C/[C@@H](O)COc3cccc(C(F)(F)F)c3)[C@H](O)C[C@@H]2O1,C18H19F3O5,70037.0
756,Latanoprost Lactone Diol,O=C1C[C@@H]2[C@@H](CC[C@@H](O)CCc3ccccc3)[C@H](O)C[C@@H]2O1,C18H24O4,70039.0
757,Latanoprost Lactol,OC1C[C@@H]2[C@@H](CC[C@@H](O)CCc3ccccc3)[C@H](O)C[C@@H]2O1,C18H26O4,70049.0
758,"(S)-(-)-1,1'-Bi-2-naphthol",Oc1ccc2ccccc2c1-c1c(O)ccc2ccccc12,C20H14O2,70052.0
759,BW 723C86,CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12.Cl,C16H19ClN2OS,70090.0
760,CAY10397,CCCOC(=O)c1ccc(N=Nc2ccc(O)c(CC(=O)O)c2)cc1,C18H18N2O5,70130.0
761,CAY10404,CS(=O)(=O)c1ccc(-c2noc(C(F)(F)F)c2-c2ccccc2)cc1,C17H12F3NO3S,70210.0
762,LY83583,O=C1C(Nc2ccccc2)=CC(=O)c2ncccc21,C15H10N2O2,70230.0
763,Tacrine (hydrochloride),Cl.Nc1c2c(nc3ccccc13)CCCC2,C13H15ClN2,70240.0
764,(R)-Flurbiprofen,C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1,C15H13FO2,70255.0
765,Aspirin,CC(=O)Oc1ccccc1C(=O)O,C9H8O4,70260.0
766,O-Acetyl Salicylhydroxamic Acid,CC(=O)ONC(=O)c1ccccc1O,C9H9NO4,70263.0
767,5-Aminosalicylic Acid,Nc1ccc(O)c(C(=O)O)c1,C7H7NO3,70265.0
768,Indomethacin,COc1ccc2c(c1)C(CC(=O)O)C(C)N2C(=O)c1ccc(Cl)cc1,C19H18ClNO4,70270.0
769,Indomethacin heptyl ester,CCCCCCCOC(=O)Cc1c(C)n(C(=O)c2ccc(Cl)cc2)c2ccc(OC)cc12,C26H30ClNO4,70271.0
770,N-(2-phenylethyl)-Indomethacin amide,COc1ccc2c(c1)c(CC(=O)NCCc1ccccc1)c(C)n2C(=O)c1ccc(Cl)cc1,C27H25ClN2O3,70272.0
771,Indomethacin N-octyl amide,CCCCCCCCNC(=O)Cc1c(C)n(C(=O)c2ccc(Cl)cc2)c2ccc(OC)cc12,C27H33ClN2O3,70273.0
772,N-(3-pyridyl)-Indomethacin amide,COc1ccc2c(c1)c(CC(=O)Nc1cccnc1)c(C)n2C(=O)c1ccc(Cl)cc1,C24H20ClN3O3,70274.0
773,IMMA,COc1ccc2c(c1)c(CC(=O)N1CCOCC1)c(C)n2C(=O)c1ccc(Cl)cc1,C23H23ClN2O4,70275.0
774,N-(4-acetamidophenyl)-Indomethacin amide,COc1ccc2c(c1)c(CC(=O)Nc1ccc(NC(C)=O)cc1)c(C)n2C(=O)c1ccc(Cl)cc1,C27H24ClN3O4,70278.0
775,Ibuprofen,CC(C)Cc1ccc(C(C)C(=O)O)cc1,C13H18O2,70280.0
776,(S)-Naproxen,COc1ccc2cc([C@H](C)C(=O)O)ccc2c1,C14H14O3,70290.0
777,tetramethyl Nordihydroguaiaretic Acid,COc1ccc(C[C@@H](C)[C@@H](C)Cc2ccc(OC)c(OC)c2)cc1OC,C22H30O4,70302.0
778,Sesamin,c1cc2c(cc1[C@H]1OC[C@H]3[C@@H]1CO[C@@H]3c1ccc3c(c1)OCO3)OCO2,C20H18O6,70310.0
779,SC-560,COc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cl)cc2)cc1,C17H12ClF3N2O,70340.0
780,Phenylbutazone,CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,C19H20N2O2,70400.0
781,Guaiacol,COc1ccccc1O,C7H8O2,70430.0
782,Filipin III,CCCCC[C@@H](O)[C@H]1C(=O)O[C@H](C)[C@@H](O)/C=C/C=C/C=C/C=C/C=C(\C)[C@@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O,C35H58O11,70440.0
783,TMB (hydrochloride hydrate),Cc1cc(-c2cc(C)c(N)c(C)c2)cc(C)c1N.Cl.Cl.O,C16H24Cl2N2O,70450.0
784,TMPD (hydrochloride),CN(C)c1ccc(N(C)C)cc1.Cl.Cl,C10H18Cl2N2,70455.0
785,Tolfenamic Acid,Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,C14H12ClNO2,70480.0
786,1-Benzylimidazole,c1ccc(Cn2ccnc2)cc1,C10H10N2,70510.0
787,Ozagrel,O=C(O)/C=C/c1ccc(Cn2ccnc2)cc1,C13H12N2O2,70515.0
788,Bestatin (hydrochloride),CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O.Cl,C16H25ClN2O4,70520.0
789,Ebselen,O=c1c2ccccc2[se]n1-c1ccccc1,C13H9NOSe,70530.0
790,Furegrelate (sodium salt),O=C([O-])c1cc2cc(Cc3cccnc3)ccc2o1.[Na+],C15H10NNaO3,70540.0
791,Meclofenamate (sodium salt),Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl.[Na+],C14H10Cl2NNaO2,70550.0
792,Oleyloxyethyl Phosphorylcholine,CCCCCCCC/C=C\CCCCCCCCOCCOP(=O)([O-])OCC[N+](C)(C)C,C25H52NO5P,70560.0
793,NS 398,CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1OC1CCCCC1,C13H18N2O5S,70590.0
794,REV 5901,CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1,C22H25NO2,70600.0
795,Caffeic Acid,O=C(O)/C=C/c1ccc(O)c(O)c1,C9H8O4,70602.0
796,"3,4-Dihydroxyphenyl ethanol",OCCc1ccc(O)c(O)c1,C8H10O3,70604.0
797,Baicalein,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,C15H10O5,70610.0
798,6-methoxy Naphthalene Acetic Acid,COc1ccc2cc(CC(=O)O)ccc2c1,C13H12O3,70620.0
799,CAY10416,COC1(c2cc(F)cc(OCc3cc(-c4ccccc4)n(-c4ccc(S(C)(=O)=O)cc4)n3)c2)CCOCC1,C29H29FN2O5S,70635.0
800,Nimesulide,CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1,C13H12N2O5S,70640.0
801,DuP-697,CS(=O)(=O)c1ccc(-c2cc(Br)sc2-c2ccc(F)cc2)cc1,C17H12BrFO2S2,70645.0
802,Niflumic Acid,O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1,C13H9F3N2O2,70650.0
803,Methyl Arachidonyl Fluorophosphonate,CCCCCCCCCCCCCCCCCCCCP(=O)(F)OC,C21H44FO2P,70660.0
804,Methyl .gamma.-Linolenyl Fluorophosphonate,CCCCC/C=C\C/C=C\C/C=C\CCCCCP(=O)(F)OC,C19H34FO2P,70664.0
805,Valeroyl Salicylate,CCCCC(=O)Oc1ccccc1C(=O)O,C12H14O4,70670.0
806,trans-Resveratrol,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,C14H12O3,70675.0
807,Diclofenac (sodium salt),O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[Na+],C14H10Cl2NNaO2,70680.0
808,Ketorolac (tromethamine salt),O=C(c1ccccc1)c1ccc2n1CCC2C(=O)[O-].[NH3+]C(CO)(CO)CO,C19H24N2O6,70690.0
809,Bromoenol lactone,O=C1O/C(=C/Br)CCC1c1cccc2ccccc12,C16H13BrO2,70700.0
810,U-75302,CCCCC/C=C\C[C@@H](O)/C=C/c1cccc(C[C@@H](O)CCCCO)n1,C22H35NO3,70705.0
811,LY171883,CCCc1c(OCCCCc2nnn[nH]2)ccc(C(C)=O)c1O,C16H22N4O3,70710.0
812,LY255283,CCc1c(OCCCCCC(C)(C)c2nnn[nH]2)cc(O)cc1C(C)=O,C19H28N4O3,70715.0
813,MK 571 (sodium salt),CN(C)C(=O)CCSC(SCCC(=O)[O-])c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1.[Na+],C26H26ClN2NaO3S2,70720.0
814,Wy 14643,Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C,C14H14ClN3O2S,70730.0
815,U-73122,COc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](NCCCCCCN3C(=O)C=CC3=O)CC[C@@H]12,C29H40N2O3,70740.0
816,Phenethyl Caffeiate,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1,C17H16O4,70750.0
817,BAY u9773,CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](Sc1ccc(C(=O)O)cc1)[C@@H](O)CCCC(=O)O,C27H36O5S,70770.0
818,GW 9662,O=C(Nc1ccccc1)c1cc([N+](=O)[O-])ccc1Cl,C13H9ClN2O3,70785.0
819,BADGE,CC(C)(c1ccc(OCC2CO2)cc1)c1ccc(OCC2CO2)cc1,C21H24O4,70790.0
820,Rosmarinic Acid,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,C18H16O8,70900.0
821,LY294002,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,C19H17NO3,70920.0
822,Chlorogenic Acid,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,C16H18O9,70930.0
823,(-)-Epigallocatechin Gallate,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,C22H18O11,70935.0
824,(+)-Catechin (hydrate),Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2,C15H14O6,70940.0
825,Celastrol,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)O)CC[C@]3(C)CC[C@]12C,C29H38O4,70950.0
826,U-0126,N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N,C18H16N6S2,70970.0
827,Lactacystin,CC(=O)N[C@@H](CSC(=O)[C@]1([C@@H](O)C(C)C)NC(=O)[C@H](C)[C@@H]1O)C(=O)O,C15H24N2O7S,70980.0
828,Clasto-Lactacystin .beta.-lactone,CC(C)[C@H](O)[C@@]12NC(=O)[C@H](C)[C@@H]1OC2=O,C10H15NO4,70988.0
829,"2,4-DPD",CCOC(=O)c1ccnc(C(=O)OCC)c1,C11H13NO4,71200.0
830,DMOG,COC(=O)CNC(=O)C(=O)OC,C6H9NO5,71210.0
831,"1,4-DPCA",O=C(O)C1=CN=C2C3=NC=CCC3C=CC2C1=O,C13H10N2O3,71220.0
832,cis-Parinaric Acid,CC/C=C\C=C\C=C\C=C/CCCCCCCC(=O)O,C18H28O2,71430.0
833,CAY10401,CCCCCCCCC#CCCCCCCCC(=O)c1nc2ncccc2o1,C24H34N2O2,71652.0
834,PHOP,O=C(CCCCCc1ccccc1)c1nc2ncccc2o1,C18H18N2O2,71655.0
835,AM251,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(I)cc1,C22H21Cl2IN4O,71670.0
836,Ciglitazone,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1,C18H23NO3S,71730.0
837,Rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,C18H19N3O3S,71740.0
838,Rosiglitazone (potassium salt),CN(CCOc1ccc(CC2SC(=O)[N-]C2=O)cc1)c1ccccn1.[K+],C18H18KN3O3S,71742.0
839,MSDC-0160,CCc1ccc(C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2)nc1,C19H18N2O4S,71748.0
840,Troglitazone,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,C24H27NO5S,71750.0
841,(Z)-Guggulsterone,C/C=C1\C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C21H28O2,71800.0
842,T0901317,O=S(=O)(c1ccccc1)N(CC(F)(F)F)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,C17H12F9NO3S,71810.0
843,Calcitriol,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,C27H44O3,71820.0
844,CAY10406,O=C1C(=O)N(Cc2ccccc2)c2ccc(S(=O)(=O)N3CCC[C@H]3COc3ccc(C(F)(F)F)cc3)cc21,C27H23F3N2O5S,72510.0
845,CAY10412,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCc1ccsc1,C25H36O2S,72620.0
846,PPHP,OOCCC/C=C/c1ccccc1,C11H14O2,75750.0
847,PPA,OCCC/C=C/c1ccccc1,C11H14O,75751.0
848,PPOH,C#CCOc1ccccc1CCCCCC(=O)O,C15H18O3,75760.0
849,MS-PPOH,C#CCOc1ccccc1CCCCCC(=O)NS(C)(=O)=O,C16H21NO4S,75770.0
850,HET0016,CCCCc1ccc(/N=C/NO)c(C)c1,C12H18N2O,75780.0
851,U-74389G,C[C@]12C=CC(=O)C=C1CC[C@@H]1C2=CC[C@]2(C)[C@@H](C(=O)CN3CCN(c4cc(N5CCCC5)nc(N5CCCC5)n4)CC3)CC[C@@H]12.O=C(O)/C=C\C(=O)O,C41H54N6O6,75860.0
852,(-)-(.alpha.)-Kainic Acid (hydrate),C=C(C)[C@H]1CN[C@H](C(=O)O)[C@H]1CC(=O)O.O,C10H17NO5,78050.0
853,L-NAME (hydrochloride),COC(=O)[C@@H](N)CCCNC(=N)N[N+](=O)[O-].Cl,C7H16ClN5O4,80210.0
854,L-NNA,N=C(NCCC[C@H](N)C(=O)O)N[N+](=O)[O-],C6H13N5O4,80220.0
855,"NG,NG-dimethyl-L-Arginine (hydrochloride)",CN(C)C(=N)NCCC[C@H](N)C(=O)O.Cl.Cl,C8H20Cl2N4O2,80230.0
856,Thioarginine (hydrobromide),Br.N=C(N)SCCC[C@H](N)C(=O)O,C6H14BrN3O2S,80240.0
857,L-NIL (hydrochloride),CC(=N)NCCCC[C@H](N)C(=O)O.Cl.Cl,C8H19Cl2N3O2,80310.0
858,L-NIO (hydrochloride),CC(=N)NCCC[C@H](N)C(=O)O.Cl.Cl,C7H17Cl2N3O2,80320.0
859,.alpha.-Guanidinoglutaric Acid,N=C(N)N[C@@H](CCC(=O)O)C(=O)O,C6H11N3O4,80340.0
860,S-methyl-L-Thiocitrulline (hydrochloride),CSC(=N)NCCC[C@H](N)C(=O)O.Cl.Cl,C7H17Cl2N3O2S,80585.0
861,N.omega.-propyl-L-Arginine,CCCNC(=N)NCCC[C@H](N)C(=O)O,C9H20N4O2,80587.0
862,S-(2-aminoethyl) Isothiourea (dihydrobromide),Br.Br.N=C(N)SCCN,C3H11Br2N3S,81005.0
863,AMT (hydrochloride),CC1CCN=C(N)S1.Cl,C5H11ClN2S,81010.0
864,2-Imino-4-methylpiperidine (acetate),CC(=O)[O-].CC1CCN=C([NH3+])C1,C8H16N2O2,81015.0
865,MEG (sulfate),N=C(N)NCCS.N=C(N)NCCS.O=S(=O)(O)O,C6H20N6O4S3,81020.0
866,Curcumin,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,C21H20O6,81025.0
867,Diphenyleneiodonium (chloride),[Cl-].c1ccc2c(c1)[I+]c1ccccc1-2,C12H8ClI,81050.0
868,"2,4-Diamino-6-hydroxypyrimidine",Nc1cc(O)nc(N)n1,C4H6N4O,81260.0
869,S-ethyl Isothiourea (hydrobromide),Br.CCSC(=N)N,C3H9BrN2S,81275.0
870,S-ethyl N-[4-(trifluoromethyl)phenyl] Isothiourea (hydrochloride),CCSC(=N)Nc1ccc(C(F)(F)F)cc1.Cl,C10H12ClF3N2S,81280.0
871,S-isopropyl Isothiourea (hydrobromide),Br.CC(C)SC(=N)N,C4H11BrN2S,81290.0
872,S-methyl Isothiourea (hemisulfate),CSC(=N)N.CSC(=N)N.O=S(=O)(O)O,C4H14N4O4S3,81300.0
873,TRIM,FC(F)(F)c1ccccc1-n1ccnc1,C10H7F3N2,81310.0
874,7-Nitroindazole,O=[N+]([O-])c1cccc2cn[nH]c12,C7H5N3O2,81340.0
875,3-bromo-7-Nitroindazole,O=[N+]([O-])c1cccc2c(Br)n[nH]c12,C7H4BrN3O2,81345.0
876,ODQ,O=c1onc2cnc3ccccc3n12,C9H5N3O2,81410.0
877,"1,3-PBIT (dihydrobromide)",Br.Br.N=C(N)SCCc1cccc(CCSC(=N)N)c1,C12H20Br2N4S2,81500.0
878,"1,4-PBIT (dihydrobromide)",Br.Br.N=C(N)SCCc1ccc(CCSC(=N)N)cc1,C12H20Br2N4S2,81510.0
879,1400W (hydrochloride),CC(=N)NCc1cccc(CN)c1.Cl.Cl,C10H17Cl2N3,81520.0
880,Aminoguanidine (hydrochloride),Cl.N=C(N)NN,CH7ClN4,81530.0
881,Carboxy-PTIO (potassium salt),CC1(C)N([O])C(c2ccc(C(=O)[O-])cc2)=[N+]([O-])C1(C)C.[K+],C14H16KN2O4,81540.0
882,YC-1,OCc1ccc(-c2nn(Cc3ccccc3)c3ccccc23)o1,C19H16N2O2,81560.0
883,Peroxynitrite,O=NO[O-].[Na+],NNaO3,81565.0
884,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,C28H26N4O3,81590.0
885,NS 2028,O=c1onc2n1-c1cc(Br)ccc1OC2,C9H5BrN2O3,81600.0
886,"(6R)-5,6,7,8-tetrahydro-L-Biopterin (hydrochloride)",C[C@H](O)[C@H](O)[C@H]1CNc2[nH]c(N)nc(=O)c2N1.Cl.Cl,C9H17Cl2N5O3,81880.0
887,"7,8-dihydro-L-Biopterin",C[C@H](O)[C@H](O)C1=Nc2c([nH]c(N)nc2=O)NC1,C9H13N5O3,81882.0
888,DEA NONOate,CCN(CC)N([O-])N=O.CC[NH2+]CC,C8H22N4O2,82100.0
889,DPTA NONOate,NCCCN(CCC[NH3+])N([O-])N=O,C6H17N5O2,82110.0
890,DETA NONOate,NCCN(CC[NH3+])N([O-])N=O,C4H13N5O2,82120.0
891,MAHMA NONOate,C[NH2+]CCCCCCN(C)N([O-])N=O,C8H20N4O2,82130.0
892,PAPA NONOate,CCCN(CCC[NH3+])N([O-])N=O,C6H16N4O2,82140.0
893,PROLI NONOate,O=C([O-])[C@@H]1CCCN1[N+]([O-])=N[O-].[Na+].[Na+],C5H7N3Na2O4,82145.0
894,Spermine NONOate,NCCCNCCCCN(CCCN)N(O)N=O,C10H26N6O2,82150.0
895,V-PYRRO/NO,C=CO/N=[N+](\[O-])N1CCCC1,C6H11N3O2,82160.0
896,Molsidomine,CCOC(=O)[N-]c1c[n+](N2CCOCC2)no1,C9H14N4O4,82200.0
897,SIN-1 (chloride),Nc1c[n+](N2CCOCC2)no1.[Cl-],C6H11ClN4O2,82220.0
898,Angeli's Salt,[Na+].[Na+].[O-]N=[N+]([O-])[O-],N2Na2O3,82230.0
899,AAPH,CC(C)(/N=N/C(C)(C)C(=N)N)C(=N)N.Cl.Cl,C8H20Cl2N6,82235.0
900,S-Nitroso-L-glutathione,N[C@@H](CCC(=O)N[C@@H](CSN=O)C(=O)NCC(=O)O)C(=O)O,C10H16N4O7S,82240.0
901,SNAP,CC(=O)NC(C(=O)O)C(C)(C)SN=O,C7H12N2O4S,82250.0
902,FK-409,CC/C(=C\C(=N/O)C(N)=O)C(C)[N+](=O)[O-],C8H13N3O4,82290.0
903,SE 175,COC(=O)c1ccccc1SC(=O)c1ccc(CO[N+](=O)[O-])cc1,C16H13NO6S,82340.0
904,Sulpho NONOate,O=NN([O-])S(=O)(=O)[O-].[Na+].[Na+],N2Na2O5S,83300.0
905,DAN-1 EE (hydrochloride),CCOC(=O)c1ccc(CNc2cc3ccccc3cc2N)cc1.Cl,C20H21ClN2O2,85070.0
906,Dihydrorhodamine 123,COC(=O)c1ccccc1C1c2ccc(N)cc2Oc2cc(N)ccc21,C21H18N2O3,85100.0
907,"2,7-Dichlorodihydrofluorescein diacetate",CC(=O)Oc1cc2c(cc1Cl)C(c1ccccc1C(=O)O)c1cc(Cl)c(OC(C)=O)cc1O2,C24H16Cl2O7,85155.0
908,DAF-2,Nc1cc2c(cc1N)C1(OC2=O)c2ccc(O)cc2Oc2cc(O)ccc21,C20H14N2O5,85160.0
909,DAF-2 diacetate,CC(=O)Oc1ccc2c(c1)Oc1cc(OC(C)=O)ccc1C21OC(=O)c2cc(N)c(N)cc21,C24H18N2O7,85165.0
910,Traumatic Acid,O=C(O)/C=C/CCCCCCCCC(=O)O,C12H20O4,88820.0
911,n-Triacontanol,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO,C30H62O,88840.0
912,Pimonidazole,O=[N+]([O-])c1nccn1CC(O)CN1CCCCC1,C11H18N4O3,89130.0
913,8-hydroxy Guanine (hydrochloride),Cl.Nc1nc(O)c2nc(O)[nH]c2n1,C5H6ClN5O2,89290.0
914,8-Hydroxyguanosine,Nc1nc2c(nc(O)n2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1,C10H13N5O6,89300.0
915,8-Hydroxy-2'-deoxyguanosine,Nc1nc2c(nc(O)n2[C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]1,C10H13N5O5,89320.0
916,Hydroxymethyl Uracil,O=c1[nH]cc(CO)c(=O)[nH]1,C5H6N2O3,89360.0
917,Sclerotiorin,CC[C@H](C)/C=C(C)/C=C/C1=CC2=C(Cl)C(=O)[C@](C)(OC(C)=O)C(=O)C2=CO1,C21H23ClO5,89460.0
918,Nitrotyrosine,N[C@@H](Cc1ccc(O)c([N+](=O)[O-])c1)C(=O)O,C9H10N2O5,89540.0
919,.gamma.-CEHC,Cc1c(O)cc2c(c1C)OC(C)(CCC(=O)O)CC2,C15H20O4,89630.0
920,Trichostatin A,CC(/C=C/C(=O)NO)=C\[C@@H](C)C(=O)c1ccc(N(C)C)cc1,C17H22N2O3,89730.0
921,CAY10398,CN(C)c1ccc(C(=O)NCCCCCC(=O)NO)cc1,C15H23N3O3,89740.0
922,Carnosol,CC(C)c1cc2c(c(O)c1O)C13CCCC(C)(C)C1CC2OC3=O,C20H26O4,89800.0
923,BHT,Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1,C15H24O,89910.0
924,Arachidonic Acid,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O2,90010.0
925,.omega.-3 Arachidonic Acid,CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCC(=O)O,C20H32O2,90011.0
926,Arachidonic Acid methyl ester,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC,C21H34O2,90014.0
927,"5,6-dehydro Arachidonic Acid",CCCCC/C=C\C/C=C\C/C=C\CC#CCCCC(=O)O,C20H30O2,90020.0
928,20-HETE,O=C(O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCO,C20H32O3,90030.0
929,Arachidonoyl Ethanolamide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO,C22H37NO2,90050.0
930,Arachidonoyl Glycine,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCC(=O)O,C22H35NO3,90051.0
931,Arvanil,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCc1ccc(O)c(OC)c1,C28H41NO3,90052.0
932,Arachidonoyl-2'-Fluoroethylamide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCF,C22H36FNO,90054.0
933,N-Arachidonoyl Dopamine,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCc1ccc(O)c(O)c1,C28H41NO3,90057.0
934,Arachidonoyl m-Nitroaniline,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)Nc1cccc([N+](=O)[O-])c1,C26H36N2O3,90059.0
935,AM404,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)Nc1ccc(O)cc1,C26H37NO2,90060.0
936,N-Arachidonoyl-L-Alanine,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N[C@@H](C)C(=O)O,C23H37NO3,90065.0
937,N-Arachidonoyl-.gamma.-Aminobutyric Acid,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCCC(=O)O,C24H39NO3,90067.0
938,R-1 Methanandamide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N[C@H](C)CO,C23H39NO2,90070.0
939,S-1 Methanandamide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N[C@@H](C)CO,C23H39NO2,90072.0
940,R-2 Methanandamide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NC[C@@H](C)O,C23H39NO2,90074.0
941,S-2 Methanandamide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NC[C@H](C)O,C23H39NO2,90076.0
942,"(-)-CP 55,940",CCCCCCC(C)(C)c1ccc([C@@H]2C[C@H](O)CC[C@H]2CCCO)c(O)c1,C24H40O3,90084.0
943,HU-308,CCCCCCC(C)(C)c1cc(OC)c([C@H]2C=C(CO)[C@H]3C[C@@H]2C3(C)C)c(OC)c1,C27H42O3,90086.0
944,Eicosapentaenoic Acid,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H30O2,90110.0
945,"5,8,11,14-Eicosatetraynoic Acid",CCCCCC#CCC#CCC#CCC#CCCCC(=O)O,C20H24O2,90120.0
946,"9(Z),11(E)-Conjugated Linoleic Acid",CCCCCC/C=C/C=C\CCCCCCCC(=O)O,C18H32O2,90140.0
947,"10(E),12(Z)-Conjugated Linoleic Acid",CCCCC/C=C\C=C\CCCCCCCCC(=O)O,C18H32O2,90145.0
948,Linoleic Acid,CCCCC/C=C\C/C=C\CCCCCCCC(=O)O,C18H32O2,90150.0
949,Linoleoyl Ethanolamide,CCCCC/C=C\C/C=C\CCCCCCCC(=O)NCCO,C20H37NO2,90155.0
950,Linoelaidic Acid,CCCCC/C=C/C/C=C/CCCCCCCC(=O)O,C18H32O2,90160.0
951,Docosapentaenoic Acid,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O,C22H34O2,90165.0
952,Docosatrienoic Acid,CC/C=C\C/C=C\C/C=C\CCCCCCCCCCCC(=O)O,C22H38O2,90170.0
953,13(Z)-Docosenoic Acid,CCCCCCCC/C=C\CCCCCCCCCCCC(=O)O,C22H42O2,90175.0
954,"5(Z),8(Z),11(Z)-Eicosatrienoic Acid",CCCCCCCC/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H34O2,90190.0
955,"11(Z),14(Z),17(Z)-Eicosatrienoic Acid",CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)O,C20H34O2,90192.0
956,"5(Z),8(Z),11(Z)-Eicosatrienoic Acid Ethanolamide",CCCCCCCC/C=C\C/C=C\C/C=C\CCCC(=O)NCCO,C22H39NO2,90195.0
957,"5,8,11-Eicosatriynoic Acid",CCCCCCCCC#CCC#CCC#CCCCC(=O)O,C20H28O2,90200.0
958,.alpha.-Linolenic Acid,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,C18H30O2,90210.0
959,.alpha.-Linolenoyl Ethanolamide,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)NCCO,C20H35NO2,90215.0
960,.gamma.-Linolenic Acid,CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O,C18H30O2,90220.0
961,Dihomo-.gamma.-Linolenic Acid,CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O,C20H34O2,90230.0
962,Dihomo-.gamma.-Linolenoyl Ethanolamide,CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)NCCO,C22H39NO2,90235.0
963,Dihomo-.gamma.-Linolenic Acid ethyl ester,CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)OCC,C22H38O2,90236.0
964,Stearoyl Ethanolamide,CCCCCCCCCCCCCCCCCC(=O)NCCO,C20H41NO2,90245.0
965,Elaidic Acid,CCCCCCCC/C=C/CCCCCCCC(=O)O,C18H34O2,90250.0
966,Oleic Acid,CCCCCCCC/C=C\CCCCCCCC(=O)O,C18H34O2,90260.0
967,Olvanil,CCCCCCCC/C=C\CCCCCCCC(=O)NCc1ccc(O)c(OC)c1,C26H43NO3,90262.0
968,Oleoyl Ethanolamide,CCCCCCCC/C=C\CCCCCCCC(=O)NCCO,C20H39NO2,90265.0
969,N-Oleoyl Glycine,CCCCCCCC/C=C\CCCCCCCC(=O)NCC(=O)O,C20H37NO3,90269.0
970,17-Octadecynoic Acid,C#CCCCCCCCCCCCCCCCC(=O)O,C18H32O2,90270.0
971,MEDICA 16,CC(C)(CCCCCCCCCCC(C)(C)CC(=O)O)CC(=O)O,C20H38O4,90290.0
972,Adrenic Acid,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O,C22H36O2,90300.0
973,Docosahexaenoic Acid,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C22H32O2,90310.0
974,Stearidonic Acid,CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O,C18H28O2,90320.0
975,"11(Z),14(Z)-Eicosadienoic Acid",CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)O,C20H36O2,90330.0
976,Heptadecanoyl Ethanolamide,CCCCCCCCCCCCCCCCC(=O)NCCO,C19H39NO2,90342.0
977,Decanoyl m-Nitroaniline,CCCCCCCCCC(=O)Nc1cccc([N+](=O)[O-])c1,C16H24N2O3,90349.0
978,Palmitoyl Ethanolamide,CCCCCCCCCCCCCCCC(=O)NCCO,C18H37NO2,90350.0
979,R-Palmitoyl-(1-methyl) Ethanolamide,CCCCCCCCCCCCCCCC(=O)N[C@H](C)CO,C19H39NO2,90353.0
980,R-Palmitoyl-(2-methyl) Ethanolamide,CCCCCCCCCCCCCCCC(=O)NC[C@@H](C)O,C19H39NO2,90357.0
981,Phytanic Acid,CC(C)CCCC(C)CCCC(C)CCCC(C)CC(=O)O,C20H40O2,90360.0
982,"9(E),11(E)-Conjugated Linoleic Acid",CCCCCC/C=C/C=C/CCCCCCCC(=O)O,C18H32O2,90370.0
983,Oleamide,CCCCCCCC/C=C\CCCCCCCC(N)=O,C18H35NO,90375.0
984,13-Docosenamide,CCCCCCCC/C=C\CCCCCCCCCCCC(N)=O,C22H43NO,90377.0
985,2-fluoro Palmitic Acid,CCCCCCCCCCCCCCC(F)C(=O)O,C16H31FO2,90380.0
986,Docosatetraenoyl Ethanolamide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NCCO,C24H41NO2,90385.0
987,2-hydroxy Myristic Acid,CCCCCCCCCCCCC(O)C(=O)O,C14H28O3,90390.0
988,"9,12-Octadecadiynoic Acid",CCCCCC#CCC#CCCCCCCCC(=O)O,C18H28O2,90400.0
989,"5(S),6(R)-Lipoxin A4",CCCCC[C@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)CCCC(=O)O,C20H32O5,90410.0
990,15(R)-Lipoxin A4,CCCCC[C@@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)CCCC(=O)O,C20H32O5,90415.0
991,Lipoxin B4,CCCCC[C@H](O)[C@H](O)/C=C/C=C/C=C\C=C\[C@@H](O)CCCC(=O)O,C20H32O5,90420.0
992,3-Thiatetradecanoic Acid,CCCCCCCCCCCSCC(=O)O,C13H26O2S,90500.0
993,O-11,CCCOCCCCCCCCCC(=O)O,C13H26O3,90510.0
994,O-Arachidonoyl Ethanolamine (hydrochloride),CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCCN.Cl,C22H38ClNO2,91050.0
995,Arachidonoyl Cyclopropylamide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NC1CC1,C23H37NO,91053.0
996,Arachidonoyl 2'-Chloroethylamide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCCl,C22H36ClNO,91054.0
997,Palmitoyl N-Isopropylamide,CCCCCCCCCCCCCCCC(=O)NC(C)C,C19H39NO,91354.0
998,Capsaicin,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,C18H27NO3,92350.0
999,Capsaicin (technical grade),COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,C18H27NO3,10010743.0
1000,Dihydrocapsaicin,COc1cc(CNC(=O)CCCCCCC(C)C)ccc1O,C18H29NO3,92355.0
1001,Petromyzonol,C[C@H](CCCO)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H42O4,98250.0
1002,Acridinium NHS ester,C[n+]1c2ccccc2c(C(=O)Oc2ccc(CCC(=O)ON3C(=O)CCC3=O)cc2)c2ccccc21.O=S(=O)([O-])C(F)(F)F,C29H23F3N2O9S,200200.0
1003,DISBAC10,CCCCCCCCCCN1C(=O)C(=C/C=C/C2C(=O)N(CCCCCCCCCC)C(=S)N(CCCCCCCCCC)C2=O)C(=O)N(CCCCCCCCCC)C1=S,C51H88N4O4S2,200280.0
1004,Prostaglandin A2-d4,[2H]C([2H])(/C=C\C[C@H]1C(=O)C=C[C@@H]1/C=C/[C@@H](O)CCCCC)C([2H])([2H])CC,C20H32O2,310210.0
1005,Prostaglandin B2-d4,[2H]C([2H])(/C=C\CC1=C(/C=C/[C@@H](O)CCCCC)CCC1=O)C([2H])([2H])CC(=O)O,C20H30O4,311210.0
1006,Prostaglandin D2-d4,[2H]C([2H])(/C=C\C[C@H]1[C@@H](O)CC(=O)[C@@H]1/C=C/[C@@H](O)CCCCC)C([2H])([2H])CC(=O)O,C20H32O5,312010.0
1007,Prostaglandin E1-d4,[2H]C([2H])(CCC[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCCCC)C([2H])([2H])CC(=O)O,C20H34O5,313010.0
1008,Prostaglandin E2-d4,[2H]C([2H])(/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCCCC)C([2H])([2H])CC(=O)O,C20H32O5,314010.0
1009,tetranor-PGEM-d6,[2H]C([2H])(CC(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCC(=O)O)C([2H])([2H])C([2H])([2H])C(=O)O,C16H24O7,314840.0
1010,6-keto Prostaglandin F1.alpha.-d4,[2H]C([2H])(CC(=O)O)C([2H])([2H])CC(=O)C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]1O,C20H34O6,315210.0
1011,Prostaglandin F2.alpha.-d4,[2H]C([2H])(/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]1O)C([2H])([2H])CC(=O)O,C20H34O5,316010.0
1012,8-iso Prostaglandin F2.alpha.-d4,[2H]C([2H])(/C=C\C[C@H]1[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]1O)C([2H])([2H])CC(=O)O,C20H34O5,316350.0
1013,17-phenyl trinor Prostaglandin F2.alpha.-d4,[2H]C([2H])(/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O)C([2H])([2H])CC(=O)O,C23H32O5,316810.0
1014,Latanoprost (free acid)-d4,[2H]C([2H])(/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O)C([2H])([2H])CC(=O)O,C23H34O5,316811.0
1015,"15-deoxy-.DELTA.12,14-Prostaglandin J2-d4",[2H]C([2H])(/C=C\C[C@H]1C=CC(=O)/C1=C/C=C/CCCCC)C([2H])([2H])CC(=O)O,C20H28O3,318570.0
1016,Thromboxane B2-d4,[2H]C([2H])(/C=C\C[C@H]1[C@@H](O)CC(O)O[C@@H]1/C=C/[C@@H](O)CCCCC)C([2H])([2H])CC(=O)O,C20H34O6,319030.0
1017,11-dehydro Thromboxane B2-d4,[2H]C([2H])(/C=C\C[C@H]1[C@@H](O)CC(=O)O[C@@H]1/C=C/[C@@H](O)CCCCC)C([2H])([2H])CC(=O)O,C20H32O6,319500.0
1018,Leukotriene B4-d4,[2H]C(/C=C/C=C/[C@H](O)C/C([2H])=C(/[2H])CCCCC)=C(\[2H])[C@@H](O)CCCC(=O)O,C20H32O4,320110.0
1019,4-hydroxy Nonenal-d3,[2H]C([2H])([2H])CCCCC(O)/C=C/C=O,C9H16O2,332101.0
1020,5(S)-HETE-d8,[2H]C(/C=C(\[2H])[C@@]([2H])(O)CCCC(=O)O)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCCC,C20H32O3,334230.0
1021,5-OxoETE-d7,[2H]C(/C=C(\[2H])C(=O)CCCC(=O)O)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCCC,C20H30O3,334250.0
1022,12(S)-HETE-d8,[2H]C(/C=C(\[2H])[C@@]([2H])(O)C/C([2H])=C(/[2H])CCCCC)=C(\[2H])C/C([2H])=C(/[2H])CCCC(=O)O,C20H32O3,334570.0
1023,15(S)-HETE-d8,[2H]C(/C=C(\[2H])[C@@]([2H])(O)CCCCC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCC(=O)O,C20H32O3,334720.0
1024,9(S)-HODE-d4,[2H]C(/C=C(\[2H])[C@@]([2H])(O)CCCCCCCC(=O)O)=C(\[2H])CCCCC,C18H32O3,338410.0
1025,13(S)-HODE-d4,[2H]C(/C=C(\[2H])[C@@]([2H])(O)CCCCC)=C(\[2H])CCCCCCCC(=O)O,C18H32O3,338610.0
1026,PAF C-16-d4,[2H]C([2H])(CCCCCCCC)C([2H])([2H])CCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(C)=O,C26H54NO7P,360900.0
1027,Lyso-PAF C-16-d4,[2H]C([2H])(CCCCCCCC)C([2H])([2H])CCCCCCOC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C24H52NO6P,360906.0
1028,2-Arachidonoyl Glycerol-d8,[2H]/C(CCCCC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCC(=O)OC(CO)CO,C23H38O4,362160.0
1029,2-Arachidonoyl Glycerol-d5,[2H]C([2H])(O)C([2H])(OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)C([2H])([2H])O,C23H38O4,362162.0
1030,Arachidonic Acid-d8,[2H]/C(CCCCC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCC(=O)O,C20H32O2,390010.0
1031,.omega.-3 Arachidonic Acid-d8,[2H]/C(CC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCCCCC(=O)O,C20H32O2,390011.0
1032,Arachidonic Acid-d8 methyl ester,[2H]/C(CCCCC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCC(=O)OC,C21H34O2,390014.0
1033,20-HETE-d6,[2H]C([2H])(/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O)C([2H])([2H])C([2H])([2H])CCO,C20H32O3,390030.0
1034,Arachidonoyl Ethanolamide-d8,[2H]/C(CCCCC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCC(=O)NCCO,C22H37NO2,390050.0
1035,Linoleic Acid-d4,[2H]/C(CCCCC)=C(\[2H])C/C([2H])=C(/[2H])CCCCCCCC(=O)O,C18H32O2,390150.0
1036,Jasmonic Acid methyl ester,CCC=CCC1C(=O)CCC1CC(=O)OC,C13H20O3,9000059.0
1037,Carbaprostacyclin methyl ester,CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)OC)C[C@H]2C[C@H]1O,C22H36O4,9000183.0
1038,Prostaglandin A1 methyl ester,CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1CCCCCCC(=O)OC,C21H34O4,9000184.0
1039,Prostaglandin A2 methyl ester,CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)OC,C21H32O4,9000185.0
1040,"5(Z),8(Z),11(Z)-Eicosatrienoic Acid methyl ester",CCCCCCCC/C=C\C/C=C\C/C=C\CCCC(=O)OC,C21H36O2,9000215.0
1041,Triphenylphosphine oxide,O=P(c1ccccc1)(c1ccccc1)c1ccccc1,C18H15OP,9000289.0
1042,8-methyl Nonanoic Acid,CC(C)CCCCCCC(=O)O,C10H20O2,9000310.0
1043,7(Z)-Tricosene,CCCCCC/C=C\CCCCCCCCCCCCCCC,C23H46,9000313.0
1044,"7(Z),11(Z)-Nonacosadiene",CCCCCC/C=C\CC/C=C\CCCCCCCCCCCCCCCCC,C29H56,9000314.0
1045,Linoleoyl Glycine,CCCCC/C=C\C/C=C\CCCCCCCC(=O)NCC(=O)O,C20H35NO3,9000326.0
1046,Docosahexaenoyl glycine,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCC(=O)O,C24H35NO3,9000328.0
1047,(S)-Acenocoumarol,CC(=O)C[C@@H](c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O,C19H15NO6,9000336.0
1048,(R)-Acenocoumarol,CC(=O)C[C@H](c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O,C19H15NO6,9000337.0
1049,Docosanoic Acid,CCCCCCCCCCCCCCCCCCCCCC(=O)O,C22H44O2,9000338.0
1050,Arachidic Acid,CCCCCCCCCCCCCCCCCCCC(=O)O,C20H40O2,9000339.0
1051,1-NBD-decanoyl-2-decanoyl-sn-Glycerol,CCCCCCCCCC(=O)O[C@@H](CO)COC(=O)CCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12,C29H46N4O8,9000341.0
1052,"17-oxo-(4Z),(7Z),(10Z),(13Z),(15E),(19Z)-Docosahexaenoic Acid",CC/C=C\CC(=O)/C=C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C22H30O3,9000346.0
1053,"17-keto-7(Z),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid",CC/C=C\CC(=O)/C=C/C=C\C/C=C\C/C=C\CCCCCC(=O)O,C22H32O3,9000347.0
1054,Oxy-16,CC(C)CC[C@@H](O)[C@](C)(O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C,C27H46O3,9000395.0
1055,"13,14-dihydro-16,16-difluoro Prostaglandin E1",CCCCC(F)(F)[C@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,C20H34F2O5,9000405.0
1056,Palmitoleic Acid-d14,[2H]C([2H])(/C=C\CCCCCC)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C16H30O2,9000431.0
1057,Rimonabant,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,C22H21Cl3N4O,9000484.0
1058,SR 144528,Cc1ccc(Cn2nc(C(=O)N[C@@H]3C(C)(C)[C@@H]4CC[C@@]3(C)C4)cc2-c2ccc(Cl)c(C)c2)cc1,C29H34ClN3O,9000491.0
1059,7(Z)-Pentacosene,CCCCCC/C=C\CCCCCCCCCCCCCCCCC,C25H50,9000530.0
1060,"7(Z),11(Z)-Pentacosadiene",CCCCCC/C=C\CC/C=C\CCCCCCCCCCCCC,C25H48,9000531.0
1061,N-Desethylamiodarone (hydrochloride),CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCNCC)c(I)c1.Cl,C23H26ClI2NO3,9000537.0
1062,Palmitoyl Ethanolamide-d4,[2H]C([2H])(O)C([2H])([2H])NC(=O)CCCCCCCCCCCCCCC,C18H37NO2,9000551.0
1063,Oleoyl Ethanolamide-d4,[2H]C([2H])(O)C([2H])([2H])NC(=O)CCCCCCC/C=C\CCCCCCCC,C20H39NO2,9000552.0
1064,Linoleoyl Ethanolamide-d4,[2H]C([2H])(O)C([2H])([2H])NC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C20H37NO2,9000553.0
1065,Dimebolin,Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1,C21H25N3,9000556.0
1066,Palmitoyl Ethanolamide-d5,[2H]C([2H])([2H])C([2H])([2H])CCCCCCCCCCCCCC(=O)NCCO,C18H37NO2,9000573.0
1067,Oleoyl Serotonin,CCCCCCCC/C=C\CCCCCCCC(=O)NCCc1c[nH]c2ccc(O)cc12,C28H44N2O2,9000629.0
1068,Palmitoyl Serotonin,CCCCCCCCCCCCCCCC(=O)NCCc1c[nH]c2ccc(O)cc12,C26H42N2O2,9000630.0
1069,Stearoyl Serotonin,CCCCCCCCCCCCCCCCCC(=O)NCCc1c[nH]c2ccc(O)cc12,C28H46N2O2,9000631.0
1070,Docosahexaenoyl Serotonin,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCc1c[nH]c2ccc(O)cc12,C32H42N2O2,9000639.0
1071,Eicosapentaenoyl Serotonin,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCc1c[nH]c2ccc(O)cc12,C30H40N2O2,9000640.0
1072,JWH 018 4-hydroxyindole metabolite,CCCCCn1cc(C(=O)c2cccc3ccccc23)c2c(O)cccc21,C24H23NO2,9000851.0
1073,JWH 018 5-hydroxyindole metabolite,CCCCCn1cc(C(=O)c2cccc3ccccc23)c2cc(O)ccc21,C24H23NO2,9000852.0
1074,JWH 018 6-hydroxyindole metabolite,CCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccc(O)cc21,C24H23NO2,9000853.0
1075,JWH 018 7-hydroxyindole metabolite,CCCCCn1cc(C(=O)c2cccc3ccccc23)c2cccc(O)c21,C24H23NO2,9000854.0
1076,JWH 018 N-(5-hydroxypentyl) metabolite,O=C(c1cccc2ccccc12)c1cn(CCCCCO)c2ccccc12,C24H23NO2,9000855.0
1077,JWH 018 N-pentanoic acid metabolite,O=C(O)CCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H21NO3,9000856.0
1078,JWH 073 4-hydroxyindole metabolite,CCCCn1cc(C(=O)c2cccc3ccccc23)c2c(O)cccc21,C23H21NO2,9000861.0
1079,JWH 073 6-hydroxyindole metabolite,CCCCn1cc(C(=O)c2cccc3ccccc23)c2ccc(O)cc21,C23H21NO2,9000863.0
1080,JWH 073 N-(4-hydroxybutyl) metabolite,O=C(c1cccc2ccccc12)c1cn(CCCCO)c2ccccc12,C23H21NO2,9000865.0
1081,JWH 073 N-butanoic acid metabolite,O=C(O)CCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C23H19NO3,9000866.0
1082,JWH 018 N-pentanoic acid metabolite-d4,[2H]C([2H])(CC(=O)O)C([2H])([2H])Cn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H21NO3,9000867.0
1083,JWH 073 N-butanoic acid metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1cccc3ccccc13)c([2H])n2CCCC(=O)O,C23H19NO3,9000870.0
1084,Docosahexaenoic Acid ethyl ester,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCC,C24H36O2,9090310.0
1085,Luteolin,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,C15H10O6,10004161.0
1086,4-oxo 2-Nonenal-d3,[2H]C([2H])([2H])CCCCC(=O)/C=C/C=O,C9H14O2,10004174.0
1087,CAY10443,O=C(NCc1ccc(Cl)c(Cl)c1)O[C@H]1CCc2ccccc21,C17H15Cl2NO2,10004177.0
1088,NESS 0327,O=C(NN1CCCCC1)c1nn(-c2ccc(Cl)cc2Cl)c2c1CCCc1cc(Cl)ccc1-2,C24H23Cl3N4O,10004184.0
1089,"3,4',5-Trismethoxybenzophenone",COc1ccc(C(=O)c2cc(OC)cc(OC)c2)cc1,C16H16O4,10004185.0
1090,(S)-Flurbiprofen,C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1,C15H13FO2,10004207.0
1091,trans-EKODE-(E)-Ib,CCCCC[C@@H]1O[C@H]1/C=C/C(=O)CCCCCCCC(=O)O,C18H30O4,10004224.0
1092,cis-Resveratrol,Oc1ccc(/C=C\c2cc(O)cc(O)c2)cc1,C14H12O3,10004235.0
1093,Fluprostenol serinol amide,O=C(CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O)NC(CO)CO,C26H36F3NO7,10004236.0
1094,17-phenyl trinor Prostaglandin F2.alpha. serinol amide,O=C(CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O)NC(CO)CO,C26H39NO6,10004237.0
1095,"trans-4,5-epoxy-2(E)-Decenal",CCCCCC1OC1/C=C/C=O,C10H16O2,10004257.0
1096,Abnormal Cannabidiol,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(O)cc1CCCCC,C21H30O2,10004259.0
1097,R-1 Methanandamide Phosphate,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N[C@H](C)COP(=O)(O)O,C23H40NO5P,10004281.0
1098,16(S)-HETE,CCCC[C@H](O)/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O3,10004384.0
1099,16(R)-HETE,CCCC[C@@H](O)/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O3,10004385.0
1100,Sulindac,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)=O)cc1,C20H17FO3S,10004386.0
1101,Reversine,c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1,C21H27N7O,10004412.0
1102,4-hydroperoxy 2-Nonenal,CCCCCC(/C=C/C=O)OO,C9H16O3,10004413.0
1103,Fmoc-L-Leucine,CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O,C21H23NO4,10004888.0
1104,O-1918,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(OC)cc(C)cc1OC,C19H26O2,10004914.0
1105,"14,15-EE-(5Z)-E",CCCCC[C@H]1O[C@H]1CCCCCCC/C=C\CCCC(=O)O,C20H36O3,10004946.0
1106,(+)-5-trans Cloprostenol,O=C(O)CCC/C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,C22H29ClO6,10004970.0
1107,"N,N'-Dicyclohexylurea",O=C(NC1CCCCC1)NC1CCCCC1,C13H24N2O,10004971.0
1108,Leptomycin B,CCC(=C/[C@H](C)C/C=C/C(C)=C/[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C/C(C)=C/C(=O)O)/C=C/[C@@H]1OC(=O)C=C[C@@H]1C,C33H48O6,10004976.0
1109,Caylin-1,COc1ccc(C2=N[C@@H](c3ccc(Cl)c(Cl)c3)[C@@H](c3ccc(Cl)c(Cl)c3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,C30H28Cl4N4O4,10004985.0
1110,Stearidonic Acid methyl ester,CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC,C19H30O2,10005000.0
1111,Caylin-2,COc1ccc(C2=N[C@@H](c3ccc(C(F)(F)F)cc3)[C@@H](c3ccc(C(F)(F)F)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,C32H30F6N4O4,10005002.0
1112,BML-210,Nc1ccccc1NC(=O)CCCCCCC(=O)Nc1ccccc1,C20H25N3O2,10005019.0
1113,L-NMMA (acetate),CC(=O)O.CNC(=N)NCCC[C@H](N)C(=O)O,C9H20N4O4,10005031.0
1114,"5(S),6(R)-7-trihydroxymethyl Heptanoate",COC(=O)CCC[C@H](O)[C@H](O)CO,C8H16O5,10005032.0
1115,CAY10444,CCCCCCCCCCCC1N[C@H](C(=O)O)CS1,C15H29NO2S,10005033.0
1116,Eicosapentaenoic Acid-d5,[2H]C([2H])([2H])C([2H])([2H])/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H30O2,10005056.0
1117,Docosahexaenoic Acid-d5,[2H]C([2H])([2H])C([2H])([2H])/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C22H32O2,10005057.0
1118,CAY10434,CN(C)CCCCCCOc1ccc(-n2ccnc2)cc1,C17H25N3O,10005067.0
1119,CAY10455,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCOC(=O)Nc1ccc2c(c1)C(=O)OC21c2ccc(OC(C)=O)cc2Oc2cc(OC(C)=O)ccc21,C47H52N2O10,10005072.0
1120,AMC Arachidonoyl Amide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)Nc1ccc2c(C)cc(=O)oc2c1,C30H39NO3,10005098.0
1121,17(R)-HDHA,CC/C=C\C[C@@H](O)/C=C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C22H32O3,10005099.0
1122,Daidzein,O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12,C15H10O4,10005166.0
1123,Genistein,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,C15H10O5,10005167.0
1124,Quercetin (hydrate),O.O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,C15H12O8,10005169.0
1125,Matairesinol,COc1cc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(O)c(OC)c2)ccc1O,C20H22O6,10005174.0
1126,CAY10441,CC(C)Oc1ccc(Cc2ccc(NC3=NCCN3)cc2)cc1,C19H23N3O,10005186.0
1127,DAUDA,CN(C)c1cccc2c(S(=O)(=O)NCCCCCCCCCCC(=O)O)cccc12,C23H34N2O4S,10005188.0
1128,AM1172,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCNC(=O)c1ccc(O)cc1,C27H39NO2,10005223.0
1129,"2,3-DCPE (hydrochloride)",Cl.OCCNCCCOc1cccc(Cl)c1Cl,C11H16Cl3NO2,10005229.0
1130,AFMK,COc1ccc(NC=O)c(C(=O)CCNC(C)=O)c1,C13H16N2O4,10005254.0
1131,TOFA,CCCCCCCCCCCCCCOc1ccc(C(=O)O)o1,C19H32O4,10005263.0
1132,DL-threo-PDMP (hydrochloride),CCCCCCCCCC(=O)N[C@@H](CN1CCOCC1)[C@@H](O)c1ccccc1.Cl,C23H39ClN2O3,10005276.0
1133,Fenofibrate,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,C20H21ClO4,10005368.0
1134,Orlistat,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,C29H53NO5,10005426.0
1135,DDA,CCCCC/C=C/C=C/C=O,C10H16O,10005432.0
1136,Tafluprost (free acid),O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C(F)(F)COc2ccccc2)[C@H](O)C[C@@H]1O,C22H28F2O5,10005439.0
1137,Tafluprost,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C(F)(F)COc2ccccc2)[C@H](O)C[C@@H]1O,C25H34F2O5,10005440.0
1138,N-Arachidonoyl-L-Serine,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N[C@@H](CO)C(=O)O,C23H37NO4,10005455.0
1139,Oleoyl Ethyl Amide,CCCCCCCC/C=C\CCCCCCCC(=O)NCC,C20H39NO,10005459.0
1140,N-Arachidonoyl Taurine,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCS(=O)(=O)O,C22H37NO4S,10005537.0
1141,Y-27632 (hydrochloride),C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1.Cl.Cl,C14H23Cl2N3O,10005583.0
1142,N-Oleoyl Taurine,CCCCCCCC/C=C\CCCCCCCC(=O)NCCS(=O)(=O)O,C20H39NO4S,10005609.0
1143,N-Stearoyl Taurine,CCCCCCCCCCCCCCCCCC(=O)NCCS(=O)(=O)O,C20H41NO4S,10005610.0
1144,N-Palmitoyl Taurine,CCCCCCCCCCCCCCCC(=O)NCCS(=O)(=O)O,C18H37NO4S,10005611.0
1145,CAY10448,COc1cc(CNC(=O)CCCCCCC(C)C)c(I)cc1O,C18H28INO3,10005633.0
1146,Cerulenin,C/C=C/C/C=C/CCC(=O)[C@H]1O[C@H]1C(N)=O,C12H17NO3,10005647.0
1147,HU-331,C=C(C)[C@@H]1CCC(C)=C[C@H]1C1=C(O)C(=O)C(CCCCC)=CC1=O,C21H28O3,10005673.0
1148,NO-Indomethacin,COc1ccc2c(c1)c(CC(=O)SC[C@H](NC(C)=O)C(=O)OCCCCO[N+](=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1,C28H30ClN3O9S,10005705.0
1149,(2S)-OMPT,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](COP(O)(O)=S)OC.CCN(CC)CC.CCN(CC)CC,C34H73N2O6PS,10005707.0
1150,DL-.alpha.-Lipoic Acid,O=C(O)CCCCC1CCSS1,C8H14O2S2,10005728.0
1151,Clofibrate,CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1,C12H15ClO3,10956.0
1152,Arachidoyl Ethanolamide,CCCCCCCCCCCCCCCCCCCC(=O)NCCO,C22H45NO2,10005765.0
1153,Docosanoyl Ethanolamide,CCCCCCCCCCCCCCCCCCCCCC(=O)NCCO,C24H49NO2,10005823.0
1154,bis(7)-Tacrine,Cl.Cl.c1ccc2c(NCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,C35H46Cl2N4,10005836.0
1155,N-Decanoyl p-Nitroaniline,CCCCCCCCCC(=O)Nc1ccc([N+](=O)[O-])cc1,C16H24N2O3,10005851.0
1156,Pentafluorobenzenesulfonyl fluorescein,O=C1OC2(c3ccc(O)cc3Oc3cc(OS(=O)(=O)c4c(F)c(F)c(F)c(F)c4F)ccc32)c2ccccc21,C26H11F5O7S,10005983.0
1157,(R)-Butaprost (free acid),CCCC1([C@H](O)C/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)CCC1,C23H38O5,10006045.0
1158,Hesperetin,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O,C16H14O6,10006084.0
1159,Leelamine,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CN)CCC[C@]21C,C20H31N,10006148.0
1160,Leukotriene C4-d5,[2H]C([2H])([2H])C([2H])([2H])CCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O,C30H47N3O9S,10006198.0
1161,Leukotriene D4-d5,[2H]C([2H])([2H])C([2H])([2H])CCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](N)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O,C25H40N2O6S,10006199.0
1162,Silybin,COc1cc([C@H]2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3O[C@@H]2CO)ccc1O,C25H22O10,10006211.0
1163,AN-7,O=C(CCCCC1CCSS1)NCCCNC(=O)CCCCC1CCSS1,C19H34N2O2S4,10006212.0
1164,Fingolimod (hydrochloride),CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1.Cl,C19H34ClNO2,10006292.0
1165,D-NMAPPD,CCCCCCCCCCCCCC(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1,C23H38N2O5,10006305.0
1166,17.beta.-Estradiol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,C18H24O2,10006315.0
1167,Mifepristone,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,C29H35NO2,10006317.0
1168,Levonorgestrel,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC,C21H28O2,10006318.0
1169,Norgestrel,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4[C@H]3CC[C@@]21CC,C21H28O2,10006319.0
1170,Quinestrol,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC5CCCC5)ccc4[C@H]3CC[C@@]21C,C25H32O2,10006320.0
1171,Tibolone,C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C,C21H28O2,10006321.0
1172,"2,3-dinor Thromboxane B1",CCCCC[C@H](O)/C=C/[C@H]1OC(O)C[C@H](O)[C@@H]1CCCCC(=O)O,C18H32O6,10006330.0
1173,PDM 11,COc1cc(/C=C/c2ccc(Cl)cc2)cc(OC)c1,C16H15ClO2,10006341.0
1174,PDM 2,Clc1ccc(/C=C/c2cc(Cl)cc(Cl)c2)cc1,C14H9Cl3,10006342.0
1175,HU-211,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@H]1CC=C(CO)C[C@H]21,C25H38O3,10006350.0
1176,CAY10462,CN(C)CCCCCCOc1ccc(-n2ccnc2)cc1.Cl.Cl,C17H27Cl2N3O,10006400.0
1177,FTY720 (R)-Phosphate,CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1,C19H34NO5P,10006407.0
1178,FTY720 (S)-Phosphate,CCCCCCCCc1ccc(CC[C@](N)(CO)COP(=O)(O)O)cc1,C19H34NO5P,10006408.0
1179,Ro 48-8071,C=CCN(C)CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1,C23H27BrFNO2,10006415.0
1180,RITA,OCc1ccc(-c2ccc(-c3ccc(CO)s3)o2)s1,C14H12O3S2,10006426.0
1181,Berberine (chloride),COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],C20H18ClNO4,10006427.0
1182,DMPO,CC1(C)CCC=[N+]1[O-],C6H11NO,10006436.0
1183,SEW2871,FC(F)(F)c1cccc(-c2noc(-c3cc(-c4ccccc4)c(C(F)(F)F)s3)n2)c1,C20H10F6N2OS,10006440.0
1184,Pentacosanoic Acid methyl ester,CCCCCCCCCCCCCCCCCCCCCCCCC(=O)OC,C26H52O2,10006451.0
1185,CAY10486,COC(=O)[C@H](Cc1ccccc1)NC(=O)/C=C/c1ccc(O)cc1,C19H19NO4,10006452.0
1186,.omega.-3 Arachidonic Acid methyl ester,CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC,C21H34O2,10006454.0
1187,CAY10487,COC(=O)[C@H](C)NC(=O)/C=C/c1ccc(O)c(O)c1,C13H15NO5,10006480.0
1188,CAY10485,O=C(CCc1ccc(O)c(O)c1)N[C@@H](CC(=O)OCc1ccccc1)C(=O)OCc1ccccc1,C27H27NO7,10006482.0
1189,Estriol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O,C18H24O3,10006484.0
1190,Estrone,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O,C18H22O2,10006485.0
1191,Ethynyl Estradiol,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,C20H24O2,10006486.0
1192,Estradiol Benzoate,C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,C25H28O3,10006487.0
1193,Gestrinone,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21CC,C21H24O2,10006488.0
1194,Oleyl Anilide,CCCCCCCC/C=C\CCCCCCCC(=O)Nc1ccccc1,C24H39NO,10006529.0
1195,CAY10464,COc1ccc(/C=C/c2cc(Cl)cc(Cl)c2)cc1,C15H12Cl2O,10006545.0
1196,CAY10465,FC(F)(F)c1ccc(/C=C/c2cc(Cl)cc(Cl)c2)cc1,C15H9Cl2F3,10006546.0
1197,.gamma.-Linolenic Acid methyl ester,CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)OC,C19H32O2,10006579.0
1198,Dihomo-.gamma.-Linolenic Acid methyl ester,CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC,C21H36O2,10006580.0
1199,Retreversine,c1nc2c(Nc3ccc(N4CCOCC4)cc3)nc(NC3CCCCC3)nc2[nH]1,C21H27N7O,10006606.0
1200,Arachidonic Acid (sodium salt),CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)[O-].[Na+],C20H31NaO2,10006607.0
1201,Thromboxane B1,CCCCC[C@H](O)/C=C/[C@H]1OC(O)C[C@H](O)[C@@H]1CCCCCCC(=O)O,C20H36O6,10006610.0
1202,Lauric Acid,CCCCCCCCCCCC(=O)O,C12H24O2,10006626.0
1203,Palmitic Acid,CCCCCCCCCCCCCCCC(=O)O,C16H32O2,10006627.0
1204,Ketoprofen,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,C16H14O3,10006661.0
1205,(+)-15-epi Cloprostenol,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,C22H29ClO6,10006692.0
1206,HEPC,CCCCCCCCCCCCCCCC(=O)SCCOP(=O)([O-])OCC[N+](C)(C)C,C23H48NO5PS,10006695.0
1207,PD 98059,COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,C16H13NO3,10006726.0
1208,PD 169316,O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,C20H13FN4O2,10006727.0
1209,VDM11,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)Nc1ccc(O)cc1C,C27H39NO2,10006731.0
1210,QNZ,Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1,C22H20N4O,10006734.0
1211,CAY10471,CN(C1CCc2c(c3ccccc3n2CC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1,C21H21FN2O4S,10006735.0
1212,"Oleic Acid-2,6-diisopropylanilide",CCCCCCCC/C=C\CCCCCCCC(=O)Nc1c(C(C)C)cccc1C(C)C,C30H51NO,10006782.0
1213,Araguspongin B,C1CCC[C@H]2CCCN3CC[C@@H](CCCCCC[C@H]4CCCN5CC[C@@H](CC1)O[C@@H]45)O[C@@H]23,C28H50N2O2,10006797.0
1214,GW 0742,Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)c(F)c3)nc2C)ccc1OCC(=O)O,C21H17F4NO3S2,10006798.0
1215,(R)-Bromoenol lactone,O=C1O/C(=C/Br)CC[C@@H]1c1cccc2ccccc12,C16H13BrO2,10006800.0
1216,(S)-Bromoenol lactone,O=C1O/C(=C/Br)CC[C@H]1c1cccc2ccccc12,C16H13BrO2,10006801.0
1217,O-1602,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(C)cc(O)cc1O,C17H22O2,10006803.0
1218,O-1821,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(C)cc1O,C17H22O2,10006804.0
1219,O-1821 (CRM),C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(C)cc1O,C17H22O2,38028.0
1220,Stearidonic Acid ethyl ester,CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)CC,C20H32O,10006856.0
1221,nor-NOHA (acetate),CC(=O)O.CC(=O)O.N/C(=N\O)NCC[C@H](N)C(=O)O,C9H20N4O7,10006861.0
1222,cis-7-Hexadecenoic Acid methyl ester,CCCCCCCC/C=C\CCCCCC(=O)OC,C17H32O2,10006864.0
1223,Docosahexaenoic Acid methyl ester,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC,C23H34O2,10006865.0
1224,Tricosanoic Acid ethyl ester,CCCCCCCCCCCCCCCCCCCCCCC(=O)OCC,C25H50O2,10006874.0
1225,Diethylstilbestrol,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1,C18H20O2,10006876.0
1226,"8,12-iso-iPF2.alpha.-VI-d11",[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])/C=C\C[C@H]1[C@@H](/C=C/C(O)CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H34O5,10006878.0
1227,Zileuton,CC(c1cc2ccccc2s1)N(O)C(N)=O,C11H12N2O2S,10006967.0
1228,Thiocarlide,CC(C)CCOc1ccc(NC(=S)Nc2ccc(OCCC(C)C)cc2)cc1,C23H32N2O2S,10006976.0
1229,Prostaglandin E2-biotin,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)NCCCCCNC(=O)CCCC[C@H]1SC[C@@H]2NC(=O)N[C@@H]21,C35H58N4O6S,10006987.0
1230,Piloty's Acid,O=S(=O)(NO)c1ccccc1,C6H7NO3S,10006995.0
1231,3-keto Petromyzonol,C[C@H](CCCO)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4CC(=O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H40O4,10007055.0
1232,1-Palmitoyl-2-Linoleoyl-sn-glycero-3-PE,CCCCC/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C39H74NO8P,10007072.0
1233,4-(1-piperazinyl)-1H-Indole (hydrochloride),Cl.Cl.c1cc(N2CCNCC2)c2cc[nH]c2c1,C12H17Cl2N3,10007075.0
1234,CAY10491,CC(C)(C)OC(=O)c1ccc(CN2CCN(c3cccc4[nH]ccc34)CC2)cc1,C24H29N3O2,10007076.0
1235,CAY10492,CC(C)(C)OC(=O)N1CCN(c2cccc3[nH]ccc23)CC1,C17H23N3O2,10007077.0
1236,CAY10493,CC(C)(C)OC(=O)c1ccc(Cn2ccc3c(N4CCN(C(=O)OC(C)(C)C)CC4)cccc32)cc1,C29H37N3O4,10007078.0
1237,5-Bromoisoquinoline,Brc1cccc2cnccc12,C9H6BrN,10007079.0
1238,6-Bromoisoquinoline,Brc1ccc2cnccc2c1,C9H6BrN,10007080.0
1239,7-Bromoisoquinoline,Brc1ccc2ccncc2c1,C9H6BrN,10007081.0
1240,8-Bromoisoquinoline,Brc1cccc2ccncc12,C9H6BrN,10007082.0
1241,"5,6,7,8-tetrahydro-2-Quinolone",O=c1ccc2c([nH]1)CCCC2,C9H11NO,10007083.0
1242,4-Cyanoindole,N#Cc1cccc2[nH]ccc12,C9H6N2,10007084.0
1243,4-Aminomethylindole,NCc1cccc2[nH]ccc12,C9H10N2,10007085.0
1244,4-formyl Indole,O=Cc1cccc2[nH]ccc12,C9H7NO,10007086.0
1245,(1H-Indol-4-yl)-Carbamic Acid tert-butyl ester,CC(C)(C)OC(=O)Nc1cccc2[nH]ccc12,C13H16N2O2,10007087.0
1246,N-(diphenylmethylene) Glycine benzyl ester,O=C(CN=C(c1ccccc1)c1ccccc1)OCc1ccccc1,C22H19NO2,10007089.0
1247,(S)-(+)-2-hydroxy-3-Methylbutyric Acid,CC(C)[C@H](O)C(=O)O,C5H10O3,10007090.0
1248,"N,N-dimethyl-L-Valine",CC(C)[C@@H](C(=O)O)N(C)C,C7H15NO2,10007091.0
1249,N-Pivaloylaniline,CC(C)(C)C(=O)Nc1ccccc1,C11H15NO,10007092.0
1250,2-Aminopyrazine,Nc1cnccn1,C4H5N3,10007093.0
1251,"7-chlorothieno[2,3-c]Pyridine",Clc1nccc2ccsc12,C7H4ClNS,10007094.0
1252,3-thio-Pheneacrylic Acid methyl ester,COC(=O)/C=C/c1ccsc1,C8H8O2S,10007102.0
1253,3-thio-Pheneacrylic Acid,O=C(O)/C=C/c1ccsc1,C7H6O2S,10007103.0
1254,2-Aminomethylpyrimidine (hydrochloride),Cl.NCc1ncccn1,C5H8ClN3,10007106.0
1255,2-Pyrimidin-2-yl-Propionic Acid,CC(C(=O)O)c1ncccn1,C7H8N2O2,10007108.0
1256,3-Pyrimidin-2-yl-Propionic Acid,O=C(O)CCc1ncccn1,C7H8N2O2,10007109.0
1257,3-Pyrimidin-2-yl-2-pyrimidin-2-ylmethyl-Propionic Acid,O=C(O)C(Cc1ncccn1)Cc1ncccn1,C12H12N4O2,10007110.0
1258,Pyrimidin-4-yl-Methanol,OCc1ccncn1,C5H6N2O,10007111.0
1259,2-(hydroxymethyl)-Pyrimidine,OCc1ncccn1,C5H6N2O,10007112.0
1260,Pyrimidine-4-Carboxylic Acid (sodium salt),O=C([O-])c1ccncn1.[Na+],C5H3N2NaO2,10007113.0
1261,methyl 4-Pyrimidine Carboxylate,COC(=O)c1ccncn1,C6H6N2O2,10007114.0
1262,2-Pyrimidine Acetic Acid,O=C(O)Cc1ncccn1,C6H6N2O2,10007116.0
1263,2-methyl-3-Pyrimidin-2-yl-Propionic Acid,CC(Cc1ncccn1)C(=O)O,C8H10N2O2,10007118.0
1264,methyl 2-Pyrimidine Carboxylate,COC(=O)c1ncccn1,C6H6N2O2,10007119.0
1265,2-cyano-Pyrimidine,N#Cc1ncccn1,C5H3N3,10007121.0
1266,2-(chloromethyl)-Pyrimidine (hydrochloride),Cl.ClCc1ncccn1,C5H6Cl2N2,10007122.0
1267,2-carboxy-Pyrimidine,O=C(O)c1ncccn1,C5H4N2O2,10007123.0
1268,4-Pyrimidine Methanamine (hydrochloride),Cl.NCc1ccncn1,C5H8ClN3,10007124.0
1269,8-Isoquinoline methanamine (hydrochloride),Cl.Cl.NCc1cccc2ccncc12,C10H12Cl2N2,10007125.0
1270,CAY10494,CC(C)(C)OC(=O)c1ccc(CN2CCN(c3nccc4ccsc34)CC2)cc1,C23H27N3O2S,10007126.0
1271,5-Chlororesorcinol dimethyl ether,COc1cc(Cl)cc(OC)c1,C8H9ClO2,10007127.0
1272,R-(-)-Mandelic Acid,O=C(O)[C@H](O)c1ccccc1,C8H8O3,10007128.0
1273,tert-butyl p-(bromomethyl) Benzoate,CC(C)(C)OC(=O)c1ccc(CBr)cc1,C12H15BrO2,10007129.0
1274,tert-butyl p-Toluate,Cc1ccc(C(=O)OC(C)(C)C)cc1,C12H16O2,10007130.0
1275,"5,6,7,8-tetrahydro-2-Naphthoic Acid",O=C(O)c1ccc2c(c1)CCCC2,C11H12O2,10007131.0
1276,(R)-(-)-2-Phenylglycinol,N[C@@H](CO)c1ccccc1,C8H11NO,10007132.0
1277,CMPF,CCCc1oc(CCC(=O)O)c(C(=O)O)c1C,C12H16O5,10007133.0
1278,5-Bromotetralone,O=C1CCCc2c(Br)cccc21,C10H9BrO,10007134.0
1279,7-Bromotetralone,O=C1CCCc2ccc(Br)cc21,C10H9BrO,10007135.0
1280,"7-Piperazin-1-yl-thieno[2,3-c] Pyridine (hydrochloride)",Cl.c1cc2ccsc2c(N2CCNCC2)n1,C11H14ClN3S,10007136.0
1281,"2-methyl-1,3-Cyclohexanedione",CC1C(=O)CCCC1=O,C7H10O2,10007138.0
1282,(R)-benzyl Mandelate,O=C(OCc1ccccc1)[C@H](O)c1ccccc1,C15H14O3,10007145.0
1283,8-piperazin-1-yl-Isoquinoline (hydrochloride),Cl.c1cc(N2CCNCC2)c2cnccc2c1,C13H16ClN3,10007146.0
1284,6-piperazin-1-yl-Isoquinoline (hydrochloride),Cl.c1cc2cc(N3CCNCC3)ccc2cn1,C13H16ClN3,10007148.0
1285,Leukotriene C4 methyl ester,CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)OC,C31H49N3O9S,10007164.0
1286,Leukotriene E4 methyl ester,CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](N)C(=O)O)[C@@H](O)CCCC(=O)OC,C24H39NO5S,10007166.0
1287,Cetaben,CCCCCCCCCCCCCCCCNc1ccc(C(=O)O)cc1,C23H39NO2,10007171.0
1288,Microcystin-LR,C=C1C(=O)N[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(=O)O)[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](/C=C/C(C)=C/[C@H](C)[C@H](Cc2ccccc2)OC)[C@H](C)C(=O)N[C@@H](C(=O)O)CCC(=O)N1C,C49H74N10O12,10007188.0
1289,Nodularin,C/C=C1/C(=O)N[C@H](C(=O)O)[C@@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](/C=C/C(C)=C/[C@@H](C)[C@@H](Cc2ccccc2)OC)[C@@H](C)C(=O)N[C@H](C(=O)O)CCC(=O)N1C,C41H60N8O10,10007190.0
1290,tetranor-12(S)-HETE,CCCCC/C=C\C[C@H](O)/C=C/C=C\CCC(=O)O,C16H26O3,10007207.0
1291,Resolvin D2,CC/C=C\C[C@H](O)[C@H](O)/C=C/C=C/C=C\C=C\[C@@H](O)C/C=C\CCC(=O)O,C22H32O5,10007279.0
1292,N-Lignoceroyl Taurine,CCCCCCCCCCCCCCCCCCCCCCCC(=O)NCCS(=O)(=O)O,C26H53NO4S,10007286.0
1293,N-Nervonoyl Taurine,CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)NCCS(=O)(=O)O,C26H51NO4S,10007287.0
1294,N-Docosanoyl Taurine,CCCCCCCCCCCCCCCCCCCCCC(=O)NCCS(=O)(=O)O,C24H49NO4S,10007288.0
1295,"cis-4,10,13,16-Docosatetraenoic Acid",CCCCC/C=C\C/C=C\C/C=C\CCCC/C=C\CCC(=O)O,C22H36O2,10007289.0
1296,cis-7-Hexadecenoic Acid,CCCCCCCC/C=C\CCCCCC(=O)O,C16H30O2,10007290.0
1297,"Arachidonoyl-N,N-dimethyl amide",CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N(C)C,C22H37NO,10007293.0
1298,Arachidonoyl-N-methyl amide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NC,C21H35NO,10007294.0
1299,Arachidonoyl amide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(N)=O,C20H33NO,10007295.0
1300,TGX-221,Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1,C21H24N4O2,10007349.0
1301,Palmitic Acid methyl ester,CCCCCCCCCCCCCCCC(=O)OC,C17H34O2,10007358.0
1302,Combrestatin A4,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O,C18H20O5,10007412.0
1303,10-Thiastearic Acid,CCCCCCCCSCCCCCCCCC(=O)O,C17H34O2S,10007417.0
1304,N-Arachidonoyl Dopamine-d8,[2H]/C(CCCCC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCC(=O)NCCc1ccc(O)c(O)c1,C28H41NO3,10007431.0
1305,Vinclozolin M2,C=CC(C)(O)C(=O)Nc1cc(Cl)cc(Cl)c1,C11H11Cl2NO2,10007452.0
1306,URB602,O=C(Nc1cccc(-c2ccccc2)c1)OC1CCCCC1,C19H21NO2,10007457.0
1307,"L-Glutathione, reduced",N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O,C10H17N3O6S,10007461.0
1308,Arachidonic Acid-biotin,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C35H58N4O3S,10007466.0
1309,N-Arachidonyl Maleimide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCN1C(=O)C=CC1=O,C24H35NO2,10007517.0
1310,Capsazepine,Oc1cc2c(cc1O)CN(C(=S)NCCc1ccc(Cl)cc1)CCC2,C19H21ClN2O2S,10007518.0
1311,Arachidonoyl Glycine-d8,[2H]/C(CCCCC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCC(=O)NCC(=O)O,C22H35NO3,10007531.0
1312,Docosahexaenoyl Ethanolamide,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCO,C24H37NO2,10007534.0
1313,Tetradecyl Phosphonate,CCCCCCCCCCCCCCP(=O)(O)O,C14H31O3P,10007565.0
1314,5.alpha.-hydroxy-6-keto Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC(=O)[C@@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O3,10007601.0
1315,.DELTA.2-cis Eicosenoic Acid,CCCCCCCCCCCCCCCCC/C=C\C(=O)O,C20H38O2,10007602.0
1316,.DELTA.2-trans Eicosenoic Acid,CCCCCCCCCCCCCCCCC/C=C/C(=O)O,C20H38O2,10007622.0
1317,(S)-H-1152 (hydrochloride),Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12.Cl.Cl,C16H23Cl2N3O2S,10007653.0
1318,L-Biopterin,C[C@H](O)[C@H](O)c1c[nH]c2nc(N)nc(=O)c-2n1,C9H11N5O3,10007662.0
1319,Acetyl Podocarpic Acid Anhydride,CC(=O)Oc1ccc2c(c1)[C@@]1(C)CCC[C@](C)(C(=O)OC(=O)[C@@]3(C)CCC[C@]4(C)c5cc(OC(C)=O)ccc5CC[C@@H]34)[C@@H]1CC2,C38H46O7,10007686.0
1320,URB754,Cc1ccc(Nc2nc3ccc(C)cc3c(=O)o2)cc1,C16H14N2O2,10007691.0
1321,Licofelone,CC1(C)Cc2c(-c3ccccc3)c(-c3ccc(Cl)cc3)c(CC(=O)O)n2C1,C23H22ClNO2,10007692.0
1322,N-Palmitoyl Dopamine,CCCCCCCCCCCCCCCC(=O)NCCc1ccc(O)c(O)c1,C24H41NO3,10007697.0
1323,N-(3-hydroxyphenyl)-Arachidonoyl amide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)Nc1cccc(O)c1,C26H37NO2,10007704.0
1324,.alpha.-CEHC,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCC(=O)O)O2,C16H22O4,10007705.0
1325,.delta.-CEHC,Cc1cc(O)cc2c1OC(C)(CCC(=O)O)CC2,C14H18O4,10007706.0
1326,AS-605240,O=C1NC(=O)/C(=C/c2ccc3nccnc3c2)S1,C12H7N3O2S,10007707.0
1327,"PtdIns-(1,2-dipalmitoyl) (ammonium salt)",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCC.[NH4+],C41H82NO13P,10007710.0
1328,"PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt)",CCCCCCCC(=O)OC[C@H](COP(=O)([O-])O[C@H]1[C@H](O)[C@@H](O)[C@H](OP(=O)([O-])O)[C@@H](O)[C@H]1O)OC(=O)CCCCCCC.[NH4+].[NH4+],C25H54N2O16P2,10007711.0
1329,"L-902,688",O=C1CC[C@H](/C=C/[C@@H](O)C(F)(F)c2ccccc2)N1CCCCCCc1nnn[nH]1,C21H27F2N5O2,10007712.0
1330,HMB-Val-Ser-Leu-VE,CCOC(=O)/C=C/[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)c1cccc(O)c1C)C(C)C,C26H39N3O7,10007713.0
1331,Lipoxin A4-d5,[2H]C([2H])([2H])C([2H])([2H])CCC[C@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)CCCC(=O)O,C20H32O5,10007737.0
1332,N-Cyclohexanecarbonylpentadecylamine,CCCCCCCCCCCCCCCNC(=O)C1CCCCC1,C22H43NO,10007739.0
1333,19(S)-HETE,C[C@H](O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O3,10007766.0
1334,19(R)-HETE,C[C@@H](O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O3,10007767.0
1335,"D-myo-Inositol-1,4,5,6-tetraphosphate (sodium salt)",O=P([O-])(O)O[C@@H]1[C@@H](OP(=O)([O-])O)[C@H](OP(=O)([O-])O)[C@@H](O)[C@@H](O)[C@H]1OP(=O)([O-])O.[Na+].[Na+].[Na+].[Na+],C6H12Na4O18P4,10007783.0
1336,"13,14-dihydro-15-keto Prostaglandin F2.alpha.-d4",[2H]C([2H])(/C=C\C[C@@H]1[C@@H](CCC(=O)CCCCC)[C@H](O)C[C@@H]1O)C([2H])([2H])CC(=O)O,C20H34O5,10007793.0
1337,Epoxomicin,CC[C@H](C)[C@H](NC(=O)[C@H]([C@@H](C)CC)N(C)C(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1)[C@@H](C)O,C28H50N4O7,10007806.0
1338,Oleoyl Ethanolamide-d2,[2H]C([2H])(/C=C\CCCCCCCC(=O)NCCO)CCCCCCC,C20H39NO2,10007823.0
1339,Pargyline (hydrochloride),C#CCN(C)Cc1ccccc1.Cl,C11H14ClN,10007852.0
1340,Leukotriene E4-d5,[2H]C([2H])([2H])C([2H])([2H])CCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](N)C(=O)O)[C@@H](O)CCCC(=O)O,C23H37NO5S,10007858.0
1341,"1,2-Dioleoyl-rac-glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC/C=C\CCCCCCCC,C39H72O5,10007863.0
1342,CAY10499,COc1nn(-c2ccc(NC(=O)OCc3ccccc3)c(C)c2)c(=O)o1,C18H17N3O5,10007875.0
1343,N-3-oxo-dodecanoyl-L-Homoserine lactone,CCCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,C16H27NO4,10007895.0
1344,N-hexanoyl-L-Homoserine lactone,CCCCCC(=O)N[C@H]1CCOC1=O,C10H17NO3,10007896.0
1345,N-hexanoyl-L-Homoserine lactone-d3,[2H]C([2H])([2H])CCCCC(=O)N[C@H]1CCOC1=O,C10H17NO3,10007897.0
1346,N-butyryl-L-Homoserine lactone,CCCC(=O)N[C@H]1CCOC1=O,C8H13NO3,10007898.0
1347,N-butyryl-L-Homoserine lactone-d5,[2H]C([2H])([2H])C([2H])([2H])CC(=O)N[C@H]1CCOC1=O,C8H13NO3,10007899.0
1348,"8,11,14-Eicosatriynoic Acid",CCCCCC#CCC#CCC#CCCCCCCC(=O)O,C20H28O2,10007900.0
1349,Sphingosine (d15:1),CCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO,C15H31NO2,10007901.0
1350,Sphingosine (d17:1),CCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO,C17H35NO2,10007902.0
1351,Sphingosine (d20:1),CCCCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO,C20H41NO2,10007903.0
1352,Arachidonoyl-1-thio-Glycerol,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)SCC(O)CO,C23H38O3S,10007904.0
1353,Sphingosine (d18:1),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO,C18H37NO2,10007907.0
1354,20-carboxy Arachidonic Acid,O=C(O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O,C20H30O4,10007912.0
1355,CUDA,O=C(O)CCCCCCCCCCCNC(=O)NC1CCCCC1,C19H36N2O3,10007923.0
1356,AUDA,O=C(O)CCCCCCCCCCCNC(=O)NC12CC3CC(CC(C3)C1)C2,C23H40N2O3,10007927.0
1357,Sphinganine (d18:0),CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO,C18H39NO2,10007945.0
1358,C16 Sphingomyelin (d18:1/16:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCC,C39H79N2O6P,10007946.0
1359,Sphingomyelin (chicken egg),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCC,C39H79N2O6P,24345.0
1360,D-erythro Lysosphingomyelin (d18:1),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)COP(=O)([O-])OCC[N+](C)(C)C,C23H49N2O5P,10007947.0
1361,CAY10498,c1ccc(Nc2nc(NC3CC4CCC3C4)c3nc[nH]c3n2)cc1,C18H20N6,10007955.0
1362,C6 NBD dihydro Ceramide (d18:0/6:0),CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=O)CCCCCNc1ccc([N+](=O)[O-])c2nonc12,C30H51N5O6,10007957.0
1363,C12 NBD Ceramide (d18:1/12:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12,C36H61N5O6,10007958.0
1364,E-64,CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)NCCCCNC(=N)N,C15H27N5O5,10007963.0
1365,E-64c,CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)O,C15H26N2O5,10007964.0
1366,FK-506,C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,C44H69NO12,10007965.0
1367,SLF,CCC(C)(C)C(=O)C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(N)c1,C30H40N2O6,10007974.0
1368,"3,4-DAA",COc1ccc(/C=C/C(=O)Nc2c(O)cccc2C(=O)O)cc1OC,C18H17NO6,10007980.0
1369,SPD-304,Cc1cc2occ(CN(C)CCN(C)Cc3cn(-c4cccc(C(F)(F)F)c4)c4ccccc34)c(=O)c2cc1C,C32H32F3N3O2,10008012.0
1370,9-Nitrooleate,CCCCCCCC/C=C(\CCCCCCCC(=O)O)[N+](=O)[O-],C18H33NO4,10008042.0
1371,10-Nitrooleate,CCCCCCCC/C(=C\CCCCCCCC(=O)O)[N+](=O)[O-],C18H33NO4,10008043.0
1372,C12 NBD dihydro Ceramide (d18:0/12:0),CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12,C36H63N5O6,10008097.0
1373,"PtdIns-(1,2-dioctanoyl) (sodium salt)",CCCCCCCC(=O)OC[C@H](COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCC.[Na+],C25H46NaO13P,10008099.0
1374,"PtdIns-(4,5)-P2 (1,2-dipalmitoyl) (sodium salt)",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(=O)([O-])O)[C@H](OP(=O)([O-])O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCC.[Na+].[Na+].[Na+],C41H78Na3O19P3,10008115.0
1375,ent-Prostaglandin F2.alpha.,CCCCC[C@@H](O)/C=C/[C@H]1[C@H](C/C=C\CCCC(=O)O)[C@H](O)C[C@@H]1O,C20H34O5,10008122.0
1376,cis-.DELTA.2-11-methyl-Dodecenoic Acid,CC(C)CCCCCCC/C=C\C(=O)O,C13H24O2,10008123.0
1377,15(R)-17-phenyl trinor Prostaglandin F2.alpha. ethyl amide,CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C25H37NO4,10008127.0
1378,"10(S),17(S)-DiHDHA",CC/C=C\C[C@H](O)/C=C/C=C\C=C\[C@@H](O)C/C=C\C/C=C\CCC(=O)O,C22H32O4,10008128.0
1379,JNJ-10198409,COc1cc2c(cc1OC)-c1[nH]nc(Nc3cccc(F)c3)c1C2,C18H16FN3O2,10008131.0
1380,5-trans-17-phenyl trinor Prostaglandin F2.alpha. ethyl amide,CCNC(=O)CCC/C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C25H37NO4,10008132.0
1381,Stearic Acid ethyl ester,CCCCCCCCCCCCCCCCCC(=O)OCC,C20H40O2,10008196.0
1382,Myristic Acid ethyl ester,CCCCCCCCCCCCCC(=O)OCC,C16H32O2,10008197.0
1383,Linoleic Acid ethyl ester,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC,C20H36O2,10008198.0
1384,?-Linolenic Acid ethyl ester,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OCC,C20H34O2,10008199.0
1385,Arachidonic Acid ethyl ester,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC,C22H36O2,10008200.0
1386,Oleic Acid ethyl ester,CCCCCCCC/C=C\CCCCCCCC(=O)OCC,C20H38O2,10008201.0
1387,Palmitic Acid ethyl ester,CCCCCCCCCCCCCCCC(=O)OCC,C18H36O2,10008202.0
1388,Lauric Acid ethyl ester,CCCCCCCCCCCC(=O)OCC,C14H28O2,10008203.0
1389,Palmitoleic Acid ethyl ester,CCCCCC/C=C\CCCCCCCC(=O)OCC,C18H34O2,10008204.0
1390,"D-myo-Inositol-1,4,5-triphosphate (sodium salt)",O=P([O-])(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(=O)([O-])O)[C@H](OP(=O)([O-])O)[C@H]1O.[Na+].[Na+].[Na+],C6H12Na3O15P3,10008205.0
1391,Zafirlukast,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,C31H33N3O6S,10008282.0
1392,N-acetyl-2-carboxy Benzenesulfonamide,CC(=O)NS(=O)(=O)c1ccccc1C(=O)O,C9H9NO5S,10008284.0
1393,ent-Prostaglandin E2,CCCCC[C@@H](O)/C=C/[C@H]1[C@H](C/C=C\CCCC(=O)O)C(=O)C[C@@H]1O,C20H32O5,10008294.0
1394,GW 610,COc1ccc(-c2nc3cc(F)ccc3s2)cc1OC,C15H12FNO2S,10008313.0
1395,N-Cyclohexanecarbonyltetradecylamine,CCCCCCCCCCCCCCNC(=O)C1CCCCC1,C21H41NO,10008317.0
1396,Montelukast (sodium salt),CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)[O-])CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1.[Na+],C35H35ClNNaO3S,10008318.0
1397,Pranlukast,O=C(Nc1cccc2c(=O)cc(-c3nnn[nH]3)oc12)c1ccc(OCCCCc2ccccc2)cc1,C27H23N5O4,10008319.0
1398,trans-.DELTA.2-11-methyl-Dodecenoic Acid,CC(C)CCCCCCC/C=C/C(=O)O,C13H24O2,10008321.0
1399,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",CCCC/C=C/C=C/C=C\CCCCCCCC(=O)OC,C19H32O2,10008333.0
1400,Gabapentin,NCC1(CC(=O)O)CCCCC1,C9H17NO2,10008346.0
1401,Gabapentin (CRM),NCC1(CC(=O)O)CCCCC1,C9H17NO2,37860.0
1402,"9(Z),11(E),13(E)-Octadecatrienoic Acid",CCCC/C=C/C=C\C=C/CCCCCCCC(=O)O,C18H30O2,10008349.0
1403,"9(Z),11(E),13(E)-Octadecatrienoic Acid ethyl ester",CCCC/C=C/C=C/C=C\CCCCCCCC(=O)OCC,C20H34O2,10008350.0
1404,AL 8810 methyl ester,COC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@H](O)C2Cc3ccccc3C2)[C@@H](F)C[C@@H]1O,C25H33FO4,10008370.0
1405,.alpha.-Tocotrienol,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC[C@]1(C)CCc2c(C)c(O)c(C)c(C)c2O1,C29H44O2,10008377.0
1406,Prostaglandin D2 methyl ester,CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)OC,C21H34O5,10008385.0
1407,"PtdIns-(3)-P1 (1,2-dioctanoyl) (sodium salt)",CCCCCCCC(=O)OC[C@H](COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](OP(=O)([O-])O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCC.[Na+].[Na+],C25H46Na2O16P2,10008394.0
1408,"D-myo-Inositol-1,5,6-triphosphate (sodium salt)",O=P([O-])(O)O[C@H]1[C@H](OP(=O)([O-])O)[C@H](O)[C@H](O)[C@@H](O)[C@@H]1OP(=O)([O-])O.[Na+].[Na+].[Na+],C6H12Na3O15P3,10008422.0
1409,D-myo-Inositol-4-phosphate (ammonium salt),O=P([O-])(O)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O.[NH4+],C6H16NO9P,10008437.0
1410,"D-myo-Inositol-1,2-diphosphate (sodium salt)",O=P([O-])(O)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OP(=O)([O-])O.[Na+].[Na+],C6H12Na2O12P2,10008439.0
1411,"D-myo-Inositol-1,3,4,6-tetraphosphate (ammonium salt)",O=P([O-])(O)O[C@@H]1[C@@H](O)[C@H](OP(=O)([O-])O)[C@@H](OP(=O)([O-])O)[C@@H](O)[C@H]1OP(=O)([O-])O.[NH4+].[NH4+].[NH4+].[NH4+],C6H28N4O18P4,10008442.0
1412,"D-myo-Inositol-1,3-diphosphate (sodium salt)",O=P([O-])(O)O[C@@H]1[C@H](O)[C@H](OP(=O)([O-])O)[C@@H](O)[C@H](O)[C@H]1O.[Na+].[Na+],C6H12Na2O12P2,10008443.0
1413,3-methoxy Limaprost,CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCC(CC(=O)O)OC,C23H40O6,10008445.0
1414,.gamma.-Tocotrienol,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC[C@]1(C)CCc2cc(O)c(C)c(C)c2O1,C28H42O2,10008494.0
1415,15(R)-Pinane Thromboxane A2,CCCCC[C@@H](O)/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)C2(C)C,C24H40O3,10008510.0
1416,.delta.-Tocotrienol,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC[C@]1(C)CCc2cc(O)cc(C)c2O1,C27H40O2,10008513.0
1417,Tienilic Acid,O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl,C13H8Cl2O4S,10008517.0
1418,4'-hydroxy Diclofenac,O=C(O)Cc1ccccc1Nc1c(Cl)cc(O)cc1Cl,C14H11Cl2NO3,10008518.0
1419,6.beta.-hydroxy Testosterone (DEA Schedule III),C[C@]12CC[C@H]3[C@@H](C[C@@H](O)C4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,C19H28O3,10008519.0
1420,4-hydroxy Tolbutamide,CCCCNC(=O)NS(=O)(=O)c1ccc(CO)cc1,C12H18N2O4S,10008520.0
1421,8-iso-15-keto Prostaglandin F2.beta.,CCCCCC(=O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@H](O)C[C@H]1O,C20H32O5,10008539.0
1422,Myristoleic Acid methyl ester,CCCC/C=C\CCCCCCCC(=O)OC,C15H28O2,10008581.0
1423,5-cis Iloprost,CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C\CCCC(=O)O)C[C@H]2C[C@H]1O,C22H32O4,10008585.0
1424,PSN375963,CCCCC1CCC(c2nc(-c3ccncc3)no2)CC1,C17H23N3O,10008593.0
1425,PSN632408,CC(C)(C)OC(=O)N1CCC(OCc2nc(-c3ccncc3)no2)CC1,C18H24N4O4,10008594.0
1426,20-HETE Ethanolamide,O=C(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCO)NCCO,C22H37NO3,10008602.0
1427,S-NEPC,O=C(OC[C@@H]1O[C@H]1c1ccccc1)Oc1ccc([N+](=O)[O-])cc1,C16H13NO6,10008609.0
1428,Epoxy Fluor 7,COc1ccc2cc(C(C#N)OC(=O)OCC3OC3c3ccccc3)ccc2c1,C23H19NO5,10008610.0
1429,azido-FTY720,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1N=[N+]=[N-],C19H32N4O2,10008612.0
1430,GW 7647,CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(=O)O,C29H46N2O3S,10008613.0
1431,Leelamine (hydrochloride),CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CN)CCC[C@]21C.Cl,C20H32ClN,10008614.0
1432,Lauric Acid Leelamide,CCCCCCCCCCCC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3CC[C@@H]12,C32H53NO,10008618.0
1433,oxy-Arachidonoyl Ethanolamide,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NOCCO,C22H37NO3,10008642.0
1434,"1,2-Dihexanoyl-sn-glycerol",CCCCCC(=O)OC[C@H](CO)OC(=O)CCCCC,C15H28O5,10008646.0
1435,11.alpha.-hydroxy Testosterone (DEA Schedule III),C[C@]12C[C@@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,C19H28O3,10008647.0
1436,"1,2-Dipalmitoyl-sn-glycerol",CCCCCCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCCCCCCCCC,C35H68O5,10008648.0
1437,1-Stearoyl-2-Arachidonoyl-sn-Glycerol,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@@H](CO)COC(=O)CCCCCCCCCCCCCCCCC,C41H72O5,10008650.0
1438,Pinolenic Acid,CCCCC/C=C\C/C=C\CC/C=C\CCCC(=O)O,C18H30O2,10008654.0
1439,Pinolenic Acid methyl ester,CCCCC/C=C\C/C=C\CC/C=C\CCCC(=O)OC,C19H32O2,10008656.0
1440,CAY10502,CCCCCCCCCCOc1ccc(OCC(=O)Cn2cc(C(=O)OC)c3cc(C(=O)O)ccc32)cc1,C30H37NO7,10008657.0
1441,Pinolenic Acid ethyl ester,CCCCC/C=C\C/C=C\CC/C=C\CCCC(=O)OCC,C20H34O2,10008658.0
1442,JP83,NC(=O)c1cccc(-c2cccc(OC(=O)NCCCCCCc3ccccc3)c2)c1,C26H28N2O3,10008660.0
1443,JP104,C#CCCCCCCCCCNC(=O)Oc1cccc(-c2cccc(C(N)=O)c2)c1,C25H30N2O3,10008661.0
1444,Prostaglandin F1.alpha.-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C[C@H](O)/C=C/[C@@H]1[C@@H](CCCCCCC(=O)O)[C@@H](O)C[C@H]1O,C20H36O5,10008665.0
1445,CAY10508,O=C1C(c2ccccc2)N(c2ccc(Br)cc2)C(=O)N1c1ccc(Br)cc1,C21H14Br2N2O2,10008669.0
1446,"13,14-dihydro-15-keto Prostaglandin J2",CCCCCC(=O)CC[C@H]1C(=O)C=C[C@@H]1C/C=C\CCCC(=O)O,C20H30O4,10008840.0
1447,Propylpyrazole Triol,CCCc1cn(-c2ccc(O)cc2)nc1-c1ccc(O)cc1,C18H18N2O2,10008841.0
1448,"2,3-bis (4-Hydroxyphenyl) Propionitrile",N#CC(Cc1ccc(O)cc1)c1ccc(O)cc1,C15H13NO2,10008842.0
1449,1-Linoleoyl Glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(O)CO,C21H38O4,10008869.0
1450,CAY10503,Oc1ccc(-c2ccc(-c3cc(O)cc(O)c3)cc2)cc1,C18H14O3,10008872.0
1451,13(S)-HODE methyl ester,CCCCC[C@H](O)/C=C/C=C\CCCCCCCC(=O)OC,C19H34O3,10008875.0
1452,3-(N-Maleimidopropionyl)-biocytin,O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)NCCCC[C@H](NC(=O)CCN1C(=O)C=CC1=O)C(=O)O,C23H33N5O7S,10008879.0
1453,Eicosapentaenoic Acid ethyl ester,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC,C22H34O2,10008884.0
1454,"(+)-2,5-epi-Goniothalesdiol",COC(=O)CC[C@H]1O[C@@H](c2ccccc2)[C@@H](O)[C@@H]1O,C14H18O5,10008887.0
1455,GW 9508,O=C(O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1,C22H21NO3,10008907.0
1456,11.beta.-Prostaglandin F2.alpha.-d4,[2H]C([2H])(/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)[C@@H](O)C[C@@H]1O)C([2H])([2H])CC(=O)O,C20H34O5,10008989.0
1457,CAY10514,CCCCCOc1ccccc1C(O)CC#CCCCC(=O)OC,C20H28O4,10009017.0
1458,JWH 015,CCCn1c(C)c(C(=O)c2cccc3ccccc23)c2ccccc21,C23H21NO,10009018.0
1459,N-Palmitoyl Glycine,CCCCCCCCCCCCCCCC(=O)NCC(=O)O,C18H35NO3,10009020.0
1460,AVE-1625,CS(=O)(=O)N(c1cc(F)cc(F)c1)C1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)C1,C23H20Cl2F2N2O2S,10009021.0
1461,(S)-SLV 319,C/N=C(\NS(=O)(=O)c1ccc(Cl)cc1)N1C[C@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1,C23H20Cl2N4O2S,10009022.0
1462,"(+)-WIN 55,212-2 (mesylate)",CS(=O)(=O)O.Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3,C28H30N2O6S,10009023.0
1463,homo-Tienilic Alcohol,O=C(c1cccs1)c1ccc(OCCCO)c(Cl)c1Cl,C14H12Cl2O3S,10009026.0
1464,6-hydroxy Chlorzoxazone,O=c1[nH]c2cc(Cl)c(O)cc2o1,C7H4ClNO3,10009029.0
1465,tetranor-PGDM-d6,[2H]C([2H])(CC(=O)CC[C@H]1C(=O)C[C@H](O)[C@@H]1CCC(=O)O)C([2H])([2H])C([2H])([2H])C(=O)O,C16H24O7,10009039.0
1466,AS-252424,O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1,C14H8FNO4S,10009052.0
1467,CAY10505,O=C1NC(=O)/C(=C\c2ccc(-c3ccc(F)cc3)o2)S1,C14H8FNO3S,10009078.0
1468,CAY10506,O=C(CCCCC1CCSS1)NCCOc1ccc(CC2SC(=O)NC2=O)cc1,C20H26N2O4S3,10009079.0
1469,Didox,O=C(NO)c1ccc(O)c(O)c1,C7H7NO4,10009081.0
1470,Trimidox,N=C(NO)c1cc(O)c(O)c(O)c1,C7H8N2O4,10009083.0
1471,U-18666A,CCN(CC)CCO[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)OCC[C@@H]32)C1.Cl,C24H42ClNO2,10009085.0
1472,W146 (trifluoroacetate salt),CCCCCCc1cccc(NC(=O)[C@H](N)CCP(=O)(O)O)c1.O=C(O)C(F)(F)F,C18H28F3N2O6P,10009109.0
1473,W140 (trifluoroacetate salt),CCCCCCc1cccc(NC(=O)[C@@H](N)CCP(=O)(O)O)c1.O=C(O)C(F)(F)F,C18H28F3N2O6P,10009110.0
1474,PHOME,COc1ccc2cc(C(C#N)OC(=O)CC3OC3c3ccccc3)ccc2c1,C23H19NO4,10009134.0
1475,.beta.-Gal-NONOate,[O-]/[N+](=N/O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)N1CCCC1,C10H19N3O7,10009137.0
1476,Bezafibrate,CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O,C19H20ClNO4,10009145.0
1477,Valinomycin,CC(C)C1NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)C(C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC1=O,C54H90N6O18,10009152.0
1478,GW 627368X,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC(=O)NS(=O)(=O)c3ccccc3)cc1)C2,C30H28N2O6S,10009162.0
1479,CAY10509,COC(=O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)CSc2ccccc2F)[C@H](O)C[C@@H]1O,C23H35FO5S,10009167.0
1480,CAY10510,COC(=O)CCCCCC[C@@H]1[C@@H](CCC(O)C#Cc2ccccc2F)[C@H](O)C[C@@H]1O,C24H33FO5,10009168.0
1481,O-2545 (hydrochloride),CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)CCCCn3ccnc3)cc1OC2(C)C.Cl,C26H37ClN2O2,10009195.0
1482,PI-103,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,C19H16N4O3,10009209.0
1483,PIK-75 (hydrochloride),Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccc(Br)cn12.Cl,C16H15BrClN5O4S,10009210.0
1484,9-OxoOTrE,CC/C=C\C/C=C\C=C\C(=O)CCCCCCCC(=O)O,C18H28O3,10009215.0
1485,Sphingosine Kinase Inhibitor 2,Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,C15H11ClN2OS,10009222.0
1486,(R)-SLV 319,C/N=C(\NS(=O)(=O)c1ccc(Cl)cc1)N1C[C@@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1,C23H20Cl2N4O2S,10009227.0
1487,8-iso-16-cyclohexyl-tetranor Prostaglandin E2,O=C(O)CCC/C=C\C[C@@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CC1CCCCC1,C22H34O5,10009278.0
1488,"L-759,633",CCCCCCC(C)(C)c1cc(OC)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C26H40O2,10009280.0
1489,SKF 96365 (hydrochloride),COc1ccc(CCCOC(Cn2ccnc2)c2ccc(OC)cc2)cc1.Cl,C22H27ClN2O3,10009312.0
1490,6-Aminonicotinamide,NC(=O)c1ccc(N)nc1,C6H7N3O,10009315.0
1491,PAC-1,C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O,C23H28N4O2,10009317.0
1492,.omega.-3 Arachidonic Acid ethyl ester,CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCC(=O)OCC,C22H36O2,10009348.0
1493,Aldehyde Reactive Probe (trifluoroacetate salt),NOCC(=O)NNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21.O=C(O)C(F)(F)F,C14H22F3N5O6S,10009350.0
1494,14(Z)-Eicosenoic Acid,CCCCC/C=C\CCCCCCCCCCCCC(=O)O,C20H38O2,10009375.0
1495,1-Stearoyl-2-Arachidonoyl-d8-sn-glycero-3-PC,[2H]/C(CCCCC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C46H84NO8P,10009431.0
1496,Kifunensine,O=C1N[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)N2C1=O,C8H12N2O6,10009437.0
1497,JTE-013,Cc1nn(C)c2nc(NNC(=O)Nc3cc(Cl)nc(Cl)c3)cc(C(C)C)c12,C17H19Cl2N7O,10009458.0
1498,"1,2-Dipalmitoyl-sn-glycero-3-PC",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC,C40H80NO8P,10009473.0
1499,Abnormal Cannabidiol-d3,[2H]C([2H])([2H])CCCCc1cc(O)cc(O)c1[C@@H]1C=C(C)CC[C@H]1C(=C)C,C21H30O2,10009523.0
1500,"PtdIns-(3,4,5)-P3-biotin (sodium salt)",CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)COP(=O)([O-])O[C@H]1[C@H](O)[C@@H](OP(=O)([O-])O)[C@H](OP(=O)([O-])O)[C@@H](OP(=O)([O-])O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],C35H61N3Na4O24P4S,10009531.0
1501,CAY10512,COc1ccc(/C=C/c2ccccc2F)cc1,C15H13FO,10009536.0
1502,Anhydrotetracycline (hydrochloride),Cc1c2c(c(O)c3c(O)cccc13)C(=O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1C2.Cl,C22H23ClN2O7,10009542.0
1503,SC-1,Cc1cc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)n(C)n1,C27H25F3N8O2,10009557.0
1504,(R)-Roscovitine,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,C19H26N6O,10009569.0
1505,Pyocyanin,Cn1c2cccc(=O)c-2nc2ccccc21,C13H10N2O,10009594.0
1506,"6,7-dihydroxy Bergamottin",C/C(=C\COc1c2ccoc2cc2oc(=O)ccc12)CCC(O)C(C)(C)O,C21H24O6,10009598.0
1507,Calcipotriol (hydrate),C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O.O,C27H42O4,10009599.0
1508,Purmorphamine,c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1,C31H32N6O2,10009634.0
1509,SOTS-1 (technical grade),O=C(O)c1ccc(CON=NOCc2ccc(C(=O)O)cc2)cc1,C16H14N2O6,10009642.0
1510,Maslinic Acid,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)C5CC[C@]43C)[C@H]2C1,C30H48O4,10009645.0
1511,2-thioacetyl MAGE,CCCCCCCCCCCCCCCCOC[C@@H](CO)SC(C)=O,C21H42O3S,10009651.0
1512,CYPMPO,CC1(C)COP(=O)(C2(C)CCC=[N+]2[O-])OC1,C10H18NO4P,10009660.0
1513,N-Octadecyl-N'-propyl-sulfamide,CCCCCCCCCCCCCCCCCCNS(=O)(=O)NCCC,C21H46N2O2S,10009661.0
1514,Ricinoleic Acid methyl ester,CCCCCC[C@@H](O)C/C=C\CCCCCCCC(=O)OC,C19H36O3,10009729.0
1515,"5(Z),8(Z),14(Z)-Eicosatrienoic Acid",CCCCC/C=C\CCCC/C=C\C/C=C\CCCC(=O)O,C20H34O2,10009733.0
1516,LY293111,CCCc1c(OCCCOc2cc(O)c(-c3ccc(F)cc3)cc2CC)cccc1Oc1ccccc1C(=O)O,C33H33FO6,10009768.0
1517,CAY10602,Nc1c(S(=O)(=O)c2ccccc2)c2nc3ccccc3nc2n1-c1ccc(F)cc1,C22H15FN4O2S,10009796.0
1518,CAY10591,COCCCn1c(N)c(C(=O)NC2CCCC2)c2nc3ccccc3nc21,C20H25N5O2,10009797.0
1519,17(S)-HDHA,CC/C=C\C[C@H](O)/C=C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C22H32O3,10009799.0
1520,thio-Miltefosine,CCCCCCCCCCCCCCCCSP(=O)([O-])OCC[N+](C)(C)C,C21H46NO3PS,10009813.0
1521,(+)-Nutlin-3,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,C30H30Cl2N4O4,10009816.0
1522,1-Stearoyl-2-Arachidonoyl-sn-glycero-3-PC,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C46H84NO8P,10009864.0
1523,Palmitoleic Acid,CCCCCC/C=C\CCCCCCCC(=O)O,C16H30O2,10009871.0
1524,1-Stearoyl-2-Arachidonoyl-d8-sn-Glycerol,[2H]/C(CCCCC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCC(=O)O[C@@H](CO)COC(=O)CCCCCCCCCCCCCCCCC,C41H72O5,10009872.0
1525,"1,2-Dioctanoyl-sn-glycero-3-PC",CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC,C24H48NO8P,10009874.0
1526,"1,2-Didecanoyl-sn-glycero-3-PC",CCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCC,C28H56NO8P,10009879.0
1527,GW 590735,Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1C(=O)NCc1ccc(OC(C)(C)C(=O)O)cc1,C23H21F3N2O4S,10009880.0
1528,Tangeretin,COc1cccc(-c2cc(=O)c3c(OC)c(OC)c(OC)c(OC)c3o2)c1,C20H20O7,10009911.0
1529,SAHA,O=C(CCCCCCC(=O)Nc1ccccc1)NO,C14H20N2O3,10009929.0
1530,Dimethoxycurcumin,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,C23H24O6,10009986.0
1531,Zeaxanthin,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C[C@@H](O)CC2(C)C)C(C)(C)C[C@H](O)C1,C40H56O2,10009992.0
1532,"5(Z),11(Z),14(Z)-Eicosatrienoic Acid",CCCCC/C=C\C/C=C\CCCC/C=C\CCCC(=O)O,C20H34O2,10009999.0
1533,LY223982,COc1ccc(/C=C/CCCCOc2ccc(C(=O)c3cccc(C(=O)O)c3)cc2CCC(=O)O)cc1,C30H30O7,10010024.0
1534,CAY10570,CCCCCCCCCCN1C(=O)C(c2ccccc2)(c2ccccc2)NC1=S,C25H32N2OS,10010032.0
1535,CAY10561,O=C(NC(CO)c1ccc(F)c(Cl)c1)c1cc(-c2[nH]ncc2-c2cccc(Cl)c2)c[nH]1,C22H17Cl2FN4O2,10010043.0
1536,17-trifluoromethylphenyl trinor Prostaglandin F2.alpha. ethyl amide,CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C26H36F3NO4,10010061.0
1537,CAY10526,O=C1OC(O)C(c2cc3ccccc3s2)=C1Br,C12H7BrO3S,10010088.0
1538,1-Oleoyl-2-hydroxy-sn-glycero-3-PA,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](O)COP(=O)(O)O,C21H41O7P,10010093.0
1539,11(Z)-Vaccenyl Acetate,CCCCCC/C=C\CCCCCCCCCCOC(C)=O,C20H38O2,10010101.0
1540,16-phenoxy tetranor Prostaglandin F2.alpha. methyl ester,COC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2ccccc2)[C@H](O)C[C@@H]1O,C23H32O6,10010102.0
1541,17-phenyl trinor Prostaglandin F2.alpha. methyl ester,COC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C24H34O5,10010110.0
1542,17-trifluoromethylphenyl trinor Prostaglandin F2.alpha. methyl ester,COC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C25H33F3O5,10010111.0
1543,(+)-Cloprostenol methyl ester,COC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,C23H31ClO6,10010115.0
1544,CB-25,CCCCCc1cc(O)cc(OCCCCCCCCCCC(=O)NC2CC2)c1,C25H41NO3,10010116.0
1545,CB-52,CCCCCCc1ccc(O)cc1OCCCCCCCCCCC(=O)NC1CC1,C26H43NO3,10010117.0
1546,AM1241,CN1CCCCC1Cn1cc(C(=O)c2cc([N+](=O)[O-])ccc2I)c2ccccc21,C22H22IN3O3,10010118.0
1547,Prostaglandin D2-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,10010123.0
1548,AG-041R,CCOC(CN1C(=O)[C@](CC(=O)Nc2ccc(C)cc2)(NC(=O)Nc2ccc(C)cc2)c2ccccc21)OCC,C31H36N4O5,10010129.0
1549,"15-deoxy-.DELTA.12,14-Prostaglandin J2-2-glyceryl ester",CCCCC/C=C/C=C1/C(=O)C=C[C@@H]1C/C=C\CCCC(=O)OC(CO)CO,C23H34O5,10010132.0
1550,Fluprostenol methyl ester,COC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C24H31F3O6,10010151.0
1551,1-Octadecyl-2-hydroxy-sn-glycero-3-phospate,CCCCCCCCCCCCCCCCCCOC[C@@H](O)COP(=O)(O)O,C21H45O6P,10010164.0
1552,(R)-Equol,Oc1ccc([C@@H]2COc3cc(O)ccc3C2)cc1,C15H14O3,10010172.0
1553,(S)-Equol,Oc1ccc([C@H]2COc3cc(O)ccc3C2)cc1,C15H14O3,10010173.0
1554,AS-604850,O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1,C11H5F2NO4S,10010175.0
1555,PI3-Kinase .alpha. Inhibitor 2,Oc1cccc(-c2nc(N3CCOCC3)c3sccc3n2)c1,C16H15N3O2S,10010177.0
1556,cis-12-Octadecenoic Acid methyl ester,CCCCC/C=C\CCCCCCCCCCC(=O)OC,C19H36O2,10010180.0
1557,1-Palmityl-2-hydroxy-sn-glycero-3-PA,CCCCCCCCCCCCCCCCOC[C@@H](O)COP(=O)(O)O,C19H41O6P,10010188.0
1558,"1,8-ANS",O=S(=O)(O)c1cccc2cccc(Nc3ccccc3)c12,C16H13NO3S,10010219.0
1559,CAY10567,O=C(O)c1ccc2nc(-c3ccccc3)c(-c3ccccc3)nc2c1,C21H14N2O2,10010233.0
1560,ML-9,Cl.O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1,C15H18Cl2N2O2S,10010236.0
1561,Triciribine,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,C13H16N6O4,10010237.0
1562,Erbstatin Analog,COC(=O)/C=C/c1cc(O)ccc1O,C10H10O4,10010238.0
1563,Kenpaullone,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,C16H11BrN2O,10010239.0
1564,Olomoucine,Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21,C15H18N6O,10010240.0
1565,AICAR,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1N,C9H14N4O5,10010241.0
1566,AG-494,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1,C16H12N2O3,10010242.0
1567,AG-825,COc1cc(C=C(C#N)C(N)=O)cc(CSc2nc3ccccc3s2)c1O,C19H15N3O3S2,10010243.0
1568,AG-1478,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC,C16H14ClN3O2,10010244.0
1569,SB 216763,Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21,C19H12Cl2N2O2,10010246.0
1570,SB-415286,O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1,C16H10ClN3O5,10010247.0
1571,AG-17,CC(C)(C)c1cc(C=C(C#N)C#N)cc(C(C)(C)C)c1O,C18H22N2O,10010248.0
1572,H-8 (hydrochloride),CNCCNS(=O)(=O)c1cccc2cnccc12.Cl.Cl,C12H17Cl2N3O2S,10010249.0
1573,LFM-A13,C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br,C11H8Br2N2O2,10010265.0
1574,BAY 11-7082,Cc1ccc(S(=O)(=O)/C=C/C#N)cc1,C10H9NO2S,10010266.0
1575,SC-514,NC(=O)c1sc(-c2ccsc2)cc1N,C9H8N2OS2,10010267.0
1576,Apigenin,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,C15H10O5,10010275.0
1577,Palmitate (calcium salt),CCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCC(=O)[O-].[Ca+2],C32H62CaO4,10010279.0
1578,1-Palmitoyl-2-hydroxy-sn-glycero-3-PA (sodium salt),CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])O.[Na+],C19H38NaO7P,10010290.0
1579,Palmitoyl 3-carbacyclic Phosphatidic Acid,CCCCCCCCCCCCCCCC(=O)OCC1CCP(=O)(O)O1,C20H39O5P,10010293.0
1580,Palmitoleoyl 3-carbacyclic Phosphatidic Acid,CCCCCC/C=C\CCCCCCCC(=O)OCC1CCP(=O)(O)O1,C20H37O5P,10010298.0
1581,Oleoyl 3-carbacyclic Phosphatidic Acid,CCCCCCCC/C=C\CCCCCCCC(=O)OCC1CCP(=O)(O)O1,C22H41O5P,10010299.0
1582,AG-18,N#CC(C#N)=Cc1ccc(O)c(O)c1,C10H6N2O2,10010300.0
1583,CAY10554,CC(C)c1cnc(NC(=O)Cc2ccccc2)s1,C14H16N2OS,10010301.0
1584,DRB,OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O,C12H12Cl2N2O4,10010302.0
1585,RG-13022,COc1ccc(/C=C(\C#N)c2cccnc2)cc1OC,C16H14N2O2,10010309.0
1586,RG-14620,N#C/C(=C\c1cc(Cl)cc(Cl)c1)c1cccnc1,C14H8Cl2N2,10010310.0
1587,AG-490,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,C17H14N2O3,10010311.0
1588,AG-82,N#CC(C#N)=Cc1cc(O)c(O)c(O)c1,C10H6N2O3,10010312.0
1589,AG-99,N#C/C(=C\c1ccc(O)c(O)c1)C(N)=O,C10H8N2O3,10010313.0
1590,AG-213,N#C/C(=C\c1ccc(O)c(O)c1)C(N)=S,C10H8N2O2S,10010314.0
1591,AG-183,N#CC(C#N)=C(N)/C(C#N)=C/c1cc(O)c(O)c(O)c1,C13H8N4O3,10010315.0
1592,Harmine,COc1ccc2c(c1)[nH]c1c(C)nccc12,C13H12N2O,10010324.0
1593,Lavendustin C,O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O,C14H13NO5,10010329.0
1594,AMP-Deoxynojirimycin,OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)CN1CCCCCOCC12CC3CC(CC(C3)C1)C2,C22H39NO5,10010332.0
1595,Misoprostol (free acid)-d5,[2H]C([2H])([2H])C(O)(C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)C([2H])([2H])CCC,C21H36O5,10010333.0
1596,Lovastatin,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,C24H36O5,10010338.0
1597,Lovastatin Hydroxy Acid (sodium salt),CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+],C24H37NaO6,10010339.0
1598,Mevastatin,CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)C21,C23H34O5,10010340.0
1599,Pravastatin (sodium salt),CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+],C23H35NaO7,10010343.0
1600,Simvastatin,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)C21,C25H38O5,10010344.0
1601,CCG-1423,CC(ONC(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc(Cl)cc1,C18H13ClF6N2O3,10010350.0
1602,ZM 336372,Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1,C23H23N3O3,10010367.0
1603,GW 842166X,O=C(NCC1CCOCC1)c1cnc(Nc2ccc(Cl)cc2Cl)nc1C(F)(F)F,C18H17Cl2F3N4O2,10010372.0
1604,5-Iodotubercidin,Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C11H13IN4O4,10010375.0
1605,ent-8-iso-15(R)-Prostaglandin F2.alpha.,CCCCC[C@H](O)/C=C/[C@H]1[C@@H](C/C=C\CCCC(=O)O)[C@H](O)C[C@@H]1O,C20H34O5,10010380.0
1606,CAY10535,COc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1,C18H21N3O7S,10010396.0
1607,CB13,CCCCCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12,C26H24O2,10010398.0
1608,15-keto-17-phenyl trinor Prostaglandin F2.alpha. ethyl amide,CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C(=O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C25H35NO4,10010405.0
1609,GW 848687X,O=C(O)c1cccc(C2=C(c3cc(Cl)ccc3OCc3ccc(F)cc3F)CCC2)n1,C24H18ClF2NO3,10010410.0
1610,NS 304,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,C26H32N4O4S,10010411.0
1611,MRE-269,CC(C)N(CCCCOCC(=O)O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,C25H29N3O3,10010412.0
1612,Zaprinast,CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1,C13H13N5O2,10010421.0
1613,Nilotinib,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,C28H22F3N7O,10010422.0
1614,"13,14-dihydro-15-keto Prostaglandin D1",CCCCCC(=O)CC[C@H]1C(=O)C[C@H](O)[C@@H]1CCCCCCC(=O)O,C20H34O5,10010425.0
1615,SP600125,O=C1c2ccccc2-c2n[nH]c3cccc1c23,C14H8N2O,10010466.0
1616,15-Lipoxygenase Inhibitor I,Cc1nc(N2CCN(C)CC2)nc2c1Nc1ccccc1S2,C16H19N5S,10010468.0
1617,ADHP,CC(=O)N1c2ccc(O)cc2Oc2cc(O)ccc21,C14H11NO4,10010469.0
1618,"5(Z),14(Z)-Eicosadienoic Acid",CCCCC/C=C\CCCCCCC/C=C\CCCC(=O)O,C20H36O2,10010484.0
1619,"14,15-EE-(8Z)-E",CCCCC[C@H]1O[C@H]1CCCC/C=C\CCCCCCC(=O)O,C20H36O3,10010486.0
1620,Tranylcypromine (hydrochloride),Cl.N[C@H]1C[C@@H]1c1ccccc1,C9H12ClN,10010494.0
1621,Manumycin A,CCCC[C@@H](C)/C=C(C)/C=C(\C)C(=O)NC1=C[C@@](O)(/C=C/C=C/C=C/C(=O)NC2=C(O)CCC2=O)[C@@H]2O[C@@H]2C1=O,C31H38N2O7,10010497.0
1622,Farnesyl Thiosalicylic Acid,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)O,C22H30O2S,10010501.0
1623,CAY10562,[O-]c1[o+]nsc1-c1ccccc1,C8H5NO2S,10010502.0
1624,BIBB 515,O=C(c1ccc(Cl)cc1)N1CCC(=Cc2ccc(C3=NCCO3)cc2)CC1,C22H21ClN2O2,10010517.0
1625,PD 146176,c1ccc2c(c1)SCc1c-2[nH]c2ccccc12,C15H11NS,10010518.0
1626,Vialinin A,O=C(Cc1ccccc1)Oc1c(OC(=O)Cc2ccccc2)c(-c2ccc(O)cc2)c(O)c(O)c1-c1ccc(O)cc1,C34H26O8,10010519.0
1627,Palmitoyl thio-PC,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)SC(=O)CCCCCCCCCCCCCCC,C40H80NO7PS,10010521.0
1628,L-threo-Sphingosine (d18:1),CCCCCCCCCCCCC/C=C/[C@H](O)[C@@H](N)CO,C18H37NO2,10010541.0
1629,O-Arachidonoyl Glycidol,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC1CO1,C23H36O3,10010547.0
1630,H-89,Cl.Cl.O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,C20H22BrCl2N3O2S,10010556.0
1631,HA-1077 (hydrochloride),Cl.Cl.O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,C14H19Cl2N3O2S,10010559.0
1632,Pyrimidine-4-Carboxylic Acid,O=C(O)c1ccncn1,C5H4N2O2,10010564.0
1633,AG-370,N#CC(C#N)=C(N)/C(C#N)=C/c1ccc2[nH]ccc2c1,C15H9N5,10010568.0
1634,Acenocoumarol,CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O,C19H15NO6,10010569.0
1635,Wortmannin,COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O,C23H24O8,10010591.0
1636,AG-1296,COc1cc2ncc(-c3ccccc3)nc2cc1OC,C16H14N2O2,10010592.0
1637,Bimatoprost cyclopropyl amide,O=C(CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O)NC1CC1,C26H37NO4,10010605.0
1638,Genipin,COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12,C11H14O5,10010622.0
1639,Latrunculin A,C/C1=C/C(=O)O[C@@H]2C[C@@H](CC[C@H](C)/C=C\C=C\CC1)O[C@@](O)(C1CSC(=O)N1)C2,C22H31NO5S,10010630.0
1640,Latrunculin B,C/C1=C/C(=O)O[C@@H]2C[C@@H](CC[C@H](C)/C=C\CC1)O[C@@](O)([C@@H]1CSC(=O)N1)C2,C20H29NO5S,10010631.0
1641,17(R)-HETE,CCC[C@@H](O)C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O3,10010637.0
1642,Zolpidem-d6,[2H]C([2H])([2H])N(C(=O)Cc1c(-c2ccc(C)cc2)nc2ccc(C)cn12)C([2H])([2H])[2H],C19H21N3O,10010652.0
1643,Zolpidem-d6 (CRM),[2H]C([2H])([2H])N(C(=O)Cc1c(-c2ccc(C)cc2)nc2ccc(C)cn12)C([2H])([2H])[2H],C19H21N3O,20286.0
1644,(-)-Deguelin,COc1cc2c(cc1OC)[C@@H]1C(=O)c3ccc4c(c3O[C@@H]1CO2)C=CC(C)(C)O4,C23H22O6,10010706.0
1645,CAY10550,O=C1CC(c2ccc([N+](=O)[O-])cc2)=NN1c1ccccc1,C15H11N3O3,10010740.0
1646,17-phenoxy trinor Prostaglandin F2.alpha. ethyl amide,CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCOc2ccccc2)[C@H](O)C[C@@H]1O,C25H37NO5,10010742.0
1647,SC-51322,O=C(CCSCc1ccco1)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,C22H20ClN3O4S,10010744.0
1648,17-phenyl trinor Prostaglandin F2.alpha. cyclopropyl methyl amide,O=C(CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O)NCC1CC1,C27H39NO4,10010810.0
1649,17-phenoxy trinor Prostaglandin F2.alpha.,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCOc2ccccc2)[C@H](O)C[C@@H]1O,C23H32O6,10010839.0
1650,PF-622,O=C(Nc1ccccc1)N1CCN(Cc2ccc3ccccc3n2)CC1,C21H22N4O,10010907.0
1651,PF-750,O=C(Nc1ccccc1)N1CCC(Cc2cnc3ccccc3c2)CC1,C22H23N3O,10010908.0
1652,.beta.-cyano-L-Alanine,N#CC[C@H](N)C(=O)O,C4H6N2O2,10010947.0
1653,DL-Propargyl Glycine (hydrochloride),C#CCC(N)C(=O)O.Cl,C5H8ClNO2,10010948.0
1654,KT 5823,COC(=O)[C@@]1(OC)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N(C)C4,C29H25N3O5,10010965.0
1655,Isopropyl 5-(Diphenylphosphoryl)pentanoate,CC(C)OC(=O)CCCCP(=O)(c1ccccc1)c1ccccc1,C20H25O3P,10010978.0
1656,W123,CCCCCCc1cccc(NC(=O)CNCCC(=O)O)c1,C17H26N2O3,10010992.0
1657,KT 5720,CCCCCCOC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,C32H31N3O5,10011011.0
1658,QX-314 (bromide),CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1C.[Br-],C16H27BrN2O,10011032.0
1659,"2,3-dihydrothieno-Thiadiazole Carboxylate",COC(=O)c1csc2snnc12,C6H4N2O2S2,10011048.0
1660,"4-phenyl-5-methyl-1,2,3-Thiadiazole",Cc1snnc1-c1ccccc1,C9H8N2S,10011049.0
1661,KB2115,CC(C)c1cc(Oc2c(Br)cc(NC(=O)CC(=O)O)cc2Br)ccc1O,C18H17Br2NO5,10011054.0
1662,"4-phenyl-1,2,3-Thiadiazole",c1ccc(-c2csnn2)cc1,C8H6N2S,10011055.0
1663,N-acetyl-D-Mannosamine,CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O,C8H15NO6,10011060.0
1664,Trimidox (hydrochloride),Cl.N=C(NO)c1cc(O)c(O)c(O)c1,C7H9ClN2O4,10011124.0
1665,Clobenpropit (hydrobromide),Br.Br.N=C(NCc1ccc(Cl)cc1)SCCCc1cnc[nH]1,C14H19Br2ClN4S,10011126.0
1666,Thioperamide (maleate),O=C(O)/C=C\C(=O)O.S=C(NC1CCCCC1)N1CCC(c2cnc[nH]2)CC1,C19H28N4O4S,10011127.0
1667,BAY 41-8543,Nc1nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc(N)c1N1CCOCC1,C21H21FN8O,10011131.0
1668,Papaverine,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,C20H21NO4,10011133.0
1669,BAY 60-7550,COc1ccc(Cc2nn3c([C@@H](CCCc4ccccc4)[C@@H](C)O)nc(C)c3c(=O)[nH]2)cc1OC,C27H32N4O4,10011135.0
1670,GX15-070 (hydrochloride),COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C/c1[nH]c(C)cc1C.Cl,C20H20ClN3O,10011180.0
1671,Elesclomol,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1,C19H20N4O2S2,10011192.0
1672,N-heptanoyl-L-Homoserine lactone,CCCCCCC(=O)N[C@H]1CCOC1=O,C11H19NO3,10011198.0
1673,N-octanoyl-L-Homoserine lactone,CCCCCCCC(=O)N[C@H]1CCOC1=O,C12H21NO3,10011199.0
1674,N-tetradecanoyl-L-Homoserine lactone,CCCCCCCCCCCCCC(=O)N[C@H]1CCOC1=O,C18H33NO3,10011200.0
1675,N-decanoyl-L-Homoserine lactone,CCCCCCCCCC(=O)N[C@H]1CCOC1=O,C14H25NO3,10011201.0
1676,N-dodecanoyl-L-Homoserine lactone,CCCCCCCCCCCC(=O)N[C@H]1CCOC1=O,C16H29NO3,10011203.0
1677,N-butyryl-L-Homocysteine thiolactone,CCCC(=O)N[C@H]1CCSC1=O,C8H13NO2S,10011204.0
1678,N-3-oxo-octanoyl-L-Homoserine lactone,CCCCCC(=O)CCC(=O)N[C@H]1CCOC1=O,C13H21NO4,10011206.0
1679,N-(.beta.-ketocaproyl)-L-Homoserine lactone,CCCC(=O)CC(=O)N[C@H]1CCOC1=O,C10H15NO4,10011207.0
1680,GW 9578,CCCCCCCN(CCc1ccc(SC(C)(C)C(=O)O)cc1)C(=O)Nc1ccc(F)cc1F,C26H34F2N2O3S,10011211.0
1681,WWL70,CN(Cc1cccc(-c2ccncc2)c1)C(=O)Oc1ccc(-c2ccc(C(N)=O)cc2)cc1,C27H23N3O3,10011213.0
1682,N-3-oxo-hexadec-11(Z)-enoyl-L-Homoserine lactone,CCCC/C=C\CCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,C20H33NO4,10011238.0
1683,WHI-P131,COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC,C16H15N3O3,10011246.0
1684,CAY10574,Nc1n[nH]c(N)c1N=Nc1ccc(O)cc1,C9H10N6O,10011247.0
1685,CAY10575,COc1cc2ncn(-c3cc(OCc4ccc(S(C)(=O)=O)cc4)c(C(N)=O)s3)c2cc1OC,C22H21N3O6S2,10011248.0
1686,CAY10576,COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC,C22H19N3O5S2,10011249.0
1687,NH125,CCCCCCCCCCCCCCCC[n+]1ccn(Cc2ccccc2)c1C.[I-],C27H45IN2,10011250.0
1688,TWS119,Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1,C18H14N4O2,10011251.0
1689,NSC 210902,O=C(O)c1c[nH]c2c(ccc3ccccc32)c1=O,C14H9NO3,10011255.0
1690,CAY10577,O=C(O)c1c[nH]c2c(Cl)c(Cl)ccc2c1=O,C10H5Cl2NO3,10011256.0
1691,CAY10578,O=C(O)CN1C(=O)c2c(I)c(I)c(I)c(I)c2C1=O,C10H3I4NO4,10011264.0
1692,Fulvestrant,C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O,C32H47F5O3S,10011269.0
1693,Chenodeoxycholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H40O4,10011286.0
1694,Stearic Acid,CCCCCCCCCCCCCCCCCC(=O)O,C18H36O2,10011298.0
1695,17(S)-HETE,CCC[C@H](O)C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O3,10011305.0
1696,Avenanthramide-C methyl ester,COC(=O)c1cc(O)ccc1NC(=O)/C=C/c1ccc(O)c(O)c1,C17H15NO6,10011336.0
1697,5-(Diphenylphosphoryl)pentanoic Acid,O=C(O)CCCCP(=O)(c1ccccc1)c1ccccc1,C17H19O3P,10011337.0
1698,Glycerophospho-N-Arachidonoyl Ethanolamine,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCOP(=O)(O)OCC(O)CO,C25H44NO7P,10011347.0
1699,Taprostene (free acid),O=C(O)c1cccc(/C=C2/C[C@@H]3[C@@H](/C=C/[C@@H](O)C4CCCCC4)[C@H](O)C[C@@H]3O2)c1,C24H30O5,10011348.0
1700,Dimebolin (hydrochloride),Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1.Cl.Cl,C21H27Cl2N3,10011349.0
1701,Glycerophospho-N-Palmitoyl Ethanolamine,CCCCCCCCCCCCCCCC(=O)NCCOP(=O)(O)OCC(O)CO,C21H44NO7P,10011356.0
1702,Glycerophospho-N-Oleoyl Ethanolamine,CCCCCCCC/C=C\CCCCCCCC(=O)NCCOP(=O)(O)OCC(O)CO,C23H46NO7P,10011357.0
1703,"14,15-Leukotriene C4",CCCCC[C@H](O)[C@@H](/C=C/C=C/C=C\C/C=C\CCCC(=O)O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,C30H47N3O9S,10011360.0
1704,"14,15-Leukotriene E4",CCCCC[C@H](O)[C@@H](/C=C/C=C/C=C\C/C=C\CCCC(=O)O)SC[C@H](N)C(=O)O,C23H37NO5S,10011362.0
1705,Lipoxin A5,CC/C=C\C[C@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)CCCC(=O)O,C20H30O5,10011453.0
1706,ent-8-iso Prostaglandin F2.alpha.,CCCCC[C@@H](O)/C=C/[C@H]1[C@@H](C/C=C\CCCC(=O)O)[C@H](O)C[C@@H]1O,C20H34O5,10011545.0
1707,SC-51089,Cl.O=C(CCc1ccncc1)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,C22H20Cl2N4O3,10011561.0
1708,"L-161,982",CCCCc1nn(-c2ccccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2sccc2C)cc1,C32H29F3N4O4S2,10011565.0
1709,Terbinafine (hydrochloride),CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12.Cl,C21H26ClN,10011619.0
1710,Raloxifene (hydrochloride),Cl.O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,C28H28ClNO4S,10011620.0
1711,Trolox,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)O)O2,C14H18O4,10011659.0
1712,1-Deoxynojirimycin (hydrochloride),Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O,C6H14ClNO4,10011718.0
1713,Deoxynojirimycin Tetrabenzyl Ether,c1ccc(COC[C@H]2NC[C@H](OCc3ccccc3)[C@@H](OCc3ccccc3)[C@@H]2OCc2ccccc2)cc1,C34H37NO4,10011914.0
1714,Ethyl-L-NIO (hydrochloride),CCCC(=N)NCCC[C@H](N)C(=O)O.Cl,C9H20ClN3O2,10012088.0
1715,Ebselen Oxide,O=C1c2ccccc2[Se](=O)N1c1ccccc1,C13H9NO2Se,10012298.0
1716,CAY10583,CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1,C25H25NO3,10012424.0
1717,PD 184161,O=C(NOCC1CC1)c1cc(Br)c(F)c(F)c1Nc1ccc(I)cc1Cl,C17H13BrClF2IN2O2,10012431.0
1718,CAY10592,O=C(O)COc1ccc(SCC=C(c2ccc(Br)cc2)c2ccc(Br)cc2)cc1Cl,C23H17Br2ClO3S,10012536.0
1719,CAY10597,O=C(O)CN1C(=O)C2(CC(=O)N(Cc3ccccc3F)C2=O)c2cc(Cl)ccc21,C20H14ClFN2O5,10012539.0
1720,CAY10595,O=C(O)CN1C(=O)C2(CC(=O)N(Cc3cc(Cl)ccc3F)C2=O)c2cc(Cl)ccc21,C20H13Cl2FN2O5,10012553.0
1721,Resolvin D1,CC/C=C\C[C@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)C/C=C\CCC(=O)O,C22H32O5,10012554.0
1722,Sodium Hydrogen Sulfide (hydrate),[Na]S,HNaS,10012555.0
1723,Phytomonic Acid,CCCCCCC1CC1CCCCCCCCCC(=O)O,C19H36O2,10012556.0
1724,CAY10566,Cc1nnc(-c2ccc(N3CCC(Oc4cc(F)ccc4Cl)CC3)nn2)o1,C18H17ClFN5O2,10012562.0
1725,CAY10568,C[N+](C)(C)CC(=O)Nc1ccccc1.[I-],C11H17IN2O,10012565.0
1726,"7(Z),11(Z)-Heptacosadiene",CCCCCC/C=C\CC/C=C\CCCCCCCCCCCCCCC,C27H52,10012567.0
1727,Diallyl Trisulfide,C=CCSSSCC=C,C6H10S3,10012577.0
1728,cis-ACCP,N[C@H]1CCCC[C@H]1NC(=O)P(=O)(O)O,C7H15N2O4P,10012583.0
1729,A-803467,COc1cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc(OC)c1,C19H16ClNO4,10012588.0
1730,CCT018159,CCc1cc(-c2n[nH]c(C)c2-c2ccc3c(c2)OCCO3)c(O)cc1O,C20H20N2O4,10012591.0
1731,Lacosamide,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,C13H18N2O3,10012592.0
1732,Allopurinol,O=c1nc[nH]c2[nH]ncc12,C5H4N4O,10012597.0
1733,Myricetin,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,C15H10O8,10012600.0
1734,(S)-MG132,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,C26H41N3O5,10012628.0
1735,Ki16425,Cc1noc(-c2ccc(CSCCC(=O)O)cc2)c1NC(=O)OC(C)c1ccccc1Cl,C23H23ClN2O5S,10012659.0
1736,N-cis-tetradec-9-enoyl-L-Homoserine lactone,CCCC/C=C\CCCCCCCC(=O)N[C@H]1CCOC1=O,C18H31NO3,10012672.0
1737,N-cis-hexadec-9-enoyl-L-Homoserine lactone,CCCCCC/C=C\CCCCCCCC(=O)N[C@H]1CCOC1=O,C20H35NO3,10012673.0
1738,N-cis-octadec-9-enoyl-L-Homoserine lactone,CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H]1CCOC1=O,C22H39NO3,10012674.0
1739,CAY10585,COC(=O)c1ccc(O)c(NC(=O)COc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)c1,C26H29NO5,10012682.0
1740,Benzisoxazole Hsp90 Inhibitor,Oc1cc(O)c(-c2noc3ccc(NCCN4CCOCC4)cc23)cc1Cl,C19H20ClN3O4,10012694.0
1741,JMV3002,COc1ccc(Cn2c(CCc3ccccc3)nnc2[C@@H](Cc2c[nH]c3ccccc23)NC(=O)c2ccccn2)c(OC)c1,C35H34N6O3,10012699.0
1742,A 922500,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)[C@@H]3CCC[C@H]3C(=O)O)cc2)cc1,C26H24N2O4,10012708.0
1743,16-phenoxy tetranor Prostaglandin F2.alpha. isopropyl ester,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2ccccc2)[C@H](O)C[C@@H]1O,C25H36O6,10010103.0
1744,AM694,O=C(c1ccccc1I)c1cn(CCCCCF)c2ccccc12,C20H19FINO,10567.0
1745,AM694 (exempt preparation),O=C(c1ccccc1I)c1cn(CCCCCF)c2ccccc12,C20H19FINO,15720.0
1746,IU1,Cc1cc(C(=O)CN2CCCC2)c(C)n1-c1ccc(F)cc1,C18H21FN2O,10617.0
1747,JWH 210,CCCCCn1cc(C(=O)c2ccc(CC)c3ccccc23)c2ccccc21,C26H27NO,10644.0
1748,Tubastatin A (trifluoroacetate salt),CN1CCc2c(c3ccccc3n2Cc2ccc(C(=O)NO)cc2)C1.O=C(O)C(F)(F)F,C22H22F3N3O4,10559.0
1749,JWH 018 N-(3-methylbutyl) isomer,CC(C)CCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,10691.0
1750,Pravadoline,COc1ccc(C(=O)c2c(C)n(CCN3CCOCC3)c3ccccc23)cc1,C23H26N2O3,10006973.0
1751,Phenazepam,O=C1CN=C(c2ccccc2Cl)c2cc(Br)ccc2N1,C15H10BrClN2O,9000849.0
1752,Pentosidine,N[C@@H](CCCCn1cccc2nc(NCCC[C@H](N)C(=O)O)nc1-2)C(=O)O.O=C(O)C(F)(F)F,C19H27F3N6O6,10010254.0
1753,coumarin-SAHA,Cc1cc(=O)oc2cc(NC(=O)CCCCCCC(=O)NO)ccc12,C18H22N2O5,10671.0
1754,"3,4-Methylenedioxy Pyrovalerone-d8",Cl.[2H]C1([2H])N(C(CCC)C(=O)c2ccc3c(c2)OCO3)C([2H])([2H])C([2H])([2H])C1([2H])[2H],C16H22ClNO3,10679.0
1755,JWH 018 6-methoxyindole analog,CCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccc(OC)cc21,C25H25NO2,10697.0
1756,"all-cis-14,17,20,23,26,29-Dotriacontahexaenol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCO,C32H54O,10562.0
1757,JWH 250-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)Cc1ccccc1OC)c([2H])n2CCCCC,C22H25NO2,10661.0
1758,23790,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)Cc1ccccc1OC)c([2H])n2CCCCC,C22H25NO2,23790.0
1759,CAY10641,CC(C)C(=O)c1cn(CC(O)COc2ccc(Oc3ccccc3)cc2)c2ccc(C(=O)O)cc12,C28H27NO6,10662.0
1760,JWH 007,CCCCCn1c(C)c(C(=O)c2cccc3ccccc23)c2ccccc21,C25H25NO,10266.0
1761,Itraconazole,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,C35H38Cl2N8O4,13288.0
1762,JWH 203,CCCCCn1cc(C(=O)Cc2ccccc2Cl)c2ccccc21,C21H22ClNO,9000736.0
1763,JWH 203 (exempt preparation),CCCCCn1cc(C(=O)Cc2ccccc2Cl)c2ccccc21,C21H22ClNO,15669.0
1764,JWH 015-d7,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])n1c(C)c(C(=O)c2cccc3ccccc23)c2ccccc21,C23H21NO,10660.0
1765,3-Deazaneplanocin A,CCC1=C[C@@H](n2cnc3c(N)nccc32)[C@H](O)[C@@H]1O,C13H16N4O2,13828.0
1766,CHIR99021,Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1,C22H18Cl2N8,13122.0
1767,JWH 201,CCCCCn1cc(C(=O)Cc2ccc(OC)cc2)c2ccccc21,C22H25NO2,10721.0
1768,JNJ-7777120,CN1CCN(C(=O)c2cc3cc(Cl)ccc3[nH]2)CC1,C14H16ClN3O,10011925.0
1769,Milrinone,Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1,C12H9N3O,13357.0
1770,AM2201,O=C(c1cccc2ccccc12)c1cn(CCCCCF)c2ccccc12,C24H22FNO,10707.0
1771,AM2201 (CRM),O=C(c1cccc2ccccc12)c1cn(CCCCCF)c2ccccc12,C24H22FNO,27043.0
1772,HU-210 (exempt preparation),CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(CO)C[C@@H]21,C25H38O3,90083.0
1773,HU-210,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(CO)C[C@@H]21,C25H38O3,90082.0
1774,C16 Ceramide (d18:1/16:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCC,C34H67NO3,10681.0
1775,URB937,NC(=O)c1cccc(-c2cc(OC(=O)NC3CCCCC3)ccc2O)c1,C20H22N2O4,10674.0
1776,JWH 302,CCCCCn1cc(C(=O)Cc2cccc(OC)c2)c2ccccc21,C22H25NO2,10722.0
1777,C20 Ceramide (d18:1/20:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCC,C38H75NO3,10724.0
1778,JWH 073-d7 (exempt preparation),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C23H21NO,9000868.0
1779,HAMI3379,O=C(O)c1ccc(OCCCc2ccc(OCCCCOC3CCCCC3)cc2)c(C(=O)N[C@H]2CCC[C@H](C(=O)O)C2)c1,C34H45NO8,10580.0
1780,HTS 01037,COC(=O)c1sc(-c2cccs2)cc1NC(=O)/C=C/C(=O)O,C14H11NO5S2,10699.0
1781,JWH 073 2-methylbutyl homolog,CCC(C)Cn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,10690.0
1782,JWH 073 5-hydroxyindole metabolite-d7,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2cccc3ccccc23)c2cc(O)ccc21,C23H21NO2,10718.0
1783,CAY10632,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCC(=O)O,C32H52O2,10497.0
1784,Salinomycin,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C,C42H70O11,13579.0
1785,GPP 78,O=C(CCCCCCCn1cc(-c2cccnc2)nn1)Nc1ccccc1-c1ccccc1,C27H29N5O,13670.0
1786,LH 21,CCCCCCc1nc(-c2ccc(Cl)cc2)n(-c2ccc(Cl)cc2Cl)n1,C20H20Cl3N3,13453.0
1787,CAY10648,CC(C)(C)OC(=O)CN1C(=O)C2(CCNC2=O)c2cc(Cl)ccc21,C17H19ClN2O4,9000549.0
1788,Arachidonoyl Ethanolamide-d4,[2H]C([2H])(O)C([2H])([2H])NC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC,C22H37NO2,10011178.0
1789,PIT-1,O=C(NC(=S)Nc1cc([N+](=O)[O-])cc(Cl)c1O)c1ccccc1,C14H10ClN3O4S,10728.0
1790,dinor-12-oxo Phytodienoic Acid,CC/C=C\C[C@@H]1C(=O)C=C[C@@H]1CCCCCC(=O)O,C16H24O3,10710.0
1791,(-)-Neplanocin A,Nc1ncnc2c1ncn2[C@H]1C=C(CO)[C@H](O)[C@@H]1O,C11H13N5O3,10584.0
1792,JWH 018 6-hydroxyindole metabolite-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2cccc3ccccc23)c2ccc(O)cc21,C24H23NO2,10714.0
1793,(+)-Cloprostenol isopropyl ester,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,C25H35ClO6,10010016.0
1794,5-methoxy DALT,C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12,C17H22N2O,10729.0
1795,Isoliquiritigenin,O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O,C15H12O4,10739.0
1796,CAY10649,COc1ccc(/C=C2\SC(c3ccc(Cl)cc3)=NC2=O)cc1,C17H12ClNO2S,10804.0
1797,Candesartan Cilexetil,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,C33H34N6O6,10489.0
1798,GANT 61,CN(C)c1ccccc1CN1CCCN(Cc2ccccc2N(C)C)C1c1ccncc1,C27H35N5,13841.0
1799,3-Fluoromethcathinone (hydrochloride),CNC(C)C(=O)c1cccc(F)c1.Cl,C10H13ClFNO,10730.0
1800,3-Fluoromethcathinone (hydrochloride) (exempt preparation),CNC(C)C(=O)c1cccc(F)c1.Cl,C10H13ClFNO,16055.0
1801,RCS-4-C4 homolog,CCCCn1cc(C(=O)c2ccc(OC)cc2)c2ccccc21,C20H21NO2,10798.0
1802,Pentylone (hydrochloride),CCCC(NC)C(=O)c1ccc2c(c1)OCO2.Cl,C13H18ClNO3,9000746.0
1803,Pentylone (hydrochloride) (CRM),CCCC(NC)C(=O)c1ccc2c(c1)OCO2.Cl,C13H18ClNO3,27504.0
1804,JWH 098,CCCCCn1c(C)c(C(=O)c2ccc(OC)c3ccccc23)c2ccccc21,C26H27NO2,10680.0
1805,JWH 200 4-hydroxyindole metabolite,O=C(c1cccc2ccccc12)c1cn(CCN2CCOCC2)c2cccc(O)c12,C25H24N2O3,10744.0
1806,UNC0638,COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1,C30H47N5O2,10734.0
1807,Vigabatrin,C=CC(N)CCC(=O)O,C6H11NO2,9000976.0
1808,.gamma.-Linolenic Acid ethyl ester,CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)OCC,C20H34O2,9000738.0
1809,AG-879,CC(C)(C)c1cc(/C=C(\C#N)C(N)=S)cc(C(C)(C)C)c1O,C18H24N2OS,10793.0
1810,AM-2201-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1cccc3ccccc13)c([2H])n2CCCCCF,C24H22FNO,10706.0
1811,"3,5-dimethyl PIT-1",Cc1cc(C)cc(C(=O)NC(=S)Nc2cc([N+](=O)[O-])ccc2O)c1,C16H15N3O4S,10727.0
1812,Pyrovalerone (hydrochloride),CCCC(C(=O)c1ccc(C)cc1)N1CCCC1,C16H23NO,10836.0
1813,KN-92 (hydrochloride),COc1ccc(S(=O)(=O)Nc2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1.Cl,C24H26Cl2N2O3S,9000890.0
1814,Colchicine,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,C22H25NO6,9000760.0
1815,4-Fluoromethcathinone (hydrochloride),CNC(C)C(=O)c1ccc(F)cc1.Cl,C10H13ClFNO,10859.0
1816,4-Fluoromethcathinone (hydrochloride) (exempt preparation),CNC(C)C(=O)c1ccc(F)cc1.Cl,C10H13ClFNO,16054.0
1817,Doramapimod,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,C31H37N5O3,10460.0
1818,CAY10650,CC(C)C(=O)c1cn(CC(=O)COc2ccc(Oc3ccccc3)cc2)c2ccc(C(=O)O)cc12,C28H25NO6,10743.0
1819,Xanomeline (oxalate),CCCCCCOc1nsnc1C1=CCCN(C)C1.O=C(O)C(=O)O,C16H25N3O5S,10790.0
1820,Dihomo-.gamma.-Linolenic Acid-d6,[2H]/C(CCCCC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCCCCC(=O)O,C20H34O2,10458.0
1821,JWH 020,CCCCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C26H27NO,10850.0
1822,JWH 203 4-chloro isomer,CCCCCn1cc(C(=O)Cc2ccc(Cl)cc2)c2ccccc21,C21H22ClNO,10867.0
1823,JWH 203 3-chloro isomer,CCCCCn1cc(C(=O)Cc2cccc(Cl)c2)c2ccccc21,C21H22ClNO,10868.0
1824,"Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaenoic Acid",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCCC(=O)O,C34H56O2,10539.0
1825,I-BET762,CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2cnnc21,C21H20ClN5O2,10676.0
1826,C10 AV Ceramide (d18:1/10:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCC/C=C/c1c2ccccc2cc2ccccc12,C44H65NO3,9000753.0
1827,3-Deazaadenosine,Nc1nccc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C11H14N4O4,9000785.0
1828,3-Deaza-2'-deoxyadenosine,Nc1nccc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,C11H14N4O3,9000786.0
1829,JWH 018 2'-naphthyl isomer,CCCCCn1cc(C(=O)c2ccc3ccccc3c2)c2ccccc21,C24H23NO,9001004.0
1830,JWH 073 2'-naphthyl-N-(2-methylpropyl) isomer,CC(C)Cn1cc(C(=O)c2ccc3ccccc3c2)c2ccccc21,C23H21NO,9001015.0
1831,JGB1741,O=C(NCc1ccccc1)c1c(/N=C/c2c(O)ccc3ccccc23)sc2c1CCCC2,C27H24N2O2S,10641.0
1832,Pifithrin-?,NS(=O)(=O)C#Cc1ccccc1,C8H7NO2S,10748.0
1833,SC-66,O=C1/C(=C/c2ccncc2)CCC/C1=C\c1ccncc1,C18H16N2O,10876.0
1834,CAY10654,CCCCCCCCNC(=O)CC(=O)Nc1cc(Cl)ccc1O,C17H25ClN2O3,10857.0
1835,Mephedrone (hydrochloride),CNC(C)C(=O)c1ccc(C)cc1.Cl,C11H16ClNO,10801.0
1836,Mephedrone (hydrochloride) (CRM),CNC(C)C(=O)c1ccc(C)cc1.Cl,C11H16ClNO,26277.0
1837,RCS-4 2-methoxy isomer,CCCCCn1cc(C(=O)c2ccccc2OC)c2ccccc21,C21H23NO2,10865.0
1838,RCS-4 3-methoxy isomer,CCCCCn1cc(C(=O)c2cccc(OC)c2)c2ccccc21,C21H23NO2,10866.0
1839,RCS-4 N-(5-hydroxypentyl) metabolite,COc1ccc(C(=O)c2cn(CCCCCO)c3ccccc23)cc1,C21H23NO3,10935.0
1840,JWH 122 N-(5-hydroxypentyl) metabolite,Cc1ccc(C(=O)c2cn(CCCCCO)c3ccccc23)c2ccccc12,C25H25NO2,10925.0
1841,AM694 4-iodo isomer,O=C(c1ccc(I)cc1)c1cn(CCCCCF)c2ccccc12,C20H19FINO,10869.0
1842,Eicosapentaenoyl Ethanolamide,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO,C22H35NO2,10964.0
1843,JWH 018 N-(5-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1cccc3ccccc13)c([2H])n2CCCCCO,C24H23NO2,10933.0
1844,"3,4-MDMA methylene homolog (hydrochloride)",CNCC(C)Cc1ccc2c(c1)OCO2.Cl,C12H18ClNO2,10979.0
1845,Palmitoleoyl Ethanolamide,CCCCCC/C=C\CCCCCCCC(=O)NCCO,C18H35NO2,10965.0
1846,RCS-4 N-(5-carboxypentyl) metabolite,COc1ccc(C(=O)c2cn(CCCCC(=O)O)c3ccccc23)cc1,C21H21NO4,10937.0
1847,SR 1001,CC(=O)Nc1nc(C)c(S(=O)(=O)Nc2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)s1,C15H13F6N3O4S2,10922.0
1848,"JWH 018 2'-naphthyl-N-(2,2-dimethylpropyl) isomer",CC(C)(C)Cn1cc(C(=O)c2ccc3ccccc3c2)c2ccccc21,C24H23NO,9001008.0
1849,"JWH 018 N-(2,2-dimethylpropyl) isomer",CC(C)(C)Cn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,9001001.0
1850,JWH 250 5-hydroxyindole metabolite,CCCCCn1cc(C(=O)Cc2ccccc2OC)c2cc(O)ccc21,C22H25NO3,9000766.0
1851,4-Methylethcathinone (hydrochloride),CCNC(C)C(=O)c1ccc(C)cc1.Cl,C12H18ClNO,9001069.0
1852,4-Methylethcathinone (hydrochloride) (exempt preparation),CCNC(C)C(=O)c1ccc(C)cc1.Cl,C12H18ClNO,16049.0
1853,(-)-trans-C75,C=C1C(=O)O[C@@H](CCCCCCCC)[C@@H]1C(=O)O,C14H22O4,9000784.0
1854,JWH 250 N-pentanoic acid metabolite,COc1ccccc1CC(=O)c1cn(CCCCC(=O)O)c2ccccc12,C22H23NO4,10938.0
1855,JWH 018 adamantyl analog,CCCCCn1cc(C(=O)C23CC4CC(CC(C4)C2)C3)c2ccccc21,C24H31NO,9000799.0
1856,(+)-trans-C75,C=C1C(=O)O[C@H](CCCCCCCC)[C@H]1C(=O)O,C14H22O4,9000783.0
1857,SAHA-BPyne,C#CCCCC(=O)Nc1ccc(C(=O)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)cc1,C27H31N3O5,10675.0
1858,Epothilone B,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1,C27H41NO6S,10924.0
1859,JWH 018 7-hydroxyindole metabolite-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2cccc3ccccc23)c2cccc(O)c21,C24H23NO2,10715.0
1860,JWH 073 7-hydroxyindole metabolite-d7,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2cccc3ccccc23)c2cccc(O)c21,C23H21NO2,10720.0
1861,Phthalazinone pyrazole,Cc1cc(Nc2nn(-c3ccccc3)c(=O)c3ccccc23)n[nH]1,C18H15N5O,10735.0
1862,Iso-Olomoucine,Cn1cnc2nc(NCCO)nc(NCc3ccccc3)c21,C15H18N6O,13325.0
1863,RCS-4 N-(4-hydroxypentyl) metabolite,COc1ccc(C(=O)c2cn(CCCC(C)O)c3ccccc23)cc1,C21H23NO3,10936.0
1864,4-Fluoromethamphetamine (hydrochloride),CNC(C)Cc1ccc(F)cc1.Cl,C10H15ClFN,9001070.0
1865,JWH 081 N-(5-hydroxypentyl) metabolite,COc1ccc(C(=O)c2cn(CCCCCO)c3ccccc23)c2ccccc12,C25H25NO3,9000768.0
1866,Bisdemethoxycurcumin,O=C(/C=C/c1ccc(O)cc1)CC(=O)/C=C/c1ccc(O)cc1,C19H16O4,10960.0
1867,JWH 022,C=CCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H21NO,9001056.0
1868,JWH 250 N-(5-hydroxypentyl) metabolite,COc1ccccc1CC(=O)c1cn(CCCCCO)c2ccccc12,C22H25NO3,9000767.0
1869,TG003,CCN1/C(=C/OC)Sc2ccc(OC)cc21,C12H15NO2S,10398.0
1870,Butylone (hydrochloride),CCC(NC)C(=O)c1ccc2c(c1)OCO2.Cl,C12H16ClNO3,10393.0
1871,Butylone (hydrochloride) (CRM),CCC(NC)C(=O)c1ccc2c(c1)OCO2.Cl,C12H16ClNO3,35016.0
1872,JWH 210 5-hydroxyindole metabolite,CCCCCn1cc(C(=O)c2ccc(CC)c3ccccc23)c2cc(O)ccc21,C26H27NO2,9000771.0
1873,16(R)-AFP 07 (free acid),CCC#CC[C@@H](C)[C@H](O)/C=C/[C@@H]1[C@@H]2[C@H](C[C@H]1O)O/C(=C/CCCC(=O)O)C2(F)F,C22H30F2O5,10991.0
1874,AM2201 N-(4-fluoropentyl) isomer,CC(F)CCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H22FNO,9001029.0
1875,Naphyrone (hydrochloride),CCCC(C(=O)c1ccc2ccccc2c1)N1CCCC1.Cl,C19H24ClNO,10517.0
1876,Naphyrone (hydrochloride) (exempt preparation),CCCC(C(=O)c1ccc2ccccc2c1)N1CCCC1.Cl,C19H24ClNO,16056.0
1877,"3,4-Methylenedioxy-.alpha.-Pyrrolidinopropiophenone (hydrochloride)",CC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1.Cl,C14H18ClNO3,10439.0
1878,4-methoxy-.alpha.-Pyrrolidinopropiophenone (tosylate),COc1ccc(C(=O)C(C)N2CCCC2)cc1.Cc1ccc(S(=O)(=O)O)cc1,C21H27NO5S,10449.0
1879,nor-Mephedrone (hydrochloride),Cc1ccc(C(=O)C(C)N)cc1.Cl,C10H14ClNO,9000940.0
1880,"Cl-Amidine (hydrochloride) - Sold under license from the University of South Carolina under U.S. Patent No. 7,964,363",Cl.N=C(CCl)NCCC[C@H](NC(=O)c1ccccc1)C(N)=O,C14H20Cl2N4O2,10599.0
1881,Zebularine,O=c1ncccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C9H12N2O5,10975.0
1882,Pentedrone (hydrochloride),CCCC(NC)C(=O)c1ccccc1.Cl,C12H18ClNO,11011.0
1883,Pentedrone (hydrochloride) (CRM),CCCC(NC)C(=O)c1ccccc1.Cl,C12H18ClNO,21322.0
1884,"3,4-Methylenedioxy-.alpha.-Pyrrolidinobutiophenone (hydrochloride)",CCC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1.Cl,C15H20ClNO3,10437.0
1885,4'-methyl-.alpha.-Pyrrolidinopropiophenone (hydrochloride),Cc1ccc(C(=O)C(C)N2CCCC2)cc1.Cl,C14H20ClNO,10446.0
1886,4'-methyl-.alpha.-Pyrrolidinopropiophenone (hydrochloride) (exempt preparation),Cc1ccc(C(=O)C(C)N2CCCC2)cc1.Cl,C14H20ClNO,16051.0
1887,.alpha.-Pyrrolidinopropiophenone (hydrochloride),CC(C(=O)c1ccccc1)N1CCCC1.Cl,C13H18ClNO,10445.0
1888,JWH 081 2-methoxynaphthyl isomer,CCCCCn1cc(C(=O)c2c(OC)ccc3ccccc23)c2ccccc21,C25H25NO2,9001044.0
1889,JWH 398 5-chloronaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3c(Cl)cccc23)c2ccccc21,C24H22ClNO,9001025.0
1890,AM694 3-iodo isomer,O=C(c1cccc(I)c1)c1cn(CCCCCF)c2ccccc12,C20H19FINO,10870.0
1891,AFP 07 (free acid),CCC#CC[C@H](C)[C@H](O)/C=C/[C@@H]1[C@@H]2[C@H](C[C@H]1O)O/C(=C/CCCC(=O)O)C2(F)F,C22H30F2O5,13626.0
1892,16-hydroxy Hexadecanoic Acid,O=C=O.[H]CCCCCCCCCCCCCCCO,C16H32O3,9000789.0
1893,JWH 073 4-methyl naphthyl analog,CCCCn1cc(C(=O)c2ccc(C)c3ccccc23)c2ccccc21,C24H23NO,9001076.0
1894,JWH 011,CCCCCC(C)n1c(C)c(C(=O)c2cccc3ccccc23)c2ccccc21,C27H29NO,9001058.0
1895,JWH 210-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2ccc(CC)c3ccccc23)c2ccccc21,C26H27NO,10510.0
1896,JWH 081-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2ccc(OC)c3ccccc23)c2ccccc21,C25H25NO2,10511.0
1897,JWH 081-d9 (exempt preparation) (Item No. 22866) is provided as a DEA exempt preparation.,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2ccc(OC)c3ccccc23)c2ccccc21,C25H25NO2,22866.0
1898,JWH 122-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2ccc(C)c3ccccc23)c2ccccc21,C25H25NO,10512.0
1899,JWH 122-d9 (exempt preparation),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2ccc(C)c3ccccc23)c2ccccc21,C25H25NO,22868.0
1900,RCS-4-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2ccc(OC)cc2)c2ccccc21,C21H23NO2,10513.0
1901,RCS-4-d9 (exempt preparation),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2ccc(OC)cc2)c2ccccc21,C21H23NO2,22867.0
1902,Tizoxanide,O=C(Nc1ncc([N+](=O)[O-])s1)c1ccccc1O,C10H7N3O4S,13693.0
1903,BAY 43-9006,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,C21H16ClF3N4O3,10009644.0
1904,F-Amidine (trifluoroacetate salt),N=C(CF)NCCC[C@H](NC(=O)c1ccccc1)C(N)=O.O=C(O)C(F)(F)F,C16H20F4N4O4,10610.0
1905,Demethoxy curcumin,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)cc2)ccc1O,C20H18O5,10961.0
1906,Thapsigargin,C/C=C(/C)C(=O)O[C@H]1C(C)=C2C([C@@H]1OC(=O)CCCCCCC)[C@@](C)(OC(C)=O)C[C@H](OC(=O)CCC)[C@@]1(O)[C@H]2OC(=O)[C@@]1(C)O,C34H50O12,10522.0
1907,HZ52,CCCCCCC(Sc1nc(Cl)cc(Nc2ccc(-c3ccccc3)cc2)n1)C(=O)O,C24H26ClN3O2S,10888.0
1908,1-NA-PP1,CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21,C19H19N5,10954.0
1909,Daidzin,O=c1c(-c2ccc(O)cc2)coc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12,C21H20O9,13202.0
1910,Guanabenz (hydrochloride),Cl.N=C(N)N/N=C/c1c(Cl)cccc1Cl,C8H9Cl3N4,10851.0
1911,Ionomycin,C[C@H](CCC(=O)O)C[C@H](C)C[C@H](C)C(=O)/C=C(\O)[C@H](C)C[C@H](C)C/C=C/[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)CC1CC[C@@](C)([C@H]2CC[C@@](C)([C@@H](C)O)O2)O1,C41H72O9,10004974.0
1912,4-chloro-.alpha.-Cyanocinnamic Acid,N#C/C(=C\c1ccc(Cl)cc1)C(=O)O,C10H6ClNO2,9000981.0
1913,3-amino Benzamide,NC(=O)c1cccc(N)c1,C7H8N2O,10397.0
1914,JWH 251 3-methylphenyl isomer,CCCCCn1cc(C(=O)Cc2cccc(C)c2)c2ccccc21,C22H25NO,9001021.0
1915,.alpha.-Pyrrolidinopentiophenone (hydrochloride),CCCC(C(=O)c1ccccc1)N1CCCC1.Cl,C15H22ClNO,9001083.0
1916,?-Pyrrolidinopentiophenone (hydrochloride) (CRM),CCCC(C(=O)c1ccccc1)N1CCCC1.Cl,C15H22ClNO,22808.0
1917,AM2201 N-(4-hydroxypentyl) metabolite,O=C(c1cccc2ccccc12)c1cn(CCCC(O)CF)c2ccccc12,C24H22FNO2,10203.0
1918,"JWH 018 N-(1,2-dimethylpropyl) isomer",CC(C)C(C)n1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,9001003.0
1919,JWH 073 2-methylnaphthyl analog,CCCCn1cc(C(=O)c2c(C)ccc3ccccc23)c2ccccc21,C24H23NO,10848.0
1920,JWH 182,CCCCCn1cc(C(=O)c2ccc(CCC)c3ccccc23)c2ccccc21,C27H29NO,10643.0
1921,JWH 210 2-ethylnaphthyl isomer,CCCCCn1cc(C(=O)c2c(CC)ccc3ccccc23)c2ccccc21,C26H27NO,9001038.0
1922,JWH 210 N-pentanoic acid metabolite,CCc1ccc(C(=O)c2cn(CCCCC(=O)O)c3ccccc23)c2ccccc12,C26H25NO3,10941.0
1923,Methylhexanamine (hydrochloride),CCC(C)CC(C)N.Cl,C7H18ClN,10749.0
1924,EHNA (hydrochloride),CCCCCC[C@@H]([C@@H](C)O)n1cnc2c(N)ncnc21.Cl,C14H24ClN5O,13352.0
1925,Eicosapentaenoic Acid methyl ester,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC,C21H32O2,9000295.0
1926,JWH 081 7-methoxynaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3ccc(OC)cc23)c2ccccc21,C25H25NO2,9001048.0
1927,AM1220,CN1CCCCC1Cn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C26H26N2O,9001055.0
1928,"JWH 018 2'-naphthyl-N-(1,2-dimethylpropyl) isomer",CC(C)C(C)n1cc(C(=O)c2ccc3ccccc3c2)c2ccccc21,C24H23NO,9001006.0
1929,JWH 030,CCCCCn1ccc(C(=O)c2cccc3ccccc23)c1,C20H21NO,10831.0
1930,JWH 081 5-methoxynaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3c(OC)cccc23)c2ccccc21,C25H25NO2,9001046.0
1931,JWH 200 6-hydroxyindole metabolite,O=C(c1cccc2ccccc12)c1cn(CCN2CCOCC2)c2cc(O)ccc12,C25H24N2O3,10746.0
1932,JWH 210 7-ethylnaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3ccc(CC)cc23)c2ccccc21,C26H27NO,9001042.0
1933,Methedrone (hydrochloride),CNC(C)C(=O)c1ccc(OC)cc1,C11H15NO2,10529.0
1934,10-HDA,O=C(O)/C=C/CCCCCCCO,C10H18O3,10976.0
1935,JWH 251 4-methylphenyl isomer,CCCCCn1cc(C(=O)Cc2ccc(C)cc2)c2ccccc21,C22H25NO,9001022.0
1936,SB-366791,COc1cccc(NC(=O)/C=C/c2ccc(Cl)cc2)c1,C16H14ClNO2,11019.0
1937,JWH 019 N-(6-hydroxyhexyl) metabolite,O=C(c1cccc2ccccc12)c1cn(CCCCCCO)c2ccccc12,C25H25NO2,9000765.0
1938,JWH 073 N-(4-hydroxybutyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1cccc3ccccc13)c([2H])n2CCCCO,C23H21NO2,10934.0
1939,Piperlongumine,COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC,C17H19NO5,11006.0
1940,all-trans Retinoic Acid,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,C20H28O2,11017.0
1941,Dexamethasone,C[C@@H]1C[C@H]2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,C22H29FO5,11015.0
1942,"JWH 018 N-(4,5-epoxypentyl) analog",O=C(c1cccc2ccccc12)c1cn(CCCC2CO2)c2ccccc12,C24H21NO2,11075.0
1943,4'-methyl-.alpha.-Pyrrolidinohexanophenone (hydrochloride),CCCCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl,C17H26ClNO,10448.0
1944,4'-methyl-?-Pyrrolidinohexanophenone (hydrochloride) (exempt preparation),CCCCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl,C17H26ClNO,39597.0
1945,2-amino-4-(4-pyridyl)-Thiazole,Nc1nc(-c2ccncc2)cs1,C8H7N3S,11058.0
1946,Pyrazine-2-amidoxime,N/C(=N\O)c1cnccn1,C5H6N4O,11059.0
1947,4-amino Benzamidoxime,N/C(=N\O)c1ccc(N)cc1,C7H9N3O,11053.0
1948,Garcinol,C=C(C)[C@@H](CC=C(C)C)C[C@@]12C[C@@H](CC=C(C)C)C(C)(C)[C@@](CC=C(C)C)(C(=O)C(C(=O)c3ccc(O)c(O)c3)=C1O)C2=O,C38H50O6,10566.0
1949,A23187,CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O,C29H37N3O6,11016.0
1950,AM2233,CN1CCCCC1Cn1cc(C(=O)c2ccccc2I)c2ccccc21,C22H23IN2O,11008.0
1951,JWH 250 N-(4-hydroxypentyl) metabolite,COc1ccccc1CC(=O)c1cn(CCCC(C)O)c2ccccc12,C22H25NO3,10939.0
1952,Biphenyl-4-amidoxime,N/C(=N\O)c1ccc(-c2ccccc2)cc1,C13H12N2O,11054.0
1953,Indole-3-amidoxime,NC(=NO)c1c[nH]c2ccccc12,C9H9N3O,11060.0
1954,2-amino-4-(1-adamantyl) Thiazole,Nc1nc(C23CC4CC(CC(C4)C2)C3)cs1,C13H18N2S,11051.0
1955,ethyl 2-(3-hydroxyphenyl)-4-methylthiazole-5-Carboxylate,CCOC(=O)c1sc(-c2cccc(O)c2)nc1C,C13H13NO3S,11055.0
1956,TPPU,CCC(=O)N1CCC(NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1,C16H20F3N3O3,11120.0
1957,JWH 210 N-(5-hydroxypentyl) metabolite,CCc1ccc(C(=O)c2cn(CCCCCO)c3ccccc23)c2ccccc12,C26H27NO2,9000772.0
1958,JWH 398 6-chloronaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3cc(Cl)ccc23)c2ccccc21,C24H22ClNO,9001026.0
1959,MDAI (hydrochloride),Cl.NC1Cc2cc3c(cc2C1)OCO3,C10H12ClNO2,9001102.0
1960,ethyl 4-methyl-2-(2-thienyl)-thiazole-5 Carboxylate,CCOC(=O)c1sc(-c2cccs2)nc1C,C11H11NO2S2,11056.0
1961,JWH 210 8-ethylnaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3cccc(CC)c23)c2ccccc21,C26H27NO,9001043.0
1962,"(R,S)-Anatabine",C1=CCC(c2cccnc2)NC1,C10H12N2,11001.0
1963,bk-MDDMA (hydrochloride),CC(C(=O)c1ccc2c(c1)OCO2)N(C)C.Cl,C12H16ClNO3,9001124.0
1964,bk-MDDMA (hydrochloride) (exempt preparation),CC(C(=O)c1ccc2c(c1)OCO2)N(C)C.Cl,C12H16ClNO3,22879.0
1965,4-Ethylmethcathinone (hydrochloride),CCc1ccc(C(=O)C(C)NC)cc1.Cl,C12H18ClNO,9001078.0
1966,JWH 398 2-chloronaphthyl isomer,CCCCCn1cc(C(=O)c2c(Cl)ccc3ccccc23)c2ccccc21,C24H22ClNO,9001023.0
1967,BIBF 1120,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,C31H33N5O4,11022.0
1968,bk-MDEA (hydrochloride),CCNC(C)C(=O)c1ccc2c(c1)OCO2.Cl,C12H16ClNO3,9001123.0
1969,Ethylone (hydrochloride) polymorph B,CCNC(C)C(=O)c1ccc2c(c1)OCO2.Cl,C12H16ClNO3,9002749.0
1970,bk-MDEA (hydrochloride) (CRM),CCNC(C)C(=O)c1ccc2c(c1)OCO2.Cl,C12H16ClNO3,27240.0
1971,bk-DMBDB (hydrochloride),CCC(C(=O)c1ccc2c(c1)OCO2)N(C)C.Cl,C13H18ClNO3,9001125.0
1972,bk-DMBDB (hydrochloride) (CRM),CCC(C(=O)c1ccc2c(c1)OCO2)N(C)C.Cl,C13H18ClNO3,27239.0
1973,"JWH 018 N-(1,1-dimethylpropyl) isomer",CCC(C)(C)n1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,9001000.0
1974,JWH 398 7-chloronaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3ccc(Cl)cc23)c2ccccc21,C24H22ClNO,9001027.0
1975,SR 16584,CN1[C@@H]2CCC[C@H]1C[C@H](N1C(=O)Cc3ccccc31)C2,C17H22N2O,10683.0
1976,4-methoxy DMT,COc1cccc2[nH]cc(CCN(C)C)c12,C13H18N2O,9000895.0
1977,4-methoxy DMT (exempt preparation),COc1cccc2[nH]cc(CCN(C)C)c12,C13H18N2O,38147.0
1978,JWH 210 5-ethylnaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3c(CC)cccc23)c2ccccc21,C26H27NO,9001040.0
1979,3-amino Benzamidoxime,NC(=NO)c1cccc(N)c1,C7H9N3O,11074.0
1980,4-amino Benzthioamide,NC(=S)c1ccc(N)cc1,C7H8N2S,11063.0
1981,Thiophene-2-amidoxime,N/C(=N\O)c1cccs1,C5H6N2OS,11061.0
1982,CCG-100602,O=C(Nc1ccc(Cl)cc1)C1CCCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)C1,C21H17ClF6N2O2,10787.0
1983,Nifedipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],C17H18N2O6,11106.0
1984,(S)-(+)-JWH 073 N-(3-hydroxybutyl) metabolite,C[C@H](O)CCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C23H21NO2,10898.0
1985,2-amino Benzamidoxime,N/C(=N\O)c1ccccc1N,C7H9N3O,11062.0
1986,Indole-3-thio Carboxamide,NC(=S)c1c[nH]c2ccccc12,C9H8N2S,11065.0
1987,2-phenyl-3-methyl-Quinoxaline,Cc1nc2ccccc2nc1-c1ccccc1,C15H12N2,11057.0
1988,3-amino Benzthioamide,NC(=S)c1cccc(N)c1,C7H8N2S,11064.0
1989,PD 166326,Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(CO)c3)nc21,C21H16Cl2N4O2,9000988.0
1990,Mitragynine,CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)C2C[C@@H]1/C(=C\OC)C(=O)OC,C23H30N2O4,11151.0
1991,(S)-Desoxy-D2PM (hydrochloride),Cl.c1ccc(C(c2ccccc2)[C@@H]2CCCN2)cc1,C17H20ClN,9001095.0
1992,JWH 018 N-(2-hydroxypentyl) metabolite,CCCC(O)Cn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO2,11119.0
1993,JWH 210 3-ethylnaphthyl isomer,CCCCCn1cc(C(=O)c2cc(CC)cc3ccccc23)c2ccccc21,C26H27NO,9001039.0
1994,GN25,COc1ccc(OC)c2c1C(=O)C=C(SCCC(=O)O)C2=O,C15H14O6S,10948.0
1995,Palmitoyl-DL-carnitine (chloride),CCCCCCCCCCCCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C.[Cl-],C23H46ClNO4,11095.0
1996,2-Fluoromethcathinone (hydrochloride),CNC(C)C(=O)c1ccccc1F.Cl,C10H13ClFNO,9001135.0
1997,(S)-(+)-JWH 018 N-(4-hydroxypentyl) metabolite,C[C@H](O)CCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO2,10920.0
1998,5-IAI (hydrochloride),Cl.NC1Cc2ccc(I)cc2C1,C9H11ClIN,11035.0
1999,Eutylone (hydrochloride),CCNC(CC)C(=O)c1ccc2c(c1)OCO2.Cl,C13H18ClNO3,9001103.0
2000,Eutylone (hydrochloride) (CRM),CCNC(CC)C(=O)c1ccc2c(c1)OCO2.Cl,C13H18ClNO3,29672.0
2001,JWH 307,CCCCCn1cc(C(=O)c2cccc3ccccc23)cc1-c1ccccc1F,C26H24FNO,10797.0
2002,AM2201 N-(2-fluoropentyl) isomer,CCCC(F)Cn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H22FNO,9001031.0
2003,tetranor-PGJM,O=C(O)CCCCC(=O)CC[C@H]1C(=O)C=C[C@@H]1CCC(=O)O,C16H22O6,13363.0
2004,4-Fluoroamphetamine (hydrochloride),CC(N)Cc1ccc(F)cc1.Cl,C9H13ClFN,11156.0
2005,JWH 368,CCCCCn1cc(C(=O)c2cccc3ccccc23)cc1-c1cccc(F)c1,C26H24FNO,10829.0
2006,tetranor-PGAM,O=C(O)CCCCC(=O)CC[C@H]1C=CC(=O)[C@@H]1CCC(=O)O,C16H22O6,13369.0
2007,(+)-YK-4-279,COc1ccc(C(=O)C[C@]2(O)C(=O)Nc3c(Cl)ccc(Cl)c32)cc1,C17H13Cl2NO4,11167.0
2008,Ceranib-2,COc1ccc(/C=C/C(=O)c2c(-c3ccccc3)c3ccccc3[nH]c2=O)cc1,C25H19NO3,11092.0
2009,4-Ethylethcathinone (hydrochloride),CCNC(C)C(=O)c1ccc(CC)cc1.Cl,C13H20ClNO,11197.0
2010,JWH 018 N-(5-hydroxypentyl) .beta.-D-Glucuronide,O=C(c1cccc2ccccc12)c1cn(CCCCCO[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)c2ccccc12,C30H31NO8,10958.0
2011,18-methyl Eicosanoic Acid,CCC(C)CCCCCCCCCCCCCCCCC(=O)O,C21H42O2,11009.0
2012,"4-ethyl-N,N-Dimethylcathinone (hydrochloride)",CCc1ccc(C(=O)C(C)N(C)C)cc1.Cl,C13H20ClNO,11207.0
2013,Forskolin,C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](O)[C@H](OC(C)=O)[C@@]2(C)O1,C22H34O7,11018.0
2014,D2PM (hydrochloride),Cl.OC(c1ccccc1)(c1ccccc1)[C@H]1CCCN1,C17H20ClNO,11160.0
2015,"CP 47,497-C8-homolog C-8-hydroxy metabolite",CC(C)(CCCCCCCO)c1ccc([C@H]2CCC[C@@H](O)C2)c(O)c1,C22H36O3,9000773.0
2016,Ketorolac,O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O,C15H13NO3,9001148.0
2017,2-AI (hydrochloride),Cl.NC1Cc2ccccc2C1,C9H12ClN,11048.0
2018,25-hydroxy Vitamin D3,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]12,C27H44O2,9000683.0
2019,JWH 081 8-methoxynaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3cccc(OC)c23)c2ccccc21,C25H25NO2,9001049.0
2020,"JWH 018 2'-naphthyl-N-(1,1-dimethylpropyl) isomer",CCC(C)(C)n1cc(C(=O)c2ccc3ccccc3c2)c2ccccc21,C24H23NO,9001007.0
2021,WYE-354,COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1,C24H29N7O5,13604.0
2022,2C-E (hydrochloride),CCc1cc(OC)c(CCN)cc1OC.Cl,C12H20ClNO2,10395.0
2023,2C-E (hydrochloride) (exempt preparation),CCc1cc(OC)c(CCN)cc1OC.Cl,C12H20ClNO2,15699.0
2024,WSP-1,COc1ccc2c(c1)Oc1cc(OC(=O)c3ccccc3SSc3ccccn3)ccc1C21OC(=O)c2ccccc21,C33H21NO6S2,11179.0
2025,2C-I (hydrochloride),COc1cc(CCN)c(OC)cc1I.Cl,C10H15ClINO2,11113.0
2026,2C-I (hydrochloride) (exempt preparation),COc1cc(CCN)c(OC)cc1I.Cl,C10H15ClINO2,15700.0
2027,4-Fluoroethcathinone (hydrochloride),CCNC(C)C(=O)c1ccc(F)cc1.Cl,C11H15ClFNO,11231.0
2028,JWH 018 N-(5-chloropentyl) analog,O=C(c1cccc2ccccc12)c1cn(CCCCCCl)c2ccccc12,C24H22ClNO,10521.0
2029,Mellein,CC1Cc2cccc(O)c2C(=O)O1,C10H10O3,10311.0
2030,5-APB (hydrochloride),CC(N)Cc1ccc2occc2c1.Cl,C11H14ClNO,11134.0
2031,AM2201 7-hydroxyindole metabolite,O=C(c1cccc2ccccc12)c1cn(CCCCCF)c2c(O)cccc12,C24H22FNO2,11193.0
2032,.alpha.-Pyrrolidinobutiophenone (hydrochloride),CCC(C(=O)c1ccccc1)N1CCCC1.Cl,C14H20ClNO,9001195.0
2033,.alpha.-Pyrrolidinobutiophenone (hydrochloride) (exempt preparation),CCC(C(=O)c1ccccc1)N1CCCC1.Cl,C14H20ClNO,16057.0
2034,Nodinitib-1,Cc1ccc(S(=O)(=O)n2c(N)nc3ccccc32)cc1,C14H13N3O2S,11040.0
2035,?2-cis-Hexadecenoic Acid,CCCCCCCCCCCCC/C=C\C(=O)O,C16H30O2,11133.0
2036,"13(R),14(R)-epoxy Fluprostenol isopropyl ester",CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H]([C@H]2O[C@@H]2[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,C26H35F3O7,11169.0
2037,Ethcathinone (hydrochloride),CCNC(C)C(=O)c1ccccc1.Cl,C11H16ClNO,11241.0
2038,"3,4-Dimethylmethcathinone (hydrochloride)",CNC(C)C(=O)c1ccc(C)c(C)c1.Cl,C12H18ClNO,9001098.0
2039,"3,4-Dimethylethcathinone (hydrochloride)",CCNC(C)C(=O)c1ccc(C)c(C)c1.Cl,C13H20ClNO,11228.0
2040,JWH 018 N-(5-bromopentyl) analog,O=C(c1cccc2ccccc12)c1cn(CCCCCBr)c2ccccc12,C24H22BrNO,11047.0
2041,JWH 210 N-(4-hydroxypentyl) metabolite,CCc1ccc(C(=O)c2cn(CCCC(C)O)c3ccccc23)c2ccccc12,C26H27NO2,10940.0
2042,DMABA NHS ester,CN(C)c1ccc(C(=O)ON2C(=O)CCC2=O)cc1,C13H14N2O4,11216.0
2043,?2-trans-Hexadecenoic Acid,CCCCCCCCCCCCC/C=C/C(=O)O,C16H30O2,11132.0
2044,Buphedrone (hydrochloride),CCC(NC)C(=O)c1ccccc1.Cl,C11H16ClNO,11283.0
2045,Naphyrone 1-naphthyl isomer (hydrochloride),CCCC(C(=O)c1cccc2ccccc12)N1CCCC1.Cl,C19H24ClNO,11240.0
2046,3-Ethylethcathinone (hydrochloride),CCNC(C)C(=O)c1cccc(CC)c1.Cl,C13H20ClNO,11198.0
2047,JWH 081 6-methoxynaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3cc(OC)ccc23)c2ccccc21,C25H25NO2,9001047.0
2048,Apicidin,CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)C([C@@H](C)CC)NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC1=O,C34H49N5O6,10575.0
2049,Chelerythrine (chloride),COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-],C21H18ClNO4,11314.0
2050,Aflatoxin B2,COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@H]1CCO[C@H]1O2,C17H14O6,11294.0
2051,Termitomycamide E,CCCCC/C=C\C/C=C\CCCCCCCC(=O)NCCc1ccc(O)cc1,C26H41NO2,11191.0
2052,4-Quinolone-3-Carboxamide Derivative,CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)c2cccc(OC)c21,C26H34N2O3,11093.0
2053,JWH 210 6-ethylnaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3cc(CC)ccc23)c2ccccc21,C26H27NO,9001041.0
2054,2-Fluoroethcathinone (hydrochloride),CCNC(C)C(=O)c1ccccc1F.Cl,C11H15ClFNO,11229.0
2055,"2,3-Methylenedioxymethcathinone (hydrochloride)",CNC(C)C(=O)c1cccc2c1OCO2.Cl,C11H14ClNO3,9001133.0
2056,Castanospermine,O[C@H]1[C@H](O)[C@@H](O)CN2CC[C@H](O)[C@H]12,C8H15NO4,11313.0
2057,Aflatoxin B1,COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)C1C=COC1O2,C17H12O6,11293.0
2058,Termitomycamide B,CCCCC/C=C\C/C=C\CCCCCCCC(=O)NCC(=O)c1cc2ccccc2[nH]1,C28H40N2O2,11190.0
2059,Alternariol,Cc1cc(O)cc2oc(=O)c3c(O)cc(O)cc3c12,C14H10O5,11306.0
2060,JWH 369,CCCCCn1cc(C(=O)c2cccc3ccccc23)cc1-c1ccccc1Cl,C26H24ClNO,10828.0
2061,JWH 081 3-methoxynaphthyl isomer,CCCCCn1cc(C(=O)c2cc(OC)cc3ccccc23)c2ccccc21,C25H25NO2,9001045.0
2062,3-Ethylmethcathinone (hydrochloride),CCc1cccc(C(=O)C(C)NC)c1.Cl,C12H18ClNO,9001082.0
2063,Maresin 1,CC/C=C\C/C=C\C[C@H](O)/C=C\C=C\C=C\[C@H](O)C/C=C\CCC(=O)O,C22H32O4,10878.0
2064,PGDM,O=C(O)C/C=C\C[C@@H]1[C@@H](CCC(=O)CCC(=O)O)[C@@H](O)C[C@@H]1O,C16H24O7,13454.0
2065,DMABA-d6 NHS ester,[2H]C([2H])([2H])N(c1ccc(C(=O)ON2C(=O)CCC2=O)cc1)C([2H])([2H])[2H],C13H14N2O4,11218.0
2066,AM1248,CN1CCCCC1Cn1cc(C(=O)C23CC4CC(CC(C4)C2)C3)c2ccccc21,C26H34N2O,11282.0
2067,25I-NMBOMe (hydrochloride),COc1cc(CCNCc2ccccc2OC)c(OC)cc1I.Cl,C18H23ClINO3,9001128.0
2068,3-Methylethcathinone (hydrochloride),CCNC(C)C(=O)c1cccc(C)c1.Cl,C12H18ClNO,11222.0
2069,3-Fluoroethcathinone (hydrochloride),CCNC(C)C(=O)c1cccc(F)c1.Cl,C11H15ClFNO,11230.0
2070,3-Fluoroamphetamine (hydrochloride),CC(N)Cc1cccc(F)c1.Cl,C9H13ClFN,9001191.0
2071,SB939,CCCCc1nc2cc(/C=C/C(=O)NO)ccc2n1CCN(CC)CC,C20H30N4O2,10443.0
2072,Meconin,COc1ccc2c(c1OC)C(=O)OC2,C10H10O4,9001140.0
2073,3-Methylmethcathinone (hydrochloride),CNC(C)C(=O)c1cccc(C)c1.Cl,C11H16ClNO,11224.0
2074,3-Methylmethcathinone (hydrochloride) (exempt preparation),CNC(C)C(=O)c1cccc(C)c1.Cl,C11H16ClNO,38141.0
2075,2-Fluoroamphetamine (hydrochloride),CC(N)Cc1ccccc1F.Cl,C9H13ClFN,11419.0
2076,2-chloro-3-Deazaadenosine,Nc1nc(Cl)cc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C11H13ClN4O4,9000787.0
2077,25-hydroxy Cholesterol,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O2,11097.0
2078,Tafluprost ethyl amide,CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C(F)(F)COc2ccccc2)[C@H](O)C[C@@H]1O,C24H33F2NO4,9000843.0
2079,JWH 249,CCCCCn1cc(C(=O)Cc2ccccc2Br)c2ccccc21,C21H22BrNO,11153.0
2080,2-Ethylethcathinone (hydrochloride),CCNC(C)C(=O)c1ccccc1CC.Cl,C13H20ClNO,11199.0
2081,Anisomycin,COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1,C14H19NO4,11308.0
2082,JWH 175,CCCCCn1cc(Cc2cccc3ccccc23)c2ccccc21,C24H25N,11201.0
2083,2-Fluoromethamphetamine (hydrochloride),CNC(C)Cc1ccccc1F.Cl,C10H15ClFN,11420.0
2084,2-Methylmethcathinone (hydrochloride),CNC(C)C(=O)c1ccccc1C.Cl,C11H16ClNO,11223.0
2085,Decitabine,Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,C8H12N4O4,11166.0
2086,JWH 309,CCCCCn1cc(C(=O)c2cccc3ccccc23)cc1-c1cccc2ccccc12,C30H27NO,10830.0
2087,4-Quinolone-3-Carboxamide Furan CB2 Agonist,CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)c2cc(-c3ccco3)cc(OC)c21,C30H36N2O4,11094.0
2088,L-Kynurenine,Nc1ccccc1C(=O)C[C@H](N)C(=O)O,C10H12N2O3,11305.0
2089,JWH 424,CCCCCn1cc(C(=O)c2cccc3cccc(Br)c23)c2ccccc21,C24H22BrNO,9001203.0
2090,AM2201 6-hydroxyindole metabolite,O=C(c1cccc2ccccc12)c1cn(CCCCCF)c2cc(O)ccc12,C24H22FNO2,11192.0
2091,"2,3-Pentylone isomer (hydrochloride)",CCCC(NC)C(=O)c1cccc2c1OCO2.Cl,C13H18ClNO3,11463.0
2092,3-Fluoromethamphetamine (hydrochloride),CNC(C)Cc1cccc(F)c1.Cl,C10H15ClFN,9001185.0
2093,5-Azacytidine,Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,C8H12N4O5,11164.0
2094,DMABA-d4 NHS ester,[2H]c1c([2H])c(N(C)C)c([2H])c([2H])c1C(=O)ON1C(=O)CCC1=O,C13H14N2O4,11217.0
2095,"1,25-dihydroxy Vitamin D2",C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,C28H44O3,11174.0
2096,BSI-201,NC(=O)c1ccc(I)c([N+](=O)[O-])c1,C7H5IN2O3,11304.0
2097,NKH477 (hydrochloride),C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](OC(=O)CCN(C)C)[C@H](OC(C)=O)[C@@]2(C)O1.Cl,C27H44ClNO8,11214.0
2098,Cyclopiazonic Acid,CC(=O)C1=C(O)[C@@H]2[C@H]3c4c[nH]c5cccc(c45)C[C@H]3C(C)(C)N2C1=O,C20H20N2O3,11326.0
2099,Citrinin,CC1=C2C(=CO[C@@H](C)[C@@H]2C)C(O)=C(C(=O)O)C1=O,C13H14O5,11320.0
2100,Beauvericin,CC(C)[C@H]1OC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H](C(C)C)OC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H](C(C)C)OC(=O)[C@H](Cc2ccccc2)N(C)C1=O,C45H57N3O9,11426.0
2101,Fumagillin,CO[C@@H]1[C@H](OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C,C26H34O7,11332.0
2102,Diethylcathinone (hydrochloride),CCN(CC)C(C)C(=O)c1ccccc1.Cl,C13H20ClNO,11333.0
2103,4-fluoro BZP (hydrochloride),Cl.Cl.Fc1ccc(CN2CCNCC2)cc1,C11H17Cl2FN2,11112.0
2104,1-(3-Trifluoromethylphenyl)piperazine (hydrochloride),Cl.Cl.FC(F)(F)c1cccc(N2CCNCC2)c1,C11H15Cl2F3N2,11205.0
2105,4-methyl-.alpha.-Pyrrolidinobutiophenone (hydrochloride),CCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl,C15H22ClNO,9001190.0
2106,JWH 031,CCCCCCn1ccc(C(=O)c2cccc3ccccc23)c1,C21H23NO,10824.0
2107,PU-H71 (hydrate),CC(C)NCCCn1c(Sc2cc3c(cc2I)OCO3)nc2c(N)ncnc21.O,C18H23IN6O3S,11450.0
2108,16-phenoxy Prostaglandin F2.alpha. ethyl amide,CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2ccccc2)[C@H](O)C[C@@H]1O,C24H35NO5,10009875.0
2109,DMABA-d10 NHS ester,[2H]c1c([2H])c(N(C([2H])([2H])[2H])C([2H])([2H])[2H])c([2H])c([2H])c1C(=O)ON1C(=O)CCC1=O,C13H14N2O4,11219.0
2110,Lupeol,C=C(C)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C30H50O,11215.0
2111,Ascomycin,CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,C43H69NO12,11309.0
2112,Cyclopamine,CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C,C27H41NO2,11321.0
2113,Cytochalasin B,C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)/C=C/[C@H](O)CCC[C@@H](C)C/C=C/[C@H]3[C@@H]1O,C29H37NO5,11328.0
2114,Zearalenone,C[C@H]1CCCC(=O)CCC/C=C/c2cc(O)cc(O)c2C(=O)O1,C18H22O5,11353.0
2115,diacetoxy Scirpenol,CC(=O)OC[C@]12CCC(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@]12CO2,C19H26O7,11427.0
2116,Thiolutin,CC(=O)Nc1c2sscc-2n(C)c1=O,C8H8N2O2S2,11350.0
2117,Phenylpiperazine (hydrochloride),Cl.Cl.c1ccc(N2CCNCC2)cc1,C10H16Cl2N2,11203.0
2118,1-(p-Fluorophenyl)piperazine (hydrochloride),Cl.Cl.Fc1ccc(N2CCNCC2)cc1,C10H15Cl2FN2,11204.0
2119,"1,4-Dibenzylpiperazine (hydrochloride)",Cl.Cl.c1ccc(CN2CCN(Cc3ccccc3)CC2)cc1,C18H24Cl2N2,11206.0
2120,"3,4-DMMA (hydrochloride)",CNC(C)Cc1ccc(OC)c(OC)c1.Cl,C12H20ClNO2,11128.0
2121,DAz-1,[N-]=[N+]=NCCCNC(=O)C1CC(=O)CC(=O)C1,C10H14N4O3,13173.0
2122,Piperlonguminine,CC(C)CNC(=O)/C=C/C=C/c1ccc2c(c1)OCO2,C16H19NO3,9001155.0
2123,Simvastatin (sodium salt),CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CCC(O)C[C@@H](O)CC(=O)[O-])C21.[Na+],C25H39NaO6,10010345.0
2124,Ursolic Acid,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,C30H48O3,10072.0
2125,Delphinidin (chloride),Oc1cc(O)c2cc(O)c(-c3cc(O)c(O)c(O)c3)[o+]c2c1.[Cl-],C15H11ClO7,11012.0
2126,Oligomycin A,CC[C@@H]1/C=C/C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C/C(=O)O[C@H]2[C@@H](C)[C@@H](CC1)O[C@@]1(CC[C@@H](C)[C@@H](C[C@H](C)O)O1)[C@@H]2C,C45H74O11,11342.0
2127,Oligomycin B,CC[C@@H]1/C=C/C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C/C(=O)O[C@H]2[C@@H](C)[C@@H](CC1)O[C@]1(O[C@H](C[C@H](C)O)[C@H](C)CC1=O)[C@@H]2C,C45H72O12,11343.0
2128,Paxilline,CC(C)(O)[C@H]1O[C@H]2CC[C@@]3(C)[C@@](O)(CC[C@H]4Cc5c([nH]c6ccccc56)[C@@]43C)C2=CC1=O,C27H33NO4,11345.0
2129,Penitrem A,C=C(C)[C@H]1O[C@H]2CC[C@@]3(C)[C@@](O)(CC[C@H]4C5OC(C)(C)[C@H]6C[C@@H]7C(=C)Cc8c(Cl)cc9[nH]c(c5c9c8[C@@]76O)[C@@]43C)[C@]23O[C@@H]3[C@H]1O,C37H44ClNO6,11347.0
2130,CAY10657,NC(=O)Nc1cc(-c2ccc(CN3CCOCC3)cc2)sc1C(N)=O,C17H20N4O3S,11140.0
2131,JWH 072,CCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C22H19NO,9001201.0
2132,JWH 147,CCCCCCn1cc(C(=O)c2cccc3ccccc23)cc1-c1ccccc1,C27H27NO,10826.0
2133,2-Methylethcathinone (hydrochloride),CCNC(C)C(=O)c1ccccc1C.Cl,C12H18ClNO,11221.0
2134,3-Methoxymethcathinone (hydrochloride),CNC(C)C(=O)c1cccc(OC)c1.Cl,C11H16ClNO2,9001187.0
2135,Meconin-d3,[2H]C([2H])([2H])Oc1c(OC)ccc2c1C(=O)OC2,C10H10O4,9001141.0
2136,AS-703026,O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F,C15H15FIN3O3,11226.0
2137,Necrostatin-7,N=C1SC(=Cc2c[nH]nc2-c2ccc(F)cc2)C(=O)N1c1nccs1,C16H10FN5OS2,10528.0
2138,Bisindolylmaleimide II,CN1CCCC1CCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,C27H26N4O2,11020.0
2139,Bafilomycin A1,CO/C1=C\C(C)=C\[C@@H](C)[C@@H](O)[C@@H](C)C/C(C)=C/C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@@H](C(C)C)O2)OC1=O,C35H58O9,11038.0
2140,Kendomycin,CC1=C2O[C@]3(O)C=C2C(=C(O)C1=O)[C@@H]1O[C@H](CC[C@H](C)/C=C(\C)C[C@@H](C)C[C@@H]3C)[C@H](C)[C@H](O)[C@H]1C,C29H42O6,11037.0
2141,CHS-828,N#CN/C(=N\c1ccncc1)NCCCCCCOc1ccc(Cl)cc1,C19H22ClN5O,11021.0
2142,17-DMAG,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,C32H48N4O8,11036.0
2143,2-DPMP (hydrochloride),Cl.c1ccc(C(c2ccccc2)C2CCCCN2)cc1,C18H22ClN,11481.0
2144,Diallyl Disulfide,C=CCSSCC=C,C6H10S2,10012582.0
2145,SMI-4a,O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1,C11H6F3NO2S,11029.0
2146,Palmitic Acid Alkyne,C#CCCCCCCCCCCCCCC(=O)O,C16H28O2,13266.0
2147,Coenzyme Q10,COC1=C(OC)C(=O)C(C/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C)=C(C)C1=O,C59H90O4,11506.0
2148,JWH 018 adamantyl carboxamide,CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c2ccccc21,C24H32N2O,9001193.0
2149,AM2201 N-(4-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1cccc3ccccc13)c([2H])n2CCCC(O)CF,C24H22FNO2,11457.0
2150,JW 480,CC(C)c1ccccc1OC(=O)NCCc1ccc2ccccc2c1,C22H23NO2,10879.0
2151,5-methoxy DMT,COc1ccc2[nH]cc(CCN(C)C)c2c1,C13H18N2O,11480.0
2152,5-methoxy DMT (CRM),COc1ccc2[nH]cc(CCN(C)C)c2c1,C13H18N2O,38996.0
2153,Rucaparib (phosphate),CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1.O=P(O)(O)O,C19H21FN3O5P,11570.0
2154,GSK1059615,O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1,C18H11N3O2S,11569.0
2155,17-AAG,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,C31H43N3O8,11039.0
2156,Concanamycin A,C/C=C/[C@H]1O[C@@](O)([C@@H](C)[C@H](O)[C@H](C)[C@@H]2OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]2OC)C[C@@H](O[C@H]2C[C@@H](O)[C@H](OC(N)=O)[C@@H](C)O2)[C@@H]1C,C46H75NO14,11050.0
2157,Bisindolylmaleimide XI (hydrochloride),CN(C)CC1CCn2c(c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)C1.Cl,C28H29ClN4O2,11073.0
2158,JWH 180,CCCc1ccc(C(=O)c2cn(CCC)c3ccccc23)c2ccccc12,C25H25NO,9001205.0
2159,DYn-2,C#CCCCC1CCC(=O)CC1=O,C11H14O2,11220.0
2160,1-Aminodecylidene bis-Phosphonic Acid,CCCCCCCCCC(N)(P(=O)(O)O)P(=O)(O)O,C10H25NO6P2,13583.0
2161,Sirtinol,CC(NC(=O)c1ccccc1/N=C/c1c(O)ccc2ccccc12)c1ccccc1,C26H22N2O2,10523.0
2162,Necrostatin-5,COc1ccc(-n2c(SCC#N)nc3sc4c(c3c2=O)CCCC4)cc1,C19H17N3O2S2,10527.0
2163,Fumitremorgin C,COc1ccc2c3c([nH]c2c1)[C@H](C=C(C)C)N1C(=O)[C@@H]2CCCN2C(=O)[C@@H]1C3,C22H25N3O3,11030.0
2164,KRN 7000,CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)CCCCCCCCCCCCCC,C50H99NO9,11208.0
2165,"15-deoxy-?12,14-Prostaglandin J2 Glutathione",CCCCC/C=C/C=C1/C(=O)CC(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[C@@H]1C/C=C\CCCC(=O)O,C30H45N3O9S,18580.0
2166,PK11195,CCC(C)N(C)C(=O)c1cc2ccccc2c(-c2ccccc2Cl)n1,C21H21ClN2O,10525.0
2167,"2,4,5-Trimethoxyamphetamine",COc1cc(OC)c(OC)cc1CC(C)N,C12H19NO3,11144.0
2168,AM2232,N#CCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H20N2O,11503.0
2169,MAM2201,Cc1ccc(C(=O)c2cn(CCCCCF)c3ccccc23)c2ccccc12,C25H24FNO,9001219.0
2170,4-Fluoroisocathinone (hydrochloride),CC(=O)C(N)c1ccc(F)cc1.Cl,C9H11ClFNO,9001146.0
2171,JWH 018 N-(1-ethylpropyl) isomer,CCC(CC)n1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,11585.0
2172,Bexarotene,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,C24H28O2,11571.0
2173,XLR11,CC1(C)C(C(=O)c2cn(CCCCCF)c3ccccc23)C1(C)C,C21H28FNO,11565.0
2174,5-methoxy MiPT,COc1ccc2[nH]cc(CCN(C)C(C)C)c2c1,C15H22N2O,11482.0
2175,AZD 7762,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,C17H19FN4O2S,11491.0
2176,CAY10647,COc1ccc(-c2nc(C(=O)c3ccc(F)cc3)c[nH]2)cc1,C17H13FN2O2,10791.0
2177,5-Fluorocytosine,Nc1nc(=O)[nH]cc1F,C4H4FN3O,11635.0
2178,Penicillic Acid,C=C(C)C(=O)/C(=C\C(=O)O)OC,C8H10O4,11440.0
2179,Amphotericin B,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,C47H73NO17,11636.0
2180,N-3-hydroxyoctanoyl-L-Homoserine lactone,CCCCCC(O)CC(=O)N[C@H]1CCOC1=O,C12H21NO4,9001150.0
2181,N-3-hydroxydecanoyl-L-Homoserine lactone,CCCCCCCC(O)CC(=O)N[C@H]1CCOC1=O,C14H25NO4,9001147.0
2182,Mitomycin C,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,C15H18N4O5,11435.0
2183,Tafluprost ethyl ester,CCOC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C(F)(F)COc2ccccc2)[C@H](O)C[C@@H]1O,C24H32F2O5,11612.0
2184,JWH 122 N-(4-pentenyl) analog,C=CCCCn1cc(C(=O)c2ccc(C)c3ccccc23)c2ccccc21,C25H23NO,11611.0
2185,(+)-JQ1,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2,C23H25ClN4O2S,11187.0
2186,(-)-JQ1,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2,C23H25ClN4O2S,11232.0
2187,Heneicosapentaenoic Acid methyl ester,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC,C22H34O2,11622.0
2188,Norsufentanil,CCC(=O)N(c1ccccc1)C1(COC)CCNCC1,C16H24N2O2,9001142.0
2189,Phlorizin,O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C21H24O10,11576.0
2190,Heneicosapentaenoic Acid,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O,C21H32O2,10670.0
2191,Mithramycin A,CO[C@H](C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1,C52H76O24,11434.0
2192,T-2 Toxin,CC(=O)OC[C@]12C[C@H](OC(=O)CC(C)C)C(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@]12CO2,C24H34O9,11444.0
2193,1'-Naphthoyl Indole,O=C(c1cccc2ccccc12)c1c[nH]c2ccccc12,C19H13NO,11687.0
2194,JWH 250 N-(5-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)Cc1ccccc1OC)c([2H])n2CCCCCO,C22H25NO3,11474.0
2195,Norsufentanil-d3,[2H]C([2H])([2H])OCC1(N(C(=O)CC)c2ccccc2)CCNCC1,C16H24N2O2,9001143.0
2196,A1-Phytoprostane-I,CCC(O)/C=C/C1C=CC(=O)C1CCCCCCCC(=O)O,C18H28O4,9000593.0
2197,Tunicamycin Mixture,CC(=O)N[C@H]1[C@@H](O[C@@H]2O[C@H](C[C@@H](O)[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)[C@H](O)[C@H](O)[C@H]2NC(=O)/C=C/CC(C)C)O[C@H](CO)[C@@H](O)[C@@H]1O,C30H46N4O16,11445.0
2198,Nigericin (sodium salt),CO[C@@H]1C[C@@H](C[C@H]2CC[C@H](C)[C@H]([C@@H](C)C(=O)[O-])O2)O[C@]2(O[C@@](C)([C@H]3CC[C@@](C)(C4O[C@@H]([C@H]5O[C@@](O)(CO)[C@H](C)C[C@@H]5C)C[C@@H]4C)O3)C[C@H]2C)[C@@H]1C.[Na+],C40H67NaO11,11437.0
2199,Alamethicin,CC(=O)NC(C)(C)C(=O)N1CCC[C@@H]1C(=O)NC(C)(C)C(=O)N[C@@H](C)C(=O)NC(C)(C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)NC(C)(C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CO)Cc1ccccc1)C(C)C)C(C)C,C92H150N22O25,11425.0
2200,AM679,CCCCCn1cc(C(=O)c2ccccc2I)c2ccccc21,C20H20INO,11504.0
2201,JWH 122 N-(5-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1ccc(C)c3ccccc13)c([2H])n2CCCCCO,C25H25NO2,11475.0
2202,Glipizide,Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1,C21H27N5O4S,11579.0
2203,Telmisartan,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,C33H30N4O2,11615.0
2204,IOX1,O=C(O)c1ccc(O)c2ncccc12,C10H7NO3,11572.0
2205,Salvinorin B,COC(=O)[C@@H]1C[C@H](O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@H](c3ccoc3)C[C@]21C,C21H26O7,11488.0
2206,XLR11 N-(4-pentenyl) analog,C=CCCCn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc21,C21H27NO,11688.0
2207,"3,4-DHMA (trifluoroacetate salt)",CNC(C)Cc1ccc(O)c(O)c1.O=C(O)C(F)(F)F,C12H16F3NO4,10515.0
2208,JWH 398 N-(5-hydroxypentyl) metabolite,O=C(c1ccc(Cl)c2ccccc12)c1cn(CCCCCO)c2ccccc12,C24H22ClNO2,9000770.0
2209,Salvinorin A,COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)C2[C@@]1(C)CC[C@H]1C(=O)O[C@H](c3ccoc3)C[C@]21C,C23H28O8,11487.0
2210,Oleanolic Acid,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,C30H48O3,11726.0
2211,4-hydroxy DIPT (hydrochloride),CC(C)N(CCc1c[nH]c2cccc(O)c12)C(C)C.Cl,C16H25ClN2O,11312.0
2212,AM2201 2-hydroxyindole metabolite,O=C(c1cccc2ccccc12)c1c(O)n(CCCCCF)c2ccccc12,C24H22FNO2,11194.0
2213,JWH 122 3-methylnaphthyl isomer,CCCCCn1cc(C(=O)c2cc(C)cc3ccccc23)c2ccccc21,C25H25NO,9001033.0
2214,JWH 122 6-methylnaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3cc(C)ccc23)c2ccccc21,C25H25NO,9001035.0
2215,Eprosartan (mesylate),CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1.CS(=O)(=O)O,C24H28N2O7S2,11578.0
2216,4-hydroxy MET,CCN(C)CCc1c[nH]c2cccc(O)c12,C13H18N2O,11148.0
2217,AM1220 azepane isomer,CN1CCCCC(n2cc(C(=O)c3cccc4ccccc34)c3ccccc32)C1,C26H26N2O,11583.0
2218,JWH 122 5-methylnaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3c(C)cccc23)c2ccccc21,C25H25NO,9001034.0
2219,JWH 122 7-methylnaphthyl isomer,CCCCCn1cc(C(=O)c2cccc3ccc(C)cc23)c2ccccc21,C25H25NO,9001036.0
2220,Vitamin D2,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12,C28H44O,11791.0
2221,Vitamin D3,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,C27H44O,11792.0
2222,Olmesartan Medoxomil,CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,C29H30N6O6,11614.0
2223,Bicuculline,CN1CCc2cc3c(cc2[C@H]1[C@@H]1OC(=O)c2c1ccc1c2OCO1)OCO3,C20H17NO6,11727.0
2224,Parthenolide,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/C)CC[C@@H]12,C15H20O3,70080.0
2225,Docetaxel (hydrate),CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O,C43H55NO15,11637.0
2226,Gemcitabine,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,C9H11F2N3O4,11690.0
2227,Platycodin D,C[C@@H]1O[C@@H](O[C@H]2[C@H](OC(=O)[C@]34CCC(C)(C)C[C@H]3C3=CC[C@@H]5[C@@]6(C)C[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)C(CO)(CO)[C@@H]6CC[C@@]5(C)[C@]3(C)C[C@H]4O)OC[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O[C@@H]1OC[C@@H](O)[C@H](O[C@@H]2OC[C@](O)(CO)[C@H]2O)[C@H]1O,C57H92O28,11725.0
2228,4-hydroxy MIPT,CC(C)N(C)CCc1c[nH]c2cccc(O)c12,C14H20N2O,11552.0
2229,JWH 122 N-(4-hydroxypentyl) metabolite,Cc1ccc(C(=O)c2cn(CCCC(C)O)c3ccccc23)c2ccccc12,C25H25NO2,11784.0
2230,Cannabipiperidiethanone,COc1ccccc1CC(=O)c1cn(CC2CCCCN2C)c2ccccc12,C24H28N2O2,11655.0
2231,4-MTA,CSc1ccc(CC(C)N)cc1,C10H15NS,11555.0
2232,DPT (hydrochloride),CCCN(CCC)CCc1c[nH]c2ccccc12.Cl,C16H25ClN2,11551.0
2233,"4-methoxy-N,N-Dimethylcathinone (hydrochloride)",COc1ccc(C(=O)C(C)N(C)C)cc1.Cl,C12H18ClNO2,11666.0
2234,2-methyl-.alpha.-Pyrrolidinopropiophenone (hydrochloride),Cc1ccccc1C(=O)C(C)N1CCCC1.Cl,C14H20ClNO,11484.0
2235,4-methyl-?-Ethylaminobutiophenone (hydrochloride),CCNC(CC)C(=O)c1ccc(C)cc1.Cl,C13H20ClNO,11489.0
2236,4-Methylbuphedrone (hydrochloride),CCC(NC)C(=O)c1ccc(C)cc1.Cl,C12H18ClNO,11486.0
2237,4-methyl-N-Methylbuphedrone (hydrochloride),CCC(C(=O)c1ccc(C)cc1)N(C)C.Cl,C13H20ClNO,11667.0
2238,UR-144 N-(5-hydroxypentyl) metabolite,CC1(C)C(C(=O)c2cn(CCCCCO)c3ccccc23)C1(C)C,C21H29NO2,11775.0
2239,UR-144 N-(4-hydroxypentyl) metabolite,CC(O)CCCn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc21,C21H29NO2,11774.0
2240,MAM2201 N-pentanoic acid metabolite,Cc1ccc(C(=O)c2cn(CCCCC(=O)O)c3ccccc23)c2ccccc12,C25H23NO3,11779.0
2241,AB-005,CN1CCCCC1Cn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc21,C23H32N2O,11766.0
2242,MI-nc (hydrochloride),CCc1cc2c(N3CCN(c4nncs4)CC3)ncnc2s1.Cl.Cl,C14H18Cl2N6S2,11621.0
2243,Necrostatin-1,CN1C(=O)C(Cc2c[nH]c3ccccc23)NC1=S,C13H13N3OS,11658.0
2244,SB 505124,Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1,C20H21N3O2,11793.0
2245,JWH 018 N-pentanoic acid metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1cccc3ccccc13)c([2H])n2CCCCC(=O)O,C24H21NO3,11748.0
2246,"2,3-Dimethylmethcathinone (hydrochloride)",CNC(C)C(=O)c1cccc(C)c1C.Cl,C12H18ClNO,11225.0
2247,5-methoxy AMT,COc1ccc2[nH]cc(CC(C)N)c2c1,C12H16N2O,11553.0
2248,5-methoxy DIPT,COc1ccc2[nH]cc(CCN(C(C)C)C(C)C)c2c1,C17H26N2O,11865.0
2249,5-methoxy DiPT (exempt preparation),COc1ccc2[nH]cc(CCN(C(C)C)C(C)C)c2c1,C17H26N2O,15697.0
2250,DiPT,CC(C)N(CCc1c[nH]c2ccccc12)C(C)C,C16H24N2,11550.0
2251,DOET,CCc1cc(OC)c(CC(C)N)cc1OC,C13H21NO2,11141.0
2252,DOET (exempt preparation),CCc1cc(OC)c(CC(C)N)cc1OC,C13H21NO2,15704.0
2253,2C-N,COc1cc([N+](=O)[O-])c(OC)cc1CCN,C10H14N2O4,11890.0
2254,2C-N (exempt preparation),COc1cc([N+](=O)[O-])c(OC)cc1CCN,C10H14N2O4,15717.0
2255,.alpha.-methyl Tryptamine (hydrochloride),CC(N)Cc1c[nH]c2ccccc12.Cl,C11H15ClN2,11135.0
2256,.alpha.-methyl Tryptamine (hydrochloride) (exempt preparation),CC(N)Cc1c[nH]c2ccccc12.Cl,C11H15ClN2,15692.0
2257,2C-H (hydrochloride),COc1ccc(OC)c(CCN)c1.Cl,C10H16ClNO2,11889.0
2258,2C-H (hydrochloride) (exempt preparation),COc1ccc(OC)c(CCN)c1.Cl,C10H16ClNO2,15715.0
2259,N-Ethylbuphedrone (hydrochloride),CCNC(CC)C(=O)c1ccccc1.Cl,C12H18ClNO,11665.0
2260,para-Methoxymethamphetamine (hydrochloride),CNC(C)Cc1ccc(OC)cc1.Cl,C11H18ClNO,11562.0
2261,UR-144 N-pentanoic acid metabolite,CC1(C)C(C(=O)c2cn(CCCCC(=O)O)c3ccccc23)C1(C)C,C21H27NO3,11773.0
2262,MAM2201-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1ccc(C)c3ccccc13)c([2H])n2CCCCCF,C25H24FNO,11619.0
2263,3-Deazaneplanocin A (hydrochloride),Cl.Nc1nccc2c1ncn2[C@@H]1C=C(CO)[C@@H](O)[C@H]1O,C12H15ClN4O3,11102.0
2264,Andrographolide,C=C1CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1O,C20H30O5,11679.0
2265,Brinzolamide,CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,C12H21N3O5S3,11660.0
2266,Camptothecin,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,C20H16N2O4,11694.0
2267,Conessine,C[C@H]1[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](N(C)C)CC[C@]5(C)[C@H]4CC[C@]23CN1C,C24H40N2,11700.0
2268,IOX2,O=C(O)CNC(=O)c1c(O)c2ccccc2n(Cc2ccccc2)c1=O,C19H16N2O5,11573.0
2269,Kaempferol,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,C15H10O6,11852.0
2270,Purpurin,O=C1c2ccccc2C(=O)c2c(O)c(O)cc(O)c21,C14H8O5,11752.0
2271,Rosiglitazone (maleate),CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O,C22H23N3O7S,11884.0
2272,Treprostinil (diethanolamine salt),CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)[O-])c3C[C@H]2C[C@H]1O.OCC[NH2+]CCO,C27H45NO7,11927.0
2273,Vincamine,CC[C@]12CCCN3CCc4c(n(c5ccccc45)[C@@](O)(C(=O)OC)C1)[C@@H]32,C21H26N2O3,11763.0
2274,Vincristine (sulfate),CC[C@]1(O)C[C@@H]2C[N@@](CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O,C46H58N4O14S,11764.0
2275,Vindoline,CC[C@]12C=CCN3CC[C@@]4(c5ccc(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32,C25H32N2O6,11765.0
2276,.alpha.-Asarone,C/C=C/c1cc(OC)c(OC)cc1OC,C12H16O3,11681.0
2277,6-APB (hydrochloride),CC(N)Cc1ccc2ccoc2c1.Cl,C11H14ClNO,11079.0
2278,Methoxetamine (hydrochloride),CCNC1(c2cccc(OC)c2)CCCCC1=O.Cl,C15H22ClNO2,11139.0
2279,Methiopropamine (hydrochloride),CNC(C)Cc1cccs1.Cl,C8H14ClNS,11161.0
2280,Methiopropamine (hydrochloride) (exempt preparation),CNC(C)Cc1cccs1.Cl,C8H14ClNS,43499.0
2281,AM2201 5-hydroxyindole metabolite,O=C(c1cccc2ccccc12)c1cn(CCCCCF)c2ccc(O)cc12,C24H22FNO2,11196.0
2282,N-ethyl-N-Methylcathinone (hydrochloride),CCN(C)C(C)C(=O)c1ccccc1.Cl,C12H18ClNO,11604.0
2283,JWH 213,CCCCCn1c(C)c(C(=O)c2ccc(CC)c3ccccc23)c2ccccc21,C27H29NO,11659.0
2284,JWH 250 N-(4-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)Cc1ccccc1OC)c([2H])n2CCCC(C)O,C22H25NO3,11749.0
2285,Artemether,CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,C16H26O5,11815.0
2286,Artesunate,C[C@H]1[C@H](OC(=O)CCC(=O)O)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,C19H28O8,11817.0
2287,Angelicin,O=c1ccc2ccc3occc3c2o1,C11H6O3,11683.0
2288,6.alpha.-Methylprednisolone 21-hemisuccinate,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)O)[C@@]2(C)C=CC(=O)C=C12,C26H34O8,11800.0
2289,Salsalate,O=C(Oc1ccccc1C(=O)O)c1ccccc1O,C14H10O5,11911.0
2290,CAY10640,O=C(Nc1ccc(OC(F)(F)F)cc1)NC1CCN(C(=O)C2CC2)CC1,C17H20F3N3O3,10642.0
2291,Brefeldin A,C[C@H]1CCC/C=C/[C@@H]2C[C@H](O)C[C@H]2[C@H](O)/C=C/C(=O)O1,C16H24O4,11861.0
2292,XLR11 N-(4-fluoropentyl) isomer,CC(F)CCCn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc21,C21H28FNO,11769.0
2293,Isopentedrone (hydrochloride),CCCC(=O)C(NC)c1ccccc1.Cl,C12H18ClNO,11563.0
2294,7-Aminoactinomycin D,Cc1c2oc3c(C)c(N)cc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O,C62H87N13O16,11397.0
2295,3-methyl-.alpha.-Pyrrolidinopropiophenone (hydrochloride),Cc1cccc(C(=O)C(C)N2CCCC2)c1.Cl,C14H20ClNO,11485.0
2296,Perifosine,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1,C25H52NO4P,10008112.0
2297,K252b,C[C@]12O[C@H](C[C@]1(O)C(=O)O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,C26H19N3O5,11339.0
2298,2C-P (hydrochloride),CCCc1cc(OC)c(CCN)cc1OC.Cl,C13H22ClNO2,11696.0
2299,2C-P (hydrochloride) (exempt preparation),CCCc1cc(OC)c(CCN)cc1OC.Cl,C13H22ClNO2,15718.0
2300,2C-C (hydrochloride),COc1cc(CCN)c(OC)cc1Cl.Cl,C10H15Cl2NO2,11735.0
2301,2C-C (hydrochloride) (exempt preparation),COc1cc(CCN)c(OC)cc1Cl.Cl,C10H15Cl2NO2,15716.0
2302,2C-D (hydrochloride),COc1cc(CCN)c(OC)cc1C.Cl,C11H18ClNO2,11888.0
2303,2C-D (hydrochloride) (exempt preparation),COc1cc(CCN)c(OC)cc1C.Cl,C11H18ClNO2,15721.0
2304,2C-T-2 (hydrochloride),CCSc1cc(OC)c(CCN)cc1OC.Cl,C12H20ClNO2S,11891.0
2305,2C-T-2 (hydrochloride) (exempt preparation),CCSc1cc(OC)c(CCN)cc1OC.Cl,C12H20ClNO2S,15681.0
2306,2C-T-4 (hydrochloride),COc1cc(SC(C)C)c(OC)cc1CCN.Cl,C13H22ClNO2S,11892.0
2307,2C-T-4 (hydrochloride) (exempt preparation),COc1cc(SC(C)C)c(OC)cc1CCN.Cl,C13H22ClNO2S,15719.0
2308,Lomeguatrib,Nc1nc(OCc2cc(Br)cs2)c2[nH]cnc2n1,C10H8BrN5OS,11732.0
2309,Oligomycin Complex,CC[C@@H]1/C=C/C=C/C[C@H](C)[C@@H](O)[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C/C(=O)O[C@H]2[C@@H](C)[C@@H](CC1)O[C@@]1(CC[C@@H](C)[C@@H](C[C@H](C)O)O1)[C@@H]2C.CC[C@@H]1/C=C/C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C/C(=O)O[C@H]2[C@@H](C)[C@@H](CC1)O[C@@]1(CC[C@@H](C)[C@@H](C[C@H](C)O)O1)[C@@H]2C.CC[C@@H]1/C=C/C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C/C(=O)O[C@H]2[C@@H](C)[C@@H](CC1)O[C@]1(O[C@H](C[C@H](C)O)[C@H](C)CC1=O)[C@@H]2C,C135H220O33,11341.0
2310,Cytochalasin A,C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)/C=C/C(=O)CCC[C@@H](C)C/C=C/[C@H]3[C@@H]1O,C29H35NO5,11327.0
2311,Cytochalasin E,C[C@H]1C/C=C/[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)[C@H]3[C@H](Cc4ccccc4)NC(=O)C32OC(=O)O/C=C/[C@@](C)(O)C1=O,C28H33NO7,11331.0
2312,Sofalcone,CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1,C27H30O6,11882.0
2313,Ferulic Acid ethyl ester,CCOC(=O)/C=C/c1ccc(O)c(OC)c1,C12H14O4,11880.0
2314,Ketazolam,CC1=CC(=O)N2CC(=O)N(C)c3ccc(Cl)cc3C2(c2ccccc2)O1,C20H17ClN2O3,11449.0
2315,PCI 34051,COc1ccc(Cn2ccc3ccc(C(=O)NO)cc32)cc1,C17H16N2O3,10444.0
2316,INK128,CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21,C15H15N7O,11811.0
2317,Nocloprost,CCCCC(C)(C)[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@H](Cl)C[C@H]1O,C22H37ClO4,10988.0
2318,Olanzapine,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,C17H20N4S,11937.0
2319,Artemisinin,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,C15H22O5,11816.0
2320,Withaferin A,CC1=C(CO)C(=O)O[C@@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1,C28H38O6,11352.0
2321,2C-C-NBOMe (hydrochloride),COc1cc(CCNCc2ccccc2OC)c(OC)cc1Cl.Cl,C18H23Cl2NO3,9001096.0
2322,25C-NBOMe (hydrochloride) (exempt preparation),COc1cc(CCNCc2ccccc2OC)c(OC)cc1Cl.Cl,C18H23Cl2NO3,15724.0
2323,2C-T-7 (hydrochloride),CCCSc1cc(OC)c(CCN)cc1OC.Cl,C13H22ClNO2S,11200.0
2324,2C-T-7 (hydrochloride) (exempt preparation),CCCSc1cc(OC)c(CCN)cc1OC.Cl,C13H22ClNO2S,15672.0
2325,AB-005 azepane isomer,CN1CCCCC(n2cc(C(=O)C3C(C)(C)C3(C)C)c3ccccc32)C1,C23H32N2O,11877.0
2326,EAM2201,CCc1ccc(C(=O)c2cn(CCCCCF)c3ccccc23)c2ccccc12,C26H26FNO,11916.0
2327,XLR11-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)C1C(C)(C)C1(C)C)c([2H])n2CCCCCF,C21H28FNO,11771.0
2328,XLR11-d5 (exempt preparation),[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)C1C(C)(C)C1(C)C)c([2H])n2CCCCCF,C21H28FNO,22857.0
2329,JWH 398 N-pentanoic acid metabolite,O=C(O)CCCCn1cc(C(=O)c2ccc(Cl)c3ccccc23)c2ccccc21,C24H20ClNO3,10942.0
2330,2C-B-FLY (hydrochloride),Cl.NCCc1c2c(c(Br)c3c1OCC3)OCC2,C12H15BrClNO2,11473.0
2331,GW 1100,CCOC(=O)c1ccc(-n2cc(Cc3cnc(OCC)nc3)c(=O)nc2SCc2ccc(F)cc2)cc1,C27H25FN4O4S,10008908.0
2332,JWH 398 N-(4-hydroxypentyl) metabolite,CC(O)CCCn1cc(C(=O)c2ccc(Cl)c3ccccc23)c2ccccc21,C24H22ClNO2,10943.0
2333,Lazabemide,NCCNC(=O)c1ccc(Cl)cn1,C8H10ClN3O,11640.0
2334,MAM2201 N-(4-hydroxypentyl) metabolite,Cc1ccc(C(=O)c2cn(CCCC(O)CF)c3ccccc23)c2ccccc12,C25H24FNO2,11778.0
2335,3-Methyladenine,Cn1cnc(N)c2ncnc1-2,C6H7N5,13242.0
2336,Patulin,O=C1C=C2C(=CCOC2O)O1,C7H6O4,11346.0
2337,2-Trifluoromethyl-2'-methoxychalcone,COc1ccccc1C(=O)/C=C/c1ccccc1C(F)(F)F,C17H13F3O2,11881.0
2338,UR-144-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)C1C(C)(C)C1(C)C)c([2H])n2CCCCC,C21H29NO,11772.0
2339,XLR11 N-(2-fluoropentyl) isomer,CCCC(F)Cn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc21,C21H28FNO,11767.0
2340,Daminozide,CN(C)NC(=O)CCC(=O)O,C6H12N2O3,12033.0
2341,BI-6015,Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)n1c(C)nc2ccccc21,C15H13N3O4S,12032.0
2342,Anastrozole,CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1,C17H19N5,11987.0
2343,Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,C25H28N6O,11952.0
2344,GQ-16,COc1ccc(Br)cc1/C=C1\SC(=O)N(Cc2ccc(C)cc2)C1=O,C19H16BrNO3S,11908.0
2345,PF-8380,O=C(CCN1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)c1ccc2[nH]c(=O)oc2c1,C22H21Cl2N3O5,12018.0
2346,cis-2-Decenoic Acid,CCCCCCC/C=C\C(=O)O,C10H18O2,11966.0
2347,Octyl-.alpha.-ketoglutarate,CCCCCCCCOC(=O)C(=O)CCC(=O)O,C13H22O5,11970.0
2348,DOM,COc1cc(CC(C)N)c(OC)cc1C,C12H19NO2,11145.0
2349,DOM (exempt preparation),COc1cc(CC(C)N)c(OC)cc1C,C12H19NO2,15703.0
2350,MAM2201 N-(3-fluoropentyl) isomer,CCC(F)CCn1cc(C(=O)c2ccc(C)c3ccccc23)c2ccccc21,C25H24FNO,11781.0
2351,UR-144 N-(5-bromopentyl) analog,CC1(C)C(C(=O)c2cn(CCCCCBr)c3ccccc23)C1(C)C,C21H28BrNO,12003.0
2352,XLR11 N-(3-fluoropentyl) isomer,CCC(F)CCn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc21,C21H28FNO,11768.0
2353,25H-NBOMe imine analog,COc1ccc(OC)c(CC/N=C/c2ccccc2OC)c1,C18H21NO3,12062.0
2354,PRE-084 (hydrochloride),Cl.O=C(OCCN1CCOCC1)C1(c2ccccc2)CCCCC1,C19H28ClNO3,9001329.0
2355,18.beta.-Glycyrrhetinic Acid,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,C30H46O4,11845.0
2356,2-NBDG,O=[N+]([O-])c1ccc(NC2C(O)OC(CO)C(O)C2O)c2nonc12,C12H14N4O8,11046.0
2357,"4-chloro-2,5-DMA (hydrochloride)",COc1cc(CC(C)N)c(OC)cc1Cl.Cl,C11H17Cl2NO2,12038.0
2358,"3,4-Methylenedioxy-N-benzylcathinone (hydrochloride)",CC(NCc1ccccc1)C(=O)c1ccc2c(c1)OCO2.Cl,C17H18ClNO3,9001330.0
2359,XLR11 N-(4-hydroxypentyl) metabolite RM,CC1(C)C(C(=O)c2cn(CCCC(O)CF)c3ccccc23)C1(C)C,C21H28FNO2,11770.0
2360,XLR11 N-(4-hydroxypentyl) metabolite (CRM),CC1(C)C(C(=O)c2cn(CCCC(O)CF)c3ccccc23)C1(C)C,C21H28FNO2,17727.0
2361,BIM5078,Cc1nc2ccccc2n1S(=O)(=O)c1cc([N+](=O)[O-])ccc1Cl,C14H10ClN3O4S,12031.0
2362,SER-601,CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)c2cc(C(C)C)ccc21,C28H38N2O2,11743.0
2363,JW 642,O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2cccc(Oc3ccccc3)c2)CC1,C21H20F6N2O3,11789.0
2364,BZP (hydrochloride),Cl.Cl.c1ccc(CN2CCNCC2)cc1,C11H18Cl2N2,11202.0
2365,BZP (hydrochloride) (CRM),Cl.Cl.c1ccc(CN2CCNCC2)cc1,C11H18Cl2N2,25523.0
2366,4-Methoxyamphetamine (hydrochloride),COc1ccc(CC(C)N)cc1.Cl,C10H16ClNO,12041.0
2367,4-Methoxyamphetamine (hydrochloride) (exempt preparation),COc1ccc(CC(C)N)cc1.Cl,C10H16ClNO,15691.0
2368,UR-144 N-(5-chloropentyl) analog,CC1(C)C(C(=O)c2cn(CCCCCCl)c3ccccc23)C1(C)C,C21H28ClNO,11951.0
2369,CAY10662,CCNC(=O)NCCCC/C=C\CCCCCCCCCC(=O)O,C19H36N2O3,11042.0
2370,SR 3335,O=S(=O)(Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1)c1cccs1,C13H9F6NO3S2,12072.0
2371,NVP-AUY922,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,C26H31N3O5,10012698.0
2372,SB 202190,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,C20H14FN3O,10010399.0
2373,Oxyresveratrol,Oc1cc(O)cc(/C=C/c2ccc(O)cc2O)c1,C14H12O4,12028.0
2374,5-fluoro AKB48,O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(CCCCCF)c2ccccc12,C23H30FN3O,12065.0
2375,NMT,CNCCc1c[nH]c2ccccc12,C11H14N2,12067.0
2376,NMT (exempt preparation),CNCCc1c[nH]c2ccccc12,C11H14N2,36744.0
2377,RCS-4 M9 metabolite,CC(O)CCCn1cc(C(=O)c2ccc(O)cc2)c2ccccc21,C20H21NO3,11977.0
2378,25I-NBOMe imine analog,COc1cc(CC/N=C/c2ccccc2OC)c(OC)cc1I,C18H20INO3,11968.0
2379,KML29,O=C(OC(C(F)(F)F)C(F)(F)F)N1CCC(C(O)(c2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)CC1,C24H21F6NO7,11777.0
2380,Metformin (hydrochloride),CN(C)C(=N)NC(=N)N.Cl,C4H12ClN5,13118.0
2381,Natamycin,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O,C33H47NO13,11634.0
2382,2-HBA,O=C(/C=C/c1ccccc1O)/C=C/c1ccccc1O,C17H14O3,11879.0
2383,GSK4112,CC(C)(C)OC(=O)CN(Cc1ccc(Cl)cc1)Cc1ccc([N+](=O)[O-])s1,C18H21ClN2O4S,11931.0
2384,Emodin,Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O,C15H10O5,13109.0
2385,Piceatannol,Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1,C14H12O4,10009366.0
2386,4-MTA (hydrochloride),CSc1ccc(CC(C)N)cc1.Cl,C10H16ClNS,11862.0
2387,Mescaline (hydrochloride),COc1cc(CCN)cc(OC)c1OC.Cl,C11H18ClNO3,11950.0
2388,Mescaline (hydrochloride) (CRM),COc1cc(CCN)cc(OC)c1OC.Cl,C11H18ClNO3,38313.0
2389,AH 7921,CN(C)C1(CNC(=O)c2ccc(Cl)c(Cl)c2)CCCCC1,C16H22Cl2N2O,12036.0
2390,AH 7921 (CRM),CN(C)C1(CNC(=O)c2ccc(Cl)c(Cl)c2)CCCCC1,C16H22Cl2N2O,19732.0
2391,Actinomycin D,Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O,C62H86N12O16,11421.0
2392,Embelin,CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O,C17H26O4,11838.0
2393,5-IT,CC(N)Cc1ccc2[nH]ccc2c1,C11H14N2,12042.0
2394,CI-994,CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1,C15H15N3O2,12084.0
2395,Butyrolactone 3,C=C1C(=O)O[C@@H](CCC)[C@@H]1C(=O)O,C9H12O4,12095.0
2396,"A-796,260",CC1(C)C(C(=O)c2cn(CCN3CCOCC3)c3ccccc23)C1(C)C,C22H30N2O2,11606.0
2397,25-hydroxy Vitamin D2,C=C1CC[C@H](O)C/C1=C\C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)(C)O)CC[C@@H]12,C28H44O2,12078.0
2398,1-hydroxy Vitamin D2,C=C1/C(=C/C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,C28H44O2,12077.0
2399,VX-702,NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F,C19H12F4N4O2,13108.0
2400,Cladribine,Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,C10H12ClN5O3,12085.0
2401,Pimecrolimus,CC[C@@H]1/C=C(/C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,C43H68ClNO11,13107.0
2402,DL-AP3,NC(CP(=O)(O)O)C(=O)O,C3H8NO5P,13852.0
2403,1-hydroxy Vitamin D3,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,C27H44O2,12082.0
2404,"1,24-dihydroxy Vitamin D3 (hydrate)",C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CC[C@@H](O)C(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O.O,C27H46O4,12079.0
2405,Etoposide,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,C29H32O13,12092.0
2406,Bleomycin (sulfate),Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)C(O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.O=S(=O)([O-])O,C55H85N17O25S4,13877.0
2407,Sildenafil,CCCc1nn(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)[nH]c12,C22H30N6O4S,10008671.0
2408,Sildenafil (CRM),CCCc1nn(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)[nH]c12,C22H30N6O4S,41132.0
2409,StemRegenin 1,CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(-c3csc4ccccc34)nc21,C24H23N5OS,10625.0
2410,Torin 1,CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1,C35H28F3N5O2,10997.0
2411,rac-Astaxanthin,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C(=O)C(O)CC2(C)C)C(C)(C)CC(O)C1=O,C40H52O4,70685.0
2412,Sulforaphane,CS(=O)CCCCN=C=S,C6H11NOS2,10496.0
2413,Puromycin (hydrochloride),COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1.Cl.Cl,C22H31Cl2N7O5,13884.0
2414,Lonafarnib,NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1,C27H31Br2ClN4O2,11746.0
2415,Okadaic Acid,C=C1[C@@H](O)C2O[C@@]3(CCC2O[C@@H]1[C@@H](O)C[C@H](C)[C@H]1O[C@@]2(CCCCO2)CC[C@H]1C)CC[C@H](/C=C/[C@@H](C)C1CC(C)=C[C@]2(O1)O[C@@H](C[C@@](C)(O)C(=O)O)CC[C@H]2O)O3,C44H68O13,10011490.0
2416,Ochratoxin A,C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(=O)O)c(O)c2C(=O)O1,C20H18ClNO6,11439.0
2417,Gliotoxin,CN1C(=O)[C@]23CC4=CC=C[C@H](O)[C@H]4N2C(=O)[C@@]1(CO)SS3,C13H14N2O4S2,11433.0
2418,Kaempferitrin,C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)c(-c4ccc(O)cc4)oc3c2)[C@H](O)[C@H](O)[C@H]1O,C27H30O14,12093.0
2419,Skyrin,Cc1cc(O)c2c(c1)C(=O)c1c(c(O)cc(O)c1-c1c(O)cc(O)c3c1C(=O)c1cc(C)cc(O)c1C3=O)C2=O,C30H18O10,13102.0
2420,Hymeglusin,CC(=C\C(=O)O)/C=C(\C)C[C@H](C)CCCC[C@H]1OC(=O)[C@@H]1CO,C18H28O5,11899.0
2421,Streptozotocin,CN(N=O)C(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO,C8H15N3O7,13104.0
2422,NU6102,NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,C18H22N6O3S,13317.0
2423,NFAT Inhibitor,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C,C75H118N20O22S,13855.0
2424,3-Methylbuphedrone (hydrochloride),CCC(NC)C(=O)c1cccc(C)c1.Cl,C12H18ClNO,12001.0
2425,"N,N-DMA (hydrochloride)",CC(Cc1ccccc1)N(C)C.Cl,C11H18ClN,11556.0
2426,"N,N-DMA (hydrochloride) (exempt preparation)",CC(Cc1ccccc1)N(C)C.Cl,C11H18ClN,15659.0
2427,N-Ethylamphetamine (hydrochloride),CCNC(C)Cc1ccccc1.Cl,C11H18ClN,11557.0
2428,N-Ethylamphetamine (hydrochloride) (exempt preparation),CCNC(C)Cc1ccccc1.Cl,C11H18ClN,15658.0
2429,"4-bromo-2,5-DMA (hydrochloride)",COc1cc(CC(C)N)c(OC)cc1Br.Cl,C11H17BrClNO2,11142.0
2430,"4-bromo-2,5-DMA (hydrochloride) (exempt preparation)",COc1cc(CC(C)N)c(OC)cc1Br.Cl,C11H17BrClNO2,15683.0
2431,CDDO,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)C2C1,C31H41NO4,81035.0
2432,CDDO methyl ester,COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2,C32H43NO4,11883.0
2433,SR 1555 (hydrochloride),CC(=O)N1CCN(Cc2ccc(-c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)cc2)CC1.Cl,C22H23ClF6N2O2,12071.0
2434,Phorbol 12-myristate 13-acetate,CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O,C36H56O8,10008014.0
2435,JWH 071,CCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C21H17NO,13890.0
2436,"2,4,6-Trimethoxyamphetamine (hydrochloride)",COc1cc(OC)c(CC(C)N)c(OC)c1.Cl,C12H20ClNO3,12099.0
2437,"3,4,5-Trimethoxyamphetamine (hydrochloride)",COc1cc(CC(C)N)cc(OC)c1OC.Cl,C12H20ClNO3,13887.0
2438,"3,4,5-Trimethoxyamphetamine (hydrochloride) (exempt preparation)",COc1cc(CC(C)N)cc(OC)c1OC.Cl,C12H20ClNO3,15682.0
2439,"(-)-WIN 55,212-3 (mesylate)",CS(=O)(=O)O.Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@@H](CN1CCOCC1)CO3,C28H30N2O6S,12022.0
2440,PFI-1,COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2,C16H17N3O4S,11155.0
2441,Bromo-DragonFLY (hydrochloride),CC(N)Cc1c2ccoc2c(Br)c2ccoc12.Cl,C13H13BrClNO2,11561.0
2442,Ionomycin (calcium salt),C[C@H](CCC(=O)[O-])C[C@H](C)C[C@H](C)C(=O)/C=C(\[O-])[C@H](C)C[C@H](C)C/C=C/[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)C[C@@H]1CC[C@@](C)([C@H]2CC[C@@](C)([C@@H](C)O)O2)O1.[Ca+2],C41H70CaO9,11932.0
2443,SU 6668,Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O,C18H18N2O3,13873.0
2444,2C-B (hydrochloride),COc1cc(CCN)c(OC)cc1Br.Cl,C10H15BrClNO2,11734.0
2445,2C-B (hydrochloride) (exempt preparation),COc1cc(CCN)c(OC)cc1Br.Cl,C10H15BrClNO2,15684.0
2446,4-acetoxy DiPT (acetate),CC(=O)O.CC(=O)Oc1cccc2[nH]cc(CCN(C(C)C)C(C)C)c12,C20H30N2O4,11311.0
2447,Veratramine,Cc1c([C@H](C)[C@@H]2NC[C@@H](C)C[C@H]2O)ccc2c1C[C@H]1[C@H]2CC=C2C[C@@H](O)CC[C@@]21C,C27H39NO2,11724.0
2448,5-Nitroso-8-quinolinol,O=Nc1ccc(O)c2ncccc12,C9H6N2O2,13856.0
2449,Pyroxamide,O=C(CCCCCCC(=O)Nc1cccnc1)NO,C13H19N3O3,13870.0
2450,JW 618,CN(Cc1cccc(-c2ccncc2)c1)C(=O)OC(C(F)(F)F)C(F)(F)F,C17H14F6N2O2,11790.0
2451,Atpenin A5,COc1[nH]c(O)c(C(=O)[C@@H](C)C[C@H](C)[C@@H](Cl)CCl)c(=O)c1OC,C15H21Cl2NO5,11898.0
2452,Pyripyropene A,CC(=O)OC[C@@]1(C)[C@@H]2C[C@H](OC(C)=O)[C@@]3(C)Oc4cc(-c5cccnc5)oc(=O)c4[C@H](O)[C@@H]3[C@@]2(C)CC[C@@H]1OC(C)=O,C31H37NO10,11896.0
2453,Decoyinine,C=C1O[C@@](CO)(n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,C11H13N5O4,13851.0
2454,LY333531 (hydrochloride),CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1.Cl,C28H29ClN4O3,13964.0
2455,Benzedrone (hydrochloride),Cc1ccc(C(=O)C(C)NCc2ccccc2)cc1.Cl,C17H20ClNO,11915.0
2456,Ruxolitinib,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,C17H18N6,11609.0
2457,(S)-Pramipexole (hydrochloride),CCCN[C@H]1CCc2nc(N)sc2C1.Cl.Cl,C10H19Cl2N3S,11981.0
2458,Canertinib (hydrochloride),C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl,C24H27Cl3FN5O3,12076.0
2459,SAG,CN[C@H]1CC[C@H](N(Cc2cccc(-c3ccncc3)c2)C(=O)c2sc3ccccc3c2Cl)CC1,C28H28ClN3OS,11914.0
2460,HC-030031,CC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1,C18H21N5O3,11923.0
2461,Lagochiline,C[C@@H]1CC[C@H]2[C@](C)(CO)[C@@H](O)CC[C@]2(C)[C@@]12CC[C@@](CO)(CCO)O2,C20H36O5,13955.0
2462,DOI (hydrochloride),COc1cc(CC(C)N)c(OC)cc1I.Cl,C11H17ClINO2,13885.0
2463,4-methyl-.alpha.-Ethyltryptamine,CCC(N)Cc1c[nH]c2cccc(C)c12,C13H18N2,13886.0
2464,JWH 200 5-hydroxyindole metabolite,O=C(c1cccc2ccccc12)c1cn(CCN2CCOCC2)c2ccc(O)cc12,C25H24N2O3,10745.0
2465,Lestaurtinib,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,C26H21N3O4,12094.0
2466,Mubritinib,FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1,C25H23F3N4O2,12096.0
2467,3C-B-FLY (hydrochloride),CC(N)Cc1c2c(c(Br)c3c1OCC3)OCC2.Cl,C13H17BrClNO2,13963.0
2468,JWH 167,CCCCCn1cc(C(=O)Cc2ccccc2)c2ccccc21,C21H23NO,13979.0
2469,AK-7,O=C(Nc1cccc(Br)c1)c1cccc(S(=O)(=O)N2CCCCCC2)c1,C19H21BrN2O3S,14004.0
2470,Bafilomycin B1,CO/C1=C\C(C)=C\[C@@H](C)[C@@H](O)[C@@H](C)C/C(C)=C/C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](OC(=O)/C=C/C(=O)NC3=C(O)CCC3=O)[C@H](C)[C@@H](C(C)C)O2)OC1=O,C44H65NO13,14005.0
2471,(R)-CR8,CC[C@H](CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1,C24H29N7O,14006.0
2472,JWH 019 5-hydroxyindole metabolite,CCCCCCn1cc(C(=O)c2cccc3ccccc23)c2cc(O)ccc21,C25H25NO2,9000764.0
2473,SR 2211,OC(c1ccc(-c2ccc(CN3CCN(Cc4ccncc4)CC3)cc2)c(F)c1)(C(F)(F)F)C(F)(F)F,C26H24F7N3O,11972.0
2474,S-(5'-Adenosyl)-L-methionine chloride (hydrochloride),C[S+](CC[C@H](N)C(=O)O)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@@H](O)C1O.Cl.Cl.[Cl-],C15H25Cl3N6O5S,13956.0
2475,Kahweol,C[C@@]12C=Cc3occc3C1CC[C@@]13C[C@@H](CCC12)[C@@](O)(CO)C3,C20H26O3,14015.0
2476,Azathioprine,Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12,C9H7N7O2S,13987.0
2477,Pirfenidone,Cc1ccc(=O)n(-c2ccccc2)c1,C12H11NO,13986.0
2478,Mycophenolate Mofetil,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,C23H31NO7,13988.0
2479,Auraptene,CC(C)=CCC/C(C)=C/COc1ccc2ccc(=O)oc2c1,C19H22O3,14000.0
2480,Acivicin,N[C@H](C(=O)O)[C@@H]1CC(Cl)=NO1,C5H7ClN2O3,14003.0
2481,(+)-Alliin,C=CC[S@](=O)C[C@H](N)C(=O)O,C6H11NO3S,14002.0
2482,L-Deoxyalliin,C=CCSC[C@H](N)C(=O)O,C6H11NO2S,14014.0
2483,Iberin,CS(=O)CCCN=C=S,C5H9NOS2,14016.0
2484,Methotrexate (hydrate),CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1.O,C20H24N8O6,13960.0
2485,INCB 3284 (dimesylate),COc1ccc([C@]2(O)CC[C@H](N3CC[C@@H](NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1.CS(=O)(=O)O.CS(=O)(=O)O,C28H39F3N4O10S2,11963.0
2486,PIK-90,COc1ccc2c(c1OC)N=C(NC(=O)c1cccnc1)N1CCN=C21,C18H17N5O3,10010749.0
2487,Fmoc-Succinimide,O=C(OCC1c2ccccc2-c2ccccc21)ON1C(=O)CCC1=O,C19H15NO5,13861.0
2488,Sildenafil Citrate,CCCc1nn(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)[nH]c12.O=C(O)CC(O)(CC(=O)O)C(=O)O,C28H38N6O11S,14008.0
2489,UR-144 Degradant,C=C(C)C(C)(C)CC(=O)c1cn(CCCCC)c2ccccc12,C21H29NO,11928.0
2490,"N,N-Dimethyltryptamine",CN(C)CCc1c[nH]c2ccccc12,C12H16N2,13959.0
2491,"N,N-DMT (CRM)",CN(C)CCc1c[nH]c2ccccc12,C12H16N2,38998.0
2492,"2,4-Dimethylethcathinone (hydrochloride)",CCNC(C)C(=O)c1ccc(C)cc1C.Cl,C13H20ClNO,11242.0
2493,"2,4-Dimethylmethcathinone (hydrochloride)",CNC(C)C(=O)c1ccc(C)cc1C.Cl,C12H18ClNO,11243.0
2494,JWH 149,CCCCCn1c(C)c(C(=O)c2ccc(C)c3ccccc23)c2ccccc21,C26H27NO,13978.0
2495,JWH 193,Cc1ccc(C(=O)c2cn(CCN3CCOCC3)c3ccccc23)c2ccccc12,C26H26N2O2,13980.0
2496,JWH 198,COc1ccc(C(=O)c2cn(CCN3CCOCC3)c3ccccc23)c2ccccc12,C26H26N2O3,13981.0
2497,Dalcetrapib,CCC(CC)CC1(C(=O)Nc2ccccc2SC(=O)C(C)C)CCCCC1,C23H35NO2S,89450.0
2498,Erucin,CSCCCCN=C=S,C6H11NS2,14017.0
2499,25B-NBOMe (hydrochloride),COc1cc(CCNCc2ccccc2OC)c(OC)cc1Br.Cl,C18H23BrClNO3,12047.0
2500,25B-NBOMe (hydrochloride) (exempt preparation),COc1cc(CCNCc2ccccc2OC)c(OC)cc1Br.Cl,C18H23BrClNO3,15723.0
2501,25D-NBOMe (hydrochloride),COc1cc(CCNCc2ccccc2OC)c(OC)cc1C.Cl,C19H26ClNO3,11946.0
2502,RCS-4 M10 metabolite,O=C(c1ccc(O)cc1)c1cn(CCCCCO)c2ccccc12,C20H21NO3,11978.0
2503,GSK-J1 (sodium salt),O=C([O-])CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1.[Na+],C22H22N5NaO2,12054.0
2504,GSK-J4 (hydrochloride),CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1.Cl,C24H28ClN5O2,12073.0
2505,N-Oxalylglycine,O=C(O)CNC(=O)C(=O)O,C4H5NO5,13944.0
2506,Olopatadine (hydrochloride),CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21.Cl,C21H24ClNO3,11999.0
2507,FC 131,N=C(N)NCCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@H](Cc2ccc3ccccc3c2)NC1=O,C36H47N11O6,11960.0
2508,Dihydroethidium,CCN1c2cc(N)ccc2-c2ccc(N)cc2C1c1ccccc1,C21H21N3,12013.0
2509,(-)-(S)-Cathinone (hydrochloride),C[C@H](N)C(=O)c1ccccc1.Cl,C9H12ClNO,13869.0
2510,(-)-(S)-Cathinone (hydrochloride) (exempt preparation),C[C@H](N)C(=O)c1ccccc1.Cl,C9H12ClNO,15655.0
2511,N-hydroxy-MDA (hydrochloride),CC(Cc1ccc2c(c1)OCO2)NO.Cl,C10H14ClNO3,13958.0
2512,N-hydroxy MDA (hydrochloride) (exempt preparation),CC(Cc1ccc2c(c1)OCO2)NO.Cl,C10H14ClNO3,15688.0
2513,6-APDB (hydrochloride),CC(N)Cc1ccc2c(c1)OCC2.Cl,C11H16ClNO,11146.0
2514,JNJ-5207852,c1cc(OCCCN2CCCCC2)ccc1CN1CCCCC1,C20H32N2O,11998.0
2515,Biphenylindanone A,Cc1c(OCc2cccc(-c3ccc(C(=O)O)cc3)c2)cc2c(c1C)C(=O)C(C1CCCC1)C2,C30H30O4,11986.0
2516,NPS 2390,O=C(NC12CC3CC(CC(C3)C1)C2)c1cnc2ccccc2n1,C19H21N3O,11989.0
2517,KL001,CS(=O)(=O)N(Cc1ccco1)CC(O)Cn1c2ccccc2c2ccccc21,C21H22N2O4S,13878.0
2518,KL002,CS(=O)(=O)N(CC(O)Cn1c2ccccc2c2ccccc21)c1ccccc1I,C22H21IN2O3S,13879.0
2519,Dextromethorphan (hydrobromide hydrate),Br.COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3.O,C18H28BrNO2,13950.0
2520,AD57 (hydrochloride),CC(C)n1nc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)ncnc21.Cl,C22H21ClF3N7O,13975.0
2521,Nervonic Acid methyl ester,CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)OC,C25H48O2,9001351.0
2522,"2,3-MDA (hydrochloride)",CC(N)Cc1cccc2c1OCO2.Cl,C10H14ClNO2,13969.0
2523,"3,4-MDMA (hydrochloride)",CNC(C)Cc1ccc2c(c1)OCO2.Cl,C11H16ClNO2,13971.0
2524,25I-NBMD (hydrochloride),COc1cc(CCNCc2cccc3c2OCO3)c(OC)cc1I.Cl,C18H21ClINO4,11947.0
2525,Etaqualone,CCc1ccccc1-n1c(C)nc2ccccc2c1=O,C17H16N2O,11152.0
2526,22(R)-hydroxy Cholesterol,CC(C)CC[C@@H](O)[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O2,89355.0
2527,Ro 01-6128,CCOC(=O)NC(=O)C(c1ccccc1)c1ccccc1,C17H17NO3,11991.0
2528,Ro 67-4853,CCCCOC(=O)NC(=O)C1c2ccccc2Oc2ccccc21,C19H19NO4,11992.0
2529,VU0360223,Cc1nc2cc(-c3cc(F)cc(C#N)c3)ccc2s1,C15H9FN2S,11995.0
2530,Haloperidol,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C21H23ClFNO2,12014.0
2531,Haloperidol (CRM),O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C21H23ClFNO2,40431.0
2532,Rosuvastatin,CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,C22H28FN3O6S,12029.0
2533,(25S)-?7-Dafachronic Acid,C[C@H](CCC[C@H](C)C(=O)O)[C@H]1CC[C@H]2C3=CC[C@H]4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H42O3,14101.0
2534,Pinostilbene,COc1cc(O)cc(/C=C/c2ccc(O)cc2)c1,C15H14O3,14044.0
2535,Betulin,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C30H50O2,11041.0
2536,Triptolide,CC(C)[C@]12O[C@H]1[C@@H]1O[C@]13[C@]1(O[C@H]1C[C@H]1C4=C(CC[C@@]13C)C(=O)OC4)[C@@H]2O,C20H24O6,11973.0
2537,Nocodazole,COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1,C14H11N3O3S,13857.0
2538,AB-PINACA,CCCCCn1nc(C(=O)N[C@H](C(N)=O)C(C)C)c2ccccc21,C18H26N4O2,14038.0
2539,3-Bromomethcathinone (hydrochloride),CNC(C)C(=O)c1cccc(Br)c1.Cl,C10H13BrClNO,14035.0
2540,AM1248 azepane isomer,CN1CCCCC(n2cc(C(=O)C34CC5CC(CC(C5)C3)C4)c3ccccc32)C1,C26H34N2O,14068.0
2541,BCTC,CC(C)(C)c1ccc(NC(=O)N2CCN(c3ncccc3Cl)CC2)cc1,C20H25ClN4O,10006309.0
2542,Polymyxin B1,CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O,C56H98N16O13,14074.0
2543,GSK-J5 (hydrochloride),CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2cccnc2)n1.Cl,C24H28ClN5O2,12074.0
2544,AB-FUBINACA,CC(C)[C@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(N)=O,C20H21FN4O2,14039.0
2545,25I-NBF (hydrochloride),COc1cc(CCNCc2ccccc2F)c(OC)cc1I.Cl,C17H20ClFINO2,14066.0
2546,A-834735,CC1(C)C(C(=O)c2cn(CC3CCOCC3)c3ccccc23)C1(C)C,C22H29NO2,11163.0
2547,.alpha.-Pyrrolidinopentiophenone metabolite 1 (trifluoroacetate salt),CCCC(C(O)c1ccccc1)N1CCCC1.O=C(O)C(F)(F)F,C17H24F3NO3,14093.0
2548,"2,3-MDMA (hydrochloride)",CNC(C)Cc1cccc2c1OCO2.Cl,C11H16ClNO2,13970.0
2549,"3,4-MDPA (hydrochloride)",CCCNC(C)Cc1ccc2c(c1)OCO2.Cl,C13H20ClNO2,13972.0
2550,5-APDB (hydrochloride),CC(N)Cc1ccc2c(c1)CCO2.Cl,C11H16ClNO,11456.0
2551,Asiaticoside,C[C@H]1[C@H](C)CC[C@]2(C(=O)O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@H]12,C48H78O19,11819.0
2552,Bisindolylmaleimide III,NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,C23H20N4O2,11072.0
2553,K252a,COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,C27H21N3O5,11338.0
2554,Fingolimod,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,C19H33NO2,11975.0
2555,AMD 3465 (hydrobromide),Br.Br.Br.Br.Br.Br.c1ccc(CNCc2ccc(CN3CCCNCCNCCCNCC3)cc2)nc1,C24H44Br6N6,11959.0
2556,Apocynin,COc1cc(C(C)=O)ccc1O,C9H10O3,11976.0
2557,ML-7 (hydrochloride),Cl.O=S(=O)(c1cccc2c(I)cccc12)N1CCCNCC1,C15H18ClIN2O2S,11801.0
2558,Atropine,CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2,C17H23NO3,12008.0
2559,Paprotrain,N#C/C(=C\c1cccnc1)c1c[nH]c2ccccc12,C16H11N3,10524.0
2560,JWH 176,CCCCCC1=C/C(=C\c2cccc3ccccc23)c2ccccc21,C25H24,11617.0
2561,JWH 412,CCCCCn1cc(C(=O)c2ccc(F)c3ccccc23)c2ccccc21,C24H22FNO,11971.0
2562,JWH 018 N-(4-oxo-pentyl) metabolite,CC(=O)CCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H21NO2,13889.0
2563,JWH 073 6-methoxyindole analog,CCCCn1cc(C(=O)c2cccc3ccccc23)c2ccc(OC)cc21,C24H23NO2,14084.0
2564,"3,4-dimethoxy-.alpha.-Pyrrolidinopentiophenone (hydrochloride)",CCCC(C(=O)c1ccc(OC)c(OC)c1)N1CCCC1.Cl,C17H26ClNO3,14106.0
2565,(Z-Ala-Ala-Ala-Ala)2Rh110,C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)Nc1ccc2c(c1)Oc1cc(NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)OCc3ccccc3)ccc1C21OC(=O)c2ccccc21,C60H66N10O15,11675.0
2566,Dynasore,O=C(N/N=C/c1ccc(O)c(O)c1)c1cc2ccccc2cc1O,C18H14N2O4,14062.0
2567,Entecavir (hydrate),C=C1[C@H](CO)[C@@H](O)C[C@@H]1n1cnc2c(=O)nc(N)[nH]c21.O,C12H17N5O4,13831.0
2568,Ganciclovir,Nc1nc(=O)c2ncn(COC(CO)CO)c2[nH]1,C9H13N5O4,13853.0
2569,Vinblastine (sulfate),CC[C@]1(O)C[C@@H]2C[N@@](CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O,C46H60N4O13S,11762.0
2570,Caffeine,Cn1c(=O)c2c(ncn2C)n(C)c1=O,C8H10N4O2,14118.0
2571,Caffeine (CRM),Cn1c(=O)c2c(ncn2C)n(C)c1=O,C8H10N4O2,27970.0
2572,"3,4-MDEA (hydrochloride)",CCNC(C)Cc1ccc2c(c1)OCO2.Cl,C12H18ClNO2,14085.0
2573,JWH 387,CCCCCn1cc(C(=O)c2ccc(Br)c3ccccc23)c2ccccc21,C24H22BrNO,12020.0
2574,D-NMMA (acetate),CC(=O)O.CNC(=N)NCCC[C@@H](N)C(=O)O,C9H20N4O4,14186.0
2575,S14161,CCOc1cccc2c1OC(c1ccc(F)cc1)C([N+](=O)[O-])=C2,C17H14FNO4,14187.0
2576,NNEI,CCCCCn1cc(C(=O)Nc2cccc3ccccc23)c2ccccc21,C24H24N2O,15001.0
2577,5-fluoro PB-22,O=C(Oc1cccc2cccnc12)c1cn(CCCCCF)c2ccccc12,C23H21FN2O2,14095.0
2578,5-fluoro PB-22 (exempt preparation),O=C(Oc1cccc2cccnc12)c1cn(CCCCCF)c2ccccc12,C23H21FN2O2,16048.0
2579,BB-22,O=C(Oc1cccc2cccnc12)c1cn(CC2CCCCC2)c2ccccc12,C25H24N2O2,14099.0
2580,YM-155,COCCn1c2c([n+](Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O.[Br-],C20H19BrN4O3,11490.0
2581,C646,CC1=NN(c2ccc(C(=O)O)cc2)C(=O)/C1=C\c1ccc(-c2cc(C)c(C)cc2[N+](=O)[O-])o1,C24H19N3O6,10549.0
2582,SD 169,NC(=O)c1ccc2[nH]ccc2c1,C9H8N2O,14156.0
2583,Amlexanox,CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1,C16H14N2O4,14181.0
2584,Risperidone,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,C23H27FN4O2,13629.0
2585,Risperidone (CRM),Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,C23H27FN4O2,40163.0
2586,Clozapine,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,C18H19ClN4,12059.0
2587,Clozapine (CRM),CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,C18H19ClN4,31084.0
2588,D-Neopterin,Nc1nc2[nH]cc([C@H](O)[C@H](O)CO)nc-2c(=O)n1,C9H11N5O4,12057.0
2589,3-methoxy PCP (hydrochloride),COc1cccc(C2(N3CCCCC3)CCCCC2)c1.Cl,C18H28ClNO,11137.0
2590,3-methoxy PCP (hydrochloride) (CRM),COc1cccc(C2(N3CCCCC3)CCCCC2)c1.Cl,C18H28ClNO,28958.0
2591,6-IT,CC(N)Cc1ccc2cc[nH]c2c1,C11H14N2,13938.0
2592,5-APDI (hydrochloride),CC(N)Cc1ccc2c(c1)CCC2.Cl,C12H18ClN,13899.0
2593,JWH 080,CCCCn1cc(C(=O)c2ccc(OC)c3ccccc23)c2ccccc21,C24H23NO2,14013.0
2594,GW 4869 (hydrochloride hydrate),Cl.Cl.O.O=C(/C=C/c1ccc(/C=C/C(=O)Nc2ccc(C3=NCCN3)cc2)cc1)Nc1ccc(C2=NCCN2)cc1,C30H32Cl2N6O3,13127.0
2595,ITF 2357,CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(C(=O)NO)cc3)ccc2c1.Cl.O,C24H30ClN3O5,11045.0
2596,Naringenin,O=C1CC(c2ccc(O)cc2)Oc2cc(O)cc(O)c21,C15H12O5,14173.0
2597,PX 12,CCC(C)SSc1ncc[nH]1,C7H12N2S2,14192.0
2598,Asiatic Acid,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@H]12,C30H48O5,11818.0
2599,Polymyxin B (sulfate),CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(Cc2ccccc2)NC(=O)C(CCN)NC1=O)C(C)O.O=S(=O)(O)O,C56H100N16O17S,14157.0
2600,PP1 (Src Inhibitor),Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1,C16H19N5,14244.0
2601,Wogonin,COc1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,C16H12O5,14248.0
2602,Coumestrol,O=c1oc2cc(O)ccc2c2oc3cc(O)ccc3c12,C15H8O5,11730.0
2603,GSK-J2 (sodium salt),O=C(O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2cccnc2)n1.[NaH],C22H23N5NaO2,12056.0
2604,Benocyclidine,c1ccc2sc(C3(N4CCCCC4)CCCCC3)cc2c1,C19H25NS,11737.0
2605,4-methoxy PCP (hydrochloride),COc1ccc(C2(N3CCCCC3)CCCCC2)cc1.Cl,C18H28ClNO,11136.0
2606,4-CAB (hydrochloride),CCC(N)Cc1ccc(Cl)cc1.Cl,C10H15Cl2N,13893.0
2607,MMAI (hydrochloride),COc1cc2c(cc1C)CC(N)C2.Cl,C11H16ClNO,13895.0
2608,Thiosildenafil,CCCc1nn(C)c2c(=S)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,C22H30N6O3S2,13939.0
2609,Bosentan,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,C27H29N5O6S,11731.0
2610,Trilostane,C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C#N)C[C@]35C)[C@@H]1CC[C@@H]2O,C20H27NO3,14164.0
2611,MS-1020,O=C(NCCc1c[nH]c2ccc(O)cc12)c1ccc2ccccc2c1O,C21H18N2O3,14273.0
2612,Bilobalide,CC(C)(C)[C@]1(O)C[C@@H]2OC(=O)C[C@@]23C(=O)O[C@@H]2OC(=O)[C@H](O)C213,C15H18O8,14272.0
2613,5-methoxy-.alpha.-Ethyltryptamine,CCC(N)Cc1c[nH]c2ccc(OC)cc12,C13H18N2O,14172.0
2614,W-5 (hydrochloride),Cl.NCCCCCCNS(=O)(=O)c1cccc2ccccc12,C16H23ClN2O2S,14271.0
2615,UR-144 N-(5-hydroxypentyl) .beta.-D-Glucuronide,CC1(C)C(C(=O)c2cn(CCCCCO[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c3ccccc23)C1(C)C,C27H37NO8,11776.0
2616,SL 0101-1,CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](O)[C@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)O[C@H]1C,C25H24O12,11704.0
2617,OAC2,O=C(Nc1ccc2[nH]ccc2c1)c1ccccc1,C15H12N2O,14103.0
2618,OAC3,O=C(Nc1ccc2[nH]ccc2c1)c1ccc(F)cc1,C15H11FN2O,14104.0
2619,Puerarin,O=c1c(-c2ccc(O)cc2)coc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12,C21H20O9,14175.0
2620,EBPC,CCOC(=O)C1=C(O)C(=O)N(Cc2ccccc2)C1,C14H15NO4,14183.0
2621,KN-93 (hydrochloride),COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1.Cl,C26H30Cl2N2O4S,13864.0
2622,JC-1,CCN1C(=C/C=C/c2n(CC)c3cc(Cl)c(Cl)cc3[n+]2CC)N(CC)c2cc(Cl)c(Cl)cc21.[I-],C25H27Cl4IN4,15003.0
2623,Bicalutamide,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,C18H14F4N2O4S,14250.0
2624,Flumazenil,CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2,C15H14FN3O3,14252.0
2625,25I-NBOMe-d3 (hydrochloride),Cl.[2H]C([2H])([2H])Oc1ccccc1CNCCc1cc(OC)c(I)cc1OC,C18H23ClINO3,14284.0
2626,25I-NBOMe-d3 (hydrochloride) (exempt preparation),Cl.[2H]C([2H])([2H])Oc1ccccc1CNCCc1cc(OC)c(I)cc1OC,C18H23ClINO3,22878.0
2627,"2,3-Dichlorophenylpiperazine (hydrochloride)",Cl.Clc1cccc(N2CCNCC2)c1Cl,C10H13Cl3N2,14296.0
2628,Pentadecanoyl Ethanolamide,CCCCCCCCCCCCCCC(=O)NCCO,C17H35NO2,9001740.0
2629,Myristoyl Ethanolamide,CCCCCCCCCCCCCC(=O)NCCO,C16H33NO2,9001742.0
2630,Lignoceroyl Ethanolamide,CCCCCCCCCCCCCCCCCCCCCCCC(=O)NCCO,C26H53NO2,9001744.0
2631,Torin 2,Nc1ccc(-c2ccc3ncc4ccc(=O)n(-c5cccc(C(F)(F)F)c5)c4c3c2)cn1,C24H15F3N4O,14185.0
2632,A-769662,N#Cc1c(O)c2c(-c3ccc(-c4ccccc4O)cc3)csc2[nH]c1=O,C20H12N2O3S,11900.0
2633,PD 150606,O=C(O)/C(S)=C/c1ccc(I)cc1,C9H7IO2S,13859.0
2634,Catharanthine (tartrate),CCC1=C[C@@H]2C[N@@]3CCc4c([nH]c5ccccc45)[C@@](C(=O)OC)(C2)[C@@H]13.CCC1=C[C@@H]2C[N@@]3CCc4c([nH]c5ccccc45)[C@@](C(=O)OC)(C2)[C@@H]13.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C46H54N4O10,11695.0
2635,Febuxostat,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,C16H16N2O3S,14127.0
2636,Floxuridine,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,C9H11FN2O5,14154.0
2637,Acyclovir,Nc1nc2c(ncn2COCCO)c(=O)[nH]1,C8H11N5O3,14160.0
2638,Pemetrexed (sodium salt hydrate),Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc3)c[nH]c2[nH]1.O.O.O.O.O.O.O.[Na+].[Na+],C20H33N5Na2O13,14269.0
2639,.alpha.-Ethylaminopentiophenone (hydrochloride),CCCC(NCC)C(=O)c1ccccc1.Cl,C13H20ClNO,14280.0
2640,PCEEA (hydrochloride),CCOCCNC1(c2ccccc2)CCCCC1.Cl,C16H26ClNO,9001365.0
2641,PF-04691502,COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1,C22H27N5O4,15017.0
2642,PF-03814735,CC(=O)NCC(=O)N1[C@@H]2CC[C@H]1c1ccc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)cc12,C23H25F3N6O2,15015.0
2643,Indirubin,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O,C16H10N2O2,14155.0
2644,Valsartan,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C,C24H29N5O3,14178.0
2645,Alsterpaullone,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,C16H11N3O3,14428.0
2646,Clindamycin,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,C18H33ClN2O5S,15006.0
2647,Torcetrapib,CCOC(=O)N1c2ccc(C(F)(F)F)cc2[C@@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)OC)C[C@H]1CC,C26H25F9N2O4,15028.0
2648,(+)-Aphidicolin,C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H]1CC[C@H]1C[C@@H]3C[C@@]12CC[C@]3(O)CO,C20H34O4,14007.0
2649,.delta.8-THC,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C21H30O2,14042.0
2650,?8-THC (Alt. Batch CRM),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C21H30O2,41193.0
2651,5-fluoro NNEI,O=C(Nc1cccc2ccccc12)c1cn(CCCCCF)c2ccccc12,C24H23FN2O,14147.0
2652,5-fluoro NNEI 2'-naphthyl isomer,O=C(Nc1ccc2ccccc2c1)c1cn(CCCCCF)c2ccccc12,C24H23FN2O,14318.0
2653,PCMPA (hydrochloride),COCCCNC1(c2ccccc2)CCCCC1.Cl,C16H26ClNO,9001363.0
2654,Tricosanoyl Ethanolamide,CCCCCCCCCCCCCCCCCCCCCCC(=O)NCCO,C25H51NO2,9001743.0
2655,Docosaenoyl Ethanolamide,CCCCCCCC/C=C\CCCCCCCCCCCC(=O)NCCO,C24H47NO2,9001745.0
2656,Nervonoyl Ethanolamide,CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)NCCO,C26H51NO2,9001746.0
2657,.gamma.-Linolenoyl Ethanolamide,CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)NCCO,C20H35NO2,9001747.0
2658,Tofacitinib (citrate),C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O,C22H28N6O8,11598.0
2659,Isopropyl dodec-11-enylfluorophosphonate,C=CCCCCCCCCCCP(=O)(F)OC(C)C,C15H30FO2P,11613.0
2660,OC000459,Cc1c(Cc2ccc3ccccc3n2)c2cc(F)ccc2n1CC(=O)O,C21H17FN2O2,12027.0
2661,PF-04708671,CCc1cncnc1N1CCN(Cc2nc3cc(C(F)(F)F)ccc3[nH]2)CC1,C19H21F3N6,15018.0
2662,PF-04981517,Cc1ccc(-c2c(-c3nn(C)c4ncnc(N5CC[C@H](N6CCCCC6)C5)c34)cnn2C)cc1,C26H32N8,15019.0
2663,Prazosin (hydrochloride),COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC.Cl,C19H22ClN5O4,15023.0
2664,Ziprasidone (hydrochloride hydrate),Cl.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,C21H24Cl2N4O2S,15031.0
2665,Topotecan (hydrochloride),CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1.Cl,C23H24ClN3O5,14129.0
2666,Irinotecan (hydrochloride hydrate),CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Cl.O.O.O,C33H45ClN4O9,14180.0
2667,Glyburide (potassium salt),COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)[N-]C(=O)NC2CCCCC2)cc1.[K+],C23H27ClKN3O5S,15009.0
2668,Bazedoxifene (acetate),CC(=O)O.Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12,C32H38N2O5,15005.0
2669,Exemestane,C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,C20H24O2,15008.0
2670,Sulfasalazine,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,C18H14N4O5S,15025.0
2671,Tigecycline,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,C29H39N5O8,15026.0
2672,Linezolid,CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,C16H20FN3O4,15012.0
2673,Doxorubicin (hydrochloride),COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,C27H30ClNO11,15007.0
2674,Methylprednisolone,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12,C22H30O5,15013.0
2675,Glycitin,COc1cc2c(=O)c(-c3ccc(O)cc3)coc2cc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C22H22O10,14161.0
2676,Genistin,O=c1c(-c2ccc(O)cc2)coc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c12,C21H20O10,14174.0
2677,2-deoxy-D-Glucose,OC[C@H]1OC(O)C[C@@H](O)[C@@H]1O,C6H12O5,14325.0
2678,1-(4-Methoxyphenyl)piperazine (hydrochloride),COc1ccc(N2CCNCC2)cc1.Cl.Cl,C11H18Cl2N2O,14020.0
2679,"(1S,3S)-3-Aminomethyl-cyclopentanol",NC[C@H]1CC[C@H](O)C1,C6H13NO,11358.0
2680,"(1R,3R)-3-Hydroxycyclopentane carboxylic acid benzyl ester",O=C(OCc1ccccc1)[C@@H]1CC[C@@H](O)C1,C13H16O3,11368.0
2681,"(1R,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester",COC(=O)[C@@H]1CC[C@@H](O)C1,C7H12O3,11372.0
2682,"(1S,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester",COC(=O)[C@H]1CC[C@@H](O)C1,C7H12O3,11375.0
2683,(S)-Tetrahydrofuran-2-yl-methylamine,NC[C@@H]1CCCO1,C5H11NO,11388.0
2684,(R)-Tetrahydrofuran-2-yl-methylamine,NC[C@H]1CCCO1,C5H11NO,11389.0
2685,(S)-Tetrahydrofuran-3-ylamine,N[C@H]1CCOC1,C4H9NO,11390.0
2686,(R)-Tetrahydrofuran-3-ylamine,N[C@@H]1CCOC1,C4H9NO,11391.0
2687,"(1R,3S)-3-Aminocyclopentane carboxylic acid",N[C@H]1CC[C@@H](C(=O)O)C1,C6H11NO2,11401.0
2688,"(1S,3R)-3-Aminocyclopentane carboxylic acid",N[C@@H]1CC[C@H](C(=O)O)C1,C6H11NO2,11402.0
2689,"BOC-(1R,3S)-3-Aminocyclopentane carboxylic acid",CC(C)(C)OC(=O)N[C@H]1CC[C@@H](C(=O)O)C1,C11H19NO4,11405.0
2690,"BOC-(1S,3R)-3-Aminocyclopentanecarboxylic acid",CC(C)(C)OC(=O)N[C@@H]1CC[C@H](C(=O)O)C1,C11H19NO4,11406.0
2691,(R)-3-Oxo-cyclopentaneacetic acid methyl ester,COC(=O)C[C@@H]1CCC(=O)C1,C8H12O3,11415.0
2692,(R)-3-Oxo-cyclopentanecarboxylic acid methyl ester,COC(=O)[C@@H]1CCC(=O)C1,C7H10O3,11416.0
2693,(S)-3-Oxo-cyclopentaneacetic acid methyl ester,COC(=O)C[C@H]1CCC(=O)C1,C8H12O3,11417.0
2694,(S)-3-Oxo-cyclopentanecarboxylic acid methyl ester,COC(=O)[C@H]1CCC(=O)C1,C7H10O3,11418.0
2695,DEPMPO,CCOP(=O)(OCC)C1(C)CCC=[N+]1[O-],C9H18NO4P,10006435.0
2696,22-Oxacalcitriol,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)OCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,C26H42O4,10794.0
2697,"7.alpha.,25-dihydroxy Cholesterol",C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O3,11032.0
2698,Resolvin D2-d5,[2H]C([2H])([2H])C([2H])([2H])/C=C\C[C@H](O)[C@H](O)/C=C/C=C/C=C\C=C\[C@@H](O)C/C=C\CCC(=O)O,C22H32O5,11184.0
2699,GANT 58,c1cc(-c2sc(-c3ccncc3)c(-c3ccncc3)c2-c2ccncc2)ccn1,C24H16N4S,14193.0
2700,W-13 (hydrochloride),Cl.NCCCCNS(=O)(=O)c1ccc2c(Cl)cccc2c1,C14H18Cl2N2O2S,14277.0
2701,Calpain Inhibitor III,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1,C22H26N2O4,14283.0
2702,.beta.-Lapachone,CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O,C15H14O3,15021.0
2703,Entacapone,CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1,C14H15N3O5,14153.0
2704,A-771726,C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1,C12H9F3N2O2,14404.0
2705,Spectinomycin (hydrochloride hydrate),CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O.Cl.Cl.O.O.O.O.O,C14H36Cl2N2O12,14324.0
2706,Cyclophosphamide (hydrate),O.O=P1(N(CCCl)CCCl)NCCCO1,C7H17Cl2N2O3P,13849.0
2707,Neomycin (sulfate),NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O,C23H52N6O25S3,14287.0
2708,5-(N-ethyl-N-isopropyl)-Amiloride,CCN(c1nc(N)c(C(=O)NC(=N)N)nc1Cl)C(C)C,C11H18ClN7O,14406.0
2709,Propidium Iodide,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],C27H34I2N4,14289.0
2710,.alpha.-Pyrrolidinopentiothiophenone (hydrochloride),CCCC(C(=O)c1cccs1)N1CCCC1.Cl,C13H20ClNOS,14182.0
2711,PB-22-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)Oc2cccc3cccnc23)c2ccccc21,C23H22N2O2,14298.0
2712,PB-22-d9 (exempt preparation),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)Oc2cccc3cccnc23)c2ccccc21,C23H22N2O2,22871.0
2713,"2,3-Dimethylethcathinone (hydrochloride)",CCNC(C)C(=O)c1cccc(C)c1C.Cl,C13H20ClNO,11227.0
2714,1-(3-Chlorophenyl)piperazine(hydrochloride),Cl.Clc1cccc(N2CCNCC2)c1,C10H14Cl2N2,13949.0
2715,1-(3-Chlorophenyl)piperazine (hydrochloride) (CRM),Cl.Clc1cccc(N2CCNCC2)c1,C10H14Cl2N2,35881.0
2716,Escaline (hydrochloride),CCOc1c(OC)cc(CCN)cc1OC.Cl,C12H20ClNO3,14107.0
2717,Jasplakinolide,C/C1=C\[C@H](C)C[C@H](C)OC(=O)C[C@H](c2ccc(O)cc2)NC(=O)[C@@H](Cc2c(Br)[nH]c3ccccc23)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)C1,C36H45BrN4O6,11705.0
2718,Diphenhydramine (hydrochloride),CN(C)CCOC(c1ccccc1)c1ccccc1.Cl,C17H22ClNO,11158.0
2719,Tolterodine (tartrate),Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C26H37NO7,15027.0
2720,Varenicline tartrate,O=C(O)[C@H](O)[C@@H](O)C(=O)O.c1cnc2cc3c(cc2n1)C1CNCC3C1,C17H19N3O6,15030.0
2721,Dapagliflozin,CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,C21H25ClO6,11574.0
2722,Temsirolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C\C=C\C=C\1C,C56H87NO16,11590.0
2723,Kartogenin,O=C(O)c1ccccc1C(=O)Nc1ccc(-c2ccccc2)cc1,C20H15NO3,11826.0
2724,AEBSF (hydrochloride),Cl.NCCc1ccc(S(=O)(=O)F)cc1,C8H11ClFNO2S,14321.0
2725,Z-DEVD-FMK,COC(=O)CC[C@H](NC(=O)[C@H](CC(=O)OC)NC(=O)OCc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)OC)C(=O)CF)C(C)C,C30H41FN4O12,14414.0
2726,Glycitein,COc1cc2c(=O)c(-c3ccc(O)cc3)coc2cc1O,C16H12O5,14162.0
2727,Gatifloxacin,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,C19H22FN3O4,14290.0
2728,Ampicillin (sodium salt),CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+],C16H18N3NaO4S,14417.0
2729,Azithromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,C38H72N2O12,15004.0
2730,Palmitelaidic Acid methyl ester,CCCCCC/C=C/CCCCCCCC(=O)OC,C17H32O2,9001797.0
2731,Palmitelaidic Acid,CCCCCC/C=C/CCCCCCCC(=O)O,C16H30O2,9001798.0
2732,Fast Green FCF,CCN(Cc1cccc(S(=O)(=O)[O-])c1)c1ccc(C(=C2C=CC(=[N+](CC)Cc3cccc(S(=O)(=O)[O-])c3)C=C2)c2ccc(O)cc2S(=O)(=O)[O-])cc1.[Na+].[Na+],C37H34N2Na2O10S3,14335.0
2733,DAPI (hydrochloride),Cl.Cl.N=C(N)c1ccc(-c2cc3ccc(C(=N)N)cc3[nH]2)cc1,C16H17Cl2N5,14285.0
2734,DAPI (hydrochloride) (solution),Cl.Cl.N=C(N)c1ccc(-c2cc3ccc(C(=N)N)cc3[nH]2)cc1,C16H17Cl2N5,40796.0
2735,Acridine Orange,CN(C)c1ccc2cc3ccc(N(C)C)cc3nc2c1,C17H19N3,14338.0
2736,Brilliant Blue G,CCOc1ccc(Nc2ccc(/C(=C3/C=C/C(=[N+](/CC)Cc4cccc(S(=O)(=O)[O-])c4)C=C3C)c3ccc(N(CC)Cc4cccc(S(=O)(=O)[O-])c4)cc3C)cc2)cc1.[Na+],C47H48N3NaO7S2,14320.0
2737,A-834735 degradant,C=C(C)C(C)(C)CC(=O)c1cn(CC2CCOCC2)c2ccccc12,C22H29NO2,14165.0
2738,4-acetoxy DMT (hydrochloride),CC(=O)Oc1cccc2[nH]cc(CCN(C)C)c12.Cl,C14H19ClN2O2,14056.0
2739,5-Fluoropentyl-3-pyridinoylindole (hydrochloride),Cl.O=C(c1cccnc1)c1cn(CCCCCF)c2ccccc12,C19H20ClFN2O,14295.0
2740,5-fluoro JWH 018 adamantyl analog,O=C(c1cn(CCCCCF)c2ccccc12)C12CC3CC(CC(C3)C1)C2,C24H30FNO,14432.0
2741,CAY10669,CCCCCOc1ccc(/C=C\c2cccc(O)c2C(=O)O)cc1,C20H22O4,10974.0
2742,ZLN005,CC(C)(C)c1ccc(-c2nc3ccccc3[nH]2)cc1,C17H18N2,14121.0
2743,Purvalanol A,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,C19H25ClN6O,14579.0
2744,MK 25 (hydrochloride),Cl.O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1,C27H26Cl2N4O2,14399.0
2745,Caspase-3/7 Inhibitor I,COCC1CCCN1S(=O)(=O)c1ccc2c(c1)C(=O)C(=O)N2,C14H16N2O5S,14464.0
2746,Ac-DEVD-AFC,CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1)C(C)C,C30H34F3N5O13,14459.0
2747,Z-VAD(OMe)-FMK,COC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)CF,C22H30FN3O7,14463.0
2748,Z-FA-FMK,CC(NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)CF,C21H23FN2O4,14462.0
2749,Phenylmethylsulfonyl fluoride,O=S(=O)(F)Cc1ccccc1,C7H7FO2S,14333.0
2750,Magnolol,C=CCc1ccc(O)c(-c2cc(CC=C)ccc2O)c1,C18H18O2,14233.0
2751,Tetrahydromagnolol,CCCc1ccc(O)c(-c2cc(CCC)ccc2O)c1,C18H22O2,14234.0
2752,LY2183240,CN(C)C(=O)n1nnnc1Cc1ccc(-c2ccccc2)cc1,C17H17N5O,10008663.0
2753,Serotonin (hydrochloride),Cl.NCCc1c[nH]c2ccc(O)cc12,C10H13ClN2O,14332.0
2754,Serotonin (hydrochloride),Cl.NCCc1c[nH]c2ccc(O)cc12,C10H13ClN2O,33680.0
2755,SIRT1/2 Inhibitor IV,O=c1[nH]c(=S)[nH]c(-c2ccccc2)c1Cc1c(O)ccc2ccccc12,C21H16N2O2S,14407.0
2756,Ro 25-6981 (maleate),C[C@@H](CN1CCC(Cc2ccccc2)CC1)[C@@H](O)c1ccc(O)cc1.O=C(O)/C=C\C(=O)O,C26H33NO6,14578.0
2757,D-AP5,N[C@H](CCCP(=O)(O)O)C(=O)O,C5H12NO5P,14539.0
2758,DL-AP5,NC(CCCP(=O)(O)O)C(=O)O,C5H12NO5P,14540.0
2759,L-AP4,N[C@@H](CCP(=O)(O)O)C(=O)O,C4H10NO5P,14538.0
2760,MPEP (hydrochloride),Cc1cccc(C#Cc2ccccc2)n1.Cl,C14H12ClN,14536.0
2761,Riluzole (hydrochloride),Cl.Nc1nc2ccc(OC(F)(F)F)cc2s1,C8H6ClF3N2OS,14577.0
2762,PPADS (sodium salt),Cc1nc(/N=N/c2ccc(S(=O)(=O)[O-])cc2S(=O)(=O)[O-])c(COP(=O)([O-])[O-])c(C=O)c1O.[Na+].[Na+].[Na+].[Na+],C14H10N3Na4O12PS2,14537.0
2763,Diazoxide,CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1,C8H7ClN2O2S,14576.0
2764,Dantrolene (sodium salt),O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)[N-]1.[Na+],C14H9N4NaO5,14326.0
2765,Ciprofloxacin (hydrochloride hydrate),Cl.O.O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,C17H21ClFN3O4,14286.0
2766,Tetracycline (hydrochloride),CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12.Cl,C22H25ClN2O8,14328.0
2767,Efavirenz,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,C14H9ClF3NO2,14412.0
2768,Resazurin (sodium salt),O=c1ccc2[n+]([O-])c3ccc([O-])cc3oc-2c1.[Na+],C12H6NNaO4,14322.0
2769,Ponceau S (sodium salt),O=S(=O)([O-])c1ccc(/N=N/c2ccc(/N=N/c3c(O)c(S(=O)(=O)[O-])cc4cc(S(=O)(=O)[O-])ccc34)c(S(=O)(=O)[O-])c2)cc1.[Na+].[Na+].[Na+].[Na+],C22H12N4Na4O13S4,14330.0
2770,Bromophenol Blue,O=S1(=O)OC(c2cc(Br)c(O)c(Br)c2)(c2cc(Br)c(O)c(Br)c2)c2ccccc21,C19H10Br4O5S,14331.0
2771,THJ 018,CCCCCn1nc(C(=O)c2cccc3ccccc23)c2ccccc21,C23H22N2O,11962.0
2772,JWH 203 N-(5-hydroxypentyl) metabolite,O=C(Cc1ccccc1Cl)c1cn(CCCCCO)c2ccccc12,C21H22ClNO2,14228.0
2773,AM694 N-(5-hydroxypentyl) metabolite,O=C(c1ccccc1I)c1cn(CCCCCO)c2ccccc12,C20H20INO2,14358.0
2774,AM694 N-pentanoic acid metabolite,O=C(O)CCCCn1cc(C(=O)c2ccccc2I)c2ccccc21,C20H18INO3,14359.0
2775,5-fluoro PB-22 3-carboxyindole metabolite,O=C(O)c1cn(CCCCCF)c2ccccc12,C14H16FNO2,14381.0
2776,5-fluoro PB-22 3-carboxyindole metabolite (CRM),O=C(O)c1cn(CCCCCF)c2ccccc12,C14H16FNO2,26318.0
2777,UR-144 N-(5-methylhexyl) analog,CC(C)CCCCn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc21,C23H33NO,9001439.0
2778,2C-G (hydrochloride),COc1cc(CCN)c(OC)c(C)c1C.Cl,C12H20ClNO2,14064.0
2779,4-methoxy-.alpha.-Pyrrolidinopentiophenone (hydrochloride),CCCC(C(=O)c1ccc(OC)cc1)N1CCCC1.Cl,C16H24ClNO2,14097.0
2780,7-APB (hydrochloride),CC(N)Cc1cccc2ccoc12.Cl,C11H14ClNO,14282.0
2781,.delta.4-Dafachronic Acid,CC(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)O,C27H42O3,14100.0
2782,Coumarin Boronic Acid pinacolate ester,CC1(C)OB(c2ccc3ccc(=O)oc3c2)OC1(C)C,C15H17BO4,10818.0
2783,A-438079 (hydrochloride),Cl.Clc1cccc(-c2nnnn2Cc2cccnc2)c1Cl,C13H10Cl3N5,14580.0
2784,Coumarin Boronic Acid,O=c1ccc2ccc(B(O)O)cc2o1,C9H7BO4,14051.0
2785,PB-22 3-carboxyindole metabolite,CCCCCn1cc(C(=O)O)c2ccccc21,C14H17NO2,14385.0
2786,5-MAPDB (hydrochloride),CNC(C)Cc1ccc2c(c1)CCO2.Cl,C12H18ClNO,14111.0
2787,Bosutinib,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,C26H29Cl2N5O3,12030.0
2788,.delta.9-THC,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C21H30O2,12068.0
2789,?9-THC (solution),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C21H30O2,9003771.0
2790,?9-THC (Alt. Batch CRM),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C21H30O2,42138.0
2791,?9-THC (CRM),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C21H30O2,43003.0
2792,MAM2201 N-(5-chloropentyl) analog,Cc1ccc(C(=O)c2cn(CCCCCCl)c3ccccc23)c2ccccc12,C25H24ClNO,13103.0
2793,Cidofovir,Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1,C8H14N3O6P,13113.0
2794,NVP-231,O=C(Nc1nc2ccc(NC(=O)C34CC5CC(CC(C5)C3)C4)cc2s1)c1ccccc1,C25H25N3O2S,13858.0
2795,Alexidine (hydrochloride),CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC.Cl.Cl,C26H58Cl2N10,13876.0
2796,UNC1215,O=C(c1ccc(C(=O)N2CCC(N3CCCC3)CC2)c(Nc2ccccc2)c1)N1CCC(N2CCCC2)CC1,C32H43N5O2,13968.0
2797,Propylthiouracil,CCCc1cc(=O)[nH]c(=S)[nH]1,C7H10N2OS,14069.0
2798,L-Thyroxine,N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,C15H11I4NO4,14116.0
2799,Clofarabine,Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F,C10H11ClFN5O3,14125.0
2800,Fludarabine,Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,C10H12FN5O4,14128.0
2801,Daunorubicin (hydrochloride),COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,C27H30ClNO10,14159.0
2802,Memantine (hydrochloride),CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl,C12H22ClN,14184.0
2803,Chrysomycin A,C=Cc1cc(OC)c2c(c1)c(=O)oc1c2cc(OC)c2c(O)ccc(C3O[C@@H](C)[C@@H](O)[C@](C)(O)[C@@H]3O)c21,C28H28O9,14188.0
2804,Chrysomycin B,COc1cc2c(oc(=O)c3cc(C)cc(OC)c32)c2c(C3OC(C)C(O)C(C)(O)C3O)ccc(O)c12,C27H28O9,14189.0
2805,Gilvocarcin V,C=Cc1cc(OC)c2c(c1)c(=O)oc1c2cc(OC)c2c(O)ccc([C@H]3O[C@@H]([C@@H](C)O)[C@H](O)[C@H]3O)c21,C27H26O9,14190.0
2806,UR-144 N-heptyl analog,CCCCCCCn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc21,C23H33NO,14231.0
2807,Ruthenium Red,N.N.N.N.N.N.N.N.N.N.N.N.N.N.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Ru+2]O[Ru+2]O[Ru+2],Cl6H42N14O2Ru3,14339.0
2808,Asperlactone,C[C@H](O)[C@H]1C=C([C@@H]2O[C@H]2C)C(=O)O1,C9H12O4,14435.0
2809,Borrelidin,C[C@@H]1C[C@H](C)C[C@H](C)[C@@H](O)CC(=O)O[C@H]([C@@H]2CCC[C@H]2C(=O)O)C/C=C/C=C(/C#N)[C@H](O)[C@@H](C)C1,C28H43NO6,14436.0
2810,Chetomin,CN1C(=O)[C@]2(Cc3cn([C@]45C[C@@]67SS[C@@](CO)(C(=O)N6[C@H]4Nc4ccccc45)N(C)C7=O)c4ccccc34)SS[C@@]1(CO)C(=O)N2C,C31H30N6O6S4,14437.0
2811,"1,5-Isoquinolinediol",O=c1[nH]ccc2c(O)cccc12,C9H7NO2,14438.0
2812,Obscurolide A1,CC(O)/C=C/C1OC(=O)CC1Nc1ccc(C(=O)O)cc1,C15H17NO5,14439.0
2813,PJ-34,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,C17H17N3O2,14440.0
2814,Pseurotin A,CC/C=C\[C@H](O)[C@H](O)C1=C(C)C(=O)[C@]2(O1)C(=O)N[C@@](OC)(C(=O)c1ccccc1)[C@@H]2O,C22H25NO8,14441.0
2815,DPQ,O=C1NCCc2c(OCCCCN3CCCCC3)cccc21,C18H26N2O2,14450.0
2816,Miglitol,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,C8H17NO5,15014.0
2817,PF-04418948,COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1,C23H20FNO5,15016.0
2818,PCPr (hydrochloride),CCCNC1(c2ccccc2)CCCCC1.Cl,C15H24ClN,9001362.0
2819,JWH 018 N-pentanoic acid ?-D-Glucuronide,O=C(CCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,C30H29NO9,10957.0
2820,Suramin (sodium salt),Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)[O-])c5cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c45)ccc3C)c2)c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],C51H34N6Na6O23S6,11126.0
2821,(+)-MK-801 (hydrogen maleate),C[C@]12N[C@H](Cc3ccccc31)c1ccccc12.O=C(O)/C=C\C(=O)O,C20H19NO4,10009019.0
2822,Venlafaxine (hydrochloride),COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1.Cl,C17H28ClNO2,11567.0
2823,Venlafaxine (hydrochloride) (CRM),COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1.Cl,C17H28ClNO2,25524.0
2824,AP-18,CC(=C\c1ccc(Cl)cc1)/C(C)=N/O,C11H12ClNO,11912.0
2825,Dorsomorphin,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,C24H25N5O,11967.0
2826,Cinnabarinic Acid,Nc1c(C(=O)O)c2nc3c(C(=O)O)cccc3oc-2cc1=O,C14H8N2O6,11988.0
2827,Rottlerin,CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O,C30H28O8,12006.0
2828,8-CPT-Cyclic AMP (sodium salt),Nc1ncnc2c1nc(Sc1ccc(Cl)cc1)n2[C@@H]1O[C@@H]2COP(=O)([O-])O[C@H]2[C@H]1O.[Na+],C16H14ClN5NaO6PS,12011.0
2829,Acetildenafil,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(C(=O)CN4CCN(CC)CC4)ccc3OCC)nc12,C25H34N6O3,12049.0
2830,NF449 (sodium salt),O=C(Nc1cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2S(=O)(=O)[O-])cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2S(=O)(=O)[O-])c1)Nc1cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2S(=O)(=O)[O-])cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2S(=O)(=O)[O-])c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],C41H24N6Na8O29S8,13324.0
2831,25G-NBOMe (hydrochloride),COc1ccccc1CNCCc1cc(OC)c(C)c(C)c1OC.Cl,C20H28ClNO3,14065.0
2832,Idarubicin (hydrochloride),CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O.Cl,C26H28ClNO9,14176.0
2833,5-Fluorouracil,O=c1[nH]cc(F)c(=O)[nH]1,C4H3FN2O2,14416.0
2834,Fluoxetine (hydrochloride),CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1.Cl,C17H19ClF3NO,14418.0
2835,Fluoxetine (hydrochloride) (CRM),CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1.Cl,C17H19ClF3NO,32720.0
2836,Doxycycline Hyclate,CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O,C46H58Cl2N4O18,14422.0
2837,Darifenacin (hydrobromide),Br.NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1,C28H31BrN2O2,14424.0
2838,Teniposide,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,C32H32O13S,14425.0
2839,Cordycepin,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)C[C@H]1O,C10H13N5O3,14426.0
2840,Melatonin,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,C13H16N2O2,14427.0
2841,Melatonin (CRM),COc1ccc2[nH]cc(CCNC(C)=O)c2c1,C13H16N2O2,42564.0
2842,8-bromo Cyclic AMP (sodium salt),Nc1ncnc2c1nc(Br)n2[C@@H]1O[C@@H]2COP(=O)([O-])O[C@H]2[C@H]1O.[Na+],C10H10BrN5NaO6P,14431.0
2843,Phloretin,O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O,C15H14O5,14452.0
2844,TBB,Brc1c(Br)c(Br)c2[nH]nnc2c1Br,C6HBr4N3,14453.0
2845,Ac-DEVD-pNA,CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)Nc1ccc([N+](=O)[O-])cc1)C(=O)O)C(C)C,C26H34N6O13,14460.0
2846,AAF-CMK (trifluoroacetate salt),C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)CCl.O=C(O)C(F)(F)F,C18H23ClF3N3O5,14461.0
2847,Gossypol,Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,C30H30O8,14482.0
2848,"L-Buthionine-(S,R)-Sulfoximine",CCCCS(=N)(=O)CC[C@H](N)C(=O)O,C8H18N2O3S,14484.0
2849,Pyronin Y,CN(C)c1ccc2cc3ccc(=[N+](C)C)cc-3oc2c1.[Cl-],C17H19ClN2O,14488.0
2850,Adenosine 5'-triphosphate (sodium salt),Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)([O-])OP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+].[Na+],C10H14N5Na2O13P3,14498.0
2851,Adenosine 5'-triphosphate (sodium salt) (solution),Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)([O-])OP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+].[Na+],C10H14N5Na2O13P3,40182.0
2852,Coomassie Blue R-250,CCOc1ccc(Nc2ccc(C(=C3C=CC(=[N+](CC)Cc4cccc(S(=O)(=O)[O-])c4)C=C3)c3ccc(N(CC)Cc4cccc(S(=O)(=O)[O-])c4)cc3)cc2)cc1.[Na+],C45H44N3NaO7S2,14500.0
2853,Virginiamycin Complex,CC1=C\[C@@H](O)CC(=O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)O[C@H](C(C)C)[C@H](C)/C=C/C(=O)NC/C=C\1.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O,C71H84N10O17,14503.0
2854,AG-1295,Cc1cc2ncc(-c3ccccc3)nc2cc1C,C16H14N2,14529.0
2855,Apafant,Cc1nnc2n1-c1sc(CCC(=O)N3CCOCC3)cc1C(c1ccccc1Cl)=NC2,C22H22ClN5O2S,14532.0
2856,25T-NBOMe (hydrochloride),COc1cc(SC)c(OC)cc1CCNCc1ccccc1OC.Cl,C19H26ClNO3S,14562.0
2857,Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,C21H26N2O7,14573.0
2858,4-DAMP,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-],C21H26INO2,14574.0
2859,1-EBIO,CCn1c(=O)[nH]c2ccccc21,C9H10N2O,14575.0
2860,NMDA,CN[C@H](CC(=O)O)C(=O)O,C5H9NO4,14581.0
2861,XE 991 (hydrochloride),Cl.Cl.O=C1c2ccccc2C(Cc2ccncc2)(Cc2ccncc2)c2ccccc21,C26H22Cl2N2O,14582.0
2862,hydroxy Bupropion,CC1NC(C)(C)COC1(O)c1cccc(Cl)c1,C13H18ClNO2,9000522.0
2863,OAC1,O=C(Nc1cc2cc[nH]c2cn1)c1ccccc1,C14H11N3O,14102.0
2864,JWH 203 N-(4-hydroxypentyl) metabolite,CC(O)CCCn1cc(C(=O)Cc2ccccc2Cl)c2ccccc21,C21H22ClNO2,14227.0
2865,BB-22 3-carboxyindole metabolite,O=C(O)c1cn(CC2CCCCC2)c2ccccc12,C16H19NO2,14378.0
2866,PB-22 N-(4-hydroxypentyl)-3-carboxyindole metabolite,CC(O)CCCn1cc(C(=O)O)c2ccccc21,C14H17NO3,14563.0
2867,PB-22 N-(5-hydroxypentyl)-3-carboxyindole metabolite,O=C(O)c1cn(CCCCCO)c2ccccc12,C14H17NO3,14564.0
2868,PB-22 N-pentanoic acid-3-carboxyindole metabolite,O=C(O)CCCCn1cc(C(=O)O)c2ccccc21,C14H15NO4,14565.0
2869,Citalopram (hydrobromide),Br.CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,C20H22BrFN2O,14572.0
2870,Citalopram (hydrobromide) (CRM),Br.CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,C20H22BrFN2O,23253.0
2871,DNQX,O=c1[nH]c2cc([N+](=O)[O-])c([N+](=O)[O-])cc2[nH]c1=O,C8H4N4O6,14583.0
2872,Ibotenic Acid,NC(C(=O)O)c1cc(=O)[nH]o1,C5H6N2O4,14584.0
2873,Ibotenic Acid (CRM),NC(C(=O)O)c1cc(=O)[nH]o1,C5H6N2O4,38029.0
2874,SR 95531 (hydrobromide),Br.COc1ccc(-c2ccc(=N)n(CCCC(=O)O)n2)cc1,C15H18BrN3O3,14585.0
2875,9-cis Retinoic Acid,CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1,C20H28O2,14587.0
2876,PF-670462 (hydrochloride),Cl.Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1,C19H22Cl2FN5,14588.0
2877,Cantharidin,C[C@@]12C(=O)OC(=O)[C@]1(C)[C@H]1CC[C@@H]2O1,C10H12O4,14589.0
2878,Stattic,O=[N+]([O-])c1ccc2c(c1)S(=O)(=O)C=C2,C8H5NO4S,14590.0
2879,Fura-2 AM,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1ccc(C)cc1OCCOc1cc2cc(-c3ncc(C(=O)OCOC(C)=O)o3)oc2cc1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O,C44H47N3O24,14591.0
2880,Calpeptin,CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,C20H30N2O4,14593.0
2881,Tobramycin,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,C18H37N5O9,14596.0
2882,Honokiol,C=CCc1ccc(O)c(-c2ccc(O)c(CC=C)c2)c1,C18H18O2,14597.0
2883,Bromocriptine (mesylate),CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O,C33H44BrN5O8S,14598.0
2884,WAY-100635 (maleate),COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1.O=C(O)/C=C\C(=O)O,C29H38N4O6,14599.0
2885,Mecamylamine (hydrochloride),CNC1(C)C2CCC(C2)C1(C)C.Cl,C11H22ClN,14602.0
2886,(-)-Epicatechin Gallate,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1,C22H18O10,11808.0
2887,A-836339,COCCn1c(C)c(C)s/c1=N\C(=O)C1C(C)(C)C1(C)C,C16H26N2O2S,13898.0
2888,BB-22 3-hydroxyquinoline isomer,O=C(Oc1cnc2ccccc2c1)c1cn(CC2CCCCC2)c2ccccc12,C25H24N2O2,14505.0
2889,Cilostamide,CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1,C20H26N2O3,14455.0
2890,JWH 203 N-(4-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)Cc1ccccc1Cl)c([2H])n2CCCC(C)O,C21H22ClNO2,14367.0
2891,N-Acetylserotonin,CC(=O)NCCc1c[nH]c2ccc(O)cc12,C12H14N2O2,14535.0
2892,N-Acetylserotonin,CC(=O)NCCc1c[nH]c2ccc(O)cc12,C12H14N2O2,33681.0
2893,"WIN 18,446",O=C(NCCCCCCCCNC(=O)C(Cl)Cl)C(Cl)Cl,C12H20Cl4N2O2,14018.0
2894,3'-fluoro-.alpha.-Pyrrolidinopropiophenone (hydrochloride),CC(C(=O)c1cccc(F)c1)N1CCCC1.Cl,C13H17ClFNO,14447.0
2895,BB-22 4-hydroxyquinoline isomer,O=C(Oc1ccnc2ccccc12)c1cn(CC2CCCCC2)c2ccccc12,C25H24N2O2,14506.0
2896,FAK Inhibitor 14,Cl.Cl.Cl.Cl.Nc1cc(N)c(N)cc1N,C6H14Cl4N4,14485.0
2897,Sumatriptan (succinate),CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1.O=C(O)CCC(=O)O,C18H27N3O6S,14600.0
2898,TCEP (hydrochloride),Cl.O=C(O)CCP(CCC(=O)O)CCC(=O)O,C9H16ClO6P,14329.0
2899,Flavopiridol (hydrochloride),CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1.Cl,C21H21Cl2NO5,10009197.0
2900,17-phenyl trinor Prostaglandin F2.alpha. methyl amide,CNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C24H35NO4,10010351.0
2901,Cytochalasin D,C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)C23C(OC(C)=O)/C=C/C(C)(O)C(=O)[C@@H](C)C/C=C/[C@H]3[C@@H]1O,C30H37NO6,11330.0
2902,CI-1040,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,C17H14ClF2IN2O2,11580.0
2903,UR-144 N-(4-chloropentyl) analog,CC(Cl)CCCn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc21,C21H28ClNO,13117.0
2904,MBDB (hydrochloride),CCC(Cc1ccc2c(c1)OCO2)NC.Cl,C12H18ClNO2,14218.0
2905,JWH 203 N-pentanoic acid metabolite,O=C(O)CCCCn1cc(C(=O)Cc2ccccc2Cl)c2ccccc21,C21H20ClNO3,14229.0
2906,Thiazovivin,O=C(NCc1ccccc1)c1csc(Nc2ccncn2)n1,C15H13N5OS,14245.0
2907,4-APB (hydrochloride),CC(N)Cc1cccc2occc12.Cl,C11H14ClNO,14281.0
2908,S3I-201,Cc1ccc(S(=O)(=O)OCC(=O)Nc2ccc(C(=O)O)c(O)c2)cc1,C16H15NO7S,14336.0
2909,JWH 203 N-(5-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)Cc1ccccc1Cl)c([2H])n2CCCCCO,C21H22ClNO2,14368.0
2910,JWH 203 N-pentanoic acid metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)Cc1ccccc1Cl)c([2H])n2CCCCC(=O)O,C21H20ClNO3,14369.0
2911,UR-144 N-(5-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)C1C(C)(C)C1(C)C)c([2H])n2CCCCCO,C21H29NO2,14375.0
2912,UR-144 N-pentanoic acid metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)C1C(C)(C)C1(C)C)c([2H])n2CCCCC(=O)O,C21H27NO3,14376.0
2913,PB-22 N-(4-hydroxypentyl) metabolite,CC(O)CCCn1cc(C(=O)Oc2cccc3cccnc23)c2ccccc21,C23H22N2O3,14386.0
2914,PB-22 N-(5-hydroxypentyl) metabolite,O=C(Oc1cccc2cccnc12)c1cn(CCCCCO)c2ccccc12,C23H22N2O3,14387.0
2915,PB-22 N-pentanoic acid metabolite,O=C(O)CCCCn1cc(C(=O)Oc2cccc3cccnc23)c2ccccc21,C23H20N2O4,14389.0
2916,Bucladesine (sodium salt),CCCC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)([O-])O[C@H]2[C@H]1OC(=O)CCC.[Na+],C18H23N5NaO8P,14408.0
2917,HA-1100 (hydrochloride),Cl.O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1,C14H18ClN3O3S,14413.0
2918,Calpain Inhibitor XII,CCCC(NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1)C(=O)C(=O)NCc1ccccn1,C26H34N4O5,14466.0
2919,UR-144 N-(2-hydroxypentyl) metabolite,CCCC(O)Cn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc21,C21H29NO2,14470.0
2920,(+)-Pilocarpine (hydrochloride),CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C.Cl,C11H17ClN2O2,14487.0
2921,BB-22 5-hydroxyquinoline isomer,O=C(Oc1cccc2ncccc12)c1cn(CC2CCCCC2)c2ccccc12,C25H24N2O2,14507.0
2922,BB-22 6-hydroxyquinoline isomer,O=C(Oc1ccc2ncccc2c1)c1cn(CC2CCCCC2)c2ccccc12,C25H24N2O2,14508.0
2923,PB-22 3-hydroxyquinoline isomer,CCCCCn1cc(C(=O)Oc2cnc3ccccc3c2)c2ccccc21,C23H22N2O2,14516.0
2924,PB-22 4-hydroxyquinoline isomer,CCCCCn1cc(C(=O)Oc2ccnc3ccccc23)c2ccccc21,C23H22N2O2,14517.0
2925,PB-22 6-hydroxyquinoline isomer,CCCCCn1cc(C(=O)Oc2ccc3ncccc3c2)c2ccccc21,C23H22N2O2,14519.0
2926,PB-22 7-hydroxyquinoline isomer,CCCCCn1cc(C(=O)Oc2ccc3cccnc3c2)c2ccccc21,C23H22N2O2,14521.0
2927,NU 1025,Cc1nc2c(O)cccc2c(=O)[nH]1,C9H8N2O2,14534.0
2928,BB-22 4-hydroxyisoquinoline isomer,O=C(Oc1cncc2ccccc12)c1cn(CC2CCCCC2)c2ccccc12,C25H24N2O2,14541.0
2929,BB-22 6-hydroxyisoquinoline isomer,O=C(Oc1ccc2cnccc2c1)c1cn(CC2CCCCC2)c2ccccc12,C25H24N2O2,14543.0
2930,PB-22 6-hydroxyisoquinoline isomer,CCCCCn1cc(C(=O)Oc2ccc3cnccc3c2)c2ccccc21,C23H22N2O2,14556.0
2931,PB-22 7-hydroxyisoquinoline isomer,CCCCCn1cc(C(=O)Oc2ccc3ccncc3c2)c2ccccc21,C23H22N2O2,14557.0
2932,Meclizine (hydrochloride),Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1.Cl,C25H28Cl2N2,14615.0
2933,DMXAA,Cc1ccc2c(=O)c3cccc(CC(=O)O)c3oc2c1C,C17H14O4,14617.0
2934,AGI-5198,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,C27H31FN4O2,14624.0
2935,Dexrazoxane,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,C11H16N4O4,14632.0
2936,SCH 79797 (hydrochloride),CC(C)c1ccc(Cn2ccc3c4c(N)nc(NC5CC5)nc4ccc32)cc1.Cl.Cl,C23H27Cl2N5,14633.0
2937,Ginkgolide B,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)C36C(OC(=O)[C@@H]6O)O[C@@]4(C(=O)O5)[C@@]12O,C20H24O10,14636.0
2938,Clemastine fumarate,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1.O=C(O)/C=C/C(=O)O,C25H30ClNO5,14637.0
2939,Maraviroc,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,C29H41F2N5O,14641.0
2940,JWH 018 N-propanoic acid metabolite,O=C(O)CCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C22H17NO3,14646.0
2941,(-)-Indolactam V,CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C,C17H23N3O2,14647.0
2942,Aloesin,CC(=O)Cc1cc(=O)c2c(C)cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c2o1,C19H22O9,14649.0
2943,.alpha.-Ethyltryptamine,CCC(N)Cc1c[nH]c2ccccc12,C12H16N2,14653.0
2944,.alpha.-Ethyltryptamine (exempt preparation),CCC(N)Cc1c[nH]c2ccccc12,C12H16N2,15671.0
2945,L-Ascorbic Acid,O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,C6H8O6,14656.0
2946,UR-144 degradant N-pentanoic acid metabolite,C=C(C)C(C)(C)CC(=O)c1cn(CCCCC(=O)O)c2ccccc12,C21H27NO3,9001453.0
2947,Cycloheximide,C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)C1,C15H23NO4,14126.0
2948,Methylone (hydrochloride),CNC(C)C(=O)c1ccc2c(c1)OCO2.Cl,C11H14ClNO3,10986.0
2949,Methylone (hydrochloride) (CRM),CNC(C)C(=O)c1ccc2c(c1)OCO2.Cl,C11H14ClNO3,20891.0
2950,FTY720 Phosphate,CCCCCCCCc1ccc(CCC([NH3+])(CO)COP(=O)([O-])O)cc1,C19H34NO5P,10008639.0
2951,JWH 019 N-(6-hydroxyhexyl) .beta.-D-Glucuronide,O=C(c1cccc2ccccc12)c1cn(CCCCCCO[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)c2ccccc12,C31H33NO8,11466.0
2952,(-)-Epicatechin,Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,C15H14O6,11807.0
2953,IWP-2,Cc1ccc2nc(NC(=O)CSc3nc4c(c(=O)n3-c3ccccc3)SCC4)sc2c1,C22H18N4O2S3,13951.0
2954,IWP-2-V2,Cc1ccc2nc(NC(=O)CSc3nc4c(c(=O)n3Cc3ccccc3)SCC4)sc2c1,C23H20N4O2S3,13952.0
2955,IWP-3,Cc1ccc2nc(NC(=O)CSc3nc4c(c(=O)n3-c3ccc(F)cc3)SCC4)sc2c1,C22H17FN4O2S3,13953.0
2956,IWP-4,COc1ccccc1-n1c(SCC(=O)Nc2nc3ccc(C)cc3s2)nc2c(c1=O)SCC2,C23H20N4O3S3,13954.0
2957,DL-Cathinone (hydrochloride),CC(N)C(=O)c1ccccc1.Cl,C9H12ClNO,14138.0
2958,DL-Cathinone (hydrochloride) (exempt preparation),CC(N)C(=O)c1ccccc1.Cl,C9H12ClNO,15654.0
2959,D-Amphetamine (hydrochloride),C[C@H](N)Cc1ccccc1.Cl,C9H14ClN,14204.0
2960,AKB48 N-(5-hydroxypentyl) metabolite,O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(CCCCCO)c2ccccc12,C23H31N3O2,14223.0
2961,JWH 146,CCCCCCCn1cc(C(=O)c2cccc3ccccc23)cc1-c1ccccc1,C28H29NO,14232.0
2962,RCS-4 4-hydroxyphenyl metabolite,CCCCCn1cc(C(=O)c2ccc(O)cc2)c2ccccc21,C20H21NO2,14345.0
2963,JWH 081 4-hydroxynaphthyl metabolite,CCCCCn1cc(C(=O)c2ccc(O)c3ccccc23)c2ccccc21,C24H23NO2,14347.0
2964,"(S)-3,5-DHPG",N[C@H](C(=O)O)c1cc(O)cc(O)c1,C8H9NO4,14411.0
2965,LE 135,CN1c2cc3c(cc2N=C(c2ccc(C(=O)O)cc2)c2ccccc21)C(C)(C)CCC3(C)C,C29H30N2O2,14415.0
2966,Calmidazolium (chloride),Clc1ccc(C(c2ccc(Cl)cc2)n2cc[n+](CC(OCc3ccc(Cl)cc3Cl)c3ccc(Cl)cc3Cl)c2)cc1.[Cl-],C31H23Cl7N2O,14442.0
2967,5-fluoro PB-22 4-hydroxyquinoline isomer,O=C(Oc1ccnc2ccccc12)c1cn(CCCCCF)c2ccccc12,C23H21FN2O2,14512.0
2968,5-fluoro PB-22 5-hydroxyquinoline isomer,O=C(Oc1cccc2ncccc12)c1cn(CCCCCF)c2ccccc12,C23H21FN2O2,14513.0
2969,5-fluoro PB-22 7-hydroxyquinoline isomer,O=C(Oc1ccc2cccnc2c1)c1cn(CCCCCF)c2ccccc12,C23H21FN2O2,14515.0
2970,BB-22 7-hydroxyisoquinoline isomer,O=C(Oc1ccc2ccncc2c1)c1cn(CC2CCCCC2)c2ccccc12,C25H24N2O2,14544.0
2971,5-fluoro PB-22 N-(4-fluoropentyl) isomer,CC(F)CCCn1cc(C(=O)Oc2cccc3cccnc23)c2ccccc21,C23H21FN2O2,14548.0
2972,PB-22 5-hydroxyisoquinoline isomer,CCCCCn1cc(C(=O)Oc2cccc3cnccc23)c2ccccc21,C23H22N2O2,14555.0
2973,PB-22 8-hydroxyisoquinoline isomer,CCCCCn1cc(C(=O)Oc2cccc3ccncc23)c2ccccc21,C23H22N2O2,14558.0
2974,Iberiotoxin (trifluoroacetate salt),[H]N[C@](Cc1ccccc1)(C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC1=O)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N3)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCSC)NC2=O)C(C)C)[C@@H](C)O)C(=O)C1CCC(=O)N1,C179H274N50O55S7,14608.0
2975,7-dehydro Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H44O,14612.0
2976,DBZ,C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@@H]1C(=O)N(C)c2ccccc2-c2ccccc21,C26H23F2N3O3,14627.0
2977,Bumetanide,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,C17H20N2O5S,14630.0
2978,Zaltoprofen,CC(C(=O)O)c1ccc2c(c1)CC(=O)c1ccccc1S2,C17H14O3S,14662.0
2979,Xanthorrhizol,CC(C)=CCC[C@@H](C)c1ccc(C)c(O)c1,C15H22O,14668.0
2980,methyl-1-(cyclohexylmethyl)-1H-indole-3-Carboxylate,COC(=O)c1cn(CC2CCCCC2)c2ccccc12,C17H21NO2,14674.0
2981,methyl-1-(5-fluoropentyl)-1H-indole-3-Carboxylate,COC(=O)c1cn(CCCCCF)c2ccccc12,C15H18FNO2,14675.0
2982,methyl-1-pentyl-1H-indole-3-Carboxylate,CCCCCn1cc(C(=O)OC)c2ccccc21,C15H19NO2,14676.0
2983,AKB48-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1nc(C(=O)NC23CC4CC(CC(C4)C2)C3)c2ccccc21,C23H31N3O,14677.0
2984,Oxandrolone,C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C19H30O3,9001819.0
2985,Levetiracetam,CC[C@@H](C(N)=O)N1CCCC1=O,C8H14N2O2,9001820.0
2986,Nat-20(S)-yne,C#CCC[C@](C)(O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,C25H38O2,9001369.0
2987,Sodium 4-Phenylbutyrate,O=C([O-])CCCc1ccccc1.[Na+],C10H11NaO2,11323.0
2988,Fluconazole,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,C13H12F2N6O,11594.0
2989,2-Fluoroisocathinone (hydrochloride),CC(=O)C(N)c1ccccc1F.Cl,C9H11ClFNO,11607.0
2990,LDN193189,c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1,C25H22N6,11802.0
2991,Gallic Acid,O=C(O)c1cc(O)c(O)c(O)c1,C7H6O5,11846.0
2992,Tubacin,O=C(CCCCCCC(=O)Nc1ccc([C@H]2O[C@@H](CSc3nc(-c4ccccc4)c(-c4ccccc4)o3)C[C@@H](c3ccc(CO)cc3)O2)cc1)NO,C41H43N3O7S,13691.0
2993,Ingenol,CC1=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1O)[C@H]1[C@@H](C[C@H]3C)C1(C)C,C20H28O5,14031.0
2994,STK393606,N#Cc1ccccc1CSc1nc2cc(Br)c[nH]c-2n1,C14H9BrN4S,14049.0
2995,NRG-3 (hydrochloride),CCCC(NC)C(=O)c1ccc2ccccc2c1.Cl,C16H20ClNO,14115.0
2996,AKB48 N-pentanoic acid metabolite,O=C(O)CCCCn1nc(C(=O)NC23CC4CC(CC(C4)C2)C3)c2ccccc21,C23H29N3O3,14224.0
2997,Verapamil (hydrochloride),COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC.Cl,C27H39ClN2O4,14288.0
2998,n-Octylglucoside,CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C14H28O6,14327.0
2999,JWH 398 N-(5-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1ccc(Cl)c3ccccc13)c([2H])n2CCCCCO,C24H22ClNO2,14371.0
3000,JWH 398 N-pentanoic acid metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1ccc(Cl)c3ccccc13)c([2H])n2CCCCC(=O)O,C24H20ClNO3,14372.0
3001,UR-144 N-(4-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)C1C(C)(C)C1(C)C)c([2H])n2CCCC(C)O,C21H29NO2,14374.0
3002,Z-VAD(OH)-FMK,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)CF,C21H28FN3O7,14467.0
3003,5-fluoro PB-22 5-hydroxyisoquinoline isomer,O=C(Oc1cccc2cnccc12)c1cn(CCCCCF)c2ccccc12,C23H21FN2O2,14550.0
3004,5-fluoro PB-22 6-hydroxyisoquinoline isomer,O=C(Oc1ccc2cnccc2c1)c1cn(CCCCCF)c2ccccc12,C23H21FN2O2,14551.0
3005,5-fluoro PB-22 8-hydroxyisoquinoline isomer,O=C(Oc1cccc2ccncc12)c1cn(CCCCCF)c2ccccc12,C23H21FN2O2,14553.0
3006,Dorzolamide (hydrochloride),CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21.Cl,C10H17ClN2O4S3,14616.0
3007,CNQX,N#Cc1cc2[nH]c(=O)c(=O)[nH]c2cc1[N+](=O)[O-],C9H4N4O4,14618.0
3008,Amisulpride,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,C17H27N3O4S,14619.0
3009,Citicoline (sodium salt),C[N+](C)(C)CCOP(=O)([O-])OP(=O)([O-])OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O.[Na+],C14H25N4NaO11P2,14629.0
3010,Gly-Phe-.beta.-naphthylamide,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1ccc2ccccc2c1,C21H21N3O2,14634.0
3011,AGI-6780,O=C(Nc1cccc(C(F)(F)F)c1)Nc1cc(S(=O)(=O)NC2CC2)ccc1-c1ccsc1,C21H18F3N3O3S2,14639.0
3012,Lonidamine,O=C(O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12,C15H10Cl2N2O2,14640.0
3013,Myoseverin,COc1ccc(CNc2nc(NCc3ccc(OC)cc3)c3ncn(C(C)C)c3n2)cc1,C24H28N6O2,14642.0
3014,Lenalidomide,Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,C13H13N3O3,14643.0
3015,G-15,Brc1cc2c(cc1[C@@H]1Nc3ccccc3[C@@H]3C=CC[C@@H]31)OCO2,C19H16BrNO2,14673.0
3016,D-Luciferin (potassium salt),O=C([O-])[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1.[K+],C11H7KN2O3S2,14681.0
3017,D-Luciferin (sodium salt),O=C([O-])[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1.[Na+],C11H7N2NaO3S2,14682.0
3018,TG101209,Cc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,C26H35N7O2S,14696.0
3019,FSLLRY-amide,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,C39H60N10O8,14709.0
3020,Dimethyl fumarate,COC(=O)/C=C/C(=O)OC,C6H8O4,14714.0
3021,AMG 9810,CC(C)(C)c1ccc(/C=C/C(=O)Nc2ccc3c(c2)OCCO3)cc1,C21H23NO3,14715.0
3022,NNEI 2'-naphthyl isomer,CCCCCn1cc(C(=O)Nc2ccc3ccccc3c2)c2ccccc21,C24H24N2O,14738.0
3023,Abacavir (sulfate),Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1.O=S(=O)(O)O,C14H20N6O5S,14746.0
3024,Letrozole,N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,C17H11N5,11568.0
3025,Leupeptin (hemisulfate),CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCNC(=N)N.CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCNC(=N)N.O=S(=O)(O)O,C40H78N12O12S,14026.0
3026,4-hydroxy-3-Methoxyamphetamine (hydrochloride),COc1cc(CC(C)N)ccc1O.Cl,C10H16ClNO2,14196.0
3027,MAM2201 N-pentanoic acid metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1ccc(C)c3ccccc13)c([2H])n2CCCCC(=O)O,C25H23NO3,14366.0
3028,I-CBP112 (hydrochloride),CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OC[C@H]2CCCN(C)C2)C1.Cl,C27H37ClN2O5,14468.0
3029,Philanthotoxin 74 (hydrochloride),CCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCCCCCCNCCCCN.Cl.Cl,C24H44Cl2N4O3,14607.0
3030,Thalidomide,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,C13H10N2O4,14610.0
3031,TAPI-2,CC(C)CC(CC(=O)NO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCCN)C(C)(C)C,C19H37N5O5,14695.0
3032,Aprotinin,[H]N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CSSC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H]3CCCN3C(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CCCN3C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N2,C284H434N84O79S7,14716.0
3033,AMPK activator,O=C(O)c1ccc(CCCc2ccc(OCCc3ccc(F)cc3)cc2)o1,C22H21FO4,14741.0
3034,IPA-3,Oc1ccc2ccccc2c1SSc1c(O)ccc2ccccc12,C20H14O2S2,14759.0
3035,L-Sulforaphane,C[S@@](=O)CCCCN=C=S,C6H11NOS2,14797.0
3036,Microcystin-LA,C=C1C(=O)N[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(=O)O)[C@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](/C=C/C(C)=C/[C@H](C)[C@H](Cc2ccccc2)OC)[C@H](C)C(=O)N[C@@H](C(=O)O)CCC(=O)N1C,C46H67N7O12,10007187.0
3037,Microcystin-RR,C=C1C(=O)N[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)O)[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](/C=C/C(C)=C/[C@H](C)[C@H](Cc2ccccc2)OC)[C@H](C)C(=O)N[C@@H](C(=O)O)CCC(=O)N1C,C49H75N13O12,10007868.0
3038,Celecoxib,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,C17H14F3N3O2S,10008672.0
3039,Ku-0063794,COc1ccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@@H](C)O[C@@H](C)C4)nc3n2)cc1CO,C25H31N5O4,13597.0
3040,KC7F2,O=S(=O)(NCCSSCCNS(=O)(=O)c1cc(Cl)ccc1Cl)c1cc(Cl)ccc1Cl,C16H16Cl4N2O4S4,14123.0
3041,Tanshinone IIA,Cc1coc2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C,C19H18O3,14323.0
3042,AM694 N-pentanoic acid metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1ccccc1I)c([2H])n2CCCCC(=O)O,C20H18INO3,14373.0
3043,(S)-10-hydroxy-Camptothecin,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(O)ccc3nc2-1,C20H16N2O5,14635.0
3044,Cysmethynil,CCCCCCCCn1cc(CC(N)=O)c2cc(-c3cccc(C)c3)ccc21,C25H32N2O,14745.0
3045,Cucurbitacin I,CC(C)(O)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C=C(O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C,C30H42O7,14747.0
3046,Shikonin,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,C16H16O5,14751.0
3047,Gambogic Acid,CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(CC=C(C)C)c2O1)O[C@]12C(=C[C@@H]4C[C@H]1C(C)(C)O[C@@]2(C/C=C(/C)C(=O)O)C4=O)C3=O,C38H44O8,14761.0
3048,SU 9516,COc1ccc2c(c1)/C(=C/c1c[nH]cn1)C(=O)N2,C13H11N3O2,14796.0
3049,1'-Naphthoyl-2-methylindole,Cc1[nH]c2ccccc2c1C(=O)c1cccc2ccccc12,C20H15NO,14801.0
3050,MN-25-2-methyl derivative,COc1cccc2c(C(=O)N[C@@H]3C(C)(C)[C@@H]4CC[C@@]3(C)C4)c(C)n(CCN3CCOCC3)c12,C27H39N3O3,9001455.0
3051,Butylone-d3 (hydrochloride),Cl.[2H]C([2H])([2H])NC(CC)C(=O)c1ccc2c(c1)OCO2,C12H16ClNO3,9001826.0
3052,Butylone-d3 (hydrochloride) (exempt preparation),Cl.[2H]C([2H])([2H])NC(CC)C(=O)c1ccc2c(c1)OCO2,C12H16ClNO3,22880.0
3053,Butylone-d3 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])NC(CC)C(=O)c1ccc2c(c1)OCO2,C12H16ClNO3,28819.0
3054,MBZP (hydrochloride),CN1CCN(Cc2ccccc2)CC1.Cl,C12H19ClN2,11736.0
3055,Epirubicin (hydrochloride),COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1.Cl,C27H30ClNO11,12091.0
3056,Phenylpiracetam,NC(=O)CN1CC(c2ccccc2)CC1=O,C12H14N2O2,13897.0
3057,MT-45 (hydrochloride),Cl.Cl.c1ccc(CC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1,C24H34Cl2N2,14082.0
3058,MT-45 (hydrochloride) (exempt preparation),Cl.Cl.c1ccc(CC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1,C24H34Cl2N2,39314.0
3059,AKB48 N-(4-hydroxypentyl) metabolite,CC(O)CCCn1nc(C(=O)NC23CC4CC(CC(C4)C2)C3)c2ccccc21,C23H31N3O2,14221.0
3060,5-fluoro AKB48 N-(4-hydroxypentyl) metabolite,O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(CCCC(O)CF)c2ccccc12,C23H30FN3O2,14222.0
3061,JWH 019 N-(5-hydroxyhexyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1cccc3ccccc13)c([2H])n2CCCCC(C)O,C25H25NO2,14687.0
3062,25I-NBOMe 3-methoxy isomer (hydrochloride),COc1cccc(CNCCc2cc(OC)c(I)cc2OC)c1.Cl,C18H23ClINO3,14784.0
3063,25I-NBOMe 4-methoxy isomer (hydrochloride),COc1ccc(CNCCc2cc(OC)c(I)cc2OC)cc1.Cl,C18H23ClINO3,14785.0
3064,ALK5 Inhibitor II,Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1,C17H13N5,14794.0
3065,R-848,CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O,C17H22N4O2,14806.0
3066,JWH 019 N-(5-hydroxyhexyl) metabolite,CC(O)CCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C25H25NO2,14814.0
3067,Ibudilast,CC(C)C(=O)c1c(C(C)C)nn2ccccc12,C14H18N2O,14832.0
3068,Akt Inhibitor X,CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21.Cl,C20H26Cl2N2O,14863.0
3069,Sertraline (hydrochloride),CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21.Cl,C17H18Cl3N,14839.0
3070,Sertraline (hydrochloride) (CRM),CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21.Cl,C17H18Cl3N,40158.0
3071,4-Aminobenzoic Acid hydrazide,NNC(=O)c1ccc(N)cc1,C7H9N3O,14845.0
3072,SU11274,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1,C28H30ClN5O4S,14861.0
3073,PS-1145,O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1,C17H11ClN4O,14862.0
3074,"4(Z),7(Z),10(Z),13(Z)-Hexadecatetraenoic Acid-d5",[2H]C([2H])([2H])C([2H])([2H])/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C16H24O2,14894.0
3075,L-(+)-Ergothioneine,C[N+](C)(C)[C@@H](Cc1c[nH]c(=S)[nH]1)C(=O)[O-],C9H15N3O2S,14905.0
3076,NSC 87877,O=S(=O)(O)c1ccc2cc(/N=N/c3cc(S(=O)(=O)O)c4cccnc4c3O)ccc2c1,C19H13N3O7S2,14908.0
3077,Cilostazol,O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,C20H27N5O2,15035.0
3078,Propylhexedrine (hydrochloride),CNC(C)CC1CCCCC1.Cl,C10H22ClN,12058.0
3079,5-fluoro PB-22 N-(3-fluoropentyl) isomer,CCC(F)CCn1cc(C(=O)Oc2cccc3cccnc23)c2ccccc21,C23H21FN2O2,14547.0
3080,JFD00244,O=C1c2ccccc2C(=O)c2c(NCCc3ccc(O)cc3)ccc(NCCc3ccc(O)cc3)c21,C30H26N2O4,14648.0
3081,Sophorose,OC[C@H]1O[C@@H](O[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,C12H22O11,14717.0
3082,"1',4""-Sophorolactone 6',6""-diacetate",CC(=O)OC[C@H]1O[C@H]2O[C@@H](C)CCCCCC/C=C/CCCCCCCC(=O)O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H](O)[C@@H]1O)O[C@@H]3COC(C)=O,C34H56O14,14718.0
3083,Butyryl fentanyl (hydrochloride),CCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O,14728.0
3084,Butyryl fentanyl (hydrochloride) (CRM),CCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O,19734.0
3085,Costunolide,C=C1C(=O)O[C@@H]2/C=C(\C)CC/C=C(\C)CC[C@@H]12,C15H20O2,14743.0
3086,CAY10677,CCCCCCCCn1cc(CN(CC)CC)c2cc(-c3cnc(N)nc3)ccc21,C25H37N5,14744.0
3087,Cyclic Pifithrin-.alpha. (hydrobromide),Br.Cc1ccc(-c2cn3c4c(sc3n2)CCCC4)cc1,C16H17BrN2S,14748.0
3088,Fusidic Acid (sodium salt),CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(/CCC=C(C)C)C(=O)[O-].[Na+],C31H47NaO6,14825.0
3089,Ceftazidime (hydrate),CC(C)(O/N=C(\C(=O)NC1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CSC12)c1csc(N)n1)C(=O)O.O.O.O.O.O,C22H32N6O12S2,14828.0
3090,Moxifloxacin (hydrochloride),COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12.Cl,C21H25ClFN3O4,14830.0
3091,AG-1024,CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O,C14H13BrN2O,14833.0
3092,Azaserine,[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O,C5H7N3O4,14834.0
3093,Gemfibrozil,Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1,C15H22O3,14835.0
3094,Nafamostat (mesylate),CS(=O)(=O)O.CS(=O)(=O)O.N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1,C21H25N5O8S2,14837.0
3095,Amlodipine,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,C20H25ClN2O5,14838.0
3096,ADBICA,CCCCCn1cc(C(=O)NC(C(N)=O)C(C)(C)C)c2ccccc21,C20H29N3O2,14293.0
3097,"2,4-Pyridinedicarboxylic Acid (hydrate)",O.O=C(O)c1ccnc(C(=O)O)c1,C7H7NO5,11138.0
3098,Prasugrel,CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2,C20H20FNO3S,14278.0
3099,5-fluoro ADB-PINACA,CC(C)(C)C(NC(=O)c1nn(CCCCCF)c2ccccc12)C(N)=O,C19H27FN4O2,14764.0
3100,5-fluoro ADBICA,CC(C)(C)C(NC(=O)c1cn(CCCCCF)c2ccccc12)C(N)=O,C20H28FN3O2,14766.0
3101,W-7 (hydrochloride),Cl.NCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12,C16H22Cl2N2O2S,14826.0
3102,Mitoxantrone (hydrochloride),Cl.Cl.O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,C22H30Cl2N4O6,14842.0
3103,Busulfan,CS(=O)(=O)OCCCCOS(C)(=O)=O,C6H14O6S2,14843.0
3104,Leflunomide,Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1,C12H9F3N2O2,14860.0
3105,Pentostatin,OC[C@H]1O[C@@H](n2cnc3c2NC=NC[C@H]3O)C[C@@H]1O,C11H16N4O4,14878.0
3106,PD 153035 (hydrochloride),COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC.Cl,C16H15BrClN3O2,14879.0
3107,Nitracaine,CCN(CC)CC(C)(C)COC(=O)c1ccc([N+](=O)[O-])cc1,C16H24N2O4,14900.0
3108,Pepstatin A,CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C,C34H63N5O9,9000469.0
3109,Oleic Acid-d17,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])/C=C\CCCCCCCC(=O)O,C18H34O2,9000432.0
3110,DC4 Crosslinker,O=C(CCC[N+]12CC[N+](CCCC(=O)ON3C(=O)CCC3=O)(CC1)CC2)ON1C(=O)CCC1=O.[Br-].[Br-],C22H32Br2N4O8,14734.0
3111,DPPH,O=[N+]([O-])c1cc([N+](=O)[O-])c([N]N(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1,C18H12N5O6,14805.0
3112,Levamisole (hydrochloride),Cl.c1ccc([C@H]2CN3CCSC3=N2)cc1,C11H13ClN2S,14874.0
3113,(-)-Levamisole (hydrochloride) (CRM),Cl.c1ccc([C@H]2CN3CCSC3=N2)cc1,C11H13ClN2S,21321.0
3114,Omeprazole,COc1ccc2[nH]c(S(=O)Cc3ncc(C)c(OC)c3C)nc2c1,C17H19N3O3S,14880.0
3115,Spermidine,NCCCCNCCCN,C7H19N3,14918.0
3116,Calpain Inhibitor I,CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O,C20H37N3O4,14921.0
3117,Fluvastatin,CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,C24H26FNO4,10010334.0
3118,Salicylcurcumin,O=C(/C=C(O)/C=C/c1ccccc1O)/C=C/c1ccccc1O,C19H16O4,11878.0
3119,ADB-FUBINACA,CC(C)(C)C(NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(N)=O,C21H23FN4O2,14292.0
3120,ADB-FUBINACA (exempt preparation),CC(C)(C)C(NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(N)=O,C21H23FN4O2,41647.0
3121,Fostriecin (sodium salt),C[C@@](O)(/C=C/[C@H]1CC=CC(=O)O1)[C@@H](C[C@@H](O)/C=C\C=C/C=C/CO)OP(=O)([O-])O.[Na+],C19H26NaO9P,14749.0
3122,25(R)-27-hydroxy Cholesterol,C[C@@H](CO)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O2,14790.0
3123,25(S)-27-hydroxy Cholesterol,C[C@H](CO)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O2,14791.0
3124,Loperamide (hydrochloride),CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1.Cl,C29H34Cl2N2O2,14875.0
3125,NU 7441,O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,C25H19NO3S,14881.0
3126,N-methyl-2-AI (hydrochloride),CNC1Cc2ccccc2C1.Cl,C10H14ClN,14897.0
3127,Arctigenin,COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O,C21H24O6,14913.0
3128,NBQX (sodium salt),NS(=O)(=O)c1cccc2c1c([N+](=O)[O-])cc1nc([O-])c([O-])nc12.[Na+].[Na+],C12H6N4Na2O6S,14914.0
3129,Oxymatrine,O=C1CCC[C@@H]2[C@H]3CCC[N+]4([O-])CCC[C@@H](CN12)[C@@H]34,C15H24N2O2,14915.0
3130,XTT (sodium salt hydrate),COc1cc([N+](=O)[O-])c(S(=O)(=O)[O-])cc1-n1nc(C(=O)Nc2ccccc2)n[n+]1-c1cc(S(=O)(=O)[O-])c([N+](=O)[O-])cc1OC.O.[Na+],C22H16N7NaO13S2(H2O)X,14919.0
3131,MTEP (hydrochloride),Cc1nc(C#Cc2cccnc2)cs1.Cl,C11H9ClN2S,14961.0
3132,Ryanodine,CC(C)[C@@]1(O)[C@@H](OC(=O)c2ccc[nH]2)[C@@]2(O)[C@@]3(C)C[C@]4(O)O[C@@]5([C@H](O)[C@@H](C)CC[C@]35O)[C@@]2(O)[C@]14C,C25H35NO9,14962.0
3133,Tetrodotoxin (citrate free),NC1=N[C@H](O)[C@H]2[C@H]3O[C@]4(O)O[C@@H](C(O)[C@@]2(N1)[C@@H]4O)[C@]3(O)CO,C11H17N3O8,14963.0
3134,Tetrodotoxin (citrate),NC1=N[C@H](O)[C@H]2[C@H]3O[C@]4(O)O[C@@H](C(O)[C@@]2(N1)[C@@H]4O)[C@]3(O)CO.O=C(O)CC(O)(CC(=O)O)C(=O)O,C17H25N3O15,14964.0
3135,RCS-8 3-methoxy isomer,COc1cccc(CC(=O)c2cn(CCC3CCCCC3)c3ccccc23)c1,C25H29NO2,10864.0
3136,RCS-8 4-methoxy isomer,COc1ccc(CC(=O)c2cn(CCC3CCCCC3)c3ccccc23)cc1,C25H29NO2,10863.0
3137,"3,4-Methylenedioxy-5-methylethcathinone (hydrochloride)",CCNC(C)C(=O)c1cc(C)c2c(c1)OCO2.Cl,C13H18ClNO3,14078.0
3138,JWH 081 N-(4-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1ccc(OC)c3ccccc13)c([2H])n2CCCC(C)O,C25H25NO3,14360.0
3139,RCS-4 N-(4-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1ccc(OC)cc1)c([2H])n2CCCC(C)O,C21H23NO3,14363.0
3140,RCS-4 N-(5-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1ccc(OC)cc1)c([2H])n2CCCCCO,C21H23NO3,14364.0
3141,RCS-4 N-pentanoic acid metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1ccc(OC)cc1)c([2H])n2CCCCC(=O)O,C21H21NO4,14365.0
3142,5-fluoro PB-22 N-(2-fluoropentyl) isomer,CCCC(F)Cn1cc(C(=O)Oc2cccc3cccnc23)c2ccccc21,C23H21FN2O2,14546.0
3143,Stearoyl Ethanolamide-d3,[2H]C([2H])([2H])CCCCCCCCCCCCCCCCC(=O)NCCO,C20H41NO2,14726.0
3144,Cyanidin chloride,Oc1cc(O)c2cc(O)c(-c3ccc(O)c(O)c3)[o+]c2c1.[Cl-],C15H11ClO6,14803.0
3145,.alpha.-Truxillic Acid,O=C(O)[C@H]1[C@H](c2ccccc2)[C@H](C(=O)O)[C@H]1c1ccccc1,C18H16O4,14865.0
3146,AM2201 8-quinolinyl carboxamide,O=C(Nc1cccc2cccnc12)c1cn(CCCCCF)c2ccccc12,C23H22FN3O,14892.0
3147,Protocatechuic Acid,O=C(O)c1ccc(O)c(O)c1,C7H6O4,14916.0
3148,Finasteride,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,C23H36N2O2,14938.0
3149,Rabeprazole (sodium salt),COCCCOc1ccnc(CS(=O)c2nc3ccccc3[n-]2)c1C.[Na+],C18H20N3NaO3S,14939.0
3150,Quinolinic Acid,O=C(O)c1cccnc1C(=O)O,C7H5NO4,14941.0
3151,Fluo-3-Acetoxymethyl ester,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1ccc(C)cc1OCCOc1cc(-c2c3cc(Cl)c(=O)cc-3oc3cc(OCOC(C)=O)c(Cl)cc23)ccc1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O,C51H50Cl2N2O23,14960.0
3152,Fluo-3 AM,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1ccc(C)cc1OCCOc1cc(-c2c3cc(Cl)c(=O)cc-3oc3cc(OCOC(C)=O)c(Cl)cc23)ccc1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O,C51H50Cl2N2O23,14960.0
3153,Clenbuterol (hydrochloride),CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1.Cl,C12H19Cl3N2O,14985.0
3154,Clenbuterol (hydrochloride),CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1.Cl,C12H19Cl3N2O,26293.0
3155,(S)-Mephenytoin,CC[C@@]1(c2ccccc2)NC(=O)N(C)C1=O,C12H14N2O2,11913.0
3156,Fatostatin (hydrobromide),Br.CCCc1cc(-c2nc(-c3ccc(C)cc3)cs2)ccn1,C18H19BrN2S,13562.0
3157,CFDA-SE,CC(=O)Oc1ccc2c(c1)Oc1cc(OC(C)=O)ccc1C21OC(=O)c2cc(C(=O)ON3C(=O)CCC3=O)ccc21,C29H19NO11,14456.0
3158,GW 6471,CCC(=O)NC[C@H](Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)cc1)N/C(C)=C\C(=O)c1ccc(C(F)(F)F)cc1,C35H36F3N3O4,11697.0
3159,"3,4-Methylenedioxy Pyrovalerone metabolite 2 (hydrochloride)",CCCC(C(=O)c1ccc(O)c(O)c1)N1CCCC1.Cl,C15H22ClNO3,12004.0
3160,5-fluoro THJ,O=C(Nc1cccc2cccnc12)c1nn(CCCCCF)c2ccccc12,C22H21FN4O,14890.0
3161,R-(-)-Deprenyl (hydrochloride),C#CCN(C)[C@H](C)Cc1ccccc1.Cl,C13H18ClN,15046.0
3162,Wiskostatin,CN(C)CC(O)Cn1c2ccc(Br)cc2c2cc(Br)ccc21,C17H18Br2N2O,15047.0
3163,Dibutyl-3-Hydroxybutyl Phosphate,CCCCOP(=O)(OCCCC)OCCC(C)O,C12H27O5P,9001825.0
3164,Octanoyl-DL-carnitine (chloride),CCCCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C.[Cl-],C15H30ClNO4,15048.0
3165,Xestospongin C,C1CCC[C@H]2CCCN3CC[C@@H](CCCCCC[C@@H]4CCCN5CC[C@@H](CC1)O[C@@H]45)O[C@@H]23,C28H50N2O2,64950.0
3166,BAPTA,O=C(O)CN(CC(=O)O)c1ccccc1OCCOc1ccccc1N(CC(=O)O)CC(=O)O,C22H24N2O10,11706.0
3167,MN-25,COc1cccc2c(C(=O)N[C@@H]3C(C)(C)[C@@H]4CC[C@@]3(C)C4)cn(CCN3CCOCC3)c12,C26H37N3O3,14249.0
3168,Rifampicin,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,C43H58N4O12,14423.0
3169,"4(Z),7(Z),10(Z),13(Z),16(Z)-N-(2-hydroxyethyl)-Docosapentaenamide",CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCO,C24H39NO2,14723.0
3170,Docosapentaenoyl Ethanolamide,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NCCO,C24H39NO2,14724.0
3171,ML-297,Cc1cc(NC(=O)Nc2ccc(F)c(F)c2)n(-c2ccccc2)n1,C17H14F2N4O,14792.0
3172,THJ,CCCCCn1nc(C(=O)Nc2cccc3cccnc23)c2ccccc21,C22H22N4O,14889.0
3173,JWH 018 8-quinolinyl carboxamide,CCCCCn1cc(C(=O)Nc2cccc3cccnc23)c2ccccc21,C23H23N3O,14891.0
3174,XLR12,CC1(C)C(C(=O)c2cn(CCCC(F)(F)F)c3ccccc23)C1(C)C,C20H24F3NO,14935.0
3175,Imiquimod,CC(C)Cn1cnc2c(N)nc3ccccc3c21,C14H16N4,14956.0
3176,Adenosine 5'-(.gamma.-thio)-triphosphate (lithium salt),Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])OP([O-])([O-])=S)[C@@H](O)[C@H]1O.[Li+].[Li+].[Li+].[Li+],C10H12Li4N5O12P3S,14957.0
3177,Polygodial,CC1(C)CCC[C@]2(C)[C@@H](C=O)C(C=O)=CC[C@@H]12,C15H22O2,14979.0
3178,Probenecid,CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1,C13H19NO4S,14981.0
3179,PTIO,CC1(C)N([O])C(c2ccccc2)=[N+]([O-])C1(C)C,C13H17N2O2,14982.0
3180,Suc-AAPF-pNA,C[C@H](NC(=O)CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1,C30H36N6O9,14993.0
3181,Ondansetron (hydrochloride hydrate),Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O.Cl.O.O,C18H24ClN3O3,14999.0
3182,Mibefradil (hydrochloride),COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C.Cl.Cl,C29H40Cl2FN3O3,15037.0
3183,Thymoquinone,CC1=CC(=O)C(C(C)C)=CC1=O,C10H12O2,15039.0
3184,Ilimaquinone,C=C1CCC[C@H]2[C@](C)(CC3=C(O)C(=O)C=C(OC)C3=O)[C@@H](C)CC[C@]12C,C22H30O4,15124.0
3185,.alpha.-NETA,C[N+](C)(C)CCC(=O)c1ccc2ccccc2c1.[I-],C16H20INO,15125.0
3186,17(R)-Resolvin D1 methyl ester,CC/C=C\C[C@@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)C/C=C\CCC(=O)OC,C23H34O5,9001072.0
3187,Eicosapentaenoyl Ethanolamide-d4,[2H]C([2H])(O)C([2H])([2H])NC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC,C22H35NO2,9001835.0
3188,6.alpha.-hydroxy Paclitaxel,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1[C@@H](O)[C@@H]2O,C47H51NO15,10009027.0
3189,(S)-nitro-Blebbistatin,O=C1c2ccc([N+](=O)[O-])cc2N=C2N(c3ccccc3)CC[C@@]12O,C17H13N3O4,13891.0
3190,6-Formylpterin,Nc1nc2ncc(C=O)nc2c(=O)[nH]1,C7H5N5O2,14247.0
3191,XLR11 6-hydroxyindole metabolite,CC1(C)C(C(=O)c2cn(CCCCCF)c3cc(O)ccc23)C1(C)C,C21H28FNO2,14354.0
3192,Tetrahydroharmine,COc1ccc2c3c([nH]c2c1)C(C)NCC3,C13H16N2O,14449.0
3193,Pipradrol (hydrochloride),Cl.OC(c1ccccc1)(c1ccccc1)C1CCCCN1,C18H22ClNO,14783.0
3194,Debromohymenialdisine,NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]ccc32)N1,C11H11N5O2,14873.0
3195,"4-bromo-2,5-DMMA",CNC(C)Cc1cc(OC)c(Br)cc1OC,C12H18BrNO2,14788.0
3196,Rivastigmine (tartrate),CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.O=C(O)C(O)C(O)C(=O)O,C18H28N2O8,14270.0
3197,N-(p-amylcinnamoyl) Anthranilic Acid,CCCCCc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1,C21H23NO3,14531.0
3198,LY341495,N[C@](CC1c2ccccc2Oc2ccccc21)(C(=O)O)[C@H]1C[C@@H]1C(=O)O,C20H19NO5,14693.0
3199,25E-NBOMe (hydrochloride),CCc1cc(OC)c(CCNCc2ccccc2OC)cc1OC.Cl,C20H28ClNO3,14727.0
3200,PV8 (hydrochloride),CCCCCC(C(=O)c1ccccc1)N1CCCC1.Cl,C17H26ClNO,14762.0
3201,PV8 (hydrochloride) (exempt preparation),CCCCCC(C(=O)c1ccccc1)N1CCCC1.Cl,C17H26ClNO,35878.0
3202,Syk Inhibitor,Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21,C18H15N3O3S,14829.0
3203,Rasagiline,C#CCN[C@@H]1CCc2ccccc21,C12H13N,14917.0
3204,FUB-PB-22,O=C(Oc1cccc2cccnc12)c1cn(Cc2ccc(F)cc2)c2ccccc12,C25H17FN2O2,14949.0
3205,Digitonin,C[C@@H]1CC[C@@]2(OC1)O[C@H]1[C@@H](O)[C@H]3[C@@H]4CC[C@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C56H92O29,14952.0
3206,FDU-PB-22,O=C(Oc1cccc2ccccc12)c1cn(Cc2ccc(F)cc2)c2ccccc12,C26H18FNO2,14968.0
3207,Metyrapone,CC(C)(C(=O)c1cccnc1)c1cccnc1,C14H14N2O,14994.0
3208,Reboxetine (mesylate),CCOc1ccccc1OC(c1ccccc1)C1CNCCO1.CS(=O)(=O)O,C20H27NO6S,15038.0
3209,SKF 525A (hydrochloride),CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1.Cl,C23H32ClNO2,15040.0
3210,Probucol,CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1,C31H48O2S2,15043.0
3211,Monastrol,CCOC(=O)C1=C(C)NC(=S)NC1c1cccc(O)c1,C14H16N2O3S,15044.0
3212,Dofetilide,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,C19H27N3O5S2,15045.0
3213,AB-PINACA N-(5-hydroxypentyl) metabolite,CC(C)C(NC(=O)c1nn(CCCCCO)c2ccccc12)C(N)=O,C18H26N4O3,15050.0
3214,AB-PINACA-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1nc(C(=O)N[C@H](C(N)=O)C(C)C)c2ccccc21,C18H26N4O2,15057.0
3215,AB-PINACA-d9 (exempt preparation),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1nc(C(=O)N[C@H](C(N)=O)C(C)C)c2ccccc21,C18H26N4O2,22859.0
3216,PV9 (hydrochloride),CCCCCCC(C(=O)c1ccccc1)N1CCCC1.Cl,C18H28ClNO,15062.0
3217,Phosphoramidon (sodium salt),CC(C)C[C@H](NP(=O)(O)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.[NaH].[NaH],C23H34N3Na2O10P,15113.0
3218,Chymostatin,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C1CCNC(=N)N1)C(=O)N[C@H](C=O)Cc1ccccc1.CC(C)[C@H](NC(=O)[C@@H](NC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C1CCNC(=N)N1)C(=O)N[C@H](C=O)Cc1ccccc1.CCC(C)[C@H](NC(=O)[C@@H](NC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C1CCNC(=N)N1)C(=O)N[C@H](C=O)Cc1ccccc1,C92H121N21O18,15114.0
3219,"2,5-DMMA",CNC(C)Cc1cc(OC)ccc1OC,C12H19NO2,15131.0
3220,Ro 3306,O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1,C18H13N3OS2,15149.0
3221,Resolvin D2 methyl ester,CC/C=C\C[C@H](O)[C@H](O)/C=C/C=C/C=C\C=C\[C@@H](O)C/C=C\CCC(=O)OC,C23H34O5,9001497.0
3222,Dimethocaine (hydrochloride),CCN(CC)CC(C)(C)COC(=O)c1ccc(N)cc1.Cl,C16H27ClN2O2,11159.0
3223,Lapatinib,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,C29H26ClFN4O4S,11493.0
3224,Cediranib,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,C25H27FN4O3,11495.0
3225,Dasatinib,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,C22H26ClN7O2S,11498.0
3226,Atazanavir,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,C38H52N6O7,11733.0
3227,Lopinavir,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,C37H48N4O5,13854.0
3228,WDR5-0103,COC(=O)c1ccc(N2CCN(C)CC2)c(NC(=O)c2cccc(OC)c2)c1,C21H25N3O4,13945.0
3229,5-MAPB (hydrochloride),CNC(C)Cc1ccc2occc2c1.Cl,C12H16ClNO,14109.0
3230,BX-912,O=C(Nc1cccc(Nc2ncc(Br)c(NCCc3cnc[nH]3)n2)c1)N1CCCC1,C20H23BrN8O,14708.0
3231,Aprepitant,C[C@@H](O[C@H]1OCCN(Cc2nc(=O)[nH][nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,C23H21F7N4O3,14867.0
3232,Akt Inhibitor VIII,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,C34H29N7O,14870.0
3233,3C-P (hydrochloride),CCCOc1c(OC)cc(CC(C)N)cc1OC.Cl,C14H24ClNO3,14954.0
3234,"1,2-Dimyristoyl-sn-glycero-3-PC",CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,C36H72NO8P,15097.0
3235,1-Palmitoyl-2-Oleoyl-sn-glycero-3-PC,CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C42H82NO8P,15102.0
3236,Cholesterol Sulfate (sodium salt),CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C3CC=C4C[C@@H](OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@]12C.[Na+],C27H45NaO4S,15106.0
3237,TPCA-1,NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,C12H10FN3O2S,15115.0
3238,Vitexin,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc(O)c12,C21H20O10,15116.0
3239,Nevirapine,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,C15H14N4O,15117.0
3240,Oltipraz,Cc1c(-c2cnccn2)ssc1=S,C8H6N2S3,15118.0
3241,Ursodeoxycholic Acid (sodium salt),C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.[NaH],C24H39O4(Na)X,15121.0
3242,LCK Inhibitor,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,C23H22N4O,15135.0
3243,Z-Asp-CH2-DCB,O=C(O)C[C@H](NC(=O)OCc1ccccc1)C(=O)COC(=O)c1c(Cl)cccc1Cl,C20H17Cl2NO7,15143.0
3244,Indinavir (sulfate),CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O.O=S(=O)(O)O,C36H49N5O8S,15150.0
3245,phospho-LEA,CCCCC/C=C\C/C=C\CCCCCCCC(=O)NCCOP(=O)(O)O.[NaH].[NaH],C20H38NNa2O5P,9001837.0
3246,.alpha.-Linolenoyl Ethanolamide-d4,[2H]C([2H])(O)C([2H])([2H])NC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC,C20H35NO2,9001841.0
3247,AZD 6244,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,C17H15BrClFN4O3,11599.0
3248,Enzastaurin,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,C32H29N5O2,11601.0
3249,Betulinic Acid,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C30H48O3,11686.0
3250,Temozolomide,Cn1nnc2c(C(N)=O)ncn2c1=O,C6H6N6O2,14163.0
3251,Salubrinal,O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1cccc2cccnc12)C(Cl)(Cl)Cl,C21H17Cl3N4OS,14735.0
3252,5-fluoro AB-PINACA,CC(C)[C@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(N)=O,C18H25FN4O2,14755.0
3253,Lucigenin,C[n+]1c2ccccc2c(-c2c3ccccc3[n+](C)c3ccccc23)c2ccccc21.O=[N+]([O-])[O-].O=[N+]([O-])[O-],C28H22N4O6,14872.0
3254,TEMPONE,CC1(C)CC(=O)CC(C)(C)N1[O],C9H16NO2,14877.0
3255,MeOSuc-Ala-Ala-Pro-Val-AMC,COC(=O)CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)Nc1ccc2c(C)cc(=O)oc2c1)C(C)C,C31H41N5O9,14907.0
3256,MIF Antagonist,COC(=O)CC1CC(c2ccc(O)cc2)=NO1,C12H13NO4,14929.0
3257,CUR 61414,COc1cccc(CN(C(=O)CC(C)(C)C)[C@H]2C[C@@H](C(=O)N3CCNCC3)N(Cc3ccc4c(c3)OCO4)C2)c1,C31H42N4O5,14931.0
3258,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,C23H26IN7O2S,14932.0
3259,HA-100 (hydrochloride),Cl.Cl.O=S(=O)(c1cccc2cnccc12)N1CCNCC1,C13H17Cl2N3O2S,14955.0
3260,BMPO,CC(C)(C)OC(=O)C1(C)CCC=[N+]1[O-],C10H17NO3,14958.0
3261,Sp-cyclic AMPS (sodium salt),Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2CO[P@](=O)([S-])O[C@H]2[C@H]1O.[Na+],C10H11N5NaO5PS,14983.0
3262,Paroxetine (hydrochloride),Cl.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,C19H21ClFNO3,14998.0
3263,AB-PINACA N-pentanoic acid metabolite,CC(C)C(NC(=O)c1nn(CCCCC(=O)O)c2ccccc12)C(N)=O,C18H24N4O4,15051.0
3264,JWH 018 benzimidazole analog,CCCCCn1c(C(=O)c2cccc3ccccc23)nc2ccccc21,C23H22N2O,15074.0
3265,"1,2-Dipalmitoyl-sn-glycero-3-phospho-L-serine (sodium salt)",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OC[C@H]([NH3+])C(=O)[O-])OC(=O)CCCCCCCCCCCCCCC.[Na+],C38H73NNaO10P,15088.0
3266,"1,2-Dioleoyl-sn-glycero-3-PE",CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCC/C=C\CCCCCCCC,C41H78NO8P,15091.0
3267,Phosphatidylethanolamine (bovine),CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCC/C=C\CCCCCCCC,C41H78NO8P,16878.0
3268,"1,2-Dipalmitoyl-sn-glycero-3-PE",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCCCCCCCCCC,C37H74NO8P,15092.0
3269,"1,2-Diarachidoyl-sn-glycero-3-PC",CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC,C48H96NO8P,15096.0
3270,"1,2-Dioleoyl-sn-glycero-3-PC",CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC,C44H84NO8P,15098.0
3271,Phosphatidylcholine (bovine),CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC,C44H84NO8P,24370.0
3272,1-Palmitoyl-2-Lauroyl-sn-glycero-3-PC,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC,C36H72NO8P,15101.0
3273,1-Stearoyl-2-Myristoyl-sn-glycero-3-PC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,C40H80NO8P,15103.0
3274,Psoralidin,CC(C)=CCc1cc2c(cc1O)oc(=O)c1c3ccc(O)cc3oc21,C20H16O5,15119.0
3275,HQNO,CCCCCCCc1cc(O)c2ccccc2[n+]1[O-],C16H21NO2,15159.0
3276,Farnesyl Pyrophosphate (ammonium salt),CC(C)=CCC/C(C)=C/CC/C(C)=C/COP(=O)([O-])OP(=O)([O-])[O-].[NH4+].[NH4+].[NH4+],C15H37N3O7P2,63250.0
3277,Geranylgeranyl Pyrophosphate (ammonium salt),CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/COP(=O)([O-])OP(=O)([O-])[O-].[NH4+].[NH4+].[NH4+],C20H45N3O7P2,63330.0
3278,Olaparib,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,C24H23FN4O3,10621.0
3279,"1,2-Dilauroyl-sn-glycero-3-PC",CCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC,C32H64NO8P,11023.0
3280,BAY 41-2272,Nc1nc(-c2nn(Cc3ccccc3F)c3ncccc23)ncc1C1CC1,C20H17FN6,10057.0
3281,4-deoxy Nivalenol,CC1=C[C@H]2O[C@@H]3[C@H](O)C[C@](C)([C@@]2(CO)[C@H](O)C1=O)[C@]31CO1,C15H20O6,11428.0
3282,Afatinib,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,C24H25ClFN5O3,11492.0
3283,Obatoclax (mesylate),COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O,C21H23N3O4S,11499.0
3284,Panobinostat,Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1,C21H23N3O2,13280.0
3285,JWH 081 N-(4-hydroxypentyl) metabolite,COc1ccc(C(=O)c2cn(CCCC(C)O)c3ccccc23)c2ccccc12,C25H25NO3,14348.0
3286,JNJ-1661010,O=C(Nc1ccccc1)N1CCN(c2nc(-c3ccccc3)ns2)CC1,C19H19N5OS,14497.0
3287,JWH 081-N-(cyclohexylmethyl) analog,COc1ccc(C(=O)c2cn(CC3CCCCC3)c3ccccc23)c2ccccc12,C27H27NO2,14655.0
3288,Tegaserod (maleate),CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12.O=C(O)/C=C\C(=O)O,C20H27N5O5,14692.0
3289,Vildagliptin,N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,C17H25N3O2,14705.0
3290,WP1066,C[C@H](NC(=O)/C(C#N)=C/c1cccc(Br)n1)c1ccccc1,C17H14BrN3O,14736.0
3291,Posaconazole,CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,C37H42F2N8O4,14737.0
3292,5-fluoro MN-18,O=C(Nc1cccc2ccccc12)c1nn(CCCCCF)c2ccccc12,C23H22FN3O,14816.0
3293,MN-18,CCCCCn1nc(C(=O)Nc2cccc3ccccc23)c2ccccc21,C23H23N3O,14817.0
3294,Sulfaphenazole,Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1,C15H14N4O2S,14844.0
3295,Vatalanib (hydrochloride),Cl.Cl.Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,C20H17Cl3N4,14868.0
3296,KRN 633,CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl,C20H21ClN4O4,14871.0
3297,STA-21,C[C@@H]1CC(=O)c2c(ccc3c2C(=O)c2cccc(O)c2C3=O)C1,C19H14O4,14996.0
3298,"Neuropeptide Y (human, rat)",[H]N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC,C189H285N55O57S,15071.0
3299,"1,2-Dilauroyl-sn-glycerol",CCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCCCCC,C27H52O5,15076.0
3300,"1,2-Dimyristoyl-sn-glycerol",CCCCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCCCCCCC,C31H60O5,15077.0
3301,"1,2-Distearoyl-sn-glycerol",CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCCCCCCCCCCC,C39H76O5,15079.0
3302,"1,2-Dilauroyl-sn-glycero-3-PA (sodium salt)",CCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])O)OC(=O)CCCCCCCCCCC.[Na+],C27H52NaO8P,15080.0
3303,"1,2-Dimyristoyl-sn-glycero-3-PA (sodium salt)",CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])O)OC(=O)CCCCCCCCCCCCC.[Na+],C31H60NaO8P,15081.0
3304,"1,2-Dipalmitoyl-sn-glycero-3-PA (sodium salt)",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])O)OC(=O)CCCCCCCCCCCCCCC.[Na+],C35H68NaO8P,15082.0
3305,"1,2-Distearoyl-sn-glycero-3-PA (sodium salt)",CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])O)OC(=O)CCCCCCCCCCCCCCCCC.[Na+],C39H76NaO8P,15083.0
3306,"1,2-Dilauroyl-sn-glycero-3-PG (sodium salt)",CCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC(O)CO)OC(=O)CCCCCCCCCCC.[Na+],C30H58NaO10P,15084.0
3307,"1,2-Dimyristoyl-sn-glycero-3-PG (sodium salt)",CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC(O)CO)OC(=O)CCCCCCCCCCCCC.[Na+],C34H66NaO10P,15085.0
3308,"1,2-Dipalmitoyl-sn-glycero-3-PG (sodium salt)",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC.[NaH],C38H74O10P(Na)X,15086.0
3309,"1,2-Distearoyl-rac-glycero-3-PG (sodium salt)",CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCCCC.[NaH],C42H83O10P(Na)X,15087.0
3310,1-O-Octadecyl-2-O-methyl-sn-glycerol,CCCCCCCCCCCCCCCCCCOC[C@H](CO)OC,C22H46O3,15108.0
3311,"1,2-Distearoyl-sn-glycero-3-PC",CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,C44H88NO8P,15100.0
3312,"1,2-Distearoyl-sn-glycero-3-PC (solution)",CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,C44H88NO8P,39189.0
3313,1-Palmitoyl-2-Oleoyl-sn-glycero-3-PG (sodium salt),CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC(O)CO.[Na+],C40H76NaO10P,15105.0
3314,1-Stearoyl-2-hydroxy-sn-glycero-3-PC,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C26H54NO7P,15107.0
3315,Zinpyr-1,O=C([O-])c1ccccc1-c1c2cc(Cl)c(=O)c(C[NH+](Cc3ccccn3)Cc3ccccn3)c-2oc2c(C[NH+](Cc3ccccn3)Cc3ccccn3)c([O-])c(Cl)cc12,C46H36Cl2N6O5,15122.0
3316,Nelfinavir (mesylate),CS(=O)(=O)O.Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,C33H49N3O7S2,15144.0
3317,Antalarmin (hydrochloride),CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C.Cl,C24H35ClN4,15147.0
3318,Abiraterone Acetate,CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccnc4)=CC[C@@H]32)C1,C26H33NO2,15148.0
3319,Pentacosanoic Acid,CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O,C25H50O2,15197.0
3320,FCCP,N#CC(C#N)=NNc1ccc(OC(F)(F)F)cc1,C10H5F3N4O,15218.0
3321,"N-acetyl-3,4-Methylenedioxymethcathinone",CC(=O)N(C)C(C)C(=O)c1ccc2c(c1)OCO2,C13H15NO4,9001492.0
3322,4-hydroxy Amphetamine (hydrochloride),CC(N)Cc1ccc(O)cc1.Cl,C9H14ClNO,9001830.0
3323,"9-oxo-10(E),12(E)-Octadecadienoic Acid",CCCCC/C=C/C=C/C(=O)CCCCCCCC(=O)O,C18H30O3,10685.0
3324,CID-2745687,COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)NC(C)(C)C,C17H19F2N5O2S,12046.0
3325,PX 866,C=CCN(/C=C1\C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C,C29H35NO8,13645.0
3326,Cathine,C[C@H](N)[C@@H](O)c1ccccc1,C9H13NO,13868.0
3327,ML-265,Cn1c2cc(S(C)=O)sc2c2cnn(Cc3cccc(N)c3)c(=O)c21,C17H16N4O2S2,13942.0
3328,JWH 081 N-pentanoic acid metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1ccc(OC)c3ccccc13)c([2H])n2CCCCC(=O)O,C25H23NO4,14362.0
3329,G-36,CC(C)c1ccc2c(c1)[C@@H]1C=CC[C@@H]1[C@H](c1cc3c(cc1Br)OCO3)N2,C22H22BrNO2,14397.0
3330,Zoledronic Acid (hydrate),O.O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,C5H12N2O8P2,14984.0
3331,"1,2-Dilauroyl-sn-glycero-3-PE",CCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCCCCCC,C29H58NO8P,15089.0
3332,"1,2-Dimyristoyl-sn-glycero-3-PE",CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCCCCCCCC,C33H66NO8P,15090.0
3333,"1,3-Dipalmitoyl glycero-2-PE",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OP(=O)([O-])OCC[NH3+],C37H74NO8P,15093.0
3334,"1,2-Diphytanoyl-sn-glycero-3-PE",CC(C)CCCC(C)CCCC(C)CCCC(C)CC(=O)OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CC(C)CCCC(C)CCCC(C)CCCC(C)C,C45H90NO8P,15094.0
3335,"1,2-Distearoyl-sn-glycero-3-PE",CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC,C41H82NO8P,15095.0
3336,"1,2-Dioleyloxy-3-dimethylamino-propane",CCCCCCCC/C=C\CCCCCCCCOCC(CN(C)C)OCCCCCCCC/C=C\CCCCCCCC,C41H81NO2,15109.0
3337,"1,2-Dioleoyl-3-trimethylammoniumpropane (chloride)",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC.[Cl-],C42H80ClNO4,15110.0
3338,Zanamivir,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1NC(=N)N,C12H20N4O7,15123.0
3339,Ro 61-8048,COc1ccc(S(=O)(=O)Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1OC,C17H15N3O6S2,15199.0
3340,Myristicin,C=CCc1cc(OC)c2c(c1)OCO2,C11H12O3,15201.0
3341,113559-13-0,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl,C21H29Cl2N3O3S,15203.0
3342,MoTP,Oc1ccc(SCCCCN2CCOCC2)cc1,C14H21NO2S,15204.0
3343,MNS,O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2,C9H7NO4,15206.0
3344,16.alpha.-hydroxy Estrone,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)C2=O,C18H22O3,15208.0
3345,19-hydroxy Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(CO)[C@H]3CC[C@]12C,C27H46O2,15209.0
3346,MLN4924,NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O,C21H25N5O4S,15217.0
3347,Dovitinib,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,C21H21FN6O,15220.0
3348,ID-8,COc1ccc(-n2c(C)c([N+](=O)[O-])c3ccc(O)cc32)cc1,C16H14N2O4,15222.0
3349,P005091,CC(=O)c1cc([N+](=O)[O-])c(Sc2cccc(Cl)c2Cl)s1,C12H7Cl2NO3S2,15224.0
3350,Z-L-Phe-CMK,O=C(N[C@@H](Cc1ccccc1)C(=O)CCl)OCc1ccccc1,C18H18ClNO3,15225.0
3351,WP1130,CCC[C@H](NC(=O)/C(C#N)=C/c1cccc(Br)n1)c1ccccc1,C19H18BrN3O,15227.0
3352,Q-VD-OPH,CC(C)[C@H](NC(=O)c1ccc2ccccc2n1)C(=O)N[C@@H](CC(=O)O)C(=O)COc1c(F)cccc1F,C26H25F2N3O6,15260.0
3353,JK 184,CCOc1ccc(Nc2nc(-c3c(C)nc4ccccn34)cs2)cc1,C19H18N4OS,15265.0
3354,Prostaglandin E1 ethyl ester,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OCC,C22H38O5,9001730.0
3355,ML-031,Cc1cc(C(=O)CN2C(=O)CCC2=O)c(C)n1Cc1ccccc1,C19H20N2O3,15171.0
3356,ML-097,O=C(O)c1ccccc1OCc1ccccc1Br,C14H11BrO3,15174.0
3357,ML-180,O=c1cc(N2CCN(c3cccc(Cl)c3)CC2)[nH]c(=O)n1C1CCCCC1,C20H25ClN4O2,15181.0
3358,ADBICA N-pentanoic acid metabolite,CC(C)(C)C(NC(=O)c1cn(CCCCC(=O)O)c2ccccc12)C(N)=O,C20H27N3O4,15061.0
3359,496775-95-2,O=C(O)c1cccnc1SCCc1ccccc1,C14H13NO2S,15176.0
3360,ML-161,CCCC(=O)Nc1cccc(NC(=O)c2ccccc2Br)c1,C17H17BrN2O2,15179.0
3361,ML-191,Cc1ccc(C2(C(=O)N3CCC(n4nc(-c5ccccc5)oc4=O)CC3)CC2)cc1,C24H25N3O3,15182.0
3362,ML-261,CCOc1ccc(CCNC(=O)c2cc3sc(Cl)cc3n2C)cc1OCC,C20H23ClN2O3S,15192.0
3363,ML-335,CCOC(=O)C1(CCc2ccccc2)CCN(Cc2ccc(NC(C)=O)cc2)CC1,C25H32N2O3,15196.0
3364,VU590 (hydrochloride),Cl.Cl.O=[N+]([O-])c1ccc(CN2CCOCCOCCN(Cc3ccc([N+](=O)[O-])cc3)CCOCC2)cc1,C24H34Cl2N4O7,15177.0
3365,2-hexyl-4-Pentynoic Acid,C#CCC(CCCCCC)C(=O)O,C11H18O2,15205.0
3366,ML-213,Cc1cc(C)c(NC(=O)C2CC3CCC2C3)c(C)c1,C17H23NO,15185.0
3367,ML-216,O=C(Nc1ccc(F)c(C(F)(F)F)c1)Nc1nnc(-c2ccncc2)s1,C15H9F4N5OS,15186.0
3368,ADB-PINACA-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1nc(C(=O)NC(C(N)=O)C(C)(C)C)c2ccccc21,C19H28N4O2,15112.0
3369,ADB-PINACA-d9 (exempt preparation),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1nc(C(=O)NC(C(N)=O)C(C)(C)C)c2ccccc21,C19H28N4O2,42069.0
3370,ADB-PINACA pentanoic acid metabolite,CC(C)(C)C(NC(=O)c1nn(CCCCC(=O)O)c2ccccc12)C(N)=O,C19H26N4O4,15055.0
3371,CID-1067700,CC1(C)Cc2c(sc(NC(=S)NC(=O)c3ccccc3)c2C(=O)O)CO1,C18H18N2O4S2,15194.0
3372,CID-2858522,Cc1cc2nc(NCCCO)n(CC(=O)c3cc(C(C)(C)C)c(O)c(C(C)(C)C)c3)c2cc1C,C28H39N3O3,14122.0
3373,CYM 5541,O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCCCC1,C19H28N2O2,15190.0
3374,KY 02111,COc1ccc(CCC(=O)Nc2nc3ccc(Cl)cc3s2)cc1OC,C18H17ClN2O3S,14315.0
3375,ML-030,COc1ccc(OC)c(-c2nnc3n2N=C(c2ccc(OC)c(OC)c2)CS3)c1,C20H20N4O4S,15169.0
3376,ML-098,Cc1ccc(C)c(OCCn2cc(C(=O)O)c3ccccc32)c1,C19H19NO3,15175.0
3377,ML-239,O=C(COc1c(Cl)cc(Cl)cc1Cl)N/N=C/c1ccc[nH]1,C13H10Cl3N3O2,15188.0
3378,ML-243,CCc1ccc(/C=C/C(=O)NC2=NCCS2)cc1,C14H16N2OS,15189.0
3379,ML-277,COc1ccc(-c2csc(NC(=O)[C@H]3CCCCN3S(=O)(=O)c3ccc(C)cc3)n2)cc1,C23H25N3O4S2,15193.0
3380,ML-289,COc1ccc(C#Cc2ccc(C(=O)N3CCC[C@@H](CO)C3)cc2)cc1,C22H23NO3,15195.0
3381,5-fluoro AB-PINACA N-(4-hydroxypentyl) metabolite,CC(C)C(NC(=O)c1nn(CCCC(O)CF)c2ccccc12)C(N)=O,C18H25FN4O3,15052.0
3382,ADB-PINACA N-(4-hydroxypentyl) metabolite,CC(O)CCCn1nc(C(=O)NC(C(N)=O)C(C)(C)C)c2ccccc21,C19H28N4O3,15053.0
3383,SR 1824,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Br)cc3)cc12,C33H29BrN2O3,11087.0
3384,Saracatinib,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,C27H32ClN5O5,11497.0
3385,Enzalutamide,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,C21H16F4N4O2S,11596.0
3386,GDC 0941,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,C23H27N7O3S2,11600.0
3387,Tandutinib,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,C31H42N6O4,12098.0
3388,IDE1,O=C(O)CCCCCC(=O)N/N=C/c1ccccc1C(=O)O,C15H18N2O5,13816.0
3389,IDE2,O=C(O)CCCCCC(=O)NN=C1CCCC1,C12H20N2O3,13817.0
3390,Valganciclovir (hydrochloride),CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)nc(N)[nH]c21.Cl,C14H23ClN6O5,13875.0
3391,CYM 50308,COCC/N=C1\S/C(=C\c2cc(C)n(-c3ccc(F)cc3F)c2C)C(=O)N1C,C20H21F2N3O2S,14667.0
3392,Dinaciclib,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,C21H28N6O2,14707.0
3393,2C-B-BZP (hydrochloride),COc1cc(CN2CCNCC2)c(OC)cc1Br.Cl.Cl,C13H21BrCl2N2O2,14793.0
3394,Vardenafil (hydrochloride hydrate),CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12.Cl.O.O.O,C23H39ClN6O7S,14930.0
3395,ML-090,c1ccc2c(c1)Nc1nc3ccccc3nc1N2,C14H10N4,15172.0
3396,FUBIMINA,O=C(c1cccc2ccccc12)c1nc2ccccc2n1CCCCCF,C23H21FN2O,15202.0
3397,Ketoconazole,CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,C26H28Cl2N4O4,15212.0
3398,Amiodarone (hydrochloride),CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1.Cl,C25H30ClI2NO3,15213.0
3399,Epalrestat,CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1,C15H13NO3S2,15214.0
3400,GSK3787,O=C(NCCS(=O)(=O)c1ccc(C(F)(F)F)cn1)c1ccc(Cl)cc1,C15H12ClF3N2O3S,15219.0
3401,IPBT-5CA,CC(C)n1nnc2cc(C(=O)O)ccc21,C10H11N3O2,15223.0
3402,ADBICA N-(4-hydroxypentyl) metabolite,CC(O)CCCn1cc(C(=O)NC(C(N)=O)C(C)(C)C)c2ccccc21,C20H29N3O3,15240.0
3403,BI-D1870,CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C,C19H23F2N5O2,15264.0
3404,MLS-573151,NS(=O)(=O)c1ccc(N2N=C(c3ccccc3)CC2c2ccccc2)cc1,C21H19N3O2S,15269.0
3405,Lycopene,CC(C)=CCC/C(C)=C/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C=C(\C)CCC=C(C)C,C40H56,70945.0
3406,15-keto Prostaglandin A1,CCCCCC(=O)/C=C/[C@H]1C=CC(=O)[C@@H]1CCCCCCC(=O)O,C20H30O4,9000142.0
3407,GW 5074,O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1,C15H8Br2INO2,10010368.0
3408,"PtdIns-(3,4,5)-P3 (1,2-dihexanoyl) (ammonium salt)",CCCCCC(=O)OC[C@H](COP(=O)([O-])O[C@H]1[C@H](O)[C@@H](OP(=O)([O-])O)[C@H](OP(=O)([O-])O)[C@@H](OP(=O)([O-])O)[C@H]1O)OC(=O)CCCCC.[NH4+].[NH4+].[NH4+].[NH4+],C21H54N4O22P4,10008390.0
3409,JWH 133,CCCC(C)(C)c1ccc2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C22H32O,10005428.0
3410,JSH-23,Cc1ccc(NCCCc2ccccc2)c(N)c1,C16H20N2,15036.0
3411,AB-PINACA N-(4-hydroxypentyl) metabolite,CC(O)CCCn1nc(C(=O)NC(C(N)=O)C(C)C)c2ccccc21,C18H26N4O3,15049.0
3412,Cdk2 Inhibitor II,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Br)cc32)cc1,C14H11BrN4O3S,15154.0
3413,Flubromazepam,O=C1CN=C(c2ccccc2F)c2cc(Br)ccc2N1,C15H10BrFN2O,15157.0
3414,Flubromazepam (CRM),O=C1CN=C(c2ccccc2F)c2cc(Br)ccc2N1,C15H10BrFN2O,41178.0
3415,Shz-1,O=S(=O)(N/N=C/c1cc(Br)ccc1O)c1ccccc1,C13H11BrN2O3S,15211.0
3416,2-Hydroxyflutamide,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,C11H11F3N2O4,15271.0
3417,ADBICA-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)NC(C(N)=O)C(C)(C)C)c2ccccc21,C20H29N3O2,15280.0
3418,CD437,O=C(O)c1ccc2cc(-c3ccc(O)c(C45CC6CC(CC(C6)C4)C5)c3)ccc2c1,C27H26O3,71610.0
3419,CAY10679,O=C(O)CNC(=O)CNC(=O)CCCCCCC(=O)NCC(=O)NCC(=O)O,C16H26N4O8,9001475.0
3420,4-methyl Erlotinib,C#Cc1cc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)ccc1C,C23H25N3O4,9001510.0
3421,.alpha.-Piperidinobutiophenone (hydrochloride),CCC(C(=O)c1ccccc1)N1CCCCC1.Cl,C15H22ClNO,9001513.0
3422,5-chloro AB-PINACA,CC(C)[C@H](NC(=O)c1nn(CCCCCCl)c2ccccc12)C(N)=O,C18H25ClN4O2,9001857.0
3423,2-Ethylamino-1-phenylbutane (hydrochloride),CCNC(CC)Cc1ccccc1.Cl,C12H20ClN,9001863.0
3424,Palmitic Acid-d2,[2H]C([2H])(CCCCCCCCCCCCCC)C(=O)O,C16H32O2,9001876.0
3425,ABT-263,CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1,C47H55ClF3N5O6S3,11500.0
3426,IC-87114,Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O,C22H19N7O,11589.0
3427,Etizolam RM,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl,C17H15ClN4S,12063.0
3428,Etizolam (CRM),CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl,C17H15ClN4S,20991.0
3429,AZD 4547,COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@@H](C)N[C@@H](C)C4)cc3)n[nH]2)cc(OC)c1,C26H33N5O3,13111.0
3430,Ritonavir,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,C37H48N6O5S2,13872.0
3431,Tenofovir,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,C9H14N5O4P,13874.0
3432,Tadalafil,CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O,C22H19N3O4,14024.0
3433,Tadalafil (CRM),CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O,C22H19N3O4,41133.0
3434,Bromazepam,O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1,C14H10BrN3O,14260.0
3435,JWH 081 N-pentanoic acid metabolite,COc1ccc(C(=O)c2cn(CCCCC(=O)O)c3ccccc23)c2ccccc12,C25H23NO4,14353.0
3436,JWH 081 N-(5-hydroxypentyl) metabolite-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1ccc(OC)c3ccccc13)c([2H])n2CCCCCO,C25H25NO3,14361.0
3437,N-Phenylacetyl-L-Prolylglycine ethyl ester,CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)Cc1ccccc1,C17H22N2O4,14496.0
3438,THJ2201,O=C(c1cccc2ccccc12)c1nn(CCCCCF)c2ccccc12,C23H21FN2O,14789.0
3439,(R)-(-)-MT-45 (hydrochloride),Cl.Cl.c1ccc(C[C@H](c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1,C24H34Cl2N2,15127.0
3440,14(S)-HDHA,CC/C=C\C/C=C\C[C@H](O)/C=C/C=C\C/C=C\C/C=C\CCC(=O)O,C22H32O3,15253.0
3441,2-Amino-1-phenylbutane (hydrochloride),CCC(N)Cc1ccccc1.Cl,C10H16ClN,9001864.0
3442,GW 3965 (hydrochloride),Cl.O=C(O)Cc1cccc(OCCCN(Cc2cccc(C(F)(F)F)c2Cl)CC(c2ccccc2)c2ccccc2)c1,C33H32Cl2F3NO3,10054.0
3443,AT-9283,O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CC1,C19H23N7O2,11496.0
3444,ABT-737,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-],C42H45ClN6O5S2,11501.0
3445,ABT-888 (hydrochloride),C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1.Cl.Cl,C13H18Cl2N4O,11505.0
3446,MK-2206 (hydrochloride),Cl.Cl.NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,C25H23Cl2N5O,11593.0
3447,Ostarine,C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,C19H14F3N3O3,11603.0
3448,Phenamil (methanesulfonate),CS(=O)(=O)O.N=C(NC(=O)c1nc(Cl)c(N)nc1N)Nc1ccccc1,C13H16ClN7O4S,14308.0
3449,(S)-Dibutyl 3-Hydroxybutyl Phosphate,CCCCOP(=O)(OCCCC)OCC[C@H](C)O,C12H27O5P,14787.0
3450,PLX4720,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,C17H14ClF2N3O3S,15142.0
3451,Ko 143,COc1ccc2c3c([nH]c2c1)[C@H](CC(C)C)N1C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)[C@@H]1C3,C26H35N3O5,15215.0
3452,PHA-665752,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,C32H34Cl2N4O4S,14703.0
3453,JAK Inhibitor I,CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1,C18H16FN3O,15146.0
3454,Colcemid,CN[C@H]1CCc2cc(OC)c(OC)c(OC)c2-c2ccc(OC)c(=O)cc21,C21H25NO5,15364.0
3455,5'-Iodoresiniferatoxin,C=C(C)[C@]12C[C@@H](C)[C@@]34O[C@](Cc5ccccc5)(O[C@@H]1[C@@H]3C=C(COC(=O)Cc1cc(I)c(O)c(OC)c1)C[C@]1(O)C(=O)C(C)=C[C@@H]41)O2,C37H39IO9,15367.0
3456,SF1670,CC(C)(C)C(=O)Nc1ccc2c(c1)C(=O)C(=O)c1ccccc1-2,C19H17NO3,15368.0
3457,Roquefortine C,C=CC(C)(C)[C@@]12C[C@H]3C(=O)N/C(=C/c4cnc[nH]4)C(=O)N3[C@@H]1Nc1ccccc12,C22H23N5O2,15376.0
3458,Venturicidin A,CCC(=O)[C@@H](C)[C@@H](O)[C@H](C)C[C@@H](C)[C@H]1OC(=O)C[C@@]2(O)CC=C(C)[C@H](O2)/C(C)=C\CCC[C@@H](O[C@H]2C[C@@H](OC(N)=O)[C@H](O)[C@@H](C)O2)/C=C/[C@H](C)C[C@H]1C,C41H67NO11,15377.0
3459,Siomycin A,C=C(NC(=O)C(=C)NC(=O)c1csc(C2=N[C@@H]3c4csc(n4)[C@H]4NC(=O)c5csc(n5)[C@H]([C@](C)(O)[C@@H](C)O)NC(=O)C5CSC(=N5)/C(=C/C)NC(=O)C([C@@H](C)O)NC(=O)c5csc(n5)[C@]3(CC2)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)C(=C)NC(=O)[C@H](C(C)C)NC2C=Cc3c([C@H](C)O)cc(nc3C2O)C(=O)O[C@@H]4C)n1)C(N)=O,C71H81N19O18S5,15378.0
3460,Piericidin A,C/C=C(\C)[C@H](O)[C@H](C)/C=C(C)/C=C/C/C(C)=C/Cc1nc(OC)c(OC)c(O)c1C,C25H37NO4,15379.0
3461,Ophiobolin A,CC(C)=C[C@H]1C[C@H](C)[C@]2(CC[C@]3(C)C[C@H]4[C@H](C(=O)C[C@@]4(C)O)/C(C=O)=C\C[C@H]32)O1,C25H36O4,15381.0
3462,Calphostin C,COc1c(C[C@@H](C)OC(=O)Oc2ccc(O)cc2)c2c3c(C[C@@H](C)OC(=O)c4ccccc4)c(OC)c(=O)c4c(O)cc(OC)c(c5c(OC)cc(O)c(c1=O)c52)c43,C44H38O14,15383.0
3463,Indolmycin,CNC1=NC(=O)[C@H]([C@H](C)c2c[nH]c3ccccc23)O1,C14H15N3O2,15385.0
3464,Ikarugamycin,CC[C@H]1[C@@H]2C=C[C@@H]3[C@H]4C/C=C\C(=O)NCCC[C@@H]5NC(=O)C(=C5O)C(=O)/C=C/[C@@H]4C[C@@H]3[C@H]2C[C@H]1C,C29H38N2O4,15386.0
3465,Galiellalactone,C[C@@H]1C=C2C(=O)O[C@@H]3CC[C@H](C1)[C@]23O,C11H14O3,15387.0
3466,Zerumbone,C/C1=C/CC/C(C)=C/CC(C)(C)/C=C/C1=O,C15H22O,15400.0
3467,RSC-133,NC(=O)c1cccc(NC(=O)/C=C/c2c[nH]c3ccccc23)c1,C18H15N3O2,9001839.0
3468,Propionyl-L-carnitine (chloride),CCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C10H20ClNO4,9001873.0
3469,Bicyclomycin Benzoate,C=C1CCO[C@]2([C@@H](O)[C@@](C)(O)COC(=O)c3ccccc3)NC(=O)[C@@]1(O)NC2=O,C19H22N2O8,15384.0
3470,MCC-555,O=C1NC(=O)C(Cc2ccc3cc(OCc4ccccc4F)ccc3c2)S1,C21H16FNO3S,70735.0
3471,SDB-006,CCCCCn1cc(C(=O)NCc2ccccc2)c2ccccc21,C21H24N2O,15156.0
3472,Boldenone Cypionate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1,C27H38O3,15158.0
3473,Benzydamine,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12,C19H23N3O,15161.0
3474,A-967079,CCC(=N\O)/C(C)=C/c1ccc(F)cc1,C12H14FNO,15207.0
3475,Minoxidil,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],C9H15N5O,15302.0
3476,LY2157299,Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1,C22H19N5O,15312.0
3477,(-)-Cotinine,CN1C(=O)CC[C@H]1c1cccnc1,C10H12N2O,15314.0
3478,(-)-Cotinine (CRM),CN1C(=O)CC[C@H]1c1cccnc1,C10H12N2O,40379.0
3479,DBeQ,c1ccc(CNc2nc(NCc3ccccc3)c3ccccc3n2)cc1,C22H20N4,15318.0
3480,Ginsenoside Rb1,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C54H92O23,15319.0
3481,Validamycin A,OCC1=C[C@H](N[C@H]2C[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,C20H35NO13,15326.0
3482,Ginsenoside Rd,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C48H82O18,15329.0
3483,20(S)-Ginsenoside Rg3,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C42H72O13,15332.0
3484,PPACKII (trifluoroacetate salt),N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1ccccc1)C(=O)CCl.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,C29H35ClF6N6O7,15360.0
3485,Ebastine,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,C32H39NO2,15372.0
3486,Arctiin,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)c2)cc1OC,C27H34O11,15375.0
3487,Enniatin B,CC(C)[C@H]1C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H](C(C)C)C(=O)N1C,C33H57N3O9,15382.0
3488,Cyclosporin D,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,C63H113N11O12,15477.0
3489,"3,4-Methylenedioxy Pyrovalerone metabolite 1 (hydrochloride)",CCCC(C(=O)c1ccc(O)c(OC)c1)N1CCCC1.Cl,C16H24ClNO3,10518.0
3490,GSK343,CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccnc(N3CCN(C)CC3)c2)cc2c1cnn2C(C)C,C31H39N7O2,14094.0
3491,Vandetanib,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,C22H24BrFN4O2,14706.0
3492,Silodosin,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,C25H32F3N3O4,14866.0
3493,SR 1664,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc([N+](=O)[O-])cc3)cc12,C33H29N3O5,11086.0
3494,Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,C53H83NO14,11597.0
3495,Roflumilast,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,C17H14Cl2F2N2O3,15141.0
3496,Stauprimide,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O,C35H28N4O5,15398.0
3497,Triacsin C,CCC/C=C/C/C=C/C=C/C=N/NN=O,C11H17N3O,10007448.0
3498,Cytochalasin C,CC(=O)O[C@@H]1/C=C/[C@@](C)(O)C(=O)[C@@H](C)C/C=C/[C@H]2[C@H](O)C(C)=C(C)C3[C@H](Cc4ccccc4)NC(=O)[C@@]312,C30H37NO6,11329.0
3499,Verruculogen,COc1ccc2c3c4n(c2c1)[C@@H](C=C(C)C)OOC(C)(C)C[C@@H]4N1C(=O)[C@@H]2CCCN2C(=O)[C@]1(O)[C@H]3O,C27H33N3O7,11351.0
3500,Ponatinib,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,C29H27F3N6O,11494.0
3501,Methcathinone (hydrochloride),CNC(C)C(=O)c1ccccc1.Cl,C10H14ClNO,11709.0
3502,Methcathinone (hydrochloride) (exempt preparation),CNC(C)C(=O)c1ccccc1.Cl,C10H14ClNO,15656.0
3503,UNC1999,CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C(C)C)CC3)nc2)cc2c1cnn2C(C)C,C33H43N7O2,14621.0
3504,25N-NBOMe (hydrochloride),COc1cc([N+](=O)[O-])c(OC)cc1CCNCc1ccccc1OC.Cl,C18H23ClN2O5,14911.0
3505,Glutathione ethyl ester,CCOC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(=O)O,C12H21N3O6S,14953.0
3506,CAL-101,CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,C22H18FN7O,15279.0
3507,Roxadustat,Cc1nc(C(=O)NCC(=O)O)c(O)c2ccc(Oc3ccccc3)cc12,C19H16N2O5,15294.0
3508,CID-2011756,O=C(Nc1ccc(CN2CCOCC2)cc1)c1ccc(-c2cccc(Cl)c2)o1,C22H21ClN2O3,15317.0
3509,Kanamycin A (sulfate),NC[C@H]1OC(O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O.O=S(=O)(O)O,C18H38N4O15S,15321.0
3510,Kasugamycin (hydrochloride),C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]2O)[C@@H](N)C[C@@H]1NC(=N)C(=O)O.Cl,C14H26ClN3O9,15322.0
3511,Ginsenoside Re,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)C[C@]12C,C48H82O18,15330.0
3512,Butein,O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O)cc1O,C15H12O5,15371.0
3513,Taurolidine,O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1,C7H16N4O4S2,15374.0
3514,PAF C-16 Carboxylic Acid,CC(=O)O[C@H](COCCCCCCCCCCCCCCCC(=O)O)COP(=O)([O-])OCC[N+](C)(C)C,C26H52NO9P,15392.0
3515,Heat Shock Protein Inhibitor I,O=CN1CC/C(=C\c2ccc3c(c2)OCO3)C1=O,C13H11NO4,15395.0
3516,PSI-7977,CC(C)OC(=O)[C@H](C)NP(=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1,C22H29FN3O9P,15402.0
3517,GW 2580,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,C20H22N4O3,15411.0
3518,N-tert-butyl-.alpha.-Phenylnitrone,CC(C)(C)/[N+]([O-])=C/c1ccccc1,C11H15NO,15412.0
3519,3-AP,NC(=S)N/N=C/c1ncccc1N,C7H9N5S,15419.0
3520,Ticagrelor,CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,C23H28F2N6O4S,15425.0
3521,Extracellular Death Factor,NC(=O)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O)C(=O)O,C27H36N10O10,15478.0
3522,Asterric Acid,COC(=O)c1cc(O)cc(OC)c1Oc1cc(C)cc(O)c1C(=O)O,C17H16O8,70630.0
3523,R406,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,C22H23FN6O5,11422.0
3524,Cyclosporin A,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,C62H111N11O12,12088.0
3525,Platencin,C=C1C[C@@]23C=CC(=O)[C@@](C)(CCC(=O)Nc4c(O)ccc(C(=O)O)c4O)[C@@H]2C[C@@H]1CC3,C24H27NO6,13264.0
3526,Safrole,C=CCc1ccc2c(c1)OCO2,C10H10O2,13894.0
3527,Batimastat,CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc1cccs1)C(=O)NO,C23H31N3O4S2,14742.0
3528,BAY 11-7085,CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1,C13H15NO2S,14795.0
3529,3-oxo Stearic Acid,CCCCCCCCCCCCCCCC(=O)CC(=O)O,C18H34O3,14807.0
3530,4-fluoro-.alpha.-Pyrrolidinopentiophenone (hydrochloride),CCCC(C(=O)c1ccc(F)cc1)N1CCCC1.Cl,C15H21ClFNO,15166.0
3531,"3,4-Ethylenedioxymethcathinone (hydrochloride)",CNC(C)C(=O)c1ccc2c(c1)OCCO2.Cl,C12H16ClNO3,15167.0
3532,IPTG (dioxane free),CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,C9H18O5S,15300.0
3533,Mepirapim (hydrochloride),CCCCCn1cc(C(=O)N2CCN(C)CC2)c2ccccc21.Cl,C19H28ClN3O,15388.0
3534,LY2109761,c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1,C26H27N5O2,15409.0
3535,Modafinil,NC(=O)CS(=O)C(c1ccccc1)c1ccccc1,C15H15NO2S,15417.0
3536,Carvedilol,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,C24H26N2O4,15418.0
3537,Apixaban,COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1,C25H25N5O4,15427.0
3538,KMN-80,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CCC(=O)N1CCCCCCC(=O)O,C21H33NO4,15435.0
3539,AB-PINACA N-(4-fluoropentyl) isomer,CC(F)CCCn1nc(C(=O)NC(C(N)=O)C(C)C)c2ccccc21,C18H25FN4O2,15441.0
3540,Oxaprozin,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,C18H15NO3,15476.0
3541,Cercosporamide,CC(=O)C1=C(O)C=C2Oc3c(C(N)=O)c(O)cc(O)c3[C@]2(C)C1=O,C16H13NO7,15500.0
3542,Chlorothricin,COc1ccc(Cl)c(C)c1C(=O)O[C@@H]1C[C@H](O[C@H]2[C@H](O)C[C@H](O[C@H]3CCC[C@@H]4[C@@H]3C=C[C@H]3CCCC/C=C\[C@@H]5C=C(C(=O)O)[C@H](C)C[C@]56OC(=O)C(=C6O)OC(=O)[C@@]43C)O[C@@H]2C)O[C@H](C)[C@H]1O,C50H63ClO16,15501.0
3543,Concanamycin B,C/C=C/[C@H]1O[C@@](O)([C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]2OC)C[C@@H](O[C@H]2C[C@@H](O)[C@H](OC(N)=O)[C@@H](C)O2)[C@@H]1C,C45H73NO14,15502.0
3544,Fidaxomycin,CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)O[C@H]1[C@H](O)[C@H](OC)[C@H](OC/C2=C\C=C\C[C@H](O)/C(C)=C\[C@H](CC)[C@@H](O[C@@H]3OC(C)(C)C(OC(=O)C(C)C)[C@H](O)[C@@H]3O)/C(C)=C/C(C)=C/C[C@@H]([C@@H](C)O)OC2=O)O[C@@H]1C,C52H74Cl2O18,15503.0
3545,Herbimycin A,CO[C@H]1[C@@H](OC)C[C@H](C)[C@@H](OC)C2=CC(=O)C=C(NC(=O)/C(C)=C/C=C\[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@@H]1C)C2=O,C30H42N2O9,15504.0
3546,Lasalocid,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(=O)O)[C@H]1O[C@](CC)([C@H]2CC[C@](O)(CC)[C@H](C)O2)C[C@@H]1C,C34H54O8,15505.0
3547,Moenomycin Complex,C=C(C/C=C(\C)CCC=C(C)C)CCC(C)(C)/C=C/CC/C(C)=C\CO[C@H](COP(=O)(O)O[C@H]1O[C@H](C(N)=O)[C@@](C)(O)[C@H](OC(N)=O)[C@H]1O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@@H]3O[C@H](C(=O)NC4=C(O)CCC4=O)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2NC(C)=O)[C@H](O)[C@H]1NC(C)=O)C(=O)O,C69H108N5O34P,15506.0
3548,Platensimycin,C[C@]12C[C@@]34C=CC(=O)[C@@](C)(CCC(=O)Nc5c(O)ccc(C(=O)O)c5O)[C@@H]3[C@H](C[C@@H]1C4)O2,C24H27NO7,15507.0
3549,Pseudoerythromycin A enol ether,CC[C@@H](O)[C@@](C)(O)C1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@]2(C)CC(C)=C(O2)[C@@H]1C,C37H65NO12,15508.0
3550,Teicoplanin Complex,CCCCC/C=C\CCC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@H](O)[C@H]1O,C88H95Cl2N9O33,15511.0
3551,Naltrexone (hydrochloride),Cl.O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,C20H24ClNO4,15520.0
3552,Prostaglandin E2-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,10581.0
3553,30C-NBOMe (hydrochloride),COc1cc(CCNCc2cc(OC)c(OC)c(OC)c2)c(OC)cc1Cl.Cl,C20H27Cl2NO5,14528.0
3554,ADBICA N-(5-hydroxypentyl) metabolite,CC(C)(C)C(NC(=O)c1cn(CCCCCO)c2ccccc12)C(N)=O,C20H29N3O3,15060.0
3555,RGDS Peptide,N=C(N)NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O,C15H27N7O8,15359.0
3556,BAPTA AM,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1ccccc1OCCOc1ccccc1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O,C34H40N2O18,15551.0
3557,Psilocin,CN(C)CCc1c[nH]c2cccc(O)c12,C12H16N2O,11864.0
3558,Psilocin (CRM),CN(C)CCc1c[nH]c2cccc(O)c12,C12H16N2O,9003135.0
3559,GW 1929,CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1,C30H29N3O4,13689.0
3560,4-fluoro Buphedrone (hydrochloride),CCC(NC)C(=O)c1ccc(F)cc1.Cl,C11H15ClFNO,15165.0
3561,Diclofensine (hydrochloride),COc1ccc2c(c1)CN(C)CC2c1ccc(Cl)c(Cl)c1.Cl,C17H18Cl3NO,15355.0
3562,EGFR Inhibitor,O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,C21H18F3N5O,15363.0
3563,5-fluoro-SDB-006,O=C(NCc1ccccc1)c1cn(CCCCCF)c2ccccc12,C21H23FN2O,15390.0
3564,Lamotrigine,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,C9H7Cl2N5,15428.0
3565,5-Fluoropentylindole,FCCCCCn1ccc2ccccc21,C13H16FN,15454.0
3566,AMB,CCCCCn1nc(C(=O)N[C@H](C(=O)OC)C(C)C)c2ccccc21,C19H27N3O3,15488.0
3567,5-fluoro AMB,COC(=O)[C@@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(C)C,C19H26FN3O3,15489.0
3568,"L-Glutathione, oxidized (sodium salt)",N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)[O-])C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)[O-].[Na+].[Na+],C20H30N6Na2O12S2,15491.0
3569,Arachidonoyl-L-carnitine (chloride),CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C27H46ClNO4,9000939.0
3570,Idebenone,COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O,C19H30O5,15475.0
3571,Ketamine (hydrochloride),CNC1(c2ccccc2Cl)CCCCC1=O.Cl,C13H17Cl2NO,11630.0
3572,Ketamine (hydrochloride) (CRM),CNC1(c2ccccc2Cl)CCCCC1=O.Cl,C13H17Cl2NO,19389.0
3573,ADB-PINACA N-(5-hydroxypentyl) metabolite,CC(C)(C)C(NC(=O)c1nn(CCCCCO)c2ccccc12)C(N)=O,C19H28N4O3,15054.0
3574,Conduritol B epoxide,O[C@H]1[C@H](O)[C@@H](O)[C@@H]2O[C@@H]2[C@@H]1O,C6H10O5,15216.0
3575,PFI-3,O=C(/C=C/N1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O,C19H19N3O2,15267.0
3576,Atglistatin,CN(C)C(=O)Nc1cccc(-c2ccc(N(C)C)cc2)c1,C17H21N3O,15284.0
3577,trans-Vaccenic Acid,CCCCCC/C=C/CCCCCCCCCC(=O)O,C18H34O2,15301.0
3578,Disulfiram,CCN(CC)C(=S)SSC(=S)N(CC)CC,C10H20N2S4,15303.0
3579,Captopril,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,C9H15NO3S,15313.0
3580,Auranofin,CC[P](CC)(CC)[Au+][S-][C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,C20H34AuO9PS,15316.0
3581,PKR Inhibitor,O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1,C13H8N4OS,15323.0
3582,5-fluoro SDB-005,O=C(Oc1cccc2ccccc12)c1nn(CCCCCF)c2ccccc12,C23H21FN2O2,15353.0
3583,4-fluoro PV8 (hydrochloride),CCCCCC(C(=O)c1ccc(F)cc1)N1CCCC1.Cl,C17H25ClFNO,15356.0
3584,Amprenavir,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,C25H35N3O6S,15369.0
3585,Amikacin,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,C22H43N5O13,15405.0
3586,Budesonide,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,C25H34O6,15407.0
3587,Miconazole (nitrate),Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1.O=[N+]([O-])O,C18H15Cl4N3O4,15420.0
3588,Nobiletin,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)c(OC)c3o2)cc1OC,C21H22O8,15421.0
3589,Carbamazepine,NC(=O)N1c2ccccc2C=Cc2ccccc21,C15H12N2O,15422.0
3590,Carbamazepine (CRM),NC(=O)N1c2ccccc2C=Cc2ccccc21,C15H12N2O,42589.0
3591,Brimonidine (tartrate),Brc1c(NC2=NCCN2)ccc2nccnc12.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C15H16BrN5O6,15426.0
3592,AB-CHMINACA,CC(C)[C@H](NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(N)=O,C20H28N4O2,15434.0
3593,AB-CHMINACA (CRM),CC(C)[C@H](NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(N)=O,C20H28N4O2,27237.0
3594,para-Fluorofentanyl (hydrochloride),CCC(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H28ClFN2O,15496.0
3595,para-Fluorofentanyl (hydrochloride) (CRM),CCC(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H28ClFN2O,19735.0
3596,Puromycin Aminonucleoside,CN(C)c1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](N)[C@H]1O,C12H18N6O3,15509.0
3597,4-fluoro-.alpha.-Pyrrolidinobutiophenone (hydrochloride),CCC(C(=O)c1ccc(F)cc1)N1CCCC1.Cl,C14H19ClFNO,15516.0
3598,ALK5 Inhibitor II (hydrochloride),Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1.Cl,C17H14ClN5,15526.0
3599,AB-FUBINACA 3-fluorobenzyl isomer,CC(C)[C@H](NC(=O)c1nn(Cc2cccc(F)c2)c2ccccc12)C(N)=O,C20H21FN4O2,9001523.0
3600,AB-FUBINACA 2-fluorobenzyl isomer,CC(C)[C@H](NC(=O)c1nn(Cc2ccccc2F)c2ccccc12)C(N)=O,C20H21FN4O2,9001524.0
3601,SC-236,NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cl)cc2)cc1,C16H11ClF3N3O2S,10004219.0
3602,Luotonin A,O=c1c2ccccc2nc2n1Cc1cc3ccccc3nc1-2,C18H11N3O,14253.0
3603,Pyrazolam,Cc1nnc2n1-c1ccc(Br)cc1C(c1ccccn1)=NC2,C16H12BrN5,14901.0
3604,5-EAPB (hydrochloride),CCNC(C)Cc1ccc2occc2c1.Cl,C13H18ClNO,15282.0
3605,Xanthohumol,COc1cc(O)c(CC=C(C)C)c(O)c1C(=O)/C=C/c1ccc(O)cc1,C21H22O5,15399.0
3606,3-Fluoropentylindole,CCC(F)CCn1ccc2ccccc21,C13H16FN,15452.0
3607,4-Fluoropentylindole,CC(F)CCCn1ccc2ccccc21,C13H16FN,15453.0
3608,4-methoxy PV8 (hydrochloride),CCCCCC(C(=O)c1ccc(OC)cc1)N1CCCC1.Cl,C18H28ClNO2,15497.0
3609,ATM4 4-acetoxy analog,COc1cc(CCN(C)C(C)=O)c2ccc3ccc(OC)c(OC(C)=O)c3c2c1,C23H25NO5,15498.0
3610,Lorcaserin (hydrochloride),C[C@H]1CNCCc2ccc(Cl)cc21.Cl,C11H15Cl2N,15521.0
3611,Lorcaserin (hydrochloride) (CRM),C[C@H]1CNCCc2ccc(Cl)cc21.Cl,C11H15Cl2N,19247.0
3612,FUB-144,CC1(C)C(C(=O)c2cn(Cc3ccc(F)cc3)c3ccccc23)C1(C)C,C23H24FNO,15537.0
3613,Phleomycin,Cc1c(N)nc(C(CC(N)=O)NCC(N)C(N)=O)nc1C(=O)NC(C(=O)NC(C)C(O)C(C)C(=O)NC(C(=O)NCCC1=NC(c2nc(C(=O)NCCCCNC(=N)N)cs2)CS1)C(C)O)C(O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](C[O-])[C@@H]([O-])[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.Cl.[Cu+2],C55H85ClCuN20O21S2,15549.0
3614,UCF 101,O=C1C(=Cc2ccc(-c3ccccc3[N+](=O)[O-])o2)C(=O)N(c2ccccc2)C(=S)N1c1ccccc1,C27H17N3O5S,15550.0
3615,Mdivi 1,COc1cc(-n2c(S)nc3ccccc3c2=O)c(Cl)cc1Cl,C15H10Cl2N2O2S,15559.0
3616,Becatecarin,CCN(CC)CCN1C(=O)c2c(c3c4cccc(Cl)c4n([C@@H]4O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]4O)c3c3[nH]c4c(Cl)cccc4c23)C1=O,C33H34Cl2N4O7,15576.0
3617,Dexmedetomidine (hydrochloride),Cc1cccc([C@H](C)c2cnc[nH]2)c1C.Cl,C13H17ClN2,15581.0
3618,Dexmedetomidine (hydrochloride) (CRM),Cc1cccc([C@H](C)c2cnc[nH]2)c1C.Cl,C13H17ClN2,38806.0
3619,ICI 118551 (hydrochloride),Cc1ccc(OC[C@H](O)[C@@H](C)NC(C)C)c2c1CCC2.Cl,C17H28ClNO2,15591.0
3620,Compound E,C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2N(C)C1=O,C27H24F2N4O3,15579.0
3621,5-Bromo-2'-deoxyuridine,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Br,C9H11BrN2O5,15580.0
3622,GW 4064,CC(C)c1onc(-c2c(Cl)cccc2Cl)c1COc1ccc(/C=C/c2cccc(C(=O)O)c2)c(Cl)c1,C28H22Cl3NO4,10006611.0
3623,Rotenone,C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1,C23H22O6,13995.0
3624,deschloro-N-ethyl-Ketamine (hydrochloride),CCNC1(c2ccccc2)CCCCC1=O.Cl,C14H20ClNO,14105.0
3625,FBBBE,CC1(C)OB(c2ccc(COc3ccc4c(c3)Oc3cc(OCc5ccc(B6OC(C)(C)C(C)(C)O6)cc5)ccc3C43OC(=O)c4ccccc43)cc2)OC1(C)C,C46H46B2O9,14606.0
3626,GSK3? Inhibitor VIII,COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,C12H12N4O4S,14704.0
3627,4-methoxy-.alpha.-Pyrrolidinobutiophenone (hydrochloride),CCC(C(=O)c1ccc(OC)cc1)N1CCCC1.Cl,C15H22ClNO2,15354.0
3628,Clencyclohexerol,Nc1c(Cl)cc(C(O)CNC2CCC(O)CC2)cc1Cl,C14H20Cl2N2O2,15365.0
3629,AZD 5363,NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,C21H25ClN6O2,15406.0
3630,Metanephrine,CNCC(O)c1ccc(O)c(OC)c1,C10H15NO3,15408.0
3631,GSK 126,CC[C@H](C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(-c3ccc(N4CCNCC4)nc3)cc21,C31H38N6O2,15415.0
3632,BW 755C,NC1=NN(c2cccc(C(F)(F)F)c2)CC1,C10H10F3N3,15490.0
3633,Zidovudine,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,C10H13N5O4,15492.0
3634,Paliperidone,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,C23H27FN4O3,15556.0
3635,Paliperidone (CRM),Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,C23H27FN4O3,40387.0
3636,Dobutamine (hydrochloride),CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1.Cl,C18H24ClNO3,15582.0
3637,Elaiophylin,CC[C@@H]1[C@@H](C)O[C@@](O)([C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C=C/C=C/[C@H](C)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]3(O)C[C@@H](O[C@H]4C[C@H](O)[C@H](O)[C@H](C)O4)[C@H](CC)[C@@H](C)O3)OC(=O)/C=C/C=C/[C@@H]2C)C[C@H]1O[C@H]1C[C@H](O)[C@H](O)[C@H](C)O1,C54H88O18,15583.0
3638,Ganglioside GD1a (bovine brain) (sodium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@]5(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O5)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[Na+].[Na+],C84H146N4Na2O39,15585.0
3639,Asialo Ganglioside GM1,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC,C62H114N2O23,15586.0
3640,Ganglioside GM3 (bovine brain) (sodium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[Na+],C59H107N2NaO21,15587.0
3641,Ganglioside GQ1b (bovine) (sodium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@]5(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@@H](O)[C@@H](CO)O[C@]6(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O6)O5)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@@H](O)[C@@H](CO)O[C@]4(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[Na+].[Na+].[Na+].[Na+],C106H178N6Na4O55,15589.0
3642,5'-Deoxy-5'-methylthioadenosine,CSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,C11H15N5O3S,15593.0
3643,Naloxone (hydrochloride),C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl,C19H22ClNO4,15594.0
3644,PP3,Nc1ncnc2c1cnn2-c1ccccc1,C11H9N5,15595.0
3645,SL 327,N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F,C16H12F3N3S,15598.0
3646,Thiorphan,O=C(O)CNC(=O)C(CS)Cc1ccccc1,C12H15NO3S,15600.0
3647,Deltarasin (hydrochloride),Cl.Cl.c1ccc(Cn2c(-c3ccc(OC[C@H](C4CCNCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1,C40H39Cl2N5O,9001536.0
3648,5-Aminolevulinic Acid (hydrochloride),Cl.NCC(=O)CCC(=O)O,C5H10ClNO3,9001902.0
3649,24(R)-hydroxy Cholesterol,CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O2,10217.0
3650,Indiplon,CC(=O)N(C)c1cccc(-c2ccnc3c(C(=O)c4cccs4)cnn23)c1,C20H16N4O2S,11638.0
3651,Glimepiride,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O,C24H34N4O5S,12090.0
3652,Fentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H29ClN2O,14719.0
3653,Fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)CC)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C22H29ClN2O,14721.0
3654,Fentanyl-d5 (hydrochloride) (CRM),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)CC)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C22H29ClN2O,19928.0
3655,CCG-203971,O=C(Nc1ccc(Cl)cc1)C1CCCN(C(=O)c2cccc(-c3ccco3)c2)C1,C23H21ClN2O3,15075.0
3656,Clotrimazole,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,C22H17ClN2,15278.0
3657,Pitavastatin (calcium salt),O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Ca+2],C25H23CaFNO4,15414.0
3658,Metoprolol (succinate),COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)CCC(=O)O,C19H31NO7,15429.0
3659,FR180204,Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,C18H13N7,15544.0
3660,Kemptide,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)O,C32H61N13O9,15555.0
3661,Ramipril,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,C23H32N2O5,15558.0
3662,CHIR98014,Nc1nc(NCCNc2ncc(-n3ccnc3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-],C20H17Cl2N9O2,15578.0
3663,Isoproterenol (hydrochloride),CC(C)NCC(O)c1ccc(O)c(O)c1.Cl,C11H18ClNO3,15592.0
3664,SNC 80,C=CCN1C[C@H](C)N([C@H](c2ccc(C(=O)N(CC)CC)cc2)c2cccc(OC)c2)C[C@H]1C,C28H39N3O2,15599.0
3665,Thaxtomin A,CN1C(=O)[C@](O)(Cc2cccc(O)c2)N(C)C(=O)[C@@H]1Cc1c[nH]c2cccc([N+](=O)[O-])c12,C22H22N4O6,15601.0
3666,Vecuronium (bromide),CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-],C34H57BrN2O4,15603.0
3667,Ranolazine (hydrochoride),COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1.Cl.Cl,C24H35Cl2N3O4,15604.0
3668,CGP 37157,O=C1CSC(c2ccccc2Cl)c2cc(Cl)ccc2N1,C15H11Cl2NOS,15611.0
3669,Cimaterol,CC(C)NCC(O)c1ccc(N)c(C#N)c1,C12H17N3O,15613.0
3670,CyPPA,Cc1cc(NC2CCCCC2)nc(-n2nc(C)cc2C)n1,C16H23N5,15614.0
3671,GBR 12909 (hydrochloride),Cl.Cl.Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1,C28H34Cl2F2N2O,15622.0
3672,IEM 1460,Br.C[N+](C)(C)CCCCCNCC12CC3CC(CC(C3)C1)C2.[Br-],C19H38Br2N2,15623.0
3673,JNK Inhibitor IX,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,C20H16N2OS,15624.0
3674,Pelitinib,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,C24H23ClFN5O2,15627.0
3675,SCH 23390 (hydrochloride),CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1.Cl,C17H19Cl2NO,15631.0
3676,AB-FUBINACA isomer 2,CCC(C)(NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(N)=O,C20H21FN4O2,9001529.0
3677,2-Bromoamphetamine (hydrochloride),CC(N)Cc1ccccc1Br.Cl,C9H13BrClN,9001848.0
3678,3-Bromoamphetamine (hydrochloride),CC(N)Cc1cccc(Br)c1.Cl,C9H13BrClN,9001849.0
3679,4-Bromoamphetamine (hydrochloride),CC(N)Cc1ccc(Br)cc1.Cl,C9H13BrClN,9001850.0
3680,3-Chloroamphetamine (hydrochloride),CC(N)Cc1cccc(Cl)c1.Cl,C9H13Cl2N,9001855.0
3681,4-Chloroamphetamine (hydrochloride),CC(N)Cc1ccc(Cl)cc1.Cl,C9H13Cl2N,9001856.0
3682,CAY10683,CCOC(=O)NCCCC(=O)NCCc1ccccc1,C15H22N2O3,15403.0
3683,24(S)-hydroxy Cholesterol,CC(C)[C@@H](O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O2,10009931.0
3684,b-AP15,C=CC(=O)N1C/C(=C\c2ccc([N+](=O)[O-])cc2)C(=O)/C(=C/c2ccc([N+](=O)[O-])cc2)C1,C22H17N3O6,11324.0
3685,2-methoxy Ketamine (hydrochloride),CNC1(c2ccccc2OC)CCCCC1=O.Cl,C14H20ClNO2,12048.0
3686,CAY10678,Cc1cc2nc(N3CCC(C(=O)NC4CCCC4)CC3)n(C(C)C)c2cc1C,C23H34N4O,15129.0
3687,Ivacaftor,CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O,C24H28N2O3,15145.0
3688,bk-2C-B (hydrochloride),COc1cc(C(=O)CN)c(OC)cc1Br.Cl,C10H13BrClNO3,15328.0
3689,.alpha.-Pyrrolidinobutiothiophenone (hydrochloride),CCC(C(=O)c1cccs1)N1CCCC1.Cl,C12H18ClNOS,15358.0
3690,Ro 106-9920,O=S(c1ccccc1)c1ccc2nnnn2n1,C10H7N5OS,15373.0
3691,AB-PINACA N-(2-fluoropentyl) isomer,CCCC(F)Cn1nc(C(=O)NC(C(N)=O)C(C)C)c2ccccc21,C18H25FN4O2,15439.0
3692,NPB-22,CCCCCn1nc(C(=O)Oc2cccc3cccnc23)c2ccccc21,C22H21N3O2,15535.0
3693,Aminoethoxyvinyl Glycine (hydrochloride),Cl.NCCO/C=C/[C@H](N)C(=O)O,C6H13ClN2O3,15546.0
3694,Hoechst 33342 (hydrochloride),CCOc1ccc(-c2nc3ccc(-c4nc5ccc(N6CCN(C)CC6)cc5[nH]4)cc3[nH]2)cc1.Cl.Cl.Cl,C27H31Cl3N6O,15547.0
3695,Hoechst 33342 (hydrochloride) (solution),CCOc1ccc(-c2nc3ccc(-c4nc5ccc(N6CCN(C)CC6)cc5[nH]4)cc3[nH]2)cc1.Cl.Cl.Cl,C27H31Cl3N6O,40797.0
3696,Ramosetron (hydrochloride),Cl.Cn1cc(C(=O)[C@@H]2CCc3nc[nH]c3C2)c2ccccc21,C17H18ClN3O,15548.0
3697,Conoidin A,[O-][n+]1c(CBr)c(CBr)[n+]([O-])c2ccccc21,C10H8Br2N2O2,15605.0
3698,4-methyl-.alpha.-Ethylaminopentiophenone (hydrochloride),CCCC(NCC)C(=O)c1ccc(C)cc1.Cl,C14H22ClNO,15609.0
3699,4-methyl-?-Ethylaminopentiophenone (hydrochloride) (CRM),CCCC(NCC)C(=O)c1ccc(C)cc1.Cl,C14H22ClNO,29160.0
3700,Eplerenone,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13,C24H30O6,15616.0
3701,.beta.-Tocotrienol,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC[C@]1(C)CCc2c(C)c(O)cc(C)c2O1,C28H42O2,9001533.0
3702,2-Chloroamphetamine (hydrochloride),CC(N)Cc1ccccc1Cl.Cl,C9H13Cl2N,9001854.0
3703,EG 018,CCCCCn1c2ccccc2c2cc(C(=O)c3cccc4ccccc34)ccc21,C28H25NO,15533.0
3704,Rucaparib,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,C19H18FN3O,15643.0
3705,Diacerein,CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O,C19H12O8,11710.0
3706,(S)-Duloxetine (hydrochloride),CNCC[C@H](Oc1cccc2ccccc12)c1cccs1.Cl,C18H20ClNOS,14317.0
3707,(S)-Duloxetine (hydrochloride) (CRM),CNCC[C@H](Oc1cccc2ccccc12)c1cccs1.Cl,C18H20ClNOS,40160.0
3708,2C-TFM (hydrochloride),COc1cc(C(F)(F)F)c(OC)cc1CCN.Cl,C11H15ClF3NO2,14471.0
3709,AM580,CC1(C)CCC(C)(C)c2cc(C(=O)Nc3ccc(C(=O)O)cc3)ccc21,C22H25NO3,15261.0
3710,Harringtonine,COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4,C28H37NO9,15361.0
3711,5-fluoro NPB-22,O=C(Oc1cccc2cccnc12)c1nn(CCCCCF)c2ccccc12,C22H20FN3O2,15536.0
3712,2-Chloroadenosine,Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C10H12ClN5O4,15612.0
3713,CAY10680,O=C(CCCc1ccccc1)Nc1nc2ccccc2c(=O)s1,C18H16N2O2S,15618.0
3714,Loratadine,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,C22H23ClN2O2,15625.0
3715,Testosterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,C19H28O2,15645.0
3716,RCS-4 (exempt preparation),CCCCCn1cc(C(=O)c2ccc(OC)cc2)c2ccccc21,C21H23NO2,15666.0
3717,AM80,CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21,C22H25NO3,71770.0
3718,Luotonin F,O=C(c1cnc2ccccc2c1)c1nc2ccccc2c(=O)[nH]1,C18H11N3O2,14254.0
3719,SANT 1,Cc1nn(-c2ccccc2)c(C)c1/C=N/N1CCN(Cc2ccccc2)CC1,C23H27N5,14933.0
3720,Cathepsin G Inhibitor I,CN(C(=O)c1cc2ccccc2cc1C(=O)C(c1cccc2ccccc12)P(=O)(O)O)C1CCN(C(=O)c2ccccc2)CC1,C36H33N2O6P,14928.0
3721,Atipamezole (hydrochloride),CCC1(c2cnc[nH]2)Cc2ccccc2C1.Cl,C14H17ClN2,9001181.0
3722,5-fluoro ABICA,CC(C)[C@H](NC(=O)c1cn(CCCCCF)c2ccccc12)C(N)=O,C19H26FN3O2,9001555.0
3723,3-Iodoamphetamine (hydrochloride),CC(N)Cc1cccc(I)c1.Cl,C9H13ClIN,9001852.0
3724,4-APDB (hydrochloride),CC(N)Cc1cccc2c1CCO2.Cl,C11H16ClNO,9001891.0
3725,3-Methoxyamphetamine (hydrochloride),COc1cccc(CC(C)N)c1.Cl,C10H16ClNO,9001916.0
3726,NM2201,O=C(Oc1cccc2ccccc12)c1cn(CCCCCF)c2ccccc12,C24H22FNO2,15334.0
3727,JWH 019 N-(4-fluorohexyl) isomer,CCC(F)CCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C25H24FNO,15444.0
3728,Diclazepam,CN1C(=O)CN=C(c2ccccc2Cl)c2cc(Cl)ccc21,C16H12Cl2N2O,15554.0
3729,Diclazepam (CRM),CN1C(=O)CN=C(c2ccccc2Cl)c2cc(Cl)ccc21,C16H12Cl2N2O,28623.0
3730,Daptomycin,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,C72H101N17O26,15615.0
3731,Fluvoxamine (maleate),COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1.O=C(O)/C=C\C(=O)O,C19H25F3N2O6,15617.0
3732,Arachidonic Acid-d11,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O2,10006758.0
3733,SecinH3,COc1nc(-c2ccc(NC(=O)CSc3ccccc3)cc2)n(-c2ccc3c(c2)OCO3)n1,C24H20N4O4S,10009570.0
3734,BMS309403,CCc1c(-c2ccccc2)c(-c2ccccc2)nn1-c1ccccc1-c1cccc(OCC(=O)O)c1,C31H26N2O3,10010206.0
3735,Rofecoxib,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,C17H14O4S,10010260.0
3736,10-Nitrolinoleate,CCCCC/C=C\C/C(=C\CCCCCCCC(=O)O)[N+](=O)[O-],C18H31NO4,10037.0
3737,UNC0631,COc1cc2c(NC3CCN(CC4CCCCC4)CC3)nc(N3CCCN(C(C)C)CC3)nc2cc1OCCCN1CCCCC1,C37H61N7O2,11084.0
3738,UNC0646,COc1cc2c(NC3CCN(C4CCCCC4)CC3)nc(N3CCCN(C(C)C)CC3)nc2cc1OCCCN1CCCCC1,C36H59N7O2,11085.0
3739,(-)-Epigallocatechin,Oc1cc(O)c2c(c1)O[C@H](c1cc(O)c(O)c(O)c1)[C@H](O)C2,C15H14O7,11809.0
3740,Piperonyl methyl ketone,CC(=O)Cc1ccc2c(c1)OCO2,C10H10O3,13892.0
3741,Yangonin,COc1ccc(/C=C/c2cc(OC)cc(=O)o2)cc1,C15H14O4,14351.0
3742,Yangonin (CRM),COc1ccc(/C=C/c2cc(OC)cc(=O)o2)cc1,C15H14O4,41211.0
3743,4-fluoro PV9 (hydrochloride),CCCCCCC(C(=O)c1ccc(F)cc1)N1CCCC1.Cl,C18H27ClFNO,15063.0
3744,4-methoxy PV9 (hydrochloride),CCCCCCC(C(=O)c1ccc(OC)cc1)N1CCCC1.Cl,C19H30ClNO2,15064.0
3745,AB-FUBINACA-d4,[2H]c1c([2H])c([2H])c2c(c(C(=O)N[C@H](C(N)=O)C(C)C)nn2Cc2ccc(F)cc2)c1[2H],C20H21FN4O2,15292.0
3746,AB-FUBINACA-d4 (CRM),[2H]c1c([2H])c([2H])c2c(c(C(=O)N[C@H](C(N)=O)C(C)C)nn2Cc2ccc(F)cc2)c1[2H],C20H21FN4O2,27238.0
3747,Cannabigerol,CCCCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1,C21H32O2,15293.0
3748,Cannabigerol (CRM),CCCCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1,C21H32O2,20164.0
3749,Cannabigerol (Alt. Batch CRM),CCCCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1,C21H32O2,42522.0
3750,SDB-005,CCCCCn1nc(C(=O)Oc2cccc3ccccc23)c2ccccc21,C23H22N2O2,15389.0
3751,(S)-MG115,CCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,C25H39N3O5,15413.0
3752,JWH 019 N-(3-fluorohexyl) isomer,CCCC(F)CCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C25H24FNO,15443.0
3753,Rauwolscine (hydrochloride),COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2CC[C@@H]1O.Cl,C21H27ClN2O3,15596.0
3754,Metamizole (sodium salt),Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+],C13H16N3NaO4S,15771.0
3755,Metamizole (sodium salt),Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+],C13H16N3NaO4S,32996.0
3756,CFTR Inhibitor II,O=C(CNc1ccc2ccccc2c1)N/N=C/c1cc(Br)c(O)c(Br)c1O,C19H15Br2N3O3,15772.0
3757,Tiotropium (bromide),C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.[Br-],C19H22BrNO4S2,15773.0
3758,6-Thioguanine,Nc1nc(S)c2nc[nH]c2n1,C5H5N5S,15774.0
3759,Cefazolin (sodium salt),Cc1nnc(SCC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1.[Na+],C14H13N8NaO4S3,15776.0
3760,Tubastatin A,CN1CCc2c(c3ccccc3n2Cc2ccc(C(=O)NO)cc2)C1,C20H21N3O2,15785.0
3761,Ivabradine (hydrochloride),COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2.Cl,C27H37ClN2O5,15868.0
3762,MreB Perturbing Compound A22,Cl.N=C(N)SCc1ccc(Cl)c(Cl)c1,C8H9Cl3N2S,15870.0
3763,Zolmitriptan,CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12,C16H21N3O2,15871.0
3764,Doxepin (hydrochloride),CN(C)CC/C=C1/c2ccccc2COc2ccccc21.Cl,C19H22ClNO,15888.0
3765,Doxepin (hydrochloride) (CRM),CN(C)CC/C=C1/c2ccccc2COc2ccccc21.Cl,C19H22ClNO,19039.0
3766,Norfluoxetine (hydrochloride),Cl.NCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,C16H17ClF3NO,15900.0
3767,CID-755673,O=C1NCCCc2c1oc1ccc(O)cc21,C12H11NO3,15924.0
3768,Clorgyline (hydrochloride),C#CCN(C)CCCOc1ccc(Cl)cc1Cl.Cl,C13H16Cl3NO,15925.0
3769,"5-Cyano-2,3-di-(p-tolyl)tetrazolium (chloride)",Cc1ccc(-n2nc(C#N)n[n+]2-c2ccc(C)cc2)cc1.[Cl-],C16H14ClN5,15926.0
3770,Edrophonium (chloride),CC[N+](C)(C)c1cccc(O)c1.[Cl-],C10H16ClNO,15928.0
3771,10058-F4,CCc1ccc(/C=C2/SC(=S)NC2=O)cc1,C12H11NOS2,15929.0
3772,AKB48 N-(4-fluorobenzyl) analog,O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(Cc2ccc(F)cc2)c2ccccc12,C25H26FN3O,15937.0
3773,AdipoRon,O=C(COc1ccc(C(=O)c2ccccc2)cc1)NC1CCN(Cc2ccccc2)CC1,C27H28N2O3,15941.0
3774,Dutasteride,C[C@]12C=CC(=O)N[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)Nc3cc(C(F)(F)F)ccc3C(F)(F)F)CC[C@@H]12,C27H30F6N2O2,15956.0
3775,"L-165,041",CCCc1c(OCCCOc2ccc(OCC(=O)O)cc2)ccc(C(C)=O)c1O,C22H26O7,9000249.0
3776,2-Methoxyamphetamine (hydrochloride),COc1ccccc1CC(C)N.Cl,C10H16ClNO,9001915.0
3777,Amifostine (hydrate,NCCCNCCSP(=O)(O)O.O.O.O,C5H21N2O6PS,14398.0
3778,SMER3,O=C1c2ccccc2-c2nc3nonc3nc21,C11H4N4O2,15324.0
3779,Oseltamivir Acid,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](N)[C@H]1NC(C)=O,C14H24N2O4,15779.0
3780,epi-Testosterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@H]2O,C19H28O2,15875.0
3781,OTX015,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2,C25H22ClN5O2S,15947.0
3782,Clonidine (hydrochloride),Cl.Clc1cccc(Cl)c1NC1=NCCN1,C9H10Cl3N3,15949.0
3783,Clonidine (hydrochloride),Cl.Clc1cccc(Cl)c1NC1=NCCN1,C9H10Cl3N3,38558.0
3784,Saquinavir (mesylate),CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1.CS(=O)(=O)O,C39H54N6O8S,9001893.0
3785,Androsterone,C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H30O2,15872.0
3786,Dihydrotestosterone,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,C19H30O2,15874.0
3787,Dihydrotestosterone (exempt preparation),C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,C19H30O2,41649.0
3788,Cannabidiol,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O,C21H30O2,90080.0
3789,Cannabidiol (Alt. Batch CRM),C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O,C21H30O2,41217.0
3790,.alpha.-Linolenic Acid-d14,[2H]C([2H])(/C=C\C/C=C\C/C=C\CC)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C18H30O2,9000433.0
3791,3-hydroxy Phenazepam,O=C1Nc2ccc(Br)cc2C(c2ccccc2Cl)=NC1O,C15H10BrClN2O2,11472.0
3792,ML-228,c1ccc(-c2ccc(CNc3nc(-c4ccccn4)nnc3-c3ccccc3)cc2)cc1,C27H21N5,14568.0
3793,Ac-DEVD-AMC,CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)Nc1ccc2c(C)cc(=O)oc2c1)C(C)C,C30H37N5O13,14986.0
3794,Z-AEVD-FMK,COC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)OCc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)OC)C(=O)CF)C(C)C,C28H39FN4O10,14987.0
3795,Ac-LETD-AFC,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)NC(C(=O)N[C@@H](CC(=O)O)C(=O)Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1)[C@@H](C)O,C31H38F3N5O12,14991.0
3796,Zinquin ethyl ester,CCOC(=O)COc1cc(NS(=O)(=O)c2ccc(C)cc2)c2nc(C)ccc2c1,C21H22N2O5S,15133.0
3797,ML-095 (hydrochloride),CCc1nccn1CC(=O)c1ccc(O)c(O)c1.Cl,C13H15ClN2O3,15173.0
3798,Ginsenoside Rg2,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)C[C@]12C,C42H72O13,15331.0
3799,Pirinixic Acid Aminothiazole,CCCCCCC(Sc1nc(Cl)cc(Nc2nc(-c3ccc4ccccc4c3)cs2)n1)C(=O)O,C25H25ClN4O2S2,15483.0
3800,Tetrahydrocannabivarin,CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C19H26O2,15538.0
3801,Tetrahydrocannabivarin (CRM),CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C19H26O2,18091.0
3802,Tetrahydrocannabivarin,CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C19H26O2,30748.0
3803,Tetrahydrocannabivarin (Alt. Batch CRM),CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C19H26O2,41381.0
3804,Metaxalone,Cc1cc(C)cc(OCC2CNC(=O)O2)c1,C12H15NO3,15777.0
3805,ISCK03,CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(-n3ccnc3)cc2)cc1,C19H21N3O2S,15781.0
3806,SB 290157 (trifluoroacetate salt),N=C(N)NCCC[C@H](NC(=O)COCC(c1ccccc1)c1ccccc1)C(=O)O.O=C(O)C(F)(F)F,C24H29F3N4O6,15783.0
3807,STAT5 Inhibitor,O=C(N/N=C/c1coc2ccccc2c1=O)c1cccnc1,C16H11N3O3,15784.0
3808,Norketamine (hydrochloride),Cl.NC1(c2ccccc2Cl)CCCCC1=O,C12H15Cl2NO,15787.0
3809,Norketamine (hydrochloride) (CRM),Cl.NC1(c2ccccc2Cl)CCCCC1=O,C12H15Cl2NO,20128.0
3810,Moxalactam (sodium salt),CO[C@@]1(NC(=O)[C@H](C(=O)[O-])c2ccc(O)cc2)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CO[C@@H]21.[Na+].[Na+],C20H18N6Na2O9S,15869.0
3811,Dehydroepiandrosterone Sulfate (sodium salt),C[C@]12CC[C@H](OS(=O)(=O)[O-])CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12.[Na+],C19H27NaO5S,15873.0
3812,Imipramine (hydrochloride),CN(C)CCCN1c2ccccc2CCc2ccccc21.Cl,C19H25ClN2,15890.0
3813,Imipramine (hydrochloride) (CRM),CN(C)CCCN1c2ccccc2CCc2ccccc21.Cl,C19H25ClN2,19037.0
3814,Prednisolone Phosphate (sodium salt),C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+],C21H27Na2O8P,15933.0
3815,Volinanserin,COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC,C22H28FNO3,15936.0
3816,ERK Inhibitor,CCOc1ccc(/C=C2\SC(=O)N(CCN)C2=O)cc1.Cl,C14H17ClN2O3S,15944.0
3817,Zoniporide (hydrochloride),Cl.NC(N)=NC(=O)c1cnn(-c2cccc3ncccc23)c1C1CC1,C17H17ClN6O,16004.0
3818,Corilagin,O=C(OC1OC2COC(=O)c3cc(O)c(O)c(O)c3-c3c(cc(O)c(O)c3O)C(=O)OC(C2O)C1O)c1cc(O)c(O)c(O)c1,C27H22O18,11832.0
3819,N-Propylamphetamine (hydrochloride),CCCNC(C)Cc1ccccc1.Cl,C12H20ClN,14205.0
3820,25C-NBOH (hydrochloride),COc1cc(CCNCc2ccccc2O)c(OC)cc1Cl.Cl,C17H21Cl2NO3,14815.0
3821,Desomorphine,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2CCC[C@H]3[C@H]1C5,C17H21NO2,15126.0
3822,Desomorphine (exempt preparation),CN1CC[C@]23c4c5ccc(O)c4O[C@H]2CCC[C@H]3[C@H]1C5,C17H21NO2,15714.0
3823,"3,4-EDMA (hydrochloride)",CNC(C)Cc1ccc2c(c1)OCCO2.Cl,C12H18ClNO2,15164.0
3824,STO-609 (acetate),CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,C21H14N2O5,15325.0
3825,Nitrocefin,O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)O)=C(/C=C/c3ccc([N+](=O)[O-])cc3[N+](=O)[O-])CS[C@H]12,C21H16N4O8S2,15424.0
3826,Keracyanin (chloride),C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc4c(O)cc(O)cc4[o+]c3-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O.[Cl-],C27H31ClO15,15778.0
3827,4-Hydroxyalprazolam,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2O,C17H13ClN4O,15878.0
3828,Amitriptyline (hydrochloride),CN(C)CCC=C1c2ccccc2CCc2ccccc21.Cl,C20H24ClN,15881.0
3829,Amitriptyline (hydrochloride) (CRM),CN(C)CCC=C1c2ccccc2CCc2ccccc21.Cl,C20H24ClN,19031.0
3830,Clomipramine (hydrochloride),CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21.Cl,C19H24Cl2N2,15884.0
3831,Clomipramine (hydrochloride) (CRM),CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21.Cl,C19H24Cl2N2,40430.0
3832,Cyclobenzaprine (hydrochloride),CN(C)CCC=C1c2ccccc2C=Cc2ccccc21.Cl,C20H22ClN,15885.0
3833,Dextrorphan (tartrate),CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(O)cc13.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C21H29NO7,15886.0
3834,Dextrorphan (tartrate) (CRM),CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(O)cc13.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C21H29NO7,18908.0
3835,Nortriptyline (hydrochloride),CNCCC=C1c2ccccc2CCc2ccccc21.Cl,C19H22ClN,15904.0
3836,Nortriptyline (hydrochloride),CNCCC=C1c2ccccc2CCc2ccccc21.Cl,C19H22ClN,19041.0
3837,Nortriptyline (hydrochloride) (CRM),CNCCC=C1c2ccccc2CCc2ccccc21.Cl,C19H22ClN,19042.0
3838,Ritalinic Acid,O=C(O)C(c1ccccc1)C1CCCCN1,C13H17NO2,15915.0
3839,cis-Tramadol (hydrochloride,COc1cccc([C@@]2(O)CCCC[C@@H]2CN(C)C)c1.Cl,C16H26ClNO2,15919.0
3840,"3,3'-Diindolylmethane",c1ccc2c(Cc3c[nH]c4ccccc34)c[nH]c2c1,C17H14N2,15927.0
3841,Taurodeoxycholic Acid (sodium salt hydrate),C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C.O.[Na+],C26H46NNaO7S,15935.0
3842,Delorazepam,O=C1CN=C(c2ccccc2Cl)c2cc(Cl)ccc2N1,C15H10Cl2N2O,15938.0
3843,Delorazepam (CRM),O=C1CN=C(c2ccccc2Cl)c2cc(Cl)ccc2N1,C15H10Cl2N2O,42198.0
3844,MK2 Inhibitor III,O.O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21,C21H18N4O2,15943.0
3845,"SMAD3 Inhibitor, SIS3",COc1cc2c(cc1OC)CN(C(=O)/C=C/c1c(-c3ccccc3)n(C)c3ncccc13)CC2,C28H27N3O3,15945.0
3846,Vitamin K3,CC1=CC(=O)c2ccccc2C1=O,C11H8O2,15950.0
3847,MMP Inhibitor II,COc1ccc(S(=O)(=O)N2CC(C)(C)CN(S(=O)(=O)c3ccc(OC)cc3)C2C(=O)NO)cc1,C21H27N3O8S2,15958.0
3848,(R)-Prunasin,N#C[C@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1,C14H17NO6,15959.0
3849,2-Methylamino-1-phenylbutane (hydrochloride),CCC(Cc1ccccc1)NC.Cl,C11H18ClN,15961.0
3850,MMB2201,COC(=O)[C@@H](NC(=O)c1cn(CCCCCF)c2ccccc12)C(C)C,C20H27FN2O3,15971.0
3851,Metolazone,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,C16H16ClN3O3S,15987.0
3852,7-Methylguanosine,C[n+]1cn([C@@H]2O[C@H](C[O-])[C@@H](O)[C@H]2O)c2nc(N)[nH]c(=O)c21,C11H15N5O5,15988.0
3853,Cefoxitin (sodium salt),CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)[O-])=C(COC(N)=O)CS[C@@H]21.[Na+],C16H16N3NaO7S2,15990.0
3854,8-bromo Cyclic GMP (sodium salt),Nc1nc(=O)c2nc(Br)n([C@@H]3O[C@@H]4COP(=O)(O)O[C@H]4[C@H]3O)c2[nH]1.[NaH],C10H11BrN5NaO7P,15992.0
3855,Luzindole,CC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12,C19H20N2O,15998.0
3856,Roseoflavin,Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1N(C)C,C18H23N5O6,16001.0
3857,L-Selenomethionine,C[Se]CC[C@H](N)C(=O)O,C5H11NO2Se,16005.0
3858,Salmeterol (xinafoate),O=C(O)c1ccc2ccccc2c1O.OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O,C36H45NO7,16009.0
3859,"Vitamin K1 2,3-epoxide",C/C(=C\CC12OC1(C)C(=O)c1ccccc1C2=O)CCCC(C)CCCC(C)CCCC(C)C,C31H46O3,16017.0
3860,Furafylline,Cc1nc2c([nH]1)c(=O)n(C)c(=O)n2Cc1ccco1,C12H12N4O3,9000058.0
3861,CDDO-TFE,CC1(C)CC[C@]2(C(=O)NCC(F)(F)F)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,C33H43F3N2O3,90001845.0
3862,Heroin,CC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341,C21H23NO5,9001543.0
3863,Sulfosuccinimidyl Oleate (sodium salt),CCCCCCCC/C=C\CCCCCCCC(=O)ON1C(=O)CC(S(=O)(=O)[O-])C1=O.[Na+],C22H36NNaO7S,11211.0
3864,6-Gingerol,CCCCC[C@H](O)CC(=O)CCc1ccc(O)c(OC)c1,C17H26O4,11707.0
3865,CJ-42794,C[C@H](NC(=O)c1cc(Cl)ccc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,C22H17ClFNO4,10010428.0
3866,5-hydroxy DMT (hydrochloride),CN(C)CCc1c[nH]c2ccc(O)cc12.Cl,C12H17ClN2O,11803.0
3867,5-hydroxy DMT (hydrochloride) (exempt preparation),CN(C)CCc1c[nH]c2ccc(O)cc12.Cl,C12H17ClN2O,15693.0
3868,Neutrophil Elastase Inhibitor,Cc1cccc(C(=O)n2nc(C#N)c3ccccc32)c1,C16H11N3O,14922.0
3869,BAY 85-3934,O=c1c(-n2ccnn2)c[nH]n1-c1cc(N2CCOCC2)ncn1,C13H14N8O2,15297.0
3870,Desmethyldoxepin (hydrochloride),CNCC/C=C1/c2ccccc2COc2ccccc21.Cl,C18H20ClNO,15907.0
3871,Desmethylene Paroxetine (hydrochloride),Cl.Oc1ccc(OC[C@@H]2CNCC[C@H]2c2ccc(F)cc2)cc1O,C18H21ClFNO3,15908.0
3872,JNK Inhibitor VIII,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,C18H20N4O4,15946.0
3873,Calpain Inhibitor II,CSCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O,C19H35N3O4S,15994.0
3874,"1,2,3,4,6-Penta-O-galloyl-.beta.-D-glucopyranose",O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,C41H32O26,16007.0
3875,L-Leucyl-L-Leucine methyl ester (hydrochloride),COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C.Cl,C13H27ClN2O3,16008.0
3876,Camostat (mesylate),CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1.CS(=O)(=O)O,C21H26N4O8S,16018.0
3877,L-(+)-Cystathionine,N[C@@H](CCSC[C@H](N)C(=O)O)C(=O)O,C7H14N2O4S,16061.0
3878,Corticosterone,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO,C21H30O4,16063.0
3879,NAD+ (free acid),NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1,C21H27N7O14P2,16077.0
3880,NADH (sodium salt hydrate),NC(=O)C1=CN([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)C=CC1.O.[Na+].[Na+],C21H29N7Na2O15P2,16078.0
3881,NADPH (sodium salt),NC(=O)C1=CN([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)([O-])[O-])[C@@H]3O)[C@@H](O)[C@H]2O)C=CC1.[Na+].[Na+].[Na+].[Na+],C21H26N7Na4O17P3,9000743.0
3882,N-phenylacetyl-L-Homoserine lactone,O=C(Cc1ccccc1)N[C@H]1CCOC1=O,C12H13NO3,9001737.0
3883,CAY10452,NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccccc2)cc1,C16H12F3N3O2S,10075.0
3884,Resolvin D1-d5,[2H]C([2H])([2H])C([2H])([2H])/C=C\C[C@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)C/C=C\CCC(=O)O,C22H32O5,11182.0
3885,MDDMA (hydrochloride),CC(Cc1ccc2c(c1)OCO2)N(C)C.Cl,C12H18ClNO2,14217.0
3886,GM 6001,CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(=O)NO)CC(C)C,C20H28N4O4,14533.0
3887,24-dehydro Cholesterol,CC(C)=CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H44O,14943.0
3888,CPI-203,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(N)=O)c1nnc(C)n1-2,C19H18ClN5OS,15479.0
3889,Darunavir,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,C27H37N3O7S,15866.0
3890,Fialuridine,O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)cc1I,C9H10FIN2O5,15867.0
3891,Lofexidine (hydrochloride),CC(Oc1c(Cl)cccc1Cl)C1=NCCN1.Cl,C11H13Cl3N2O,15989.0
3892,Mildronate (hydrate),C[N+](C)(C)NCCC(=O)[O-].O.O,C6H18N2O4,15997.0
3893,5-chloro NNEI,O=C(Nc1cccc2ccccc12)c1cn(CCCCCCl)c2ccccc12,C24H23ClN2O,16003.0
3894,SDB-006 N-phenyl analog,CCCCCn1cc(C(=O)Nc2ccccc2)c2ccccc21,C20H22N2O,16044.0
3895,7-Ethoxyresorufin,CCOc1ccc2nc3ccc(=O)cc-3oc2c1,C14H11NO3,16122.0
3896,Difenoxin (hydrochloride),Cl.N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1,C28H29ClN2O2,9001921.0
3897,N-Formylmethamphetamine,CC(Cc1ccccc1)N(C)C=O,C11H15NO,15634.0
3898,3-CAF,O=C(Oc1ccc2ccccc2c1)c1nn(-c2ccccc2F)c2ccccc12,C24H15FN2O2,15962.0
3899,25B-NBF (hydrochloride),COc1cc(CCNCc2ccccc2F)c(OC)cc1Br.Cl,C17H20BrClFNO2,15967.0
3900,25C-NBF (hydrochloride),COc1cc(CCNCc2ccccc2F)c(OC)cc1Cl.Cl,C17H20Cl2FNO2,15969.0
3901,MMB018,CCCCCn1cc(C(=O)N[C@H](C(=O)OC)C(C)C)c2ccccc21,C20H28N2O3,15970.0
3902,Etifoxine,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1,C17H17ClN2O,15999.0
3903,Imipenem (hydrate),C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCCNC=N)C[C@H]12.O,C12H19N3O5S,16039.0
3904,Cefotaxime (sodium salt),CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(COC(C)=O)CS[C@H]12)c1csc(N)n1.[Na+],C16H16N5NaO7S2,16040.0
3905,Rivaroxaban,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,C19H18ClN3O5S,16043.0
3906,Muscone,CC1CCCCCCCCCCCCC(=O)C1,C16H30O,16067.0
3907,Oseltamivir (phosphate),CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1.O=P(O)(O)O,C16H31N2O8P,16070.0
3908,Pheophorbide a,C=Cc1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)[C@@H]4C(=O)OC)[C@@H](CCC(=O)O)[C@@H]3C,C35H36N4O5,16072.0
3909,Iodonitrotetrazolium chloride,O=[N+]([O-])c1ccc(-n2nc(-c3ccccc3)n[n+]2-c2ccc(I)cc2)cc1.[Cl-],C19H13ClIN5O2,16073.0
3910,"5,15-DPP",C1=Cc2nc1cc1ccc([nH]1)c(-c1ccccc1)c1nc(cc3ccc([nH]3)c2-c2ccccc2)C=C1,C32H22N4,16090.0
3911,2-Iodoamphetamine (hydrochloride),CC(N)Cc1ccccc1I.Cl,C9H13ClIN,9001851.0
3912,4-Iodoamphetamine (hydrochloride),CC(N)Cc1ccc(I)cc1.Cl,C9H13ClIN,9001853.0
3913,.alpha.-Pyrrolidinohexanophenone (hydrochloride),CCCCC(C(=O)c1ccccc1)N1CCCC1.Cl,C16H24ClNO,9001934.0
3914,?-Pyrrolidinohexanophenone (hydrochloride) (CRM),CCCCC(C(=O)c1ccccc1)N1CCCC1.Cl,C16H24ClNO,29146.0
3915,D609 (potassium salt),S=C([S-])OC1CC2CC1C1CCCC21.[K+],C11H15KOS2,13307.0
3916,Bromosporine,CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12,C17H20N6O4S,14119.0
3917,2-Phenethylamine (hydrochloride),Cl.NCCc1ccccc1,C8H12ClN,14206.0
3918,ONO-AE3-208,CC(C(=O)Nc1cc(C#N)ccc1CCCC(=O)O)c1ccc(F)c2ccccc12,C24H21FN2O3,14522.0
3919,TBCA,O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br,C9H4Br4O2,14831.0
3920,Diphenidine (hydrochloride),Cl.c1ccc(CC(c2ccccc2)N2CCCCC2)cc1,C19H24ClN,15518.0
3921,Misonidazole,COCC(O)Cn1ccnc1[N+](=O)[O-],C7H11N3O4,15606.0
3922,SN-38,CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,C22H20N2O5,15632.0
3923,Voriconazole,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,C16H14F3N5O,15633.0
3924,PTP1B Inhibitor,CCc1oc2cc(S(=O)(=O)Nc3ccc(S(=O)(=O)Nc4nccs4)cc3)ccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,C26H19Br2N3O7S3,15782.0
3925,ARM1,NC1=[SH]C=C(c2ccc(Cc3ccccc3)cc2)N1,C16H16N2S,15865.0
3926,Maprotiline (hydrochloride),CNCCCC12CCC(c3ccccc31)c1ccccc12.Cl,C20H24ClN,15892.0
3927,Maprotiline (hydrochloride) (CRM),CNCCCC12CCC(c3ccccc31)c1ccccc12.Cl,C20H24ClN,33077.0
3928,TZ9,Nc1nc(COC(=O)c2ccc([N+](=O)[O-])cc2)nc(Nc2ccccc2)n1,C17H14N6O4,15964.0
3929,MF498,CCOc1c2c(c(OCC)c3ncccc13)CN(c1ccc(CS(=O)(=O)NC(=O)Cc3ccccc3OC)cc1C)C2=O,C32H33N3O7S,15973.0
3930,Dibutyryl-Cyclic GMP (sodium salt),CCCC(=O)Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)([O-])O[C@H]3[C@H]2OC(=O)CCC)c(=O)[nH]1.[Na+],C18H23N5NaO9P,15991.0
3931,Sp-8-bromo-Cyclic AMPS (sodium salt),Nc1ncnc2c1nc(Br)n2[C@@H]1O[C@@H]2COP([O-])(=S)O[C@H]2[C@H]1O.[Na+],C10H10BrN5NaO5PS,16002.0
3932,Zalcitabine,Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1,C9H13N3O3,16019.0
3933,Enalapril (maleate),CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O.O=C(O)/C=C\C(=O)O,C24H32N2O9,16041.0
3934,Cytarabine,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,C9H13N3O5,16069.0
3935,Raltegravir (potassium salt),Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c([O-])c(=O)n2C)o1.[K+],C20H20FKN6O5,16071.0
3936,A-7 (hydrochloride),Cl.NCCCCCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12,C20H30Cl2N2O2S,16076.0
3937,M-144,Cc1c(C(=O)C2C(C)(C)C2(C)C)c2ccccc2n1CCCCCF,C22H30FNO,16084.0
3938,Clomiphene (citrate),CCN(CC)CCOc1ccc(/C(=C(\Cl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O,C32H36ClNO8,16087.0
3939,Oenin,COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc(OC)c1O.[Cl-],C23H25ClO12,16092.0
3940,Delphinidin-3-?-D-glucoside (chloride),OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2cc(O)c(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O.[Cl-],C21H21ClO12,16093.0
3941,(-)-Apomorphine (hydrochloride hydrate),CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl.O,C17H20ClNO3,16094.0
3942,Hedgehog Antagonist VII,O=C(NCc1nc2ccccc2c(=O)n1-c1ccc(F)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1,C23H15ClF4N4O2,16097.0
3943,DL-Sulforaphane N-acetyl-L-cysteine,CC(=O)N[C@@H](CSC(=S)NCCCCS(C)=O)C(=O)O,C11H20N2O4S3,16098.0
3944,PD 123319 (trifluoroacetate salt),Cc1cc(Cn2cnc3c2C[C@@H](C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)ccc1N(C)C.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,C35H34F6N4O7,16099.0
3945,trans-3'-Hydroxycotinine,CN1C(=O)C(O)C[C@H]1c1cccnc1,C10H12N2O2,16100.0
3946,5-Methylcytidine,Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)nc1N,C10H15N3O5,16111.0
3947,DIDS (sodium salt),O=S(=O)([O-])c1cc(N=C=S)ccc1C=Cc1ccc(N=C=S)cc1S(=O)(=O)[O-].[Na+].[Na+],C16H8N2Na2O6S4,16125.0
3948,Coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCS,C21H36N7O16P3S,16147.0
3949,ML-336,CN1CCN(C)/C(=N/c2ccc([N+](=O)[O-])cc2C(=O)Nc2ccccc2)C1,C19H21N5O3,9001920.0
3950,Psoralen,O=c1ccc2cc3ccoc3cc2o1,C11H6O3,11751.0
3951,(+)-Etomoxir (sodium salt),O=C([O-])[C@@]1(CCCCCCOc2ccc(Cl)cc2)CO1.[Na+],C15H18ClNaO4,11969.0
3952,EPZ005687,Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(CN4CCOCC4)cc3)cc3c2cnn3C2CCCC2)c(=O)[nH]1,C32H37N5O3,13966.0
3953,(+)-Methamphetamine (hydrochloride),CN[C@@H](C)Cc1ccccc1.Cl,C10H16ClN,13997.0
3954,(+)-Methamphetamine (hydrochloride) (CRM),CN[C@@H](C)Cc1ccccc1.Cl,C10H16ClN,26615.0
3955,25I-NBOH (hydrochloride),COc1cc(CCNCc2ccccc2O)c(OC)cc1I.Cl,C17H21ClINO3,14909.0
3956,GSK429286A,CC1=C(C(=O)Nc2cc3cn[nH]c3cc2F)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1,C21H16F4N4O2,15262.0
3957,Methoxphenidine (hydrochloride),COc1ccccc1C(Cc1ccccc1)N1CCCCC1.Cl,C20H26ClNO,15519.0
3958,AB-FUBINACA metabolite 2A,CC(C(=O)O)C(NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(N)=O,C20H19FN4O4,15529.0
3959,AB-FUBINACA metabolite 2B,CC(C(=O)O)C(NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(N)=O,C20H19FN4O4,17947.0
3960,N-ethyl Pentylone (hydrochloride),CCCC(NCC)C(=O)c1ccc2c(c1)OCO2.Cl,C14H20ClNO3,16037.0
3961,N-ethyl Pentylone (hydrochloride) (CRM),CCCC(NCC)C(=O)c1ccc2c(c1)OCO2.Cl,C14H20ClNO3,24337.0
3962,Cinacalcet (hydrochloride),C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12.Cl,C22H23ClF3N,16042.0
3963,Cefpodoxime,COCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC)c3csc(N)n3)[C@H]2SC1,C15H17N5O6S2,16075.0
3964,TPT-260 (hydrochloride),Cl.Cl.N=C(N)SCc1ccc(CSC(=N)N)s1,C8H14Cl2N4S3,16079.0
3965,4-Methylumbelliferyl Palmitate,CCCCCCCCCCCCCCCC(=O)Oc1ccc2c(C)cc(=O)oc2c1,C26H38O4,16089.0
3966,N-Acetylneuraminic Acid,CC(=O)N[C@@H]([C@@H](O)[C@H](O)[C@H](O)CO)[C@@H](O)CC(=O)C(=O)O,C11H19NO9,16091.0
3967,Penta-N-acetylchitopentaose,CC(=O)NC(C=O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4NC(C)=O)[C@H](O)[C@H]3NC(C)=O)[C@H](O)[C@H]2NC(C)=O)[C@H](O)[C@H]1NC(C)=O)[C@H](O)CO,C40H67N5O26,16101.0
3968,ONO-AE3-208 (sodium salt),CC(C(=O)Nc1cc(C#N)ccc1CCCC(=O)[O-])c1ccc(F)c2ccccc12.[Na+],C24H20FN2NaO3,16108.0
3969,Cefoperazone (sodium salt),CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)[O-])=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O.[Na+],C25H26N9NaO8S2,16113.0
3970,Boc-D-FMK,COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)CF,C11H18FNO5,16118.0
3971,3-Iodothyronamine (hydrochloride),Cl.NCCc1ccc(Oc2ccc(O)cc2)c(I)c1,C14H15ClINO2,16121.0
3972,N-desmethyl Loperamide,CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,C28H31ClN2O2,16126.0
3973,Cefsulodin (sodium salt hydrate),NC(=O)c1cc[n+](CC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)[C@@H](c4ccccc4)S(=O)(=O)[O-])[C@H]3SC2)cc1.O.[Na+],C22H19N4NaO8S2(H2O)X,16127.0
3974,Levosimendan,C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1,C14H12N6O,16128.0
3975,Chlorpromazine (hydrochloride),CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21.Cl,C17H20Cl2N2S,16129.0
3976,Rifaximin,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,C43H51N3O11,16131.0
3977,1-Aminocyclopropanecarboxylic Acid,NC1(C(=O)O)CC1,C4H7NO2,16132.0
3978,Procarbazine (hydrochloride),CNNCc1ccc(C(=O)NC(C)C)cc1.Cl,C12H20ClN3O,16133.0
3979,Phentolamine (mesylate),CS(=O)(=O)O.Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,C18H23N3O4S,16135.0
3980,Sotalol (hydrochloride),CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1.Cl,C12H21ClN2O3S,16136.0
3981,Isofagomine (D-tartrate),O=C(O)[C@@H](O)[C@H](O)C(=O)O.OC[C@H]1CNC[C@@H](O)[C@@H]1O,C10H19NO9,16137.0
3982,20-hydroxy Ecdysone,CC(C)(O)CC[C@@H](O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C,C27H44O7,16145.0
3983,"17.alpha.,20.beta.-Dihydroxy-4-pregnen-3-one",C[C@@H](O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,C21H32O3,16146.0
3984,AGK7,N#C/C(=C\c1ccc(-c2cc(Cl)ccc2Cl)o1)C(=O)Nc1cccc2cccnc12,C23H13Cl2N3O2,16152.0
3985,CH 223191,Cc1ccccc1/N=N/c1ccc(NC(=O)c2ccnn2C)c(C)c1,C19H19N5O,16154.0
3986,.beta.-Estradiol 3-(.beta.-D-Glucuronide) (sodium salt),C[C@]12CC[C@@H]3c4ccc(O[C@@H]5O[C@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]5O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O.[Na+],C24H31NaO8,16155.0
3987,Coelenterazine 400a,O=c1c(Cc2ccccc2)nc2c(Cc3ccccc3)[nH]c(-c3ccccc3)cn1-2,C26H21N3O,16157.0
3988,Acetyl-Coenzyme A (sodium salt),CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O.[NaH],C23H38N7NaO17P3S,16160.0
3989,ISX-9,O=C(NC1CC1)c1cc(-c2cccs2)on1,C11H10N2O2S,16165.0
3990,EPZ5676,CC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)[C@H]1C[C@@H](CCc2nc3ccc(C(C)(C)C)cc3[nH]2)C1,C30H42N8O3,16175.0
3991,GGTI 298 (trifluoroacetate salt),COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1cccc2ccccc12.O=C(O)C(F)(F)F,C29H34F3N3O5S,16176.0
3992,NU 6027,Nc1nc(N)c(N=O)c(OCC2CCCCC2)n1,C11H17N5O2,16177.0
3993,Pyrintegrin,O=S(=O)(NCC1CC1)c1ccc(Nc2nccc(N3CCCc4cc(O)ccc43)n2)cc1,C23H25N5O3S,16179.0
3994,N1-Acetylspermidine (hydrochloride),CC(=O)NCCCNCCCCN.Cl.Cl,C9H23Cl2N3O,9001535.0
3995,"N,N-Dimethylpentylone (hydrochloride)",CCCC(C(=O)c1ccc2c(c1)OCO2)N(C)C.Cl,C14H20ClNO3,9001933.0
3996,"N,N-Dimethylpentylone (hydrochloride) (CRM)",CCCC(C(=O)c1ccc2c(c1)OCO2)N(C)C.Cl,C14H20ClNO3,31085.0
3997,3-Acetylmorphine,CC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341,C19H21NO4,9001954.0
3998,MMB-FUBINACA,COC(=O)[C@@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(C)C,C21H22FN3O3,9001960.0
3999,MMB-FUBINACA (CRM),COC(=O)[C@@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(C)C,C21H22FN3O3,31090.0
4000,NADP+ (sodium salt hydrate),NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)(O)O)[C@@H]3O)[C@@H](O)[C@H]2O)c1.O.[Na+],C21H27N7NaO17P3(H2O)n,10004675.0
4001,Halofuginone (hydrochloride),Cl.O=C(C[C@H]1NCCC[C@@H]1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O,C16H18BrCl2N3O3,13370.0
4002,JNJ-10397049,CC1(C)OC[C@H](NC(=O)Nc2ccc(Br)cc2Br)[C@H](c2ccccc2)O1,C19H20Br2N2O3,14139.0
4003,DL-Norephedrine (hydrochloride),C[C@@H](N)[C@@H](O)c1ccccc1.Cl,C9H14ClNO,14212.0
4004,RH-34,COc1ccccc1CNCCn1c(=O)[nH]c2ccccc2c1=O,C18H19N3O3,14445.0
4005,BQCA,COc1ccc(Cn2cc(C(=O)O)c(=O)c3ccccc32)cc1,C18H15NO4,15393.0
4006,CFTR Inhibitor-172,O=C(O)c1ccc(/C=C2\SC(=S)N(c3cccc(C(F)(F)F)c3)C2=O)cc1,C18H10F3NO3S2,15545.0
4007,Neoruscogenin,C=C1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O)C[C@@H](O)[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C27H40O4,15567.0
4008,Caspofungin (acetate),CC(=O)O.CC(=O)O.CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O,C56H96N10O19,15923.0
4009,Prothionamide,CCCc1cc(C(N)=S)ccn1,C9H12N2S,16074.0
4010,Coelenterazine,O=c1c(Cc2ccc(O)cc2)nc2c(Cc3ccccc3)[nH]c(-c3ccc(O)cc3)cn1-2,C26H21N3O3,16123.0
4011,trans-Clovamide,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,C18H17NO7,16138.0
4012,Pyronaridine (phosphate),COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O,C29H44ClN5O18P4,16139.0
4013,"1-Oxyl-2,2,5,5-tetramethylpyrroline-3-carboxylate NHS ester",CC1(C)C=C(C(=O)ON2C(=O)CCC2=O)C(C)(C)N1[O],C13H17N2O5,16148.0
4014,1-(1-Naphthyl)piperazine (hydrochloride),Cl.c1ccc2c(N3CCNCC3)cccc2c1,C14H17ClN2,16150.0
4015,O-Phospho-L-Serine,N[C@@H](COP(=O)(O)O)C(=O)O,C3H8NO6P,16151.0
4016,IQ-1,CC(=O)c1ccc(/N=N/C(C(N)=O)=C2\NC(C)(C)Cc3ccccc32)cc1,C21H22N4O2,16153.0
4017,PluriSln,O=C(NNc1ccccc1)c1ccncc1,C12H11N3O,16161.0
4018,Ochratoxin B,C[C@@H]1Cc2ccc(C(=O)N[C@@H](Cc3ccccc3)C(=O)O)c(O)c2C(=O)O1,C20H19NO6,16167.0
4019,Citrulline-specific Probe--rhodamine,CC(C(=O)Nc1cccc(C(=O)C=O)c1)n1cc(CNC(=O)c2ccc3c(c2)C(=O)OC32c3ccc(N(C)C)cc3Oc3cc(N(C)C)ccc32)nn1.O,C39H37N7O8,16172.0
4020,WHI-P154,COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,C16H14BrN3O3,16178.0
4021,WWL113,CCOC(=O)c1ccc(-c2ccc(OC(=O)N(C)Cc3cccc(-c4ccncc4)c3)cc2)cc1,C29H26N2O4,16181.0
4022,Ingenol-3-angelate,C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C,C25H34O6,16207.0
4023,p-nitro-Pifithrin-.alpha.,Br.N=c1sc2c(n1CC(=O)c1ccc([N+](=O)[O-])cc1)CCCC2,C15H16BrN3O3S,16209.0
4024,2'-Deoxyadenosine-5'-monophosphate (hydrate),Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](COP(=O)(O)O)O1.O,C10H16N5O7P,16218.0
4025,Uric Acid (sodium salt),O=c1nc([O-])c2[nH]c(=O)[nH]c2[nH]1.[Na+],C5H3N4NaO3,16219.0
4026,Pimozide,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,C28H29F2N3O,16222.0
4027,"7,8,9,10-Tetrahydrobenzo[a]pyren-7-ol",OC1CCCc2c1cc1ccc3cccc4ccc2c1c34,C20H16O,16225.0
4028,Nourseothricin (sulfate),O=S(=O)(O)O.[H]NCCC[C@H](N)CC(=O)N[C@@H]1[C@H](O)[C@@H](OC(N)=O)[C@@H](CO)O[C@H]1NC1=N[C@@H]2[C@H](O)CNC(=O)[C@H]2N1,C13H24N6O11S(C6H12N2O)n,16227.0
4029,PRIMA-1 MET,COCC1(CO)C(=O)C2CCN1CC2,C10H17NO3,9000487.0
4030,(R)-nitro-Blebbistatin,O=C1c2ccc([N+](=O)[O-])cc2N=C2N(c3ccccc3)CC[C@]12O,C17H13N3O4,9001935.0
4031,"(1H-Indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone",CC1(C)C(C(=O)c2c[nH]c3ccccc23)C1(C)C,C16H19NO,9001966.0
4032,Phenylacetone (exempt preparation),CC(=O)Cc1ccccc1,C9H10O,16444.0
4033,Phenylacetone,CC(=O)Cc1ccccc1,C9H10O,16103.0
4034,Carnosic Acid,CC(C)c1cc2c(c(O)c1O)[C@@]1(C(=O)O)CCCC(C)(C)C1CC2,C20H28O4,89820.0
4035,Etoposide catechol,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(O)c1O,C28H30O13,9001957.0
4036,Etoposide quinone,COC1=CC([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@@H]32)OCO4)=CC(=O)C1=O,C28H28O13,9001958.0
4037,Fosmidomycin (sodium salt),O=CN(O)CCCP(=O)([O-])O.[Na+],C4H9NNaO5P,16000.0
4038,Sinomenine (hydrochloride),COC1=C[C@@H]2[C@H]3Cc4ccc(OC)c(O)c4[C@]2(CCN3C)CC1=O.Cl,C19H24ClNO4,16143.0
4039,KP372-1A,O=C1c2ccccc2-c2nn3nnnc3nc21,C10H4N6O,16163.0
4040,GSA 10,CCCCCCn1c(=O)c(C(=O)Nc2ccc(C(=O)OCCC)cc2)c(O)c2ccccc21,C26H30N2O5,16164.0
4041,5-Methyl-2'-deoxycytidine,Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)nc1N,C10H15N3O4,16166.0
4042,Benztropine (mesylate),CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2.CS(=O)(=O)O,C22H29NO4S,16214.0
4043,Lutein,CC1=C[C@H](O)CC(C)(C)[C@H]1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,C40H56O2,10010811.0
4044,10-Nitrooleate-d17,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])/C(=C\CCCCCCCC(=O)O)[N+](=O)[O-],C18H33NO4,10558.0
4045,UNC669,O=C(c1cncc(Br)c1)N1CCC(N2CCCC2)CC1,C15H20BrN3O,10875.0
4046,Citreoviridin,COc1cc(=O)oc(/C=C/C=C/C=C/C(C)=C/[C@@]2(C)O[C@H](C)[C@](C)(O)[C@H]2O)c1C,C23H30O6,11319.0
4047,JIB-04,Clc1ccc(N/N=C(\c2ccccc2)c2ccccn2)nc1,C17H13ClN4,15338.0
4048,Lauroyl-DL-Carnitine (chloride),CCCCCCCCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C.[Cl-],C19H38ClNO4,16006.0
4049,5-hydroxy Tryptophol,OCCc1c[nH]c2ccc(O)cc12,C10H11NO2,16114.0
4050,Clodronate (sodium salt hydrate),O.O.O.O.O=P([O-])(O)C(Cl)(Cl)P(=O)([O-])O.[Na+].[Na+],CH10Cl2Na2O10P2,16134.0
4051,L-DOPA methyl ester (hydrochloride),COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1.Cl,C10H14ClNO4,16149.0
4052,2-Hydroxypropyl-.beta.-cyclodextrin,CC(O)COC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8COCC(C)O)O[C@@H]7COCC(C)O)O[C@@H]6COCC(C)O)O[C@@H]5COCC(C)O)O[C@@H]4COCC(C)O)O[C@@H]3COCC(C)O,C63H112O42,16169.0
4053,PX-1,NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cn(CCCCCF)c2ccccc12,C23H26FN3O2,16201.0
4054,Hydroxydimetridazole,Cn1c([N+](=O)[O-])cnc1CO,C5H7N3O3,16208.0
4055,Phenoxybenzamine (hydrochloride),CC(COc1ccccc1)N(CCCl)Cc1ccccc1.Cl,C18H23Cl2NO,16211.0
4056,Chlorthalidone,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,C14H11ClN2O4S,16213.0
4057,Juglone,O=C1C=CC(=O)c2c(O)cccc21,C10H6O3,16216.0
4058,Guanethidine (sulfate),NC(N)=NCCN1CCCCCCC1.O=S(=O)(O)O,C10H24N4O4S,16217.0
4059,Calcein,O=C(O)CN(CC(=O)O)Cc1cc2c(cc1O)Oc1cc(O)c(CN(CC(=O)O)CC(=O)O)cc1C21OC(=O)c2ccccc21,C30H26N2O13,16221.0
4060,.alpha.-Phenyl-.alpha.-(2-pyridyl)acetonitrile,N#CC(c1ccccc1)c1ccccn1,C13H10N2,16224.0
4061,NQDI-1,CCOC(=O)c1c2c3c(cccc3[nH]c1=O)C(=O)c1ccccc1-2,C19H13NO4,16226.0
4062,trans-Urocanic Acid,O=C(O)/C=C/c1cnc[nH]1,C6H6N2O2,16228.0
4063,ABT-199,CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1,C45H50ClN7O7S,16233.0
4064,CGK733,O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1,C23H18Cl3FN4O3S,16242.0
4065,GNF 2,NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,C18H13F3N4O2,16253.0
4066,GW 788388,O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,C25H23N5O2,16255.0
4067,ICG-001,O=C1[C@H](Cc2ccc(O)cc2)N2C(=O)CCN(C(=O)NCc3ccccc3)[C@H]2CN1Cc1cccc2ccccc12,C33H32N4O4,16257.0
4068,MC 1568,Cn1c(/C=C/C(=O)NO)ccc1/C=C/C(=O)c1cccc(F)c1,C17H15FN2O3,16265.0
4069,Ibrutinib,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,C25H24N6O2,16274.0
4070,Trametinib,CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,C26H23FIN5O4,16292.0
4071,O6-Benzylguanine,Nc1nc(OCc2ccccc2)c2nc[nH]c2n1,C12H11N5O,16332.0
4072,.beta.-Nicotyrine,Cn1cccc1-c1cccnc1,C10H10N2,16333.0
4073,Cyclothiazide,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,C14H16ClN3O4S2,16335.0
4074,KU-55933,O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,C21H17NO3S2,16336.0
4075,SB-3CT,O=S(=O)(CC1CS1)c1ccc(Oc2ccccc2)cc1,C15H14O3S2,16337.0
4076,7-keto Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C(=O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H44O2,16339.0
4077,Pregnenolone Carbonitrile,CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,C22H31NO2,16343.0
4078,3-deoxy Glucosone,O=CC(=O)C[C@H](O)[C@H](O)CO,C6H10O5,16347.0
4079,DNA Base Excision Repair Pathway Inhibitor,O=C(O)c1cc2cccc([N+](=O)[O-])c2[nH]1,C9H6N2O4,16348.0
4080,PNU 74654,Cc1ccc(/C=N/NC(=O)c2ccccc2Oc2ccccc2)o1,C19H16N2O3,16349.0
4081,AAL-993,O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1,C20H16F3N3O,16351.0
4082,KB-R7943,CS(=O)(=O)O.N=C(N)SCCc1ccc(OCc2ccc([N+](=O)[O-])cc2)cc1,C17H21N3O6S2,16352.0
4083,TCID,O=C1CC(=O)c2c(Cl)c(Cl)c(Cl)c(Cl)c21,C9H2Cl4O2,16353.0
4084,Ataciguat,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cc(Cl)ccc1NS(=O)(=O)c1ccc(Cl)s1,C21H19Cl2N3O6S3,16371.0
4085,Dihydrolipoic Acid,O=C(O)CCCCC(S)CCS,C8H16O2S2,16372.0
4086,4-Thiouridine,O=c1[nH]c(=S)ccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C9H12N2O5S,16373.0
4087,2-Hydroxyglutaric Acid (sodium salt),O=C([O-])CCC(O)C(=O)[O-].[Na+].[Na+],C5H6Na2O5,16374.0
4088,Sucrose octasulfate (potassium salt),O=S(=O)([O-])OC[C@H]1O[C@@](COS(=O)(=O)[O-])(O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+],C12H14K8O35S8,16382.0
4089,Fluorescein-5-maleimide,O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccc(N3C(=O)C=CC3=O)cc21,C24H13NO7,16383.0
4090,Ponasterone A,CC(C)CC[C@@H](O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C,C27H44O6,16386.0
4091,AB-CHMINACA metabolite M4,O=C(O)c1nn(CC2CCCCC2)c2ccccc12,C15H18N2O2,16393.0
4092,S-(4-nitrobenzyl)-6-thioinosine,O=[N+]([O-])c1ccc(CSc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1,C17H17N5O6S,16403.0
4093,"3,4,6-Tri-O-benzyl-.beta.-D-mannopyranose 1,2-(methyl orthoacetate)",COC1(C)O[C@@H]2O[C@H](COCc3ccccc3)[C@@H](OCc3ccccc3)[C@H](OCc3ccccc3)[C@@H]2O1,C30H34O7,16405.0
4094,Cyanidin 3-O-glucoside (chloride),OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O.[Cl-],C21H21ClO11,16406.0
4095,MA-CHMINACA,COC(=O)[C@@H](NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(C)C,C21H29N3O3,16421.0
4096,4-Methylmethamphetamine (hydrochloride),CNC(C)Cc1ccc(C)cc1.Cl,C11H18ClN,9001345.0
4097,MCHB-1,CCOc1ccc(Cc2nc3cc(C(=O)N(CC)CC)ccc3n2CC2CCCCC2)cc1,C28H37N3O2,9001949.0
4098,Hexadecanal,CCCCCCCCCCCCCCCC=O,C16H32O,9001996.0
4099,Allylescaline (hydrochloride),C=CCOc1c(OC)cc(CCN)cc1OC.Cl,C13H20ClNO3,9001982.0
4100,25T4-NBOMe (hydrochloride),COc1cc(SC(C)C)c(OC)cc1CCNCc1ccccc1OC.Cl,C21H30ClNO3S,9001989.0
4101,Mescaline NBOMe (hydrochloride),COc1ccccc1CNCCc1cc(OC)c(OC)c(OC)c1.Cl,C19H26ClNO4,9001990.0
4102,Pioglitazone (potassium salt),CCc1ccc(CCOc2ccc(CC3SC(=O)[N-]C3=O)cc2)nc1.[K+],C19H19KN2O3S,10028.0
4103,Pioglitazone,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,C19H20N2O3S,71745.0
4104,SGC-CBP30,COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl,C28H33ClN4O3,14469.0
4105,ARN1203,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCC(O)CF,C23H38FNO2,16065.0
4106,CAY10685,C#CCN(N=C1CCCC1)c1nc(-c2ccc(Cl)cc2)cs1,C17H16ClN3S,16086.0
4107,MDMB-CHMINACA,COC(=O)[C@@H](NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(C)(C)C,C22H31N3O3,16200.0
4108,L-Leucine 4-methoxy-.beta.-naphthylamide (hydrochloride),COc1cc(NC(=O)[C@@H](N)CC(C)C)cc2ccccc12.Cl,C17H23ClN2O2,16223.0
4109,ISRIB,O=C(COc1ccc(Cl)cc1)N[C@H]1CC[C@H](NC(=O)COc2ccc(Cl)cc2)CC1,C22H24Cl2N2O4,16258.0
4110,Ezetimibe,O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1,C24H21F2NO3,16331.0
4111,SU 1498,CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O,C25H30N2O2,16354.0
4112,Gaboxadol (hydrochloride),Cl.O=c1[nH]oc2c1CCNC2,C6H9ClN2O2,16355.0
4113,CMP-Sialic Acid (sodium salt),CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](OP(=O)([O-])OC[C@H]2O[C@@H](n3ccc(N)nc3=O)[C@H](O)[C@@H]2O)(C(=O)O)C[C@@H]1O.[Na+],C20H30N4NaO16P,16404.0
4114,Carprofen,CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12,C15H12ClNO2,16409.0
4115,SGI-1776,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,C20H22F3N5O,16423.0
4116,RVX-208,COc1cc(OC)c2c(=O)nc(-c3cc(C)c(OCCO)c(C)c3)[nH]c2c1,C20H22N2O5,16424.0
4117,CUDC-101,C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1,C24H26N4O4,16426.0
4118,MTSSL,CC1(C)C=C(CSS(C)(=O)=O)C(C)(C)N1[O],C10H18NO3S2,16463.0
4119,Docosahexaenoic Acid ethyl ester-d5,[2H]C([2H])([2H])C([2H])([2H])OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC,C24H36O2,9001245.0
4120,PTI-1 (hydrochloride),CCCCCn1cc(-c2nc(CN(CC)CC)cs2)c2ccccc21.Cl,C21H30ClN3S,9001948.0
4121,(S)-Ketamine (hydrochloride),CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl,C13H17Cl2NO,9001961.0
4122,(S)-Ketamine (hydrochloride) (CRM),CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl,C13H17Cl2NO,26317.0
4123,(S)-Ketamine (hydrochloride),CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl,C13H17Cl2NO,38399.0
4124,Seratrodast,CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O,C22H26O4,9002014.0
4125,HDMAPP (ammonium salt),C/C(=C\COP(=O)([O-])OP(=O)([O-])[O-])CO.[NH4+].[NH4+].[NH4+],C5H21N3O8P2,13580.0
4126,Amodiaquine,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,C20H22ClN3O,15954.0
4127,CYT387,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,C23H22N6O2,16246.0
4128,Foretinib,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,C34H34F2N4O6,16249.0
4129,Monomethyl Auristatin E,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C,C39H67N5O7,16267.0
4130,2'-Deoxyguanosine 5'-monophosphate (sodium salt hydrate),Nc1nc2c(ncn2[C@H]2C[C@H](O)[C@@H](COP(=O)([O-])[O-])O2)c(=O)[nH]1.[Na+].[Na+],C10H12N5Na2O7P,16408.0
4131,Hexanoyl Glycine,CCCCCC(=O)NCC(=O)O,C8H15NO3,16412.0
4132,.alpha.-(difluoromethyl)-DL-Arginine,N=C(N)NCCCC(N)(C(=O)O)C(F)F,C7H14F2N4O2,16415.0
4133,PF-04620110,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,C21H24N4O4,16425.0
4134,LAQ824,O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO,C22H25N3O3,16427.0
4135,Biotin-HPDP,O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)NCCCCCCNC(=O)CCSSc1ccccn1,C24H37N5O3S3,16459.0
4136,"1,2-Di-O-hexadecyl-rac-glycerol",CCCCCCCCCCCCCCCCOCC(CO)OCCCCCCCCCCCCCCCC,C35H72O3,16490.0
4137,"1,2-Di-O-octadecyl-rac-glycerol",CCCCCCCCCCCCCCCCCCOCC(CO)OCCCCCCCCCCCCCCCCCC,C39H80O3,16491.0
4138,Palmitic Acid-d31,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C16H32O2,16497.0
4139,MK-0524,CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3,C21H19ClFNO4S,10009835.0
4140,Robotnikinin,O=C(C[C@@H]1C/C=C/CCC(=O)O[C@H](c2ccccc2)CNC1=O)NCc1ccc(Cl)cc1,C25H27ClN2O4,13204.0
4141,CJ-023423,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,C26H29N5O3S,10010355.0
4142,I-BET151,COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12,C23H21N5O3,11181.0
4143,D-.alpha.-Hydroxyglutaric Acid (sodium salt),O=C([O-])CC[C@@H](O)C(=O)[O-].[Na+].[Na+],C5H6Na2O5,11605.0
4144,Atractyloside (potassium salt),C=C1[C@@H]2CC[C@H]3[C@]4(C)C[C@H](O[C@H]5O[C@@H](CO)[C@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]5OC(=O)CC(C)C)CC(C(=O)O)[C@H]4CC[C@]3(C2)[C@H]1O.[K+].[K+],C30H44K2O16S2,14804.0
4145,PSB-SB1202,CCCCCc1cc(OC)c2cc(Cc3ccccc3OC)c(=O)oc2c1,C23H26O4,15621.0
4146,S1RA,Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1,C20H23N3O2,16279.0
4147,Tenovin-3,CC(C)(C)c1ccc(C(=O)NC(=S)Nc2ccc(N)cc2)cc1,C18H21N3OS,16288.0
4148,PX 2,NC(=O)[C@H](Cc1ccccc1)NC(=O)c1nn(CCCCCF)c2ccccc12,C22H25FN4O2,16434.0
4149,TNP-470,CO[C@@H]1[C@H](OC(=O)NC(=O)CCl)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C,C19H28ClNO6,16449.0
4150,L-Ascorbic Acid 2-phosphate (magnesium salt hydrate),O.O=C1O[C@H]([C@@H](O)CO)C(O)=C1OP(=O)(O)O.O=C1O[C@H]([C@@H](O)CO)C(O)=C1OP(=O)(O)O.[MgH2].[MgH2].[MgH2],C12H20Mg3O19P2,16457.0
4151,Danazol,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,C22H27NO2,16471.0
4152,Reserpine,COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,C33H40N2O9,16474.0
4153,Promethazine (hydrochloride),CC(CN1c2ccccc2Sc2ccccc21)N(C)C.Cl,C17H21ClN2S,16478.0
4154,Promethazine (hydrochloride) (CRM),CC(CN1c2ccccc2Sc2ccccc21)N(C)C.Cl,C17H21ClN2S,21331.0
4155,Blonanserin,CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1,C23H30FN3,16480.0
4156,Epothilone A,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@@H]2CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1,C26H39NO6S,16482.0
4157,Zilpaterol (hydrochloride),CC(C)N[C@H]1CCn2c(=O)[nH]c3cccc(c32)[C@@H]1O.Cl,C14H20ClN3O2,16484.0
4158,Erythromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,C37H67NO13,16486.0
4159,SR 1078,O=C(Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1)c1ccc(C(F)(F)F)cc1,C17H10F9NO2,16503.0
4160,25T7-NBOMe (hydrochloride),CCCSc1cc(OC)c(CCNCc2ccccc2OC)cc1OC.Cl,C21H30ClNO3S,9001988.0
4161,CEP-Lysine-d4,[2H]C([2H])(C(=O)O)C([2H])([2H])c1cccn1CCCC[C@H](N)C(=O)O,C13H20N2O4,9000595.0
4162,Doxifluridine,C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C(O)C1O,C9H11FN2O5,10253.0
4163,Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,C22H23N3O4,10483.0
4164,Atorvastatin (calcium salt hydrate),CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].O.[Ca+2],C66H70CaF2N4O11,10493.0
4165,MDA 77,CCCCCN1C(=O)/C(=N\NC(=O)c2ccccc2)c2ccc(OC)cc21,C21H23N3O3,10639.0
4166,KM 233,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccccc3)cc1OC2(C)C,C25H30O2,10640.0
4167,Muristerone A,CC(C)CC[C@@H](O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@]4(O)C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3[C@H](O)C[C@]12C,C27H44O8,11741.0
4168,HDAC6 Inhibitor,Cn1cccc1C(=O)N1CCc2cc(C(=O)NO)ccc2C1,C16H17N3O3,15200.0
4169,YZ9,CCOC(=O)c1cc2ccc(O)cc2oc1=O,C12H10O5,15352.0
4170,"L-3,3',5-Triiodothyronine (sodium salt hydrate)",N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)[O-].O.[Na+],C15H13I3NNaO5,16028.0
4171,TTNPB,C/C(=C\c1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C,C24H28O2,16144.0
4172,AZD 9291,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,C28H33N7O2,16237.0
4173,CK 636,Cc1[nH]c2ccccc2c1CCNC(=O)c1cccs1,C16H16N2OS,16243.0
4174,JW 55,COc1ccc(C2(CNC(=O)c3ccc(NC(=O)c4ccco4)cc3)CCOCC2)cc1,C25H26N2O5,16260.0
4175,LDE 225 (phosphate),Cc1c(C(=O)Nc2ccc(N3C[C@@H](C)O[C@@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1.O=P(O)(O)O.O=P(O)(O)O,C26H32F3N3O11P2,16263.0
4176,PBIT,Cc1ccc(-n2sc3ccccc3c2=O)cc1,C14H11NOS,16272.0
4177,SB-525334,Cc1cccc(-c2nc(C(C)(C)C)[nH]c2-c2ccc3nccnc3c2)n1,C21H21N5,16281.0
4178,TGR5 Receptor Agonist,Cc1onc(-c2ccccc2Cl)c1C(=O)N(C)c1ccc(Cl)cc1,C18H14Cl2N2O2,16291.0
4179,7-methyl-6-Thioguanosine (technical grade),C[n+]1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2nc([NH-])[nH]c(=S)c21,C11H15N5O4S,16381.0
4180,UNC3230,NC(=O)c1nc(Nc2ccccc2)sc1NC(=O)C1CCCCC1,C17H20N4O2S,16401.0
4181,"(1'S,2'S)-Nicotine-1'-oxide",C[N@+]1([O-])CCC[C@H]1c1cccnc1,C10H14N2O,16413.0
4182,Nullscript,O=C(CCCN1C(=O)c2cccc3cccc(c23)C1=O)NO,C16H14N2O4,16433.0
4183,Medetomidine (hydrochloride),Cc1cccc(C(C)c2cnc[nH]2)c1C.Cl,C13H17ClN2,16454.0
4184,Medetomidine (hydrochloride) (CRM),Cc1cccc(C(C)c2cnc[nH]2)c1C.Cl,C13H17ClN2,38807.0
4185,1-methyl-D-Tryptophan,Cn1cc(C[C@@H](N)C(=O)O)c2ccccc21,C12H14N2O2,16456.0
4186,3-[2-N-(Biotinyl)aminoethyldithio]propanoic Acid,O=C(O)CCSSCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C15H25N3O4S3,16461.0
4187,Azumolene (sodium salt),O=C1CN(/N=C/c2ncc(-c3ccc(Br)cc3)o2)C(=O)[N-]1.[Na+],C13H8BrN4NaO3,16462.0
4188,Rifabutin,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O,C46H62N4O11,16468.0
4189,Pyrimethamine,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,C12H13ClN4,16472.0
4190,Trimethoprim,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,C14H18N4O3,16473.0
4191,L-(-)-Fucose,C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C=O,C6H12O5,16479.0
4192,"1,3-Dilinoleoyl Glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C39H68O5,16481.0
4193,Monensin (sodium salt),CC[C@@]1([C@@H]2O[C@@H]([C@H]3O[C@@](O)(CO)[C@H](C)C[C@@H]3C)C[C@@H]2C)CC[C@H]([C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(=O)[O-])O3)O2)O1.[Na+],C36H61NaO11,16488.0
4194,"1,2,3-Triheptadecanoyl Glycerol",CCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC,C54H104O6,16489.0
4195,n-Dodecyl-.beta.-D-maltoside,CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,C24H46O11,16494.0
4196,A-443654,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,C24H23N5O,16499.0
4197,BRD32048,COc1ccc(Nc2nc(N)nc(CN3CCCCC3)n2)cc1,C16H22N6O,16516.0
4198,6-Azidohexanoic Acid,[N-]=[N+]=NCCCCCC(=O)O,C6H11N3O2,16518.0
4199,Spinosyn A,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1,C41H65NO10,16528.0
4200,Oleandomycin,CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3O)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1O,C35H61NO12,16552.0
4201,Ferutinin,CC1=CC[C@@]2(C)CC[C@@](O)(C(C)C)[C@@H]2[C@@H](OC(=O)c2ccc(O)cc2)C1,C22H30O4,16554.0
4202,SGC0946,CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O,C28H40BrN7O4,13967.0
4203,(R)-PFI-2 (hydrochloride),Cl.O=C([C@@H](Cc1cccc(C(F)(F)F)c1)NS(=O)(=O)c1cc(F)c2c(c1)CCNC2)N1CCCC1,C23H26ClF4N3O3S,14678.0
4204,TIQ-A,O=c1[nH]c2sccc2c2ccccc12,C11H7NOS,16112.0
4205,Cannabidiol-d9 (CRM),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(O)c1,C21H30O2,16203.0
4206,BMS 303141,COc1ccc(-c2ccccc2)cc1NS(=O)(=O)c1cc(Cl)cc(Cl)c1O,C19H15Cl2NO4S,16239.0
4207,PPQ-102,Cc1ccc(C2Nc3ccccc3-n3c(-c4ccccc4)c4c(=O)n(C)c(=O)n(C)c4c32)o1,C26H22N4O3,16275.0
4208,SRPIN340,O=C(Nc1cc(C(F)(F)F)ccc1N1CCCCC1)c1ccncc1,C18H18F3N3O,16284.0
4209,GIT 27,O=C(O)CC1CC(c2ccccc2)=NO1,C11H11NO3,16293.0
4210,Y320,Cc1c(C(=O)Nc2ccc(N3CCC(N4CCOCC4)CC3)c(C#N)c2)cnn1-c1ccc(Cl)cc1,C27H29ClN6O2,16314.0
4211,S-(5'-Adenosyl)-L-methionine (tosylate),C[S+](CC[C@H](N)C(=O)O)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O.Cc1ccc(S(=O)(=O)[O-])cc1,C22H30N6O8S2,16376.0
4212,(S)-Ketoprofen,C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1,C16H14O3,16407.0
4213,LB 42708,O=C(c1cn(Cc2cncn2Cc2ccc(Br)cc2)cc1-c1cccc2ccccc12)N1CCOCC1,C30H27BrN4O2,16428.0
4214,RHC-80267,O=C(NCCCCCCNC(=O)ON=C1CCCCC1)ON=C1CCCCC1,C20H34N4O4,16432.0
4215,4-Chloromethcathinone (hydrochloride),CNC(C)C(=O)c1ccc(Cl)cc1.Cl,C10H13Cl2NO,16436.0
4216,GSK-LSD1 (hydrochloride),Cl.Cl.c1ccc([C@@H]2C[C@H]2NC2CCNCC2)cc1,C14H22Cl2N2,16439.0
4217,Picaridin,CCC(C)OC(=O)N1CCCCC1CCO,C12H23NO3,16458.0
4218,Biochanin A,COc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1,C16H12O5,16476.0
4219,1-thio-.beta.-D-Glucose (sodium salt),OC[C@H]1O[C@@H]([S-])[C@H](O)[C@@H](O)[C@@H]1O.[Na+],C6H11NaO5S,16485.0
4220,X-Gal,OC[C@H]1O[C@@H](Oc2c[nH]c3ccc(Br)c(Cl)c23)[C@H](O)[C@@H](O)[C@H]1O,C14H15BrClNO6,16495.0
4221,Ac-Calpastatin (184-210),CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)[C@@H](C)CC)[C@@H](C)O)C(C)C,C142H230N36O44S,16501.0
4222,5-Azidopentanoic Acid,[N-]=[N+]=NCCCCC(=O)O,C5H9N3O2,16517.0
4223,Gimeracil,O=c1cc(O)c(Cl)c[nH]1,C5H4ClNO2,16525.0
4224,"Nisin (>900 IU/mg, contains min. 50% NaCl)",C=C(NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CS[C@@H](C)[C@H]2NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]3CS[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CS[C@@H](C)[C@H](NC(=O)[C@@H]5CSC[C@@H](NC(=O)/C(=C/C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NC(=C)C(=O)N[C@@H](CC(C)C)C(=O)N5)C(=O)N5CCC[C@H]5C(=O)NCC(=O)N4)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N3)[C@H](C)SC[C@H](NC2=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,C143H230N42O37S7,16532.0
4225,CHIR124,O=c1[nH]c2ccc(Cl)cc2c(N[C@@H]2CN3CCC2CC3)c1-c1nc2ccccc2[nH]1,C23H22ClN5O,16553.0
4226,"cis,cis-Octadeca-9,12-dienol",CCCCC/C=C\C/C=C\CCCCCCCCO,C18H34O,16556.0
4227,MAB-CHMINACA,CC(C)(C)C(NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(N)=O,C21H30N4O2,16616.0
4228,MAB-CHMINACA (CRM),CC(C)(C)C(NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(N)=O,C21H30N4O2,22047.0
4229,Wnt-C59,Cc1cc(-c2ccc(CC(=O)Nc3ccc(-c4cccnc4)cc3)cc2)ccn1,C25H21N3O,16644.0
4230,JWH 145,CCCCCn1cc(C(=O)c2cccc3ccccc23)cc1-c1ccccc1,C26H25NO,10825.0
4231,JWH 370,CCCCCn1cc(C(=O)c2cccc3ccccc23)cc1-c1ccccc1C,C27H27NO,10827.0
4232,JWH 016,CCCCn1c(C)c(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,10849.0
4233,AM2201 2'-naphthyl isomer,O=C(c1ccc2ccccc2c1)c1cn(CCCCCF)c2ccccc12,C24H22FNO,10862.0
4234,Harmaline,COc1ccc2c3c([nH]c2c1)C(C)=NCC3,C13H14N2O,10995.0
4235,Carbamoylcholine chloride,C[N+](C)(C)CCOC(N)=O.[Cl-],C6H15ClN2O2,14486.0
4236,W-15,O=S(=O)(/N=C1/CCCCN1CCc1ccccc1)c1ccc(Cl)cc1,C19H21ClN2O2S,14898.0
4237,W-15 (CRM),O=S(=O)(/N=C1/CCCCN1CCc1ccccc1)c1ccc(Cl)cc1,C19H21ClN2O2S,19482.0
4238,W-18,O=[N+]([O-])c1ccc(CCN2CCCC/C2=N/S(=O)(=O)c2ccc(Cl)cc2)cc1,C19H20ClN3O4S,15480.0
4239,W-18 (CRM),O=[N+]([O-])c1ccc(CCN2CCCC/C2=N/S(=O)(=O)c2ccc(Cl)cc2)cc1,C19H20ClN3O4S,19483.0
4240,IWP-L6,O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1,C25H20N4O2S2,15243.0
4241,Amobarbital (sodium salt),CCC1(CCC(C)C)C(=O)NC(=O)NC1=O.[NaH],C11H18N2NaO3,15882.0
4242,(-)-Pentazocine,CC(C)=CCN1CC[C@@]2(C)c3cc(O)ccc3C[C@@H]1C2C,C19H27NO,15912.0
4243,Galangin,O=c1c(O)c(-c2ccccc2)oc2cc(O)cc(O)c12,C15H10O5,15948.0
4244,ATB-346,COc1ccc2cc(C(C)C(=O)Oc3ccc(C(N)=S)cc3)ccc2c1,C21H19NO3S,16234.0
4245,CX-6258,CN1CCCN(C(=O)c2cccc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,C26H24ClN3O3,16245.0
4246,Dapivirine,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,C20H19N5,16247.0
4247,MDL 29951,O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12,C12H9Cl2NO4,16266.0
4248,PTC-209,COc1cc(Br)c(Nc2nc(-c3c(C)nc4ncccn34)cs2)c(Br)c1,C17H13Br2N5OS,16277.0
4249,TAK-632,N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12,C27H18F4N4O3S,16285.0
4250,XL019,O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)[C@@H]1CCCN1,C25H28N6O2,16298.0
4251,XL765,COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)c(OC)c3)cc2)cc(OC)c1,C31H29N5O6S,16299.0
4252,N?-(1-Carboxymethyl)-L-lysine,N[C@@H](CCCCNCC(=O)O)C(=O)O,C8H16N2O4,16483.0
4253,Isorhamnetin,COc1cc(-c2oc3cc(O)cc(O)c3c(=O)c2O)ccc1O,C16H12O7,16496.0
4254,(R)-Ketamine (hydrochloride),CN[C@@]1(c2ccccc2Cl)CCCCC1=O.Cl,C13H17Cl2NO,16519.0
4255,(R)-Ketamine (hydrochloride) (CRM),CN[C@@]1(c2ccccc2Cl)CCCCC1=O.Cl,C13H17Cl2NO,26316.0
4256,2-Chloro-4-nitrophenyl-.alpha.-D-glucopyranoside,O=[N+]([O-])c1ccc(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(Cl)c1,C12H14ClNO8,16527.0
4257,Sodium (2-Sulfonatoethyl)methanethiosulfonate,CS(=O)(=O)SCCS(=O)(=O)[O-].[Na+],C3H7NaO5S3,16529.0
4258,NOC-5,CC(C)N(CCCN)N(O)N=O,C6H16N4O2,16534.0
4259,Dilauroyl-rac-glycerol,CCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC.CCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCC,C54H104O10,16536.0
4260,D-Mannoheptulose,O=C(CO)[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,C7H14O7,16548.0
4261,SB-590885,CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1,C27H27N5O2,16643.0
4262,Sotrastaurin,CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1,C25H22N6O2,16726.0
4263,AZD 2858,CN1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cccnc4)n3)cc2)CC1,C21H23N7O3S,16728.0
4264,AZ 960,Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)c(C#N)cc2F)n[nH]1,C18H16F2N6,16731.0
4265,PTC-124,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1,C15H9FN2O3,16758.0
4266,AF3485,O=C(Nc1ccc2c(c1)c1ccccc1n2CCO)c1ccccc1C(F)(F)F,C22H17F3N2O2,9001962.0
4267,Thiopropamine (hydrochloride),CC(N)Cc1cccs1.Cl,C7H12ClNS,9002037.0
4268,Enniatin Complex,CCC(C)[C@H]1C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H](C(C)CC)C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H](C(C)CC)C(=O)O[C@H](C(C)C)C(=O)N1C,C36H63N3O9,9002040.0
4269,Mebolazine,C[C@@H]1C[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@@]2(C)[C@H]3CC[C@]2(C)O)C/C1=N/N=C1/C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3CC[C@]4(C)O)[C@@]2(C)C[C@H]1C,C42H68N2O2,9002042.0
4270,EC 23,CC1(C)CCC(C)(C)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,C23H24O2,9002073.0
4271,CAY10665,CNC(=O)C(=O)NCCCC/C=C\CCCCCCCCCC(=O)O,C19H34N2O4,11044.0
4272,Echinomycin,CSC1SCC2C(=O)N(C)C(C(C)C)C(=O)OCC(NC(=O)c3cnc4ccccc4n3)C(=O)NC(C)C(=O)N(C)C1C(=O)N(C)C(C(C)C)C(=O)OCC(NC(=O)c1cnc3ccccc3n1)C(=O)NC(C)C(=O)N2C,C51H64N12O12S2,11049.0
4273,25-hydroxy Cholesterol-d6,[2H]C([2H])([2H])C(O)(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C([2H])([2H])[2H],C27H46O2,11099.0
4274,NVP-BKM120,Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,C18H21F3N6O2,11587.0
4275,Tamoxifen (citrate),CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O,C32H37NO8,11629.0
4276,24.alpha.-ethyl Cholesterol (technical grade),CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,C29H50O,11756.0
4277,24?-ethyl Cholesterol,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,C29H50O,37386.0
4278,Chaetocin,CN1C(=O)[C@@]23C[C@]4([C@]56C[C@@]78SS[C@@](CO)(C(=O)N7[C@H]5Nc5ccccc56)N(C)C8=O)c5ccccc5N[C@@H]4N2C(=O)[C@]1(CO)SS3,C30H28N6O6S4,13156.0
4279,PPM-18,O=C(NC1=CC(=O)c2ccccc2C1=O)c1ccccc1,C17H11NO3,13327.0
4280,PP242,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,C16H16N6O,13643.0
4281,CAY10622,NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1,C25H25N5O3,13687.0
4282,Nitazoxanide,CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,C12H9N3O5S,13692.0
4283,4-Methylbenzylidene camphor,Cc1ccc(/C=C2\C(=O)C3(C)CCC2C3(C)C)cc1,C18H22O,13840.0
4284,Methylpiperidino pyrazole,Cc1c(-c2ccc(O)cc2)nn(-c2ccc(O)cc2)c1-c1ccc(OCCN2CCCCC2)cc1,C29H31N3O3,13863.0
4285,Nervonic Acid,CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)O,C24H46O2,13940.0
4286,2C-T (hydrochloride),COc1cc(SC)c(OC)cc1CCN.Cl,C11H18ClNO2S,13957.0
4287,JWH 116,CCCCCn1c(CC)c(C(=O)c2cccc3ccccc23)c2ccccc21,C26H27NO,13977.0
4288,Cafestol,C[C@@]12CCc3occc3[C@H]1CC[C@@]13C[C@@H](CC[C@H]12)[C@@](O)(CO)C3,C20H28O3,13999.0
4289,Src Kinase Inhibitor I,COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC,C22H19N3O3,14592.0
4290,Meloxicam,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,C14H13N3O4S2,14906.0
4291,Cl2201,O=C(c1ccc(Cl)c2ccccc12)c1cn(CCCCCF)c2ccccc12,C24H21ClFNO,15065.0
4292,Trifluoperazine (hydrochloride),CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1.Cl.Cl,C21H26Cl2F3N3S,15068.0
4293,(+)-BAY-K-8644,COC(=O)C1=C(C)NC(C)=C([N+](=O)[O-])[C@@H]1c1ccccc1C(F)(F)F,C16H15F3N2O4,15263.0
4294,Progesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C21H30O2,15876.0
4295,LY411575,C[C@H](NC(=O)[C@@H](O)c1cc(F)cc(F)c1)C(=O)N[C@@H]1C(=O)N(C)c2ccccc2-c2ccccc21,C26H23F2N3O4,16162.0
4296,WWL229,COCCCC1CCCCN1C(=O)Oc1ccc([N+](=O)[O-])cc1,C16H22N2O5,16182.0
4297,SC-58125,CS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(F)cc2)cc1,C17H12F4N2O2S,70655.0
4298,Sulindac sulfide,CSc1ccc(/C=C2\C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1,C20H17FO2S,10004387.0
4299,Eeyarestatin 1,CC1(C)C(N(O)C(=O)Nc2ccc(Cl)cc2)N(c2ccc(Cl)cc2)C(=O)N1CC(=O)N/N=C/C=C/c1ccc([N+](=O)[O-])o1,C27H25Cl2N7O7,10012609.0
4300,WIKI4,COc1ccc(-n2c(SCCCN3C(=O)c4cccc5cccc(c45)C3=O)nnc2-c2ccncc2)cc1,C29H23N5O3S,14057.0
4301,Thioridazine (hydrochloride),CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2.Cl,C21H27ClN2S2,14400.0
4302,MS-436,Cc1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)c(N)cc1O,C18H17N5O3S,15484.0
4303,Taurocholic Acid (sodium salt),C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C.[Na+],C26H44NNaO7S,16215.0
4304,CO 1686,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1,C27H28F3N7O3,16244.0
4305,ONX 0912,COC[C@H](NC(=O)c1cnc(C)s1)C(=O)N[C@@H](COC)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1,C25H32N4O7S,16269.0
4306,TDZD-8,Cn1sc(=O)n(Cc2ccccc2)c1=O,C10H10N2O2S,16287.0
4307,(R)-5-fluoro ADB,COC(=O)[C@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(C)(C)C,C20H28FN3O3,16603.0
4308,BIBR 1532,C/C(=C\C(=O)Nc1ccccc1C(=O)O)c1ccc2ccccc2c1,C21H17NO3,16608.0
4309,3'-Sialyllactose (sodium salt),CC(=O)NC1[C@H]([C@H](O)[C@H](O)CO)O[C@@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]([C@H](O)[C@@H](O)C=O)[C@H](O)CO)[C@@H]2O)(C(=O)[O-])C[C@@H]1O.[Na+],C23H38NNaO19,16617.0
4310,Bupivacaine,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,C18H28N2O,16618.0
4311,4-Methylumbelliferyl-N-acetyl-.alpha.-D-Neuraminic Acid (sodium salt),CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@@](Oc2ccc3c(C)cc(=O)oc3c2)(C(=O)[O-])C[C@@H]1O.[Na+],C21H24NNaO11,16620.0
4312,Mito-TEMPO (hydrate),CC1(C)CC(NC(=O)C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)CC(C)(C)N1[O].O.[Cl-],C29H37ClN2O3P,16621.0
4313,Kanosamine (hydrochloride),Cl.N[C@@H]([C@H](O)[C@H](O)CO)[C@@H](O)C=O,C6H14ClNO5,16623.0
4314,Mozavaptan (hydrochloride),Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1.Cl,C27H30ClN3O2,16664.0
4315,Melphalan,N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,C13H18Cl2N2O2,16665.0
4316,5-Fluoroanthranilic Acid,Nc1ccc(F)cc1C(=O)O,C7H6FNO2,16669.0
4317,Flupirtine (maleate),CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N.O=C(O)/C=C\C(=O)O,C19H21FN4O6,16674.0
4318,Glufosinate (ammonium salt),CP(=O)([O-])CCC(N)C(=O)O.[NH4+],C5H15N2O4P,16675.0
4319,AZD 1080,N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1,C19H18N4O2,16676.0
4320,Celiprolol (hydrochloride),CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1.Cl,C20H34ClN3O4,16715.0
4321,NSC 348884,Cc1ccc2[nH]c(CN(CCN(Cc3nc4ccc(C)cc4[nH]3)Cc3nc4ccc(C)cc4[nH]3)Cc3nc4ccc(C)cc4[nH]3)nc2c1,C38H40N10,16716.0
4322,4-Nitrophenyl-N-acetyl-.alpha.-D-galactosaminide,CC(=O)N[C@H]1[C@@H](Oc2ccc([N+](=O)[O-])cc2)O[C@H](CO)[C@H](O)[C@@H]1O,C14H18N2O8,16755.0
4323,Creatinine-d3,[2H]C([2H])([2H])N1CC(=O)N=C1N,C4H7N3O,16763.0
4324,Uridine-3'-monophosphate (sodium salt),O=c1ccn([C@@H]2O[C@H](CO)[C@@H](OP(=O)([O-])[O-])[C@H]2O)c(=O)[nH]1.[Na+].[Na+],C9H11N2Na2O9P,16774.0
4325,.beta.-D-Glucose,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,C6H12O6,16775.0
4326,Sulindac sulfone,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C/c1ccc(S(C)(=O)=O)cc1,C20H17FO4S,16805.0
4327,OTSSP 167 (hydrochloride),CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1.Cl,C25H29Cl3N4O2,16873.0
4328,6-IATR,CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2ccc(NC(=O)CI)cc21,C26H24IN3O4,16531.0
4329,2-Ethylmethcathinone (hydrochloride),CCc1ccccc1C(=O)C(C)NC.Cl,C12H18ClNO,9001081.0
4330,SRT 1720 (hydrochloride),Cl.O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1,C25H24ClN7OS,10011020.0
4331,Arachidonic Acid Alkyne,C#CCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H28O2,10538.0
4332,LGK974,Cc1cc(-c2ncc(CC(=O)Nc3ccc(-c4cnccn4)cn3)cc2C)ccn1,C23H20N6O,14072.0
4333,AY 9944,Cl.Cl.Clc1ccccc1CNCC1CCC(CNCc2ccccc2Cl)CC1,C22H30Cl4N2,14611.0
4334,5-Octyl L-glutamate,CCCCCCCCOC(=O)CC[C@H](N)C(=O)O,C13H25NO4,16107.0
4335,GNE 7915,CCNc1nc(Nc2cc(F)c(C(=O)N3CCOCC3)cc2OC)ncc1C(F)(F)F,C19H21F4N5O3,16252.0
4336,PR-619,N#CSc1cc(SC#N)c(N)nc1N,C7H5N5S2,16276.0
4337,VU0364439,O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2Cl)c(Cl)c1)c1ccccn1,C18H13Cl2N3O3S,16296.0
4338,Darapladib,CCN(CC)CCN(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(=O)Cn1c(SCc2ccc(F)cc2)nc(=O)c2c1CCC2,C36H38F4N4O2S,16429.0
4339,L-138037,CCN(CC)c1ccc(/C=N/N2CCN(C(c3ccccc3)c3ccccc3)CC2)cc1,C28H34N4,16526.0
4340,.alpha.-Zearalenol,C[C@H]1CCC[C@H](O)CCC/C=C/c2cc(O)cc(O)c2C(=O)O1,C18H24O5,16549.0
4341,4-epi-Chlortetracycline (hydrochloride),CN(C)[C@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12.Cl,C22H24Cl2N2O8,16663.0
4342,Monocrotaline,C[C@H]1C(=O)O[C@@H]2CCN3CC=C(COC(=O)[C@](C)(O)[C@]1(C)O)[C@H]23,C16H23NO6,16666.0
4343,Astragaloside A,CC(C)(O)[C@H]1CC[C@@](C)([C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H]5C(C)(C)[C@@H](O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)CC[C@@]56C[C@@]46CC[C@]23C)O1,C41H68O14,16677.0
4344,LY2784544,Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1,C23H25ClFN7O,16705.0
4345,Baricitinib,CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,C16H17N7O2S,16707.0
4346,SR 3677,CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1,C22H24N4O4,16708.0
4347,Avagacestat,NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1,C20H17ClF4N4O4S,16711.0
4348,CZC-8004,NCc1ccc(Nc2ncc(F)c(Nc3ccccc3)n2)cc1,C17H16FN5,16718.0
4349,Amastatin (hydrochloride),CC(C)C[C@@H](N)[C@H](O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(C)C.Cl,C21H39ClN4O8,16719.0
4350,Phenylacetyl L-Glutamine,NC(=O)CC[C@H](NC(=O)Cc1ccccc1)C(=O)O,C13H16N2O4,16724.0
4351,ZM 39923 (hydrochloride),CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1.Cl,C23H26ClNO,16729.0
4352,1-Azakenpaullone,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1,C15H10BrN3O,16733.0
4353,"L-3,3'-Diiodothyronine",N[C@@H](Cc1ccc(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,C15H13I2NO4,16748.0
4354,D-Carnitine,C[N+](C)(C)C[C@@H](O)CC(=O)[O-],C7H15NO3,16749.0
4355,Biocytin,N[C@H](CCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)C(=O)O,C16H28N4O4S,16751.0
4356,Deferasirox,O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1,C21H15N3O4,16753.0
4357,CBF? Inhibitor,CCc1sc(N)nc1-c1ccc(OC)cc1,C12H14N2OS,16771.0
4358,D-(+)-Raffinose (hydrate),O.O.O.O.O.OC[C@H]1O[C@H](OC[C@H]2O[C@H](O[C@]3(CO)O[C@H](CO)[C@@H](O)[C@@H]3O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O,C18H42O21,16773.0
4359,Oxolinic Acid,CCn1cc(C(=O)O)c(=O)c2cc3c(cc21)OCO3,C13H11NO5,16789.0
4360,Kynurenic Acid (hydrate),O.O=C(O)c1cc(O)c2ccccc2n1,C10H9NO4,16792.0
4361,(S)-Ibuprofen,CC(C)Cc1ccc([C@H](C)C(=O)O)cc1,C13H18O2,16793.0
4362,3-chloro-5-Hydroxybenzoic Acid,O=C(O)c1cc(O)cc(Cl)c1,C7H5ClO3,16795.0
4363,4.alpha.-Phorbol 12-myristate 13-acetate,CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O,C36H56O8,16806.0
4364,AZD 2461,COC1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1,C22H22FN3O3,16876.0
4365,2-Thiothinone (hydrochloride),CNC(C)C(=O)c1cccs1.Cl,C8H12ClNOS,9002101.0
4366,"4,4'-Dimethylaminorex",Cc1ccc(C2OC(N)=NC2C)cc1,C11H14N2O,15281.0
4367,N-Acetyl-4-benzoquinone imine,CC(=O)N=C1C=CC(=O)C=C1,C8H7NO2,16115.0
4368,AT7519 (hydrochloride),Cl.O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,C16H18Cl3N5O2,16231.0
4369,GNF 5,O=C(NCCO)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,C20H17F3N4O3,16254.0
4370,ONX 0914,COc1ccc(C[C@H](NC(=O)[C@H](C)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]2(C)CO2)cc1,C31H40N4O7,16271.0
4371,.beta.-Nicotinamide Mononucleotide,NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]2O)c1,C11H15N2O8P,16411.0
4372,Cellulose triacetate,CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,C4H6O2(C24H32O17)n,16521.0
4373,K02288,COc1cc(-c2cc(-c3cccc(O)c3)cnc2N)cc(OC)c1OC,C20H20N2O4,16678.0
4374,P7C3,OC(CNc1ccccc1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21,C21H18Br2N2O,16682.0
4375,MK-0752,O=C(O)CC[C@H]1CC[C@@](c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1,C21H21ClF2O4S,16706.0
4376,Pacritinib,C1=N/C2=N/c3ccc(OCCN4CCCC4)c(c3)COC/C=C/COCc3cccc(c3)C(=C1)N2,C28H32N4O3,16709.0
4377,NVP-BSK805 (hydrochloride),Cl.Cl.Fc1cc(-c2cccc3ncc(-c4cnn(C5CCNCC5)c4)nc23)cc(F)c1CN1CCOCC1,C27H30Cl2F2N6O,16714.0
4378,Fudosteine,N[C@@H](CSCCCO)C(=O)O,C6H13NO3S,16722.0
4379,3-Guanidinopropionic Acid,N=C(N)NCCC(=O)O,C4H9N3O2,16725.0
4380,Palonosetron (hydrochloride),Cl.O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2,C19H25ClN2O,16752.0
4381,Bialaphos (sodium salt),C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(=O)O)C(=O)[O-].[Na+],C11H21N3NaO6P,16754.0
4382,3-Deoxygalactosone,O=CC(=O)C[C@@H](O)[C@H](O)CO,C6H10O5,16801.0
4383,R-3-Hydroxymyristic Acid,CCCCCCCCCCC[C@@H](O)CC(=O)O,C14H28O3,16871.0
4384,Nexturastat A,CCCCN(Cc1ccc(C(=O)NO)cc1)C(=O)Nc1ccccc1,C19H23N3O3,16874.0
4385,Coelenterazine h,O=c1c(Cc2ccccc2)nc2c(Cc3ccccc3)[nH]c(-c3ccc(O)cc3)cn1-2,C26H21N3O2,16894.0
4386,.alpha.-Naphthoflavone,O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12,C19H12O2,16924.0
4387,WSP-5,O=C(Oc1ccc2c(c1)Oc1cc(OC(=O)c3ccccc3SSc3ccccn3)ccc1C21OC(=O)c2ccccc21)c1ccccc1SSc1ccccn1,C44H26N2O7S4,16929.0
4388,Desloratadine,Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1,C19H19ClN2,16931.0
4389,Ranitidine (hydrochloride),CN/C(=C\[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1.Cl,C13H23ClN4O3S,16939.0
4390,BCATc Inhibitor 2,O=C(NNS(=O)(=O)c1ccccc1C(F)(F)F)c1cc2cc(Cl)ccc2o1,C16H10ClF3N2O4S,9002002.0
4391,Cephalexin,CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1,C16H17N3O4S,9002009.0
4392,Exendin-4 (48-86) amide (acetate),CC(=O)O.[H]N[C@@H](Cc1cnc[nH]1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O,C186H286N50O62S,11096.0
4393,HPOB,O=C(NO)c1ccc(CC(=O)N(CCO)c2ccccc2)cc1,C17H18N2O4,15066.0
4394,5-Octyl D-glutamate,CCCCCCCCOC(=O)CC[C@@H](N)C(=O)O,C13H25NO4,16106.0
4395,MAZ51,CN(C)c1ccc(/C=C2/C(=O)Nc3ccccc32)c2ccccc12,C21H18N2O,16168.0
4396,.delta.8-THC-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C21H30O2,16205.0
4397,?8-THC-d9 (CRM),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C21H30O2,41379.0
4398,BIX02188,CN(C)Cc1cccc(N/C(=C2\C(=O)Nc3cc(C(N)=O)ccc32)c2ccccc2)c1,C25H24N4O2,16238.0
4399,Kobe 2602,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1NNC(=S)Nc1ccc(F)cc1,C14H9F4N5O4S,16262.0
4400,TCS PIM-1 1,N#Cc1c(-c2ccccc2)cc(-c2cc(Br)ccc2O)[nH]c1=O,C18H11BrN2O2,16286.0
4401,WZ4002,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1,C25H27ClN6O3,16297.0
4402,LEI-106,CC1(C)CCc2cc(S(=O)(=O)N(CC(=O)O)Cc3ccc(Oc4ccccc4)cc3)ccc2O1,C26H27NO6S,16419.0
4403,Actinonin,CCCCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)N1CCC[C@H]1CO)C(C)C,C19H35N3O5,16605.0
4404,CX-4945,O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12,C19H12ClN3O2,16779.0
4405,Tesaglitazar,CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O,C20H24O7S,16791.0
4406,(R)-Ibuprofen,CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1,C13H18O2,16794.0
4407,Brassinazole,CC(O)(c1ccccc1)C(Cc1ccc(Cl)cc1)n1cncn1,C18H18ClN3O,16804.0
4408,Coenzyme Q9,COC1=C(OC)C(=O)C(C/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(/C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C)=C(C)C1=O,C54H82O4,16866.0
4409,Guanylyl Imidodiphosphate (lithium salt),Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])NP(=O)([O-])[O-])[C@@H](O)[C@H]2O)c(=O)[nH]1.[Li+].[Li+].[Li+].[Li+],C10H13Li4N6O13P3,16880.0
4410,DL-.alpha.-Difluoromethylornithine (hydrochloride hydrate),Cl.NCCCC(N)(C(=O)O)C(F)F.O,C6H15ClF2N2O3,16889.0
4411,Metformin-d6 (hydrochloride),Cl.[2H]C([2H])([2H])N(C(=N)NC(=N)N)C([2H])([2H])[2H],C4H12ClN5,16921.0
4412,Clinafloxacin (hydrochloride),Cl.NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,C17H18Cl2FN3O3,16923.0
4413,Allopregnanolone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C21H34O2,16930.0
4414,Allopregnanolone (exempt preparation),CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C21H34O2,43516.0
4415,Umifenovir (hydrochloride),CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12.Cl,C22H26BrClN2O3S,16933.0
4416,"1,3,7-Trimethyluric Acid",Cn1c(=O)c2c([nH]c(=O)n2C)n(C)c1=O,C8H10N4O3,16949.0
4417,F2201,O=C(c1ccc(F)c2ccccc12)c1cn(CCCCCF)c2ccccc12,C24H21F2NO,9001580.0
4418,Piperine,O=C(/C=C/C=C/c1ccc2c(c1)OCO2)N1CCCCC1,C17H19NO3,11750.0
4419,(+)-ar-Turmerone,CC(C)=CC(=O)C[C@H](C)c1ccc(C)cc1,C15H20O,11759.0
4420,MF63,N#Cc1cccc(C#N)c1-c1nc2c3ccc(Cl)cc3c3ccccc3c2[nH]1,C23H11ClN4,13217.0
4421,BDB (hydrochloride),CCC(N)Cc1ccc2c(c1)OCO2.Cl,C11H16ClNO2,14213.0
4422,BDB (hydrochloride) (exempt preparation),CCC(N)Cc1ccc2c(c1)OCO2.Cl,C11H16ClNO2,39441.0
4423,AWD 131-138,O=C1N=C(N2CCOCC2)CN1c1ccc(Cl)cc1,C13H14ClN3O2,16235.0
4424,Kobe 0065,Cc1ccc(NC(=S)NNc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[N+](=O)[O-])cc1Cl,C15H11ClF3N5O4S,16261.0
4425,RKI-1447,O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1,C16H14N4O2S,16278.0
4426,B32B3,C(=N/Nc1ncnc2sc3c(c12)CCCC3)\c1c[nH]c2ccccc12,C19H17N5S,16364.0
4427,MBDB-d3 (hydrochloride),Cl.[2H]C([2H])([2H])NC(CC)Cc1ccc2c(c1)OCO2,C12H18ClNO2,16555.0
4428,LY2811376,C[C@@]1(c2cc(-c3cncnc3)c(F)cc2F)CCSC(N)=N1,C15H14F2N4S,16712.0
4429,SLIGRL-NH2 (trifluoroacetate salt),CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O,C29H56N10O7,16723.0
4430,Luminol,Nc1cccc2c(=O)[nH][nH]c(=O)c12,C8H7N3O2,16803.0
4431,Dibenzylfluorescein,O=C(OCc1ccccc1)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(OCc3ccccc3)ccc12,C34H24O5,16808.0
4432,AZ 505,O=C1COc2c(CCNCCN(C(=O)CCNCCc3ccc(Cl)c(Cl)c3)C3CCCCC3)ccc(O)c2N1,C29H38Cl2N4O4,16875.0
4433,"(4-Chloro-3,5-dimethylphenoxy)acetic Acid",Cc1cc(OCC(=O)O)cc(C)c1Cl,C10H11ClO3,16877.0
4434,Clozapine N-oxide,C[N+]1([O-])CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,C18H19ClN4O,16882.0
4435,(+)-Evodiamine,CN1c2ccccc2C(=O)N2CCc3c([nH]c4ccccc34)[C@H]21,C19H17N3O,16885.0
4436,GSK690693,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCNC3)c21,C21H27N7O3,16891.0
4437,NSC 632839,Cc1ccc(/C=C2/CNC/C(=C/c3ccc(C)cc3)C2=O)cc1.Cl,C21H22ClNO,16893.0
4438,RGFP966,Nc1cc(F)ccc1NC(=O)/C=C/c1cnn(C/C=C/c2ccccc2)c1,C21H19FN4O,16917.0
4439,BRD73954,O=C(NO)c1cccc(C(=O)NCCc2ccccc2)c1,C16H16N2O3,16919.0
4440,Limonin,CC1(C)O[C@H]2CC(=O)OC[C@]23[C@H]2CC[C@@]4(C)[C@H](c5ccoc5)OC(=O)[C@H]5O[C@]54[C@]2(C)C(=O)C[C@@H]13,C26H30O8,16932.0
4441,Cariporide,CC(C)c1ccc(C(=O)NC(=N)N)cc1S(C)(=O)=O,C12H17N3O3S,16935.0
4442,2'-O-Methyladenosine,CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(N)ncnc21,C11H15N5O4,16936.0
4443,Tomatidine (hydrochloride),C[C@H]1CC[C@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C.Cl,C27H46ClNO2,16938.0
4444,(-)-Gallocatechin,Oc1cc(O)c2c(c1)O[C@@H](c1cc(O)c(O)c(O)c1)[C@H](O)C2,C15H14O7,16944.0
4445,Acetyl-L-Carnitine (chloride),CC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C9H18ClNO4,16948.0
4446,Sanguinarine (chloride),C[n+]1cc2c3c(ccc2c2ccc4cc5c(cc4c21)OCO5)OCO3.[Cl-],C20H14ClNO4,16951.0
4447,Sulforhodamine 101,O=S(=O)([O-])c1cc(S(=O)(=O)O)ccc1-c1c2cc3c4c(c2[o+]c2c5c6c(cc12)CCCN6CCC5)CCCN4CCC3,C31H30N2O7S2,16953.0
4448,3-Indoleacetic Acid (sodium salt),O=C([O-])Cc1c[nH]c2ccccc12.[Na+],C10H8NNaO2,16954.0
4449,Astemizole,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,C28H31FN4O,16967.0
4450,"all-cis-4,7,10,13,16-Docosapentaenoic Acid",CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C22H34O2,10008335.0
4451,".alpha.,.beta.-Methyleneadenosine 5'-triphosphate (sodium salt)",Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])CP(=O)([O-])OP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+],C11H15N5Na3O12P3,10008956.0
4452,6-MAPB (hydrochloride),CNC(C)Cc1ccc2ccoc2c1.Cl,C12H16ClNO,14110.0
4453,TCPOBOP,Clc1cnc(Oc2ccc(Oc3ncc(Cl)cc3Cl)cc2)c(Cl)c1,C16H8Cl4N2O2,14140.0
4454,Quetiapine (hemifumarate),O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,C25H29N3O6S,14152.0
4455,BMS 833923,CNCc1ccc(C)c(NC(=O)c2ccc(Nc3nc(-c4ccccc4)c4ccccc4n3)cc2)c1,C30H27N5O,16240.0
4456,LY2940680,CN(C(=O)c1ccc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1,C26H24F4N6O,16264.0
4457,TG101348,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,C27H36N6O3S,16289.0
4458,VS-5584,Cc1nc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2n1C(C)C,C17H22N8O,16294.0
4459,XL888,CC[C@@H](C)Nc1cc(C(=O)N[C@H]2C[C@H]3CC[C@@H](C2)N3c2ccc(C(=O)C3CC3)cn2)c(C)cc1C(N)=O,C29H37N5O3,16309.0
4460,Chitobiose Octaacetate,CC(=O)N[C@H]1[C@H](O[C@H]2[C@H](OC(C)=O)[C@@H](NC(C)=O)C(OC(C)=O)O[C@@H]2COC(C)=O)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,C28H40N2O17,16379.0
4461,AB-CHMINACA metabolite M2,CC(C)[C@H](NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(=O)O,C20H27N3O3,16389.0
4462,AB-CHMINACA metabolite M3A,CC(C)[C@H](NC(=O)c1nn(CC2CCC(O)CC2)c2ccccc12)C(=O)O,C20H27N3O4,16391.0
4463,AB-CHMINACA metabolite M5A,O=C(O)c1nn(CC2CCC(O)CC2)c2ccccc12,C15H18N2O3,16394.0
4464,AB-CHMINACA metabolite M6,CC(C(=O)O)C(NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(N)=O,C20H26N4O4,16453.0
4465,BVT 948,CC1(C)C(=O)N=C2C1=C(O)C(=O)c1ccccc12,C14H11NO3,16615.0
4466,Semagacestat,CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc21,C19H27N3O4,16713.0
4467,Tideglusib,O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1,C19H14N2O2S,16727.0
4468,CEP-33779,CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1,C24H26N6O2S,16732.0
4469,R-59-022,Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1,C27H26FN3OS,16772.0
4470,(S)-(+)-Methoprene,COC(C)(C)CCC[C@H](C)C/C=C/C(C)=C/C(=O)OC(C)C,C19H34O3,16807.0
4471,Ximelagatran,CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(C(=N)NO)cc1)C1CCCCC1,C24H35N5O5,16862.0
4472,NNGH,COc1ccc(S(=O)(=O)N(CC(=O)NO)CC(C)C)cc1,C13H20N2O5S,16886.0
4473,JX-401,COc1cc(SC)ccc1C(=O)N1CCC(Cc2ccccc2)CC1,C21H25NO2S,16898.0
4474,BRL 50481,Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)C,C9H12N2O4S,16899.0
4475,GW 441756,Cn1cc(/C=C2/C(=O)Nc3cccnc32)c2ccccc21,C17H13N3O,16915.0
4476,CL-82198,O=C(NCCCCN1CCOCC1)c1cc2ccccc2o1,C17H22N2O3,16928.0
4477,Doripenem (hydrate),C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)[C@H](C)[C@H]12.O,C15H26N4O7S2,16934.0
4478,SCH 202676 (hydrobromide),Br.C/N=c1/nc(-c2ccccc2)n(-c2ccccc2)s1,C15H14BrN3S,16945.0
4479,"7,8-Dihydroxyflavone",O=c1cc(-c2ccccc2)oc2c(O)c(O)ccc12,C15H10O4,16946.0
4480,Enoxacin,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21,C15H17FN4O3,16956.0
4481,MDMB-FUBINACA,COC(=O)[C@@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(C)(C)C,C22H24FN3O3,16966.0
4482,Rp-Cyclic AMPS (triethylammonium salt),CC[NH+](CC)CC.Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2CO[P@@](=O)([S-])O[C@H]2[C@H]1O,C16H27N6O5PS,16985.0
4483,Naltrindole (hydrochloride),Cl.Oc1ccc2c3c1O[C@H]1c4[nH]c5ccccc5c4C[C@@]4(O)[C@@H](C2)N(CC2CC2)CC[C@]314,C26H27ClN2O3,9000705.0
4484,6-EAPB (hydrochloride),CCNC(C)Cc1ccc2ccoc2c1.Cl,C13H18ClNO,9002053.0
4485,"2,3-Methylenedioxy-?-ethylaminopropiophenone (hydrochloride)",CCNC(C)C(=O)c1cccc2c1OCO2.Cl,C12H16ClNO3,9002142.0
4486,Bakuchiol,C=C[C@@](C)(/C=C/c1ccc(O)cc1)CCC=C(C)C,C18H24O,11684.0
4487,BRD4770,COC(=O)c1ccc2c(c1)nc(NC(=O)c1ccccc1)n2CCCc1ccccc1,C25H23N3O3,11787.0
4488,5-Octyl-.alpha.-ketoglutarate,CCCCCCCCOC(=O)CCC(=O)C(=O)O,C13H22O5,16105.0
4489,2-Oleoyl Glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OC(CO)CO,C21H40O4,16537.0
4490,IPI-145,C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1,C22H17ClN6O,16800.0
4491,WWL123,CN(Cc1cccc(-c2ccccc2)c1)C(=O)Oc1ccc(-c2ccc(C(N)=O)cc2)cc1,C28H24N2O3,16849.0
4492,BG45,Nc1ccccc1NC(=O)c1cnccn1,C11H10N4O,16918.0
4493,12-SAHSA,CCCCCCCCCCCCCCCCCC(=O)OC(CCCCCC)CCCCCCCCCCC(=O)O,C36H70O4,17106.0
4494,PF-299804,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1,C24H25ClFN5O2,9001879.0
4495,Lanicemine,N[C@@H](Cc1ccccn1)c1ccccc1,C13H14N2,9002129.0
4496,Docosahexaenoyl Ethanolamide-d4,[2H]C([2H])(O)C([2H])([2H])NC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC,C24H37NO2,9001108.0
4497,"N,N-Dimethylcathinone (hydrochloride)",CC(C(=O)c1ccccc1)N(C)C.Cl,C11H16ClNO,9001144.0
4498,NO-Losartan A,CCCCc1nc(Cl)c(COC(=O)c2cccc(CO[N+](=O)[O-])c2)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,C30H28ClN7O5,10006456.0
4499,AM281,Cc1c(C(=O)NN2CCOCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(I)cc1,C21H19Cl2IN4O2,10006972.0
4500,AM630,COc1ccc(C(=O)c2c(C)n(CCN3CCOCC3)c3cc(I)ccc23)cc1,C23H25IN2O3,10006974.0
4501,CAY10573,CCCc1c(OCCCOc2ccc3c(ccn3CC(=O)O)c2)ccc2cc(C(=O)c3ccccc3)ccc12,C33H31NO5,10008846.0
4502,G-1,CC(=O)c1ccc2c(c1)[C@@H]1C=CC[C@@H]1[C@H](c1cc3c(cc1Br)OCO3)N2,C21H18BrNO3,10008933.0
4503,Methyl-L-NIO (hydrochloride),CCC(=N)NCCC[C@H](N)C(=O)O.Cl,C8H18ClN3O2,10010252.0
4504,A 54556A,C/C=C/C=C/C=C/C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1COC(=O)[C@@H]2C[C@@H](C)CN2C(=O)[C@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H]2CCCN2C1=O,C38H50N6O8,15305.0
4505,JNJ-26854165,c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,C21H20N4,16259.0
4506,GSK3 Inhibitor X,CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1,C18H12BrN3O3,16329.0
4507,1-Methylnicotinamide (chloride),C[n+]1cccc(C(N)=O)c1.[Cl-],C7H9ClN2O,16604.0
4508,Hoechst 33258,CN1CCN(c2ccc3[nH]c(-c4ccc5[nH]c(-c6ccc(O)cc6)nc5c4)nc3c2)CC1.Cl.Cl.Cl,C25H27Cl3N6O,16756.0
4509,Indoxyl Sulfate (potassium salt),O=S(=O)([O-])Oc1c[nH]c2ccccc12.[K+],C8H6KNO4S,16926.0
4510,ZM 306416,COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC,C16H13ClFN3O2,16968.0
4511,Tenocyclidine (hydrochloride),Cl.c1csc(C2(N3CCCCC3)CCCCC2)c1,C15H24ClNS,17014.0
4512,9-PAHSA,CCCCCCCCCCCCCCCC(=O)OC(CCCCCCCCC)CCCCCCCC(=O)O,C34H66O4,17037.0
4513,9-OAHSA,CCCCCCCC/C=C\CCCCCCCC(=O)OC(CCCCCCCCC)CCCCCCCC(=O)O,C36H68O4,17039.0
4514,9-POHSA,CCCCCC/C=C\CCCCCCCC(=O)OC(CCCCCCCCC)CCCCCCCC(=O)O,C34H64O4,17040.0
4515,SB-269970 (hydrochloride),CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1.Cl,C18H29ClN2O3S,17081.0
4516,Apamin (trifluoroacetate salt),CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc3c[nH]cn3)C(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](CSSC[C@@H](N)C(=O)N[C@H](CC(N)=O)C(=O)N2)NC1=O.O=C(O)C(F)(F)F,C81H132F3N31O26S4,17082.0
4517,.alpha.-Propylaminopentiophenone (hydrochloride),CCCNC(CCC)C(=O)c1ccccc1.Cl,C14H22ClNO,17085.0
4518,Tildipirosin,CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CCN2CCCCC2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CN1CCCCC1,C41H71N3O8,17089.0
4519,A 54556B,C/C=C/C=C/C=C/C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1COC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H]2CCCN2C1=O,C37H48N6O8,17090.0
4520,Amphomycin,CCC(C)CCCCC/C=C\CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)N2CCCC[C@@H]2C(=O)N[C@@H]([C@H](C)C(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H]([C@@H](C)N)C(=O)N[C@@H](C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H]1C,C58H91N13O20,17091.0
4521,Enopeptin A,C[C@@H]1C[C@H]2C(=O)OC[C@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)/C=C/C=C/C=C/C=C/C=C/C(=O)NC3=C(O)CCC3=O)C(=O)N3CCC[C@H]3C(=O)N(C)[C@@H](C)C(=O)N[C@@H](C)C(=O)N2C1,C47H57N7O11,17092.0
4522,Micrococcin P1,C/C=C(\NC(=O)c1csc(-c2csc(-c3ccc4c(n3)-c3csc(n3)[C@H]([C@@H](C)O)NC(=O)c3csc(n3)[C@H](C(C)C)NC(=O)c3csc(n3)/C(=C/C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c3csc-4n3)n2)n1)C(=O)NC[C@@H](C)O,C48H49N13O9S6,17093.0
4523,Nosiheptide,C=C(NC(=O)c1csc(-c2nc3c(cc2O)-c2nc(cs2)C(=O)N[C@@H]([C@H](C)O)C(=O)N/C(=C\C)c2nc(cs2)C(=O)N[C@H]2C[C@H](O)C(=O)OCc4cccc5[nH]c(c(C)c45)C(=O)SC[C@H](NC(=O)c4csc2n4)c2nc-3cs2)n1)C(N)=O,C51H43N13O12S6,17094.0
4524,Pyridomycin,CC/C(C)=C1\OC(=O)[C@H](C)[C@H](O)[C@H](Cc2cccnc2)NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC1=O,C27H32N4O8,17095.0
4525,12-POHSA,CCCCCC/C=C\CCCCCCCC(=O)OC(CCCCCC)CCCCCCCCCCC(=O)O,C34H64O4,17105.0
4526,12-PAHSA,CCCCCCCCCCCCCCCC(=O)OC(CCCCCC)CCCCCCCCCCC(=O)O,C34H66O4,17107.0
4527,12-OAHSA,CCCCCCCC/C=C\CCCCCCCC(=O)OC(CCCCCC)CCCCCCCCCCC(=O)O,C36H68O4,17108.0
4528,9-SAHSA,CCCCCCCCCCCCCCCCCC(=O)OC(CCCCCCCCC)CCCCCCCC(=O)O,C36H70O4,17109.0
4529,MJ33 (lithium salt),CCCCCCCCCCCCCCCCOCC(COCC(F)(F)F)OP(=O)([O-])OC.[Li+],C22H43F3LiO6P,90001844.0
4530,XLR11 Degradant,C=C(C)C(C)(C)CC(=O)c1cn(CCCCCF)c2ccccc12,C21H28FNO,14055.0
4531,Psilocybin,CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12,C12H17N2O4P,14041.0
4532,Psilocybin (CRM),CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12,C12H17N2O4P,9003134.0
4533,Ezatiostat,CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1,C27H35N3O6S,16248.0
4534,GNE 0877,CNc1nc(Nc2cn(C(C)(C)C#N)nc2C)ncc1C(F)(F)F,C14H16F3N7,16251.0
4535,AB-CHMINACA metabolite M1B,CC(C)[C@H](NC(=O)c1nn(CC2CCCC(O)C2)c2ccccc12)C(N)=O,C20H28N4O3,16388.0
4536,Emtricitabine,Nc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F,C8H10FN3O3S,16879.0
4537,1-Methyladenosine,Cn1cnc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1=N,C11H15N5O4,16937.0
4538,Helenalin,C=C1C(=O)O[C@@H]2C[C@@H](C)[C@@H]3C=CC(=O)[C@@]3(C)[C@@H](O)[C@H]12,C15H18O4,17050.0
4539,Azidoindolene 1,CC1(C)C(C(=O)N/N=C2\C(=O)N(CCCCCF)c3ccccc32)C1(C)C,C21H28FN3O2,17083.0
4540,4-Chloromethamphetamine (hydrochloride),CNC(C)Cc1ccc(Cl)cc1.Cl,C10H15Cl2N,9002185.0
4541,Combrestatin A4 3'-O-Phosphate (sodium salt),COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+],C18H19Na2O8P,10007415.0
4542,PLX4032,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,C23H18ClF2N3O3S,10618.0
4543,Psammaplin A,O=C(NCCSSCCNC(=O)/C(Cc1ccc(O)c(Br)c1)=N\O)/C(Cc1ccc(O)c(Br)c1)=N\O,C22H24Br2N4O6S2,11130.0
4544,Pellitorine,CCCCC/C=C/C=C/C(=O)NCC(C)C,C14H25NO,11662.0
4545,11-keto-.beta.-Boswellic Acid,C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)C4[C@@]5(C)CC[C@@H](O)[C@](C)(C(=O)O)C5CC[C@]43C)C2[C@H]1C,C30H46O4,11668.0
4546,"14-deoxy-11,12-Didehydroandrographolide",C=C1CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O,C20H28O4,11670.0
4547,3-acetyl-11-keto-.beta.-Boswellic Acid,CC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2C(=O)C=C2[C@@H]4[C@@H](C)[C@H](C)CC[C@]4(C)CC[C@]23C)[C@@]1(C)C(=O)O,C32H48O5,11672.0
4548,Aloe-emodin,O=C1c2cccc(O)c2C(=O)c2c(O)cc(CO)cc21,C15H10O5,11677.0
4549,Hypophyllanthin,COC[C@H]1Cc2cc(OC)c3c(c2[C@@H](c2ccc(OC)c(OC)c2)[C@@H]1COC)OCO3,C24H30O7,11715.0
4550,Neoandrographolide,C=C1CC[C@@H]2[C@](C)(CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)CCC[C@@]2(C)[C@@H]1CCC1=CCOC1=O,C26H40O8,11742.0
4551,Phyllanthin,COC[C@@H](Cc1ccc(OC)c(OC)c1)[C@@H](COC)Cc1ccc(OC)c(OC)c1,C24H34O6,11745.0
4552,Rubiadin,Cc1c(O)cc2c(c1O)C(=O)c1ccccc1C2=O,C15H10O4,11753.0
4553,Sesamolin,c1cc2c(cc1O[C@H]1OC[C@H]3[C@@H]1CO[C@@H]3c1ccc3c(c1)OCO3)OCO2,C20H18O7,11754.0
4554,Vasicinone,O=c1c2ccccc2nc2n1CC[C@@H]2O,C11H10N2O2,11761.0
4555,L-Homopropargyl Glycine (hydrochloride),C#CCC[C@H](N)C(=O)O.Cl,C6H10ClNO2,11785.0
4556,Biotin-azide,[N-]=[N+]=NCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C13H22N6O2S,13040.0
4557,Carmofur,CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O,C11H16FN3O3,14243.0
4558,PF-573228,CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1,C22H20F3N5O3S,14924.0
4559,Sulbactam,CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O,C8H11NO5S,15024.0
4560,PYR41,CCOC(=O)c1ccc(N2NC(=O)C(=Cc3ccc([N+](=O)[O-])o3)C2=O)cc1,C17H13N3O7,15226.0
4561,ZD 7288,CCN(c1ccccc1)c1cc(NC)[n+](C)c(C)n1.[Cl-],C15H21ClN4,15228.0
4562,AZ 628,Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1,C27H25N5O2,15336.0
4563,CCT137690,Cc1cc(CN2CCN(c3c(Br)cnc4nc(-c5ccc(N6CCN(C)CC6)cc5)[nH]c34)CC2)no1,C26H31BrN8O,15552.0
4564,CV-6209 (chloride),CCCCCCCCCCCCCCCCCCNC(=O)OCC(COC(=O)N(Cc1cccc[n+]1CC)C(C)=O)OC.[Cl-],C34H60ClN3O6,15955.0
4565,Losartan Carboxylic Acid,CCCCc1nc(Cl)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,C22H21ClN6O2,15957.0
4566,PHTPP,Oc1ccc(-c2c(-c3ccccc3)nn3c(C(F)(F)F)cc(C(F)(F)F)nc23)cc1,C20H11F6N3O,16025.0
4567,TIC10,Cc1ccccc1CN1C(=O)C2=C(CCN(Cc3ccccc3)C2)N2CCN=C12,C24H26N4O,16109.0
4568,VU0361737,COc1cc(NC(=O)c2ccccn2)ccc1Cl,C13H11ClN2O2,16295.0
4569,SR 11302,CC1=C(/C=C/C(=C/C=C/C(C)=C/C(=O)O)c2ccc(C)cc2)C(C)(C)CCC1,C26H32O2,16338.0
4570,AB-CHMINACA metabolite M1A,CC(C)[C@H](NC(=O)c1nn(CC2CCC(O)CC2)c2ccccc12)C(N)=O,C20H28N4O3,16387.0
4571,Flubromazolam,Cc1nnc2n1-c1ccc(Br)cc1C(c1ccccc1F)=NC2,C17H12BrFN4,16435.0
4572,Flubromazolam (CRM),Cc1nnc2n1-c1ccc(Br)cc1C(c1ccccc1F)=NC2,C17H12BrFN4,26352.0
4573,Rhodamine 123 (chloride),COC(=O)c1ccccc1-c1c2ccc(N)cc2[o+]c2cc(N)ccc12.[Cl-],C21H17ClN2O3,16672.0
4574,m-3M3FBS,Cc1cc(C)c(S(=O)(=O)Nc2cccc(C(F)(F)F)c2)c(C)c1,C16H16F3NO2S,16867.0
4575,R-7050,FC(F)(F)c1nnc2c(Sc3ccccc3)nc3ccc(Cl)cc3n12,C16H8ClF3N4S,16870.0
4576,FUB-NPB-22,O=C(Oc1cccc2cccnc12)c1nn(Cc2ccc(F)cc2)c2ccccc12,C24H16FN3O2,16883.0
4577,P32/98 (hemifumarate),CC[C@H](C)[C@H](N)C(=O)N1CCSC1.CC[C@H](C)[C@H](N)C(=O)N1CCSC1.O=C(O)/C=C/C(=O)O,C22H40N4O6S2,16887.0
4578,Pyr3,CCOC(=O)c1cnn(-c2ccc(NC(=O)C(Cl)=C(Cl)Cl)cc2)c1C(F)(F)F,C16H11Cl3F3N3O3,16888.0
4579,Guanosine 5'-monophosphate (sodium salt),Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)([O-])[O-])[C@@H](O)[C@H]2O)c(=O)[nH]1.[Na+].[Na+],C10H12N5Na2O8P,16957.0
4580,MDMB-CHMICA,COC(=O)[C@@H](NC(=O)c1cn(CC2CCCCC2)c2ccccc12)C(C)(C)C,C23H32N2O3,16965.0
4581,RU-SKI 43 (hydrochloride),CCC(C)CNCC(=O)N1CCc2sccc2C1COc1cccc(C)c1.Cl,C22H31ClN2O2S,16972.0
4582,GSK2830371,Cc1ncc(Cl)cc1NCc1ccc(C(=O)N[C@@H](CC2CCCC2)C(=O)NC2CC2)s1,C23H29ClN4O2S,16973.0
4583,AZD 8055,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,C25H31N5O4,16978.0
4584,UK 5099,N#C/C(=C\c1cn(-c2ccccc2)c2ccccc12)C(=O)O,C18H12N2O2,16980.0
4585,CPI-613,O=C(O)CCCCC(CCSCc1ccccc1)SCc1ccccc1,C22H28O2S2,16981.0
4586,Perhexiline (maleate),C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1.O=C(O)/C=C\C(=O)O,C23H39NO4,16982.0
4587,BYL719,Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,C19H22F3N5O2S,16986.0
4588,Cryptotanshinone,C[C@H]1COC2=C1C(=O)C(=O)c1c2ccc2c1CCCC2(C)C,C19H20O3,16987.0
4589,Dabrafenib,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,C23H20F3N5O2S2,16989.0
4590,RAF265,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,C24H16F6N6O,16991.0
4591,Binimetinib,Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21,C17H15BrF2N4O3,16996.0
4592,Refametinib,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1,C19H20F3IN2O5S,16997.0
4593,BIX02189,CN(C)Cc1cccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)C)ccc32)c2ccccc2)c1,C27H28N4O2,16999.0
4594,GSK650394,O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1,C25H22N2O2,17001.0
4595,PF-543 (hydrochloride),Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1.Cl,C27H32ClNO4S,17034.0
4596,TUG-891,Cc1ccc(-c2ccc(F)cc2COc2ccc(CCC(=O)O)cc2)cc1,C23H21FO3,17035.0
4597,5-PAHSA,CCCCCCCCCCCCCCCC(=O)OC(CCCCCCCCCCCCC)CCCC(=O)O,C34H66O4,17043.0
4598,Monobromobimane,Cc1c(C)n2c(CBr)c(C)c(=O)n2c1=O,C10H11BrN2O2,17097.0
4599,13-SAHSA,CCCCCCCCCCCCCCCCCC(=O)OC(CCCCC)CCCCCCCCCCCC(=O)O,C36H70O4,17110.0
4600,13-POHSA,CCCCCC/C=C\CCCCCCCC(=O)OC(CCCCC)CCCCCCCCCCCC(=O)O,C34H64O4,17111.0
4601,13-OAHSA,CCCCCCCC/C=C\CCCCCCCC(=O)OC(CCCCC)CCCCCCCCCCCC(=O)O,C36H68O4,17112.0
4602,5-SAHSA,CCCCCCCCCCCCCCCCCC(=O)OC(CCCCCCCCCCCCC)CCCC(=O)O,C36H70O4,17113.0
4603,5-OAHSA,CCCCCCCC/C=C\CCCCCCCC(=O)OC(CCCCCCCCCCCCC)CCCC(=O)O,C36H68O4,17115.0
4604,CH5183284,Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1,C20H16N6O,17120.0
4605,MTTA (hydrochloride),CNCC1CCc2ccccc2C1=O.Cl,C12H16ClNO,17121.0
4606,CGS 21680 (hydrochloride),CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc32)[C@H](O)[C@@H]1O.Cl,C23H30ClN7O6,17126.0
4607,MRS1523,CCCOC(=O)c1c(-c2ccccc2)nc(CC)c(C(=O)SCC)c1CCC,C23H29NO3S,17128.0
4608,Romidepsin,C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O,C24H36N4O6S2,17130.0
4609,Dabigatran etexilate,CCCCCCOC(=O)NC(=N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1,C34H41N7O5,17131.0
4610,ARN-509,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,C21H15F4N5O2S,17132.0
4611,Dabigatran,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,C25H25N7O3,17133.0
4612,Tivantinib,O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12,C23H19N3O2,17135.0
4613,N-ethyl-4-Methoxyamphetamine (hydrochloride),CCNC(C)Cc1ccc(OC)cc1.Cl,C12H20ClNO,17139.0
4614,L-Sulforaphene,CS(=O)/C=C/CCN=C=S,C6H9NOS2,17152.0
4615,1-Deoxygalactonojirimycin (hydrochloride),Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O,C6H14ClNO4,17179.0
4616,Colistin Methanesulfonate (sodium salt),CC(C)CCCCC(=O)N[C@@H](CCNCS(=O)(=O)[O-])C(=O)N[C@H](C(=O)N[C@@H](CCNCS(=O)(=O)[O-])C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCNCS(=O)(=O)[O-])NC(=O)[C@H](CCNCS(=O)(=O)[O-])NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS(=O)(=O)[O-])NC1=O)[C@@H](C)O.CC[C@@H](C)CCCCC(=O)N[C@@H](CCNCS(=O)(=O)[O-])C(=O)N[C@H](C(=O)N[C@@H](CCNCS(=O)(=O)[O-])C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCNCS(=O)(=O)[O-])NC(=O)[C@H](CCNCS(=O)(=O)[O-])NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS(=O)(=O)[O-])NC1=O)[C@@H](C)O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],C115H208N32Na10O56S10,17180.0
4617,Cyclosporin H,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@H](C(C)C)C(=O)N1C,C62H111N11O12,17182.0
4618,BODIPY-aminoacetaldehyde diethyl acetal,CCOC(CNC(=O)CCc1ccc2n1[B-](F)(F)[N+]1=C(C)C=C(C)C1=C2)OCC,C20H28BF2N3O3,9002056.0
4619,4'-chloro-.alpha.-Pyrrolidinopropiophenone (hydrochloride),CC(C(=O)c1ccc(Cl)cc1)N1CCCC1.Cl,C13H17Cl2NO,9002179.0
4620,4-fluoro Pentedrone (hydrochloride),CCCC(NC)C(=O)c1ccc(F)cc1.Cl,C12H17ClFNO,9002182.0
4621,2-Methoxymethamphetamine (hydrochloride),CNC(C)Cc1ccccc1OC.Cl,C11H18ClNO,9002184.0
4622,Alloxan (hydrate),O.O=C1NC(=O)C(=O)C(=O)N1,C4H4N2O5,9002196.0
4623,Wedelolactone,COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21,C16H10O7,11796.0
4624,Withanolide A,CC1=C(C)C(=O)O[C@@H]([C@](C)(O)[C@H]2CC[C@H]3[C@@H]4[C@@H]5O[C@@H]5[C@@]5(O)CC=CC(=O)[C@]5(C)[C@H]4CC[C@]23C)C1,C28H38O6,11797.0
4625,CITCO,Clc1ccc(-c2nc3sccn3c2/C=N/OCc2ccc(Cl)c(Cl)c2)cc1,C19H12Cl3N3OS,16027.0
4626,SB-224289 (hydrochloride),Cc1nc(-c2ccc(-c3ccc(C(=O)N4CCc5cc6c(cc54)C4(CCN(C)CC4)CO6)cc3)c(C)c2)no1.Cl,C32H33ClN4O3,17036.0
4627,8-pCPT-2'-O-methyl Cyclic AMP,CO[C@@H]1[C@@H]2OP(=O)([O-])OC[C@H]2O[C@H]1n1c(Sc2ccc(Cl)cc2)nc2c(N)ncnc21.[Na+],C17H16ClN5NaO6PS,17143.0
4628,"4'-Aminomethyl-4,5',8-trimethylpsorale",Cc1oc2c(C)c3oc(=O)cc(C)c3cc2c1CN,C15H15NO3,17162.0
4629,2-deoxy-2-fluoro L-Fucose,C[C@H](O)[C@@H](O)[C@@H](O)[C@H](F)C=O,C6H11FO4,17171.0
4630,Guvacoline (hydrobromide),Br.COC(=O)C1=CCCNC1,C7H12BrNO2,17190.0
4631,Erythromycin A enol ether,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@]2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@]1(C)O,C37H65NO12,17191.0
4632,12-PAHSA-d31,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OC(CCCCCC)CCCCCCCCCCC(=O)O,C34H66O4,17194.0
4633,12-OAHSA-d17,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])/C=C\CCCCCCCC(=O)OC(CCCCCC)CCCCCCCCCCC(=O)O,C36H68O4,17195.0
4634,5-POHSA-d14,[2H]C([2H])(/C=C\CCCCCC)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OC(CCCCCCCCCCCCC)CCCC(=O)O,C34H64O4,17196.0
4635,5-PAHSA-d31,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OC(CCCCCCCCCCCCC)CCCC(=O)O,C34H66O4,17197.0
4636,L-Phenylephrine,CNC[C@H](O)c1cccc(O)c1,C9H13NO2,17205.0
4637,PPIase-Parvulin Inhibitor,CCOC(=O)CN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CC(=O)OCC)C3=O,C22H18N2O8,17214.0
4638,NNC 55-0396,CC(C)[C@H]1c2ccc(F)cc2CC[C@@]1(CCN(C)CCCc1nc2ccccc2[nH]1)OC(=O)C1CC1.Cl.Cl,C30H40Cl2FN3O2,17216.0
4639,NNC 55-0396,CC(C)[C@H]1c2ccc(F)cc2CC[C@@]1(CCN(C)CCCc1nc2ccccc2[nH]1)OC(=O)C1CC1.Cl.Cl,C30H40Cl2FN3O2,17216.0
4640,Trequinsin (hydrochloride),COc1cc2c(cc1OC)-c1c/c(=N\c3c(C)cc(C)cc3C)n(C)c(=O)n1CC2.Cl,C24H28ClN3O3,17217.0
4641,(2R)-Glycerol-O-.beta.-D-galactopyranoside,OC[C@@H](O)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,C9H18O8,17218.0
4642,p-MPPI (hydrochloride),COc1ccccc1N1CCN(CCN(C(=O)c2ccc(I)cc2)c2ccccn2)CC1.Cl,C25H28ClIN4O2,17220.0
4643,RBI 257 (maleate),CC(C)Oc1cccnc1N(C)C1CCN(Cc2ccc(I)cc2)CC1.O=C(O)/C=C\C(=O)O,C25H32IN3O5,17223.0
4644,UVI3003,CCCCCOc1cc2c(cc1-c1cc(/C=C/C(=O)O)ccc1O)C(C)(C)CCC2(C)C,C28H36O4,16026.0
4645,Rp-8-CPT-Cyclic AMP (sodium salt),Nc1ncnc2c1nc(Sc1ccc(Cl)cc1)n2[C@@H]1O[C@@H]2CO[P@@](=O)([S-])O[C@H]2[C@H]1O.[Na+],C16H14ClN5NaO5PS2,17142.0
4646,Milbemycin A4,CC[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C32H46O7,17155.0
4647,Maleimidoacetic Acid N-hydroxysuccinimide ester,O=C(CN1C(=O)C=CC1=O)ON1C(=O)CCC1=O,C10H8N2O6,17160.0
4648,1-Deoxymannojirimycin (hydrochloride),Cl.OC[C@H]1NC[C@@H](O)[C@@H](O)[C@@H]1O,C6H14ClNO4,17178.0
4649,BPIQ-I,Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,C16H12BrN5,17224.0
4650,"JAK3 Inhibitor, negative control (hydrochloride)",COc1cc2ncnc(Nc3ccccc3)c2cc1OC.Cl,C16H16ClN3O2,17225.0
4651,BPIQ-II (hydrochloride),Brc1cccc(Nc2ncnc3cc4nc[nH]c4cc23)c1.Cl,C15H11BrClN5,17226.0
4652,Toll-Like Receptor 7 Ligand II,COCCOc1nc(N)c2[nH]c(=O)n(Cc3ccccc3)c2n1,C15H17N5O3,17228.0
4653,Gemcitabine monophosphate (formate salt),Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)C2(F)F)c(=O)n1.O=CO,C10H14F2N3O9P,17238.0
4654,Dexamethasone .beta.-D-Glucuronide,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,C28H37FO11,17239.0
4655,"4-(2-Quinoxalinyl)-3-butene-1,2-diol",OC[C@@H](O)/C=C/c1cnc2ccccc2n1,C12H12N2O2,17242.0
4656,Sandoz 58-035,CCCCCCCCCC[Si](C)(C)CCC(=O)NC(Cc1ccc(C)cc1)c1ccccc1,C30H47NOSi,17244.0
4657,Enniatin B1,CC[C@H](C)[C@H]1C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H](C(C)C)C(=O)N1C,C34H59N3O9,17245.0
4658,N-Acetyl Sulfamethoxazole,CC(=O)Nc1ccc(S(=O)(=O)Nc2cc(C)on2)cc1,C12H13N3O4S,17247.0
4659,NIR-664-Iodoacetamide,CN1/C(=C/C=C/C=C/C2=[N+](CCCCS(=O)(=O)[O-])c3ccc4ccccc4c3C2(C)C)C(C)(C)c2cc(CNC(=O)CI)ccc21,C37H42IN3O4S,17252.0
4660,CGP 74514A (hydrochloride),CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21.Cl,C19H25Cl2N7,17253.0
4661,Compound 56,CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC,C18H18BrN3O2,17254.0
4662,6-(Biotinylamino)thiocaproic Acid S-ethyl ester,CCSC(=O)CCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C18H31N3O3S2,17256.0
4663,VER-155008,N#Cc1ccc(COC[C@H]2O[C@@H](n3c(NCc4ccc(Cl)c(Cl)c4)nc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1,C25H23Cl2N7O4,17257.0
4664,NU 6140,CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3[nH]cnc3n2)cc1,C23H30N6O2,17271.0
4665,NPPB,O=C(O)c1cc([N+](=O)[O-])ccc1NCCCc1ccccc1,C16H16N2O4,17292.0
4666,Valdecoxib,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,C16H14N2O3S,10006120.0
4667,Licochalcone A,C=CC(C)(C)c1cc(/C=C/C(=O)c2ccc(O)cc2)c(OC)cc1O,C21H22O4,11853.0
4668,CGP 36216 (hydrochloride),CCP(=O)(O)CCCN.Cl,C5H15ClNO2P,11985.0
4669,Almorexant (hydrochloride),CNC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1.Cl,C29H32ClF3N2O3,13638.0
4670,CAY10681,O=C1c2c(c(-c3ccccc3)nn2Cc2ccccc2)C(c2ccc(Br)cc2)N1CCCn1ccnc1,C30H26BrN5O,15573.0
4671,MMP-9 Inhibitor I,CCN(CC)Cc1cc(C)c(N(Cc2ccccc2)S(=O)(=O)c2ccc(OC)cc2)c(C(=O)NO)c1,C27H33N3O5S,15942.0
4672,BMS 195614,CC1(C)CC=C(c2cnc3ccccc3c2)c2cc(C(=O)Nc3ccc(C(=O)O)cc3)ccc21,C29H24N2O3,16029.0
4673,"3,4-Methylenedioxy-.alpha.-Pyrrolidinohexanophenone (hydrochloride)",CCCCC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1.Cl,C17H24ClNO3,16361.0
4674,"3-desoxy-3,4-Methylenedioxy Pyrovalerone (hydrochloride)",CCCC(C(=O)c1ccc2c(c1)CCO2)N1CCCC1.Cl,C17H24ClNO2,16437.0
4675,Cyclic di-GMP (sodium salt),Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)([O-])O[C@H]4[C@@H](O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP(=O)([O-])O[C@H]3[C@H]2O)c(=O)[nH]1.[Na+].[Na+],C20H22N10Na2O14P2,17144.0
4676,Angiotensin II (human) (acetate),CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O,C52H75N13O14,17150.0
4677,(Z)-PUGNAc,CC(=O)N[C@H]1/C(=N/OC(=O)Nc2ccccc2)O[C@H](CO)[C@@H](O)[C@@H]1O,C15H19N3O7,17151.0
4678,Bilirubin Conjugate,C=CC1=C(C)/C(=C/c2[nH]c(Cc3[nH]c(/C=C4\NC(=O)C(C)=C4C=C)c(C)c3CCC(=O)NCCS(=O)(=O)[O-])c(CCC(=O)NCCS(=O)(=O)[O-])c2C)NC1=O.[Na+].[Na+],C37H44N6Na2O10S2,17170.0
4679,Cefixime,C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OCC(=O)O)c3csc(N)n3)[C@H]2SC1,C16H15N5O7S2,17176.0
4680,p-iodo-Clonidine (hydrochloride),Cl.Clc1cc(I)cc(Cl)c1NC1=NCCN1,C9H9Cl3IN3,17177.0
4681,Rebamipide,O=C(NC(Cc1cc(=O)[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1,C19H15ClN2O4,17186.0
4682,Erythromycin lactobionate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O.O=C(O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,C49H89NO25,17189.0
4683,.alpha.-hydroxy Tamoxifen,CC(O)/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,C26H29NO2,17204.0
4684,CUMYL-PICA,CCCCCn1cc(C(=O)NC(C)(C)c2ccccc2)c2ccccc21,C23H28N2O,17211.0
4685,GSK4716,CC(C)c1ccc(/C=N/NC(=O)c2ccc(O)cc2)cc1,C17H18N2O2,17233.0
4686,Noscapine (hydrochloride),COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C.Cl,C22H24ClNO7,17255.0
4687,EHT 1864,Cl.Cl.O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12,C25H29Cl2F3N2O4S,17258.0
4688,AG-957,COC(=O)c1ccc(NCc2cc(O)ccc2O)cc1,C15H15NO4,17259.0
4689,IC261,COc1cc(OC)c(/C=C2/C(=O)Nc3ccccc32)c(OC)c1,C18H17NO4,17260.0
4690,PD 145305,O=C(O)C(S)Cc1ccccc1,C9H10O2S,17261.0
4691,MRS2395,CNc1nc(Cl)nc2c1ncn2CC(COC(=O)C(C)(C)C)COC(=O)C(C)(C)C,C20H30ClN5O4,17262.0
4692,Coenzyme Q4,COC1=C(OC)C(=O)C(C/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C)=C(C)C1=O,C29H42O4,17263.0
4693,Pristanic Acid,CC(C)CCCC(C)CCCC(C)CCCC(C)C(=O)O,C19H38O2,17264.0
4694,BI 6C9,COc1ccc(S(=O)(=O)NCCCC(=O)Nc2ccc(Sc3ccc(N)cc3)cc2)cc1,C23H25N3O4S2,17265.0
4695,Phenyl .alpha.-L-iduronide (cyclohexyl ammonium salt),NC1CCCCC1.O=C(O)[C@@H]1O[C@@H](Oc2ccccc2)[C@H](O)[C@@H](O)[C@@H]1O,C18H27NO7,17266.0
4696,MMP-2 Inhibitor II,CS(=O)(=O)Nc1ccc(Oc2ccc(S(=O)(=O)CC3CO3)cc2)cc1,C16H17NO6S2,17267.0
4697,Thidiazuron,O=C(Nc1ccccc1)Nc1cnns1,C9H8N4OS,17272.0
4698,N-acetyl Dapsone,CC(=O)Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1,C14H14N2O3S,17274.0
4699,GSK 1016790A,CC(C)C[C@H](NC(=O)c1cc2ccccc2s1)C(=O)N1CCN(C(=O)[C@H](CO)NS(=O)(=O)c2ccc(Cl)cc2Cl)CC1,C28H32Cl2N4O6S2,17289.0
4700,FUB-JWH 018,O=C(c1cccc2ccccc12)c1cn(Cc2ccc(F)cc2)c2ccccc12,C26H18FNO,17332.0
4701,FTI-277 (hydrochloride),COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1.Cl,C22H30ClN3O3S2,10011667.0
4702,Cycloguanil (hydrochloride),CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1.Cl,C11H15Cl2N5,16861.0
4703,MO-CHMINACA,COC(=O)C(OC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(C)(C)C,C22H30N2O4,17136.0
4704,.alpha.-Phthalimidopropiophenone,CC(C(=O)c1ccccc1)N1C(=O)c2ccccc2C1=O,C17H13NO3,17141.0
4705,Tazobactam (sodium salt),C[C@]1(Cn2ccnn2)[C@H](C(=O)[O-])N2C(=O)C[C@H]2S1(=O)=O.[Na+],C10H11N4NaO5S,17185.0
4706,9-amino Camptothecin,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(N)cccc3nc2-1,C20H17N3O4,17232.0
4707,DL-threo-PPMP (hydrochloride),CCCCCCCCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c1ccccc1.Cl,C29H51ClN2O3,17236.0
4708,D-threo-PPMP,CCCCCCCCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c1ccccc1.Cl,C29H51ClN2O3,22677.0
4709,Calhex 231,C[C@@H](N[C@H]1CCCC[C@@H]1NC(=O)c1ccc(Cl)cc1)c1cccc2ccccc12,C25H27ClN2O,17268.0
4710,Taurolithocholic Acid (sodium salt),C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.[Na+],C26H44NNaO5S,17275.0
4711,Necrox-5 (methanesulfonate),CS(=O)(=O)O.CS(=O)(=O)O.O=S1(=O)CCN(Cc2cc(NCC3CCOCC3)c3[nH]c(-c4ccccc4)cc3c2)CC1,C27H39N3O9S3,17278.0
4712,Necrox-2,CS(=O)(=O)N1CCC(Nc2cc(CN3CCS(=O)(=O)CC3)cc3cc(-c4ccccc4)[nH]c23)CC1,C25H32N4O4S2,17279.0
4713,1-Benzyl-1-methyl-4-cyclopentylmethoxycarbonyl-piperidinium (bromide),C[N+]1(Cc2ccccc2)CCC(C(=O)OCC2CCCC2)CC1.[Br-],C20H30BrNO2,17280.0
4714,DA-3003-2,O=C1C(NCCN2CCOCC2)=C(Cl)C(=O)c2ncccc21,C15H16ClN3O3,17282.0
4715,NIR-5c,Br.Br.CC1(C)C(/C=C/C2=C(Cl)/C(=C/C=C3\N(CCCN)c4ccc5ccccc5c4C3(C)C)CCC2)=[N+](CCCN)c2ccc3ccccc3c21.[Br-],C44H52Br3ClN4,17301.0
4716,Esomeprazole (sodium salt),COc1ccc2[nH]c([S@@](=O)Cc3ncc(C)c(OC)c3C)nc2c1,C17H19N3O3S,17303.0
4717,Esomeprazole,COc1ccc2[nH]c([S@@](=O)Cc3ncc(C)c(OC)c3C)nc2c1,C17H19N3O3S,40851.0
4718,Shikimate-3-phosphate (sodium salt),O=C([O-])C1=C[C@@H](OP(=O)([O-])[O-])[C@@H](O)[C@H](O)C1.[Na+].[Na+].[Na+],C7H8Na3O8P,17306.0
4719,Anatalline,c1cncc([C@H]2CCN[C@@H](c3cccnc3)C2)c1,C15H17N3,17307.0
4720,(E/Z)-4-hydroxy Tamoxifen,CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,C26H29NO2,17308.0
4721,NG 52,CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(NCCO)nc21,C16H19ClN6O,17309.0
4722,SB-705498,O=C(Nc1ccccc1Br)N[C@@H]1CCN(c2ccc(C(F)(F)F)cn2)C1,C17H16BrF3N4O,17313.0
4723,GS4012,COc1ccc(SCCc2ccncc2)cc1.Cl,C14H16ClNOS,17321.0
4724,JM 34,Cc1cc(C)nc(NC(=O)c2ccco2)c1,C12H12N2O2,17322.0
4725,7-fluoro Tryptamine (hydrochloride),Cl.NCCc1c[nH]c2c(F)cccc12,C10H12ClFN2,17323.0
4726,OGT 2115,O=C(O)Cc1ccc2oc(-c3ccc(NC(=O)/C=C/c4ccc(Br)cc4)c(F)c3)nc2c1,C24H16BrFN2O4,17324.0
4727,Coenzyme Q2,COC1=C(OC)C(=O)C(C/C=C(\C)CCC=C(C)C)=C(C)C1=O,C19H26O4,17327.0
4728,Gedunin,CC(=O)O[C@@H]1C[C@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@H]2CC[C@@]3(C)[C@H](c4ccoc4)OC(=O)[C@H]4O[C@]43[C@@]21C,C28H34O7,17328.0
4729,RS 504393,Cc1ccc2c(c1)C1(CCN(CCc3nc(-c4ccccc4)oc3C)CC1)OC(=O)N2,C25H27N3O3,17330.0
4730,"5,7-dichloro Tryptamine (hydrochloride)",Cl.NCCc1c[nH]c2c(Cl)cc(Cl)cc12,C10H11Cl3N2,17331.0
4731,24-methyl Cholesterol,CC(C)C(C)CC[C@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C28H48O,17344.0
4732,"4-methyl-N,N-Dimethylcathinone (hydrochloride)",Cc1ccc(C(=O)C(C)N(C)C)cc1.Cl,C12H18ClNO,17393.0
4733,9-PAHSA-d31,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OC(CCCCCCCCC)CCCCCCCC(=O)O,C34H66O4,17397.0
4734,Calcium Ionophore I,CCOC(=O)CCCCCCCCCCCN(C)C(=O)CO[C@H](C)[C@@H](C)OCC(=O)N(C)CCCCCCCCCCCC(=O)OCC,C38H72N2O8,17407.0
4735,10074-G5,O=[N+]([O-])c1ccc(Nc2ccccc2-c2ccccc2)c2nonc12,C18H12N4O3,17408.0
4736,"3,6-diacetoxy Phthalonitrile",CC(=O)Oc1ccc(OC(C)=O)c(C#N)c1C#N,C12H8N2O4,17409.0
4737,Illudin S,CC1=C2C(=C[C@@](C)(CO)[C@@H]2O)C(=O)[C@](C)(O)C12CC2,C15H20O4,17451.0
4738,Zaragozic Acid A,C=C(CC[C@]12O[C@H](C(=O)O)[C@@](O)(C(=O)O)[C@](C(=O)O)(O1)[C@H](OC(=O)/C=C/[C@@H](C)C[C@@H](C)CC)[C@H]2O)[C@@H](OC(C)=O)[C@H](C)Cc1ccccc1,C35H46O14,17452.0
4739,Avermectin B1b,CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,C47H70O14,17453.0
4740,Virginiamycin S1,CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O,C43H49N7O10,17455.0
4741,Enniatin A,CC[C@H](C)[C@H]1C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)C(=O)O[C@H](C(C)C)C(=O)N1C,C36H63N3O9,17456.0
4742,Enniatin A1,CC[C@H](C)[C@H]1C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H](C(C)C)C(=O)N1C,C35H61N3O9,17457.0
4743,Reveromycin A,CCCC[C@@]1(OC(=O)CCC(=O)O)CC[C@]2(CC[C@H](C)[C@@H](C/C=C(C)/C=C/[C@H](O)[C@@H](C)/C=C/C(=O)O)O2)O[C@H]1/C=C/C(C)=C/C(=O)O,C36H52O11,17458.0
4744,(5Z)-7-Oxozeaenol,COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O,C19H22O7,17459.0
4745,Virginiamycin M1,CC1=C\[C@@H](O)CC(=O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)O[C@H](C(C)C)[C@H](C)/C=C/C(=O)NC/C=C\1,C28H35N3O7,9002172.0
4746,STF-31,CC(C)(C)c1ccc(S(=O)(=O)NCc2ccc(C(=O)Nc3cccnc3)cc2)cc1,C23H25N3O3S,11173.0
4747,BYK 191023 (hydrochloride),COc1ccnc(CCc2nc3ncccc3[nH]2)c1.Cl.Cl,C14H16Cl2N4O,13177.0
4748,Fisetin,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,C15H10O6,15246.0
4749,Bilirubin,C=CC1=C(C)/C(=C/c2[nH]c(Cc3[nH]c(/C=C4\NC(=O)C(C)=C4C=C)c(C)c3CCC(=O)O)c(CCC(=O)O)c2C)NC1=O,C33H36N4O6,17161.0
4750,Sedanolide,CCCCC1OC(=O)C2=CCCCC21,C12H18O2,17166.0
4751,5(6)-Carboxyfluorescein,O=C(O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21.O=C(O)c1ccc2c(c1)C1(OC2=O)c2ccc(O)cc2Oc2cc(O)ccc21,C42H24O14,17172.0
4752,"2',7'-bis(carboxyethyl)-5(6)-Carboxyfluorescein",O=C(O)CCc1cc2c(cc1O)Oc1cc(O)c(CCC(=O)O)cc1C21OC(=O)c2cc(C(=O)O)ccc21.O=C(O)CCc1cc2c(cc1O)Oc1cc(O)c(CCC(=O)O)cc1C21OC(=O)c2ccc(C(=O)O)cc21,C54H40O22,17183.0
4753,n-Octyl-?-D-thioglucopyranoside,CCCCCCCCS[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C14H28O5S,17184.0
4754,ADAMTS-5 Inhibitor,Cn1nc(C(F)(F)F)c(/C=C2\SC(=S)NC2=O)c1SCc1ccc(Cl)cc1,C16H11ClF3N3OS3,17188.0
4755,CI-976,CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC,C23H39NO4,17235.0
4756,MTSEA-biotin,CS(=O)(=O)SCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C13H23N3O4S3,17237.0
4757,o-3M3FBS,Cc1cc(C)c(S(=O)(=O)Nc2ccccc2C(F)(F)F)c(C)c1,C16H16F3NO2S,17251.0
4758,Furosemide,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,C12H11ClN2O5S,17273.0
4759,IKK2 Inhibitor VI,NC(=O)Nc1sc(-c2ccccc2)cc1C(N)=O,C12H11N3O2S,17276.0
4760,sPLA2 Inhibitor,O=C(O)CC[C@@H](Cc1ccc(OCc2ccccc2)cc1)NC(=O)CCCCCCc1ccccc1,C31H37NO4,17277.0
4761,LP44 (hydrochloride),CSc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1.Cl,C27H38ClN3OS,17287.0
4762,D-Pantothenic Acid (sodium salt),CC(C)(C[O-])[C@@H](O)C(=O)NCCC(=O)O.[Na+],C9H16NNaO5,17288.0
4763,TMA-DPH,C[N+](C)(C)c1ccc(/C=C/C=C/C=C/c2ccccc2)cc1.Cc1ccc(S(=O)(=O)[O-])cc1,C28H31NO3S,17294.0
4764,Fendiline (hydrochloride),CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1.Cl,C23H26ClN,17295.0
4765,o-Dianisidine (hydrochloride),COc1cc(-c2ccc(N)c(OC)c2)ccc1N.Cl.Cl,C14H18Cl2N2O2,17316.0
4766,Spiro-MeOTAD,COc1ccc(N(c2ccc(OC)cc2)c2ccc3c(c2)C2(c4cc(N(c5ccc(OC)cc5)c5ccc(OC)cc5)ccc4-3)c3cc(N(c4ccc(OC)cc4)c4ccc(OC)cc4)ccc3-c3ccc(N(c4ccc(OC)cc4)c4ccc(OC)cc4)cc32)cc1,C81H68N4O8,17317.0
4767,5-Fluoroorotic Acid (hydrate),O.O=C(O)c1[nH]c(=O)[nH]c(=O)c1F,C5H5FN2O5,17318.0
4768,Mirabegron,Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1,C21H24N4O2S,17319.0
4769,Solifenacin (succinate),O=C(O)CCC(=O)O.O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1,C27H32N2O6,17320.0
4770,TAK-875,Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OC[C@H]3CC(=O)O)c1,C29H32O7S,17335.0
4771,Glaucine,COc1cc2c(cc1OC)-c1c(OC)c(OC)cc3c1[C@H](C2)N(C)CC3,C21H25NO4,17338.0
4772,Oxcarbazepine,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,C15H12N2O2,17340.0
4773,Oxcarbazepine (CRM),NC(=O)N1c2ccccc2CC(=O)c2ccccc21,C15H12N2O2,42590.0
4774,Tetrazolium (chloride),[Cl-].c1ccc(-c2nn(-c3ccccc3)[n+](-c3ccccc3)n2)cc1,C19H15ClN4,17342.0
4775,A-61603,Br.CS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1,C14H20BrN3O3S,17358.0
4776,Fexaramine,COC(=O)/C=C/c1cccc(N(Cc2ccc(-c3ccc(N(C)C)cc3)cc2)C(=O)C2CCCCC2)c1,C32H36N2O3,17369.0
4777,SU 5614,Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(Cl)cc32)[nH]1,C15H13ClN2O,17410.0
4778,4-P-PDOT,CCC(=O)NC1Cc2ccccc2C(c2ccccc2)C1,C19H21NO,17411.0
4779,AC-93253,CC[n+]1c(/C=C/C=C2/N(C)c3ccccc3C2(C)C)sc2ccccc21.[I-],C23H25IN2S,17412.0
4780,Tenidap,NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21,C14H9ClN2O3S,17413.0
4781,YM-750,Cc1cc(C)c(NC(=O)N(Cc2ccc3c(c2)Cc2ccccc2-3)C2CCCCCC2)c(C)c1,C31H36N2O,17414.0
4782,R-568,COc1cccc([C@@H](C)NCCCc2ccccc2Cl)c1.Cl,C18H23Cl2NO,17415.0
4783,R 568,COc1cccc([C@@H](C)NCCCc2ccccc2Cl)c1.Cl,C18H23Cl2NO,17415.0
4784,SB-258585 (hydrochloride),COc1ccc(NS(=O)(=O)c2ccc(I)cc2)cc1N1CCN(C)CC1.Cl,C18H23ClIN3O3S,17416.0
4785,MRS1706,CCCn1c(=O)c2[nH]c(-c3ccc(OCC(=O)Nc4ccc(C(C)=O)cc4)cc3)nc2n(CCC)c1=O,C27H29N5O5,17417.0
4786,BMS 493,CC1(C)CC=C(C#Cc2ccccc2)c2cc(/C=C/c3ccc(C(=O)O)cc3)ccc21,C29H24O2,17418.0
4787,TCS-OX 2-29,COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccncc1)C(C)(C)C)CC2.Cl,C23H32ClN3O3,17419.0
4788,NPEC-caged-dopamine,CC(OC(=O)NCCc1ccc(O)c(O)c1)c1ccccc1[N+](=O)[O-],C17H18N2O6,17420.0
4789,Raclopride,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,C15H20Cl2N2O3,17422.0
4790,Dihydrodaidzein,O=C1c2ccc(O)cc2OCC1c1ccc(O)cc1,C15H12O4,17423.0
4791,PNU 282987,O=C(N[C@H]1CN2CCC1CC2)c1ccc(Cl)cc1,C14H17ClN2O,17424.0
4792,NO-1886,CCOP(=O)(Cc1ccc(C(=O)Nc2ccc(Br)cc2C#N)cc1)OCC,C19H20BrN2O4P,17425.0
4793,SGC707,O=C(NCC(=O)N1CCCC1)Nc1ccc2cnccc2c1,C16H18N4O2,17017.0
4794,SAMS Peptide,[H]N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C,C74H131N29O18S2,17061.0
4795,2-MAPB (hydrochloride),CNC(C)Cc1cc2ccccc2o1.Cl,C12H16ClNO,17140.0
4796,Orbifloxacin,C[C@@H]1CN(c2c(F)c(F)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1,C19H20F3N3O3,17353.0
4797,Saclofen,NCC(CS(=O)(=O)O)c1ccc(Cl)cc1,C9H12ClNO3S,17355.0
4798,Phytol,C/C(=C\CO)CCCC(C)CCCC(C)CCCC(C)C,C20H40O,17401.0
4799,Phytol (CRM),C/C(=C\CO)CCCC(C)CCCC(C)CCCC(C)C,C20H40O,37421.0
4800,BQ-788,CCCC[C@@H](NC(=O)[C@@H](Cc1cn(C(=O)OC)c2ccccc12)NC(=O)[C@H](CC(C)(C)C)NC(=O)N1[C@H](C)CCC[C@@H]1C)C(=O)O.[NaH],C34H51N5NaO7,17403.0
4801,Cefapirin,CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1,C17H17N3O6S2,17406.0
4802,Evernic Acid,COc1cc(C)c(C(=O)Oc2cc(C)c(C(=O)O)c(O)c2)c(O)c1,C17H16O7,17430.0
4803,N-Benzylpalmitamide,CCCCCCCCCCCCCCCC(=O)NCc1ccccc1,C23H39NO,9002235.0
4804,Lomitapide,O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1,C39H37F6N3O2,10009610.0
4805,L-ANAP (trifluoroacetate salt),CC(=O)c1ccc2cc(NC[C@H](N)C(=O)O)ccc2c1.O=C(O)C(F)(F)F,C17H17F3N2O5,15436.0
4806,(2R)-Octyl-.alpha.-hydroxyglutarate,CCCCCCCCOC(=O)[C@H](O)CCC(=O)O,C13H24O5,16366.0
4807,VU0483605,O=C(Nc1ccc(N2C(=O)c3cccc(Cl)c3C2=O)c(Cl)c1)c1ncccc1Cl,C20H10Cl3N3O3,16941.0
4808,.alpha.-Pyrrolidinononanophenone (hydrochloride),CCCCCCCC(C(=O)c1ccccc1)N1CCCC1.Cl,C19H30ClNO,17138.0
4809,5-fluoro CUMYL-PICA,CC(C)(NC(=O)c1cn(CCCCCF)c2ccccc12)c1ccccc1,C23H27FN2O,17212.0
4810,MMP-3 Inhibitor VIII,COc1ccc(S(=O)(=O)N(Cc2ccccc2)C(CC(C)C)C(=O)NO)cc1,C20H26N2O5S,17246.0
4811,IMD 0354,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,C15H8ClF6NO2,17290.0
4812,Verteporfin,C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)c(CCC(=O)OC)c4C)[C@@]1(C)C3=CC=C(C(=O)OC)[C@H]1C(=O)OC,C41H40N4O8,17334.0
4813,U-73343,COc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](NCCCCCCN3C(=O)CCC3=O)CC[C@@H]12,C29H42N2O3,17339.0
4814,Chlorhexidine (hydrochloride),Cl.Cl.N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,C22H32Cl4N10,17343.0
4815,Salicin,OCc1ccccc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C13H18O7,17357.0
4816,Antileukinate,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,C45H66N18O7S,17359.0
4817,Chrysin,O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12,C15H10O4,17402.0
4818,.beta.-Hydroxythiofentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CC(O)c2cccs2)CC1.Cl,C20H27ClN2O2S,17421.0
4819,.beta.-Hydroxythiofentanyl (hydrochloride) (CRM),CCC(=O)N(c1ccccc1)C1CCN(CC(O)c2cccs2)CC1.Cl,C20H27ClN2O2S,19736.0
4820,?-Hydroxythiofentanyl (hydrochloride) (CRM),CCC(=O)N(c1ccccc1)C1CCN(CC(O)c2cccs2)CC1.Cl,C20H27ClN2O2S,39681.0
4821,4'-methyl Acetyl fentanyl (hydrochloride),CC(=O)N(c1ccccc1)C1CCN(CCc2ccc(C)cc2)CC1.Cl,C22H29ClN2O,9002271.0
4822,Acetyl fentanyl 4-methylphenethyl analog (hydrochloride) (CRM),CC(=O)N(c1ccccc1)C1CCN(CCc2ccc(C)cc2)CC1.Cl,C22H29ClN2O,19733.0
4823,Ifenprodil (hemitartrate),CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C25H33NO8,17201.0
4824,SGI-1027,Cc1cc(Nc2ccc(NC(=O)c3ccc(Nc4ccnc5ccccc45)cc3)cc2)nc(N)n1,C27H23N7O,11165.0
4825,UNC0642,COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1,C29H44F2N6O2,14604.0
4826,HNMPA,O=P(O)(O)C(O)c1ccc2ccccc2c1,C11H11O4P,15543.0
4827,EPZ6438,CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,C34H44N4O4,16174.0
4828,AM6545,Cc1c(C(=O)NN2CCS(=O)(=O)CC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CCCC#N)cc1,C26H23Cl2N5O3S,16316.0
4829,EG2201 RM,O=C(c1ccc2c(c1)c1ccccc1n2CCCCCF)c1cccc2ccccc12,C28H24FNO,16884.0
4830,MAGL Inhibitor 21,O=C(CCCCCc1ccc(-c2ccccc2)cc1)OCc1ccc2c(c1)OCO2,C26H26O4,16964.0
4831,Skepinone-L,O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21,C24H21F2NO4,16974.0
4832,SR8278,CCOC(=O)C1Cc2ccccc2CN1C(=O)c1ccc(SC)s1,C18H19NO3S2,17000.0
4833,MitoB,OB(O)c1cccc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],C25H23BBrO2P,17116.0
4834,Rhein,O=C(O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O,C15H8O6,17345.0
4835,Amoxapine,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,C17H16ClN3O,17347.0
4836,Ganglioside GD3 (bovine brain) (sodium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]4(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[Na+].[Na+],C70H123N3Na2O29,17481.0
4837,JWH 307 3'-isomer,CCCCCn1cc(C(=O)c2cccc3ccccc23)c(-c2ccccc2F)c1,C26H24FNO,17506.0
4838,Bisindolylmaleimide X (hydrochloride),Cl.Cn1cc(C2=C(c3c4n(c5ccccc35)CCC(CN)C4)C(=O)NC2=O)c2ccccc21,C26H25ClN4O2,17511.0
4839,A-366,COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCC1,C19H27N3O2,16081.0
4840,VPC 23019,CCCCCCCCc1cccc(NC(=O)[C@H](N)COP(=O)(O)O)c1,C17H29N2O5P,13240.0
4841,Letermovir,COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1,C29H28F4N4O4,17556.0
4842,Aminoacetone (hydrochloride),CC(=O)CN.Cl,C3H8ClNO,17573.0
4843,trans-Ned-19,COc1ccc([C@H]2N[C@H](C(=O)O)Cc3c2[nH]c2ccccc32)cc1CN1CCN(c2ccccc2F)CC1,C30H31FN4O3,17527.0
4844,AR-420626,CC1=C(C(=O)Nc2cc(Cl)ccc2Cl)C(c2ccco2)C2=C(CCCC2=O)N1,C21H18Cl2N2O3,17531.0
4845,UBP 301,N[C@@H](Cn1cc(I)c(=O)n(Cc2ccc(C(=O)O)cc2)c1=O)C(=O)O,C15H14IN3O6,17597.0
4846,Remodelin,N#Cc1ccc(-c2csc(NN=C3CCCC3)n2)cc1,C15H14N4S,17346.0
4847,CAY10682,O=C1c2c(c(-c3ccccc3)nn2Cc2ccc(F)cc2)C(c2ccc(Br)cc2)N1CCCn1ccnc1,C30H25BrFN5O,15574.0
4848,Vacquinol-1,OC(c1cc(-c2ccc(Cl)cc2)nc2ccccc12)C1CCCCN1,C21H21ClN2O,16321.0
4849,trans-AUCB,O=C(NC12CC3CC(CC(C3)C1)C2)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1,C24H32N2O4,16568.0
4850,Encorafenib,COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1,C22H27ClFN7O4S,16994.0
4851,OF-1,COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C,C17H18BrN3O4S,17124.0
4852,Milbemycin oxime,CC1=C[C@H]2C(=O)O[C@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C4\CO[C@H](/C1=N\O)[C@@]42O)O[C@@]1(CC[C@H](C)[C@@H](C)O1)C3.CC1=C[C@H]2C(=O)O[C@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C4\CO[C@H](/C1=N\O)[C@@]42O)O[C@@]1(CC[C@H](C)[C@@H](C)O1)C3.CC[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C3\CO[C@@H]4/C(=N\O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CC[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C3\CO[C@@H]4/C(=N\O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C126H176N4O28,17164.0
4853,Moxidectin,CO/N=C1/C[C@]2(C[C@@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C4\CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@H](/C(C)=C/C(C)C)[C@H]1C,C37H53NO8,17165.0
4854,VLX600,C/C(=N/Nc1nnc2c(n1)[nH]c1c(C)cccc12)c1ccccn1,C17H15N7,17192.0
4855,EPZ015666,O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1cc(NC2COC2)ncn1,C20H25N5O3,17285.0
4856,Temoporfin,Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc(c(-c5cccc(O)c5)c5ccc2[nH]5)CC4)C=C3)c1,C44H32N4O4,17333.0
4857,Temafloxacin,CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1,C21H18F3N3O3,17352.0
4858,NF-.kappa.B Control,[H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)C(C)C,C123H215N33O30S,17475.0
4859,Isradipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12,C19H21N3O5,17536.0
4860,Nicardipine (hydrochloride),COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1.Cl,C26H30ClN3O6,17537.0
4861,N-4-Tosyl-L-arginine methyl ester (hydrochloride),COC(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)c1ccc(C)cc1.Cl,C14H23ClN4O4S,17550.0
4862,Chk2 Inhibitor II,NC(=O)c1ccc2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)[nH]c2c1,C20H14ClN3O2,17552.0
4863,Carfilzomib,CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,C40H57N5O7,17554.0
4864,Minoxidil-d10,[2H]C1([2H])N(c2cc(N)[n+]([O-])c(N)n2)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],C9H15N5O,17563.0
4865,(E)-2-Hexadecenal,CCCCCCCCCCCCC/C=C/C=O,C16H30O,17566.0
4866,EGFR/ErbB2 Inhibitor,COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC,C23H21N3O3,17568.0
4867,Glycogen Phosphorylase Inhibitor,CNC(=O)Nc1ccc(OC)c(NC(=O)NC(=O)c2cc(F)c(F)cc2Cl)c1,C17H15ClF2N4O4,17578.0
4868,L-.alpha.-Aminoadipic Acid,N[C@@H](CCCC(=O)O)C(=O)O,C6H11NO4,17579.0
4869,6-Diazo-5-oxo-L-norleucine,[N-]=[N+]=CC(=O)CC[C@H](N)C(=O)O,C6H9N3O3,17580.0
4870,L-Cysteine-glutathione disulfide,N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)O,C13H22N4O8S2,17582.0
4871,G3335,N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O,C16H19N3O5,17593.0
4872,WS-3,CN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC(=O)C5CC5)ncn4)cc3)cc2C(F)(F)F)CC1,C28H30F3N7O3,17667.0
4873,PND1186,CNC(=O)c1ccccc1Nc1cc(Nc2ccc(N3CCOCC3)cc2OC)ncc1C(F)(F)F,C25H26F3N5O3,17668.0
4874,Filgotinib,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1,C21H23N5O3S,17669.0
4875,TAE684,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,C30H40ClN7O3S,17670.0
4876,AMG 706,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21.O=P(O)(O)O.O=P(O)(O)O,C22H29N5O9P2,17671.0
4877,WS-6,CN1CCN(Cc2ccc(NC(=O)Cc3ccc(Oc4cc(NC(=O)C5CC5)ncn4)cc3)cc2C(F)(F)F)CC1,C29H31F3N6O3,17672.0
4878,IM-12,Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O,C22H20FN3O2,17673.0
4879,NMS-873,Cc1cc(OCc2nnc(SC3CCCC3)n2-c2cccnc2)ccc1-c1ccc(S(C)(=O)=O)cc1,C27H28N4O3S2,17674.0
4880,PF-431396,CN(c1ccccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,C22H21F3N6O3S,17665.0
4881,LEE011,CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1,C23H30N8O,17666.0
4882,CZC-24832,CC(C)(C)NS(=O)(=O)c1cncc(-c2cc(F)c3nc(N)nn3c2)c1,C15H17FN6O2S,14307.0
4883,ADB-CHMICA,CC(C)(C)C(NC(=O)c1cn(CC2CCCCC2)c2ccccc12)C(N)=O,C22H31N3O2,17213.0
4884,Ras Inhibitory Peptide,[H]N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C,C53H91N19O11,17474.0
4885,PKC? Inhibitor Peptide,[H]N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C,C37H65N9O13,17476.0
4886,Clozapine-d4,[2H]C1([2H])CN(C)CC([2H])([2H])N1C1=Nc2cc(Cl)ccc2Nc2ccccc21,C18H19ClN4,17513.0
4887,4-fluoro PV8 piperidine analog (hydrochloride),CCCCCC(C(=O)c1ccc(F)cc1)N1CCCCC1.Cl,C18H27ClFNO,17519.0
4888,Felodipine,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,C18H19Cl2NO4,17535.0
4889,JNK Inhibitor V,N#CC(c1ccnc(NCCc2cccnc2)n1)c1nc2ccccc2s1,C20H16N6S,17542.0
4890,DMPQ (hydrochloride),COc1cc(OC)c2cc(-c3ccncc3)cnc2c1.Cl.Cl,C16H16Cl2N2O2,17551.0
4891,Zoxazolamine,Nc1nc2cc(Cl)ccc2o1,C7H5ClN2O,17565.0
4892,"11(Z),14(Z),17(Z)-Eicosatrienoic Acid methyl ester",CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)OC,C21H36O2,17622.0
4893,JAK2 Inhibitor V,CC(CCc1ccccn1)(CCc1ccccn1)C(=O)c1ccccc1,C23H24N2O,17684.0
4894,NVP-TAE226,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,C23H25ClN6O3,17685.0
4895,LH 846,Cc1cc2sc(NC(=O)Cc3ccccc3)nc2cc1Cl,C16H13ClN2OS,17686.0
4896,Docosapentaenoic Acid methyl ester,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC,C23H36O2,9001870.0
4897,PD 158780,CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,C14H12BrN5,13329.0
4898,(2S)-Octyl-.alpha.-hydroxyglutarate,CCCCCCCCOC(=O)[C@@H](O)CCC(=O)O,C13H24O5,16367.0
4899,Nitro Blue Tetrazolium (chloride),COc1cc(-c2ccc(-[n+]3nc(-c4ccccc4)nn3-c3ccc([N+](=O)[O-])cc3)c(OC)c2)ccc1-[n+]1nc(-c2ccccc2)nn1-c1ccc([N+](=O)[O-])cc1.[Cl-].[Cl-],C40H30Cl2N10O6,17341.0
4900,Tianeptine (sodium salt),CN1c2ccccc2C(NCCCCCCC(=O)[O-])c2ccc(Cl)cc2S1(=O)=O.[Na+],C21H24ClN2NaO4S,17561.0
4901,Tianeptine (sodium salt) (CRM),CN1c2ccccc2C(NCCCCCCC(=O)[O-])c2ccc(Cl)cc2S1(=O)=O.[Na+],C21H24ClN2NaO4S,35880.0
4902,5-chloro Hydrochlorothiazide,NS(=O)(=O)c1cc2c(c(Cl)c1Cl)NCNS2(=O)=O,C7H7Cl2N3O4S2,17571.0
4903,Calindol (hydrochloride),C[C@@H](NCc1cc2ccccc2[nH]1)c1cccc2ccccc12.Cl,C21H21ClN2,17575.0
4904,APP-CHMINACA,NC(=O)[C@H](Cc1ccccc1)NC(=O)c1nn(CC2CCCCC2)c2ccccc12,C24H28N4O2,17614.0
4905,Amylose,OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O,C12H22O12(C6H10O4)n,17664.0
4906,6-OAU,CCCCCCCCNc1cc(=O)[nH]c(=O)[nH]1,C12H21N3O2,17687.0
4907,Fenretinide,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)Nc2ccc(O)cc2)C(C)(C)CCC1,C26H33NO2,17688.0
4908,PFK-15,O=C(/C=C/c1ccc2ccccc2n1)c1ccncc1,C17H12N2O,17689.0
4909,"CP 640,186",O=C(c1c2ccccc2cc2ccccc12)N1CCC(N2CCC[C@@H](C(=O)N3CCOCC3)C2)CC1,C30H35N3O3,17691.0
4910,Tasquinimod,COc1cccc2c1c(O)c(C(=O)N(C)c1ccc(C(F)(F)F)cc1)c(=O)n2C,C20H17F3N2O4,17692.0
4911,AZ191,COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2cn(C)c3cnccc23)n1,C24H27N7O,17693.0
4912,CASIN,OCCNC1CCCc2c1[nH]c1ccc(-c3ccccc3)cc21,C20H22N2O,17694.0
4913,Clemizole (hydrochloride),Cl.Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1,C19H21Cl2N3,17695.0
4914,ELR510444,Cc1ccc(S(=O)(=O)Nc2cc(-c3ccc(C#N)s3)ccc2C)cc1,C19H16N2O2S2,17696.0
4915,FK-3311,CC(=O)c1ccc(NS(C)(=O)=O)c(Oc2ccc(F)cc2F)c1,C15H13F2NO4S,17697.0
4916,LDN212854,c1cc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)c2cccnc2c1,C25H22N6,17698.0
4917,MM-102,CCC(CC)(NC(=O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC1(C(=O)NC(c2ccc(F)cc2)c2ccc(F)cc2)CCCC1,C35H49F2N7O4,17699.0
4918,GBR 12935 (hydrochloride),Cl.Cl.c1ccc(CCCN2CCN(CCOC(c3ccccc3)c3ccccc3)CC2)cc1,C28H36Cl2N2O,17700.0
4919,TAK-960,COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc1ncc2c(n1)N(C1CCCC1)CC(F)(F)C(=O)N2C,C27H34F3N7O3,17701.0
4920,TTP 22,Cc1ccc(-c2csc3ncnc(SCCC(=O)O)c23)cc1,C16H14N2O2S2,17702.0
4921,UNC2250,CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,C24H36N6O2,17703.0
4922,WAY-262611,NCC1CCN(c2nccc(-c3ccc4ccccc4c3)n2)CC1,C20H22N4,17704.0
4923,HA155,O=C1S/C(=C\c2ccc(OCc3ccc(B(O)O)cc3)cc2)C(=O)N1Cc1ccc(F)cc1,C24H19BFNO5S,11034.0
4924,GSK2578215,O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1,C24H18FN3O2,14603.0
4925,SP-2509,C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1)c1cc(Cl)ccc1O,C19H20ClN3O5S,15487.0
4926,ADT-OH,Oc1ccc(-c2cc(=S)ss2)cc1,C9H6OS3,17102.0
4927,"3,4-dimethoxy-.alpha.-Pyrrolidinohexanophenone (hydrochloride)",CCCCC(C(=O)c1ccc(OC)c(OC)c1)N1CCCC1.Cl,C18H28ClNO3,17137.0
4928,CUMYL-THPINACA,CC(C)(NC(=O)c1nn(CC2CCOCC2)c2ccccc12)c1ccccc1,C23H27N3O2,17210.0
4929,3-Chloromethcathinone (hydrochloride),CNC(C)C(=O)c1cccc(Cl)c1.Cl,C10H13Cl2NO,17394.0
4930,OG-L002,N[C@H]1C[C@@H]1c1ccc(-c2cccc(O)c2)cc1,C15H15NO,17471.0
4931,BMS 754807,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)[nH]n2)c2cccn2n1,C23H24FN9O,17505.0
4932,A-796260 Degradant,C=C(C)C(C)(C)CC(=O)c1cn(CCN2CCOCC2)c2ccccc12,C22H30N2O2,17515.0
4933,GTP 14564,c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1,C15H10N2O,17543.0
4934,Pyrrolidine Ricinoleamide,CCCCCC[C@@H](O)C/C=C\CCCCCCCC(=O)N1CCCC1,C22H41NO2,17548.0
4935,Lorglumide (sodium salt),CCCCCN(CCCCC)C(=O)C(CCC(=O)[O-])NC(=O)c1ccc(Cl)c(Cl)c1.[Na+],C22H31Cl2N2NaO4,17555.0
4936,Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,C7H15Cl2N2O2P,17562.0
4937,Guanidinoethyl sulfonate,N=C(N)NCCS(=O)(=O)O,C3H9N3O3S,17572.0
4938,rac-7-methoxy Propranolol,COc1ccc2cccc(OCC(O)CNC(C)C)c2c1,C17H23NO3,17576.0
4939,VE-821,CS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1,C18H16N4O3S,17587.0
4940,AZ 20,C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1,C21H24N4O3S,17589.0
4941,N-Acetyl-S-allyl-L-cysteine,C=CCSC[C@H](NC(C)=O)C(=O)O,C8H13NO3S,17592.0
4942,AS-1949490,C[C@H](NC(=O)c1sccc1OCc1ccc(Cl)cc1)c1ccccc1,C20H18ClNO2S,17627.0
4943,YM-26734,CCCCCCCCCCCC(=O)c1c(O)c(C(=O)CCCCCCCCCCC)c(O)c(C2CC(c3ccc(O)cc3)Oc3cc(O)ccc32)c1O,C45H62O8,17631.0
4944,ML-345,O=c1c2cc(F)ccc2sn1-c1cc(S(=O)(=O)N2CCOCC2)ccc1N1CCOCC1,C21H22FN3O5S2,17633.0
4945,cis-Flupenthixol (hydrochloride),Cl.Cl.OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,C23H27Cl2F3N2OS,17634.0
4946,SMI-481,O=C(c1ccc(Cl)c([N+](=O)[O-])c1)N1CCN(c2ccccc2F)CC1,C17H15ClFN3O3,17637.0
4947,CYM 5520,Cc1cc(C(=O)Cn2cc(C#N)ccc2=O)c(C)n1Cc1ccccc1,C21H19N3O2,17638.0
4948,ML-347,COc1ccc(-c2cnc3c(-c4cccc5ncccc45)cnn3c2)cc1,C22H16N4O,17640.0
4949,ML-184,Cc1cccc(N2CCN(C(=O)c3cc(S(=O)(=O)N(C)C)ccc3N3CCCC3)CC2)c1C,C25H34N4O3S,17641.0
4950,APD668,CC(C)OC(=O)N1CCC(Oc2ncnc3c2cnn3-c2ccc(S(C)(=O)=O)cc2F)CC1,C21H24FN5O5S,17642.0
4951,BIIB-057,NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1,C19H23N9O,17652.0
4952,GS-9973,c1cn2cc(-c3ccc4cn[nH]c4c3)nc(Nc3ccc(N4CCOCC4)cc3)c2n1,C23H21N7O,17653.0
4953,AC-55541,C/C(=N\NC(=O)C(NC(=O)c1ccccc1)c1n[nH]c(=O)c2ccccc12)c1cccc(Br)c1,C25H20BrN5O3,17736.0
4954,Defactinib,CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1,C20H21F3N8O3S,17737.0
4955,TMP269,O=C(NCC1(c2nc(-c3ccccc3)cs2)CCOCC1)c1cccc(-c2noc(C(F)(F)F)n2)c1,C25H21F3N4O3S,17738.0
4956,UNBS-5162,CN(C)CCN1C(=O)c2cccc3cc(NC(N)=O)cc(c23)C1=O,C17H18N4O3,17739.0
4957,LY2835219 (methanesulfonate),CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1.CS(=O)(=O)O,C28H36F2N8O3S,17740.0
4958,AZD 2932,COc1cc2ncnc(Oc3ccc(CC(=O)Nc4cnn(C(C)C)c4)cc3)c2cc1OC,C24H25N5O4,17741.0
4959,VEGFR2 Kinase Inhibitor I,CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C,C18H18N2O3,13578.0
4960,Plumbagin,CC1=CC(=O)c2c(O)cccc2C1=O,C11H8O3,14314.0
4961,STF-118804,Cc1ccc(S(=O)(=O)Cc2nc(-c3ccc(C(=O)NCc4cccnc4)cc3)oc2C)cc1,C25H23N3O4S,15283.0
4962,4EGI-1,O=C(O)/C(Cc1ccccc1[N+](=O)[O-])=N/Nc1nc(-c2ccc(Cl)c(Cl)c2)cs1,C18H12Cl2N4O4S,15362.0
4963,galacto-Dapagliflozin,CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,C21H25ClO6,15952.0
4964,KD 025,CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1,C26H24N6O2,17055.0
4965,5-fluoro CUMYL-PINACA,CC(C)(NC(=O)c1nn(CCCCCF)c2ccccc12)c1ccccc1,C22H26FN3O,17206.0
4966,5-fluoro CUMYL-PINACA (exempt preparation),CC(C)(NC(=O)c1nn(CCCCCF)c2ccccc12)c1ccccc1,C22H26FN3O,41303.0
4967,Betaine Aldehyde (chloride),C[N+](C)(C)CC=O.[Cl-],C5H12ClNO,17270.0
4968,UNC2170 (maleate),CC(C)(C)NCCCNC(=O)c1cccc(Br)c1.O=C(O)/C=C\C(=O)O,C18H25BrN2O5,17374.0
4969,ML-324,CN(C)CCCNC(=O)c1ccc(-c2cc(O)c3ncccc3c2)cc1,C21H23N3O2,17472.0
4970,PKA Inhibitor Fragment (6-22) amide,[H]N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O,C80H130N28O24,17486.0
4971,TNF-.alpha. Antagonist,[H]N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O,C58H71N11O15S2,17492.0
4972,FDU-NNEI,O=C(Nc1cccc2ccccc12)c1cn(Cc2ccc(F)cc2)c2ccccc12,C26H19FN2O,17495.0
4973,Cytosporone B,CCCCCCCC(=O)c1c(O)cc(O)cc1CC(=O)OCC,C18H26O5,17501.0
4974,Ku-60019,C[C@@H]1CN(CC(=O)Nc2ccc3c(c2)Cc2cccc(-c4cc(=O)cc(N5CCOCC5)o4)c2S3)C[C@H](C)O1,C30H33N3O5S,17502.0
4975,P11,Cc1ccc([C@@H]2CC=C(C(=O)O)[C@H](c3ccc(C(C)(C)C)cc3)N2S(=O)(=O)c2ccc(C)cc2)cc1,C30H33NO4S,17507.0
4976,Pyrrolidine Linoleamide,CCCCC/C=C\C/C=C\CCCCCCCC(=O)N1CCCC1,C22H39NO,17539.0
4977,VEGFR2 Kinase Inhibitor II,O=C1Nc2ccc(Br)cc2/C1=C/c1cc2c([nH]1)CCCC2,C17H15BrN2O,17544.0
4978,Nitrendipine,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,C18H20N2O6,17549.0
4979,Formononetin,COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1,C16H12O4,17558.0
4980,N-(2-hydroxyethyl)-Naphthalimide,O=C1c2cccc3cccc(c23)C(=O)N1CCO,C14H11NO3,17567.0
4981,GSK2636771,Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F,C22H22F3N3O3,17380.0
4982,Isovaleroylglycine,CC(C)CC(=O)NCC(=O)O,C7H13NO3,17581.0
4983,MJN110,O=C(ON1C(=O)CCC1=O)N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1,C22H21Cl2N3O4,17583.0
4984,Galeterone,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12,C26H32N2O,17586.0
4985,"3,3',5'-Triiodo-L-thyronine",N[C@@H](Cc1ccc(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,C15H12I3NO4,17598.0
4986,DL-Tryptophan octyl ester (hydrochloride),CCCCCCCCOC(=O)C(N)Cc1c[nH]c2ccccc12.Cl,C19H29ClN2O2,17599.0
4987,S-Methyl-L-Cysteine-S-oxide,CS(=O)C[C@H](N)C(=O)O,C4H9NO3S,17600.0
4988,Enalaprilat (hydrate),C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O,C18H28N2O7,17603.0
4989,ML-211,CC(C)(C)C1CCN(C(=O)n2ncc(C(O)(c3ccccc3)c3ccccc3)n2)CC1,C25H30N4O2,17630.0
4990,ML-299,C[C@@H](CN1CCC2(CC1)C(=O)NCN2c1cccc(F)c1)NC(=O)c1ccc(Br)cc1,C23H26BrFN4O2,17632.0
4991,MN-64,CC(C)c1ccc(-c2cc(=O)c3ccccc3o2)cc1,C18H16O2,17635.0
4992,LT175,O=C(O)[C@H](Cc1ccccc1)Oc1ccc(-c2ccccc2)cc1,C21H18O3,17636.0
4993,TG4-155,COc1cc(/C=C/C(=O)NCCn2c(C)cc3ccccc32)cc(OC)c1OC,C23H26N2O4,17639.0
4994,6-fluoro-DL-Tryptophan,NC(Cc1c[nH]c2cc(F)ccc12)C(=O)O,C11H11FN2O2,17643.0
4995,"1,2-Diamino-4,5-dimethoxybenzene (hydrochloride)",COc1cc(N)c(N)cc1OC.Cl.Cl,C8H14Cl2N2O2,17644.0
4996,"2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine",CCc1nc2[nH]c(C)cc(C)c-2n1,C10H13N3,17645.0
4997,Lasofoxifene (tartrate),O=C(O)[C@@H](O)[C@H](O)C(=O)O.Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1,C32H37NO8,17646.0
4998,"2,3,3-Trimethylindolenine-5-sulfonic Acid (potassium salt)",CC1=Nc2ccc(S(=O)(=O)[O-])cc2C1(C)C.[K+],C11H12KNO3S,17647.0
4999,PD 174265,CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,C17H15BrN4O,17649.0
5000,p38 MAPK Inhibitor,O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1,C20H13ClFN3O,17650.0
5001,VEGFR Tyrosine Kinase Inhibitor II,O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1,C19H16ClN3O,17654.0
5002,YS-035 (hydrochloride),COc1ccc(CCN(C)CCc2ccc(OC)c(OC)c2)cc1OC.Cl,C21H30ClNO4,17705.0
5003,9-PAHSA-d4,[2H]C([2H])(CCCCCCCC)C([2H])([2H])CCCCCC(=O)OC(CCCCCCCCC)CCCCCCCC(=O)O,C34H66O4,17724.0
5004,UPF-1069,O=C(COc1cccc2c(=O)[nH]ccc12)c1ccccc1,C17H13NO3,17760.0
5005,GKT137831,CN(C)c1cccc(-c2c3c(=O)n(-c4ccccc4Cl)[nH]c3cc(=O)n2C)c1,C21H19ClN4O2,17764.0
5006,OICR-9429,CN1CCN(c2ccc(-c3cccc(CN4CCOCC4)c3)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1,C29H32F3N5O3,16095.0
5007,Eg5-I,COc1ccc(C(SC[C@H](N)CO)(c2ccccc2)c2ccccc2)cc1,C23H25NO2S,16668.0
5008,APP-FUBINACA,NC(=O)[C@H](Cc1ccccc1)NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12,C24H21FN4O2,17200.0
5009,MCC950,CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1,C20H24N2O5S,17510.0
5010,AB-CHMINACA 2'-indazole isomer,CC(C)[C@H](NC(=O)c1c2ccccc2nn1CC1CCCCC1)C(N)=O,C20H28N4O2,17521.0
5011,Albuterol methyl ether,COC(CNC(C)(C)C)c1ccc(O)c(CO)c1,C14H23NO3,17577.0
5012,6-(4-Methoxyphenyl)-3-pyridazinamine,COc1ccc(-c2ccc(N)nn2)cc1,C11H11N3O,17588.0
5013,Ac-YVAD-AFC,CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1)C(C)C,C33H36F3N5O10,17591.0
5014,MeOSuc-AAPV-pNA,COC(=O)CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)Nc1ccc([N+](=O)[O-])cc1)C(C)C,C27H38N6O9,17601.0
5015,TSI-01,CC(C)OC(=O)c1ccc(N2C(=O)C(Cl)=C(Cl)C2=O)cc1,C14H11Cl2NO4,17628.0
5016,Apoptozole,COc1ccc(-c2nc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)n(Cc3ccc(C(N)=O)cc3)c2-c2ccc(OC)cc2)cc1,C33H25F6N3O3,17675.0
5017,5-fluoro 203,Cc1cc(-c2nc3cc(F)ccc3s2)ccc1N,C14H11FN2S,17677.0
5018,AH 7614,Cc1ccc(S(=O)(=O)NC2c3ccccc3Oc3ccccc32)cc1,C20H17NO3S,17713.0
5019,Toceranib,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN1CCCC1,C22H25FN4O2,17714.0
5020,Ferrostatin-1,CCOC(=O)c1ccc(NC2CCCCC2)c(N)c1,C15H22N2O2,17729.0
5021,Erastin,CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O,C30H31ClN4O4,17754.0
5022,Stiripentol,CC(C)(C)C(O)/C=C/c1ccc2c(c1)OCO2,C14H18O3,17781.0
5023,Oleic Acid Alkyne,C#CCCCCCC/C=C\CCCCCCCC(=O)O,C18H30O2,9002078.0
5024,Syntide-2,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O,C68H122N20O18,15934.0
5025,TAK-242,CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc1ccc(F)cc1Cl,C15H17ClFNO4S,13871.0
5026,9-PAHSA 13C4,CCCCCCCCCCCC[13CH2][13CH2][13CH2][13C](=O)OC(CCCCCCCCC)CCCCCCCC(=O)O,C34H66O4,17725.0
5027,Meleagrin,C=CC(C)(C)C12C=C(O)C(=O)N3/C(=C\c4c[nH]cn4)C(=O)NC31N(OC)c1ccccc12,C23H23N5O4,17850.0
5028,CCVJ,N#C/C(=C\c1cc2c3c(c1)CCCN3CCC2)C(=O)O,C16H16N2O2,17870.0
5029,(R)-Crizotinib,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,C21H22Cl2FN5O,12087.0
5030,PD 0332991 (hydrochloride),CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O.Cl,C24H30ClN7O2,16273.0
5031,DMH1,CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1,C24H20N4O,16679.0
5032,Moniliformin (sodium salt),O=c1cc([O-])c1=O.[Na+],C4HNaO3,17497.0
5033,4-Bromomethcathinone (hydrochloride),CNC(C)C(=O)c1ccc(Br)cc1.Cl,C10H13BrClNO,12089.0
5034,O-7460,CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(C)C)COP(C)(=O)F,C25H48FO5P,14009.0
5035,PF-03550096,CC(C)(O)CCn1c(=O)n(C(=O)N[C@H](C(N)=O)C(C)(C)C)c2ccccc21,C19H28N4O4,15620.0
5036,fluoro-Dapagliflozin,CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O)ccc2Cl)cc1,C21H24ClFO5,15951.0
5037,LLY-507,Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12,C36H42N6O,16441.0
5038,(S)-.alpha.-Methylbenzyl Ricinoleamide,CCCCCC[C@@H](O)C/C=C\CCCCCCCC(=O)N[C@@H](C)c1ccccc1,C26H43NO2,17546.0
5039,Cdk4 Inhibitor,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21,C20H10BrN3O2,17648.0
5040,Darglitazone,Cc1oc(-c2ccccc2)nc1CCC(=O)c1ccc(CC2SC(=O)NC2=O)cc1,C23H20N2O4S,17681.0
5041,NKY80,Nc1ncc2c(n1)CC(c1ccco1)CC2=O,C12H11N3O2,17777.0
5042,Isopropyl Benzenesulfonate,CC(C)OS(=O)(=O)c1ccccc1,C9H12O3S,17795.0
5043,"Methyl 5,6,7,8-Tetradehydro Risperidone",Cc1ccc2nc(C)c(CCN3CCC(c4noc5cc(F)ccc45)CC3)c(=O)n2c1,C24H25FN4O2,17801.0
5044,Cevimeline (hydrochloride),C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1.Cl,C10H18ClNOS,17802.0
5045,Voriconazole-d3,[2H]C([2H])([2H])[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,C16H14F3N5O,17803.0
5046,SCH 51344,COc1ccc2nc3[nH]nc(C)c3c(NCCOCCO)c2c1,C16H20N4O3,17804.0
5047,VP-14637,Cc1nnnn1/N=C\c1ccc(O)c(C(c2ccc(O)cc2)c2cc(/C=N/n3nnnc3C)ccc2O)c1,C25H22N10O3,17805.0
5048,CAY10697,Cc1nc(Cl)cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)n1,C16H13Cl2N5OS,17806.0
5049,p-nitro Cyclic Pifithrin-.alpha.,O=[N+]([O-])c1ccc(-c2cn3c4c(sc3n2)CCCC4)cc1,C15H13N3O2S,17848.0
5050,3MB-PP1,Cc1cccc(Cc2nn(C(C)(C)C)c3ncnc(N)c23)c1,C17H21N5,17860.0
5051,DL-Glyceraldehyde 3-phosphate,O=CC(O)COP(=O)(O)O,C3H7O6P,17865.0
5052,Salvianolic Acid B,O=C(/C=C/c1ccc(O)c2c1[C@H](C(=O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,C36H30O16,9001577.0
5053,GSK2801,CCCOc1ccn2c(C(C)=O)cc(-c3ccccc3S(C)(=O)=O)c2c1,C20H21NO4S,14120.0
5054,PF-05212384,CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1,C32H41N9O4,14567.0
5055,Cocaine,COC(=O)C1C(OC(=O)c2ccccc2)CC2CCC1N2C,C17H21NO4,16186.0
5056,CYM 5442,CCOc1ccc(-c2nc(-c3cccc4c3CCC4NCCO)no2)cc1OCC,C23H27N3O4,16925.0
5057,AP39,O=C(CCCCCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1ccc(-c2cc(=S)ss2)cc1,C37H38O2PS3,17100.0
5058,AP219,O=C(O)CCCCCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1,C28H34O2P,17101.0
5059,Thiodigalactoside,OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,C12H22O10S,17154.0
5060,3-Fluorophenmetrazine (hydrochloride),CC1NCCOC1c1cccc(F)c1.Cl,C11H15ClFNO,17208.0
5061,ML-240,COc1cccc2c(NCc3ccccc3)nc(-n3c(N)nc4ccccc43)nc12,C23H20N6O,17373.0
5062,BGP-15,Cl.Cl.N/C(=N\OCC(O)CN1CCCCC1)c1cccnc1,C14H24Cl2N4O2,17503.0
5063,NNEI 2'-indazole isomer,CCCCCn1nc2ccccc2c1C(=O)Nc1cccc2ccccc12,C23H23N3O,17520.0
5064,MS37452,COc1cccc(C(=O)N2CCN(C(=O)COc3cccc(C)c3)CC2)c1OC,C22H26N2O5,17533.0
5065,Resminostat (hydrochloride),CN(C)Cc1ccc(S(=O)(=O)n2ccc(/C=C/C(=O)NO)c2)cc1.Cl,C16H20ClN3O4S,17553.0
5066,GSK137647A,COc1ccc(S(=O)(=O)Nc2c(C)cc(C)cc2C)cc1,C16H19NO3S,17712.0
5067,Paricalcitol,C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@]12C,C27H44O3,17716.0
5068,Spautin-1,Fc1ccc(CNc2ncnc3ccc(F)cc23)cc1,C15H11F2N3,17769.0
5069,ALLO-1,CC1C(=O)N(c2ccc(Cl)cc2)C(=O)N1Cc1ccccc1,C17H15ClN2O2,17776.0
5070,L002,COc1ccc(S(=O)(=O)ON=C2C=C(C)C(=O)C(C)=C2)cc1,C15H15NO5S,17778.0
5071,Bufuralol (hydrochloride),CCc1cccc2cc(C(O)CNC(C)(C)C)oc12.Cl,C16H24ClNO2,17794.0
5072,Atracurium (besylate),COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,C65H82N2O18S2,17796.0
5073,N-(p-Coumaroyl) Serotonin,O=C(/C=C/c1ccc(O)cc1)NCCc1c[nH]c2ccc(O)cc12,C19H18N2O3,17797.0
5074,Elvitegravir,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,C23H23ClFNO5,17798.0
5075,2-Phenyl-2-(1-piperidinyl)propane,CC(C)(c1ccccc1)N1CCCCC1,C14H21N,17799.0
5076,Salvianolic Acid A,O=C(/C=C/c1ccc(O)c(O)c1/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,C26H22O10,17800.0
5077,KP372-1,O=C1c2ccccc2-c2nc3nnnn3nc21.O=C1c2ccccc2-c2nn3nnnc3nc21,C20H8N12O2,17808.0
5078,Pim-1 Inhibitor 2,Nc1nccc(-c2ccc3noc(-c4ccc(Cl)cc4)c3c2)n1,C17H11ClN4O,17809.0
5079,Sulfinpyrazone,O=C1C(CCS(=O)c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1,C23H20N2O3S,17847.0
5080,Fomepizole,Cc1cn[nH]c1,C4H6N2,17851.0
5081,Uniconazole,CC(C)(C)C(O)/C(=C\c1ccc(Cl)cc1)n1cncn1,C15H18ClN3O,17852.0
5082,Detomidine (hydrochloride),Cc1cccc(Cc2c[nH]cn2)c1C.Cl,C12H15ClN2,17853.0
5083,RTA 408,CC1(C)CC[C@]2(NC(=O)C(C)(F)F)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,C33H44F2N2O3,17854.0
5084,PF-477736,Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c3c2C=NNC4=O)cn1,C22H25N7O2,17859.0
5085,6'-Sialyllactose (sodium salt),CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@@](OC[C@H]2O[C@@H](O[C@@H]([C@H](O)[C@@H](O)C=O)[C@H](O)CO)[C@H](O)[C@@H](O)[C@H]2O)(C(=O)[O-])C[C@@H]1O.[Na+],C23H38NNaO19,17866.0
5086,.beta.-D-Glucosamine Pentaacetate,CC(=O)N[C@H]1[C@H](OC(C)=O)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,C16H23NO10,17867.0
5087,Tilorone (hydrochloride),CCN(CC)CCOc1ccc2c(c1)C(=O)c1cc(OCCN(CC)CC)ccc1-2.Cl.Cl,C25H36Cl2N2O3,17868.0
5088,"Dimethyl biphenyl-4,4'-dicarboxylate",COC(=O)c1ccc(-c2ccc(C(=O)OC)cc2)cc1,C16H14O4,17869.0
5089,Clopidogrel Carboxylic Acid (hydrochloride),Cl.O=C(O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,C15H15Cl2NO2S,17871.0
5090,Caffeic Acid methyl ester,COC(=O)/C=C/c1ccc(O)c(O)c1,C10H10O4,17873.0
5091,Ibufenac,CC(C)Cc1ccc(CC(=O)O)cc1,C12H16O2,17874.0
5092,Pranoprofen,CC(C(=O)O)c1ccc2c(c1)Cc1cccnc1O2,C15H13NO3,17875.0
5093,Fusaric Acid,CCCCc1ccc(C(=O)O)nc1,C10H13NO2,17876.0
5094,IAA-94,C[C@]1(C2CCCC2)Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O,C17H18Cl2O4,17877.0
5095,N-5-Carboxypentyl-1-deoxynojirimycin,O=C(O)CCCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,C12H23NO6,17878.0
5096,Ferulic Acid methyl ester,COC(=O)/C=C/c1ccc(O)c(OC)c1,C11H12O4,17881.0
5097,2-Palmitoylglycerol,CCCCCCCCCCCCCCCC(=O)OC(CO)CO,C19H38O4,17882.0
5098,Articaine (hydrochloride),CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC.Cl,C13H21ClN2O3S,17883.0
5099,Bambuterol (hydrochloride),CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1.Cl,C18H30ClN3O5,17887.0
5100,trans-2-Decenoic Acid,CCCCCCC/C=C/C(=O)O,C10H18O2,17888.0
5101,Pemirolast (potassium salt),Cc1cccn2c(=O)c(-c3nnn[n-]3)cnc12.[K+],C10H7KN6O,17889.0
5102,"3,4-dihydro Naratriptan",CNS(=O)(=O)CCc1ccc2[nH]cc(C3=CCN(C)CC3)c2c1,C17H23N3O2S,17890.0
5103,N6-(.delta.2-Isopentenyl)adenine,CC(C)=CCNc1[nH]cnc2ncnc1-2,C10H13N5,17906.0
5104,3'-Deoxyguanosine,Nc1nc2c(ncn2[C@@H]2O[C@H](CO)C[C@H]2O)c(=O)[nH]1,C10H13N5O4,17907.0
5105,Myosmine,c1cncc(C2=NCCC2)c1,C9H10N2,17908.0
5106,Chlorothiazide,NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O,C7H6ClN3O4S2,17909.0
5107,Hydroxychloroquine (sulfate),CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O,C18H28ClN3O5S,17911.0
5108,1H-1-ethyl Candesartan Cilexetil,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnnn2CC)cc1,C35H38N6O6,17912.0
5109,Tryptanthrin,O=C1c2ccccc2-n2c1nc1ccccc1c2=O,C15H8N2O2,17913.0
5110,3-(4-Pyridyl)indole,c1ccc2c(-c3ccncc3)c[nH]c2c1,C13H10N2,17922.0
5111,Naringin,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(c3)O[C@H](c3ccc(O)cc3)CC4=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C27H32O14,17923.0
5112,Nitisinone,O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-],C14H10F3NO5,17924.0
5113,Dyphylline,Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O,C10H14N4O4,17958.0
5114,SR 49059,COc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3[C@](O)(c3ccccc3Cl)[C@@H]2C(=O)N2CCC[C@H]2C(N)=O)cc1OC,C28H27Cl2N3O7S,17972.0
5115,LY311727,CCc1c(CC(N)=O)c2cc(OCCCP(=O)(O)O)ccc2n1Cc1ccccc1,C22H27N2O5P,17973.0
5116,Triamcinolone acetonide,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,C24H31FO6,18026.0
5117,Eicosapentaenoyl 1-propanol-2-amide,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NC(C)CO,C23H37NO2,17547.0
5118,Sephin1,N=C(N)N/N=C/c1ccccc1Cl,C8H9ClN4,17757.0
5119,.beta.-Asarone,C/C=C\c1cc(OC)c(OC)cc1OC,C12H16O3,11682.0
5120,Pazopanib,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,C21H23N7O2S,12097.0
5121,para-Fluorobutyryl fentanyl (hydrochloride),CCCC(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H30ClFN2O,17049.0
5122,para-Fluorobutyryl fentanyl (hydrochloride) (CRM),CCCC(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H30ClFN2O,19826.0
5123,MiPT,CC(C)N(C)CCc1c[nH]c2ccccc12,C14H20N2,17296.0
5124,5-methoxy DPT,CCCN(CCC)CCc1c[nH]c2ccc(OC)cc12,C17H26N2O,17297.0
5125,5-methoxy EiPT,CCN(CCc1c[nH]c2ccc(OC)cc12)C(C)C,C16H24N2O,17299.0
5126,5-methoxy DET,CCN(CC)CCc1c[nH]c2ccc(OC)cc12,C15H22N2O,17300.0
5127,IRAK1/4 Inhibitor,O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1,C20H21N5O4,17540.0
5128,MMDA (hydrochloride),COc1cc(CC(C)N)cc2c1OCO2.Cl,C11H16ClNO3,17658.0
5129,MMDMA (hydrochloride),CNC(C)Cc1cc(OC)c2c(c1)OCO2.Cl,C12H18ClNO3,17660.0
5130,Cyclic di-AMP (sodium salt),Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)([O-])O[C@H]3[C@@H](O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)([O-])O[C@H]2[C@H]1O.[Na+].[Na+],C20H22N10Na2O12P2,17753.0
5131,Rebeccamycin,CO[C@H]1[C@H](O)[C@@H](O)[C@H](n2c3c(Cl)cccc3c3c4c(c5c6cccc(Cl)c6[nH]c5c32)C(=O)NC4=O)O[C@@H]1CO,C27H21Cl2N3O7,17914.0
5132,Phalloidin,C[C@@H]1NC(=O)[C@H](C[C@@](C)(O)CO)NC(=O)[C@@H]2Cc3c([nH]c4ccccc34)SC[C@H](NC(=O)[C@@H]([C@H](C)O)NC1=O)C(=O)N1C[C@@H](O)C[C@H]1C(=O)N[C@@H](C)C(=O)N2,C35H48N8O11S,18039.0
5133,6H05 (trifluoroacetate salt),CN(C)CCSSCCNC(=O)C1CCN(C(=O)CSc2ccc(Cl)cc2)CC1.O=C(O)C(F)(F)F,C22H31ClF3N3O4S3,17985.0
5134,Quizartinib,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,C29H32N6O4S,17986.0
5135,ADX-47273,O=C(c1ccc(F)cc1)N1CCC[C@H](c2nc(-c3ccc(F)cc3)no2)C1,C20H17F2N3O2,17987.0
5136,Afuresertib (hydrochloride),Cl.Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl,C18H18Cl3FN4OS,17988.0
5137,AG-1557,COc1cc2ncnc(Nc3cccc(I)c3)c2cc1OC,C16H14IN3O2,17989.0
5138,AVL-292,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1,C22H22FN5O3,17993.0
5139,Balicatib,CCCN1CCN(c2ccc(C(=O)NC3(C(=O)NCC#N)CCCCC3)cc2)CC1,C23H33N5O2,17995.0
5140,BS-181 (hydrochloride),CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12.Cl,C22H33ClN6,17996.0
5141,CIQ,COc1ccc(OCC2c3cc(OC)c(OC)cc3CCN2C(=O)c2cccc(Cl)c2)cc1,C26H26ClNO5,17997.0
5142,CZC 54252,COc1cc(N2CCOCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1,C22H25ClN6O4S,17998.0
5143,DY 131,CCN(CC)c1ccc(/C=N/NC(=O)c2ccc(O)cc2)cc1,C18H21N3O2,17999.0
5144,Felbamate,NC(=O)OCC(COC(N)=O)c1ccccc1,C11H14N2O4,18000.0
5145,K-Ras(G12C) Inhibitor 9,C=CS(=O)(=O)NC1CCN(C(=O)CNc2cc(I)c(Cl)cc2OC)CC1,C16H21ClIN3O4S,18005.0
5146,LDN214117,COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC,C25H29N3O3,18006.0
5147,Meisoindigo,CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21,C17H12N2O2,18007.0
5148,MHY1485,O=[N+]([O-])c1ccc(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)cc1,C17H21N7O4,18008.0
5149,Micafungin (sodium salt),CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)O)c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1.[NaH],C56H71N9NaO23S,18009.0
5150,N-Arachidonoyl-L-Serine-d8,[2H]/C(CCCCC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCC(=O)N[C@@H](CO)C(=O)O,C23H37NO4,10007428.0
5151,4-hydroxy Hexenal-d3,[2H]C([2H])([2H])CC(O)/C=C/C=O,C6H10O2,10007657.0
5152,2-Thenoyltrifluoroacetone,O=C(CC(=O)C(F)(F)F)c1cccs1,C8H5F3O2S,15517.0
5153,Dehydroepiandrosterone,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H28O2,15728.0
5154,Nitrazepam-d5,[2H]c1c([2H])c([2H])c(C2=NCC(=O)Nc3ccc([N+](=O)[O-])cc32)c([2H])c1[2H],C15H11N3O3,16197.0
5155,Nitrazepam-d5 (exempt preparation),[2H]c1c([2H])c([2H])c(C2=NCC(=O)Nc3ccc([N+](=O)[O-])cc32)c([2H])c1[2H],C15H11N3O3,38139.0
5156,SP-141,COc1ccc2[nH]c3c(-c4cccc5ccccc45)nccc3c2c1,C22H16N2O,17003.0
5157,Pentadecanoic Acid,CCCCCCCCCCCCCCC(=O)O,C15H30O2,17399.0
5158,PFI-4,COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(C)c(=O)n2C,C21H24N4O3,17663.0
5159,Amidepsine A,COc1cc(C)c(C(=O)Oc2cc(C)c(C(=O)Oc3cc(C)c(C(=O)NC(C)C(=O)O)c(O)c3)c(O)c2)c(OC)c1,C29H29NO11,17774.0
5160,Amidepsine D,COc1cc(C)c(C(=O)Oc2cc(C)c(C(=O)Oc3cc(C)c(C(=O)O)c(O)c3)c(O)c2)c(OC)c1,C26H24O10,17775.0
5161,.beta.-Amanitin,CC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@@H]2Cc3c([nH]c4cc(O)ccc34)S(=O)C[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CC(=O)O)C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H]([C@@H](C)[C@@H](O)CO)C(=O)N2,C39H53N9O15S,18142.0
5162,.alpha.-Amanitin,CC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@@H]2Cc3c([nH]c4cc(O)ccc34)S(=O)C[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H]([C@@H](C)[C@@H](O)CO)C(=O)N2,C39H54N10O14S,17898.0
5163,"1,2,3,5-Tetra-O-acetyl-D-xylofuranose",CC(=O)OC[C@H]1OC(OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,C13H18O9,17925.0
5164,3'3'-cGAMP (sodium salt),Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)([O-])O[C@H]4[C@@H](O)[C@H](n5cnc6c(N)ncnc65)O[C@@H]4COP(=O)([O-])O[C@H]3[C@H]2O)c(=O)[nH]1.[Na+].[Na+],C20H22N10Na2O13P2,17966.0
5165,FH535,Cc1cc([N+](=O)[O-])ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl,C13H10Cl2N2O4S,18001.0
5166,kb NB 142-70,O=C1NCCSc2c1sc1ccc(O)cc21,C11H9NO2S2,18002.0
5167,Ibutamoren (mesylate),CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12.CS(=O)(=O)O,C28H40N4O8S2,18003.0
5168,Ki8751,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)c2cc1OC,C24H18F3N3O4,18004.0
5169,ML-323,Cc1cnc(-c2ccccc2C(C)C)nc1NCc1ccc(-n2ccnn2)cc1,C23H24N6,18010.0
5170,Pilaralisib,COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1,C25H25ClN6O4S,18011.0
5171,PLX647,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncccc34)cn2)cc1,C21H17F3N4,18012.0
5172,Ispinesib,Cc1ccc(C(=O)N(CCCN)[C@@H](c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1,C30H33ClN4O2,18014.0
5173,SCR7,O=c1[nH]c(=S)[nH]c(/N=C/c2ccccc2)c1/N=C/c1ccccc1,C18H14N4OS,18015.0
5174,Cyclobenzaprine-d3 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])N(C)CCC=C1c2ccccc2C=Cc2ccccc21,C20H22ClN,18027.0
5175,VX-745,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,C19H9Cl2F2N3OS,18075.0
5176,PD 153035,COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC,C16H14BrN3O2,18080.0
5177,Phallacidin,CC(C)[C@@H]1NC(=O)[C@H](CC(C)(O)CO)NC(=O)[C@@H]2Cc3c([nH]c4ccccc34)SC[C@H](NC(=O)[C@@H]([C@H](O)C(=O)O)NC1=O)C(=O)N1C[C@@H](O)C[C@H]1C(=O)N[C@@H](C)C(=O)N2,C37H50N8O13S,18146.0
5178,Suc-Leu-Tyr-AMC,Cc1cc(=O)oc2cc(NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CC(C)C)NC(=O)CCC(=O)O)ccc12,C29H33N3O8,10008120.0
5179,Octyl-.alpha.-hydroxyglutarate,CCCCCCCCOC(=O)C(O)CCC(=O)O,C13H24O5,16365.0
5180,Cellobiosan,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H]3OC[C@H]2O3)[C@H](O)[C@@H](O)[C@@H]1O,C12H20O10,16378.0
5181,UNC0379,COc1cc2nc(N3CCCC3)nc(NCCCCCN3CCCC3)c2cc1OC,C23H35N5O2,16400.0
5182,4-oxo-2-Nonenal Alkyne,C#CCCCC(=O)/C=C/C=O,C9H10O2,17104.0
5183,BI 2536,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,C28H39N7O3,17385.0
5184,XY1,O=C(NCC(=O)N1CCCC1)Nc1ccc2ccccc2c1,C17H19N3O2,17518.0
5185,DBIBB,O=C(O)c1ccccc1S(=O)(=O)NCCCCN1C(=O)c2cccc3cccc(c23)C1=O,C23H20N2O6S,17529.0
5186,BHPI,Cc1cccc2c1NC(=O)C2(c1ccc(O)cc1)c1ccc(O)cc1,C21H17NO3,17750.0
5187,GDC-0152,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1,C25H34N6O3S,17810.0
5188,NPS 2143 (hydrochloride),CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N.Cl,C24H26Cl2N2O2,17903.0
5189,Spermine,NCCCNCCCCNCCCN,C10H26N4,18041.0
5190,Codeine-d3 (CRM),[2H]C([2H])([2H])N1CC[C@]23c4c5ccc(OC)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,C18H21NO3,18052.0
5191,GSK2334470,CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1,C25H34N8O,18095.0
5192,GSK461364,C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,C27H28F3N5O2S,18099.0
5193,(S)-PFI-2 (hydrochloride),Cl.O=C([C@H](Cc1cccc(C(F)(F)F)c1)NS(=O)(=O)c1cc(F)c2c(c1)CCNC2)N1CCCC1,C23H26ClF4N3O3S,18119.0
5194,SCH 900776,Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1,C15H18BrN7,18131.0
5195,Suc-Leu-Leu-Val-Tyr-AMC,Cc1cc(=O)oc2cc(NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CCC(=O)O)C(C)C)ccc12,C40H53N5O10,10008119.0
5196,Ricinoleic Acid ethyl ester,CCCCCC[C@@H](O)C/C=C\CCCCCCCC(=O)OCC,C20H38O3,10009730.0
5197,Ribavirin,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,C8H12N4O5,16757.0
5198,Aurora Kinase Inhibitor II,COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC,C23H20N4O3,17541.0
5199,Eggmanone,C=C(C)Cn1c(SCC(=O)c2cccs2)nc2sc3c(c2c1=O)CCCC3,C20H20N2O2S3,17751.0
5200,BAM15,Fc1ccccc1Nc1nc2nonc2nc1Nc1ccccc1F,C16H10F2N6O,17811.0
5201,3-Deoxy-D-glycero-D-galacto-2-nonulosonic Acid,O=C(O)C1(O)C[C@H](O)[C@@H](O)[C@H]([C@H](O)[C@H](O)CO)O1,C9H16O9,17862.0
5202,Berteroin,CSCCCCCN=C=S,C7H13NS2,17880.0
5203,Monogalactosyldiacylglyceride (hydrogenated) (plant),CCCCCCCCCCCCCCCCCC(=O)OCC(CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCCCC,C45H86O10,17886.0
5204,SNS-032,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,C17H24N4O2S2,17904.0
5205,N1-Acetylspermine (hydrochloride),CC(=O)NCCCNCCCCNCCCN.Cl.Cl.Cl,C12H31Cl3N4O,17919.0
5206,Cdk4/6 Inhibitor IV,CCNc1cc(N[C@H]2CC[C@H](O)CC2)nc(Nc2ccc3c(ccn3Cc3ccccc3)c2)n1,C27H32N6O,17974.0
5207,UCN-01,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O,C28H26N4O4,18130.0
5208,Equisetin,C/C=C/[C@@H]1C=C[C@@H]2C[C@H](C)CC[C@H]2[C@]1(C)/C(O)=C1/C(=O)[C@H](CO)N(C)C1=O,C22H31NO4,18196.0
5209,13-PAHSA,CCCCCCCCCCCCCCCC(=O)OC(CCCCC)CCCCCCCCCCCC(=O)O,C34H66O4,17044.0
5210,"3,4-Dimethoxymethcathinone (hydrochloride)",CNC(C)C(=O)c1ccc(OC)c(OC)c1.Cl,C12H18ClNO3,17447.0
5211,5-fluoro AEB,CCOC(=O)[C@@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(C)C,C20H28FN3O3,17735.0
5212,5-fluoro AEB (exempt preparation),CCOC(=O)[C@@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(C)C,C20H28FN3O3,39445.0
5213,ML-167,Cc1ccc(CNc2ncnc3ccc(-c4ccc(CO)o4)cc23)o1,C19H17N3O3,18098.0
5214,MTSEA,Br.CS(=O)(=O)SCCN,C3H10BrNO2S2,9002267.0
5215,.alpha.-Linolenic Acid-d5,[2H]C([2H])([2H])C([2H])([2H])/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,C18H30O2,9002286.0
5216,Stigmasterol,CC[C@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,C29H48O,18079.0
5217,SGX523,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,C18H13N7S,18093.0
5218,Nifuroxazide,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc(O)cc1,C12H9N3O5,18163.0
5219,Trimetazidine (hydrochloride),COc1ccc(CN2CCNCC2)c(OC)c1OC.Cl.Cl,C14H24Cl2N2O3,18165.0
5220,Dipyridamole,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,C24H40N8O4,18189.0
5221,Tolmetin (sodium salt hydrate),Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.O.O.[Na+],C15H18NNaO5,18195.0
5222,Primaquine (phosphate),COc1cc(NC(C)CCCN)c2ncccc2c1.O=P(O)(O)O.O=P(O)(O)O,C15H27N3O9P2,18223.0
5223,5.alpha.-Androst-16-en-3-one,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C=CC[C@@H]12,C19H28O,18233.0
5224,L-Canaline,NOCC[C@H](N)C(=O)O,C4H10N2O3,9002357.0
5225,GPR120 Compound A,O=C(O)CC1CCC2(CC1)CCN(c1cc(OC(F)(F)F)ccc1Cl)CC2,C19H23ClF3NO3,16624.0
5226,Apoptosis Activator 2,O=C1C(=O)N(Cc2ccc(Cl)c(Cl)c2)c2ccccc21,C15H9Cl2NO2,10004176.0
5227,MLN8237,COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O,C27H20ClFN4O4,13602.0
5228,Sivelestat (sodium salt hydrate),CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)[O-])cc1.O.O.O.O.[Na+],C20H29N2NaO11S,17779.0
5229,Liproxstatin-1,Clc1cccc(CNC2=Nc3ccccc3NC23CCNCC3)c1,C19H21ClN4,17730.0
5230,SW033291,CCCCS(=O)c1sc2nc(-c3cccs3)cc(-c3ccccc3)c2c1N,C21H20N2OS3,18040.0
5231,2-Acetamidophenyl 5-chloro-2-nitrophenyl sulfide,CC(=O)Nc1ccccc1Sc1cc(Cl)ccc1[N+](=O)[O-],C14H11ClN2O3S,18085.0
5232,Elacridar,COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cccc4c(=O)c5cccc(OC)c5[nH]c34)cc1)CC2,C34H33N3O5,18128.0
5233,Epinastine (hydrochloride),Cl.NC1=NCC2c3ccccc3Cc3ccccc3N12,C16H16ClN3,18136.0
5234,Cefamandole (sodium salt),Cn1nnnc1SCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)[C@H](O)c3ccccc3)[C@H]2SC1.[Na+],C18H17N6NaO5S2,18138.0
5235,N6-Methyladenine,CNc1[nH]cnc2ncnc1-2,C6H7N5,18153.0
5236,5'-deoxy Thymidine,Cc1cn([C@H]2C[C@H](O)[C@@H](C)O2)c(=O)[nH]c1=O,C10H14N2O4,18154.0
5237,5-Chloro-2'-deoxyuridine,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Cl,C9H11ClN2O5,18155.0
5238,Fexofenadine (hydrochloride),CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1.Cl,C32H40ClNO4,18191.0
5239,BI 6727,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C,C34H50N8O3,18193.0
5240,Gestodene,C#C[C@]1(O)C=C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC,C21H26O2,18217.0
5241,Hydrocortisone 21-hemisuccinate (sodium salt),C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)[O-].[Na+],C25H33NaO8,18226.0
5242,(R)-Lansoprazole,Cc1c(OCC(F)(F)F)ccnc1C[S@@](=O)c1nc2ccccc2[nH]1,C16H14F3N3O2S,18235.0
5243,2-Nitro-5-thiocyanatobenzoic Acid,N#CSc1ccc([N+](=O)[O-])c(C(=O)O)c1,C8H4N2O4S,18236.0
5244,AZ 5104,C=CC(=O)Nc1cc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,C27H31N7O2,17994.0
5245,Xylazine,Cc1cccc(C)c1NC1=NCCCS1,C12H16N2S,14113.0
5246,Xylazine (CRM),Cc1cccc(C)c1NC1=NCCCS1,C12H16N2S,37854.0
5247,3-Nitropropionic Acid,O=C(O)CC[N+](=O)[O-],C3H5NO4,14684.0
5248,Stavudine,Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,C10H12N2O4,14975.0
5249,CRT0066101 (hydrochloride),CC[C@@H](N)CNc1ccnc(-c2cc(-c3cnn(C)c3)ccc2O)n1.Cl.Cl.Cl,C18H25Cl3N6O,15337.0
5250,Cinaciguat (hydrochloride),Cl.O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1,C36H40ClNO5,17468.0
5251,Aceclidine (hydrochloride),CC(=O)OC1CN2CCC1CC2.Cl,C9H16ClNO2,17910.0
5252,Oxytetracycline,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12,C22H24N2O9,18076.0
5253,Resorufin benzyl ether,O=c1ccc2nc3ccc(OCc4ccccc4)cc3oc-2c1,C19H13NO3,18077.0
5254,GSK5959,COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C,C22H26N4O3,18123.0
5255,Avasimibe,CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C)c(C(C)C)c1,C29H43NO4S,18129.0
5256,Xanthosine 5'-monophosphate (sodium salt),O=c1[nH]c(=O)c2ncn([C@@H]3O[C@H](COP(=O)([O-])[O-])[C@@H](O)[C@H]3O)c2[nH]1.[Na+].[Na+],C10H11N4Na2O9P,18134.0
5257,Inosine-5'-monophosphate (sodium salt hydrate),O.O.O.O.O.O.O.O.O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+],C10H27N4Na2O16P,18135.0
5258,Cytidine 5'-triphosphate (sodium salt hydrate),Nc1ccn([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OP(=O)([O-])O)[C@@H](O)[C@H]2O)c(=O)n1.O.[Na+].[Na+],C9H16N3Na2O15P3,18147.0
5259,Adenine (hemisulfate),Nc1[nH]cnc2ncnc1-2.Nc1[nH]cnc2ncnc1-2.O=S(=O)(O)O,C10H12N10O4S,18148.0
5260,Vidarabine,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,C10H13N5O4,18149.0
5261,5'-(N-Cyclopropyl)carboxamidoadenosine,Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)NC2CC2)[C@@H](O)[C@H]1O,C13H16N6O4,18157.0
5262,Tilmicosin (phosphate),CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CCN2C[C@H](C)C[C@H](C)C2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC.O=P(O)(O)O,C46H83N2O17P,18190.0
5263,Estradiol 3-sulfate 17.beta.-Glucuronide (potassium salt),C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)[O-])cc4CC[C@H]3[C@@H]1CC[C@@H]2O[C@@H]1O[C@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O.[K+].[K+],C24H30K2O11S,18224.0
5264,Digitoxigenin,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O,C23H34O4,18229.0
5265,(R)-Pramipexole (hydrochloride),CCCN[C@@H]1CCc2nc(N)sc2C1.Cl.Cl,C10H19Cl2N3S,18234.0
5266,R547,COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,C18H21F2N5O4S,17905.0
5267,GSK484 (hydrochloride),COc1cc(C(=O)N2CC[C@@H](O)[C@@H](N)C2)cc2nc(-c3cc4ccccc4n3CC3CC3)n(C)c12.Cl,C27H32ClN5O3,17488.0
5268,Acetaminophen,CC(=O)Nc1ccc(O)cc1,C8H9NO2,10024.0
5269,Acetaminophen (CRM),CC(=O)Nc1ccc(O)cc1,C8H9NO2,32839.0
5270,Phortress (hydrochloride),Cc1cc(-c2nc3cc(F)ccc3s2)ccc1NC(=O)[C@@H](N)CCCCN.Cl.Cl,C20H25Cl2FN4OS,15342.0
5271,ML-351,CNc1oc(-c2cccc3ccccc23)nc1C#N,C15H11N3O,16119.0
5272,ALEPH-4,COc1cc(SC(C)C)c(OC)cc1CC(C)N,C14H23NO2S,17283.0
5273,ALEPH-2,CCSc1cc(OC)c(CC(C)N)cc1OC,C13H21NO2S,17284.0
5274,INT-777,CC[C@H]1[C@@H](O)[C@@H]2[C@H](C[C@H](O)[C@]3(C)[C@@H]([C@H](C)C[C@H](C)C(=O)O)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12,C27H46O5,17678.0
5275,Isosafrole,C/C=C/c1ccc2c(c1)OCO2,C10H10O2,17782.0
5276,SCH 28080,Cc1nc2c(OCc3ccccc3)cccn2c1CC#N,C17H15N3O,17885.0
5277,"N1,N12-Diacetylspermine (hydrochloride)",CC(=O)NCCCNCCCCNCCCNC(C)=O.Cl.Cl,C14H32Cl2N4O2,17918.0
5278,LRRK2-IN-1,COc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C,C31H38N8O3,18094.0
5279,8-Bromoguanosine,Nc1nc2c(nc(Br)n2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1,C10H12BrN5O5,18152.0
5280,7-Methylguanine,Cn1cnc2[nH]c(N)nc(=O)c21,C6H7N5O,18161.0
5281,4-acetoxy DET (hydrochloride),CCN(CC)CCc1c[nH]c2cccc(OC(C)=O)c12.Cl,C16H23ClN2O2,18171.0
5282,Capsiconiate,COc1cc(/C=C/COC(=O)CCCC/C=C/C(C)C)ccc1O,C20H28O4,18172.0
5283,CCT128930,NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,C18H20ClN5,18194.0
5284,RS 102895 (hydrochloride),Cl.O=C1Nc2ccccc2C2(CCN(CCc3ccc(C(F)(F)F)cc3)CC2)O1,C21H22ClF3N2O2,18207.0
5285,Ciclesonide,CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C,C32H44O7,18227.0
5286,Diminutol,CC(C)[C@H](CO)Nc1nc(Sc2cccc(N)c2)c2ncn(C(C)C)c2n1,C19H26N6OS,18237.0
5287,Sucrose hexasulfate (potassium salt),O=S(=O)([O-])OC[C@H]1O[C@@](COS(=O)(=O)[O-])(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](OS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-].[K+].[K+].[K+].[K+].[K+].[K+],C12H16K6O29S6,18239.0
5288,Milbemycin A3,CC1=C[C@H]2C(=O)O[C@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C4\CO[C@H]([C@@H]1O)[C@@]42O)O[C@@]1(CC[C@H](C)[C@@H](C)O1)C3,C31H44O7,18360.0
5289,(+)-Chloropseudoephedrine (hydrochloride),CN[C@@H](C)[C@@H](Cl)c1ccccc1.Cl,C10H15Cl2N,9002347.0
5290,Isoxanthopterin,Nc1nc(=O)c2ncc(=O)[nH]c2[nH]1,C6H5N5O2,17564.0
5291,BMPEA (hydrochloride),CC(CN)c1ccccc1.Cl,C9H14ClN,17742.0
5292,CE3F4,CC1CCc2c(cc(Br)c(F)c2Br)N1C=O,C11H10Br2FNO,17767.0
5293,Cannabidiolic Acid (CRM),C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)c(C(=O)O)c1O,C22H30O4,18090.0
5294,Cannabidiolic Acid,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)c(C(=O)O)c1O,C22H30O4,36871.0
5295,Riboflavin 5'-monophosphate (sodium salt hydrate),Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)([O-])O)c2cc1C.O.O.[Na+],C17H24N4NaO11P,18167.0
5296,Carbenoxolone (sodium salt),CC1(C)[C@@H](OC(=O)CCC(=O)[O-])CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)[O-])CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12.[Na+].[Na+],C34H48Na2O7,18240.0
5297,U-104,NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1,C13H12FN3O3S,16717.0
5298,IKK-16 (hydrochloride),Cl.O=C(c1ccc(Nc2nccc(-c3cc4ccccc4s3)n2)cc1)N1CCC(N2CCCC2)CC1,C28H30ClN5OS,13313.0
5299,Bindarit,CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(=O)O,C19H20N2O3,11479.0
5300,NS 6180,O=C1CSc2ccccc2N1Cc1cccc(C(F)(F)F)c1,C16H12F3NOS,14664.0
5301,ZCL 278,Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)COc3ccc(Br)cc3Cl)cc2)n1,C21H19BrClN5O4S2,14849.0
5302,CX-516,O=C(c1ccc2nccnc2c1)N1CCCCC1,C14H15N3O,14936.0
5303,GSK0660,COC(=O)c1sccc1S(=O)(=O)Nc1ccc(Nc2ccccc2)cc1OC,C19H18N2O5S2,15272.0
5304,LY2584702 (tosylate),Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1,C28H27F4N7O3S,15320.0
5305,UNC2025,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,C28H40N6O,16613.0
5306,GSK2606414,Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21,C24H20F3N5O,17376.0
5307,GSK2126458,COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,C25H17F2N5O3S,17377.0
5308,LY315920,CCc1c(C(=O)C(N)=O)c2c(OCC(=O)O)cccc2n1Cc1ccccc1,C21H20N2O5,18267.0
5309,Pexidartinib,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1,C20H15ClF3N5,18271.0
5310,3-Hydroxyglutaric Acid,O=C(O)CC(O)CC(=O)O,C5H8O5,16334.0
5311,(-)-Norepinephrine (bitartrate hydrate),NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C12H19NO10,16673.0
5312,5-CFSE,O=C(ON1C(=O)CCC1=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21,C25H15NO9,16802.0
5313,Midodrine (hydrochloride),COc1ccc(OC)c(C(O)CNC(=O)CN)c1.Cl,C12H19ClN2O4,17349.0
5314,8-Prenylnaringenin,CC(C)=CCc1c(O)cc(O)c2c1OC(c1ccc(O)cc1)CC2=O,C20H20O5,17462.0
5315,PKC.zeta. Pseudosubstrate Inhibitor,[H]N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC,C76H128N30O16,17482.0
5316,SB 265610,N#Cc1ccc(NC(=O)Nc2ccccc2Br)c2nn[nH]c12,C14H9BrN6O,17879.0
5317,N-desmethyl Sildenafil,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCNCC4)ccc3OCC)nc12,C21H28N6O4S,18208.0
5318,Temocapril (hydrochloride),CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@H](c2cccs2)CN(CC(=O)O)C1=O.Cl,C23H29ClN2O5S2,18241.0
5319,Alprazolam-d8,[2H]c1c([2H])c([2H])c(C2=NCc3nnc(C([2H])([2H])[2H])n3-c3ccc(Cl)cc32)c([2H])c1[2H],C17H13ClN4,18302.0
5320,Alprazolam-d8 (exempt preparation),[2H]c1c([2H])c([2H])c(C2=NCc3nnc(C([2H])([2H])[2H])n3-c3ccc(Cl)cc32)c([2H])c1[2H],C17H13ClN4,23785.0
5321,NBD-Fructose,O=C(CNc1ccc([N+](=O)[O-])c2nonc12)[C@@H](O)[C@H](O)[C@H](O)CO,C12H14N4O8,9002314.0
5322,MIV-150,CCC(=O)c1ccc(F)c([C@@H]2C[C@@H]2NC(=O)Nc2ccc(C#N)cn2)c1O,C19H17FN4O3,9002360.0
5323,N-(8Z-Heptadecen-1-yl)-O-(3-pyridylmethyl)carbamate,CCCCCCCC/C=C\CCCCCCCNC(=O)OCc1cccnc1,C24H40N2O2,9002365.0
5324,"N,N'-Diacetyl-L-cystine",CC(=O)N[C@@H](CSSC[C@H](NC(C)=O)C(=O)O)C(=O)O,C10H16N2O6S2,17596.0
5325,Azoramide,CCCC(=O)NCCc1csc(-c2ccc(Cl)cc2)n1,C15H17ClN2OS,18045.0
5326,IOX4,CC(C)(C)OC(=O)c1ccc(-n2[nH]cc(-n3ccnn3)c2=O)nc1,C15H16N6O3,18181.0
5327,Rp-8-bromo Cyclic GMPS (sodium salt),Nc1nc2c(nc(Br)n2[C@@H]2O[C@@H]3CO[P@@](=O)([S-])O[C@H]3[C@H]2O)c(=O)[nH]1.[Na+],C10H10BrN5NaO6PS,18441.0
5328,Cytochalasin J,C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23[C@H](O)/C=C/[C@](C)(O)C[C@@H](C)C/C=C/[C@H]3[C@@H]1O,C28H37NO4,18443.0
5329,Luzopeptin A,COc1ccc2nc(C(=O)N[C@@H]3COC(=O)[C@H](C(C)(C)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@@H]4[C@@H](OC(C)=O)CC=NN4C(=O)[C@H](NC(=O)c4nc5ccc(OC)cc5cc4O)COC(=O)[C@H](C(C)(C)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@@H]4[C@@H](OC(C)=O)CC=NN4C3=O)c(O)cc2c1,C64H78N14O24,18444.0
5330,Rp-8-pCPT-Cyclic GMPS (sodium salt),Nc1nc2c(nc(Sc3ccc(Cl)cc3)n2[C@@H]2O[C@@H]3CO[P@@](=O)([S-])O[C@H]3[C@H]2O)c(=O)[nH]1.[Na+],C16H14ClN5NaO6PS2,18445.0
5331,Boldine,COc1cc2c(cc1O)C[C@H]1c3c(cc(O)c(OC)c3-2)CCN1C,C19H21NO4,18447.0
5332,QX-314 (chloride),CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1C.[Cl-],C16H27ClN2O,18454.0
5333,Exo1,COC(=O)c1ccccc1NC(=O)c1ccc(F)cc1,C15H12FNO3,18455.0
5334,Valnoctamide,CCC(C)C(CC)C(N)=O,C8H17NO,18456.0
5335,PTP Inhibitor IV,CC(C)(c1ccc(NS(=O)(=O)C(F)(F)F)cc1)c1ccc(C(C)(C)c2ccc(NS(=O)(=O)C(F)(F)F)cc2)cc1,C26H26F6N2O4S2,18458.0
5336,Aerothionin,COC1=C(Br)[C@H](O)[C@@]2(C=C1Br)CC(C(=O)NCCCCNC(=O)C1=NO[C@]3(C=C(Br)C(OC)=C(Br)[C@@H]3O)C1)=NO2,C24H26Br4N4O8,18459.0
5337,Taurolithocholic Acid 3-sulfate (sodium salt),C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@]12C.[Na+].[Na+],C26H43NNa2O8S2,18468.0
5338,CA-074 methyl ester,CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)OC)[C@@H](C)CC,C19H31N3O6,18469.0
5339,TMPyP4 (tosylate),C[n+]1ccc(-c2c3nc(c(-c4cc[n+](C)cc4)c4ccc([nH]4)c(-c4cc[n+](C)cc4)c4nc(c(-c5cc[n+](C)cc5)c5ccc2[nH]5)C=C4)C=C3)cc1.Cc1ccc(S(=O)(=O)[O-])cc1.Cc1ccc(S(=O)(=O)[O-])cc1.Cc1ccc(S(=O)(=O)[O-])cc1.Cc1ccc(S(=O)(=O)[O-])cc1,C72H66N8O12S4,18474.0
5340,Resolvin D3,CC/C=C\C[C@H](O)/C=C/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCC(=O)O,C22H32O5,13834.0
5341,Phentermine (hydrochloride),CC(C)(N)Cc1ccccc1.Cl,C10H16ClN,14207.0
5342,PNU 120596,COc1cc(OC)c(NC(=O)Nc2cc(C)on2)cc1Cl,C13H14ClN3O4,14304.0
5343,JNJ-42041935,O=C(O)c1cnn(-c2nc3cc(Cl)c(OC(F)(F)F)cc3[nH]2)c1,C12H6ClF3N4O3,14316.0
5344,BMS-536924,Cc1cc(N2CCOCC2)cc2nc(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)[nH]c12,C25H26ClN5O3,14666.0
5345,CID-16020046,Cc1ccc(-c2n[nH]c3c2C(c2cccc(O)c2)N(c2ccc(C(=O)O)cc2)C3=O)cc1,C25H19N3O4,15247.0
5346,"2,4-Diacetylphloroglucinol",CC(=O)c1c(O)cc(O)c(C(C)=O)c1O,C10H10O5,16345.0
5347,Isoprinosine,CC(=O)Nc1ccc(C(=O)O)cc1.CC(=O)Nc1ccc(C(=O)O)cc1.CC(=O)Nc1ccc(C(=O)O)cc1.CC(O)CN(C)C.CC(O)CN(C)C.CC(O)CN(C)C.O=c1nc[nH]c2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C52H78N10O17,16492.0
5348,(E)-8-Methyl-6-nonenoic Acid,CC(C)/C=C/CCCCC(=O)O,C10H18O2,16609.0
5349,Tenofovir Disoproxil (fumarate),CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.O=C(O)/C=C/C(=O)O,C23H34N5O14P,16922.0
5350,Empagliflozin,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,C23H27ClO7,17375.0
5351,ZSTK474,FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,C19H21F2N7O2,17381.0
5352,Perindoprilat,CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)O,C17H28N2O5,17574.0
5353,MAB-CHMINACA metabolite M3 RM,CC(C)(C)[C@H](NC(=O)c1nn(CC2CCC(O)CC2)c2ccccc12)C(=O)O,C21H29N3O4,17814.0
5354,Tie2 Kinase Inhibitor,COc1ccc2cc(-c3[nH]c(-c4ccc(S(C)=O)cc4)nc3-c3ccncc3)ccc2c1,C26H21N3O2S,17858.0
5355,Hexa-N-acetylchitohexaose,CC(=O)N[C@H]1[C@H](O[C@@H]([C@H](O)[C@H](C=O)NC(C)=O)[C@H](O)CO)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5NC(C)=O)[C@H](O)[C@H]4NC(C)=O)[C@H](O)[C@H]3NC(C)=O)[C@H](O)[C@H]2NC(C)=O)[C@@H]1O,C48H80N6O31,17864.0
5356,AB-CHMICA,CC(C)[C@H](NC(=O)c1cn(CC2CCCCC2)c2ccccc12)C(N)=O,C21H29N3O2,18048.0
5357,SirReal2,Cc1cc(C)nc(SCC(=O)Nc2ncc(Cc3cccc4ccccc34)s2)n1,C22H20N4OS2,18116.0
5358,ADP-Glucose (sodium salt),Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H]1O.[Na+].[Na+],C16H23N5Na2O15P2,18139.0
5359,CPI-169,CCS(=O)(=O)N1CCC(C(C)n2c(C)c(C(=O)NCc3c(OC)cc(C)[nH]c3=O)c3ccccc32)CC1,C27H36N4O5S,18299.0
5360,BI-847325,CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(/Nc1ccc(CN(C)C)cc1)c1ccccc1,C29H28N4O2,18301.0
5361,Bortezomib,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,C19H25BN4O4,10008822.0
5362,TCS 5861528,CCC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1,C19H23N5O3,18380.0
5363,INCB024360 analog,Nc1nonc1/C(=N/c1ccc(F)c(Cl)c1)NO,C9H7ClFN5O2,18265.0
5364,Ro 20-1724,CCCCOc1cc(CC2CNC(=O)N2)ccc1OC,C15H22N2O3,18272.0
5365,MI-192,C=C1CN(Cc2ccc(C(=O)Nc3ccccc3N)cc2)C(=O)c2ccccc21,C24H21N3O2,18288.0
5366,SR9243,Cc1cc(C)c(S(=O)(=O)N(CCc2cccc(Br)c2)Cc2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)c(C)c1,C31H32BrNO4S2,18420.0
5367,Cytochalasin H,C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23[C@H](OC(C)=O)/C=C/[C@](C)(O)C[C@@H](C)C/C=C/[C@H]3[C@@H]1O,C30H39NO5,18434.0
5368,SBI-0206965,CNC(=O)c1ccccc1Oc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Br,C21H21BrN4O5,18477.0
5369,Regorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,C21H15ClF4N4O3,18498.0
5370,"4-amino-1,8-Naphthalimide",Nc1ccc2c3c(cccc13)C(=O)NC2=O,C12H8N2O2,18509.0
5371,TLR4-C34,CC(=O)N[C@H]1[C@@H](OC(C)C)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,C17H27NO9,18512.0
5372,NIAD-4,N#CC(C#N)=Cc1ccc(-c2ccc(-c3ccc(O)cc3)s2)s1,C18H10N2OS2,18520.0
5373,Y11,OCC[N+]12CN3CN(CN(C3)C1)C2.[Br-],C8H17BrN4O,18521.0
5374,ML-348,O=C(CN1CCN(C(=O)c2ccco2)CC1)Nc1cc(C(F)(F)F)ccc1Cl,C18H17ClF3N3O3,18523.0
5375,NBI 35965 (mesylate),CC[C@H]1Cn2nc(-c3ccc(Cl)cc3Cl)c3nc(C)cc(c32)N1CC1CC1.CS(=O)(=O)O,C22H26Cl2N4O3S,18524.0
5376,AZD 1480,Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)n[nH]1,C14H14ClFN8,10702.0
5377,6-Shogaol,CCCCC/C=C/C(=O)CCc1ccc(O)c(OC)c1,C17H24O3,11901.0
5378,Adenosine-5'-diphosphate,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,C10H15N5O10P2,16778.0
5379,Niclosamide (ethanolamine salt),NCCO.O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,C15H15Cl2N3O5,17118.0
5380,OSI-027,COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12,C21H22N6O3,17379.0
5381,Galantamine,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,C17H21NO3,17559.0
5382,APP-PICA,CCCCCn1cc(C(=O)N[C@@H](Cc2ccccc2)C(N)=O)c2ccccc21,C23H27N3O2,17613.0
5383,bk-EABDI (hydrochloride),CCNC(CC)C(=O)c1ccc2c(c1)CCC2.Cl,C15H22ClNO,17990.0
5384,Aspirin-d4,[2H]c1c([2H])c([2H])c(C(=O)O)c(OC(C)=O)c1[2H],C9H8O4,18243.0
5385,Genistein-d4,[2H]c1c([2H])c(-c2coc3cc(O)cc(O)c3c2=O)c([2H])c([2H])c1O,C15H10O5,18244.0
5386,Gabapentin-d4,[2H]C([2H])(N)C1(C([2H])([2H])C(=O)O)CCCCC1,C9H17NO2,18254.0
5387,Imatinib-d3,[2H]C([2H])([2H])N1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc2)CC1,C29H31N7O,18257.0
5388,Primobolan Depot,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)C=C(C)[C@]4(C)[C@H]3CC[C@]12C,C27H42O3,17148.0
5389,"Estra-4,9,11-triene-3,17-dione",C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CCC2=O,C18H20O2,17366.0
5390,"[3,2-c]Pyrazole-androst-4-en-17.beta.-ol",C[C@]12CC[C@H]3[C@@H](CCC4=Cc5[nH]ncc5C[C@@]43C)[C@@H]1CC[C@@H]2O,C20H28N2O,17930.0
5391,PF-04217903,OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,C19H16N8O,17931.0
5392,"[3,2-c]Pyrazole-5.alpha.-androstan-17.beta.-ol",C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,C20H30N2O,17943.0
5393,Methasterone,C[C@@H]1C[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@@]2(C)[C@H]3CC[C@]2(C)O)CC1=O,C21H34O2,17944.0
5394,"[3,2-c]Furazan-5.alpha.-androstan-17.beta.-ol",C[C@]12Cc3nonc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,C19H28N2O2,18083.0
5395,TH287,CNc1cc(-c2cccc(Cl)c2Cl)nc(N)n1,C11H10Cl2N4,18132.0
5396,TH588,Nc1nc(NC2CC2)cc(-c2cccc(Cl)c2Cl)n1,C13H12Cl2N4,18133.0
5397,Mocetinostat,Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1,C23H20N6O,18287.0
5398,PF-06463922,C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21,C21H19FN6O2,18371.0
5399,TCS 1102,Cn1c(SCC(=O)N2CCC[C@@H]2C(=O)Nc2ccccc2-c2ccccc2)nc2ccccc21,C27H26N4O2S,18495.0
5400,ML-141,COc1ccc(C2CC(c3ccccc3)=NN2c2ccc(S(N)(=O)=O)cc2)cc1,C22H21N3O3S,18496.0
5401,S0859,Cc1ccc(CN(Cc2ccc(-c3ccccc3S(=O)(=O)NC#N)cc2)C(=O)c2ccccc2Cl)cc1,C29H24ClN3O3S,18497.0
5402,SB-271046 (hydrochloride),COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1.Cl,C20H23Cl2N3O3S2,18513.0
5403,CH5424802,CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,C30H34N4O2,18516.0
5404,T16A(inh)-A01,CCc1c(C)[nH]c(SCC(=O)Nc2nc(-c3ccc(OC)cc3)cs2)nc1=O,C19H20N4O3S2,18518.0
5405,AC-5216,CCN(Cc1ccccc1)C(=O)Cn1c(=O)n(C)c2cnc(-c3ccccc3)nc21,C23H23N5O2,18522.0
5406,ML-178,Clc1ccc(OCCOc2ccc(Br)nc2Br)c(Cl)c1,C13H9Br2Cl2NO2,18527.0
5407,(R)-Gyramide A (hydrochloride),Cc1ccc(F)cc1S(=O)(=O)N[C@@H]1CCN(Cc2ccc(OC(C)C)cc2)C1.Cl,C21H28ClFN2O3S,18528.0
5408,17.alpha.-Methyl-androstan-3-hydroxyimine-17.beta.-ol,C[C@]12CC/C(=N\O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H33NO2,17367.0
5409,17.alpha.-Methyl-5.alpha.-androstan-17.beta.-ol,C[C@]12CCCC[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H34O,17368.0
5410,"17.beta.-Hydroxy-androstano[3,2-c]isoxazole",C[C@]12Cc3conc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,C20H29NO2,17929.0
5411,"5.alpha.-Androstan-3,6,17-trione",C[C@]12CCC(=O)C[C@@H]1C(=O)C[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H26O3,17945.0
5412,4-hydroxy Androstenedione,C[C@]12CCC(=O)C(O)=C1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H26O3,18282.0
5413,Bioymifi,N=C1S/C(=C\c2ccc(-c3ccc4c(c3)C(=O)NC4=O)o2)C(=O)N1c1ccc(Br)cc1,C22H12BrN3O4S,14242.0
5414,ML-115,COc1cc(NC(=O)c2cc(C3CC3)on2)c(OC)cc1Cl,C15H15ClN2O4,15178.0
5415,Lorazepam,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,C15H10Cl2N2O2,15891.0
5416,Heroin-d3,[2H]C([2H])([2H])N1CC[C@]23c4c5ccc(OC(C)=O)c4O[C@H]2[C@@H](OC(C)=O)C=C[C@H]3[C@H]1C5,C21H23NO5,16192.0
5417,Heroin-d3 (exempt preparation),[2H]C([2H])([2H])N1CC[C@]23c4c5ccc(OC(C)=O)c4O[C@H]2[C@@H](OC(C)=O)C=C[C@H]3[C@H]1C5,C21H23NO5,22882.0
5418,MI-77301,CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,C29H34Cl2FN3O3,17473.0
5419,I-BRD9,CCn1cc(-c2cccc(C(F)(F)F)c2)c2sc(C(=N)NC3CCS(=O)(=O)CC3)cc2c1=O,C22H22F3N3O3S2,17749.0
5420,6-methoxy Methylone (hydrochloride),CNC(C)C(=O)c1cc2c(cc1OC)OCO2.Cl,C12H16ClNO4,18029.0
5421,BIIB021,COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc32)c1C,C14H15ClN6O,18269.0
5422,MHY908,CC(C)(Oc1ccc(-c2nc3cc(Cl)ccc3s2)cc1)C(=O)O,C17H14ClNO3S,18293.0
5423,GDC-0980,Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,C23H30N8O3S,18303.0
5424,Diazepam-d8,[2H]c1c([2H])c([2H])c(C2=NCC(=O)N(C([2H])([2H])[2H])c3ccc(Cl)cc32)c([2H])c1[2H],C16H13ClN2O,18309.0
5425,Diazepam-d8 (exempt preparation),[2H]c1c([2H])c([2H])c(C2=NCC(=O)N(C([2H])([2H])[2H])c3ccc(Cl)cc32)c([2H])c1[2H],C16H13ClN2O,23786.0
5426,Cardamonin,COc1cc(O)cc(O)c1C(=O)/C=C/c1ccccc1,C16H14O4,18310.0
5427,WYE-125132,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1,C27H33N7O4,18372.0
5428,RN-1 (hydrochloride),CN1CCN(C(=O)CN[C@H]2C[C@@H]2c2ccc(OCc3ccccc3)cc2)CC1.Cl.Cl,C23H31Cl2N3O2,18124.0
5429,Acetaminophen-d4,[2H]c1c([2H])c(NC(C)=O)c([2H])c([2H])c1O,C8H9NO2,18245.0
5430,Acetaminophen-d4 (CRM),[2H]c1c([2H])c(NC(C)=O)c([2H])c([2H])c1O,C8H9NO2,22646.0
5431,Bupivacaine-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])N1CCCCC1C(=O)Nc1c(C)cccc1C,C18H28N2O,18246.0
5432,Caffeine-d3,[2H]C([2H])([2H])n1c(=O)c2c(ncn2C)n(C)c1=O,C8H10N4O2,18247.0
5433,Caffeine-d3 (CRM),[2H]C([2H])([2H])n1c(=O)c2c(ncn2C)n(C)c1=O,C8H10N4O2,27971.0
5434,Biotin hydrazide,NNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C10H18N4O2S,18418.0
5435,Ginkgolic Acid C15:1,CCCCCC/C=C\CCCCCCCc1cccc(O)c1C(=O)O,C22H34O3,18422.0
5436,DOPAL,O=CCc1ccc(O)c(O)c1,C8H8O3,18448.0
5437,Patchouli Alcohol,C[C@H]1CC[C@@]2(O)C(C)(C)[C@@H]3CC[C@@]2(C)[C@H]1C3,C15H26O,18450.0
5438,Novobiocin (sodium salt),CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc([O-])c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C.[Na+],C31H35N2NaO11,18457.0
5439,Nicorandil,O=C(NCCO[N+](=O)[O-])c1cccnc1,C8H9N3O4,18460.0
5440,XL184,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,C28H24FN3O5,18464.0
5441,Temazepam-d8,[2H]c1c([2H])c([2H])c(C2=NC(O)C(=O)N(C([2H])([2H])[2H])c3ccc(Cl)cc32)c([2H])c1[2H],C16H13ClN2O2,18481.0
5442,Temazepam-d8 (exempt preparation),[2H]c1c([2H])c([2H])c(C2=NC(O)C(=O)N(C([2H])([2H])[2H])c3ccc(Cl)cc32)c([2H])c1[2H],C16H13ClN2O2,23789.0
5443,ME0328,C[C@H](NC(=O)CCc1nc(=O)c2ccccc2[nH]1)c1ccccc1,C19H19N3O2,18488.0
5444,NVP-BHG712,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc(-c2cccnc2)nc2c1cnn2C,C26H20F3N7O,18489.0
5445,ASP3026,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1,C29H40N8O3S,18491.0
5446,JNJ-7706621,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,C15H12F2N6O3S,18494.0
5447,Apremilast,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,C22H24N2O7S,18502.0
5448,BX 471,C[C@@H]1CN(Cc2ccc(F)cc2)CCN1C(=O)COc1ccc(Cl)cc1NC(N)=O,C21H24ClFN4O3,18503.0
5449,4-Aminopyridine,Nc1ccncc1,C5H6N2,18511.0
5450,Lamivudine,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,C8H11N3O3S,18514.0
5451,Ciprofibrate,CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O,C13H14Cl2O3,18515.0
5452,BMS-777607,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,C25H19ClF2N4O4,18517.0
5453,3-MAPB (hydrochloride),CNC(C)Cc1coc2ccccc12.Cl,C12H16ClNO,9002299.0
5454,NVP-BEP800,CCNC(=O)c1cc2c(-c3cc(OCCN4CCCC4)c(Cl)cc3Cl)nc(N)nc2s1,C21H23Cl2N5O2S,18383.0
5455,MEAI (hydrochloride),COc1ccc2c(c1)CC(N)C2.Cl,C10H14ClNO,18286.0
5456,Menaquinone 4,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=C(C)C(=O)c2ccccc2C1=O,C31H40O2,18423.0
5457,Azlocillin (sodium salt),CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+],C20H22N5NaO6S,18424.0
5458,Eltoprazine (hydrochloride),Cl.c1cc2c(c(N3CCNCC3)c1)OCCO2,C12H17ClN2O2,18428.0
5459,"3?,5?-THDOC",C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)CO)CC[C@@H]12,C21H34O3,18431.0
5460,4-methyl-1-Pentanol,CC(C)CCCO,C6H14O,18446.0
5461,all-trans Retinal,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=O)C(C)(C)CCC1,C20H28O,18449.0
5462,"(3S,5S)-Atorvastatin (sodium salt)",CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@H](O)C[C@H](O)CC(=O)[O-].[Na+],C33H34FN2NaO5,18465.0
5463,"10,11-dihydro-10-hydroxy Carbamazepine",NC(=O)N1c2ccccc2CC(O)c2ccccc21,C15H14N2O2,18467.0
5464,Iopromide,COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I,C18H24I3N3O8,18470.0
5465,PF-562271 (besylate),CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O.O=S(=O)(O)c1ccccc1,C27H26F3N7O6S2,18499.0
5466,R788 (sodium salt),COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)([O-])[O-])C(=O)C(C)(C)O4)n2)cc(OC)c1OC.[Na+].[Na+],C23H24FN6Na2O9P,18501.0
5467,Trelagliptin,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O,C18H20FN5O2,18504.0
5468,TAPI-1,CC(C)CC(CC(=O)NO)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)NCCN,C26H37N5O5,18505.0
5469,Arphamenine B (hemisulfate),N=C(N)NCCC[C@H](N)C(=O)C[C@@H](Cc1ccc(O)cc1)C(=O)O.N=C(N)NCCC[C@H](N)C(=O)C[C@@H](Cc1ccc(O)cc1)C(=O)O.O=S(=O)(O)O,C32H50N8O12S,18506.0
5470,Buformin (hydrochloride),CCCCNC(=N)NC(=N)N.Cl,C6H16ClN5,18507.0
5471,Ledipasvir,COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1ncc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5nc([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)ccc2-3)[nH]1)C(C)C,C49H54F2N8O6,18519.0
5472,BMS-806,COc1ccnc2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c12,C22H22N4O4,18525.0
5473,GSK503,Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(N4CCN(C)CC4)nc3)cc3c2c(C)cn3C(C)C)c(=O)[nH]1,C31H38N6O2,18531.0
5474,CRT5,CCOc1ccc2cc(-c3cc(-c4cccc(C(=O)NCCN(C)C)c4)cnc3N)ccc2c1,C28H30N4O2,18532.0
5475,L-Selenocystine,N[C@@H](C[Se][Se]C[C@H](N)C(=O)O)C(=O)O,C6H12N2O4Se2,17793.0
5476,A-419259 (hydrochloride),CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1.Cl.Cl.Cl,C29H37Cl3N6O,18168.0
5477,AZD 6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,C22H24N4O4,15250.0
5478,LDN57444,CC(=O)O/N=C1\C(=O)N(Cc2cc(Cl)ccc2Cl)c2ccc(Cl)cc21,C17H11Cl3N2O3,15396.0
5479,Bufalin,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)CC[C@]12O,C24H34O4,15725.0
5480,CAY10684,Cc1cc(Cl)ccc1-c1cccc(C(O)/C=C/[C@H]2CCC(=O)N2CCCCCCC(=O)O)c1,C27H32ClNO4,15966.0
5481,Celecoxib-d7,[2H]c1c([2H])c(C([2H])([2H])[2H])c([2H])c([2H])c1-c1cc(C(F)(F)F)nn1-c1ccc(S(N)(=O)=O)cc1,C17H14F3N3O2S,18248.0
5482,Daidzein-d4,[2H]c1c([2H])c(-c2coc3cc(O)ccc3c2=O)c([2H])c([2H])c1O,C15H10O4,18249.0
5483,.alpha.-Ecdysone,C[C@H]([C@H](O)CCC(C)(C)O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C,C27H44O6,11711.0
5484,Norgestimate,C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC,C23H31NO3,16547.0
5485,9(S)-PAHSA,CCCCCCCCCCCCCCCC(=O)O[C@@H](CCCCCCCCC)CCCCCCCC(=O)O,C34H66O4,18023.0
5486,NASPM (hydrochloride),Cl.Cl.Cl.NCCCNCCCCNCCCNC(=O)Cc1cccc2ccccc12,C22H37Cl3N4O,18453.0
5487,FLT3 Inhibitor,COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC,C18H20N2O4S,18462.0
5488,"N-(2,6-Dimethylphenyl)-2-(ethylmethylamino)acetamide (hydrochloride)",CCN(C)CC(=O)Nc1c(C)cccc1C.Cl,C13H21ClN2O,18463.0
5489,BCH,NC1(C(=O)O)CC2CCC1C2,C8H13NO2,15249.0
5490,4-Thiouracil,O=c1[nH]ccc(=S)[nH]1,C4H4N2OS,16952.0
5491,S18886,Cc1ccc2c(c1CCC(=O)O)CC[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)C2,C20H22ClNO4S,14059.0
5492,CVT-10216,CS(=O)(=O)Nc1ccc(-c2coc3cc(OCc4cccc(C(=O)O)c4)ccc3c2=O)cc1,C24H19NO7S,18318.0
5493,?-acetyl-Boswellic Acid,CC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2CC=C2[C@@H]4[C@@H](C)[C@H](C)CC[C@]4(C)CC[C@]23C)[C@@]1(C)C(=O)O,C32H50O4,11674.0
5494,WAY-161503,O=C1Nc2cc(Cl)c(Cl)cc2N2CCNCC12,C11H11Cl2N3O,17269.0
5495,Jacaric Acid,CCCCC/C=C\C=C\C=C/CCCCCCC(=O)O,C18H30O2,16036.0
5496,Cystamine (hydrochloride),Cl.Cl.NCCSSCCN,C4H14Cl2N2S2,14882.0
5497,CAY10698,COc1cccc(CNc2ccc(S(=O)(=O)Nc3nccs3)cc2)c1O,C17H17N3O4S2,18582.0
5498,NI-57,COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C,C19H17N3O4S,17662.0
5499,N-Isopropylnoratropine,CC(C)N1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2,C19H27NO3,18611.0
5500,Thiodiglycolic Acid-d4,[2H]C([2H])(SC([2H])([2H])C(=O)O)C(=O)O,C4H6O4S,9002478.0
5501,Urodilatin,CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O,C145H234N52O44S3,17400.0
5502,Temazepam-d5 (CRM),[2H]c1c([2H])c([2H])c(C2=NC(O)C(=O)N(C)c3ccc(Cl)cc32)c([2H])c1[2H],C16H13ClN2O2,18565.0
5503,Temazepam-d5,[2H]c1c([2H])c([2H])c(C2=NC(O)C(=O)N(C)c3ccc(Cl)cc32)c([2H])c1[2H],C16H13ClN2O2,15859.0
5504,Nordiazepam-d5 (CRM),[2H]c1c([2H])c([2H])c(C2=NCC(=O)Nc3ccc(Cl)cc32)c([2H])c1[2H],C15H11ClN2O,18346.0
5505,Nordiazepam-d5,[2H]c1c([2H])c([2H])c(C2=NCC(=O)Nc3ccc(Cl)cc32)c([2H])c1[2H],C15H11ClN2O,15831.0
5506,Diazepam-d5 (CRM),[2H]c1c([2H])c([2H])c(C2=NCC(=O)N(C)c3ccc(Cl)cc32)c([2H])c1[2H],C16H13ClN2O,18548.0
5507,Norfentanyl-d5,[2H]c1c([2H])c([2H])c(N(C(=O)CC)C2CCNCC2)c([2H])c1[2H],C14H20N2O,15832.0
5508,Norfentanyl-d5 (CRM),[2H]c1c([2H])c([2H])c(N(C(=O)CC)C2CCNCC2)c([2H])c1[2H],C14H20N2O,18729.0
5509,Norfentanyl,CCC(=O)N(c1ccccc1)C1CCNCC1,C14H20N2O,15899.0
5510,CD2665,COCCOCOc1cc2ccc(-c3ccc(C(=O)O)cc3)cc2cc1C12CC3CC(CC(C3)C1)C2,C31H34O5,16031.0
5511,Clonazolam,Cc1nnc2n1-c1ccc([N+](=O)[O-])cc1C(c1ccccc1Cl)=NC2,C17H12ClN5O2,18173.0
5512,Clonazolam (CRM),Cc1nnc2n1-c1ccc([N+](=O)[O-])cc1C(c1ccccc1Cl)=NC2,C17H12ClN5O2,25614.0
5513,Donepezil-d4 (hydrochloride),Cl.[2H]C([2H])(C1CCN(C([2H])([2H])c2ccccc2)CC1)C1Cc2cc(OC)c(OC)cc2C1=O,C24H30ClNO3,18251.0
5514,Fluconazole-d4,[2H]C([2H])(n1cncn1)C(O)(c1ccc(F)cc1F)C([2H])([2H])n1cncn1,C13H12F2N6O,18252.0
5515,Fluoxetine-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(C(CCNC)Oc2ccc(C(F)(F)F)cc2)c([2H])c1[2H],C17H19ClF3NO,18253.0
5516,Pioglitazone-d4,[2H]c1c([2H])c(OCCc2ccc(CC)cn2)c([2H])c([2H])c1CC1SC(=O)NC1=O,C19H20N2O3S,18259.0
5517,Roflumilast-d4,[2H]C1([2H])C(COc2cc(C(=O)Nc3c(Cl)cncc3Cl)ccc2OC(F)F)C1([2H])[2H],C17H14Cl2F2N2O3,18260.0
5518,Sildenafil-d3,[2H]C([2H])([2H])N1CCN(S(=O)(=O)c2ccc(OCC)c(-c3nc(=O)c4c([nH]3)c(CCC)nn4C)c2)CC1,C22H30N6O4S,18261.0
5519,Tamoxifen-d5,[2H]C([2H])([2H])C([2H])([2H])/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,C26H29NO,18262.0
5520,AEM1,Fc1ccc(-c2csc3ncnc(NCc4ccc5c(c4)OCO5)c23)cc1,C20H14FN3O2S,18321.0
5521,L189,Nc1[nH]c(=S)[nH]c(=O)c1/N=C/c1ccccc1,C11H10N4OS,18374.0
5522,PF-06447475,N#Cc1cccc(-c2c[nH]c3ncnc(N4CCOCC4)c23)c1,C17H15N5O,18375.0
5523,GS-967,FC(F)(F)Oc1ccc(-c2ccc3nnc(C(F)(F)F)n3c2)cc1,C14H7F6N3O,18376.0
5524,Vidofludimus,COc1cccc(-c2ccc(NC(=O)C3=C(C(=O)O)CCC3)c(F)c2)c1,C20H18FNO4,18377.0
5525,Boceprevir,CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C,C27H45N5O5,18379.0
5526,Bikinin,O=C(O)CCC(=O)Nc1ccc(Br)cn1,C9H9BrN2O3,18381.0
5527,Mutant IDH1-IN-1,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1cnc2ccccc21)c1cccc(F)c1,C30H31FN4O2,18394.0
5528,CYT997,CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1,C24H30N6O2,18395.0
5529,A77-01,Cc1cccc(-c2n[nH]cc2-c2ccnc3ccccc23)n1,C18H14N4,18396.0
5530,RI-2,COc1ccc(C2=C(N3CCOCC3)C(=O)N(c3ccc(Cl)c(Cl)c3)C2=O)cc1,C21H18Cl2N2O4,18397.0
5531,Eliprodil,OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1,C20H23ClFNO,18398.0
5532,4E1RCat,O=C(O)c1ccc(N2C(=O)/C(=C\c3ccc(-c4ccc([N+](=O)[O-])cc4)o3)C=C2c2ccccc2)cc1,C28H18N2O6,18399.0
5533,Neratinib,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,C30H29ClN6O3,18404.0
5534,BLU-9931,C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1,C26H22Cl2N4O3,18405.0
5535,CEP-28122,COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2,C28H35ClN6O3,18406.0
5536,JNJ-31020028,CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3cccnc3)cc2F)CC1,C34H36FN5O2,18407.0
5537,LY404039,N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2[C@H](C(=O)O)[C@H]21,C7H9NO6S,18408.0
5538,GDC-0068,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1,C24H32ClN5O2,18412.0
5539,BMS 626529,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12,C24H23N7O4,18413.0
5540,CGI1746,Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1,C34H37N5O4,18414.0
5541,BRD-K4477,CC(=O)Nc1ccc(Cc2ccc(NC(C)=O)cc2)cc1,C17H18N2O2,18415.0
5542,AEE788,CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1,C27H32N6,18416.0
5543,Fluphenazine-N-2-chloroethane (hydrochloride),Cl.Cl.FC(F)(F)c1ccc2c(c1)N(CCCN1CCN(CCCl)CC1)c1ccccc1S2,C22H27Cl3F3N3S,18427.0
5544,FG-2216,O=C(O)CNC(=O)c1nc(Cl)c2ccccc2c1O,C12H9ClN2O4,18382.0
5545,SB-743921 (hydrochloride),Cc1ccc(C(=O)N(CCCN)[C@@H](c2oc3cc(Cl)ccc3c(=O)c2Cc2ccccc2)C(C)C)cc1.Cl,C31H34Cl2N2O3,18384.0
5546,MLN2238,CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O,C14H19BCl2N2O4,18385.0
5547,MLN9708,CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)CC(CC(=O)O)(C(=O)O)O1,C20H23BCl2N2O9,18386.0
5548,Danusertib,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1,C26H30N6O3,18387.0
5549,PHA-793887,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,C19H31N5O2,18388.0
5550,GSK923295,CC(C)Oc1ccc(C(=O)N[C@H](CNC(=O)CN(C)C)Cc2ccc(-c3cn4cccc([C@H](C)O)c4n3)cc2)cc1Cl,C32H38ClN5O4,18389.0
5551,Golgicide A,Fc1cc(F)c2c(c1)C1C=CCC1C(c1cccnc1)N2,C17H14F2N2,18430.0
5552,Dabigatran etexilate-d13,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])OC(=O)NC(=N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1,C34H41N7O5,18451.0
5553,Aldicarb,CNC(=O)O/N=C/C(C)(C)SC,C7H14N2O2S,18466.0
5554,ABT-333,COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C,C26H27N3O5S,18482.0
5555,Tyramine,NCCc1ccc(O)cc1,C8H11NO,18601.0
5556,Asoxime (chloride),NC(=O)c1cc[n+](COC[n+]2ccccc2/C=N\O)cc1.[Cl-].[Cl-],C14H16Cl2N4O3,18607.0
5557,2-Aminopurine (hydrochloride),Cl.Cl.Nc1nc2ncnc-2c[nH]1,C5H7Cl2N5,18609.0
5558,Betaxolol (hydrochloride),CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1.Cl,C18H30ClNO3,18625.0
5559,"L-755,507",CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1,C30H40N4O6S,18629.0
5560,MKT-077,CCn1c(=O)/c(=C2\Sc3ccccc3N2C)s/c1=C/c1cccc[n+]1CC.[Cl-],C21H22ClN3OS2,14395.0
5561,Rilmenidine (hemifumarate),C1COC(NC(C2CC2)C2CC2)=N1.C1COC(NC(C2CC2)C2CC2)=N1.O=C(O)/C=C/C(=O)O,C24H36N4O6,16988.0
5562,MAB-CHMINACA metabolite M11,CC(C)(CO)C(NC(=O)c1nn(CC2CCC(O)CC2)c2ccccc12)C(N)=O,C21H30N4O4,17818.0
5563,Lisdexamfetamine (mesylate),CS(=O)(=O)O.CS(=O)(=O)O.C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN,C17H33N3O7S2,18050.0
5564,Lisdexamfetamine (mesylate) (CRM),CS(=O)(=O)O.CS(=O)(=O)O.C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN,C17H33N3O7S2,27044.0
5565,NVP-ADW742,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](CN2CCCC2)C1,C28H31N5O,18390.0
5566,PSI-6206,C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O,C10H13FN2O5,18391.0
5567,CX-5461,Cc1cnc(CNC(=O)c2c(=O)c3ccc(N4CCCN(C)CC4)nc3n3c2sc2ccccc23)cn1,C27H27N7O2S,18392.0
5568,Fexinidazole,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,C12H13N3O3S,18393.0
5569,Cuspin-1,Cc1ccc(C(=O)c2cncc(Br)c2)cc1,C13H10BrNO,18526.0
5570,ML-355,COc1cccc(CNc2ccc(S(=O)(=O)Nc3nc4ccccc4s3)cc2)c1O,C21H19N3O4S2,18537.0
5571,Oxazepam-d5 (CRM),[2H]c1c([2H])c([2H])c(C2=NC(O)C(=O)Nc3ccc(Cl)cc32)c([2H])c1[2H],C15H11ClN2O2,18566.0
5572,Oxazepam-d5,[2H]c1c([2H])c([2H])c(C2=NC(O)C(=O)Nc3ccc(Cl)cc32)c([2H])c1[2H],C15H11ClN2O2,15844.0
5573,Carbetapentane (citrate),CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1.O=C(O)CC(O)(CC(=O)O)C(=O)O,C26H39NO10,18606.0
5574,Zatebradine (hydrochloride),COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC.Cl,C26H37ClN2O5,18608.0
5575,Butafosfan,CCCCNC(C)(C)[PH](=O)O,C7H18NO2P,18613.0
5576,BRL 37344 (sodium salt),C[C@@H](Cc1ccc(OCC(=O)[O-])cc1)NC[C@@H](O)c1cccc(Cl)c1.[Na+],C19H21ClNNaO4,18622.0
5577,(-)-Epinephrine,CNC[C@H](O)c1ccc(O)c(O)c1,C9H13NO3,18626.0
5578,3-hydroxy-3-Methylglutaric anhydride,CC1(O)CC(=O)OC(=O)C1,C6H8O4,18632.0
5579,Doxazosin (mesylate),COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC.CS(=O)(=O)O,C24H29N5O8S,18633.0
5580,Gomisin C,COc1cc2c(c(OC)c1OC)-c1c(cc3c(c1OC)OCO3)C[C@H](C)[C@](C)(O)[C@H]2OC(=O)c1ccccc1,C30H32O9,18643.0
5581,Quercetin 3-D-galactoside,O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,C21H20O12,18648.0
5582,Adefovir,Nc1ncnc2c1ncn2CCOCP(=O)(O)O,C8H12N5O4P,18650.0
5583,Nitecapone,CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O,C12H11NO6,18656.0
5584,Ch 55,CC(C)(C)c1cc(C(=O)/C=C/c2ccc(C(=O)O)cc2)cc(C(C)(C)C)c1,C24H28O3,18658.0
5585,"2,5-Deoxyfructosazine (hydrochloride)",Cl.Cl.OC[C@@H](O)[C@@H](O)[C@H](O)c1cnc(C[C@H](O)[C@H](O)CO)cn1,C12H22Cl2N2O7,18662.0
5586,GTx-007,CC(=O)Nc1ccc(OC[C@](C)(O)C(=O)Nc2ccc([N+](=O)[O-])c(C(F)(F)F)c2)cc1,C19H18F3N3O6,18772.0
5587,RAD140,Cc1c(N[C@@H](c2nnc(-c3ccc(C#N)cc3)o2)[C@H](C)O)ccc(C#N)c1Cl,C20H16ClN5O2,18773.0
5588,Altiratinib,O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1,C26H21F3N4O4,18777.0
5589,SB-207266,CCCCN1CCC(CNC(=O)c2c3n(c4ccccc24)CCCO3)CC1,C22H31N3O2,18778.0
5590,ITSA1,O=C(c1ccc(Cl)cc1Cl)n1nnc2ccccc21,C13H7Cl2N3O,18681.0
5591,Florfenicol amine (hydrochloride),CS(=O)(=O)c1ccc([C@@H](O)[C@H](N)CF)cc1.Cl,C10H15ClFNO3S,18631.0
5592,4-tert-Octylphenol diethoxylate,CC(C)(C)CC(C)(C)c1ccc(OCCOCCO)cc1,C18H30O3,18655.0
5593,Vinyl-L-NIO (hydrochloride),C=CCC(=N)NCCC[C@H](N)C(=O)O.Cl,C9H18ClN3O2,80330.0
5594,ARN14974,O=C(NCCCCc1ccccc1)n1c(=O)oc2cc(-c3ccc(F)cc3)ccc21,C24H21FN2O3,17119.0
5595,Cucurbitacin B,CC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C[C@H](O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C,C32H46O8,14820.0
5596,Meperidine-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(C2(C(=O)OCC)CCN(C)CC2)c([2H])c1[2H],C15H22ClNO2,15823.0
5597,Meperidine-d5 (hydrochloride) (exempt preparation),Cl.[2H]c1c([2H])c([2H])c(C2(C(=O)OCC)CCN(C)CC2)c([2H])c1[2H],C15H22ClNO2,23788.0
5598,6-Acetylmorphine,CC(=O)O[C@H]1C=C[C@H]2[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3C)[C@H]1O5,C19H21NO4,15880.0
5599,6-Acetylmorphine (CRM),CC(=O)O[C@H]1C=C[C@H]2[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3C)[C@H]1O5,C19H21NO4,19418.0
5600,Endothall,O=C(O)C1C2CCC(O2)C1C(=O)O,C8H10O5,17404.0
5601,"L-779,450",Oc1cc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)ccc1Cl,C20H14ClN3O,17807.0
5602,Flurazepam (CRM),CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,C21H23ClFN3O,18160.0
5603,Flurazepam,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,C21H23ClFN3O,16190.0
5604,Ulixertinib (hydrochloride),CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1.Cl,C21H23Cl3N4O2,18298.0
5605,Tamoxifen N-oxide,CC/C(=C(\c1ccccc1)c1ccc(OCC[N+](C)(C)[O-])cc1)c1ccccc1,C26H29NO2,18642.0
5606,Hesperidin,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O,C28H34O15,18646.0
5607,4-Aminobenzoic Acid (sodium salt),Nc1ccc(C(=O)[O-])cc1.[Na+],C7H6NNaO2,18659.0
5608,SBFI AM,COc1cc2cc(-c3ccc(C(=O)OCOC(C)=O)cc3C(=O)OCOC(C)=O)oc2cc1N1CCOCCOCCN(c2cc3oc(-c4ccc(C(=O)OCOC(C)=O)cc4C(=O)OCOC(C)=O)cc3cc2OC)CCOCC1,C56H58N2O23,18764.0
5609,LY2409881,CN1CCN(CCCNc2ncc(Cl)c(-c3cc4c(C(=O)NC5CC5)cccc4s3)n2)CC1.Cl.Cl.Cl,C24H32Cl4N6OS,18774.0
5610,AP26113,COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,C26H34ClN6O2P,18775.0
5611,CEP32496,COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC,C24H22F3N5O5,18776.0
5612,LGD4033,N#Cc1ccc(N2CCC[C@@H]2[C@@H](O)C(F)(F)F)cc1C(F)(F)F,C14H12F6N2O,9002046.0
5613,PI-3065,Fc1ccc2[nH]ccc2c1-c1nc(N2CCOCC2)c2sc(CN3CCN(CC4CC4)CC3)cc2n1,C27H31FN6OS,9002394.0
5614,Ginsenoside Rg1,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C,C42H72O14,15315.0
5615,SR9009,CCOC(=O)N1CCC(CN(Cc2ccc(Cl)cc2)Cc2ccc([N+](=O)[O-])s2)C1,C20H24ClN3O4S,11929.0
5616,Picroside I,O=C(/C=C/c1ccccc1)OC[C@H]1O[C@@H](O[C@@H]2OC=C[C@H]3[C@H](O)[C@@H]4O[C@]4(CO)[C@@H]23)[C@H](O)[C@@H](O)[C@@H]1O,C24H28O11,15431.0
5617,ML-204,Cc1cc(N2CCCCC2)nc2ccccc12,C15H18N2,15626.0
5618,Amphetamine-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(CC(C)N)c([2H])c1[2H],C9H14ClN,15797.0
5619,"3,4-MDEA-d5 (hydrochloride)",Cl.[2H]C([2H])([2H])C([2H])([2H])NC(C)Cc1ccc2c(c1)OCO2,C12H18ClNO2,15821.0
5620,"3,4-MDEA-d5 (hydrochloride) (exempt preparation)",Cl.[2H]C([2H])([2H])C([2H])([2H])NC(C)Cc1ccc2c(c1)OCO2,C12H18ClNO2,22876.0
5621,"3,4-MDMA-d3 (hydrochloride)",Cl.[2H]C([2H])([2H])NC(C)Cc1ccc2c(c1)OCO2,C11H16ClNO2,15822.0
5622,Trimipramine (maleate),CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\C(=O)O,C24H30N2O4,15921.0
5623,UM171,Cn1nnc(-c2ccc3c(c2)[nH]c2nc(Cc4ccccc4)nc(N[C@H]4CC[C@H](N)CC4)c23)n1,C25H27N9,16864.0
5624,Methoxmetamine (hydrochloride),CNC1(c2cccc(OC)c2)CCCCC1=O.Cl,C14H20ClNO2,17168.0
5625,AB-CHMINACA metabolite M4-d4,[2H]c1c([2H])c([2H])c2c(c(C(=O)O)nn2CC2CCCCC2)c1[2H],C15H18N2O2,18086.0
5626,para-methoxy-Butyryl fentanyl (hydrochloride),CCCC(=O)N(c1ccc(OC)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C24H33ClN2O2,18089.0
5627,4-methoxy-Butyryl fentanyl (hydrochloride) (CRM),CCCC(=O)N(c1ccc(OC)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C24H33ClN2O2,19632.0
5628,para-methoxy-Butyryl Fentanyl (hydrochloride) (exempt preparation),CCCC(=O)N(c1ccc(OC)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C24H33ClN2O2,39388.0
5629,JNK Inhibitor XVI,Cc1cc(NC(=O)c2cccc(NC(=O)/C=C/CN(C)C)c2)ccc1Nc1nccc(-c2cccnc2)n1,C29H29N7O2,18096.0
5630,SR-12813,CCOP(=O)(OCC)C(=Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)P(=O)(OCC)OCC,C24H42O7P2,18115.0
5631,UM729,COC(=O)c1ccc2c(c1)[nH]c1ncnc(NCCCN3CCCCC3)c12,C20H25N5O2,18378.0
5632,L-Phenylephrine (hydrochloride),CNC[C@H](O)c1cccc(O)c1.Cl,C9H14ClNO2,18619.0
5633,Tropine,CN1[C@@H]2CC[C@H]1C[C@@H](O)C2,C8H15NO,18627.0
5634,Pentylenetetrazole,C1CCc2nnnn2CC1,C6H10N4,18682.0
5635,SB 202474,CCc1[nH]c(-c2ccc(OC)cc2)nc1-c1ccncc1,C17H17N3O,18749.0
5636,Epothilone D,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1,C27H41NO5S,18765.0
5637,DAF-FM diacetate,CNc1ccc2c(c1N)C(=O)OC21c2cc(F)c(OC(C)=O)cc2Oc2cc(OC(C)=O)c(F)cc21,C25H18F2N2O7,18767.0
5638,Dihydroavermectin B1a,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C48H74O14,18768.0
5639,Ivermectin,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C48H74O14,35518.0
5640,Berninamycin A,C=C(NC(=O)C(=C)NC(=O)c1ccc2c(n1)-c1coc(n1)C(=C)NC(=O)C(=C)NC(=O)c1nc(oc1C)C(=C)NC(=O)[C@H](C(C)(C)O)NC(=O)C(=C)NC(=O)c1nc(oc1C)/C(=C/C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c1csc-2n1)C(N)=O,C51H51N15O15S,18769.0
5641,Thielavin B,COc1c(C)c(OC(=O)c2c(C)c(C)c(OC(=O)c3c(C)cc(O)c(C)c3O)c(C)c2OC)c(C)c(C)c1C(=O)O,C31H34O10,18770.0
5642,GW 501516,Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)cc3)nc2C)ccc1OCC(=O)O,C21H18F3NO3S2,10004272.0
5643,Ricinoleic Acid,CCCCCC[C@@H](O)C/C=C\CCCCCCCC(=O)O,C18H34O3,10009369.0
5644,"3,4-Methylenedioxy PV8 (hydrochloride)",CCCCCC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1.Cl,C18H26ClNO3,16358.0
5645,MMB-CHMICA,COC(=O)[C@@H](NC(=O)c1cn(CC2CCCCC2)c2ccccc12)C(C)C,C22H30N2O3,17984.0
5646,MMB-CHMICA (exempt preparation),COC(=O)[C@@H](NC(=O)c1cn(CC2CCCCC2)c2ccccc12)C(C)C,C22H30N2O3,41648.0
5647,"3',4'-trimethylene-.alpha.-Pyrrolidinohexanophenone (hydrochloride)",CCCCC(C(=O)c1ccc2c(c1)CCC2)N1CCCC1.Cl,C19H28ClNO,18030.0
5648,Ophiobolin B,CC(C)=CCC[C@H](C)[C@@]1(O)CC[C@]2(C)C[C@H]3[C@H](C(=O)C[C@@]3(C)O)/C(C=O)=C\C[C@H]21,C25H38O4,18432.0
5649,FGIN-1-27,CCCCCCN(CCCCCC)C(=O)Cc1c(-c2ccc(F)cc2)[nH]c2ccccc12,C28H37FN2O,18461.0
5650,Carazolol,CC(C)NCC(O)COc1cccc2[nH]c3ccccc3c12,C18H22N2O2,18628.0
5651,Diosmetin,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1O,C16H12O6,18649.0
5652,Diphenidol (hydrochloride),Cl.OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,C21H28ClNO,18674.0
5653,5-methyl Chrysene,Cc1cc2ccccc2c2ccc3ccccc3c12,C19H14,18677.0
5654,3'-Azido-3'-deoxythymidine .beta.-D-glucuronide (sodium salt),Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO[C@@H]3O[C@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]3O)O2)c(=O)[nH]c1=O.[Na+],C16H20N5NaO10,18679.0
5655,N-Acetylanthranilic Acid,CC(=O)Nc1ccccc1C(=O)O,C9H9NO3,18707.0
5656,A-674563,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,C22H22N4O,18715.0
5657,PRL-3 Inhibitor,O=C1NC(=S)S/C1=C/c1cc(Br)ccc1OCc1ccccc1Br,C17H11Br2NO2S2,18719.0
5658,Pentoxifylline,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,C13H18N4O3,18720.0
5659,Oxyphenbutazone,CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O,C19H20N2O3,18723.0
5660,Coenzyme Q1,COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O,C14H18O4,18741.0
5661,Ellipticine (hydrochloride),Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12.Cl,C17H15ClN2,18742.0
5662,Bifonazole,c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1,C22H18N2,18744.0
5663,Cefonicid (sodium salt),O=C([O-])C1=C(CSc2nnnn2CS(=O)(=O)[O-])CS[C@@H]2[C@H](NC(=O)[C@H](O)c3ccccc3)C(=O)N12.[Na+].[Na+],C18H16N6Na2O8S3,18745.0
5664,NSC 245214,O=C1CCCCC1c1sc([N+](=O)[O-])cc1[N+](=O)[O-],C10H10N2O5S,9002543.0
5665,"1,9-dideoxy Forskolin",C=C[C@@]1(C)CC(=O)C2[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CCC[C@]21C,C22H34O5,11664.0
5666,Lorazepam-13C2-d4,[2H]c1c([2H])c([2H])c(C2=N[13CH](O)[13C](=O)Nc3ccc(Cl)cc32)c(Cl)c1[2H],C15H10Cl2N2O2,17965.0
5667,Lorazepam-13C2-d4 (CRM),[2H]c1c([2H])c([2H])c(C2=N[13CH](O)[13C](=O)Nc3ccc(Cl)cc32)c(Cl)c1[2H],C15H10Cl2N2O2,18731.0
5668,MS049 (hydrochloride),CNCCN1CCC(OCc2ccccc2)CC1.Cl.Cl,C15H26Cl2N2O,18348.0
5669,Dimethyl DL-Glutamate (hydrochloride),COC(=O)CCC(N)C(=O)OC.Cl,C7H14ClNO4,18602.0
5670,N-Acetyltryptamine,CC(=O)NCCc1c[nH]c2ccccc12,C12H14N2O,18605.0
5671,Quercetagetin,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)c(O)c(O)c12,C15H10O8,18645.0
5672,Phloxine B,O=C1OC2(c3cc(Br)c([O-])c(Br)c3Oc3c2cc(Br)c([O-])c3Br)c2c(Cl)c(Cl)c(Cl)c(Cl)c21.[Na+].[Na+],C20H2Br4Cl4Na2O5,18675.0
5673,Anthranilic Acid,Nc1ccccc1C(=O)O,C7H7NO2,18708.0
5674,Triadimefon,CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1cncn1,C14H16ClN3O2,18714.0
5675,RWJ 67657,OCCC#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1CCCc1ccccc1,C27H24FN3O,18718.0
5676,WST-8,COc1cc([N+](=O)[O-])ccc1-[n+]1nc(-c2ccc(S(=O)(=O)[O-])cc2S(=O)(=O)[O-])nn1-c1ccc([N+](=O)[O-])cc1.[Na+],C20H13N6NaO11S2,18721.0
5677,Pidotimod,O=C1CC[C@@H](C(=O)N2CSC[C@H]2C(=O)O)N1,C9H12N2O4S,18725.0
5678,Triticonazole,CC1(C)CC/C(=C/c2ccc(Cl)cc2)C1(O)Cn1cncn1,C17H20ClN3O,18726.0
5679,L-Histidinol (hydrochloride),Cl.Cl.N[C@H](CO)Cc1c[nH]cn1,C6H13Cl2N3O,18739.0
5680,Cimetidine,CN/C(=N\CCSCc1nc[nH]c1C)NC#N,C10H16N6S,18743.0
5681,Doxofylline,Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O,C11H14N4O4,18746.0
5682,Protodioscin,C[C@H](CC[C@@]1(O)O[C@H]2C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2[C@@H]1C)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C51H84O22,11887.0
5683,UWA-101 (hydrochloride),CNC(Cc1ccc2c(c1)OCO2)C1CC1.Cl,C13H18ClNO2,15433.0
5684,Vedaprofen,CC(C(=O)O)c1ccc(C2CCCCC2)c2ccccc12,C19H22O2,15960.0
5685,Quinacrine analog 34,CN1CCN(CCNc2c3c(nc4cc(Cl)ccc24)CCCC3)CC1,C20H27ClN4,17733.0
5686,Perlapine,CN1CCN(C2=Nc3ccccc3Cc3ccccc32)CC1,C19H21N3,17756.0
5687,Amobarbital,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,C11H18N2O3,17784.0
5688,Amobarbital (CRM),CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,C11H18N2O3,22912.0
5689,25iP-NBOMe (hydrochloride),COc1cc(C(C)C)c(OC)cc1CCNCc1ccccc1OC.Cl,C21H30ClNO3,18170.0
5690,Syk Inhibitor II,NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1,C14H15F3N6O,18202.0
5691,4-methoxy DiPT (hydrochloride),COc1cccc2[nH]cc(CCN(C(C)C)C(C)C)c12.Cl,C17H27ClN2O,18311.0
5692,6-methoxy DiPT (hydrochloride),COc1ccc2c(CCN(C(C)C)C(C)C)c[nH]c2c1.Cl,C17H27ClN2O,18312.0
5693,7-methoxy DiPT (hydrochloride),COc1cccc2c(CCN(C(C)C)C(C)C)c[nH]c12.Cl,C17H27ClN2O,18313.0
5694,MCB-613,CCC1C/C(=C\c2cccnc2)C(=O)/C(=C/c2cccnc2)C1,C20H20N2O,18315.0
5695,25B-NBOH (hydrochloride),COc1cc(CCNCc2ccccc2O)c(OC)cc1Br.Cl,C17H21BrClNO3,18328.0
5696,Dehydrocostus lactone,C=C1CC[C@H]2C(=C)CC[C@H]3C(=C)C(=O)O[C@@H]3[C@@H]12,C15H18O2,18485.0
5697,CGP 35348,CCOC(OCC)P(=O)(O)CCCN,C8H20NO4P,18599.0
5698,Safingol,CCCCCCCCCCCCCCC[C@H](O)[C@@H](N)CO,C18H39NO2,18624.0
5699,Mitotane,Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1,C14H10Cl4,18651.0
5700,Lactisole,COc1ccc(OC(C)C(=O)[O-])cc1.[Na+],C10H11NaO4,18657.0
5701,Diminazene (aceturate),CC(=O)NCC(=O)O.CC(=O)NCC(=O)O.N=C(N)c1ccc(/N=N/Nc2ccc(C(=N)N)cc2)cc1,C22H29N9O6,18678.0
5702,Balsalazide,O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1,C17H15N3O6,18680.0
5703,.gamma.-Butyrolactone,O=C1CCCO1,C4H6O2,18706.0
5704,Phenylacetic Acid,O=C(O)Cc1ccccc1,C8H8O2,18709.0
5705,Piperonal,O=Cc1ccc2c(c1)OCO2,C8H6O3,18710.0
5706,L-p-Bromotetramisole (oxalate),Brc1ccc([C@H]2CN3CCSC3=N2)cc1.O=C(O)C(=O)O,C13H13BrN2O4S,18713.0
5707,Oclacitinib,CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2ncnc3[nH]ccc23)CC1,C15H23N5O2S,18722.0
5708,9-Ethylguanine,CCn1cnc2c(=O)[nH]c(N)nc21,C7H9N5O,18738.0
5709,Cdk1/5 Inhibitor,Nc1n[nH]c2nc3ccccc3nc12,C9H7N5,18740.0
5710,Azamulin,CC[C@]1(C)C[C@@H](OC(=O)CSc2nnc(N)[nH]2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,C24H38N4O4S,18748.0
5711,Ravuconazole,C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,C22H17F2N5OS,18750.0
5712,BH3I-1,CC(C)C(C(=O)O)N1C(=O)/C(=C\c2ccc(Br)cc2)SC1=S,C15H14BrNO3S2,18763.0
5713,N6-benzoyl-Cyclic AMP (sodium salt),O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)([O-])O[C@H]2[C@H]1O)c1ccccc1.[Na+],C17H15N5NaO7P,18819.0
5714,Cyclic AMP,Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1O,C10H12N5O6P,18820.0
5715,Cyclic GMP (sodium salt),Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)([O-])O[C@H]3[C@H]2O)c(=O)[nH]1.[Na+],C10H11N5NaO7P,18821.0
5716,"Sp-5,6-dichloro-cBIMPS (sodium salt)",O=[P@]1([S-])OC[C@H]2O[C@@H](n3cnc4cc(Cl)c(Cl)cc43)[C@H](O)[C@@H]2O1.[Na+],C12H10Cl2N2NaO5PS,18822.0
5717,Rp-8-bromo-PET-Cyclic GMPS (sodium salt),O=c1c2nc(Br)n([C@@H]3O[C@@H]4CO[P@@](=O)([S-])O[C@H]4[C@H]3O)c2[nH]c2nc(-c3ccccc3)cn12.[Na+],C18H14BrN5NaO6PS,18823.0
5718,"SP600125, negative control",Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2,C15H10N2O,18858.0
5719,Cdk1/2 Inhibitor III,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F,C15H13F2N7O2S2,18859.0
5720,MMPIP (hydrochloride),COc1ccc(-c2cc3onc(-c4ccncc4)c3c(=O)n2C)cc1.Cl,C19H16ClN3O3,18862.0
5721,C-6 NBD,O=C(O)CCCCCNc1ccc([N+](=O)[O-])c2nonc12,C12H14N4O5,18871.0
5722,"4,5,6,7-Tetrabromobenzimidazole",Brc1c(Br)c(Br)c2[nH]cnc2c1Br,C7H2Br4N2,18886.0
5723,NS 309,O=C1Nc2c(ccc(Cl)c2Cl)/C1=N/O,C8H4Cl2N2O2,18889.0
5724,ONO-4059,C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,C25H24N6O3,18924.0
5725,Tapentadol (hydrochloride),CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C.Cl,C14H24ClNO,9000620.0
5726,Tapentadol (hydrochloride) (CRM),CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C.Cl,C14H24ClNO,18660.0
5727,GHB (sodium salt),O=C([O-])CCCO.[Na+],C4H7NaO3,9002506.0
5728,GHB (sodium salt) (exempt preparation),O=C([O-])CCCO.[Na+],C4H7NaO3,15661.0
5729,Chloroquine (phosphate),CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=P(O)(O)O.O=P(O)(O)O,C18H32ClN3O8P2,14194.0
5730,5-methoxy EPT (hydrochloride),CCCN(CC)CCc1c[nH]c2ccc(OC)cc12.Cl,C16H25ClN2O,17298.0
5731,DOBU,CCCCc1cc(OC)c(CC(C)N)cc1OC,C15H25NO2,17655.0
5732,DOAM,CCCCCc1cc(OC)c(CC(C)N)cc1OC,C16H27NO2,17656.0
5733,MMDA-2 (hydrochloride),COc1cc2c(cc1CC(C)N)OCO2.Cl,C11H16ClNO3,17659.0
5734,Aniracetam,COc1ccc(C(=O)N2CCCC2=O)cc1,C12H13NO3,17752.0
5735,"3',4'-tetramethylene-.alpha.-Pyrrolidinovalerophenone (hydrochloride)",CCCC(C(=O)c1ccc2c(c1)CCCC2)N1CCCC1.Cl,C19H28ClNO,17955.0
5736,Halazepam,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F,C17H12ClF3N2O,18290.0
5737,25C-NB3OMe (hydrochloride),COc1cccc(CNCCc2cc(OC)c(Cl)cc2OC)c1.Cl,C18H23Cl2NO3,18560.0
5738,PAF C-18:1,CCCCCCCC/C=C\CCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(C)=O,C28H56NO7P,18779.0
5739,Rosuvastatin (calcium salt),CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2],C44H54CaF2N6O12S2,18813.0
5740,Dapoxetine (hydrochloride),CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1.Cl,C21H24ClNO,9002488.0
5741,Resolvin D5,CC/C=C\C[C@H](O)/C=C/C=C\C/C=C\C=C\[C@@H](O)C/C=C\CCC(=O)O,C22H32O4,10007280.0
5742,Resolvin E1,CC[C@@H](O)/C=C/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)O,C20H30O5,10007848.0
5743,MIRA-1,CCC(=O)OCN1C(=O)C=CC1=O,C8H9NO4,14858.0
5744,EMB-FUBINACA,CCOC(=O)[C@@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(C)C,C22H24FN3O3,17449.0
5745,EMB-FUBINACA (exempt preparation),CCOC(=O)[C@@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(C)C,C22H24FN3O3,39442.0
5746,"3',4'-tetramethylene-.alpha.-Pyrrolidinobutiophenone (hydrochloride)",CCC(C(=O)c1ccc2c(c1)CCCC2)N1CCCC1.Cl,C18H26ClNO,17956.0
5747,U-47700,CN(C)[C@@H]1CCCC[C@H]1N(C)C(=O)c1ccc(Cl)c(Cl)c1,C16H22Cl2N2O,18596.0
5748,U-47700 (CRM),CN(C)[C@@H]1CCCC[C@H]1N(C)C(=O)c1ccc(Cl)c(Cl)c1,C16H22Cl2N2O,19397.0
5749,Furanyl fentanyl (hydrochloride),Cl.O=C(c1ccco1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H27ClN2O2,18705.0
5750,Furanyl fentanyl (hydrochloride) (CRM),Cl.O=C(c1ccco1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H27ClN2O2,19633.0
5751,TBTA,c1ccc(Cn2cc(CN(Cc3cn(Cc4ccccc4)nn3)Cc3cn(Cc4ccccc4)nn3)nn2)cc1,C30H30N10,18816.0
5752,Rhodamine 110 (chloride),Nc1ccc2c(-c3ccccc3C(=O)O)c3ccc(N)cc3[o+]c2c1.[Cl-],C20H15ClN2O3,19061.0
5753,Diclofenac-d4,[2H]c1c([2H])c([2H])c(Nc2c(Cl)cccc2Cl)c(CC(=O)O)c1[2H],C14H11Cl2NO2,19072.0
5754,CPHPC,O=C(O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(=O)O,C16H24N2O6,75500.0
5755,Thromboxane B3,CC/C=C\C[C@H](O)/C=C/[C@H]1OC(O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O6,19990.0
5756,HMMA (hydrochloride),CNC(C)Cc1ccc(O)c(OC)c1.Cl,C11H18ClNO2,14195.0
5757,TDIQ (hydrochloride),Cl.c1c2c(cc3c1OCO3)CNCC2,C10H12ClNO2,16083.0
5758,4-methyl PV8 (hydrochloride),CCCCCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl,C18H28ClNO,16356.0
5759,"3,4-Methylenedioxy PV9 (hydrochloride)",CCCCCCC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1.Cl,C19H28ClNO3,16359.0
5760,"3',4'-trimethylene-.alpha.-Pyrrolidinobutiophenone (hydrochloride)",CCC(C(=O)c1ccc2c(c1)CCC2)N1CCCC1.Cl,C17H24ClNO,18031.0
5761,5-AEDB (hydrochloride),Cl.NCCc1ccc2c(c1)CCO2,C10H14ClNO,18351.0
5762,"3',4'-trimethylene-.alpha.-Pyrrolidinovalerophenone (hydrochloride)",CCCC(C(=O)c1ccc2c(c1)CCC2)N1CCCC1.Cl,C18H26ClNO,18554.0
5763,N-methyl-2-Phenylpropan-1-amine (hydrochloride),CNCC(C)c1ccccc1.Cl,C10H16ClN,18563.0
5764,Oxipurinol,O=c1[nH]c(=O)c2cn[nH]c2[nH]1,C5H4N4O2,18716.0
5765,Regadenoson,CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1,C15H18N8O5,18814.0
5766,1-Methyl-4-imidazoleacetic Acid (hydrochloride),Cl.Cn1cnc(CC(=O)O)c1,C6H9ClN2O2,18815.0
5767,"Fructose-1,6-bisphosphatase-1 Inhibitor",O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1cc(Cl)ccc1Cl,C13H7Cl3N2O3S,18860.0
5768,Nizatidine,CN/C(=C\[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1,C12H21N5O2S2,18861.0
5769,Ceftriaxone (sodium salt hydrate),CO/N=C(\C(=O)NC1C(=O)N2C(C(=O)[O-])=C(CSc3nc(=O)c([O-])nn3C)CS[C@H]12)c1csc(N)n1.CO/N=C(\C(=O)NC1C(=O)N2C(C(=O)[O-])=C(CSc3nc(=O)c([O-])nn3C)CS[C@H]12)c1csc(N)n1.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+],C36H46N16Na4O21S6,18866.0
5770,NF-?B Activation Inhibitor III,O=C(Nc1ncc([N+](=O)[O-])s1)c1ccc([N+](=O)[O-])c(Cl)c1,C10H5ClN4O5S,19083.0
5771,"4,9-Anhydrotetrodotoxin",NC1=N[C@]23[C@@H]4[C@H]5O[C@](O)(O[C@@H]([C@H]2O)[C@]5(O)CO)[C@H]3O[C@@H]4N1,C11H15N3O7,19084.0
5772,25P-NBOMe (hydrochloride),CCCc1cc(OC)c(CCNCc2ccccc2OC)cc1OC.Cl,C21H30ClNO3,9001991.0
5773,Cannabinodiol,C=C(C)c1ccc(C)cc1-c1c(O)cc(CCCCC)cc1O,C21H26O2,9002479.0
5774,Cannabinol methyl ether,CCCCCc1cc(OC)c2c(c1)OC(C)(C)c1ccc(C)cc1-2,C22H28O2,9002480.0
5775,Carmustine,O=NN(CCCl)C(=O)NCCCl,C5H9Cl2N3O2,15775.0
5776,"8,12-iso-iPF2.alpha.-VI",CCCCC/C=C\C[C@H]1[C@@H](/C=C/C(O)CCCC(=O)O)[C@@H](O)C[C@H]1O,C20H34O5,16310.0
5777,Malonyl Coenzyme A (lithium salt),CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)O.[LiH],C24H38LiN7O19P3S,16455.0
5778,GSK106 (hydrochloride),CCn1c(-c2nc3ccc(C(=O)N4CCCC(N)C4)cc3n2C)cc2ccccc21.Cl,C24H28ClN5O,17490.0
5779,GSK121 (trifluoroacetate salt),Cn1c(-c2nc3cc(C(=O)N4CCCC(N)C4)ccc3n2C)cc2ccccc21.O=C(O)C(F)(F)F,C25H26F3N5O3,17491.0
5780,"CL 316,243 (sodium salt)",C[C@H](Cc1ccc2c(c1)OC(C(=O)[O-])(C(=O)[O-])O2)NC[C@H](O)c1cccc(Cl)c1.[Na+].[Na+],C20H18ClNNa2O7,17499.0
5781,Syk Inhibitor II (hydrochloride),Cl.Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1,C14H17Cl2F3N6O,18805.0
5782,Imidapril (hydrochloride),CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O.Cl,C20H28ClN3O6,18854.0
5783,Losartan Carboxaldehyde,CCCCc1nc(Cl)c(C=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,C22H21ClN6O,18855.0
5784,Thiomuscimol,NCc1cc(=O)[nH]s1,C4H6N2OS,18857.0
5785,Tolazoline (hydrochloride),Cl.c1ccc(CC2=NCCN2)cc1,C10H13ClN2,18865.0
5786,CC-401,c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1,C22H24N6O,18867.0
5787,Chlorzoxazone,O=c1[nH]c2cc(Cl)ccc2o1,C7H4ClNO2,18869.0
5788,Rufinamide,NC(=O)c1cn(Cc2c(F)cccc2F)nn1,C10H8F2N4O,18870.0
5789,Mebendazole,COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1,C16H13N3O3,18872.0
5790,Ro 90-7501,Nc1ccc(-c2nc3ccc(-c4nc5cc(N)ccc5[nH]4)cc3[nH]2)cc1,C20H16N6,18881.0
5791,Triclabendazole,CSc1nc2cc(Oc3cccc(Cl)c3Cl)c(Cl)cc2[nH]1,C14H9Cl3N2OS,18883.0
5792,"1,6-Anhydro-.beta.-D-mannopyranose",O[C@@H]1[C@H](O)[C@@H]2OC[C@@H](O2)[C@H]1O,C6H10O5,18892.0
5793,"4,6-O-Benzylidene-D-glucose",O=C[C@H](O)[C@@H](O)[C@@H]1OC(c2ccccc2)OC[C@H]1O,C13H16O6,18894.0
5794,"1,6-Anhydro-D-galactose",O[C@H]1[C@@H](O)[C@H]2CO[C@H](O2)[C@@H]1O,C6H10O5,18895.0
5795,"D-Saccharic Acid 1,4-lactone (hydrate)",O.O=C(O)[C@@H](O)[C@H]1OC(=O)[C@H](O)[C@H]1O,C6H10O8,18896.0
5796,DREADD Agonist 21,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,C17H18N4,18907.0
5797,CAY10703,O=C(NCCN(CCNC(=O)C(Cl)Cl)CCNC(=O)C(Cl)Cl)C(Cl)Cl,C12H18Cl6N4O3,18911.0
5798,"5-(N,N-dimethyl)-Amiloride (hydrochloride)",CN(C)c1nc(N)c(C(=O)NC(=N)N)nc1Cl.Cl,C8H13Cl2N7O,19100.0
5799,Resolvin D1 methyl ester,CC/C=C\C[C@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)C/C=C\CCC(=O)OC,C23H34O5,9001815.0
5800,NCT-501 (hydrochoride),CC(C)CCn1c(CN2CCN(C(=O)C3CC3)CC2)nc2c1c(=O)n(C)c(=O)n2C.Cl,C21H33ClN6O3,18319.0
5801,MS023 (hydrochloride),CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1.Cl.Cl.Cl,C17H28Cl3N3O,18361.0
5802,N-acetyl-L-Carnosine,CC(=O)NCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,C11H16N4O4,18817.0
5803,Paclobutrazol,CC(C)(C)[C@H](O)[C@H](Cc1ccc(Cl)cc1)n1cncn1,C15H20ClN3O,18864.0
5804,(R)-Omeprazole (sodium salt),COc1ccc2[nH]c([S@](=O)Cc3ncc(C)c(OC)c3C)nc2c1.[NaH],C17H19N3NaO3S,18874.0
5805,Domperidone,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,C22H24ClN5O2,18875.0
5806,NS 1619,O=c1[nH]c2cc(C(F)(F)F)ccc2n1-c1cc(C(F)(F)F)ccc1O,C15H8F6N2O2,18876.0
5807,CAY10700,CC(C)(C)C(=O)NCc1ccc(Cl)c(C(=O)Nc2ncc[nH]2)c1,C16H19ClN4O2,18905.0
5808,Sodium Oxamate,NC(=O)C(=O)[O-].[Na+],C2H2NNaO3,19057.0
5809,Methyldienolone,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@@]21C,C19H26O2,9002585.0
5810,Methyldienolone (CRM),C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@@]21C,C19H26O2,21677.0
5811,Omeprazole sulfone,COc1ccc2[nH]c(S(=O)(=O)Cc3ncc(C)c(OC)c3C)nc2c1,C17H19N3O4S,18882.0
5812,Heptelidic Acid,CC(C)[C@H]1CC[C@@]2(CO2)[C@H]2C(=O)OCC(C(=O)O)=C[C@H]12,C15H20O5,14079.0
5813,Ramiprilat,C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,C21H28N2O5,15557.0
5814,5-chloro AKB48,O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(CCCCCCl)c2ccccc12,C23H30ClN3O,18166.0
5815,Adinazolam,CN(C)Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,C19H18ClN5,18205.0
5816,Adinazolam (CRM),CN(C)Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,C19H18ClN5,30186.0
5817,Naloxone-d5 (CRM),[2H]C([2H])=C([2H])C([2H])([2H])N1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,C19H21NO4,18274.0
5818,Naloxone-d5,[2H]C([2H])=C([2H])C([2H])([2H])N1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,C19H21NO4,16195.0
5819,Ocfentanil (hydrochloride),COCC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1.Cl,C22H28ClFN2O2,18583.0
5820,Ocfentanil (hydrochloride) (CRM),COCC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1.Cl,C22H28ClFN2O2,19635.0
5821,Isobutyryl fentanyl (hydrochloride),CC(C)C(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O,18584.0
5822,Isobutyryl fentanyl (hydrochloride) (CRM),CC(C)C(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O,19634.0
5823,"3',4'-Methylenedioxy-N,N-diethylcathinone (hydrochloride)",CCN(CC)C(C)C(=O)c1ccc2c(c1)OCO2.Cl,C14H20ClNO3,18586.0
5824,"3',4'-Methylenedioxy-N-tert-butylcathinone (hydrochloride)",CC(NC(C)(C)C)C(=O)c1ccc2c(c1)OCO2.Cl,C14H20ClNO3,18587.0
5825,Tapentadol-d3 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])N(C)C[C@H](C)[C@@H](CC)c1cccc(O)c1,C14H24ClNO,18730.0
5826,Crenolanib,CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1,C26H29N5O2,18873.0
5827,Droperidol,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,C22H22FN3O2,18884.0
5828,PF-9184,O=C(Nc1ccc(-c2ccc(Cl)c(Cl)c2)cc1)C1=C(O)c2ccccc2S(=O)(=O)N1,C21H14Cl2N2O4S,18904.0
5829,Mycophenolic Acid .beta.-D-Glucuronide,COc1c(C)c2c(c(O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2,C23H28O12,19078.0
5830,Purvalanol B,CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(=O)O)c(Cl)c2)c2ncn(C(C)C)c2n1,C20H25ClN6O3,19115.0
5831,Cannabicitran,CCCCCc1cc2c3c(c1)OC(C)(C)C1CCC(C)(CC31)O2,C21H30O2,9002481.0
5832,Cannabicitran (CRM),CCCCCc1cc2c3c(c1)OC(C)(C)C1CCC(C)(CC31)O2,C21H30O2,21295.0
5833,Cannabicitran (Alt. Batch CRM),CCCCCc1cc2c3c(c1)OC(C)(C)C1CCC(C)(CC31)O2,C21H30O2,41377.0
5834,Heneicosapentaenoic Acid ethyl ester,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OCC,C23H36O2,9002624.0
5835,Dimethyl-W84 (dibromide),Cc1ccc2c(c1)C(=O)N(CCC[N+](C)(C)CCCCCC[N+](C)(C)CCCN1C(=O)c3ccc(C)cc3C1=O)C2=O.[Br-].[Br-],C34H48Br2N4O4,16927.0
5836,4-acetoxy MET (hydrochloride),CCN(C)CCc1c[nH]c2cccc(OC(C)=O)c12.Cl,C15H21ClN2O2,18367.0
5837,5-fluoro AMB metabolite 7,CC(C)[C@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(=O)O,C18H24FN3O3,18545.0
5838,5-fluoro AMB metabolite 7 (CRM),CC(C)[C@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(=O)O,C18H24FN3O3,18789.0
5839,Deschloroketamine (hydrochloride),CNC1(c2ccccc2)CCCCC1=O.Cl,C13H18ClNO,18683.0
5840,Deschloroketamine (hydrochloride) (CRM),CNC1(c2ccccc2)CCCCC1=O.Cl,C13H18ClNO,25688.0
5841,Oxiconazole (nitrate),Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1.O=[N+]([O-])O,C18H14Cl4N4O4,18724.0
5842,Spinosyn D,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C(C)[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1,C42H67NO10,19158.0
5843,LL-Z 1640-4,COc1cc(O)c2c(c1)/C=C/CC(O)C(O)C(O)/C=C\CC(C)OC2=O,C19H24O7,19159.0
5844,Oligomycin C,CC[C@H]1/C=C/C=C/C[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)O[C@@H]2[C@H](C)[C@H](CC1)O[C@]1(CC[C@H](C)[C@H](C[C@@H](C)O)O1)[C@H]2C,C45H74O10,19162.0
5845,LMK 235,Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1,C15H22N2O4,14969.0
5846,Ryuvidine,Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1,C15H12N2O2S,16614.0
5847,KC01,CCCCCCCCCCCCCC1OC(=O)/C1=C\CCCCC(N)=O,C22H39NO3,17364.0
5848,KC02,NC(=O)CCCC/C=C1\C(=O)OC1CCc1ccccc1,C17H21NO3,17365.0
5849,Hydroxytacrine (maleate),Nc1c2c(nc3ccccc13)CCCC2O.O=C(O)/C=C\C(=O)O,C17H18N2O5,18508.0
5850,5-bromo THJ 018,O=C(c1cccc2ccccc12)c1nn(CCCCCBr)c2ccccc12,C23H21BrN2O,18578.0
5851,N-Ethylnorketamine (hydrochloride),CCNC1(c2ccccc2Cl)CCCCC1=O.Cl,C14H19Cl2NO,18591.0
5852,Valeryl fentanyl (hydrochloride),CCCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C24H33ClN2O,18934.0
5853,FzM1,O=C(Nc1cc(O)cc(-c2cccs2)c1)Nc1ccc2ccccc2c1,C21H16N2O2S,19074.0
5854,BMS 453,CC1(C)CC=C(c2ccccc2)c2cc(/C=C/c3ccc(C(=O)O)cc3)ccc21,C27H24O2,19076.0
5855,TG6-129,CCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)/C=C/c3ccc(F)cc3)cc2)s1,C20H18FN5O3S3,19085.0
5856,HLY78,CCc1cccc2c1N(C)Cc1cc3c(cc1-2)OCO3,C17H17NO2,19087.0
5857,LLP-3,N#Cc1c(-c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)cc(-c2cc(Cl)ccc2O)[nH]c1=O,C32H23ClN2O4,19088.0
5858,HTH-01-015,Cc1nc(Nc2cnn(C3CCNCC3)c2)nc2c1N(C)C(=O)c1cc3ccccc3cc1N2C,C26H28N8O,19091.0
5859,HJC0197,Cc1ccc(C)c(CSc2nc(=O)c(C#N)c(C3CCCC3)[nH]2)c1,C19H21N3OS,19092.0
5860,Apilimod,Cc1cccc(/C=N/Nc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1,C23H26N6O2,19094.0
5861,CB-5083,Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2,C24H23N5O2,19311.0
5862,PF-04457845,O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1,C23H20F3N5O2,19306.0
5863,Pitolisant,Cl.Clc1ccc(CCCOCCCN2CCCCC2)cc1,C17H27Cl2NO,19307.0
5864,PF-4989216,N#Cc1ccc(-c2c(-c3nnc[nH]3)sc(N3CCOCC3)c2C#N)c(F)c1,C18H13FN6OS,19308.0
5865,AZD 3264,Cc1noc(C)c1-c1ccc(-c2cc(C(N)=O)c(NC(N)=O)s2)c(O[C@H]2CCNC2)c1,C21H23N5O4S,19309.0
5866,Maresin 2,CC/C=C\C/C=C\C[C@H](O)[C@H](O)/C=C/C=C/C=C\C/C=C\CCC(=O)O,C22H32O4,16369.0
5867,5-fluoro PB-22 3-carboxyindole metabolite-d5 (CRM),[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)O)c([2H])n2CCCCCF,C14H16FNO2,18144.0
5868,NIBR189,COc1ccc(C(=O)N2CCN(C(=O)/C=C/c3ccc(Br)cc3)CC2)cc1,C21H21BrN2O3,18792.0
5869,11-keto Testosterone (CRM),C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,C19H26O3,9002564.0
5870,Calcein AM,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)Cc1cc2c(cc1OC(C)=O)Oc1cc(OC(C)=O)c(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)cc1C21OC(=O)c2ccccc21,C46H46N2O23,14948.0
5871,4'-chloro-.alpha.-Pyrrolidinovalerophenone (hydrochloride),CCCC(C(=O)c1ccc(Cl)cc1)N1CCCC1.Cl,C15H21Cl2NO,18326.0
5872,4'-chloro-?-Pyrrolidinovalerophenone (hydrochloride) (exempt preparation),CCCC(C(=O)c1ccc(Cl)cc1)N1CCCC1.Cl,C15H21Cl2NO,39198.0
5873,4-ANPP,c1ccc(CCN2CCC(Nc3ccccc3)CC2)cc1,C19H24N2,18810.0
5874,4-ANPP (CRM),c1ccc(CCN2CCC(Nc3ccccc3)CC2)cc1,C19H24N2,22700.0
5875,4'-fluoro-?-Pyrrolidinohexanophenone (hydrochloride),CCCCC(C(=O)c1ccc(F)cc1)N1CCCC1.Cl,C16H23ClFNO,18818.0
5876,4-Chloroethcathinone (hydrochloride),CCNC(C)C(=O)c1ccc(Cl)cc1.Cl,C11H15Cl2NO,18912.0
5877,VU0255035,O=C(CCNS(=O)(=O)c1cccc2nsnc12)N1CCN(c2ccncc2)CC1,C18H20N6O3S2,19353.0
5878,2-Guanidinoethylmercaptosuccinic Acid,N=C(N)NCCSC(CC(=O)O)C(=O)O,C7H13N3O4S,19354.0
5879,Rhod-2 AM,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1ccc(C)cc1OCCOc1cc(-c2c3ccc(N(C)C)cc3[o+]c3cc(N(C)C)ccc23)ccc1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O.[Br-],C52H59BrN4O19,19355.0
5880,Clopamide,C[C@@H]1CCC[C@H](C)N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,C14H20ClN3O3S,19356.0
5881,Pyridoxal isonicotinoyl hydrazone,Cc1ncc(CO)c(/C=N/NC(=O)c2ccncc2)c1O,C14H14N4O3,19357.0
5882,(R)-(+)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)N[C@H](C)CO,C25H39NO2,9001229.0
5883,(R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide,CCCCC/C=C\C/C=C\CCCCCCCC(=O)N[C@H](C)CO,C21H39NO2,9001233.0
5884,Cholic Acid 7-sulfate,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](OS(=O)(=O)O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H40O8S,9002532.0
5885,VR23,O=[N+]([O-])c1ccc(S(=O)(=O)N2CCN(c3ccnc4cc(Cl)ccc34)CC2)c([N+](=O)[O-])c1,C19H16ClN5O6S,19133.0
5886,MK-5108,O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1,C22H21ClFN3O3S,19167.0
5887,BMS-265246,CCCCOc1c(C(=O)c2c(F)cc(C)cc2F)cnc2[nH]ncc12,C18H17F2N3O2,19168.0
5888,Taurocholic Acid 3-sulfate (sodium salt),C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C.[Na+].[Na+],C26H43NNa2O10S2,9002538.0
5889,GNF 5837,Cc1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1,C28H21F4N5O2,14883.0
5890,Nimetazepam,CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21,C16H13N3O3,18352.0
5891,Nimetazepam (CRM),CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21,C16H13N3O3,19206.0
5892,KT109,O=C(N1CCCCC1Cc1ccccc1)n1cc(-c2ccc(-c3ccccc3)cc2)nn1,C27H26N4O,18933.0
5893,TCN 201,O=C(NNC(=O)c1ccc(CNS(=O)(=O)c2ccc(F)c(Cl)c2)cc1)c1ccccc1,C21H17ClFN3O4S,19086.0
5894,UCM05,O=C(Oc1cc(OC(=O)c2cc(O)c(O)c(O)c2)c2ccccc2c1)c1cc(O)c(O)c(O)c1,C24H16O10,19090.0
5895,PRT4165,O=C1C(=Cc2cccnc2)C(=O)c2ccccc21,C15H9NO2,19093.0
5896,ESI-09,CC(C)(C)c1cc(C(=O)/C(C#N)=N/Nc2cccc(Cl)c2)no1,C16H15ClN4O2,19130.0
5897,PD-1/PD-L1 Inhibitor 2,COc1nc(OCc2cccc(-c3ccccc3)c2C)ccc1CNCCNC(C)=O,C25H29N3O3,19132.0
5898,KT195,COc1ccc(-c2ccc(-c3cn(C(=O)N4CCCCC4c4ccccc4)nn3)cc2)cc1,C27H26N4O2,14818.0
5899,9-PAHPA,CCCCCCCCCCCCCCCC(=O)OC(CCCCCCC)CCCCCCCC(=O)O,C32H62O4,17038.0
5900,Commendamide,CCCCCCCCCCCCCC(O)CC(=O)NCC(=O)O,C18H35NO4,18421.0
5901,Reversin 121,CC(C)(C)OC(=O)N[C@@H](CC(=O)OCc1ccccc1)C(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)OC(C)(C)C,C34H47N3O9,18603.0
5902,D-Ribulose,O=C(CO)[C@H](O)[C@H](O)CO,C5H10O5,18893.0
5903,XAP044,O=c1c(Oc2ccc(I)cc2)coc2cc(O)ccc12,C15H9IO4,19095.0
5904,Flavoxate (hydrochloride),Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O.Cl,C24H26ClNO4,19096.0
5905,GSK837149A,Cc1ccnc(NS(=O)(=O)c2ccc(NC(=O)Nc3ccc(S(=O)(=O)Nc4nccc(C)n4)cc3)cc2)n1,C23H22N8O5S2,19098.0
5906,CBL0137,CC(=O)c1ccc2c(c1)c1cc(C(C)=O)ccc1n2CCNC(C)C,C21H24N2O2,19110.0
5907,Coumarin hydrazine,Cc1cc(=O)oc2cc(NN)ccc12,C10H10N2O2,19111.0
5908,SBC-115076,Cc1cc(C(=O)C2=C(O)C(=O)N(CCCN3CCOCC3)C2c2ccncc2)ccc1OCc1ccccc1,C31H33N3O5,19134.0
5909,EI1,CCC(CC)n1ccc2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(C#N)cc21,C23H26N4O2,19146.0
5910,KIRA6,CC(C)(C)c1nc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c3ccccc23)c2c(N)nccn12,C28H25F3N6O,19151.0
5911,EPZ011989,CCN(c1cc(C#CCN2CCOCC2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)[C@H]1CC[C@H](N(C)CCOC)CC1,C35H51N5O4,19161.0
5912,SCH 772984,O=C(Nc1ccc2[nH]nc(-c3ccncc3)c2c1)[C@@H]1CCN(CC(=O)N2CCN(c3ccc(-c4ncccn4)cc3)CC2)C1,C33H33N9O2,19166.0
5913,"CP 673,451",COCCOc1ccc2c(c1)ncn2-c1ccc2cccc(N3CCC(N)CC3)c2n1,C24H27N5O2,19170.0
5914,PF-4800567,Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1,C17H18ClN5O2,19171.0
5915,BIX 02565,C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21,C26H30N6O2,19183.0
5916,PF-3758309,Cc1nc(Nc2n[nH]c3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1,C25H30N8OS,19186.0
5917,NS 3694,O=C(Nc1cccc(C(F)(F)F)c1)Nc1cc(Cl)ccc1C(=O)O,C15H10ClF3N2O3,19190.0
5918,S-Phenylsulfonylcysteine,N[C@@H](CSS(=O)(=O)c1ccccc1)C(=O)O,C9H11NO4S2,19281.0
5919,CBL0137 (hydrochloride),CC(=O)c1ccc2c(c1)c1cc(C(C)=O)ccc1n2CCNC(C)C.Cl,C21H25ClN2O2,19373.0
5920,Mps1-IN-2,CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)CCC(=O)N2C,C26H36N6O3,19401.0
5921,IDO-IN-1,Nc1nonc1/C(=N/c1ccc(F)c(Br)c1)NO,C9H7BrFN5O2,19402.0
5922,GSK2879552,O=C(O)c1ccc(CN2CCC(CN[C@@H]3C[C@H]3c3ccccc3)CC2)cc1,C23H28N2O2,19403.0
5923,BMS 687453,COC(=O)N(CC(=O)O)Cc1cccc(OCc2nc(-c3ccc(Cl)cc3)oc2C)c1,C22H21ClN2O6,19404.0
5924,Chaetoglobosin A,C/C1=C/[C@@H](C)C/C=C/[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)[C@H]3[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@]32C(=O)/C=C/C(=O)[C@@H]1O,C32H36N2O5,19405.0
5925,CC-115,CCN1C(=O)CN=C2NC=C(c3ccc(-c4nnc[nH]4)nc3C)N=C21,C16H16N8O,19420.0
5926,BMS-3,O=C(Nc1ncc(-c2cc(C(F)F)nn2-c2c(Cl)cccc2Cl)s1)C1CC1,C17H12Cl2F2N4OS,19421.0
5927,25T2-NBOMe (hydrochloride),CCSc1cc(OC)c(CCNCc2ccccc2OC)cc1OC.Cl,C20H28ClNO3S,9002690.0
5928,BMK methyl glycidate,COC(=O)C1(C)OC1c1ccccc1,C11H12O3,9002714.0
5929,JW 74,COc1ccc(-n2c(SCc3nc(-c4ccc(C)cc4)no3)nnc2-c2ccncc2)cc1,C24H20N6O2S,19124.0
5930,O4I2,CCOC(=O)c1csc(Nc2ccc(Cl)cc2)n1,C12H11ClN2O2S,19135.0
5931,Sotagliflozin,CCOc1ccc(Cc2cc([C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,C21H25ClO5S,19141.0
5932,SB 239063,COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1,C20H21FN4O2,19142.0
5933,HSP-990,COc1cccc(-c2cc(F)ccc2[C@H]2Cc3nc(N)nc(C)c3C(=O)N2)n1,C20H18FN5O2,19149.0
5934,HS-173,CCOC(=O)c1cnc2ccc(-c3cncc(NS(=O)(=O)c4ccccc4)c3)cn12,C21H18N4O4S,19156.0
5935,Ebelactone A,CC[C@@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)/C=C(\C)C[C@H](C)[C@@H]1OC(=O)[C@H]1C,C20H34O4,19163.0
5936,Bafetinib,Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1,C30H31F3N8O,19169.0
5937,AMG 900,Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1,C28H21N7OS,19176.0
5938,WZ4003,CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1,C25H29ClN6O3,19177.0
5939,GSK269962A,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21,C29H30N8O5,19180.0
5940,Trimesic Acid,O=C(O)c1cc(C(=O)O)cc(C(=O)O)c1,C9H6O6,19198.0
5941,2-hydroxy-6-Methylbenzoic Acid,Cc1cccc(O)c1C(=O)O,C8H8O3,19199.0
5942,Tulathromycin A,CCCNC[C@]1(O)[C@H](C)O[C@@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3O)[C@](C)(O)C[C@@H](C)CN[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]2C)C[C@@]1(C)OC,C41H79N3O12,19202.0
5943,Isopropylphenidate (hydrochloride),CC(C)OC(=O)C(c1ccccc1)C1CCCCN1.Cl,C16H24ClNO2,19264.0
5944,2-nonyl-3-hydroxy-4-Quinolone,CCCCCCCCCc1[nH]c2ccccc2c(=O)c1O,C18H25NO2,9002699.0
5945,BMK ethyl glycidate,CCOC(=O)C1(C)OC1c1ccccc1,C12H14O3,9002713.0
5946,SC-57461A,CN(CCCOc1ccc(Cc2ccccc2)cc1)CCC(=O)O.Cl,C20H26ClNO3,10108.0
5947,Mitragynine (CRM),CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C23H30N2O4,18567.0
5948,CL-387785,CC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,C18H13BrN4O,19081.0
5949,XEN445,O=C(O)c1cc(C(F)(F)F)ccc1N1CC[C@H](OCc2ccccn2)C1,C18H17F3N2O3,19144.0
5950,URMC-099,CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1,C27H27N5,19147.0
5951,"CP 724,714",COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,C27H27N5O3,19172.0
5952,Diflunisal,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,C13H8F2O3,19187.0
5953,Isoquinoline-3-carboxylic Acid,O=C(O)c1cc2ccccc2cn1,C10H7NO2,19194.0
5954,Flibanserin,O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1,C20H21F3N4O,19203.0
5955,Antimycin A1,CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C,C28H40N2O9,19433.0
5956,Antimycin A Complex,CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C,C28H40N2O9,34799.0
5957,Actinotetraose Hexatiglate,C/C=C(\C)C(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](COC(=O)/C(C)=C/C)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](OC(=O)/C(C)=C/C)[C@H](OC(=O)/C(C)=C/C)[C@H]2O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](OC(=O)/C(C)=C/C)[C@H](OC(=O)/C(C)=C/C)[C@H]2O)[C@@H](O)[C@@H]1O,C54H78O27,19434.0
5958,Apoptolidin,COC[C@@H](C[C@H]1O[C@@](O)([C@H](O)[C@@H]2C[C@H](OC)[C@@H](O)CC/C=C(C)/C=C/[C@@H](O[C@@H]3O[C@@H](C)[C@H](OC)[C@@H](O)[C@@H]3O)[C@H](C)/C=C(C)/C=C(C)/C=C(\C)C(=O)O2)[C@H](C)[C@@H](O)[C@H]1C)O[C@H]1C[C@](C)(O)[C@@H](O[C@H]2C[C@@H](OC)[C@H](O)[C@@H](C)O2)[C@H](C)O1,C58H96O21,19435.0
5959,Ascochlorin,CC(/C=C/[C@@]1(C)[C@H](C)CCC(=O)[C@@H]1C)=C\Cc1c(O)c(Cl)c(C)c(C=O)c1O,C23H29ClO4,19437.0
5960,Kigamicin C,CO[C@@H]1C[C@H](O[C@H]2CC[C@H](O[C@@H]3C[C@H](O)c4c(oc5c6c7c(c(O)c5c4=O)-c4c(cc5c(c4O)C(=O)N4CCO[C@]4(C)C5)C[C@H]7OCO6)[C@H]3O)O[C@@H]2C)O[C@H](C)[C@H]1O,C41H47NO16,19445.0
5961,Narasin (sodium salt),CC[C@@H](C(=O)[O-])[C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@]3(C=C[C@@H](O)[C@]4(CC[C@@](C)([C@H]5CC[C@](O)(CC)[C@H](C)O5)O4)O3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@@H]1C.[Na+],C43H71NaO11,19447.0
5962,Aureothin,COc1oc([C@H]2C/C(=C/C(C)=C/c3ccc([N+](=O)[O-])cc3)CO2)c(C)c(=O)c1C,C22H23NO6,19463.0
5963,Prodigiosin,CCCCCC1=C/C(=C\c2[nH]c(-c3ccc[nH]3)cc2OC)N=C1C,C20H25N3O,19464.0
5964,Roxithromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O,C41H76N2O15,19465.0
5965,GDC-0623,O=C(NOCCO)c1ccc2cncn2c1Nc1ccc(I)cc1F,C16H14FIN4O3,19479.0
5966,CWHM12,CC(C)(C)c1cc(Br)cc([C@H](CC(=O)O)NC(=O)CNC(=O)c2cc(O)cc(NC3=NCC(O)CN3)c2)c1,C26H32BrN5O6,19480.0
5967,HM61713,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1,C26H26N6O2S,19481.0
5968,VX-509,CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F,C18H19F3N6O,19513.0
5969,INK1117,Nc1nc2cc(-c3ccc4ncc(C(=O)N5CCOCC5)n4c3)ccc2o1,C19H17N5O3,19514.0
5970,Bischloroanthrabenzoxocinone,COc1cc(C)c2c(c1)O[C@]1(C)Cc3cc4c(c(O)c3[C@H]2O1)C(=O)c1c(O)c(Cl)c(O)c(Cl)c1C4(C)C,C28H24Cl2O7,19439.0
5971,Osthole,COc1ccc2ccc(=O)oc2c1CC=C(C)C,C15H16O3,19195.0
5972,SB 218078,O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1,C24H15N3O3,13335.0
5973,XCT790,COc1cc(/C=C(\C#N)C(=O)Nc2nnc(C(F)(F)F)s2)ccc1OCc1ccc(C(F)(F)F)cc1C(F)(F)F,C23H13F9N4O3S,16035.0
5974,Grifolic Acid,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,C23H32O4,17398.0
5975,Fenoldopam (mesylate),CS(=O)(=O)O.Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,C17H20ClNO6S,17629.0
5976,Linsitinib,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,C26H23N5O,17708.0
5977,PF-04929113,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](OC(=O)CN)CC4)c3)c2C1,C25H30F3N5O4,18270.0
5978,12(S)-HETrE,CCCCC/C=C\C[C@H](O)/C=C/C=C\CCCCCCC(=O)O,C20H34O3,18483.0
5979,(+)-Atenolol,CC(C)NC[C@@H](O)COc1ccc(CC(N)=O)cc1,C14H22N2O3,18623.0
5980,Clonazepam-d4 (CRM),[2H]c1c([2H])c([2H])c(C2=NCC(=O)Nc3ccc([N+](=O)[O-])cc32)c(Cl)c1[2H],C15H10ClN3O3,18727.0
5981,PF-CBP1,CCCOc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1,C29H36N4O3,18811.0
5982,Omeprazole sulfide,COc1ccc2[nH]c(SCc3ncc(C)c(OC)c3C)nc2c1,C17H19N3O2S,18885.0
5983,Cantharidic Acid (sodium salt),C[C@]1(C(=O)[O-])[C@@H]2CC[C@@H](O2)[C@@]1(C)C(=O)[O-].[Na+].[Na+],C10H12Na2O5,19073.0
5984,RQ-00203078,O=C(O)c1ccc(S(=O)(=O)N(Cc2ccc(OC(F)(F)F)cc2)c2ncc(C(F)(F)F)cc2Cl)cc1,C21H13ClF6N2O5S,19075.0
5985,KJ Pyr 9,NC(=O)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(-c3ccco3)c2)cc1,C22H15N3O4,19116.0
5986,ML-354,Cn1c(CO)c(-c2ccccc2)c2cc([N+](=O)[O-])ccc21,C16H14N2O3,19120.0
5987,ORY-1001,Cl.Cl.NC1CCC(N[C@@H]2C[C@H]2c2ccccc2)CC1,C15H24Cl2N2,19136.0
5988,UMI-77,O=C(O)CSc1cc(NS(=O)(=O)c2ccc(Br)cc2)c2ccccc2c1O,C18H14BrNO5S2,19148.0
5989,6-thio-2'-Deoxyguanosine,Nc1nc2c(ncn2[C@H]2C[C@H](O)[C@@H](CO)O2)c(=S)[nH]1,C10H13N5O3S,19154.0
5990,Sulfosuccinimidyl Myristate (sodium salt),CCCCCCCCCCCCCC(=O)ON1C(=O)CC(S(=O)(=O)[O-])C1=O.[Na+],C18H30NNaO7S,11212.0
5991,BGJ398,CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1,C26H31Cl2N7O3,19157.0
5992,XMD8-92,CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C,C26H30N6O3,19173.0
5993,MLCK Inhibitor Peptide 18,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O,C60H105N23O11,19181.0
5994,Amoxicillin (hydrate),CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O.O.O.O,C16H25N3O8S,19188.0
5995,Statil,O=C(O)Cc1nn(Cc2ccc(Br)cc2F)c(=O)c2ccccc12,C17H12BrFN2O3,19189.0
5996,Phosphoenolpyruvic Acid (potassium salt),C=C(OP(=O)([O-])O)C(=O)O.[K+],C3H4KO6P,19192.0
5997,Tranexamic Acid,NC[C@H]1CC[C@H](C(=O)O)CC1,C8H15NO2,19193.0
5998,Syringic Acid,COc1cc(C(=O)O)cc(OC)c1O,C9H10O5,19196.0
5999,Thiostrepton,C=C(NC(=O)C(=C)NC(=O)c1csc(C2=N[C@@H]3c4csc(n4)[C@H]4NC(=O)c5csc(n5)[C@H]([C@](C)(O)[C@@H](C)O)NC(=O)[C@H]5CSC(=N5)/C(=C/C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c5csc(n5)[C@]3(CC2)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)N[C@@H]2C=Cc3c([C@H](C)O)cc(nc3[C@H]2O)C(=O)O[C@@H]4C)n1)C(N)=O,C72H85N19O18S5,19200.0
6000,Abamectin,CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,C95H142O28,19201.0
6001,Abamectin (CRM),CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,C95H142O28,39354.0
6002,Inulin,OC[C@H]1O[C@@](CO)(OC[C@@]2(O[C@H]3O[C@H](O)[C@@H](O)[C@H](O)[C@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O,C11H20O11(C6H10O5)n,19229.0
6003,Valeryl fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)CCCC)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C24H33ClN2O,19243.0
6004,Flunitrazepam-d7 (CRM),[2H]c1c([2H])c([2H])c(C2=NCC(=O)N(C([2H])([2H])[2H])c3ccc([N+](=O)[O-])cc32)c(F)c1[2H],C16H12FN3O3,19251.0
6005,Tanomastat,O=C(C[C@H](CSc1ccccc1)C(=O)O)c1ccc(-c2ccc(Cl)cc2)cc1,C23H19ClO3S,19258.0
6006,Pheleuin,CC(C)Cc1ncc(Cc2ccccc2)[nH]c1=O,C15H18N2O,19269.0
6007,.delta.9-THC-d3 (CRM),[2H]C([2H])([2H])CCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C21H30O2,19332.0
6008,?9-THC-d3 (CRM),[2H]C([2H])([2H])CCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C21H30O2,41210.0
6009,25H-NB4OMe (hydrochloride),COc1ccc(CNCCc2cc(OC)ccc2OC)cc1.Cl,C18H24ClNO3,19365.0
6010,Meperidine (hydrochloride) (CRM),CCOC(=O)C1(c2ccccc2)CCN(C)CC1.Cl,C15H22ClNO2,19406.0
6011,Meperidine (hydrochloride),CCOC(=O)C1(c2ccccc2)CCN(C)CC1.Cl,C15H22ClNO2,37982.0
6012,meta-Fluorofentanyl (hydrochloride),CCC(=O)N(c1cccc(F)c1)C1CCN(CCc2ccccc2)CC1.Cl,C22H28ClFN2O,19424.0
6013,meta-Fluorofentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1cccc(F)c1)C1CCN(CCc2ccccc2)CC1.Cl,C22H28ClFN2O,38142.0
6014,Bafilomycin D,CO/C1=C\C(C)=C\[C@@H](C)[C@@H](O)[C@@H](C)C/C(C)=C/C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)C(=O)/C=C/[C@H](C)[C@H](O)C(C)C)OC1=O,C35H56O8,19438.0
6015,Derquantel,CN1C(=O)[C@]23C[C@H]4C(C)(C)[C@]5(CNc6c5ccc5c6OC=CC(C)(C)O5)C[C@@]41CN2CC[C@@]3(C)O,C28H37N3O4,19441.0
6016,Ivermectin B1a aglycone,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C34H50O8,19442.0
6017,Ivermectin B1a monosaccharide,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C41H62O11,19443.0
6018,Kibdelone B,CCCc1c(Cl)c2c(c(=O)n1C)C(=O)C1=C(CCc3c1c(O)c1c(=O)c4c(oc1c3OC)[C@@H](O)C[C@H](O)[C@@H]4O)C2=O,C29H26ClNO10,19444.0
6019,O-Methylviridicatin,COc1c(-c2ccccc2)c2ccccc2[nH]c1=O,C16H13NO2,19446.0
6020,Phomopsin A,C=C(C)[C@@H]1NC(=O)[C@@H](NC)[C@@H](O)c2cc(Cl)c(O)c(c2)O[C@](C)(CC)[C@H](C(=O)N2CC=C[C@H]2C(=O)N/C(C(=O)N/C(=C/C(=O)O)C(=O)O)=C(\C)CC)NC1=O,C36H45ClN6O12,19448.0
6021,Piperafizine A,Cn1c(=O)/c(=C/c2ccccc2)[nH]c(=O)/c1=C/c1ccccc1,C19H16N2O2,19449.0
6022,RK-682 (calcium salt),CCCCCCCCCCCCCCCC(=O)C1=C([O-])[C@@H](CO)OC1=O.CCCCCCCCCCCCCCCC(=O)C1=C([O-])[C@@H](CO)OC1=O.[Ca+2],C42H70CaO10,19450.0
6023,"4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic Acid methyl ester",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC,C20H30O2,19472.0
6024,Phenibut (hydrochloride),Cl.NCC(CC(=O)O)c1ccccc1,C10H14ClNO2,9002652.0
6025,"4(Z),7(Z),10(Z),13(Z)-Hexadecatetraenoic Acid methyl ester",CC/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC,C17H26O2,9002661.0
6026,NSC 697923,Cc1ccc(S(=O)(=O)c2ccc([N+](=O)[O-])o2)cc1,C11H9NO5S,15346.0
6027,NSC 66811,Cc1ccc2ccc(C(Nc3ccccc3)c3ccccc3)c(O)c2n1,C23H20N2O,16431.0
6028,BI-9564,COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C,C20H23N3O3,17897.0
6029,4-EA-NBOMe (hydrochloride),CCc1ccc(CC(C)NCc2ccccc2OC)cc1.Cl,C19H26ClNO,18754.0
6030,Gardiquimod,CCNCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O,C17H23N5O,18877.0
6031,2-Acetylphenothiazine,CC(=O)c1ccc2c(c1)Nc1ccccc1S2,C14H11NOS,19056.0
6032,CD1530,O=C(O)c1ccc(-c2ccc3cc(O)c(C45CC6CC(CC(C6)C4)C5)cc3c2)cc1,C27H26O3,19062.0
6033,ONO-8130,Cc1csc(S(=O)(=O)N(CC(C)C)c2cc3c(cc2OCc2ccc(C(=O)O)cc2)CCC3)n1,C25H28N2O5S2,19118.0
6034,TY 52156,CC(C)(C)C(=O)/C(=N/c1ccc(Cl)cc1)NNc1ccc(Cl)cc1,C18H19Cl2N3O,19119.0
6035,NQTrp,O=C1C=C(N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)C(=O)c2ccccc21,C21H16N2O4,19127.0
6036,CAY10704,CN1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1,C18H20Cl2N2,19240.0
6037,Fenofibric Acid,CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O,C17H15ClO4,19262.0
6038,Butyryl fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)CCC)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C23H31ClN2O,19294.0
6039,Butyryl fentanyl-d5 (hydrochloride) (CRM),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)CCC)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C23H31ClN2O,19390.0
6040,MDMB-CHMCZCA,COC(=O)[C@@H](NC(=O)c1ccc2c(c1)c1ccccc1n2CC1CCCCC1)C(C)(C)C,C27H34N2O3,19295.0
6041,Acrylfentanyl (hydrochloride),C=CC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H27ClN2O,19312.0
6042,Acrylfentanyl (hydrochloride) (CRM),C=CC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H27ClN2O,23060.0
6043,FIBF (hydrochloride),CC(C)C(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H30ClFN2O,19313.0
6044,FIBF (hydrochloride) (CRM),CC(C)C(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H30ClFN2O,19795.0
6045,"4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic Acid",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C19H28O2,19471.0
6046,Ferulenol,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)c2ccccc2oc1=O,C24H30O3,19568.0
6047,Ganglioside GD1b (porcine) (sodium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]4(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[Na+].[Na+],C84H146N4Na2O39,19569.0
6048,CTPB,CCCCCCCCCCCCCCCc1cccc(OCC)c1C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1,C31H43ClF3NO2,19570.0
6049,DMNQ,COC1=C(OC)C(=O)c2ccccc2C1=O,C12H10O4,19571.0
6050,Psicofuranine,Nc1ncnc2c1ncn2[C@]1(CO)O[C@H](CO)[C@@H](O)[C@H]1O,C11H15N5O5,19574.0
6051,Podophyllotoxin,COc1cc(C2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,C22H22O8,19575.0
6052,Eupatilin,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(O)cc3o2)cc1OC,C18H16O7,19601.0
6053,BLZ-945,CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1,C20H22N4O3S,19626.0
6054,Cannabigerolic Acid,CCCCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1C(=O)O,C22H32O4,9001572.0
6055,Cannabigerolic Acid (CRM),CCCCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1C(=O)O,C22H32O4,20019.0
6056,Cannabigerolic Acid (Alt. Batch CRM),CCCCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1C(=O)O,C22H32O4,42523.0
6057,Hyperforin (dicyclohexylammonium salt),C1CCC(NC2CCCCC2)CC1.CC(C)=CCC[C@]1(C)[C@@H](CC=C(C)C)C[C@]2(CC=C(C)C)C(=O)C(CC=C(C)C)=C(O)[C@@]1(C(=O)C(C)C)C2=O,C47H75NO4,19572.0
6058,"1a,1b-dihomo Prostaglandin E2",CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCCCC(=O)O,C22H36O5,18665.0
6059,RB394,CCC(Cc1ccc(C(=O)NCc2ccc(OC)cc2C(F)(F)F)cc1)C(=O)O,C21H22F3NO4,18909.0
6060,DG-172 (hydrochloride),CN1CCN(c2ccc(/C=C(\C#N)c3ccccc3Br)cc2)CC1.Cl.Cl,C20H22BrCl2N3,19128.0
6061,NK 252,O=C(NCc1ccccn1)Nc1nnc(-c2ccco2)o1,C13H11N5O3,19131.0
6062,Biliverdin (hydrochloride),C=CC1=C(C)/C(=C/C2=N/C(=C\c3[nH]c(/C=C4\NC(=O)C(C)=C4C=C)c(C)c3CCC(=O)O)C(CCC(=O)O)=C2C)NC1=O.Cl,C33H35ClN4O6,19257.0
6063,Se-Aspirin,CC(=O)Oc1ccccc1C(=O)NCC[Se]C#N,C12H12N2O3Se,19315.0
6064,Naltrexone-d3 (CRM),[2H]C1(C([2H])([2H])N2CC[C@]34c5c6ccc(O)c5O[C@H]3C(=O)CC[C@@]4(O)[C@H]2C6)CC1,C20H23NO4,19323.0
6065,Naltrexone-d3,[2H]C1(C([2H])([2H])N2CC[C@]34c5c6ccc(O)c5O[C@H]3C(=O)CC[C@@]4(O)[C@H]2C6)CC1,C20H23NO4,18325.0
6066,AH 8533,CN(C)C1(CNC(=O)c2ccccc2Cl)CCCCC1,C16H23ClN2O,19336.0
6067,AH 8529,CN(C)C1(CNC(=O)c2ccc(Cl)cc2)CCCCC1,C16H23ClN2O,19368.0
6068,4-chloro Pentedrone (hydrochloride),CCCC(NC)C(=O)c1ccc(Cl)cc1.Cl,C12H17Cl2NO,19383.0
6069,4-chloro-N-Isopropylcathinone (hydrochloride),CC(C)NC(C)C(=O)c1ccc(Cl)cc1.Cl,C12H17Cl2NO,19392.0
6070,LDN-193189 (hydrochloride),Cl.Cl.c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1,C25H24Cl2N6,19396.0
6071,MeBIO,CN1C(=O)/C(=C2\Nc3ccccc3\C2=N/O)c2ccc(Br)cc21,C17H12BrN3O2,19573.0
6072,Cytostatin (sodium salt),C/C=C/C=C\C=C/[C@H](O)[C@H](C)[C@H](CC[C@H](C)[C@@H]1OC(=O)C=C[C@@H]1C)OP(=O)([O-])O.[Na+],C21H32NaO7P,19602.0
6073,Rubratoxin A,CCCCCC[C@@H](O)[C@@H]1C2=C(C[C@H]([C@H](O)[C@@H]3CC=CC(=O)O3)CC3=C(C(=O)OC3=O)[C@@H]1O)C(O)OC2=O,C26H32O11,19605.0
6074,Viridiol,CO[C@@H]1[C@H](O)c2coc3c2[C@@](C)(c2ccc4c(c2C3=O)CCC4=O)[C@@H]1O,C20H18O6,19607.0
6075,16-epi Latrunculin B,C/C1=C/C(=O)O[C@@H]2C[C@@H](CC[C@H](C)/C=C\CC1)O[C@@](O)([C@H]1CSC(=O)N1)C2,C20H29NO5S,19608.0
6076,Swinholide A,CO[C@H]1C[C@H](CC[C@H](C)[C@H](O)[C@H](C)C2OC(=O)/C=C/C(C)=C/C[C@H](O)C[C@@H]3C=CC[C@@H](C[C@H](OC)[C@@H](C)[C@@H](O)C[C@@H](O)[C@H](C)C([C@@H](C)[C@@H](O)[C@@H](C)CC[C@H]4C[C@H](OC)C[C@H](C)O4)OC(=O)/C=C/C(C)=C/C[C@H](O)C[C@@H]4C=CC[C@@H](C[C@H](OC)[C@@H](C)[C@@H](O)C[C@@H](O)[C@@H]2C)O4)O3)O[C@@H](C)C1,C78H132O20,19611.0
6077,Amorfrutin B,COc1cc(CCc2ccccc2)c(C(=O)O)c(O)c1C/C=C(\C)CCC=C(C)C,C26H32O4,19618.0
6078,7BIO,O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccccc2/C1=N\O,C16H10BrN3O2,19619.0
6079,Harzianopyridone,C/C=C/C[C@H](C)C(=O)c1c(O)c(OC)c(OC)[nH]c1=O,C14H19NO5,19620.0
6080,Iromycin A,CCCc1c(C/C=C(\C)C/C=C/C(C)C)[nH]c(=O)c(C)c1O,C19H29NO2,19621.0
6081,Asteltoxin,CC[C@H]1O[C@@H]2O[C@H](/C=C/C=C/C=C/c3oc(=O)cc(OC)c3C)[C@H](O)[C@]2(C)[C@@]1(C)O,C23H30O7,19622.0
6082,Bafilomycin C1,CO/C1=C\C(C)=C\[C@@H](C)[C@@H](O)[C@@H](C)C/C(C)=C/C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](OC(=O)/C=C/C(=O)O)[C@H](C)[C@@H](C(C)C)O2)OC1=O,C39H60O12,19625.0
6083,Abiraterone,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cccnc3)=CC[C@@H]12,C24H31NO,9002768.0
6084,PHPS1,O=C1/C(=N/Nc2ccc(S(=O)(=O)O)cc2)C(c2ccc([N+](=O)[O-])cc2)=NN1c1ccccc1,C21H15N5O6S,18856.0
6085,NPS 1034,Cc1c(C(=O)Nc2ccc(Oc3ccnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)n1C,C31H23F2N5O3,19627.0
6086,GS-9620,CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)CC(=O)N2,C22H30N6O2,19628.0
6087,MLN2480,C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1,C17H12Cl2F3N7O2S,19675.0
6088,SCH 58261,Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12,C18H15N7O,19676.0
6089,Salinosporamide A,C[C@@]12OC(=O)[C@]1([C@@H](O)[C@@H]1C=CCCC1)NC(=O)[C@@H]2CCCl,C15H20ClNO4,10007311.0
6090,Muraglitazar,COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccccc4)oc3C)cc2)cc1,C29H28N2O7,10007853.0
6091,Sodium Stibogluconate,O.O.O.O.O.O.O.O.O.O=C(O)[C@@H]1O[Sb](=O)(O[Sb]2(=O)O[C@H]([C@H](O)CO)[C@H](O)[C@H](C(=O)O)O2)O[C@H]([C@H](O)CO)[C@@H]1O.[NaH].[NaH].[NaH],C12H38Na3O26Sb2,16038.0
6092,Ephenidine (hydrochloride),CCNC(Cc1ccccc1)c1ccccc1.Cl,C16H20ClN,18327.0
6093,12-doxyl Stearic Acid,CCCCCCC1(CCCCCCCCCCC(=O)O)OCC(C)(C)N1[O],C22H42NO4,19259.0
6094,AZD 7545,CN(C)C(=O)c1ccc(S(=O)(=O)c2ccc(NC(=O)[C@@](C)(O)C(F)(F)F)c(Cl)c2)cc1,C19H18ClF3N2O5S,19282.0
6095,"3',4'-Methylenedioxy-N-isopropylaminocathinone (hydrochloride)",CC(C)NC(C)C(=O)c1ccc2c(c1)OCO2.Cl,C13H18ClNO3,19370.0
6096,"3,4-Methylenedioxy-N-propylcathinone (hydrochloride)",CCCNC(C)C(=O)c1ccc2c(c1)OCO2.Cl,C13H18ClNO3,19371.0
6097,W-19 (hydrochloride),Cl.Nc1ccc(CCN2CCCC/C2=N/S(=O)(=O)c2ccc(Cl)cc2)cc1,C19H23Cl2N3O2S,19484.0
6098,"1,7-Dimethyluric Acid",Cn1c(=O)[nH]c2[nH]c(=O)n(C)c2c1=O,C7H8N4O3,19584.0
6099,1-(Ethoxycarbonylmethyl)-6-methoxyquinolinium (bromide),CCOC(=O)C[n+]1cccc2cc(OC)ccc21.[Br-],C14H16BrNO3,19585.0
6100,MMP-2 Inhibitor I,CCCCCCCC/C=C\CCCCCCCC(=O)NO,C18H35NO2,19644.0
6101,Rocaglamide,COc1ccc([C@@]23Oc4cc(OC)cc(OC)c4[C@]2(O)[C@H](O)[C@H](C(=O)N(C)C)[C@H]3c2ccccc2)cc1,C29H31NO7,14841.0
6102,Madecassic Acid,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@]43C)[C@H]12,C30H48O6,11854.0
6103,GSK2193874,O=C(NC1(c2ccccc2)CC1)c1c(CN2CCC(N3CCCCC3)CC2)c(-c2cccc(C(F)(F)F)c2)nc2cc(Br)ccc12,C37H38BrF3N4O,17715.0
6104,SMER28,C=CCNc1ncnc2ccc(Br)cc12,C11H10BrN3,17768.0
6105,5-fluoro PY-PICA,O=C(c1cn(CCCCCF)c2ccccc12)N1CCCC1,C18H23FN2O,18363.0
6106,Desalkylflurazepam,O=C1CN=C(c2ccccc2F)c2cc(Cl)ccc2N1,C15H10ClFN2O,18484.0
6107,Desalkylflurazepam (CRM),O=C1CN=C(c2ccccc2F)c2cc(Cl)ccc2N1,C15H10ClFN2O,19698.0
6108,N-Desmethylclobazam,O=C1CC(=O)N(c2ccccc2)c2cc(Cl)ccc2N1,C15H11ClN2O2,18564.0
6109,N-Desmethylclobazam (CRM),O=C1CC(=O)N(c2ccccc2)c2cc(Cl)ccc2N1,C15H11ClN2O2,18888.0
6110,PTP Inhibitor III,O=C(O)COc1ccc(C(=O)CBr)cc1,C10H9BrO4,19059.0
6111,3PO,O=C(/C=C/c1cccnc1)c1ccncc1,C13H10N2O,19276.0
6112,ortho-Fluorofentanyl (hydrochloride),CCC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1.Cl,C22H28ClFN2O,19425.0
6113,ortho-Fluorofentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1.Cl,C22H28ClFN2O,38651.0
6114,Pleuromutilin,C=C[C@]1(C)C[C@@H](OC(=O)CO)C2(C)[C@H](C)CCC3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,C22H34O5,19452.0
6115,Florfenicol,CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)cc1,C12H14Cl2FNO4S,19458.0
6116,SR 0987,O=C(Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1)c1ccccc1Cl,C16H10ClF6NO2,19503.0
6117,Vinpocetine,CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32,C22H26N2O2,19578.0
6118,6-Methylsulfinylhexyl isothiocyanate,CS(=O)CCCCCCN=C=S,C8H15NOS2,19638.0
6119,Bepridil (hydrochloride),CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1.Cl,C24H35ClN2O,19645.0
6120,Juvenile Hormone III,COC(=O)/C=C(\C)CC/C=C(\C)CCC1OC1(C)C,C16H26O3,19646.0
6121,Cepharanthine,COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3c(cc4c(c3Oc3cc5c(cc3OC)CCN(C)[C@@H]5C2)OCO4)CCN1C,C37H38N2O6,19648.0
6122,"D,L-1'-Acetoxychavicol Acetate",C=CC(OC(C)=O)c1ccc(OC(C)=O)cc1,C13H14O4,19649.0
6123,Racanisodamine,CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C(O)C2,C17H23NO4,19650.0
6124,Dihydroresveratrol,Oc1ccc(CCc2cc(O)cc(O)c2)cc1,C14H14O3,19651.0
6125,Flavokawain B,COc1cc(O)c(C(=O)/C=C/c2ccccc2)c(OC)c1,C17H16O4,19652.0
6126,Flavokawain B (CRM),COc1cc(O)c(C(=O)/C=C/c2ccccc2)c(OC)c1,C17H16O4,41058.0
6127,Thienyldecyl isothiocyanate,S=C=NCCCCCCCCCCc1cccs1,C15H23NS2,19653.0
6128,"4(Z),7(Z),10(Z),13(Z)-Hexadecatetraenoic Acid",CC/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C16H24O2,9002202.0
6129,AZD 1152 (hydrochloride),CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)n[nH]3)ncnc2c1)CCOP(=O)(O)O.Cl.Cl,C26H33Cl2FN7O6P,13647.0
6130,Aureusimine B,CC(C)c1ncc(Cc2ccccc2)[nH]c1=O,C14H16N2O,18752.0
6131,BMX-IN-1,C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C,C29H24N4O4S,19165.0
6132,CBR-5884,CCOC(=O)c1sc(NC(=O)c2ccco2)c(SC#N)c1C,C14H12N2O4S2,19236.0
6133,Chlorcyclizine (hydrochloride),CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1.Cl,C18H22Cl2N2,19239.0
6134,DC260126,CCCCc1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1,C16H18FNO2S,19388.0
6135,Clarithromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,C38H69NO13,19455.0
6136,Zearalanone,C[C@H]1CCCC(=O)CCCCCc2cc(O)cc(O)c2C(=O)O1,C18H24O5,19459.0
6137,Griseofulvin,COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O,C17H17ClO6,19461.0
6138,Dirithromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O,C42H78N2O14,19466.0
6139,Doramectin,CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C6CCCCC6)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,C50H74O14,19467.0
6140,1-Methylhistamine (hydrochloride),Cl.Cl.Cn1cnc(CCN)c1,C6H13Cl2N3,19516.0
6141,4.beta.-hydroxy Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4[C@@H](O)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O2,19518.0
6142,Lanosterol,CC(C)=CCC[C@@H](C)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1CC3,C30H50O,19521.0
6143,Tie2 Inhibitor 7,Cc1ccc(OC(=O)N(CC(=O)N[C@@H](C)C2CCCCC2)Cc2ccc(-c3cncc(C(=O)O)c3)cc2)cc1,C31H35N3O5,19535.0
6144,Di-8-ANEPPS,CCCCCCCCN(CCCCCCCC)c1ccc2cc(/C=C/c3cc[n+](CCCS(=O)(=O)[O-])cc3)ccc2c1,C36H52N2O3S,19541.0
6145,Linopirdine,O=C1N(c2ccccc2)c2ccccc2C1(Cc1ccncc1)Cc1ccncc1,C26H21N3O,19547.0
6146,5-Carboxyfluorescein,O=C(O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21,C21H12O7,19581.0
6147,7-ethoxy-4-Methylcoumarin,CCOc1ccc2c(C)cc(=O)oc2c1,C12H12O3,19586.0
6148,4-Methylumbelliferyl Oleate,CCCCCCCC/C=C\CCCCCCCC(=O)Oc1ccc2c(C)cc(=O)oc2c1,C28H40O4,19590.0
6149,Argatroban,CC1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1,C23H36N6O5S,19639.0
6150,.beta.-Elemene,C=C[C@]1(C)CC[C@@H](C(=C)C)C[C@H]1C(=C)C,C15H24,19641.0
6151,Fenbendazole,COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1,C15H13N3O2S,19687.0
6152,Heptadecanoic Acid,CCCCCCCCCCCCCCCCC(=O)O,C17H34O2,19722.0
6153,Nonadecanoic Acid,CCCCCCCCCCCCCCCCCCC(=O)O,C19H38O2,19723.0
6154,14-Pentadecenoic Acid,C=CCCCCCCCCCCCCC(=O)O,C15H28O2,19724.0
6155,Tridecanoic Acid,CCCCCCCCCCCCC(=O)O,C13H26O2,19725.0
6156,Combretastatin A1,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)c(O)c1O,C18H20O6,19750.0
6157,Sinensetin,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1OC,C20H20O7,19751.0
6158,Malvidin (chloride),COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O)cc(OC)c1O.[Cl-],C17H15ClO7,19752.0
6159,Pelargonidin (chloride),Oc1ccc(-c2[o+]c3cc(O)cc(O)c3cc2O)cc1.[Cl-],C15H11ClO5,19753.0
6160,Peonidin (chloride),COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O)ccc1O.[Cl-],C16H13ClO6,19754.0
6161,Petunidin (chloride),COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O)cc(O)c1O.[Cl-],C16H13ClO7,19755.0
6162,Apigeninidin (chloride),Oc1ccc(-c2ccc3c(O)cc(O)cc3[o+]2)cc1.[Cl-],C15H11ClO4,19756.0
6163,7-methoxy Apigeninidin (chloride),COc1cc(O)c2ccc(-c3ccc(O)cc3)[o+]c2c1.[Cl-],C16H13ClO4,19757.0
6164,Jaceosidin,COc1cc(-c2cc(=O)c3c(O)c(OC)c(O)cc3o2)ccc1O,C17H14O7,19758.0
6165,Vanillic Acid 4-.beta.-D-glucopyranoside,COc1cc(C(=O)O)ccc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C14H18O9,19759.0
6166,Sakuranetin,COc1cc(O)c2c(c1)OC(c1ccc(O)cc1)CC2=O,C16H14O5,19761.0
6167,FUB-JWH 018-d5,[2H]c1c([2H])c([2H])c2c(c1[2H])c(C(=O)c1cccc3ccccc13)c([2H])n2Cc1ccc(F)cc1,C26H18FNO,9002630.0
6168,Mebroqualone,Cc1nc2ccccc2c(=O)n1-c1ccccc1Br,C15H11BrN2O,9002644.0
6169,Undecanoic Acid,CCCCCCCCCCC(=O)O,C11H22O2,19721.0
6170,Trigonelline (chloride),C[n+]1cccc(C(=O)O)c1.[Cl-],C7H8ClNO2,11904.0
6171,Galloflavin,O=c1oc2c(cc1O)oc(=O)c1cc(O)c(O)c(O)c12,C12H6O8,14846.0
6172,4-Nitrophenyl Phenylphosphonate,O=[N+]([O-])c1ccc(OP(=O)(O)c2ccccc2)cc1,C12H10NO5P,17436.0
6173,25B-NB3OMe (hydrochloride),COc1cccc(CNCCc2cc(OC)c(Br)cc2OC)c1.Cl,C18H23BrClNO3,19364.0
6174,25B-NB4OMe (hydrochloride),COc1ccc(CNCCc2cc(OC)c(Br)cc2OC)cc1.Cl,C18H23BrClNO3,19499.0
6175,Cyproheptadine (hydrochloride hydrate),CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1.CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1.Cl.Cl.O.O.O,C42H50Cl2N2O3,19551.0
6176,Sauchinone,C[C@@H]1[C@H]2c3cc4c(cc3O[C@@]35OCOC3=CC(=O)[C@H](C[C@H]1C)[C@@H]25)OCO4,C20H20O6,19577.0
6177,Tetramethylrhodamine isothiocyanate (mixed isomers),CN(C)c1ccc2c(-c3ccc(N=C=S)cc3C(=O)[O-])c3ccc(N(C)C)cc3[o+]c2c1.CN(C)c1ccc2c(-c3cccc(N=C=S)c3C(=O)[O-])c3ccc(N(C)C)cc3[o+]c2c1,C50H42N6O6S2,19593.0
6178,cis-10-Heptadecenoic Acid,CCCCCC/C=C\CCCCCCCCC(=O)O,C17H32O2,19748.0
6179,cis-10-Nonadecenoic Acid,CCCCCCCC/C=C\CCCCCCCCC(=O)O,C19H36O2,19749.0
6180,ETP-46464,CC(C)(C#N)c1ccc(N2C(=O)OCc3cnc4ccc(-c5cnc6ccccc6c5)cc4c32)cc1,C30H22N4O2,19809.0
6181,NSC 109555,C/C(=N\NC(=N)N)c1ccc(NC(=O)Nc2ccc(/C(C)=N/NC(=N)N)cc2)cc1.CS(=O)(=O)O.CS(=O)(=O)O,C21H32N10O7S2,19811.0
6182,RY785,COc1cccc(CC(C)C(=O)Nc2ccc3[nH]c(-c4cscn4)nc3c2)c1,C21H20N4O2S,19813.0
6183,HI TOPK 032,N#Cc1c2nc3ccccc3nc2n2ccc(NC(=O)c3cccs3)cc12,C20H11N5OS,19815.0
6184,LBQ657,C[C@H](C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O)C(=O)O,C22H25NO5,19829.0
6185,DFPM,S=C(c1ccc(-c2ccc(Cl)c(Cl)c2)o1)N1CCCCC1,C16H15Cl2NOS,19830.0
6186,ML-291,O=C(Nc1ccc(S(=O)(=O)N2CCC(Cl)CC2)cc1)c1ccc([N+](=O)[O-])o1,C16H16ClN3O6S,19831.0
6187,MIM1,Cc1cs/c(=N\C2CCCCC2)n1/N=C/c1ccc(O)c(O)c1O,C17H21N3O3S,19832.0
6188,KIN59,O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](COC(c2ccccc2)(c2ccccc2)c2ccccc2)[C@@H](O)[C@H]1O,C29H26N4O5,19833.0
6189,"9,10-Anthracenediyl-bis(methylene)dimalonic Acid",O=C(O)C(Cc1c2ccccc2c(CC(C(=O)O)C(=O)O)c2ccccc12)C(=O)O,C22H18O8,19580.0
6190,ICI 192605,O=C(O)CC/C=C\C[C@@H]1CO[C@H](c2ccccc2Cl)O[C@@H]1c1ccccc1O,C22H23ClO5,10135.0
6191,SC 26196,N#CC(CCCN1CCN(/N=C/c2cccnc2)CC1)(c1ccccc1)c1ccccc1,C27H29N5,1079.0
6192,SC-26196,N#CC(CCCN1CCN(/N=C/c2cccnc2)CC1)(c1ccccc1)c1ccccc1,C27H29N5,10792.0
6193,Aflatoxin G1,COc1cc2c(c3oc(=O)c4c(c13)CCOC4=O)[C@@H]1C=CO[C@@H]1O2,C17H12O7,11295.0
6194,Aflatoxin G2,COc1cc2c(c3oc(=O)c4c(c13)CCOC4=O)[C@@H]1CCO[C@@H]1O2,C17H14O7,11296.0
6195,AZD 8330,Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O,C16H17FIN3O4,11588.0
6196,MS 245 (oxalate),COc1ccc2c(c1)c(CCN(C)C)cn2S(=O)(=O)c1ccccc1.O=C(O)C(=O)O,C21H24N2O7S,11936.0
6197,VU0357017 (hydrochloride),CCOC(=O)N1CCC(NCCNC(=O)c2ccccc2C)CC1.Cl,C18H28ClN3O3,11939.0
6198,KW 3902,CCCn1c(=O)c2nc(C34CC5CC(CC3C5)C4)[nH]c2n(CCC)c1=O,C20H28N4O2,11940.0
6199,(-)-Huperzine A,C/C=C1\[C@H]2C=C(C)C[C@]1(N)c1ccc(=O)[nH]c1C2,C15H18N2O,14620.0
6200,para-Fluorobutyryl fentanyl-d7 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1,C23H30ClFN2O,19596.0
6201,para-Fluorobutyryl fentanyl-d7 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1,C23H30ClFN2O,19945.0
6202,Aliskiren (hemifumarate),COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.O=C(O)/C=C/C(=O)O,C64H110N6O16,19640.0
6203,Dehydroergosterol,CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)C3=CC[C@]12C,C28H42O,19709.0
6204,4-hydroxy-3-Methoxyphenylglycol (piperazine salt),C1CNCCN1.COc1cc(C(O)CO)ccc1O.COc1cc(C(O)CO)ccc1O,C22H34N2O8,19714.0
6205,BRD4884,Nc1ccc(-c2ccc(F)cc2)cc1NC(=O)C1CCOCC1,C18H19FN2O2,19834.0
6206,HAT Inhibitor II,O=C1/C(=C/c2ccc(O)c(Br)c2)CCC/C1=C\c1ccc(O)c(Br)c1,C20H16Br2O3,19835.0
6207,BRD6688,Nc1ccc(-c2ccncc2)cc1NC(=O)N1CCCC1,C16H18N4O,19836.0
6208,FIIN-2,C=CC(=O)Nc1ccc(CN2C(=O)N(c3cc(OC)cc(OC)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)cc1,C35H38N8O4,19837.0
6209,Quininib,Oc1ccccc1/C=C/c1ccc2ccccc2n1,C17H13NO,19838.0
6210,iKIX1,N#CCC(=O)NNC(=S)Nc1ccc(Cl)c(Cl)c1,C10H8Cl2N4OS,19839.0
6211,Etoricoxib,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,C18H15ClN2O2S,10091.0
6212,BAY 61-3606 (hydrochloride),COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC.Cl,C20H19ClN6O3,11423.0
6213,B-HT 933 (hydrochloride),CCN1CCc2nc(N)oc2CC1.Cl.Cl,C9H17Cl2N3O,11941.0
6214,SB 277011A (hydrochloride),Cl.Cl.N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,C28H32Cl2N4O,11982.0
6215,RD162,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,C22H16F4N4O2S,13039.0
6216,UMB-32,Cc1noc(C)c1-c1ccc(-c2nc3cnccn3c2NC(C)(C)C)cc1,C21H23N5O,17123.0
6217,Monoacetylphloroglucinol (hydrate),CC(=O)c1c(O)cc(O)cc1O.O,C8H10O5,19451.0
6218,MT-45-d11 (hydrochloride),Cl.Cl.[2H]C1([2H])C([2H])([2H])C([2H])([2H])C([2H])(N2CCN(C(Cc3ccccc3)c3ccccc3)CC2)C([2H])([2H])C1([2H])[2H],C24H34Cl2N2,19506.0
6219,MT-45-d11 (hydrochloride) (exempt preparation),Cl.Cl.[2H]C1([2H])C([2H])([2H])C([2H])([2H])C([2H])(N2CCN(C(Cc3ccccc3)c3ccccc3)CC2)C([2H])([2H])C1([2H])[2H],C24H34Cl2N2,36876.0
6220,"3',4'-Dihydroxyphenylacetone",CC(=O)Cc1ccc(O)c(O)c1,C9H10O3,19522.0
6221,.beta.-Hydroxythiofentanyl-d5 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])([2H])C(=O)N(c1ccccc1)C1CCN(CC(O)c2cccs2)CC1,C20H27ClN2O2S,19598.0
6222,?-Hydroxythiofentanyl-d5 (hydrochloride) (exempt preparation),Cl.[2H]C([2H])([2H])C([2H])([2H])C(=O)N(c1ccccc1)C1CCN(CC(O)c2cccs2)CC1,C20H27ClN2O2S,41302.0
6223,LG 100754,CCCOc1cc2c(cc1/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC2(C)C,C26H36O3,19647.0
6224,Cetirizine (hydrochloride),Cl.Cl.O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,C21H27Cl3N2O3,19686.0
6225,Tpl2 Kinase Inhibitor,N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1,C21H14ClFN6,19710.0
6226,2-Iodomelatonin,COc1ccc2[nH]c(I)c(CCNC(C)=O)c2c1,C13H15IN2O2,19711.0
6227,"3,5-DMA (hydrochloride)",COc1cc(CC(C)N)cc(OC)c1.Cl,C11H18ClNO2,19743.0
6228,"2,4-DMA (hydrochloride)",COc1ccc(CC(C)N)c(OC)c1.Cl,C11H18ClNO2,19746.0
6229,Riociguat,COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N,C20H19FN8O2,9000554.0
6230,Lavendustin A,O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O,C21H19NO6,10010268.0
6231,3-O-Methyl-N-acetyl-D-Glucosamine,COC1C(O)C(CO)OC(O)C1NC(C)=O,C9H17NO6,10011056.0
6232,Caspase-3 Inhibitor VII,CC(=O)OCCN1C(=O)c2c(C)nc3ccc(S(=O)(=O)N4CCOCC4)cc3c2C1=O,C20H21N3O7S,13306.0
6233,DASA-58,Nc1cccc(S(=O)(=O)N2CCCN(S(=O)(=O)c3ccc4c(c3)OCCO4)CC2)c1,C19H23N3O6S2,13941.0
6234,GW 803430,COc1cc(-n2cnc3cc(-c4ccc(Cl)cc4)sc3c2=O)ccc1OCCN1CCCC1,C25H24ClN3O3S,13948.0
6235,"3,4-DMA (hydrochloride)",COc1ccc(CC(C)N)cc1OC.Cl,C11H18ClNO2,14142.0
6236,B-HT 920 (hydrochloride),C=CCN1CCc2nc(N)sc2CC1.Cl.Cl,C10H17Cl2N3S,14177.0
6237,BAM 7,CCOc1ccccc1N/N=C1/C(=O)N(c2nc(-c3ccccc3)cs2)N=C1C,C21H19N5O2S,14566.0
6238,BAM7,CCOc1ccccc1N/N=C1/C(=O)N(c2nc(-c3ccccc3)cs2)N=C1C,C21H19N5O2S,14566.0
6239,QNZ 46,COc1ccc2nc(/C=C/c3cccc([N+](=O)[O-])c3)n(-c3ccc(C(=O)O)cc3)c(=O)c2c1,C24H17N3O6,14857.0
6240,AS-1892802,O=C(Nc1ccc(-c2ccncc2)cc1)N[C@H](CO)c1ccccc1,C20H19N3O2,14978.0
6241,UK 383367,NC(=O)c1noc([C@H](CCCC2CCCCC2)CC(=O)NO)n1,C15H24N4O4,15029.0
6242,VPS34-IN-1,CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccnc(Cl)c3)n2)c(CC2CC2)n1,C21H24ClN7O,17392.0
6243,MJN228,CN1CCN(C(=O)c2[nH]c3ccc([N+](=O)[O-])cc3c2-c2ccccc2)CC1,C20H20N4O3,18275.0
6244,Entrectinib,CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,C31H34F2N6O2,19476.0
6245,Arglabin,C=C1C(=O)O[C@@H]2[C@H]3C(C)=CC[C@@]34O[C@@]4(C)CC[C@@H]12,C15H18O3,19502.0
6246,N-(n-Butyl)deoxygalactonojirimycin,CCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO,C10H21NO4,19520.0
6247,4-Nitrophenyl .beta.-D-Cellotrioside,O=[N+]([O-])c1ccc(O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)cc1,C24H35NO18,19523.0
6248,4-Methylumbelliferyl 6-thio-Palmitate-.beta.-D-Glucopyranoside,CCCCCCCCCCCCCCCC(=O)SCC1O[C@@H](Oc2ccc3c(C)cc(=O)oc3c2)[C@H](O)[C@@H](O)[C@@H]1O,C32H48O8S,19524.0
6249,Niguldipine (hydrochloride),COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1.Cl,C36H40ClN3O6,19534.0
6250,Dehydro Aripiprazole (hydrochloride),Cl.O=c1ccc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,C23H26Cl3N3O2,19539.0
6251,ML-314,COc1cc2nc(C3CC3)nc(N3CCN(c4ccccc4OC)CC3)c2cc1OC,C24H28N4O3,19550.0
6252,(2S)-Octyl-.alpha.-hydroxyglutarate-d17,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])OC(=O)[C@@H](O)CCC(=O)O,C13H24O5,19695.0
6253,Inauhzin,CCC(Sc1nnc2c(n1)[nH]c1ccccc12)C(=O)N1c2ccccc2Sc2ccccc21,C25H19N5OS2,19771.0
6254,Tonabersat,CC(=O)c1ccc2c(c1)[C@H](NC(=O)c1ccc(F)c(Cl)c1)[C@H](O)C(C)(C)O2,C20H19ClFNO4,19796.0
6255,Actagardin,CC[C@H](C)[C@@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2NC(=O)CNC(=O)[C@@H]3CS[C@@H](C)[C@@H](NC(=O)[C@@H]4CSC[C@@H](N)C(=O)N[C@H](CO)C(=O)NCC(=O)N[C@@H](Cc5c[nH]c6ccccc56)C(=O)N[C@@H](C(C)C)C(=O)N4)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N3)[C@H](C)SC[C@H](NC1=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)CS(=O)[C@H]2C,C81H124N20O24S4,19940.0
6256,Anhydrochlortetracycline (hydrochloride),Cc1c2c(c(O)c3c(O)ccc(Cl)c13)C(=O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1C2.Cl,C22H22Cl2N2O7,19941.0
6257,Aureothricin,CCC(=O)Nc1c2sscc-2n(C)c1=O,C9H10N2O2S2,19942.0
6258,Chromanol 293B,CCS(=O)(=O)N(C)[C@H]1c2cc(C#N)ccc2OC(C)(C)[C@@H]1O,C15H20N2O4S,19993.0
6259,m-Iodobenzylguanidine (hemisulfate),N=C(N)NCc1cccc(I)c1.N=C(N)NCc1cccc(I)c1.O=S(=O)(O)O,C16H22I2N6O4S,19998.0
6260,SJ 172550,CCOc1cc(/C=C2\C(=O)N(c3ccccc3)N=C2C)cc(Cl)c1OCC(=O)OC,C22H21ClN2O5,19999.0
6261,N-Desethyl Vardenafil,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCNCC4)ccc3OCC)[nH]n12,C21H28N6O4S,9001800.0
6262,S-5751,CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccc(O)cc34)[C@@H]1C2,C25H31NO4S,10004030.0
6263,Glycyrrhizic Acid (ammonium salt),CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12.N,C42H65NO16,11847.0
6264,"CP 945,598 (hydrochloride)",CCNC1(C(N)=O)CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1.Cl,C25H26Cl3N7O,11955.0
6265,SU 5402,Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O,C17H16N2O3,13182.0
6266,Eltrombopag,CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\Nc1cccc(-c2cccc(C(=O)O)c2)c1O,C25H22N4O4,13247.0
6267,Voglibose,OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O,C10H21NO7,14179.0
6268,ANA 12,O=C(Nc1ccccc1C(=O)NC1CCCCNC1=O)c1cc2ccccc2s1,C22H21N3O3S,14309.0
6269,CMPDA,CC(C)S(=O)(=O)NCCc1ccc(CCNS(=O)(=O)C(C)C)cc1,C16H28N2O4S2,14626.0
6270,VUF 10460,CN1CCN(c2cc(-c3ccccc3)nc(N)n2)CC1,C15H19N5,14665.0
6271,NSC 405020,CCCC(C)NC(=O)c1ccc(Cl)c(Cl)c1,C12H15Cl2NO,14859.0
6272,S18986,O=S1(=O)N[C@H]2CCCN2c2ccccc21,C10H12N2O2S,14937.0
6273,SC-79,CCOC(=O)C1=C(N)Oc2ccc(Cl)cc2C1C(C#N)C(=O)OCC,C17H17ClN2O5,14972.0
6274,Ku-0060648,CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c(=O)cc(N5CCOCC5)oc34)c3sc4ccccc4c23)CC1,C33H34N4O4S,15344.0
6275,ON-01910 (sodium salt),COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)[O-])c2)c(OC)c1.[Na+],C21H24NNaO8S,15553.0
6276,BAY-60-6583,N#Cc1c(N)nc(SCC(N)=O)c(C#N)c1-c1ccc(OCC2CC2)cc1,C19H17N5O2S,17127.0
6277,STF-083010,O=S(=O)(/N=C/c1c(O)ccc2ccccc12)c1cccs1,C15H11NO3S2,17370.0
6278,A 66,Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1,C17H23N5O2S2,17382.0
6279,PD 168368,C[C@@](Cc1c[nH]c2ccccc12)(NC(=O)Nc1ccc([N+](=O)[O-])cc1)C(=O)NCC1(c2ccccn2)CCCCC1,C31H34N6O4,17920.0
6280,UNC2327,O=C(NCC(=O)N1CCCCC1)Nc1ccc2nnsc2c1,C14H17N5O2S,18122.0
6281,NBI 31772,O=C(O)c1cc2cc(O)c(O)cc2c(C(=O)c2ccc(O)c(O)c2)n1,C17H11NO7,19122.0
6282,BRD7552,CCOC(=O)c1ccc(NC(=O)O[C@H]2[C@H](OC(=O)Nc3ccc4c(c3)OCO4)[C@@H](OC(=O)Nc3ccc4c(c3)OCO4)[C@@H](OC)O[C@@H]2CO)cc1,C33H33N3O15,19143.0
6283,SB-334867,Cc1nc2ccc(NC(=O)Nc3ccnc4cccnc34)cc2o1,C17H13N5O2,19145.0
6284,SKF 38393 (hydrobromide),Br.Oc1cc2c(cc1O)C(c1ccccc1)CNCC2,C16H18BrNO2,19150.0
6285,EW-7197,Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1,C22H18FN7,19231.0
6286,Oxycodone-d6 (CRM),[2H]C([2H])([2H])Oc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C([2H])([2H])[2H])CC[C@]314,C18H21NO4,19249.0
6287,AH 8532,CN(C)C1(CNC(=O)c2cccc(Cl)c2)CCCCC1,C16H23ClN2O,19338.0
6288,Ceritinib,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,C28H36ClN5O3S,19374.0
6289,Lenvatinib,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,C21H19ClN4O4,19375.0
6290,AST-487,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,C26H30F3N7O2,19477.0
6291,"6-Formylindolo[3,2-b]carbazole",O=Cc1c2[nH]c3ccccc3c2cc2[nH]c3ccccc3c12,C19H12N2O,19529.0
6292,SI-2,C/C(=N\Nc1nc2ccccc2n1C)c1ccccn1,C15H15N5,19565.0
6293,para-Fluorofentanyl-d5 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])([2H])C(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1,C22H28ClFN2O,19597.0
6294,para-Fluorofentanyl-d5 (hydro-chloride) (CRM),Cl.[2H]C([2H])([2H])C([2H])([2H])C(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1,C22H28ClFN2O,19946.0
6295,Ocfentanil-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(CCN2CCC(N(C(=O)COC)c3ccccc3F)CC2)c([2H])c1[2H],C22H28ClFN2O2,19599.0
6296,Ocfentanil-d5 (hydrochloride) (CRM),Cl.[2H]c1c([2H])c([2H])c(CCN2CCC(N(C(=O)COC)c3ccccc3F)CC2)c([2H])c1[2H],C22H28ClFN2O2,19857.0
6297,NE 100,CCCN(CCC)CCc1ccc(OC)c(OCCc2ccccc2)c1.Cl,C23H34ClNO2,19642.0
6298,"L-748,337",CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccccc3)cc2)c1,C26H31N3O5S,19643.0
6299,Birinapant,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c(-c2[nH]c3cc(F)ccc3c2C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)[nH]c2cc(F)ccc12,C42H56F2N8O6,19699.0
6300,Bizine,NNCCc1ccc(NC(=O)CCCc2ccccc2)cc1,C18H23N3O,19705.0
6301,"4-Methylumbelliferyl-.beta.-D-N,N',N''-Triacetylchitotrioside",CC(=O)N[C@H]1[C@H](Oc2ccc3c(C)cc(=O)oc3c2)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3NC(C)=O)[C@H](O)[C@H]2NC(C)=O)[C@@H]1O,C34H47N3O18,19715.0
6302,PTP Inhibitor I,O=C(CBr)c1ccc(O)cc1,C8H7BrO2,19766.0
6303,BMN-673,Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,C19H14F2N6O,19782.0
6304,Fluorenol,OC1c2ccccc2-c2ccccc21,C13H10O,19799.0
6305,7-hydroxy Coumarin Glucuronide (sodium salt),O=C([O-])[C@H]1O[C@@H](Oc2ccc3ccc(=O)oc3c2)[C@H](O)[C@@H](O)[C@@H]1O.[Na+],C15H13NaO9,19882.0
6306,Lornoxicam,CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O,C13H10ClN3O4S2,70220.0
6307,WH-4-023,COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c(OC)c1,C32H36N6O4,9002067.0
6308,Naringenin-7-O-.beta.-D-Glucuronide,O=C1CC(c2ccc(O)cc2)Oc2cc(O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c21,C21H20O11,10388.0
6309,Acarbose,C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]([C@H](O)[C@@H](O)C=O)[C@H](O)CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,C25H43NO18,11885.0
6310,WAY-208466 (hydrochloride),CN(C)CCn1cc(S(=O)(=O)c2cccc(F)c2)c2cccnc21.Cl.Cl,C17H20Cl2FN3O2S,11938.0
6311,trans-Resveratrol-4'-O-D-Glucuronide,O=C(O)[C@H]1O[C@@H](Oc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)[C@H](O)[C@@H](O)[C@@H]1O,C20H20O9,13833.0
6312,Aldosterone,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12,C21H28O5,15273.0
6313,MitoP,Oc1cccc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],C25H22BrOP,17117.0
6314,Glutaminase Inhibitor Compound 968,CN(C)c1ccc(C2Nc3ccc4ccccc4c3C3=C2C(=O)CC(C)(C)C3)cc1Br,C27H27BrN2O,17199.0
6315,GSK2269557,CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1.Cl,C26H29ClN6O,17388.0
6316,"5,3-AB-CHMFUPPYCA",CC(C)[C@H](NC(=O)c1cc(-c2ccc(F)cc2)n(CC2CCCCC2)n1)C(N)=O,C22H29FN4O2,18296.0
6317,Ribocil,CNc1ncc(CN2CCCC(c3nc(O)cc(-c4cccs4)n3)C2)cn1,C19H22N6OS,18487.0
6318,"5-fluoro-3,5-ADB-PFUPPYCA",CC(C)(C)C(NC(=O)c1cc(-c2ccc(F)cc2)nn1CCCCCF)C(N)=O,C21H28F2N4O2,18530.0
6319,5-chloro THJ 018,O=C(c1cccc2ccccc12)c1nn(CCCCCCl)c2ccccc12,C23H21ClN2O,18581.0
6320,N-Formylamphetamine,CC(Cc1ccccc1)NC=O,C10H13NO,18597.0
6321,N-Formylamphetamine (CRM),CC(Cc1ccccc1)NC=O,C10H13NO,19208.0
6322,"3,4-DMA-NBOMe (hydrochloride)",COc1ccccc1CNC(C)Cc1ccc(OC)c(OC)c1.Cl,C19H26ClNO3,18753.0
6323,AB-BICA,CC(C)[C@H](NC(=O)c1cn(Cc2ccccc2)c2ccccc12)C(N)=O,C21H23N3O2,18759.0
6324,BAW 2881,Nc1nccc(Oc2ccc3c(C(=O)Nc4cccc(C(F)(F)F)c4)cccc3c2)n1,C22H15F3N4O2,18910.0
6325,Xanthurenic Acid,O=C(O)c1cc(O)c2cccc(O)c2n1,C10H7NO4,19191.0
6326,MDBP (hydrochloride),Cl.Cl.c1cc2c(cc1CN1CCNCC1)OCO2,C12H18Cl2N2O2,19215.0
6327,Isobutyryl fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)C(C)C)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C23H31ClN2O,19242.0
6328,Isobutyryl fentanyl-d5 (hydrochloride) (exempt preparation),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)C(C)C)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C23H31ClN2O,36633.0
6329,MI-136,N#Cc1cc2cc(CN3CCC(Nc4ncnc5sc(CC(F)(F)F)cc45)CC3)ccc2[nH]1,C23H21F3N6S,19245.0
6330,YLF-466D,O=C(O)c1cccc(CN2C(=O)/C(=C(\c3ccccc3)c3ccc(Cl)cc3)c3ccccc32)c1,C29H20ClNO3,19475.0
6331,4-Methylumbelliferyl .alpha.-L-iduronide (free acid),Cc1cc(=O)oc2cc(O[C@@H]3O[C@@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)ccc12,C16H16O9,19543.0
6332,.alpha.-D-Galactopyranosylphenyl isothiocyanate,OC[C@H]1O[C@H](Oc2ccc(N=C=S)cc2)[C@H](O)[C@@H](O)[C@H]1O,C13H15NO6S,19544.0
6333,Cobimetinib,O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1,C21H21F3IN3O2,19563.0
6334,meta-Fluorobutyryl fentanyl (hydrochloride),CCCC(=O)N(c1cccc(F)c1)C1CCN(CCc2ccccc2)CC1.Cl,C23H30ClFN2O,19566.0
6335,meta-Fluorobutyryl fentanyl (hydrochloride) (exempt preparation),CCCC(=O)N(c1cccc(F)c1)C1CCN(CCc2ccccc2)CC1.Cl,C23H30ClFN2O,39595.0
6336,5(6)-Carboxyfluorescein diacetate,CC(=O)Oc1ccc2c(c1)Oc1cc(OC(C)=O)ccc1C21OC(=O)c2cc(C(=O)O)ccc21.CC(=O)Oc1ccc2c(c1)Oc1cc(OC(C)=O)ccc1C21OC(=O)c2ccc(C(=O)O)cc21,C50H32O18,19582.0
6337,"(E,Z) 2-Propyl-2-pentenoic Acid",CC/C=C(/CCC)C(=O)O,C8H14O2,19591.0
6338,Acetyl fentanyl 4-methylphenethyl analog-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(C)=O)C2CCN(CCc3ccc(C)cc3)CC2)c([2H])c1[2H],C22H29ClN2O,19594.0
6339,4'-methyl Acetyl fentanyl-d5 (hydrochloride) (exempt preparation),Cl.[2H]c1c([2H])c([2H])c(N(C(C)=O)C2CCN(CCc3ccc(C)cc3)CC2)c([2H])c1[2H],C22H29ClN2O,35276.0
6340,Tolvaptan,Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1,C26H25ClN2O3,19691.0
6341,ADB-BICA,CC(C)(C)C(NC(=O)c1cn(Cc2ccccc2)c2ccccc12)C(N)=O,C22H25N3O2,19729.0
6342,5-fluoro BEPIRAPIM (hydrochloride),Cl.O=C(c1cn(CCCCCF)c2ccccc12)N1CCN(Cc2ccccc2)CC1,C25H31ClFN3O,19730.0
6343,"2,6-DMA (hydrochloride)",COc1cccc(OC)c1CC(C)N.Cl,C11H18ClNO2,19745.0
6344,Benzbromarone,CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,C17H12Br2O3,19768.0
6345,Aztreonam,C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O,C13H17N5O8S2,19784.0
6346,Ginkgolide C,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@@H]5OC(=O)[C@]3(O[C@@H]3OC(=O)[C@H](O)C34[C@H](C(C)(C)C)[C@H]5O)[C@@]12O,C20H24O11,19872.0
6347,INCB024360,NS(=O)(=O)NCCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1,C11H13BrFN7O4S,19875.0
6348,5-hydroxy Propranolol,CC(C)NCC(O)COc1cccc2c(O)cccc12,C16H21NO3,19880.0
6349,AG-120,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,C28H22ClF3N6O3,19894.0
6350,AZ 6102,Cc1cc(N2C[C@@H](C)N[C@@H](C)C2)ncc1-c1ccc(-c2nc(=O)c3ccn(C)c3[nH]2)cc1,C25H28N6O,19898.0
6351,Acalabrutinib,CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,C26H23N7O2,19899.0
6352,ON-123300,CN1CCN(c2ccc(Nc3ncc4cc(C#N)c(=O)n(C5CCCC5)c4n3)cc2)CC1,C24H27N7O,19902.0
6353,Uprosertib,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl,C18H16Cl2F2N4O2,19904.0
6354,AZD 3965,Cc1[nH]nc(C(F)(F)F)c1Cc1sc2c(c1C(=O)N1C[C@](C)(O)CO1)c(=O)n(C)c(=O)n2C(C)C,C21H24F3N5O5S,19912.0
6355,LJH685,CN1CCN(c2ccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)cc2)CC1,C22H21F2N3O,19913.0
6356,Daprodustat,O=C(O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O,C19H27N3O6,19915.0
6357,CC-223,CO[C@H]1CC[C@H](N2C(=O)CN=C3NC=C(c4ccc(C(C)(C)O)nc4)N=C32)CC1,C21H27N5O3,19917.0
6358,GNF-7,Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1,C28H24F3N7O2,19918.0
6359,NSC59984,CN1CCN(C(=O)/C=C/c2ccc([N+](=O)[O-])o2)CC1,C12H15N3O4,19919.0
6360,Radotinib,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cnccn5)n4)c3)cc(C(F)(F)F)c2)cn1,C27H21F3N8O,19923.0
6361,LJI308,Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F,C21H18F2N2O2,19924.0
6362,NVP-TNKS656,COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc(=O)c4c([nH]3)CCOC4)CC3CC3)CC2)cc1,C27H34N4O5,19930.0
6363,TCS ERK 11e,Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1,C24H20Cl2FN5O2,19932.0
6364,3-hydroxy Palmitic Acid,CCCCCCCCCCCCCC(O)CC(=O)O,C16H32O3,19934.0
6365,4-chloro-N-Butylcathinone (hydrochloride),CCCCNC(C)C(=O)c1ccc(Cl)cc1.Cl,C13H19Cl2NO,19972.0
6366,.alpha.-Isopropylaminopentiophenone (hydrochloride),CCCC(NC(C)C)C(=O)c1ccccc1.Cl,C14H22ClNO,20021.0
6367,HG-10-102-01,CNc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)ncc1Cl,C17H20ClN5O3,20049.0
6368,Pixantrone (maleate),NCCNc1ccc(NCCN)c2c1C(=O)c1ccncc1C2=O.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,C25H27N5O10,20055.0
6369,INCB 28060,CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F,C23H17FN6O,20056.0
6370,A-804598,C[C@H](N/C(=N\c1cccc2ncccc12)NC#N)c1ccccc1,C19H17N5,20060.0
6371,Phenacetin,CCOc1ccc(NC(C)=O)cc1,C10H13NO2,20082.0
6372,Despropionyl para-Fluorofentanyl,Fc1ccc(NC2CCN(CCc3ccccc3)CC2)cc1,C19H23FN2,20104.0
6373,Despropionyl para-Fluorofentanyl (CRM),Fc1ccc(NC2CCN(CCc3ccccc3)CC2)cc1,C19H23FN2,26428.0
6374,SGI-7079,Cc1c[nH]c2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc(-c3cccc(CC#N)c3)c12,C26H26FN7,20111.0
6375,ML-281,CC(C)c1ccc(NC(=O)c2cccs2)c(-c2nc3ccccc3[nH]c2=O)c1,C22H19N3O2S,20116.0
6376,NSC 12,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(O)CC(O)(C(F)(F)F)C(F)(F)F,C24H34F6O3,20117.0
6377,K-Ras(G12C) Inhibitor 12,C=CC(=O)N1CCN(C(=O)CNc2cc(I)c(Cl)cc2O)CC1,C15H17ClIN3O3,20118.0
6378,Chlorisondamine (iodide),C[N+](C)(C)CC[N+]1(C)Cc2c(Cl)c(Cl)c(Cl)c(Cl)c2C1.[I-].[I-],C14H20Cl4I2N2,20119.0
6379,CGP 54626 (hydrochloride),C[C@H](NC[C@H](O)CP(=O)(O)CC1CCCCC1)c1ccc(Cl)c(Cl)c1.Cl,C18H29Cl3NO3P,20121.0
6380,FPL-64176,COC(=O)c1c(C)[nH]c(C)c1C(=O)c1ccccc1Cc1ccccc1,C22H21NO3,20122.0
6381,Asukamycin,O=C(/C=C/C=C/C=C/C1CCCCC1)NC1=C[C@@](O)(/C=C/C=C/C=C/C(=O)NC2=C(O)CCC2=O)[C@@H]2O[C@@H]2C1=O,C31H34N2O7,20133.0
6382,Cinnamycin,CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H]3CCCN3C(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H]3CNCCCC[C@@H](C(=O)O)NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H]([C@@H](O)C(=O)O)NC(=O)[C@H](CSC[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS[C@H]4C)C(=O)N[C@@H](CS[C@H]2C)C(=O)N3)NC1=O,C89H125N25O25S3,20136.0
6383,Kazusamycin A,CCC(=C/[C@H](C)C/C=C/C(C)=C/[C@@H](CO)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C/C(C)=C/C(=O)O)/C=C/[C@@H]1OC(=O)C=C[C@@H]1C,C33H48O7,20137.0
6384,Pirlimycin,CC[C@@H]1CCN[C@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)C1,C17H31ClN2O5S,20138.0
6385,UK 1,COC(=O)c1cccc2oc(-c3cccc4oc(-c5ccccc5O)nc34)nc12,C22H14N2O5,20139.0
6386,Valnemulin,C=C[C@]1(C)C[C@@H](OC(=O)CSC(C)(C)CNC(=O)[C@H](N)C(C)C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,C31H52N2O5S,20141.0
6387,Ochratoxin C,CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(Cl)c2c(c1O)C(=O)O[C@H](C)C2,C22H22ClNO6,20183.0
6388,Oligomycin D,CC[C@H]1/C=C/C=C/C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)O[C@H]2C[C@@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)O[C@@H](CC1)[C@H]2C,C44H72O11,20184.0
6389,Oligomycin E,CC[C@H]1/C=C/C=C/C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)O[C@@H]2[C@H](C)[C@H](CC1)O[C@@]1(O[C@@H](C[C@@H](C)O)[C@@H](C)CC1=O)[C@]2(C)O,C45H72O13,20185.0
6390,Ophiobolin C,CC(C)=CCC[C@H](C)[C@H]1CC[C@]2(C)C[C@H]3[C@H](C(=O)C[C@@]3(C)O)/C(C=O)=C\C[C@@H]12,C25H38O3,20186.0
6391,Teicoplanin A2-1,CCCCC/C=C\CCC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O,C88H95Cl2N9O33,20187.0
6392,Teicoplanin A2-5,CC(=O)N[C@H]1[C@H](O[C@@H]2c3ccc(c(Cl)c3)Oc3cc4cc(c3O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCC(C)C)Oc3ccc(cc3Cl)C[C@H]3NC(=O)[C@H](N)c5ccc(O)c(c5)Oc5cc(O)cc(c5)[C@H](NC3=O)C(=O)N[C@H]4C(=O)N[C@H]3C(=O)N[C@@H]2C(=O)N[C@H](C(=O)O)c2cc(O)cc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c2-c2cc3ccc2O)O[C@H](CO)[C@@H](O)[C@@H]1O,C89H99Cl2N9O33,20192.0
6393,Teicoplanin A3-1,CC(=O)N[C@H]1[C@H](O[C@@H]2c3ccc(c(Cl)c3)Oc3cc4cc(c3O)Oc3ccc(cc3Cl)C[C@H]3NC(=O)[C@H](N)c5ccc(O)c(c5)Oc5cc(O)cc(c5)[C@H](NC3=O)C(=O)N[C@H]4C(=O)N[C@H]3C(=O)N[C@@H]2C(=O)N[C@H](C(=O)O)c2cc(O)cc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c2-c2cc3ccc2O)O[C@H](CO)[C@@H](O)[C@@H]1O,C72H68Cl2N8O28,20193.0
6394,Cannabidivarin,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCC)cc1O,C19H26O2,9001574.0
6395,Cannabidivarin (CRM),C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCC)cc1O,C19H26O2,20165.0
6396,Cannabidivarin (Alt. Batch CRM),C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCC)cc1O,C19H26O2,42628.0
6397,THZ1,CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1,C31H28ClN7O2,9002215.0
6398,11-keto Testosterone-d3,[2H]C1([2H])C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1([2H])O,C19H26O3,9002754.0
6399,5.alpha.-dihydro-11-keto Testosterone-d3,[2H]C1([2H])C[C@H]2[C@@H]3CC[C@H]4CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1([2H])O,C19H28O3,9002761.0
6400,Bavachin,CC(C)=CCc1cc2c(cc1O)O[C@H](c1ccc(O)cc1)CC2=O,C20H20O4,11685.0
6401,AB-FUBINACA metabolite 3,CC(C)[C@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(=O)O,C20H20FN3O3,17761.0
6402,AB-FUBINACA metabolite 3 (CRM),CC(C)[C@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(=O)O,C20H20FN3O3,17771.0
6403,Esculetin,O=c1ccc2cc(O)c(O)cc2o1,C9H6O4,19286.0
6404,ortho-Fluorobutyryl fentanyl (hydrochloride),CCCC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1.Cl,C23H30ClFN2O,19567.0
6405,ortho-Fluorobutyryl fentanyl (hydrochloride) (exempt preparation),CCCC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1.Cl,C23H30ClFN2O,39596.0
6406,NCT-502,Cc1cc(C)nc(NC(=S)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c1,C18H20F3N5S,19716.0
6407,NCT-503,Cc1cc(C)nc(NC(=S)N2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)c1,C20H23F3N4S,19718.0
6408,Tiletamine (hydrochloride),CCNC1(c2cccs2)CCCCC1=O.Cl,C12H18ClNOS,19794.0
6409,Diosgenin,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C27H42O3,19847.0
6410,Deoxyschizandrin,COc1cc2c(c(OC)c1OC)-c1c(cc(OC)c(OC)c1OC)C[C@H](C)[C@H](C)C2,C24H32O6,19849.0
6411,Paeoniflorin,C[C@@]12C[C@@]3(O)O[C@@H](O1)[C@]1(COC(=O)c4ccccc4)[C@H]3C[C@@]12O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C23H28O11,19861.0
6412,Paeonol,COc1ccc(C(C)=O)c(O)c1,C9H10O3,19862.0
6413,Procyanidin B2,Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@H](O)[C@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,C30H26O12,19865.0
6414,Rhapontin,COc1ccc(/C=C/c2cc(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c2)cc1O,C21H24O9,19867.0
6415,Rutin (hydrate),C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O.O.O.O,C27H36O19,19868.0
6416,Chrysophanol,Cc1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O,C15H10O4,19870.0
6417,Isobavachalcone,CC(C)=CCc1c(O)ccc(C(=O)/C=C/c2ccc(O)cc2)c1O,C20H20O4,19873.0
6418,Benzyl fentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1.Cl,C21H27ClN2O,19883.0
6419,Benzyl fentanyl (hydrochloride) (CRM),CCC(=O)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1.Cl,C21H27ClN2O,25936.0
6420,MDMB-FUBINACA metabolite M1,CC(C)(C)[C@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(=O)O,C21H22FN3O3,20061.0
6421,Benzocaine,CCOC(=O)c1ccc(N)cc1,C9H11NO2,20132.0
6422,Teicoplanin A2-3,CCCCCCCCCC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O,C88H97Cl2N9O33,20188.0
6423,Teicoplanin A2-4,CCC(C)CCCCCCC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O,C89H99Cl2N9O33,20189.0
6424,5.alpha.-dihydro-11-keto Testosterone,C[C@]12CCC(=O)C[C@@H]1CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC(=O)[C@@H]12,C19H28O3,20200.0
6425,1-(4-Fluorophenyl)-2-methyl-2-propylamine,CC(C)(N)Cc1ccc(F)cc1,C10H14FN,9002780.0
6426,HA130,O=C1S/C(=C\c2ccc(OCc3cccc(B(O)O)c3)cc2)C(=O)N1Cc1ccc(F)cc1,C24H19BFNO5S,10498.0
6427,CCG-50014,Cc1ccc(-n2sc(=O)n(Cc3ccc(F)cc3)c2=O)cc1,C16H13FN2O2S,10802.0
6428,L-Mimosine,N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O,C8H10N2O4,14337.0
6429,Alprazolam-d5 (CRM),[2H]c1c([2H])c([2H])c(C2=NCc3nnc(C)n3-c3ccc(Cl)cc32)c([2H])c1[2H],C17H13ClN4,18347.0
6430,Methsuximide,CN1C(=O)CC(C)(c2ccccc2)C1=O,C12H13NO2,19058.0
6431,"N,N-DET (hydrochloride)",CCN(CC)CCc1c[nH]c2ccccc12.Cl,C14H21ClN2,19108.0
6432,"N,N-DET (hydrochloride) (exempt preparation)",CCN(CC)CCc1c[nH]c2ccccc12.Cl,C14H21ClN2,22877.0
6433,CPI-360,COc1cc(C)[nH]c(=O)c1CNC(=O)c1c(C)n([C@H](C)C2CCOCC2)c2ccccc12,C25H31N3O4,19125.0
6434,GSK621,COc1cccc(-n2c(=O)[nH]c3cc(Cl)n(-c4ccc(-c5cccc(OC)c5O)cc4)c3c2=O)c1,C26H20ClN3O5,19155.0
6435,MPS1-IN-1,COc1cc(N2CCC(O)CC2)ccc1Nc1cc(Nc2ccccc2S(=O)(=O)C(C)C)c2cc[nH]c2n1,C28H33N5O4S,19175.0
6436,Rolicyclidine (hydrochloride),Cl.c1ccc(C2(N3CCCC3)CCCCC2)cc1,C16H24ClN,19263.0
6437,Fluorescein-5-thiosemicarbazide,NNC(=S)Nc1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21,C21H15N3O5S,19587.0
6438,4-methoxy-Butyryl fentanyl-d7 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)N(c1ccc(OC)cc1)C1CCN(CCc2ccccc2)CC1,C24H33ClN2O2,19595.0
6439,para-methoxy-Butyryl fentanyl-d7 (hydrochloride) (exempt preparation),Cl.[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)N(c1ccc(OC)cc1)C1CCN(CCc2ccccc2)CC1,C24H33ClN2O2,36588.0
6440,Valeryl fentanyl,CCCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H32N2O,19629.0
6441,Valeryl fentanyl (CRM),CCCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H32N2O,19798.0
6442,Valeryl fentanyl-d5,[2H]c1c([2H])c([2H])c(N(C(=O)CCCC)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C24H32N2O,19631.0
6443,Valeryl fentanyl-d5 (CRM),[2H]c1c([2H])c([2H])c(N(C(=O)CCCC)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C24H32N2O,19925.0
6444,(S)-p38 MAPK Inhibitor III,CSc1nc(-c2ccnc(N[C@@H](C)c3ccccc3)c2)c(-c2ccc(F)cc2)[nH]1,C23H21FN4S,19696.0
6445,PHGDH-inactive,Cc1cc(C)nc(NC(=S)N2CCN(c3ccncc3)CC2)c1,C17H21N5S,19717.0
6446,GSK583,CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1,C20H19FN4O2S,19739.0
6447,Melperone (hydrochloride),CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1.Cl,C16H23ClFNO,19770.0
6448,Tephrosin (synthetic),COc1cc2c(cc1OC)[C@]1(O)C(=O)c3ccc4c(c3O[C@@H]1CO2)C=CC(C)(C)O4,C23H22O7,19840.0
6449,SEA0400,CCOc1ccc(Oc2ccc(OCc3cc(F)ccc3F)cc2)c(N)c1,C21H19F2NO3,19876.0
6450,CeMMEC1,Cn1cc(C(=O)Nc2ccc3c(c2)OCCO3)c2ccccc2c1=O,C19H16N2O4,19956.0
6451,Methamnetamine (hydrochloride),CNC(C)Cc1ccc2ccccc2c1.Cl,C14H18ClN,20008.0
6452,para-Methoxyfentanyl (hydrochloride),CCC(=O)N(c1ccc(OC)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O2,20035.0
6453,para-Methoxyfentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1ccc(OC)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O2,39315.0
6454,Lidocaine,CCN(CC)CC(=O)Nc1c(C)cccc1C,C14H22N2O,20081.0
6455,Methylsulfonylmethane,CS(C)(=O)=O,C2H6O2S,20131.0
6456,AB-FUBINACA metabolite 4,O=C(O)c1nn(Cc2ccc(F)cc2)c2ccccc12,C15H11FN2O2,20179.0
6457,Trichostatin C,CC(/C=C/C(=O)NO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)=C\[C@@H](C)C(=O)c1ccc(N(C)C)cc1,C23H32N2O8,20220.0
6458,UCN-02,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,C28H26N4O4,20221.0
6459,CeMMEC13,Cn1c(=O)cc(C(=O)Nc2ccc3c(c2)OCCO3)c2ccccc21,C19H16N2O4,20224.0
6460,A 83-01,Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccnc3ccccc23)n1,C25H19N5S,9001799.0
6461,RK-33,COc1ccc(Cn2c3ncnc4c(ncn4Cc4ccc(OC)cc4)c-3nc2=O)cc1,C23H20N6O3,20312.0
6462,GSK2881078,C[C@H](CS(C)(=O)=O)n1ccc2c(C(F)(F)F)c(C#N)ccc21,C14H13F3N2O2S,20313.0
6463,Delafloxacin,Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F,C18H12ClF3N4O4,20314.0
6464,21-desacetyl Deflazacort,CC1=N[C@]2(C(=O)CO)[C@@H](C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@@]32C)O1,C23H29NO5,20316.0
6465,Cerivastatin (sodium salt),COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])c1-c1ccc(F)cc1.[Na+],C26H33FNNaO5,20362.0
6466,"1,2,3-Tri-?-Linolenoyl Glycerol",CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC,C57H92O6,10009758.0
6467,"1,2,3-Triarachidonoyl Glycerol",CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC,C63H98O6,10009826.0
6468,HA 14-1,CCOC(=O)C1=C(N)Oc2ccc(Br)cc2C1C(C#N)C(=O)OCC,C17H17BrN2O5,14876.0
6469,Tetrahydrouridine,O=C1NC(O)CCN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C9H16N2O6,16402.0
6470,GDC 0032,Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1,C24H28N8O2,17387.0
6471,MDMB-FUBICA,COC(=O)[C@@H](NC(=O)c1cn(Cc2ccc(F)cc2)c2ccccc12)C(C)(C)C,C23H25FN2O3,18364.0
6472,CCT251545,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,C23H24ClN5O,18761.0
6473,CAY10711,S=C(NCCCNCCCCCNCCCNC(=S)NCC(c1ccccc1)c1ccccc1)NCC(c1ccccc1)c1ccccc1,C41H54N6S2,19473.0
6474,AP-III-a4,NCCOCCOCCNC(=O)Cc1ccc(Nc2nc(NCc3ccc(F)cc3)nc(NCC3CCCCC3)n2)cc1,C31H43FN8O3,19933.0
6475,10-PAHSA,CCCCCCCCCCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCCC(=O)O,C34H66O4,19973.0
6476,10-OAHSA,CCCCCCCC/C=C\CCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCCC(=O)O,C36H68O4,19975.0
6477,10-SAHSA,CCCCCCCCCCCCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCCC(=O)O,C36H70O4,19976.0
6478,PCI 24781,CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12,C21H23N3O5,20059.0
6479,MMB-FUBICA,COC(=O)[C@@H](NC(=O)c1cn(Cc2ccc(F)cc2)c2ccccc12)C(C)C,C22H23FN2O3,20182.0
6480,Rhamnetin,COc1cc(O)c2c(=O)c(O)c(-c3ccc(O)c(O)c3)oc2c1,C16H12O7,20302.0
6481,Terfenadine,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,C32H41NO2,20305.0
6482,GSK481,CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21,C21H19N3O4,20308.0
6483,Ezutromid,CCS(=O)(=O)c1ccc2oc(-c3ccc4ccccc4c3)nc2c1,C19H15NO3S,20309.0
6484,BI-7273,COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN(C)C,C20H23N3O3,20311.0
6485,"all-cis-1,2,3-Docosahexaenoyl Glycerol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCC(COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC,C69H98O6,10009667.0
6486,"1,2,3-Trieicosapentaenoyl Glycerol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC,C63H92O6,10009732.0
6487,(Z)-4-hydroxy Tamoxifen,CC/C(=C(\c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,C26H29NO2,14854.0
6488,Aflatoxin M2,COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)C1(O)CCOC1O2,C17H14O7,11298.0
6489,3-A-DON,CC(=O)O[C@@H]1C[C@]2(C)[C@@]3(CO)[C@H](O)C(=O)C(C)=C[C@H]3O[C@H]1[C@@]21CO1,C17H22O7,11429.0
6490,15-acetoxy Scirpenol,CC(=O)OC[C@]12CCC(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@]2(C)[C@]12CO2,C17H24O6,11431.0
6491,Neosolaniol,CC(=O)OC[C@]12C[C@H](O)C(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@]12CO2,C19H26O8,11436.0
6492,Nivalenol,CC1=C[C@H]2O[C@@H]3[C@H](O)[C@@H](O)[C@](C)([C@@]2(CO)[C@H](O)C1=O)[C@]31CO1,C15H20O7,11438.0
6493,Sterigmatocystin,COc1cc2c(c3oc4cccc(O)c4c(=O)c13)[C@@H]1C=CO[C@@H]1O2,C18H12O6,11441.0
6494,Makisterone A,C[C@H](C[C@@H](O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C)C(C)(C)O,C28H46O7,11739.0
6495,K252c,O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21,C20H13N3O,13514.0
6496,Midazolam,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,C18H13ClFN3,16193.0
6497,Midazolam (CRM),Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,C18H13ClFN3,19391.0
6498,AH 7563,CN(C)C1(CNC(=O)c2ccccc2)CCCCC1,C16H24N2O,19335.0
6499,Butyryl norfentanyl (hydrochloride),CCCC(=O)N(c1ccccc1)C1CCNCC1.Cl,C15H23ClN2O,19428.0
6500,Butyryl norfentanyl (hydrochloride) (CRM),CCCC(=O)N(c1ccccc1)C1CCNCC1.Cl,C15H23ClN2O,19561.0
6501,Furanyl norfentanyl (hydrochloride),Cl.O=C(c1ccco1)N(c1ccccc1)C1CCNCC1,C16H19ClN2O2,19429.0
6502,Furanyl norfentanyl (hydrochloride) (CRM),Cl.O=C(c1ccco1)N(c1ccccc1)C1CCNCC1,C16H19ClN2O2,19559.0
6503,Resorufin butyrate,CCCC(=O)Oc1ccc2nc3ccc(=O)cc-3oc2c1,C16H13NO4,19592.0
6504,E7046,C[C@H](NC(=O)c1c(C(F)F)nn(C)c1Oc1cccc(C(F)(F)F)c1)c1ccc(C(=O)O)cc1,C22H18F5N3O4,19673.0
6505,(2R)-Octyl-.alpha.-hydroxyglutarate-d17,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])OC(=O)[C@H](O)CCC(=O)O,C13H24O5,19694.0
6506,Retinyl Acetate,CC(=O)OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C,C22H32O2,20242.0
6507,Methysticin,COC1=CC(=O)O[C@@H](/C=C/c2ccc3c(c2)OCO3)C1,C15H14O5,20258.0
6508,Methysticin (CRM),COC1=CC(=O)O[C@@H](/C=C/c2ccc3c(c2)OCO3)C1,C15H14O5,41195.0
6509,Narciclasine,O=C1N[C@@H]2C(=C[C@H](O)[C@@H](O)[C@H]2O)c2cc3c(c(O)c21)OCO3,C14H13NO7,20361.0
6510,L-(+)-Erythrose,O=C[C@@H](O)[C@@H](O)CO,C4H8O4,20381.0
6511,Simetryn,CCNc1nc(NCC)nc(SC)n1,C8H15N5S,20392.0
6512,Atrazine Mercapturate,CCNc1nc(NC(C)C)nc(SC[C@H](NC(C)=O)C(=O)O)n1,C13H22N6O3S,20395.0
6513,SKF 86466 (hydrochloride),CN1CCc2cccc(Cl)c2CC1.Cl,C11H15Cl2N,11953.0
6514,Aflatoxin M1,COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@]1(O)C=CO[C@@H]1O2,C17H12O7,11297.0
6515,Fusarenon X,CC(=O)O[C@@H]1[C@@H](O)[C@H]2O[C@@H]3C=C(C)C(=O)[C@@H](O)[C@]3(CO)[C@]1(C)[C@]21CO1,C17H22O8,11432.0
6516,TC-O 9311,COc1cc(OC)cc(C(=O)NNC(=O)Nc2cccc3ccccc23)c1,C20H19N3O4,14030.0
6517,ML-193,Cc1cc(C)c2nc(-c3ccccn3)cc(C(=O)Nc3ccc(S(=O)(=O)Nc4onc(C)c4C)cc3)c2c1,C28H25N5O4S,15184.0
6518,GSK3.beta. Inhibitor II,Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1,C14H10IN3OS,19077.0
6519,Clavulanate (potassium salt),O=C([O-])[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21.[K+],C8H8KNO5,19456.0
6520,.beta.-Zearalenol,C[C@H]1CCC[C@@H](O)CCC/C=C/c2cc(O)cc(O)c2C(=O)O1,C18H24O5,19460.0
6521,Isocyclosporin A,C/C=C/CC(C)C1OC(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(C(C)C)NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C(=O)C(CC)NC(=O)C1NC,C62H111N11O12,19462.0
6522,Propofol .beta.-D-Glucuronide,CC(C)c1cccc(C(C)C)c1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,C18H26O7,19517.0
6523,Green CMFDA,CC(=O)Oc1ccc2c(c1)Oc1cc(OC(C)=O)ccc1C21OC(=O)c2cc(CCl)ccc21,C25H17ClO7,19583.0
6524,ReAsH-EDT2,O=c1ccc2nc3ccc(O)c([As]4SCCS4)c3oc-2c1[As]1SCCS1,C16H13As2NO3S4,19767.0
6525,5-fluoro PY-PINACA (CRM),O=C(c1nn(CCCCCF)c2ccccc12)N1CCCC1,C17H22FN3O,19801.0
6526,WZB117,O=C(Oc1cccc(F)c1OC(=O)c1cccc(O)c1)c1cccc(O)c1,C20H13FO6,19900.0
6527,EGTA AM,CC(=O)OCOC(=O)CN(CCOCCOCCN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O,C26H40N2O18,20401.0
6528,Fluo-3 (ammonium salt),Cc1ccc(N(CC(=O)[O-])CC(=O)[O-])c(OCCOc2cc(-c3c4cc(Cl)c(=O)cc-4oc4cc([O-])c(Cl)cc34)ccc2N(CC(=O)[O-])CC(=O)[O-])c1.[NH4+].[NH4+].[NH4+].[NH4+].[NH4+],C36H45Cl2N7O13,20402.0
6529,Fluo-3 (potassium salt),Cc1ccc(N(CC(=O)[O-])CC(=O)[O-])c(OCCOc2cc(-c3c4cc(Cl)c(=O)cc-4oc4cc([O-])c(Cl)cc34)ccc2N(CC(=O)[O-])CC(=O)[O-])c1.[K+].[K+].[K+].[K+].[K+],C36H25Cl2K5N2O13,20403.0
6530,Fluo-3FF (potassium salt),O=C([O-])CN(CC(=O)[O-])c1ccc(-c2c3cc(Cl)c(=O)cc-3oc3cc([O-])c(Cl)cc23)cc1OCCOc1c(N(CC(=O)[O-])CC(=O)[O-])ccc(F)c1F.[K+].[K+].[K+].[K+].[K+],C35H21Cl2F2K5N2O13,20406.0
6531,Fura-FF (potassium salt),O=C([O-])CN(CC(=O)[O-])c1cc2oc(-c3ncc(C(=O)[O-])o3)cc2cc1OCCOc1c(N(CC(=O)[O-])CC(=O)[O-])ccc(F)c1F.[K+].[K+].[K+].[K+].[K+],C28H18F2K5N3O14,20415.0
6532,Fura-FF AM,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1cc2oc(-c3ncc(C(=O)OCOC(C)=O)o3)cc2cc1OCCOc1c(N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)ccc(F)c1F,C43H43F2N3O24,20416.0
6533,Indo-1 AM,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1ccc(C)cc1OCCOc1cc(-c2cc3ccc(C(=O)OCOC(C)=O)cc3[nH]2)ccc1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O,C47H51N3O22,20417.0
6534,Vacuolin-1,Ic1cccc(/C=N/Nc2nc(N3CCOCC3)nc(N(c3ccccc3)c3ccccc3)n2)c1,C26H24IN7O,20425.0
6535,2-deoxy Artemisinin,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32O4,C15H22O4,20426.0
6536,RO8191,FC(F)(F)c1cc(C(F)(F)F)c2ccc3nc(-c4nnco4)cn3c2n1,C14H5F6N5O,20449.0
6537,Madrasin,COc1ccc2c(C)nc(Nc3nc(=O)c(C)c(C)[nH]3)nc2c1,C16H17N5O2,20451.0
6538,1198408-78-4,O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O,C21H21ClN4O5,20453.0
6539,LY266097 (hydrochloride),COc1ccc(CC2NCCc3c2[nH]c2ccc(C)cc32)c(Cl)c1OC.Cl,C21H24Cl2N2O2,11935.0
6540,SR 58611A (hydrochloride),CCOC(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1cccc(Cl)c1)CC2.Cl,C22H27Cl2NO4,11954.0
6541,Ro 67-7476,Cc1ccc(S(=O)(=O)N2CCC[C@H]2c2ccc(F)cc2)cc1,C17H18FNO2S,11993.0
6542,BQU57,Cc1nn(C)c2c1C(c1ccc(C(F)(F)F)cc1)C(C#N)=C(N)O2,C16H13F3N4O,16960.0
6543,(S)-(-)-Propranolol (hydrochloride),CC(C)NC[C@H](O)COc1cccc2ccccc12.Cl,C16H22ClNO2,17291.0
6544,GSK591,O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1ccnc(NC2CCC2)c1,C22H28N4O2,18354.0
6545,Ubiquinol,COc1c(O)c(C)c(C/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(/C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(O)c1OC,C59H92O4,19677.0
6546,Metaescaline (hydrochloride),CCOc1cc(CCN)cc(OC)c1OC.Cl,C12H20ClNO3,19927.0
6547,AT-406,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,C32H43N5O4,19929.0
6548,COTI-2,S=C(N/N=C1/CCCc2cccnc21)N1CCN(c2ccccn2)CC1,C19H22N6S,20031.0
6549,para-Chlorofentanyl (hydrochloride),CCC(=O)N(c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H28Cl2N2O,20034.0
6550,para-Chlorofentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H28Cl2N2O,36370.0
6551,Scopoletin,COc1cc2ccc(=O)oc2cc1O,C10H8O4,20042.0
6552,Trioxsalen,Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1,C14H12O3,20044.0
6553,Homogentisic Acid,O=C(O)Cc1cc(O)ccc1O,C8H8O4,20045.0
6554,Scoparone,COc1cc2ccc(=O)oc2cc1OC,C11H10O4,20046.0
6555,Icaritin,COc1ccc(-c2oc3c(CC=C(C)C)c(O)cc(O)c3c(=O)c2O)cc1,C21H20O6,20236.0
6556,PH-797804,CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1,C22H19BrF2N2O3,20244.0
6557,TMC-207,COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12,C32H31BrN2O2,20247.0
6558,Spiramycin,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@H]1OC.CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O.CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O,C134H228N6O44,20267.0
6559,Indo-1 (potassium salt),Cc1ccc(N(CC(=O)[O-])CC(=O)[O-])c(OCCOc2cc(-c3cc4ccc(C(=O)[O-])cc4[nH]3)ccc2N(CC(=O)[O-])CC(=O)[O-])c1.[K+].[K+].[K+].[K+].[K+],C32H26K5N3O12,20418.0
6560,Quin-2 (potassium salt),COc1cc(N(CC(=O)[O-])CC(=O)[O-])c2nc(COc3cc(C)ccc3N(CC(=O)[O-])CC(=O)[O-])ccc2c1.[K+].[K+].[K+].[K+],C26H23K4N3O10,20421.0
6561,Quin-2 AM,COc1cc(N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)c2nc(COc3cc(C)ccc3N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)ccc2c1,C38H43N3O18,20422.0
6562,BTC (potassium salt),Cc1ccc(N(CC(=O)[O-])CC(=O)[O-])c(OCCOc2cc3cc(-c4nc5ccccc5s4)c(=O)oc3cc2N(CC(=O)[O-])CC(=O)[O-])c1.[K+].[K+].[K+].[K+],C33H25K4N3O12S,20423.0
6563,BTC AM,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1ccc(C)cc1OCCOc1cc2cc(-c3nc4ccccc4s3)c(=O)oc2cc1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O,C45H45N3O20S,20424.0
6564,Destruxin A,C=CC[C@H]1OC(=O)CCNC(=O)[C@H](C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CCCN2C1=O,C29H47N5O7,20428.0
6565,Destruxin B,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(C)C)OC(=O)CCNC(=O)[C@H](C)N(C)C(=O)[C@H](C(C)C)N(C)C1=O,C30H51N5O7,20429.0
6566,HT-2 Toxin,CC(=O)OC[C@]12C[C@H](OC(=O)CC(C)C)C(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@]2(C)[C@]12CO2,C22H32O8,20431.0
6567,T-2 Tetraol,CC1=C[C@H]2O[C@@H]3[C@H](O)[C@@H](O)[C@](C)([C@@]2(CO)C[C@@H]1O)[C@]31CO1,C15H22O6,20432.0
6568,T-2 Triol,CC1=C[C@H]2O[C@@H]3[C@H](O)[C@@H](O)[C@](C)([C@@]2(CO)C[C@@H]1OC(=O)CC(C)C)[C@]31CO1,C20H30O7,20433.0
6569,Fumonisin B3,CCCC[C@@H](C)[C@@H](OC(=O)C[C@@H](CC(=O)O)C(=O)O)[C@H](C[C@@H](C)C[C@H](O)CCCCCC[C@H](O)[C@H](C)N)OC(=O)C[C@@H](CC(=O)O)C(=O)O,C34H59NO14,20434.0
6570,Dimethylamino Parthenolide,C/C1=C/CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)[C@@H](CN(C)C)[C@@H]2CC1,C17H27NO3,20436.0
6571,Aflatoxin R0,COc1cc2c(c3oc(=O)c4c(c13)CC[C@@H]4O)[C@@H]1C=CO[C@@H]1O2,C17H14O6,20437.0
6572,4-bromo A23187,CNc1c(Br)cc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O,C29H36BrN3O6,20438.0
6573,Rhod-5N (potassium salt),CN(C)c1ccc2c(-c3ccc(N(CC(=O)[O-])CC(=O)[O-])c(OCCOc4cc([N+](=O)[O-])ccc4N(CC(=O)[O-])CC(=O)[O-])c3)c3ccc(=[N+](C)C)cc-3oc2c1.[K+].[K+].[K+],C39H36K3N5O13,20441.0
6574,ZM 241385,Nc1nc(NCCc2ccc(O)cc2)nc2nc(-c3ccco3)nn12,C16H15N7O2,20447.0
6575,Barnidipine (hydrochloride),COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1.Cl,C27H30ClN3O6,20448.0
6576,PCNA-I1,Cc1ccsc1C(=O)N/N=C/c1ccc2ccccc2c1O,C17H14N2O2S,20454.0
6577,OXA-01,Nc1nccn2c1c(-c1cc3cccc(Cl)c3[nH]1)nc2[C@H]1CC[C@H](C(=O)O)CC1,C21H20ClN5O2,20456.0
6578,FAUC-365,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,C23H25Cl2N3OS,20457.0
6579,JYL1421,CC(C)(C)c1ccc(CNC(=S)NCc2ccc(NS(C)(=O)=O)c(F)c2)cc1,C20H26FN3O2S2,20458.0
6580,2-D08,O=c1cc(-c2ccc(O)c(O)c2O)oc2ccccc12,C15H10O5,20459.0
6581,TFMB-R-2-HG,O=C1CC[C@H](C(=O)OCc2cccc(C(F)(F)F)c2)O1,C13H11F3O4,20461.0
6582,TAE-1,C[N+](C)(C)CCOC(=O)c1ccc(Oc2nc(Oc3ccc(C(=O)OCC[N+](C)(C)C)cc3)nc(Oc3ccc(C(=O)OCC[N+](C)(C)C)cc3)n2)cc1.[I-].[I-].[I-],C39H51I3N6O9,20464.0
6583,VU0364572 (trifluoroacetate salt),CCOC(=O)N1CCC(N2CCC[C@@H](NC(=O)c3ccccc3C)C2)CC1.O=C(O)C(F)(F)F,C23H32F3N3O5,20466.0
6584,NDMC101,O=C(Nc1ccc(Cl)cc1F)c1ccccc1O,C13H9ClFNO2,20468.0
6585,"CP-392,110 (maleate)",CCN(CC)Cc1cccc(/C=C/c2nc3ccc(F)cc3c(=O)n2-c2ccccc2Cl)n1.O=C(O)/C=C\C(=O)O,C30H28ClFN4O5,20473.0
6586,?-Linolenic Acid methyl ester,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OC,C19H32O2,9000290.0
6587,(-)-Methamphetamine (hydrochloride),CN[C@H](C)Cc1ccccc1.Cl,C10H16ClN,13998.0
6588,(-)-Methamphetamine (hydrochloride) (CRM),CN[C@H](C)Cc1ccccc1.Cl,C10H16ClN,26616.0
6589,EPI-001,CC(C)(c1ccc(OCC(O)CO)cc1)c1ccc(OCC(O)CCl)cc1,C21H27ClO5,16970.0
6590,SR 2595,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,C37H38N2O3,18291.0
6591,"N-methyl-4,4-difluoro-Modafinil",CNC(=O)CS(=O)C(c1ccc(F)cc1)c1ccc(F)cc1,C16H15F2NO2S,18332.0
6592,5-fluoro CUMYL-P7AICA,CC(C)(NC(=O)c1cn(CCCCCF)c2ncccc12)c1ccccc1,C22H26FN3O,18370.0
6593,APINAC,CCCCCn1nc(C(=O)OC23CC4CC(CC(C4)C2)C3)c2ccccc21,C23H30N2O2,18589.0
6594,AB-FUBICA,CC(C)[C@H](NC(=O)c1cn(Cc2ccc(F)cc2)c2ccccc12)C(N)=O,C21H22FN3O2,18758.0
6595,ATHPINACA isomer 2,O=C(NC1C2CC3CC(C2)CC1C3)c1nn(CC2CCOCC2)c2ccccc12,C24H31N3O2,19040.0
6596,EPZ020411,CNCCN(C)Cc1c[nH]nc1-c1ccc(O[C@H]2C[C@H](OCCC3CCOCC3)C2)cc1,C25H38N4O3,19160.0
6597,FUB-PB-22 3-carboxyindole metabolite,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccccc12,C16H12FNO2,19267.0
6598,AH 7959,O=C(NCC1(N2CCCCC2)CCCCC1)c1ccc(Cl)c(Cl)c1,C19H26Cl2N2O,19366.0
6599,MMP-13 Inhibitor,Cc1cc(CNC(=O)c2cc(C(=O)NCc3ccc(F)c(C)c3)ncn2)ccc1F,C22H20F2N4O2,19540.0
6600,Ozanimod,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N,C23H24N4O3,19922.0
6601,para-Chloroisobutyryl fentanyl (hydrochloride),CC(C)C(=O)N(c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H30Cl2N2O,20018.0
6602,4-Anilinopiperidine (hydrochloride),Cl.Cl.c1ccc(NC2CCNCC2)cc1,C11H18Cl2N2,20085.0
6603,4-Anilino-1-benzylpiperidine,c1ccc(CN2CCC(Nc3ccccc3)CC2)cc1,C18H22N2,20086.0
6604,Phenethylbromide,BrCCc1ccccc1,C8H9Br,20087.0
6605,(R)-CCG-1423,C[C@@H](ONC(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc(Cl)cc1,C18H13ClF6N2O3,20106.0
6606,(S)-CCG-1423,C[C@H](ONC(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc(Cl)cc1,C18H13ClF6N2O3,20107.0
6607,SU 4312,CN(C)c1ccc(C=C2C(=O)Nc3ccccc32)cc1,C17H16N2O,20213.0
6608,AZD 1208,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,C21H21N3O2S,20235.0
6609,Nadifloxacin,CC1CCc2c(N3CCC(O)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,C19H21FN2O4,20252.0
6610,N-acetyl W-19,CC(=O)Nc1ccc(CCN2CCCC/C2=N/S(=O)(=O)c2ccc(Cl)cc2)cc1,C21H24ClN3O3S,20266.0
6611,MDMB-FUBICA metabolite 3,CC(C)(C)[C@H](NC(=O)c1cn(Cc2ccc(F)cc2)c2ccccc12)C(=O)O,C22H23FN2O3,20271.0
6612,N-Propylnorketamine (hydrochloride),CCCNC1(c2ccccc2Cl)CCCCC1=O.Cl,C15H21Cl2NO,20272.0
6613,Glycolithocholic Acid (sodium salt),C[C@H](CCC(=O)NCC(=O)[O-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.[Na+],C26H42NNaO4,20273.0
6614,N-desmethyl U-47700,CN[C@@H]1CCCC[C@H]1N(C)C(=O)c1ccc(Cl)c(Cl)c1,C15H20Cl2N2O,20279.0
6615,Benserazide (hydrochloride),Cl.NC(CO)C(=O)NNCc1ccc(O)c(O)c1O,C10H16ClN3O5,20298.0
6616,Ketotifen (fumarate),CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1.O=C(O)/C=C/C(=O)O,C23H23NO5S,20303.0
6617,Tenoxicam,CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O,C13H11N3O4S2,20304.0
6618,Rifapentine,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,C47H64N4O12,20307.0
6619,1-Piperidinocyclohexanecarbonitrile,N#CC1(N2CCCCC2)CCCCC1,C12H20N2,20367.0
6620,D-Glucose-6-phosphate (sodium salt),O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)([O-])O.[Na+],C6H12NaO9P,20376.0
6621,Sulfacetamide (sodium salt),CC(=O)[N-]S(=O)(=O)c1ccc(N)cc1.[Na+],C8H9N2NaO3S,20377.0
6622,Isoniazid,NNC(=O)c1ccncc1,C6H7N3O,20378.0
6623,Levofloxacin (hydrate),C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,C36H42F2N6O9,20382.0
6624,DL-Folinic Acid (calcium salt),Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1)N2C=O.[Ca+2],C20H21CaN7O7,20383.0
6625,Deferiprone,Cc1c(O)c(=O)ccn1C,C7H9NO2,20387.0
6626,Ramelteon,CCC(=O)NCC[C@@H]1CCc2ccc3c(c21)CCO3,C16H21NO2,20389.0
6627,2-oxo Clopidogrel,COC(=O)C(c1ccccc1Cl)N1CCC2SC(=O)C=C2C1,C16H16ClNO3S,20394.0
6628,CAY10719,COc1ccc(C(=O)N2CCc3c([nH]c4ccccc34)C2c2ccc(Cl)c(Cl)c2)cc1,C25H20Cl2N2O2,20469.0
6629,ML-148,Cc1cccc(-n2cnc3cc(C(=O)N4CCCCC4)ccc32)c1,C20H21N3O,20475.0
6630,Methoxy-X04,COc1cc(/C=C/c2ccc(O)cc2)ccc1/C=C/c1ccc(O)cc1,C23H20O3,20476.0
6631,NPP,O=C1CCN(CCc2ccccc2)CC1,C13H17NO,20528.0
6632,Methaqualone,Cc1ccccc1-n1c(C)nc2ccccc2c1=O,C16H14N2O,9000636.0
6633,Methaqualone (CRM),Cc1ccccc1-n1c(C)nc2ccccc2c1=O,C16H14N2O,20283.0
6634,HE-3235,C#C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,C21H32O2,9002769.0
6635,17.beta.-Estradiol-d2,[2H]c1cc2c(c([2H])c1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,C18H24O2,9002846.0
6636,Amphetamine Methyl Carbamate,COC(=O)NC(C)Cc1ccccc1,C11H15NO2,9002843.0
6637,Estrone-d2,[2H]c1cc2c(c([2H])c1O)CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C18H22O2,9002844.0
6638,Estriol-d2,[2H]c1cc2c(c([2H])c1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)[C@H](O)C[C@@H]12,C18H24O3,9002845.0
6639,BMK Glycidic Acid (sodium salt),CC1(C(=O)[O-])OC1c1ccccc1.[Na+],C10H9NaO3,19683.0
6640,Z3-Dodecenyl E2-butenoate,C/C=C/C(=O)OCC/C=C\CCCCCCCC,C16H28O2,19787.0
6641,nor-W-18-d4,[2H]c1c([2H])c(S(=O)(=O)NC2=NCCCC2)c([2H])c([2H])c1Cl,C11H13ClN2O2S,20317.0
6642,RPI-1,COc1cc2c(cc1OC)/C(=C/c1ccc(O)cc1)C(=O)N2,C17H15NO4,20384.0
6643,Flecainide (acetate),CC(=O)O.O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F,C19H24F6N2O5,20388.0
6644,3-hydroxy Anthranilic Acid,Nc1c(O)cccc1C(=O)O,C7H7NO3,20512.0
6645,Docosatrienoic Acid methyl ester,CC/C=C\C/C=C\C/C=C\CCCCCCCCCCCC(=O)OC,C23H40O2,20567.0
6646,13(Z)-Docosenoic Acid methyl ester,CCCCCCCC/C=C\CCCCCCCCCCCC(=O)OC,C23H44O2,20568.0
6647,NSC 624206,CCCCCCCCCCNCCSSCc1ccc(Cl)cc1.Cl,C19H33Cl2NS2,20569.0
6648,AN3365 (hydrochloride),Cl.NC[C@H]1OB(O)c2c(OCCCO)cccc21,C11H17BClNO4,20572.0
6649,CP21R7,Cn1cc(C2=C(c3cccc(N)c3)C(=O)NC2=O)c2ccccc21,C19H15N3O2,20573.0
6650,.alpha.-Pyrrolidinopentiophenone-d8 (hydrochloride),Cl.[2H]C1([2H])N(C(CCC)C(=O)c2ccccc2)C([2H])([2H])C([2H])([2H])C1([2H])[2H],C15H22ClNO,9002649.0
6651,?-Pyrrolidinopentiophenone-d8 (hydrochloride) (CRM),Cl.[2H]C1([2H])N(C(CCC)C(=O)c2ccccc2)C([2H])([2H])C([2H])([2H])C1([2H])[2H],C15H22ClNO,19204.0
6652,RP 001 (hydrochloride),CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCC4NCCC(=O)O)no2)cc1C#N.Cl,C24H25ClN4O4,16636.0
6653,5-fluoro AMB metabolite 2,COC(=O)[C@@H](NC(=O)c1nn(CCCCCO)c2ccccc12)C(C)C,C19H27N3O4,17892.0
6654,MAB-CHMINACA-d4,[2H]c1c([2H])c([2H])c2c(c(C(=O)NC(C(N)=O)C(C)(C)C)nn2CC2CCCCC2)c1[2H],C21H30N4O2,18878.0
6655,MAB-CHMINACA-d4 (CRM),[2H]c1c([2H])c([2H])c2c(c(C(=O)NC(C(N)=O)C(C)(C)C)nn2CC2CCCCC2)c1[2H],C21H30N4O2,19858.0
6656,AB-CHMINACA-d4,[2H]c1c([2H])c([2H])c2c(c(C(=O)N[C@H](C(N)=O)C(C)C)nn2CC2CCCCC2)c1[2H],C20H28N4O2,18879.0
6657,AB-CHMINACA-d4 (CRM),[2H]c1c([2H])c([2H])c2c(c(C(=O)N[C@H](C(N)=O)C(C)C)nn2CC2CCCCC2)c1[2H],C20H28N4O2,23200.0
6658,ND-336,Cl.NCc1ccc(Oc2ccc(S(=O)(=O)CC3CS3)cc2)cc1,C16H18ClNO3S2,19207.0
6659,Sandramycin,CC(C)[C@H]1C(=O)OC[C@@H](NC(=O)c2nc3ccccc3cc2O)C(=O)N2CCCC[C@H]2C(=O)NCC(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)OC[C@@H](NC(=O)c2nc3ccccc3cc2O)C(=O)N2CCCC[C@H]2C(=O)NCC(=O)N(C)CC(=O)N1C,C60H76N12O16,20575.0
6660,Indacaterol,CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,C24H28N2O3,20070.0
6661,Fevipiprant,Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1C(F)(F)F,C19H17F3N2O4S,20263.0
6662,3-methoxy Tyramine (hydrochloride),COc1cc(CCN)ccc1O.Cl,C9H14ClNO2,20511.0
6663,Maduramicin,CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C,C47H80O17,20583.0
6664,Lydicamycin,CC1=CC2C(O)C(O)CCC2C(C)(C(=O)C2=C(O)CNC2=O)C1CCC(C)C(O)/C(C)=C/CC(O)/C=C/C(C)C(O)/C=C/CC(O)/C(C)=C/CC(O)CC1CCCN1C(=N)N,C47H74N4O10,20584.0
6665,Leucomycin A1,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O,C40H67NO14,20585.0
6666,Kijanimicin,COC(=O)N[C@H]1[C@@H](C)O[C@@H](O[C@H]2C/C=C(/C)[C@@H]3C=C[C@@H]4[C@@H](O[C@H]5C[C@@H](O[C@H]6C[C@@H](O[C@H]7C[C@@H](O)[C@@H](O)[C@H](C)O7)[C@@H](O[C@@H]7C[C@@H](O)[C@@H](OC)[C@H](C)O7)[C@H](C)O6)[C@@H](O)[C@H](C)O5)[C@@H](C)C[C@H](C)[C@H]4[C@]3(C)C(=O)C3=C(O)[C@@]4(C[C@@H](C)C(CO)=C[C@H]4/C=C/2C)OC3=O)C[C@]1(C)[N+](=O)[O-],C67H100N2O24,20586.0
6667,PC-766B,C/C=C/C=C/[C@H]1O[C@@](O)([C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](C)C/C(C)=C/C=C/[C@@H]2OC)C[C@@H](O[C@H]2C[C@@H](O)[C@H](O)[C@@H](C)O2)[C@@H]1C,C43H68O12,20587.0
6668,Monazomycin,C/C1=C\C(C)C(O)/C(C)=C/C(O[C@H]2OC(CO)[C@@H](O)[C@H](O)[C@@H]2O)C(O)C(C)C(O)CC(O)/C=C/C(C)C(O)C(C)CCC(O)CC(O)C(C)C(O)C(C)C(O)CC(O)CC(O)C(C)C(C(C)CCCCCCN)OC(=O)CCCCCC(O)C(C)C(O)CC/C=C/C(C)C1O,C72H133NO22,20589.0
6669,Germicidin B,CCc1c(O)cc(C(C)C)oc1=O,C10H14O3,20591.0
6670,Enterocin,COc1cc([C@H]2[C@@]3(O)[C@H](O)[C@H]4C[C@]2(O)[C@](O)(C(=O)O4)[C@H]3C(=O)c2ccccc2)oc(=O)c1,C22H20O10,20592.0
6671,Anguinomycin A,CC(/C=C/C1CC=CC(=O)O1)=C\C(C)C/C=C/C(C)=C/C(C)C(=O)C(C)C(O)C(C)C/C(C)=C/C(=O)O,C31H44O6,20598.0
6672,21-hydroxy Oligomycin A,CC[C@H]1/C=C/C=C/C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)O[C@@H]2[C@H](C)[C@H](C[C@H]1O)O[C@]1(CC[C@H](C)[C@H](C[C@@H](C)O)O1)[C@H]2C,C45H74O12,20599.0
6673,Lagosin,CCCCC[C@@H](O)[C@H]1C(=O)O[C@H](C)[C@@H](O)/C=C/C=C/C=C/C=C/C=C(\C)[C@@H](O)[C@H](O)[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O,C35H58O12,20600.0
6674,Docosadienoic Acid methyl ester,CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)OC,C23H42O2,20602.0
6675,Oleic Acid methyl ester,CCCCCCCC/C=C\CCCCCCCC(=O)OC,C19H36O2,20604.0
6676,Indole-3-carbinol,OCc1c[nH]c2ccccc12,C9H9NO,11325.0
6677,Resolvin D4,CC/C=C\C[C@H](O)/C=C/C=C\C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)CCC(=O)O,C22H32O5,13835.0
6678,(S)-NIFE,COCCOC(=O)[C@H](Cc1ccccc1)NC(=O)Oc1ccc([N+](=O)[O-])cc1,C19H20N2O7,17431.0
6679,5-fluoro APINAC,O=C(OC12CC3CC(CC(C3)C1)C2)c1nn(CCCCCF)c2ccccc12,C23H29FN2O2,18592.0
6680,AH 8507,CN1CCN(C2(CNC(=O)c3ccc(Cl)c(Cl)c3)CCCCC2)CC1,C19H27Cl2N3O,19367.0
6681,Ergosterol,CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C28H44O,19850.0
6682,Isoimperatorin,CC(C)=CCOc1c2ccoc2cc2oc(=O)ccc12,C16H14O4,19851.0
6683,Mogroside V,C[C@H](CC[C@@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)O)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4[C@@H](CC[C@H](O[C@@H]5O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O)[C@H]5O)C4(C)C)[C@]3(C)[C@H](O)C[C@]12C,C60H102O29,19853.0
6684,Physcion,COc1cc(O)c2c(c1)C(=O)c1cc(C)cc(O)c1C2=O,C16H12O5,19863.0
6685,Pregnenolone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C21H32O2,19864.0
6686,Quercitrin,C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O,C21H20O11,19866.0
6687,Yohimbine (hydrochloride),COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O.Cl,C21H27ClN2O3,19869.0
6688,Ferulic Acid,COc1cc(/C=C/C(=O)O)ccc1O,C10H10O4,19871.0
6689,Tetrandrine,COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1C)Oc1c(OC)c(OC)cc3c1[C@H](C2)N(C)CC3,C38H42N2O6,19874.0
6690,Pomalidomide,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,C13H11N3O4,19877.0
6691,Wnt Agonist I,COc1cccc(-c2cc(NCc3ccc4c(c3)OCO4)nc(N)n2)c1,C19H18N4O3,19903.0
6692,JNJ-42165279,O=C(Nc1cnccc1Cl)N1CCN(Cc2ccc3c(c2)OC(F)(F)O3)CC1,C18H17ClF2N4O3,19987.0
6693,Norharmane,c1ccc2c(c1)[nH]c1cnccc12,C11H8N2,20043.0
6694,Eletriptan,CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12,C22H26N2O2S,20048.0
6695,4-cyano CUMYL-BUTINACA,CC(C)(NC(=O)c1nn(CCCCC#N)c2ccccc12)c1ccccc1,C22H24N4O,20194.0
6696,4-cyano CUMYL-BUTINACA (CRM),CC(C)(NC(=O)c1nn(CCCCC#N)c2ccccc12)c1ccccc1,C22H24N4O,30774.0
6697,Idoxuridine,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I,C9H11IN2O5,20222.0
6698,Tauroursodeoxycholic Acid,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C26H45NO6S,20277.0
6699,Maltotriose,O=C[C@H](O)[C@@H](O)[C@H](O[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,C18H32O16,20306.0
6700,Flutamide,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,C11H11F3N2O3,20359.0
6701,"(6R,S)-5,6,7,8-Tetrahydrofolic acid (hydrochloride)",Cl.Cl.Cl.Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2,C19H26Cl3N7O6,20526.0
6702,Linamarin,CC(C)(C#N)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C10H17NO6,20532.0
6703,(+)-Biotin 4-Amidobenzoic Acid (sodium salt),O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)Nc1ccc(C(=O)[O-])cc1.[Na+],C17H20N3NaO4S,20534.0
6704,Ristocetin A (sulfate),COC(=O)[C@H]1NC(=O)[C@H]2NC(=O)[C@H](NC(=O)[C@@H]3NC(=O)[C@H]4NC(=O)[C@H](NC(=O)[C@H]([NH3+])c5ccc(O)c(c5)Oc5cc4cc(O)c5C)[C@H](O)c4ccc(cc4)Oc4cc3cc(c4O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O[C@@H]3OC[C@@H](O)[C@@H](O)[C@@H]3O)Oc3ccc(cc3)[C@H]2O[C@H]2C[C@@H]([NH3+])[C@@H](O)[C@H](C)O2)c2ccc(O)c(c2)-c2c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)cc(O)cc21.O=S(=O)([O-])[O-],C95H112N8O48S,20601.0
6705,Palmitoleic Acid methyl ester,CCCCCC/C=C\CCCCCCCC(=O)OC,C17H32O2,20605.0
6706,11(Z)-Eicosenoic Acid,CCCCCCCC/C=C\CCCCCCCCCC(=O)O,C20H38O2,20606.0
6707,Nonadecanoic Acid methyl ester,CCCCCCCCCCCCCCCCCCC(=O)OC,C20H40O2,20607.0
6708,Lauric Acid methyl ester,CCCCCCCCCCCC(=O)OC,C13H26O2,20608.0
6709,"N,N-dimethyl Undecylamine N-oxide",CCCCCCCCCCC[N+](C)(C)[O-],C13H29NO,20650.0
6710,Myristic Acid methyl ester,CCCCCCCCCCCCCC(=O)OC,C15H30O2,9001867.0
6711,JNJ-26481585 (hydrochloride),Cl.Cl.Cn1cc(CNCC2CCN(c3ncc(C(=O)NO)cn3)CC2)c2ccccc21,C21H28Cl2N6O2,14088.0
6712,6.beta.-Naltrexol,Oc1ccc2c3c1O[C@H]1[C@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CC2)CC[C@]314,C20H25NO4,15896.0
6713,6.beta.-Naltrexol (CRM),Oc1ccc2c3c1O[C@H]1[C@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CC2)CC[C@]314,C20H25NO4,18790.0
6714,AMG 319,C[C@H](Nc1ncnc2nc[nH]c12)c1cc2ccc(F)cc2nc1-c1ccccn1,C21H16FN7,17383.0
6715,MAB-CHMINACA metabolite M6,CC(C)(C(=O)O)C(NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(N)=O,C21H28N4O4,17815.0
6716,6.beta.-Naltrexol-d3,[2H]C1(C([2H])([2H])N2CC[C@]34c5c6ccc(O)c5O[C@H]3[C@H](O)CC[C@@]4(O)[C@H]2C6)CC1,C20H25NO4,18350.0
6717,6.beta.-Naltrexol-d3 (CRM),[2H]C1(C([2H])([2H])N2CC[C@]34c5c6ccc(O)c5O[C@H]3[C@H](O)CC[C@@]4(O)[C@H]2C6)CC1,C20H25NO4,20396.0
6718,ATHPINACA isomer 1,O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(CC2CCOCC2)c2ccccc12,C24H31N3O2,18365.0
6719,Tenatoprazole,COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)nc-2[nH]1,C16H18N4O3S,18717.0
6720,Mito-TEMPOL,CC1(C)CC(OCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)CC(C)(C)N1[O].[Br-],C32H42BrNO2P,18796.0
6721,IBTP (iodide),ICCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[I-],C22H23I2P,18802.0
6722,A-939572,CNC(=O)c1cccc(NC(=O)N2CCC(Oc3ccccc3Cl)CC2)c1,C20H22ClN3O3,19123.0
6723,Nimbolide,COC(=O)C[C@H]1[C@]2(C)C3=C(C)C(c4ccoc4)C[C@H]3O[C@@H]2[C@@H]2OC(=O)[C@]3(C)C=CC(=O)[C@@]1(C)C23,C27H30O7,19230.0
6724,BPTES,O=C(Cc1ccccc1)Nc1nnc(CCSCCc2nnc(NC(=O)Cc3ccccc3)s2)s1,C24H24N6O2S3,19284.0
6725,Repaglinide,CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O,C27H36N2O4,19387.0
6726,W-19-d4 (hydrochloride),Cl.[2H]c1c([2H])c(S(=O)(=O)/N=C2/CCCCN2CCc2ccc(N)cc2)c([2H])c([2H])c1Cl,C19H23Cl2N3O2S,19487.0
6727,"4-(2,2,3-Trimethylcyclopentyl)butanoic Acid",CC1CCC(CCCC(=O)O)C1(C)C,C12H22O2,19606.0
6728,Curvulin,CCOC(=O)Cc1cc(O)cc(O)c1C(C)=O,C12H14O5,19609.0
6729,BMK Glycidic Acid,CC1(C(=O)O)OC1c1ccccc1,C10H10O3,19682.0
6730,Baicalin,O=C(O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O,C21H18O11,19843.0
6731,Neobavaisoflavone,CC(C)=CCc1cc(-c2coc3cc(O)ccc3c2=O)ccc1O,C20H18O4,19852.0
6732,Etretinate,CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C,C23H30O3,19878.0
6733,Aripiprazole,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,C23H27Cl2N3O2,19989.0
6734,Aripiprazole (CRM),O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,C23H27Cl2N3O2,40171.0
6735,CCT007093,O=C1/C(=C/c2cccs2)CC/C1=C\c1cccs1,C15H12OS2,19992.0
6736,Mirtazapine,CN1CCN2c3ncccc3Cc3ccccc3C2C1,C17H19N3,19994.0
6737,Mirtazapine (CRM),CN1CCN2c3ncccc3Cc3ccccc3C2C1,C17H19N3,31089.0
6738,Ro 4929097,CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@@H]1C(=O)Nc2ccccc2-c2ccccc21,C22H20F5N3O3,19996.0
6739,Loganin,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2[C@@H](C)[C@@H](O)C[C@H]12,C17H26O10,19997.0
6740,para-Methylfentanyl (hydrochloride),CCC(=O)N(c1ccc(C)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O,20038.0
6741,para-Methylfentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1ccc(C)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O,41384.0
6742,Econazole (nitrate),Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1.O=[N+]([O-])O,C18H16Cl3N3O4,20223.0
6743,ONO-RS-082,CCCCCc1ccc(/C=C/C(=O)Nc2cc(Cl)ccc2C(=O)O)cc1,C21H22ClNO3,20243.0
6744,XL147 analog,Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1,C21H16N6O2S2,20245.0
6745,Rotigotine,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,C19H25NOS,20246.0
6746,Nelarabine,COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,C11H15N5O5,20248.0
6747,Labetalol (hydrochloride),CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1.Cl,C19H25ClN2O3,20249.0
6748,Cholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H40O5,20250.0
6749,3-formyl Rifamycin,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(C=O)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,C38H47NO13,20260.0
6750,N-acetyl-L-Cysteine,CC(=O)N[C@@H](CS)C(=O)O,C5H9NO3S,20261.0
6751,Glycocholic Acid,C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C26H43NO6,20276.0
6752,MMP-2/MMP-9 Inhibitor I,O=C(O)[C@@H](Cc1ccccc1)NS(=O)(=O)c1ccc(-c2ccccc2)cc1,C21H19NO4S,20315.0
6753,Galactosylsphingosine (d18:1),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,C24H47NO7,20338.0
6754,Galactosylsphingosine (d18:1) (synthetic),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,C24H47NO7,31594.0
6755,Triclosan,Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl,C12H7Cl3O2,20342.0
6756,Pyrogallol,Oc1cccc(O)c1O,C6H6O3,20347.0
6757,LY2603618,Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1,C18H22BrN5O3,20351.0
6758,D-Cellobiose,O=C[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,C12H22O11,20364.0
6759,Cyclopentyl fentanyl (hydrochloride),Cl.O=C(C1CCCC1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C25H33ClN2O,20439.0
6760,Cyclopentyl fentanyl (hydrochloride) (exempt preparation),Cl.O=C(C1CCCC1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C25H33ClN2O,39593.0
6761,"4.alpha.-Phorbol 12,13-didecanoate",CCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCCCCCCCC,C40H64O8,20446.0
6762,U-47931E,CN(C)[C@@H]1CCCC[C@H]1NC(=O)c1ccc(Br)cc1,C15H21BrN2O,20530.0
6763,L-Tetrahydropalmatine,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2,C21H25NO4,20535.0
6764,RN-486,CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1,C35H35FN6O3,20536.0
6765,UNC1079,O=C(c1ccc(C(=O)N2CCC(N3CCCCC3)CC2)cc1)N1CCC(N2CCCCC2)CC1,C28H42N4O2,20566.0
6766,Stearic Acid methyl ester,CCCCCCCCCCCCCCCCCC(=O)OC,C19H38O2,20609.0
6767,Cyclocreatine,NC1=NCCN1CC(=O)O,C5H9N3O2,20649.0
6768,Rhodamine 101 (inner salt),O=C([O-])c1ccccc1-c1c2cc3c4c(c2[o+]c2c5c6c(cc12)CCCN6CCC5)CCCN4CCC3,C32H30N2O3,20654.0
6769,Docosapentaenoic Acid ethyl ester,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OCC,C24H38O2,20669.0
6770,Resistomycin,Cc1cc(O)c2c3c4c(cc(O)c13)C(C)(C)C(=O)c1c(O)cc(O)c(c1-4)C2=O,C22H16O6,20685.0
6771,TS 155-2,CO[C@H]1/C=C/C=C(\C)C[C@H](C)[C@H](O)[C@H](C)/C=C(C)/C=C(\C)C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](OC(=O)/C=C/C(=O)O)[C@H](C)[C@@H](C(C)C)O1,C39H60O11,20689.0
6772,Tetromycin A,CC(=O)O[C@H]1CC[C@H](C)[C@@H]2[C@@H]1C=C(C)[C@H]1/C(C)=C/CC/C(C)=C/[C@]3(C)C=C(C)[C@H](C)C[C@]34OC(=O)C(=C4O)C(=O)[C@@]21C,C36H48O6,20690.0
6773,Ternatin,CC[C@H](C)[C@H]1NC(=O)[C@@H]([C@H](O)C(C)C)NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C1=O,C37H67N7O8,20691.0
6774,DSP-4,CCN(CCCl)Cc1ccccc1Br.Cl,C11H16BrCl2N,20707.0
6775,Lumichrome,Cc1cc2nc3c(=O)[nH]c(=O)nc-3[nH]c2cc1C,C12H10N4O2,20730.0
6776,"CP 154,526 (hydrochloride)",CCCCN(CC)c1nc(C)nc2c1c(C)cn2-c1c(C)cc(C)cc1C.Cl,C23H33ClN4,20732.0
6777,3-O-methyl-L-DOPA (hydrate),COc1cc(C[C@H](N)C(=O)O)ccc1O.O,C10H15NO5,20737.0
6778,"13Z,16Z-Docosadienoic Acid",CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)O,C22H40O2,20749.0
6779,Eicosadienoic Acid methyl ester,CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)OC,C21H38O2,20750.0
6780,Fusapyrone,CCCCCCC(C)C/C(C)=C\C(/C=C(C)/C=C/C(O)C(C)(C)c1cc(=O)c([C@@H]2O[C@H](CO)C[C@H](O)[C@H]2O)c(O)o1)CO,C34H54O9,20751.0
6781,Dinactin,CC[C@@H]1C[C@H]2CC[C@H](O2)[C@H](C)C(=O)O[C@@H](C)C[C@@H]2CC[C@@H](O2)[C@@H](C)C(=O)O[C@H](CC)C[C@H]2CC[C@H](O2)[C@H](C)C(=O)O[C@@H](C)C[C@@H]2CC[C@@H](O2)[C@@H](C)C(=O)O1,C42H68O12,20752.0
6782,Anidulafungin,CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)cc5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)cc2)cc1,C58H73N7O17,20753.0
6783,Dicoumarol,O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O,C19H12O6,20764.0
6784,Rhod-2 (potassium salt),Cc1ccc(N(CC(=O)[O-])CC(=O)[O-])c(OCCOc2cc(-c3c4ccc(=[N+](C)C)cc-4oc4cc(N(C)C)ccc34)ccc2N(CC(=O)[O-])CC(=O)[O-])c1.[K+].[K+].[K+],C40H39K3N4O11,20777.0
6785,Trovafloxacin (mesylate),CS(=O)(=O)O.N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12,C21H19F3N4O6S,9000303.0
6786,Resibufogenin,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)C[C@H]3O[C@]132,C24H32O4,9001348.0
6787,N-(3-Aminopropyl)acetamide,CC(=O)NCCCN,C5H12N2O,9002787.0
6788,Disuccinimidyl Sulfoxide,O=C(CCS(=O)CCC(=O)ON1C(=O)CCC1=O)ON1C(=O)CCC1=O,C14H16N2O9S,9002863.0
6789,Concanamycin C,C/C=C/[C@H]1O[C@@](O)([C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]2OC)C[C@@H](O[C@H]2C[C@@H](O)[C@H](O)[C@@H](C)O2)[C@@H]1C,C45H74O13,19616.0
6790,"2',5'-dideoxy Adenosine",C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)C[C@@H]1O,C10H13N5O2,20358.0
6791,4-Methylumbelliferyl Phosphate,Cc1cc(=O)oc2cc(OP(=O)(O)O)ccc12,C10H9O6P,16645.0
6792,Z-LLE-AMC,Cc1cc(=O)oc2cc(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc3ccccc3)ccc12,C35H44N4O9,10008117.0
6793,Z-LLL-AMC,Cc1cc(=O)oc2cc(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc3ccccc3)ccc12,C36H48N4O7,10008118.0
6794,Inotilone,CC1=CC(=O)/C(=C/c2ccc(O)c(O)c2)O1,C12H10O4,10010089.0
6795,4-methoxy-.alpha.-Pyrrolidinopropiophenone (hydrochloride),COc1ccc(C(=O)C(C)N2CCCC2)cc1.Cl,C14H20ClNO2,10394.0
6796,"1-Naphthyl 3,5-dinitrobenzoate",O=C(Oc1cccc2ccccc12)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1,C17H10N2O6,11729.0
6797,O-Desmethyl-cis-tramadol (hydrochloride),CN(C)C[C@H]1CCCC[C@]1(O)c1cccc(O)c1.Cl,C15H24ClNO2,13976.0
6798,O-Desmethyl-cis-tramadol (hydrochloride) (CRM),CN(C)C[C@H]1CCCC[C@]1(O)c1cccc(O)c1.Cl,C15H24ClNO2,18751.0
6799,Homoharringtonine,COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4,C29H39NO9,14631.0
6800,H2L5186303,O=C(O)/C=C\C(=O)Nc1ccc(Oc2cccc(Oc3ccc(NC(=O)/C=C\C(=O)O)cc3)c2)cc1,C26H20N2O8,14663.0
6801,1-Aminobenzotriazole,Nn1nnc2ccccc21,C6H6N4,15252.0
6802,NS 11021,FC(F)(F)c1cc(NC(=S)Nc2ccc(Br)cc2-c2nnn[nH]2)cc(C(F)(F)F)c1,C16H9BrF6N6S,15347.0
6803,TAK-733,Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21,C17H15F2IN4O4,16998.0
6804,OTS964 (hydrochloride),Cc1cc(O)c(-c2ccc([C@@H](C)CN(C)C)cc2)c2c1[nH]c(=O)c1sccc12.Cl,C23H25ClN2O2S,17052.0
6805,Furamidine (hydrochloride),Cl.Cl.N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)o2)cc1,C18H18Cl2N4O,19121.0
6806,CCT241533 (hydrochloride),COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC.Cl,C23H28ClFN4O4,19178.0
6807,Ambroxol (hydrochloride),Cl.Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1,C13H19Br2ClN2O,19377.0
6808,Pyoluteorin,O=C(c1cc(Cl)c(Cl)[nH]1)c1c(O)cccc1O,C11H7Cl2NO3,19457.0
6809,Capreomycin (sulfate),NCCC[C@H](N)C(=O)NC[C@H]1NC(=O)[C@H](CO)NC(=O)[C@H](N)CNC(=O)[C@H](C2CCN=C(N)N2)NC(=O)/C(=C/NC(N)=O)NC1=O.O=S(=O)(O)O,C24H44N14O12S,19469.0
6810,Cyclosporin B,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,C61H109N11O12,19525.0
6811,Pyrithiamine (hydrobromide),Br.Cc1ncc(C[n+]2cccc(CCO)c2C)c(N)n1.[Br-],C14H20Br2N4O,19526.0
6812,4-hydroperoxy Cyclophosphamide,O=P1(N(CCCl)CCCl)NC(OO)CCO1,C7H15Cl2N2O4P,19527.0
6813,Ethacrynic Acid,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,C13H12Cl2O4,19536.0
6814,(S)-(-)-BAY-K-8644,COC(=O)C1=C(C)NC(C)=C([N+](=O)[O-])[C@H]1c1ccccc1C(F)(F)F,C16H15F3N2O4,19988.0
6815,ABD459,COc1ccc(C(=O)c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Br)cc3)c2C)cc1,C24H17BrCl2N2O2,20003.0
6816,Despropionyl ortho-Fluorofentanyl,Fc1ccccc1NC1CCN(CCc2ccccc2)CC1,C19H23FN2,20126.0
6817,C2 dihydro Ceramide (d18:0/2:0),CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O,C20H41NO3,20168.0
6818,Vipadenant,Cc1cc(Cn2nnc3c(-c4ccco4)nc(N)nc32)ccc1N,C16H15N7O,20239.0
6819,Vitamin A,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1,C20H30O,20241.0
6820,Nabumetone,COc1ccc2cc(CCC(C)=O)ccc2c1,C15H16O2,20251.0
6821,16-O-Methylcafestol,CO[C@]1(CO)C[C@@]23CC[C@@H]4c5ccoc5CC[C@@]4(C)[C@@H]2CC[C@@H]1C3,C21H30O3,20259.0
6822,"N,N-didesmethyl AH 7921",NC1(CNC(=O)c2ccc(Cl)c(Cl)c2)CCCCC1,C14H18Cl2N2O,20281.0
6823,Uridine,O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1,C9H12N2O6,20300.0
6824,Enrofloxacin,CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1,C19H22FN3O3,20301.0
6825,Epibrassinolide,CC(C)[C@@H](C)[C@@H](O)[C@H](O)[C@@H](C)[C@H]1CC[C@H]2[C@@H]3COC(=O)[C@H]4C[C@H](O)[C@H](O)C[C@]4(C)[C@H]3CC[C@]12C,C28H48O6,20337.0
6826,Pyridoxal 5'-phosphate (hydrate),Cc1ncc(COP(=O)(O)O)c(C=O)c1O.O,C8H10NO6P(H2O)X,20352.0
6827,16-doxyl Stearic Acid,CCC1(CCCCCCCCCCCCCCC(=O)O)OCC(C)(C)N1[O],C22H42NO4,20355.0
6828,Betamethasone,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,C22H29FO5,20363.0
6829,Cefadroxil (hydrate),CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1.O,C16H19N3O6S,20365.0
6830,Tetrabenazine,COc1cc2c(cc1OC)[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2,C19H27NO3,20380.0
6831,Flunarizine (hydrochloride),Cl.Cl.Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1,C26H28Cl2F2N2,20385.0
6832,Deflazacort,CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C,C25H31NO6,20386.0
6833,Racecadotril,CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1,C21H23NO4S,20390.0
6834,TCS 401,Cl.O=C(O)C(=O)Nc1sc2c(c1C(=O)O)CCNC2,C10H11ClN2O5S,20393.0
6835,ML-162,COc1ccc(N(C(=O)CCl)C(C(=O)NCCc2ccccc2)c2cccs2)cc1Cl,C23H22Cl2N2O3S,20455.0
6836,Folic Acid,Nc1nc2[nH]cc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)nc-2c(=O)n1,C19H19N7O6,20515.0
6837,"D-Fructose-1,6-bisphosphate (sodium salt hydrate)",O.O.O.O.O.O.O.O.O=C(COP(=O)([O-])O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)([O-])[O-].[Na+].[Na+].[Na+],C6H27Na3O20P2,20516.0
6838,Trehalose (hydrate),O.O.OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,C12H26O13,20517.0
6839,5-Ethynyl-2'-deoxyuridine,C#Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,C11H12N2O5,20518.0
6840,Thymidine,Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,C10H14N2O5,20519.0
6841,N6-(.delta.2-Isopentenyl)adenosine,CC(C)=CCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C15H21N5O4,20522.0
6842,Ertapenem (sodium salt),C[C@@H](O)[C@H]1C(=O)N2C(C(=O)[O-])=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)[O-])c4)C3)[C@H](C)[C@H]12.[Na+].[Na+],C22H23N3Na2O7S,20523.0
6843,Ansamitocin P-3,CCCC(=O)O[C@H]1CC(=O)N(C)c2cc(cc(OC)c2Cl)C/C(C)=C/C=C/[C@@H](OC)[C@@]2(O)C[C@H](OC(=O)N2)[C@@H](C)[C@@H]2O[C@@]12C,C32H43ClN2O9,20538.0
6844,5-hydroxy-L-Tryptophan,N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O,C11H12N2O3,20539.0
6845,BRD7116,CC1(C)C(C(=O)Nc2ccc(S(=O)(=O)c3ccc(NC(=O)C4C(C)(C)C4(C)C)cc3)cc2)C1(C)C,C28H36N2O4S,20570.0
6846,POBN,CC(C)(C)/[N+]([O-])=C/c1cc[n+]([O-])cc1,C10H14N2O2,20623.0
6847,"5,6-dihydroxy Indole",Oc1cc2cc[nH]c2cc1O,C8H7NO2,20630.0
6848,Disuccinimidyl Glutarate,O=C(CCCC(=O)ON1C(=O)CCC1=O)ON1C(=O)CCC1=O,C13H14N2O8,20646.0
6849,.alpha.-Ethylaminohexanophenone (hydrochloride),CCCCC(NCC)C(=O)c1ccccc1.Cl,C14H22ClNO,20661.0
6850,?-Ethylaminohexanophenone (hydrochloride) (exempt preparation),CCCCC(NCC)C(=O)c1ccccc1.Cl,C14H22ClNO,38986.0
6851,Memantine Lactose Adduct,CC12CC3CC(C)(C1)CC(NC1O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]1O)(C3)C2,C24H41NO10,20662.0
6852,3-BODIPY-propanoylaminocaproic Acid N-hydroxysuccinimide ester,CC1=CC(C)=[N+]2C1=Cc1ccc(CCC(=O)NCCCCCC(=O)ON3C(=O)CCC3=O)n1[B-]2(F)F,C24H29BF2N4O5,20672.0
6853,Prednisone,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,C21H26O5,20677.0
6854,Tramiprosate,NCCCS(=O)(=O)O,C3H9NO3S,20701.0
6855,FRAX1036,CCn1c(=O)c(-c2ccc(-c3cncc(C)n3)cc2Cl)cc2cnc(NCCC3CCN(C)CC3)nc21,C28H32ClN7O,20711.0
6856,4-Aminonicotinic Acid,Nc1ccncc1C(=O)O,C6H6N2O2,20733.0
6857,sn-glycero-3-Phosphocholine,C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO,C8H20NO6P,20736.0
6858,Hydrocortisone,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,C21H30O5,20739.0
6859,4-cyano CUMYL-BUTINACA isomer 2,CC(C)(NC(=O)c1c2ccccc2nn1CCCCC#N)c1ccccc1,C22H24N4O,20748.0
6860,Deoxycholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H40O4,20756.0
6861,Maltoheptaose,O=C[C@H](O)[C@@H](O)[C@H](O[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,C42H72O36,20758.0
6862,Thienyl fentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(Cc2cccs2)CC1.Cl,C19H25ClN2OS,20785.0
6863,2-Iminobiotin,N=C1N[C@H]2[C@H](CS[C@H]2CCCCC(=O)O)N1,C10H17N3O2S,20812.0
6864,N-desethyl Amodiaquine (hydrochloride),CCNCc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl.Cl,C18H20Cl3N3O,20822.0
6865,1-Thioglycerol,OCC(O)CS,C3H8O2S,20824.0
6866,Oleic Anhydride,CCCCCCCC/C=C\CCCCCCCC(=O)OC(=O)CCCCCCC/C=C\CCCCCCCC,C36H66O3,20825.0
6867,Lithocholic Acid-d4,[2H]C1([2H])C[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]32)C([2H])([2H])[C@@H]1O,C24H40O3,20831.0
6868,L-Theanine,CCNC(=O)CC[C@H](N)C(=O)O,C7H14N2O3,20832.0
6869,Chenodeoxycholic Acid-d4,[2H]C1([2H])C[C@@]2(C)[C@H](C[C@@H](O)[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]32)C([2H])([2H])[C@@H]1O,C24H40O4,20848.0
6870,Cholic Acid-d4,[2H]C1([2H])C[C@@]2(C)[C@H](C[C@@H](O)[C@@H]3[C@@H]2C[C@H](O)[C@]2(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]32)C([2H])([2H])[C@@H]1O,C24H40O5,20849.0
6871,JWH 016-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])n1c(C)c(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,20850.0
6872,Deoxycholic Acid-d4,[2H]C1([2H])C[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2C[C@H](O)[C@]2(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]32)C([2H])([2H])[C@@H]1O,C24H40O4,20851.0
6873,Cephaeline,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(O)c(OC)cc21,C28H38N2O4,20916.0
6874,Triparanol,CCN(CC)CCOc1ccc(C(O)(Cc2ccc(Cl)cc2)c2ccc(C)cc2)cc1,C27H32ClNO2,20918.0
6875,Ganaxolone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C,C22H36O2,20919.0
6876,Fenbendazole sulfone,COC(=O)Nc1nc2cc(S(=O)(=O)c3ccccc3)ccc2[nH]1,C15H13N3O4S,20921.0
6877,Desacetyl Bisacodyl,Oc1ccc(C(c2ccc(O)cc2)c2ccccn2)cc1,C18H15NO2,20928.0
6878,Geranyl Pyrophosphate (triammonium salt),CC(C)=CCC/C(C)=C/COP(=O)([O-])OP(=O)([O-])[O-].[NH4+].[NH4+].[NH4+],C10H29N3O7P2,63320.0
6879,Metronidazole,Cc1ncc([N+](=O)[O-])n1CCO,C6H9N3O3,9002409.0
6880,8-bromo Cyclic AMP,Nc1ncnc2c1nc(Br)n2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1O,C10H11BrN5O6P,18141.0
6881,N-Hydroxysulfosuccinimide (sodium salt),O=C1CC(S(=O)(=O)[O-])C(=O)N1O.[Na+],C4H4NNaO6S,20680.0
6882,"N,N',N''-Triacetylchitotriose",CC(=O)N[C@H]1[C@H](O[C@@H]([C@H](O)[C@H](C=O)NC(C)=O)[C@H](O)CO)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]1O,C24H41N3O16,20759.0
6883,124-87-8,C=C(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C.CC(C)(O)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C,C30H34O13,20771.0
6884,AS-8351,O=C(N/N=C/c1c(O)ccc2ccccc12)c1ccncc1,C17H13N3O2,20811.0
6885,Lofepramine,CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1,C26H27ClN2O,20813.0
6886,H2S Donor 5a,O=C(NSC(=O)c1ccccc1)c1ccccc1,C14H11NO2S,11238.0
6887,Tentoxin,CC(C)C[C@@H]1NC(=O)[C@H](C)N(C)C(=O)CNC(=O)/C(=C\c2ccccc2)N(C)C1=O,C22H30N4O4,11442.0
6888,Cycloastragenol,CC(C)(O)[C@H]1CC[C@@](C)([C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O)[C@H]5C(C)(C)[C@@H](O)CC[C@@]56C[C@@]46CC[C@]23C)O1,C30H50O5,11722.0
6889,Madecassoside,CC1CCC2(C(=O)OC3OC(COC4OC(CO)C(OC5OC(C)C(O)C(O)C5O)C(O)C4O)C(O)C(O)C3O)CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(CO)C5C(O)CC43C)C2C1C,C48H78O20,11855.0
6890,FPS-ZM1,O=C(c1ccc(Cl)cc1)N(Cc1ccccc1)C1CCCCC1,C20H22ClNO,11909.0
6891,SB 297006,CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1ccccc1,C18H18N2O5,11964.0
6892,Valilactone,CCCCCC[C@@H]1C(=O)O[C@H]1C[C@H](CCCCC)OC(=O)[C@@H](NC=O)C(C)C,C22H39NO5,13690.0
6893,Resveratrol-3-O-Sulfate (sodium salt),O=S(=O)([O-])Oc1cc(O)cc(/C=C/c2ccc(O)cc2)c1.[Na+],C14H11NaO6S,14942.0
6894,LY303511 (hydrochloride),Cl.Cl.O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12,C19H20Cl2N2O2,15514.0
6895,Glycopyrrolate,C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-],C19H28BrNO3,16498.0
6896,Casticin,COc1ccc(-c2oc3cc(OC)c(OC)c(O)c3c(=O)c2OC)cc1O,C19H18O8,16976.0
6897,Onalespib,CC(C)c1cc(C(=O)N2Cc3ccc(CN4CCN(C)CC4)cc3C2)c(O)cc1O,C24H31N3O3,10655.0
6898,MitoPQ,C[n+]1ccc(-c2cc[n+](CCCCCCCCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)cc2)cc1.[I-].[I-].[I-],C39H46I3N2P,18808.0
6899,JJH260,CN(C)c1ccc(C(=O)N2CCN3C(=O)N(OC(=O)N4CCC(CCc5ccc(Cl)cc5)CC4)C(=O)C3C2)cc1,C29H34ClN5O5,19384.0
6900,NS 1643,O=C(Nc1cc(C(F)(F)F)ccc1O)Nc1cc(C(F)(F)F)ccc1O,C15H10F6N2O3,20343.0
6901,Praziquantel,O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1,C19H24N2O2,20508.0
6902,Closantel,Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O,C22H14Cl2I2N2O2,20531.0
6903,AM4113,Cc1c(C(N)=O)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,C17H12Cl3N3O,20581.0
6904,PTP Inhibitor II,COc1ccc(C(=O)CBr)cc1,C9H9BrO2,20629.0
6905,MK-4827 (tosylate),Cc1ccc(S(=O)(=O)O)cc1.NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,C26H28N4O4S,20842.0
6906,Ethyl 3-Aminobenzoate (methanesulfonate),CCOC(=O)c1cccc(N)c1.CS(=O)(=O)O,C10H15NO5S,20660.0
6907,Lumefantrine,CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1,C30H32Cl3NO,20678.0
6908,Pentamidine,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,C19H24N4O2,20679.0
6909,Vilanterol,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O,C24H33Cl2NO5,20702.0
6910,7-epi Taxol,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,C47H51NO14,20741.0
6911,13C6-3-Nitrophenylhydrazine (hydrochloride),Cl.NN[13c]1[13cH][13cH][13cH][13c]([N+](=O)[O-])[13cH]1,C6H8ClN3O2,20744.0
6912,Piperacillin (sodium salt),CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)[O-])c2ccccc2)C(=O)C1=O.[Na+],C23H26N5NaO7S,20766.0
6913,.beta.-hydroxy Fentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CC(O)c2ccccc2)CC1.Cl,C22H29ClN2O2,20789.0
6914,?-hydroxy Fentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1ccccc1)C1CCN(CC(O)c2ccccc2)CC1.Cl,C22H29ClN2O2,40504.0
6915,"2,3-Butanedione-2-monoxime",CC(=O)/C(C)=N/O,C4H7NO2,20828.0
6916,Cambendazol,CC(C)OC(=O)Nc1ccc2nc(-c3cscn3)[nH]c2c1,C14H14N4O2S,20841.0
6917,LY2874455,C[C@@H](Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl,C21H19Cl2N5O2,20843.0
6918,Necrosulfonamide,COc1nccnc1NS(=O)(=O)c1ccc(NC(=O)/C=C/c2ccc([N+](=O)[O-])s2)cc1,C18H15N5O6S2,20844.0
6919,Dihydrocytochalasin B,C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)CC[C@H](O)CCC[C@@H](C)C/C=C/[C@H]3[C@@H]1O,C29H39NO5,20845.0
6920,N-methyl Protoporphyrin IX,C=CC1=C(C)c2cc3c(C=C)c(C)c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(=O)O)C(CCC(=O)O)=C4C)n3C,C35H35N4O4,20846.0
6921,Oxotremorine M (iodide),C[N+](C)(C)CC#CCN1CCCC1=O.[I-],C11H19IN2O,20847.0
6922,CD3254,Cc1cc2c(cc1-c1cc(/C=C/C(=O)O)ccc1O)C(C)(C)CCC2(C)C,C24H28O3,20870.0
6923,ML-356,CCC(CC)C(=O)Nc1nc(-c2ccc(S(=O)(=O)N3CCOCC3)cc2)cs1,C19H25N3O4S2,20940.0
6924,Cyclopamine-KAAD,CC1=C2C[C@H]3[C@@H](CC=C4CC(=O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN(CCNC(=O)CCCCCNC(=O)CCc3ccccc3)[C@H]1[C@H]2C,C44H63N3O4,20943.0
6925,Aminoglutethimide,CCC1(c2ccc(N)cc2)CCC(=O)NC1=O,C13H16N2O2,20947.0
6926,Amiselimod (hydrochloride),CCCCCCCOc1ccc(CCC(N)(CO)CO)cc1C(F)(F)F.Cl,C19H31ClF3NO3,20970.0
6927,Pamapimod,Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21,C19H20F2N4O4,20971.0
6928,Selonsertib,Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1,C24H24FN7O,20972.0
6929,CPI-268456,Cc1noc2c1-c1ccc(Cl)cc1C(c1ccc(Cl)cc1)=N[C@H]2CC(N)=O,C20H15Cl2N3O2,20973.0
6930,GSK2981278,CCc1ccc(N(CC(C)C)S(=O)(=O)c2ccc(OCC3CCOCC3)c(CO)c2)cc1,C25H35NO5S,20974.0
6931,PQ401,COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12,C18H16ClN3O2,20979.0
6932,Eniporide,Cc1cc(-n2cccc2)c(S(C)(=O)=O)cc1C(=O)NC(=N)N,C14H16N4O3S,20984.0
6933,Lurasidone,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1,C28H36N4O2S,9000570.0
6934,.beta.-methyl Fentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CC(C)c2ccccc2)CC1.Cl,C23H31ClN2O,9002860.0
6935,?-methyl Fentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1ccccc1)C1CCN(CC(C)c2ccccc2)CC1.Cl,C23H31ClN2O,38835.0
6936,JWH 251,CCCCCn1cc(C(=O)Cc2ccccc2C)c2ccccc21,C22H25NO,10578.0
6937,A-196,Clc1cc2c(NC3CCCC3)nnc(-c3ccncc3)c2cc1Cl,C18H16Cl2N4,18317.0
6938,PX-478,Cl.Cl.N[C@@H](Cc1ccc([N+]([O-])(CCCl)CCCl)cc1)C(=O)O,C13H20Cl4N2O3,10005189.0
6939,5'-deoxy-5-Fluorocytidine,C[C@H]1O[C@@H](n2cc(F)c(N)nc2=O)[C@H](O)[C@@H]1O,C9H12FN3O4,10010682.0
6940,Dinophysistoxin-1,C=C1[C@@H](O)[C@@H]2O[C@]3(CC[C@H](/C=C/[C@@H](C)[C@@H]4CC(C)=C[C@@]5(O[C@H](C[C@@](C)(O)C(=O)O)CC[C@H]5O)O4)O3)CC[C@H]2O[C@@H]1[C@@H](O)C[C@H](C)[C@H]1O[C@@]2(CC[C@H]1C)OCCC[C@H]2C,C45H70O13,10011497.0
6941,Hispidin,O=c1cc(O)cc(/C=C/c2ccc(O)c(O)c2)o1,C13H10O5,10012605.0
6942,FR900098 (sodium salt),CC(=O)N(O)CCCP(=O)([O-])O.[Na+],C5H11NNaO5P,10012681.0
6943,LP-533401,Nc1nc(OC(c2ccc(-c3cccc(F)c3)cc2)C(F)(F)F)cc(-c2ccc(C[C@H](N)C(=O)O)cc2)n1,C27H22F4N4O3,10492.0
6944,FLLL32,COc1ccc(/C=C/C(=O)C2(C(=O)/C=C/c3ccc(OC)c(OC)c3)CCCCC2)cc1OC,C28H32O6,10638.0
6945,PRMT4/CARM1 Inhibitor,O=C1/C(=C/c2ccc(O)c(Br)c2)CN(Cc2ccccc2)C/C1=C\c1ccc(O)c(Br)c1,C26H21Br2NO3,11033.0
6946,CHR-6494,CCCNc1ccc2ncc(-c3ccc4[nH]ncc4c3)n2n1,C16H16N6,11478.0
6947,Zaleplon,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,C17H15N5O,11577.0
6948,Zaleplon (CRM),CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,C17H15N5O,20411.0
6949,5'-Ethynyl-2'-deoxycytidine,C#Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)nc1N,C11H13N3O4,11581.0
6950,Necrostatin-2,CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O,C13H12ClN3O2,11657.0
6951,K145 (hydrochloride),CCCCOc1ccc(CC/C=C2\SC(=O)N(CCN)C2=O)cc1.Cl,C18H25ClN2O3S,11691.0
6952,BRD9539,O=C(O)c1ccc2c(c1)nc(NC(=O)c1ccccc1)n2CCCc1ccccc1,C24H21N3O3,11788.0
6953,8-Gingerol,CCCCCCC[C@H](O)CC(=O)CCc1ccc(O)c(OC)c1,C19H30O4,11841.0
6954,10-Gingerol,CCCCCCCCC[C@H](O)CC(=O)CCc1ccc(O)c(OC)c1,C21H34O4,11842.0
6955,MN-001,CCCc1c(SCCCOc2ccc(C(C)=O)c(OCCCC(=O)O)c2CCC)ccc(C(C)=O)c1O,C29H38O7S,11948.0
6956,MJ15,Cc1c(C(=O)NCc2cccnc2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,C23H17Cl3N4O,11956.0
6957,Sonepiprazole,NS(=O)(=O)c1ccc(N2CCN(CC[C@@H]3OCCc4ccccc43)CC2)cc1,C21H27N3O3S,11983.0
6958,Punicalagin,O=CC1OC(=O)c2cc(O)c(O)c(O)c2-c2c(cc(O)c(O)c2O)C(=O)OC1C1OC(=O)c2cc(O)c(O)c(O)c2-c2c(O)c(O)c3oc(=O)c4c(c(O)c(O)c5oc(=O)c2c3c54)-c2c(cc(O)c(O)c2O)C(=O)OCC1O,C48H28O30,13069.0
6959,Geranylgeranyl Alcohol,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CO,C20H34O,13272.0
6960,PSI-6130,C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O,C10H14FN3O4,13575.0
6961,GW 856553X,Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1,C22H26FN3O2,13614.0
6962,MDL 12330A (hydrochloride),Cl.c1ccc([C@@H]2CCC[C@@H]2N/C2=N/CCCCCCCCCCC2)cc1,C23H37ClN2,14559.0
6963,SF7-AM,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(N=[N+]=[N-])cc2Oc2cc(N=[N+]=[N-])ccc21,C31H23N7O12,14623.0
6964,KT203,O=C(O)c1cccc(-c2ccc(-c3cn(C(=O)N4CCCCC4Cc4ccccc4)nn3)cc2)c1,C28H26N4O3,14819.0
6965,Methylmalonic Acid,CC(C(=O)O)C(=O)O,C4H6O4,14885.0
6966,SIB 1553A (hydrochloride),CN1CCCC1CCSc1ccc(O)cc1.Cl,C13H20ClNOS,14973.0
6967,SNS-314 (mesylate),CS(=O)(=O)O.O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1,C19H19ClN6O4S3,14974.0
6968,TAS 301,COc1ccc(C(=C2C(=O)Nc3ccccc32)c2ccc(OC)cc2)cc1,C23H19NO3,14976.0
6969,Normeperidine (hydrochloride),CCOC(=O)C1(c2ccccc2)CCNCC1.Cl,C14H20ClNO2,15285.0
6970,Normeperidine (hydrochloride) (CRM),CCOC(=O)C1(c2ccccc2)CCNCC1.Cl,C14H20ClNO2,20899.0
6971,KT182,O=C(N1CCCCC1c1ccccc1)n1cc(-c2ccc(-c3cccc(CO)c3)cc2)nn1,C27H26N4O2,15404.0
6972,Adenosine Dialdehyde,Nc1ncnc2c1ncn2C(C=O)OC(C=O)CO,C10H11N5O4,15644.0
6973,Zolpidem,Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1,C19H21N3O,15792.0
6974,Zolpidem (CRM),Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1,C19H21N3O,20648.0
6975,AT7867,Clc1ccc(C2(c3ccc(-c4cn[nH]c4)cc3)CCNCC2)cc1,C20H20ClN3,16848.0
6976,I-BET726,CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C,C25H23ClN2O3,16872.0
6977,Arylquin 1,CN(C)c1ccc2cc(-c3ccccc3F)c(N)nc2c1,C17H16FN3,16961.0
6978,PIK-III,Nc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1,C17H17N7,17002.0
6979,GSK2656157,Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1,C23H21FN6O,17372.0
6980,TC-E 5002,O=C(O)CCN(O)C(=O)CCCCCCCCC1CC1,C15H27NO4,17717.0
6981,Tivozanib (hydrate),COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC.O,C22H21ClN4O6,18493.0
6982,BAY-678,CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1,C20H15F3N4O2,18615.0
6983,Zaleplon-d4,[2H]c1c([2H])c(-c2ccnc3c(C#N)cnn23)c([2H])c(N(CC)C(C)=O)c1[2H],C17H15N5O,18620.0
6984,Zaleplon-d4 (CRM),[2H]c1c([2H])c(-c2ccnc3c(C#N)cnn23)c([2H])c(N(CC)C(C)=O)c1[2H],C17H15N5O,20412.0
6985,ML-264,CN(C(=O)CNC(=O)/C=C/c1cccc(Cl)c1)C1CCS(=O)(=O)CC1,C17H21ClN2O4S,18880.0
6986,SW203668 (trifluoroacetate salt,COc1ccc2nc(NC(=O)c3ccc(C(N)c4ccccc4)cc3)sc2c1.O=C(O)C(F)(F)F,C24H20F3N3O4S,19379.0
6987,Adaptaquin,Oc1cccnc1NC(c1ccc(Cl)cc1)c1ccc2cccnc2c1O,C21H16ClN3O2,19720.0
6988,HLCL-61 (hydrochloride),CCn1c2ccccc2c2cc(CNCc3ccccc3OC)ccc21.Cl,C23H25ClN2O,19897.0
6989,MRT68921,CN1CCc2cc(Nc3ncc(C4CC4)c(NCCCNC(=O)C4CCC4)n3)ccc2C1,C25H34N6O,19905.0
6990,AZD 3759,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C,C22H23ClFN5O3,19931.0
6991,SHP099,CC1(N)CCN(c2cnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1,C16H19Cl2N5,20000.0
6992,3-Hydroxyhexadecanoic Acid methyl ester,CCCCCCCCCCCCCC(O)CC(=O)OC,C17H34O3,20108.0
6993,3-hydroxy Palmitic Acid methyl ester,CCCCCCCCCCCCCC(O)CC(=O)OC,C17H34O3,20108.0
6994,GW 405833,COc1ccc2c(c1)c(CCN1CCOCC1)c(C)n2C(=O)c1cccc(Cl)c1Cl,C23H24Cl2N2O3,20219.0
6995,Nitrofen,O=[N+]([O-])c1ccc(Oc2ccc(Cl)cc2Cl)cc1,C12H7Cl2NO3,20341.0
6996,Sparfloxacin,C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1,C19H22F2N4O3,20379.0
6997,4'-bromo-Resveratrol,Oc1cc(O)cc(/C=C/c2ccc(Br)cc2)c1,C14H11BrO2,20541.0
6998,GSK2837808A,COc1ncc(-c2ccc3c(Nc4cc(Oc5cc(F)cc(F)c5)cc(C(=O)O)c4)c(S(=O)(=O)NC4CC4)cnc3c2)c(OC)n1,C31H25F2N5O7S,20626.0
6999,"1-(3,5-Dimethylphenyl)piperazine",Cc1cc(C)cc(N2CCNCC2)c1,C12H18N2,20627.0
7000,Lumiflavine,Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C)c2cc1C,C13H12N4O2,20645.0
7001,"2',7'-Dichlorofluorescein diacetate",CC(=O)Oc1cc2c(cc1Cl)C1(OC(=O)c3ccccc31)c1cc(Cl)c(OC(C)=O)cc1O2,C24H14Cl2O7,20656.0
7002,Gallocyanine,CN(C)c1ccc2nc3c(C(=O)O)cc(O)c(O)c3[o+]c2c1.[Cl-],C15H13ClN2O5,20657.0
7003,5-(Hydroxymethyl)furfuryl Alcohol,OCc1ccc(CO)o1,C6H8O3,20658.0
7004,Isoxsuprine (hydrochloride),CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1.Cl,C18H24ClNO3,20688.0
7005,FlAsH-EDT2,O=C1OC2(c3ccccc31)c1ccc(O)c([As]3SCCS3)c1Oc1c2ccc(O)c1[As]1SCCS1,C24H18As2O5S4,20704.0
7006,Pyridoxine,Cc1ncc(CO)c(CO)c1O,C8H11NO3,20706.0
7007,U-48753E (maleate),CCC(=O)N(c1ccc(Cl)c(Cl)c1)[C@@H]1CCC[C@H]1N(C)C.O=C(O)/C=C\C(=O)O,C20H26Cl2N2O5,20734.0
7008,Perphenazine,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,C21H26ClN3OS,20735.0
7009,Risedronate (sodium salt),O=P([O-])(O)C(O)(Cc1cccnc1)P(=O)(O)O.[Na+],C7H10NNaO7P2,20740.0
7010,Piracetam,NC(=O)CN1CCCC1=O,C6H10N2O2,20755.0
7011,Loxapine (succinate),CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.O=C(O)CCC(=O)O,C22H24ClN3O5,20760.0
7012,Pizotifen (malate),CN1CCC(=C2c3ccccc3CCc3sccc32)CC1.O=C(O)CC(O)C(=O)O,C23H27NO5S,20765.0
7013,Toltrazuril,Cc1cc(-n2c(=O)[nH]c(=O)n(C)c2=O)ccc1Oc1ccc(SC(F)(F)F)cc1,C18H14F3N3O4S,20767.0
7014,Tolcapone,Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1,C14H11NO5,20768.0
7015,Etidronate (sodium salt),CC(O)(P(=O)([O-])O)P(=O)([O-])O.[Na+].[Na+],C2H6Na2O7P2,20769.0
7016,Chlorprothixene (hydrochloride),CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21.Cl,C18H19Cl2NS,20772.0
7017,17.alpha.-Estradiol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@H]2O,C18H24O2,20776.0
7018,Thiofentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CCc2cccs2)CC1.Cl,C20H27ClN2OS,20786.0
7019,Thiofentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1ccccc1)C1CCN(CCc2cccs2)CC1.Cl,C20H27ClN2OS,40361.0
7020,Perindopril,CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC,C19H32N2O5,20796.0
7021,Isoquercitroside,O=c1c(O[C@@H]2O[C@H]([C@H](O)CO)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,C21H20O12,20802.0
7022,5-fluoro MDMB-PICA,COC(=O)[C@@H](NC(=O)c1cn(CCCCCF)c2ccccc12)C(C)(C)C,C21H29FN2O3,20803.0
7023,5-fluoro MDMB-PICA (exempt preparation),COC(=O)[C@@H](NC(=O)c1cn(CCCCCF)c2ccccc12)C(C)(C)C,C21H29FN2O3,38163.0
7024,M50054,O=C1CCCC(=O)C1CC1C(=O)CCCC1=O,C13H16O4,20810.0
7025,.alpha.-methyl Thiofentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(C(C)Cc2cccs2)CC1.Cl,C21H29ClN2OS,20821.0
7026,?-methyl Thiofentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1ccccc1)C1CCN(C(C)Cc2cccs2)CC1.Cl,C21H29ClN2OS,40362.0
7027,Acacetin,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1,C16H12O5,20827.0
7028,L-(-)-Glucose,O=C[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)CO,C6H12O6,20829.0
7029,D-Xylulose,O=C(CO)[C@@H](O)[C@H](O)CO,C5H10O5,20830.0
7030,Etodolac,CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3,C17H21NO3,20833.0
7031,Decanoic Acid (sodium salt),CCCCCCCCCC(=O)[O-].[Na+],C10H19NaO2,20838.0
7032,Acitretin,COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C,C21H26O3,20853.0
7033,Toremifene (citrate),CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O,C32H36ClNO8,20854.0
7034,Benzodioxole fentanyl,O=C(c1ccc2c(c1)OCO2)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C27H28N2O3,20858.0
7035,Benzodioxole fentanyl (CRM),O=C(c1ccc2c(c1)OCO2)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C27H28N2O3,26276.0
7036,S-Phenylmercapturic Acid,CC(=O)N[C@@H](CSc1ccccc1)C(=O)O,C11H13NO3S,20869.0
7037,MY-5445,Clc1cccc(Nc2nnc(-c3ccccc3)c3ccccc23)c1,C20H14ClN3,20872.0
7038,Neocuproine,Cc1ccc2ccc3ccc(C)nc3c2n1,C14H12N2,20874.0
7039,Amino Tadalafil,NN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O,C21H18N4O4,20876.0
7040,"D-Gulono-1,4-lactone",O=C1O[C@@H]([C@H](O)CO)[C@@H](O)[C@H]1O,C6H10O6,20888.0
7041,7-Hydroxy Coumarin sulfate (potassium salt),O=c1ccc2ccc(OS(=O)(=O)[O-])cc2o1.[K+],C9H5KO6S,20892.0
7042,7-hydroxy Coumarin sulfate (potassium salt),O=c1ccc2ccc(OS(=O)(=O)[O-])cc2o1.[K+],C9H5KO6S,20892.0
7043,3-Mercaptopicolinic Acid (hydrochloride),Cl.O=C(O)c1ncccc1S,C6H6ClNO2S,20895.0
7044,PGP-4008,O=C(Cc1ccccc1)Nc1c2c(nc3ccccc13)N(Cc1ccccc1)CC2,C26H23N3O,20901.0
7045,Ormeloxifene,COc1ccc2c(c1)OC(C)(C)[C@H](c1ccccc1)[C@H]2c1ccc(OCCN2CCCC2)cc1,C30H35NO3,20903.0
7046,Metastin (45-54),CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,C63H83N17O14,20905.0
7047,nNOS Inhibitor I,N=C(NCCC[C@H](N)CNCCN)N[N+](=O)[O-].O=C(O)C(F)(F)F,C10H22F3N7O4,20906.0
7048,4-Methylumbelliferyl .beta.-D-Galactopyranoside-6-sulfate (sodium salt),Cc1cc(=O)oc2cc(O[C@@H]3O[C@H](COS(=O)(=O)[O-])[C@H](O)[C@H](O)[C@H]3O)ccc12.[Na+],C16H17NaO11S,20907.0
7049,2-keto D-Glucose,O=CC(=O)[C@@H](O)[C@H](O)[C@H](O)CO,C6H10O6,20908.0
7050,N-Butylfluorescein,CCCCOc1ccc2c(c1)Oc1cc(O)ccc1C21OC(=O)c2ccccc21,C24H20O5,20909.0
7051,Tyvelose,C[C@@H](O)[C@@H](O)C[C@H](O)C=O,C6H12O4,20910.0
7052,6-deoxy-L-Talose,C[C@H](O)[C@@H](O)[C@@H](O)[C@@H](O)C=O,C6H12O5,20911.0
7053,Mitomycin A,COC1=C(C)C(=O)C2=C(C1=O)[C@@H](COC(N)=O)[C@@]1(OC)[C@H]3N[C@H]3CN21,C16H19N3O6,20915.0
7054,Brassinin,CSC(=S)NCc1c[nH]c2ccccc12,C11H12N2S2,20922.0
7055,HC-067047,Cc1c(C(=O)Nc2cccc(C(F)(F)F)c2)cc(-c2ccccc2)n1CCCN1CCOCC1,C26H28F3N3O2,20927.0
7056,Flurandrenolide,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,C24H33FO6,20933.0
7057,Dp44mT,CN(C)C(=S)NN=C(c1ccccn1)c1ccccn1,C14H15N5S,20936.0
7058,"1,4-dideoxy-1,4-imino-D-Arabinitol (hydrochloride)",Cl.OC[C@H]1NC[C@@H](O)[C@@H]1O,C5H12ClNO3,20939.0
7059,4-Methylumbelliferyl-.beta.-D-Glucopyranoside,Cc1cc(=O)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12,C16H18O8,20948.0
7060,Mepyramine (maleate),COc1ccc(CN(CCN(C)C)c2ccccn2)cc1.O=C(O)/C=C\C(=O)O,C21H27N3O5,20978.0
7061,GSK6853,COc1ccccc1C(=O)Nc1cc2c(cc1N1CCNC[C@H]1C)n(C)c(=O)n2C,C22H27N5O3,20985.0
7062,Brompheniramine (maleate),CN(C)CCC(c1ccc(Br)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O,C20H23BrN2O4,20996.0
7063,Pregnenolone sulfate (sodium salt),CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@]12C.[Na+],C21H31NaO5S,21004.0
7064,Methicillin (sodium salt),COc1cccc(OC)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)[O-].[Na+],C17H19N2NaO6S,21007.0
7065,Nitrosobenzene,O=Nc1ccccc1,C6H5NO,21009.0
7066,HEMADO,CCCCC#Cc1nc(NC)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1,C17H23N5O4,21015.0
7067,"9-(2,2-Dicyanovinyl)julolidine",N#CC(C#N)=Cc1cc2c3c(c1)CCCN3CCC2,C16H15N3,21016.0
7068,MBCQ,Clc1ccc2ncnc(NCc3ccc4c(c3)OCO4)c2c1,C16H12ClN3O2,21017.0
7069,Demethylasterriquinone B1,C=CC(C)(C)c1[nH]c2ccccc2c1C1=C(O)C(=O)C(c2c[nH]c3c(CC=C(C)C)cccc23)=C(O)C1=O,C32H30N2O4,21026.0
7070,Decylubiquinone,CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(OC)C1=O,C19H30O4,21027.0
7071,BAY 59-3074,N#Cc1c(Oc2cccc(OS(=O)(=O)CCCC(F)(F)F)c2)cccc1C(F)(F)F,C18H13F6NO4S,21036.0
7072,RS-1,O=C(Nc1ccc(Br)cc1)c1ccc(Br)c(S(=O)(=O)NCc2ccccc2)c1,C20H16Br2N2O3S,21037.0
7073,CVT-313,COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1,C20H28N6O3,21044.0
7074,PD 168393,C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,C17H13BrN4O,21059.0
7075,BMS-5,CC(C)C(=O)Nc1ncc(-c2cc(C(F)F)nn2-c2c(Cl)cccc2Cl)s1,C17H14Cl2F2N4OS,21072.0
7076,Bohemine,CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21,C18H24N6O,21073.0
7077,Omecamtiv Mecarbil,COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1,C20H24FN5O3,21074.0
7078,"all-cis-4,7,10,13,16-Docosapentaenoic Acid methyl ester",CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC,C23H36O2,21124.0
7079,TAS 120,C=CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1,C22H22N6O3,21136.0
7080,para-Methoxymethamphetamine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])NC(C)Cc1ccc(OC)cc1,C11H18ClNO,9002806.0
7081,2-O-Hexadecyl Glycerol,CCCCCCCCCCCCCCCCOC(CO)CO,C19H40O3,11924.0
7082,MPI-0441138,COc1ccc(N(C)c2nc(Cl)nc3ccccc23)cc1,C16H14ClN3O,13098.0
7083,7-Aminoclonazepam-d4 (CRM),[2H]c1c([2H])c([2H])c(C2=NCC(=O)Nc3ccc(N)cc32)c(Cl)c1[2H],C15H12ClN3O,18684.0
7084,.alpha.-methyl Acetyl fentanyl (hydrochloride),CC(=O)N(c1ccccc1)C1CCN(C(C)Cc2ccccc2)CC1.Cl,C22H29ClN2O,20816.0
7085,?-methyl Acetyl fentanyl (hydrochloride) (CRM),CC(=O)N(c1ccccc1)C1CCN(C(C)Cc2ccccc2)CC1.Cl,C22H29ClN2O,26636.0
7086,Proxyphylline,CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C,C10H14N4O3,20937.0
7087,Ubiquitin Isopeptidase Inhibitor I,O=C1/C(=C\c2ccc([N+](=O)[O-])cc2)CS(=O)(=O)C/C1=C/c1ccc([N+](=O)[O-])cc1,C19H14N2O7S,21006.0
7088,AZD 6738,C[C@@H]1COCCN1c1cc(C2([S@@](C)(=N)=O)CC2)nc(-c2ccnc3[nH]ccc23)n1,C20H24N6O2S,21035.0
7089,CXD101,Cc1nn(C)cc1CN1CCC(c2ccc(C(=O)Nc3ccccc3N)cc2)CC1,C24H29N5O,21159.0
7090,NCT-501,CC(C)CCn1c(CN2CCN(C(=O)C3CC3)CC2)nc2c1c(=O)n(C)c(=O)n2C,C21H32N6O3,21162.0
7091,Buprenorphine (hydrochloride),CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5.Cl,C29H42ClNO4,14025.0
7092,(S)-BAY 598,CCN(C(=O)CO)[C@H]1CN(/C(=N\C#N)Nc2cccc(OC(F)F)c2)N=C1c1ccc(Cl)c(Cl)c1,C22H20Cl2F2N6O3,18238.0
7093,Cocaine-d3 (CRM),[2H]C([2H])([2H])N1C2CCC1C(C(=O)OC)C(OC(=O)c1ccccc1)C2,C17H21NO4,19423.0
7094,2'3'-cGAMP (sodium salt),Nc1nc(=O)c2ncn([C@@H]3O[C@@H]4COP(=O)([O-])O[C@H]5[C@@H](O)[C@H](n6cnc7c(N)ncnc76)O[C@@H]5COP(=O)([O-])O[C@@H]3[C@@H]4O)c2[nH]1.[Na+].[Na+],C20H22N10Na2O13P2,19887.0
7095,CUMYL-PINACA (CRM),CCCCCn1nc(C(=O)NC(C)(C)c2ccccc2)c2ccccc21,C22H27N3O,19948.0
7096,Methyl Gallate,COC(=O)c1cc(O)c(O)c(O)c1,C8H8O5,19951.0
7097,cis-Vaccenic Acid,CCCCCC/C=C\CCCCCCCCCC(=O)O,C18H34O2,20023.0
7098,cis-Petroselinic Acid,CCCCCCCCCCC/C=C\CCCCC(=O)O,C18H34O2,20024.0
7099,20(S)-hydroxy Cholesterol,CC(C)CCC[C@](C)(O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,C27H46O2,20103.0
7100,Flurazepam-d10 (CRM),[2H]C([2H])([2H])C([2H])([2H])N(CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21)C([2H])([2H])C([2H])([2H])[2H],C21H23ClFN3O,20284.0
7101,Benzyl Carfentanil (hydrochloride),CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(Cc2ccccc2)CC1.Cl,C23H29ClN2O3,20350.0
7102,Copanlisib,COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21,C23H28N8O4,20354.0
7103,trans-4-phenyl-4-Piperidinocyclohexanol,O[C@H]1CC[C@](c2ccccc2)(N2CCCCC2)CC1,C17H25NO,20565.0
7104,EMPO,CCOC(=O)C1(C)CCC=[N+]1[O-],C8H13NO3,20618.0
7105,4-Aminophenylphosphorylcholine,C[N+](C)(C)CCOP(=O)([O-])Oc1ccc(N)cc1,C11H19N2O4P,20643.0
7106,HX 531,CN1c2ccc([N+](=O)[O-])cc2N=C(c2ccc(C(=O)O)cc2)c2cc3c(cc21)C(C)(C)CCC3(C)C,C29H29N3O4,20762.0
7107,AZD 1981,CC(=O)Nc1cccc2c1c(Sc1ccc(Cl)cc1)c(C)n2CC(=O)O,C19H17ClN2O3S,20763.0
7108,Methoxyacetyl fentanyl (hydrochloride),COCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H29ClN2O2,20782.0
7109,Methoxyacetyl fentanyl (hydrochloride) (CRM),COCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H29ClN2O2,23540.0
7110,Marinobufagenin,C[C@]12CC[C@H](O)C[C@@]1(O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)C[C@H]3O[C@]132,C24H32O5,20798.0
7111,Piperaquine,Clc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1,C29H32Cl2N6,20799.0
7112,.alpha.-methyl Butyryl fentanyl (hydrochloride),CCCC(=O)N(c1ccccc1)C1CCN(C(C)Cc2ccccc2)CC1.Cl,C24H33ClN2O,20818.0
7113,Asunaprevir,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@H](Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,C35H46ClN5O9S,20835.0
7114,Actarit,CC(=O)Nc1ccc(CC(=O)O)cc1,C10H11NO3,20852.0
7115,AZD 5153,COc1nnc2ccc(N3CCC(c4ccc(OCCN5CCN(C)C(=O)[C@H]5C)cc4)CC3)nn12,C25H33N7O3,20864.0
7116,Prednisolone,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,C21H28O5,20866.0
7117,Azelastine (hydrochloride),CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1.Cl,C22H25Cl2N3O,20873.0
7118,Fenpropimorph,CC(Cc1ccc(C(C)(C)C)cc1)CN1C[C@@H](C)O[C@@H](C)C1,C20H33NO,20875.0
7119,(-)-Nicotine (tartrate),CN1CCC[C@H]1c1cccnc1.O=C(O)[C@H](O)[C@@H](O)C(=O)O.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C18H26N2O12,20887.0
7120,p-Coumaric Acid,O=C(O)/C=C/c1ccc(O)cc1,C9H8O3,20929.0
7121,Octaethylene Glycol monododecyl ether,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCO,C28H58O9,20938.0
7122,Norethindrone,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,C20H26O2,20941.0
7123,NADPH (cyclohexyl ammonium salt),NC(=O)C1=CN([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)(O)O)[C@@H]3O)[C@@H](O)[C@H]2O)C=CC1.NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC1CCCCC1,C45H82N11O17P3,20945.0
7124,Etravirine,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,C20H15BrN6O,20946.0
7125,Norverapamil (hydrochloride),COc1ccc(CCNCCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC.Cl,C26H37ClN2O4,20950.0
7126,Atorvastatin lactone,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H]1C[C@@H](O)CC(=O)O1,C33H33FN2O4,20951.0
7127,Cinnarizine,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1,C26H28N2,21001.0
7128,(S)-(+)-Clopidogrel (sulfate),COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1.O=S(=O)(O)O,C16H18ClNO6S2,21002.0
7129,Salbutamol,CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,C13H21NO3,21003.0
7130,Supercinnamaldehyde,CC(=O)/C=C1\C(=O)N(C)c2ccccc21,C12H11NO2,21019.0
7131,NIDA-41020,COc1ccc(-c2c(C)c(C(=O)NN3CCCCC3)nn2-c2ccc(Cl)cc2Cl)cc1,C23H24Cl2N4O2,21020.0
7132,2-PMAP,Oc1ccccc1NCc1ccccn1,C12H12N2O,21021.0
7133,Etofibrate,CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cccnc1,C18H18ClNO5,21022.0
7134,BTB06584,O=C(Oc1cc(S(=O)(=O)c2ccccc2)ccc1[N+](=O)[O-])c1ccc(Cl)cc1,C19H12ClNO6S,21032.0
7135,ABBV-075,CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(=O)c3[nH]ccc23)c1,C22H19F2N3O4S,21033.0
7136,"6,7-dimethyl-5,6,7,8-Tetrahydropterin (hydrochloride)",CC1Nc2[nH]c(N)nc(=O)c2NC1C.Cl,C8H14ClN5O,21050.0
7137,Phenserine,CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@@H]12,C20H23N3O2,21060.0
7138,.alpha.-Phenylacetoacetonitrile,CC(=O)C(C#N)c1ccccc1,C10H9NO,21105.0
7139,para-fluoro Acrylfentanyl,C=CC(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1,C22H25FN2O,21116.0
7140,Timolol (maleate),CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1.O=C(O)/C=C\C(=O)O,C17H28N4O7S,13974.0
7141,"3,4-Dimethoxyphenethylamine (hydrochloride)",COc1ccc(CCN)cc1OC.Cl,C10H16ClNO2,14141.0
7142,7-Aminoflunitrazepam,CN1C(=O)CN=C(c2ccccc2F)c2cc(N)ccc21,C16H14FN3O,14258.0
7143,7-Aminoflunitrazepam (CRM),CN1C(=O)CN=C(c2ccccc2F)c2cc(N)ccc21,C16H14FN3O,19053.0
7144,Flunitrazepam-d3,[2H]C([2H])([2H])N1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,C16H12FN3O3,16189.0
7145,Flunitrazepam-d3 (exempt preparation),[2H]C([2H])([2H])N1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,C16H12FN3O3,22855.0
7146,7-Aminonimetazepam,CN1C(=O)CN=C(c2ccccc2)c2cc(N)ccc21,C16H15N3O,18353.0
7147,7-Aminonimetazepam (CRM),CN1C(=O)CN=C(c2ccccc2)c2cc(N)ccc21,C16H15N3O,19293.0
7148,Epitetracycline (hydrochloride),CN(C)[C@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12.Cl,C22H25ClN2O8,19470.0
7149,Desalkylflurazepam-d4,[2H]c1c([2H])c([2H])c(C2=NCC(=O)Nc3ccc(Cl)cc32)c(F)c1[2H],C15H10ClFN2O,19508.0
7150,Desalkylflurazepam-d4 (CRM),[2H]c1c([2H])c([2H])c(C2=NCC(=O)Nc3ccc(Cl)cc32)c(F)c1[2H],C15H10ClFN2O,21320.0
7151,Nudifloramide,Cn1cc(C(N)=O)ccc1=O,C7H8N2O2,20507.0
7152,O-Desmethyl-cis-tramadol-d6 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])N(C[C@H]1CCCC[C@]1(O)c1cccc(O)c1)C([2H])([2H])[2H],C15H24ClNO2,20593.0
7153,Ethyl (R)-(-)-3-Hydroxybutyrate,CCOC(=O)C[C@@H](C)O,C6H12O3,20659.0
7154,D-Galactose,O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO,C6H12O6,20890.0
7155,Diallyl Sulfide,C=CCSCC=C,C6H10S,20894.0
7156,Atosiban,CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,C43H67N11O12S2,20952.0
7157,"1,5,7-Triazabicyclo[4.4.0]dec-5-ene",C1CN=C2NCCCN2C1,C7H13N3,20975.0
7158,Sulfamethazine,Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1,C12H14N4O2S,20976.0
7159,Nifekalant (hydrochloride),Cl.Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O,C19H28ClN5O5,20997.0
7160,Nisoldipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],C20H24N2O6,20998.0
7161,Nafcillin (sodium salt hydrate),CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)[O-].O.[Na+],C21H23N2NaO6S,21008.0
7162,2-Thiouridine,O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=S)[nH]1,C9H12N2O5S,21011.0
7163,5'-chloro-5'-Deoxyadenosine (hydrate),Nc1ncnc2c1ncn2[C@@H]1O[C@H](CCl)[C@@H](O)[C@H]1O.O,C10H12ClN5O3(H2O)x,21012.0
7164,CB-1954,NC(=O)c1cc(N2CC2)c([N+](=O)[O-])cc1[N+](=O)[O-],C9H8N4O5,21023.0
7165,eCF309,CCOC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OCC,C18H21N7O3,21118.0
7166,Isogarcinol,CC(C)=CC[C@H]1C[C@@]23C[C@@H](CC=C(C)C)C(C)(C)[C@@](CC=C(C)C)(C(=O)C(C(=O)c4ccc(O)c(O)c4)=C2OC1(C)C)C3=O,C38H50O6,21164.0
7167,"1,2-Dilinoleoyl-sn-glycero-3-PC",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C44H80NO8P,20954.0
7168,Phosphatidylcholine (soy),CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C44H80NO8P,34800.0
7169,Tipranavir,CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,C31H33F3N2O5S,21028.0
7170,(E)-5-(2-Bromovinyl)uracil,O=c1[nH]cc(/C=C/Br)c(=O)[nH]1,C6H5BrN2O2,21030.0
7171,DR2313,Cc1nc(=O)c2c([nH]1)CCSC2,C8H10N2OS,21181.0
7172,DMAT,CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1,C9H7Br4N3,21182.0
7173,BI-78D3,O=c1[nH]nc(Sc2ncc([N+](=O)[O-])s2)n1-c1ccc2c(c1)OCCO2,C13H9N5O5S2,21183.0
7174,Chk2 Inhibitor,NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c4ccccc4c32)N1,C15H13N5O2,21184.0
7175,NVP-BEZ235 (hydrochloride),Cl.Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,C30H24ClN5O,21185.0
7176,Loxoribine,C=CCn1c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2nc(N)[nH]c(=O)c21,C13H17N5O6,21186.0
7177,PI-103 (hydrochloride),Cl.Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,C19H17ClN4O3,21187.0
7178,TNP,O=[N+]([O-])c1ccc(CNc2nc(NCc3cccc(C(F)(F)F)c3)nc3nc[nH]c23)cc1,C20H16F3N7O2,21189.0
7179,C2-8,O=C(Nc1ccc(Br)cc1)c1cccc(S(=O)(=O)Nc2ccc(Br)cc2)c1,C19H14Br2N2O3S,21177.0
7180,Bisindolylmaleimide I (hydrochloride),CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21.Cl,C25H25ClN4O2,21180.0
7181,Virstatin,O=C(O)CCCN1C(=O)c2cccc3cccc(c23)C1=O,C16H13NO4,21176.0
7182,CAY10796,Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1,C18H15N5,21190.0
7183,Phosphodiesterase 4 Inhibitor,CCOC(=O)c1c(C)nn(-c2cccc([N+](=O)[O-])c2)c1C,C14H15N3O4,21191.0
7184,p-Nitrophenylphosphorylcholine,C[N+](C)(C)CCOP(=O)([O-])Oc1ccc([N+](=O)[O-])cc1,C11H17N2O6P,21042.0
7185,N-acetyl-D-Lactosamine,CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,C14H25NO11,21043.0
7186,AZ 3146,COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc2c(n1)n(C1CCCC1)c(=O)n2C,C24H32N6O3,19991.0
7187,Drotaverine (hydrochloride),CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC.Cl,C24H32ClNO4,20944.0
7188,"1,2-Diarachidonoyl-sn-glycero-3-PC",CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC,C48H80NO8P,20953.0
7189,"1,2-Dioleoyl-sn-glycero-3-PG (sodium salt)",CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC(O)CO)OC(=O)CCCCCCC/C=C\CCCCCCCC.[Na+],C42H78NaO10P,20957.0
7190,1-Palmitoyl-2-Linoleoyl-sn-glycero-3-PC,CCCCC/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C42H80NO8P,20962.0
7191,1-Palmitoyl-2-Oleoyl-sn-glycero-3-PA,CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)O,C37H71O8P,20963.0
7192,"1,2-Dimyristoyl-sn-glycero-3-PS (sodium salt)",CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OC[C@@H](N)C(=O)O)OC(=O)CCCCCCCCCCCCC.[Na+],C34H65NNaO10P,20955.0
7193,S1QEL1.1,CC(=O)Nc1cccc(NC(=O)C(=O)NCCc2sc(-c3ccc(C)cc3)nc2C)c1,C23H24N4O3S,20982.0
7194,AM2394,CNC(=O)Nc1cc(Oc2cncc(C)c2)c(-c2ccc(OCC(C)(C)O)nc2)cn1,C22H25N5O4,20992.0
7195,MK-1064,COc1ccc(CNC(=O)c2cc(-c3cncc(Cl)c3)cnc2-c2ccccn2)nc1OC,C24H20ClN5O3,20993.0
7196,MRS2578,S=C=Nc1cccc(NC(=S)NCCCCNC(=S)Nc2cccc(N=C=S)c2)c1,C20H20N6S4,19704.0
7197,Bitopertin,C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cc2F)CC1)C(F)(F)F,C21H20F7N3O4S,19896.0
7198,O4I1,COc1ccc(COc2ccc(CC#N)cc2)cc1,C16H15NO2,19935.0
7199,Diltiazem (hydrochloride),COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1.Cl,C22H27ClN2O4S,20079.0
7200,MGCD-265,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1,C26H20FN5O2S2,20097.0
7201,Tosyl Phenylalanyl Chloromethyl Ketone,Cc1ccc(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)CCl)cc1,C17H18ClNO3S,20166.0
7202,.beta.-Cembrenediol,C/C1=C/[C@H](O)C[C@@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,C20H34O2,21031.0
7203,Emetine (hydrochloride hydrate),CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21.Cl.Cl,C29H42Cl2N2O4,21048.0
7204,L-Iduronic Acid (sodium salt),O=C[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)[O-].[Na+],C6H9NaO7,21066.0
7205,"5-bromo-5-nitro-1,3-Dioxane",O=[N+]([O-])C1(Br)COCOC1,C4H6BrNO4,20935.0
7206,Tenofovir-d6,[2H]C([2H])([2H])C([2H])(OCP(=O)(O)O)C([2H])([2H])n1cnc2c(N)ncnc21,C9H14N5O4P,21071.0
7207,Necrostatin-1 Inactive Control,O=C1NC(=S)NC1Cc1c[nH]c2ccccc12,C12H11N3OS,21192.0
7208,Bucindolol,CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N,C22H25N3O2,21070.0
7209,Isoguanine,Nc1nc(=O)[nH]c2nc[nH]c12,C5H5N5O,21703.0
7210,BD 1008 (hydrobromide),Br.Br.CN(CCc1ccc(Cl)c(Cl)c1)CCN1CCCC1,C15H24Br2Cl2N2,9001336.0
7211,Paraxanthine,Cn1c(=O)[nH]c2ncn(C)c2c1=O,C7H8N4O2,21068.0
7212,3-Methylcytidine (methosulfate),COS(=O)(=O)O.Cn1c(=N)ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1=O,C11H19N3O9S,21064.0
7213,N-Butyldeoxynojirimycin (hydrochloride),CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO.Cl,C10H22ClNO4,21065.0
7214,(-)-Catechin,Oc1cc(O)c2c(c1)O[C@@H](c1ccc(O)c(O)c1)[C@H](O)C2,C15H14O6,18644.0
7215,GSK864,COc1c(C)cc(NC(=O)c2nn(Cc3ccc(F)cc3)c3c2CN(C(=O)c2ccc[nH]2)C[C@]3(C)C(N)=O)cc1C,C30H31FN6O4,18762.0
7216,1-(1-Phenylcyclohexyl)-4-hydroxypiperidine,OC1CCN(C2(c3ccccc3)CCCCC2)CC1,C17H25NO,20563.0
7217,SD-1029,Br.Br.CN(C)CC1CCC2=C(C1=O)C(c1ccc(Cl)c(Cl)c1)C1=C(CCC(CN(C)C)C1=O)O2,C25H32Br2Cl2N2O3,21029.0
7218,N-Nitroso-N-ethylaniline,CCN(N=O)c1ccccc1,C8H10N2O,21063.0
7219,7-Methyluric Acid,Cn1c(=O)[nH]c2[nH]c(=O)[nH]c(=O)c21,C6H6N4O3,21067.0
7220,Ensartinib,C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl,C25H25Cl2FN6O3,21341.0
7221,FGFR4-IN-1,COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)ncc1C#N,C24H27N7O5,21342.0
7222,Fenebrutinib,C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1,C37H44N8O4,21346.0
7223,Davercin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@H]2OC(=O)O[C@@]21C,C38H65NO14,21348.0
7224,IL-1R Antagonist,CC(C)[C@H](NC(=O)CCc1ccccc1)C(=O)N1CCCC1,C18H26N2O2,21349.0
7225,Il-1R Antagonist,CC(C)[C@H](NC(=O)CCc1ccccc1)C(=O)N1CCCC1,C18H26N2O2,21349.0
7226,U-49900,CCN(CC)[C@@H]1CCCC[C@H]1N(C)C(=O)c1ccc(Cl)c(Cl)c1,C18H26Cl2N2O,21098.0
7227,U-49900 (CRM),CCN(CC)[C@@H]1CCCC[C@H]1N(C)C(=O)c1ccc(Cl)c(Cl)c1,C18H26Cl2N2O,23999.0
7228,1-Stearoyl-2-hydroxy-sn-glycero-3-PG (sodium salt),CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC(O)CO.[Na+],C24H48NaO9P,20964.0
7229,Bavachinin,COc1cc2c(cc1CC=C(C)C)C(=O)C[C@@H](c1ccc(O)cc1)O2,C21H22O4,19376.0
7230,JNJ-10181457,C(#Cc1cccc(CN2CCOCC2)c1)CCN1CCCCC1,C20H28N2O,11997.0
7231,Spironolactone,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,C24H32O4S,9000324.0
7232,NMS-P118,NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2,C20H24F3N3O2,21340.0
7233,AZD 1152-HQPA,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)n[nH]3)ncnc2c1,C26H30FN7O3,11602.0
7234,BI605906,CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12,C17H22F2N4O3S2,19184.0
7235,Naftifine (hydrochloride),CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12.Cl,C21H22ClN,19234.0
7236,4-Methylumbelliferyl-?-D-galactopyranoside,Cc1cc(=O)oc2cc(O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)ccc12,C16H18O8,16551.0
7237,GSK2194069,O=C(C1CC1)N1CC[C@@H](Cc2n[nH]c(=O)n2-c2ccc(-c3ccc4occc4c3)cc2)C1,C25H24N4O3,20022.0
7238,"ethyl 2,5-Dihydroxybenzoate",CCOC(=O)c1cc(O)ccc1O,C9H10O4,21013.0
7239,DCP-LA,CCCCCC1CC1CC1CC1CCCCCCCC(=O)O,C20H36O2,21375.0
7240,Nemonapride,CNc1cc(OC)c(C(=O)N[C@@H]2CCN(Cc3ccccc3)[C@@H]2C)cc1Cl,C21H26ClN3O2,21376.0
7241,11-cis Retinal,CC1=C(/C=C/C(C)=C/C=C\C(C)=C\C=O)C(C)(C)CCC1,C20H28O,21377.0
7242,all-trans-4-hydroxy Retinoic Acid,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1O,C20H28O3,21378.0
7243,Acetazolamide,CC(=O)Nc1nnc(S(N)(=O)=O)s1,C4H6N4O3S2,21218.0
7244,11(Z)-Eicosenoic Acid methyl ester,CCCCCCCC/C=C\CCCCCCCCCC(=O)OC,C21H40O2,21332.0
7245,GLYX 13,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)[C@@H](C)O,C18H31N5O6,21385.0
7246,BFH772,O=C(Nc1cccc(C(F)(F)F)c1)c1cccc2cc(Oc3cc(CO)ncn3)ccc12,C23H16F3N3O3,21386.0
7247,Verubecestat,CN1C(N)=N[C@](C)(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)CS1(=O)=O,C17H17F2N5O3S,21115.0
7248,ML-290,CC(C)Oc1ccccc1C(=O)Nc1ccccc1C(=O)Nc1cccc(S(=O)(=O)C(F)(F)F)c1,C24H21F3N2O5S,21134.0
7249,SA 57,CNC(=O)COC(=O)N1CCC(CCc2ccc(Cl)cc2)CC1,C17H23ClN2O3,14848.0
7250,Bendroflumethiazide,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,C15H14F3N3O4S2,21311.0
7251,Torasemide,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,C16H20N4O3S,21312.0
7252,Ritanserin,Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,C27H25F2N3OS,21374.0
7253,Ritanserin,Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,C27H25F2N3OS,21374.0
7254,Avitinib,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1,C26H26FN7O2,21387.0
7255,PI3-Kinase ? Inhibitor 2 (hydrochloride),Cl.Cl.Oc1cccc(-c2nc(N3CCOCC3)c3sccc3n2)c1,C16H17Cl2N3O2S,21197.0
7256,SB 202190 (hydrochloride),Cl.Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,C20H15ClFN3O,21201.0
7257,4-MA-NBOMe (hydrochloride),COc1ccccc1CNC(C)Cc1ccc(C)cc1.Cl,C18H24ClNO,20867.0
7258,Vitamin K1,CC1=C(C/C=C(\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=O)c2ccccc2C1=O,C31H46O2,21051.0
7259,Dexamethasone Phosphate (sodium salt),C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+],C22H28FNa2O8P,20340.0
7260,Diosmin,COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O,C28H32O15,19848.0
7261,Boldenone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@@H]2O,C19H26O2,15432.0
7262,Boldenone (exempt preparation),C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@@H]2O,C19H26O2,43533.0
7263,Fluticasone Propionate,CCC(=O)OC1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C25H31F3O5S,20703.0
7264,Etonogestrel,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC,C22H28O2,21062.0
7265,Hexadecanamide,CCCCCCCCCCCCCCCC(N)=O,C16H33NO,21086.0
7266,Stearamide,CCCCCCCCCCCCCCCCCC(N)=O,C18H37NO,21087.0
7267,"3,4-Dichloroisocoumarin",O=c1oc(Cl)c(Cl)c2ccccc12,C9H4Cl2O2,21194.0
7268,CDK/CRK Inhibitor,CC(C)c1nn(-c2c(Cl)cccc2Cl)c2[nH]c(Cc3ccc(OCCO)cc3)nc(=O)c12,C23H22Cl2N4O3,21195.0
7269,PP121,Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1,C17H17N7,21196.0
7270,Nilvadipine,COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,C19H19N3O6,21243.0
7271,WYE-23,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NC5CC5)cc4)nc32)CC1,C26H32N8O4,21199.0
7272,WYE-28,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)Nc5ccc(CO)cc5)cc4)nc32)CC1,C30H34N8O5,21200.0
7273,ARQ 092,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,C27H24N6,21388.0
7274,5-methoxy Tryptophol,COc1ccc2[nH]cc(CCO)c2c1,C11H13NO2,21061.0
7275,SR9011,CCCCCNC(=O)N1CCC(CN(Cc2ccc(Cl)cc2)Cc2ccc([N+](=O)[O-])s2)C1,C23H31ClN4O3S,11930.0
7276,Inflachromene,CC1(C)Oc2cc(O)ccc2C2C1=CCn1c(=O)n(-c3ccccc3)c(=O)n12,C21H19N3O4,17006.0
7277,Adenosine 5'-monophosphate (sodium salt hydrate),Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O.O.[NaH],C10H14N5O7P(Na)X(H2O)X,21094.0
7278,WT161,O=C(CCCCCCC(=O)N/N=C/c1ccc(N(c2ccccc2)c2ccccc2)cc1)NO,C27H30N4O3,21099.0
7279,A-1210477,Cc1nn(C)c(COc2ccc(N3CCN(S(=O)(=O)N(C)C)CC3)cc2)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)n(CCN3CCOCC3)c12,C46H55N7O7S,21113.0
7280,ML-385,Cc1ccccc1C(=O)N1CCc2cc(-c3nc(NC(=O)Cc4ccc5c(c4)OCO5)sc3C)ccc21,C29H25N3O4S,21114.0
7281,LXR-623,Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1,C21H12ClF5N2,21117.0
7282,Nandrolone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O,C18H26O2,21173.0
7283,Triamterene,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,C12H11N7,21242.0
7284,Triamterene,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,C12H11N7,22486.0
7285,GSK2838232,CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2([C@@H](O)CN(CCN(C)C)Cc2ccc(Cl)cc2)CC1=O,C48H73ClN2O6,21390.0
7286,(+)-JQ1 (free acid),Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)O)c1nnc(C)n1-2,C19H17ClN4O2S,9002910.0
7287,TASIN-1,COc1ccc(S(=O)(=O)N2CCC(N3CCC(C)CC3)CC2)cc1,C18H28N2O3S,21155.0
7288,AZD 8186,C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12,C24H25F2N3O4,17384.0
7289,Nicotianamine,N[C@@H](CCN[C@@H](CCN1CC[C@H]1C(=O)O)C(=O)O)C(=O)O,C12H21N3O6,19958.0
7290,TP-472,CC(=O)c1cc(-c2cc(C(=O)NC3CC3)ccc2C)c2ncccn12,C20H19N3O2,20030.0
7291,2'-O-Methylguanosine,CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(=O)[nH]c(N)nc21,C11H15N5O5,21039.0
7292,Carboxyatractyloside (potassium salt),C=C1[C@@H]2CC[C@H]3[C@]4(C)C[C@H](O[C@H]5O[C@H](CO)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@H]5OC(=O)CC(C)C)CC(C(=O)[O-])(C(=O)[O-])[C@H]4CC[C@]3(C2)[C@H]1O.[K+].[K+],C31H44K2O18S2,21120.0
7293,"4-Amino-6-chloro-1,3-benzenedisulfonamide",Nc1cc(Cl)c(S(N)(=O)=O)cc1S(N)(=O)=O,C6H8ClN3O4S2,21309.0
7294,MDL 72527 (hydrochloride),C=C=CCNCCCCNCC=C=C,C12H20N2,13996.0
7295,Benzamidine (hydrochloride),Cl.N=C(N)c1ccccc1,C7H9ClN2,20651.0
7296,Gemifloxacin (mesylate),CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN.CS(=O)(=O)O,C19H24FN5O7S,21047.0
7297,MMP-9/MMP-13 Inhibitor I,COc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccc(-c4ccccc4)cc3)CC2C(=O)NO)cc1,C25H25N3O6S,21265.0
7298,Hydrochlorothiazide,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,C7H8ClN3O4S2,21304.0
7299,Hydrochlorothiazide,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,C7H8ClN3O4S2,22671.0
7300,Bis-(2-chloroisopropyl) ether,CC(CCl)OC(C)CCl,C6H12Cl2O,20683.0
7301,UNC3866,CCN(CC)CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1)C(=O)N[C@@H](CO)C(=O)OC,C43H66N6O8,19237.0
7302,Ciclopirox,Cc1cc(C2CCCCC2)n(O)c(=O)c1,C12H17NO2,16021.0
7303,6-NBDG,O=[N+]([O-])c1ccc(NCC2OC(O)C(O)C(O)C2O)c2nonc12,C12H14N4O8,13961.0
7304,PF-2545920,Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1,C25H20N4O,18266.0
7305,Cyclofenil,CC(=O)Oc1ccc(C(=C2CCCCC2)c2ccc(OC(C)=O)cc2)cc1,C23H24O4,18676.0
7306,ADB-FUBICA,CC(C)(C)C(NC(=O)c1cn(Cc2ccc(F)cc2)c2ccccc12)C(N)=O,C22H24FN3O2,18756.0
7307,AZD 2014,CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1,C25H30N6O3,17378.0
7308,Nicotinamide,NC(=O)c1cccnc1,C6H6N2O,11127.0
7309,Fasnall (benzenesulfonate),Cc1sc2ncnc(NC3CCN(Cc4ccccc4)C3)c2c1C.O=S(=O)(O)c1ccccc1,C25H28N4O3S2,19957.0
7310,L-Quisqualic Acid,N[C@@H](Cn1oc(=O)[nH]c1=O)C(=O)O,C5H7N3O5,20211.0
7311,Bestatin,CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O,C16H24N2O4,21217.0
7312,?-Ketoisocaproic Acid (sodium salt),CC(C)CC(=O)C(=O)[O-].[Na+],C6H9NaO3,21052.0
7313,Adenosine 5'-diphosphate (potassium salt),Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)([O-])O)[C@@H](O)[C@H]1O.[K+],C10H14KN5O10P2,21121.0
7314,Altertoxin I,O=C1C[C@H](O)[C@@H]2c3c(ccc(O)c31)-c1ccc(O)c3c1[C@@]2(O)CCC3=O,C20H16O6,21129.0
7315,Altenuene,COc1cc(O)c2c(c1)C1=C[C@@H](O)[C@H](O)C[C@@]1(C)OC2=O,C15H16O6,21130.0
7316,Canrenone,C[C@]12CCC(=O)C=C1C=C[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]21CCC(=O)O1,C22H28O3,21307.0
7317,PX-866-17OH,C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)[C@@H](O)CC[C@@H]12)CC=C,C29H37NO8,21204.0
7318,LX7101 (hydrochloride),Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12.Cl,C23H30ClN7O3,21209.0
7319,4-Bromoethcathinone (hydrochloride),CCNC(C)C(=O)c1ccc(Br)cc1.Cl,C11H15BrClNO,17395.0
7320,AS-1842856,CCn1cc(C(=O)O)c(=O)c2c(N)c(F)c(NC3CCCCC3)cc21,C18H22FN3O3,16761.0
7321,Nefazodone (hydrochloride),CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl,C25H33Cl2N5O2,10012642.0
7322,Alkynyl-biotin,C#CCCCC(=O)NCCOCCOCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C22H36N4O5S,13038.0
7323,TC-S 7001,Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12,C18H13ClF2N6O,19129.0
7324,L-Alanosine,N[C@@H](CN(O)N=O)C(=O)O,C3H7N3O4,19545.0
7325,Clobetasol Propionate,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C25H32ClFO5,21251.0
7326,"4,4'-Dicyanobenzhydrol",N#Cc1ccc(C(O)c2ccc(C#N)cc2)cc1,C15H10N2O,21316.0
7327,Oleuropein,C/C=C1/[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C(C(=O)OC)[C@H]1CC(=O)OCCc1ccc(O)c(O)c1,C25H32O13,21220.0
7328,TN-16,C/C(Nc1ccccc1)=C1/C(=O)NC(Cc2ccccc2)C1=O,C19H18N2O2,21222.0
7329,Digallic Acid,O=C(O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,C14H10O9,21224.0
7330,Methyllycaconitine (citrate),CCN1C[C@]2(COC(=O)c3ccccc3N3C(=O)C[C@H](C)C3=O)CC[C@H](OC)[C@]34C1[C@](O)([C@@H](OC)[C@H]23)[C@@]1(O)C[C@H](OC)[C@H]2C[C@@H]4[C@@H]1[C@H]2OC.O=C(O)CC(O)(CC(=O)O)C(=O)O,C43H58N2O17,21398.0
7331,R 1530,COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2,C18H14ClFN4O,15255.0
7332,Nilotinib-d6,[2H]c1c([2H])c(C([2H])([2H])[2H])c(Nc2nccc(-c3cccnc3)n2)c([2H])c1C(=O)Nc1cc(-n2cnc(C)c2)cc(C(F)(F)F)c1,C28H22F3N7O,19280.0
7333,Azithromycin-d3,[2H]C([2H])([2H])N1C[C@H](C)C[C@@](C)(O)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C,C38H72N2O12,20675.0
7334,L-?-Hydroxyglutaric Acid,O=C(O)CC[C@H](O)C(=O)O,C5H8O5,21123.0
7335,Adenosine,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C10H13N5O4,21232.0
7336,Secnidazole,Cc1ncc([N+](=O)[O-])n1CC(C)O,C7H11N3O3,21236.0
7337,Deoxycholic Acid (sodium salt hydrate),C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C.O.[Na+],C24H41NaO5,18231.0
7338,Levocabastine (hydrochloride),C[C@@H]1CN([C@H]2CC[C@](C#N)(c3ccc(F)cc3)CC2)CC[C@]1(C(=O)O)c1ccccc1.Cl,C26H30ClFN2O2,21014.0
7339,NS 1738,O=C(Nc1cc(Cl)ccc1O)Nc1cc(C(F)(F)F)ccc1Cl,C14H9Cl2F3N2O2,21018.0
7340,Glucagon Receptor Antagonist I,CCC(CC)C(=O)Nc1sc2c(c1C#N)CCC(C(C)(C)CC)C2,C20H30N2OS,21223.0
7341,6-Carboxyfluorescein,O=C(O)c1ccc2c(c1)C1(OC2=O)c2ccc(O)cc2Oc2cc(O)ccc21,C21H12O7,21233.0
7342,Tropisetron (hydrochloride),CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1c[nH]c3ccccc13)C2.Cl,C17H21ClN2O2,21240.0
7343,SBE 13 (hydrochloride),COc1ccc(CCNCc2ccc(OCc3ccc(Cl)nc3)c(OC)c2)cc1OC.Cl,C24H28Cl2N2O4,21241.0
7344,EAI045,O=C(Nc1nccs1)C(c1cc(F)ccc1O)N1Cc2ccccc2C1=O,C19H14FN3O3S,19719.0
7345,XL388,Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F,C23H22FN3O4S,20237.0
7346,GDC-0994,Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1,C21H18ClFN6O2,21107.0
7347,Naftopidil (hydrochloride),COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1.Cl,C24H29ClN2O3,21122.0
7348,H-Gly-Pro-Arg-Pro-OH (acetate),CC(=O)O.N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)N1CCC[C@H]1C(=O)O,C20H35N7O7,21163.0
7349,Dorsomorphin (hydrochloride),Cl.Cl.c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,C24H27Cl2N5O,21207.0
7350,Bacitracin (zinc),CCC(C)C(N)C1N=C(C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)[O-])C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)[O-])NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1.[Zn+2],C66H101N17O16SZn,21212.0
7351,"1,N6-Ethenoadenosine 5'-monophosphate (sodium salt)",O=P([O-])([O-])OC[C@H]1O[C@@H](n2cnc3c2ncn2ccnc32)[C@H](O)[C@@H]1O.[Na+].[Na+],C12H12N5Na2O7P,21227.0
7352,"3,4'-5-Trihydroxystilbene-3-?-D-Glucopyranoside",OC[C@H]1O[C@@H](Oc2cc(O)cc(C=Cc3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,C20H22O8,21246.0
7353,A-205804,Cc1ccc(Sc2cncc3sc(C(N)=O)cc23)cc1,C15H12N2OS2,21252.0
7354,Mycophenolic Acid,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2,C17H20O6,21716.0
7355,PLX7904,CCN(C)S(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cnc(C5CC5)nc4)cc23)c1F,C24H22F2N6O3S,20710.0
7356,DprE1-IN2,Cc1cnc2c(C(=O)NCCO)cn(Cc3ncnc(N(C)C)c3C)c2c1,C19H24N6O2,21034.0
7357,Basmisanil,Cc1onc(-c2ccc(F)cc2)c1COc1ccc(C(=O)N2CCS(=O)(=O)CC2)cn1,C21H20FN3O5S,21137.0
7358,PKI-179 (hydrochloride),Cl.O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CCOCC3)nc(N3C4CCC3COC4)n2)cc1,C25H29ClN8O3,21202.0
7359,PX-13-17OH,COC[C@H]1OC(=O)/C(=C/N(C)CCCN(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,C29H42N2O8,21203.0
7360,CYC-116,Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1,C18H20N6OS,21205.0
7361,SANT-2,CCOc1cc(C(=O)Nc2ccc(Cl)c(-c3nc4ccccc4[nH]3)c2)cc(OCC)c1OCC,C26H26ClN3O4,21208.0
7362,BRL 54443,CN1CCC(c2c[nH]c3ccc(O)cc23)CC1,C14H18N2O,21263.0
7363,N-6022,Cc1cc(C(N)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-n2ccnc2)cc1,C24H22N4O3,21269.0
7364,MPT0B014,COc1cc(C(=O)c2ccc3ncccc3c2)cc(OC)c1OC,C19H17NO4,21718.0
7365,Furanyl fentanyl 3-furancarboxamide isomer (hydrochloride),Cl.O=C(c1ccoc1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H27ClN2O2,21213.0
7366,Furanyl fentanyl 3-furancarboxamide isomer (hydrochloride) (exempt preparation),Cl.O=C(c1ccoc1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H27ClN2O2,37947.0
7367,Danirixin,Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O,C19H21ClFN3O4S,20980.0
7368,"3',4',7-Trihydroxyisoflavone",O=c1c(-c2ccc(O)c(O)c2)coc2cc(O)ccc12,C15H10O5,20930.0
7369,15(S)-HETE methyl ester,CCCCC[C@H](O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)OC,C21H34O3,21327.0
7370,Topiroxostat,N#Cc1cc(-c2nnc(-c3ccncc3)[nH]2)ccn1,C13H8N6,21267.0
7371,UF010,CCCCNNC(=O)c1ccc(Br)cc1,C11H15BrN2O,21273.0
7372,Moexipril (hydrochloride),CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O.Cl,C27H35ClN2O7,21255.0
7373,1-methoxy-5-Methylphenazinium (methyl sulfate),COS(=O)(=O)[O-].COc1cccc2c1nc1ccccc1[n+]2C,C15H16N2O5S,21258.0
7374,Tiamulin (fumarate),C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O.O=C(O)/C=C/C(=O)O,C32H51NO8S,21216.0
7375,Linoleamide,CCCCC/C=C\C/C=C\CCCCCCCC(N)=O,C18H33NO,21055.0
7376,VAS2870,c1ccc(Cn2nnc3c(Sc4nc5ccccc5o4)ncnc32)cc1,C18H12N6OS,19205.0
7377,JS-K,CCOC(=O)N1CCN(/[N+]([O-])=N/Oc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])CC1,C13H16N6O8,21225.0
7378,Adenosine 5'-phosphosulfate (sodium salt),Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OS(=O)(=O)O)[C@@H](O)[C@H]1O.[NaH].[NaH],C10H14N5Na2O10PS,21226.0
7379,ABC34,COc1ccc(N2CCN(C(=O)ON3C(=O)C4CN(Cc5ccc(Oc6ccccc6)cc5)CCN4C3=O)CC2)cc1,C31H33N5O6,19385.0
7380,Glabridin,CC1(C)C=Cc2c(ccc3c2OC[C@@H](c2ccc(O)cc2O)C3)O1,C20H20O4,11843.0
7381,NSC 95397,O=C1C(SCCO)=C(SCCO)C(=O)c2ccccc21,C14H14O4S2,21431.0
7382,p38 MAPK Inhibitor VIII,Cc1ccccc1C(=O)c1ccc(Nc2ccc(Br)cc2N)cc1Cl,C20H16BrClN2O,21229.0
7383,2-Methylthioadenosine diphosphate (sodium salt),CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)([O-])OP(=O)([O-])[O-])[C@@H](O)[C@H]3O)c2n1.[Na+].[Na+].[Na+],C11H14N5Na3O10P2S,21230.0
7384,Granisetron (hydrochloride),CN1[C@@H]2CCC[C@H]1C[C@@H](NC(=O)c1nn(C)c3ccccc13)C2.Cl,C18H25ClN4O,21239.0
7385,Azelnidipine,CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1,C33H34N4O6,21249.0
7386,Hyodeoxycholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H40O4,20294.0
7387,Mesna,O=S(=O)([O-])CCS.[Na+],C2H5NaO3S2,21238.0
7388,A-740003,COc1ccc(CC(=O)NC(N/C(=N\c2cccc3ncccc23)NC#N)C(C)(C)C)cc1OC,C26H30N6O3,21256.0
7389,Tetrahydrofuran fentanyl (hydrochloride),Cl.O=C(C1CCCO1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H31ClN2O2,20859.0
7390,Tetrahydrofuran fentanyl (hydrochloride) (CRM),Cl.O=C(C1CCCO1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H31ClN2O2,23998.0
7391,Furanylethyl fentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CCc2ccco2)CC1.Cl,C20H27ClN2O2,20819.0
7392,Diapocynin,COc1cc(C(C)=O)cc(-c2cc(C(C)=O)cc(OC)c2O)c1O,C18H18O6,14052.0
7393,MC70,COc1cc2c(cc1OC)CN(Cc1ccc(-c3ccc(O)cc3)cc1)CC2,C24H25NO3,21330.0
7394,TX-1918,Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O,C14H12O3,20840.0
7395,Guaifenesin,COc1ccccc1OCC(O)CO,C10H14O4,21250.0
7396,Guaifenesin,COc1ccccc1OCC(O)CO,C10H14O4,32998.0
7397,PT1,Cc1cc(-c2ccc(/C=C3/SC(Nc4ccc(Cl)c(C(=O)O)c4)=NC3=O)o2)c([N+](=O)[O-])cc1C,C23H16ClN3O6S,21335.0
7398,SB-674042,Cc1nc(C(=O)N2CCC[C@H]2Cc2nnc(-c3ccccc3)o2)c(-c2ccccc2F)s1,C24H21FN4O2S,21270.0
7399,Nitenpyram,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC,C11H15ClN4O2,21271.0
7400,Flufenamic Acid,O=C(O)c1ccccc1Nc1cccc(C(F)(F)F)c1,C14H10F3NO2,21447.0
7401,(E)-2-Hexadecenal Alkyne,C#CCCCCCCCCCCC/C=C/C=O,C16H26O,20714.0
7402,NBD-556,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC(C)(C)N1,C17H24ClN3O2,21274.0
7403,CPPHA,O=C(Nc1ccc(Cl)cc1CN1C(=O)c2ccccc2C1=O)c1ccccc1O,C22H15ClN2O4,21275.0
7404,AK-1,O=C(Nc1cccc([N+](=O)[O-])c1)c1cccc(S(=O)(=O)N2CCCCCC2)c1,C19H21N3O5S,21276.0
7405,CEP-37440,CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl,C30H38ClN7O3,21278.0
7406,W-54011,COc1ccc2c(c1)C(C(=O)N(Cc1ccc(N(C)C)cc1)c1ccc(C(C)C)cc1)CCC2.Cl,C30H37ClN2O2,21231.0
7407,QS11,OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3c(c2)CCC3)nc2c1ncn2Cc1ccc(-c2ccccc2)cc1,C36H33N5O2,21247.0
7408,Roxatidine Acetate (hydrochloride),CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1.Cl,C19H29ClN2O4,21248.0
7409,ML-349,COc1ccc(N2CCN(C(=O)c3cc4c(s3)-c3ccccc3S(=O)(=O)C4)CC2)cc1,C23H22N2O4S2,20923.0
7410,Linoleic Acid Alkyne,C#CCCC/C=C\C/C=C\CCCCCCCC(=O)O,C18H28O2,10541.0
7411,Apcin,Cc1ncc([N+](=O)[O-])n1CCOC(=O)NC(Nc1ncccn1)C(Cl)(Cl)Cl,C13H14Cl3N7O4,17080.0
7412,1-Myristoyl-2-hydroxy-sn-glycero-3-PC,CCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C22H46NO7P,20958.0
7413,Fenoterol (hydrobromide),Br.CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1,C17H22BrNO4,21293.0
7414,JTC 801,CCc1ccc(OCc2ccccc2C(=O)Nc2ccc3nc(C)cc(N)c3c2)cc1.Cl,C26H26ClN3O2,21254.0
7415,Dienogest,C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N,C20H25NO2,21257.0
7416,R428,Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2,C30H34N8,21523.0
7417,Fascaplysin (chloride),O=C1c2ccccc2-[n+]2ccc3[nH]c4ccccc4c3c21.[Cl-],C18H11ClN2O,21715.0
7418,3-methoxy PCE (hydrochloride),CCNC1(c2cccc(OC)c2)CCCCC1.Cl,C15H24ClNO,9001355.0
7419,FLI-06,CC1=C(C(=O)OC2CCCCC2)C(c2ccc([N+](=O)[O-])cc2)C2=C(CC(C)(C)CC2=O)N1,C25H30N2O5,21272.0
7420,Suprofen,CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1,C14H12O3S,21350.0
7421,1-Palmitoyl-2-hydroxy-sn-glycero-3-PG (sodium salt),CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC(O)CO.[Na+],C22H44NaO9P,20961.0
7422,Kukoamine B,NCCCN(CCCCNCCCNC(=O)CCc1ccc(O)c(O)c1)C(=O)CCc1ccc(O)c(O)c1,C28H42N4O6,21091.0
7423,RU-505,CN(C)CCN(Cc1ccccc1)C(=O)c1cc(-c2ccc(F)cc2)n2nc(C(C)(C)C)cc2n1,C28H32FN5O,16445.0
7424,"N,N-Diethylpentylone (hydrochloride)",CCCC(C(=O)c1ccc2c(c1)OCO2)N(CC)CC.Cl,C16H24ClNO3,20801.0
7425,Trospium (chloride),O=C(O[C@H]1C[C@H]2CC[C@@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1.[Cl-],C25H30ClNO3,21279.0
7426,FSB,O=C(O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(F)c2)ccc1O,C24H17FO6,10651.0
7427,Hexahydrocurcumin,COc1cc(CCC(=O)CC(O)CCc2ccc(O)c(OC)c2)ccc1O,C21H26O6,11714.0
7428,Tafamidis,O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1,C14H7Cl2NO3,13694.0
7429,DDD85646,Cc1nn(C)c(C)c1NS(=O)(=O)c1c(Cl)cc(-c2ccnc(N3CCNCC3)c2)cc1Cl,C21H24Cl2N6O2S,13839.0
7430,SR 9186,N#Cc1ccc(-c2ccc(NC(=O)Nc3ccc(-c4ccnc5[nH]cnc45)cc3)cc2)cc1,C26H18N6O,13888.0
7431,SAR405,C[C@@H]1COCCN1c1cc(=O)n2c(n1)N(Cc1cncc(Cl)c1)[C@H](C(F)(F)F)CC2,C19H21ClF3N5O2,16979.0
7432,OTS514,Cc1cc(O)c(-c2ccc([C@@H](C)CN)cc2)c2c1[nH]c(=O)c1sccc12,C21H20N2O2S,17053.0
7433,Velpatasvir,COC[C@H]1C[C@@H](c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6nc([C@@H]7CC[C@H](C)N7C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c65)cc3-4)[nH]2)N(C(=O)[C@H](NC(=O)OC)c2ccccc2)C1,C49H54N8O8,21280.0
7434,RBC8,COc1ccc(OC)c(C2C(C#N)=C(N)Oc3[nH]nc(-c4ccc5ccccc5c4)c32)c1,C25H20N4O3,21281.0
7435,Tipifarnib,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,C27H22Cl2N4O,11747.0
7436,VU0409551,O=C(c1ccc(F)cc1)N1CCc2nc(COc3ccccc3)oc2C1,C20H17FN2O3,18042.0
7437,S3QEL-2,CCCN(CCC)c1ncnc2c1cnn2-c1ccc(C)c(C)c1,C19H25N5,18556.0
7438,Butyryl fentanyl carboxy metabolite,O=C(O)CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C23H28N2O3,20494.0
7439,1-Oleoyl-2-hydroxy-sn-glycero-3-PG (sodium salt),CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC(O)CO.[Na+],C24H46NaO9P,20960.0
7440,Kibdelone A,CCCc1c(Cl)c2c(c(=O)n1C)C(=O)c1c(ccc3c(OC)c4oc5c(c(=O)c4c(O)c13)[C@@H](O)[C@@H](O)C[C@@H]5O)C2=O,C29H24ClNO10,21524.0
7441,Kibdelone C,CCCc1c(Cl)c2c(O)c3c(c(O)c2c(=O)n1C)-c1c(c(OC)c2oc4c(c(=O)c2c1O)[C@@H](O)[C@@H](O)C[C@@H]4O)CC3,C29H28ClNO10,21525.0
7442,EB 1089,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/C=C/C(O)(CC)CC)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,C30H46O3,21579.0
7443,PIK-293,Cc1ccccc1-n1c(Cn2ncc3c(N)ncnc32)nc2cccc(C)c2c1=O,C22H19N7O,21283.0
7444,EGT-1442,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(OCCOC4CC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,C24H29ClO7,21359.0
7445,Lincomycin,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,C18H34N2O6S,21526.0
7446,BMS 986188,CC1(C)CC(=O)C2=C(C1)OC1=C(C(=O)CC(C)(C)C1)C2c1ccc(OCc2ccccc2Br)cc1,C30H31BrO4,21548.0
7447,BMS 986187,Cc1ccccc1COc1ccc(C2C3=C(CC(C)(C)CC3=O)OC3=C2C(=O)CC(C)(C)C3)cc1,C31H34O4,21549.0
7448,B355252,O=S(=O)(NCc1cccc2ccccc12)c1cc(Cl)c(Oc2cccc(N3CCNCC3)c2)s1,C25H24ClN3O3S2,21550.0
7449,Canagliflozin,Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,C24H25FO5S,11575.0
7450,4-MMA-NBOMe (hydrochloride),COc1ccccc1CN(C)C(C)Cc1ccc(C)cc1.Cl,C19H26ClNO,18755.0
7451,Rostafuroxin,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@](O)(c3ccoc3)CC[C@]12O,C23H34O4,21282.0
7452,AVN-944,CC[C@H](CC#N)OC(=O)N[C@@H](C)c1cccc(NC(=O)Nc2ccc(-c3cnco3)c(OC)c2)c1,C25H27N5O5,21284.0
7453,AMG 337,COCCOc1cnc2ccn([C@H](C)c3nnc4c(F)cc(-c5cnn(C)c5)cn34)c(=O)c2c1,C23H22FN7O3,21333.0
7454,?-Amyrin,CC1(C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,C30H50O,20949.0
7455,PCI 27483,N=C(N)c1ccc2nc(-c3cc(CC(=O)N[C@@H](CC(=O)O)C(=O)O)cc(-c4cc(S(N)(=O)=O)ccc4O)c3O)[nH]c2c1,C26H24N6O9S,21334.0
7456,Pantoprazole,COc1ccnc(CS(=O)c2nc3ccc(OC(F)F)cc3[nH]2)c1OC,C16H15F2N3O4S,21345.0
7457,Bicyclol,COC(=O)c1cc(OC)c2c(c1-c1c(CO)cc(OC)c3c1OCO3)OCO2,C19H18O9,21551.0
7458,Eptifibatide (acetate),CC(=O)O.N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O,C37H53N11O11S2,21578.0
7459,MK-1775,C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1,C27H32N8O2,21266.0
7460,BMY 7378,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1.Cl.Cl,C22H33Cl2N3O3,21369.0
7461,1-Deoxynojirimycin,OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O,C6H13NO4,21500.0
7462,SCH 529074,CN(C)CCCNc1nc(CN2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)nc2ccccc12,C31H36Cl2N6,21552.0
7463,Fluensulfone,O=S(=O)(CCC(F)=C(F)F)c1ncc(Cl)s1,C7H5ClF3NO2S2,21554.0
7464,MPP+ Iodide,C[n+]1ccc(-c2ccccc2)cc1.[I-],C12H12IN,16958.0
7465,Alda-1,O=C(NCc1ccc2c(c1)OCO2)c1c(Cl)cccc1Cl,C15H11Cl2NO3,21555.0
7466,Alda-1,O=C(NCc1ccc2c(c1)OCO2)c1c(Cl)cccc1Cl,C15H11Cl2NO3,21555.0
7467,AT-13148,NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,C17H16ClN3O,21597.0
7468,AZD 5438,Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C,C18H21N5O2S,21598.0
7469,Aurora A Inhibitor I,CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1,C31H31ClFN7O2,21600.0
7470,JWH 018-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,10901.0
7471,JWH 018-d9 (CRM),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,C24H23NO,27726.0
7472,Malformin C,CC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](NC1=O)C(=O)N2,C23H39N5O5S2,21613.0
7473,Dihydrochlamydocin,C[C@@H](O)C(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)C(C)(C)NC1=O,C28H40N4O6,21614.0
7474,Isomaltose,O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C12H22O11,20797.0
7475,Methacycline (hydrochloride),C=C1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12.Cl,C22H23ClN2O8,21338.0
7476,Homarylamine (hydrochloride),CNCCc1ccc2c(c1)OCO2.Cl,C10H14ClNO2,21351.0
7477,Gly-Pro-pNA (hydrochloride),Cl.NCC(=O)N1CCC[C@H]1C(=O)Nc1ccc([N+](=O)[O-])cc1,C13H17ClN4O4,21244.0
7478,3-Chloroethcathinone (hydrochloride),CCNC(C)C(=O)c1cccc(Cl)c1.Cl,C11H15Cl2NO,21261.0
7479,Vinorelbine (tartrate),CCC1=C[C@@H]2C[N@](C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)[C@H](O)[C@@H](O)C(=O)O.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C53H66N4O20,21262.0
7480,Vilazodone (hydrochloride),Cl.N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,C26H28ClN5O2,21547.0
7481,NGB 2904 (hydrochloride),Cl.N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,C26H28ClN5O2,21457.0
7482,1-Palmitoyl-2-formylyl PC,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC=O,C25H50NO8P,9002943.0
7483,RGFP109,Cc1ccc(C(=O)NCCCCCC(=O)Nc2ccccc2N)cc1,C20H25N3O2,21568.0
7484,GZD-824,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1,C29H27F3N6O,21508.0
7485,Selamectin,CO[C@H]1C[C@H](O[C@@H]2/C(C)=C/C[C@@H]3C[C@@H](C[C@]4(CC[C@H](C)[C@@H](C5CCCCC5)O4)O3)OC(=O)[C@@H]3C=C(C)/C(=N/O)[C@H]4OC/C(=C\C=C\[C@@H]2C)[C@]43O)O[C@@H](C)[C@@H]1O,C43H63NO11,21529.0
7486,PF-04449913,CN1CC[C@@H](NC(=O)Nc2ccc(C#N)cc2)C[C@@H]1c1nc2ccccc2[nH]1,C21H22N6O,9002936.0
7487,"N,N-didesmethyl U-47700 (trifluoroacetate salt)",CN(C(=O)c1ccc(Cl)c(Cl)c1)[C@@H]1CCCC[C@H]1N,C14H18Cl2N2O,20295.0
7488,Noroxymorphone,O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3)[C@H]1O5,C16H17NO4,15903.0
7489,Enasidenib,CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,C19H17F6N7O,21277.0
7490,Thiamphenicol,CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1,C12H15Cl2NO5S,21357.0
7491,Propylphosphonic Acid,CCCP(=O)(O)O,C3H9O3P,21702.0
7492,GNE-495,Nc1ncc(C(=O)NC2CN(C(=O)C3CC3)C2)c2ccc(-c3cccc(F)c3)nc12,C22H20FN5O2,21808.0
7493,Trifluorothymidine,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F,C10H11F3N2O5,21366.0
7494,Desonide,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,C24H32O6,21368.0
7495,WEHI-539,NCc1ccc(OCCCc2sc(-c3ccc4c(c3)/C(=N/Nc3nc5ccccc5s3)CCC4)nc2C(=O)O)cc1,C31H29N5O3S2,21478.0
7496,CPCCOEt,CCOC(=O)C12CC1/C(=N\O)c1ccccc1O2,C13H13NO4,21486.0
7497,XL228,CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1,C22H31N9O,21506.0
7498,Anagrelide (hydrochloride),Cl.O=C1CN2Cc3c(ccc(Cl)c3Cl)NC2=N1,C10H8Cl3N3O,21411.0
7499,Quinapril (hydrochloride),CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O.Cl,C25H31ClN2O5,21439.0
7500,Mometasone Furoate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl,C27H30Cl2O6,21365.0
7501,JNJ-5207787,CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C#N)c3)C3CCN(CCC4CCCC4)CC3)cc21,C32H38N4O2,13947.0
7502,Apatinib,N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,C24H23N5O,21268.0
7503,RG7388,COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F,C31H29Cl2F2N3O4,21532.0
7504,HO-3867,CC1(C)C=C(CN2C/C(=C\c3ccc(F)cc3)C(=O)/C(=C/c3ccc(F)cc3)C2)C(C)(C)N1O,C28H30F2N2O2,21581.0
7505,D-Sedoheptulose-7-phosphate (barium salt),O=P([O-])([O-])OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@H](O)[C@@H]1O.[Ba+2],C7H13BaO10P,21344.0
7506,AN2728,N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1,C14H10BNO3,21455.0
7507,Deferoxamine (mesylate),CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN.CS(=O)(=O)O,C26H52N6O11S,14595.0
7508,Picropodophyllotoxin,COc1cc(C2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC,C22H22O8,17329.0
7509,Pinacidil (hydrate),CC(N/C(=N/c1ccncc1)NC#N)C(C)(C)C.O,C13H21N5O,15416.0
7510,Tazarotenic Acid,CC1(C)CCSc2ccc(C#Cc3ccc(C(=O)O)cn3)cc21,C19H17NO2S,21367.0
7511,D-Ribulose-5-phosphate (sodium salt),O=C(CO)[C@H](O)[C@H](O)COP(=O)(O)O.[NaH],C5H11NaO8P,21423.0
7512,Cholesteryl heptadecanoate,CCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C44H78O2,21750.0
7513,Cholesteryl Heptadecanoate,CCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C44H78O2,21750.0
7514,Prolintane (hydrochloride),CCCC(Cc1ccccc1)N1CCCC1.Cl,C15H24ClN,11147.0
7515,?-Muricholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)[C@@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H40O5,20291.0
7516,PA-457,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C36H56O6,21339.0
7517,Baccatin III,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](O)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,C31H38O11,21404.0
7518,PBFI AM,COc1cc2cc(-c3ccc(C(=O)OCOC(C)=O)cc3C(=O)OCOC(C)=O)oc2cc1N1CCOCCOCCN(c2cc3oc(-c4ccc(C(=O)OCOC(C)=O)cc4C(=O)OCOC(C)=O)cc3cc2OC)CCOCCOCC1,C58H62N2O24,21602.0
7519,Butabindide (oxalate),CCCCNC(=O)[C@@H]1Cc2ccccc2N1C(=O)[C@@H](N)CC.O=C(O)C(=O)O,C19H27N3O6,21610.0
7520,N-3-oxo-hexadecanoyl-L-Homoserine lactone,CCCCCCCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,C20H35NO4,13062.0
7521,N-Palmitoyl-L-Aspartate,CCCCCCCCCCCCCCCC(=O)N[C@@H](CC(=O)O)C(=O)O,C20H37NO5,19952.0
7522,TW-37,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O,C33H35NO6S,20999.0
7523,Odanacatib,CC(C)(F)C[C@H](N[C@@H](c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1,C25H27F4N3O3S,21466.0
7524,Ertugliflozin,CCOc1ccc(Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1,C22H25ClO7,21507.0
7525,LY2886721,NC1=N[C@@]2(c3cc(NC(=O)c4ccc(F)cn4)ccc3F)COC[C@H]2CS1,C18H16F2N4O2S,21599.0
7526,Optovin,Cc1cc(/C=C2/SC(=S)NC2=O)c(C)n1-c1cccnc1,C15H13N3OS2,14851.0
7527,RO4987655,O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F,C20H19F3IN3O5,19488.0
7528,SKQ1 (bromide),CC1=C(C)C(=O)C(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)=CC1=O.[Br-],C36H42BrO2P,19891.0
7529,Chlorpyrifos,CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl,C9H11Cl3NO3PS,21412.0
7530,KN-93 (phosphate) ),COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1.O=P(=O)OO.[HH],C26H31ClN2O8PS,21472.0
7531,Eliglustat (hemitartrate),CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2.CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C50H78N4O14,21487.0
7532,Dianemycin,CO[C@@H]1CC[C@@H](O[C@H]2C[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)/C=C(\C)C(=O)[C@H](C)C[C@H](C)C(=O)O)O4)O3)O[C@]3(O[C@@H]([C@H]4O[C@@](O)(CO)[C@H](C)C[C@@H]4C)C[C@@H]3C)[C@@H]2C)O[C@H]1C,C47H78O14,21679.0
7533,Buparvaquone,CC(C)(C)C1CCC(CC2=C(O)C(=O)c3ccccc3C2=O)CC1,C21H26O3,21704.0
7534,AZD 9496,C[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2c(F)cc(/C=C/C(=O)O)cc2F)N1CC(C)(C)F,C25H25F3N2O2,21805.0
7535,AZD 9496,C[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2c(F)cc(/C=C/C(=O)O)cc2F)N1CC(C)(C)F,C25H25F3N2O2,21805.0
7536,Blasticidin S (hydrochloride),CN(CC[C@H](N)CC(=O)N[C@H]1C=C[C@H](n2ccc(N)nc2=O)O[C@@H]1C(=O)O)C(=N)N.Cl,C17H27ClN8O5,14499.0
7537,GNE-3511,N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)cc(N3CCC(F)(F)C3)n2)c1,C23H26F2N6O,19174.0
7538,Tosufloxacin (tosylate),Cc1ccc(S(=O)(=O)O)cc1.NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1,C26H23F3N4O6S,21427.0
7539,C3a Receptor Agonist,O=C(NC1CCN(C(=O)CCc2cccnc2)CC1)C(c1ccccc1)C1CCCCC1,C27H35N3O2,21683.0
7540,Glycolithocholic Acid,C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C26H43NO4,21723.0
7541,BAY-299,Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C,C25H23N3O4,19777.0
7542,Hecogenin,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC(=O)[C@]3(C)[C@H]1[C@@H]2C,C27H42O4,21372.0
7543,DK-AH 269,COc1ccc(CCN2CCCC(CN3CCc4cc(OC)c(OC)cc4CC3=O)C2)cc1OC.Cl,C28H39ClN2O5,21425.0
7544,3-(4-Chlorophenyl)-4-hydroxybutyric Acid (sodium salt),O=C(O)CC(CO)c1ccc(Cl)cc1.[NaH],C10H11ClNaO3,21483.0
7545,Retapamulin,C=C[C@]1(C)C[C@@H](OC(=O)CS[C@@H]2C[C@H]3CC[C@@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,C30H47NO4S,21528.0
7546,GSK805,CCS(=O)(=O)c1ccc(CC(=O)Nc2cc(Cl)c(-c3ccccc3OC(F)(F)F)c(Cl)c2)cc1,C23H18Cl2F3NO4S,9002444.0
7547,CID-5951923,CN(C(=O)COC(=O)/C=C/c1cccc([N+](=O)[O-])c1)C1CCS(=O)(=O)C1,C16H18N2O7S,21649.0
7548,10-oxo Docetaxel,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)C(=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C,C43H51NO14,21672.0
7549,Doxorubicinone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O,C21H18O9,21693.0
7550,ML-352,COc1ccc(C(=O)NCc2cc(C(C)C)no2)cc1OC1CCN(C)CC1,C21H29N3O4,21878.0
7551,Tauro-?-muricholic Acid (sodium salt),C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@H]2[C@@H]3[C@@H](O)[C@@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.[Na+],C26H44NNaO7S,20289.0
7552,N-Oleoyl Proline,CCCCCCCC/C=C\CCCCCCCC(=O)N1CCC[C@H]1C(=O)O,C23H41NO3,20369.0
7553,Gilteritinib,CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1,C29H44N8O3,21503.0
7554,Pneumocandin B0,CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)C([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)C([C@@H](C)O)NC1=O,C50H80N8O17,21527.0
7555,Dihydromorphine (hydrate),CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@H]3[C@H]1C5.O,C17H23NO4,21536.0
7556,Dihydromorphine (hydrate) (exempt preparation),CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@H]3[C@H]1C5.O,C17H23NO4,22881.0
7557,6?-Oxycodol,COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314,C18H23NO4,21538.0
7558,Clindamycin Sulfoxide,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](S(C)=O)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,C18H33ClN2O6S,21696.0
7559,KD 5170,CC(=O)SCC(=O)c1ccc(NS(=O)(=O)c2ccc(OCCCN(C)C)cc2)nc1,C20H25N3O5S2,13214.0
7560,N-desmethyl AH 7921 (hydrochloride),CNC1(CNC(=O)c2ccc(Cl)c(Cl)c2)CCCCC1.Cl,C15H21Cl3N2O,20280.0
7561,Pyropheophorbide a,C=Cc1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)O)[C@@H]3C,C33H34N4O3,21371.0
7562,NU 2058,Nc1nc2ncnc-2c(OCC2CCCCC2)[nH]1,C12H17N5O,21415.0
7563,KX2-391,O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1,C26H29N3O3,21429.0
7564,Rp-8-bromo-Cyclic AMPS (sodium salt),Nc1ncnc2c1nc(Br)n2[C@@H]1O[C@@H]2CO[P@@](=O)([S-])O[C@H]2[C@H]1O.[Na+],C10H10BrN5NaO5PS,21584.0
7565,2-methyl-4'-(methylthio)-2-Morpholinopropiophenone,CSc1ccc(C(=O)C(C)(C)N2CCOCC2)cc1,C15H21NO2S,21651.0
7566,Chlorin e6,C=Cc1c(C)c2cc3nc(c(CC(=O)O)c4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CC)c(C)c4C(=O)O)[C@@H](CCC(=O)O)[C@@H]3C,C34H34N4O6,21684.0
7567,MK-8669,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,C53H84NO14P,10543.0
7568,Trandolapril,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21,C24H34N2O5,13522.0
7569,BRD7389,O=C1c2ccccc2-c2c(NCCc3ccccc3)c(=O)[nH]c3cccc1c23,C24H18N2O2,20214.0
7570,BMS-911543,CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21.O=C1c2ccccc2-c2c(NCCc3ccccc3)c(=O)[nH]c3cccc1c23,C47H46N10O3,21088.0
7571,Helvolic Acid,CC(=O)O[C@H]1C[C@@]2(C)[C@@H](CC[C@H]3[C@@]4(C)C=CC(=O)[C@@H](C)[C@@H]4[C@H](OC(C)=O)C(=O)[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O,C33H44O8,21580.0
7572,Motilin (porcine),CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O,C120H188N34O35S,21619.0
7573,Hordenine,CN(C)CCc1ccc(O)cc1,C10H15NO,21626.0
7574,"2,3,4,6-Tetra-O-benzoyl-?-D-glucopyranose",O=C(OC[C@H]1O[C@@H](O)[C@H](OC(=O)c2ccccc2)[C@@H](OC(=O)c2ccccc2)[C@@H]1OC(=O)c1ccccc1)c1ccccc1,C34H28O10,17163.0
7575,Icosabutate,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCOC(CC)C(=O)O,C24H38O3,19386.0
7576,Biotin LC hydrazide,NNC(=O)CCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C16H29N5O3S,21497.0
7577,LY3009120,CNc1ncc2cc(-c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C)c(C)nc2n1,C23H29FN6O,21504.0
7578,Cefdinir,C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\O)c3csc(N)n3)[C@H]2SC1,C14H13N5O5S2,21521.0
7579,6.alpha.-Oxymorphol,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@@]3(O)[C@H]1C5,C17H21NO4,21542.0
7580,6?-Oxymorphol (CRM),CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@@]3(O)[C@H]1C5,C17H21NO4,25940.0
7581,6.beta.-Oxymorphol,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@H](O)CC[C@@]3(O)[C@H]1C5,C17H21NO4,21543.0
7582,N-(3-hydroxy-7-cis tetradecenoyl)-L-Homoserine lactone,CCCCCC/C=C\CCCC(O)CC(=O)N[C@H]1CCOC1=O,C18H31NO4,9002939.0
7583,CC-885,Cc1ccc(NC(=O)NCc2ccc3c(c2)CN(C2CCC(=O)NC2=O)C3=O)cc1Cl,C22H21ClN4O4,19966.0
7584,TP-064,CNCCN1CCC(c2cc(CN(C)C(=O)c3cccc(Oc4ccccc4)c3)ccn2)CC1,C28H34N4O2,20256.0
7585,TP-064,CNCCN1CCC(c2cc(CN(C)C(=O)c3cccc(Oc4ccccc4)c3)ccn2)CC1,C28H34N4O2,20256.0
7586,Etrasimod,O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21,C26H26F3NO3,21661.0
7587,Tolnaftate,Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1,C19H17NOS,21446.0
7588,ACY-1215,O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2)nc1)NO,C24H27N5O3,21531.0
7589,ZLN024,Cc1ccc(OCCSc2ncccn2)c(Br)c1,C13H13BrN2OS,21644.0
7590,9-Deazaguanine,Nc1nc2cc[nH]c2c(=O)[nH]1,C6H6N4O,21674.0
7591,?-Pyrrolidinoisohexanophenone (hydrochloride),CC(C)CC(C(=O)c1ccccc1)N1CCCC1.Cl,C16H24ClNO,21682.0
7592,3-Propylxanthine,CCCn1c(=O)[nH]c(=O)c2nc[nH]c21,C8H10N4O2,21746.0
7593,(S)-3-Hydroxybutyrate (sodium salt),C[C@H](O)CC(=O)[O-].[Na+],C4H7NaO3,21822.0
7594,3-hydroxy Desloratadine,Oc1cnc2c(c1)CCc1cc(Cl)ccc1C2=C1CCNCC1,C19H19ClN2O,21847.0
7595,Taurochenodeoxycholic Acid (sodium salt),C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.[Na+],C26H44NNaO6S,20275.0
7596,Docosapentaenoic Acid-d5,[2H]C([2H])([2H])C([2H])([2H])/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O,C22H34O2,20913.0
7597,Retigabine,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N,C16H18FN3O2,21449.0
7598,Safinamide (mesylate),CS(=O)(=O)O.C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,C18H23FN2O5S,21546.0
7599,N-methyl-1-Phenylpropan-1-amine (hydrochloride),CCC(NC)c1ccccc1.Cl,C10H16ClN,21630.0
7600,Paynantheine,C=C[C@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C23H28N2O4,21841.0
7601,Paynantheine (CRM),C=C[C@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C23H28N2O4,38999.0
7602,Glycodeoxycholic Acid (hydrate),C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C.O,C26H45NO6,20274.0
7603,?-Muricholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)[C@@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H40O5,20287.0
7604,Bentamapimod,N#CC(c1ccnc(OCc2ccc(CN3CCOCC3)cc2)n1)c1nc2ccccc2s1,C25H23N5O2S,21482.0
7605,Zosuquidar (hydrochloride),Cl.Cl.Cl.O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1,C32H34Cl3F2N3O2,21533.0
7606,C-7280948,Nc1ccc(S(=O)(=O)NCCc2ccccc2)cc1,C14H16N2O2S,21601.0
7607,D-NAME (hydrochloride),COC(=O)[C@H](N)CCCNC(=N)N[N+](=O)[O-].Cl,C7H16ClN5O4,21687.0
7608,7-hydroxy Mitragynine,CC[C@@H]1CN2CC[C@@]3(O)C(=Nc4cccc(OC)c43)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C23H30N2O5,13114.0
7609,7-hydroxy Mitragynine (CRM),CC[C@@H]1CN2CC[C@@]3(O)C(=Nc4cccc(OC)c43)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C23H30N2O5,35468.0
7610,Hexaflumuron,O=C(NC(=O)c1c(F)cccc1F)Nc1cc(Cl)c(OC(F)(F)C(F)F)c(Cl)c1,C16H8Cl2F6N2O3,18598.0
7611,Pyrrolidinedithiocarbamic Acid (ammonium salt),S=C([S-])N1CCCC1.[NH4+],C5H12N2S2,20713.0
7612,Todralazine (hydrochloride),CCOC(=O)NNc1nncc2ccccc12.Cl,C11H13ClN4O2,20893.0
7613,Quercetin 3-O-glucuronide,O=C(O)[C@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H](O)[C@@H]1O,C21H18O13,21289.0
7614,Afatinib (maleate),CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,C32H33ClFN5O11,21567.0
7615,bis-ANS (potassium salt),O=S(=O)([O-])c1cccc2c(-c3ccc(Nc4ccccc4)c4c(S(=O)(=O)[O-])cccc34)ccc(Nc3ccccc3)c12.[K+].[K+],C32H22K2N2O6S2,21820.0
7616,SGC2085 (hydrochloride),Cc1cc(C)cc(Oc2ccc(CNC(=O)[C@H](C)N)cc2C)c1.Cl,C19H25ClN2O2,21879.0
7617,4BP-TQS,NS(=O)(=O)c1ccc2c(c1)C1C=CCC1C(c1ccc(Br)cc1)N2,C18H17BrN2O2S,21881.0
7618,ARRY-520 (trifluoroacetate salt),CON(C)C(=O)N1N=C(c2cc(F)ccc2F)S[C@@]1(CCCN)c1ccccc1.O=C(O)C(F)(F)F,C22H23F5N4O4S,21883.0
7619,Azadirachtin,C/C=C(\C)C(=O)O[C@H]1C[C@@H](OC(C)=O)[C@@]2(C(=O)OC)CO[C@H]3[C@@H](O)[C@@](C)([C@]45O[C@@]4(C)[C@H]4C[C@@H]5O[C@@H]5OC=C[C@@]54O)[C@H]4[C@]1(CO[C@]4(O)C(=O)OC)[C@@H]32,C35H44O16,21893.0
7620,JNJ-42153605,FC(F)(F)c1c(N2CCC(c3ccccc3)CC2)ccn2c(CC3CC3)nnc12,C22H23F3N4,21984.0
7621,Levobunolol (hydrochloride),CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O.Cl,C17H26ClNO3,21005.0
7622,BC 11-38,CCCSc1nc2c(c(=O)n1-c1ccccc1)SCC2,C15H16N2OS2,20167.0
7623,Metergoline,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21,C25H29N3O2,21336.0
7624,TC-E 5003,O=C(CCl)Nc1ccc(S(=O)(=O)c2ccc(NC(=O)CCl)cc2)cc1,C16H14Cl2N2O4S,17718.0
7625,"N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid",CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1O,C11H17NO8,19939.0
7626,(+)-PD 128907 (hydrochloride),CCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@H]21.Cl,C14H20ClNO3,21235.0
7627,NLG-919 analog,OC(CC1c2ccccc2-c2cncn21)C1CCCCC1,C18H22N2O,21509.0
7628,Tasisulam,O=C(NS(=O)(=O)c1ccc(Br)s1)c1ccc(Cl)cc1Cl,C11H6BrCl2NO3S2,21556.0
7629,Tasisulam,O=C(NS(=O)(=O)c1ccc(Br)s1)c1ccc(Cl)cc1Cl,C11H6BrCl2NO3S2,21556.0
7630,Solithromycin,CC[C@H]1OC(=O)[C@@](C)(F)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cc(-c4cccc(N)c4)nn3)C(=O)O[C@]12C,C43H65FN6O10,21681.0
7631,SAR407899,O=c1[nH]ccc2cc(OC3CCNCC3)ccc12,C14H16N2O2,21717.0
7632,GSK2292767,COc1ncc(-c2cc(-c3ncc(CN4C[C@@H](C)O[C@@H](C)C4)o3)c3cn[nH]c3c2)cc1NS(C)(=O)=O,C24H28N6O5S,21757.0
7633,GSK2292767,COc1ncc(-c2cc(-c3ncc(CN4C[C@@H](C)O[C@@H](C)C4)o3)c3cn[nH]c3c2)cc1NS(C)(=O)=O,C24H28N6O5S,21757.0
7634,Aurora Kinase Inhibitor III,O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1,C21H18F3N5O,21851.0
7635,Glycocholic Acid-d4,[2H]C1([2H])C[C@@]2(C)[C@H](C[C@@H](O)[C@@H]3[C@@H]2C[C@H](O)[C@]2(C)[C@@H]([C@H](C)CCC(=O)NCC(=O)O)CC[C@@H]32)C([2H])([2H])[C@@H]1O,C26H43NO6,21889.0
7636,2-(Phosphonomethyl)-pentanedioic Acid,O=C(O)CCC(CP(=O)(O)O)C(=O)O,C6H11O7P,21916.0
7637,PF-4136309,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1,C29H31F3N6O3,21965.0
7638,(S)-MCPG,C[C@@](N)(C(=O)O)c1ccc(C(=O)O)cc1,C10H11NO4,21450.0
7639,(S)-MCPG,C[C@@](N)(C(=O)O)c1ccc(C(=O)O)cc1,C10H11NO4,21450.0
7640,eFT508,Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1,C17H20N6O2,21957.0
7641,MK-3102,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,C17H20F2N4O3S,21454.0
7642,Anacetrapib,COc1cc(F)c(C(C)C)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)O[C@H](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H]1C,C30H25F10NO3,21558.0
7643,Anacetrapib,COc1cc(F)c(C(C)C)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)O[C@H](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H]1C,C30H25F10NO3,21558.0
7644,SKLB610,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2)ccn1,C21H16F3N3O3,21561.0
7645,kb-NB77-78,CC(C)(C)[Si](C)(C)Oc1ccc2oc(=O)c3c(c2c1)CCCN3,C18H25NO3Si,21562.0
7646,E7449,O=c1[nH]nc2c3c(cccc13)NC(CN1Cc3ccccc3C1)=N2,C18H15N5O,21658.0
7647,Betrixaban,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1,C23H22ClN5O3,21563.0
7648,Walrycin B,Cn1nc(-c2ccc(C(F)(F)F)cc2)nc2c(=O)n(C)c(=O)nc1-2,C14H10F3N5O2,21566.0
7649,GTS-21 (hydrochloride),COc1ccc(/C=C2\CCCN=C2c2cccnc2)c(OC)c1.Cl.Cl,C19H22Cl2N2O2,21570.0
7650,Rilpivirine,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,C22H18N6,21559.0
7651,LY2835219,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,C27H32F2N8,21560.0
7652,LY2835219,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,C27H32F2N8,21560.0
7653,Nemadipine A,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1c(F)c(F)c(F)c(F)c1F,C19H18F5NO4,21689.0
7654,Megestryl Acetate,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,C24H32O4,21749.0
7655,SHA-68,O=C(NCc1ccc(F)cc1)N1CCN2C(=O)OC(c3ccccc3)(c3ccccc3)C2C1,C26H24FN3O3,21512.0
7656,NIBR0213,Cc1cc([C@@H](C)Nc2cccc(-c3cc(C)c(C(=O)N[C@@H](C)C(=O)O)c(C)c3)c2)ccc1Cl,C27H29ClN2O3,21513.0
7657,Polydatin,OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,C20H22O8,13932.0
7658,ABO (hydrochloride),Cl.Cl.Nc1ccc2c(c1)NC(CO)CO2,C9H14Cl2N2O2,21515.0
7659,YK-3-237,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1B(O)O,C19H21BO7,21516.0
7660,RSM-932A,CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)c5ccccc54)cc3)cc2)c2ccccc12.[Br-].[Br-],C46H38Br2Cl2N4,21518.0
7661,PD 089828,CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl,C18H18Cl2N6O,21435.0
7662,CpdA,CNCC(Cl)c1ccc(OC(C)=O)cc1.Cl,C11H15Cl2NO2,21438.0
7663,Masitinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,C28H30N6OS,13105.0
7664,Glatiramer (acetate),CC(=O)O.C[C@H](N)C(=O)O.NCCCC[C@H](N)C(=O)O.N[C@@H](CCC(=O)O)C(=O)O.N[C@@H](Cc1ccc(O)cc1)C(=O)O,C25H45N5O13,9000571.0
7665,Fidarestat,NC(=O)[C@@H]1C[C@]2(NC(=O)NC2=O)c2cc(F)ccc2O1,C12H10FN3O4,21756.0
7666,Aminopterin,Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1,C19H20N8O5,21802.0
7667,Aloisine RP106,CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,C17H19N3O,21873.0
7668,VU0071063,Cn1c(=O)c2c(ncn2Cc2ccc(C(C)(C)C)cc2)n(C)c1=O,C18H22N4O2,21897.0
7669,Docosapentaenoic Acid (sodium salt),CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)[O-].[Na+],C22H33NaO2,21907.0
7670,MLR-1023,Cc1cccc(Oc2cnc(=O)[nH]c2)c1,C11H10N2O2,21496.0
7671,M8-B (hydrochloride),COc1cc(CN(CCN)C(=O)c2cccs2)ccc1OCc1ccccc1.Cl,C22H25ClN2O3S,21646.0
7672,PF-3716556,Cc1cn2cc(C(=O)N(C)CCO)cc(N[C@@H]3CCOc4cccc(C)c43)c2n1,C22H26N4O3,17710.0
7673,Aclidinium (bromide),O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-],C26H30BrNO4S2,20699.0
7674,MEP-FUBICA,CCC[C@H](NC(=O)c1cn(Cc2ccc(F)cc2)c2ccccc12)C(=O)OC,C22H23FN2O3,21653.0
7675,Neamine (hydrochloride),Cl.Cl.Cl.Cl.NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O,C12H30Cl4N4O6,21752.0
7676,MK-886,CC(C)c1ccc2c(c1)c(SC(C)(C)C)c(CC(C)(C)C(=O)O)n2Cc1ccc(Cl)cc1,C27H34ClNO2S,21753.0
7677,UDP-?-D-Glucose (sodium salt),O=c1ccn([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1.[Na+].[Na+],C15H22N2Na2O17P2,21620.0
7678,Picrotin,CC(C)(O)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C,C15H18O7,21870.0
7679,Palmitoleic Acid (sodium salt),CCCCCC/C=C\CCCCCCCC(=O)[O-].[Na+],C16H29NaO2,21911.0
7680,Siramesine (fumarate),Fc1ccc(-n2cc(CCCCN3CCC4(CC3)OCc3ccccc34)c3ccccc32)cc1.O=C(O)/C=C/C(=O)O,C34H35FN2O5,21817.0
7681,5-bromo-2-chloro-4-Methoxypyrimidine,COc1nc(Cl)ncc1Br,C5H4BrClN2O,21862.0
7682,Valeryl fentanyl carboxy metabolite,O=C(O)CCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H30N2O3,20497.0
7683,Tezacaftor,CC(C)(CO)c1cc2cc(NC(=O)C3(c4ccc5c(c4)OC(F)(F)O5)CC3)c(F)cc2n1C[C@@H](O)CO,C26H27F3N2O6,21480.0
7684,12-oxo Stearic Acid methyl ester,CCCCCCC(=O)CCCCCCCCCCC(=O)OC,C19H36O3,10007012.0
7685,12-oxo Stearic Acid methyl ester,CCCCCCC(=O)CCCCCCCCCCC(=O)OC,C19H36O3,10007012.0
7686,NPC-15437 (hydrochloride),CCCCCCCCCCCCC(=O)N1CCCCC1CNC(=O)[C@@H](N)CCCCN.Cl.Cl,C25H52Cl2N4O2,20212.0
7687,Oxymetholone,C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C21H32O3,21643.0
7688,Oxymetholone (exempt preparation),C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C21H32O3,41383.0
7689,4-Chlorophenyl-2-pyridinylmethanol,OC(c1ccc(Cl)cc1)c1ccccn1,C12H10ClNO,21861.0
7690,Eicosapentaenoic Acid (sodium salt),CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)[O-].[Na+],C20H29NaO2,21908.0
7691,Linoleic Acid (sodium salt),CCCCC/C=C\C/C=C\CCCCCCCC(=O)[O-].[Na+],C18H31NaO2,21909.0
7692,?-Linolenic Acid (sodium salt),CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)[O-].[Na+],C18H29NaO2,21910.0
7693,6?-Oxycodol N-oxide,COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)[N+](C)([O-])CC[C@]314,C18H23NO5,21539.0
7694,Dimethylcurcumin,COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,C23H24O6,10008187.0
7695,ABC294640,O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2,C23H25ClN2O,10587.0
7696,BML-278,CCOC(=O)C1=CN(Cc2ccccc2)C=C(C(=O)OCC)C1c1ccccc1,C24H25NO4,20209.0
7697,N-methoxy Mephedrone (hydrochloride),CON(C)C(C)C(=O)c1ccc(C)cc1.Cl,C12H18ClNO2,20808.0
7698,SR 59230A (hydrochloride),CCc1ccccc1OC[C@@H](O)CN[C@H]1CCCc2ccccc21.Cl,C21H28ClNO2,21407.0
7699,CHPG,NC(C(=O)O)c1cc(O)ccc1Cl,C8H8ClNO3,21408.0
7700,N6-Cyclopentyladenosine,OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O,C15H21N5O4,21448.0
7701,"Angiotensin III (human, mouse)",CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O,C46H66N12O9,21618.0
7702,Farampator,O=C(c1ccc2nonc2c1)N1CCCCC1,C12H13N3O2,21510.0
7703,Farampator,O=C(c1ccc2nonc2c1)N1CCCCC1,C12H13N3O2,21510.0
7704,Nonyloxytryptamine (oxalate),CCCCCCCCCOc1ccc2[nH]cc(CCN)c2c1.O=C(O)C(=O)O,C21H32N2O5,21517.0
7705,Arachidic Acid (sodium salt),CCCCCCCCCCCCCCCCCCCC(=O)[O-].[Na+],C20H39NaO2,21906.0
7706,PMK methyl glycidate,COC(=O)C1(C)OC1c1ccc2c(c1)OCO2,C12H12O5,21833.0
7707,NFAT Activation Inhibitor III,O=C1C=CC(=O)C2=C1C1c3ccccc3C2c2ccccc21,C20H12O2,21812.0
7708,Resorufin Acetate,CC(=O)Oc1ccc2nc3ccc(=O)cc-3oc2c1,C14H9NO4,21686.0
7709,para-fluoro Methoxyacetyl fentanyl (hydrochloride),COCC(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H28ClFN2O2,21741.0
7710,Propafenone (hydrochloride),CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1.Cl,C21H28ClNO3,21871.0
7711,JNJ-47965567,O=C(NCC1(N2CCN(c3ccccc3)CC2)CCOCC1)c1cccnc1Sc1ccccc1,C28H32N4O2S,21895.0
7712,N-methyl Benzedrone (hydrochloride),Cc1ccc(C(=O)C(C)N(C)Cc2ccccc2)cc1.Cl,C18H22ClNO,21214.0
7713,VH 298,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(C#N)CC2)C(C)(C)C)cc1,C27H33N5O4S,21133.0
7714,Methylone-d3 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])NC(C)C(=O)c1ccc2c(c1)OCO2,C11H14ClNO3,18732.0
7715,Fludarabine Phosphate,Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]1O,C10H13FN5O7P,14251.0
7716,Tolbutamide,CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,C12H18N2O3S,19888.0
7717,ML-252 (hydrochloride),CC[C@H](C(=O)Nc1ccccc1N1CCCC1)c1ccccc1.Cl,C20H25ClN2O,15191.0
7718,Calcein Blue,Cc1cc(=O)oc2c(CN(CC(=O)O)CC(=O)O)c(O)ccc12,C15H15NO7,20636.0
7719,Mesterolone,C[C@H]1CC(=O)C[C@@H]2CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@]21C,C20H32O2,21171.0
7720,Mesterolone (exempt preparation),C[C@H]1CC(=O)C[C@@H]2CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@]21C,C20H32O2,43537.0
7721,Glycochenodeoxycholic Acid-d4,[2H]C1([2H])C[C@@]2(C)[C@H](C[C@@H](O)[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)NCC(=O)O)CC[C@@H]32)C([2H])([2H])[C@@H]1O,C26H43NO5,21890.0
7722,SW155246,O=[N+]([O-])c1cc(S(=O)(=O)Nc2ccc(O)c3ccccc23)ccc1Cl,C16H11ClN2O5S,21865.0
7723,JCP174,CCCOc1oc(=O)c2cc(N)ccc2c1Cl,C12H12ClNO3,21866.0
7724,PQ-10,COc1cc2ncnc(N3CC[C@@H](Oc4cnc5ccccc5n4)C3)c2cc1OC,C22H21N5O3,21867.0
7725,Stanozolol,C[C@]12Cc3cn[nH]c3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C21H32N2O,21167.0
7726,Mazindol,OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21,C16H13ClN2O,21642.0
7727,Benidipine (hydrochloride),COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)[C@@H]1c1cccc([N+](=O)[O-])c1.Cl,C28H32ClN3O6,21607.0
7728,ML-309 (hydrochloride),Cc1ccccc1C(C(=O)NC1CCCC1)N(C(=O)Cn1cnc2ccccc21)c1cccc(F)c1.Cl,C29H30ClFN4O2,21519.0
7729,Calcein Blue AM,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)Cc1c(O)ccc2c(C)cc(=O)oc12,C21H23NO11,20637.0
7730,"14,15-Leukotriene D4",CCCCC[C@H](O)[C@@H](/C=C/C=C/C=C\C/C=C\CCCC(=O)O)SC[C@H](N)C(=O)NCC(=O)O,C25H40N2O6S,10011361.0
7731,ML-298,O=C(NCCN1CCC2(CC1)C(=O)NCN2c1cccc(F)c1)c1ccc(F)c(F)c1,C22H23F3N4O2,15349.0
7732,N-Oleoyl Valine,CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](C(=O)O)C(C)C,C23H43NO3,20065.0
7733,ML-192,Cc1nc(N2CCN(C(=O)c3ccco3)CC2)c2c3c(sc2n1)CCCC3,C20H22N4O2S,15183.0
7734,Sisomicin,CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O,C19H37N5O7,21046.0
7735,Fosamprenavir (calcium salt),CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O,C19H37N5O7,21609.0
7736,Picotamide,COc1ccc(C(=O)NCc2cccnc2)cc1C(=O)NCc1cccnc1,C21H20N4O3,21690.0
7737,MM-11253,CC1(C)CCC(C)(C)c2cc(C3(c4ccc5cc(C(=O)O)ccc5c4)SCCS3)ccc21,C28H30O2S2,21800.0
7738,CM037,CCOC(=O)CSc1nc2c(sc3ccccc32)c(=O)n1CCCN1CCCC1,C21H25N3O3S2,21868.0
7739,JNJ-40418677,CC(C)C[C@H](C(=O)O)c1cc(-c2ccc(C(F)(F)F)cc2)cc(-c2ccc(C(F)(F)F)cc2)c1,C26H22F6O2,21869.0
7740,preQ1 (hydrochloride),Cl.Cl.NCc1c[nH]c2nc(N)[nH]c(=O)c12,C7H11Cl2N5O,21864.0
7741,G244-LM,CS(=O)(=O)c1ccccc1N1CCN(c2nc(=O)c3c([nH]2)CCSC3)CC1,C18H22N4O3S2,21876.0
7742,MONNA,COc1cc(Nc2ccc([N+](=O)[O-])cc2C(=O)O)cc2ccccc12,C18H14N2O5,21917.0
7743,OBA-09,CC(=O)C(=O)Oc1ccccc1C(=O)O,C10H8O5,21918.0
7744,CHM-122,Cc1ccc(C(=O)c2cn(CC3CCCCC3)c3ccccc23)c2ccccc12,C27H27NO,22043.0
7745,Rhodamine B isothiocyanate (mixed isomers),CCN(CC)c1ccc2c(-c3cc(N=C=S)ccc3C(=O)O)c3ccc(N(CC)CC)cc3[o+]c2c1.CCN(CC)c1ccc2c(-c3ccc(N=C=S)cc3C(=O)O)c3ccc(N(CC)CC)cc3[o+]c2c1.[Cl-].[Cl-],C58H60Cl2N6O6S2,20653.0
7746,2-Chloroethcathinone (hydrochloride),CCNC(C)C(=O)c1ccccc1Cl.Cl,C11H15Cl2NO,21260.0
7747,Prazobind,COc1cc2nc(N3CCN(C(=O)C4=CC5C=CC4CC5)CC3)nc(N)c2cc1OC,C23H27N5O3,21409.0
7748,MCTR1,CC/C=C\C/C=C\C[C@H](O)[C@@H](/C=C/C=C/C=C\C/C=C\CCC(=O)O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,C32H47N3O9S,17007.0
7749,Hellebrin,C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C=O)[C@H]4CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C36H52O15,21442.0
7750,p-Nitrobenzyl Mesylate,CS(=O)(=O)OCc1ccc([N+](=O)[O-])cc1,C8H9NO5S,21456.0
7751,Indapamide,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,C16H16ClN3O3S,21308.0
7752,T2AA (hydrochloride),Cl.N[C@H](CO)Cc1cc(I)c(Oc2ccc(O)cc2)c(I)c1,C15H16ClI2NO3,21921.0
7753,NCGC607,CN(C(=O)CNC(=O)c1ccccc1OCC(=O)Nc1ccc(I)cc1)c1ccccc1,C24H22IN3O4,21923.0
7754,OSMI-1,COc1ccccc1[C@@H](NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)C(=O)N(Cc1ccco1)Cc1cccs1,C28H25N3O6S2,21894.0
7755,OSMI-1,COc1ccccc1[C@@H](NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)C(=O)N(Cc1ccco1)Cc1cccs1,C28H25N3O6S2,21894.0
7756,BC-1215,c1ccc(-c2ccc(CNCCNCc3ccc(-c4ccccn4)cc3)cc2)nc1,C26H26N4,21964.0
7757,CJ-13610,Cc1nccn1-c1ccc(Sc2cccc(C3(C(N)=O)CCOCC3)c2)cc1,C22H23N3O2S,21764.0
7758,Endosidin 2,COc1cc(/C=N/NC(=O)c2cccc(F)c2)cc(I)c1O,C15H12FIN2O3,21888.0
7759,Pyriproxyfen,CC(COc1ccc(Oc2ccccc2)cc1)Oc1ccccn1,C20H19NO3,21872.0
7760,6-hydroxy Melatonin,COc1cc2c(CCNC(C)=O)c[nH]c2cc1O,C13H16N2O3,21857.0
7761,Ricobendazole,CCCS(=O)c1ccc2nc(NC(=O)OC)[nH]c2c1,C12H15N3O3S,21880.0
7762,AZ82,CCCc1cc(C(=O)N[C@H](Cc2ccc(-c3cccc(OC(F)(F)F)c3)nc2)C(=O)N[C@@H]2CCNC2)sc1C,C28H31F3N4O3S,21898.0
7763,Fosinopril (sodium salt),CCC(=O)O[C@@H](OP(=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)[O-])C(C)C.[Na+],C30H45NNaO7P,21899.0
7764,Fosinopril (sodium salt),CCC(=O)O[C@@H](OP(=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)[O-])C(C)C.[Na+],C30H45NNaO7P,21899.0
7765,Ridaifen-B,CCC(=C(c1ccc(OCCN2CCCC2)cc1)c1ccc(OCCN2CCCC2)cc1)c1ccccc1,C34H42N2O2,21966.0
7766,(S)-Lansoprazole,Cc1c(OCC(F)(F)F)ccnc1C[S@](=O)c1nc2ccccc2[nH]1,C16H14F3N3O2S,21967.0
7767,Roslin-2,[Br-].c1ccc(C[N+]23CN4CN(CN(C4)C2)C3)cc1,C13H19BrN4,21985.0
7768,TTK21,CCCOc1ccccc1C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1,C17H15ClF3NO2,21959.0
7769,Etomidate,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,C14H16N2O2,21993.0
7770,Etomidate (CRM),CCOC(=O)c1cncn1[C@H](C)c1ccccc1,C14H16N2O2,41826.0
7771,AHU377 (calcium salt),CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)[O-].CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)[O-].[Ca+2],C48H56CaN2O10,21473.0
7772,6?-Hydromorphol,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@H](O)CC[C@H]3[C@H]1C5,C17H21NO3,21537.0
7773,MCTR2,CC/C=C\C/C=C\C[C@H](O)[C@@H](/C=C/C=C/C=C\C/C=C\CCC(=O)O)SC[C@H](N)C(=O)NCC(=O)O,C27H40N2O6S,17008.0
7774,(S)-Ketorolac,O=C(c1ccccc1)c1ccc2n1CC[C@@H]2C(=O)O,C15H13NO3,11348.0
7775,CK-869,COc1ccc(N2C(=O)CSC2c2cccc(Br)c2)c(OC)c1,C17H16BrNO3S,15251.0
7776,(-)-Caryophyllene oxide,C=C1CC[C@H]2O[C@]2(C)CC[C@@H]2[C@@H]1CC2(C)C,C15H24O,21573.0
7777,(E/Z)-Endoxifen,CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1,C25H27NO2,21502.0
7778,PMK ethyl glycidate,CCOC(=O)C1(C)OC1c1ccc2c(c1)OCO2,C13H14O5,21990.0
7779,BRD6125,Cc1ccc(Cl)cc1N(CC(=O)Nc1c(F)cccc1F)S(C)(=O)=O,C16H15ClF2N2O3S,21804.0
7780,Flumequine,CC1CCc2cc(F)cc3c(=O)c(C(=O)O)cn1c23,C14H12FNO3,21645.0
7781,Indanomycin,CC/C(=C\C=C\[C@@H]1C=C[C@@H]2[C@@H](CC)CC[C@H]2[C@@H]1C(=O)c1ccc[nH]1)[C@@H]1O[C@@H]([C@@H](C)C(=O)O)CC[C@@H]1C,C31H43NO4,21761.0
7782,Leptomycin A,CC(=C/[C@H](C)C/C=C/C(C)=C/[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C/C(C)=C/C(=O)O)/C=C/[C@@H]1OC(=O)C=C[C@@H]1C,C32H46O6,21762.0
7783,Viridicatin,O=c1[nH]c2ccccc2c(-c2ccccc2)c1O,C15H11NO2,21763.0
7784,Cinnamtannin B-1,Oc1cc(O)c2c(c1)O[C@@]1(c3ccc(O)c(O)c3)Oc3cc(O)c4c(c3[C@@H]2[C@H]1O)O[C@H](c1ccc(O)c(O)c1)[C@H](O)[C@H]4c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,C45H36O18,21694.0
7785,N-Docosahexaenoyl Dopamine,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCc1ccc(O)c(O)c1,C30H41NO3,9001394.0
7786,Elasnin,CCCCCC(=O)C(CCCC)c1oc(=O)c(CCCC)c(O)c1CCCC,C24H40O4,21481.0
7787,Amorfrutin A,COc1cc(CCc2ccccc2)c(C(=O)O)c(O)c1CC=C(C)C,C21H24O4,21106.0
7788,Clidinium (bromide),C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2.[Br-],C22H26BrNO3,21428.0
7789,Clidinium (bromide),C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2.[Br-],C22H26BrNO3,21428.0
7790,H-7 (hydrochloride),CC1CNCCN1S(=O)(=O)c1cccc2cnccc12.Cl.Cl,C14H19Cl2N3O2S,21434.0
7791,Lixivaptan,Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1,C27H21ClFN3O2,21511.0
7792,Retro-2,Cc1ccc(C2Nc3ccccc3C(=O)N2c2ccccc2)s1,C19H16N2OS,21946.0
7793,NSC 23925,COc1ccc(-c2cc(C(O)C3CCCCN3)c3ccccc3n2)cc1.Cl.Cl,C22H26Cl2N2O2,21947.0
7794,CID-2818500,O=[N+]([O-])/C(=C/c1ccccc1)c1ccccc1,C14H11NO2,21919.0
7795,GRI-977143,O=C(O)c1ccccc1SCCCN1C(=O)c2cccc3cccc(c23)C1=O,C22H17NO4S,21900.0
7796,ML-262,CCOc1ccc(CCNC(=O)c2cc(-c3ccccc3)c(N3CCOCC3)s2)cc1OCC,C27H32N2O4S,21902.0
7797,Curvularin,C[C@H]1CCCCCC(=O)c2c(O)cc(O)cc2CC(=O)O1,C16H20O5,21758.0
7798,"10,11-dehydro Curvularin",C[C@H]1CCC/C=C/C(=O)c2c(O)cc(O)cc2CC(=O)O1,C16H18O5,21801.0
7799,SAR260301,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(=O)cc(N2CCOCC2)[nH]1,C19H22N4O3,17391.0
7800,2-fluoro Deschloroketamine (hydrochloride),CNC1(c2ccccc2F)CCCCC1=O.Cl,C13H17ClFNO,19786.0
7801,2-fluoro Deschloroketamine (hydrochloride) (CRM),CNC1(c2ccccc2F)CCCCC1=O.Cl,C13H17ClFNO,41176.0
7802,Aniline (hydrochloride),Cl.Nc1ccccc1,C6H8ClN,21963.0
7803,"5(S),12(S)-DiHETE",CCCCC/C=C\C[C@H](O)/C=C/C=C\C=C\[C@@H](O)CCCC(=O)O,C20H32O4,35260.0
7804,Sibutramine (hydrochloride),CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1.Cl,C17H27Cl2N,14476.0
7805,Alcaftadine,CN1CCC(=C2c3ccccc3CCn3c(C=O)cnc32)CC1,C19H21N3O,21290.0
7806,Amuvatinib,S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1,C23H21N5O3S,21461.0
7807,6?-Hydrocodol,COc1ccc2c3c1O[C@H]1[C@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341,C18H23NO3,21534.0
7808,Brassinolide,CC(C)[C@H](C)[C@@H](O)[C@H](O)[C@@H](C)[C@H]1CC[C@H]2[C@@H]3COC(=O)[C@H]4C[C@H](O)[C@H](O)C[C@]4(C)[C@H]3CC[C@]12C,C28H48O6,21594.0
7809,Ribavirin 5'-monophosphate (lithium salt),NC(=O)c1ncn([C@@H]2O[C@H](COP(=O)([O-])[O-])[C@@H](O)[C@H]2O)n1.[Li+].[Li+],C8H11Li2N4O8P,21821.0
7810,N-Methylnicotinamide,CNC(=O)c1cccnc1,C7H8N2O,21850.0
7811,L-Alanyl-L-Glutamine,C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)O,C8H15N3O4,21809.0
7812,Tinidazole,CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C,C8H13N3O4S,21755.0
7813,Ac-Nle-Pro-Nle-Asp-AMC (trifluoroacetate salt),CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCC)NC(C)=O)C(=O)N[C@@H](CC(=O)O)C(=O)Nc1ccc2c(C)cc(=O)oc2c1.O=C(O)C(F)(F)F,C35H46F3N5O11,21639.0
7814,nor-6?-Oxycodol,COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)NCC[C@]314,C17H21NO4,21544.0
7815,(R)-IMPP,COc1ccc(CCC(=O)N(c2nccc3ccccc23)[C@@H]2CCCNC2)cc1,C24H27N3O2,20861.0
7816,Cinolazepam,N#CCCN1C(=O)C(O)N=C(c2ccccc2F)c2cc(Cl)ccc21,C18H13ClFN3O2,20529.0
7817,U-51754 (hydrochloride),CN(C)[C@H]1CCCC[C@@H]1N(C)C(=O)Cc1ccc(Cl)c(Cl)c1.Cl,C17H25Cl3N2O,20285.0
7818,10(R)-PAHSA,CCCCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCC)CCCCCCCCC(=O)O,C34H66O4,21362.0
7819,10(S)-PAHSA,CCCCCCCCCCCCCCCC(=O)O[C@@H](CCCCCCCC)CCCCCCCCC(=O)O,C34H66O4,21419.0
7820,9(Z)-Tricosene,CCCCCCCC/C=C\CCCCCCCCCCCCC,C23H46,13236.0
7821,Alizarin,O=C1c2ccccc2C(=O)c2c1ccc(O)c2O,C14H8O4,11676.0
7822,CNX-774,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3)ncc2F)c1,C26H22FN7O3,21475.0
7823,AMG 837,CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1,C26H21F3O3,21815.0
7824,PKI-166,C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1,C20H18N4O,21896.0
7825,MP-A08,Cc1ccc(S(=O)(=O)Nc2ccccc2/C=N/c2ccccc2NS(=O)(=O)c2ccc(C)cc2)cc1,C27H25N3O4S2,21903.0
7826,Yoda1,Clc1cccc(Cl)c1CSc1nnc(-c2cnccn2)s1,C13H8Cl2N4S2,21904.0
7827,MK6-83,Cc1ccc(S(=O)(=O)Nc2ccccc2N2CCCCC2)s1,C16H20N2O2S2,21944.0
7828,BCI (hydrochloride),Cl.O=C1/C(=C/c2ccccc2)C(NC2CCCCC2)c2ccccc21,C22H24ClNO,21945.0
7829,NSC 617145,CC(C)(CN1C(=O)C(Cl)=C(Cl)C1=O)CN1C(=O)C(Cl)=C(Cl)C1=O,C13H10Cl4N2O4,21973.0
7830,SGA360,C=CCn1nc(-c2ccc(OC)cc2OC)c2cccc(C(F)(F)F)c21,C19H17F3N2O2,21986.0
7831,VU0029251,CSc1nc(N)c2c3c(sc2n1)CCC3,C10H11N3S2,21987.0
7832,Buspirone (hydrochloride),Cl.O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,C21H32ClN5O2,22028.0
7833,NQ301,CC(=O)c1ccc(NC2=C(Cl)C(=O)c3ccccc3C2=O)cc1,C18H12ClNO3,21958.0
7834,MK-0812,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)(C(C)C)C1,C24H34F3N3O3,21803.0
7835,N6-Benzyladenine,c1ccc(CNc2ncnc3nc[nH]c23)cc1,C12H11N5,21711.0
7836,"5,6-dihydro-5-Fluorouracil",O=C1NCC(F)C(=O)N1,C4H5FN2O2,20977.0
7837,?-methyl Fentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(C(C)Cc2ccccc2)CC1.Cl,C23H31ClN2O,18280.0
7838,?-methyl Fentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1ccccc1)C1CCN(C(C)Cc2ccccc2)CC1.Cl,C23H31ClN2O,38654.0
7839,Dioscin,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C45H72O16,11834.0
7840,N-Oleoyl Alanine,CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](C)C(=O)O,C21H39NO3,20368.0
7841,Geranylgeranylacetone,CC(=O)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C,C23H38O,20218.0
7842,Tetramethylrhodamine ethyl ester (perchlorate),CCOC(=O)c1ccccc1-c1c2ccc(N(C)C)cc2[o+]c2cc(N(C)C)ccc12.[O-][Cl+3]([O-])([O-])[O-],C26H27ClN2O7,21426.0
7843,Herkinorin,COC(=O)[C@@H]1C[C@H](OC(=O)c2ccccc2)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@H](c3ccoc3)C[C@]21C,C28H30O8,20925.0
7844,Tetramethylrhodamine methyl ester (perchlorate),COC(=O)c1ccccc1-c1c2ccc(N(C)C)cc2[o+]c2cc(N(C)C)ccc12.[O-][Cl+3]([O-])([O-])[O-],C25H25ClN2O7,21437.0
7845,Rebastinib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1,C30H28FN7O3,21465.0
7846,PHA-848125,CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2,C25H32N8O,21474.0
7847,Theobromine,Cn1cnc2c1c(=O)[nH]c(=O)n2C,C7H8N4O2,21745.0
7848,Mazindol-d4,[2H]C1([2H])N=C2c3ccccc3C(O)(c3ccc(Cl)cc3)N2C1([2H])[2H],C16H13ClN2O,21640.0
7849,Glycoursodeoxycholic Acid,C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C26H43NO5,21698.0
7850,JNJ-42756493,COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,C25H30N6O2,21813.0
7851,Remifentanil Acid (trifluoroacetate salt),CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)O)CC1.O=C(O)C(F)(F)F,C21H27F3N2O7,21926.0
7852,1-(2-Trifluoromethylphenyl)piperazine (hydrochloride),Cl.FC(F)(F)c1ccccc1N1CCNCC1,C11H14ClF3N2,21948.0
7853,1-(4-Trifluoromethylphenyl)piperazine (hydrochloride),Cl.Cl.FC(F)(F)c1ccc(N2CCNCC2)cc1,C11H15Cl2F3N2,21949.0
7854,Bithionol,Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O,C12H6Cl4O2S,21844.0
7855,N-benzyl-4-Piperidone,O=C1CCN(Cc2ccccc2)CC1,C12H15NO,21962.0
7856,Compound C108,C/C(=N\NC(=O)c1ccccc1O)c1ccccc1O,C15H14N2O3,9002951.0
7857,25H-NBOH (hydrochloride),COc1ccc(OC)c(CCNCc2ccccc2O)c1.Cl,C17H22ClNO3,22033.0
7858,"1,3-Dimethylbutylamine (hydrochloride)",CC(C)CC(C)N.Cl,C6H16ClN,21928.0
7859,UBP 310,Cc1cn(C[C@H](N)C(=O)O)c(=O)n(Cc2ccsc2C(=O)O)c1=O,C14H15N3O6S,21806.0
7860,(+)-Limonene,C=C(C)[C@H]1CC=C(C)CC1,C10H16,21719.0
7861,Manzamine A,O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CC[N@@](CCCC/C=C/CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@H]12,C36H44N4O,21444.0
7862,(+)-Aeroplysinin-1,COC1=C(Br)[C@H](O)[C@](O)(CC#N)C=C1Br,C9H9Br2NO3,21498.0
7863,ortho-Fluoroisobutyryl fentanyl (hydrochloride),CC(C)C(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1.Cl,C23H30ClFN2O,20207.0
7864,ortho-Fluoroisobutyryl fentanyl (hydrochloride) (exempt preparation),CC(C)C(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1.Cl,C23H30ClFN2O,39996.0
7865,dBET1,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCCNC(=O)COc1cccc3c1C(=O)N(C1CCC(=O)NC1=O)C3=O)c1nnc(C)n1-2,C38H37ClN8O7S,18044.0
7866,1-(3-Fluorophenyl)piperazine (hydrochloride),Cl.Cl.Fc1cccc(N2CCNCC2)c1,C10H15Cl2FN2,21953.0
7867,1-(o-Fluorophenyl)piperazine (hydrochloride),Cl.Cl.Fc1ccccc1N1CCNCC1,C10H15Cl2FN2,21954.0
7868,BAY 1217389,COc1ccc(Oc2cc(NCCC(F)(F)F)c3ncc(-c4ccc(C(=O)NC5CC5)c(C)c4)n3n2)c(F)c1F,C27H24F5N5O3,21660.0
7869,Taurocholic Acid-d4 (sodium salt),[2H]C1([2H])C[C@@]2(C)[C@H](C[C@@H](O)[C@@H]3[C@@H]2C[C@H](O)[C@]2(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)[O-])CC[C@@H]32)C([2H])([2H])[C@@H]1O.[Na+],C26H44NNaO7S,21891.0
7870,Ursodeoxycholic Acid-d4,[2H]C1([2H])C[C@@]2(C)[C@H](C[C@H](O)[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]32)C([2H])([2H])[C@@H]1O,C24H40O4,21892.0
7871,Taurochenodeoxycholic Acid-d4 (sodium salt),[2H]C1([2H])C[C@@]2(C)[C@H](C[C@@H](O)[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)[O-])CC[C@@H]32)C([2H])([2H])[C@@H]1O.[Na+],C26H44NNaO6S,21905.0
7872,Androstenedione,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H26O2,9001311.0
7873,Thiamine Pyrophosphate (chloride),Cc1ncc(C[n+]2csc(CCOP(=O)(O)OP(=O)(O)O)c2C)c(N)n1.[Cl-],C12H19ClN4O7P2S,20254.0
7874,Phytosphingosine (yeast),CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO,C18H39NO3,20217.0
7875,Remogliflozin A,Cc1c(Cc2ccc(OC(C)C)cc2)c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)nn1C(C)C,C23H34N2O7,14340.0
7876,Hinokitiol,CC(C)c1cccc(=O)c(O)c1,C10H12O2,17538.0
7877,Hinokitiol,CC(C)c1cccc(=O)c(O)c1,C10H12O2,17538.0
7878,MDL 11939,OC(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C20H25NO,21414.0
7879,Aminopurvalanol A,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,C19H26ClN7O,21424.0
7880,Aminopurvalanol A,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,C19H26ClN7O,21424.0
7881,R-59-949,O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,C28H25F2N3OS,21221.0
7882,SR 202,COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC,C11H17ClO7P2,21846.0
7883,P1075,CCC(C)(C)/N=C(\NC#N)Nc1cccnc1,C12H17N5,21849.0
7884,Taurohyodeoxycholic Acid (sodium salt),C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.[Na+],C26H44NNaO6S,21956.0
7885,LM11A-31 (hydrochloride),CC[C@H](C)[C@H](N)C(=O)NCCN1CCOCC1.Cl.Cl,C12H27Cl2N3O2,21982.0
7886,CCR4 Antagonist (hydrochloride),COc1cc2nc(N3CCC(N4CCCCC4)CC3)nc(NC3CCCCCC3)c2cc1OC.Cl.Cl,C27H43Cl2N5O2,21885.0
7887,CGS 15943,Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12,C13H8ClN5O,22073.0
7888,CGS 15943,Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12,C13H8ClN5O,22073.0
7889,VU0360172 (hydrochloride),Cl.O=C(NC1CCC1)c1ccc(C#Cc2cccc(F)c2)nc1,C18H16ClFN2O,22074.0
7890,Cerdulatinib,CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1,C20H27N7O3S,20076.0
7891,Cerdulatinib,CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1,C20H27N7O3S,20076.0
7892,ortho-fluoro Acrylfentanyl (hydrochloride),C=CC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1.Cl,C22H26ClFN2O,21932.0
7893,Chloral hydrate,OC(O)C(Cl)(Cl)Cl,C2H3Cl3O2,21843.0
7894,L-Carnitine,C[N+](C)(C)C[C@H](O)CC(=O)[O-],C7H15NO3,21489.0
7895,Reparixin (L-Lysine salt),CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1.NCCCC[C@H](N)C(=O)O,C20H35N3O5S,21492.0
7896,9(R)-PAHSA,CCCCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCC)CCCCCCCC(=O)O,C34H66O4,18022.0
7897,CUMYL-PICA N-pentanoic acid metabolite,CC(C)(NC(=O)c1cn(CCCCC(=O)O)c2ccccc12)c1ccccc1,C23H26N2O3,20232.0
7898,Procaine (hydrochloride),CCN(CC)CCOC(=O)c1ccc(N)cc1.Cl,C13H21ClN2O2,20093.0
7899,5-fluoro ADB metabolite 7,CC(C)(C)[C@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(=O)O,C19H26FN3O3,20178.0
7900,API-1,NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c2c1=O,C13H15N5O6,22081.0
7901,LM22A-4,O=C(NCCO)c1cc(C(=O)NCCO)cc(C(=O)NCCO)c1,C15H21N3O6,22082.0
7902,XMU-MP-1,CN1C(=O)c2sccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21,C17H16N6O3S2,22083.0
7903,Hyocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H40O5,20293.0
7904,LP99,Cc1cc(=O)n(C)c2cc(N3C(=O)CC[C@H](NS(=O)(=O)CC(C)C)[C@H]3c3ccc(Cl)cc3)ccc12,C26H30ClN3O4S,17661.0
7905,N-Formyl-Met-Leu-Phe,CSCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,C21H31N3O5S,21495.0
7906,Boldenone Undecylenate,C=CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,C30H44O3,21632.0
7907,Ibandronate (sodium hydrate),CCCCCN(C)CCC(O)(P(=O)([O-])O)P(=O)(O)O.O.[Na+],C9H24NNaO8P2,21361.0
7908,Diclofenac amide,O=C1Cc2ccccc2N1c1c(Cl)cccc1Cl,C14H9Cl2NO,21969.0
7909,KR-33493,O=C(CSc1ccc(Br)cc1)Nc1cn(CCc2ccccc2)nc1C(=O)O,C20H18BrN3O3S,22071.0
7910,5-fluoro MDMB-PICA metabolite 7,CC(C)(C)[C@H](NC(=O)c1cn(CCCCCF)c2ccccc12)C(=O)O,C20H27FN2O3,22095.0
7911,Cisapride,COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCOc2ccc(F)cc2)C[C@@H]1OC,C23H29ClFN3O4,21657.0
7912,Rizatriptan (benzoate salt),CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12.O=C(O)c1ccccc1,C22H25N5O2,16475.0
7913,AGL 2263,N#C/C(=C\c1ccc2oc(=O)[nH]c2c1)C(=O)c1ccc(O)c(O)c1,C17H10N2O5,21776.0
7914,ST034307,O=c1cc(C(Cl)(Cl)Cl)oc2ccc(Cl)cc12,C10H4Cl4O2,21777.0
7915,6-hydroxy Bexarotene,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)C(O)CC2(C)C,C24H28O3,22098.0
7916,LSN2463359,CC(C)NC(=O)c1ccc(C#Cc2ccncc2)cn1,C16H15N3O,22104.0
7917,Diclofenac ethyl ester,CCOC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,C16H15Cl2NO2,22105.0
7918,DCPG,N[C@H](C(=O)O)c1ccc(C(=O)O)c(C(=O)O)c1,C10H9NO6,22072.0
7919,3-Acetylpyridine NAD,CC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1,C22H28N6O14P2,21884.0
7920,MMP-8 Inhibitor I,COc1ccc(S(=O)(=O)N2Cc3ccccc3C[C@@H]2C(=O)NO)cc1,C17H18N2O5S,21852.0
7921,Ipsapirone (hydrochloride),Cl.O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1,C19H24ClN5O3S,22075.0
7922,Ipsapirone,Cl.O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1,C19H24ClN5O3S,39918.0
7923,PG-01037 (hydrochloride),Cl.Cl.O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,C26H28Cl4N4O,22079.0
7924,NXY-059,CC(C)(C)/[N+]([O-])=C/c1ccc(S(=O)(=O)[O-])cc1S(=O)(=O)[O-].[Na+].[Na+],C11H13NNa2O7S2,22109.0
7925,4?8C,Cc1cc(=O)oc2c(C=O)c(O)ccc12,C11H8O4,22110.0
7926,4?8C,Cc1cc(=O)oc2c(C=O)c(O)ccc12,C11H8O4,22110.0
7927,PF-01247324,CNC(=O)c1ccc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1,C13H10Cl3N3O,22111.0
7928,PF-01247324,CNC(=O)c1ccc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1,C13H10Cl3N3O,22111.0
7929,K858,CC(=O)NC1=NN(C(C)=O)C(C)(c2ccccc2)S1,C13H15N3O2S,22112.0
7930,SSR 128129E,COc1c(C)c(C(=O)c2ccc(N)c(C(=O)[O-])c2)n2ccccc12.[Na+],C18H15N2NaO4,22128.0
7931,TUG-770,N#CCc1ccccc1C#Cc1ccc(CCC(=O)O)c(F)c1,C19H14FNO2,22131.0
7932,iCRT14,Cc1cc(/C=C2\SC(=O)N(c3ccccc3)C2=O)c(C)n1-c1cccnc1,C21H17N3O2S,22132.0
7933,4-Nitrophenyl ?-D-Cellotetraoside,O=[N+]([O-])c1ccc(O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)cc1,C30H45NO23,21406.0
7934,Importazole,CC(Nc1nc(N2CCCC2)nc2ccccc12)c1ccccc1,C20H22N4,21491.0
7935,L-DOPA-d3,[2H]c1c([2H])c(C[C@H](N)C(=O)O)c([2H])c(O)c1O,C9H11NO4,22089.0
7936,Psoromic Acid,COc1cc(C(=O)O)c2c(c1C)OC(=O)c1c(C)cc(O)c(C=O)c1O2,C18H14O8,22168.0
7937,Psoromic Acid,COc1cc(C(=O)O)c2c(c1C)OC(=O)c1c(C)cc(O)c(C=O)c1O2,C18H14O8,22168.0
7938,Adipostatin A,CCCCCCCCCCCCCCCc1cc(O)cc(O)c1,C21H36O2,22163.0
7939,Adipostatin A,CCCCCCCCCCCCCCCc1cc(O)cc(O)c1,C21H36O2,22163.0
7940,?-hydroxy Alprazolam,OCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,C17H13ClN4O,15287.0
7941,?-hydroxy Alprazolam (CRM),OCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,C17H13ClN4O,25517.0
7942,PF-05175157,Cc1nc2ccc(C(=O)N3CCC4(CC3)CC(=O)c3c(cnn3C(C)C)C4)cc2[nH]1,C23H27N5O2,21778.0
7943,MG 149,CCCCCCCc1ccc(CCc2cccc(O)c2C(=O)O)cc1,C22H28O3,22135.0
7944,MPI-0479605,Cc1cc(N2CCOCC2)ccc1Nc1nc(NC2CCCCC2)c2[nH]cnc2n1,C22H29N7O,22136.0
7945,Ro 3280,COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)CC(F)(F)C(=O)N2C,C27H35F2N7O3,21669.0
7946,Steviol,C=C1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)O)[C@@H]2CC[C@]1(O)C3,C20H30O3,10011344.0
7947,5-hydroxy Omeprazole,COc1ccc2[nH]c(S(=O)Cc3ncc(CO)c(OC)c3C)nc2c1,C17H19N3O4S,10009028.0
7948,RAD51 Inhibitor B02,O=c1c2ccccc2nc(/C=C/c2cccnc2)n1Cc1ccccc1,C22H17N3O,22133.0
7949,Aceclofenac ethyl ester,CCOC(=O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,C18H17Cl2NO4,22115.0
7950,Aceclofenac methyl ester,COC(=O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,C17H15Cl2NO4,22121.0
7951,LY2606368,COc1cccc(OCCCN)c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1,C18H19N7O2,21490.0
7952,Salvinorin B Mesylate,COC(=O)[C@@H]1C[C@H](OS(C)(=O)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@H](c3ccoc3)C[C@]21C,C22H28O9S,22244.0
7953,BAY 57-1293,Cc1nc(N(C)C(=O)Cc2ccc(-c3ccccn3)cc2)sc1S(N)(=O)=O,C18H18N4O3S2,22129.0
7954,BAY 57-1293,Cc1nc(N(C)C(=O)Cc2ccc(-c3ccccn3)cc2)sc1S(N)(=O)=O,C18H18N4O3S2,22129.0
7955,3-Fluorofentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1F.Cl,C22H28ClFN2O,21952.0
7956,Rapamycin-d3,[2H]C([2H])([2H])O[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,C51H79NO13,22093.0
7957,MK-0557,O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4F)n3)CC2)c2cnccc21,C22H19FN4O3,22134.0
7958,Illudin M,CC1=C2C(=CC(C)(C)[C@@H]2O)C(=O)[C@](C)(O)C12CC2,C15H20O3,22062.0
7959,Spirolaxine,COc1cc(O)cc2c1C(=O)O[C@@H]2CCCCC[C@@H]1CCC[C@]2(CC[C@@H](C)O2)O1,C23H32O6,22063.0
7960,Nepicastat (hydrochloride),Cl.NCc1c[nH]c(=S)n1[C@H]1CCc2c(F)cc(F)cc2C1,C14H16ClF2N3S,22126.0
7961,CPI-455,CC(C)c1c(-c2ccccc2)[nH]c2c(C#N)cnn2c1=O,C16H14N4O,22127.0
7962,CPI-455,CC(C)c1c(-c2ccccc2)[nH]c2c(C#N)cnn2c1=O,C16H14N4O,22127.0
7963,Compound 401,O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12,C16H15N3O2,21769.0
7964,"CP 547,632",NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1,C20H24BrF2N5O3S,21773.0
7965,ML-364,Cc1ccc(S(=O)(=O)Nc2cc(C(F)(F)F)ccc2C(=O)Nc2nc(-c3ccccc3)cs2)cc1,C24H18F3N3O3S2,21774.0
7966,ML-364,Cc1ccc(S(=O)(=O)Nc2cc(C(F)(F)F)ccc2C(=O)Nc2nc(-c3ccccc3)cs2)cc1,C24H18F3N3O3S2,21774.0
7967,Sulfadoxin,COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC,C12H14N4O4S,21488.0
7968,Drostanolone,C[C@@H]1C[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]32)CC1=O,C20H32O2,21170.0
7969,Drostanolone (exempt preparation),C[C@@H]1C[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]32)CC1=O,C20H32O2,43536.0
7970,APS-2-79 (hydrochloride),COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3C)c2cc1OC.Cl,C23H22ClN3O3,22137.0
7971,G-749,CN1CCC(Nc2nc(Nc3ccc(Oc4ccccc4)cc3)c3c(=O)[nH]cc(Br)c3n2)CC1,C25H25BrN6O2,22139.0
7972,CB-839,O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)s2)nn1,C26H24F3N7O3S,22038.0
7973,AM966,Cc1noc(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)c1NC(=O)O[C@H](C)c1ccccc1Cl,C27H23ClN2O5,22048.0
7974,Isochlortetracycline,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(=O)C[C@@H]([C@]3(C)OC(=O)c4c(O)ccc(Cl)c43)C[C@@H]12,C22H23ClN2O8,22125.0
7975,T5601640,Cc1cc(C(=O)Nc2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)on1,C19H14F3N3O3,22140.0
7976,NVP-BGT226,COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1.O=C(O)/C=C\C(=O)O,C32H29F3N6O6,22142.0
7977,LY379268,N[C@@]1(C(=O)O)CO[C@H]2[C@H](C(=O)O)[C@H]21,C7H9NO5,15351.0
7978,Astragaloside IV,CC(C)(O)[C@@H]1CC[C@](C)([C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H]5C(C)(C)[C@@H](O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)CC[C@@]56C[C@@]46CC[C@]23C)O1,C41H68O14,12069.0
7979,4-oxo-Docosahexaenoic Acid,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C=C\C(=O)CCC(=O)O,C22H30O3,21373.0
7980,DG-051,Cl.O=C(O)CCCN1CCC[C@H]1COc1ccc(Oc2ccc(Cl)cc2)cc1,C21H25Cl2NO4,21688.0
7981,?-Pinene,CC1=CCC2CC1C2(C)C,C10H16,21576.0
7982,Golvatinib,CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1,C33H37F2N7O4,22143.0
7983,Simeprevir (sodium salt),COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C,C38H47N5O7S2,22144.0
7984,BEC (hydrochloride),Cl.N[C@@H](CSCCB(O)O)C(=O)O,C5H13BClNO4S,22145.0
7985,(2'S)-Nicotine-1-oxide,CN1CCC[C@H]1c1ccc[n+]([O-])c1,C10H14N2O,22153.0
7986,(2'S)-Nicotine-1-oxide,CN1CCC[C@H]1c1ccc[n+]([O-])c1,C10H14N2O,22153.0
7987,4-Piperidone (hydrochloride hydrate),Cl.OC1(O)CCNCC1,C5H12ClNO2,21961.0
7988,"3,4-Dimethylpyrazole (phosphate)",Cc1c[nH]nc1C.O=P(O)(O)O,C5H11N2O4P,21887.0
7989,Pantoprazole sulfone,COc1ccnc(CS(=O)(=O)c2nc3ccc(OC(F)F)cc3[nH]2)c1OC,C16H15F2N3O5S,22252.0
7990,Glucagon Receptor Antagonist 4,CCC[C@H](Oc1cc(C)c(-n2cc(C(F)(F)F)cn2)c(C)c1)c1ccc(C(=O)NCCC(=O)O)cc1,C26H28F3N3O4,22164.0
7991,Temocaprilat,O=C(O)CN1C[C@@H](c2cccs2)SC[C@H](N[C@@H](CCc2ccccc2)C(=O)O)C1=O,C21H24N2O5S2,22169.0
7992,Temocaprilat,O=C(O)CN1C[C@@H](c2cccs2)SC[C@H](N[C@@H](CCc2ccccc2)C(=O)O)C1=O,C21H24N2O5S2,22169.0
7993,TH-302,Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-],C9H16Br2N5O4P,22195.0
7994,CTX-0294885,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCNCC3)cc2)ncc1Cl,C22H24ClN7O,22197.0
7995,SB-742457,O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1,C19H19N3O2S,22200.0
7996,KS-176,O=C(Nc1ccccc1C(=O)Nc1ccc(CCO)cc1)c1ccc([N+](=O)[O-])cc1,C22H19N3O5,22201.0
7997,KS-176,O=C(Nc1ccccc1C(=O)Nc1ccc(CCO)cc1)c1ccc([N+](=O)[O-])cc1,C22H19N3O5,22201.0
7998,FRAX597,CCn1c(=O)c(-c2ccc(-c3cncs3)cc2Cl)cc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,C29H28ClN7OS,22205.0
7999,LY2090314,O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2,C28H25FN6O3,22211.0
8000,LY2090314,O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2,C28H25FN6O3,22211.0
8001,Salvinorin A Propionate,CCC(=O)O[C@H]1C[C@@H](C(=O)OC)[C@]2(C)CC[C@H]3C(=O)O[C@H](c4ccoc4)C[C@]3(C)[C@H]2C1=O,C24H30O8,22290.0
8002,Syringin,COc1cc(/C=C/CO)cc(OC)c1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C17H24O9,22387.0
8003,Procyanidin B1,Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@H](O)[C@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2,C30H26O12,22411.0
8004,11-oxo MGV,C[C@H](CC[C@@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)O)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4[C@@H](CC[C@H](O[C@@H]5O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O)[C@H]5O)C4(C)C)[C@]3(C)C(=O)C[C@]12C,C60H100O29,22416.0
8005,Cyclohexyl fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)C2CCCCC2)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C26H35ClN2O,22454.0
8006,Cyclohexyl fentanyl-d5 (hydrochloride) (exempt preparation),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)C2CCCCC2)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C26H35ClN2O,35875.0
8007,5'-hydroxy Meloxicam,CN1C(C(=O)Nc2ncc(CO)s2)=C(O)c2ccccc2S1(=O)=O,C14H13N3O5S2,22159.0
8008,Emricasan,C[C@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)COc1c(F)c(F)cc(F)c1F,C26H27F4N3O7,22204.0
8009,BMS 470539 (hydrochloride),CCCC(=O)C1(c2ccccc2)CCN(C(=O)[C@@H](Cc2ccc(OC)cc2)NC(=O)[C@@H](N)Cc2cncn2C)CC1.Cl.Cl,C32H43Cl2N5O4,22231.0
8010,TRX-818 (sodium salt),COc1ccc2[nH]c(-c3cccc(F)c3)cc(=O)c2c1OP(=O)([O-])[O-].[Na+].[Na+],C16H11FNNa2O6P,22209.0
8011,CHIR090,C[C@@H](O)[C@H](NC(=O)c1ccc(C#Cc2ccc(CN3CCOCC3)cc2)cc1)C(=O)NO,C24H27N3O5,22256.0
8012,Cyclohexyl fentanyl (hydrochloride),Cl.O=C(C1CCCCC1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C26H35ClN2O,22390.0
8013,Cyclohexyl fentanyl (hydrochloride) (exempt preparation),Cl.O=C(C1CCCCC1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C26H35ClN2O,39958.0
8014,"3,5-Diiodothyroacetic Acid",O=C(O)Cc1cc(I)c(Oc2ccc(O)cc2)c(I)c1,C14H10I2O4,22108.0
8015,KX1-004,O=C(NCc1cccc(O)c1)c1cc2cc(F)ccc2[nH]1,C16H13FN2O2,22198.0
8016,PBTZ169,O=c1nc(N2CCN(CC3CCCCC3)CC2)sc2c([N+](=O)[O-])cc(C(F)(F)F)cc12,C20H23F3N4O3S,22202.0
8017,VU0357121,CCCCOc1ccc(C(=O)Nc2ccc(F)cc2F)cc1,C17H17F2NO2,22199.0
8018,KW 2449,O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1,C20H20N4O,22207.0
8019,p38 MAP Kinase Inhibitor IV,O=S(=O)(c1c(O)c(Cl)cc(Cl)c1Cl)c1c(O)c(Cl)cc(Cl)c1Cl,C12H4Cl6O4S,22219.0
8020,Napabucasin,CC(=O)c1cc2c(o1)C(=O)c1ccccc1C2=O,C14H8O4,22255.0
8021,MBX-2982,CCc1cnc(N2CCC(c3nc(COc4ccc(-n5cnnn5)cc4)cs3)CC2)nc1,C22H24N8OS,22206.0
8022,BVT 2733,Cc1c(Cl)cccc1S(=O)(=O)Nc1nc(CC(=O)N2CCN(C)CC2)cs1,C17H21ClN4O3S2,22203.0
8023,Diclofenac methyl ester,COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,C15H13Cl2NO2,22218.0
8024,Remifentanil (hydrochloride),CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1.Cl,C20H29ClN2O5,19291.0
8025,Remifentanil (hydrochloride) (CRM),CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1.Cl,C20H29ClN2O5,22429.0
8026,L-(-)-?-Methyldopa,C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,C10H13NO4,21814.0
8027,Cyclopentyl fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)C2CCCC2)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C25H33ClN2O,22391.0
8028,SCH 442416,COc1ccc(CCCn2ncc3c2nc(N)n2nc(-c4ccco4)nc32)cc1,C20H19N7O2,22233.0
8029,DB07268,NC(=O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1,C17H15N5O2,22257.0
8030,Preladenant,COCCOc1ccc(N2CCN(CCn3ncc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)cc1,C25H29N9O3,22210.0
8031,Tetrahydrofuran fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)C2CCCO2)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C24H31ClN2O2,21935.0
8032,Methoxyacetyl fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)COC)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C22H29ClN2O2,21830.0
8033,Clonixin,Cc1c(Cl)cccc1Nc1ncccc1C(=O)O,C13H11ClN2O2,22284.0
8034,Terazosin (hydrochloride),COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC.Cl,C19H26ClN5O4,20216.0
8035,BMS 191011,O=c1oc(-c2ccc(C(F)(F)F)cc2)nn1Cc1cc(Cl)ccc1O,C16H10ClF3N2O3,22299.0
8036,(R)-?-Valerolactone,C[C@@H]1CCC(=O)O1,C5H8O2,20837.0
8037,PI-828,Nc1ccc(-c2cccc3c(=O)cc(N4CCOCC4)oc23)cc1,C19H18N2O3,21811.0
8038,Primidone,CCC1(c2ccccc2)C(=O)NCNC1=O,C12H14N2O2,19277.0
8039,Primidone (CRM),CCC1(c2ccccc2)C(=O)NCNC1=O,C12H14N2O2,40161.0
8040,MEP-CHMICA,CCC[C@H](NC(=O)c1cn(CC2CCCCC2)c2ccccc12)C(=O)OC,C22H30N2O3,21652.0
8041,P2NP,C/C(=C\c1ccccc1)[N+](=O)[O-],C9H9NO2,22185.0
8042,meta-fluoro Methoxyacetyl fentanyl (hydrochloride),COCC(=O)N(c1cccc(F)c1)C1CCN(CCc2ccccc2)CC1.Cl,C22H28ClFN2O2,21740.0
8043,M2I-1,CC(C)CN(CC(C)C)c1ccc(C=C2C(=O)NC(=S)NC2=O)cc1[N+](=O)[O-],C19H24N4O4S,22297.0
8044,Testosterone Enanthate,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C26H40O3,22546.0
8045,Aloperine,C1=C2CCCN[C@H]2[C@@H]2C[C@H]1[C@H]1CCCCN1C2,C15H24N2,22259.0
8046,Terreic Acid,CC1=C(O)C(=O)[C@@H]2O[C@@H]2C1=O,C7H6O4,10010235.0
8047,Dimethylenastron,CC1(C)CC(=O)C2=C(C1)NC(=S)NC2c1cccc(O)c1,C16H18N2O2S,22357.0
8048,U-50488 (hydrochloride),CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@@H]1CCCC[C@H]1N1CCCC1.Cl,C19H27Cl3N2O,19363.0
8049,Ki20227,COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1,C24H24N4O5S,22258.0
8050,IT-901,COc1cc(OC)c2ccccc2c1C=C1C(=O)NC(=S)NC1=O,C17H14N2O4S,22298.0
8051,Aminophylline,Cn1c(=O)c2nc[nH]c2n(C)c1=O.Cn1c(=O)c2nc[nH]c2n(C)c1=O.NCCN,C16H24N10O4,22235.0
8052,Cyclopropyl fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)C2CC2)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C23H29ClN2O,22605.0
8053,"L-741,626",OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,C20H21ClN2O,22354.0
8054,CAY10722,O=C(Cc1ccccc1)Nc1ccc2oc(-c3ccc(Cl)cc3Cl)nc2c1,C21H14Cl2N2O2,22404.0
8055,2-Chloromethcathinone (hydrochloride),CNC(C)C(=O)c1ccccc1Cl.Cl,C10H13Cl2NO,17744.0
8056,Ipragliflozin,OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O,C21H21FO5S,22287.0
8057,BMS-8,Cc1c(COc2ccc(CN3CCCCC3C(=O)O)cc2Br)cccc1-c1ccccc1,C27H28BrNO3,22355.0
8058,4-Methylamphetamine (hydrochloride),Cc1ccc(CC(C)N)cc1.Cl,C10H16ClN,14215.0
8059,Norcarfentanil (hydrochloride),CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCNCC1.Cl,C16H23ClN2O3,19859.0
8060,Clostebol,C[C@]12CC[C@H]3[C@@H](CCC4=C(Cl)C(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,C19H27ClO2,21168.0
8061,CAY10721,O=C(CSc1ncnc2c1oc1ccccc12)Nc1cccc(O)c1,C18H13N3O3S,22403.0
8062,Hydroxy Varenicline,O=c1cnc2cc3c(cc2[nH]1)C1CNCC3C1,C13H13N3O,22388.0
8063,3-Trifluoromethylamphetamine (hydrochloride),CC(N)Cc1cccc(C(F)(F)F)c1.Cl,C10H13ClF3N,22604.0
8064,Dextrorphan-d3 (tartrate),O=C(O)[C@H](O)[C@@H](O)C(=O)O.[2H]C([2H])([2H])N1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(O)cc13,C21H29NO7,15810.0
8065,Dextrorphan-d3 (tartrate) (CRM),O=C(O)[C@H](O)[C@@H](O)C(=O)O.[2H]C([2H])([2H])N1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(O)cc13,C21H29NO7,20814.0
8066,Eucalyptol,CC12CCC(CC1)C(C)(C)O2,C10H18O,22183.0
8067,Phenyl fentanyl (hydrochloride),Cl.O=C(c1ccccc1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C26H29ClN2O,22551.0
8068,Phenyl fentanyl (hydrochloride) (CRM),Cl.O=C(c1ccccc1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C26H29ClN2O,25887.0
8069,KIN-1400,Oc1c(C(Nc2nc3ccccc3s2)c2ccc(OC(F)F)cc2)ccc2cccnc12,C24H17F2N3O2S,22441.0
8070,Benazeprilat,O=C(O)CN1C(=O)[C@@H](N[C@@H](CCc2ccccc2)C(=O)O)CCc2ccccc21,C22H24N2O5,21796.0
8071,Grazoprevir,C=C[C@H]1C[C@@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]1C[C@H]1CCCCCc1nc3ccc(OC)cc3nc1O2)C(=O)NS(=O)(=O)C1CC1,C38H50N6O9S,21816.0
8072,G10,O=C(NCc1ccco1)c1ccc2c(c1)N(Cc1c(F)cccc1Cl)C(=O)CS2,C21H16ClFN2O3S,22353.0
8073,Testosterone Cypionate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1,C27H40O3,22543.0
8074,Nazartinib,Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1,C26H31ClN6O2,22409.0
8075,Testosterone Isocaproate,CC(C)CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C25H38O3,22547.0
8076,Linoleoyl Phenylalaninee,CCCCC/C=C\C/C=C\CCCCCCCC(=O)N[C@@H](Cc1ccccc1)C(=O)O,C27H41NO3,20063.0
8077,SNX-2112,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](O)CC4)c3)c2C1,C23H27F3N4O3,22359.0
8078,Methylclostebol,C[C@]12CCC(=O)C(Cl)=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H29ClO2,22448.0
8079,Testosterone Decanoate,CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C29H46O3,22544.0
8080,Pitavastatin lactone,O=C1C[C@H](O)C[C@@H](/C=C/c2c(C3CC3)nc3ccccc3c2-c2ccc(F)cc2)O1,C25H22FNO3,21785.0
8081,LCL-161,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1,C26H33FN4O3S,22420.0
8082,PKF118-310,Cn1ncnc2c(=O)n(C)c(=O)nc1-2,C7H7N5O2,22440.0
8083,Vitamin D4,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CC[C@H](C)C(C)C)CC[C@@H]12,C28H46O,22471.0
8084,Aramchol,CCCCCCCCCCCCCCCCCCCC(=O)N[C@H]1CC[C@@]2(C)[C@@H](C1)C[C@@H](O)[C@@H]1[C@@H]2C[C@H](O)[C@]2(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]12,C44H79NO5,22478.0
8085,GNE-617,O=C(NCc1ccc(S(=O)(=O)c2cc(F)cc(F)c2)cc1)c1ccc2nccn2c1,C21H15F2N3O3S,22463.0
8086,ML-329,NS(=O)(=O)c1ccc(NC2=CC(=O)c3ccccc3C2=O)cc1,C16H12N2O4S,22481.0
8087,KIN1408,COc1ccc2sc(NC(c3ccc(OC(F)F)cc3)c3ccc4cccnc4c3O)nc2c1,C25H19F2N3O3S,21790.0
8088,TPI-1,O=C1C=CC(=O)C(c2cc(Cl)ccc2Cl)=C1,C12H6Cl2O2,22480.0
8089,Dopamine (hydrochloride),Cl.NCCc1ccc(O)c(O)c1,C8H12ClNO2,21992.0
8090,PF-429242 (hydrochloride),CCN(CC)Cc1ccc(C(=O)N(CCc2ccccc2OC)[C@@H]2CCNC2)cc1.Cl.Cl,C25H37Cl2N3O2,15140.0
8091,CaCC(inh)-A01,CC(C)(C)C1CCc2c(sc(NC(=O)c3ccco3)c2C(=O)O)C1,C18H21NO4S,21922.0
8092,Salvinorin A Carbamate,COC(=O)[C@@H]1C[C@H](OC(N)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@H](c3ccoc3)C[C@]21C,C22H27NO8,22245.0
8093,Furanyl fentanyl 3-furancarboxamide isomer-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)c2ccoc2)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C24H27ClN2O2,21934.0
8094,Acrylfentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)C=C)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C22H27ClN2O,21828.0
8095,Acrylfentanyl-d5 (hydrochloride) (CRM),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)C=C)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C22H27ClN2O,23061.0
8096,Cyclobutyl fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)C2CCC2)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C24H31ClN2O,22425.0
8097,CC-930,O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1,C21H23F3N6O2,22466.0
8098,O-Desmethyl Metoprolol,CC(C)NCC(O)COc1ccc(CCO)cc1,C14H23NO3,21787.0
8099,DM1-SMe,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCSSC)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,C36H50ClN3O10S2,22477.0
8100,PD 166866,COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1,C20H24N6O3,22464.0
8101,GJ-103 (sodium salt),COc1cccc(-n2c(SCC(=O)[O-])nnc2-c2ccccn2)c1.[Na+],C16H13N4NaO3S,22482.0
8102,PF-1163B,CCCCC[C@@H]1CC[C@H](C)CCCCC(=O)N(C)[C@@H](Cc2ccc(OCCO)cc2)C(=O)O1,C27H43NO5,22066.0
8103,Triazolam,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,C17H12Cl2N4,22577.0
8104,Triazolam (CRM),Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,C17H12Cl2N4,39683.0
8105,13-Methylberberine (chloride),COc1ccc2c(C)c3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],C21H20ClNO4,21154.0
8106,6?-Naloxol,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@H](O)CC[C@@]3(O)[C@H]1C5,C19H23NO4,22148.0
8107,6?-Naloxol (CRM),C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@H](O)CC[C@@]3(O)[C@H]1C5,C19H23NO4,22717.0
8108,Antimycin A2,CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CCC,C27H38N2O9,21997.0
8109,Benzomalvin C,CN1C(=O)c2ccccc2-n2c(nc3ccccc3c2=O)[C@@]12O[C@@H]2c1ccccc1,C24H17N3O3,22064.0
8110,Moroxydine (hydrochloride),Cl.N=C(N)NC(=N)N1CCOCC1,C6H14ClN5O,21647.0
8111,Mertansine,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCS)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,C35H48ClN3O10S,22483.0
8112,Des-4-fluorobenzyl Mosapride,CCOc1cc(N)c(Cl)cc1C(=O)NCC1CNCCO1,C14H20ClN3O3,22157.0
8113,Antimycin A3,CCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C,C26H36N2O9,21998.0
8114,MPC-3100,C[C@H](O)C(=O)N1CCC(CCn2c(Sc3cc4c(cc3Br)OCO4)nc3c(N)ncnc32)CC1,C22H25BrN6O4S,22496.0
8115,AZD 3147,C[C@H]1COCCN1c1cc(C2(S(=O)(=O)C3CC3)CC2)nc(-c2ccc(NC(=S)NCCO)cc2)n1,C24H31N5O4S2,22474.0
8116,ML-00253764 (hydrochloride),COc1ccc(Br)cc1CCc1c(F)cccc1C1=NCCN1.Cl,C18H19BrClFN2O,22473.0
8117,Sodium Ionophore III,O=C(COc1ccccc1OCC(=O)N(C1CCCCC1)C1CCCCC1)N(C1CCCCC1)C1CCCCC1,C34H52N2O4,22465.0
8118,NMS-E973,CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1,C22H22N4O7,22352.0
8119,Nifurtimox,CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1,C10H13N3O5S,21784.0
8120,Naphthol AS-BI-Phosphate,COc1ccccc1NC(=O)c1cc2cc(Br)ccc2cc1OP(=O)(O)O,C18H15BrNO6P,21845.0
8121,Lasofoxifene,Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1,C28H31NO2,21754.0
8122,HJC0152 (hydrochloride),Cl.NCCOc1ccc(Cl)cc1C(=O)Nc1ccc([N+](=O)[O-])cc1Cl,C15H14Cl3N3O4,22351.0
8123,Finafloxacin (hydrochloride),Cl.N#Cc1c(N2C[C@@H]3NCCO[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,C20H20ClFN4O4,22410.0
8124,9-Amino-6-chloro-2-methoxyacridine,COc1ccc2nc3cc(Cl)ccc3c(N)c2c1,C14H11ClN2O,22439.0
8125,Glycohyodeoxycholic Acid,C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C26H43NO5,22643.0
8126,Ansatrienin B,CO[C@H]1/C=C/C=C/C=C/C[C@H](OC(=O)[C@@H](C)NC(=O)C2CCCCC2)[C@H](C)[C@@H](O)/C(C)=C\CCc2cc(O)cc(c2O)NC(=O)C1,C36H50N2O8,21996.0
8127,Antimycin A4,CCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CCC,C25H34N2O9,21999.0
8128,Duclauxin,CO[C@@]12c3c(C)cc(O)c4c(=O)occ(c34)C(=O)[C@@H]1[C@]13COC(=O)c4c(O)cc(C)c(c41)C(=O)[C@H]2C3OC(C)=O,C29H22O11,22068.0
8129,Ansatrienin A,CO[C@H]1/C=C/C=C/C=C/C[C@H](OC(=O)[C@@H](C)NC(=O)C2CCCCC2)[C@H](C)[C@@H](O)/C(C)=C\CCC2=CC(=O)C=C(NC(=O)C1)C2=O,C36H48N2O8,21995.0
8130,Paclitaxel-d5,[2H]c1c([2H])c([2H])c(C(=O)N[C@@H](c2ccccc2)[C@@H](O)C(=O)O[C@H]2C[C@@]3(O)[C@@H](OC(=O)c4ccccc4)[C@@H]4[C@]5(OC(C)=O)CO[C@@H]5C[C@H](O)[C@@]4(C)C(=O)[C@H](OC(C)=O)C(=C2C)C3(C)C)c([2H])c1[2H],C47H51NO14,22092.0
8131,Andrastin A,COC(=O)[C@@]12C(=O)C(C)C(=O)[C@]1(C)C(C)=C[C@H]1[C@]3(C=O)CC[C@H](OC(C)=O)C(C)(C)[C@H]3CC[C@@]12C,C28H38O7,22067.0
8132,4-ANPP-d5,[2H]c1c([2H])c([2H])c(NC2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C19H24N2,19232.0
8133,4-ANPP-d5 (exempt preparation),[2H]c1c([2H])c([2H])c(NC2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C19H24N2,36781.0
8134,Bosentan-d4,[2H]C([2H])(O)C([2H])([2H])Oc1nc(-c2ncccn2)nc(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)c1Oc1ccccc1OC,C27H29N5O6S,22097.0
8135,2-hydroxy Lignoceric Acid,CCCCCCCCCCCCCCCCCCCCCCC(O)C(=O)O,C24H48O3,22680.0
8136,Erlotinib-d6 (hydrochloride),Cl.[2H]C([2H])([2H])OCCOc1cc2ncnc(Nc3cccc(C#C)c3)c2cc1OCCOC([2H])([2H])[2H],C22H24ClN3O4,22101.0
8137,C30 (?-hydroxy) Ceramide (d18:1/30:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCO,C48H95NO4,22688.0
8138,Milbemectin,CC1=C[C@H]2C(=O)O[C@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C4\CO[C@H]([C@@H]1O)[C@@]42O)O[C@@]1(CC[C@H](C)[C@@H](C)O1)C3.CC[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C63H90O14,22003.0
8139,Bassianolide,CC(C)C[C@H]1C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@@H](C(C)C)C(=O)N1C,C48H84N4O12,22001.0
8140,7-hydroxy Warfarin,CC(=O)CC(c1ccccc1)c1c(O)c2ccc(O)cc2oc1=O,C19H16O5,900672.0
8141,Dexamethasone-d4,[2H]C1=C2C([2H])C[C@H]3[C@@H]4C[C@@H](C)[C@](O)(C(=O)C([2H])([2H])O)[C@@]4(C)C[C@H](O)[C@]3(F)[C@@]2(C)C=CC1=O,C22H29FO5,22100.0
8142,(+)-D-threo-PDMP (hydrochloride),CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c1ccccc1.Cl,C23H39ClN2O3,10178.0
8143,C6 Biotin Ceramide (d18:1/6:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C34H62N4O5S,9000415.0
8144,Citalopram-d4 (hydrobromide),Br.[2H]c1c([2H])c(C2(CCCN(C)C)OCc3cc(C#N)ccc32)c([2H])c([2H])c1F,C20H22BrFN2O,22102.0
8145,Montelukast-d6 (sodium salt),[2H]C([2H])([2H])C(O)(c1ccccc1CC[C@@H](SCC1(CC(=O)[O-])CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1)C([2H])([2H])[2H].[Na+],C35H35ClNNaO3S,22180.0
8146,Risperidone E-oxime,Cc1nc2n(c(=O)c1CCN1CCC(/C(=N\O)c3ccc(F)cc3F)CC1)CCCC2,C23H28F2N4O2,22156.0
8147,4'-O-methyl Quercetin,COc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2O)cc1O,C16H12O7,22406.0
8148,SAHA-d5,[2H]c1c([2H])c([2H])c(NC(=O)CCCCCCC(=O)NO)c([2H])c1[2H],C14H20N2O3,22107.0
8149,6?-hydroxy Dexamethasone,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](O)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,C22H29FO6,22099.0
8150,Dapsone-d8,[2H]c1c([2H])c(S(=O)(=O)c2c([2H])c([2H])c(N)c([2H])c2[2H])c([2H])c([2H])c1N,C12H12N2O2S,22113.0
8151,1'-hydroxy Bufuralol,CC(O)c1cccc2cc(C(O)CNC(C)(C)C)oc12,C16H23NO3,22160.0
8152,6-hydroxy Warfarin,CC(=O)CC(c1ccccc1)c1c(O)c2cc(O)ccc2oc1=O,C19H16O5,9000632.0
8153,Cyclophosphamide-d4,[2H]C1([2H])COP(=O)(N(CCCl)CCCl)NC1([2H])[2H],C7H15Cl2N2O2P,22114.0
8154,Sucralose-d6,[2H]C([2H])(O)[C@H]1O[C@H](O[C@]2(C([2H])([2H])Cl)O[C@H](C([2H])([2H])Cl)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1Cl,C12H19Cl3O8,22176.0
8155,Tolmetin ?-D-Glucuronide,Cc1ccc(C(=O)c2ccc(CC(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)n2C)cc1,C21H23NO9,22161.0
8156,Tyrothricin,CC(C)C[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCO)C(C)C)C(C)C)C(C)C.CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,C165H227N33O30,22177.0
8157,847949-49-9,Oc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,C21H22ClFN4O3,22365.0
8158,Hydrochlorothiazide Impurity C,NS(=O)(=O)c1cc2c(cc1Cl)N(CNS(=O)(=O)c1cc3c(cc1Cl)NCNS3(=O)=O)CNS2(=O)=O,C15H16Cl2N6O8S4,22384.0
8159,Hydroxy Bosentan,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)CO)cc2)nc(-c2ncccn2)nc1OCCO,C27H29N5O7S,22366.0
8160,CH5138303,NC(=O)CCCSc1nc(N)nc(-c2c(Cl)cc3c4c(cccc24)COC3)n1,C19H18ClN5O2S,22417.0
8161,Cercosporin,COc1c(O)c2c(=O)cc3c4c5c(cc(O)c6c(=O)c(OC)c(CC(C)O)c(c(c1CC(C)O)c24)c65)OCO3,C29H26O10,22175.0
8162,Quinidine N-oxide,C=C[C@H]1C[N@+]2([O-])CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,C20H24N2O3,22381.0
8163,meta-Fluoxetine (hydrochloride),CNCCC(Oc1cccc(C(F)(F)F)c1)c1ccccc1.Cl,C17H19ClF3NO,22158.0
8164,Sulochrin,COC(=O)c1cc(O)cc(OC)c1C(=O)c1c(O)cc(C)cc1O,C17H16O7,21797.0
8165,Posaconazole-d5,[2H]C([2H])([2H])C([2H])([2H])[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,C37H42F2N8O4,22376.0
8166,Stachybotrylactam,C[C@@H]1CC[C@H]2C(C)(C)[C@H](O)CC[C@]2(C)[C@@]12Cc1c(O)cc3c(c1O2)CNC3=O,C23H31NO4,22584.0
8167,Chromomycin A3,CO[C@@H]1[C@H](O)C[C@@H](O[C@@H]2C[C@H](Oc3cc4cc5c(c(O)c4c(O)c3C)C(=O)[C@@H](O[C@H]3C[C@@H](O[C@H]4C[C@@H](O[C@H]6C[C@](C)(O)[C@@H](OC(C)=O)[C@H](C)O6)[C@H](O)[C@@H](C)O4)[C@H](O)[C@@H](C)O3)[C@H]([C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)C5)O[C@H](C)[C@@H]2OC(C)=O)O[C@@H]1C,C57H82O26,11315.0
8168,Gefitinib-d6,[2H]C([2H])(Oc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC)C([2H])([2H])C([2H])([2H])N1CCOCC1,C22H24ClFN4O3,22364.0
8169,Conglobatin,C/C1=C\[C@H](C)C[C@H](C)[C@H](Cc2cnco2)OC(=O)/C(C)=C/[C@H](C)C[C@H](C)[C@H](Cc2cnco2)OC1=O,C28H38N2O6,21766.0
8170,Carfilzomib Impurity 13 (hydrochloride),Cl.O=C(CN1CCOCC1)N[C@@H](CCc1ccccc1)C(=O)O,C16H23ClN2O4,22385.0
8171,Macbecin I,CO[C@@H]1[C@@H](OC)C[C@H](C)[C@@H](OC)C2=CC(=O)C=C(NC(=O)/C(C)=C/C=C/[C@H](C)[C@@H](OC(N)=O)/C(C)=C/[C@@H]1C)C2=O,C30H42N2O8,22225.0
8172,Vildagliptin-d7,[2H]C1([2H])N(C(=O)CNC23CC4CC(CC(O)(C4)C2)C3)[C@]([2H])(C#N)C([2H])([2H])C1([2H])[2H],C17H25N3O2,22373.0
8173,MM-206,O=S(=O)(Nc1cc(Sc2ccccc2)c(O)c2ccccc12)c1c(F)c(F)c(F)c(F)c1F,C22H12F5NO3S2,22032.0
8174,Lenalidomide-d5,[2H]C1([2H])C(=O)NC(=O)C([2H])(N2Cc3c(N)cccc3C2=O)C1([2H])[2H],C13H13N3O3,22370.0
8175,Bicalutamide-d4,[2H]c1c([2H])c(S(=O)(=O)CC(C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c([2H])c([2H])c1F,C18H14F4N2O4S,22377.0
8176,8-hydroxy Loxapine,CN1CCN(C2=Nc3cc(O)ccc3Oc3ccc(Cl)cc32)CC1,C18H18ClN3O2,21786.0
8177,75741,O=C(c1ccccc1)c1ccc2nc(NC(=O)c3csc(C4CCN(c5ncnc6ccsc56)CC4)n3)[nH]c2c1,C29H23N7O2S2,21818.0
8178,Hydroxychloroquine-d4 (sulfate),O=S(=O)(O)O.[2H]C([2H])(O)C([2H])([2H])N(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,C18H28ClN3O5S,22375.0
8179,ABL 127,COC(=O)N1C(=O)[C@](c2ccccc2)(C2CCCC2)N1C(=O)OC,C17H20N2O5,10833.0
8180,FFN-102 (trifluoroacetate salt),NCCc1cc(=O)oc2cc(O)c(Cl)cc12.O=C(O)C(F)(F)F,C13H11ClF3NO5,21458.0
8181,Ponesimod,CCC/N=C1\S/C(=C\c2ccc(OC[C@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C,C23H25ClN2O4S,22053.0
8182,RWJ 52353 (hydrochloride),C1=C(c2cnc[nH]2)c2ccsc2CC1.Cl,C11H11ClN2S,11942.0
8183,Escitalopram,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,C20H21FN2O,22405.0
8184,11(E)-Eicosenoic Acid,CCCCCCCC/C=C/CCCCCCCCCC(=O)O,C20H38O2,22578.0
8185,Cholesteryl Linoleate,CCCCC/C=C\C/C=C\CCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C45H76O2,22597.0
8186,Temozolomide-d3,[2H]C([2H])([2H])n1nnc2c(C(N)=O)ncn2c1=O,C6H6N6O2,22372.0
8187,Losartan-d4,[2H]c1c([2H])c(-c2ccccc2-c2nnn[nH]2)c([2H])c([2H])c1Cn1c(CCCC)nc(Cl)c1CO,C22H23ClN6O,22567.0
8188,Celecoxib Carboxylic Acid Acyl-.beta.-D-Glucuronide,NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)cc2)cc1,C23H20F3N3O10S,22457.0
8189,"Gemcitabine-13C,15N2 (hydrochloride)",Cl.Nc1cc[15n]([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)[13c](=O)[15n]1,C9H12ClF2N3O4,22560.0
8190,Dapagliflozin-3-O-?-D-Glucuronide,CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)[C@H]3O)ccc2Cl)cc1,C27H33ClO12,22458.0
8191,Alternariol monomethyl ether,COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1,C15H12O5,11307.0
8192,Bazedoxifene-d4,[2H]C([2H])(Oc1ccc(Cn2c(-c3ccc(O)cc3)c(C)c3cc(O)ccc32)cc1)C([2H])([2H])N1CCCCCC1,C30H34N2O3,22554.0
8193,Rivaroxaban-d4,[2H]c1c([2H])c(N2C[C@H](CNC(=O)c3ccc(Cl)s3)OC2=O)c([2H])c([2H])c1N1CCOCC1=O,C19H18ClN3O5S,22563.0
8194,Acetaminophen sulfate (potassium salt),CC(=O)Nc1ccc(OS(=O)(=O)[O-])cc1.[K+],C8H8KNO5S,22571.0
8195,Diclofenac Acyl-.beta.-D-Glucuronide,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,C20H19Cl2NO8,22455.0
8196,Apremilast-d5,[2H]C([2H])([2H])C([2H])([2H])Oc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,C22H24N2O7S,22553.0
8197,TAK-063,COc1cn(-c2ccc(-n3cccn3)cc2F)nc(-c2ccnn2-c2ccccc2)c1=O,C23H17FN6O2,22208.0
8198,ML-390,O=C(CCNC(=O)c1ccc(OC(F)(F)F)cc1)N[C@@H]1CCCc2ccccc21,C21H21F3N2O3,21395.0
8199,Telmisartan-d3,[2H]C([2H])([2H])n1c(-c2cc(C)c3nc(CCC)n(Cc4ccc(-c5ccccc5C(=O)O)cc4)c3c2)nc2ccccc21,C33H30N4O2,22568.0
8200,Rosiglitazone-d3,[2H]C([2H])([2H])N(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,C18H19N3O3S,22562.0
8201,10-PAHSA 13C4,CCCCCCCCCCCC[13CH2][13CH2][13CH2][13C](=O)OC(CCCCCCCC)CCCCCCCCC(=O)O,C34H66O4,22657.0
8202,Irinotecan-d10 (hydrochloride),Cl.[2H]C1([2H])N(C2CCN(C(=O)Oc3ccc4nc5c(c(CC)c4c3)Cn3c-5cc4c(c3=O)COC(=O)[C@]4(O)CC)CC2)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],C33H39ClN4O6,22566.0
8203,UCM53,O=C(Oc1cc(OC(=O)c2ccc(O)c(Cl)c2)c2ccccc2c1)c1ccc(O)c(Cl)c1,C24H14Cl2O6,21768.0
8204,Cdk1 Inhbitor,O=C1Nc2ccccc2/C1=C/c1c(Cl)[nH]c2ccccc12,C17H11ClN2O,21501.0
8205,Benzyl Acrylfentanyl (hydrochloride),C=CC(=O)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1.Cl,C21H25ClN2O,22660.0
8206,ARS853,C=CC(=O)N1CC(N2CCN(C(=O)CNc3cc(C4(C)CC4)c(Cl)cc3O)CC2)C1,C22H29ClN4O3,19137.0
8207,Hydroxy Itraconazole,CC(O)C(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,C35H38Cl2N8O5,22576.0
8208,meta-Fluoroisobutyryl fentanyl (hydrochloride),CC(C)C(=O)N(c1cccc(F)c1)C1CCN(CCc2ccccc2)CC1.Cl,C23H30ClFN2O,20206.0
8209,meta-Fluoroisobutyryl fentanyl (hydrochloride) (exempt preparation),CC(C)C(=O)N(c1cccc(F)c1)C1CCN(CCc2ccccc2)CC1.Cl,C23H30ClFN2O,40350.0
8210,Valproic Acid ?-D-Glucuronide,CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,C14H24O8,22459.0
8211,"2',2'-cGAMP (sodium salt)",Nc1nc(=O)c2ncn([C@@H]3O[C@@H]4COP(=O)([O-])O[C@@H]5C(O)[C@@H](COP(=O)([O-])O[C@@H]3C4O)O[C@H]5n3cnc4c(N)ncnc43)c2[nH]1.[Na+].[Na+],C20H22N10Na2O13P2,22419.0
8212,Dihydro Montelukast,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(CCc2ccc3ccc(Cl)cc3n2)c1,C35H38ClNO3S,22374.0
8213,Dasatinib-d8,[2H]C1([2H])N(CCO)C([2H])([2H])C([2H])([2H])N(c2cc(Nc3ncc(C(=O)Nc4c(C)cccc4Cl)s3)nc(C)n2)C1([2H])[2H],C22H26ClN7O2S,22368.0
8214,Rimonabant-d10,[2H]C1([2H])N(NC(=O)c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],C22H21Cl3N4O,9001821.0
8215,rac-7-hydroxy Propranolol (hydrochloride),CC(C)NCC(O)COc1cccc2ccc(O)cc12.Cl,C16H22ClNO3,22380.0
8216,Simvastatin-d6,[2H]C([2H])([2H])C(CC)(C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21)C([2H])([2H])[2H],C25H38O5,22181.0
8217,FK-506-13C-d2,[2H][13C]([2H])=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,C44H69NO12,22178.0
8218,Apigenin-d5,[2H]c1cc(-c2oc3c([2H])c(O)c([2H])c(O)c3c(=O)c2[2H])cc([2H])c1O,C15H10O5,22106.0
8219,C18 Phytoceramide (t18:0/18:0),CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC,C36H73NO4,22686.0
8220,Everolimus-d4,[2H]C([2H])(O)C([2H])([2H])O[C@@H]1CC[C@@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)[C@@H](OC)C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)C[C@H]1OC,C53H83NO14,22559.0
8221,Ganciclovir-d5,[2H]C([2H])(O)C([2H])(OCn1cnc2c(=O)nc(N)[nH]c21)C([2H])([2H])O,C9H13N5O4,22565.0
8222,trans-10-Heptadecenoic Acid,CCCCCC/C=C/CCCCCCCCC(=O)O,C17H32O2,22468.0
8223,SR 48692,COc1cccc(OC)c1-c1cc(C(=O)NC2(C(=O)O)C3CC4CC(C3)CC2C4)nn1-c1ccnc2cc(Cl)ccc12,C32H31ClN4O5,20124.0
8224,Cocaine (hydrochloride),COC(=O)C1C(OC(=O)c2ccccc2)CC2CCC1N2C.Cl,C17H22ClNO4,22165.0
8225,1-oxo Ibuprofen,CC(C)C(=O)c1ccc(C(C)C(=O)O)cc1,C13H16O3,22573.0
8226,10-PAHSA-d31,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OC(CCCCCCCC)CCCCCCCCC(=O)O,C34H66O4,22658.0
8227,2-NMC,Cc1ccc(N(C)C(=O)C(C)C)cc1,C12H17NO,22488.0
8228,8-Nitroguanine,Nc1nc2nc([N+](=O)[O-])[nH]c2c(=O)[nH]1,C5H4N6O3,89295.0
8229,22(S)-hydroxy Cholesterol,CC(C)CC[C@H](O)[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O2,21399.0
8230,VX-809,Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1,C24H18F2N2O5,22196.0
8231,KLH45,O=C(N(CCc1ccccc1)C1CCCCC1)n1ncc(-c2ccc(OC(F)(F)F)cc2)n1,C24H25F3N4O2,19889.0
8232,Thielavin A,Cc1cc(O)c(C)c(O)c1C(=O)Oc1c(C)c(C)c(C(=O)Oc2c(C)c(C)c(C(=O)O)c(O)c2C)c(O)c1C,C29H30O10,21767.0
8233,SU 16f,Cc1[nH]c(/C=C2\C(=O)Nc3cc(-c4ccccc4)ccc32)c(C)c1CCC(=O)O,C24H22N2O3,19555.0
8234,SSR 69071,COc1cc(C(C)C)c2c(c1)S(=O)(=O)N(COc1cc(=O)n3cccc(OCCN4CCCCC4)c3n1)C2=O,C27H32N4O7S,21477.0
8235,SR 18292,Cc1ccc(CN(CC(O)COc2cccc3[nH]ccc23)C(C)(C)C)cc1,C23H30N2O2,22084.0
8236,Omeprazole-d3,[2H]c1c(OC)c([2H])c2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1[2H],C17H19N3O3S,22087.0
8237,LPA2 Antagonist 1,Cc1csc2c(N[C@@H](C)CN3CCN(S(=O)(=O)c4ccc(Cl)c(Cl)c4)CC3)ncnc12,C20H23Cl2N5O2S2,22051.0
8238,JTE-907,CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4c(c3)OCO4)c(=O)[nH]c12,C24H26N2O6,10009857.0
8239,PCP (hydrochloride),Cl.c1ccc(C2(N3CCCCC3)CCCCC2)cc1,C17H26ClN,14276.0
8240,YMU1,CCOC(=O)N1CCN(C(=O)Cn2sc3nc(C)cc(C)c3c2=O)CC1,C17H22N4O4S,21981.0
8241,Annonacin,CCCCCCCCCCCC[C@@H](O)[C@H]1CC[C@H]([C@H](O)CCCC[C@H](O)CCCCC[C@@H](O)CC2=C[C@H](C)OC2=O)O1,C35H64O7,22415.0
8242,PF-06281355,COc1ccc(OC)c(-c2cc(=O)[nH]c(=S)n2CC(N)=O)c1,C14H15N3O4S,22222.0
8243,CIL56,O=S(=O)(c1ccc2c(c1)C(=NO)c1cc(S(=O)(=O)N3CCCCC3)ccc1-2)N1CCCCC1,C23H27N3O5S2,19287.0
8244,"all-trans-5,6-epoxy Retinoic Acid",CC(/C=C/C12OC1(C)CCCC2(C)C)=C\C=C\C(C)=C\C(=O)O,C20H28O3,22124.0
8245,Ricinelaidic Acid,CCCCCC[C@@H](O)C/C=C/CCCCCCCC(=O)O,C18H34O3,22470.0
8246,Hydroxyebastine,CC(C)(CO)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,C32H39NO3,22379.0
8247,Dapagliflozin-d5,[2H]C([2H])([2H])C([2H])([2H])Oc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,C21H25ClO6,22611.0
8248,Carfilzomib-d8,[2H]C1([2H])OC([2H])([2H])C([2H])([2H])N(CC(=O)N[C@@H](CCc2ccccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]2(C)CO2)C1([2H])[2H],C40H57N5O7,22558.0
8249,Butyrolactone I,COC(=O)[C@]1(Cc2ccc(O)c(CC=C(C)C)c2)OC(=O)C(O)=C1c1ccc(O)cc1,C24H24O7,21765.0
8250,BMH21,CN(C)CCNC(=O)c1cccn2c(=O)c3cc4ccccc4cc3nc12,C21H20N4O2,22282.0
8251,G-5555,CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1,C25H25ClN6O3,21469.0
8252,Tolperisone-d10 (hydrochloride),Cl.[2H]C1([2H])N(CC(C)C(=O)c2ccc(C)cc2)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],C16H24ClNO,22592.0
8253,Heat Shock Protein Inhibitor II,O=C1NCC/C1=C\c1ccc2c(c1)OCO2,C12H11NO3,22358.0
8254,ortho-Methylfentanyl (hydrochloride),CCC(=O)N(c1ccccc1C)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O,22634.0
8255,ortho-Methylfentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1ccccc1C)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O,36372.0
8256,Cholesteryl Arachidonate,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C47H76O2,22595.0
8257,10(E)-Pentadecenoic Acid,CCCC/C=C/CCCCCCCCC(=O)O,C15H28O2,22467.0
8258,8(Z)-Eicosenoic Acid,CCCCCCCCCCC/C=C\CCCCCCC(=O)O,C20H38O2,22579.0
8259,EED226,CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1,C17H15N5O3S,22031.0
8260,3-trifluoromethyl-N-Methylamphetamine (hydrochloride),CNC(C)Cc1cccc(C(F)(F)F)c1.Cl,C11H15ClF3N,22492.0
8261,Oxazepam,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O,C15H11ClN2O2,15909.0
8262,Methoxyacetyl norfentanyl (hydrochloride),COCC(=O)N(c1ccccc1)C1CCNCC1.Cl,C14H21ClN2O2,22422.0
8263,GLPG0187,COc1ccc(S(=O)(=O)N[C@@H](CNc2nc(C)nc(N3CCC(C4=CC=C5CCCN=C5N4)CC3)c2C)C(=O)O)cc1,C29H37N7O5S,21792.0
8264,"4-Chloro-17?-methyl-androst-4-ene-3?,17?-diol",C[C@]12CC[C@H](O)C(Cl)=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H31ClO2,22447.0
8265,Murideoxycholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H40O4,20290.0
8266,Cholesterol ?-Linolenate,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C45H74O2,22596.0
8267,INH6,Cc1cc(C)c(-c2csc(NC(=O)c3ccccc3)n2)c(C)c1,C19H18N2OS,21772.0
8268,Meperidine-d4 (hydrochloride),Cl.[2H]C1([2H])CN(C)CC([2H])([2H])C1(C(=O)OCC)c1ccccc1,C15H22ClNO2,18561.0
8269,Meperidine-d4 (hydrochloride) (CRM),Cl.[2H]C1([2H])CN(C)CC([2H])([2H])C1(C(=O)OCC)c1ccccc1,C15H22ClNO2,21323.0
8270,Barbital,CCC1(CC)C(=O)NC(=O)NC1=O,C8H12N2O3,22012.0
8271,Barbital (CRM),CCC1(CC)C(=O)NC(=O)NC1=O,C8H12N2O3,22854.0
8272,Erteberel,Oc1ccc([C@@H]2Oc3ccc(O)cc3[C@@H]3CCC[C@@H]32)cc1,C18H18O3,22130.0
8273,Aristolochic Acid,COc1cccc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3,C17H11NO7,21520.0
8274,UAMC-0039 (hydrochloride),Cl.Cl.N[C@@H](CCNCc1ccc(Cl)cc1)C(=O)N1CCCCC1,C16H26Cl3N3O,15340.0
8275,Ciliobrevin A,N#C/C(C(=O)c1ccc(Cl)cc1Cl)=C1/NC(=O)c2ccccc2N1,C17H9Cl2N3O2,22587.0
8276,D-Cycloserine,N[C@@H]1CONC1=O,C3H6N2O2,22194.0
8277,NAPIE,CCCCCn1cc(C(=O)Cc2cccc3ccccc23)c2ccccc21,C25H25NO,22632.0
8278,Lecanoric Acid,Cc1cc(OC(=O)c2c(C)cc(O)cc2O)cc(O)c1C(=O)O,C16H14O7,22710.0
8279,para-fluoro Tetrahydrofuran fentanyl (hydrochloride),Cl.O=C(C1CCCO1)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1,C24H30ClFN2O2,22752.0
8280,Allicin,C=CCSS(=O)CC=C,C6H10OS2,15570.0
8281,"N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide",CCCCCCCC/C=C\CCCCCCCC(=O)NC(C)Cc1ccc(O)c(O)c1,C27H45NO3,9002954.0
8282,Ketanserin (tartrate),O=C(O)[C@H](O)[C@@H](O)C(=O)O.O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,C26H28FN3O9,22058.0
8283,Amentoflavone,O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12,C30H18O10,21779.0
8284,Benzoylecgonine-d3 (CRM),[2H]C([2H])([2H])N1C2CCC1C(C(=O)O)C(OC(=O)c1ccccc1)C2,C16H19NO4,20860.0
8285,Isobutyryl norfentanyl,CC(C)C(=O)N(c1ccccc1)C1CCNCC1,C15H22N2O,20204.0
8286,Despropionyl meta-Fluorofentanyl,Fc1cccc(NC2CCN(CCc3ccccc3)CC2)c1,C19H23FN2,20125.0
8287,4'-methyl Fentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CCc2ccc(C)cc2)CC1.Cl,C23H31ClN2O,21914.0
8288,4'-methyl Fentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1ccccc1)C1CCN(CCc2ccc(C)cc2)CC1.Cl,C23H31ClN2O,36374.0
8289,6?-Naltrexol,Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CC2)CC[C@]314,C20H25NO4,21975.0
8290,"2,2,3,3-tetramethyl-Cyclopropyl fentanyl (hydrochloride)",CC1(C)C(C(=O)N(c2ccccc2)C2CCN(CCc3ccccc3)CC2)C1(C)C.Cl,C27H37ClN2O,22744.0
8291,"2,2,3,3-tetramethyl-Cyclopropyl fentanyl (hydrochloride) (exempt preparation)",CC1(C)C(C(=O)N(c2ccccc2)C2CCN(CCc3ccccc3)CC2)C1(C)C.Cl,C27H37ClN2O,35877.0
8292,Rebaudioside A,C=C1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]2CC[C@]1(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C3,C44H70O23,11894.0
8293,FIBF-d7 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])(C(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1)C([2H])([2H])[2H],C23H30ClFN2O,22621.0
8294,2-hydroxy Decanoic Acid,CCCCCCCCC(O)C(=O)O,C10H20O3,22678.0
8295,Fentanyl (citrate),CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O,C28H36N2O8,22659.0
8296,Normeperidine-d4 (hydrochloride),Cl.[2H]C1([2H])CNCC([2H])([2H])C1(C(=O)OCC)c1ccccc1,C14H20ClNO2,18568.0
8297,Normeperidine-d4 (hydrochloride) (CRM),Cl.[2H]C1([2H])CNCC([2H])([2H])C1(C(=O)OCC)c1ccccc1,C14H20ClNO2,20896.0
8298,2-hydroxy Palmitic Acid,CCCCCCCCCCCCCCC(O)C(=O)O,C16H32O3,22679.0
8299,Herbacetin,O=c1c(O)c(-c2ccc(O)cc2)oc2c(O)c(O)cc(O)c12,C15H10O7,19285.0
8300,Lifitegrast,CS(=O)(=O)c1cccc(C[C@H](NC(=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc4ccoc4c2)C3)C(=O)O)c1,C29H24Cl2N2O7S,22588.0
8301,Palomid 529,COc1ccc(COc2cc3oc(=O)c4cc(C(C)O)ccc4c3cc2OC)cc1,C24H22O6,22706.0
8302,"12(Z),15(Z)-Heneicosadienoic Acid",CCCCC/C=C\C/C=C\CCCCCCCCCCC(=O)O,C21H38O2,22594.0
8303,Timosaponin AIII,C[C@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C39H64O13,22236.0
8304,3-hydroxy Stearic Acid,CCCCCCCCCCCCCCCC(O)CC(=O)O,C18H36O3,22692.0
8305,?-Estradiol 17-valerate,CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C,C23H32O3,22221.0
8306,?-Elemonic Acid,CC(C)=CCC[C@H](C(=O)O)[C@@H]1CC[C@]2(C)C3=C(CC[C@@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1CC3,C30H46O3,11712.0
8307,para-fluoro Cyclopropyl fentanyl (hydrochloride),Cl.O=C(C1CC1)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1,C23H28ClFN2O,22749.0
8308,Zopiclone,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,C17H17ClN6O3,14235.0
8309,Zopiclone (CRM),CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,C17H17ClN6O3,20397.0
8310,Testosterone Phenylpropionate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2OC(=O)CCc1ccccc1,C28H36O3,22548.0
8311,N-methyl Homarylamine (hydrochloride),CN(C)CCc1ccc2c(c1)OCO2.Cl,C11H16ClNO2,22239.0
8312,Tetrahydrofuran fentanyl 3-tetrahydrofurancarboxamide (hydrochloride),Cl.O=C(C1CCOC1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H31ClN2O2,22664.0
8313,ortho-methyl Furanyl fentanyl (hydrochloride),Cc1ccccc1N(C(=O)c1ccco1)C1CCN(CCc2ccccc2)CC1.Cl,C25H29ClN2O2,22779.0
8314,NAMIE,Cn1cc(C(=O)Cc2cccc3ccccc23)c2ccccc21,C21H17NO,22631.0
8315,meta-Methylfentanyl (hydrochloride),CCC(=O)N(c1cccc(C)c1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O,22633.0
8316,meta-Methylfentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1cccc(C)c1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O,36371.0
8317,1-Arachidonoyl-d8-rac-glycerol,[2H]/C(CCCCC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCC(=O)OCC(O)CO,C23H38O4,22694.0
8318,LYG-202,COc1c(OCCCCN2CCN(C)CC2)cc(O)c2c(=O)cc(-c3ccccc3)oc12,C25H30N2O5,21976.0
8319,Biotin,O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C10H16N2O3S,22582.0
8320,Laurdan,CCCCCCCCCCCC(=O)c1ccc2cc(N(C)C)ccc2c1,C24H35NO,19706.0
8321,Cloxacillin (sodium salt),Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)[O-].[Na+],C19H17ClN3NaO5S,22249.0
8322,Mirogabalin,CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)O,C12H19NO2,22475.0
8323,3-keto Sphinganine (d8:0) (hydrochloride,CCCCCC(=O)C(N)CO.Cl,C8H18ClNO2,22824.0
8324,BAR502,CC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H]([C@H](C)CCO)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12,C25H44O3,22462.0
8325,Usnic Acid,CC(=O)c1c(O)c(C)c(O)c2c1OC1=CC(=O)C(C(C)=O)C(=O)C12C,C18H16O7,22585.0
8326,Falcarinol,C=C[C@@H](O)C#CC#CC/C=C\CCCCCCC,C17H24O,22407.0
8327,Tubeimoside I,C[C@@H]1O[C@H]2O[C@H]3[C@@H](OC[C@H](O)[C@@H]3O)OC(=O)[C@]34CCC(C)(C)C[C@H]3C3=CC[C@@H]5[C@@]6(C)C[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@@H]7OC[C@H](OC(=O)C[C@](C)(O)CC(=O)O[C@@H]1[C@@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)[C@H]2O)[C@H](O)[C@H]7O)[C@@](C)(CO)[C@@H]6CC[C@@]5(C)[C@]3(C)CC4,C63H98O29,22276.0
8328,Batefenterol,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,C40H42ClN5O7,21793.0
8329,Propyl Gallate,CCCOC(=O)c1cc(O)c(O)c(O)c1,C10H12O5,22293.0
8330,Fluazuron,O=C(NC(=O)c1c(F)cccc1F)Nc1ccc(Cl)c(Oc2ncc(C(F)(F)F)cc2Cl)c1,C20H10Cl2F5N3O3,22283.0
8331,?-Spinasterol,CC[C@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,C29H48O,14197.0
8332,Dibucaine,CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1,C20H29N3O2,22237.0
8333,Kojic Acid,O=c1cc(CO)occ1O,C6H6O4,22712.0
8334,3-hydroxy Tridecanoic Acid,CCCCCCCCCCC(O)CC(=O)O,C13H26O3,22689.0
8335,7'-methoxy NABUTIE,CCCCn1cc(C(=O)Cc2cccc3ccccc23)c2cccc(OC)c21,C25H25NO2,22630.0
8336,Leuprorelin (acetate),CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1,C61H88N16O14,22275.0
8337,BAR501,CC[C@@H]1[C@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H]([C@H](C)CCCO)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12,C26H46O3,22460.0
8338,Ethyl p-methoxycinnamate,CCOC(=O)/C=C/c1ccc(OC)cc1,C12H14O3,11740.0
8339,3-hydroxy-Lignoceric Acid,CCCCCCCCCCCCCCCCCCCCCC(O)CC(=O)O,C24H48O3,22667.0
8340,3-hydroxy Docosanoic Acid,CCCCCCCCCCCCCCCCCCCC(O)CC(=O)O,C22H44O3,22666.0
8341,N-Desmethylclomipramine (hydrochloride),CNCCCN1c2ccccc2CCc2ccc(Cl)cc21.Cl,C18H22Cl2N2,19034.0
8342,N-Desmethylclomipramine (hydrochloride) (CRM),CNCCCN1c2ccccc2CCc2ccc(Cl)cc21.Cl,C18H22Cl2N2,19035.0
8343,Alfentanil (hydrochloride),CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1.Cl,C21H33ClN6O3,19292.0
8344,Alfentanil (hydrochloride) (exempt preparation),CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1.Cl,C21H33ClN6O3,40503.0
8345,Ceramide (d18:1/18:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCC,C36H71NO3,19556.0
8346,Oxycodone,COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314,C18H21NO4,15465.0
8347,Avibactam (sodium salt),NC(=O)[C@H]1CC[C@H]2CN1C(=O)N2OS(=O)(=O)[O-].[Na+],C7H10N3NaO6S,22825.0
8348,10-Deacetylbaccatin III,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](O)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C,C29H36O10,22261.0
8349,Prazepam,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1,C19H17ClN2O,18358.0
8350,Prazepam (CRM),O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1,C19H17ClN2O,21701.0
8351,Trenbolone,C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O,C18H22O2,16896.0
8352,Esmolol (hydrochloride),COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1.Cl,C16H26ClNO4,22581.0
8353,Alosetron (hydrochoride),Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O.Cl,C17H19ClN4O,22434.0
8354,Crotonyl fentanyl,C/C=C/C(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C23H28N2O,22801.0
8355,Diproqualone,Cc1nc2ccccc2c(=O)n1CC(O)CO,C12H14N2O3,21836.0
8356,AAT-008,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1cccc(F)c1)c1ccc(C(=O)O)cc1,C21H16ClFN2O4,21810.0
8357,C2 Phytoceramide (t18:0/2:0),CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(C)=O,C20H41NO4,22823.0
8358,Butalbital,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,C11H16N2O3,15788.0
8359,Butalbital (CRM),C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,C11H16N2O3,20091.0
8360,Thiophene fentanyl (hydrochloride),Cl.O=C(c1cccs1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H27ClN2OS,22802.0
8361,HDAC3 Inhibitor,CCCNNC(=O)c1ccc(CNC(=O)/C=C/c2ccccc2)cc1,C20H23N3O2,21057.0
8362,Fluralaner,Cc1cc(C2=NOC(c3cc(Cl)cc(Cl)c3)(C(F)(F)F)C2)ccc1C(=O)NCC(=O)NCC(F)(F)F,C22H17Cl2F6N3O3,22061.0
8363,L-Homoarginine (hydrochloride),Cl.N=C(N)NCCCC[C@H](N)C(=O)O,C7H17ClN4O2,22285.0
8364,C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)[C@@H](O)CCCCCCCCCCCCCC,C34H67NO4,22516.0
8365,Phenobarbital,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,C12H12N2O3,9001494.0
8366,Phenobarbital (CRM),CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,C12H12N2O3,20987.0
8367,para-fluoro Furanyl fentanyl (hydrochloride),Cl.O=C(c1ccco1)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1,C24H26ClFN2O2,22750.0
8368,Cabazitaxel,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C,C45H57NO14,22262.0
8369,AR-7,Cc1ccc(C2=Nc3ccc(Cl)cc3OC2)cc1,C15H12ClNO,22946.0
8370,Motolimod,CCCN(CCC)C(=O)C1=Cc2ccc(-c3ccc(C(=O)N4CCCC4)cc3)cc2N=C(N)C1,C28H34N4O2,22952.0
8371,BMS 986020,Cc1noc(-c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3)cc2)c1NC(=O)O[C@H](C)c1ccccc1,C29H26N2O5,22049.0
8372,Pirodavir,CCOC(=O)c1ccc(OCCC2CCN(c3ccc(C)nn3)CC2)cc1,C21H27N3O3,22922.0
8373,R112,Oc1cccc(Nc2ncc(F)c(Nc3cccc(O)c3)n2)c1,C16H13FN4O2,22929.0
8374,BD 1047 (hydrobromide),Br.Br.CN(C)CCN(C)CCc1ccc(Cl)c(Cl)c1,C13H22Br2Cl2N2,22928.0
8375,para-methyl Furanyl fentanyl (hydrochloride),Cc1ccc(N(C(=O)c2ccco2)C2CCN(CCc3ccccc3)CC2)cc1.Cl,C25H29ClN2O2,22713.0
8376,"3,4 MDMA tert-butyl Carbamate",CC(Cc1ccc2c(c1)OCO2)N(C)C(=O)OC(C)(C)C,C16H23NO4,22740.0
8377,Afobazole (hydrochloride),CCOc1ccc2[nH]c(SCCN3CCOCC3)nc2c1.Cl,C15H22ClN3O2S,22923.0
8378,RKI-1313,COc1cccc(CNC(=O)Nc2nc(-c3ccncc3)cs2)c1,C17H16N4O2S,22933.0
8379,CW069,O=C(O)c1cc(I)ccc1NC(=O)[C@H](Cc1ccccc1)NCc1ccccc1,C23H21IN2O3,22936.0
8380,TBPB,Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1,C25H32N4O,22943.0
8381,Methamphetamine tert-butyl Carbamate,CC(Cc1ccccc1)N(C)C(=O)OC(C)(C)C,C15H23NO2,22742.0
8382,Tofisopam,CCC1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc21,C22H26N2O4,22026.0
8383,Benzoylecgonine,CN1C2CCC1C(C(=O)O)C(OC(=O)c1ccccc1)C2,C16H19NO4,9001495.0
8384,Demeclocycline (hydrochloride),CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12.Cl,C21H22Cl2N2O8,21759.0
8385,Elastatinal,CC(C)C[C@H](NC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C=O)[C@@H]1CCN=C(N)N1)C(=O)O,C21H36N8O7,22288.0
8386,Hypoxanthine,O=c1[nH]cnc2nc[nH]c12,C5H4N4O,22254.0
8387,?-Boswellic Acid,C[C@H]1[C@H](C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@@H](O)[C@](C)(C(=O)O)[C@@H]5CC[C@]43C)[C@H]12,C30H48O3,11693.0
8388,BIBS39,CCCCc1nc2ccc(NC(=O)NC3CCCCC3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,C32H36N4O3,22932.0
8389,BTZ043,C[C@H]1COC2(CCN(c3nc(=O)c4cc(C(F)(F)F)cc([N+](=O)[O-])c4s3)CC2)O1,C17H16F3N3O5S,22930.0
8390,Zopiclone-d4 (CRM),[2H]C1([2H])CN(C)CC([2H])([2H])N1C(=O)OC1c2nccnc2C(=O)N1c1ccc(Cl)cn1,C17H17ClN6O3,18932.0
8391,Astragaloside I,CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](O[C@H]2CC[C@]34C[C@]35CC[C@]3(C)[C@@H]([C@@]6(C)CC[C@@H](C(C)(C)O)O6)[C@@H](O)C[C@@]3(C)[C@@H]5C[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]4C2(C)C)OC[C@H]1O,C45H72O16,22431.0
8392,Poziotinib,C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1,C23H21Cl2FN4O3,22437.0
8393,N-methyl Norcarfentanil (hydrochloride),CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(C)CC1.Cl,C17H25ClN2O3,20784.0
8394,CID-5721353,O=C(O)CC(C(=O)O)N1C(=O)/C(=C2/C(=O)Nc3ccc(Br)cc32)SC1=S,C15H9BrN2O6S2,22967.0
8395,17(R)-Resolvin D4,CC/C=C\C[C@@H](O)/C=C/C=C\C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)CCC(=O)O,C22H32O5,9002881.0
8396,Tiagabine (hydrochloride),Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C.Cl,C20H26ClNO2S2,22926.0
8397,Dolutegravir,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,C20H19F2N3O5,22191.0
8398,Mavacamten,CC(C)n1c(=O)cc(N[C@@H](C)c2ccccc2)[nH]c1=O,C15H19N3O2,19216.0
8399,Dolasetron,O=C(O[C@H]1C[C@H]2CC3C[C@@H](C1)[N@]2CC3=O)c1c[nH]c2ccccc12,C19H20N2O3,22234.0
8400,5-hydroxy Indole-3-acetic Acid,O=C(O)Cc1c[nH]c2ccc(O)cc12,C10H9NO3,22889.0
8401,JH-II-127,CNc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]cc(Cl)c12,C19H21ClN6O3,22905.0
8402,G007-LK,CS(=O)(=O)c1ccc(-c2nnc(/C=C/c3nnc(-c4ccc(C#N)cc4)o3)n2-c2ccccc2Cl)nc1,C25H16ClN7O3S,22934.0
8403,LY310762,CC1(C)C(=O)N(CCN2CCC(C(=O)c3ccc(F)cc3)CC2)c2ccccc21.Cl,C24H28ClFN2O2,22938.0
8404,APD597,COc1c(Nc2ccc(S(C)(=O)=O)nc2C)ncnc1OC1CCN(C(=O)OC(C)C)CC1,C21H29N5O6S,22950.0
8405,Orexin 2 Receptor Agonist,COc1ccc(-c2cccc(C(=O)N(C)C)c2)cc1S(=O)(=O)Nc1cccc(NCCNC(=O)c2cccc(C)c2)c1,C32H34N4O5S,22937.0
8406,"CP 544,326",O=C(O)COc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)c1,C24H22N4O5S,22945.0
8407,GSK2256098,CONC(=O)c1ccccc1Nc1cc(Nc2cc(C)nn2C(C)C)ncc1Cl,C20H23ClN6O2,22955.0
8408,meta-methyl Methoxyacetyl fentanyl (hydrochloride),COCC(=O)N(c1cccc(C)c1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O2,22978.0
8409,para-methyl Methoxyacetyl fentanyl (hydrochloride),COCC(=O)N(c1ccc(C)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O2,22979.0
8410,Cucurbitacin E,CC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C=C(O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C,C32H44O8,14821.0
8411,Indisulam,NS(=O)(=O)c1ccc(S(=O)(=O)Nc2cccc3c(Cl)c[nH]c23)cc1,C14H12ClN3O4S2,22759.0
8412,YM-298198 (hydrochloride),Cc1c(C(=O)N(C)C2CCCCC2)sc2nc3ccc(N)cc3n12.Cl,C18H23ClN4OS,22925.0
8413,C12 Ceramide (d18:1/12:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCC,C32H63NO3,22531.0
8414,Pantoprazole Sulfide,COc1ccnc(CSc2nc3ccc(OC(F)F)cc3[nH]2)c1OC,C16H15F2N3O3S,22251.0
8415,meta-methyl Furanyl fentanyl (hydrochloride),Cc1cccc(N(C(=O)c2ccco2)C2CCN(CCc3ccccc3)CC2)c1.Cl,C25H29ClN2O2,22844.0
8416,Phenobarbital-d5 (ethyl-d5),[2H]C([2H])([2H])C([2H])([2H])C1(c2ccccc2)C(=O)NC(=O)NC1=O,C12H12N2O3,21353.0
8417,Phenobarbital-d5 (ethyl-d5) (CRM),[2H]C([2H])([2H])C([2H])([2H])C1(c2ccccc2)C(=O)NC(=O)NC1=O,C12H12N2O3,21354.0
8418,BAR501 Impurity,CC[C@@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H]([C@H](C)CCCO)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12,C26H46O3,22461.0
8419,Camalexin,c1ccc2c(-c3nccs3)c[nH]c2c1,C11H8N2S,21971.0
8420,BLU-554,C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1,C24H24Cl2N4O4,22438.0
8421,Astragaloside III,CC(C)(O)[C@@H]1CC[C@](C)([C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O)[C@H]5C(C)(C)[C@@H](O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)CC[C@@]56C[C@@]46CC[C@]23C)O1,C41H68O14,22432.0
8422,Olodaterol,COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1,C21H26N2O5,21794.0
8423,3-trifluoromethyl-N-Ethylamphetamine (hydrochloride),CCNC(C)Cc1cccc(C(F)(F)F)c1.Cl,C12H17ClF3N,22491.0
8424,Brexpiprazole,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,C25H27N3O2S,22906.0
8425,Hydroquinidine,CC[C@H]1C[N@]2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,C20H26N2O2,22295.0
8426,Zilpaterol-d7,[2H]C([2H])([2H])C([2H])(N[C@H]1CCn2c(=O)[nH]c3cccc(c32)[C@@H]1O)C([2H])([2H])[2H],C14H19N3O2,22903.0
8427,Cysteamine (hydrochloride),Cl.NCCS,C2H8ClNS,22193.0
8428,Jervine,CC1=C2C(=O)[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C,C27H39NO3,11723.0
8429,HJC0350,Cc1cc(C)c(S(=O)(=O)n2cc(C)cc2C)c(C)c1,C15H19NO2S,22949.0
8430,para-fluoro Furanyl fentanyl 3-furancarboxamide  (hydrochloride),Cl.O=C(c1ccoc1)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1,C24H26ClFN2O2,22751.0
8431,Sertaconazole (nitrate),Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1.O=[N+]([O-])O,C20H16Cl3N3O4S,22232.0
8432,Siponimod,CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1,C29H35F3N2O3,22057.0
8433,Ofloxacin,CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,C18H20FN3O4,22891.0
8434,3'-hydroxy Lidocaine,CCN(CC)CC(=O)Nc1c(C)ccc(O)c1C,C14H22N2O2,22899.0
8435,Ethisterone,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,C21H28O2,22893.0
8436,Rebaudioside C,C=C1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]2CC[C@]1(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C3,C44H70O22,11895.0
8437,SF2523,O=c1cc(N2CCOCC2)oc2c(-c3ccc4c(c3)OCCO4)csc12,C19H17NO5S,21638.0
8438,Oleoyl Ethanolamide Phosphate,CCCCCCCC/C=C\CCCCCCCC(=O)NCCOP(=O)(O)O,C20H40NO5P,22886.0
8439,Bergamottin,CC(C)=CCC/C(C)=C/COc1c2ccoc2cc2oc(=O)ccc12,C21H22O4,10009439.0
8440,VU0364770,O=C(Nc1cccc(Cl)c1)c1ccccn1,C12H9ClN2O,22927.0
8441,Sphingosine-1-phosphate (d16:1),CCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)COP(=O)(O)O,C16H34NO5P,9002921.0
8442,BMS 582949,CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C,C22H26N6O2,22892.0
8443,MRT10,COc1cc(C(=O)NC(=S)Nc2cccc(NC(=O)c3ccccc3)c2)cc(OC)c1OC,C24H23N3O5S,22138.0
8444,Dexamethasone Acetate,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C24H31FO6,22286.0
8445,Aloin,O=C1c2c(O)cccc2C([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cc(CO)cc(O)c21,C21H22O9,22435.0
8446,Neohesperidin,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)cc3O2)cc1O,C28H34O15,23028.0
8447,Phenylacetyl fentanyl (hydrochloride),Cl.O=C(Cc1ccccc1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C27H31ClN2O,22743.0
8448,?14-Triamcinolone acetonide,CC1(C)O[C@@H]2C=C3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,C24H29FO6,9000087.0
8449,Peficitinib,NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(O)(C3)C2,C18H22N4O2,22954.0
8450,ENMD-2076,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C25H31N7O6,22956.0
8451,A-1331852,Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC12CC3CC(CC(C3)C1)C2,C38H38N6O3S,22963.0
8452,PAOA,Nc1ccccc1NC(=O)CCCCCC(=O)Nc1ccccc1,C19H23N3O2,22942.0
8453,para-Fluoroacetyl fentanyl (hydrochloride),CC(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C21H26ClFN2O,23017.0
8454,Digoxin,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,C41H64O14,22266.0
8455,Gly-Gly-AMC,Cc1cc(=O)oc2cc(NC(=O)CNC(=O)CN)ccc12,C14H15N3O4,85140.0
8456,T-5224,O=C(O)CCc1cc(C(=O)c2ccc(OC3CCCC3)cc2O)ccc1OCc1ccc2c(=O)[nH]oc2c1,C29H27NO8,22904.0
8457,HG-14-10-04,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(-c2c[nH]c3ccccc23)n1,C29H34ClN7O,22984.0
8458,Palmitoleoyl Chloride,CCCCCC/C=C\CCCCCCCC(=O)Cl,C16H29ClO,22723.0
8459,CPI-1205,COc1cc(C)[nH]c(=O)c1CNC(=O)c1c(C)n([C@H](C)C2CCN(CC(F)(F)F)CC2)c2ccccc12,C27H33F3N4O3,22962.0
8460,TB5,CN(C)c1ccc(/C=C/C(=O)c2ccc(Br)s2)cc1,C15H14BrNOS,22947.0
8461,para-methyl Tetrahydrofuran fentanyl (hydrochloride),Cc1ccc(N(C(=O)C2CCCO2)C2CCN(CCc3ccccc3)CC2)cc1.Cl,C25H33ClN2O2,23054.0
8462,11-deoxy Corticosterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO,C21H30O3,22916.0
8463,Penciclovir,Nc1nc(=O)c2ncn(CCC(CO)CO)c2[nH]1,C10H15N5O3,22918.0
8464,Oxonic Acid (potassium salt),O=C([O-])c1nc(=O)[nH]c(=O)[nH]1.[K+],C4H2KN3O4,22586.0
8465,Cholesteryl Docosapentaenoate,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C49H78O2,22718.0
8466,YYA-021,Cc1ccc(NC(=O)C(=O)NC2CC(C)(C)NC(C)(C)C2)cc1,C18H27N3O2,22915.0
8467,"9(E),11(E),13(E)-Octadecatrienoic Acid",CCCC/C=C/C=C/C=C/CCCCCCCC(=O)O,C18H30O2,22976.0
8468,para-fluoro Valeryl fentanyl,CCCCC(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C24H32ClFN2O,23085.0
8469,3-Hydroxyglutaric Acid dimethyl ester,COC(=O)CC(O)CC(=O)OC,C7H12O5,22919.0
8470,4'-hydroxy Chalcone,O=C(/C=C/c1ccccc1)c1ccc(O)cc1,C15H12O2,22898.0
8471,ortho-methyl Methoxyacetyl fentanyl (hydrochloride),COCC(=O)N(c1ccccc1C)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O2,22977.0
8472,Iberdomide,O=C1CC[C@H](N2Cc3c(OCc4ccc(CN5CCOCC5)cc4)cccc3C2=O)C(=O)N1,C25H27N3O5,22615.0
8473,D-64131,COc1ccc2[nH]c(C(=O)c3ccccc3)cc2c1,C16H13NO2,22944.0
8474,Morantel (tartrate),Cc1ccsc1/C=C/C1=NCCCN1C.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C16H22N2O6S,22902.0
8475,Gymnemagenin,CC1(C)C[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(CO)[C@@H](O)[C@@H]1O,C30H50O6,11713.0
8476,Fucosterol,C/C=C(\CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,C29H48O,21858.0
8477,Ginsenoside Rb2,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2OC[C@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C53H90O22,22265.0
8478,Heneicosanoic Acid,CCCCCCCCCCCCCCCCCCCCC(=O)O,C21H42O2,22593.0
8479,Matrine,O=C1CCC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34,C15H24N2O,22901.0
8480,Indole-3-butyric Acid,O=C(O)CCCc1c[nH]c2ccccc12,C12H13NO2,22591.0
8481,4-deoxy Pyridoxine (hydrochloride),Cc1ncc(CO)c(C)c1O.Cl,C8H12ClNO2,21863.0
8482,VU0155041 (sodium salt),O=C([O-])[C@H]1CCCC[C@H]1C(=O)Nc1cc(Cl)cc(Cl)c1.[Na+],C14H14Cl2NNaO3,21775.0
8483,StA-IFN-1,CC(=O)n1cc(C2C(=O)NN=C2C)c2ccccc21,C14H13N3O2,22402.0
8484,AM2201-d5 (exempt preparation),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2ccc(Cl)c3ccccc23)c2ccccc21,C24H22ClNO,22870.0
8485,JWH 398-d9 (exempt preparation),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Cn1cc(C(=O)c2ccc(Cl)c3ccccc23)c2ccccc21,C24H22ClNO,22874.0
8486,Urolithin A,O=c1oc2cc(O)ccc2c2ccc(O)cc12,C13H8O4,22607.0
8487,TCN 238,Nc1nccc(/C=C/c2ccccc2)n1,C12H11N3,11994.0
8488,HPPH,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)O)[C@@H]3C,C39H48N4O4,20611.0
8489,APY-29,c1cc(Nc2cc(C3CC3)[nH]n2)nc(Nc2ccc3nc[nH]c3c2)n1,C17H16N8,22913.0
8490,ZM 323881 (hydrochloride),Cc1cc(F)c(Nc2ncnc3cc(OCc4ccccc4)ccc23)cc1O.Cl,C22H19ClFN3O2,21347.0
8491,C10 Ceramide (d18:1/10:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCC,C30H59NO3,22530.0
8492,FTase Inhibitor I,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC[C@@H](NC[C@@H](N)CS)C(C)C)C(=O)O,C22H38N4O3S2,22755.0
8493,BAY-876,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1,C24H16F4N6O2,19961.0
8494,para-methyl Cyclopropyl fentanyl (hydrochloride),Cc1ccc(N(C(=O)C2CC2)C2CCN(CCc3ccccc3)CC2)cc1.Cl,C24H31ClN2O,23045.0
8495,Myristoleic Acid,CCCC/C=C\CCCCCCCC(=O)O,C14H26O2,9002461.0
8496,MZ1,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1,C49H60ClN9O8S2,21622.0
8497,Echinulin,C=CC(C)(C)c1[nH]c2c(CC=C(C)C)cc(CC=C(C)C)cc2c1C[C@@H]1NC(=O)[C@H](C)NC1=O,C29H39N3O2,22711.0
8498,Estazolam,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,C16H11ClN4,15889.0
8499,C16 Ceramide-1-phosphate (d18:1/16:0) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])O)NC(=O)CCCCCCCCCCCCCCC.[NH4+],C34H71N2O6P,22542.0
8500,PRT060318,Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)ncc2C(N)=O)c1,C18H24N6O,22476.0
8501,Pivaloyl fentanyl (hydrochloride),CC(C)(C)C(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C24H33ClN2O,22991.0
8502,Benfotiamine,C/C(=C(\CCOP(=O)(O)O)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N,C19H23N4O6PS,22192.0
8503,C22 Ceramide (d18:1/22:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCC,C40H79NO3,22533.0
8504,AUY954,O=C(O)CCNCc1ccc2sc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)cc2c1,C25H20F3NO2S,9000548.0
8505,Brassicasterol,CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C28H46O,22296.0
8506,"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",Cn1c(N)nc2ncc(-c3ccccc3)cc21,C13H12N4,22590.0
8507,2'-Deoxycytidine 5'-diphosphate (sodium salt hydrate),Nc1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)([O-])OP(=O)([O-])[O-])O2)c(=O)n1.O.[Na+].[Na+].[Na+],C9H12N3Na3O10P2(H2O)n,22982.0
8508,MTT,Cc1nc(-n2nc(-c3ccccc3)n[n+]2-c2ccccc2)sc1C.[Br-],C18H16BrN5S,21795.0
8509,CAY10717,COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1,C29H25F3N6O3,19955.0
8510,4-desmethoxy Omeprazole,COc1ccc2[nH]c(S(=O)Cc3ncc(C)cc3C)nc2c1,C16H17N3O2S,22122.0
8511,"4,5-MDAI (hydrochloride)",Cl.NC1Cc2ccc3c(c2C1)OCO3,C10H12ClNO2,9002653.0
8512,para-chloro Furanyl fentanyl 3-furancarboxamide,O=C(c1ccoc1)N(c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1,C24H25ClN2O2,22843.0
8513,Farnesyl Alcohol,CC(C)=CCC/C(C)=C/CC/C(C)=C/CO,C15H26O,13268.0
8514,4-isocyanato TEMPO,CC1(C)CC(N=C=O)CC(C)(C)N1[O],C10H17N2O2,23075.0
8515,Pioglitazone (hydrochloride),CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1.Cl,C19H21ClN2O3S,22263.0
8516,PCTR1,CC/C=C\C[C@H](O)[C@@H](/C=C/C=C/C=C\C/C=C\C/C=C\CCC(=O)O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,C32H47N3O9S,19064.0
8517,Desethylene Ciprofloxacin (hydrochloride),Cl.NCCNc1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1,C15H17ClFN3O3,22123.0
8518,para-methoxy Acetyl fentanyl (hydrochloride),COc1ccc(N(C(C)=O)C2CCN(CCc3ccccc3)CC2)cc1.Cl,C22H29ClN2O2,23190.0
8519,Bexarotene-d4,[2H]c1c([2H])c(C(=O)O)c([2H])c([2H])c1C(=C)c1cc2c(cc1C)C(C)(C)CCC2(C)C,C24H28O2,22610.0
8520,LG 100268,Cc1cc2c(cc1C1(c3ccc(C(=O)O)cn3)CC1)C(C)(C)CCC2(C)C,C24H29NO2,21606.0
8521,Sphinganine (d20:0),CCCCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO,C20H43NO2,22509.0
8522,1-(6-Methoxy-2-naphthyl)ethanol,COc1ccc2cc(C(C)O)ccc2c1,C13H14O2,22162.0
8523,para-chloro Valeryl fentanyl (hydrochloride),CCCCC(=O)N(c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C24H32Cl2N2O,23058.0
8524,3'-Hydroxystanozolol,C[C@]12Cc3c(O)n[nH]c3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C21H32N2O2,21380.0
8525,IWP-12,Cc1ccc2nc(NC(=O)CSc3nc4c(c(=O)n3C)SC(C)C4)sc2c1,C18H18N4O2S3,22729.0
8526,Darinaparsin,C[As](C)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,C12H22AsN3O6S,21659.0
8527,Cholesteryl Eicosapentaenoate,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C47H74O2,22719.0
8528,Eicosapentaenoyl Chloride,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)Cl,C20H29ClO,22721.0
8529,Butalbital-d5 (CRM),[2H]C([2H])=C([2H])C([2H])([2H])C1(CC(C)C)C(=O)NC(=O)NC1=O,C11H16N2O3,20092.0
8530,Diclofenac (diethylamine),CCNCC.O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,C18H22Cl2N2O2,22983.0
8531,LDN-0212320,Cc1ccccc1CSc1ccc(-c2ccccn2)nn1,C17H15N3S,21650.0
8532,para-methoxy Acrylfentanyl (hydrochloride),C=CC(=O)N(c1ccc(OC)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H29ClN2O2,23192.0
8533,C16 Phytoceramide (t18:0/16:0),CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC,C34H69NO4,22826.0
8534,ortho-methoxy Butyryl fentanyl (hydrochloride),CCCC(=O)N(c1ccccc1OC)C1CCN(CCc2ccccc2)CC1.Cl,C24H33ClN2O2,22035.0
8535,ortho-methoxy Butyryl fentanyl (hydrochloride) (exempt preparation),CCCC(=O)N(c1ccccc1OC)C1CCN(CCc2ccccc2)CC1.Cl,C24H33ClN2O2,39949.0
8536,?'-methyl Butyryl fentanyl (hydrochloride),CCC(C)C(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C24H33ClN2O,22994.0
8537,para-methyl Isobutyryl fentanyl (hydrochloride),Cc1ccc(N(C(=O)C(C)C)C2CCN(CCc3ccccc3)CC2)cc1.Cl,C24H33ClN2O,23057.0
8538,Carebastine,CC(C)(C(=O)O)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,C32H37NO4,23076.0
8539,Docosapentaenoyl Chloride,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)Cl,C22H33ClO,22720.0
8540,Dronedarone (hydrochloride),CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1.Cl,C31H45ClN2O5S,9000543.0
8541,U-48800 (hydrochloride),CN(C)[C@H]1CCCC[C@@H]1N(C)C(=O)Cc1ccc(Cl)cc1Cl.Cl,C17H25Cl3N2O,22278.0
8542,U-48800 (hydrochloride) (CRM),CN(C)[C@H]1CCCC[C@@H]1N(C)C(=O)Cc1ccc(Cl)cc1Cl.Cl,C17H25Cl3N2O,25522.0
8543,"CP-91,149",CN(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2cc(Cl)ccc2[nH]1,C21H22ClN3O3,17709.0
8544,"CP 91,149",CN(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2cc(Cl)ccc2[nH]1,C21H22ClN3O3,17709.0
8545,Perampanel,N#Cc1ccccc1-c1cc(-c2ccccn2)cn(-c2ccccc2)c1=O,C23H15N3O,23003.0
8546,Isovaleryl fentanyl (hydrochloride),CC(C)CC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C24H33ClN2O,22990.0
8547,D-Galactosamine (hydrochloride),Cl.N[C@@H](C=O)[C@@H](O)[C@@H](O)[C@H](O)CO,C6H14ClNO5,22981.0
8548,Doxylamine (succinate),CN(C)CCOC(C)(c1ccccc1)c1ccccn1.O=C(O)CCC(=O)O,C21H28N2O5,21826.0
8549,C17 Ceramide (d18:1/17:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCC,C35H69NO3,22532.0
8550,EOS (d18:1/32:1/18:2),CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCCCCCCCCC/C=C\CCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCC,C68H127NO5,22442.0
8551,Nalidixic Acid,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,C12H12N2O3,19807.0
8552,para-Chlorobutyryl fentanyl (hydrochloride),CCCC(=O)N(c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H30Cl2N2O,23015.0
8553,C12 NBD Galactosylceramide (d18:1/12:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12,C42H71N5O11,22851.0
8554,Cyclopentenyl fentanyl (hydrochloride),Cl.O=C(C1=CCCC1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C25H31ClN2O,23010.0
8555,para-methoxy Furanyl fentanyl (hydrochloride),COc1ccc(N(C(=O)c2ccco2)C2CCN(CCc3ccccc3)CC2)cc1.Cl,C25H29ClN2O3,23197.0
8556,Cardanol monoene,CCCCCC/C=C\CCCCCCCc1cccc(O)c1,C21H34O,23154.0
8557,para-methoxy Methoxyacetyl fentanyl (hydrochloride),COCC(=O)N(c1ccc(OC)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O3,23199.0
8558,SB-408124,Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1,C19H18F2N4O,22961.0
8559,Ethoxyquin,CCOc1ccc2c(c1)C(C)=CC(C)(C)N2,C14H19NO,23094.0
8560,Sphingomyelin (bovine spinal cord),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCCCC,C41H83N2O6P,22674.0
8561,R-8507,FC(F)(F)c1nc2ccccc2n2c(-c3ccc(Cl)cc3)nnc12,C16H8ClF3N4,22479.0
8562,Lin28 1632,CC(=O)N(C)c1cccc(-c2ccc3nnc(C)n3n2)c1,C15H15N5O,22401.0
8563,Cardanol diene,CCC/C=C\C/C=C\CCCCCCCc1cccc(O)c1,C21H32O,23153.0
8564,AN-2690,OB1OCc2cc(F)ccc21,C7H6BFO2,23101.0
8565,Rhodamine B Hydrazide,CCN(CC)c1ccc2c(c1)Oc1cc(N(CC)CC)ccc1C21c2ccccc2C(=O)N1N,C28H32N4O2,23133.0
8566,para-chloro Furanyl fentanyl,O=C(c1ccco1)N(c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1,C24H25ClN2O2,22807.0
8567,ortho-methoxy Furanyl fentanyl,COc1ccccc1N(C(=O)c1ccco1)C1CCN(CCc2ccccc2)CC1,C25H28N2O3,22805.0
8568,Lansoprazole sulfone,Cc1c(OCC(F)(F)F)ccnc1CS(=O)(=O)c1nc2ccccc2[nH]1,C16H14F3N3O3S,22569.0
8569,Pravastatin lactone,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,C23H34O6,22572.0
8570,Cardanol triene,C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1,C21H30O,23155.0
8571,Acetyl-?-methylcholine (chloride),CC(=O)OC(C)C[N+](C)(C)C.[Cl-],C8H18ClNO2,23092.0
8572,4-hydroxy Atorvastatin (calcium salt),CC(C)c1c(C(=O)Nc2ccc(O)cc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1c(C(=O)Nc2ccc(O)cc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2],C66H68CaF2N4O12,22575.0
8573,Pinostrobin,COc1cc(O)c2c(c1)O[C@H](c1ccccc1)CC2=O,C16H14O4,22436.0
8574,"3,3'-Dihexyloxacarbocyanine (iodide)",CCCCCCN1/C(=C/C=C/c2oc3ccccc3[n+]2CCCCCC)Oc2ccccc21.[I-],C29H37IN2O2,23124.0
8575,Tylosin,CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)C(CC=O)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC,C46H77NO17,22599.0
8576,Tizanidine (hydrochloride),Cl.Clc1ccc2nsnc2c1NC1=NCCN1,C9H9Cl2N5S,16477.0
8577,Methylisothiazolinone,Cn1sccc1=O,C4H5NOS,28136.0
8578,C24 Phytoceramide (t18:0/24:0),CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC,C42H85NO4,22827.0
8579,C6 NBD Lactosylceramide (d18:1/6:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCNc1ccc([N+](=O)[O-])c2nonc12,C42H69N5O16,22828.0
8580,C12 NBD Lactosylceramide (d18:1/12:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12,C48H81N5O16,22829.0
8581,C6 NBD Galactosylceramide (d18:1/6:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCNc1ccc([N+](=O)[O-])c2nonc12,C36H59N5O11,22830.0
8582,"2-Amino-3-methylimidazo[4,5-f]quinoline",Cn1c(N)nc2c3cccnc3ccc21,C11H10N4,21853.0
8583,BXL-628,C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@@H](C)C/C=C/C(O)(CC)CC)=CC[C@@H]23)C[C@@H](O)C[C@@H]1F,C29H43FO2,23129.0
8584,Busulfan-d8,[2H]C([2H])(OS(C)(=O)=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])OS(C)(=O)=O,C6H14O6S2,23096.0
8585,para-methyl Acetyl fentanyl (hydrochloride),CC(=O)N(c1ccc(C)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H29ClN2O,23191.0
8586,Caffeic Acid-13C3,O=[13C](O)/[13CH]=[13CH]/c1ccc(O)c(O)c1,C9H8O4,23232.0
8587,Danofloxacin (mesylate),CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1.CS(=O)(=O)O,C20H24FN3O6S,22408.0
8588,Disopyramide,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,C21H29N3O,23227.0
8589,WEHI-345,Cc1ccc(-c2nn(C(C)(C)CNC(=O)c3ccncc3)c3ncnc(N)c23)cc1,C22H23N7O,23023.0
8590,Cimicoxib,COc1ccc(-c2c(Cl)ncn2-c2ccc(S(N)(=O)=O)cc2)cc1F,C16H13ClFN3O3S,10006295.0
8591,AG-555,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCc1ccccc1,C19H18N2O3,23247.0
8592,Succinyl-Coenzyme A (sodium salt),CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC(=O)O.[NaH],C25H40N7O19P3S(Na)n,23297.0
8593,N-desmethyl Rosiglitazone,O=C1NC(=O)C(Cc2ccc(OCCNc3ccccn3)cc2)S1,C17H17N3O3S,22103.0
8594,Chlorthalidone Impurity G,O=C1NC(O)(c2ccc(Cl)c(Cl)c2)c2ccccc21,C14H9Cl2NO2,22574.0
8595,ortho-isopropyl Furanyl fentanyl,CC(C)c1ccccc1N(C(=O)c1ccco1)C1CCN(CCc2ccccc2)CC1,C27H32N2O2,22804.0
8596,ortho-methyl Furanyl fentanyl,Cc1ccccc1N(C(=O)c1ccco1)C1CCN(CCc2ccccc2)CC1,C25H28N2O2,22806.0
8597,AB-FUBINACA 2'-indazole isomer,CC(C)[C@H](NC(=O)c1c2ccccc2nn1Cc1ccc(F)cc1)C(N)=O,C20H21FN4O2,23065.0
8598,Afloqualone,Cc1ccccc1-n1c(CF)nc2ccc(N)cc2c1=O,C16H14FN3O,21834.0
8599,Atomoxetine (hydrochloride),CNCC[C@@H](Oc1ccccc1C)c1ccccc1.Cl,C17H22ClNO,22248.0
8600,SBC-110736,CC(=O)Nc1ccc(C(=O)N2CCN(c3ccc(C)cc3)CC2c2ccccc2)cc1,C26H27N3O2,23103.0
8601,Mizoribine,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O,C9H13N3O6,23128.0
8602,2'-C-Methylcytidine,C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O,C10H15N3O5,22887.0
8603,Ruxolitinib (phosphate),N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O,C17H21N6O4P,23215.0
8604,4'-hydroxy Flurbiprofen,O=C(COCC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1)Nc1ccc(Cl)cc1C(=O)[O-].[Na+],C28H27ClN3NaO5,21691.0
8605,Malathion,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,C10H19O6PS2,22998.0
8606,Acetyl-L-Homoserine lactone,CC(=O)N[C@H]1CCOC1=O,C6H9NO3,23241.0
8607,UCPH-101,COc1ccc(C2C(C#N)=C(N)OC3=C2C(=O)CC(c2cccc4ccccc24)C3)cc1,C27H22N2O3,21460.0
8608,Methiothepin (maleate),CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2.O=C(O)/C=C\C(=O)O,C24H28N2O4S2,23138.0
8609,4-carboxy TEMPO,CC1(C)CC(C(=O)O)CC(C)(C)N1[O],C10H18NO3,23139.0
8610,(R)-CPP,O=C(O)[C@H]1CN(CCCP(=O)(O)O)CCN1,C8H17N2O5P,21569.0
8611,Cangrelor (sodium salt),CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])C(Cl)(Cl)P(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],C17H21Cl2F3N5Na4O12P3S2,22086.0
8612,Rutaecarpine,O=c1c2ccccc2nc2n1CCc1c-2[nH]c2ccccc12,C18H13N3O,22897.0
8613,Cacodylic Acid (sodium salt hydrate),C[As](C)(=O)[O-].O.O.O.[Na+],C2H12AsNaO5,22996.0
8614,A-39183A,CC(=O)[C@H]1c2c(c(O)c3c(O)cccc3c2-c2c3c(c(O)c4c(O)cccc24)C(=O)C[C@](C)(O)[C@H]3C(C)=O)C(=O)C[C@]1(C)O,C34H30O10,23239.0
8615,para-chloro Methoxyacetyl fentanyl (hydrochloride),COCC(=O)N(c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H28Cl2N2O2,23343.0
8616,FQI 1,CCOc1ccccc1C1CC(=O)Nc2cc3c(cc21)OCO3,C18H17NO4,23104.0
8617,ICA 069673,O=C(Nc1cnc(Cl)nc1)c1ccc(F)c(F)c1,C11H6ClF2N3O,22995.0
8618,Istradefylline,CCn1c(=O)c2c(nc(/C=C/c3ccc(OC)c(OC)c3)n2C)n(CC)c1=O,C20H24N4O4,22958.0
8619,BPIPP,Cn1c2c(c(=O)n(C)c1=O)C(c1cccc(Br)c1)C1=C(N2)c2ccccc2C1=O,C22H16BrN3O3,21675.0
8620,para-chloro Cyclobutyl fentanyl (hydrochloride),Cl.O=C(C1CCC1)N(c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1,C24H30Cl2N2O,23339.0
8621,para-chloro Cyclopropyl fentanyl (hydrochloride),Cl.O=C(C1CC1)N(c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1,C23H28Cl2N2O,23342.0
8622,Pindolol,CC(C)NCC(O)COc1cccc2[nH]ccc12,C14H20N2O2,21445.0
8623,AB-7-FUBAICA,CC(C)[C@H](NC(=O)c1cn(Cc2ccc(F)cc2)c2ncccc12)C(N)=O,C20H21FN4O2,23059.0
8624,Phloroglucinol,Oc1cc(O)cc(O)c1,C6H6O3,23223.0
8625,Dehydronifedipine,COC(=O)c1c(C)nc(C)c(C(=O)OC)c1-c1ccccc1[N+](=O)[O-],C17H16N2O6,23229.0
8626,"6,7-Dimethyl-8-(1-D-ribityl)lumazine",Cc1nc2c(=O)[nH]c(=O)nc-2n(C[C@H](O)[C@H](O)[C@H](O)CO)c1C,C13H18N4O6,23370.0
8627,"1,2,3-Tripalmitoyl Glycerol",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C51H98O6,23334.0
8628,4-hydroxy Atorvastatin lactone,CC(C)c1c(C(=O)Nc2ccc(O)cc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H]1C[C@@H](O)CC(=O)O1,C33H33FN2O5,23358.0
8629,Pirlindole,Cc1ccc2c(c1)c1c3n2CCNC3CCC1,C15H18N2,22060.0
8630,Tropodithietic Acid,O=C(O)c1c(=O)cccc2ssc12,C8H4O3S2,23244.0
8631,Briciclib,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(OP(=O)(O)O)c2)c(OC)c1,C19H23O10PS,22989.0
8632,Pamoic Acid,O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,C23H16O6,13946.0
8633,A-317491,O=C(O)c1cc(C(=O)O)c(C(=O)N(Cc2cccc(Oc3ccccc3)c2)[C@H]2CCCc3ccccc32)cc1C(=O)O,C33H27NO8,19256.0
8634,Fluocinolone acetonide,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,C24H30F2O6,23027.0
8635,Thiomyristoyl,CCCCCCCCCCCCCC(=S)NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)Nc1ccccc1,C34H51N3O3S,19398.0
8636,D-Mannitol,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,C6H14O6,23372.0
8637,CB-7921220,Nc1ccc(/C=C/c2cccc(C(=O)O)n2)cc1,C14H12N2O2,23332.0
8638,?'-methoxy Fentanyl (hydrochloride),COC(C)C(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O2,23013.0
8639,Clomipramine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])N(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,C19H24Cl2N2,15803.0
8640,Methacrylfentanyl,C=C(C)C(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C23H28N2O,22884.0
8641,PTZ-343,O=S(=O)([O-])CCCN1c2ccccc2Sc2ccccc21.[Na+],C15H14NNaO3S2,22908.0
8642,"1,2,3-Trilauroyl Glycerol",CCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCC,C39H74O6,23336.0
8643,"(1S,2S)-(+)-Pseudoephedrine",CN[C@@H](C)[C@@H](O)c1ccccc1,C10H15NO,14209.0
8644,Ethoxyacetyl fentanyl (hydrochloride),CCOCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O2,22992.0
8645,Melatonin-d4,[2H]C([2H])(NC(C)=O)C([2H])([2H])c1c[nH]c2ccc(OC)cc12,C13H16N2O2,22291.0
8646,Methylcardol triene,C=CC/C=C\C/C=C\CCCCCCCc1cc(O)c(C)c(O)c1,C22H32O2,23404.0
8647,Mabuterol,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(C(F)(F)F)c1,C13H18ClF3N2O,23246.0
8648,KRIBB11,CNc1ccc([N+](=O)[O-])c(Nc2ccc3[nH]ncc3c2)n1,C13H12N6O2,9002528.0
8649,Arteether,CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,C17H28O5,11814.0
8650,Pseudoephedrine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])N[C@@H](C)[C@@H](O)c1ccccc1,C10H16ClNO,22494.0
8651,Guvacine (hydrochloride),Cl.O=C(O)C1=CCCNC1,C6H10ClNO2,23361.0
8652,Ampiroxicam,CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21,C20H21N3O7S,23026.0
8653,GSK872,CC(C)S(=O)(=O)c1ccc2nccc(Nc3ccc4scnc4c3)c2c1,C19H17N3O2S2,23300.0
8654,Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,C9H18Cl3N2O2P,21874.0
8655,Oxprenolol (hydrochloride),C=CCOc1ccccc1OCC(O)CNC(C)C.Cl,C15H24ClNO3,16080.0
8656,Leteprinim (potassium salt),O=C(CCn1cnc2c(=O)nc[nH]c21)Nc1ccc(C(=O)[O-])cc1.[K+],C15H12KN5O4,21748.0
8657,Cadazolid,O=C(O)c1cn(C2CC2)c2cc(N3CCC(O)(COc4ccc(N5C[C@H](CO)OC5=O)cc4F)CC3)c(F)cc2c1=O,C29H29F2N3O8,23030.0
8658,O-Phospho-L-Tyrosine,N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)O,C9H12NO6P,23064.0
8659,Cyanine,CC(C)CCN1C=C/C(=C/c2cc[n+](CCC(C)C)c3ccccc23)c2ccccc21.[I-],C29H35IN2,23078.0
8660,para-chloro Acrylfentanyl (hydrochloride),C=CC(=O)N(c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C22H26Cl2N2O,23338.0
8661,3?-hydroxy-5-Cholestenoic Acid,CC(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)O,C27H44O3,21859.0
8662,Albofungin,CO[C@@H]1CC[C@H](O)c2c1oc1c3c4c(c(O)c1c2=O)-c1c(cc2cc(C)n(N)c(=O)c2c1O)C[C@H]4OCO3,C27H24N2O9,23142.0
8663,Reticulol,COc1c(O)cc2cc(C)oc(=O)c2c1O,C11H10O5,23148.0
8664,Tetrachlorohydroquinone,Oc1c(Cl)c(Cl)c(O)c(Cl)c1Cl,C6H2Cl4O2,23231.0
8665,OTX008,CN(C)CCNC(=O)COc1c2cccc1Cc1cccc(c1OCC(=O)NCCN(C)C)Cc1cccc(c1OCC(=O)NCCN(C)C)Cc1cccc(c1OCC(=O)NCCN(C)C)C2,C52H72N8O8,23130.0
8666,3-Deazauridine,O=c1cc(O)ccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C10H13NO6,23125.0
8667,para-chloro Cyclopentyl fentanyl (hydrochloride),Cl.O=C(C1CCCC1)N(c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1,C25H32Cl2N2O,23341.0
8668,Rosuvastatin-d6 (sodium salt),[2H]C([2H])([2H])C(c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C([2H])([2H])[2H].[Na+],C22H27FN3NaO6S,23359.0
8669,Tetrahydrozoline (hydrochloride),Cl.c1ccc2c(c1)CCCC2C1=NCCN1,C13H17ClN2,23004.0
8670,Acetosyringone,COc1cc(C(C)=O)cc(OC)c1O,C10H12O4,23224.0
8671,Cardol triene,C=CC/C=C\C/C=C\CCCCCCCc1cc(O)cc(O)c1,C21H30O2,23374.0
8672,Bopindolol (malonate),Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1.O=C(O)CC(=O)O,C26H32N2O7,23365.0
8673,Metoprolol (tartrate),COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C34H56N2O12,21165.0
8674,Penicillin G (potassium salt),CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[K+],C16H17KN2O4S,21615.0
8675,Ethyl Orsellinate,CCOC(=O)c1c(C)cc(O)cc1O,C10H12O4,22709.0
8676,Methazolamide,CC(=O)/N=c1/sc(S(N)(=O)=O)nn1C,C5H8N4O3S2,23413.0
8677,Aspartocin D,CC(C)CCCCC/C=C\CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)N2CCCC[C@@H]2C(=O)N[C@@H]([C@H](C)C(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H]([C@@H](C)N)C(=O)N[C@@H](C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H]1C,C57H89N13O20,23143.0
8678,Luliconazole,N#C/C(=C1/SC[C@@H](c2ccc(Cl)cc2Cl)S1)n1ccnc1,C14H9Cl2N3S2,23120.0
8679,Avanafil,COc1ccc(CNc2nc(N3CCC[C@H]3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,C23H26ClN7O3,23024.0
8680,para-methoxy Valeryl fentanyl (hydrochloride),CCCCC(=O)N(c1ccc(OC)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C25H35ClN2O2,23471.0
8681,Isoxanthohumol,COc1cc(O)c(CC=C(C)C)c2c1C(=O)CC(c1ccc(O)cc1)O2,C21H22O5,23233.0
8682,Equilenin,C[C@]12CCc3c(ccc4cc(O)ccc34)[C@@H]1CCC2=O,C18H18O2,23322.0
8683,RN-18,COc1ccccc1NC(=O)c1ccccc1Sc1ccc([N+](=O)[O-])cc1,C20H16N2O4S,23331.0
8684,Sulfamethizole,Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1,C9H10N4O2S2,23355.0
8685,JWH 412 N-(5-hydroxypentyl) metabolite,O=C(c1ccc(F)c2ccccc12)c1cn(CCCCCO)c2ccccc12,C24H22FNO2,17789.0
8686,13-cis-Retinoic Acid-d5,[2H]C([2H])([2H])C1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1([2H])[2H],C20H28O2,21855.0
8687,Aspercolorin,COc1ccc2c(c1)C(=O)NC(Cc1ccccc1)C(=O)NCCC(=O)N1CCCC1C(=O)N2,C25H28N4O5,23144.0
8688,(+)-Oxanthromicin,Cc1ccc2c(c1O)C(=O)c1c(cc(O)c(C(=O)O)c1C)[C@@]2(C)OO[C@]1(C)c2cc(O)c(C(=O)O)c(C)c2C(=O)c2c1ccc(C)c2O,C36H30O12,23150.0
8689,Suvorexant,Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1,C23H23ClN6O2,22911.0
8690,L67,Cc1c(Br)cc(NCC(=O)N/N=C/c2cc([N+](=O)[O-])ccc2O)cc1Br,C16H14Br2N4O4,22941.0
8691,Clomazone,CC1(C)CON(Cc2ccccc2Cl)C1=O,C12H14ClNO2,23298.0
8692,Pseudomonic Acid,C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O,C26H44O9,23238.0
8693,Terrein,C/C=C/C1=CC(=O)[C@H](O)[C@H]1O,C8H10O3,23496.0
8694,ML-210,Cc1onc(C(=O)N2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)c1[N+](=O)[O-],C22H20Cl2N4O4,23282.0
8695,ML-210N6-Methyladenosine 5'-monophosphate (sodium salt),CNc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+],C11H14N5Na2O7P,23382.0
8696,PU 02,c1ccc2c(CSc3ncnc4nc[nH]c34)cccc2c1,C16H12N4S,14312.0
8697,C6 NBD Glucosylceramide (d18:1/6:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCNc1ccc([N+](=O)[O-])c2nonc12,C36H59N5O11,23209.0
8698,SB 204990,O=C(O)C[C@@]1(O)C[C@@H](CCCCCCc2ccc(Cl)cc2Cl)OC1=O,C18H22Cl2O5,15245.0
8699,Menaquinone 7,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=C(C)C(=O)c2ccccc2C1=O,C46H64O2,10011051.0
8700,9-cis Retinal,CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C=O)C(C)(C)CCC1,C20H28O,21692.0
8701,Ametantrone,O=C1c2ccccc2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,C22H28N4O4,22924.0
8702,TM5441,O=C(COCC(=O)Nc1ccc(Cl)cc1C(=O)O)Nc1cccc(-c2ccoc2)c1,C21H17ClN2O6,22965.0
8703,AF-353 (hydrochloride),COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1I.Cl,C14H18ClIN4O2,23034.0
8704,DNP-INT,Cc1c([N+](=O)[O-])cc(C(C)C)c(Oc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])c1I,C16H14IN3O7,9003061.0
8705,N-desethyl Sunitinib,CCNCCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,C20H23FN4O2,22292.0
8706,Antazoline (hydrochloride),Cl.c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1,C17H20ClN3,23415.0
8707,CGP 3466 (maleate),C#CCN(C)CC1=Cc2ccccc2Oc2ccccc21.O=C(O)/C=C\C(=O)O,C23H21NO5,23362.0
8708,Divalproex (sodium salt),CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)O.[NaH],C16H32NaO4,22960.0
8709,Cardol diene,CCC/C=C\C/C=C\CCCCCCCc1cc(O)cc(O)c1,C21H32O2,23373.0
8710,Abiraterone Acetate-d4,[2H]c1nc([2H])c(C2=CC[C@H]3[C@@H]4CC=C5C[C@@H](OC(C)=O)CC[C@]5(C)[C@H]4CC[C@]23C)c([2H])c1[2H],C26H33NO2,22096.0
8711,13(E)-Docosenoic Acid,CCCCCCCC/C=C/CCCCCCCCCCCC(=O)O,C22H42O2,22580.0
8712,6?-methyl-11?-Hydroxyprogesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,C22H32O3,19533.0
8713,"Diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate",CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1C,C14H21NO4,23230.0
8714,C6 Biotin Glucosylceramide (d18:1/6:0),CCCCCCCCC/C=C/CC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C40H70N4O10S,23208.0
8715,Demethylwedelolactone,O=c1oc2cc(O)cc(O)c2c2oc3cc(O)c(O)cc3c12,C15H8O7,11703.0
8716,Corynecin I,CC(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1,C11H14N2O5,23237.0
8717,Tipiracil (hydrochloride),Cl.N=C1CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl,C9H12Cl2N4O2,23319.0
8718,LAS191859,CCN(Cc1cc(C(F)(F)F)ccc1-n1cc(CC(=O)O)c2ccc(C)nc21)C(=O)C1CC1,C24H24F3N3O3,20238.0
8719,Clevidipine,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,C21H23Cl2NO6,23025.0
8720,Sal-003,O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1ccc(Cl)cc1)C(Cl)(Cl)Cl,C18H15Cl4N3OS,23414.0
8721,MSX-122,c1cnc(NCc2ccc(CNc3ncccn3)cc2)nc1,C16H16N6,23426.0
8722,Mepivacaine,Cc1cccc(C)c1NC(=O)C1CCCCN1C,C15H22N2O,23402.0
8723,4-Nitrophenyl ?-D-Cellobioside,O=[N+]([O-])c1ccc(O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)cc1,C18H25NO13,23378.0
8724,Vancomycin (hydrochloride),CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O.Cl,C66H76Cl3N9O24,15327.0
8725,Leukadherin 1,O=C(O)c1ccc(-c2ccc(/C=C3\SC(=S)N(Cc4ccccc4)C3=O)o2)cc1,C22H15NO4S2,14855.0
8726,Clofazimine,CC(C)/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1,C27H22Cl2N4,23301.0
8727,Carisbamate,NC(=O)OC[C@@H](O)c1ccccc1Cl,C9H10ClNO3,23514.0
8728,2?-Mannobiose,OC[C@H]1O[C@H](O[C@@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H](O)[C@@H]1O,C12H22O11,21848.0
8729,15-Acetyldeoxy Nivalenol,CC(=O)OC[C@]12[C@H](O)C(=O)C(C)=C[C@H]1O[C@@H]1[C@H](O)C[C@@]2(C)C12CO2,C17H22O7,11430.0
8730,Tauro-?-muricholic Acid (sodium salt),C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@H]2[C@@H]3[C@H](O)[C@@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.[Na+],C26H44NNaO7S,20288.0
8731,"5,6-epoxy-13-cis Retinoic Acid",CC(=C/C(=O)O)/C=C/C=C(C)/C=C/C12OC1(C)CCCC2(C)C,C20H28O3,23091.0
8732,Actinopyrone A,C/C=C(\C)[C@H](O)[C@H](C)/C=C(C)/C=C/C/C(C)=C/Cc1oc(OC)c(C)c(=O)c1C,C25H36O4,23140.0
8733,4-Epianhydrochlortetracycline (hydrochloride),Cc1c2c(c(O)c3c(O)ccc(Cl)c13)C(=O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H](N(C)C)[C@@H]1C2.Cl,C22H22Cl2N2O7,23146.0
8734,Linagliptin,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,C25H28N8O2,23306.0
8735,Sancycline,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4C[C@H]3C[C@@H]12,C21H22N2O7,23100.0
8736,4-Epidoxycycline,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,C22H24N2O8,23225.0
8737,B-RAF IN 1,CN(C)Cc1ccc(-c2cnn3c(-c4cccc(NC(=O)c5cccc(C(F)(F)F)c5)c4)ccnc23)cc1,C29H24F3N5O,23434.0
8738,Dihydrocodeine,COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341,C18H23NO3,15460.0
8739,Vildagliptin carboxylic acid metabolite (trifluoroacetate salt),O=C(O)C(F)(F)F.O=C(O)[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,C19H27F3N2O6,22088.0
8740,PIK-294,Cc1ccccc1-n1c(Cn2nc(-c3cccc(O)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O,C28H23N7O2,23427.0
8741,Butabarbital-d5,[2H]C([2H])([2H])C([2H])([2H])C1(C(C)CC)C(=O)NC(=O)NC1=O,C10H16N2O3,20089.0
8742,Butabarbital-d5 (CRM),[2H]C([2H])([2H])C([2H])([2H])C1(C(C)CC)C(=O)NC(=O)NC1=O,C10H16N2O3,20090.0
8743,Cathepsin L Inhibitor,O=C[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1,C26H26N2O5,23249.0
8744,XL335,CC(C)OC(=O)C1=CN(C(=O)c2ccc(F)c(F)c2)CC(C)(C)c2c1[nH]c1ccccc21,C25H24F2N2O3,23350.0
8745,XMD8-87,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2,C24H27N7O2,23354.0
8746,Vorapaxar,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1,C29H33FN2O4,23119.0
8747,?-Pseudouridine,O=c1[nH]cc([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1,C9H12N2O6,23383.0
8748,T-705,NC(=O)c1nc(F)c[nH]c1=O,C5H4FN3O2,23384.0
8749,para-methyl Acrylfentanyl (hydrochloride),C=CC(=O)N(c1ccc(C)cc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H29ClN2O,23038.0
8750,N-Oleoyl Leucine,CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](CC(C)C)C(=O)O,C24H45NO3,20064.0
8751,HZ-1157,CC(C)(C)Oc1cccc2nc(N)nc(N)c12,C12H16N4O,23436.0
8752,Mirtazapine-d3,[2H]C([2H])([2H])N1CCN2c3ncccc3Cc3ccccc3C2C1,C17H19N3,21126.0
8753,Mirtazapine-d3 (CRM),[2H]C([2H])([2H])N1CCN2c3ncccc3Cc3ccccc3C2C1,C17H19N3,31762.0
8754,Myristelaidic Acid,CCCC/C=C/CCCCCCCC(=O)O,C14H26O2,22361.0
8755,Diflubenzuron,O=C(NC(=O)c1c(F)cccc1F)Nc1ccc(Cl)cc1,C14H9ClF2N2O2,23095.0
8756,Gemcitabine (hydrochloride),Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,C9H12ClF2N3O4,9003096.0
8757,Guanfacine (hydrochloride),Cl.N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,C9H10Cl3N3O,22907.0
8758,YM-90709,COc1cc2c(cc1OC)-c1cc3nc4ccccc4nc3n1C(C)(C)C2,C22H21N3O2,23448.0
8759,Solcitinib,CC1(C)CN(C(=O)c2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)C1,C22H23N5O2,23439.0
8760,20(S)-Ginsenoside Rh2,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C36H62O8,23390.0
8761,Sphinganine-1-phosphate (d18:0),CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)COP(=O)(O)O,C18H40NO5P,22500.0
8762,Valrubicin,CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O,C34H36F3NO13,22964.0
8763,10(Z)-Pentadecenoic Acid,CCCC/C=C\CCCCCCCCC(=O)O,C15H28O2,22362.0
8764,Pseudoephedrine tert-butyl Carbamate,C[C@@H]([C@@H](O)c1ccccc1)N(C)C(=O)OC(C)(C)C,C15H23NO3,22741.0
8765,Gramine,CN(C)Cc1c[nH]c2ccccc12,C11H14N2,23401.0
8766,S-trityl-L-Cysteine,N[C@@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O,C22H21NO2S,23236.0
8767,MI 2,COCCOc1nc(-c2ccc(Cl)c(Cl)c2)n(-c2ccc(NC(=O)CCl)cc2)n1,C19H17Cl3N4O3,23437.0
8768,7ACC2,CN(Cc1ccccc1)c1ccc2cc(C(=O)O)c(=O)oc2c1,C18H15NO4,23445.0
8769,Bimiralisib,Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,C17H20F3N7O2,23441.0
8770,1-?-D-Glucosylsphingosine (d18:1),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C24H47NO7,23211.0
8771,1-?-D-Glucosylsphingosine,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C24H47NO7,31556.0
8772,JNJ-63533054,C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1,C17H17ClN2O2,23450.0
8773,LCZ696,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C.CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O.O.O.O.O.O.[NaH].[NaH].[NaH].[NaH].[NaH].[NaH],C48H68N6Na6O13,23425.0
8774,BM212,Cc1c(CN2CCN(C)CC2)cc(-c2ccc(Cl)cc2)n1-c1ccc(Cl)cc1,C23H25Cl2N3,22986.0
8775,"8-Aminopyrene-1,3,6-trisulfonic Acid (sodium salt)",Nc1cc(S(=O)(=O)[O-])c2ccc3c(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c4ccc1c2c43.[Na+].[Na+].[Na+],C16H8NNa3O9S3,23098.0
8776,Nateglinide,CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1,C19H27NO3,23320.0
8777,Sulfamerazine (sodium salt),Cc1ccnc([N-]S(=O)(=O)c2ccc(N)cc2)n1.[Na+],C11H11N4NaO2S,23380.0
8778,Mefloquine (hydrochloride),Cl.O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1,C17H17ClF6N2O,23665.0
8779,6-Nitroveratraldehyde,COc1cc(C=O)c([N+](=O)[O-])cc1OC,C9H9NO5,23364.0
8780,(3S)-hydroxy Quinidine,C=C[C@@]1(O)C[N@]2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,C20H24N2O3,23411.0
8781,5-fluoro-tert-Butylbenzyl-PINACA,CC(C)(C)C(NC(=O)c1nn(CCCCCF)c2ccccc12)c1ccccc1,C24H30FN3O,23351.0
8782,Fluphenazine (hydrochloride),Cl.OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,C22H27ClF3N3OS,23555.0
8783,(3R)-hydroxy Quinidine,C=C[C@]1(O)C[N@]2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,C20H24N2O3,23410.0
8784,Adjudin,NNC(=O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12,C15H12Cl2N4O,22939.0
8785,S63845,Cc1c(-c2c(-c3ccc(F)o3)sc3ncnc(O[C@H](Cc4ccccc4OCc4ccnn4CC(F)(F)F)C(=O)O)c23)ccc(OCCN2CCN(C)CC2)c1Cl,C39H37ClF4N6O6S,21131.0
8786,RS 127445 (hydrochloride),CC(C)c1cc(-c2ccc(F)c3ccccc23)nc(N)n1.Cl,C17H17ClFN3,23451.0
8787,TG6-10-1,COc1cc(/C=C/C(=O)NCCn2c(C(F)(F)F)cc3ccccc32)cc(OC)c1OC,C23H23F3N2O4,23444.0
8788,Fluoroclebopride,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccc(F)cc2)CC1,C20H23ClFN3O2,23447.0
8789,(+)-Rugulosin,Cc1cc(O)c2c(c1)C(=O)[C@@]13C(=C(O)[C@H]4[C@@H](O)[C@@H]1[C@H]1[C@H](O)[C@@H]3C(O)=C3C(=O)c5c(O)cc(C)cc5C(=O)[C@@]314)C2=O,C30H22O10,23558.0
8790,Macitentan,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,C19H20Br2N6O4S,23304.0
8791,Isocarboxazid,Cc1cc(C(=O)NNCc2ccccc2)no1,C12H13N3O2,23625.0
8792,Paromomycin (sulfate),NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O.O=S(=O)(O)O,C23H45N5O14(H2O4S)n,23634.0
8793,Dichlorphenamide,NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1,C6H6Cl2N2O4S2,23658.0
8794,Metoclopramide (hydrochloride),CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC.Cl,C14H23Cl2N3O2,23360.0
8795,Hydroflumethiazide,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,C8H8F3N3O4S2,23612.0
8796,Medroxyprogesterone 17-acetate,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,C24H34O4,23664.0
8797,Cefuroxime (sodium salt),CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(COC(N)=O)CS[C@H]12)c1ccco1.[Na+],C16H15N4NaO8S,23627.0
8798,Eslicarbazepine Acetate,CC(=O)O[C@H]1Cc2ccccc2N(C(N)=O)c2ccccc21,C17H16N2O3,23656.0
8799,Cyclopropyl fentanyl (hydrochloride) (CRM),Cl.O=C(C1CC1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C23H29ClN2O,23603.0
8800,Cyclopropyl fentanyl (hydrochloride),Cl.O=C(C1CC1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C23H29ClN2O,21739.0
8801,"1-Methyl-1,4-dihydronicotinamide",CN1C=CCC(C(N)=O)=C1,C7H10N2O,23226.0
8802,Amiprofos-methyl,COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-],C11H17N2O4PS,23379.0
8803,SLC5111312 (hydrochloride),CCCCCOc1ccc2cc(-c3noc([C@@H]4[C@@H](O)CCN4C(=N)N)n3)ccc2c1.Cl,C22H28ClN5O3,23288.0
8804,Sphinganine (d17:0),CCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO,C17H37NO2,22510.0
8805,Raxatrigine (hydrochloride),Cl.NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3F)cc2)N1,C18H20ClFN2O2,23490.0
8806,PFK158,O=C(/C=C/c1ccc2ccc(C(F)(F)F)cc2n1)c1ccncc1,C18H11F3N2O,22987.0
8807,"Androst-3,5-diene-7,17-dione",C[C@]12CCC=CC1=CC(=O)[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H24O2,23086.0
8808,Tirofiban (hydrochloride hydrate),CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O.Cl.O,C22H39ClN2O6S,23392.0
8809,Ginsenoside Rf,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C,C42H72O14,23667.0
8810,"3,6-dichloro-benzo[b]thiophene-2-Carboxylic Acid",O=C(O)c1sc2cc(Cl)ccc2c1Cl,C9H4Cl2O2S,22948.0
8811,BMS 986120,COc1cc(OCc2nc(N3CCOCC3)sc2C)c2cc(-c3cn4nc(OC)sc4n3)oc2c1,C23H23N5O5S2,23497.0
8812,Bivalirudin,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O,C98H138N24O33,23035.0
8813,NSC 5844,Clc1ccc2c(NCCNc3ccnc4cc(Cl)ccc34)ccnc2c1,C20H16Cl2N4,23443.0
8814,Alamethicin F50,CC(=O)NC(C)(C)C(=O)N1CCC[C@H]1C(=O)NC(C)(C)C(=O)N[C@@H](C)C(=O)NC(C)(C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)NC(C)(C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CO)Cc1ccccc1)C(C)C)C(C)C,C92H151N23O24,23141.0
8815,Alprazolam-d3 (exempt preparation),[2H]C([2H])([2H])c1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,C17H13ClN4,23784.0
8816,C22 Glucosylceramide (d18:1/22:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCCCCCC,C46H89NO8,23210.0
8817,C-DIM12,Clc1ccc(C(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)cc1,C23H17ClN2,22951.0
8818,Amsacrine (hydrochloride),COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12.Cl,C21H20ClN3O3S,22223.0
8819,Estramustine Phosphate (sodium salt),C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2OP(=O)([O-])[O-].[Na+].[Na+],C23H30Cl2NNa2O6P,23126.0
8820,Protopine (hydrochloride),CN1CCc2cc3c(cc2C(=O)Cc2ccc4c(c2C1)OCO4)OCO3.Cl,C20H20ClNO5,23366.0
8821,Drospirenone,C[C@]12CCC(=O)C=C1[C@@H]1C[C@@H]1[C@H]1[C@@H]3[C@@H]4C[C@@H]4[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@@H]12,C24H30O3,23347.0
8822,"all-cis-4,7,10,13,16-Docosapentaenoic Acid ethyl ester",CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCC,C24H38O2,23607.0
8823,5-fluoro EDMB-PINACA,CCOC(=O)[C@@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(C)(C)C,C21H30FN3O3,23005.0
8824,Eptapirone,Cn1c(=O)cnn(CCCCN2CCN(c3ncccn3)CC2)c1=O,C16H23N7O2,23449.0
8825,C24 Ceramide-d7 (d18:1-d7/24:0),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCC,C42H83NO3,22789.0
8826,SW044248,CCC(Sc1nnc2c3ccccc3n(CC)c2n1)C(=O)Nc1ccccc1OC,C22H23N5O2S,23459.0
8827,PIK-93,CC(=O)Nc1nc(C)c(-c2ccc(Cl)c(S(=O)(=O)NCCO)c2)s1,C14H16ClN3O4S2,10009212.0
8828,?-Cyclodextrin (hydrate),OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO,C42H70O35,23387.0
8829,WHI-P258,COc1cc2ncnc(Nc3ccccc3)c2cc1OC,C16H15N3O2,23453.0
8830,L-Allylglycine,C=CC[C@H](N)C(=O)O,C5H9NO2,23348.0
8831,Besifloxacin (hydrochloride),Cl.N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,C19H22Cl2FN3O3,23692.0
8832,4-Aminohippuric Acid,Nc1ccc(C(=O)NCC(=O)O)cc1,C9H10N2O3,23726.0
8833,Conivaptan (hydrochloride),Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2.Cl,C32H27ClN4O2,23728.0
8834,Proscaline (hydrochloride),CCCOc1c(OC)cc(CCN)cc1OC.Cl,C13H22ClNO3,19926.0
8835,Flunisolide,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,C24H31FO6,23842.0
8836,NVP-ACC789,Cc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1Br,C21H17BrN4,23458.0
8837,Rocuronium (bromide),C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1.[Br-],C32H53BrN2O4,23698.0
8838,C18 Ceramide-d7 (d18:17/18:0),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCC,C36H71NO3,22788.0
8839,D-(+)-Glucose,O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,C6H12O6,23733.0
8840,Gamithromycin,CCCN1C[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@H]1C,C40H76N2O12,23389.0
8841,Binucleine 2,CN(C)/C=N/c1c(C#N)cnn1-c1ccc(F)c(Cl)c1,C13H11ClFN5,23367.0
8842,Methimazole,Cn1cc[nH]c1=S,C4H6N2S,23718.0
8843,Vortioxetine (hydrobromide),Br.Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,C18H23BrN2S,23694.0
8844,"D,L-Buthionine-(S,R)-Sulfoximine",CCCCS(=N)(=O)CCC(N)C(=O)O,C8H18N2O3S,23691.0
8845,Pimavanserin,CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1,C25H34FN3O2,23462.0
8846,Tiopronin,CC(S)C(=O)NCC(=O)O,C5H9NO3S,23720.0
8847,6-Aminocaproic Acid,NCCCCCC(=O)O,C6H13NO2,23724.0
8848,ortho-methyl Acetyl fentanyl (hydrochloride),CC(=O)N(c1ccccc1C)C1CCN(CCc2ccccc2)CC1.Cl,C22H29ClN2O,23548.0
8849,Dihydrospinosyn A aglycone,CC[C@H]1CCC[C@H](O)[C@@H](C)C(=O)C2=C[C@H]3[C@@H]4C[C@H](O)C[C@H]4CC[C@H]3[C@@H]2CC(=O)O1,C24H36O5,23641.0
8850,Chloramphenicol Acetate,CC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1,C13H14Cl2N2O6,23811.0
8851,Fentanyl,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C22H28N2O,23580.0
8852,ortho-methyl Acrylfentanyl (hydrochloride),C=CC(=O)N(c1ccccc1C)C1CCN(CCc2ccccc2)CC1.Cl,C23H29ClN2O,23036.0
8853,N-Hippuryl-His-Leu (hydrate),CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)c1ccccc1)C(=O)O.O,C21H27N5O5(H2O)n,23329.0
8854,ATN-224,C[N+](C)(C)CCO.C[N+](C)(C)CCO.S=[Mo-2](=S)(=S)=S,C10H28MoN2O2S4,23553.0
8855,TAK-599,CC(=O)[O-].CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,C24H25N8O10PS4,23696.0
8856,Bepotastine (besylate),O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1.O=S(=O)(O)c1ccccc1,C27H31ClN2O6S,23721.0
8857,CPI-637,C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2N1,C22H22N6O,23500.0
8858,Ethambutol (hydrochloride),CC[C@@H](CO)NCCN[C@@H](CC)CO.Cl.Cl,C10H26Cl2N2O2,23713.0
8859,?-Secretase Inhibitor IV,C[C@@H](NC(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CC2)cc(N(C)S(C)(=O)=O)c1)c1ccccc1,C31H38N4O5S,23388.0
8860,Desmethyl Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCO)cc23)c1,C21H21N3O4,23394.0
8861,Metaproterenol (hemisulfate),CC(C)NCC(O)c1cc(O)cc(O)c1.CC(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O,C22H36N2O10S,23611.0
8862,Cyclohexanoyl-Coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C1CCCCC1,C28H46N7O17P3S,23504.0
8863,WHI-P180,COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC,C16H15N3O3,23452.0
8864,Trazodone (hydrochloride),Cl.O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,C19H23Cl2N5O,19048.0
8865,Trazodone (hydrochloride) (CRM),Cl.O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,C19H23Cl2N5O,19049.0
8866,C16 Ceramide-d7 (d18:1-d7/16:0),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCC,C34H67NO3,22787.0
8867,C24:1 Ceramide-d7 (d18:1-d7/24:1(15Z)),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC,C42H81NO3,22790.0
8868,Bupropion-d9 (hydrochloride),Cl.[2H]C([2H])([2H])C(NC(C)C(=O)c1cccc(Cl)c1)(C([2H])([2H])[2H])C([2H])([2H])[2H],C13H19Cl2NO,10010679.0
8869,Bupropion-d9 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])C(NC(C)C(=O)c1cccc(Cl)c1)(C([2H])([2H])[2H])C([2H])([2H])[2H],C13H19Cl2NO,22487.0
8870,(S)-Methamphetamine p-toluenesulfonamide,Cc1ccc(S(=O)(=O)N(C)[C@@H](C)Cc2ccccc2)cc1,C17H21NO2S,23605.0
8871,Nicaraven,CC(CNC(=O)c1cccnc1)NC(=O)c1cccnc1,C15H16N4O2,23482.0
8872,"1,2,3-Tristearoyl Glycerol",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC,C57H110O6,23335.0
8873,Desmethylcitalopram (hydrochloride),CNCCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21.Cl,C19H20ClFN2O,15905.0
8874,Desmethylcitalopram (hydrochloride) (CRM),CNCCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21.Cl,C19H20ClFN2O,23255.0
8875,ortho-methyl Phenyl fentanyl (hydrochloride),Cc1ccccc1N(C(=O)c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C27H31ClN2O,23652.0
8876,ortho-methyl Cyclopropyl fentanyl (hydrochloride),Cc1ccccc1N(C(=O)C1CC1)C1CCN(CCc2ccccc2)CC1.Cl,C24H31ClN2O,23043.0
8877,APY0201,Cc1cccc(/C=N/Nc2cc(N3CCOCC3)n3nc(-c4ccncc4)cc3n2)c1,C23H23N7O,9001589.0
8878,Saxagliptin (hydrochloride),Cl.N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,C18H26ClN3O2,23697.0
8879,Acetyl-6-formylpterin,CC(=O)Nc1nc2ncc(C=O)nc2c(=O)[nH]1,C9H7N5O3,23303.0
8880,Cyclopeptine,CN1C(=O)c2ccccc2NC(=O)[C@@H]1Cc1ccccc1,C17H16N2O2,23476.0
8881,"(1S,3R)-RSL3",COC(=O)c1ccc([C@H]2c3[nH]c4ccccc4c3C[C@H](C(=O)OC)N2C(=O)CCl)cc1,C23H21ClN2O5,19288.0
8882,(-)-Propoxyphene (hydrochloride),CCC(=O)O[C@@](Cc1ccccc1)(c1ccccc1)[C@@H](C)CN(C)C.Cl,C22H30ClNO2,22769.0
8883,Desogestrel,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC,C22H30O,23651.0
8884,1-?-D-Glucosylsphingadienine,CCCCCCCCC/C=C/CC/C=C/[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C24H45NO7,23213.0
8885,Altretamine,CN(C)c1nc(N(C)C)nc(N(C)C)n1,C9H18N6,23662.0
8886,Prednicarbate,CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,C27H36O8,23668.0
8887,CID-797718,O=c1oc2ccc(O)cc2c2c1NCCC2,C12H11NO3,23428.0
8888,Cannabigerorcin,CC(C)=CCC/C(C)=C/Cc1c(O)cc(C)cc1O,C17H24O2,23257.0
8889,Sphinganine-1-phosphate (d17:0),CCCCCCCCCCCCCC[C@@H](O)[C@@H](N)COP(=O)(O)O,C17H38NO5P,22501.0
8890,Graphislactone A,COc1cc(O)c2c(=O)oc3c(O)c(OC)cc(C)c3c2c1,C16H14O6,23643.0
8891,Nicotinamide riboside,*O[C@H]1OC(CO)[C@H](*)[C@@H](O)C1O.NC(=O)c1ccc[n+]([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1,C11H15N2O5(C6H10O5)n,23132.0
8892,Butabarbital,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,C10H16N2O3,15883.0
8893,Butabarbital (CRM),CCC(C)C1(CC)C(=O)NC(=O)NC1=O,C10H16N2O3,20088.0
8894,Tosedostat,CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO,C21H30N2O6,23395.0
8895,Biotin-PEG3-azide,[N-]=[N+]=NCCOCCOCCOCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C18H32N6O5S,23419.0
8896,Amauromine,C=CC(C)(C)[C@@]12C[C@H]3C(=O)N4[C@@H](C[C@@]5(C(C)(C)C=C)c6ccccc6N[C@@H]45)C(=O)N3[C@@H]1Nc1ccccc12,C32H36N4O2,23886.0
8897,para-methoxy Tetrahydrofuran fentanyl (hydrochloride),COc1ccc(N(C(=O)C2CCCO2)C2CCN(CCc3ccccc3)CC2)cc1.Cl,C25H33ClN2O3,23472.0
8898,KM 11060,O=S(=O)(c1ccc(Cl)cc1)N1CCN(c2ccnc3cc(Cl)ccc23)CC1,C19H17Cl2N3O2S,23481.0
8899,Akt Inhibitor IV,CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21.[I-],C31H27IN4S,15569.0
8900,12-Deoxywithastramonolide,CC1=C(CO)C(=O)O[C@@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4[C@@H]5O[C@@H]5[C@@]5(O)CC=CC(=O)[C@]5(C)[C@H]4CC[C@]23C)C1,C28H38O6,11669.0
8901,AL 082D06,CN(C)c1ccc(C(c2ccc(N(C)C)cc2)c2cc([N+](=O)[O-])ccc2Cl)cc1,C23H24ClN3O2,23455.0
8902,Pentobarbital-d5,[2H]C([2H])([2H])C([2H])([2H])C1(C(C)CCC)C(=O)NC(=O)NC1=O,C11H18N2O3,20968.0
8903,Pentobarbital-d5 (CRM),[2H]C([2H])([2H])C([2H])([2H])C1(C(C)CCC)C(=O)NC(=O)NC1=O,C11H18N2O3,20969.0
8904,Butenafine (hydrochloride),CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12.Cl,C23H28ClN,23797.0
8905,Acetylcholine (chloride),CC(=O)OCC[N+](C)(C)C.[Cl-],C7H16ClNO2,23829.0
8906,Aspochalasin D,CC1=C[C@@H]2/C=C(\C)CC[C@@H](O)[C@@H](O)/C=C/C(=O)[C@]23C(=O)N[C@@H](CC(C)C)[C@@H]3[C@@H]1C,C24H35NO4,23864.0
8907,Nornidulin,C/C=C(/C)c1c(Cl)c(O)c(C)c2c1Oc1c(Cl)c(O)c(Cl)c(C)c1C(=O)O2,C19H15Cl3O5,23646.0
8908,Terphenyllin,COc1cc(-c2ccc(O)cc2)c(OC)c(O)c1-c1ccc(O)cc1,C20H18O5,23480.0
8909,Methyclothiazide,CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,C9H11Cl2N3O4S2,23799.0
8910,Mexiletine (hydrochloride),Cc1cccc(C)c1OCC(C)N.Cl,C11H18ClNO,23782.0
8911,Ethyl Loflazepate,CCOC(=O)C1N=C(c2ccccc2F)c2cc(Cl)ccc2NC1=O,C18H14ClFN2O3,23630.0
8912,Secobarbital,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,C12H18N2O3,15791.0
8913,Heronamide C,CCC/C=C/C=C/C[C@@H]1C/C=C/C=C(C)/C=C/C=C\[C@@H](O)[C@@H](O)/C=C(C)/C=C/C=C/C(=O)N1,C29H39NO3,23644.0
8914,Rolitetracycline,CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCCC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,C27H33N3O8,23479.0
8915,Doramectin aglycone,CC1=C[C@H]2C(=O)O[C@H]3C[C@@H](C/C=C(\C)[C@@H](O)[C@@H](C)/C=C/C=C4\CO[C@H]([C@@H]1O)[C@@]42O)O[C@@]1(C=C[C@H](C)[C@@H](C2CCCCC2)O1)C3,C36H50O8,23655.0
8916,Penigequinolone A,COc1ccc([C@@]2(O)c3c(ccc(/C=C/[C@]4(C)CCC(C)(C)CO4)c3O)NC(=O)[C@@H]2OC)cc1,C27H33NO6,23647.0
8917,Thebaine (CRM),COC1=CC=C2[C@H]3Cc4ccc(OC)c5c4[C@@]2(CCN3C)[C@H]1O5,C19H21NO3,22024.0
8918,Thebaine,COC1=CC=C2[C@H]3Cc4ccc(OC)c5c4[C@@]2(CCN3C)[C@H]1O5,C19H21NO3,36540.0
8919,Doxapram (hydrochloride hydrate),CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O.Cl.O,C24H33ClN2O3,23794.0
8920,Tetromycin B,CC1=C[C@@]2(C)/C=C(\C)CC/C=C(\C)[C@@H]3C(C)=C[C@H]4[C@@H]([C@@H](C)CC[C@@H]4O)[C@]3(C)C(=O)C3=C(O)[C@@]2(C[C@H]1C)OC3=O,C34H46O5,23766.0
8921,Lactulose,O=C(CO)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,C12H22O11,23795.0
8922,Retinyl Palmitate,CCCCCCCCCCCCCCCC(=O)OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C,C36H60O2,23796.0
8923,Isosorbide Dinitrate,O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-],C6H8N2O8,23990.0
8924,Methyldopate,CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1,C12H17NO4,24002.0
8925,Diazinon,CCOP(=S)(OCC)Oc1cc(C)nc(C(C)C)n1,C12H21N2O3PS,23769.0
8926,Diflorasone Diacetate,CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C26H32F2O7,23808.0
8927,Lodoxamide,N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1,C11H6ClN3O6,23994.0
8928,Trientine (hydrochloride),Cl.Cl.NCCNCCNCCN,C6H20Cl2N4,24000.0
8929,NSC 23005 (sodium salt),O=C([O-])c1ccc(S(=O)(=O)NC2CCCCC2)cc1.[Na+],C13H16NNaO4S,23327.0
8930,Ropinirole (hydrochloride),CCCN(CCC)CCc1cccc2c1CC(=O)N2.Cl,C16H25ClN2O,23871.0
8931,Phenelzine (sulfate),NNCCc1ccccc1.O=S(=O)(O)O,C8H14N2O4S,23956.0
8932,Dapsone,Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1,C12H12N2O2S,23743.0
8933,Azilsartan Medoxomil,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,C30H24N4O8,23805.0
8934,Elafibranor,CSc1ccc(C(=O)/C=C/c2cc(C)c(OC(C)(C)C(=O)O)c(C)c2)cc1,C22H24O4S,23508.0
8935,Thio-TEPA,S=P(N1CC1)(N1CC1)N1CC1,C6H12N3PS,23745.0
8936,6-Mercaptopurine (hydrate),O.S=c1[nH]cnc2[nH]cnc12,C5H6N4OS,23675.0
8937,Naratriptan (hydrochloride),CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1.Cl,C17H26ClN3O2S,23754.0
8938,5-hydroxy Diclofenac,O=C(O)Cc1cc(O)ccc1Nc1c(Cl)cccc1Cl,C14H11Cl2NO3,23369.0
8939,Isoflurane,FC(F)OC(Cl)C(F)(F)F,C3H2ClF5O,23989.0
8940,Daclatasvir,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,C40H50N8O6,23730.0
8941,HX 1171,CCCCCCOc1cc(C)c(O)c(C)c1C,C15H24O2,22652.0
8942,Chlorambucil,O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1,C14H19Cl2NO2,23744.0
8943,Ethosuximide,CCC1(C)CC(=O)NC1=O,C7H11NO2,23947.0
8944,Sufentanil,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,C22H30N2O2S,15917.0
8945,Sufentanil (CRM),CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,C22H30N2O2S,23983.0
8946,Nebivolol (hydrochloride),Cl.O[C@@H](CNC[C@H](O)[C@H]1CCc2cc(F)ccc2O1)[C@@H]1CCc2cc(F)ccc2O1,C22H26ClF2NO4,23660.0
8947,EDO-S101,Cn1c(CCCCCCC(=O)NO)nc2cc(N(CCCl)CCCl)ccc21,C19H28Cl2N4O2,23328.0
8948,Hydroxyurea,NC(=O)NO,CH4N2O2,23725.0
8949,Cilengitide (trifluoroacetate salt),CC(C)[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2ccccc2)C(=O)N1C.O=C(O)C(F)(F)F,C29H41F3N8O9,22289.0
8950,Fluorometholone,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C22H29FO4,9000157.0
8951,Ergoloid (mesylates),CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC[C@H](C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O,C134H184N20O32S4,24095.0
8952,Sufentanil-d5,[2H]C([2H])([2H])C([2H])([2H])C(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,C22H30N2O2S,18571.0
8953,Sufentanil-d5 (CRM),[2H]C([2H])([2H])C([2H])([2H])C(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,C22H30N2O2S,23930.0
8954,Emedastine (fumarate),CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O,C25H34N4O9,23946.0
8955,Mefenamic Acid,Cc1cccc(Nc2ccccc2C(=O)O)c1C,C15H15NO2,23650.0
8956,Pyrazinamide,NC(=O)c1cnccn1,C5H5N3O,23416.0
8957,Olmesartan,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,C24H26N6O3,23412.0
8958,Vesnarinone,COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC,C22H25N3O4,23489.0
8959,Ethionamide,CCc1cc(C(N)=S)ccn1,C8H10N2S,23714.0
8960,Sulfanilamide,Nc1ccc(S(N)(=O)=O)cc1,C6H8N2O2S,23723.0
8961,Lesinurad,O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12,C17H14BrN3O2S,23688.0
8962,(S)-5-fluoro ADB,COC(=O)[C@@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(C)(C)C,C20H28FN3O3,23631.0
8963,(S)-5-fluoro ADB (CRM),COC(=O)[C@@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(C)(C)C,C20H28FN3O3,25012.0
8964,DAA1106,COc1ccc(OC)c(CN(C(C)=O)c2cc(F)ccc2Oc2ccccc2)c1,C23H22FNO4,23454.0
8965,Amphetamine-d6 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])(N)C([2H])([2H])c1ccccc1,C9H14ClN,22831.0
8966,AGN 193109-d7,[2H]c1c([2H])c(C([2H])([2H])[2H])c([2H])c([2H])c1C1=CCC(C)(C)c2ccc(C#Cc3ccc(C(=O)O)cc3)cc21,C28H24O2,23976.0
8967,Iohexol,CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,C19H26I3N3O9,23753.0
8968,BIA 10-2474,CN(C(=O)n1cnc(-c2ccc[n+]([O-])c2)c1)C1CCCCC1,C16H20N4O2,23157.0
8969,?'-Phenyl fentanyl,O=C(CCc1ccccc1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C28H32N2O,23858.0
8970,Pralidoxime (chloride),C[n+]1ccccc1/C=N/O.[Cl-],C7H9ClN2O,23666.0
8971,Umirolimus,CCOCCO[C@@H]1CC[C@@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)[C@@H](OC)C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)C[C@H]1OC,C55H87NO14,23585.0
8972,Dicloxacillin (sodium salt hydrate),Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)[O-].O.[Na+],C19H18Cl2N3NaO6S,23770.0
8973,RAF709,Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1,C28H29F3N4O4,23820.0
8974,Methylscopolamine (bromide),C[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12.[Br-],C18H24BrNO4,23862.0
8975,Fosphenytoin (sodium salt),O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)([O-])[O-].[Na+].[Na+],C16H13N2Na2O6P,23889.0
8976,Norhydrocodone (hydrochloride),COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)NCC[C@]314.Cl,C17H20ClNO3,15901.0
8977,Norhydrocodone (hydrochloride) (CRM),COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)NCC[C@]314.Cl,C17H20ClNO3,22661.0
8978,MGL-3196,CC(C)c1cc(Oc2c(Cl)cc(-n3nc(C#N)c(=O)[nH]c3=O)cc2Cl)n[nH]c1=O,C17H12Cl2N6O4,23845.0
8979,TMP-195,CC(C)(CNC(=O)c1cccc(-c2noc(C(F)(F)F)n2)c1)c1coc(-c2ccccc2)n1,C23H19F3N4O3,23242.0
8980,P22077,CC(=O)c1cc([N+](=O)[O-])c(Sc2ccc(F)cc2F)s1,C12H7F2NO3S2,23704.0
8981,LY2228820 (mesylate),CC(C)(C)Cn1c(N)nc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3)nc21.CS(=O)(=O)O.CS(=O)(=O)O,C26H37FN6O6S2,23259.0
8982,VHL Ligand 1 (hydrochloride),Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](N)C(C)(C)C)cc1.Cl,C22H31ClN4O3S,21591.0
8983,Lanreotide (acetate),CC(=O)O.CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccc3ccccc3c2)CSSC[C@@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC1=O,C54H69N11O10S2(C2H4O2)n,24084.0
8984,Trimethadione,CN1C(=O)OC(C)(C)C1=O,C6H9NO3,23893.0
8985,TMB 8 (hydrochloride),CCN(CC)CCCCCCCCOC(=O)c1cc(OC)c(OC)c(OC)c1.Cl,C22H38ClNO5,23928.0
8986,Tasimelteon,CCC(=O)NC[C@@H]1C[C@H]1c1cccc2c1CCO2,C15H19NO2,23546.0
8987,(+)-Menthol,CC(C)[C@H]1CC[C@H](C)C[C@@H]1O,C10H20O,23463.0
8988,Difluprednate,CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C27H34F2O7,23776.0
8989,ML-346,COc1ccc(/C=C/C=C2C(=O)NC(=O)NC2=O)cc1,C14H12N2O4,23844.0
8990,Tofogliflozin (hydrate),CCc1ccc(Cc2ccc3c(c2)[C@]2(OC3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1.O,C22H28O7,23509.0
8991,ACPT-I,N[C@@]1(C(=O)O)C[C@H](C(=O)O)[C@H](C(=O)O)C1,C8H11NO6,78010.0
8992,Amcinonide,CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,C28H35FO7,23903.0
8993,Amcasertib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2/C(=O)Nc3ccc(-c4csc(-c5ccccc5)n4)cc32)c1C,C31H33N5O2S,22980.0
8994,"L-778,123 (hydrochloride)",Cl.N#Cc1ccc(Cn2cncc2CN2CCN(c3cccc(Cl)c3)C(=O)C2)cc1,C22H21Cl2N5O,22940.0
8995,Diacetylcercosporin,COc1c(C[C@H](C)OC(C)=O)c2c3c(C[C@H](C)OC(C)=O)c(OC)c(=O)c4c(O)cc5c(c6c(cc(O)c(c1=O)c62)OCO5)c43,C33H30O12,23639.0
8996,Pamidronate (sodium salt),NCCC(O)(P(=O)([O-])O)P(=O)([O-])O.[Na+].[Na+],C3H9NNa2O7P2,23699.0
8997,trans-Petroselinic Acid,CCCCCCCCCCC/C=C/CCCCC(=O)O,C18H34O2,20026.0
8998,Mestranol,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C,C21H26O2,23822.0
8999,Cobicistat,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,C40H53N7O5S2,23433.0
9000,4-hydroxy Alternariol,Cc1cc(O)c(O)c2oc(=O)c3c(O)cc(O)cc3c12,C14H10O6,23636.0
9001,Etofenamate,O=C(OCCOCCO)c1ccccc1Nc1cccc(C(F)(F)F)c1,C18H18F3NO4,23674.0
9002,ortho-isopropyl Furanyl fentanyl (hydrochloride),CC(C)c1ccccc1N(C(=O)c1ccco1)C1CCN(CCc2ccccc2)CC1.Cl,C27H33ClN2O2,22777.0
9003,L-Arginine (hydrochloride),Cl.N=C(N)NCCC[C@H](N)C(=O)O,C6H15ClN4O2,23703.0
9004,Oxymetazoline (hydrochloride),Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1.Cl,C16H25ClN2O,23826.0
9005,Fluocinonide,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,C26H32F2O7,23803.0
9006,Theophylline,Cn1c(=O)c2nc[nH]c2n(C)c1=O,C7H8N4O2,23760.0
9007,Carbidopa (hydrate),C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O,C10H16N2O5,23783.0
9008,Mepenzolate (bromide),C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1.[Br-],C21H26BrNO3,23717.0
9009,Ethylphenethyl-FUBICA,CCC(Cc1ccccc1)NC(=O)c1cn(Cc2ccc(F)cc2)c2ccccc12,C26H25FN2O,23764.0
9010,Thiabendazole,c1ccc2[nH]c(-c3cscn3)nc2c1,C10H7N3S,23391.0
9011,Docosanol,CCCCCCCCCCCCCCCCCCCCCCO,C22H46O,23793.0
9012,Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,C11H18N2O3,20965.0
9013,Pentobarbital (CRM),CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,C11H18N2O3,20966.0
9014,Cyclopentolate (hydrochloride),CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1.Cl,C17H26ClNO3,23944.0
9015,L-Valacyclovir (hydrochloride),CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21.Cl,C13H21ClN6O4,23801.0
9016,Cyclovirobuxine D,CN[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](NC)CC[C@@]45C[C@@]35CC[C@]12C,C26H46N2O,22260.0
9017,Estropipate,C1CNCCN1.C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O,C22H32N2O5S,23806.0
9018,Erythromycin C,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,C36H65NO13,23478.0
9019,Neoantimycin,CC[C@H](C)[C@@H]1OC(=O)C(C)(C)[C@@H](O)[C@@H](Cc2ccccc2)OC(=O)[C@H](C(C)C)OC(=O)[C@@H](NC(=O)c2cccc(NC=O)c2O)[C@@H](C)OC1=O,C36H46N2O12,23645.0
9020,Alclometasone Dipropionate,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl,C28H37ClO7,23901.0
9021,Sartorypyrone A,C=C1CC[C@H](OC(C)=O)C(C)(C)[C@@H]1CC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)oc1=O,C28H40O5,23863.0
9022,Dihydroergotamine (mesylate),CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O,C34H41N5O8S,23847.0
9023,N-butyl Amphetamine (hydrochloride),CCCCNC(C)Cc1ccccc1.Cl,C13H22ClN,23547.0
9024,Peramivir,CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N,C15H28N4O4,23765.0
9025,SLM6031434,CCCCCCCCOc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1C(F)(F)F,C22H30F3N5O2,23289.0
9026,Siccanin,Cc1cc(O)c2c(c1)O[C@@]1(C)CC[C@H]3C(C)(C)CCC[C@]34CO[C@@H]2[C@H]41,C22H30O3,23654.0
9027,Carbinoxamine (maleate),CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O,C20H23ClN2O5,23937.0
9028,Edoxaban (tosylate),CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1.Cc1ccc(S(=O)(=O)O)cc1,C31H38ClN7O7S2,24030.0
9029,AGN 193109 (sodium salt),Cc1ccc(C2=CCC(C)(C)c3ccc(C#Cc4ccc(C(=O)[O-])cc4)cc32)cc1.[Na+],C28H23NaO2,23975.0
9030,Methylhomatropine (bromide),C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2.[Br-],C17H24BrNO3,23832.0
9031,Acetohexamide,CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,C15H20N2O4S,23900.0
9032,NSC 319726,C/C(=N\NC(=S)N1CCC1)c1ccccn1,C11H14N4S,23701.0
9033,4-Methylhistamine (hydrochloride),Cc1[nH]cnc1CCN.Cl.Cl,C6H13Cl2N3,23761.0
9034,Halobetasol Propionate,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C25H31ClF2O5,23781.0
9035,Fludrocortisone Acetate,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C23H31FO6,24032.0
9036,Sufentanil (citrate),CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O,C28H38N2O9S,9003093.0
9037,RU-SKI 201 (hydrochloride),CCC(C)CNCC(=O)N1CCc2sccc2C1c1cccc(C)n1.Cl.Cl,C20H29Cl2N3OS,21101.0
9038,Bifenazate,COc1ccc(-c2ccccc2)cc1NNC(=O)OC(C)C,C17H20N2O3,24147.0
9039,Brivanib,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,C19H19FN4O3,23690.0
9040,Halcinonide,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1,C24H32ClFO5,23780.0
9041,Apraclonidine (hydrochloride),Cl.Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1,C9H11Cl3N4,23904.0
9042,Droxidopa,N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1,C9H11NO5,23779.0
9043,Linaclotide,C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)NC([C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)CSSC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCC(=O)O)NC3=O)C(=O)N2,C59H79N15O21S6,24085.0
9044,Nafarelin (acetate),CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,C68H87N17O15,24070.0
9045,Naphazoline (hydrochloride),Cl.c1ccc2c(CC3=NCCN3)cccc2c1,C14H15ClN2,23774.0
9046,Propantheline (bromide),CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C.[Br-],C23H30BrNO3,23609.0
9047,Butoconazole (nitrate),Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1.O=[N+]([O-])O,C19H18Cl3N3O3S,23554.0
9048,L-Glutamine,NC(=O)CC[C@H](N)C(=O)O,C5H10N2O3,23716.0
9049,Fesoterodine (fumarate),CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1.O=C(O)/C=C/C(=O)O,C30H41NO7,23777.0
9050,TRAM-34,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1cccn1,C22H17ClN2,23385.0
9051,Cabergoline,C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,C26H37N5O2,23934.0
9052,2-Methylamphetamine (hydrochloride),Cc1ccccc1CC(C)N.Cl,C10H16ClN,24014.0
9053,Metaraminol (tartrate),C[C@H](N)[C@H](O)c1cccc(O)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C13H19NO8,23938.0
9054,Nepafenac,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N,C15H14N2O2,23700.0
9055,1-Benzyl-3-methylpiperazine,CC1CN(Cc2ccccc2)CCN1,C12H18N2,23709.0
9056,Echothiophate (iodide),CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-],C9H23INO3PS,24029.0
9057,Dehydrocyclopeptine,CN1C(=O)c2ccccc2NC(=O)/C1=C/c1ccccc1,C17H14N2O2,23638.0
9058,Acrivastine,Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1,C22H24N2O2,24021.0
9059,Doramectin monosaccharide,CO[C@H]1C[C@H](O[C@@H]2/C(C)=C/C[C@@H]3C[C@@H](C[C@]4(C=C[C@H](C)[C@@H](C5CCCCC5)O4)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC/C(=C\C=C\[C@@H]2C)[C@]43O)O[C@@H](C)[C@@H]1O,C43H62O11,23823.0
9060,Integracin A,CCC[C@H](CCCCCCCc1cc(O)cc(O)c1C(=O)O[C@H](CCC)CCCCCCCc1cc(O)cc(O)c1)OC(C)=O,C37H56O8,23423.0
9061,Roquefortine E,C=CC(C)(C)c1nc[nH]c1/C=C1/NC(=O)[C@@H]2C[C@@]3(C(C)(C)C=C)c4ccccc4N[C@H]3N2C1=O,C27H31N5O2,23648.0
9062,PD 198306,Cc1cc(I)ccc1Nc1c(C(=O)NOCC2CC2)cc(F)c(F)c1F,C18H16F3IN2O2,23966.0
9063,Fondaparinux (sodium salt),CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)[O-])[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)[O-])[C@H]3NS(=O)(=O)[O-])[C@H](O)[C@H]2OS(=O)(=O)[O-])[C@H](O)[C@H]1NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],C31H43N3Na10O49S8,24033.0
9064,Norhydrocodone-d3 (hydrochloride),Cl.[2H]C([2H])([2H])Oc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)NCC[C@]314,C17H20ClNO3,15834.0
9065,Norhydrocodone-d3 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])Oc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)NCC[C@]314,C17H20ClNO3,22662.0
9066,Ethotoin,CCN1C(=O)NC(c2ccccc2)C1=O,C11H12N2O2,24022.0
9067,?-Lipomycin,CC(/C=C/C=C/C=C/C=C/C(=O)C1=C(O)C(CCC(=O)O)N(C)C1=O)=C\C(C)C(O[C@H]1C[C@H](O)[C@H](O)[C@@H](C)O1)C(C)C,C32H45NO9,23659.0
9068,epi-Doramectin,CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C6CCCCC6)O5)O4)OC(=O)[C@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,C50H74O14,23850.0
9069,"3,4-methylenedioxy-?-methylamino-Isovalerophenone (hydrochloride)",CNC(C(=O)c1ccc2c(c1)OCO2)C(C)C.Cl,C13H18ClNO3,23711.0
9070,Sulfamethoxazole,Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,C10H11N3O3S,23613.0
9071,Tamsulosin (hydrochloride),CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1.Cl,C20H29ClN2O5S,24020.0
9072,Temazepam,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,C16H13ClN2O2,15918.0
9073,TPX-0005,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,C16H13ClN2O2,23397.0
9074,Unguisin A,CC(C)[C@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C)NC(=O)CCCNC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](C)NC1=O,C40H54N8O7,23878.0
9075,Orfamide B,CCCCCCCCCCCC(O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H]1C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CO)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H]1C,C63H112N10O17,23897.0
9076,Methenamine Hippurate,C1N2CN3CN1CN(C2)C3.O=C(O)CNC(=O)c1ccccc1,C15H21N5O3,24004.0
9077,PSB-1115 (potassium salt),CCCn1c(=O)[nH]c2nc(-c3ccc(S(=O)(=O)[O-])cc3)[nH]c2c1=O.[K+],C14H13KN4O5S,23929.0
9078,N-Desmethylflunitrazepam,O=C1CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc2N1,C15H10FN3O3,9002548.0
9079,N-Desmethylflunitrazepam (CRM),O=C1CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc2N1,C15H10FN3O3,23982.0
9080,Ivermectin B1b,CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,C47H72O14,23824.0
9081,3-hydroxy Carbofuran,CNC(=O)Oc1cccc2c1OC(C)(C)C2O,C12H15NO4,24146.0
9082,NS 11394,CC(C)(O)c1ccc2c(c1)ncn2-c1cccc(-c2ccccc2C#N)c1,C23H19N3O,23872.0
9083,Leucomycin A5,CCCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@H]2[C@H](N(C)C)[C@@H](O)[C@H](O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]3OC)O[C@@H]2C)C[C@@]1(C)O,C39H65NO14,24177.0
9084,EADB-FUBINACA,CCNC(=O)[C@@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(C)(C)C,C23H27FN4O2,23345.0
9085,Carbendazim,COC(=O)Nc1nc2ccccc2[nH]1,C9H9N3O2,23852.0
9086,"L-156,602",CC[C@H](C)C[C@H]1CC[C@](O)([C@](C)(O)C(=O)N[C@@H]2C(=O)N3NCCC[C@@H]3C(=O)N(O)[C@@H](C)C(=O)NCC(=O)N3NCCC[C@H]3C(=O)N(O)[C@H](C)C(=O)O[C@H]2C(C)C)O[C@@H]1C,C38H64N8O13,23896.0
9087,Pralatrexate,C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,C23H23N7O5,23689.0
9088,Digoxigenin Monodigitoxoside,C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3C[C@@H](O)[C@]3(C)[C@@H](C5=CC(=O)OC5)CC[C@]43O)C2)C[C@H](O)[C@@H]1O,C29H44O8,21699.0
9089,Pipequaline,c1ccc(-c2cc(CCC3CCNCC3)c3ccccc3n2)cc1,C22H24N2,23888.0
9090,Mc-Val-Cit-PABC-PNP,CC(C)[C@H](NC(=O)CCCCCN1C(=O)C=CC1=O)C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(COC(=O)Oc2ccc([N+](=O)[O-])cc2)cc1,C35H43N7O11,23881.0
9091,Epicoccamide,CC(CCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)C1=C(O)N(C)C(C)C1=O,C29H51NO9,24176.0
9092,Calpain Inhibitor VI,CC(C)C[C@@H](C=O)NC(=O)[C@@H](NS(=O)(=O)c1ccc(F)cc1)C(C)C,C17H25FN2O4S,23942.0
9093,Marimastat,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,C15H29N3O5,14869.0
9094,13C6 Glucosylsphingosine (d18:1),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO[13C@@H]1O[13C@H]([13CH2]O)[13C@@H](O)[13C@H](O)[13C@H]1O,C24H47NO7,23212.0
9095,Nodusmicin,CO[C@H]1C[C@H]2C=C[C@H]3[C@H]4O[C@]2(/C(C)=C/[C@@H](C)[C@@H]([C@@H](C)O)OC1=O)[C@@H]3[C@H](O)[C@@H](C)[C@H]4O,C23H34O7,23147.0
9096,Cannabigerorcinic Acid,CC(C)=CCC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,C18H24O4,23258.0
9097,Droxinostat,Cc1cc(Cl)ccc1OCCCC(=O)NO,C11H14ClNO3,23869.0
9098,?-methyl Acetyl fentanyl (hydrochloride),CC(=O)N(c1ccccc1)C1CCN(CC(C)c2ccccc2)CC1.Cl,C22H29ClN2O,21736.0
9099,Cyclopropyl fentanyl (citrate),O=C(C1CC1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O,C29H36N2O8,24101.0
9100,Taurohyocholic Acid (sodium salt),C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@H]2[C@@H]3[C@H](O)[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.[Na+],C26H44NNaO7S,22669.0
9101,Rolapitant,C[C@@H](OC[C@@]1(c2ccccc2)CC[C@]2(CCC(=O)N2)CN1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,C25H26F6N2O2,23906.0
9102,Argipressin (acetate),CC(=O)O.N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,C46H65N15O12S2(C2H4O2)X,24154.0
9103,N-Carbamyl-L-Glutamic Acid,NC(=O)N[C@@H](CCC(=O)O)C(=O)O,C6H10N2O5,23512.0
9104,Phanerosporic Acid,C[C@@H](O)CCCCCCCCCCCCCc1cc(O)cc(O)c1C(=O)O,C22H36O5,23879.0
9105,Cloniprazepam,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1CC1CC1,C19H16ClN3O3,23106.0
9106,Quetiapine (hemifumarate) (CRM),O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,C46H54N6O8S2,23981.0
9107,TPU-0037C,CC1=CC2C(O)CCCC2C(C)(C(=O)C2=C(O)CNC2=O)C1CCC(C)C(O)/C(C)=C/CC(O)/C=C/C(C)C(O)/C=C/CC(O)/C=C/CC(O)CC1CCCN1C(=N)N,C46H72N4O9,24179.0
9108,para-methyl Cyclopentyl fentanyl (hydrochloride),Cc1ccc(N(C(=O)C2CCCC2)C2CCN(CCc3ccccc3)CC2)cc1.Cl,C26H35ClN2O,23041.0
9109,Parvodicin Complex,CN[C@H]1C(=O)N[C@@H]2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1[C@@H](C(=O)O)NC3=O,C83H88Cl2N8O29,24036.0
9110,Calcitonin (salmon) (trifluoroacetate salt),CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O,C145H240N44O48S2,24410.0
9111,Mitragynine-d3,[2H]C([2H])([2H])Oc1cccc2[nH]c3c(c12)CCN1C[C@@H](CC)[C@@H](/C(=C\OC)C(=O)OC)C[C@@H]31,C23H30N2O4,18929.0
9112,Mitragynine-d3 (CRM),[2H]C([2H])([2H])Oc1cccc2[nH]c3c(c12)CCN1C[C@@H](CC)[C@@H](/C(=C\OC)C(=O)OC)C[C@@H]31,C23H30N2O4,18930.0
9113,CUMYL-PeGACLONE,CCCCCn1c2ccccc2c2c(=O)n(C(C)(C)c3ccccc3)ccc21,C25H28N2O,22696.0
9114,Metyrosine,C[C@@](N)(Cc1ccc(O)cc1)C(=O)O,C10H13NO3,24001.0
9115,DM1-SMCC,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCSC1CC(=O)N(CC3CCC(C(=O)ON4C(=O)CCC4=O)CC3)C1=O)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,C51H66ClN5O16S,23926.0
9116,?-Zearalanol,C[C@H]1CCC[C@H](O)CCCCCc2cc(O)cc(O)c2C(=O)O1,C18H26O5,23424.0
9117,UBP 302,N[C@@H](Cn1ccc(=O)n(Cc2ccccc2C(=O)O)c1=O)C(=O)O,C15H15N3O6,24309.0
9118,Cirazoline (hydrochloride),Cl.c1ccc(C2CC2)c(OCC2=NCCN2)c1,C13H17ClN2O,21791.0
9119,D-Glucosamine-6-sulfate,N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)COS(=O)(=O)O,C6H13NO8S,23097.0
9120,GBT-440,CC(C)n1nccc1-c1ncccc1COc1cccc(O)c1C=O,C19H19N3O3,23933.0
9121,UNC569,CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,C22H29FN6,22966.0
9122,HBX 41108,N#Cc1nc2c(nc1C#N)-c1ccc(Cl)cc1C2=O,C13H3ClN4O,23759.0
9123,Trimethobenzamide (hydrochloride),COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC.Cl,C21H29ClN2O5,24145.0
9124,Fentanyl Carbamate,CCOC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C22H28N2O2,23749.0
9125,Secobarbital-d5,[2H]C([2H])=C([2H])C([2H])([2H])C1(C(C)CCC)C(=O)NC(=O)NC1=O,C12H18N2O3,15856.0
9126,Secobarbital-d5 (CRM),[2H]C([2H])=C([2H])C([2H])([2H])C1(C(C)CCC)C(=O)NC(=O)NC1=O,C12H18N2O3,21708.0
9127,Acetyldigitoxin,CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O,C43H66O14,24024.0
9128,Delanzomib,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)c1cccc(-c2ccccc2)n1)[C@@H](C)O)B(O)O,C21H28BN3O5,23557.0
9129,Nitrofurantoin,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,C8H6N4O5,23510.0
9130,Ospemifene,OCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1,C24H23ClO2,23755.0
9131,1-(3-Methoxyphenyl)piperazine,COc1cccc(N2CCNCC2)c1,C11H16N2O,19273.0
9132,Piperazine,C1CNCCN1,C4H10N2,24019.0
9133,4-hydroxy Xylazine,Cc1cc(O)cc(C)c1NC1=NCCCS1,C12H16N2OS,22920.0
9134,4-hydroxy Xylazine (CRM),Cc1cc(O)cc(C)c1NC1=NCCCS1,C12H16N2OS,39607.0
9135,"4-Chloro-17?-hydroxy-17-methylandrost-4-ene-3,11-dione",C[C@]12CCC(=O)C(Cl)=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H27ClO3,23310.0
9136,Cannabivarin,CCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2,C19H22O2,21664.0
9137,Cannabivarin (CRM),CCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2,C19H22O2,42150.0
9138,BI-882370,CCCS(=O)(=O)Nc1ccc(F)c(-n2cc(-c3cncnc3)c3nc(N(C)C4CCN(CC)CC4)ccc32)c1F,C28H33F2N7O2S,24273.0
9139,Despropionyl ortho-Methylfentanyl,Cc1ccccc1NC1CCN(CCc2ccccc2)CC1,C20H26N2,24279.0
9140,(-)-?-Pinene,C=C1CC[C@H]2C[C@@H]1C2(C)C,C10H16,21577.0
9141,WOBE437,CCCCCCC/C=C/C=C/C(=O)NCCc1ccc(OC)c(OC)c1,C22H33NO3,23506.0
9142,SLP7111228 (hydrochloride),CCCCCCCCc1ccc(-c2noc(C[C@@H]3CCCN3C(=N)N)n2)cc1.Cl,C22H34ClN5O,23290.0
9143,Vinclozolin,C=CC1(C)OC(=O)N(c2cc(Cl)cc(Cl)c2)C1=O,C12H9Cl2NO3,23939.0
9144,Nifoxipam,O=C1Nc2ccc([N+](=O)[O-])cc2C(c2ccccc2F)=NC1O,C15H10FN3O4,9002425.0
9145,Nifoxipam (CRM),O=C1Nc2ccc([N+](=O)[O-])cc2C(c2ccccc2F)=NC1O,C15H10FN3O4,27242.0
9146,p-Cymene,Cc1ccc(C(C)C)cc1,C10H14,23159.0
9147,"Androsta-1,4-diene-3,17-dione",C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H24O2,24081.0
9148,19-Norandrosterone,C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@H]43)[C@@H]1CCC2=O,C18H28O2,22683.0
9149,"6?-Methyl-androst-4-ene-3,17-dione",C[C@H]1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)CCC(=O)C=C12,C20H28O2,18284.0
9150,"17?-Hydroxy-androstano[2,3-d]isoxazole",C[C@]12Cc3cnoc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,C20H29NO2,17928.0
9151,19-Noretiocholanolone,C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@H](O)CC[C@@H]43)[C@@H]1CCC2=O,C18H28O2,22684.0
9152,Chlortetracycline,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12,C22H23ClN2O8,23302.0
9153,Fluoxymesterone,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C20H29FO3,24082.0
9154,1-(4-Chlorophenyl)piperazine,Clc1ccc(N2CCNCC2)cc1,C10H13ClN2,14481.0
9155,AZEFUBIM,O=C(c1cn(Cc2ccc(F)cc2)c2ccccc12)N1CCC1,C19H17FN2O,23653.0
9156,LDC-4297,CC(C)c1cnn2c(NCc3ccccc3-n3cccn3)nc(OC3CCCNC3)nc12,C23H28N8O,23398.0
9157,GDC-0326,CC(C)n1ncnc1-c1cn2c(n1)-c1ccc(O[C@@H](C)C(N)=O)cc1OCC2,C19H22N6O3,19241.0
9158,Resistoflavine,Cc1cc(O)c2c3c1C(=O)C=C1C(C)(C)C(=O)c4c(O)cc(O)c(c4C13O)C2=O,C22H16O7,24178.0
9159,Bacillosporin C,Cc1cc(O)c2c3c1C(=O)C[C@]1(O)Oc4c(c(O)c5c6c(c(O)cc(C)c46)C(=O)OC5)[C@]31COC2=O,C26H18O10,23877.0
9160,"L-826,266",COc1ccc(Br)cc1S(=O)(=O)NC(=O)/C=C/c1cc(Cl)ccc1Cc1ccc2ccccc2c1,C27H21BrClNO4S,18538.0
9161,MEP-FUBINACA,CCC[C@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(=O)OC,C21H22FN3O3,21654.0
9162,Glycohyocholic Acid,C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C26H43NO6,22670.0
9163,"4(Z),7(Z)-Decadienoic Acid",CC/C=C\C/C=C\CCC(=O)O,C10H16O2,23516.0
9164,Calcitriol-d6,[2H]C([2H])([2H])C(O)(CCC[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3/C[C@@H](O)C[C@H](O)C3=C)CCC[C@]12C)C([2H])([2H])[2H],C27H44O3,22179.0
9165,TRAP-6 Peptide,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O,C34H56N10O9,24125.0
9166,BLU-285,Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1,C26H27FN10,22985.0
9167,C17 3'-sulfo Galactosylceramide (d18:1/17:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(=O)(=O)O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCC,C41H79NO11S,24348.0
9168,Herbicidin A,C/C=C(\CO)C(=O)O[C@H]1[C@H](O)[C@@H](C(=O)OC)O[C@@H]2C[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OC)[C@H]3O[C@]21O,C23H29N5O11,23485.0
9169,C15 D-erythro Ceramide (d18:1/15:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCC,C33H65NO3,24393.0
9170,Vercirnon,CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1,C22H21ClN2O4S,23131.0
9171,C2 L-erythro Ceramide (d18:1/2:0),CCCCCCCCCCCCC/C=C/[C@H](O)[C@@H](CO)NC(C)=O,C20H39NO3,24387.0
9172,Gabexate (mesylate),CCOC(=O)c1ccc(OC(=O)CCCCCNC(=N)N)cc1.CS(=O)(=O)O,C17H27N3O7S,23767.0
9173,Metandienone,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H28O2,21172.0
9174,Pyridostigmine (bromide),CN(C)C(=O)Oc1ccc[n+](C)c1.[Br-],C9H13BrN2O2,23831.0
9175,Didanosine,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,C10H12N4O3,23715.0
9176,"N1,N8-Diacetylspermidine (hydrochloride)",CC(=O)NCCCCNCCCNC(C)=O.Cl,C11H24ClN3O2,21588.0
9177,C6 L-erythro Ceramide (d18:1/6:0),CCCCCCCCCCCCC/C=C/[C@H](O)[C@@H](CO)NC(=O)CCCCC,C24H47NO3,24388.0
9178,Polmacoxib,CC1(C)OC(c2ccc(S(N)(=O)=O)cc2)=C(c2cccc(F)c2)C1=O,C18H16FNO4S,17509.0
9179,KRIBB3,CCc1cc(-c2oncc2-c2ccc(OC)cc2)c(O)cc1OC,C19H19NO4,23973.0
9180,Tetradecyltrimethylammonium (bromide),CCCCCCCCCCCCCC[N+](C)(C)C.[Br-],C17H38BrN,23248.0
9181,Cilastatin,CC1(C)C[C@@H]1C(=O)N/C(=C\CCCCSC[C@H](N)C(=O)O)C(=O)O,C16H26N2O5S,23511.0
9182,Permethrin,CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1,C21H20Cl2O3,23821.0
9183,Permethrin (CRM),CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1,C21H20Cl2O3,39355.0
9184,TCS 2210,O=C(NO)c1ccc2[nH]c(=O)c(CCCc3ccccc3)nc2c1,C18H17N3O3,16142.0
9185,Epiblastin A,Nc1nc(N)c2nc(-c3cccc(Cl)c3)c(N)nc2n1,C12H10ClN7,22758.0
9186,Clofibric Acid,CC(C)(Oc1ccc(Cl)cc1)C(=O)O,C10H11ClO3,21608.0
9187,Ambrisentan,COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O,C22H22N2O4,23669.0
9188,Acamprosate (calcium salt),CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2],C10H20CaN2O8S2,23899.0
9189,Bromfenac (sodium salt),Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.[Na+],C15H11BrNNaO3,23763.0
9190,PKSI-527,Cl.NC[C@H]1CC[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)Nc2ccc(CC(=O)O)cc2)CC1,C25H32ClN3O4,23974.0
9191,Zibotentan,COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(-c2nnco2)cc1,C19H16N6O4S,23702.0
9192,Cortisone Acetate,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C,C23H30O6,23798.0
9193,Tedizolid Phosphate,Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](COP(=O)(O)O)OC4=O)cc3F)cn2)n1,C17H16FN6O6P,23729.0
9194,Ulipristal Acetate,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,C30H37NO4,23657.0
9195,Fenoprofen (calcium salt hydrate),CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.O.O.[Ca+2],C30H30CaO8,23835.0
9196,HNMPA-(AM)3,CC(=O)OCOC(c1ccc2ccccc2c1)P(=O)(OCOC(C)=O)OCOC(C)=O,C20H23O10P,23245.0
9197,4-acetoxy DPT (acetate),CC(=O)O.CCCN(CCC)CCc1c[nH]c2cccc(OC(C)=O)c12,C20H30N2O4,23541.0
9198,Leukotriene B5,CC/C=C\C/C=C\CC(O)/C=C/C=C/C=C\C(O)CCCC(=O)O,C20H30O4,21110.0
9199,7-keto Dehydroepiandrosterone,C[C@]12CC[C@H](O)CC1=CC(=O)[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H26O3,22497.0
9200,N-methyl U-47931E,CN(C)[C@@H]1CCCC[C@H]1N(C)C(=O)c1ccc(Br)cc1,C16H23BrN2O,24286.0
9201,Isopropyl U-47700,CC(C)N(C(=O)c1ccc(Cl)c(Cl)c1)[C@@H]1CCCC[C@H]1N(C)C,C18H26Cl2N2O,24263.0
9202,5-Hydroxymethyl-2-furancarboxylic Acid,O=C(O)c1ccc(CO)o1,C6H6O4,22999.0
9203,Ziconotide (trifluoroacetate salt),O=C(O)C(F)(F)F.[H]N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N3)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC2=O,C104H173F3N36O34S7,23913.0
9204,N-Benzyl phenyl norfentanyl (hydrochloride),Cl.O=C(c1ccccc1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1,C25H27ClN2O,24249.0
9205,Lindane,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl,C6H6Cl6,23952.0
9206,Procainamide (hydrochloride),CCN(CC)CCNC(=O)c1ccc(N)cc1.Cl,C13H22ClN3O,24359.0
9207,HKI 357,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,C31H29ClFN5O3,14847.0
9208,Cyclopropyl norfentanyl (hydrochloride),Cl.O=C(C1CC1)N(c1ccccc1)C1CCNCC1,C15H21ClN2O,24061.0
9209,MMP-2/MMP-9 Inhibitor II,O=C(NO)[C@@H](Cc1ccccc1)NS(=O)(=O)c1ccc(-c2ccccc2)cc1,C21H20N2O4S,24314.0
9210,Marcfortine A,CN1C(=O)[C@@]23CCCCN2C[C@@]12C[C@@]1(C(=O)Nc4c1ccc1c4OC=CC(C)(C)O1)C(C)(C)C2C3,C28H35N3O4,23486.0
9211,C12 3'-sulfo Galactosylceramide (d18:1/12:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(=O)(=O)O)[C@H]1O)NC(=O)CCCCCCCCCCC,C36H69NO11S,24349.0
9212,C6 D-threo Ceramide (d18:1/6:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](CO)NC(=O)CCCCC,C24H47NO3,24389.0
9213,Penicillin V (potassium salt),CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[K+],C16H17KN2O5S,23635.0
9214,C18 L-threo Ceramide (d18:1/18:0),CCCCCCCCCCCCC/C=C/[C@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCC,C36H71NO3,24399.0
9215,Sodium 4-Phenylbutyrate-d11,[2H]c1c([2H])c([2H])c(C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)[O-])c([2H])c1[2H].[Na+],C10H11NaO2,22085.0
9216,TAK-901,CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1,C28H32N4O3S,23772.0
9217,C18 Sphingomyelin (d18:1/18:0),CCCCCCCCCCCCC/C=C/C(O)C(COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCCCC,C41H83N2O6P,24355.0
9218,C18:1 Ceramide (d18:1/18:1(9Z)),CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCC,C36H69NO3,24397.0
9219,C6 dihydro Ceramide (d18:0/6:0),CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=O)CCCCC,C24H49NO3,24368.0
9220,7-Aminoclonazepam (CRM),Nc1ccc2c(c1)C(c1ccccc1Cl)=NCC(=O)N2,C15H12ClN3O,20225.0
9221,Hexaminolevulinate (hydrochloride),CCCCCCOC(=O)CCC(=O)CN.Cl,C11H22ClNO3,23949.0
9222,Substance P (trifluoroacetate salt),CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(N)=O.O=C(O)C(F)(F)F,C65H99F3N18O15S,24035.0
9223,6?-Hydroxymetandienone,C[C@]12C=CC(=O)C=C1[C@H](O)C[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H28O3,24077.0
9224,Streptomycin (sulfate),CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(=N)N)[C@@H](O)[C@@H]3NC(=N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O,C21H45N7O24S3,21211.0
9225,N-methyl Cyclopropyl norfentanyl (hydrochloride),CN1CCC(N(C(=O)C2CC2)c2ccccc2)CC1.Cl,C16H23ClN2O,24278.0
9226,C8 Galactosylceramide (d18:1/8:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCCC,C32H61NO8,24346.0
9227,GSK3? Inhibitor XI,O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1,C18H15N5O3,23940.0
9228,C8 dihydro Ceramide (d18:0/8:0),CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=O)CCCCCCC,C26H53NO3,24358.0
9229,C30 Ceramide (d18:1/30:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCC,C48H95NO3,24400.0
9230,N-Methylethylone (hydrochloride),CCN(C)C(C)C(=O)c1ccc2c(c1)OCO2.Cl,C13H18ClNO3,23710.0
9231,IDH305,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,C23H22F4N6O2,24107.0
9232,Arcyriaflavin A,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21,C20H11N3O2,13516.0
9233,Zotepine,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,C18H18ClNOS,23909.0
9234,Dichlorvos,COP(=O)(OC)OC=C(Cl)Cl,C4H7Cl2O4P,23727.0
9235,C12 NBD L-threo dihydro Ceramide (d18:0/12:0),CCCCCCCCCCCCCCC[C@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12,C36H63N5O6,24441.0
9236,C2 Adamantanyl Galactosylceramide (d18:1/2:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CC12CC3CC(CC(C3)C1)C2,C36H63NO8,24472.0
9237,Oritavancin (phosphate),CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O.O=P(O)(O)O.O=P(O)(O)O,C86H103Cl3N10O34P2,24091.0
9238,(R)-Cetirizine (hydrochloride),Cl.Cl.O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1,C21H27Cl3N2O3,23992.0
9239,Methocarbamol,COc1ccccc1OCC(O)COC(N)=O,C11H15NO5,23870.0
9240,MK-0974,O=C(N[C@@H]1CC[C@@H](c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c(=O)[nH]c3ncccc32)CC1,C26H27F5N6O3,23960.0
9241,?-Humulene,C/C1=C\CC/C(C)=C/CC(C)(C)/C=C/C1,C15H24,21574.0
9242,Thiothixene,CN1CCN(CC/C=C2\c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,C23H29N3O2S2,23649.0
9243,Prilocaine (hydrochloride),CCCNC(C)C(=O)Nc1ccccc1C.Cl,C13H21ClN2O,24360.0
9244,Agmatine (sulfate),N=C(N)NCCCCN.O=S(=O)(O)O,C5H16N4O4S,23513.0
9245,Benzonatate,CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1,C30H53NO11,23936.0
9246,NSC 185058,S=C(Nc1ccccn1)c1ccccn1,C11H9N3S,23957.0
9247,Trazodone-d6 (hydrochloride) (CRM),Cl.[2H]C([2H])(N1CCN(c2cccc(Cl)c2)CC1)C([2H])([2H])C([2H])([2H])n1nc2ccccn2c1=O,C19H23Cl2N5O,19052.0
9248,Elbasvir,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc3c(c2)O[C@@H](c2ccccc2)n2c-3cc3cc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)ccc32)[nH]1)C(C)C,C49H55N9O7,24031.0
9249,3-Methylcrotonyl Glycine,CC(C)=CC(=O)NCC(=O)O,C7H11NO3,22888.0
9250,Phorbol,CC1=C[C@H]2[C@@]3(O)[C@H](C)[C@@H](O)[C@]4(O)[C@H]([C@@H]3C=C(CO)C[C@]2(O)C1=O)C4(C)C,C20H28O6,24479.0
9251,KR-32568,Cc1ccc(F)cc1-c1ccc(C(=O)NC(=N)N)o1,C13H12FN3O2,23968.0
9252,Atrial Natriuretic Peptide (1-28) (human) (trifluoroacetate salt),CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O.O=C(O)C(F)(F)F,C129H204F3N45O41S3,24539.0
9253,Phenytoin,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,C15H12N2O2,24037.0
9254,3-hydroxy Flunitrazepam,CN1C(=O)C(O)N=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,C16H12FN3O4,9002549.0
9255,Ghrelin (rat) (trifluoroacetate salt),CCCCCCCC(=O)OC[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,C147H245N45O42,24458.0
9256,"1,2,3-Trimyristoyl Glycerol",CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC,C45H86O6,23337.0
9257,Gastrin I (human),CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,C97H124N20O31S,24457.0
9258,Mca-DEVDAP-K(Dnp)-OH,COc1ccc2c(CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCNc3ccc([N+](=O)[O-])cc3[N+](=O)[O-])C(=O)O)C(C)C)cc(=O)oc2c1,C50H62N10O22,24563.0
9259,Ac-DNLD-AMC,CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)Nc1ccc2c(C)cc(=O)oc2c1,C30H38N6O12,24566.0
9260,Acetohydroxamic Acid,CC(=O)NO,C2H5NO2,23979.0
9261,C8 L-threo Ceramide (d18:1/8:0),CCCCCCCCCCCCC/C=C/[C@H](O)[C@H](CO)NC(=O)CCCCCCC,C26H51NO3,24392.0
9262,Venlafaxine-d6 (hydrochloride),Cl.[2H]C([2H])([2H])N(CC(c1ccc(OC)cc1)C1(O)CCCCC1)C([2H])([2H])[2H],C17H28ClNO2,15863.0
9263,Venlafaxine-d6 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])N(CC(c1ccc(OC)cc1)C1(O)CCCCC1)C([2H])([2H])[2H],C17H28ClNO2,25525.0
9264,Hydralazine (hydrochloride),Cl.N/N=c1\[nH]ncc2ccccc12,C8H9ClN4,23121.0
9265,XMD16-5,CN1c2ccccc2C(=O)Nc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21,C23H24N6O2,23353.0
9266,ITD 1,CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1,C27H29NO3,23326.0
9267,BD 1063 (hydrochloride),CN1CCN(CCc2ccc(Cl)c(Cl)c2)CC1.Cl.Cl,C13H20Cl4N2,23874.0
9268,Mca-YVADAP-K(Dnp)-OH (trifluoroacetate salt),COc1ccc2c(CC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCNc3ccc([N+](=O)[O-])cc3[N+](=O)[O-])C(=O)O)C(C)C)cc(=O)oc2c1.O=C(O)C(F)(F)F,C55H65F3N10O21,24562.0
9269,C17 dihydro Ceramide (d18:0/17:0),CCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC,C35H71NO3,24427.0
9270,Galactosylceramide (bovine spinal cord),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)C(O)CCCCCCCCCCCCCCCCCCCCCC,C48H93NO9,24322.0
9271,C6 NBD Sphingomyelin (d18:1/6:0),CCCCCCCCCCCCC/C=C/C(O)C(COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCNc1ccc([N+](=O)[O-])c2nonc12,C35H61N6O9P,24328.0
9272,C18 Ceramide-1-phosphate-d3 (d18:1/18:0-d3),[2H]C([2H])([2H])CCCCCCCCCCCCCCCCC(=O)N[C@@H](COP(=O)(O)O)[C@H](O)/C=C/CCCCCCCCCCCCC,C36H72NO6P,24464.0
9273,Oxindole,O=C1Cc2ccccc2N1,C8H7NO,23851.0
9274,Deoxyviolacein,O=C1NC(c2c[nH]c3ccccc23)=C/C1=C1\C(=O)Nc2ccccc21,C20H13N3O2,23477.0
9275,Erythromycin A N-oxide,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H]([N+](C)(C)[O-])[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,C37H67NO14,23642.0
9276,Fumiquinazoline D,C[C@@H]1N[C@H]2N(C1=O)c1ccccc1[C@]21C[C@@H]2C(=O)N[C@](C)(O1)c1nc3ccccc3c(=O)n12,C24H21N5O4,23848.0
9277,Dipivefrin (hydrochloride),CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1.Cl,C19H30ClNO5,24028.0
9278,Sphingosine (d14:1),CCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO,C14H29NO2,24373.0
9279,EOS-d9 (d18:1-d9/32:0/18:2),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C68H129NO5,24423.0
9280,Sulfadiazine,Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,C10H10N4O2S,23719.0
9281,Flunitrazepam,CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,C16H12FN3O3,16188.0
9282,Saccharocarcin B,CCCC1C=CC2/C=C(\C)C(OC3CC(C)(O)C(NC(C)=O)C(C)O3)C(C)/C=C(/C)C3C=CC4C(OC5CC(O)C(OC6CC(OC7CCC(O)C(C)O7)C(OC7CC(O)C(O)C(C)O7)C(C)O6)C(C)O5)C(C)CC(C)C4C3(C)C(=O)C3=C(O)C2(C1)OC3=O,C68H103NO20,23861.0
9283,Z-DEVD-AFC,CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1,C36H38F3N5O14,24564.0
9284,C2 Sphingomyelin (d18:1/2:0),CCCCCCCCCCCCC/C=C/C(O)C(COP(=O)([O-])OCC[N+](C)(C)C)NC(C)=O,C25H51N2O6P,24353.0
9285,Fenethylline (hydrochloride),CC(Cc1ccccc1)NCCn1cnc2c1c(=O)n(C)c(=O)n2C.Cl,C18H24ClN5O2,14146.0
9286,Fenethylline (hydrochloride) (CRM),CC(Cc1ccccc1)NCCn1cnc2c1c(=O)n(C)c(=O)n2C.Cl,C18H24ClN5O2,40336.0
9287,3-fluoro-?-Pyrrolidinopentiophenone (hydrochloride),CCCC(C(=O)c1cccc(F)c1)N1CCCC1.Cl,C15H21ClFNO,24496.0
9288,Emamectin B1a,CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@H](NC)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C49H75NO13,24060.0
9289,Oxtriphylline,C[N+](C)(C)CCO.Cn1c(=O)c2nc[n-]c2n(C)c1=O,C12H21N5O3,24006.0
9290,1-Benzyl-2-methylpiperazine (hydrochloride),CC1CNCCN1Cc1ccccc1.Cl.Cl,C12H20Cl2N2,23708.0
9291,?-Terpinene,CC1=CCC(C(C)C)=CC1,C10H16,23722.0
9292,Avobenzone,COc1ccc(C(=O)CC(=O)c2ccc(C(C)(C)C)cc2)cc1,C20H22O3,23836.0
9293,Sevoflurane,FCOC(C(F)(F)F)C(F)(F)F,C4H3F7O,23996.0
9294,Thyrotropin-Releasing Hormone,NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1,C16H22N6O4,22917.0
9295,MKC-3946,CN1CCN(C(=O)c2ccc(-c3ccc4c(C=O)c(O)ccc4c3)s2)CC1,C21H20N2O3S,19152.0
9296,GDC-0349,CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOC[C@@H]4C)n2)CCN(C2COC2)C3)cc1,C24H32N6O3,24058.0
9297,Milnacipran (hydrochloride),CCN(CC)C(=O)[C@]1(c2ccccc2)C[C@@H]1CN.Cl,C15H23ClN2O,23837.0
9298,C18 dihydro Ceramide-d3 (d18:0/18:0-d3),[2H]C([2H])([2H])CCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC,C36H73NO3,24428.0
9299,C12 Galactosylceramide (d18:1/12:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCC,C36H69NO8,24347.0
9300,PF-04447943,C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc(=O)c2cnn(C3CCOCC3)c2[nH]1,C20H25N7O2,24299.0
9301,TAS 102,Cl.N=C1CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl.O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F,C19H23Cl2F3N6O7,23932.0
9302,Bendamustine (hydrochloride),Cl.Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21,C16H22Cl3N3O2,23693.0
9303,LDN-192960 (hydrochloride),COc1ccc2nc3ccc(OC)cc3c(SCCCN)c2c1.Cl.Cl,C18H22Cl2N2O2S,19089.0
9304,C18 Ceramide-d3 (d18:1/18:0-d3),[2H]C([2H])([2H])CCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCC,C36H71NO3,24396.0
9305,MK-7655,O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O,C12H20N4O6S,23890.0
9306,SPHINX31,O=C(Nc1cc(C(F)(F)F)ccc1N1CCN(Cc2ccccn2)CC1)c1ccc(-c2ccncc2)o1,C27H24F3N5O2,21582.0
9307,SHU9119 (trifluoroacetate salt),CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O.O=C(O)C(F)(F)F,C56H72F3N15O11,24152.0
9308,Isoforskolin,C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](OC(C)=O)[C@H](O)[C@@]2(C)O1,C22H34O7,11716.0
9309,?-Hydroxythioacetylfentanyl,CC(=O)N(c1ccccc1)C1CCN(CC(O)c2cccs2)CC1,C19H24N2O2S,24280.0
9310,C6 L-threo Ceramide (d18:1/6:0),CCCCCCCCCCCCC/C=C/[C@H](O)[C@H](CO)NC(=O)CCCCC,C24H47NO3,24390.0
9311,Dicyclomine (hydrochloride),CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1.Cl,C19H36ClNO2,23867.0
9312,SKA-121,Cc1cc2nc(N)oc2c2ccccc12,C12H10N2O,9003088.0
9313,7-oxo Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O,C28H24N4O4,23346.0
9314,C16 dihydro Ceramide (d18:0/16:0),CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC,C34H69NO3,24369.0
9315,CAY10726,O=C(O)CCCCCCCCCCCCCCCNC(=O)Nc1ccc(Cl)c(C(F)(F)F)c1,C24H36ClF3N2O3,23859.0
9316,2?-methyl Androsterone,C[C@@H]1C[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]32)C[C@@H]1O,C20H32O2,23087.0
9317,Myclobutanil,CCCCC(C#N)(Cn1cncn1)c1ccc(Cl)cc1,C15H17ClN4,24100.0
9318,Citromycetin,Cc1cc(=O)c2c(o1)-c1c(cc(O)c(O)c1C(=O)O)OC2,C14H10O7,24175.0
9319,1-(3-Methylbenzyl)piperazine,Cc1cccc(CN2CCNCC2)c1,C12H18N2,24018.0
9320,Norcodeine,COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)NCC[C@@]341,C17H19NO3,23816.0
9321,meta-methyl Acetyl fentanyl (hydrochloride),CC(=O)N(c1cccc(C)c1)C1CCN(CCc2ccccc2)CC1.Cl,C22H29ClN2O,23997.0
9322,Sporidesmolide I,CC(C)NCC(COc1cccc2ccccc12)O[C@@H]1O[C@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O.[Na+],C22H28NNaO8,23882.0
9323,PF-4693627,O=C(N[C@H]1CCC[C@H](CO)C1)C1CCN(c2nc3cc(Cl)c(-c4ccc(Cl)cc4)cc3o2)CC1,C26H29Cl2N3O3,22768.0
9324,Alvimopan,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1,C25H32N2O4,23902.0
9325,Bisoprolol (hemifumarate),CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.O=C(O)/C=C/C(=O)O,C22H35NO8,23827.0
9326,ND-630,COc1ccccc1[C@H](Cn1c(=O)n(C(C)(C)C(=O)O)c(=O)c2c(C)c(-c3ncco3)sc21)OC1CCOCC1,C28H31N3O8S,23961.0
9327,3-keto Sphinganine (d6:0) (hydrochloride),CCCC(=O)C(N)CO.Cl,C6H14ClNO2,24381.0
9328,Chartreusin,CO[C@H]1[C@@H](O)[C@@H](C)O[C@H](O[C@H]2[C@H](Oc3cccc4c(O)c5c(=O)oc6ccc(C)c7c(=O)oc(c34)c5c67)O[C@H](C)[C@H](O)[C@@H]2O)[C@@H]1O,C32H32O14,23773.0
9329,Carteolol (hydrochloride),CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2.Cl,C16H25ClN2O3,23758.0
9330,INDY,CCN1/C(=C/C(C)=O)Sc2ccc(O)cc21,C12H13NO2S,23895.0
9331,C17 Lactosylceramide (d18:1/17:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCC,C47H89NO13,24356.0
9332,Phosphatidylcholines (egg),CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC,C44H84NO8P,24343.0
9333,C32 Ceramide (d18:1/32:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,C50H99NO3,24424.0
9334,Goserelin (acetate),CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,C61H88N18O16,24071.0
9335,Famotidine,N=C(N)Nc1nc(CSCCC(=N)NS(N)(=O)=O)cs1,C8H15N7O2S3,23828.0
9336,Mafenide,NCc1ccc(S(N)(=O)=O)cc1,C7H10N2O2S,23995.0
9337,"CP 101,606",C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1,C20H25NO3,23884.0
9338,Famciclovir,CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O,C14H19N5O4,23834.0
9339,Sphingosine-d9 (d18:1),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO,C18H37NO2,24371.0
9340,Sulconazole (nitrate),Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1.O=[N+]([O-])O,C18H16Cl3N3O3S,23800.0
9341,PCTR3,CC/C=C\C[C@H](O)[C@@H](/C=C/C=C/C=C\C/C=C\C/C=C\CCC(=O)O)SC[C@H](N)C(=O)O,C25H37NO5S,19066.0
9342,Ac-IETD-pNA,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)Nc1ccc([N+](=O)[O-])cc1)[C@@H](C)O,C27H38N6O12,24568.0
9343,Cefepime (hydrochloride hydrate),CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1.Cl.O.[Cl-],C19H28Cl2N6O6S2,23633.0
9344,2-hydroxy Myristic Acid methyl ester,CCCCCCCCCCCCC(O)C(=O)OC,C15H30O3,24588.0
9345,C6 NBD L-threo Ceramide (d18:1/6:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](CO)NC(=O)CCCCCNc1ccc([N+](=O)[O-])c2nonc12,C30H49N5O6,24439.0
9346,.beta.-Defensin-4 (human) (trifluoroacetate salt),O=C(O)C(F)(F)F.[H]N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](C)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)NC2=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N3)[C@@H](C)CC,C182H296F3N63O54S6,24579.0
9347,Mca-PLAC(p-OMeBz)-WAR(Dpa)-NH2 (trifluoroacetate salt),COc1ccc(CSC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)Cc2cc(=O)oc3cc(OC)ccc23)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])C(N)=O)cc1.O=C(O)C(F)(F)F,C68H83F3N16O19S,24703.0
9348,L-erythro Sphinganine (d18:0),CCCCCCCCCCCCCCC[C@H](O)[C@H](N)CO,C18H39NO2,24374.0
9349,DL-erythro/threo Sphinganine (d18:0),CCCCCCCCCCCCCCC[C@H](O)[C@H](N)CO,C18H39NO2,24367.0
9350,Histrelin (acetate),CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1cn(Cc2ccccc2)cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1,C66H86N18O12(C2H4O2)n,23663.0
9351,(-)-Borneol,CC1(C)[C@H]2CC[C@]1(C)[C@H](O)C2,C10H18O,23468.0
9352,Marbofloxacin,CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2OCN4C)CC1,C17H19FN4O4,24174.0
9353,3-Aminopropylphosphonic Acid,NCCCP(=O)(O)O,C3H10NO3P,23556.0
9354,Cellocidin,NC(=O)C#CC(N)=O,C4H4N2O2,23637.0
9355,1-Testosterone,C[C@]12C=CC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,C19H28O2,24079.0
9356,Mca-P-Cha-G-Nva-HA-Dap(Dnp)-NH2 (trifluoroacetate salt),CCC[C@H](NC(=O)CNC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H]1CCCN1C(=O)Cc1cc(=O)oc2cc(OC)ccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CNc1ccc([N+](=O)[O-])cc1[N+](=O)[O-])C(N)=O.O=C(O)C(F)(F)F,C53H66F3N13O17,24702.0
9357,4-chloro-.alpha.-Pyrrolidinohexanophenone (hydrochloride),CCCCC(C(=O)c1ccc(Cl)cc1)N1CCCC1.Cl,C16H23Cl2NO,22490.0
9358,Lalistat 1,O=C(Oc1nsnc1N1CCCCC1)N1CCOCC1,C12H18N4O3S,23891.0
9359,MMP-2/MMP-9 Inhibitor III,CC(C)C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)O)NC1=O.O=C(O)C(F)(F)F,C54H72F3N13O16S2,24697.0
9360,ML RR-S2 CDA (ammonium salt),Nc1ncnc2c1ncn2C1OC2COP(=O)([S-])OC3C(O)C(COP(=O)([S-])OC2C1O)OC3n1cnc2c(N)ncnc21.[NH4+].[NH4+],C20H30N12O10P2S2,24106.0
9361,Tyr-?-CGRP (human) (trifluoroacetate salt),CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C.O=C(O)C(F)(F)F,C174H277F3N52O53S2,24724.0
9362,PCTR2,CC/C=C\C[C@H](O)[C@@H](/C=C/C=C/C=C\C/C=C\C/C=C\CCC(=O)O)SC[C@H](N)C(=O)NCC(=O)O,C27H40N2O6S,19065.0
9363,"S-(2,4-Dinitrophenyl)-Glutathione",N[C@@H](CCC(=O)N[C@@H](CSc1ccc([N+](=O)[O-])cc1[N+](=O)[O-])C(=O)NCC(=O)O)C(=O)O,C16H19N5O10S,24660.0
9364,Atovaquone,O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21,C22H19ClO3,23802.0
9365,Delavirdine (mesylate),CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1.CS(=O)(=O)O,C23H32N6O6S2,24026.0
9366,RI-1,O=C1C(Cl)=C(N2CCOCC2)C(=O)N1c1ccc(Cl)c(Cl)c1,C14H11Cl3N2O3,24182.0
9367,(+)-3-Carene,CC1=CC[C@@H]2[C@H](C1)C2(C)C,C10H16,23165.0
9368,Norbuprenorphine (CRM),CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1)[C@H]2O5,C25H35NO4,20127.0
9369,Norbuprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1)[C@H]2O5,C25H35NO4,15897.0
9370,Tolazamide,Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1,C14H21N3O3S,23545.0
9371,Brevianamide F,O=C1N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N2CCC[C@@H]12,C16H17N3O2,23493.0
9372,Neostigmine (methyl sulfate),CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.COS(=O)(=O)[O-],C13H22N2O6S,23501.0
9373,(R)-Salbutamol (hydrochloride),CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.Cl,C13H22ClNO3,23991.0
9374,C18 dihydro Ceramide (d18:0/18:0),CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC,C36H73NO3,24379.0
9375,Lipoxin B4 methyl ester,CCCCC[C@H](O)[C@H](O)/C=C/C=C/C=C\C=C\[C@@H](O)CCCC(=O)OC,C21H34O5,24073.0
9376,Gonadorelin (acetate),CC(=O)O.CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,C55H75N17O13(C2H4O2)n,24240.0
9377,?-Defensin-2 (human) (trifluoroacetate salt),CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)NC2=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N3)[C@@H](C)O)C(C)C.O=C(O)C(F)(F)F,C190H306F3N55O52S6,24577.0
9378,Desoximetasone,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO,C22H29FO4,23945.0
9379,Degarelix (acetate),CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O.CC(=O)O,C84H107ClN18O18,24069.0
9380,LY320135,COc1ccc(-c2oc3cc(OC)ccc3c2C(=O)c2ccc(C#N)cc2)cc1,C24H17NO4,11738.0
9381,Hydroxyprogesterone Caproate,CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,C27H40O4,23978.0
9382,Oxyphenonium (bromide),CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1.[Br-],C21H34BrNO3,23880.0
9383,Cariprazine (hydrochloride),CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1.Cl,C21H33Cl3N4O,24025.0
9384,Hydroxyzine,OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,C21H27ClN2O2,24039.0
9385,Quinine,C=C[C@H]1C[N@]2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,C20H24N2O2,23958.0
9386,Ombitasvir,COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc([C@@H]2CC[C@@H](c3ccc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C,C50H67N7O8,24116.0
9387,Fadrozole (hydrochloride),Cl.N#Cc1ccc(C2CCCc3cncn32)cc1,C14H14ClN3,24272.0
9388,Obestatin (human),CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C,C116H176N32O33,24552.0
9389,Azelaic Acid,O=C(O)CCCCCCCC(=O)O,C9H16O4,23977.0
9390,Columbin,C[C@@]12C[C@@H](c3ccoc3)OC(=O)[C@@H]1CC[C@]1(C)[C@H]2[C@H]2C=C[C@]1(O)C(=O)O2,C20H22O6,24105.0
9391,Neuropeptide FF (trifluoroacetate salt),CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O.O=C(O)C(F)(F)F,C56H77F3N14O12,24548.0
9392,NSC 668036,CC(NC(=O)C(OC(=O)C(C)NC(=O)OC(C)(C)C)C(C)C)C(=O)OC(C(=O)O)C(C)C,C21H36N2O9,23499.0
9393,3-Formylsalicylic Acid,O=Cc1cccc(C(=O)O)c1O,C8H6O4,23368.0
9394,Cortistatin-29 (rat) (trifluoroacetate salt),CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O.O=C(O)C(F)(F)F,C163H241F3N46O43S2,24740.0
9395,Urocortin II (human) (trifluoroacetate salt),CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CS)C(N)=O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C.O=C(O)C(F)(F)F,C196H340F3N63O56S,24746.0
9396,Urocortin (rat) (trifluoroacetate salt),CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O.O=C(O)C(F)(F)F,C208H339F3N62O66,24745.0
9397,Levonordefrin,C[C@H](N)[C@H](O)c1ccc(O)c(O)c1,C9H13NO3,23993.0
9398,Lorediplon,CC(=O)N(C)c1cc(-c2ccnc3c(C(=O)c4cccs4)cnn23)ccc1F,C20H15FN4O2S,23868.0
9399,Icatibant (acetate),CC(=O)O.N=C(N)NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C[C@@H]2CCCC[C@@H]21,C61H93N19O15S,24083.0
9400,Sugammadex (sodium salt),O=C([O-])CCSC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]9CSCCC(=O)[O-])O[C@@H]8CSCCC(=O)[O-])O[C@@H]7CSCCC(=O)[O-])O[C@@H]6CSCCC(=O)[O-])O[C@@H]5CSCCC(=O)[O-])O[C@@H]4CSCCC(=O)[O-])O[C@@H]3CSCCC(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],C72H104Na8O48S8,24096.0
9401,Flualprazolam,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,C17H12ClFN4,24481.0
9402,Flualprazolam (CRM),Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,C17H12ClFN4,25577.0
9403,"Angiotensin I (human, rat, mouse)",CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)O,C62H89N17O14,24737.0
9404,ETC-159,Cn1c(=O)c2c(ncn2CC(=O)Nc2ccc(-c3ccccc3)nn2)n(C)c1=O,C19H17N7O3,24104.0
9405,AMG 208,COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1,C22H17N5O2,24197.0
9406,Acolbifene,CC1=C(c2ccc(O)cc2)[C@H](c2ccc(OCCN3CCCCC3)cc2)Oc2cc(O)ccc21,C29H31NO4,23931.0
9407,Phenazepam-d4,[2H]c1c([2H])c([2H])c(C2=NCC(=O)Nc3ccc(Br)cc32)c(Cl)c1[2H],C15H10BrClN2O,16198.0
9408,Oxybutynin (hydrochloride),CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1.Cl,C22H32ClNO3,23825.0
9409,Naloxegol (oxalate),C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5.O=C(O)C(=O)O,C36H55NO15,23731.0
9410,Plinabulin,CC(C)(C)c1nc[nH]c1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O,C19H20N4O2,24190.0
9411,Orteronel,CNC(=O)c1ccc2cc([C@@]3(O)CCn4cncc43)ccc2c1,C18H17N3O2,24191.0
9412,LY354740,N[C@@]1(C(=O)O)CC[C@H]2[C@H](C(=O)O)[C@H]21,C8H11NO4,24215.0
9413,3-hydroxy Octanoic Acid methyl ester,CCCCCC(O)CC(=O)OC,C9H18O3,24610.0
9414,2-hydroxy Arachidic Acid methyl ester,CCCCCCCCCCCCCCCCCCC(O)C(=O)OC,C21H42O3,24593.0
9415,2-hydroxy Lignoceric Acid methyl ester,CCCCCCCCCCCCCCCCCCCCCCC(O)C(=O)OC,C25H50O3,24599.0
9416,3-hydroxy Myristic Acid methyl ester,CCCCCCCCCCCC(O)CC(=O)OC,C15H30O3,24645.0
9417,17-hydroxy Heptadecanoic Acid,O=C(O)CCCCCCCCCCCCCCCCO,C17H34O3,24650.0
9418,22-hydroxy Docosanoic Acid,O=C(O)CCCCCCCCCCCCCCCCCCCCCO,C22H44O3,24655.0
9419,Gabaculine (hydrochloride),Cl.NC1C=CC=C(C(=O)O)C1,C7H10ClNO2,24209.0
9420,5-fluoro ethylbenzyl-PICA,CCC(NC(=O)c1cn(CCCCCF)c2ccccc12)c1ccccc1,C23H27FN2O,24430.0
9421,2-hydroxy Palmitic Acid methyl ester,CCCCCCCCCCCCCCC(O)C(=O)OC,C17H34O3,24589.0
9422,C22 Sphingomyelin (d18:1/22:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCCCCCCCC,C45H91N2O6P,24451.0
9423,3-keto Sphinganine (d12:0) (hydrochloride),CCCCCCCCCC(=O)C(N)CO.Cl,C12H26ClNO2,24384.0
9424,Alogliptin (benzoate salt),Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O.O=C(O)c1ccccc1,C25H27N5O4,23768.0
9425,TP-808,CN(C)[C@@H]1c2onc(OCc3ccccc3)c2C(=O)[C@@]2(O[Si](C)(C)C(C)(C)C)C(=O)C=CC[C@@H]12,C26H34N2O5Si,24181.0
9426,Chlorotoluron,Cc1ccc(NC(=O)N(C)C)cc1Cl,C10H13ClN2O,24225.0
9427,3-hydroxy Nonanoic Acid,CCCCCCC(O)CC(=O)O,C9H18O3,24611.0
9428,3-hydroxy Undecanoic Acid methyl ester,CCCCCCCCC(O)CC(=O)OC,C12H24O3,24641.0
9429,Kisspeptin-54 (human),CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C,C258H401N79O78,24477.0
9430,D-threo Sphinganine (d18:0),CCCCCCCCCCCCCCC[C@@H](O)[C@H](N)CO,C18H39NO2,24375.0
9431,Arry-380 analog,Cc1cc(Nc2ncnc3ccc(-c4ccc(CNCCS(C)(=O)=O)o4)cc23)ccc1Oc1ccn2ncnc2c1,C29H27N7O4S,24186.0
9432,C8 Phytoceramide (t18:0/8:0),CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC,C26H53NO4,24357.0
9433,C16 Lactosylceramide (d18:1/16:0)),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCC,C46H87NO13,24352.0
9434,C18 L-erythro Ceramide (d18:1/18:0),CCCCCCCCCCCCC/C=C/[C@H](O)[C@@H](CO)NC(=O)CCCCCCCCCCCCCCCCC,C36H71NO3,24398.0
9435,Ganirelix (acetate),CC(=O)O.CC(=O)O.CCNC(=NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN=C(NCC)NCC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O)NCC,C84H121ClN18O17,24098.0
9436,A-841720,CN(C)c1ccnc2sc3c(=O)n(N4CCCCCC4)cnc3c12,C17H21N5OS,21807.0
9437,Bethanechol (chloride),CC(C[N+](C)(C)C)OC(N)=O.[Cl-],C7H17ClN2O2,23830.0
9438,3-hydroxy Undecanoic Acid,CCCCCCCCC(O)CC(=O)O,C11H22O3,24640.0
9439,"9(E),11(E)-Conjugated Linoleic Acid methyl ester",CCCCCC/C=C/C=C/CCCCCCCC(=O)OC,C19H34O2,24580.0
9440,"9(Z),11(Z)-Conjugated Linoleic Acid methyl ester",CCCCCC/C=C\C=C/CCCCCCCC(=O)OC,C19H34O2,24583.0
9441,C24 3'-sulfo Galactosylceramide (d18:1/24:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(=O)(=O)O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCCCCCCCC,C48H93NO11S,24351.0
9442,C2 L-threo Ceramide (d18:1/2:0),CCCCCCCCCCCCC/C=C/[C@H](O)[C@H](CO)NC(C)=O,C20H39NO3,24386.0
9443,C19 Ceramide (d18:1/19:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCC,C37H73NO3,24395.0
9444,C6 Phytoceramide (t18:0/6:0),CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCC,C24H49NO4,24438.0
9445,Sphingosine-1-phosphate (d17:1),CCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)COP(=O)(O)O,C17H36NO5P,22498.0
9446,Neuromedin S (rat) (trifluoroacetate salt),CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O)[C@@H](C)O)[C@@H](C)O,C193H307N57O49S,24547.0
9447,PHT-427,CCCCCCCCCCCCc1ccc(S(=O)(=O)Nc2nncs2)cc1,C20H31N3O2S2,24188.0
9448,4-Methylumbelliferyl 2-sulfamino-2-deoxy-?-D-Glucopyranoside (sodium salt),Cc1cc(=O)oc2cc(O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3NS(=O)(=O)[O-])ccc12.[Na+],C16H18NNaO10S,24931.0
9449,6?-hydroxy Metandienone,C[C@]12C=CC(=O)C=C1[C@@H](O)C[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H28O3,24827.0
9450,2-hydroxy Lauric Acid methyl ester,CCCCCCCCCCC(O)C(=O)OC,C13H26O3,24587.0
9451,Benazepril (hydrochloride),CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O.Cl,C24H29ClN2O5,23804.0
9452,Flumethasone,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,C22H28F2O5,24184.0
9453,Zonisamide,NS(=O)(=O)Cc1noc2ccccc12,C8H8N2O3S,24183.0
9454,Dexchlorpheniramine (maleate),CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O,C20H23ClN2O4,24027.0
9455,Crotamiton,C/C=C/C(=O)N(CC)c1ccccc1C,C13H17NO,23943.0
9456,(+)-Fenchol,CC1(C)[C@H]2CC[C@](C)(C2)[C@H]1O,C10H18O,23162.0
9457,Efinaconazole,C=C1CCN([C@H](C)[C@](O)(Cn2cncn2)c2ccc(F)cc2F)CC1,C18H22F2N4O,23839.0
9458,PCE (hydrochloride),CCNC1(c2ccccc2)CCCCC1.Cl,C14H22ClN,14130.0
9459,Hexachlorophene,Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl,C13H6Cl6O2,23948.0
9460,Methylnaltrexone (bromide),C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.[Br-],C21H26BrNO4,24072.0
9461,D-Amino Acid Oxidase Inhibitor,O=C(O)c1cc2sccc2[nH]1,C7H5NO2S,23894.0
9462,Nilutamide,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,C12H10F3N3O4,23953.0
9463,2-fluoro Palmitic Acid methyl ester,CCCCCCCCCCCCCCC(F)C(=O)OC,C17H33FO2,24526.0
9464,L-erythro Sphingosine (d18:1),CCCCCCCCCCCCC/C=C/[C@H](O)[C@H](N)CO,C18H37NO2,24372.0
9465,3-keto Sphinganine (d18:0) (hydrochloride),CCCCCCCCCCCCCCCC(=O)[C@@H](N)CO.Cl,C18H38ClNO2,24380.0
9466,N-methyl Norfentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(C)CC1.Cl,C15H23ClN2O,24446.0
9467,"N,N-dimethyl Sphingosine (d17:1)",CCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C,C19H39NO2,22503.0
9468,Cosyntropin (acetate),CC(=O)O.CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)C(C)C,C138H214N40O33S,23912.0
9469,Pasireotide (aspartate) (trifluoroacetate salt),NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](c2ccccc2)NC(=O)[C@@H]2C[C@@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O.N[C@@H](CC(=O)O)C(=O)O.N[C@@H](CC(=O)O)C(=O)O.O=C(O)C(F)(F)F,C68H81F3N12O19,24092.0
9470,Casein Kinase 2 Substrate,C[C@@H](O)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O,C52H87N19O24,24848.0
9471,FIIN-3,C=CC(=O)Nc1ccc(CN(C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1,C34H36Cl2N8O4,20709.0
9472,Morphine,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,C17H19NO3,15464.0
9473,Codeine,COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341,C18H21NO3,15459.0
9474,CCK (27-33) (non-sulfated),CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,C45H57N9O10S2,24952.0
9475,"?-Endorphin (human, mouse, rat, porcine, bovine, ovine)",CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O,C77H120N18O26S,24958.0
9476,CCK (26-31) (non-sulfated),CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(C)=O)C(N)=O,C38H50N8O10S2,24951.0
9477,CCK (26-31) (sulfated),CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@H](CC(=O)O)NC(C)=O)C(N)=O,C38H50N8O13S3,24950.0
9478,"N,N-dimethyl Sphinganine (d18:0)",CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)N(C)C,C20H43NO2,22504.0
9479,"GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat)",CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C,C151H228N40O47,24887.0
9480,PF-6274484,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,C18H14ClFN4O2,22698.0
9481,4-deoxy-4?-Phorbol,CC1=C[C@@H]2[C@@H](CC(CO)=C[C@H]3[C@@H]4C(C)(C)[C@]4(O)[C@H](O)[C@@H](C)[C@]23O)C1=O,C20H28O5,24998.0
9482,Methyl 1-(4-fluorobenzyl)-1H-indazole-3-carboxylate,COC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12,C16H13FN2O2,24855.0
9483,(+)-Taxifolin,O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@H]1O,C15H12O7,23234.0
9484,Prucalopride,COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1,C18H26ClN3O3,24192.0
9485,4-Methyldiethcathinone (hydrochloride),CCN(CC)C(C)C(=O)c1ccc(C)cc1.Cl,C14H22ClNO,24799.0
9486,"cis-9,10-Methyleneoctadecanoic Acid",CCCCCCCC[C@H]1C[C@H]1CCCCCCCC(=O)O,C19H36O2,24824.0
9487,"cis-9,10-Methyleneoctadecanoic Acid methyl ester",CCCCCCCC[C@H]1C[C@H]1CCCCCCCC(=O)OC,C20H38O2,24825.0
9488,Transcrocetin,CC(/C=C/C=C(\C)C(=O)O)=C\C=C\C=C(C)\C=C\C=C(/C)C(=O)O,C20H24O4,24217.0
9489,Alprazolam,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,C17H13ClN4,14255.0
9490,3-hydroxy Decanoic Acid methyl ester,CCCCCCCC(O)CC(=O)OC,C11H22O3,24614.0
9491,3-hydroxy Octanoic Acid,CCCCCC(O)CC(=O)O,C8H16O3,24609.0
9492,Cenicriviroc,CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@](=O)Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1,C41H52N4O4S,23927.0
9493,Dacarbazine,CN(C)/N=N/c1nc[nH]c1C(N)=O,C6H10N6O,21877.0
9494,EOS (d18:1/30:0/18:2),CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)C(O)/C=C/CCCCCCCCCCCCC,C66H125NO5,24394.0
9495,RN-1734,CC(C)NCCN(C(C)C)S(=O)(=O)c1ccc(Cl)cc1Cl,C14H22Cl2N2O2S,24205.0
9496,Olsalazine (sodium salt),O=C([O-])c1cc(/N=N/c2ccc(O)c(C(=O)[O-])c2)ccc1O.[Na+].[Na+],C14H8N2Na2O6,23661.0
9497,L-threo Lysosphingomyelin (d18:1),CCCCCCCCCCCCC/C=C/[C@H](O)[C@@H](N)COP(=O)([O-])OCC[N+](C)(C)C,C23H49N2O5P,24454.0
9498,"9(Z),11(E)-Conjugated Linoleic Acid methyl ester",CCCCCC/C=C/C=C\CCCCCCCC(=O)OC,C19H34O2,24581.0
9499,15-hydroxy Pentadecanoic Acid methyl ester,COC(=O)CCCCCCCCCCCCCCO,C16H32O3,24649.0
9500,"9(Z),11(Z)-Conjugated Linoleic Acid",CCCCCC/C=C\C=C/CCCCCCCC(=O)O,C18H32O2,24582.0
9501,3-hydroxy Tridecanoic Acid methyl ester,CCCCCCCCCCC(O)CC(=O)OC,C14H28O3,24644.0
9502,2-hydroxy Tricosanoic Acid methyl ester,CCCCCCCCCCCCCCCCCCCCCC(O)C(=O)OC,C24H48O3,24598.0
9503,Tariquidar,COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cc(OC)c(OC)cc3NC(=O)c3cnc4ccccc4c3)cc1)CC2,C38H38N4O6,24180.0
9504,2'-fluoro ortho-Fluorofentanyl (hydrochloride),CCC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2F)CC1.Cl,C22H27ClF2N2O,23400.0
9505,2'-fluoro ortho-Fluorofentanyl (hydrochloride) (exempt preparation),CCC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2F)CC1.Cl,C22H27ClF2N2O,35680.0
9506,Glucagon (hydrochloride),CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O.Cl,C153H226ClN43O49S,24204.0
9507,Reveromycin C,CC(/C=C/[C@H](O)[C@@H](C)/C=C/C(=O)O)=C\C[C@H]1O[C@]2(CC[C@@H]1C)CC[C@@](CCC(C)C)(OC(=O)CCC(=O)O)[C@H](/C=C/C(C)=C/C(=O)O)O2,C37H54O11,23488.0
9508,C8 D-threo Ceramide (d18:1/8:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](CO)NC(=O)CCCCCCC,C26H51NO3,24391.0
9509,Phosphatidylethanolamine (chicken egg),CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCC/C=C\CCCCCCCC,C41H78NO8P,24332.0
9510,Brain-Derived Basic Fibroblast Growth Factor (1-24) (bovine),CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O,C118H173N31O33,24760.0
9511,Hydrocodone,COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314,C18H21NO3,15461.0
9512,Laquinimod,CCN(C(=O)c1c(O)c2c(Cl)cccc2n(C)c1=O)c1ccccc1,C19H17ClN2O3,24187.0
9513,FX1,O=C(O)CCN1C(=O)/C(=C2/C(=O)Nc3ccc(Cl)cc32)SC1=S,C14H9ClN2O4S2,23908.0
9514,Cereblon Ligand 1,O=C(O)COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,C15H12N2O7,21589.0
9515,SAfit2,COc1ccc(CC[C@@H](OC(=O)[C@@H]2CCCCN2C(=O)[C@H](c2cc(OC)c(OC)c(OC)c2)C2CCCCC2)c2cccc(OCCN3CCOCC3)c2)cc1OC,C46H62N2O10,24366.0
9516,[Orn8]-Urotensin II (human),CC(C)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)O,C63H83N13O18S2,24754.0
9517,Docosahexaenoic Acid Alkyne,C#C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C22H28O2,16689.0
9518,Drimentine A,C=C1CC[C@H]2C(C)(C)CCC[C@]2(C)[C@H]1C[C@@]12C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)N3[C@@H]1Nc1ccccc12,C32H45N3O2,23495.0
9519,U-92016A,CCCN(CCC)[C@@H]1CCc2ccc3[nH]c(C#N)cc3c2C1.Cl,C19H26ClN3,23807.0
9520,Manidipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1,C35H38N4O6,23614.0
9521,2'-C-Methyladenosine,C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(N)ncnc21,C11H15N5O4,23062.0
9522,Sclerotigenin,O=C1NCc2nc3ccccc3c(=O)n2-c2ccccc21,C16H11N3O2,23492.0
9523,GSK3179106,CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)on2)c(F)c1,C22H21F4N3O4,24023.0
9524,NSC 146109 (hydrochloride),Cc1c2ccccc2c(CSC(=N)N)c2ccccc12.Cl,C17H17ClN2S,16430.0
9525,Sarpogrelate (hydrochloride),COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O)c1.Cl,C24H32ClNO6,24194.0
9526,Fleroxacin,CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1,C17H18F3N3O3,24173.0
9527,C2 3'-sulfo Galactosylceramide (d18:1/2:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(=O)(=O)O)[C@H]1O)NC(C)=O,C26H49NO11S,24861.0
9528,Lyso-Lactosylceramide (synthetic),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,C30H57NO12,24867.0
9529,Lactosylsphingosine (d18:1),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,C30H57NO12,24868.0
9530,?-Hydroxymethyl Atropine,CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)(CO)c1ccccc1)C2,C18H25NO4,24266.0
9531,Tazarotene,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1,C21H21NO2S,23559.0
9532,LY2608204,O=C(Nc1ncc(SCCN2CCCC2)s1)[C@]1(c2ccc(S(=O)(=O)C3CC3)cc2)C[C@H]1C1CCCCC1,C28H37N3O3S3,22914.0
9533,MDMB-CHMCZCA metabolite M3,O=C(O)c1ccc2c(c1)c1ccccc1n2CC1CCCCC1,C20H21NO2,25064.0
9534,Xanthine amine congener (hydrochloride),CCCn1c(=O)c2nc(-c3ccc(OCC(=O)NCCN)cc3)[nH]c2n(CCC)c1=O.Cl,C21H29ClN6O4,23077.0
9535,"DL-2,6-dimethyl Heptanoic Acid",CC(C)CCCC(C)C(=O)O,C9H18O2,24822.0
9536,"3,4-Ethylenedioxy U-47700 (hydrochloride)",CN(C)[C@@H]1CCCC[C@H]1N(C)C(=O)c1ccc2c(c1)OCCO2.Cl,C18H27ClN2O3,23752.0
9537,17-methyl Stearic Acid methyl ester,COC(=O)CCCCCCCCCCCCCCCC(C)C,C20H40O2,24816.0
9538,12-methyl Myristic Acid methyl ester,CCC(C)CCCCCCCCCCC(=O)OC,C16H32O2,24818.0
9539,12-methyl Myristic Acid,CCC(C)CCCCCCCCCCC(=O)O,C15H30O2,24817.0
9540,P7C3-A20,COc1cccc(NCC(F)Cn2c3ccc(Br)cc3c3cc(Br)ccc32)c1,C22H19Br2FN2O,24201.0
9541,Genz-644282,CNCCn1c(=O)c2cc(OC)c(OC)cc2c2cnc3cc4c(cc3c21)OCO4,C22H21N3O5,24193.0
9542,Xamoterol (hemifumarate),O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1.O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1.O=C(O)/C=C/C(=O)O,C36H54N6O14,24267.0
9543,12-methyl Tridecanoic Acid methyl ester,COC(=O)CCCCCCCCCCC(C)C,C15H30O2,24810.0
9544,CCK (26-30) (sulfated),CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@H](CC(=O)O)NC(C)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,C33H41N7O12S2,24949.0
9545,Galactosylceramides (hydroxy) (bovine),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)C(O)CCCCCCCCCCCCCCCC,C42H81NO9,24836.0
9546,Galactosylceramide (non-hydroxy) (bovine),CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC,C48H91NO8,24835.0
9547,Cefotetan (sodium salt),CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)[O-])S2)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CS[C@@H]21.[Na+].[Na+],C17H15N7Na2O8S4,23624.0
9548,Enfuvirtide,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,C204H301N51O64,24097.0
9549,"CP 809,101",Clc1cccc(COc2cncc(N3CCNCC3)n2)c1,C15H17ClN4O,24214.0
9550,"10(E),12(Z)-Conjugated Linoleic Acid methyl ester",CCCCC/C=C\C=C\CCCCCCCCC(=O)OC,C19H34O2,24584.0
9551,2-hydroxy Docosanoic Acid,CCCCCCCCCCCCCCCCCCCCC(O)C(=O)O,C22H44O3,24594.0
9552,3-hydroxy Heptadecanoic Acid methyl ester,CCCCCCCCCCCCCCC(O)CC(=O)OC,C18H36O3,24646.0
9553,17-hydroxy Heptadecanoic Acid methyl ester,COC(=O)CCCCCCCCCCCCCCCCO,C18H36O3,24651.0
9554,Vonoprazan (fumarate),CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccnc2)c1.O=C(O)/C=C/C(=O)O,C21H20FN3O6S,24200.0
9555,Medetomidine-13C-d3 (hydrochloride),Cl.[2H][13C]([2H])([2H])C(c1cnc[nH]1)c1cccc(C)c1C,C13H17ClN2,25041.0
9556,ACHMINACA,O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(CC2CCCCC2)c2ccccc12,C25H33N3O,25006.0
9557,LL-37 amide (trifluoroacetate salt),CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC.O=C(O)C(F)(F)F,C207H342F3N61O54,24764.0
9558,Progesterone-d9,[2H]C1=C2C([2H])([2H])C[C@@H]3[C@H](CC[C@@]4(C)[C@H]3CC[C@]4([2H])C(=O)C([2H])([2H])[2H])[C@@]2(C)CC([2H])([2H])C1=O,C21H30O2,25047.0
9559,Hydromorphone,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5,C17H19NO3,15463.0
9560,Incensole,C/C1=C/CC/C(C)=C/C[C@]2(C(C)C)CC[C@@](C)(O2)[C@@H](O)CC1,C20H34O2,22895.0
9561,2-(4-Fluorophenyl)piperazine,Fc1ccc(C2CNCCN2)cc1,C10H13FN2,24421.0
9562,meta-fluoro Acrylfentanyl,C=CC(=O)N(c1cccc(F)c1)C1CCN(CCc2ccccc2)CC1,C22H25FN2O,21931.0
9563,Difenoconazole,CC1COC(Cn2cncn2)(c2ccc(Oc3ccc(Cl)cc3)cc2Cl)O1,C19H17Cl2N3O3,24053.0
9564,Gliorosein,COC1=C(OC)C(=O)[C@@H](C)[C@H](C)C1=O,C10H14O4,24921.0
9565,5-fluoro 7-QUPAIC,O=C(Oc1cccc2cccnc12)c1cn(CCCCCF)c2ncccc12,C22H20FN3O2,23011.0
9566,ortho-fluoro Furanyl fentanyl (hydrochloride),Cl.O=C(c1ccco1)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1,C24H26ClFN2O2,23628.0
9567,PSI-7977-13C-d3,[2H][13C]([2H])([2H])[C@@]1(F)[C@H](O)[C@@H](CO[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)Oc2ccccc2)O[C@H]1n1ccc(=O)[nH]c1=O,C22H29FN3O9P,25045.0
9568,Tebuconazole,CC(C)(C)C(O)(CCc1ccc(Cl)cc1)Cn1cncn1,C16H22ClN3O,24052.0
9569,Acetamiprid,C/C(=N\C#N)N(C)Cc1ccc(Cl)nc1,C10H11ClN4,24129.0
9570,Globotriaosylceramide (porcine RBC),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCCCCCCCC,C60H113NO18,24870.0
9571,Bitertanol,CC(C)(C)C(O)C(Oc1ccc(-c2ccccc2)cc1)n1cncn1,C20H23N3O2,24054.0
9572,Cypermethrin,CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1,C22H19Cl2NO3,24117.0
9573,MST-312,O=C(Nc1cccc(NC(=O)c2cccc(O)c2O)c1)c1cccc(O)c1O,C20H16N2O6,24301.0
9574,2-BZP,c1ccc(CC2CNCCN2)cc1,C11H16N2,24419.0
9575,A-77636 (hydrochloride),Cl.NC[C@@H]1O[C@H](C23CC4CC(CC(C4)C2)C3)Cc2c1ccc(O)c2O,C20H28ClNO3,24316.0
9576,"1-(2,5-Dimethoxybenzyl)piperazine (hydrochloride)",COc1ccc(OC)c(CN2CCNCC2)c1.Cl,C13H21ClN2O2,24017.0
9577,PA-824,O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(OC(F)(F)F)cc1)C2,C14H12F3N3O5,13142.0
9578,22-hydroxy Docosanoic Acid methyl ester,COC(=O)CCCCCCCCCCCCCCCCCCCCCO,C23H46O3,24656.0
9579,C6 Ceramide-d7 (d18:1-d7/6:0),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCC,C24H47NO3,24826.0
9580,4-fluoro ADB,COC(=O)[C@@H](NC(=O)c1nn(CCCC(C)F)c2ccccc12)C(C)(C)C,C20H28FN3O3,9002717.0
9581,Hesperadin,CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2,C29H32N4O3S,24199.0
9582,DDG,CCCCCCCCCCSCCC(=O)NC(C)(CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C29H55NO13S,24778.0
9583,CALXCHOL,CC(C)CCCC(C)C1CCC2C3CC=C4CC(n5cc(COc6c7cccc6Cc6cc(CC(=O)[O-])cc(c6O)Cc6cc(CC(=O)[O-])cc(c6O)Cc6cc(CC(=O)[O-])cc(c6O)C7)nn5)CCC4(C)C3CCC12C.[Na+].[Na+].[Na+],C64H74N3Na3O10,24783.0
9584,Dieldrin,ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@@H]([C@H]5O[C@@H]45)[C@@H]3[C@@]1(Cl)C2(Cl)Cl,C12H8Cl6O,24043.0
9585,Oxymorphone,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,C17H19NO4,15911.0
9586,Hexaconazole,CCCCC(O)(Cn1cncn1)c1ccc(Cl)cc1Cl,C14H17Cl2N3O,24118.0
9587,C16 Ceramide (d16:1/16:0),CCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCC,C32H63NO3,24426.0
9588,1-Methyl-3-BZP,CN1CCNC(Cc2ccccc2)C1,C12H18N2,24418.0
9589,Cetrorelix (acetate),CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCCC1C(=O)N[C@H](C)C(N)=O.CC(=O)O,C72H96ClN17O16,23910.0
9590,27-alkyne Cholesterol,C#C[C@H](C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C28H44O,24319.0
9591,6?-chloro Testosterone,C[C@]12CC[C@H]3[C@@H](C[C@H](Cl)C4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,C19H27ClO2,24557.0
9592,CALXGLUK,CCCCCCCOc1c2cccc1Cc1cc(CCn3cc(CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)cc(c1OC)Cc1cc(CCn3cc(CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)cc(c1OC)Cc1cc(CCn3cc(CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)cc(c1OC)C2,C71H95N9O22,24784.0
9593,DL-erythro/threo Sphinganine (d16:0),CCCCCCCCCCCCCC(O)C(N)CO,C16H35NO2,24376.0
9594,Fura-2 (potassium salt),Cc1ccc(N(CC(=O)[O-])CC(=O)[O-])c(OCCOc2cc3cc(-c4ncc(C(=O)[O-])o4)oc3cc2N(CC(=O)[O-])CC(=O)[O-])c1.[K+].[K+].[K+].[K+].[K+],C29H22K5N3O14,19531.0
9595,"N,N-dihexyl Sphingosine (d18:1/6:0/6:0)",CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(CCCCCC)CCCCCC,C30H61NO2,24385.0
9596,C16 Sphingomyelin-13C (d18:1/16:0-13C),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])OCC[N+](C)(C)C)N[13C](=O)CCCCCCCCCCCCCCC,C39H79N2O6P,24452.0
9597,C15 Galactosylceramide (d18:1/15:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCC,C39H75NO8,24466.0
9598,GSK3117391,O=C(CCc1ccc(CN[C@H](C(=O)OC2CCCC2)C2CCCCC2)cn1)NO,C22H33N3O4,23846.0
9599,ODG,CCCCCCCCSCCC(=O)NC(C)(CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C27H51NO13S,24782.0
9600,C20 Sphingomyelin (d18:1/20:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCCCCCC,C43H87N2O6P,24450.0
9601,Funalenone,COC1=C(O)c2c(O)cc(C)c3c(O)cc(O)c(c23)C1=O,C15H12O6,23491.0
9602,Fipronil,N#Cc1nn(-c2c(Cl)cc(C(F)(F)F)cc2Cl)c(N)c1S(=O)C(F)(F)F,C12H4Cl2F6N4OS,24128.0
9603,Sappanone A,O=C1/C(=C/c2ccc(O)c(O)c2)COc2cc(O)ccc21,C16H12O5,23205.0
9604,21-hydroxy Heneicosanoic Acid methyl ester,COC(=O)CCCCCCCCCCCCCCCCCCCCO,C22H44O3,24654.0
9605,4-phenyl U-51754 (hydrochloride),CN(C)[C@@H]1CCCC[C@H]1N(C)C(=O)Cc1ccc(-c2ccccc2)cc1.Cl,C23H31ClN2O,24980.0
9606,Prochloraz,CCCN(CCOc1c(Cl)cc(Cl)cc1Cl)C(=O)n1ccnc1,C15H16Cl3N3O2,24051.0
9607,Terconazole,CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,C26H31Cl2N5O3,23959.0
9608,2-hydroxy Arachidic Acid,CCCCCCCCCCCCCCCCCCC(O)C(=O)O,C20H40O3,24592.0
9609,Albendazole,CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,C12H15N3O2S,23705.0
9610,Flutoprazepam,O=C1CN=C(c2ccccc2F)c2cc(Cl)ccc2N1CC1CC1,C19H16ClFN2O,23543.0
9611,Neohydroxyaspergillic Acid,CC(C)Cc1ncc([C@@H](O)C(C)C)n(O)c1=O,C12H20N2O3,24918.0
9612,Hydroaurantiogliocladin,COc1c(O)c(C)c(C)c(O)c1OC,C10H14O4,24920.0
9613,C18 Galactosylceramide-d35 (d18:1/18:0-d35),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC,C42H81NO8,24467.0
9614,"1,2-Diheptadecanoyl-sn-glycero-3-PC",CCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCC,C42H84NO8P,24630.0
9615,Folipastatin,C/C=C(/C)c1cc(O)c(C)c2c1Oc1c(C)c(O)cc(/C(C)=C/C)c1C(=O)O2,C23H24O5,24924.0
9616,Hirsutide,CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)N(C)C1=O,C34H40N4O4,25014.0
9617,2-hydroxy Lauric Acid,CCCCCCCCCCC(O)C(=O)O,C12H24O3,24586.0
9618,2-hydroxy Stearic Acid methyl ester,CCCCCCCCCCCCCCCCC(O)C(=O)OC,C19H38O3,24591.0
9619,2-hydroxy Tricosanoic Acid,CCCCCCCCCCCCCCCCCCCCCC(O)C(=O)O,C23H46O3,24597.0
9620,3-hydroxy Hexanoic Acid methyl ester,CCCC(O)CC(=O)OC,C7H14O3,24608.0
9621,3-hydroxy Lauric Acid methyl ester,CCCCCCCCCC(O)CC(=O)OC,C13H26O3,24643.0
9622,3-hydroxy Decanoic Acid,CCCCCCCC(O)CC(=O)O,C10H20O3,24613.0
9623,13-methyl Myristic Acid,CC(C)CCCCCCCCCCCC(=O)O,C15H30O2,24811.0
9624,15-hydroxy Pentadecanoic Acid,O=C(O)CCCCCCCCCCCCCCO,C15H30O3,24648.0
9625,20-hydroxy Arachidic Acid methyl ester,COC(=O)CCCCCCCCCCCCCCCCCCCO,C21H42O3,24653.0
9626,13-methyl Myristic Acid methyl ester,COC(=O)CCCCCCCCCCCC(C)C,C16H32O2,24812.0
9627,5-fluoro ADB metabolite 2,COC(=O)[C@@H](NC(=O)c1nn(CCCCCO)c2ccccc12)C(C)(C)C,C20H29N3O4,20173.0
9628,FUBIMINA N-(5-hydroxypentyl) metabolite,O=C(c1cccc2ccccc12)c1nc2ccccc2n1CCCCCO,C23H22N2O2,24468.0
9629,13-methyl Pentadecanoic Acid methyl ester,CCC(C)CCCCCCCCCCCC(=O)OC,C17H34O2,24819.0
9630,FLAC6,O=C(NCCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,C21H28F13NO11,24781.0
9631,10-methyl Palmitic Acid methyl ester,CCCCCCC(C)CCCCCCCCC(=O)OC,C18H36O2,24823.0
9632,Maculosin,O=C1N[C@@H](Cc2ccc(O)cc2)C(=O)N2CCC[C@@H]12,C14H16N2O3,25019.0
9633,C18 Ganglioside GD3-d3 (ammonium salt),[2H]C([2H])([2H])CCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]4(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O3)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC.[NH4+].[NH4+],C70H131N5O29,24852.0
9634,2-(3-(Trifluoromethyl)phenyl)piperazine (hydrochloride),Cl.Cl.FC(F)(F)c1cccc(C2CNCCN2)c1,C11H15Cl2F3N2,24420.0
9635,11-methyl Lauric Acid methyl ester,COC(=O)CCCCCCCCCC(C)C,C14H28O2,24809.0
9636,4-hydroxy DPT,CCCN(CCC)CCc1c[nH]c2cccc(O)c12,C16H24N2O,23542.0
9637,Dabcyl-YVADAPV-EDANS,CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccc(/N=N/c2ccc(N(C)C)cc2)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCNc1cccc2c(S(=O)(=O)O)cccc12)C(C)C,C61H76N12O14S,24993.0
9638,Ixabepilone,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1,C27H42N2O5S,23732.0
9639,Cyclo(L-Phe-L-Val),CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC1=O,C14H18N2O2,24943.0
9640,Cyclo(L-Leu-L-Pro),CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C1=O,C11H18N2O2,24941.0
9641,Cyclo(L-Tyr-L-Val),CC(C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,C14H18N2O3,24944.0
9642,Cyclo(L-Leu-L-Trp),CC(C)C[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O,C17H21N3O2,24942.0
9643,15-methyl Palmitic Acid,CC(C)CCCCCCCCCCCCCC(=O)O,C17H34O2,24814.0
9644,Crotonyl fentanyl-d5,[2H]c1c([2H])c([2H])c(N(C(=O)/C=C/C)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C23H28N2O,25132.0
9645,Cyclo(D-Ala-L-Pro),C[C@H]1NC(=O)[C@@H]2CCCN2C1=O,C8H12N2O2,24940.0
9646,15-methyl Palmitic Acid methyl ester,COC(=O)CCCCCCCCCCCCCC(C)C,C18H36O2,24815.0
9647,Flambalactone,COc1c(Cl)c(O)c(Cl)c(C)c1C(=O)O[C@H]1[C@H](O)C[C@H](O[C@H]2[C@@H](O)CC(=O)O[C@@H]2C)O[C@@H]1C,C21H26Cl2O10,24916.0
9648,Kotanin A,COc1cc(C)c2c(OC)cc(=O)oc2c1-c1c(OC)cc(C)c2c(OC)cc(=O)oc12,C24H22O8,24917.0
9649,C16 Globotriaosylceramide (d18:1/16:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCC,C52H97NO18,24875.0
9650,BZP-d7 (hydrochloride) (CRM),Cl.Cl.[2H]c1c([2H])c([2H])c(C([2H])([2H])N2CCNCC2)c([2H])c1[2H],C11H18Cl2N2,19411.0
9651,GSK2330672,CCCC[C@]1(CC)CS(=O)(=O)c2cc(CNC(CC(=O)O)CC(=O)O)c(OC)cc2[C@@H](c2ccccc2)N1,C28H38N2O7S,23843.0
9652,Tadalafil-d3,[2H]C([2H])([2H])N1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O,C22H19N3O4,25030.0
9653,Febuxostat-d9,[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])Oc1ccc(-c2nc(C)c(C(=O)O)s2)cc1C#N,C16H16N2O3S,25033.0
9654,Imidacloprid,O=[N+]([O-])/N=C1\NCCN1Cc1ccc(Cl)nc1,C9H10ClN5O2,24130.0
9655,Diuron,CN(C)C(=O)Nc1ccc(Cl)c(Cl)c1,C9H10Cl2N2O,24040.0
9656,CUDC-305,CN(C)c1cc2c(cc1Sc1nc3c(N)nccc3n1CCNCC(C)(C)C)OCO2,C22H30N6O2S,24683.0
9657,ML-365,COc1ccccc1C(=O)Nc1cccc(NC(=O)c2cccc(C)c2)c1,C22H20N2O3,24666.0
9658,AZD 8931,CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,C23H25ClFN5O3,24196.0
9659,Kumbicin C,COc1c(O)c(-c2c[nH]c3ccccc23)c2c(c1-c1c[nH]c3ccccc13)OC(C)(C)C=C2,C28H24N2O3,25015.0
9660,Isosilybin,COc1cc(C2Oc3ccc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)cc3OC2CO)ccc1O,C25H22O10,24913.0
9661,Acephate,COP(=O)(NC(C)=O)SC,C4H10NO3PS,24038.0
9662,C18 3'-sulfo Galactosylceramide (d18:1/18:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(=O)(=O)O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC,C42H81NO11S,24863.0
9663,C18:1 3'-sulfo Galactosylceramide (d18:1/18:1(9Z)),CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(=O)(=O)O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC,C42H79NO11S,24864.0
9664,Lyso-Globotriaosylceramide (d18:1),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,C36H67NO17,24873.0
9665,Stictic Acid,COc1cc(C)c2c(c1C=O)Oc1c(c(C)c(O)c3c1C(O)OC3=O)OC2=O,C19H14O9,25017.0
9666,C18 Globotriaosylceramide (d18:1/18:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC,C54H101NO18,24877.0
9667,Tebufenozide,CCc1ccc(C(=O)NN(C(=O)c2cc(C)cc(C)c2)C(C)(C)C)cc1,C22H28N2O2,24055.0
9668,PF-05089771 (tosylate),Cc1ccc(S(=O)(=O)O)cc1.Nc1n[nH]cc1-c1cc(Cl)ccc1Oc1cc(F)c(S(=O)(=O)Nc2cscn2)cc1Cl,C25H20Cl2FN5O6S3,24449.0
9669,AFN-1252,Cc1c(CN(C)C(=O)/C=C/C2=CNC3=NC(=O)CCC3=C2)oc2ccccc12,C22H21N3O3,24686.0
9670,TA-01,Fc1ccc(-c2[nH]c(-c3c(F)cccc3F)nc2-c2ccncc2)cc1,C20H12F3N3,24667.0
9671,X-NeuNAc,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@@](Oc2c[nH]c3ccc(Br)c(Cl)c23)(C(=O)[O-])C[C@@H]1O.[Na+],C19H21BrClN2NaO9,24206.0
9672,CALX8,CCCCCCCCOc1c2cccc1Cc1cc(CC(=O)[O-])cc(c1O)Cc1cc(CC(=O)[O-])cc(c1O)Cc1cc(CC(=O)[O-])cc(c1O)C2.[Na+].[Na+].[Na+],C42H43Na3O10,24777.0
9673,"3,4-Ethylenedioxy U-51754 (hydrochloride)",CN(C)[C@@H]1CCCC[C@H]1N(C)C(=O)Cc1ccc2c(c1)OCCO2.Cl,C19H29ClN2O3,23747.0
9674,C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)),CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(=O)(=O)O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC,C48H91NO11S,24865.0
9675,N-Glycine Globotriaosylsphingosine (d18:1),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CN,C38H70N2O18,24874.0
9676,C23 Globotriaosylceramide (d18:1/23:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCCCCCCC,C59H111NO18,24878.0
9677,Penicolinate A,COC(=O)c1ccc(CCCCCCCCCc2ccc(C(=O)OC)nc2)cn1,C23H30N2O4,25013.0
9678,Aszonalenin,C=CC(C)(C)[C@]12C[C@@H]3C(=O)Nc4ccccc4C(=O)N3[C@H]1Nc1ccccc12,C23H23N3O2,25018.0
9679,Azoxystrobin,CO/C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1,C22H17N3O5,24056.0
9680,Marmesin,CC(C)(O)[C@@H]1Cc2cc3ccc(=O)oc3cc2O1,C14H14O4,25049.0
9681,Oleoyl Serinol,CCCCCCCC/C=C\CCCCCCCC(=O)NC(CO)CO,C21H41NO3,13637.0
9682,Amlodipine-d4 (maleate),O=C(O)/C=C\C(=O)O.[2H]C([2H])(N)C([2H])([2H])OCC1=C(C(=O)OCC)C(c2ccccc2Cl)C(C(=O)OC)=C(C)N1,C24H29ClN2O9,25035.0
9683,Agnuside,O=C(OCC1=C[C@@H](O)[C@@H]2C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]12)c1ccc(O)cc1,C22H26O11,24971.0
9684,Decamethonium (bromide),C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-],C16H38Br2N2,24907.0
9685,Linezolid-d3,[2H]C([2H])([2H])C(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,C16H20FN3O4,25038.0
9686,(+)-Praeruptorin A,C/C=C(/C)C(=O)O[C@H]1[C@@H](OC(C)=O)c2c(ccc3ccc(=O)oc23)OC1(C)C,C21H22O7,24915.0
9687,ICA 121431,O=C(Nc1ccc(S(=O)(=O)Nc2nccs2)cc1)C(c1ccccc1)c1ccccc1,C23H19N3O3S2,24669.0
9688,GSK1070916,CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1,C30H33N7O,22953.0
9689,C16 3'-sulfo Galactosylceramide (d18:1/16:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(=O)(=O)O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCC,C40H77NO11S,24862.0
9690,2-hydroxy Docosanoic Acid methyl ester,CCCCCCCCCCCCCCCCCCCCC(O)C(=O)OC,C23H46O3,24596.0
9691,2-hydroxy Decanoic Acid methyl ester,CCCCCCCCC(O)C(=O)OC,C11H22O3,24585.0
9692,2-hydroxy Stearic Acid,CCCCCCCCCCCCCCCCC(O)C(=O)O,C18H36O3,24590.0
9693,3-hydroxy Hexanoic Acid,CCCC(O)CC(=O)O,C6H12O3,24607.0
9694,3-hydroxy Nonanoic Acid methyl ester,CCCCCCC(O)CC(=O)OC,C10H20O3,24612.0
9695,3-hydroxy Lauric Acid,CCCCCCCCCC(O)CC(=O)O,C12H24O3,24642.0
9696,3-hydroxy Stearic Acid methyl ester,CCCCCCCCCCCCCCCC(O)CC(=O)OC,C19H38O3,24647.0
9697,20-hydroxy Arachidic Acid,O=C(O)CCCCCCCCCCCCCCCCCCCO,C20H40O3,24652.0
9698,27-hydroxy Heptacosanoic Acid methyl ester,COC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCO,C28H56O3,24657.0
9699,DLAC,CCCCCCCCCCNC(=O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,C22H43NO11,24780.0
9700,DDLAC,CCCCCCCCCCCCNC(=O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,C24H47NO11,24785.0
9701,14-methyl Palmitic Acid,CCC(C)CCCCCCCCCCCCC(=O)O,C17H34O2,24820.0
9702,14-methyl Palmitic Acid methyl ester,CCC(C)CCCCCCCCCCCCC(=O)OC,C18H36O2,24821.0
9703,Bromadol,CN(C)[C@]1(c2ccc(Br)cc2)CC[C@](O)(CCc2ccccc2)CC1,C22H28BrNO,15608.0
9704,"9(Z),11(E),13(Z)-Octadecatrienoic Acid methyl ester",CCCC/C=C\C=C\C=C/CCCCCCCC(=O)OC,C19H32O2,24807.0
9705,14-methyl Pentadecanoic Acid methyl ester,COC(=O)CCCCCCCCCCCCC(C)C,C17H34O2,24813.0
9706,Asialo Ganglioside GM2,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3NC(C)=O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC,C56H104N2O18,24629.0
9707,Levomilnacipran (hydrochloride),CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN.Cl,C15H23ClN2O,23951.0
9708,"3,4-Dihydroxyphenylacetic Acid",O=C(O)Cc1ccc(O)c(O)c1,C8H8O4,24912.0
9709,Umbelliferone,O=c1ccc2ccc(O)cc2o1,C9H6O3,24665.0
9710,Isokotanin B,COc1cc2oc(=O)cc(OC)c2c(C)c1-c1c(O)cc2oc(=O)cc(OC)c2c1C,C23H20O8,25082.0
9711,Padanamide A,COCC(=O)N[C@@H](C(=O)N1NCCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@H](C)C(=O)N[C@H]1CCN(C(N)=O)C1=O)[C@H](O)C(C)C,C31H47N7O9,25085.0
9712,Lobaric Acid,CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2,C25H28O8,25205.0
9713,TA-02,Fc1ccc(-c2[nH]c(-c3ccccc3F)nc2-c2ccncc2)cc1,C20H13F2N3,24668.0
9714,Azeliragon,CCCCc1nc(-c2ccc(OCCCN(CC)CC)cc2)cn1-c1ccc(Oc2ccc(Cl)cc2)cc1,C32H38ClN3O2,24678.0
9715,Oxacillin (sodium salt),Cc1onc(-c2ccccc2)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)[O-].[Na+],C19H18N3NaO5S,23954.0
9716,Atorvastatin-d5 (calcium salt),[2H]c1c([2H])c([2H])c(-c2c(C(=O)Nc3ccccc3)c(C(C)C)n(CC[C@@H](O)C[C@@H](O)CC(=O)[O-])c2-c2ccc(F)cc2)c([2H])c1[2H].[2H]c1c([2H])c([2H])c(-c2c(C(=O)Nc3ccccc3)c(C(C)C)n(CC[C@@H](O)C[C@@H](O)CC(=O)[O-])c2-c2ccc(F)cc2)c([2H])c1[2H].[Ca+2],C66H68CaF2N4O10,25043.0
9717,Filipin Complex,CCCCCC[C@H]1C(=O)O[C@H](C)C/C=C/C=C/C=C/C=C/C=C(\C)[C@@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O.CCCCCC[C@H]1C(=O)O[C@H](C)[C@@H](O)/C=C/C=C/C=C/C=C/C=C(\C)[C@@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O.CCCCC[C@@H](O)[C@H]1C(=O)O[C@H](C)[C@@H](O)/C=C/C=C/C=C/C=C/C=C(\C)[C@@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O,C105H174O30,25073.0
9718,Spirohexenolide A,CC1=C[C@@]2(C)/C=C(C)\C=C/C[C@@H](O)/C=C3\C=C/C(=C4/C(=O)O[C@@]2(C[C@@H]1C)C4=O)OC3,C25H28O5,25116.0
9719,Flunitrazolam,Cc1nnc2n1-c1ccc([N+](=O)[O-])cc1C(c1ccccc1F)=NC2,C17H12FN5O2,23108.0
9720,Ningetinib,Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)c(F)c2)c(=O)n(-c2ccccc2)n1C,C31H29FN4O5,25233.0
9721,Sunitinib-d10,[2H]C([2H])([2H])C([2H])([2H])N(CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C)C([2H])([2H])C([2H])([2H])[2H],C22H27FN4O2,22614.0
9722,Zingerone,COc1cc(CCC(C)=O)ccc1O,C11H14O3,24909.0
9723,Molindone (hydrochloride),CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2.Cl,C16H25ClN2O2,23841.0
9724,Asterriquinol D dimethyl ether,COc1c(OC)c(-c2c[nH]c3ccccc23)c(OC)c(OC)c1-c1c[nH]c2ccccc12,C26H24N2O4,25080.0
9725,Procyanidin A2,Oc1cc(O)c2c(c1)O[C@@]1(c3ccc(O)c(O)c3)Oc3cc(O)c4c(c3[C@@H]2C1O)O[C@H](c1ccc(O)c(O)c1)[C@H](O)C4,C30H24O12,25200.0
9726,BMS 986205,C[C@@H](C(=O)Nc1ccc(Cl)cc1)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1,C24H24ClFN2O,25025.0
9727,WZ3146,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2Cl)c1,C24H25ClN6O2,23440.0
9728,Anamorelin,CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1,C31H42N6O3,24676.0
9729,Apixaban-13C-d3,[2H][13C]([2H])([2H])Oc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1,C25H25N5O4,25034.0
9730,RU-58841,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCCCO,C17H18F3N3O3,24680.0
9731,Voacangine,CC[C@H]1C[C@H]2C[N@]3CCc4c([nH]c5ccc(OC)cc45)[C@](C(=O)OC)(C2)[C@H]13,C22H28N2O3,24692.0
9732,GSK1838705A,CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12,C27H29FN8O3,24904.0
9733,XL413 (hydrochloride),Cl.O=c1nc([C@@H]2CCCN2)[nH]c2c1oc1ccc(Cl)cc12,C14H13Cl2N3O2,24906.0
9734,Fingolimod-d4,[2H]C([2H])(O)C(N)(CCc1ccc(CCCCCCCC)cc1)C([2H])([2H])O,C19H33NO2,25037.0
9735,Morphine-d3 (CRM),[2H]C([2H])([2H])N1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,C17H19NO3,24514.0
9736,Carbadox,COC(=O)N/N=C/c1c[n+]([O-])c2ccccc2[n+]1[O-],C11H10N4O4,24903.0
9737,Asperphenamate,O=C(N[C@H](COC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1)Cc1ccccc1)c1ccccc1,C32H30N2O4,25086.0
9738,LY3200882,CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccn1,C24H29N5O3,25276.0
9739,FUBIMINA N-pentanoic acid metabolite,O=C(O)CCCCn1c(C(=O)c2cccc3ccccc23)nc2ccccc21,C23H20N2O3,24469.0
9740,N-acetyl 25I-NBOMe,COc1cc(CCN(Cc2ccccc2OC)C(C)=O)c(OC)cc1I,C20H24INO4,24806.0
9741,AG-14361,CN(C)Cc1ccc(-c2nc3cccc4c3n2CCNC4=O)cc1,C19H20N4O,24677.0
9742,"L-Thyroxine-13C9,15N",[15NH2][13C@@H]([13CH2][13c]1[13cH][13c](I)[13c](Oc2cc(I)c(O)c(I)c2)[13c](I)[13cH]1)[13C](=O)O,C15H11I4NO4,25039.0
9743,Loratadine-d5,[2H]c1nc2c(c([2H])c1[2H])C([2H])([2H])Cc1cc(Cl)ccc1C2=C1CCN(C(=O)OCC)CC1,C22H23ClN2O2,25040.0
9744,Cisatracurium (besylate),COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,C65H82N2O18S2,22959.0
9745,Ticagrelor-d7,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])Sc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,C23H28F2N6O4S,25027.0
9746,Benzomalvin B,CN1C(=O)c2ccccc2-n2c(nc3ccccc3c2=O)/C1=C/c1ccccc1,C24H17N3O2,25088.0
9747,Aspochalasin M,CC1=C[C@@H]2/C=C(\C)CCC(=O)[C@@H](O)CCC(=O)[C@]23C(=O)N[C@@H](CC(C)C)[C@@H]3[C@@H]1C,C24H35NO4,25087.0
9748,14?-hydroxy Paspalinine,CC1(C)O[C@@]23CC[C@]4(C)[C@@]5(C)c6[nH]c7ccccc7c6C[C@@H]5C[C@H](O)[C@@]4(O)C2=CC(=O)[C@@H]1O3,C27H31NO5,25081.0
9749,Viridicatol,O=c1[nH]c2ccccc2c(-c2cccc(O)c2)c1O,C15H11NO3,25206.0
9750,C17 Globotriaosylceramide (d18:1/17:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCC,C53H99NO18,24876.0
9751,Benzomalvin A,CN1C(=O)c2ccccc2-n2c(nc3ccccc3c2=O)C1Cc1ccccc1,C24H19N3O2,25016.0
9752,Ezetimibe-d4,[2H]c1c([2H])c([C@@H](O)CC[C@H]2C(=O)N(c3ccc(F)cc3)[C@@H]2c2ccc(O)cc2)c([2H])c([2H])c1F,C24H21F2NO3,25044.0
9753,Globotetraosylceramide (porcine RBC),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4NC(C)=O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCCCCCCCC,C68H126N2O23,24881.0
9754,Palitantin,CCC/C=C/C=C/[C@@H]1C[C@@H](O)[C@@H](O)C(=O)[C@H]1CO,C14H22O4,25208.0
9755,Eupenifeldin,Cc1cc(=O)c(O)cc2c1C[C@H]1CC(C)(C)/C=C/C[C@]3(C)Oc4cc(O)c(=O)cc(C)c4C[C@H]3C[C@H](O)[C@@]1(C)O2,C33H40O7,25114.0
9756,"6(Z),9(Z),12(Z),15(Z),18(Z),21(Z)-Tetracosahexaenoic Acid",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O,C24H36O2,10005165.0
9757,Cochlioquinone B,CC[C@H](C)C(=O)[C@@H](C)C1=CC(=O)C2=C(O[C@]3(C)CC[C@H]4O[C@@H](C(C)(C)O)CC[C@]4(C)[C@H]3C2)C1=O,C28H40O6,25121.0
9758,ALW-II-41-27,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1,C32H32F3N5O2S,25275.0
9759,Duloxetine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])NCCC(Oc1cccc2ccccc12)c1cccs1,C18H20ClNOS,25229.0
9760,Metipranolol (hydrochloride),CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C.Cl,C17H28ClNO4,24003.0
9761,Valsartan-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C,C24H29N5O3,25226.0
9762,Nemorosone,CC(C)=CCC1=C(O)[C@@]2(C(=O)c3ccccc3)C(=O)[C@](CC=C(C)C)(C[C@H](CC=C(C)C)C2(C)C)C1=O,C33H42O4,24256.0
9763,Arformoterol (tartrate),COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C23H30N2O10,23935.0
9764,Lurasidone-d8,[2H]C1([2H])N(C[C@@H]2CCCC[C@H]2CN2C(=O)[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3C2=O)C([2H])([2H])C([2H])([2H])N(c2nsc3ccccc23)C1([2H])[2H],C28H36N4O2S,25222.0
9765,Cinnamamide,NC(=O)/C=C/c1ccccc1,C9H9NO,25117.0
9766,(+)-Nootkatone,C=C(C)[C@@H]1CCC2=CC(=O)C[C@@H](C)[C@]2(C)C1,C15H22O,24910.0
9767,PD 166793,CC(C)[C@H](NS(=O)(=O)c1ccc(-c2ccc(Br)cc2)cc1)C(=O)O,C17H18BrNO4S,23762.0
9768,3-hydroxy-PCP (hydrochloride),Cl.Oc1cccc(C2(N3CCCCC3)CCCCC2)c1,C17H26ClNO,14421.0
9769,Zuclopenthixol,OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1,C22H25ClN2OS,24961.0
9770,Petromurin C,COc1c(OC)c(-c2c[nH]c3ccc(O)cc23)c(OC)c(OC)c1-c1c[nH]c2ccccc12,C26H24N2O5,25089.0
9771,Vardenafil-d5,[2H]C([2H])([2H])C([2H])([2H])N1CCN(S(=O)(=O)c2ccc(OCC)c(-c3nc(=O)c4c(C)nc(CCC)n4[nH]3)c2)CC1,C23H32N6O4S,25225.0
9772,Trenbolone Acetate,CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@]12C,C20H24O3,24966.0
9773,"2,2,3,3-tetramethyl-Cyclopropyl fentanyl-d5",[2H]c1c([2H])c([2H])c(N(C(=O)C2C(C)(C)C2(C)C)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C27H36N2O,25133.0
9774,Boscalid,O=C(Nc1ccccc1-c1ccc(Cl)cc1)c1cccnc1Cl,C18H12Cl2N2O,24135.0
9775,Fusicoccin,C=CC(C)(C)OC[C@H]1O[C@H](O[C@@H]2C3=C(C(C)COC(C)=O)C[C@H](O)[C@]3(C)/C=C3/[C@@H](COC)CC[C@H]3[C@@H](C)[C@H]2O)[C@H](O)[C@@H](OC(C)=O)[C@@H]1O,C36H56O12,25020.0
9776,Unguisin B,CC(C)C[C@@H]1NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C)NC(=O)CCCNC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](C)NC(=O)[C@@H](C(C)C)NC1=O,C37H56N8O7,25115.0
9777,?2-Doramectin,CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C6CCCCC6)O5)O4)OC(=O)C4=C[C@H](C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,C50H74O14,25120.0
9778,4-Hydroxy-6-methyl-2-pyrone,Cc1cc(O)cc(=O)o1,C6H6O3,25210.0
9779,LYN-1604,CC(C)CN(CC(=O)N1CCN(CC(OCc2ccc3ccccc3c2)c2ccc(Cl)cc2Cl)CC1)CC(C)C,C33H43Cl2N3O2,24007.0
9780,MMB-FUBICA metabolite 3,CC(C)[C@H](NC(=O)c1cn(Cc2ccc(F)cc2)c2ccccc12)C(=O)O,C21H21FN2O3,24619.0
9781,Verbascoside,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,C29H36O15,24965.0
9782,Canagliflozin-d4,[2H]c1c([2H])c(-c2ccc(Cc3cc([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)ccc3C)s2)c([2H])c([2H])c1F,C24H25FO5S,25223.0
9783,Schizandrin B,COc1cc2c(c(OC)c1OC)-c1c(cc3c(c1OC)OCO3)CC(C)C(C)C2,C23H28O6,24968.0
9784,Captan,O=C1C2CC=CCC2C(=O)N1SC(Cl)(Cl)Cl,C9H8Cl3NO2S,24138.0
9785,Abietic Acid,CC(C)C1=CC2=CC[C@@H]3[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1,C20H30O2,24927.0
9786,?-BHC,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@H](Cl)[C@@H](Cl)[C@@H]1Cl,C6H6Cl6,24134.0
9787,Bromacil,CCC(C)n1c(=O)[nH]c(C)c(Br)c1=O,C9H13BrN2O2,24136.0
9788,MG624,CC[N+](CC)(CC)CCOc1ccc(/C=C/c2ccccc2)cc1.[I-],C22H30INO,24298.0
9789,Erythromycin-13C-d3,[2H][13C]([2H])([2H])N(C)[C@H]1C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)[C@@H]1O,C37H67NO13,25310.0
9790,Sulforhodamine 101 DHPE,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCNS(=O)(=O)c1ccc(-c2c3cc4c5c(c3[o+]c3c6c7c(cc23)CCCN7CCC6)CCCN5CCC4)c(S(=O)(=O)[O-])c1)OC(=O)CCCCCCCCCCCCCCC.CC[NH+](CC)CC,C74H117N4O14PS2,23235.0
9791,Lansoprazole-d4,[2H]c1c([2H])c([2H])c2[nH]c(S(=O)Cc3nccc(OCC(F)(F)F)c3C)nc2c1[2H],C16H14F3N3O2S,25227.0
9792,Dutasteride-13C6,C[C@]12C=CC(=O)N[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)N[13c]3[13cH][13c](C(F)(F)F)[13cH][13cH][13c]3C(F)(F)F)CC[C@@H]12,C27H30F6N2O2,25313.0
9793,PSC 833,C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,C63H111N11O12,20391.0
9794,Enalapril-d5 (maleate),O=C(O)/C=C\C(=O)O.[2H]c1c([2H])c([2H])c(CC[C@H](N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O)C(=O)OCC)c([2H])c1[2H],C24H32N2O9,25318.0
9795,Digoxin-d3,[2H]C1=C([C@H]2CC[C@]3(O)[C@@H]4CC[C@@H]5C[C@@H](O[C@H]6C[C@H](O)[C@H](O[C@H]7C[C@H](O)[C@H](O[C@H]8C[C@H](O)[C@H](O)[C@@H](C)O8)[C@@H](C)O7)[C@@H](C)O6)CC[C@]5(C)[C@H]4C[C@@H](O)[C@]23C)C([2H])([2H])OC1=O,C41H64O14,10010657.0
9796,Mycophenolate Mofetil-d4,[2H]C([2H])(OC(=O)CC/C(C)=C/Cc1c(O)c2c(c(C)c1OC)COC2=O)C([2H])([2H])N1CCOCC1,C23H31NO7,25281.0
9797,Cholesterol-d7,[2H]C([2H])([2H])C([2H])(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C([2H])([2H])[2H],C27H46O,25265.0
9798,Buprofezin,CC(C)N1C(=O)N(c2ccccc2)CS/C1=N\C(C)(C)C,C16H23N3OS,24137.0
9799,Bendiocarb,CNC(=O)Oc1cccc2c1OC(C)(C)O2,C11H13NO4,24133.0
9800,Naquotinib,C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1,C30H42N8O3,23498.0
9801,1448232-80-1,O=C(O)C[C@@H]1CC[C@H](NC(=O)Cc2cccs2)B(O)O1,C12H16BNO5S,23962.0
9802,Carbaryl,CNC(=O)Oc1cccc2ccccc12,C12H11NO2,24139.0
9803,Cannabigerovarin,CCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1,C19H28O2,9002437.0
9804,Cannabigerovarin (CRM),CCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1,C19H28O2,29117.0
9805,Allethrin,C=CCC1=C(C)C(OC(=O)C2C(C=C(C)C)C2(C)C)CC1=O,C19H26O3,24132.0
9806,"3,5-Dicaffeoylquinic Acid",O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,C25H24O12,24964.0
9807,Levonorgestrel-d6,[2H]C1=C2C([2H])([2H])C[C@H]3[C@@H]4CC[C@@](O)(C#C)[C@@]4(CC)CC[C@@H]3[C@@]2([2H])CC([2H])([2H])C1=O,C21H28O2,25231.0
9808,Methidathion,COc1nn(CSP(=S)(OC)OC)c(=O)s1,C6H11N2O4PS3,24144.0
9809,(S)-4'-nitro-Blebbistatin,Cc1ccc2c(c1)C(=O)[C@]1(O)CCN(c3ccc([N+](=O)[O-])cc3)C1=N2,C18H15N3O4,24171.0
9810,N-ethyl Hexylone (hydrochloride),CCCCC(NCC)C(=O)c1ccc2c(c1)OCO2.Cl,C15H22ClNO3,25315.0
9811,Triadimenol,CC(C)(C)C(O)C(Oc1ccc(Cl)cc1)n1cncn1,C14H18ClN3O2,24216.0
9812,"o,p'-DDE",ClC(Cl)=C(c1ccc(Cl)cc1)c1ccccc1Cl,C14H8Cl4,24235.0
9813,Chlorpheniramine (maleate),CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O,C20H23ClN2O4,21253.0
9814,Endosulfan sulfate,O=S1(=O)OCC2C(CO1)C1(Cl)C(Cl)=C(Cl)C2(Cl)C1(Cl)Cl,C9H6Cl6O4S,24255.0
9815,6-Bromo-2-oxindole,O=C1Cc2ccc(Br)cc2N1,C8H6BrNO,20041.0
9816,Itraconazole-d5,[2H]C([2H])([2H])C([2H])([2H])C(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,C35H38Cl2N8O4,25219.0
9817,20(R)-Ginsenoside Rg3,CC(C)=CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C42H72O13,24978.0
9818,Ibogaine (hydrochloride),CC[C@H]1C[C@@H]2C[C@H]3c4[nH]c5ccc(OC)cc5c4CC[N@@](C2)[C@@H]13.Cl,C20H27ClN2O,20083.0
9819,Ibogaine (hydrochloride) (CRM),CC[C@H]1C[C@@H]2C[C@H]3c4[nH]c5ccc(OC)cc5c4CC[N@@](C2)[C@@H]13.Cl,C20H27ClN2O,39570.0
9820,"1,2-Dilinoleoyl-sn-glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C39H68O5,25422.0
9821,VK3-OCH3,COCCSC1=C(C)C(=O)c2ccccc2C1=O,C14H14O3S,21476.0
9822,(-)-Gallocatechin Gallate,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,C22H18O11,24962.0
9823,Cannabigerovarinic Acid,CCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1C(=O)O,C20H28O4,25469.0
9824,Cannabigerovarinic Acid (CRM),CCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1C(=O)O,C20H28O4,29787.0
9825,Aconine,CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)C34C1C([C@H](OC)[C@@H]32)[C@]1(O)[C@@H]2[C@H]4C[C@](O)([C@@H]2O)[C@@H](OC)[C@@H]1O,C25H41NO9,25048.0
9826,Diazepam,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,C16H13ClN2O,15887.0
9827,FAI,Cc1occc1C(=O)n1ccnc1,C9H8N2O2,23429.0
9828,Isosakuranetin,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1,C16H14O5,25198.0
9829,NVS-PAK1-1,CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1,C23H25ClF3N5O,19964.0
9830,?-Mangostin,COc1cc2oc3cc(O)c(OC)c(CC=C(C)C)c3c(=O)c2c(O)c1CC=C(C)C,C25H28O6,25071.0
9831,Heptanoyl fentanyl (hydrochloride),CCCCCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C26H37ClN2O,25488.0
9832,Amantadine (hydrochloride),Cl.NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3,C10H18ClN,21364.0
9833,Chelidonine,CN1Cc2c(ccc3c2OCO3)[C@@H]2[C@H]1c1cc3c(cc1C[C@@H]2O)OCO3,C20H19NO5,25097.0
9834,Colchicine-d6,[2H]C([2H])([2H])Oc1ccc2c(cc1=O)[C@@H](NC(=O)C([2H])([2H])[2H])CCc1cc(OC)c(OC)c(OC)c1-2,C22H25NO6,25280.0
9835,Captopril-d3,[2H]C1([2H])CC[C@@]([2H])(C(=O)O)N1C(=O)[C@H](C)CS,C9H15NO3S,25235.0
9836,Thiamine (nitrate),Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1.O=[N+]([O-])[O-],C12H17N5O4S,25332.0
9837,(+)-Norpropoxyphene (maleate),CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CNC.O=C(O)/C=C\C(=O)O,C25H31NO6,15291.0
9838,(+)-Norpropoxyphene (maleate) (CRM),CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CNC.O=C(O)/C=C\C(=O)O,C25H31NO6,19047.0
9839,6-Acetylmorphine-d6 (CRM),[2H]C([2H])([2H])C(=O)O[C@H]1C=C[C@H]2[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3C([2H])([2H])[2H])[C@H]1O5,C19H21NO4,25518.0
9840,Chlorantraniliprole,CNC(=O)c1cc(Cl)cc(C)c1NC(=O)c1cc(Br)nn1-c1ncccc1Cl,C18H14BrCl2N5O2,24140.0
9841,Tannic Acid,O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,C76H52O46,21421.0
9842,Ginkgolide A,O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,C76H52O46,24970.0
9843,Baohuoside I,COc1ccc(-c2oc3c(CC=C(C)C)c(O)cc(O)c3c(=O)c2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)cc1,C27H30O10,25062.0
9844,Caftaric Acid,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](O)C(=O)O,C13H12O9,25090.0
9845,Meprobamate-d7,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C(C)(COC(N)=O)COC(N)=O,C9H18N2O4,18059.0
9846,Chlorfenapyr,CCOCn1c(-c2ccc(Cl)cc2)c(C#N)c(Br)c1C(F)(F)F,C15H11BrClF3N2O,24141.0
9847,Dihydroaeruginoic Acid,O=C(O)[C@H]1CSC(c2ccccc2O)=N1,C10H9NO3S,25514.0
9848,"o,p'-DDT",Clc1ccc(C(c2ccccc2Cl)C(Cl)(Cl)Cl)cc1,C14H9Cl5,24242.0
9849,Filipin II,CCCCCC[C@H]1C(=O)O[C@H](C)[C@@H](O)/C=C/C=C/C=C/C=C/C=C(\C)[C@@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O,C35H58O10,25521.0
9850,Cinacalcet-d3 (hydrochloride),Cl.[2H]C([2H])([2H])[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,C22H23ClF3N,25036.0
9851,Endosulfan II,O=[S@@]1OC[C@@H]2[C@H](CO1)[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl,C9H6Cl6O3S,24254.0
9852,PD 161570,CCN(CC)CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1,C26H35Cl2N7O,24681.0
9853,Sporidesmolide V,CC[C@H](C)[C@H]1NC(=O)[C@H](C(C)C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)OC(=O)[C@@H](CC(C)C)NC1=O,C35H62N4O8,25531.0
9854,Reveromycin B,CCCC[C@]1([C@H](/C=C/C(C)=C/C(=O)O)OC(=O)CCC(=O)O)CC[C@]2(CC[C@H](C)[C@@H](C/C=C(C)/C=C/[C@H](O)[C@@H](C)/C=C/C(=O)O)O2)O1,C36H52O11,25481.0
9855,Corynecin II,CCC(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1,C12H16N2O5,25461.0
9856,Nargenicin,CO[C@H]1C[C@H]2C=C[C@H]3[C@H]4O[C@]2(C(C)=C[C@@H](C)[C@@H]([C@@H](C)O)OC1=O)[C@@H]3[C@H](O)[C@@H](C)[C@H]4OC(=O)c1ccc[nH]1,C28H37NO8,25456.0
9857,Teleocidin A1,C=C[C@@](C)(CCC=C(C)C)c1ccc2c3c(c[nH]c13)C[C@@H](CO)NC(=O)[C@@H](C(C)C)N2C,C27H39N3O2,25482.0
9858,Notoginsenoside Ft1,CC(C)=CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4OC[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C47H80O17,24976.0
9859,Scutellarein,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c(O)c(O)c12,C15H10O6,24977.0
9860,Maltotetraose,O=C[C@H](O)[C@@H](O)[C@H](O[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,C24H42O21,24975.0
9861,Cyprodinil,Cc1cc(C2CC2)nc(Nc2ccccc2)n1,C14H15N3,24233.0
9862,Cryptochlorogenic Acid,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1O,C16H18O9,25098.0
9863,"15,16-Dihydrotanshinone I",Cc1cccc2c3c(ccc12)C1=C(C(=O)C3=O)[C@@H](C)CO1,C18H14O3,25051.0
9864,20-HEPE,O=C(O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCO,C20H30O3,19322.0
9865,Isotretinoin,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1,C20H28O2,21648.0
9866,Ticlopidine (hydrochloride),Cl.Clc1ccccc1CN1CCc2sccc2C1,C14H15Cl2NS,20770.0
9867,Calycosin 7-O-?-D-Glucoside,COc1ccc(-c2coc3cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)ccc3c2=O)cc1O,C22H22O10,25095.0
9868,Cefprozil,C/C=C/C1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1,C18H19N3O5S,23840.0
9869,Cymoxanil,CCNC(=O)NC(=O)/C(C#N)=N/OC,C7H10N4O3,24232.0
9870,5-bromo APINACA,O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(CCCCCBr)c2ccccc12,C23H30BrN3O,25209.0
9871,3-Bromopyruvic Acid,O=C(O)C(=O)CBr,C3H3BrO3,19068.0
9872,Pomalidomide-d5,[2H]C1([2H])C(=O)NC(=O)C([2H])(N2C(=O)c3cccc(N)c3C2=O)C1([2H])[2H],C13H11N3O4,25358.0
9873,Periplocin,CO[C@H]1C[C@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C36H56O13,25216.0
9874,"p,p'-DDD",Clc1ccc(C(c2ccc(Cl)cc2)C(Cl)Cl)cc1,C14H10Cl4,24234.0
9875,Azidamfenicol,[N-]=[N+]=NCC(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1,C11H13N5O5,25449.0
9876,Cycloechinulin,COc1ccc2c3c([nH]c2c1)C(C)(C)/C=C\N1C(=O)[C@H](C)NC(=O)/C1=C/3,C20H21N3O3,25455.0
9877,4-octyl Itaconate,C=C(CC(=O)OCCCCCCCC)C(=O)O,C13H22O4,25374.0
9878,Nodakenin,CC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1Cc2cc3ccc(=O)oc3cc2O1,C20H24O9,25213.0
9879,Drimentine B,C=C1CC[C@H]2C(C)(C)CCC[C@]2(C)[C@H]1C[C@@]12C[C@H]3C(=O)N4CCC=C4C(=O)N3[C@@H]1Nc1ccccc12,C31H39N3O2,25451.0
9880,Saikosaponin A,C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@]4(C)[C@@H]3C=C[C@]35OC[C@@]6(CCC(C)(C)C[C@H]63)[C@@H](O)C[C@]54C)[C@]2(C)CO)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O,C42H68O13,25026.0
9881,"Cefazolin-13C2,15N",Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](N[13C](=O)[13CH2][15n]4cnnn4)[C@H]3SC2)s1,C14H14N8O4S3,25319.0
9882,7?-hydroxy Cholesterol-d7,[2H]C([2H])([2H])C([2H])(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C([2H])([2H])[2H],C27H46O2,25547.0
9883,MitoPBN,CC(C)(C)/[N+]([O-])=C/c1ccc(OCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1.[Br-],C33H37BrNO2P,18809.0
9884,Thiophene fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)c2cccs2)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C24H27ClN2OS,25135.0
9885,Metronidazole-d4,[2H]C([2H])(O)C([2H])([2H])n1c([N+](=O)[O-])cnc1C,C6H9N3O3,10010659.0
9886,Phenyl fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)c2ccccc2)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C26H29ClN2O,25134.0
9887,Phenyl fentanyl-d5 (hydrochloride) (exempt preparation),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)c2ccccc2)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C26H29ClN2O,39197.0
9888,22-HDHA,O=C(O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCO,C22H32O3,19321.0
9889,Corynecin III,CC(C)C(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1,C13H18N2O5,25450.0
9890,Alprenolol,C=CCc1ccccc1OCC(O)CNC(C)C,C15H23NO2,25338.0
9891,3-Cyano-7-ethoxycoumarin,CCOc1ccc2cc(C#N)c(=O)oc2c1,C12H9NO3,25441.0
9892,Epiequisetin,C/C=C/[C@@H]1C=C[C@@H]2C[C@H](C)CC[C@H]2[C@]1(C)/C(O)=C1/C(=O)[C@@H](CO)N(C)C1=O,C22H31NO4,25454.0
9893,Pestalotin,CCCC[C@H](O)[C@@H]1CC(OC)=CC(=O)O1,C11H18O4,25516.0
9894,GPR39-C3,CNc1nc(NCc2ccc(NS(C)(=O)=O)cc2Cl)cc(-c2ccccn2)n1,C18H19ClN6O2S,25445.0
9895,Chloramphenicol Succinate,O=C(O)CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1,C15H16Cl2N2O8,25453.0
9896,2'-methyl Fentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2C)CC1.Cl,C23H31ClN2O,25475.0
9897,Viridicatumtoxin,COc1cc(O)c2c(O)c3c(c4c2c1[C@@]1(C4)C(C)=CCCC1(C)C)[C@H](O)[C@@]1(O)CC(O)=C(C(N)=O)C(=O)[C@@]1(O)C3=O,C30H31NO10,25480.0
9898,Leucanicidin,CO/C1=C\C(C)=C/[C@@H](C)[C@@H](O)[C@@H](C)C/C(C)=C\C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3OC)[C@H](C)[C@@H](C(C)C)O2)OC1=O,C42H70O13,25479.0
9899,Blasticidin A,CCCCCCCCCC[C@@H](O)C[C@]1(O)O[C@H](C[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](O)C[C@@H](O)[C@H](C)[C@@H](O)[C@H](O)C[C@H](C)C[C@H](C)/C=C(C)/C(O)=C2\C(=O)CN(C)C2=O)[C@@H](O)[C@H](O)[C@@H]1O,C58H107NO23,25519.0
9900,Delpazolid,CN1CCN(c2ccc(N3C[C@H](CO)OC3=O)cc2F)C=N1,C14H17FN4O3,25532.0
9901,CPI-444,Cc1ccc(-c2nc(N)nc3c2nnn3Cc2cccc(CO[C@H]3CCOC3)n2)o1,C20H21N7O3,25024.0
9902,"p,p'-DDE",ClC(Cl)=C(c1ccc(Cl)cc1)c1ccc(Cl)cc1,C14H8Cl4,24241.0
9903,Atractylenolide III,C=C1CCC[C@]2(C)C[C@]3(O)OC(=O)C(C)=C3C[C@@H]12,C15H20O3,24911.0
9904,Phenoxyacetyl fentanyl (hydrochloride),Cl.O=C(COc1ccccc1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C27H31ClN2O2,25604.0
9905,Gemfibrozil 1-O-?-Glucuronide,Cc1ccc(C)c(OCCCC(C)(C)C(=O)O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)c1,C21H30O9,19080.0
9906,Isoquercetin,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,C21H20O12,24926.0
9907,"3-chloro-N,N-Dimethylcathinone (hydrochloride)",CC(C(=O)c1cccc(Cl)c1)N(C)C.Cl,C11H15Cl2NO,24847.0
9908,4-methoxy PCE (hydrochloride),CCNC1(c2ccc(OC)cc2)CCCCC1.Cl,C15H24ClNO,9001356.0
9909,MLE-4901,CC[C@H](NC(=O)c1c(NS(C)(=O)=O)c(-c2ccccc2)nc2ccccc12)c1ccccc1,C26H25N3O3S,23587.0
9910,Benzodioxole fentanyl-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)c2ccc3c(c2)OCO3)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C27H29ClN2O3,25131.0
9911,Alizarin-3-methyliminodiacetic Acid,O=C(O)CN(CC(=O)O)Cc1cc2c(c(O)c1O)C(=O)c1ccccc1C2=O,C19H15NO8,22890.0
9912,Lopinavir-d8,[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])(C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)COc1c(C)cccc1C)N1CCCNC1=O,C37H48N4O5,25284.0
9913,Chicoric Acid,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,C22H18O12,24960.0
9914,Kinsenoside,O=C1C[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)CO1,C10H16O8,25144.0
9915,"2-chloro-N,N-Dimethylcathinone (hydrochloride)",CC(C(=O)c1ccccc1Cl)N(C)C.Cl,C11H15Cl2NO,24846.0
9916,"2,3-seco-Fentanyl (hydrochloride)",CCC(=O)N(c1ccccc1)C(C)CCN(C)CCc1ccccc1.Cl,C22H31ClN2O,25092.0
9917,Tiotropium-d3 (bromide),[2H]C([2H])([2H])[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.[Br-],C19H22BrNO4S2,25285.0
9918,"CP 466,722",COc1cc2ncnc(-n3nc(-c4ccccn4)nc3N)c2cc1OC,C17H15N7O2,25417.0
9919,Indomethacin-d4,[2H]c1c([2H])c(C(=O)n2c(C)c(CC(=O)O)c3cc(OC)ccc32)c([2H])c([2H])c1Cl,C19H16ClNO4,25434.0
9920,Prochlorperazine (maleate),CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,C28H32ClN3O8S,20742.0
9921,Voacamine,C/C=C1\CN(C)[C@H]2Cc3c([nH]c4ccccc34)[C@@H](c3cc4[nH]c5c(c4cc3OC)CC[N@@]3C[C@@H]4C[C@H](CC)[C@H]3[C@@]5(C(=O)OC)C4)C[C@@H]1[C@@H]2C(=O)OC,C43H52N4O5,25204.0
9922,3'-methyl Fentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CCc2cccc(C)c2)CC1.Cl,C23H31ClN2O,25476.0
9923,AMG 47a,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1,C29H28F3N5O2,25339.0
9924,Iloperidone,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,C24H27FN2O4,22957.0
9925,Lithocholic Acid 3-sulfate (sodium salt),C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@]12C.[Na+].[Na+],C24H38Na2O6S,20676.0
9926,Tazobactam,C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O,C10H12N4O5S,25679.0
9927,Aucubin,OCC1=C[C@@H](O)[C@@H]2C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]12,C15H22O9,24928.0
9928,DEL-22379,COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(NC(=O)CCN5CCCCC5)cc43)c2c1,C26H28N4O3,22433.0
9929,5-O-Caffeoylquinic Acid,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@@](O)(C(=O)O)C[C@@H](O)[C@@H]1O,C16H18O9,25054.0
9930,N-Acetyltyramine,CC(=O)NCCc1ccc(O)cc1,C10H13NO2,9001373.0
9931,Liraglutide (acetate),CC(=O)O.CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)C(=O)O,C174H269N43O53,24727.0
9932,Spinosyn A 17-pseudoaglycone,CC[C@H]1CCC[C@H](O)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1,C33H50O9,25530.0
9933,Luteoreticulin,COc1cc(/C(C)=C/C(C)=C/c2ccc([N+](=O)[O-])cc2)oc(=O)c1C,C19H19NO5,25515.0
9934,Herbimycin C,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,C29H40N2O9,25485.0
9935,Galactitol,OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)CO,C6H14O6,25023.0
9936,"2,3-Dimethoxy-5-methyl-p-benzoquinone",COC1=C(OC)C(=O)C(C)=CC1=O,C9H10O4,20504.0
9937,ONO-7300243,COc1cc(C(=O)N(CCCc2ccccc2)Cc2ccc(CC(=O)O)cc2)cc(OC)c1C,C28H31NO5,22052.0
9938,Rimantadine (hydrochloride),CC(N)C12CC3CC(CC(C3)C1)C2.Cl,C12H22ClN,23838.0
9939,(-)-Isoxanthohumol,COc1cc(O)c(CC=C(C)C)c2c1C(=O)C[C@@H](c1ccc(O)cc1)O2,C21H22O5,25105.0
9940,Propyl U-47700,CCCN(C(=O)c1ccc(Cl)c(Cl)c1)[C@@H]1CCCC[C@H]1N(C)C,C18H26Cl2N2O,24434.0
9941,Biotin-LC-LC-NHS,O=C(CCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)NCCCCCC(=O)ON1C(=O)CCC1=O,C26H41N5O7S,18887.0
9942,Piromidic Acid,CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21,C14H16N4O3,19255.0
9943,Mangiferin,O=c1c2cc(O)c(O)cc2oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,C19H18O11,22360.0
9944,?-Myrcene,C=CC(=C)CCC=C(C)C,C10H16,21720.0
9945,Amiodarone-d4 (hydrochloride),Cl.[2H]C([2H])(Oc1c(I)cc(C(=O)c2c(CCCC)oc3ccccc23)cc1I)C([2H])([2H])N(CC)CC,C25H30ClI2NO3,10010668.0
9946,Dehydroevodiamine (hydrochloride),CN1C2=C3N=c4ccccc4=C3CCN2C(=O)c2ccccc21.Cl,C19H16ClN3O,25101.0
9947,Deacetylasperulosidic Acid,O=C(O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2C(CO)=C[C@H](O)[C@H]12,C16H22O11,25100.0
9948,(+)-Isopulegol,C=C(C)[C@H]1CC[C@H](C)C[C@@H]1O,C10H18O,23160.0
9949,(1R)-(+)-Camphor,CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2,C10H16O,23175.0
9950,Palmitoleic Acid Alkyne,C#CCCCC/C=C\CCCCCCCC(=O)O,C16H26O2,25362.0
9951,Soyasaponin Bb,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3[C@H](O[C@H]4CC[C@@]5(C)[C@@H](CC[C@]6(C)[C@@H]5CC=C5[C@@H]7CC(C)(C)C[C@@H](O)[C@]7(C)CC[C@]56C)[C@@]4(C)CO)O[C@H](C(=O)O)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C48H78O18,25140.0
9952,Cetylpyridinium (chloride),CCCCCCCCCCCCCCCC[n+]1ccccc1.[Cl-],C21H38ClN,21983.0
9953,"(E)-2-(2-Chlorostyryl)-3,5,6-trimethylpyrazine",Cc1nc(C)c(/C=C/c2ccccc2Cl)nc1C,C15H15ClN2,9003202.0
9954,"1,5-Dicaffeoylquinic Acid",O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@@H](O)[C@H]1O,C25H24O12,25050.0
9955,Venturicidin B,CCC(=O)[C@@H](C)[C@@H](O)[C@H](C)C[C@@H](C)[C@H]1OC(=O)C[C@@]2(O)CC=C(C)[C@H](O2)/C(C)=C\CCC[C@@H](O[C@H]2C[C@@H](O)[C@H](O)[C@@H](C)O2)/C=C/[C@H](C)C[C@H]1C,C40H66O10,25478.0
9956,Sennoside A,O=C(O)c1cc(O)c2c(c1)[C@H]([C@H]1c3cc(C(=O)O)cc(O)c3C(=O)c3c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cccc31)c1cccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c1C2=O,C42H38O20,24969.0
9957,(+)-Valencene,C=C(C)[C@@H]1CCC2=CCC[C@@H](C)[C@]2(C)C1,C15H24,23167.0
9958,CCT196969,CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)cc2F)n(-c2ccccc2)n1,C27H24FN7O3,25537.0
9959,(+)-?-Citronellol,CC(C)=CCC[C@@H](C)CCO,C10H20O,23464.0
9960,Mps1/TTK Inhibitor,CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc1-2,C33H40N8O2,25554.0
9961,AHU377-d4,[2H]C([2H])(C(=O)O)C([2H])([2H])C(=O)N[C@H](Cc1ccc(-c2ccccc2)cc1)C[C@@H](C)C(=O)OCC,C24H29NO5,25264.0
9962,Carvedilol-d5,[2H]C([2H])(NCCOc1ccccc1OC)C([2H])(O)C([2H])([2H])Oc1cccc2[nH]c3ccccc3c12,C24H26N2O4,25218.0
9963,Chevalone C,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)Oc5oc(C)cc(=O)c5C[C@H]4[C@]3(C)CC[C@H]2C1(C)C,C28H40O5,25084.0
9964,Acetylaszonalenin,C=CC(C)(C)[C@]12C[C@@H]3C(=O)Nc4ccccc4C(=O)N3[C@H]1N(C(C)=O)c1ccccc12,C25H25N3O3,25207.0
9965,N-acetyl Histamine,CC(=O)NCCc1c[nH]cn1,C7H11N3O,25118.0
9966,3-methyl Orsellinic Acid,Cc1cc(O)c(C)c(O)c1C(=O)O,C9H10O4,25113.0
9967,Chevalone B,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)Oc5cc(C)oc(=O)c5C[C@H]4[C@]3(C)CC[C@H]2C1(C)C,C28H40O5,25083.0
9968,FIN56,O=S(=O)(NC1CCCCC1)c1ccc2c(c1)C(=NO)c1cc(S(=O)(=O)NC3CCCCC3)ccc1-2,C25H31N3O5S2,25180.0
9969,Secoisolariciresinol Diglucoside,COc1cc(C[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)Cc2ccc(O)c(OC)c2)ccc1O,C32H46O16,24974.0
9970,Catalpol,OC[C@H]1O[C@@H](O[C@@H]2OC=C[C@H]3[C@H](O)[C@@H]4O[C@]4(CO)[C@@H]23)[C@H](O)[C@@H](O)[C@@H]1O,C15H22O10,24925.0
9971,Evacetrapib,Cc1cc(C)c2c(c1)[C@@H](N(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1nnn(C)n1)CCCN2C[C@H]1CC[C@H](C(=O)O)CC1,C31H36F6N6O2,23670.0
9972,Acetochlor,CCOCN(C(=O)CCl)c1c(C)cccc1CC,C14H20ClNO2,24131.0
9973,N-benzyl Furanyl norfentanyl (hydrochloride),Cl.O=C(c1ccco1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1,C23H25ClN2O2,25239.0
9974,Colivelin,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O,C119H206N32O35,24239.0
9975,Bromantane,Brc1ccc(NC2C3CC4CC(C3)CC2C4)cc1,C16H20BrN,24688.0
9976,Salbutamol-d9,[2H]C([2H])([2H])C(NCC(O)c1ccc(O)c(CO)c1)(C([2H])([2H])[2H])C([2H])([2H])[2H],C13H21NO3,25234.0
9977,rac-Aprepitant-d4,[2H]c1c([2H])c(C2C(OC(C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)OCCN2Cc2n[nH]c(=O)[nH]2)c([2H])c([2H])c1F,C23H21F7N4O3,25232.0
9978,(-)-Catechin Gallate,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@H]1c1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1,C22H18O10,24963.0
9979,Chlorothalonil,N#Cc1c(Cl)c(Cl)c(Cl)c(C#N)c1Cl,C8Cl4N2,24142.0
9980,Isoginkgetin,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4OC)c3o2)cc1,C32H22O10,25104.0
9981,Ginsenoside Ro,CC1(C)CC[C@]2(C(=O)O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,C48H76O19,25137.0
9982,Capecitabine-d11,CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)C(O)C2O)cc1F,C15H22FN3O6,10010681.0
9983,Darunavir-d9,[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])N(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,C27H37N3O7S,25220.0
9984,Geranyl Acetate,CC(=O)OC/C=C(\C)CCC=C(C)C,C12H20O2,22184.0
9985,Oleic Acid (sodium salt),CCCCCCCC/C=C\CCCCCCCC(=O)[O-].[Na+],C18H33NaO2,24659.0
9986,Candesartan-d4,[2H]c1c([2H])c(-c2ccccc2-c2nnn[nH]2)c([2H])c([2H])c1Cn1c(OCC)nc2cccc(C(=O)O)c21,C24H20N6O3,25419.0
9987,Nomilin,CC(=O)O[C@H]1CC(=O)OC(C)(C)[C@@H]2CC(=O)[C@]3(C)[C@H](CC[C@@]4(C)[C@H](c5ccoc5)OC(=O)[C@H]5O[C@]543)[C@@]12C,C28H34O9,20836.0
9988,PD 334581,Fc1cc(I)ccc1Nc1c(-c2nnc(NCCN3CCOCC3)o2)ccc(F)c1F,C20H19F3IN5O2,14970.0
9989,N?-(1-Carboxyethyl)-L-lysine,CC(NCCCC[C@H](N)C(=O)O)C(=O)O,C9H18N2O4,25333.0
9990,AMTB,Cc1cccc(COc2ccccc2C(=O)N(CCCN)Cc2cccs2)c1.Cl,C23H27ClN2O2S,25336.0
9991,YU238259,COc1ccc(S(=O)(=O)NCc2ccc(C(=O)NCCc3ccc(Cl)cn3)cc2)cc1,C22H22ClN3O4S,25452.0
9992,Coelenterazine 400a (hydrochloride),Cl.O=c1c(Cc2ccccc2)nc2c(Cc3ccccc3)[nH]c(-c3ccccc3)cn1-2,C26H22ClN3O,25738.0
9993,(-)-Isopulegol,C=C(C)[C@@H]1CC[C@@H](C)C[C@H]1O,C10H18O,23161.0
9994,(-)-Guaiol,C[C@H]1CC[C@@H](C(C)(C)O)CC2=C1CC[C@@H]2C,C15H26O,23172.0
9995,Desmethylcitalopram-d3 (hydrochloride),Cl.[2H]C([2H])([2H])NCCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,C19H20ClFN2O,15840.0
9996,AZ 33,Cc1nc2ccc(NC(=O)CCNC(=O)CCCc3ccc(CC(C(=O)O)C(=O)O)cc3)cc2s1,C25H27N3O6S,25444.0
9997,PKC-9,CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1,C25H25N7,25556.0
9998,Sumanirole (maleate),CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1.O=C(O)/C=C\C(=O)O,C15H17N3O5,11984.0
9999,Thiocolchicine,COc1cc2c(c(OC)c1OC)-c1ccc(SC)c(=O)cc1[C@@H](NC(C)=O)CC2,C22H25NO5S,17427.0
10000,Talampanel,CC(=O)N1N=C(c2ccc(N)cc2)c2cc3c(cc2C[C@H]1C)OCO3,C19H19N3O3,15341.0
10001,2-fluoro MT-45 (hydrochloride),Cl.Cl.Fc1ccccc1C(Cc1ccccc1)N1CCN(C2CCCCC2)CC1,C24H33Cl2FN2,25288.0
10002,A-971432,O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1,C18H17Cl2NO3,25326.0
10003,Didymin,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1,C28H34O14,25197.0
10004,Hexanoyl fentanyl (hydrochloride),CCCCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C25H35ClN2O,23751.0
10005,TRO 19622,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H45NO,21264.0
10006,VU0467154,Cc1nnc2sc(C(=O)NCc3ccc(S(=O)(=O)C(F)(F)F)cc3)c(N)c2c1C,C17H15F3N4O3S2,25555.0
10007,CCT241161,CSc1cc(Oc2ccnc3[nH]c(=O)cnc23)ccc1NC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1,C28H27N7O3S,25536.0
10008,EOS200271,O=C1CC(c2c[nH]c3ccc(F)cc23)C(=O)N1,C12H9FN2O2,25003.0
10009,4-ethyl Pentedrone (hydrochloride),CCCC(NC)C(=O)c1ccc(CC)cc1.Cl,C14H22ClNO,22993.0
10010,Kaempferol-3-glucoside,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,C21H20O11,25060.0
10011,Deltamethrin,CC1(C)[C@H](C(=O)O[C@H](C#N)c2cccc(Oc3ccccc3)c2)[C@@H]1C=C(Br)Br,C22H19Br2NO3,24172.0
10012,Bifenthrin,Cc1c(COC(=O)[C@@H]2[C@H](/C=C(\Cl)C(F)(F)F)C2(C)C)cccc1-c1ccccc1,C23H22ClF3O2,24057.0
10013,25E-NBOH (hydrochloride),CCc1cc(OC)c(CCNCc2ccccc2O)cc1OC.Cl,C19H26ClNO3,20075.0
10014,AM095,Cc1noc(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)c1NC(=O)O[C@H](C)c1ccccc1,C27H24N2O5,22141.0
10015,4-(Neopentyloxysulfonyl)phenylboronic Acid,CC(C)(C)COS(=O)(=O)c1ccc(B(O)O)cc1,C11H17BO5S,21493.0
10016,Calycosin,COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1O,C16H12O5,25091.0
10017,Cyfluthrin,CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1ccc(F)c(Oc2ccccc2)c1,C22H18Cl2FNO3,24231.0
10018,Sarsasapogenin,C[C@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C27H44O3,24973.0
10019,"3,4-Dicaffeoylquinic Acid",O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1[C@H](O)C[C@@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,C25H24O12,25053.0
10020,Nonivamide,CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1,C17H27NO3,25328.0
10021,4-Methylumbelliferyl 2-Acetamido-2-deoxy-?-D-galactopyranoside,CC(=O)N[C@H]1[C@@H](Oc2ccc3c(C)cc(=O)oc3c2)O[C@H](CO)[C@H](O)[C@@H]1O,C18H21NO8,23099.0
10022,Setosusin,CC(=O)O[C@H]1CC(=O)OC(C)(C)[C@@H]2CC[C@]3(C)[C@H](CC=C(C)[C@@]34C[C@]3(OC(C)=C(C)C3=O)C(=O)O4)[C@@]12C,C29H38O8,25484.0
10023,Anhydroophiobolin A,CC(C)=C[C@H]1C[C@H](C)[C@]2(CC[C@]3(C)C[C@@H]4C(C)=CC(=O)[C@@H]4/C(C=O)=C\C[C@H]32)O1,C25H34O3,25483.0
10024,(-)-Rugulosin,Cc1cc(O)c2c(c1)C(=O)[C@]13C(=C(O)[C@@H]4[C@H](O)[C@H]1[C@@H]1[C@@H](O)[C@H]3C(O)=C3C(=O)c5c(O)cc(C)cc5C(=O)[C@]314)C2=O,C30H22O10,25477.0
10025,SSR 240612,COc1ccc2cc(S(=O)(=O)N[C@H](CC(=O)N[C@H](Cc3ccc(CN4[C@H](C)CCC[C@@H]4C)cc3)C(=O)N(C)C(C)C)c3ccc4c(c3)OCO4)ccc2c1.Cl,C42H53ClN4O7S,25544.0
10026,Ceralifimod,CCCc1ccc(COc2ccc3c(c2)CCC(CN2CC(C(=O)O)C2)=C3C)c(OC)c1,C27H33NO4,24159.0
10027,NCH-51,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(-c2ccccc2)cs1,C20H26N2O2S2,21234.0
10028,?-Carotene,CC1=CCCC(C)(C)[C@H]1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C,C40H56,19772.0
10029,(-)-Voacangarine,COC(=O)[C@@]12C[C@H]3C[C@H]([C@H](C)O)[C@@H]1[N@@](CCc1c2[nH]c2ccc(OC)cc12)C3,C22H28N2O4,25468.0
10030,Flurbiprofen-d3,[2H]C([2H])([2H])C(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,C15H13FO2,25277.0
10031,"Phosphatidylinositol (plant, soy) (sodium salt)",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@@H](COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC.[Na+],C45H78NaO13P,24523.0
10032,MTIC,CN/N=N/c1[nH]cnc1C(N)=O,C5H8N6O,18863.0
10033,L-hydroxy Arginine (acetate),CC(=O)[O-].N=C(NO)NCCC[C@H]([NH3+])C(=O)O,C8H18N4O5,80300.0
10034,Umeclidinium (bromide),OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2.[Br-],C29H34BrNO2,20700.0
10035,Acridine Orange 10-nonyl (bromide),CCCCCCCCC[n+]1c2cc(N(C)C)ccc2cc2ccc(N(C)C)cc21.[Br-],C26H38BrN3,25545.0
10036,Sinapic Acid,COc1cc(/C=C/C(=O)O)cc(OC)c1O,C11H12O5,25457.0
10037,Amprolium (hydrochloride),CCCc1ncc(C[n+]2ccccc2C)c(N)n1.Cl.[Cl-],C14H20Cl2N4,25506.0
10038,3-fluoro MT-45 (hydrochloride),Cl.Cl.Fc1cccc(C(Cc2ccccc2)N2CCN(C3CCCCC3)CC2)c1,C24H33Cl2FN2,25289.0
10039,Decursin,CC(C)=CC(=O)O[C@H]1Cc2cc3ccc(=O)oc3cc2OC1(C)C,C19H20O5,25214.0
10040,Tilfrinib,Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1,C17H13N3O,25647.0
10041,Cannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2,C21H26O2,25495.0
10042,Cannabinol (Alt. Batch CRM),CCCCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2,C21H26O2,42139.0
10043,7-Diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin,CCN(CC)c1ccc2c(C)c(-c3ccc(N4C(=O)C=CC4=O)cc3)c(=O)oc2c1,C24H22N2O4,18209.0
10044,Fluorescein Biotin,O=C(CCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)NCCCCCNC(=S)Nc1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21,C42H50N6O8S2,25574.0
10045,Ceftibuten (hydrate),Nc1nc(/C(=C/CC(=O)O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=CCS[C@H]23)cs1,C15H14N4O6S2,25334.0
10046,"(R,S)-BHFF",CC(C)(C)c1cc(C(C)(C)C)c2c(c1)C(O)(C(F)(F)F)C(=O)O2,C17H21F3O3,25535.0
10047,GSK2033,Cc1cc(C)c(S(=O)(=O)N(Cc2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)Cc2ccc(C(F)(F)F)o2)c(C)c1,C29H28F3NO5S2,25443.0
10048,17?-Methyltestosterone,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H30O2,24080.0
10049,Lalistat 2,O=C(Oc1nsnc1N1CCCCC1)N1CCCCC1,C13H20N4O2S,25347.0
10050,Orientin,O=c1cc(-c2ccc(O)c(O)c2)oc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc(O)c12,C21H20O11,25143.0
10051,NVS-PAK1-C,CN(C)C(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1,C22H23ClF3N5O,19965.0
10052,BMS 986122,COc1ccc(C2SCCN2S(=O)(=O)c2ccc(Cl)cc2)cc1Br,C16H15BrClNO3S2,23269.0
10053,CCG-232601,O=C(Nc1ccc(Cl)cc1)C1CN(C(=O)c2cccc(-c3ccncc3)c2)CC(F)(F)C1,C24H20ClF2N3O2,24382.0
10054,Chlorpyrifos-methyl,COP(=S)(OC)Oc1nc(Cl)c(Cl)cc1Cl,C7H7Cl3NO3PS,24227.0
10055,Sertindole,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,C24H26ClFN4O,23883.0
10056,U-62066 (mesylate),CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1.CS(=O)(=O)O,C23H34Cl2N2O5S,25072.0
10057,Ampicillin-d5,[2H]c1c([2H])c([2H])c(C(N)C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c([2H])c1[2H],C16H19N3O4S,25356.0
10058,SRS11-92,CCOC(=O)c1ccc(NC2CCCCC2)c(NCc2ccccc2)c1,C22H28N2O2,25689.0
10059,Luteoloside,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c12,C21H20O11,25141.0
10060,Decursinol angelate,C/C=C(/C)C(=O)O[C@H]1Cc2cc3ccc(=O)oc3cc2OC1(C)C,C19H20O5,25212.0
10061,TX1-85-1,C=CC(=O)Nc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1Oc1ccccc1,C32H36N8O3,19164.0
10062,AF-DX 384,CCCN(CCC)CC1CCCCN1CCNC(=O)N1c2ccccc2C(=O)Nc2cccnc21,C27H38N6O2,25638.0
10063,Hederacoside C,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CC[C@]6(C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O)CC[C@]45C)[C@]3(C)CO)OC[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C59H96O26,25138.0
10064,Phen Green SK diacetate,CC(=O)Oc1cc2c(cc1Cl)C1(OC(=O)c3cc(C(=O)Nc4cc5cccnc5c5ncccc45)ccc31)c1cc(Cl)c(OC(C)=O)cc1O2,C37H21Cl2N3O8,25393.0
10065,Propiconazole,CCCC1COC(Cn2cncn2)(c2ccc(Cl)cc2Cl)O1,C15H17Cl2N3O2,18853.0
10066,Tetrahydrocurcumin,COc1cc(CCC(=O)CC(=O)CCc2ccc(O)c(OC)c2)ccc1O,C21H24O6,11757.0
10067,Dimethoate,CNC(=O)CSP(=S)(OC)OC,C5H12NO3PS2,24246.0
10068,Despropionyl para-Methylfentanyl,Cc1ccc(NC2CCN(CCc3ccccc3)CC2)cc1,C20H26N2,25745.0
10069,20(R)-Protopanaxadiol,CC(C)=CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,C30H52O3,25052.0
10070,Theaflavin,O=c1c(O)cc([C@H]2Oc3cc(O)cc(O)c3C[C@H]2O)cc2c([C@H]3Oc4cc(O)cc(O)c4C[C@H]3O)cc(O)c(O)c12,C29H24O12,25129.0
10071,Spirotetramat,CCOC(=O)OC1=C(c2cc(C)ccc2C)C(=O)N[C@]12CC[C@@H](OC)CC2,C21H27NO5,25634.0
10072,0568224,CCOC(=O)OC1=C(c2cc(C)ccc2C)C(=O)N[C@]12CC[C@@H](OC)CC2,C21H27NO5,39351.0
10073,SCH 39166 (hydrobromide),Br.CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21,C19H21BrClNO,25331.0
10074,BODIPY 480/508-Cholesterol,CC1=CC(C)=[N+]2C1=C(CC[C@@H](C)[C@H]1CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]13C)c1c(C)cc(C)n1[B-]2(F)F,C36H51BF2N2O,24618.0
10075,Ciprofloxacin-d8 (hydrochloride),Cl.[2H]C1([2H])NC([2H])([2H])C([2H])([2H])N(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C1([2H])[2H],C17H19ClFN3O3,25466.0
10076,Mitraphylline,COC(=O)C1=CO[C@@H](C)[C@H]2CN3CC[C@]4(C(=O)Nc5ccccc54)[C@@H]3C[C@H]12,C21H24N2O4,25528.0
10077,Clopyralid,O=C(O)c1nc(Cl)ccc1Cl,C6H3Cl2NO2,24229.0
10078,7?-hydroxy-4-Cholesten-3-one,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)CC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H44O2,25442.0
10079,Diniconazole,CC(C)(C)C(O)/C(=C\c1ccc(Cl)cc1Cl)n1cncn1,C15H17Cl2N3O,24248.0
10080,Spinosad,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C(C)[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1,C83H132N2O20,25649.0
10081,Spinosad (CRM),CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C(C)[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1,C83H132N2O20,39349.0
10082,(S)-3'-hydroxy Blebbistatin,Cc1ccc2c(c1)C(=O)[C@]1(O)CCN(c3cccc(O)c3)C1=N2,C18H16N2O3,24169.0
10083,Artemisinin-d3,[2H]C([2H])([2H])[C@H]1C(=O)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,C15H22O5,25359.0
10084,Cefpodoxime-d3,[2H]C([2H])([2H])O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC)CS[C@H]12)c1csc(N)n1,C15H17N5O6S2,25412.0
10085,Carbofuran,CNC(=O)Oc1cccc2c1OC(C)(C)C2,C12H15NO3,25635.0
10086,Entacapone-d10,[2H]C([2H])([2H])C([2H])([2H])N(C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1)C([2H])([2H])C([2H])([2H])[2H],C14H15N3O5,10010571.0
10087,N-(3-ethylindole) Norfentanyl,CCC(=O)N(c1ccccc1)C1CCN(CCc2c[nH]c3ccccc23)CC1,C24H29N3O,24721.0
10088,Pravastatin-d3 (sodium salt),[2H]C([2H])([2H])[C@@H](CC)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+],C23H35NaO7,25464.0
10089,Flonicamid,N#CCNC(=O)c1cnccc1C(F)(F)F,C9H6F3N3O,25608.0
10090,Afatinib-d6,[2H]C([2H])([2H])N(C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)C([2H])([2H])[2H],C24H25ClFN5O3,22552.0
10091,MK-0941,CCS(=O)(=O)c1ccc(Oc2cc(O[C@@H](C)CO)cc(C(=O)Nc3ccn(C)n3)c2)cn1.CS(=O)(=O)O,C22H28N4O9S2,25642.0
10092,Atractylenolide I,C=C1CCC[C@]2(C)C=C3OC(=O)C(C)=C3C[C@@H]12,C15H18O2,25061.0
10093,RK-20448,CN1CCN([C@H]2CC[C@@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1,C29H34N6O,25606.0
10094,GM 1489,CC(C)C[C@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)c1ccccc1,C27H33N3O4,24313.0
10095,"Riluzole-13C,15N2",[15NH2][13c]1[15n]c2ccc(OC(F)(F)F)cc2s1,C8H5F3N2OS,25361.0
10096,Ranitidine-d6 (hydrochloride),Cl.[2H]C([2H])([2H])N(Cc1ccc(CSCCN/C(=C/[N+](=O)[O-])NC)o1)C([2H])([2H])[2H],C13H23ClN4O3S,22583.0
10097,"1,2-Dihexanoyl-sn-glycero-3-PC",CCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCC,C20H40NO8P,25585.0
10098,Limaprost-d3,[2H]C([2H])([2H])[C@@H](CCCC)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)O,C22H36O5,25416.0
10099,"4-Chloro-17?-methyl-androsta-1,4-diene-3,17-diol",C[C@]12C=CC(O)C(Cl)=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H29ClO2,22446.0
10100,Pyrroloquinoline quinone,O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2,C14H6N2O8,20681.0
10101,C17 Sphingomyelin (d18:1/17:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCCC,C40H81N2O6P,25592.0
10102,Chlormezanone,CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1,C11H12ClNO3S,25716.0
10103,4-Nitrophenyl Butyrate,CCCC(=O)Oc1ccc([N+](=O)[O-])cc1,C10H11NO4,25439.0
10104,Glyburide-d3,[2H]C([2H])([2H])Oc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,C23H28ClN3O5S,25740.0
10105,Irbesartan-d4,[2H]c1c([2H])c(-c2ccccc2-c2nn[nH]n2)c([2H])c([2H])c1CN1C(=O)C2(CCCC2)N=C1CCCC,C25H28N6O,25509.0
10106,7?-hydroxy Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O2,20099.0
10107,Lythridine,COc1cc2c(cc1OC)C1CC(CC3CCCCN31)OC(=O)CC(O)c1ccc(O)c-2c1,C26H31NO6,25865.0
10108,Anastrozole-d12,[2H]C([2H])([2H])C(C#N)(c1cc(Cn2cncn2)cc(C(C#N)(C([2H])([2H])[2H])C([2H])([2H])[2H])c1)C([2H])([2H])[2H],C17H19N5,25360.0
10109,Clofentezine,Clc1ccccc1-c1nnc(-c2ccccc2Cl)nn1,C14H8Cl2N4,24228.0
10110,Acibenzolar-S-methyl,CSC(=O)c1cccc2nnsc12,C8H6N2OS2,24212.0
10111,"p,p'-DDT",Clc1ccc(C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl)cc1,C14H9Cl5,24243.0
10112,Telotristat Etiprate,CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1.O=C(O)CNC(=O)c1ccccc1,C36H35ClF3N7O6,25342.0
10113,Lythrine,COc1cc2c(cc1OC)[C@@H]1C[C@H](C[C@@H]3CCCCN31)OC(=O)/C=C\c1ccc(O)c-2c1,C26H29NO5,25804.0
10114,Moclobemide,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,C13H17ClN2O2,24361.0
10115,Dapansutrile,CS(=O)(=O)CCC#N,C4H7NO2S,24671.0
10116,Amarogentin,C=C[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2OC(=O)c2c(O)cc(O)cc2-c2cccc(O)c2)OC=C2C(=O)OCC[C@H]21,C29H30O13,24914.0
10117,Fenofibrate-d6,[2H]C([2H])([2H])C(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)(C(=O)OC(C)C)C([2H])([2H])[2H],C20H21ClO4,25710.0
10118,Ruscogenin,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O)C[C@@H](O)[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C27H42O4,25217.0
10119,2-HOBA,NCc1ccccc1O,C7H9NO,25357.0
10120,6-OHDA (hydrobromide),Br.NCCc1cc(O)c(O)cc1O,C8H12BrNO3,25330.0
10121,Risperidone-d4,[2H]C([2H])(c1c(C)nc2n(c1=O)CCCC2)C([2H])([2H])N1CCC(c2noc3cc(F)ccc23)CC1,C23H27FN4O2,10010570.0
10122,Dihexadecyl Phosphate,CCCCCCCCCCCCCCCCOP(=O)(O)OCCCCCCCCCCCCCCCC,C32H67O4P,25727.0
10123,DL-Mevalonolactone,CC1(O)CCOC(=O)C1,C6H10O3,20348.0
10124,(R)-(+)-Pulegone,CC(C)=C1CC[C@@H](C)CC1=O,C10H16O,23163.0
10125,PRLX-93936,CCOc1ccccc1-n1c(CN2CCNCC2)nc2ccccc2c1=O,C21H24N4O2,25631.0
10126,(S)-3'-amino Blebbistatin,Cc1ccc2c(c1)C(=O)[C@]1(O)CCN(c3cccc(N)c3)C1=N2,C18H17N3O2,24170.0
10127,Succinylacetone,CC(=O)CC(=O)CCC(=O)O,C7H10O4,25501.0
10128,Aldicarb sulfone,CNC(=O)O/N=C/C(C)(C)S(C)(=O)=O,C7H14N2O4S,24210.0
10129,Aldicarb Sulfoxide,CNC(=O)O/N=C/C(C)(C)S(C)=O,C7H14N2O3S,24211.0
10130,Fenspiride (hydrochloride),Cl.O=C1NCC2(CCN(CCc3ccccc3)CC2)O1,C15H21ClN2O2,25512.0
10131,Compound 43 TAO Kinase Inhibitor,O=C(CNC(=O)c1ccc(-c2ccccc2)cc1)NC1CCCc2ccccc21,C25H24N2O2,25632.0
10132,CCCP,N#CC(C#N)=NNc1cccc(Cl)c1,C9H5ClN4,25458.0
10133,Propoxur,CNC(=O)Oc1ccccc1OC(C)C,C11H15NO3,25628.0
10134,"5?,6?-epoxy Cholestanol",CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@H]4O[C@]45C[C@@H](O)CC[C@]5(C)[C@H]3CC[C@]12C,C27H46O2,25603.0
10135,1-Oleoyl-2-hydroxy-sn-glycero-3-PE,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[NH3+],C23H46NO7P,25596.0
10136,E7820,Cc1ccc(NS(=O)(=O)c2cccc(C#N)c2)c2[nH]cc(C#N)c12,C17H12N4O2S,25502.0
10137,Cholesteryl Hemisuccinate,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CCC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C,C31H50O4,25698.0
10138,Nitrofurazone,NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1,C6H6N4O4,21656.0
10139,ODM-201,CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,C19H19ClN6O2,25643.0
10140,1-Stearoyl-2-Palmitoyl-rac-glycerol,CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC,C37H72O5,25594.0
10141,Despropionyl meta-Methylfentanyl,Cc1cccc(NC2CCN(CCc3ccccc3)CC2)c1,C20H26N2,25744.0
10142,Despropionyl meta-Methylfentanyl (hydrochloride),Cc1cccc(NC2CCN(CCc3ccccc3)CC2)c1.Cl.Cl,C20H28Cl2N2,25879.0
10143,4-Fluoroethamphetamine (hydrochloride),CCNC(C)Cc1ccc(F)cc1.Cl,C11H17ClFN,25811.0
10144,Terpinolene,CC1=CCC(=C(C)C)CC1,C10H16,21712.0
10145,Ranolazine-d5,[2H]C([2H])(Oc1ccccc1OC)C([2H])(O)C([2H])([2H])N1CCN(CC(=O)Nc2c(C)cccc2C)CC1,C24H33N3O4,25424.0
10146,Menaquinone 9,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=C(C)C(=O)c2ccccc2C1=O,C56H80O2,18242.0
10147,Milrinone-d3,[2H]C([2H])([2H])c1[nH]c(=O)c(C#N)cc1-c1ccncc1,C12H9N3O,25429.0
10148,(+)-Borneol,CC1(C)[C@@H]2CC[C@@]1(C)[C@@H](O)C2,C10H18O,23467.0
10149,Ginsenoside Rg5,CC(C)=CC/C=C(\C)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C42H70O12,25147.0
10150,2-Fluoroethamphetamine (hydrochloride),CCNC(C)Cc1ccccc1F.Cl,C11H17ClFN,25266.0
10151,Geraniol,CC(C)=CCC/C(C)=C/CO,C10H18O,23166.0
10152,"1,2-Dinonadecanoyl-sn-glycero-3-PC",CCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCC,C46H92NO8P,25597.0
10153,Riociguat-13C-d3,[2H][13C]([2H])([2H])N(C(=O)OC)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N,C20H19FN8O2,25314.0
10154,Methiocarb,CNC(=O)Oc1cc(C)c(SC)c(C)c1,C11H15NO2S,25627.0
10155,Brequinar,Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)O,C23H15F2NO2,24445.0
10156,Leu-Enkephalin (trifluoroacetate salt),CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O.O=C(O)C(F)(F)F,C30H38F3N5O9,23283.0
10157,Hexythiazox,C[C@H]1[C@H](c2ccc(Cl)cc2)SC(=O)N1C(=O)NC1CCCCC1,C17H21ClN2O2S,25626.0
10158,PD 0332991-d8,[2H]C1([2H])NC([2H])([2H])C([2H])([2H])N(c2ccc(Nc3ncc4c(C)c(C(C)=O)c(=O)n(C5CCCC5)c4n3)nc2)C1([2H])[2H],C24H29N7O2,25421.0
10159,TCEP-biotin,O=C(O)CCP(CCC(=O)O)CCC(=O)NCCOCCOCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C25H43N4O9PS,25365.0
10160,GDC-0879,OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1,C19H18N4O2,16993.0
10161,Magnolin,COc1ccc([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2cc(OC)c(OC)c(OC)c2)cc1OC,C23H28O7,25123.0
10162,AC1903,c1ccc(Cn2c(NCc3ccco3)nc3ccccc32)cc1,C19H17N3O,25324.0
10163,Sulfamethoxypyridazine,COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1,C11H12N4O3S,21875.0
10164,BTYNB IMP1 Inhibitor,NC(=O)c1ccccc1/N=C/c1ccc(Br)s1,C12H9BrN2OS,25623.0
10165,Ramipril-d5,[2H]c1c([2H])c([2H])c(CC[C@H](N[C@@H](C)C(=O)N2[C@H](C(=O)O)C[C@@H]3CCC[C@@H]32)C(=O)OCC)c([2H])c1[2H],C23H32N2O5,25425.0
10166,Dimethomorph,COc1ccc(/C(=C/C(=O)N2CCOCC2)c2ccc(Cl)cc2)cc1OC,C21H22ClNO4,24247.0
10167,Gracillin,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C45H72O17,11848.0
10168,Rivastigmine-d6 (tartrate),O=C(O)[C@H](O)[C@@H](O)C(=O)O.[2H]C([2H])([2H])N([C@@H](C)c1cccc(OC(=O)N(C)CC)c1)C([2H])([2H])[2H],C18H28N2O8,25633.0
10169,Narirutin,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(c3)O[C@H](c3ccc(O)cc3)CC4=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C27H32O14,25124.0
10170,?-Eudesmol,C=C1CCC[C@]2(C)CC[C@@H](C(C)(C)O)C[C@@H]12,C15H26O,25771.0
10171,Chlorpromazine-d6 (hydrochloride),Cl.[2H]C([2H])([2H])N(CCCN1c2ccccc2Sc2ccc(Cl)cc21)C([2H])([2H])[2H],C17H20Cl2N2S,25636.0
10172,1-Palmitoyl-2-Arachidonoyl-sn-glycero-3-PC,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C44H80NO8P,25658.0
10173,Lathosterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O,9003102.0
10174,CU-CPT8m,Cc1cccc(-c2ccnc3c(C(N)=O)cnn23)c1,C14H12N4O,25349.0
10175,Meloxicam-d3,[2H]C([2H])([2H])N1C(C(=O)Nc2ncc(C)s2)=C(O)c2ccccc2S1(=O)=O,C14H13N3O4S2,25508.0
10176,1-Deoxysphingosine (m18:1(14Z)),CCC/C=C\CCCCCCCCCC[C@@H](O)[C@H](C)N,C18H37NO,24515.0
10177,Brimonidine-d4,[2H]C1([2H])N=C(Nc2ccc3nccnc3c2Br)NC1([2H])[2H],C11H10BrN5,25465.0
10178,Regorafenib-13C-d3,[2H][13C]([2H])([2H])NC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,C21H15ClF4N4O3,25486.0
10179,Glycine-?-muricholic Acid,C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)[C@@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C26H43NO6,9003230.0
10180,Fentanyl Methyl Carbamate,COC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C21H26N2O2,25678.0
10181,CCT244747,COc1cc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)ncc1-c1cnn(C)c1,C20H24N8O2,25666.0
10182,Coumaphos,CCOP(=S)(OCC)Oc1ccc2c(C)c(Cl)c(=O)oc2c1,C14H16ClO5PS,24230.0
10183,Oxybutynin-d10 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])([2H])N(CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1)C([2H])([2H])C([2H])([2H])[2H],C22H32ClNO3,10010655.0
10184,Kinetin,c1coc(CNc2[nH]cnc3ncnc2-3)c1,C10H9N5O,20712.0
10185,"5,7-Dichlorokynurenic Acid",O=C(O)c1cc(O)c2c(Cl)cc(Cl)cc2n1,C10H5Cl2NO3,25533.0
10186,Glucocorticoid Resistance Inhibitor,Nc1ncc(-c2ccncc2)c(C2CC2)n1,C12H12N4,25553.0
10187,Procyanidin C1,Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@H](O)[C@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)[C@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,C45H38O18,25201.0
10188,CA-074,CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC,C18H29N3O6,24679.0
10189,Meclonazepam,C[C@@H]1N=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2NC1=O,C16H12ClN3O3,25110.0
10190,4-fluoro MT-45 (hydrochloride),Cl.Cl.Fc1ccc(C(Cc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1,C24H33Cl2FN2,25290.0
10191,Cholesterol-d6,[2H]C([2H])([2H])C(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C([2H])([2H])[2H],C27H46O,25546.0
10192,Ramelteon-d5,[2H]C([2H])([2H])C([2H])([2H])C(=O)NCCC1CCc2ccc3c(c21)CCO3,C16H21NO2,25420.0
10193,BYK204165,Cn1cccc1/C=C1/C(=O)NC(=O)c2ccccc21,C15H12N2O2,21430.0
10194,"Theaflavin 3,3'-digallate",O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(=O)c2c(O)c(O)cc([C@H]3Oc4cc(O)cc(O)c4C[C@H]3OC(=O)c3cc(O)c(O)c(O)c3)c2c1)c1cc(O)c(O)c(O)c1,C43H32O20,25215.0
10195,C12FDG,CCCCCCCCCCCC(=O)Nc1ccc2c(c1)C(=O)OC21c2ccc(O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)cc2Oc2cc(O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)ccc21,C44H55NO16,25583.0
10196,3CAI,O=C(CCl)c1c[nH]c2ccccc12,C10H8ClNO,14303.0
10197,Lucifer Yellow CH,NNC(=O)NN1C(=O)c2cc(S(=O)(=O)[O-])cc3c(N)c(S(=O)(=O)[O-])cc(c23)C1=O.[Li+].[Li+],C13H9Li2N5O9S2,25573.0
10198,5-hydroxy Thiabendazole,Oc1ccc2nc(-c3cscn3)[nH]c2c1,C10H7N3OS,25021.0
10199,Artemisinic Acid,C=C(C(=O)O)[C@@H]1CC[C@@H](C)[C@@H]2CCC(C)=C[C@@H]21,C15H22O2,25059.0
10200,Imazalil,C=CCOC(Cn1ccnc1)c1ccc(Cl)cc1Cl,C14H14Cl2N2O,25815.0
10201,Piperonyl Butoxide,CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2,C19H30O5,25820.0
10202,Lapatinib-d4 (tosylate),Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.[2H]C([2H])(NCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)C([2H])([2H])S(C)(=O)=O,C43H42ClFN4O10S3,25459.0
10203,Amoxicillin-d4,[2H]c1c([2H])c([C@@H](N)C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c([2H])c([2H])c1O,C16H19N3O5S,25428.0
10204,XMD17-109,CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C,C36H46N8O3,25448.0
10205,1-Stearoyl-2-Arachidonoyl-sn-glycero-3-PE,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C43H78NO8P,25871.0
10206,Diphenylamine,c1ccc(Nc2ccccc2)cc1,C12H11N,24250.0
10207,3-Fluoroethamphetamine (hydrochloride),CCNC(C)Cc1cccc(F)c1.Cl,C11H17ClFN,23819.0
10208,MGK-264,CCCCC(CC)CN1C(=O)C2C3C=CC(C3)C2C1=O,C17H25NO2,25819.0
10209,MGK-264 (CRM),CCCCC(CC)CN1C(=O)C2C3C=CC(C3)C2C1=O,C17H25NO2,39357.0
10210,Adapalene-d3,[2H]C([2H])([2H])Oc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2,C28H28O3,25758.0
10211,Olmesartan Medoxomil-d6,[2H]C([2H])([2H])C(O)(c1nc(CCC)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c1C(=O)OCc1oc(=O)oc1C)C([2H])([2H])[2H],C29H30N6O6,25759.0
10212,Spiroxamine,CCCN(CC)CC1COC2(CCC(C(C)(C)C)CC2)O1,C18H35NO2,25823.0
10213,Pazopanib-d6,[2H]C([2H])([2H])N(c1ccc2c(C)n(C([2H])([2H])[2H])nc2c1)c1ccnc(Nc2ccc(C)c(S(N)(=O)=O)c2)n1,C21H23N7O2S,25446.0
10214,Olanzapine-d8,[2H]C1([2H])N(C)C([2H])([2H])C([2H])([2H])N(C2=Nc3ccccc3Nc3sc(C)cc32)C1([2H])[2H],C17H20N4S,25447.0
10215,Edoxaban-d6,[2H]C([2H])([2H])N(C(=O)[C@H]1CC[C@H](NC(=O)C(=O)Nc2ccc(Cl)cn2)[C@H](NC(=O)c2nc3c(s2)CN(C)CC3)C1)C([2H])([2H])[2H],C24H30ClN7O4S,25760.0
10216,PD 407824,O=C1NC(=O)c2c1c(-c1ccccc1)cc1[nH]c3ccc(O)cc3c21,C20H12N2O3,25989.0
10217,Curcumin-d6,[2H]C([2H])([2H])Oc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC([2H])([2H])[2H])c2)ccc1O,C21H20O6,25438.0
10218,Trifloxystrobin,CO/N=C(/C(=O)OC)c1ccccc1CO/N=C(\C)c1cccc(C(F)(F)F)c1,C20H19F3N2O4,25825.0
10219,Vilazodone-d8,[2H]C1([2H])N(CCCCc2c[nH]c3ccc(C#N)cc23)C([2H])([2H])C([2H])([2H])N(c2ccc3oc(C(N)=O)cc3c2)C1([2H])[2H],C26H27N5O2,25712.0
10220,Fludioxonil,N#Cc1c[nH]cc1-c1cccc2c1OC(F)(F)O2,C12H6F2N2O2,25818.0
10221,11(Z)-Vaccenic Acid methyl ester,CCCCCC/C=C\CCCCCCCCCC(=O)OC,C19H36O2,20693.0
10222,7-keto Cholesterol-d7,[2H]C([2H])([2H])C([2H])(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C(=O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C([2H])([2H])[2H],C27H44O2,25972.0
10223,Pyridaben,CC(C)(C)c1ccc(CSc2cnn(C(C)(C)C)c(=O)c2Cl)cc1,C19H25ClN2OS,25821.0
10224,Ivabradine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])N(CCCN1CCc2cc(OC)c(OC)cc2CC1=O)C[C@H]1Cc2cc(OC)c(OC)cc21,C27H37ClN2O5,25711.0
10225,Etofenprox,CCOc1ccc(C(C)(C)COCc2cccc(Oc3ccccc3)c2)cc1,C25H28O3,25785.0
10226,"N,N-Dimethylamido-despropionyl fentanyl",CN(C)C(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C22H29N3O,23750.0
10227,Isoborneol,CC1(C)[C@@H]2CC[C@@]1(C)[C@H](O)C2,C10H18O,23177.0
10228,N-Acetylpuromycin,COc1ccc(C[C@H](NC(C)=O)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1,C24H31N7O6,25335.0
10229,Menaquinone 4-d7,[2H]c1c([2H])c([2H])c2c(c1[2H])C(=O)C(C/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C)=C(C([2H])([2H])[2H])C2=O,C31H40O2,25709.0
10230,Ritonavir-d6,[2H]C([2H])([2H])C(c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1)C([2H])([2H])[2H],C37H48N6O5S2,25462.0
10231,Fenoxycarb,CCOC(=O)NCCOc1ccc(Oc2ccccc2)cc1,C17H19NO4,25607.0
10232,"1,2-Dioleoyl-3-dimethylammonium-propane",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(CN(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC,C41H77NO4,25726.0
10233,Phosmet,COP(=S)(OC)SCN1C(=O)c2ccccc2C1=O,C11H12NO4PS2,25812.0
10234,Prallethrin,C#CCC1=C(C)C(OC(=O)C2C(C=C(C)C)C2(C)C)CC1=O,C19H24O3,25813.0
10235,?-Ocimene,C=C/C(C)=C/CC=C(C)C,C10H16,23466.0
10236,trans-?-Ocimene,C=C/C(C)=C/CC=C(C)C,C10H16,29393.0
10237,?-Phellandrene,CC1=CCC(C(C)C)C=C1,C10H16,23179.0
10238,Methomyl,CNC(=O)O/N=C(/C)SC,C5H10N2O2S,25610.0
10239,Flavopiridol,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,C21H20ClNO5,26024.0
10240,Pyrethrins (technical grade),C=C/C=C/CC1=C(C)C(OC(=O)[C@@H]2C(/C=C(\C)C(=O)OC)C2(C)C)CC1=O.C=C/C=C/CC1=C(C)[C@@H](OC(=O)[C@@H]2C(C=C(C)C)C2(C)C)CC1=O,C43H56O8,25814.0
10241,Pyrethrins (CRM),C=C/C=C/CC1=C(C)C(OC(=O)[C@@H]2C(/C=C(\C)C(=O)OC)C2(C)C)CC1=O.C=C/C=C/CC1=C(C)[C@@H](OC(=O)[C@@H]2C(C=C(C)C)C2(C)C)CC1=O,C43H56O8,39348.0
10242,EMA401,COc1ccc2c(c1OCc1ccccc1)C[C@@H](C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2,C32H29NO5,22988.0
10243,Elinogrel,CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F,C20H15ClFN5O5S2,25976.0
10244,Methyl Parathion,COP(=S)(OC)Oc1ccc([N+](=O)[O-])cc1,C8H10NO5PS,25786.0
10245,Porcupine-IN-1,Cc1cc(-c2ncc(CNC(=O)c3ccc4c(c3)[nH]c3ccccc34)cc2F)ccn1,C25H19FN4O,25834.0
10246,Unguinol,C/C=C(\C)c1cc(O)c(C)c2c1Oc1cc(O)cc(C)c1C(=O)O2,C19H18O5,24207.0
10247,TPU-0037A,CC1=CC2C(O)C(O)CCC2C(C)(C(=O)C2=C(O)CNC2=O)C1CCC(C)C(O)/C(C)=C/CC(O)/C=C/C(C)C(O)/C=C/CC(O)/C=C/CC(O)CC1CCCN1C(=N)N,C46H72N4O10,25761.0
10248,Acumapimod,Cc1ccc(C(=O)NC2CC2)cc1-n1ncc(C(=O)c2cccc(C#N)c2)c1N,C22H19N5O2,25832.0
10249,Tropifexor,O=C(O)c1cc(F)c2nc(N3[C@@H]4CC[C@H]3C[C@@H](OCc3c(-c5ccccc5OC(F)(F)F)noc3C3CC3)C4)sc2c1,C29H25F4N3O5S,25748.0
10250,ortho-fluoro Valeryl fentanyl (hydrochloride),CCCCC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1.Cl,C24H32ClFN2O,23083.0
10251,2'-Fluorofentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2F)CC1.Cl,C22H28ClFN2O,25883.0
10252,Trinactin,CC[C@H]1C[C@@H]2CC[C@@H](O2)[C@@H](C)C(=O)O[C@H](CC)C[C@H]2CC[C@H](O2)[C@H](C)C(=O)O[C@@H](C)C[C@@H]2CC[C@@H](O2)[C@@H](C)C(=O)O[C@H](CC)C[C@H]2CC[C@H](O2)[C@H](C)C(=O)O1,C43H70O12,25741.0
10253,Drimentine C,C=C1CC[C@H]2C(C)(C)CCC[C@]2(C)[C@H]1C[C@@]12C[C@H]3C(=O)N4CCC[C@H]4C(=O)N3[C@@H]1Nc1ccccc12,C31H41N3O2,25763.0
10254,MMB022,C=CCCCn1cc(C(=O)N[C@H](C(=O)OC)C(C)C)c2ccccc21,C20H26N2O3,25906.0
10255,Pimprinine,Cc1ncc(-c2c[nH]c3ccccc23)o1,C12H10N2O,25507.0
10256,6?-hydroxy Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H48O2,25715.0
10257,Loxiglumide,CCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1,C21H30Cl2N2O5,25534.0
10258,Tigecycline-d9,[2H]C([2H])([2H])C(NCC(=O)Nc1cc(N(C)C)c2c(c1O)C(=O)C1=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3C[C@@H]1C2)(C([2H])([2H])[2H])C([2H])([2H])[2H],C29H39N5O8,25414.0
10259,4'-Fluorofentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CCc2ccc(F)cc2)CC1.Cl,C22H28ClFN2O,25877.0
10260,1-Myristoyl-2-hydroxy-sn-glycero-3-PG (sodium salt),CCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC(O)CO.[Na+],C20H40NaO9P,25587.0
10261,Parishin C,O=C(CC(O)(CC(=O)OCc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)O)OCc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,C32H40O19,25127.0
10262,"5?,6?-Dihydroxycholestanol",CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@@H](O)[C@@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H48O3,25538.0
10263,"1,2-Dihexadecyl-sn-glycero-3-PC",CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OCCCCCCCCCCCCCCCC,C40H84NO6P,25588.0
10264,Lomustine,O=NN(CCCl)C(=O)NC1CCCCC1,C9H16ClN3O2,21237.0
10265,Memantine-d6 (hydrochloride),Cl.[2H]C([2H])([2H])C12CC3CC(N)(C1)CC(C([2H])([2H])[2H])(C3)C2,C12H22ClN,25463.0
10266,"p,p'-Dicofol",OC(c1ccc(Cl)cc1)(c1ccc(Cl)cc1)C(Cl)(Cl)Cl,C14H9Cl5O,24244.0
10267,(E)-Fenpyroximate,Cc1nn(C)c(Oc2ccccc2)c1/C=N/OCc1ccc(C(=O)OC(C)(C)C)cc1,C24H27N3O4,25625.0
10268,(E)-Fenpyroximate (CRM),Cc1nn(C)c(Oc2ccccc2)c1/C=N/OCc1ccc(C(=O)OC(C)(C)C)cc1,C24H27N3O4,39358.0
10269,"1,2-Diheptanoyl-sn-glycero-3-PC",CCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCC,C22H44NO8P,25586.0
10270,SKI 178,COc1ccc(-c2cc(C(=O)N/N=C(\C)c3ccc(OC)c(OC)c3)[nH]n2)cc1,C21H22N4O4,24880.0
10271,Parishin E,O=C(O)CC(O)(CC(=O)OCc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)O,C19H24O13,25128.0
10272,A-419259,CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1,C29H34N6O,25605.0
10273,"N,N-didesmethyl U-47700 (trifluoroacetate salt) (CRM)",CN(C(=O)c1ccc(Cl)c(Cl)c1)[C@@H]1CCCC[C@H]1N.O=C(O)C(F)(F)F,C16H19Cl2F3N2O3,24289.0
10274,Ondansetron (hydrochloride) (CRM),Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O.Cl,C18H20ClN3O,21710.0
10275,N-benzyl para-fluoro Norfentanyl (hydrochloride),CCC(=O)N(c1ccc(F)cc1)C1CCN(Cc2ccccc2)CC1.Cl,C21H26ClFN2O,25542.0
10276,Lanifibranor,O=C(O)CCCc1cc2cc(Cl)ccc2n1S(=O)(=O)c1ccc2ncsc2c1,C19H15ClN2O4S2,25572.0
10277,LY2955303,CN1CCN(C(=O)c2ccc(-n3nc(-c4ccc(C(=O)O)cc4)cc3-c3cc(C(C)(C)C)cc(C(C)(C)C)c3)cc2)CC1,C36H42N4O3,25833.0
10278,3'-Fluorofentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1CCN(CCc2cccc(F)c2)CC1.Cl,C22H28ClFN2O,25884.0
10279,Quinidine,C=C[C@H]1C[N@]2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,C20H24N2O2,20356.0
10280,Glucosylceramide (plant),CCCCCCCCC/C=C/CC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)NC(=O)C(O)CCCCCCCCCCCCCC,C40H75NO9,25850.0
10281,Deoxyenterocin,COc1cc([C@H]2[C@@]3(O)C[C@H]4C[C@]2(O)[C@](O)(C(=O)O4)[C@H]3C(=O)c2ccccc2)oc(=O)c1,C22H20O9,25764.0
10282,N-benzyl ortho-fluoro Norfentanyl (hydrochloride),CCC(=O)N(c1ccccc1F)C1CCN(Cc2ccccc2)CC1.Cl,C21H26ClFN2O,25540.0
10283,Monactin,CC[C@@H]1C[C@H]2CC[C@H](O2)[C@H](C)C(=O)O[C@@H](C)C[C@@H]2CC[C@@H](O2)[C@@H](C)C(=O)O[C@H](C)C[C@H]2CC[C@H](O2)[C@H](C)C(=O)O[C@@H](C)C[C@@H]2CC[C@@H](O2)[C@@H](C)C(=O)O1,C41H66O12,25742.0
10284,BAY-588,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1,C27H25F4N5O2,19960.0
10285,para-fluoro 4-ANBP,Fc1ccc(NC2CCN(Cc3ccccc3)CC2)cc1,C18H21FN2,25960.0
10286,"5?,6?-Dihydroxycholestanol-d7",[2H]C([2H])([2H])C([2H])(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@@H](O)[C@@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C([2H])([2H])[2H],C27H48O3,25968.0
10287,ortho-fluoro 4-ANBP,Fc1ccccc1NC1CCN(Cc2ccccc2)CC1,C18H21FN2,25958.0
10288,"3,4-dichloro-N,N-Dimethcathinone (hydrochloride)",CC(C(=O)c1ccc(Cl)c(Cl)c1)N(C)C.Cl,C11H14Cl3NO,25377.0
10289,Diffractaic Acid,COc1cc(C)c(C(=O)Oc2cc(C)c(C(=O)O)c(O)c2C)c(OC)c1C,C20H22O7,24208.0
10290,Sitostanol,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,C29H52O,26094.0
10291,Tyrocidine Complex,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O.CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O.CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O.CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O.CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O.CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O.CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O.CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,C549H711N113O102,25655.0
10292,Senkyunolide A,CCCC[C@@H]1OC(=O)C2=C1CCC=C2,C12H16O2,25199.0
10293,(S)-KT109,O=C(N1CCCC[C@H]1Cc1ccccc1)n1cc(-c2ccc(-c3ccccc3)cc2)nn1,C27H26N4O,25683.0
10294,FF-MAS,CC(C)=CCC[C@@H](C)[C@H]1CC=C2C3=C(CC[C@@]21C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1CC3,C29H46O,26093.0
10295,Oxamyl,CNC(=O)O/N=C(\SC)C(=O)N(C)C,C7H13N3O3S,25609.0
10296,Cefamandole Nafate,Cn1nnnc1SCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)[C@H](OC=O)c3ccccc3)[C@H]2SC1.[Na+],C19H17N6NaO6S2,23988.0
10297,N-benzyl meta-fluoro Norfentanyl (hydrochloride),CCC(=O)N(c1cccc(F)c1)C1CCN(Cc2ccccc2)CC1.Cl,C21H26ClFN2O,25541.0
10298,Gilvocarcin M,COc1cc2c(oc(=O)c3cc(C)cc(OC)c32)c2c([C@H]3O[C@@H]([C@@H](C)O)[C@H](O)[C@H]3O)ccc(O)c12,C26H26O9,25762.0
10299,sn-glycero-3-Phosphocholine-d9,[2H]C([2H])([2H])[N+](CCOP(=O)([O-])OC[C@H](O)CO)(C([2H])([2H])[2H])C([2H])([2H])[2H],C8H20NO6P,26099.0
10300,4?-hydroxy Cholesterol-d7,[2H]C([2H])([2H])C([2H])(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4[C@@H](O)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C([2H])([2H])[2H],C27H46O2,25971.0
10301,(R)-KT109,O=C(N1CCCC[C@@H]1Cc1ccccc1)n1cc(-c2ccc(-c3ccccc3)cc2)nn1,C27H26N4O,25682.0
10302,GLPG1837,CC1(C)Cc2c(sc(NC(=O)c3cc[nH]n3)c2C(N)=O)C(C)(C)O1,C16H20N4O3S,9003143.0
10303,Cilofexor,O=C(O)c1ccnc(N2CC(O)(c3ccc(OCc4c(-c5c(Cl)cccc5Cl)noc4C4CC4)cc3Cl)C2)c1,C28H22Cl3N3O5,25747.0
10304,CEP-40783,COc1cc2nccc(Oc3ccc(NC(=O)c4cn(C(C)C)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)c2cc1OC,C31H26F2N4O6,25749.0
10305,7-dehydro Cholesterol-d7,[2H]C([2H])([2H])C([2H])(CCC[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C([2H])([2H])[2H],C27H44O,25969.0
10306,"12,15-epoxy-13-methyl-12,14-Eicosadienoic Acid",CCCCCc1cc(C)c(CCCCCCCCCCC(=O)O)o1,C21H36O3,25862.0
10307,Nifedipine-d6,[2H]C([2H])([2H])OC(=O)C1=C(C)NC(C)=C(C(=O)OC([2H])([2H])[2H])C1c1ccccc1[N+](=O)[O-],C17H18N2O6,25510.0
10308,Spiromesifen,Cc1cc(C)c(C2=C(OC(=O)CC(C)(C)C)C3(CCCC3)OC2=O)c(C)c1,C23H30O4,25822.0
10309,Spiromesifen (CRM),Cc1cc(C)c(C2=C(OC(=O)CC(C)(C)C)C3(CCCC3)OC2=O)c(C)c1,C23H30O4,39350.0
10310,HG-9-91-01,COc1ccc(N(C(=O)Nc2c(C)cccc2C)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c(OC)c1,C32H37N7O3,19179.0
10311,Endosulfan I,O=[S@]1OC[C@@H]2[C@H](CO1)[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl,C9H6Cl6O3S,24253.0
10312,Aspterric Acid,CC(C)=C1CC[C@]23CO[C@H](C2)[C@@](O)(C(=O)O)CC[C@@H]13,C15H22O4,25919.0
10313,Carbazeran,CCNC(=O)OC1CCN(c2nncc3cc(OC)c(OC)cc23)CC1,C18H24N4O4,26092.0
10314,Fexofenadine-d10 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(C(O)(c2c([2H])c([2H])c([2H])c([2H])c2[2H])C2CCN(CCCC(O)c3ccc(C(C)(C)C(=O)O)cc3)CC2)c([2H])c1[2H],C32H40ClNO4,26115.0
10315,DBO-83,Cl.Cl.Clc1ccc(N2CC3CCC(C2)N3)nn1,C10H15Cl3N4,25991.0
10316,4-ANPP-13C6,c1ccc(CCN2CCC(N[13c]3[13cH][13cH][13cH][13cH][13cH]3)CC2)cc1,C19H24N2,25559.0
10317,4-ANPP-13C6 (CRM),c1ccc(CCN2CCC(N[13c]3[13cH][13cH][13cH][13cH][13cH]3)CC2)cc1,C19H24N2,26313.0
10318,Kresoxim-methyl,CO/N=C(/C(=O)OC)c1ccccc1COc1ccccc1C,C18H19NO4,25816.0
10319,8-dehydro Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)CC1=CC3,C27H44O,25970.0
10320,Dodecylphosphocholine,CCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,C17H38NO4P,25629.0
10321,Protogracillin,C[C@H](CC[C@@]1(O)O[C@H]2C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2[C@@H]1C)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C51H84O23,11893.0
10322,(+)-Cedrol,C[C@@H]1CC[C@H]2C(C)(C)[C@H]3C[C@@]12CC[C@@]3(C)O,C15H26O,25769.0
10323,proTAME,COC(=O)[C@H](CCCN=C(NC(=O)OCOC(=O)Cc1ccccc1)NC(=O)OCOC(=O)Cc1ccccc1)NS(=O)(=O)c1ccc(C)cc1,C34H38N4O12S,25835.0
10324,Tetradecylphosphocholine,CCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,C19H42NO4P,25700.0
10325,Haloperidol-d4,[2H]c1c([2H])c(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)c([2H])c([2H])c1Cl,C21H23ClFNO2,26116.0
10326,Nerol,CC(C)=CCC/C(C)=C\CO,C10H18O,25774.0
10327,Fentanyl-13C6 (hydrochloride),CCC(=O)N(C1CCN(CCc2ccccc2)CC1)[13c]1[13cH][13cH][13cH][13cH][13cH]1.Cl,C22H29ClN2O,25564.0
10328,Fentanyl-13C6 (hydrochloride) (CRM),CCC(=O)N(C1CCN(CCc2ccccc2)CC1)[13c]1[13cH][13cH][13cH][13cH][13cH]1.Cl,C22H29ClN2O,26315.0
10329,Dydrogesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C,C21H28O2,20514.0
10330,N-methyl-2-HOBA (hydrochloride),CNCc1ccccc1O.Cl,C8H12ClNO,25399.0
10331,1-Deoxysphinganine (m18:0),CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N,C18H39NO,13511.0
10332,Terpineol,C=C(C)C1CCC(C)(O)CC1.CC(C)=C1CCC(C)(O)CC1.CC1=CCC(C(C)(C)O)CC1,C30H54O3,23173.0
10333,Thiamethoxam,CN1COCN(Cc2cnc(Cl)s2)/C1=N/[N+](=O)[O-],C8H10ClN5O3S,25784.0
10334,Ondansetron-13C-d3,[2H][13C]([2H])([2H])n1c2c(c3ccccc31)C(=O)C(Cn1ccnc1C)CC2,C18H19N3O,25754.0
10335,Metalaxyl,COCC(=O)N(c1c(C)cccc1C)C(C)C(=O)OC,C15H21NO4,25817.0
10336,IMP-1088,Cc1nn(C)c(C)c1CCOc1c(-c2ccc3c(c2)c(CN(C)C)nn3C)ccc(F)c1F,C25H29F2N5O,25366.0
10337,Gallamine (iodide),CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-],C30H60I3N3O3,26086.0
10338,4-Phenyl fentanyl (hydrochloride),CCC(=O)N(c1ccccc1)C1(c2ccccc2)CCN(CCc2ccccc2)CC1.Cl,C28H33ClN2O,20790.0
10339,BODIPY-C12 Ceramide (d18:1/12:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCC1=C2C(C)=CC(C)=[N+]2[B-](F)(F)n2c(C)cc(C)c21,C42H70BF2N3O3,25997.0
10340,18-hydroxy-11-deoxy Corticosterone,C[C@]12CCC(=O)C=C1CC[C@H]1[C@@H]3CC[C@H](C(=O)CO)[C@@]3(CO)CC[C@@H]12,C21H30O4,10007851.0
10341,7?-hydroxy-4-Cholesten-3-one-d7,[2H]C([2H])([2H])C([2H])(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)CC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C([2H])([2H])[2H],C27H44O2,26100.0
10342,Ferrichrome (iron-free),CC(=O)N(O)CCC[C@@H]1NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCN(O)C(C)=O)NC(=O)[C@H](CCCN(O)C(C)=O)NC1=O,C27H45N9O12,19528.0
10343,1-Palmitoyl-2-hydroxy-sn-glycero-3-PE,CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[NH3+],C21H44NO7P,26011.0
10344,KT109 N2 Regioisomer,O=C(N1CCCCC1Cc1ccccc1)n1ncc(-c2ccc(-c3ccccc3)cc2)n1,C27H26N4O,26127.0
10345,"3'-Ethoxy-5,6-dihydro Spinosyn J 17-pseudoaglycone",CCO[C@@H]1[C@@H](OC)[C@H](C)O[C@@H](O[C@@H]2C[C@H]3CC[C@@H]4[C@@H](C=C5C(=O)[C@H](C)[C@@H](O)CCC[C@H](CC)OC(=O)C[C@H]54)[C@@H]3C2)[C@@H]1OC,C34H54O9,25765.0
10346,Thiophene fentanyl 3-thiophenecarboxamide (hydrochloride),Cl.O=C(c1ccsc1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H27ClN2OS,23009.0
10347,Cyclo(?-Ala-L-Val),C=C1NC(=O)[C@H](C(C)C)NC1=O,C8H12N2O2,25739.0
10348,SCH 725674,CCCCC[C@@H]1CCCCC[C@@H](O)C[C@H](O)[C@H](O)/C=C/C(=O)O1,C18H32O5,25743.0
10349,Nuclear Yellow,CN1CCN(c2ccc3[nH]c(-c4ccc5[nH]c(-c6ccc(S(N)(=O)=O)cc6)nc5c4)nc3c2)CC1.Cl.Cl.Cl,C25H28Cl3N7O2S,25178.0
10350,4-methyl Pentedrone (hydrochloride) (CRM),CCCC(NC)C(=O)c1ccc(C)cc1.Cl,C13H20ClNO,25670.0
10351,?-Copaene,CC1=CC[C@H]2[C@H]3[C@@H]1[C@]2(C)CC[C@H]3C(C)C,C15H24,25770.0
10352,Bosutinib-d8,[2H]C1([2H])N(C)C([2H])([2H])C([2H])([2H])N(CCCOc2cc3ncc(C#N)c(Nc4cc(OC)c(Cl)cc4Cl)c3cc2OC)C1([2H])[2H],C26H29Cl2N5O3,25460.0
10353,"1,2-Diphytanoyl-sn-glycero-3-PC",CC(C)CCCC(C)CCCC(C)CCCC(C)CC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CC(C)CCCC(C)CCCC(C)CCCC(C)C,C48H96NO8P,25598.0
10354,Thiacloprid,N#C/N=C1\SCCN1Cc1ccc(Cl)nc1,C10H9ClN4S,25824.0
10355,3'-fluoro ortho-Fluorofentanyl (hydrochloride),CCC(=O)N(c1ccccc1F)C1CCN(CCc2cccc(F)c2)CC1.Cl,C22H27ClF2N2O,23971.0
10356,Diampromide (hydrochloride),CCC(=O)N(CC(C)N(C)CCc1ccccc1)c1ccccc1.Cl,C21H29ClN2O,25079.0
10357,Berninamycin D,C=C1NC(=O)c2nc(oc2C)C(=C)NC(=O)C(C(C)(C)O)NC(=O)C(=C)NC(=O)c2nc(oc2C)/C(=C\C)NC(=O)C(C(C)O)NC(=O)c2csc(n2)-c2ccc(C(N)=O)nc2-c2coc(n2)C(=C)NC1=O,C45H45N13O13S,25513.0
10358,Echinocandin B,CCCCC/C=C\C/C=C\CCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O,C52H81N7O16,25520.0
10359,Senecioylfentanyl,CC(C)=CC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H30N2O,25440.0
10360,(+)-Gallocatechin,Oc1cc(O)c2c(c1)O[C@H](c1cc(O)c(O)c(O)c1)[C@@H](O)C2,C15H14O7,25125.0
10361,Cyclopropyl fentanyl-13C6 (hydrochloride),Cl.O=C(C1CC1)N(C1CCN(CCc2ccccc2)CC1)[13c]1[13cH][13cH][13cH][13cH][13cH]1,C23H29ClN2O,25563.0
10362,Cyclopropyl fentanyl-13C6 (hydrochloride) (CRM),Cl.O=C(C1CC1)N(C1CCN(CCc2ccccc2)CC1)[13c]1[13cH][13cH][13cH][13cH][13cH]1,C23H29ClN2O,26314.0
10363,Rifaximin-d6,[2H]c1c(C([2H])([2H])[2H])c([2H])c2nc3c4c5c6c(C)c(O)c4c(O)c(c3n2c1[2H])NC(=O)/C(C)=C\C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)/C=C\O[C@@](C)(O6)C5=O,C43H51N3O11,26101.0
10364,Seneciphylline,C=C1C/C(=C/C)C(=O)O[C@@H]2CCN3CC=C(COC(=O)[C@]1(C)O)[C@H]23,C18H23NO5,25146.0
10365,Nerolidol,C=CC(C)(O)CC/C=C(\C)CCC=C(C)C,C15H26O,23182.0
10366,trans-Nerolidol,C=CC(C)(O)CC/C=C(\C)CCC=C(C)C,C15H26O,25778.0
10367,AZD 0156,CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCOCC2)c(=O)n4C)cn1,C26H31N5O3,25648.0
10368,Protectin D1,CC/C=C\C[C@H](O)/C=C\C=C\C=C\[C@H](O)C/C=C\C/C=C\CCC(=O)O,C22H32O4,10010390.0
10369,Nampt-IN-1,CC(C)(O)CS(=O)(=O)Nc1ccc2c(c1)CCN(C(=O)COc1cccnc1)C2,C20H25N3O5S,26066.0
10370,Piperitenone,CC1=CC(=O)C(=C(C)C)CC1,C10H14O,25752.0
10371,Hexamethonium (bromide),C[N+](C)(C)CCCCCC[N+](C)(C)C.[Br-].[Br-],C12H30Br2N2,25505.0
10372,Senecionine,C/C=C1/C[C@@H](C)[C@@](C)(O)C(=O)OCC2=CCN3CC[C@@H](OC1=O)[C@@H]23,C18H25NO5,25145.0
10373,10-methyl-9-(phenoxycarbonyl) Acridinium (trifluoromethylsulfonate),C[n+]1c2ccccc2c(C(=O)Oc2ccccc2)c2ccccc21.O=S(=O)([O-])C(F)(F)F,C22H16F3NO5S,25885.0
10374,Benzoylaconine,CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)C34C1C([C@H](OC)[C@@H]32)[C@]1(O)[C@@H]2[C@H]4C[C@](O)([C@@H]2OC(=O)c2ccccc2)[C@@H](OC)[C@@H]1O,C32H45NO10,25687.0
10375,Hecogenin Acetate,CC(=O)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC(=O)[C@]2(C)[C@@H]4[C@H](C[C@@H]32)O[C@]2(CC[C@@H](C)CO2)[C@H]4C)C1,C29H44O5,25977.0
10376,Etoxazole,CCOc1cc(C(C)(C)C)ccc1C1COC(c2c(F)cccc2F)=N1,C21H23F2NO2,25782.0
10377,Oxycodone-d3,[2H]C([2H])([2H])N1CC[C@]23c4c5ccc(OC)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,C18H21NO4,15845.0
10378,ML-226,CCC1CCCCN1C(=O)n1ncc(C(O)(c2ccccc2)c2ccccc2)n1,C23H26N4O2,25681.0
10379,n-Nonyl-?-D-glucopyranoside,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C15H30O6,25705.0
10380,CUDC-907,COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1,C23H24N8O4S,25651.0
10381,NVP-BAG956,Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C(C)(C)C#N)cc1,C28H21N5,24195.0
10382,D-Luciferin,O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1,C11H8N2O3S2,25836.0
10383,Repaglinide-d5,[2H]C([2H])([2H])C([2H])([2H])Oc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O,C27H36N2O4,26104.0
10384,Methylclonazepam,CN1C(=O)CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc21,C16H12ClN3O3,22747.0
10385,LY2801653,Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1,C30H22F2N6O3,25978.0
10386,Acalisib,C[C@H](Nc1ncnc2nc[nH]c12)c1nc2ccc(F)cc2c(=O)n1-c1ccccc1,C21H16FN7O,25983.0
10387,FM-381,CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1,C24H24N6O2,23204.0
10388,Tirapazamine,Nc1n[n+]([O-])c2ccccc2[n+]1[O-],C7H6N4O2,25981.0
10389,D-?-Hydroxyglutaric Acid,O=C(O)CC[C@@H](O)C(=O)O,C5H8O5,25895.0
10390,Tryptamine,NCCc1c[nH]c2ccccc12,C10H12N2,20995.0
10391,Buclizine (hydrochloride),CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1.Cl.Cl,C28H35Cl3N2,25641.0
10392,"1,2-Dipalmitoyl-sn-glycero-3-N,N-dimethyl-PE",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN(C)C)OC(=O)CCCCCCCCCCCCCCC,C39H78NO8P,25589.0
10393,PF-06424439,CS(=O)(=O)O.O=C([C@@H]1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCCC1,C23H30ClN7O4S,17680.0
10394,meta-methyl Cyclopropyl fentanyl (hydrochloride),Cc1cccc(N(C(=O)C2CC2)C2CCN(CCc3ccccc3)CC2)c1.Cl,C24H31ClN2O,23044.0
10395,Tetrahydrothiophene fentanyl,O=C(C1CCCS1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H30N2OS,23399.0
10396,Monodansylcadaverine,CN(C)c1cccc2c(S(=O)(=O)NCCCCCN)cccc12,C17H25N3O2S,15571.0
10397,Daphnetin,O=c1ccc2ccc(O)c(O)c2o1,C9H6O4,20826.0
10398,Tegafur,O=c1[nH]c(=O)n(C2CCCO2)cc1F,C8H9FN2O3,26076.0
10399,"9(Z),12(Z),15(Z),18(Z),21(Z)-Tetracosapentaenoic Acid",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,C24H38O2,10005157.0
10400,"1,2-Dipalmitoyl Ethylene Glycol",CCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCC,C34H66O4,25590.0
10401,Sulfisoxazole,Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C,C11H13N3O3S,25980.0
10402,Pergolide (mesylate),CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O,C20H30N2O3S2,26085.0
10403,"9(Z),11(E),13(Z)-Octadecatrienoic Acid",CCCC/C=C\C=C\C=C/CCCCCCCC(=O)O,C18H30O2,26057.0
10404,H3B-6527,C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1,C29H34Cl2N8O4,26072.0
10405,"1,2-Dierucoyl-sn-glycero-3-PC",CCCCCCCC/C=C\CCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC,C52H100NO8P,25728.0
10406,Clozapine N-oxide (hydrochloride),C[N+]1([O-])CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1.Cl.Cl,C18H21Cl3N4O,25780.0
10407,Moxonidine,COc1nc(C)nc(Cl)c1NC1=NCCN1,C9H12ClN5O,25639.0
10408,Propargylcholine (bromide),C#CC[N+](C)(C)CCO.[Br-],C7H14BrNO,25870.0
10409,Cholestanol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H48O,9003101.0
10410,Dalbavancin,CC(C)CCCCCCCCC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(cc5)O3)NC(=O)[C@H](N(C)C)c3ccc(O)c(c3)Oc3cc(O)c(Cl)c4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)NCCCN(C)C)NC2=O)O[C@H](C(=O)O)[C@@H](O)[C@@H]1O.CCCCCCCCCCC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(cc5)O3)NC(=O)[C@H](NC)c3ccc(O)c(c3)Oc3cc(O)c(Cl)c4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)NCCCN(C)C)NC2=O)O[C@H](C(=O)O)[C@@H](O)[C@@H]1O.CCCCCCCCCCCC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(cc5)O3)NC(=O)[C@H](NC)c3ccc(O)c(c3)Oc3cc(O)c(Cl)c4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)NCCCN(C)C)NC2=O)O[C@H](C(=O)O)[C@@H](O)[C@@H]1O.CN[C@H]1C(=O)N[C@@H]2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCC(C)C)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1[C@@H](C(=O)NCCCN(C)C)NC3=O.CN[C@H]1C(=O)N[C@@H]2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1[C@@H](C(=O)NCCCN(C)C)NC3=O,C439H498Cl10N50O140,21161.0
10411,GAL-021,CCCNc1nc(NCCC)nc(N(C)OC)n1,C11H22N6O,22609.0
10412,1-Palmitoleoyl glycerol,CCCCCC/C=C\CCCCCCCC(=O)OCC(O)CO,C19H36O4,25697.0
10413,"1,3-Dicaffeoylquinic Acid",O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@@H](O)[C@@H]1O,C25H24O12,25022.0
10414,1-O-Hexadecyl-sn-glycerol,CCCCCCCCCCCCCCCCOC[C@@H](O)CO,C19H40O3,25723.0
10415,Varenicline-d4,[2H]C1([2H])NC([2H])([2H])C2CC1c1cc3nccnc3cc12,C13H13N3,26102.0
10416,Clioquinol,Oc1c(I)cc(Cl)c2cccnc12,C9H5ClINO,10021.0
10417,Pitofenone (hydrochloride),COC(=O)c1ccccc1C(=O)c1ccc(OCCN2CCCCC2)cc1.Cl,C22H26ClNO4,23865.0
10418,4-chloro CUMYL-PINACA,CCCCCn1nc(C(=O)NC(C)(C)c2ccc(Cl)cc2)c2ccccc21,C22H26ClN3O,26132.0
10419,Alizapride (hydrochloride),C=CCN1CCCC1CNC(=O)c1cc2nn[nH]c2cc1OC.Cl,C16H22ClN5O2,25645.0
10420,Aminophenazone,Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C,C13H17N3O,15770.0
10421,5-OxoETE methyl ester,CCCCC/C=C\C/C=C\C/C=C\C=C\C(=O)CCCC(=O)OC,C21H32O3,26059.0
10422,Lonicerin,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)c(O)c5)oc4c3)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C27H30O15,25148.0
10423,PRL-8-53 (hydrochloride),COC(=O)c1cccc(CCN(C)Cc2ccccc2)c1.Cl,C18H22ClNO2,26208.0
10424,SH-4-54,CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F,C29H27F5N2O5S,25982.0
10425,Gliclazide,Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1,C15H21N3O3S,25503.0
10426,KW 2478,CCc1c(O)cc(O)c(C(=O)c2ccc(OCCN3CCOCC3)c(OC)c2)c1CC(=O)N(CCOC)CCOC,C30H42N2O9,22418.0
10427,5-fluoro phenyl-PICA,O=C(Nc1ccccc1)c1cn(CCCCCF)c2ccccc12,C20H21FN2O,23924.0
10428,Nedocromil (sodium salt),CCCc1c2oc(C(=O)[O-])cc(=O)c2cc2c(=O)cc(C(=O)[O-])n(CC)c12.[Na+].[Na+],C19H15NNa2O7,24005.0
10429,Rbin-1,C=C(C)CSc1nnc2c(n1)[nH]c1ccccc12,C13H12N4S,20745.0
10430,PSB-603,CCCn1c(=O)[nH]c2nc(-c3ccc(S(=O)(=O)N4CCN(c5ccc(Cl)cc5)CC4)cc3)[nH]c2c1=O,C24H25ClN6O4S,25637.0
10431,Chebulagic Acid,O=C(O)C[C@@H]1C(=O)O[C@@H]2C3COC(=O)c4cc(O)c(O)c(O)c4-c4c(cc(O)c(O)c4O)C(=O)O[C@H]2C(OC(=O)c2cc(O)c(O)c4c2[C@H]1[C@H](O)C(=O)O4)[C@H](OC(=O)c1cc(O)c(O)c(O)c1)O3,C41H30O27,25203.0
10432,GLPG1690,CCc1nc2c(C)cc(N3CCN(CC(=O)N4CC(O)C4)CC3)cn2c1N(C)c1nc(-c2ccc(F)cc2)c(C#N)s1,C30H33FN8O2S,25498.0
10433,2-chloro Stearic Acid,CCCCCCCCCCCCCCCCC(Cl)C(=O)O,C18H35ClO2,26108.0
10434,R-(-)-?-Methylhistamine (hydrochloride),C[C@@H](N)Cc1cnc[nH]1.Cl.Cl,C6H13Cl2N3,25601.0
10435,Dihydroartemisinic Acid,CC1=C[C@H]2[C@@H](CC1)[C@H](C)CC[C@H]2[C@@H](C)C(=O)O,C15H24O2,25142.0
10436,Thiamine (hydrochloride),Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1.Cl.[Cl-],C12H18Cl2N4OS,25656.0
10437,Dequalinium (chloride),Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21.[Cl-].[Cl-],C30H40Cl2N4,17557.0
10438,BODIPY 493/503,CC1=CC(C)=[N+]2C1=C(C)c1c(C)cc(C)n1[B-]2(F)F,C14H17BF2N2,25892.0
10439,Trimethoprim-d3,[2H]C([2H])([2H])Oc1c(OC)cc(Cc2cnc(N)nc2N)cc1OC,C14H18N4O3,26119.0
10440,"1,2-Dipalmitoyl-sn-glycero-3-PE-N-(cap biotin) (sodium salt)",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCCNC(=O)CCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)OC(=O)CCCCCCCCCCCCCCC.[Na+],C53H98N4NaO11PS,25724.0
10441,C24 dihydro Ceramide (d18:0/24:0)),CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC,C42H85NO3,25602.0
10442,meta-methoxy Furanyl fentanyl,COc1cccc(N(C(=O)c2ccco2)C2CCN(CCc3ccccc3)CC2)c1,C25H28N2O3,26050.0
10443,3'-methyl Acetyl fentanyl (hydrochloride),CC(=O)N(c1ccccc1)C1CCN(CCc2cccc(C)c2)CC1.Cl,C22H29ClN2O,25474.0
10444,9(Z)-Pentacosene,CCCCCCCC/C=C\CCCCCCCCCCCCCCC,C25H50,9002807.0
10445,Oridonin,C=C1C(=O)[C@]23[C@H](O)[C@H]1CC[C@H]2[C@@]12CO[C@]3(O)[C@@H](O)[C@@H]1C(C)(C)CC[C@@H]2O,C20H28O6,25665.0
10446,Lipofermata,O=C1Nc2ccc(Br)cc2C12NN=C(c1ccccc1)S2,C15H10BrN3OS,25869.0
10447,AZD 4635,Cc1cc(-c2nnc(N)nc2-c2ccc(F)cc2)cc(Cl)n1,C15H11ClFN5,26322.0
10448,CCT241736,Cc1nn(C)cc1-c1nc2ncc(Cl)c(N3CCN(Cc4ccc(Cl)cc4)CC3)c2[nH]1,C22H23Cl2N7,26185.0
10449,MEGA-8,CCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,C15H31NO6,25701.0
10450,Betamethasone 17-valerate,CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C27H37FO6,25640.0
10451,MEGA-10,CCCCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,C17H35NO6,25703.0
10452,CC-671,CNC(=O)c1ccc(Nc2nc(OC3CCCC3)c3c(-c4ccc5nc(C)oc5c4)c[nH]c3n2)c(OC)c1,C28H28N6O4,26184.0
10453,T-863,CC1(C)Oc2ncnc(N)c2N=C1c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,C22H26N4O3,25807.0
10454,LAU-159,COc1cccc(-n2nc3c4cc(Cl)ccc4[nH]cc-3c2=O)c1,C17H12ClN3O2,26336.0
10455,NAV2729,O=c1cc(-c2ccc([N+](=O)[O-])cc2)[nH]c2c(-c3ccc(Cl)cc3)c(Cc3ccccc3)nn12,C25H17ClN4O3,26202.0
10456,2-chloro Palmitic Acid,CCCCCCCCCCCCCCC(Cl)C(=O)O,C16H31ClO2,26107.0
10457,2'-methyl Acetyl fentanyl (hydrochloride),CC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2C)CC1.Cl,C22H29ClN2O,25473.0
10458,Schisandrol B,COc1cc2c(c(OC)c1OC)-c1c(cc3c(c1OC)OCO3)CC(C)C(C)(O)C2,C23H28O7,25149.0
10459,LDAO,CCCCCCCCCCCC[N+](C)(C)[O-],C14H31NO,25699.0
10460,23-epi-26-Deoxyactein,CC(=O)O[C@@H]1C[C@@]23C[C@@]24CC[C@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)C(C)(C)[C@@H]4CC[C@H]3[C@]2(C)C[C@@H]3O[C@]4(C[C@@H](C)[C@@H]3[C@@]12C)OC[C@@]1(C)O[C@@H]41,C37H56O10,25126.0
10461,Secologanin,C=C[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C(C(=O)OC)[C@H]1CC=O,C17H24O10,20647.0
10462,n-Decyl-?-D-maltoside,CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,C22H42O11,25704.0
10463,Pramlintide (acetate hydrate),CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O.O,C173H273N51O56S2,24093.0
10464,Fludiazepam,CN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,C16H12ClFN2O,22424.0
10465,Cynaropicrin,C=C(CO)C(=O)O[C@H]1CC(=C)[C@@H]2C[C@H](O)C(=C)[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]21,C19H22O6,25099.0
10466,c-Kit-IN-1,Cn1cc(-c2cc(Oc3cc(F)c(NC(=O)C4(C(=O)Nc5ccccc5)CC4)cc3F)ccn2)cn1,C26H21F2N5O3,26174.0
10467,JNJ-632,Cc1cc(NC(=O)c2cccc(S(=O)(=O)N[C@H]3CCOC3)c2)ccc1F,C18H19FN2O4S,26325.0
10468,Mephedrone-d3 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])c1ccc(C(=O)C(C)NC)cc1,C11H16ClNO,26246.0
10469,UM-164,Cc1nc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)s2)cc(N2CCN(CCO)CC2)n1,C30H31F3N8O3S,26188.0
10470,SKL2001,O=C(NCCCn1ccnc1)c1cc(-c2ccco2)on1,C14H14N4O3,26334.0
10471,Norfloxacin,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,C16H18FN3O3,25975.0
10472,O-304,O=C(Nc1nc(=O)n(Cc2ccc(Cl)cc2)s1)c1ccc(Cl)cc1,C16H11Cl2N3O2S,26186.0
10473,MEGA-9,CCCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,C16H33NO6,25702.0
10474,Orsellinic Acid,Cc1cc(O)cc(O)c1C(=O)O,C8H8O4,22708.0
10475,Orsellinic Acid (CRM),Cc1cc(O)cc(O)c1C(=O)O,C8H8O4,39478.0
10476,Amorolfine (hydrochloride),CCC(C)(C)c1ccc(CC(C)CN2C[C@@H](C)O[C@@H](C)C2)cc1.Cl,C21H36ClNO,26077.0
10477,H-151,CCc1ccc(NC(=O)Nc2c[nH]c3ccccc23)cc1,C17H17N3O,25857.0
10478,3-Methylquinoxaline-2-carboxylic Acid,Cc1nc2ccccc2nc1C(=O)O,C10H8N2O2,25664.0
10479,Kukoamine A,O=C(CCc1ccc(O)c(O)c1)NCCCNCCCCNCCCNC(=O)CCc1ccc(O)c(O)c1,C28H42N4O6,25139.0
10480,?-Hydroxyglutaric Acid,O=C(O)CCC(O)C(=O)O,C5H8O5,25894.0
10481,(R)-Mephenytoin,CC[C@]1(c2ccccc2)NC(=O)N(C)C1=O,C12H14N2O2,25891.0
10482,Magnoflorine,COc1ccc2c(c1O)-c1c(O)c(OC)cc3c1[C@H](C2)[N+](C)(C)CC3,C20H24NO4,25122.0
10483,C527,O=C1c2ccccc2C(=O)c2oc(-c3ccc(F)cc3)nc21,C17H8FNO3,21771.0
10484,Olivetolic Acid,CCCCCc1cc(O)cc(O)c1C(=O)O,C12H16O4,26282.0
10485,Clozapine (hydrochloride),CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1.Cl.Cl,C18H21Cl3N4,25779.0
10486,Feprazone,CC(C)=CCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,C20H20N2O2,20652.0
10487,4-fluoro-CUMYL-5-fluoro-PICA,CC(C)(NC(=O)c1cn(CCCCCF)c2ccccc12)c1ccc(F)cc1,C23H26F2N2O,26131.0
10488,Sordarin (sodium salt),CO[C@H]1[C@@H](O)[C@H](O)[C@H](OC[C@@]23C[C@@H]4[C@H](C)CC[C@H]4[C@@]4(C=O)C[C@@H]2C=C(C(C)C)[C@@]34C(=O)[O-])O[C@@H]1C.[Na+],C27H39NaO8,26255.0
10489,Bufexamac,CCCCOc1ccc(CC(=O)NO)cc1,C12H17NO3,26068.0
10490,trans-4-hydroxy L-Proline,O=C(O)[C@@H]1C[C@@H](O)CN1,C5H9NO3,26061.0
10491,5-methyl-2-HOBA (hydrochloride),Cc1ccc(O)c(CN)c1.Cl,C8H12ClNO,25351.0
10492,Cilnidipine,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1,C27H28N2O7,26080.0
10493,Sabinene,C=C1CCC2(C(C)C)CC12,C10H16,25777.0
10494,L-?-Hydroxyglutaric Acid (sodium salt),O=C(O)CC[C@H](O)C(=O)O.[NaH].[NaH],C5H8Na2O5,11876.0
10495,Cedrene,C=C1CC[C@@]23C[C@@H]1C(C)(C)[C@@H]2CC[C@H]3C.CC1=CC[C@@]23C[C@@H]1C(C)(C)[C@@H]2CC[C@H]3C,C30H48,23180.0
10496,LY3177833,C[C@@]1(c2ncncc2F)NC(=O)c2cc(-c3cn[nH]c3)ccc21,C16H12FN5O,25988.0
10497,Acipimox,Cc1cnc(C(=O)O)c[n+]1[O-],C6H6N2O3,26090.0
10498,1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PE,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=C\C/C=C\C/C=C\C=C\[C@H](CCCCC)OO,C43H78NO10P,25856.0
10499,Cho-Arg (trifluoroacetate salt),CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CCCCCNC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])CC[C@]4(C)[C@H]3CC[C@]12C.O=C([O-])C(F)(F)F.O=C([O-])C(F)(F)F,C43H71F6N5O7,25943.0
10500,P053,C[C@@](N)(CO)CCc1ccc(OCc2ccc(Cl)c(Cl)c2)cc1,C18H21Cl2NO2,26113.0
10501,Aloin B,O=C1c2c(O)cccc2[C@@H]([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cc(CO)cc(O)c21,C21H22O9,23321.0
10502,Tirasemtiv,C#Cc1cnc2[nH]c(=O)n(C(CC)CC)c2n1,C12H14N4O,26075.0
10503,Lacosamide-d3,[2H]C([2H])([2H])OC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,C13H18N2O3,25426.0
10504,Inosine 5'-triphosphate (sodium salt),O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+],C10H12N4Na3O14P3,23063.0
10505,Imperatorin,CC(C)=CCOc1c2occc2cc2ccc(=O)oc12,C16H14O4,26070.0
10506,ABT-751,COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1,C18H17N3O4S,22935.0
10507,Bis(methylthio)gliotoxin,CS[C@]1(CO)C(=O)N2[C@H]3C(=CC=C[C@@H]3O)C[C@@]2(SC)C(=O)N1C,C15H20N2O4S2,26271.0
10508,meta-fluoro 4-ANBP,Fc1cccc(NC2CCN(Cc3ccccc3)CC2)c1,C18H21FN2,25959.0
10509,Cefalothin (sodium salt),CC(=O)OCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)Cc3cccs3)[C@H]2SC1.[Na+],C16H15N2NaO6S2,26063.0
10510,Fulvic Acid,CC1(O)Cc2oc3cc(O)c(O)c(C(=O)O)c3c(=O)c2CO1,C14H12O8,19063.0
10511,Acyclovir-d4,[2H]C([2H])(O)C([2H])([2H])OCn1cnc2c(=O)[nH]c(N)nc21,C8H11N5O3,26272.0
10512,7-keto-25-hydroxy Cholesterol,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H44O3,25973.0
10513,Medroxyprogesterone,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,C22H32O3,24908.0
10514,Penfluridol,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,C28H27ClF5NO,26071.0
10515,Raltitrexed,Cc1nc(=O)c2cc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)ccc2[nH]1,C21H22N4O6S,26079.0
10516,Ritodrine (hydrochloride),C[C@@H](NCCc1ccc(O)cc1)[C@@H](O)c1ccc(O)cc1.Cl,C17H22ClNO3,26084.0
10517,WAY-316606,O=S(=O)(NC1CCNCC1)c1cc(S(=O)(=O)c2ccccc2)ccc1C(F)(F)F,C18H19F3N2O4S2,26324.0
10518,5-fluoro MPP-PICA,COC(=O)[C@H](Cc1ccccc1)NC(=O)c1cn(CCCCCF)c2ccccc12,C24H27FN2O3,25916.0
10519,Azilsartan,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,C25H20N4O5,26091.0
10520,Febrifugine,O=C(C[C@H]1NCCC[C@@H]1O)Cn1cnc2ccccc2c1=O,C16H19N3O3,14246.0
10521,"N-[1-(2,3-Dioleyloxy)propyl]-N,N,N-trimethylammonium (chloride)",CCCCCCCC/C=C\CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC/C=C\CCCCCCCC.[Cl-],C42H84ClNO2,25926.0
10522,2H-Cho-Arg (trifluoroacetate salt),CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OC(=O)CCCCCNC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])CC[C@]4(C)[C@H]3CC[C@]12C.O=C([O-])C(F)(F)F.O=C([O-])C(F)(F)F,C43H73F6N5O7,25944.0
10523,1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA (sodium salt),CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@@H](O)COP(=O)([O-])O.[NH4+],C23H42NO7P,10019.0
10524,Nordiazepam,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1,C15H11ClN2O,15898.0
10525,N-benzyl meta-fluoro Cyclopropyl norfentanyl (hydrochloride),Cl.O=C(C1CC1)N(c1cccc(F)c1)C1CCN(Cc2ccccc2)CC1,C22H26ClFN2O,25274.0
10526,Ferrostatin-1 Diyne,CCCCC#CC#CCNc1ccc(C(=O)OCC)cc1N,C18H22N2O2,25492.0
10527,Tioconazole,Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1,C16H13Cl3N2OS,26069.0
10528,Aspartame,COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O,C14H18N2O5,26089.0
10529,Cobicistat-d8,[2H]C1([2H])OC([2H])([2H])C([2H])([2H])N(CC[C@H](NC(=O)N(C)Cc2csc(C(C)C)n2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)C1([2H])[2H],C40H53N7O5S2,26442.0
10530,TC 2559 (fumarate),CCOc1cncc(/C=C/CCNC)c1.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O,C20H26N2O9,25600.0
10531,4SC-202,Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1,C30H29N5O6S2,26175.0
10532,12:0 N-Biotinyl Fatty Acid,O=C(O)CCCCCCCCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C22H39N3O4S,25714.0
10533,4-fluoro-CUMYL-5-fluoro-PINACA,CC(C)(NC(=O)c1nn(CCCCCF)c2ccccc12)c1ccc(F)cc1,C22H25F2N3O,26134.0
10534,NBD Sphingosine,N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12,C24H39N5O5,25348.0
10535,Ulipristal Acetate-d6,[2H]C([2H])([2H])N(c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@]3(OC(C)=O)C(C)=O)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1)C([2H])([2H])[2H],C30H37NO4,26446.0
10536,NUC-1031,C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O)Oc1ccccc1)C(=O)OCc1ccccc1,C25H27F2N4O8P,9003247.0
10537,ABC99,O=C1C2CN(Cc3ccc(Cl)cc3)CCN2C(=O)N1OC(=O)N1CCOc2ccccc21,C22H21ClN4O5,25858.0
10538,Segesterone Acetate,C=C1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]2(C)[C@@]1(OC(C)=O)C(C)=O,C23H30O4,26441.0
10539,1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=C\C/C=C\C/C=C\C=C\[C@@H](O)CCCCC,C43H78NO9P,21139.0
10540,Difludiazepam,CN1C(=O)CN=C(c2c(F)cccc2F)c2cc(Cl)ccc21,C16H11ClF2N2O,23507.0
10541,4-acetoxy MiPT (hydrochloride),CC(=O)Oc1cccc2[nH]cc(CCN(C)C(C)C)c12.Cl,C16H23ClN2O2,25672.0
10542,DS16570511,Cc1onc(-c2c(Cl)cccc2Cl)c1CNc1cccc(C(=O)c2cn(CCCC(=O)O)c3ccccc23)c1,C30H25Cl2N3O4,24160.0
10543,N-Desmethylclozapine-d8,[2H]C1([2H])NC([2H])([2H])C([2H])([2H])N(C2=Nc3cc(Cl)ccc3Nc3ccccc32)C1([2H])[2H],C17H17ClN4,26027.0
10544,"1,2-Dibromo-4,5-methylenedioxybenzene",Brc1cc2c(cc1Br)OCO2,C7H4Br2O2,26357.0
10545,U-48520,CN(C)[C@@H]1CCCC[C@H]1N(C)C(=O)c1ccc(Cl)cc1,C16H23ClN2O,26274.0
10546,n-Dodecyl-?-D-maltoside,CCCCCCCCCCCCO[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,C24H46O11,26152.0
10547,Topiramate-d12,[2H]C([2H])([2H])C1(C([2H])([2H])[2H])O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C([2H])([2H])[2H])(C([2H])([2H])[2H])O[C@@H]23)O1,C12H21NO8S,26443.0
10548,Chlorpropamide,CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,C10H13ClN2O3S,26087.0
10549,1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\C=C\[C@H](CCCCC)OO,C46H84NO10P,26531.0
10550,Oncrasin-1,O=Cc1cn(Cc2ccc(Cl)cc2)c2ccccc12,C16H12ClNO,25808.0
10551,"2,6-Dibromoquinone-4-chloroimide",O=C1C(Br)=CC(=NCl)C=C1Br,C6H2Br2ClNO,21056.0
10552,N-acetyl-L-Cysteine amide,CC(=O)N[C@@H](CS)C(N)=O,C5H10N2O2S,25866.0
10553,N-Desmethylclozapine,Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,C17H17ClN4,26153.0
10554,Meclizine-d8 (hydrochloride),Cl.Cl.[2H]C1([2H])N(Cc2cccc(C)c2)C([2H])([2H])C([2H])([2H])N(C(c2ccccc2)c2ccc(Cl)cc2)C1([2H])[2H],C25H29Cl3N2,26444.0
10555,BODIPY 505/515,CC1=CC(C)=[N+]2C1=Cc1c(C)cc(C)n1[B-]2(F)F,C13H15BF2N2,25893.0
10556,Gentiopicrin,C=C[C@@H]1C2=CCOC(=O)C2=CO[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C16H20O9,25102.0
10557,6-Amino-8-trifluoromethylphenanthridine,Nc1nc2ccccc2c2ccc(C(F)(F)F)cc12,C14H9F3N2,26419.0
10558,Cetirizine-d8 (hydrochloride),Cl.Cl.[2H]C1([2H])N(CCOCC(=O)O)C([2H])([2H])C([2H])([2H])N(C(c2ccccc2)c2ccc(Cl)cc2)C1([2H])[2H],C21H27Cl3N2O3,26445.0
10559,Galantamine-d3 (hydrobromide),Br.[2H]C([2H])([2H])Oc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,C17H22BrNO3,26103.0
10560,Doravirine,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n[nH]c1=O,C17H11ClF3N5O3,26405.0
10561,Leflunomide-d4,[2H]c1c([2H])c(C(F)(F)F)c([2H])c([2H])c1NC(=O)c1cnoc1C,C12H9F3N2O2,26448.0
10562,NSI-189,CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1,C22H30N4O,26166.0
10563,Dodecylphosphocholine-d38,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])OP(=O)([O-])OC([2H])([2H])C([2H])([2H])[N+](C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H],C17H38NO4P,25996.0
10564,N-benzyl meta-fluoro Acetyl norfentanyl (hydrochloride),CC(=O)N(c1cccc(F)c1)C1CCN(Cc2ccccc2)CC1.Cl,C20H24ClFN2O,26370.0
10565,Mexedrone (hydrochloride) (CRM),CNC(COC)C(=O)c1ccc(C)cc1.Cl,C12H18ClNO2,26279.0
10566,Nitrazolam,Cc1nnc2n1-c1ccc([N+](=O)[O-])cc1C(c1ccccc1)=NC2,C17H13N5O2,22620.0
10567,"1,2,3-Triheneicosanoyl Glycerol",CCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCC,C66H128O6,10010540.0
10568,Ticarcillin (sodium salt),CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)[O-])c3ccsc3)C(=O)N2[C@H]1C(=O)[O-].[Na+].[Na+],C15H14N2Na2O6S2,26065.0
10569,3-Hydroxyisobutyrate (sodium salt),CC(CO)C(=O)[O-].[Na+],C4H7NaO3,26105.0
10570,Imiquimod-d9,[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])n1cnc2c(N)nc3ccccc3c21,C14H16N4,26424.0
10571,Acetyl-L-carnitine-d3 (chloride),[2H]C([2H])([2H])C(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C9H18ClNO4,26564.0
10572,Brivanib Alaninate,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1,C22H24FN5O4,26081.0
10573,Dofetilide-d4,[2H]C([2H])(Oc1ccc(NS(C)(=O)=O)cc1)C([2H])([2H])N(C)CCc1ccc(NS(C)(=O)=O)cc1,C19H27N3O5S2,26451.0
10574,AZD 9668,Cc1c(-c2ccnn2C)cc(C(=O)NCc2ccc(S(C)(=O)=O)cn2)c(=O)n1-c1cccc(C(F)(F)F)c1,C25H22F3N5O4S,26083.0
10575,Denatonium (benzoate salt),CC[N+](CC)(CC(=O)Nc1c(C)cccc1C)Cc1ccccc1.O=C([O-])c1ccccc1,C28H34N2O3,26350.0
10576,(+)-Geodin,COC(=O)C1=CC(=O)C=C(OC)[C@]12Oc1c(Cl)c(C)c(Cl)c(O)c1C2=O,C17H12Cl2O7,26421.0
10577,Flubendazole,COC(=O)Nc1nc2ccc(C(=O)c3ccc(F)cc3)cc2[nH]1,C16H12FN3O3,26064.0
10578,Hydrocortisone-d4,[2H]C1([2H])[C@]([2H])(O)[C@@]2([2H])[C@@H](CCC3=CC(=O)CC[C@@]32C)[C@@H]2CC[C@](O)(C(=O)CO)[C@]21C,C21H30O5,26500.0
10579,3-Cysteinylacetaminophen (trifluoroacetate salt),CC(=O)Nc1ccc(O)c(SC[C@H](N)C(=O)O)c1.O=C(O)C(F)(F)F,C13H15F3N2O6S,26388.0
10580,6-Aminophenanthridine,Nc1nc2ccccc2c2ccccc12,C13H10N2,26420.0
10581,Tolvaptan-d7,[2H]c1c([2H])c([2H])c(C([2H])([2H])[2H])c(C(=O)Nc2ccc(C(=O)N3CCCC(O)c4cc(Cl)ccc43)c(C)c2)c1[2H],C26H25ClN2O3,26453.0
10582,Brexpiprazole-d8,[2H]C1([2H])N(CCCCOc2ccc3ccc(=O)[nH]c3c2)C([2H])([2H])C([2H])([2H])N(c2cccc3sccc23)C1([2H])[2H],C25H27N3O2S,26450.0
10583,KPT-185,COc1cc(-c2ncn(/C=C\C(=O)OC(C)C)n2)cc(C(F)(F)F)c1,C16H16F3N3O3,26074.0
10584,Anacardic Acid diene,CCC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O,C22H32O3,22663.0
10585,Conivaptan-d4,[2H]c1c([2H])c(C(=O)N2CCc3nc(C)[nH]c3-c3ccccc32)c([2H])c([2H])c1NC(=O)c1ccccc1-c1ccccc1,C32H26N4O2,26455.0
10586,Terbinafine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])N(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12,C21H26ClN,26392.0
10587,Valeryl fentanyl-13C6,CCCCC(=O)N(C1CCN(CCc2ccccc2)CC1)[13c]1[13cH][13cH][13cH][13cH][13cH]1,C24H32N2O,26220.0
10588,"2,3-Benzodioxole fentanyl",CCCCC(=O)N(C1CCN(CCc2ccccc2)CC1)[13c]1[13cH][13cH][13cH][13cH][13cH]1,C24H32N2O,26618.0
10589,GAT229,O=[N+]([O-])C[C@@H](c1ccccc1)c1c(-c2ccccc2)[nH]c2ccccc12,C22H18N2O2,24486.0
10590,Bromosulfalein,O=C1OC(c2ccc(O)c(S(=O)(=O)[O-])c2)(c2ccc(O)c(S(=O)(=O)[O-])c2)c2c(Br)c(Br)c(Br)c(Br)c21.[Na+].[Na+],C20H8Br4Na2O10S2,21058.0
10591,Letrozole-d4,[2H]c1c([2H])c(C(c2ccc(C#N)cc2)n2cncn2)c([2H])c([2H])c1C#N,C17H11N5,26517.0
10592,Salmeterol-d3,[2H]C([2H])(O)c1cc(C([2H])(O)CNCCCCCCOCCCCc2ccccc2)ccc1O,C25H37NO4,26449.0
10593,Dihydropleuromutilin,CC[C@]1(C)C[C@@H](OC(=O)CO)C2(C)[C@H](C)CCC3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,C22H36O5,26497.0
10594,Ac-PAL-AMC,CC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)Nc1ccc2c(C)cc(=O)oc2c1,C26H34N4O6,26592.0
10595,Myristoyl-L-carnitine (chloride),CCCCCCCCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C21H42ClNO4,26559.0
10596,AMG 232,CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,C28H35Cl2NO5S,25667.0
10597,"D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (sodium salt)",O=P([O-])(O)O[C@H]1[C@H](OP(=O)([O-])O)[C@@H](OP(=O)([O-])O)[C@H](OP(=O)([O-])O)[C@@H](OP(=O)([O-])O)[C@H]1OP(=O)([O-])O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],C6H12Na6O24P6,10008415.0
10598,Plerixafor-d4,[2H]c1c([2H])c(CN2CCCNCCNCCCNCC2)c([2H])c([2H])c1CN1CCCNCCNCCCNCC1,C28H54N8,26490.0
10599,Lateropyrone,COC(=O)c1oc(=O)c2c(O)c3c(=O)cc(C)oc3cc2c1O,C15H10O8,26463.0
10600,Lachnone A,Cc1cc(O)c2c(=O)c(O)c(C)oc2c1,C11H10O4,26462.0
10601,Cilomilast,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1,C20H25NO4,25979.0
10602,Nalfurafine,CN(C(=O)/C=C/c1ccoc1)[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,C28H32N2O5,23186.0
10603,Pyrocoll,O=c1c2cccn2c(=O)c2cccn12,C10H6N2O2,26464.0
10604,Stearoyl-L-carnitine-d3 (chloride),[2H]C([2H])([2H])[N+](C)(C)C[C@@H](CC(=O)O)OC(=O)CCCCCCCCCCCCCCCCC.[Cl-],C25H50ClNO4,26580.0
10605,7-hydroxy Pestalotin,CCC[C@@H](O)[C@H](O)[C@@H]1CC(OC)=CC(=O)O1,C11H18O5,26523.0
10606,PD 151746,O=C(O)/C(S)=C/c1c[nH]c2ccc(F)cc12,C11H8FNO2S,23417.0
10607,Sporidesmolide III,CC(C)C[C@@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)OC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C(C)C)OC1=O,C32H56N4O8,26593.0
10608,Dorzolamide-d5 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])([2H])N[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,C10H17ClN2O4S3,26518.0
10609,Corynecin IV,CC(=O)N[C@H](COC(C)=O)[C@H](O)c1ccc([N+](=O)[O-])cc1,C13H16N2O6,26393.0
10610,CAY10734,CC(C)Cc1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1,C23H25N3O3,10007833.0
10611,Myristoyl-L-carnitine-d3 (chloride),[2H]C([2H])([2H])[N+](C)(C)C[C@@H](CC(=O)O)OC(=O)CCCCCCCCCCCCC.[Cl-],C21H42ClNO4,26581.0
10612,1-demethyl Phenazolam,Clc1ccccc1C1=NCc2nncn2-c2ccc(Br)cc21,C16H10BrClN4,23525.0
10613,ARN14988,CCCCCCNC(=O)n1cc(Cl)c(=O)n(C(=O)OCC(C)C)c1=O,C16H24ClN3O5,24284.0
10614,Tizanidine-d4 (hydrochloride),Cl.[2H]C1([2H])N=C(Nc2c(Cl)ccc3nsnc23)NC1([2H])[2H],C9H9Cl2N5S,26521.0
10615,Hexanoyl-L-carnitine-d3 (chloride),[2H]C([2H])([2H])[N+](C)(C)C[C@@H](CC(=O)O)OC(=O)CCCCC.[Cl-],C13H26ClNO4,26570.0
10616,Anacardic Acid triene,C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O,C22H30O3,26611.0
10617,Phenylephrine-3-O-Sulfate,CNC[C@H](O)c1cccc(OS(=O)(=O)O)c1,C9H13NO5S,26620.0
10618,1-Oleoyl-2-Palmitoyl-sn-glycero-3-PC,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC,C42H82NO8P,26012.0
10619,Phenylephrine Glucuronide,CNC[C@H](O)c1cccc(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)c1,C15H21NO8,26647.0
10620,Bromazolam,Cc1nnc2n1-c1ccc(Br)cc1C(c1ccccc1)=NC2,C17H13BrN4,22665.0
10621,Bromazolam (CRM),Cc1nnc2n1-c1ccc(Br)cc1C(c1ccccc1)=NC2,C17H13BrN4,38201.0
10622,Octanoyl-L-carnitine-d3 (chloride),[2H]C([2H])([2H])[N+](C)(C)C[C@@H](CC(=O)O)OC(=O)CCCCCCC.[Cl-],C15H30ClNO4,26577.0
10623,Bromfenac-d4 (sodium salt),[2H]c1c([2H])c(C(=O)c2cccc(CC(=O)[O-])c2N)c([2H])c([2H])c1Br.[Na+],C15H11BrNNaO3,26598.0
10624,4-hydroxy Solifenacin N-oxide,O=C(O[C@H]1C[N+]2([O-])CCC1CC2)N1CC(O)c2ccccc2C1c1ccccc1,C23H26N2O4,26649.0
10625,Propionyl-L-carnitine-d3 (chloride),[2H]C([2H])([2H])[N+](C)(C)C[C@@H](CC(=O)O)OC(=O)CC.[Cl-],C10H20ClNO4,26579.0
10626,Butyryl-L-carnitine-d3 (chloride),[2H]C([2H])([2H])[N+](C)(C)C[C@@H](CC(=O)O)OC(=O)CCC.[Cl-],C11H22ClNO4,26567.0
10627,Arachidonoyl Chloride,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)Cl,C20H31ClO,18078.0
10628,Palmitoyl-L-carnitine (chloride),CCCCCCCCCCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C23H46ClNO4,26553.0
10629,20?-dihydro Prednisolone,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)[C@H](O)CO,C21H30O5,26502.0
10630,AP-237 (hydrochloride),CCCC(=O)N1CCN(C/C=C/c2ccccc2)CC1.Cl,C17H25ClN2O,26484.0
10631,Metamizole-d3 (sodium salt),[2H]C([2H])([2H])N(CS(=O)(=O)[O-])c1c(C)n(C)n(-c2ccccc2)c1=O.[Na+],C13H16N3NaO4S,26496.0
10632,4-chloro Buphedrone (hydrochloride),CCC(NC)C(=O)c1ccc(Cl)cc1.Cl,C11H15Cl2NO,25298.0
10633,Lurasidone metabolite 14283,O=C1[C@@H]2[C@@H]3C[C@@H](C[C@H]3O)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1,C28H36N4O3S,26651.0
10634,?-acetyl Boswellic Acid,CC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2CC=C2[C@@H]4CC(C)(C)CC[C@]4(C)CC[C@]23C)[C@@]1(C)C(=O)O,C32H50O4,11673.0
10635,Ac-WLA-AMC,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)Nc1ccc2c(C)cc(=O)oc2c1,C32H37N5O6,26639.0
10636,Lauroyl-L-carnitine (chloride),CCCCCCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C19H38ClNO4,26550.0
10637,Germacrene D,C=C1/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,C15H24,26539.0
10638,Campestanol,CC(C)[C@H](C)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C28H50O,26538.0
10639,1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\C=C\[C@@H](O)CCCCC,C46H84NO9P,21138.0
10640,Dios-Arg (trifluoroacetate salt),C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](OC(=O)CCCCCNC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C.O=C([O-])C(F)(F)F.O=C([O-])C(F)(F)F,C43H67F6N5O9,25945.0
10641,"1-(1,3-Diphenylpropan-2-yl)pyrrolidine (hydrochloride)",Cl.c1ccc(CC(Cc2ccccc2)N2CCCC2)cc1,C19H24ClN,26033.0
10642,Piperidylthiambutene (hydrochloride),CC(C=C(c1cccs1)c1cccs1)N1CCCCC1.Cl,C17H22ClNS2,26335.0
10643,Cholesteryl Behenate,CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C49H88O2,26466.0
10644,Cholesteryl Arachidate,CCCCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C47H84O2,26465.0
10645,LMW-PTP Inhibitor I (hydrochloride),CCN(CC)C(=O)c1ccc(-c2cc(NCCCN3CCCCC3)c3ccccc3n2)cc1.Cl.Cl,C28H38Cl2N4O,22277.0
10646,LUF6283,CCCCc1cc(C(=O)O)n[nH]1,C8H12N2O2,15423.0
10647,Palmitoyl-L-carnitine-d3 (chloride),[2H]C([2H])([2H])[N+](C)(C)C[C@@H](CC(=O)O)OC(=O)CCCCCCCCCCCCCCC.[Cl-],C23H46ClNO4,26569.0
10648,(-)-Viriditoxin,COC(=O)C[C@@H]1Cc2cc3c(-c4c(OC)cc(O)c5c(O)c6c(cc45)C[C@@H](CC(=O)OC)OC6=O)c(OC)cc(O)c3c(O)c2C(=O)O1,C34H30O14,26601.0
10649,Agistatin B,CC[C@@H]1CC[C@@H]2O[C@H]3C[C@H](O)[C@]2(O)[C@@H]1O3,C11H18O4,26600.0
10650,Lurasidone metabolite 14326,O=C1[C@@H]2[C@@H]3C[C@@H](C[C@@H]3O)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1,C28H36N4O3S,26652.0
10651,Kirenol,C[C@@]1(CO)C[C@@H](O)C[C@@]2(C)[C@@H]3CC[C@](C)([C@@H](O)CO)C=C3CC[C@H]12,C20H34O4,26212.0
10652,Dabigatran Acyl-?-D-Glucuronide,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c3ccccn3)ccc21,C31H33N7O9,26655.0
10653,Decanoyl-L-carnitine-d3 (chloride),[2H]C([2H])([2H])[N+](C)(C)C[C@@H](CC(=O)O)OC(=O)CCCCCCCCC.[Cl-],C17H34ClNO4,26568.0
10654,Hexanoyl-L-carnitine (chloride),CCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C13H26ClNO4,26554.0
10655,Lauroyl-L-carnitine-d3 (chloride),[2H]C([2H])([2H])[N+](C)(C)C[C@@H](CC(=O)O)OC(=O)CCCCCCCCCCC.[Cl-],C19H38ClNO4,26571.0
10656,Cholesteryl Myristate,CCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C41H72O2,26439.0
10657,4-hydroxy Nebivolol (hydrochloride),Cl.OC1CC(C(O)CNCC(O)C2CCc3cc(F)ccc3O2)Oc2ccc(F)cc21,C22H26ClF2NO5,26658.0
10658,Cyanidin 3-O-?-D-Galactopyranoside (chloride),OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@H]1O.[Cl-],C21H21ClO11,22264.0
10659,Bictegravir,O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c(O)c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2,C21H18F3N3O5,26532.0
10660,ACY-241,O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2Cl)nc1)NO,C24H26ClN5O3,26173.0
10661,"Cholesteryl 11,14-Eicosadienoate",CCCCC/C=C/C/C=C/CCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C47H80O2,26467.0
10662,Atenolol,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,C14H22N2O3,26284.0
10663,Stearoyl-L-carnitine (chloride),CCCCCCCCCCCCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C25H50ClNO4,26556.0
10664,1-Myristoyl-2-hydroxy-sn-glycero-3-PE,CCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[NH3+],C19H40NO7P,25591.0
10665,4-fluoro MDMB-BUTINACA,COC(=O)[C@@H](NC(=O)c1nn(CCCCF)c2ccccc12)C(C)(C)C,C19H26FN3O3,26645.0
10666,Decanoyl-L-carnitine (chloride),CCCCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C17H34ClNO4,26549.0
10667,Asimadoline,CN(C(=O)C(c1ccccc1)c1ccccc1)[C@H](CN1CC[C@H](O)C1)c1ccccc1,C27H30N2O2,26411.0
10668,Corynecin V,CCC(=O)N[C@H](COC(C)=O)[C@H](O)c1ccc([N+](=O)[O-])cc1,C14H18N2O6,26167.0
10669,?-GalCer analog 8,CCCCCCCCCCCCCCCCCCCCCCCCc1cn([C@@H](CO[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)CCCCCCCCCCCCCC)nn1,C50H97N3O8,26660.0
10670,L-Carnitine-d3 (chloride),[2H]C([2H])([2H])[N+](C)(C)C[C@H](O)CC(=O)O.[Cl-],C7H16ClNO3,26565.0
10671,"3,4-Dichloroethcathinone (hydrochloride)",CCNC(C)C(=O)c1ccc(Cl)c(Cl)c1.Cl,C11H14Cl3NO,25375.0
10672,N-methyl-N-Ethyltryptamine (oxalate),CCN(C)CCc1c[nH]c2ccccc12.O=C(O)C(=O)O,C15H20N2O4,25268.0
10673,"5-Fluorouracil-13C,15N2",O=c1[15nH][13c](=O)[15nH]cc1F,C4H3FN2O2,26683.0
10674,Clarithromycin-13C-d3,[2H][13C]([2H])([2H])N(C)[C@H]1C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)OC)[C@@H]1O,C38H69NO13,26678.0
10675,Saxagliptin-13C-d2 (hydrochloride),Cl.[2H][13C]1([2H])[C@H]2C[C@@H](C#N)N(C(=O)[C@@H](N)C34CC5CC(CC(O)(C5)C3)C4)[C@H]21,C18H26ClN3O2,26709.0
10676,Vigabatrin-13C-d2 (hydrochloride),Cl.[2H][13C]([2H])=CC(N)CCC(=O)O,C6H12ClNO2,26672.0
10677,Di-4-ANEPPS,CCCCN(CCCC)c1ccc2cc(/C=C/c3cc[n+](CCCS(=O)(=O)[O-])cc3)ccc2c1,C28H36N2O3S,26801.0
10678,L-Fucitol,C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO,C6H14O5,26540.0
10679,Fantofarone,COc1ccc(CCN(C)CCCOc2ccc(S(=O)(=O)c3c(C(C)C)cn4ccccc34)cc2)cc1OC,C31H38N2O5S,26381.0
10680,Oleoyl-L-carnitine,CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C,C25H47NO4,26557.0
10681,AZ 32,CNC(=O)c1ccc(-c2cnc3cnc(-c4ccccc4)cn23)cc1,C20H16N4O,26380.0
10682,Tolperisone (hydrochloride),Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1.Cl,C16H24ClNO,26078.0
10683,Palmitoyl-D-carnitine (chloride),CCCCCCCCCCCCCCCC(=O)O[C@@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C23H46ClNO4,26552.0
10684,1-Stearoyl-2-Docosahexaenoyl-sn-glycero-3-PC,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C48H84NO8P,25595.0
10685,(R)-Crizotinib-d5,[2H]C1([2H])CNCC([2H])([2H])C1([2H])n1cc(-c2cnc(N)c(O[C@H](C)c3c(Cl)ccc(F)c3Cl)c2)cn1,C21H22Cl2FN5O,26762.0
10686,"3,4-Dichloromethcathinone (hydrochloride)",CNC(C)C(=O)c1ccc(Cl)c(Cl)c1.Cl,C10H12Cl3NO,25376.0
10687,Lomibuvir,CC(C)(C)C#Cc1cc(N(C(=O)[C@H]2CC[C@H](C)CC2)[C@H]2CC[C@@H](O)CC2)c(C(=O)O)s1,C25H35NO4S,26630.0
10688,Emtricitabine S-oxide,Nc1nc(=O)n([C@@H]2CS(=O)[C@H](CO)O2)cc1F,C8H10FN3O4S,26654.0
10689,2-methyl AP-237 (hydrochloride),CCCC(=O)N1CCN(C/C=C/c2ccccc2)CC1C.Cl,C18H27ClN2O,26485.0
10690,5-fluoro MDMB-7-PAICA,COC(=O)[C@@H](NC(=O)c1cn(CCCCCF)c2ncccc12)C(C)(C)C,C20H28FN3O3,25286.0
10691,Isovaleryl-L-carnitine (chloride),CC(C)CC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C12H24ClNO4,26555.0
10692,Axitinib-13C-d3,[2H][13C]([2H])([2H])NC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,C22H18N4OS,26676.0
10693,NDT 9513727,CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1ccc2c(c1)OCO2)Cc1ccc2c(c1)OCO2,C36H35N3O4,24448.0
10694,1-Stearoyl-2-hydroxy-sn-glycero-3-PE,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[NH3+],C23H48NO7P,25593.0
10695,Sitagliptin N-Sulfate (sodium salt),O=C(C[C@@H](Cc1cc(F)c(F)cc1F)NS(=O)(=O)[O-])N1CCn2c(nnc2C(F)(F)F)C1.[Na+],C16H14F6N5NaO4S,26625.0
10696,DL-Carnitine-d9 (chloride),[2H]C([2H])([2H])[N+](CC(O)CC(=O)O)(C([2H])([2H])[2H])C([2H])([2H])[2H].[Cl-],C7H16ClNO3,26566.0
10697,THZ531,CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1,C30H32ClN7O2,26386.0
10698,Paraherquamide E,C[C@H]1CCN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6OC=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@]12C(=O)N4C,C28H35N3O4,26680.0
10699,PNU 142300,CC(=O)NC[C@H]1CN(c2ccc(NCCOCC(=O)O)c(F)c2)C(=O)O1,C16H20FN3O6,26608.0
10700,Quadrone,CC1(C)C[C@@]23[C@@H]4CC(=O)[C@@H]2COC(=O)[C@@H]3CC[C@H]41,C15H20O3,26688.0
10701,3'-Ethoxy Spinosyn L,CCO[C@@H]1[C@@H](OC)[C@H](C)O[C@@H](O[C@H]2C[C@H]3[C@@H]4C=C5C(=O)[C@H](C)[C@@H](O[C@H]6CC[C@H](N(C)C)[C@@H](C)O6)CCC[C@H](CC)OC(=O)C[C@H]5[C@@H]4C=C(C)[C@@H]3C2)[C@@H]1OC,C43H69NO10,26664.0
10702,Sterculic Acid methyl ester,CCCCCCCCC1=C(CCCCCCCC(=O)OC)C1,C20H36O2,26736.0
10703,Avermectin B1a monosaccharide,CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C41H60O11,26690.0
10704,TAK-779,Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCC3)cc1.[Cl-],C33H39ClN2O2,26744.0
10705,Amiloride (hydrochloride),Cl.N=C(N)NC(=O)c1nc(Cl)c(N)nc1N,C6H9Cl2N7O,26295.0
10706,AEG 3482,NS(=O)(=O)c1nn2cc(-c3ccccc3)nc2s1,C10H8N4O2S2,26213.0
10707,Deschloronorketamine (hydrochloride),Cl.NC1(c2ccccc2)CCCCC1=O,C12H16ClNO,26401.0
10708,3-hydroxy Medetomidine,Cc1c(CO)cccc1C(C)c1cnc[nH]1,C13H16N2O,26609.0
10709,Thiocillin I,C/C=C(\NC(=O)c1csc(-c2csc(-c3ccc4c(n3)-c3csc(n3)[C@H]([C@@H](C)O)NC(=O)c3csc(n3)[C@H](C(C)(C)O)NC(=O)c3csc(n3)/C(=C/C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c3csc-4n3)n2)n1)C(=O)NC[C@@H](C)O,C48H49N13O10S6,26681.0
10710,LY2828360,Cc1nc(N2CCN(C)CC2)c2nc(-c3ccccc3Cl)n(C3CCOCC3)c2n1,C22H27ClN6O,26791.0
10711,Acamprosate-d3 (calcium salt),[2H]C([2H])([2H])C(=O)NCCCS(=O)(=O)[O-].[2H]C([2H])([2H])C(=O)NCCCS(=O)(=O)[O-].[Ca+2],C10H20CaN2O8S2,26780.0
10712,Fluorescein di-?-Galactopyranoside,O=C1OC2(c3ccc(O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)cc3Oc3cc(O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)ccc32)c2ccccc21,C32H32O15,26860.0
10713,Bumetanide-d5,[2H]c1c([2H])c([2H])c(Oc2c(NCCCC)cc(C(=O)O)cc2S(N)(=O)=O)c([2H])c1[2H],C17H20N2O5S,26773.0
10714,Sterculic Acid,CCCCCCCCC1=C(CCCCCCCC(=O)O)C1,C19H34O2,26735.0
10715,10(Z)-Pentadecenoic Acid methyl ester,CCCC/C=C\CCCCCCCCC(=O)OC,C16H30O2,26729.0
10716,"1,3-Didecanoyl Glycerol",CCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCC,C23H44O5,26845.0
10717,Didecanoin,CCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCC,C23H44O5,26992.0
10718,Methylene Blue (hydrate),CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.O.[Cl-],C16H20ClN3OS,26095.0
10719,TFAP,Nc1ccc(NC(=O)c2ccc(C(F)(F)F)cc2)nc1,C13H10F3N3O,26745.0
10720,"CP 671,305",C[C@@H](Oc1ccc(CNC(=O)c2cccnc2Oc2ccc3c(c2)OCO3)c(F)c1)C(=O)O,C23H19FN2O7,26743.0
10721,Chloramphenicol Palmitate,CCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1,C27H42Cl2N2O6,26663.0
10722,Tetranactin,CC[C@H]1C[C@@H]2CC[C@@H](O2)[C@@H](C)C(=O)O[C@H](CC)C[C@H]2CC[C@H](O2)[C@H](C)C(=O)O[C@@H](CC)C[C@@H]2CC[C@@H](O2)[C@@H](C)C(=O)O[C@H](CC)C[C@H]2CC[C@H](O2)[C@H](C)C(=O)O1,C44H72O12,26687.0
10723,Dotriacontanoic Acid methyl ester,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OC,C33H66O2,26728.0
10724,Loratadine-d4,[2H]C1([2H])CN(C(=O)OCC)CC([2H])([2H])C1=C1c2ccc(Cl)cc2CCc2cccnc21,C22H23ClN2O2,26759.0
10725,Morphine (sulfate hydrate),CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.O.O.O.O.O.O=S(=O)(O)O,C34H50N2O15S,25955.0
10726,Hydroxystilbamidine (methanesulfonate),CS(=O)(=O)O.CS(=O)(=O)O.N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1,C18H24N4O7S2,26858.0
10727,Flibanserin-d4 (hydrochloride),Cl.[2H]C([2H])(N1CCN(c2cccc(C(F)(F)F)c2)CC1)C([2H])([2H])n1c(=O)[nH]c2ccccc21,C20H22ClF3N4O,26779.0
10728,Chlorambucil-d8,[2H]C([2H])(Cl)C([2H])([2H])N(c1ccc(CCCC(=O)O)cc1)C([2H])([2H])C([2H])([2H])Cl,C14H19Cl2NO2,26774.0
10729,24-dehydro Cholesterol-d6,[2H]C([2H])([2H])C(=CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C([2H])([2H])[2H],C27H44O,26777.0
10730,Verdinexor,O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1ccccn1,C18H12F6N6O,26171.0
10731,Gramicidin A,CC(C)C[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCO)C(C)C)C(C)C)C(C)C,C99H140N20O17,26384.0
10732,Deoxybrevianamide E,C=CC(C)(C)c1[nH]c2ccccc2c1C[C@@H]1NC(=O)[C@@H]2CCCN2C1=O,C21H25N3O2,26662.0
10733,"1,2,3-Tri-12(Z)-Heneicosanoyl Glycerol",CCCCCCCC/C=C\CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCC/C=C\CCCCCCCC,C66H122O6,26844.0
10734,GSK180736A,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1,C19H16FN5O2,26182.0
10735,Cystamine-d8 (hydrochloride),Cl.Cl.[2H]C([2H])(N)C([2H])([2H])SSC([2H])([2H])C([2H])([2H])N,C4H14Cl2N2S2,26775.0
10736,AMG 517,CC(=O)Nc1nc2c(Oc3cc(-c4ccc(C(F)(F)F)cc4)ncn3)cccc2s1,C20H13F3N4O2S,26191.0
10737,Omeprazole sulfone-d3,[2H]c1c(OC)c([2H])c2nc(S(=O)(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1[2H],C17H19N3O4S,26784.0
10738,SKPin C1,O=C(O)COc1ccc(Br)cc1/C=C1/SC(=S)N(Cc2cccnc2)C1=O,C18H13BrN2O4S2,26141.0
10739,Azido-Thalidomide,[N-]=[N+]=NCCCCNC(=O)COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,C19H20N6O6,26146.0
10740,Paraherquamide A,CN1C(=O)[C@]23C[C@H]4C(C)(C)[C@@]5(C[C@@]41CN2CC[C@@]3(C)O)C(=O)Nc1c5ccc2c1OC=CC(C)(C)O2,C28H35N3O5,26685.0
10741,Penicillin V-d5 (potassium salt),[2H]c1c([2H])c([2H])c(OCC(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)[O-])c([2H])c1[2H].[K+],C16H17KN2O5S,26786.0
10742,Probenecid-d14,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])N(C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])S(=O)(=O)c1ccc(C(=O)O)cc1,C13H19NO4S,26787.0
10743,L-Carnosine-d4,[2H]C([2H])(N)C([2H])([2H])C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,C9H14N4O3,26781.0
10744,Sulfamethizole-d4,[2H]c1c([2H])c(S(=O)(=O)Nc2nnc(C)s2)c([2H])c([2H])c1N,C9H10N4O2S2,26789.0
10745,GAT228,O=[N+]([O-])C[C@H](c1ccccc1)c1c(-c2ccccc2)[nH]c2ccccc12,C22H18N2O2,24485.0
10746,NIH 12848,FC(F)(F)c1ccccc1-c1nc(NCc2cccs2)c2ccccc2n1,C20H14F3N3S,26035.0
10747,BMS 794833,Nc1nccc(Oc2ccc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,C23H15ClF2N4O3,26180.0
10748,DMPAC-Chol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)NCCCN(C)C)CC[C@]4(C)[C@H]3CC[C@]12C,C33H58N2O2,26583.0
10749,Tetrahydro-11-deoxy Cortisol,C[C@]12CC[C@@H](O)CC1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,C21H34O4,26501.0
10750,True Blue,Cl.Cl.N=C(N)c1ccc2oc(/C=C/c3cc4cc(C(=N)N)ccc4o3)cc2c1,C20H18Cl2N4O2,26863.0
10751,Zileuton-d4,[2H]C([2H])([2H])C([2H])(c1cc2ccccc2s1)N(O)C(N)=O,C11H12N2O2S,26761.0
10752,Codeine (phosphate hydrate),COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341.COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341.O.O=P(O)(O)O.O=P(O)(O)O,C36H50N2O15P2,26514.0
10753,Pirfenidone-d5,[2H]c1c([2H])c([2H])c(-n2cc(C)ccc2=O)c([2H])c1[2H],C12H11NO,26452.0
10754,Cholestenone,C[C@H](CCCCCO)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C26H42O2,25713.0
10755,RG-7112,CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1,C38H48Cl2N4O4S,25673.0
10756,Eganelisib,C[C@H](NC(=O)c1c(N)nn2cccnc12)c1cc2cccc(C#Cc3cnn(C)c3)c2c(=O)n1-c1ccccc1,C30H24N8O2,26416.0
10757,11-Hexadecenoic Acid,CCCC/C=C/CCCCCCCCCC(=O)O,C16H30O2,26730.0
10758,Desloratadine-d4,[2H]C1([2H])CNCC([2H])([2H])C1=C1c2ccc(Cl)cc2CCc2cccnc21,C19H19ClN2,26776.0
10759,Furanyl fentanyl-13C6 (hydrochloride),Cl.O=C(c1ccco1)N(C1CCN(CCc2ccccc2)CC1)[13c]1[13cH][13cH][13cH][13cH][13cH]1,C24H27ClN2O2,25565.0
10760,Furanyl fentanyl-13C6 (hydrochloride) (CRM),Cl.O=C(c1ccco1)N(C1CCN(CCc2ccccc2)CC1)[13c]1[13cH][13cH][13cH][13cH][13cH]1,C24H27ClN2O2,26755.0
10761,VH 032 Linker 2,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCN)C(C)(C)C)cc1.Cl,C32H50ClN5O8S,26149.0
10762,Ibuprofen Carboxylic Acid,CC(Cc1ccc(C(C)C(=O)O)cc1)C(=O)O,C13H16O4,26594.0
10763,Cyanidin 3-O-arabinoside,Oc1cc(O)c2cc(O[C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)c(-c3ccc(O)c(O)c3)[o+]c2c1,C20H19O10,26183.0
10764,Pregnanediol-3-Glucuronide,C[C@H](O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H44O8,26714.0
10765,9-Anthryldiazomethane,[N-]=[N+]=Cc1c2ccccc2cc2ccccc12,C15H10N2,26806.0
10766,Ketoconazole-d3,[2H]C([2H])([2H])C(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,C26H28Cl2N4O4,10010656.0
10767,Diquat (bromide),[Br-].[Br-].c1cc[n+]2c(c1)-c1cccc[n+]1CC2,C12H12Br2N2,26251.0
10768,Levetiracetam-d6,[2H]C1([2H])C(=O)N([C@@H](CC)C(N)=O)C([2H])([2H])C1([2H])[2H],C8H14N2O2,26457.0
10769,USP7-USP47 Inhibitor,CS(=O)(=O)c1ccc(NC(=O)c2cc(C#N)c(Sc3c(Cl)cncc3Cl)s2)cc1,C18H11Cl2N3O3S3,25622.0
10770,Propiconazole-d3 (nitrate),O=[N+]([O-])O.[2H]C1([2H])OC(Cn2cncn2)(c2ccc(Cl)cc2Cl)OC1([2H])CCC,C15H18Cl2N4O5,26788.0
10771,Febuxostat Acyl Glucuronide,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,C22H24N2O9S,26599.0
10772,Pentaacetylquercetin,CC(=O)Oc1cc(OC(C)=O)c2c(=O)c(OC(C)=O)c(-c3ccc(OC(C)=O)c(OC(C)=O)c3)oc2c1,C25H20O12,26694.0
10773,Antipain (hydrochloride),CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)NC(Cc1ccccc1)C(=O)O)C(=O)NC(C=O)CCCNC(=N)N.Cl.Cl,C27H46Cl2N10O6,26705.0
10774,D-Eritadenine,Nc1ncnc2c1ncn2C[C@@H](O)[C@@H](O)C(=O)O,C9H11N5O4,21747.0
10775,Torasemide-d7,[2H]C([2H])([2H])C([2H])(NC(=O)NS(=O)(=O)c1cnccc1Nc1cccc(C)c1)C([2H])([2H])[2H],C16H20N4O3S,26790.0
10776,4-Methylumbelliferyl Caprylate,CCCCCCCC(=O)Oc1ccc2c(C)cc(=O)oc2c1,C18H22O4,26802.0
10777,GS-7340,CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1,C21H29N6O5P,26214.0
10778,Chlorhexidine (acetate hydrate),CC(=O)O.CC(=O)O.N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1.O,C26H40Cl2N10O5,26924.0
10779,Acetyl Resveratrol,CC(=O)Oc1ccc(/C=C/c2cc(OC(C)=O)cc(OC(C)=O)c2)cc1,C20H18O6,26379.0
10780,Specnuezhenide,C/C=C1\[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C(C(=O)OC)[C@H]1CC(=O)OC[C@H]1O[C@@H](OCCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O,C31H42O17,26385.0
10781,Lusutrombopag,CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC,C29H32Cl2N2O5S,26533.0
10782,"1,2-Dioleoyl-3-linoleoyl-rac-glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C57H102O6,62610.0
10783,MK-8745,O=C(c1cccc(Cl)c1F)N1CCN(Cc2cccc(Nc3nccs3)n2)CC1,C20H19ClFN5OS,26190.0
10784,17-methyl Stearic Acid,CC(C)CCCCCCCCCCCCCCCC(=O)O,C19H38O2,26766.0
10785,NAB 2,Cc1ccc(C)c(-n2cnc3cc(C(=O)NCc4ccccc4Cl)ccc32)c1,C23H20ClN3O,26145.0
10786,(+)-Kavain,COC1=CC(=O)O[C@@H](/C=C/c2ccccc2)C1,C14H14O3,26524.0
10787,EGA,Cc1cccc(C)c1NC(=O)N/N=C/c1ccc(Br)cc1,C16H16BrN3O,21882.0
10788,Levorin Complex,C[C@H]1/C=C/C=C/C=C/C=C/C=C\C=C\C=C\[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)CCC[C@@H](O)CC(=O)O[C@@H]1[C@@H](C)C[C@H](C)[C@@H](O)CC(=O)c1ccc(N)cc1)C[C@H](O)[C@H]2C(=O)O,C59H86N2O18,26708.0
10789,Valeryl-L-carnitine (chloride),CCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C12H24ClNO4,26563.0
10790,N?-(1-Carboxymethyl)-L-lysine-d3,[2H]C([2H])(CCC[C@]([2H])(N)C(=O)O)NCC(=O)O,C8H16N2O4,26785.0
10791,Ezetimibe Hydroxy Glucuronide,O=C(O)[C@H]1O[C@@H](O[C@@H](CC[C@H]2C(=O)N(c3ccc(F)cc3)[C@@H]2c2ccc(O)cc2)c2ccc(F)cc2)[C@H](O)[C@@H](O)[C@@H]1O,C30H29F2NO9,26602.0
10792,Almotriptan (malate),CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12.O=C(O)CC(O)C(=O)O,C21H31N3O7S,25646.0
10793,DMHAPC-Chol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)NCCC[N+](C)(C)CCO)CC[C@]4(C)[C@H]3CC[C@]12C,C35H63N2O3,26582.0
10794,TC-E3 5032,O=C1CCC(N2C(=O)c3cccc(F)c3C2=O)C(=O)N1,C13H9FN2O4,26147.0
10795,Arbutin,OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O,C12H16O7,26407.0
10796,IACS-010759,Cc1nc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cccc(N2CCC(S(C)(=O)=O)CC2)c1,C25H25F3N6O4S,25867.0
10797,LY2119620,Cc1c(Cl)c(OCC(=O)N2CCN(C)CC2)nc2sc(C(=O)NC3CC3)c(N)c12,C19H24ClN5O3S,26373.0
10798,"10,13-epoxy-10,12-Octadecadienoic Acid",CCCCCc1ccc(CCCCCCCCC(=O)O)o1,C18H30O3,26767.0
10799,C-178,O=C(Nc1ccc2c(c1)oc1ccccc12)c1ccc([N+](=O)[O-])o1,C17H10N2O5,25860.0
10800,Linoleoyl-L-carnitine (chloride),CCCCC/C=C\C/C=C\CCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C25H46ClNO4,26560.0
10801,HMN-214,COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1,C22H20N2O5S,26210.0
10802,Bergenin,COc1c(O)cc2c(c1O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1OC2=O,C14H16O9,26406.0
10803,Fasentin,CC(=O)CC(=O)Nc1ccc(Cl)c(C(F)(F)F)c1,C11H9ClF3NO2,27050.0
10804,para-hydroxy Butyryl fentanyl,CCCC(=O)N(c1ccc(O)cc1)C1CCN(CCc2ccccc2)CC1,C23H30N2O2,26053.0
10805,"1,2-Dioleoyl-3-Palmitoyl-rac-glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C55H102O6,27070.0
10806,Ipriflavone,CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1,C18H16O3,26319.0
10807,4-HOBA,NCc1ccc(O)cc1,C7H9NO,25398.0
10808,Isavuconazole,C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1cc(F)ccc1F,C22H17F2N5OS,26211.0
10809,p-APMSF (hydrochloride),Cl.N=C(N)c1ccc(CS(=O)(=O)F)cc1,C8H10ClFN2O2S,14971.0
10810,Penicillide,COc1c([C@@H](O)CC(C)C)ccc2c1C(=O)OCc1cc(C)cc(O)c1O2,C21H24O6,26912.0
10811,Terpendole C,CC(C)=C[C@H]1O[C@H]2[C@H]3O[C@@]34[C@H](CC[C@@]3(C)[C@@]4(O)CC[C@H]4Cc5c([nH]c6ccccc56)[C@@]43C)O[C@@H]2C(C)(C)O1,C32H41NO5,26910.0
10812,ETC-1002,CC(C)(CCCCCC(O)CCCCCC(C)(C)C(=O)O)C(=O)O,C19H36O5,26409.0
10813,Chromomycin A2,CO[C@@H]1[C@H](O)C[C@@H](O[C@@H]2C[C@H](Oc3cc4cc5c(c(O)c4c(O)c3C)C(=O)[C@@H](O[C@H]3C[C@@H](O[C@H]4C[C@@H](O[C@H]6C[C@](C)(O)[C@@H](OC(=O)C(C)C)[C@H](C)O6)[C@H](O)[C@@H](C)O4)[C@H](O)[C@@H](C)O3)[C@H]([C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)C5)O[C@H](C)[C@@H]2OC(C)=O)O[C@@H]1C,C59H86O26,26954.0
10814,N-methyl Paroxetine,CN1CC[C@@H](c2ccc(F)cc2)[C@H](COc2ccc3c(c2)OCO3)C1,C20H22FNO3,26160.0
10815,APP-BUTINACA,CCCCn1nc(C(=O)N[C@@H](Cc2ccccc2)C(N)=O)c2ccccc21,C21H24N4O2,26905.0
10816,APP-BUTINACA (CRM),CCCCn1nc(C(=O)N[C@@H](Cc2ccccc2)C(N)=O)c2ccccc21,C21H24N4O2,28624.0
10817,GSK1292263,CC(C)c1noc(N2CCC(COc3ccc(-c4ccc(S(C)(=O)=O)cc4)nc3)CC2)n1,C23H28N4O4S,26181.0
10818,p-chloro Phenylalanine,NC(Cc1ccc(Cl)cc1)C(=O)O,C9H10ClNO2,26168.0
10819,YK-11,COC(=O)/C=C1/OC(C)(OC)O[C@]12CC[C@H]1[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]12C,C25H34O6,9003137.0
10820,Z-IETD-AFC,CC[C@H](C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1)[C@@H](C)O,C37H42F3N5O13,27101.0
10821,CVT-12012,Cc1nc2ccc(NCc3cccc(C(F)(F)F)c3)cc2n(CCNC(=O)CO)c1=O,C21H21F3N4O3,27156.0
10822,"1,2-Dilauroyl-sn-glycero-3-phospho-(2S)-glycerol (sodium salt)",CCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OC[C@@H](O)CO)OC(=O)CCCCCCCCCCC.[Na+],C30H58NaO10P,27198.0
10823,Withanolide B,CC1=C(C)C(=O)O[C@@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4[C@@H]5O[C@@H]5[C@@]5(O)CC=CC(=O)[C@]5(C)[C@H]4CC[C@]23C)C1,C28H38O5,11798.0
10824,Cholesteryl Dihomo-?-Linolenate,CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C47H78O2,26469.0
10825,C18 3'-sulfo Lactosylceramide (d18:1/18:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](OS(=O)(=O)O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC,C48H91NO16S,27201.0
10826,Dihydrotetrabenazine,COc1cc2c(cc1OC)C1CC(O)C(CC(C)C)CN1CC2,C19H29NO3,27182.0
10827,GAT211,O=[N+]([O-])CC(c1ccccc1)c1c(-c2ccccc2)[nH]c2ccccc12,C22H18N2O2,24484.0
10828,Cholesteryl Lignocerate,CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C51H92O2,26470.0
10829,U-93631,CC(C)(C)OC(=O)c1ncn2c1C(C)(C)Nc1ccccc1-2,C17H21N3O2,26417.0
10830,CH5132799,CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21,C15H19N7O3S,26410.0
10831,.beta.-L-Gulopyranosyl-caldarchaetidyl-glycerol,C[C@@H]1CCC[C@H](C)CCC[C@H](C)CC[C@@H](C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@@H](C)CCO[C@H](COP(=O)(O)OCC(O)CO)COCC[C@H](C)CCC[C@H](C)CCC[C@H](C)CCC[C@H](C)CC[C@@H](C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@@H](C)CCO[C@H](CO[C@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)COCC[C@H](C)CCC1,C95H189O16P,27203.0
10832,Telatinib,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1,C20H16ClN5O3,26203.0
10833,N-desmethyl Bendamustine,O=C(O)CCCc1nc2cc(N(CCCl)CCCl)ccc2[nH]1,C15H19Cl2N3O2,27171.0
10834,Tetrahydropiperine,O=C(CCCCc1ccc2c(c1)OCO2)N1CCCCC1,C17H23NO3,11758.0
10835,OH-C-Chol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)NCCNCCO)CC[C@]4(C)[C@H]3CC[C@]12C,C32H56N2O3,26587.0
10836,Roridin E,CC1=C[C@H]2O[C@@H]3C[C@H]4OC(=O)/C=C/C=C/[C@H]([C@@H](C)O)OCC/C(C)=C/C(=O)OC[C@@]2(CC1)[C@]4(C)[C@]31CO1,C29H38O8,26955.0
10837,C18 Phytoceramide-d3 (t18:0/18:0-d3),[2H]C([2H])([2H])CCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC,C36H73NO4,27199.0
10838,Parishin A,O=C(CC(O)(CC(=O)OCc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)OCc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)OCc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,C45H56O25,26665.0
10839,Territrem B,COc1cc(-c2cc3c(c(=O)o2)C[C@]2(O)[C@@]4(C)C(=O)C=CC(C)(C)[C@]4(O)CC[C@@]2(C)O3)cc(OC)c1OC,C29H34O9,26913.0
10840,Ganglioside GM2 (bovine brain) (sodium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[Na+],C67H120N3NaO26,27192.0
10841,"1,3-Dieicosenoyl Glycerol",CCCCCCCC/C=C\CCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCC/C=C\CCCCCCCC,C43H80O5,26795.0
10842,1-Oleoyl Glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(O)CO,C21H40O4,26793.0
10843,"1,2-Dioleoyl-3-Decanoyl-rac-glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C49H90O6,26931.0
10844,"1,3-Dipalmitoyl-2-Elaidoyl Glycerol",CCCCCCCC/C=C/CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC,C53H100O6,27165.0
10845,1-Myristoyl-3-Butyryl-rac-glycerol,CCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCC,C21H40O5,26794.0
10846,1-Myristoyl-2-Palmitoyl-3-Butyryl-rac-glycerol,CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC)COC(=O)CCCCCCCCCCCCC,C37H70O6,26821.0
10847,"1,3-Dioleoyl-2-Octanoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC,C47H86O6,26836.0
10848,PF-3084014,CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1,C27H41F2N5O,27061.0
10849,TAK-715,CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1,C24H21N3OS,26170.0
10850,SA 4503,COc1ccc(CCN2CCN(CCCc3ccccc3)CC2)cc1OC.Cl.Cl,C23H34Cl2N2O2,26241.0
10851,MHAPC-Chol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)NCCCN(C)CCO)CC[C@]4(C)[C@H]3CC[C@]12C,C34H60N2O3,26585.0
10852,10(Z)-Nonadecenoic Acid methyl ester,CCCCCCCC/C=C\CCCCCCCCC(=O)OC,C20H38O2,26733.0
10853,RO8994,COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F,C31H31Cl2FN4O4,25674.0
10854,1-Oleoyl-2-Palmitoyl-3-Linoleoyl-rac-glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C55H100O6,27159.0
10855,Cefmenoxime (hydrochloride),CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@H]12)c1csc(N)n1.CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@H]12)c1csc(N)n1.Cl,C32H35ClN18O10S6,26440.0
10856,1-Myristoyl-2-Oleoyl-3-Butyryl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCC)COC(=O)CCCCCCCCCCCCC,C39H72O6,26823.0
10857,Hexacosanoic Acid methyl ester,CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OC,C27H54O2,26725.0
10858,"1,2-Distearoyl-3-Decanoyl-rac-glycerol",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC,C49H94O6,26831.0
10859,1-Myristoyl-3-Docosanoyl-rac-glycerol,CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCC,C39H76O5,26999.0
10860,1-Palmitoyl-2-Stearoyl-rac-glycerol,CCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCCCCCCCCCC,C37H72O5,26884.0
10861,1-Palmitoyl-2-Stearoyl-3-Butyryl-rac-glycerol,CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC)COC(=O)CCCCCCCCCCCCCCC,C41H78O6,26842.0
10862,Elagolix (sodium salt),COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)[O-])c3ccccc3)c2=O)c1F.[Na+],C32H29F5N3NaO5,26534.0
10863,4-Methylthio-N-benzylcathinone (hydrochloride),CSc1ccc(C(=O)C(C)NCc2ccccc2)cc1.Cl,C17H20ClNOS,27185.0
10864,Vitexin 2-O-rhamnoside,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2c2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)[C@H](O)[C@H](O)[C@H]1O,C27H30O14,26816.0
10865,"1,2-Dipalmitoleoyl-3-Oleoyl-rac-glycerol",CCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC,C53H96O6,26798.0
10866,"9(S),10(S),13(S)-TriHOME",CCCCC[C@H](O)/C=C/[C@H](O)[C@@H](O)CCCCCCCC(=O)O,C18H34O5,26768.0
10867,D-(+)-Glucose-13C6,O=[13CH][13C@H](O)[13C@@H](O)[13C@H](O)[13C@H](O)[13CH2]O,C6H12O6,26707.0
10868,CGP 52432,CCOC(OCC)P(=O)(O)CCCNCc1ccc(Cl)c(Cl)c1,C15H24Cl2NO4P,27212.0
10869,Edaglitazone,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC2SC(=O)NC2=O)c2sccc12,C24H20N2O4S2,19117.0
10870,ARN19874,O=c1[nH]c(=O)c2cc(S(=O)(=O)Nc3ccc(-c4ccncc4)cc3)ccc2[nH]1,C19H14N4O4S,24283.0
10871,Altenusin,COc1cc(O)c(C(=O)O)c(-c2cc(O)c(O)cc2C)c1,C15H14O6,26911.0
10872,"2,7-Dimethoxy-6-(1-acetoxyethyl)juglone",COC1=CC(=O)c2c(cc(OC)c(C(C)OC(C)=O)c2O)C1=O,C16H16O7,27267.0
10873,Crocin/Gardenia Extract,CC(/C=C/C=C(\C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)=C\C=C\C=C(C)\C=C\C=C(/C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O,C44H64O24,26337.0
10874,Palosuran,Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1,C25H30N4O2,23460.0
10875,Streptazolin,C/C=C1/C2=CCCN3C(=O)O[C@H]([C@H]1O)[C@H]23,C11H13NO3,27266.0
10876,Autophinib,Cc1cc(Nc2cc(Cl)nc(Oc3ccc([N+](=O)[O-])cc3)n2)n[nH]1,C14H11ClN6O3,27320.0
10877,"N-benzyl-3,4-DMA (hydrochloride)",COc1ccc(CC(C)NCc2ccccc2)cc1OC.Cl,C18H24ClNO2,27184.0
10878,Pachybasin,Cc1cc(O)c2c(c1)C(=O)c1ccccc1C2=O,C15H10O3,27268.0
10879,4'-hydroxyphenyl Carvedilol,COc1cc(O)ccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,C24H26N2O5,27172.0
10880,ABT-594 (hydrochloride),Cl.Clc1ccc(OC[C@H]2CCN2)cn1,C9H12Cl2N2O,22822.0
10881,MDMB-INACA,COC(=O)[C@@H](NC(=O)c1n[nH]c2ccccc12)C(C)(C)C,C15H19N3O3,27248.0
10882,AX-024 (hydrochloride),COc1ccc2c(c1)C(c1ccc(F)cc1)=C(CN1CCCC1)CO2.Cl,C21H23ClFNO2,27333.0
10883,"2,3,4-Trimethoxyamphetamine (hydrochloride)",COc1ccc(CC(C)N)c(OC)c1OC.Cl,C12H20ClNO3,26491.0
10884,27-hydroxy Cholestenone,C[C@@H](CO)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H44O2,25550.0
10885,Tetrabenazine-d7,[2H]C([2H])([2H])C([2H])(C[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2CC1=O)C([2H])([2H])[2H],C19H27NO3,27181.0
10886,"1,3-Dipalmitoleoyl Glycerol",CCCCCC/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C\CCCCCC,C35H64O5,26797.0
10887,Dipalmitolein,CCCCCC/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C\CCCCCC,C35H64O5,26997.0
10888,Tetrabenazine-d6,[2H]C([2H])([2H])Oc1cc2c(cc1OC([2H])([2H])[2H])[C@H]1CC(=O)[C@H](CC(C)C)CN1CC2,C19H27NO3,26811.0
10889,MX69,Cc1ccc(NS(=O)(=O)c2ccc3c(c2)C2C=CCC2C(c2ccc(C(=O)O)cc2)N3)cc1C,C27H26N2O4S,27224.0
10890,Cholesteryl Erucate,CCCCCCCC/C=C\CCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C49H86O2,26468.0
10891,1-Palmitoyl-3-Oleoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCC,C37H70O5,27167.0
10892,1-Oleoyl-2-Palmitoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC,C37H70O5,27166.0
10893,"1,2,3-Tri-11(Z)-Eicosenoyl Glycerol",CCCCCCCC/C=C\CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCC/C=C\CCCCCCCC,C63H116O6,26926.0
10894,2-Stearoyl-rac-glycerol,CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO,C21H42O4,27282.0
10895,6-O-desmethyl Donepezil,COc1cc2c(cc1O)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,C23H27NO3,27175.0
10896,Uracil,O=c1cc[nH]c(=O)[nH]1,C4H4N2O2,26088.0
10897,LOXO-101,O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1,C21H22F2N6O2,27056.0
10898,STK16-IN-1,Cc1cc(-n2c(=O)ccc3c[nH]c4nccc-4c32)ccc1F,C17H12FN3O,27370.0
10899,A-1155463,CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1,C35H32FN5O4S2,27369.0
10900,"1,3-Dipalmitoyl-2-Docosahexaenoyl Glycerol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC,C57H98O6,26988.0
10901,"1,2-Dipalmitoyl-3-Stearoyl-rac-glycerol",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C53H102O6,26990.0
10902,5-hydroxy NMT (oxalate),CNCCc1c[nH]c2ccc(O)cc12.O=C(O)C(=O)O,C13H16N2O5,26699.0
10903,"1,2-Dimyristoyl-3-Eicosapentaenoyl-rac-glycerol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC,C51H88O6,26826.0
10904,"1,3-Distearoyl-2-Linoleoyl Glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC,C57H106O6,26967.0
10905,Citrulline-specific Probe-biotin,CC(C(=O)Nc1cccc(C(=O)C=O)c1)n1cc(CCCC(=O)NCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)nn1,C29H38N8O6S,17450.0
10906,Butyryl-L-carnitine (chloride),CCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C11H22ClNO4,26542.0
10907,"1,2-Dipalmitoyl-3-Arachidonoyl-rac-glycerol",CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C55H98O6,27161.0
10908,DC-Chol (hydrochloride),CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)NCCN(C)C)CC[C@]4(C)[C@H]3CC[C@]12C.Cl,C32H57ClN2O2,16943.0
10909,epi-Aszonalenin A,C=CC(C)(C)[C@]12C[C@H]3C(=O)Nc4ccccc4C(=O)N3[C@H]1N(C(C)=O)c1ccccc12,C25H25N3O3,27464.0
10910,N-butyl Pentylone (hydrochloride),CCCCNC(CCC)C(=O)c1ccc2c(c1)OCO2.Cl,C16H24ClNO3,26701.0
10911,1-Palmitoyl-2-Linoleoyl-3-Stearoyl-rac-glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC,C55H102O6,26966.0
10912,"1,3-Dipalmitoyl-2-Stearoyl Glycerol",CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC,C53H102O6,26989.0
10913,?-Rubromycin,COC(=O)c1cc2cc3c(c(O)c2c(=O)o1)O[C@]1(CC3)CC2=C(O1)C(=O)c1c(O)c(OC)cc(OC)c1C2=O,C27H20O12,27477.0
10914,1-Stearoyl-2-Lauroyl-rac-glycerol,CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC,C33H64O5,26883.0
10915,1-Palmitoyl-3-Linolenoyl-rac-glycerol,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCC,C37H66O5,26828.0
10916,"1,2-Dieicosapentaenoyl-3-Palmitoyl-rac-glycerol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC,C59H94O6,26822.0
10917,ML-18,COc1ccc(C2(CNC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)Nc3ccc([N+](=O)[O-])cc3)CCCCC2)cc1,C32H35N5O5,27319.0
10918,Eriocitrin,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(c3)O[C@H](c3ccc(O)c(O)c3)CC4=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C27H32O15,25838.0
10919,"1,3-Dimyristoyl-2-Eicosapentaenoyl Glycerol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC,C51H88O6,26986.0
10920,Aranorosin,CCCCCC[C@@H](C)/C(C)=C/C=C/C(=O)N[C@H]1C[C@@]2(O[C@H]1O)[C@@H]1O[C@@H]1C(=O)[C@@H]1O[C@@H]12,C23H33NO6,27478.0
10921,Herboxidiene,CO[C@H]([C@@H](C)[C@H]1O[C@]1(C)C[C@H](C)/C=C/C=C(\C)[C@H]1O[C@@H](CC(=O)O)CC[C@@H]1C)[C@@H](C)O,C25H42O6,25136.0
10922,Valbenazine,COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2,C24H38N2O4,26809.0
10923,N-propyl Hexylone (hydrochloride),CCCCC(NCCC)C(=O)c1ccc2c(c1)OCO2.Cl,C16H24ClNO3,27078.0
10924,"2,3,6-Trimethoxyamphetamine (hydrochloride)",COc1ccc(OC)c(OC)c1CC(C)N.Cl,C12H20ClNO3,26492.0
10925,C11 BODIPY 581/591,O=C([O-])CCCCCCCCCCc1ccc2n1[B-](F)(F)[N+]1=C(/C=C/C=C/c3ccccc3)C=CC1=C2.[H+],C30H35BF2N2O2,27086.0
10926,Remogliflozin etabonate,CCOC(=O)OC[C@H]1O[C@@H](Oc2nn(C(C)C)c(C)c2Cc2ccc(OC(C)C)cc2)[C@H](O)[C@@H](O)[C@@H]1O,C26H38N2O9,14341.0
10927,"(R,S)-Carvedilol Glucuronide",COc1ccccc1OCCNCC(COc1cccc2[nH]c3ccccc3c12)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,C30H34N2O10,27173.0
10928,Aftin-4,CC[C@H](CO)Nc1nc(N(C)Cc2ccccc2)c2ncn(C(C)C)c2n1,C20H28N6O,27341.0
10929,4-hydroxy MPT,CCCN(C)CCc1c[nH]c2cccc(O)c12,C14H20N2O,26493.0
10930,Heptanoyl-L-carnitine (chloride),CCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C14H28ClNO4,26551.0
10931,Zymostenol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C[C@@H]1CC3,C27H46O,26209.0
10932,CAY10733,C=CCOc1cc2c(cc1Cl)C1(OC(=O)c3ccccc31)c1cc(Cl)c(OCC=C)cc1O2,C26H18Cl2O5,26751.0
10933,GSK3326595,CC(=O)N1CCC(Nc2cc(C(=O)NC[C@H](O)CN3CCc4ccccc4C3)ncn2)CC1,C24H32N6O3,27305.0
10934,(+)-Ephedrine (hydrochloride),CN[C@H](C)[C@@H](O)c1ccccc1.Cl,C10H16ClNO,14143.0
10935,Heneicosanoic Acid methyl ester,CCCCCCCCCCCCCCCCCCCCC(=O)OC,C22H44O2,26865.0
10936,NG 012,C[C@@H]1Cc2cc(O)cc(O)c2C(=O)O[C@H](C)CC(=O)O[C@H](CO)CC(=O)O[C@H](C)Cc2cc(O)cc(O)c2C(=O)O[C@H](C)CC(=O)O1,C32H38O15,27509.0
10937,OM173-?A,COC(=O)C[C@H]1CC2=C(C(=O)c3c(O)cccc3C2=O)[C@H](C)O1,C17H16O6,27570.0
10938,1-Stearoyl-rac-glycerol,CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO,C21H42O4,26827.0
10939,Tricosanoic Acid methyl ester,CCCCCCCCCCCCCCCCCCCCCCC(=O)OC,C24H48O2,26868.0
10940,Bikaverin,COC1=CC(=O)c2c(c(O)c3oc4cc(OC)cc(C)c4c(=O)c3c2O)C1=O,C20H14O8,27467.0
10941,Octanoyl-L-carnitine (chloride),CCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C15H30ClNO4,26558.0
10942,10(Z)-Heptadecenoic Acid methyl ester,CCCCCC/C=C\CCCCCCCCC(=O)OC,C18H34O2,26869.0
10943,Malformin A,CC[C@H](C)[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](NC1=O)C(=O)N2,C23H39N5O5S2,27510.0
10944,Globosuxanthone A,COC(=O)[C@@]1(O)c2c(oc3cccc(O)c3c2=O)C=C[C@H]1O,C15H12O7,27486.0
10945,Fuscin,CC1OC(=O)C=C2C3=C(OC(C)(C)CC3)C(=O)C(O)=C21,C15H16O5,27485.0
10946,Tricosanoic Acid,CCCCCCCCCCCCCCCCCCCCCCC(=O)O,C23H46O2,26867.0
10947,17-hydroxy Venturicidin A,CCC(=O)[C@@H](C)[C@@H](O)[C@H](C)C[C@@H](C)[C@H]1OC(=O)C[C@@]2(O)CC=C(C)[C@H](O2)/C(C)=C\CCC[C@@H](O[C@H]2C[C@@H](OC(N)=O)[C@H](O)[C@@H](C)O2)/C=C/[C@H](C)C(O)[C@H]1C,C41H67NO12,27508.0
10948,Apigenin 7-glucoside,O=c1cc(-c2ccc(O)cc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c12,C21H20O10,26813.0
10949,1-Palmitoyl-2-Oleoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OC(CO)COC(=O)CCCCCCCCCCCCCCC,C37H70O5,27164.0
10950,Aurodox,C/C=C\C=C\[C@@H]1O[C@](O)([C@H](CC)C(=O)NC/C=C/C=C(\C)[C@@H](OC)[C@@H](C)[C@@H]2O[C@H](/C=C/C=C/C=C(\C)C(=O)c3c(O)ccn(C)c3=O)[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)C1(C)C,C44H62N2O12,27584.0
10951,Pyranonigrin A,C/C=C/c1oc2c(c(=O)c1O)C(=O)N[C@@H]2O,C10H9NO5,27535.0
10952,1233B,CC(=C\C(=O)O)/C=C(\C)CC(C)CCCCC(O)C(CO)C(=O)O,C18H30O6,27712.0
10953,Donepezil N-oxide,COc1cc2c(cc1OC)C(=O)C(CC1CC[N+]([O-])(Cc3ccccc3)CC1)C2,C24H29NO4,27174.0
10954,"1,2,3-Tritridecanoyl Glycerol",CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC,C42H80O6,26899.0
10955,D-Pinitol,CO[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O,C7H14O6,26815.0
10956,PF-06409577,O=C(O)c1c[nH]c2cc(Cl)c(-c3ccc(C4(O)CCC4)cc3)cc12,C19H16ClNO3,27366.0
10957,LOXO-195,C[C@@H]1CCc2ncc(F)cc2[C@H]2CCCN2c2ccn3ncc(c3n2)C(=O)N1,C20H21FN6O,27062.0
10958,5-methoxy DBT,CCCCN(CCCC)CCc1c[nH]c2ccc(OC)cc12,C19H30N2O,27465.0
10959,Theacrine,Cn1c(=O)c2c(n(C)c1=O)n(C)c(=O)n2C,C9H12N4O3,26855.0
10960,Sphingosine (d12:1),CCCCCCC/C=C/[C@@H](O)[C@@H](N)CO,C12H25NO2,26893.0
10961,8-Aminoclonazolam,Cc1nnc2n1-c1ccc(N)cc1C(c1ccccc1Cl)=NC2,C17H14ClN5,27247.0
10962,Sphingosine-d7 (d18:1),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO,C18H37NO2,22786.0
10963,6-fluoro DET,CCN(CC)CCc1c[nH]c2cc(F)ccc12,C14H19FN2,20834.0
10964,Olanzapine Thiolactam Impurity,CC(=O)/C=C1\C(=S)Nc2ccccc2N=C1N1CCN(C)CC1,C17H20N4OS,27784.0
10965,Dimetridazole-d3,[2H]C([2H])([2H])n1c([N+](=O)[O-])cnc1C,C5H7N3O2,27841.0
10966,Levofloxacin N-oxide,C[C@H]1COc2c(N3CC[N+](C)([O-])CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,C18H20FN3O5,27177.0
10967,LysoFP-NO2,O=C1c2cccc3cc([N+](=O)[O-])cc(c23)C(=O)N1CCN1CCOCC1,C18H17N3O5,27024.0
10968,PAQ,Nc1ccc2ncc(-c3ccccc3)nc2c1,C14H11N3,20234.0
10969,Sphinganine-d7 (d18:0),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC[C@@H](O)[C@@H](N)CO,C18H39NO2,27145.0
10970,Methiocarb-d3,[2H]C([2H])([2H])NC(=O)Oc1cc(C)c(SC)c(C)c1,C11H15NO2S,27776.0
10971,C4 Ceramide (d18:1/4:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCC,C22H43NO3,22528.0
10972,Chrodrimanin B,CC(=O)O[C@@H]1c2c3c(cc(O)c2C(=O)O[C@@H]1C)O[C@@]1(C)[C@@H](O)C[C@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@@H]1C3,C27H32O8,27585.0
10973,CAY10732,C=CCOc1ccc2c(c1)Oc1cc(OCC=C)ccc1C21OC(=O)c2ccccc21,C26H20O5,26750.0
10974,Difloxacin-d3,[2H]C([2H])([2H])N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2)CC1,C21H19F2N3O3,27617.0
10975,BB-Cl-Yne,C#Cc1ccc(-c2ccc(C(=O)N[C@@H](CCCNC(=N)CCl)c3nc4ccccc4[nH]3)cc2)cc1,C28H26ClN5O,25378.0
10976,4-(Dimethylamino)-1-methylpyridinium (iodide),CN(C)c1cc[n+](C)cc1.[I-],C8H13IN2,25861.0
10977,Arachidic Acid methyl ester,CCCCCCCCCCCCCCCCCCCC(=O)OC,C21H42O2,26724.0
10978,4-Methylumbelliferyl-?-D-Glucopyranoside,Cc1cc(=O)oc2cc(O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12,C16H18O8,26810.0
10979,Octacosanoic Acid methyl ester,CCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OC,C29H58O2,26726.0
10980,Triacontanoic Acid methyl ester,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OC,C31H62O2,26727.0
10981,Iperoxo (iodide),C[N+](C)(C)CC#CCOC1=NOCC1.[I-],C10H17IN2O2,27235.0
10982,Isoxsuprine-d6 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])(NC(C)C(O)c1ccc(O)cc1)C([2H])([2H])Oc1ccccc1,C18H24ClNO3,27847.0
10983,Cymoxanil-d3,[2H]C([2H])([2H])O/N=C(\C#N)C(=O)NC(=O)NCC,C7H10N4O3,27840.0
10984,"1,2,3-Tri-13(Z)-Docosenoyl Glycerol",CCCCCCCC/C=C\CCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC,C69H128O6,26894.0
10985,CAY10730,COc1ccc2c(c1)Oc1cc(OCc3ccc([N+](=O)[O-])cc3)ccc1C21OC(=O)c2ccccc21,C28H19NO7,26547.0
10986,Speciogynine,CC[C@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C23H30N2O4,25794.0
10987,Speciogynine (CRM),CC[C@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C23H30N2O4,38997.0
10988,"?-ethylamino-3,3-Dimethylbutyrophenone (hydrochloride)",CCNC(C(=O)c1ccccc1)C(C)(C)C.Cl,C14H22ClNO,25657.0
10989,LLY-283,Nc1ncnc2c1ccn2[C@@H]1O[C@H]([C@H](O)c2ccccc2)[C@@H](O)[C@H]1O,C17H18N4O4,21596.0
10990,(S)-Laudanosine,COc1ccc(C[C@H]2c3cc(OC)c(OC)cc3CCN2C)cc1OC,C21H27NO4,27170.0
10991,SGK1 Inhibitor,Nc1n[nH]c2nc(-c3ccc(NS(=O)(=O)c4cccc(Cl)c4Cl)cc3)cnc12,C17H12Cl2N6O2S,25652.0
10992,Fenretinide-d4,[2H]c1c([2H])c(NC(=O)/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)c([2H])c([2H])c1O,C26H33NO2,26489.0
10993,Atazanavir-d6,[2H]C([2H])([2H])OC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC([2H])([2H])[2H])C(C)(C)C)C(C)(C)C,C38H52N6O7,26456.0
10994,Metrizamide,CC(=O)Nc1c(I)c(C(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO)c(I)c(N(C)C(C)=O)c1I,C18H22I3N3O8,27724.0
10995,FGF401,COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N,C25H30N8O4,23029.0
10996,?ARK1 Inhibitor,COC(=O)c1ccc(/C=C/c2ccc([N+](=O)[O-])o2)o1,C12H9NO6,21751.0
10997,"1,3-Dinonadecanoyl Glycerol",CCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCCC,C41H80O5,26770.0
10998,Dinonadecanoin,CCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCCC,C41H80O5,26981.0
10999,"1,2-Di-13(Z)-Docosenoyl-3-Oleoyl-rac-glycerol",CCCCCCCC/C=C\CCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC,C65H120O6,27162.0
11000,"1,3-Dioctanoyl-2-Oleoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC)COC(=O)CCCCCCC,C37H68O6,26820.0
11001,Phenazolam,Cc1nnc2n1-c1ccc(Br)cc1C(c1ccccc1Cl)=NC2,C17H12BrClN4,26700.0
11002,U-47109,CN(C)[C@@H]1CCCC[C@H]1NC(=O)c1ccc(Cl)c(Cl)c1,C15H20Cl2N2O,21663.0
11003,Glimepiride-d4,[2H]C([2H])(NC(=O)N1CC(C)=C(CC)C1=O)C([2H])([2H])c1ccc(S(=O)(=O)NC(=O)NC2CCC(C)CC2)cc1,C24H34N4O5S,27846.0
11004,"1,3-Dilinoleoyl-2-Stearoyl Glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCCCC,C57H102O6,26971.0
11005,1-Stearoyl-2-Oleoyl-3-Linoleoyl-rac-glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C57H104O6,26968.0
11006,BODIPY 558/568 C12,O=C([O-])CCCCCCCCCCCc1ccc2n1[B-](F)(F)[N+]1=C(c3cccs3)C=CC1=C2.[H+],C25H31BF2N2O2S,27014.0
11007,"1,2-Dilinoleoyl-3-stearoyl-rac-glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C57H102O6,27063.0
11008,Elaidic Acid methyl ester,CCCCCCCC/C=C/CCCCCCCC(=O)OC,C19H36O2,26870.0
11009,Monodecanoin,CCCCCCCCCC(=O)OC(CO)CO.CCCCCCCCCC(=O)OCC(O)CO,C26H52O8,26888.0
11010,"1,3-Distearoyl-2-Palmitoyl Glycerol",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C55H106O6,27065.0
11011,1-Palmitoyl-2-Stearoyl-3-Oleoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC,C55H104O6,27068.0
11012,Carfentanil (CRM),CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,C24H30N2O3,19884.0
11013,8-hydroxy Efavirenz,O=C1Nc2c(O)cc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,C14H9ClF3NO3,27853.0
11014,Monohydroxy Melphalan (hydrochloride),Cl.Cl.N[C@@H](Cc1ccc(N(CCO)CCCl)cc1)C(=O)O,C13H21Cl3N2O3,27856.0
11015,Fluclotizolam,Cc1nnc2n1-c1sc(Cl)cc1C(c1ccccc1F)=NC2,C15H10ClFN4S,23524.0
11016,1-Palmitoyl-2-Oleoyl-3-Stearoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC,C55H104O6,27067.0
11017,"1,2,3-13(Z),16(Z)-Tridocosadienoyl-glycerol",CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC,C69H122O6,26998.0
11018,N-sec-butyl Pentylone (hydrochloride),CCCC(NC(C)CC)C(=O)c1ccc2c(c1)OCO2.Cl,C16H24ClNO3,27084.0
11019,Isotonitazene,CCN(CC)CCn1c(Cc2ccc(OC(C)C)cc2)nc2cc([N+](=O)[O-])ccc21,C23H30N4O3,27255.0
11020,Isotonitazene (CRM),CCN(CC)CCn1c(Cc2ccc(OC(C)C)cc2)nc2cc([N+](=O)[O-])ccc21,C23H30N4O3,30880.0
11021,Heptadecanoic Acid methyl ester,CCCCCCCCCCCCCCCCC(=O)OC,C18H36O2,26723.0
11022,Avanafil metabolite M16,COc1ccc(CNc2nc(NC(CO)CCC(=O)O)ncc2C(=O)NCc2ncccn2)cc1Cl,C23H26ClN7O5,27844.0
11023,"1,2-Distearoyl-3-Butyryl-rac-glycerol",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCCCCCC,C43H82O6,26834.0
11024,"1,2-Dioleoyl-3-Docosohexaenoyl-rac-glycerol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C61H102O6,26824.0
11025,Bostrycin,COC1=CC(=O)c2c(O)c3c(c(O)c2C1=O)C[C@](C)(O)[C@H](O)[C@H]3O,C16H16O8,27466.0
11026,Noroxycodone (hydrochloride),COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)NCC[C@]314.Cl,C17H20ClNO4,27217.0
11027,Noroxycodone (hydrochloride) (CRM),COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)NCC[C@]314.Cl,C17H20ClNO4,35521.0
11028,"1,3-Didocosahexaenoyl-2-Palmitoyl-rac-glycerol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCC(COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCC,C63H98O6,26987.0
11029,Raloxifene 6-Glucuronide,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)ccc12,C34H35NO10S,27832.0
11030,Calpinactam,CC[C@H](C)[C@@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@H]1CCCCNC1=O,C38H57N9O8,27735.0
11031,DiIC1(5),CN1/C(=C/C=C/C=C/C2=[N+](C)c3ccccc3C2(C)C)C(C)(C)c2ccccc21.[I-],C27H31IN2,26861.0
11032,"CRL-40,941",O=C(CS(=O)C(c1ccc(F)cc1)c1ccc(F)cc1)NO,C15H13F2NO3S,19138.0
11033,Amygdalin,N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1,C20H27NO11,26668.0
11034,Harzianum A,CC1=C[C@H]2O[C@@H]3C[C@@H](OC(=O)/C=C\C=C\C=C\C(=O)O)C(C)(C34CO4)[C@@]2(C)CC1,C23H28O6,27740.0
11035,11-O-Methylpseurotin A,CC/C=C\[C@H](OC)[C@H](O)C1=C(C)C(=O)[C@]2(O1)C(=O)N[C@@](OC)(C(=O)c1ccccc1)[C@@H]2O,C23H27NO8,27734.0
11036,Cinobufagin,CC(=O)O[C@H]1[C@H]2O[C@]23[C@@H]2CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]2CC[C@]3(C)[C@H]1c1ccc(=O)oc1,C26H34O6,19844.0
11037,Aspergillimide,C[C@H]1CCN2C[C@]34C[C@]5(CC(=O)N(C)C5=O)C(C)(C)[C@@H]3CC12C(=O)N4C,C20H29N3O3,27738.0
11038,4-fluoro MDMB-BUTINACA 2'-indazole isomer,COC(=O)[C@@H](NC(=O)c1c2ccccc2nn1CCCCF)C(C)(C)C,C19H26FN3O3,27442.0
11039,Streptochlorin,Clc1ncoc1-c1c[nH]c2ccccc12,C11H7ClN2O,27605.0
11040,Abacavir Carboxylate,Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](C(=O)O)C3)c2n1,C14H16N6O2,27777.0
11041,Pexmetinib,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1,C31H33FN6O3,26187.0
11042,Iloperidone metabolite P95,COc1cc(C(=O)O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,C23H25FN2O5,27807.0
11043,3-hydroxy Darifenacin,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)C(O)CO3)C1,C28H30N2O3,27852.0
11044,SRS16-86,CC(C)(C)OC(=O)c1ccc(NC23CC4CC(CC(C4)C2)C3)c(/N=C\c2cncnc2)c1,C26H32N4O2,26752.0
11045,Fosaprepitant dimeglumine,CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C[C@@H](O[C@H]1OCCN(Cc2nn(P(=O)(O)O)c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,C37H56F7N6O16P,24034.0
11046,Martinomycin,CO[C@H]1CC[C@H](O[C@H]2[C@H](C)[C@@H]([C@H]3CC[C@H]([C@@H]4CC[C@H]([C@@]5(C)O[C@]6(O[C@H](C[C@@H]7O[C@](O)([C@@H](C)C(=O)O)[C@@H](C)[C@H](OC)[C@@]7(C)OC)C[C@@H](OC)[C@H]6C)[C@H](C)[C@H]5OC)O4)O3)O[C@](C)(O)[C@@H]2C)O[C@@H]1C,C49H84O17,27737.0
11047,BMP-22,CCCCCCCCCCCCCCCc1ccc(CP(=O)(O)O)cc1,C22H39O3P,27264.0
11048,Aspergillin PZ,CC1=C[C@@H]2[C@@H]3[C@H](CC(=O)[C@]24C(=O)N[C@@H](CC(C)C)[C@@H]4[C@@H]1C)[C@@H]1O[C@@]3(C)CC[C@H]1O,C24H35NO4,27722.0
11049,1-Myristoyl-2-Lauroyl-rac-glycerol,CCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC,C29H56O5,26880.0
11050,1-Palmitoyl-3-Butyryl-rac-glycerol,CCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCC,C23H44O5,26885.0
11051,5-fluoro AB-PINACA 3-carboxyindazole metabolite,O=C(O)c1nn(CCCCCF)c2ccccc12,C13H15FN2O2,27733.0
11052,4-fluoro MDMB-BUTINACA 3-carboxy-2'-indazole metabolite,O=C(O)c1c2ccccc2nn1CCCCF,C12H13FN2O2,27820.0
11053,Herquline A,CN1C[C@@H]2C[C@H]3CCC(=O)[C@H]4[C@H]3N2C[C@@H]1CC1=C[C@H]4C(=O)CC1,C19H26N2O2,27731.0
11054,Tridecanoic Acid methyl ester,CCCCCCCCCCCCC(=O)OC,C14H28O2,26721.0
11055,LMI070,CC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)(C)N1,C22H27N5O2,26757.0
11056,AB-PINACA 3-carboxyindazole metabolite,CCCCCn1nc(C(=O)O)c2ccccc21,C13H16N2O2,27732.0
11057,5'-Deoxy-5'-methylthioadenosine-d3,[2H]C([2H])([2H])SC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,C11H15N5O3S,27836.0
11058,Raltegravir-d4,[2H]c1c([2H])c(CNC(=O)c2nc(C(C)(C)NC(=O)c3nnc(C)o3)n(C)c(=O)c2O)c([2H])c([2H])c1F,C20H21FN6O5,26458.0
11059,Octanoic Acid methyl ester,CCCCCCCC(=O)OC,C9H18O2,26717.0
11060,Butyryl-Coenzyme A (sodium salt),CCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O.[NaH],C25H42N7NaO17P3S,27865.0
11061,Ornidazole,Cc1ncc([N+](=O)[O-])n1CC(O)CCl,C7H10ClN3O3,26818.0
11062,o-Nitrophenyl ?-D-Galactopyranoside,O=[N+]([O-])c1ccccc1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,C12H15NO8,26624.0
11063,5-fluoro CUMYL-PeGACLONE,CC(C)(c1ccccc1)n1ccc2c(c1=O)c1ccccc1n2CCCCCF,C25H27FN2O,25435.0
11064,Nonanoic Acid,CCCCCCCCC(=O)O,C9H18O2,26718.0
11065,OSU03012,NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1,C26H19F3N4O,10008005.0
11066,?-hydroxy Metoprolol,COCC(O)c1ccc(OCC(O)CNC(C)C)cc1,C15H25NO4,28020.0
11067,cis-8-Octadecenoic Acid,CCCCCCCCC/C=C\CCCCCCC(=O)O,C18H34O2,27447.0
11068,4-Hydroxyphenylacetic Acid,O=C(O)Cc1ccc(O)cc1,C8H8O3,26613.0
11069,Sorafenib N-oxide,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)cc[n+]1[O-],C21H16ClF3N4O4,27830.0
11070,GNE-477,Cc1c(CN2CCN(S(C)(=O)=O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,C21H28N8O3S2,27977.0
11071,C-DIM5,COc1ccc(C(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)cc1,C24H20N2O,27980.0
11072,Furanyl UF-17 (hydrochloride),CN(C)[C@@H]1CCCC[C@H]1N(C(=O)c1ccco1)c1ccccc1.Cl,C19H25ClN2O2,27924.0
11073,Pioglitazone Ketone,CC(=O)c1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,C19H18N2O4S,28044.0
11074,Linoelaidic Acid methyl ester,CCCCC/C=C/C/C=C/CCCCCCCC(=O)OC,C19H34O2,26732.0
11075,Iloperidone metabolite P88,COc1cc(C(C)O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,C24H29FN2O4,27806.0
11076,Hydroxy Pioglitazone,CC(O)c1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,C19H20N2O4S,28043.0
11077,Saroglitazar,CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O,C25H29NO4S,27851.0
11078,FINO2,CC1(CCO)C[C@]2(CC[C@H](C(C)(C)C)CC2)OO1,C15H28O3,25096.0
11079,Fenbendazole-d3,[2H]C([2H])([2H])OC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1,C15H13N3O2S,27842.0
11080,N-acetyl-5-Aminosalicylic Acid,CC(=O)Nc1ccc(O)c(C(=O)O)c1,C9H9NO4,27618.0
11081,Dehydro Amlodipine (fumarate),CCOC(=O)c1c(COCCN)nc(C)c(C(=O)OC)c1-c1ccccc1Cl.O=C(O)/C=C/C(=O)O,C24H27ClN2O9,26622.0
11082,Dihydroxy Melphalan,N[C@@H](Cc1ccc(N(CCO)CCO)cc1)C(=O)O,C13H20N2O4,27857.0
11083,Oxycodone (hydrochloride),COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.Cl,C18H22ClNO4,26513.0
11084,Acetaminophen Glucuronide (sodium salt),CC(=O)Nc1ccc(O[C@@H]2O[C@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]2O)cc1.[Na+],C14H16NNaO8,27850.0
11085,AS-19,Cc1nn(C)c(C)c1-c1cccc2c1CC[C@H](N(C)C)C2,C18H25N3,20642.0
11086,(-)-Perillyl Alcohol,C=C(C)[C@@H]1CC=C(CO)CC1,C10H16O,21860.0
11087,Cinobufotalin,CC(=O)O[C@H]1[C@H]2O[C@]23[C@@H]2CC[C@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]2CC[C@]3(C)[C@H]1c1ccc(=O)oc1,C26H34O7,19845.0
11088,Flunixin (meglumine),CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.Cc1c(Nc2ncccc2C(=O)O)cccc1C(F)(F)F,C21H28F3N3O7,26644.0
11089,BODIPY 630/650X succinimide ester,O=C(COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCC(=O)ON1C(=O)CCC1=O,C33H31BF2N4O6S,27758.0
11090,1P-LSD (solution),CCC(=O)n1cc2c3c(cccc31)C1=C[C@@H](C(=O)N(CC)CC)CN(C)[C@@H]1C2,C23H29N3O2,27727.0
11091,9-Methylstreptimidone,C/C=C\C(C)=C\[C@H](C)C(=O)C[C@H](O)CC1CC(=O)NC(=O)C1,C17H25NO4,27621.0
11092,K-TMZ,CC(=O)c1ncn2c(=O)n(C)nnc12,C7H7N5O2,27022.0
11093,Geninthiocin A,C=C(NC(=O)C(=C)NC(=O)c1ccc2c(n1)-c1coc(n1)C(=C)NC(=O)C(=C)NC(=O)c1nc(oc1C)C(=C)NC(=O)[C@H](C(C)(C)O)NC(=O)C(=C)NC(=O)c1coc(n1)/C(=C/C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c1csc-2n1)C(N)=O,C50H49N15O15S,28125.0
11094,(+)-Quinolactacin A1,CC[C@H](C)[C@H]1NC(=O)c2c1n(C)c1ccccc1c2=O,C16H18N2O2,27939.0
11095,Meclocycline,C=C1c2c(Cl)ccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12,C22H21ClN2O8,27940.0
11096,4-palmitamido TEMPO,CCCCCCCCCCCCCCCC(=O)NC1CC(C)(C)N([O])C(C)(C)C1,C25H49N2O2,25995.0
11097,Collismycin A,COc1cc(-c2ccccn2)nc(/C=N/O)c1SC,C13H13N3O2S,27622.0
11098,FKGK 18,O=C(CCCCc1ccc2ccccc2c1)C(F)(F)F,C16H15F3O,13943.0
11099,MAGL Inhibitor Compound 23,CC(C)c1ccc(C(=O)C2CCN(C(=O)c3cc(O)ccc3F)CC2)cc1,C22H24FNO3,27348.0
11100,Sphingosine (d18:1) Alkyne,C#CCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO,C18H33NO2,24518.0
11101,Milbemycin A4 oxime,CC[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C3\CO[C@@H]4/C(=N/O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C32H45NO7,27938.0
11102,Nevirapine-d4,[2H]C1([2H])C(N2c3ncccc3C(=O)Nc3c(C)ccnc32)C1([2H])[2H],C15H14N4O,28093.0
11103,Povidone-Iodine,CCC(C)N1CCCC1=O.II,C2H6(C6H9NO)n(I2)X,27883.0
11104,Spinosyn D aglycone,CC[C@H]1CCC[C@H](O)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C(C)[C@@H]4C[C@@H](O)C[C@@H]34)[C@@H]2CC(=O)O1,C25H36O5,27937.0
11105,1B-LSD (solution),CCCC(=O)n1cc2c3c(cccc31)C1=C[C@@H](C(=O)N(CC)CC)CN(C)[C@@H]1C2,C24H31N3O2,27817.0
11106,Streptonigrin,COC1=C(N)C(=O)c2nc(-c3nc(C(=O)O)c(C)c(-c4ccc(OC)c(OC)c4O)c3N)ccc2C1=O,C25H22N4O8,27952.0
11107,Anhydroerythromycin A,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@]2(C)C[C@@H](C)[C@@]3(O[C@@]1(C)[C@H](O)[C@H]3C)O2,C37H65NO12,27960.0
11108,Brevicompanine B,C=CC(C)(C)[C@@]12C[C@H]3C(=O)N[C@H](CC(C)C)C(=O)N3[C@@H]1Nc1ccccc12,C22H29N3O2,27962.0
11109,?-Butylaminohexanophenone (hydrochloride),CCCCNC(CCCC)C(=O)c1ccccc1.Cl,C16H26ClNO,27728.0
11110,Deoxyfusapyrone,CCCCCCC(C)C/C(C)=C\C(C)/C=C(C)/C=C/C(O)C(C)(C)c1cc(=O)c([C@@H]2O[C@H](CO)C[C@H](O)[C@H]2O)c(O)o1,C34H54O8,27963.0
11111,Spinosyn D 17-pseudoaglycone,CC[C@H]1CCC[C@H](O)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C(C)[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1,C34H52O9,27975.0
11112,Bromamphenicol,O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Br)Br,C11H12Br2N2O5,28016.0
11113,Telomycin,CC(C)[C@H](O)C1NC(=O)[C@H](C(C)c2c[nH]c3ccccc23)NC(=O)/C(=C/c2c[nH]c3ccccc23)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)CNC(=O)[C@H](C)NC(=O)[C@H]([C@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)C[C@H](N)C(=O)O)[C@@H](C)OC(=O)[C@@H]2[C@H](O)CCN2C1=O,C59H77N13O19,28137.0
11114,TAN 1364B,CCCCCCCCCCCCCCCC(=O)C1=C(O)C(CO)OC1=O,C21H36O5,27964.0
11115,Sultriecin,CCCCC/C=C/C=C\C=C/[C@H](O)[C@H](C)[C@H](C/C=C/[C@@H]1OC(=O)C=C[C@@H]1O)OP(=O)([O-])O.[Na+],C23H34NaO8P,27976.0
11116,10'-Desmethoxystreptonigrin,COC1=C(N)C(=O)c2nc(-c3nc(C(=O)O)c(C)c(-c4cccc(OC)c4O)c3N)ccc2C1=O,C24H20N4O7,28065.0
11117,Neoaureothin,COc1oc([C@H]2C/C(=C/C(C)=C/C(C)=C/C(C)=C/c3ccc([N+](=O)[O-])cc3)CO2)c(C)c(=O)c1C,C28H31NO6,28091.0
11118,Avenaciolide,C=C1C(=O)O[C@@H]2C(=O)O[C@@H](CCCCCCCC)[C@H]12,C15H22O4,28128.0
11119,2-epi-Abamectin,CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@H](C(=O)O1)[C@]34O)O2,C48H72O14,27993.0
11120,1-Alaninechlamydocin,C[C@@H]1NC(=O)[C@H](CCCCCC(=O)[C@@H]2CO2)NC(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O,C27H36N4O6,28102.0
11121,Desotamide,CC[C@@H](C)[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O,C35H52N8O7,28129.0
11122,Desmethylclotiazepam,CCc1cc2c(s1)NC(=O)CN=C2c1ccccc1Cl,C15H13ClN2OS,27838.0
11123,MGR2,CC(C)(C)C(=O)OCOc1cccc2ccccc12,C16H18O3,27575.0
11124,GK187,COc1ccc(CCCCC(=O)C(F)(F)C(F)(F)F)cc1,C14H15F5O2,25130.0
11125,Leniolisib,CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1,C21H25F3N6O2,28078.0
11126,cis-6-Hexadecenoic Acid,CCCCCCCCC/C=C\CCCCC(=O)O,C16H30O2,9001845.0
11127,Acesulfame-d4 (potassium salt),[2H]C1=C(C([2H])([2H])[2H])OS(=O)(=O)[N-]C1=O.[K+],C4H4KNO4S,27786.0
11128,Nybomycin,Cc1cc(=O)n2c3c(c4c(cc13)c(CO)cc(=O)n4C)OC2,C16H14N2O4,28099.0
11129,Deacetylravidomycin,C=Cc1cc(OC)c2c(c1)c(=O)oc1c2cc(OC)c2c(O)ccc([C@@H]3O[C@H](C)[C@H](O)[C@H](N(C)C)[C@H]3O)c21,C29H31NO8,27991.0
11130,Orfamide A,CCCCCCCCCCCC(O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H]1C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CO)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H]1C,C64H114N10O17,28131.0
11131,trans-Vaccenic Acid methyl ester,CCCCCC/C=C/CCCCCCCCCC(=O)OC,C19H36O2,26731.0
11132,Reduced Haloperidol,OC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C21H25ClFNO2,28017.0
11133,Saccharocarcin A,CCC1C=CC2/C=C(\C)C(OC3CC(C)(O)C(NC(C)=O)C(C)O3)C(C)/C=C(/C)C3C=CC4C(OC5CC(O)C(OC6CC(OC7CCC(O)C(C)O7)C(OC7CC(O)C(O)C(C)O7)C(C)O6)C(C)O5)C(C)CC(C)C4C3(C)C(=O)C3=C(O)C2(C1)OC3=O,C67H101NO20,28094.0
11134,Leucomycin A4,CCCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@H]2[C@H](N(C)C)[C@@H](O)[C@H](O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](OC(C)=O)[C@@H]3OC)O[C@@H]2C)C[C@@]1(C)O,C41H67NO15,28066.0
11135,SCH 38519,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(O)cc3c(c1C2=O)[C@H]1C[C@@H](N(C)C)[C@H](O)[C@]3(C)O1,C24H25NO8,28092.0
11136,Hygrolidin,CC[C@H]1O[C@@](O)([C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C(C)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](C)C/C(C)=C/C=C/[C@@H]2OC)C[C@@H](OC(=O)/C=C/C(=O)O)[C@H]1C,C38H58O11,28116.0
11137,"19,20-Epoxycytochalasin C",CC(=O)O[C@@H]1[C@@H]2O[C@H]2[C@@](C)(O)C(=O)[C@@H](C)C/C=C/[C@H]2[C@H](O)C(C)=C(C)[C@H]3[C@H](Cc4ccccc4)NC(=O)[C@@]123,C30H37NO7,28025.0
11138,Lignoceric Acid methyl ester,CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC,C25H50O2,26706.0
11139,5-IAF,O=C(CI)Nc1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21,C22H14INO6,26807.0
11140,SZL P1-41,CCc1cc2c(=O)c(-c3nc4ccccc4s3)coc2c(CN2CCCCC2)c1O,C24H24N2O3S,26142.0
11141,N-methyl Mesoporphyrin IX,CCC1=C(C)c2cc3[nH]c(cc4nc(cc5c(CC)c(C)c(cc1n2)n5C)C(C)=C4CCC(=O)O)c(CCC(=O)O)c3C,C35H39N4O4,27210.0
11142,Tenellin,CC[C@@H](C)/C=C(C)/C=C/C(=O)c1c(O)c(-c2ccc(O)cc2)cn(O)c1=O,C21H23NO5,28090.0
11143,Sporidesmolide II,CC[C@H](C)[C@H]1NC(=O)[C@H](C(C)C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)OC(=O)[C@@H](CC(C)C)NC1=O,C34H60N4O8,28133.0
11144,"19,20-Epoxycytochalasin D",C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@@]23[C@H](/C=C/C[C@H](C)C(=O)[C@](C)(O)[C@@H]2O[C@H]2[C@H]3OC(C)=O)[C@@H]1O,C30H37NO7,28050.0
11145,Terrecyclic Acid,C=C1C(=O)C[C@@H]2[C@H]3CC[C@@H](C(=O)O)[C@@]12CC3(C)C,C15H20O3,28117.0
11146,BTZO-1,O=c1nc(-c2ccccn2)sc2ccccc12,C13H8N2OS,28161.0
11147,EM574,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C(C)C)[C@H]2O)[C@@]2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@]1(C)O,C39H69NO12,27752.0
11148,Avermectin B1a aglycone,CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C34H48O8,28051.0
11149,Ononin,COc1ccc(-c2coc3cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)ccc3c2=O)cc1,C22H22O9,27046.0
11150,CMPD101,Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1,C24H21F3N6O,26808.0
11151,"1,2-Dilauroyl-rac-glycerol",CCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC,C27H52O5,26846.0
11152,Axitinib Sulfoxide,CNC(=O)c1ccccc1S(=O)c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,C22H18N4O2S,28042.0
11153,Tanshinone I,Cc1coc2c1C(=O)C(=O)c1c-2ccc2c(C)cccc12,C18H12O3,26852.0
11154,Estriol 3-?-D-Glucuronide (sodium salt),C[C@]12CC[C@@H]3c4ccc(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O.[NaH],C24H32NaO9,14827.0
11155,Leonurine,COc1cc(C(=O)OCCCCNC(=N)N)cc(OC)c1O,C14H21N3O5,26850.0
11156,Setomimycin,CC(=O)C1C(C)=CC(=O)c2c1c(-c1c3c(c(O)c4c(O)cccc14)C(=O)CC(C)(O)C3C(C)=O)c1cccc(O)c1c2O,C34H28O9,27958.0
11157,SPQ,COc1ccc2c(ccc[n+]2CCCS(=O)(=O)[O-])c1,C13H15NO4S,27604.0
11158,4-hydroxy Valsartan,CC(O)CCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C,C24H29N5O4,27849.0
11159,16?-hydroxy Prednisolone,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1C[C@@H](O)[C@]2(O)C(=O)CO,C21H28O6,27169.0
11160,Taurine,NCCS(=O)(=O)O,C2H7NO3S,27031.0
11161,B-RAF Inhibitor 1 (hydrochloride),Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2nc[nH]c12.Cl.Cl,C26H21Cl3N8,26792.0
11162,Anhydroepiophiobolin A,CC(C)=C[C@H]1C[C@H](C)[C@]2(CC[C@]3(C)C[C@@H]4C(C)=CC(=O)[C@H]4/C(C=O)=C\C[C@H]32)O1,C25H34O3,28026.0
11163,Spinosyn A aglycone,CC[C@H]1CCC[C@H](O)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O)C[C@@H]34)[C@@H]2CC(=O)O1,C24H34O5,27992.0
11164,Integracin B,CCC[C@@H](O)CCCCCCCc1cc(O)cc(O)c1C(=O)O[C@H](CCC)CCCCCCCc1cc(O)cc(O)c1,C35H54O7,28088.0
11165,"1,6-Dimethoxyphenazine",COc1cccc2nc3c(OC)cccc3nc12,C14H12N2O2,28061.0
11166,Decatromicin B,CC[C@H]1C[C@@]23OC(=O)C(=C2O)C(=O)[C@@]2(CC)[C@@H]4CC[C@H](C)[C@H](O[C@H]5C[C@@H](O)[C@H](NC(=O)c6[nH]c(Cl)cc6Cl)[C@@H](C)O5)[C@H]4C=C[C@H]2C/C=C/C/C(C)=C/[C@@]3(C)C=C1C(=O)O,C45H56Cl2N2O10,28132.0
11167,AVN-492,CNc1nn2c(C)c(N(C)C)c(C)nc2c1S(=O)(=O)c1ccccc1,C17H21N5O2S,28079.0
11168,Tabersonine,CC[C@]12C=CCN3CC[C@]4(C(=C(C(=O)OC)C1)Nc1ccccc14)[C@@H]32,C21H24N2O2,26848.0
11169,1-Lauroyl-2-Stearoyl-rac-glycerol,CCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCCCCCC,C33H64O5,26881.0
11170,Speciociliatine,CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C23H30N2O4,27246.0
11171,Speciociliatine (CRM),CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C23H30N2O4,38994.0
11172,1-Palmitoyl-d9-2-Palmitoyl-sn-glycerol,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCCCCCCCCC,C35H68O5,27591.0
11173,"1,2,3-Tridocosanoyl Glycerol",CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC,C69H134O6,26847.0
11174,Erastin2,CC(C)Oc1ccc(-c2ccccc2)cc1-n1c(CN2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O,C36H35ClN4O4,27087.0
11175,Desidustat,O=C(O)CNC(=O)c1c(O)c2ccccc2n(OCC2CC2)c1=O,C16H16N2O6,28074.0
11176,(-)-MK-801 (maleate),C[C@@]12N[C@@H](Cc3ccccc31)c1ccccc12.O=C(O)/C=C\C(=O)O,C20H19NO4,27213.0
11177,"1,2,3-Trioleoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C57H104O6,26871.0
11178,C29,COc1cccc(/C=N/c2cccc(C(=O)O)c2C)c1O,C16H15NO4,27029.0
11179,C-176,O=C(Nc1ccc(I)cc1)c1ccc([N+](=O)[O-])o1,C11H7IN2O4,25859.0
11180,MRK-560,O=S(=O)(N[C@H]1CC[C@@](c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F,C19H17ClF5NO4S2,27599.0
11181,CAY10731,COc1ccc2c(c1)Oc1cc(OC(=O)OCCBr)ccc1C21OC(=O)c2ccccc21,C24H17BrO7,26548.0
11182,"1,2-Distearoyl-3-Oleoyl-rac-glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC,C57H108O6,27069.0
11183,"1,3-Dipalmitoyl-2-Linoleoyl Glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC,C53H98O6,27072.0
11184,ASP9521,COc1ccc2[nH]c(C(=O)N3CCC(CC(C)(C)O)CC3)cc2c1,C19H26N2O3,27308.0
11185,Voriconazole N-oxide,C[C@@H](c1nc[n+]([O-])cc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,C16H14F3N5O2,28047.0
11186,"1,3-Distearoyl-2-Oleoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC,C57H108O6,27163.0
11187,Pyridoxine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])c1ncc(CO)c(CO)c1O,C8H12ClNO3,28149.0
11188,"1,3-Dioleoyl-2-Decanoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCC,C49H90O6,27276.0
11189,Decanoic Acid methyl ester,CCCCCCCCCC(=O)OC,C11H22O2,26864.0
11190,15S-acetate Prostaglandin A2 methyl ester,CCCCC[C@@H](/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)OC)OC(C)=O,C23H34O5,28195.0
11191,Spinetoram,CCO[C@@H]1[C@@H](OC)[C@H](C)O[C@@H](O[C@@H]2C[C@H]3CC[C@@H]4[C@@H](C=C5C(=O)[C@H](C)[C@@H](O[C@H]6CC[C@H](N(C)C)[C@@H](C)O6)CCC[C@H](CC)OC(=O)C[C@H]54)[C@@H]3C2)[C@@H]1OC.CCO[C@@H]1[C@@H](OC)[C@H](C)O[C@@H](O[C@H]2C[C@H]3[C@@H]4C=C5C(=O)[C@H](C)[C@@H](O[C@H]6CC[C@H](N(C)C)[C@@H](C)O6)CCC[C@H](CC)OC(=O)C[C@H]5[C@@H]4C=C(C)[C@@H]3C2)[C@@H]1OC,C85H138N2O20,26623.0
11192,Spinetoram (CRM),CCO[C@@H]1[C@@H](OC)[C@H](C)O[C@@H](O[C@@H]2C[C@H]3CC[C@@H]4[C@@H](C=C5C(=O)[C@H](C)[C@@H](O[C@H]6CC[C@H](N(C)C)[C@@H](C)O6)CCC[C@H](CC)OC(=O)C[C@H]54)[C@@H]3C2)[C@@H]1OC.CCO[C@@H]1[C@@H](OC)[C@H](C)O[C@@H](O[C@H]2C[C@H]3[C@@H]4C=C5C(=O)[C@H](C)[C@@H](O[C@H]6CC[C@H](N(C)C)[C@@H](C)O6)CCC[C@H](CC)OC(=O)C[C@H]5[C@@H]4C=C(C)[C@@H]3C2)[C@@H]1OC,C85H138N2O20,39359.0
11193,Alverine (citrate),CCN(CCCc1ccccc1)CCCc1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O,C26H35NO7,26892.0
11194,Peimisine (hydrochloride),CC1=C2C[C@H]3[C@@H](CC(=O)[C@H]4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C.Cl,C27H42ClNO3,26438.0
11195,Linarin,COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1,C28H32O14,26900.0
11196,(R)-?-Lipoic Acid,O=C(O)CCCC[C@@H]1CCSS1,C8H14O2S2,27299.0
11197,"1,2-Dioleoyl-3-Stearoyl-rac-glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C57H106O6,27071.0
11198,"1,2-Distearoyl-3-Arachidoyl-rac-glycerol",CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC,C59H114O6,27386.0
11199,Squalene,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C=C(\C)CC/C=C(\C)CCC=C(C)C,C30H50,27058.0
11200,Cholesteryl Palmitoleate,CCCCCC/C=C\CCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C43H74O2,26474.0
11201,21-hydroxy Eplerenone,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CC(O)C(=O)O4)[C@H]13,C24H30O7,28021.0
11202,17.beta.-hydroxy Exemestane,C=C1C[C@H]2[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]2[C@@]2(C)C=CC(=O)C=C12,C20H26O2,27989.0
11203,"1,3-Di-9(E)-Palmitoleoyl Glycerol",CCCCCC/C=C/CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C/CCCCCC,C35H64O5,26890.0
11204,Dipalmitelaidin,CCCCCC/C=C/CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C/CCCCCC,C35H64O5,26978.0
11205,CAP 3,CC(C)[C@H](N)C(=O)NCC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](C1)C[C@@H](OC(=O)CNC(=O)[C@@H](N)C(C)C)[C@@H]1[C@@H]2C[C@H](OC(=O)CNC(=O)[C@@H](N)C(C)C)[C@]2(C)[C@@H]([C@H](C)CCC(=O)OCc3ccccc3)CC[C@@H]12,C52H82N6O11,27505.0
11206,Pimobendan,COc1ccc(-c2nc3ccc(C4=NNC(=O)CC4C)cc3[nH]2)cc1,C19H18N4O2,26082.0
11207,"1,3-Diarachidoyl Glycerol",CCCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCCCC,C43H84O5,26956.0
11208,Dieicosanoin,CCCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCCCC,C43H84O5,26957.0
11209,Sarcosine,CNCC(=O)O,C3H7NO2,26799.0
11210,Epioxytetracycline,CN(C)[C@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12,C22H24N2O9,27987.0
11211,Ganoderic Acid D,CC(CC(=O)C[C@@H](C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O,C30H42O7,26765.0
11212,A-485,CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O,C25H24F4N4O5,24119.0
11213,TEMPOL,CC1(C)CC(O)CC(C)(C)N1[O],C9H18NO2,27051.0
11214,Cholesteryl Palmitate,CCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C43H76O2,26473.0
11215,(+)-Macrosphelide A,C[C@@H]1OC(=O)/C=C/[C@@H](O)[C@H](C)OC(=O)C[C@H](C)OC(=O)/C=C/[C@H]1O,C16H22O8,27704.0
11216,Trilobatin,O=C(CCc1ccc(O)cc1)c1c(O)cc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1O,C21H24O10,25837.0
11217,Antibiotic PF 1052,CCC(C)C1C(=O)/C(=C(\O)C2C3C(C)CC(C)CC3C=CC2C2(C)OC2C)C(=O)N1C,C26H39NO4,27743.0
11218,Tauro-Obeticholic Acid,CC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)O)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12,C28H49NO6S,28243.0
11219,"1,3-Dimyristoyl-2-Oleoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC,C49H92O6,27280.0
11220,Pentadecanoic Acid methyl ester,CCCCCCCCCCCCCCC(=O)OC,C16H32O2,26722.0
11221,Prasugrel-d5,[2H]C1([2H])C([2H])([2H])C1([2H])C(=O)C(c1ccccc1F)N1CCc2sc(OC(C)=O)cc2C1,C20H20FNO3S,28160.0
11222,Neoxaline,C=CC(C)(C)[C@@]12C[C@H](O)C(=O)N3/C(=C/c4cnc[nH]4)C(=O)N[C@]31N(OC)c1ccccc12,C23H25N5O4,27751.0
11223,Rugulotrosin A,COC(=O)C12Oc3cc(C)c(-c4c(C)cc5c(c4O)C(=O)C4=C(O)CCC(O)C4(C(=O)OC)O5)c(O)c3C(=O)C1=C(O)CCC2O,C32H30O14,28157.0
11224,FRAX486,CCn1c(=O)c(-c2ccc(Cl)cc2Cl)cc2cnc(Nc3ccc(N4CCNCC4)c(F)c3)nc21,C25H23Cl2FN6O,24682.0
11225,"PAR2 (1-6) (mouse, rat)",CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O,C29H55N9O8,27125.0
11226,Trelagliptin-13C-d3,[2H][13C]([2H])([2H])n1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O,C18H20FN5O2,28203.0
11227,20(R)-Ginsenoside Rh2,CC(C)=CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C36H62O8,27300.0
11228,Neoeriocitrin,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(c3)O[C@H](c3ccc(O)c(O)c3)CC4=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C27H32O15,25839.0
11229,PBD-BODIPY,CC1=CC(C)=[N+]2C1=Cc1ccc(/C=C/C=C/c3ccccc3)n1[B-]2(F)F,C21H19BF2N2,27945.0
11230,Photoclick Sphingosine,C#CCCCC1(CCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO)N=N1,C19H33N3O2,25364.0
11231,Hederagenin,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,C30H48O4,27030.0
11232,Diflapolin,Cc1cc(OCc2nc3ccccc3s2)ccc1NC(=O)Nc1ccc(Cl)c(Cl)c1,C22H17Cl2N3O2S,28103.0
11233,"1,3-Dioleoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C\CCCCCCCC,C39H72O5,26896.0
11234,Diolein,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C\CCCCCCCC,C39H72O5,26976.0
11235,Indocyanine Green,CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)[O-])c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21.[Na+],C43H47N2NaO6S2,27462.0
11236,Acecainide (hydrochloride),CCN(CC)CCNC(=O)c1ccc(NC(C)=O)cc1.Cl,C15H24ClN3O2,27312.0
11237,4-epi Minocycline,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,C23H27N3O7,90001066.0
11238,23-hydroxy Betulinic Acid,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]12,C30H48O4,27446.0
11239,Roridin L2,CC1=C[C@H]2O[C@@H]3C[C@@H](OC(=O)/C=C\C=C\C(OCCC4=CC(=O)OC4)C(C)O)[C@](C)([C@@]2(CO)CC1)[C@]31CO1,C29H38O9,27374.0
11240,"1,2-Dipalmitoyl-3-Octanoyl-rac-glycerol",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C43H82O6,26839.0
11241,"1,3-Dioleoyl-2-Myristoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCC,C53H98O6,26872.0
11242,"1,3-Didocosahexaenoyl Glycerol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCC(O)COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC,C47H68O5,27011.0
11243,Didocosahexaenoin,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCC(O)COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC,C47H68O5,27003.0
11244,Curcumol,C=C1C[C@@]2(O)O[C@@]3(C[C@H]2C(C)C)[C@@H](C)CC[C@@H]13,C15H24O2,26849.0
11245,"1,2,3-Trinonadecanoyl Glycerol",CCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCC,C60H116O6,26898.0
11246,4-Methylumbelliferyl-2-acetamido-2-deoxy-?-D-Glucopyranoside,CC(=O)N[C@H]1[C@H](Oc2ccc3c(C)cc(=O)oc3c2)O[C@H](CO)[C@@H](O)[C@@H]1O,C18H21NO8,26953.0
11247,Difenoconazole-d6 (hydrochloride),Cl.[2H]C([2H])([2H])C1([2H])OC(Cn2cncn2)(c2ccc(Oc3ccc(Cl)cc3)cc2Cl)OC1([2H])[2H],C19H18Cl3N3O3,27834.0
11248,Photoclick Myristic Acid,C#CCCC1(CCCCCCCCC(=O)O)N=N1,C14H22N2O2,25363.0
11249,UAMC-3203,O=S(=O)(NCCN1CCNCC1)c1ccc(NC2CCCCC2)c(NCc2ccccc2)c1,C25H37N5O2S,26525.0
11250,N-trans-Feruloyltyramine,COc1cc(/C=C/C(=O)NCCc2ccc(O)cc2)ccc1O,C18H19NO4,27459.0
11251,PF-06700841 (tosylate),Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1,C25H29F2N7O4S,26125.0
11252,Hypothemycin,COc1cc(O)c2c(c1)[C@H]1O[C@H]1C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O,C19H22O8,27913.0
11253,Schizandrin,COc1cc2c(c(OC)c1OC)-c1c(cc(OC)c(OC)c1OC)C[C@](C)(O)[C@@H](C)C2,C24H32O7,27211.0
11254,ML-221,O=C(Oc1coc(CSc2ncccn2)cc1=O)c1ccc([N+](=O)[O-])cc1,C17H11N3O6S,27313.0
11255,Quinaldopeptin,C[C@@H]1NC(=O)[C@@H]2CCCCN2C(=O)CN(C)C(=O)CNC(=O)[C@@H]2CCCCN2C(=O)[C@H](NC(=O)c2nc3ccccc3cc2O)[C@H](C)NC(=O)[C@@H]2CCCCN2C(=O)CN(C)C(=O)CNC(=O)[C@@H]2CCCCN2C(=O)[C@@H]1NC(=O)c1nc2ccccc2cc1O,C62H78N14O14,28167.0
11256,Desertomycin A,C/C1=C\CC[C@H](C)[C@@H](O)[C@@H](C)[C@@H](O)CC/C=C/[C@H](C)[C@@H](O)/C=C/[C@H](C)[C@@H](O)/C(C)=C/[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)[C@H](O)C[C@@H](O)C[C@H](O)C[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)[C@H](O)C[C@@H](O)C[C@H](O)/C=C/C[C@@H]([C@H](C)[C@H](O)CCCN)OC1=O,C61H109NO21,28169.0
11257,4-Hydroxybenzoic Acid,O=C(O)c1ccc(O)cc1,C7H6O3,27468.0
11258,Imidocarb (propionate),CCC(=O)O.CCC(=O)O.O=C(Nc1cccc(C2=NCCN2)c1)Nc1cccc(C2=NCCN2)c1,C25H32N6O5,27053.0
11259,Telbivudine,Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O,C10H14N2O5,21453.0
11260,Daphnoretin,COc1cc2cc(Oc3ccc4ccc(=O)oc4c3)c(=O)oc2cc1O,C19H12O7,26408.0
11261,Echinocystic Acid,CC1(C)CC[C@]2(C(=O)O)[C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,C30H48O4,27476.0
11262,Lu AF21934,NC(=O)[C@@H]1CCCC[C@@H]1C(=O)Nc1ccc(Cl)c(Cl)c1,C14H16Cl2N2O2,27045.0
11263,"1,3-Dipalmitoyl-2-Eicosapentaenoyl Glycerol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC,C55H96O6,26840.0
11264,Clopidol,Cc1nc(C)c(Cl)c(O)c1Cl,C7H7Cl2NO,26800.0
11265,Jatrorrhizine (chloride),COc1cc2c(cc1O)CC[n+]1cc3c(OC)c(OC)ccc3cc1-2.[Cl-],C20H20ClNO4,27314.0
11266,"1,2,3-Tripalmitoleoyl Glycerol",CCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC,C51H92O6,26897.0
11267,"3,4-Dihydroxybenzaldehyde",O=Cc1ccc(O)c(O)c1,C7H6O3,27547.0
11268,Heptadecanoic Acid-d3,[2H]C([2H])([2H])CCCCCCCCCCCCCCCC(=O)O,C17H34O2,27870.0
11269,"CP 31,398 (hydrochloride)",COc1ccc(/C=C/c2nc(NCCCN(C)C)c3ccccc3n2)cc1.Cl.Cl,C22H28Cl2N4O,27455.0
11270,Pal-GHK,CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)O,C30H54N6O5,27059.0
11271,para-methoxy 4-ANPP,COc1ccc(NC2CCN(CCc3ccccc3)CC2)cc1,C20H26N2O,27946.0
11272,GHK,NCCCC[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CN)C(=O)O,C14H24N6O4,27168.0
11273,1-Stearoyl-3-Linoleoyl-rac-glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC,C39H72O5,26830.0
11274,"1,3-Dioleoyl-2-Heptadecanoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC,C56H104O6,26879.0
11275,S-23,C[C@](O)(COc1ccc(Cl)c(F)c1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,C18H13ClF4N2O3,27304.0
11276,Acetyl Tetrapeptide-5,CC(=O)NCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,C20H28N8O7,27152.0
11277,Kirromycin,C/C=C\C=C\[C@@H]1O[C@](O)([C@H](CC)C(=O)NC/C=C/C=C(\C)[C@@H](OC)[C@@H](C)[C@@H]2O[C@H](/C=C/C=C/C=C(\C)C(=O)c3c(O)cc[nH]c3=O)[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)C1(C)C,C43H60N2O12,25189.0
11278,N-desmethyl Zolmitriptan,CNCCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12,C15H19N3O2,28058.0
11279,Azacyclonol,OC(c1ccccc1)(c1ccccc1)C1CCNCC1,C18H21NO,27303.0
11280,9(E)-Erythromycin A oxime,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\O)[C@H](C)[C@@H](O)[C@]1(C)O,C37H68N2O13,27966.0
11281,"1,3-Dieicosapentaenoyl Glycerol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(O)COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC,C43H64O5,27010.0
11282,.beta.-Apooxytetracycline,Cc1c2c(c(O)c3c(O)cccc13)C(=O)O[C@@H]2[C@H]1[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@H]1O,C22H22N2O8,27099.0
11283,Violacein,O=C1NC(c2c[nH]c3ccc(O)cc23)=C/C1=C1\C(=O)Nc2ccccc21,C20H13N3O3,27959.0
11284,Pyridoxatin,C=C[C@@H]1C[C@H](C)C[C@H](C)[C@H]1c1c(O)ccn(O)c1=O,C15H21NO3,27607.0
11285,"24(S),25-epoxy Cholesterol",C[C@H](CC[C@@H]1OC1(C)C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H44O2,10131.0
11286,D-Mannose,O=C[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,C6H12O6,27388.0
11287,Homovanillic Acid,COc1cc(CC(=O)O)ccc1O,C9H10O4,27307.0
11288,"1,2,3-Tridecanoyl Glycerol",CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC,C33H62O6,26958.0
11289,Silodosin Glucuronide (sodium salt),C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO[C@@H]1O[C@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O)CC2)NCCOc1ccccc1OCC(F)(F)F.[Na+],C31H39F3N3NaO10,28045.0
11290,Cholesteryl Oleate,CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C45H78O2,26472.0
11291,N-Demethylerythromycin A,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](NC)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,C36H65NO13,27988.0
11292,D-Glutamine,NC(=O)CC[C@@H](N)C(=O)O,C5H10N2O3,27032.0
11293,Latanoprostene Bunod,O=C(CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O)OCCCCO[N+](=O)[O-],C27H41NO8,25830.0
11294,Asciminib,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1,C20H18ClF2N5O3,26126.0
11295,Caffeine-13C3 (CRM),[13CH3]n1c(=O)c2c(ncn2[13CH3])n([13CH3])c1=O,C8H10N4O2,27972.0
11296,"1,3-Dioleoyl-2-Palmitoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C55H102O6,26843.0
11297,3-Hydroxypropionic Acid (sodium salt),O=C([O-])CCO.[Na+],C3H5NaO3,27603.0
11298,Desacetyl Cefapirin (sodium salt),O=C(CSc1ccncc1)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(CO)CS[C@H]12.[Na+],C15H14N3NaO5S2,27578.0
11299,Phenelfamycin E,C/C=C\C=C\[C@@H]1O[C@](O)([C@H](CO[C@H]2C[C@H](OC)[C@H](O[C@@H]3C[C@@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@H](O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)C(=O)NC/C=C/C=C(\C)[C@@H](OC)[C@@H](C)[C@H]2C[C@H](O)[C@H](/C=C/C=C/C=C/C(=O)O)O2)[C@H](OC(=O)Cc2ccccc2)[C@H](O)C1(C)C,C65H95NO21,28168.0
11300,1-Palmitoyl-2-Elaidoyl-3-Linoleoyl-rac-glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C/CCCCCCCC,C55H100O6,26841.0
11301,"1,2-Dipalmitoleoyl-3-Palmitoyl-rac-glycerol",CCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC,C51H94O6,27387.0
11302,Feglymycin,CC(C)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](N)c1ccc(O)cc1)c1cc(O)cc(O)c1)C(C)C)c1cc(O)cc(O)c1)c1ccc(O)cc1)c1cc(O)cc(O)c1)c1ccc(O)cc1)c1cc(O)cc(O)c1)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)c1ccc(O)cc1)c1cc(O)cc(O)c1,C95H97N13O30,28166.0
11303,Shikimic Acid,O=C(O)C1=C[C@@H](O)[C@@H](O)[C@H](O)C1,C7H10O5,26851.0
11304,GS-143,O=C(O)c1ccc(N2N=C(Cc3ccccc3)/C(=C\c3ccc(-c4ccccc4F)o3)C2=O)cc1,C28H19FN2O4,26138.0
11305,ARS1620,C=CC(=O)N1CCN(c2ncnc3c(F)c(-c4c(O)cccc4F)c(Cl)cc23)CC1,C21H17ClF2N4O2,27915.0
11306,BTB-1,O=[N+]([O-])c1cc(Cl)ccc1S(=O)(=O)c1ccccc1,C12H8ClNO4S,27219.0
11307,3-Aminoisobutyric Acid (sodium salt),CC(CN)C(=O)[O-].[Na+],C4H8NNaO2,26537.0
11308,BB-F-Yne,C#Cc1ccc(-c2ccc(C(=O)N[C@@H](CCCNC(=N)CF)c3nc4ccccc4[nH]3)cc2)cc1,C28H26FN5O,25379.0
11309,4-fluoro MDMB-BUTINACA 3-carboxyindazole metabolite,O=C(O)c1nn(CCCCF)c2ccccc12,C12H13FN2O2,27819.0
11310,?4-Abiraterone,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cccnc3)=CC[C@@H]12,C24H29NO,27594.0
11311,Curcumenol,CC1=C[C@@]2(O)O[C@@]3(CC2=C(C)C)[C@@H](C)CC[C@@H]13,C15H22O2,26715.0
11312,5-hydroxymethyl Tolterodine (formate),CC(C)N(CC[C@H](c1ccccc1)c1cc(CO)ccc1O)C(C)C.O=CO,C23H33NO4,27833.0
11313,Brucine,COc1cc2c(cc1OC)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43,C23H26N2O4,27221.0
11314,Olaquindox,Cc1c(C(=O)NCCO)[n+]([O-])c2ccccc2[n+]1[O-],C12H13N3O4,27725.0
11315,"1,2-Didecanoyl-3-Stearoyl-rac-glycerol",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC,C41H78O6,26835.0
11316,1-Myristoyl-3-Palmitoyl-rac-glycerol,CCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCC,C33H64O5,26873.0
11317,Lariatin A,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O,C94H143N27O25,28165.0
11318,Mulberroside A,OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3O)c2)[C@H](O)[C@@H](O)[C@@H]1O,C26H32O14,27545.0
11319,1-Palmitoyl-2-Lauroyl-rac-glycerol,CCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC,C31H60O5,26875.0
11320,ACTH (18-39) (human),CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,C112H165N27O36,27274.0
11321,cis-Entacapone,CCN(CC)C(=O)/C(C#N)=C\c1cc(O)c(O)c([N+](=O)[O-])c1,C14H15N3O5,28046.0
11322,Formoterol O-?-D-Glucuronide,COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c(NC=O)c2)cc1,C25H32N2O10,27805.0
11323,Arachidic Acid-d3,[2H]C([2H])([2H])CCCCCCCCCCCCCCCCCCC(=O)O,C20H40O2,27874.0
11324,Monomethyl fumarate,COC(=O)/C=C/C(=O)O,C5H6O4,27813.0
11325,2'-Deoxyuridine,O=c1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]1,C9H12N2O5,27803.0
11326,"4-Methylumbelliferyl ?-D-N,N'-diacetylchitobioside",CC(=O)N[C@H]1[C@H](Oc2ccc3c(C)cc(=O)oc3c2)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]1O,C26H34N2O13,27730.0
11327,Coprostanol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H48O,26764.0
11328,Pyrantel (pamoate),CN1CCCN=C1/C=C/c1cccs1.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,C34H30N2O6S,27368.0
11329,Plantamajoside,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](OCCc2ccc(O)c(O)c2)O[C@@H]1CO,C29H36O16,27296.0
11330,Raloxifene 4'-Glucuronide,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)cc2)sc2cc(O)ccc12,C34H35NO10S,27831.0
11331,Gboxin,CCc1n(CC(=O)O[C@@H]2C[C@H](C)CC[C@H]2C(C)C)c2ccccc2[n+]1C.[Cl-],C22H33ClN2O2,27861.0
11332,CCF-642,COc1ccc(N2C(=O)/C(=C\c3ccc([N+](=O)[O-])s3)SC2=S)cc1,C15H10N2O4S3,27054.0
11333,(Z)-Ligustilide,CCC/C=C1\OC(=O)C2=C1CCC=C2,C12H14O2,26908.0
11334,5?-dihydro Levonorgestrel,C#C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC,C21H30O2,27854.0
11335,Rifampicin-d3,[2H]C([2H])([2H])N1CCN(/N=C/c2c3c(O)c4c(O)c(C)c5c(c4c2O)C(=O)[C@@](C)(O/C=C/[C@H](OC)[C@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(\C)C(=O)N3)O5)CC1,C43H58N4O12,27848.0
11336,AT-121,CC(C)[C@H]1CC[C@@H](N2CCC3(CC2)C(=O)N(CCNS(N)(=O)=O)Cc2ccccc23)CC1,C24H38N4O3S,26150.0
11337,OH-Chol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](C(=O)NCCNCCO)CC[C@]4(C)[C@H]3CC[C@]12C,C32H56N2O2,26586.0
11338,Tiaprofenic Acid,CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1,C14H12O3S,27364.0
11339,Glyco-Obeticholic Acid,CC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H]([C@H](C)CCC(=O)NCC(=O)O)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12,C28H47NO5,28242.0
11340,LSD (D-tartrate) (solution),CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1.O=C(O)[C@@H](O)[C@H](O)C(=O)O,C24H31N3O7,28289.0
11341,LSD (D-tartrate),CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1.O=C(O)[C@@H](O)[C@H](O)C(=O)O,C24H31N3O7,41823.0
11342,LSD (D-tartrate),CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1.O=C(O)[C@@H](O)[C@H](O)C(=O)O,C24H31N3O7,41823.0
11343,Lu AE58054,Fc1ccc2c(CCNCc3cccc(OCC(F)(F)C(F)F)c3)c[nH]c2c1,C20H19F5N2O,27335.0
11344,Cefaclor,N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1,C15H14ClN3O4S,23626.0
11345,Santonin,CC1=C2[C@H]3OC(=O)[C@@H](C)[C@@H]3CC[C@@]2(C)C=CC1=O,C15H18O3,27460.0
11346,Micronomicin (sulfate),CNC[C@@H]1CC[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H](N)C[C@@H]2N)O1,C20H41N5O7,27951.0
11347,"1,2,3-Tripentadecanoyl Glycerol",CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC,C48H92O6,26962.0
11348,PZM21,C[C@@H](Cc1ccsc1)NC(=O)NC[C@H](Cc1ccc(O)cc1)N(C)C,C19H27N3O2S,20576.0
11349,3-hydroxy-DL-Kynurenine,Nc1c(O)cccc1C(=O)CC(N)C(=O)O,C10H12N2O4,27778.0
11350,GSK4027,CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccccc2)C1,C17H21BrN4O,23421.0
11351,4-cyano MDMB-BUTINACA,COC(=O)[C@@H](NC(=O)c1nn(CCCCC#N)c2ccccc12)C(C)(C)C,C20H26N4O3,26507.0
11352,UNC926,O=C(c1cccc(Br)c1)N1CCC(N2CCCC2)CC1,C16H21BrN2O,27302.0
11353,2-fluoro QMPSB,Cc1ccc(C(=O)Oc2cccc3cccnc23)cc1S(=O)(=O)N1CCC(F)(F)CC1,C22H20F2N2O4S,27325.0
11354,7-Amino-4-methylcoumarin,Cc1cc(=O)oc2cc(N)ccc12,C10H9NO2,27792.0
11355,Biotinyl Tyramide,O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)NCCc1ccc(O)cc1,C18H25N3O3S,27997.0
11356,Diphencyprone,O=c1c(-c2ccccc2)c1-c1ccccc1,C15H10O,27982.0
11357,Ligustroflavone,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C33H40O18,27431.0
11358,Mc-Val-Cit-PAB,CC(C)[C@H](NC(=O)CCCCCN1C(=O)C=CC1=O)C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(CO)cc1,C28H40N6O7,28285.0
11359,3?-Aminocholestane,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](N)CC[C@]4(C)[C@H]3CC[C@]12C,C27H49N,27885.0
11360,"ACTH (4-11) (human, mouse, rat, porcine, bovine, ovine)",CSCC[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O,C50H71N15O11S,27430.0
11361,Cabotegravir,C[C@H]1CO[C@@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,C19H17F2N3O5,27215.0
11362,Etelcalcetide (hydrochloride),CC(=O)N[C@H](CSSC[C@H](N)C(=O)O)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(N)=O.Cl,C38H74ClN21O10S2,26901.0
11363,Isoorientin,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,C21H20O11,26862.0
11364,Solifenacin N-oxide,O=C(O[C@H]1C[N+]2([O-])CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1,C23H26N2O3,26648.0
11365,Photoswitchable PAD Inhibitor (technical grade),N=C(CCl)NCCC[C@H](NC(=O)c1ccc(/N=N/c2ccccc2)cc1)c1nc2ccccc2[nH]1,C26H26ClN7O,28104.0
11366,Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O,9003100.0
11367,Cholesterol (solution),CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O,39088.0
11368,Cholesterol (plant),CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O,39448.0
11369,Itacitinib,N#CCC1(n2cc(-c3ncnc4[nH]ccc34)cn2)CN(C2CCN(C(=O)c3ccnc(C(F)(F)F)c3F)CC2)C1,C26H23F4N9O,27597.0
11370,5-Chlorouracil,O=c1[nH]cc(Cl)c(=O)[nH]1,C4H3ClN2O2,27790.0
11371,XL647,COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1,C24H25Cl2FN4O2,27049.0
11372,4-Methylpentanoic Acid-d12,[2H]OC(=O)C([2H])([2H])C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H],C6H12O2,27873.0
11373,JQEZ5,CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C,C30H38N8O2,27457.0
11374,Hederoside D2,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,C41H66O13,27507.0
11375,MEGX (hydrochloride),CCNCC(=O)Nc1c(C)cccc1C.Cl,C12H19ClN2O,28019.0
11376,Sciadopitysin,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(OC)cc6o5)ccc4OC)c3o2)cc1,C33H24O10,27900.0
11377,GHV (sodium salt),CC(O)CCC(=O)[O-].[Na+],C5H9NaO3,28241.0
11378,Oxibendazole,CCCOc1ccc2[nH]c(NC(=O)OC)nc2c1,C12H15N3O3,27365.0
11379,?-Valerolactone,CC1CCC(=O)O1,C5H8O2,28240.0
11380,"2,5-dimethyl Celecoxib",Cc1ccc(C)c(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)c1,C18H16F3N3O2S,10008006.0
11381,RIPGBM,CC(=O)N(Cc1ccc(F)cc1)C1=C(NCc2ccccc2)C(=O)c2ccccc2C1=O,C26H21FN2O3,27860.0
11382,Dihydrolycorine,O[C@H]1[C@H]2c3cc4c(cc3CN3CC[C@H](C[C@@H]1O)[C@H]23)OCO4,C16H19NO4,27809.0
11383,"Phorbol 12,13-dibutyrate",CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC,C28H40O8,27785.0
11384,Deracoxib,COc1ccc(-c2cc(C(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1F,C17H14F3N3O3S,27371.0
11385,Dracorhodin Perchlorate,COc1c(C)c(O)cc2[o+]c(-c3ccccc3)ccc12.[O-][Cl+3]([O-])([O-])[O-],C17H15ClO7,27294.0
11386,"2',3',5'-Triacetyluridine",CC(=O)OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O,C15H18N2O9,27445.0
11387,Loureirin B,COc1cc(OC)c(CCC(=O)c2ccc(O)cc2)c(OC)c1,C18H20O5,27454.0
11388,Corosolic Acid,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,C30H48O4,27887.0
11389,Lauric Acid-d23,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C12H24O2,28080.0
11390,5-Hydroxymethylfurfural,O=Cc1ccc(CO)o1,C6H6O3,27835.0
11391,2-O-Acetyl-20-hydroxyecdysone,CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@H]1O)C(=O)C=C1[C@@H]2CC[C@]2(C)[C@@H]([C@@](C)(O)[C@H](O)CCC(C)(C)O)CC[C@@]12O,C29H46O8,28063.0
11392,"1,3-Didocosanoyl-2-Oleoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC,C65H124O6,27278.0
11393,Ribitol,OC[C@@H](O)[C@@H](O)[C@@H](O)CO,C5H12O5,27362.0
11394,"1,2,3-Trihexanoyl Glycerol",CCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCC,C21H38O6,27281.0
11395,Hispidulin,COc1c(O)cc2oc(-c3ccc(O)cc3)cc(=O)c2c1O,C16H12O6,26383.0
11396,Frovatriptan (succinate hydrate),CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1.O.O=C(O)CCC(=O)O,C18H25N3O6,23771.0
11397,1-Myristoyl-3-Oleoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCC,C35H66O5,26886.0
11398,Euphorbiasteroid,CC(=O)O[C@H]1[C@H]2[C@@H](OC(=O)Cc3ccccc3)[C@@H](C)C[C@]2(OC(C)=O)C(=O)/C(C)=C/[C@@H]2[C@H](CC[C@@]13CO3)C2(C)C,C32H40O8,27822.0
11399,Betahistine (hydrochloride),CNCCc1ccccn1.Cl.Cl,C8H14Cl2N2,27602.0
11400,5-Methyluridine,Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]c1=O,C10H14N2O6,27986.0
11401,Telocinobufagin,C[C@]12CC[C@H](O)C[C@@]1(O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)CC[C@]12O,C24H34O5,27981.0
11402,Rubimaillin,COC(=O)c1c2c(c3ccccc3c1O)OC(C)(C)C=C2,C17H16O4,27999.0
11403,"1,3-Dioleoyl-2-Stearoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC,C57H106O6,26889.0
11404,BAY-6035,C[C@H]1CC(=O)Nc2cc(C(=O)NCCC3CC3)ccc2N1C(=O)N1CC2CC2C1,C22H28N4O3,25925.0
11405,"1,3-Dilauroyl-glycerol",CCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCC,C27H52O5,26975.0
11406,SB-756050,COc1ccc(S(=O)(=O)N2CCCN(S(=O)(=O)c3ccc(OC)c(OC)c3)CC2)cc1OC,C21H28N2O8S2,27998.0
11407,Didocosanoin,CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCCCCCC,C47H92O5,26963.0
11408,Sancycline (hydrochloride),CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4C[C@H]3C[C@@H]12.Cl,C21H23ClN2O7,28118.0
11409,"1,3-Dipalmitoyl Glycerol",CCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCC,C35H68O5,26974.0
11410,Xanthotoxol,O=c1ccc2cc3ccoc3c(O)c2o1,C11H6O4,27801.0
11411,Brorphine (hydrochloride),CC(c1ccc(Br)cc1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1.Cl,C20H23BrClN3O,27816.0
11412,Brorphine (hydrochloride) (CRM),CC(c1ccc(Br)cc1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1.Cl,C20H23BrClN3O,34184.0
11413,Epianhydrotetracycline (hydrochloride),Cc1c2c(c(O)c3c(O)cccc13)C(=O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H](N(C)C)[C@@H]1C2.Cl,C22H23ClN2O7,27954.0
11414,Sematilide (hydrochloride),CCN(CC)CCNC(=O)c1ccc(NS(C)(=O)=O)cc1.Cl,C14H24ClN3O3S,28272.0
11415,Epimedin A,COc1ccc(-c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,C39H50O20,27582.0
11416,Rebaudioside D,C=C1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]2CC[C@]1(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C3,C50H80O28,27880.0
11417,YW1159,Cc1c(C(=O)Nc2ccc3ccccc3n2)nnn1-c1ccccc1F,C19H14FN5O,27451.0
11418,"1,6-Diphenyl-1,3,5-hexatriene",C(=C/C=C/c1ccccc1)\C=C\c1ccccc1,C18H16,28277.0
11419,(+)-Pinoresinol,COc1cc([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2ccc(O)c(OC)c2)ccc1O,C20H22O6,27700.0
11420,Lavendustin B,O=C(O)c1cc(N(Cc2ccccc2O)Cc2ccccc2O)ccc1O,C21H19NO5,27311.0
11421,17(R)-Resolvin D3,CC/C=C\C[C@@H](O)/C=C/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCC(=O)O,C22H32O5,9002880.0
11422,Acetylcimigenol Arabinoside,CC(=O)O[C@H](C[C@@H](C)[C@H]1C(=O)[C@H](O)[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@@H]5OC[C@H](O)[C@H](O)[C@H]5O)CC[C@@]45C[C@@]35CC[C@]12C)[C@@H]1OC1(C)C,C37H58O10,27596.0
11423,Dilinoelaidin,CCCCC/C=C/C/C=C/CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C/C/C=C/CCCCC,C39H68O5,26980.0
11424,"1,3-Dilinoelaidoyl Glycerol",CCCCC/C=C/C/C=C/CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C/C/C=C/CCCCC,C39H68O5,26983.0
11425,Fluticasone 17?-Carboxylic Acid,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)O,C21H26F2O5,27855.0
11426,1-Stearoyl-3-Oleoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC,C39H74O5,26876.0
11427,MD001,Cc1c(O)cc(O)c2c(-c3ccccc3)c(C(=O)/C=C/c3ccccc3)c(=O)oc12,C25H18O5,27443.0
11428,"N,N-diethyl Hexylone (hydrochloride)",CCCCC(C(=O)c1ccc2c(c1)OCO2)N(CC)CC.Cl,C17H26ClNO3,28475.0
11429,Cephalomannine,C/C=C(\C)C(=O)N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C,C45H53NO14,27878.0
11430,LY3214996,Cn1nccc1Nc1nccc(-c2cc3c(s2)C(C)(C)N(CCN2CCOCC2)C3=O)n1,C22H27N7O2S,27936.0
11431,Begacestat,O=S(=O)(N[C@H](CO)C(C(F)(F)F)C(F)(F)F)c1ccc(Cl)s1,C9H8ClF6NO3S2,27916.0
11432,SR 1903,Cc1cc(CN2CCN(Cc3ccncc3)CC2)ccc1-c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,C27H27F6N3O,28253.0
11433,DSPE-mPEG(2000) (sodium salt),CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCNC(=O)OCCOC)OC(=O)CCCCCCCCCCCCCCCCC.[Na+],C43H83NNaO10P(C2H4O)n,28181.0
11434,DSPE-MPEG(5000) (sodium salt),CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCNC(=O)OCCOC)OC(=O)CCCCCCCCCCCCCCCCC.[Na+],C43H83NNaO10P(C2H4O)n,34652.0
11435,"4,5-Dicaffeoylquinic Acid",O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,C25H24O12,27892.0
11436,1-Octacosanol,CCCCCCCCCCCCCCCCCCCCCCCCCCCCO,C28H58O,28010.0
11437,Dipeptide diaminobutyroyl benzylamide (acetate),CC(=O)O.CC(=O)O.NCCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCN)C(=O)NCc1ccccc1,C23H37N5O7,27566.0
11438,Stearic Acid-d35,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C18H36O2,9003318.0
11439,BMS 986158,Cc1nnn(C)c1-c1cnc2c3ccc(C(C)(C)O)cc3n([C@H](c3ccccc3)C3CCOCC3)c2c1,C30H33N5O2,27789.0
11440,LXH254,Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(OCCO)nc(N2CCOCC2)c1,C25H25F3N4O4,28231.0
11441,Betulinic Aldehyde,C=C(C)[C@@H]1CC[C@]2(C=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C30H48O2,27810.0
11442,Questiomycin A,Nc1cc2nc3ccccc3oc-2cc1=O,C12H8N2O2,27623.0
11443,OPC 21268,CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1,C26H31N3O4,27226.0
11444,AUNP-12,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(N)=O,C142H226N40O48,28053.0
11445,3'-Dephosphocoenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)[C@@H](O)C(=O)NCCC(=O)NCCS,C21H35N7O13P2S,27390.0
11446,SR 16832,COc1ccc2nccc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)c2c1,C17H12ClN3O4,27632.0
11447,Dioctanoin,CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC,C19H36O5,26982.0
11448,"1,3-Dioctanoyl Glycerol",CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC,C19H36O5,27012.0
11449,Monotropein,O=C(O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]2[C@@H]1C=C[C@]2(O)CO,C16H22O11,27595.0
11450,N-Acetylmethamphetamine,CC(=O)N(C)C(C)Cc1ccccc1,C12H17NO,27889.0
11451,Schaftoside,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)c(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,C26H28O14,27950.0
11452,"1,2-Dioctanoyl-3-Stearoyl-rac-glycerol",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,C37H70O6,27285.0
11453,N-methyl para-methyl Phenyl fentanyl (hydrochloride),Cc1ccc(N(C(=O)c2ccccc2)C2CCN(C)CC2)cc1.Cl,C20H25ClN2O,28077.0
11454,Oxychlororaphine,NC(=O)c1cccc2nc3ccccc3nc12,C13H9N3O,27624.0
11455,(-)-Bicuculline methochloride,C[N+]1(C)CCc2cc3c(cc2[C@@H]1[C@H]1OC(=O)c2c1ccc1c2OCO1)OCO3.[Cl-],C21H20ClNO6,27802.0
11456,STY-BODIPY,CC1=CC(C)=[N+]2C1=Cc1ccc(/C=C/c3ccccc3)n1[B-]2(F)F,C19H17BF2N2,27089.0
11457,"7(Z),10(Z),13(Z)-Hexadecatrienoic Acid-d6",[2H]/C(CC)=C(\[2H])C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCCCC(=O)O,C16H26O2,28226.0
11458,Alkannin,CC(C)=CC[C@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,C16H16O5,25058.0
11459,Azimilide (hydrochloride),CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1.Cl.Cl,C23H30Cl3N5O3,28300.0
11460,9-Hydroxyellipticine (hydrochloride),Cc1c2ccncc2c(C)c2c1[nH]c1ccc(O)cc12.Cl,C17H15ClN2O,17921.0
11461,AZD 5069,C[C@@H](Oc1cc(NS(=O)(=O)N2CCC2)nc(SCc2cccc(F)c2F)n1)[C@@H](O)CO,C18H22F2N4O5S2,28297.0
11462,"L-685,458",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,C39H52N4O6,14926.0
11463,T-26c,COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1,C24H21N3O6S,19962.0
11464,cis-6-Hexadecenoic Acid-d19,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])/C=C\CCCCC(=O)O,C16H30O2,28227.0
11465,Diprotin A,CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)CC,C17H31N3O4,28014.0
11466,Averantin,CCCCC[C@H](O)c1c(O)cc2c(c1O)C(=O)c1c(O)cc(O)cc1C2=O,C20H20O7,28059.0
11467,Eprinomectin,CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@H](NC(C)=O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@H]1NC(C)=O,C99H148N2O28,28182.0
11468,Z-Phe-Tyr(tBu)-diazomethylketone,CC(C)(C)Oc1ccc(C[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)OCc2ccccc2)C(=O)C=[N+]=[N-])cc1,C31H34N4O5,27877.0
11469,Setipiprant,O=C(O)Cn1c2c(c3cc(F)ccc31)CN(C(=O)c1cccc3ccccc13)CC2,C24H19FN2O3,28291.0
11470,Dihydrokainic Acid,CC(C)[C@H]1CN[C@H](C(=O)O)[C@H]1CC(=O)O,C10H17NO4,28478.0
11471,"1,2-Dilinoleoyl-3-Oleoyl-rac-glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C57H100O6,28178.0
11472,Fraxinol,COc1cc2oc(=O)ccc2c(OC)c1O,C11H10O5,28218.0
11473,Carbimazole,CCOC(=O)n1ccn(C)c1=S,C7H10N2O2S,28280.0
11474,Acepromazine (maleate),CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2.O=C(O)/C=C\C(=O)O,C23H26N2O5S,27821.0
11475,Vulpinic Acid,COC(=O)/C(=C1/OC(=O)C(c2ccccc2)=C1O)c1ccccc1,C19H14O5,21685.0
11476,?-Cyano-4-hydroxycinnamic Acid,N#C/C(=C\c1ccc(O)cc1)C(=O)O,C10H7NO3,15254.0
11477,Netilimicin (sulfate),CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O,C21H45N5O15S2,26666.0
11478,Liproxstatin-1 analog,CC(C)(C)NC1=Nc2ccccc2NC12CCNCC2,C16H24N4,28591.0
11479,Cridanimod (sodium salt),O=C([O-])Cn1c2ccccc2c(=O)c2ccccc21.[Na+],C15H10NNaO3,27884.0
11480,Semax,CSCC[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,C37H51N9O10S,27719.0
11481,Ecabet (sodium salt),CC(C)c1cc2c(cc1S(=O)(=O)[O-])[C@@]1(C)CCC[C@@](C)(C(=O)O)[C@@H]1CC2.[Na+],C20H27NaO5S,28013.0
11482,6-Paradol,CCCCCCCC(=O)CCc1ccc(O)c(OC)c1,C17H26O3,27554.0
11483,Astringin,OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)c(O)c3)c2)[C@H](O)[C@@H](O)[C@@H]1O,C20H22O9,27979.0
11484,Bretazenil,CC(C)(C)OC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc1-2,C19H20BrN3O3,28411.0
11485,Suc-YVAD-pNA,CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)Nc1ccc([N+](=O)[O-])cc1,C31H38N6O12,28135.0
11486,Geniposide,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2C(CO)=CC[C@H]12,C17H24O10,28281.0
11487,4-oxo-27-TBDMS Withaferin A,CC1=C(CO[Si](C)(C)C(C)(C)C)C(=O)O[C@@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56C(=O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1,C34H50O6Si,28323.0
11488,Pinosylvin,Oc1cc(O)cc(/C=C/c2ccccc2)c1,C14H12O2,27612.0
11489,N-?-Benzoyl-L-Arginine ethyl ester (hydrochloride),CCOC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1.Cl,C15H23ClN4O3,27183.0
11490,MOZ-IN-3,Cc1cc(-c2ccccc2)cc(C(=O)NNS(=O)(=O)c2ccccc2)c1F,C20H17FN2O3S,27402.0
11491,Lys05 (hydrochloride),CN(CCNc1ccnc2cc(Cl)ccc12)CCNc1ccnc2cc(Cl)ccc12.Cl.Cl.Cl,C23H26Cl5N5,27334.0
11492,"CP 775,146",CC(C)c1ccc(CC(=O)N2CCC[C@@H](c3cccc(OC(C)(C)C(=O)O)c3)C2)cc1,C26H33NO4,28290.0
11493,Virustomycin A,C/C=C\[C@H]1O[C@@](O)([C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]2OC)C[C@@H](OC(=O)/C=C/C(=O)NC2=C(O)CCC2=O)[C@@H]1C,C48H71NO14,27736.0
11494,Asarinin,c1cc2c(cc1[C@H]1OC[C@@H]3[C@H]1CO[C@H]3c1ccc3c(c1)OCO3)OCO2,C20H18O6,27456.0
11495,CHF5074,O=C(O)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)c(F)c2)CC1,C16H11Cl2FO2,27917.0
11496,Varinolic Acid,CCCc1cc(O)cc(O)c1C(=O)O,C10H12O4,26283.0
11497,"7-(2,4-Dinitrophenoxy)-4-methyl-2H-chromen-2-one",Cc1cc(=O)oc2cc(Oc3ccc([N+](=O)[O-])cc3[N+](=O)[O-])ccc12,C16H10N2O7,28472.0
11498,Scutellarin,O=C(O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccc(O)cc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O,C21H18O12,27461.0
11499,1-Oleoyl-3-Arachidoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCCCC,C41H78O5,26838.0
11500,1-Palmitoyl-3-Stearoyl-rac-glycerol,CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCC,C37H72O5,26874.0
11501,Sphingosine-13C2-d2 (d18:1),[2H][13C]([2H])(O)[13C@H](N)[C@H](O)/C=C/CCCCCCCCCCCCC,C18H37NO2,27875.0
11502,Pibrentasvir,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc([C@H]3CC[C@H](c4cc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)[nH]c5cc4F)N3c3cc(F)c(N4CCC(c5ccc(F)cc5)CC4)c(F)c3)c(F)cc2[nH]1)[C@@H](C)OC,C57H65F5N10O8,27546.0
11503,"(6aR,9S)-?10-THC",CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@H](C)C=C21,C21H30O2,25707.0
11504,"(6aR,9S)-?10-THC (CRM)",CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@H](C)C=C21,C21H30O2,33012.0
11505,Lignoceric Acid-d47,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C24H48O2,9003320.0
11506,2'-Deoxyadenosine (hydrate),Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1.O,C10H15N5O4,27315.0
11507,Pogostone,Cc1cc(O)c(C(=O)CCC(C)C)c(=O)o1,C12H16O4,27812.0
11508,Triacetylphloroglucinol,CC(=O)c1c(O)c(C(C)=O)c(O)c(C(C)=O)c1O,C12H12O6,27073.0
11509,"1,2-Dilinoleoyl-3-Palmitoyl-rac-glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C55H98O6,26887.0
11510,Estrone 3-methyl ether,COc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H24O2,27978.0
11511,Di-?-linolenin,CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)OCC(O)COC(=O)CCCC/C=C\C/C=C\C/C=C\CCCCC,C39H64O5,26973.0
11512,3-Iodotyrosine,N[C@@H](Cc1ccc(O)c(I)c1)C(=O)O,C9H10INO3,27798.0
11513,Resorufin ?-D-Galactopyranoside,O=c1ccc2nc3ccc(O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)cc3oc-2c1,C18H17NO8,28015.0
11514,4-Methyl-7-(4-nitrophenoxy)-2H-chromen-2-one,Cc1cc(=O)oc2cc(Oc3ccc([N+](=O)[O-])cc3)ccc12,C16H11NO5,28474.0
11515,GI 254023X,CNC(=O)[C@@H](NC(=O)[C@H](CCCc1ccccc1)[C@H](C)N(O)C=O)C(C)(C)C,C21H33N3O4,28284.0
11516,NAP-1,CCOC(=O)c1cc(-c2ccc(Cl)cc2)n(-c2ccccc2)c1C,C20H18ClNO2,28719.0
11517,CC-122,Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O,C14H14N4O3,26257.0
11518,Solamargine,C[C@@H]1CC[C@@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C45H73NO15,28110.0
11519,TPTZ,c1ccc(-c2nc(-c3ccccn3)nc(-c3ccccn3)n2)nc1,C18H12N6,28274.0
11520,Oleanolic Acid Acrylate,C=CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@]5(C(=O)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C,C33H50O4,27206.0
11521,Pitstop2,O=C1N=C(NS(=O)(=O)c2cccc3ccccc23)S/C1=C\c1ccc(Br)cc1,C20H13BrN2O3S2,23885.0
11522,?-Hederin,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CC[C@]6(C(=O)O)CC[C@]45C)[C@]3(C)CO)OC[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C41H66O12,28164.0
11523,MRX-2843,CN1CCN(Cc2ccc(-c3cn([C@H]4CC[C@H](O)CC4)c4nc(NCCC5CC5)ncc34)cc2)CC1,C29H40N6O,27923.0
11524,PF-06869206,Cc1[nH]c2c(N3CCO[C@H](CO)C3)c(C#N)c(C(F)(F)F)nc2c1Cl,C15H14ClF3N4O2,28158.0
11525,Arachidic Acid-d2,[2H]C([2H])(CCCCCCCCCCCCCCCCCC)C(=O)O,C20H40O2,28083.0
11526,Efaproxiral,Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(=O)O)cc2)c1,C20H23NO4,28294.0
11527,Vadadustat,O=C(O)CNC(=O)c1ncc(-c2cccc(Cl)c2)cc1O,C14H11ClN2O4,15295.0
11528,Delafloxacin (meglumine),CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F,C25H29ClF3N5O9,27935.0
11529,4-oxo Withaferin A,CC1=C(CO)C(=O)O[C@@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56C(=O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1,C28H36O6,28295.0
11530,STING Agonist C11,CNC(=O)NC(=O)C(Sc1nnc(-c2ccc(C)cc2)o1)c1ccccc1,C19H18N4O3S,27615.0
11531,Pinoresinol Diglucoside,COc1cc([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2ccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)c2)ccc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C32H42O16,27708.0
11532,H-Gly-Arg-pNA (hydrochloride),Cl.Cl.N=C(N)NCCC[C@H](NC(=O)CN)C(=O)Nc1ccc([N+](=O)[O-])cc1,C14H23Cl2N7O4,27705.0
11533,Meclofenoxate (hydrochloride),CN(C)CCOC(=O)COc1ccc(Cl)cc1.Cl,C12H17Cl2NO3,28283.0
11534,A-484954,CCn1c(=O)c2cc(C(N)=O)c(N)nc2n(C2CC2)c1=O,C13H15N5O3,28279.0
11535,Methyl 2-phenylacetoacetate,COC(=O)C(C(C)=O)c1ccccc1,C11H12O3,28352.0
11536,PH-002,Cn1nc(CC(=O)Nc2ccc(CN3CCN(C(=O)OC(C)(C)C)CC3)cc2)c2ccccc2c1=O,C27H33N5O4,27739.0
11537,4-Hydroxyisoleucine,C[C@@H]([C@H](C)O)[C@H](N)C(=O)O,C6H13NO3,11812.0
11538,CAY10737,C=CCOC(=O)Oc1ccc2c(c1)OC1=C(/C=C/C3=[N+](C)c4ccccc4C3(C)C)CCCC1=C2,C30H30NO4,27026.0
11539,Dimyristolein,CCCC/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C\CCCC,C31H56O5,26977.0
11540,1-Lauroyl-2-Palmitoyl-rac-glycerol,CCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCCCCCC,C31H60O5,26882.0
11541,Tyramine-d4 (hydrochloride),Cl.[2H]C([2H])(N)C([2H])([2H])c1ccc(O)cc1,C8H12ClNO,28531.0
11542,Lignoceric Acid-d3,[2H]C([2H])([2H])CCCCCCCCCCCCCCCCCCCCCCC(=O)O,C24H48O2,28084.0
11543,Sebaleic Acid-d19,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])/C=C\C/C=C\CCCC(=O)O,C18H32O2,28228.0
11544,Olprinone (hydrochloride),Cc1[nH]c(=O)c(C#N)cc1-c1ccc2nccn2c1.Cl,C14H11ClN4O,28396.0
11545,Y-26763,CC(=O)N(O)[C@@H]1c2cc(C#N)ccc2OC(C)(C)[C@H]1O,C14H16N2O4,21459.0
11546,Elaidamide,CCCCCCCC/C=C/CCCCCCCC(N)=O,C18H35NO,21079.0
11547,Lisinopril-d5,[2H]c1c([2H])c([2H])c(CC[C@H](N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)O)C(=O)O)c([2H])c1[2H],C21H31N3O5,28520.0
11548,YW1128,Cc1ccccc1-n1nnc(C(=O)Nc2ccc3ccccc3n2)c1C,C20H17N5O,27450.0
11549,Cabazitaxel-d9,[2H]C([2H])([2H])C(OC(=O)N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](OC)[C@@]3(C)C(=O)[C@H](OC)C(=C1C)C2(C)C)(C([2H])([2H])[2H])C([2H])([2H])[2H],C45H57NO14,28488.0
11550,S 32212 (hydrochloride),COc1ccc(NC(=O)N2CCc3c2ccc2ccccc32)cc1N1CCN(C)CC1.Cl,C25H29ClN4O2,27639.0
11551,3-Hydroxyterphenyllin,COc1cc(-c2ccc(O)cc2)c(OC)c(O)c1-c1ccc(O)c(O)c1,C20H18O6,28502.0
11552,Carbenicillin (sodium salt),CC1(C)SC2C(NC(=O)C(C(=O)[O-])c3ccccc3)C(=O)N2C1C(=O)[O-].[Na+].[Na+],C17H16N2Na2O6S,20871.0
11553,Pyrenophorol,C[C@@H]1CC[C@H](O)/C=C/C(=O)O[C@H](C)CC[C@H](O)/C=C/C(=O)O1,C16H24O6,28100.0
11554,"1,2-Dipalmitoyl-3-Myristoyl-rac-glycerol",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C49H94O6,27283.0
11555,CAY10735,C=C1C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@]5(C(=O)NCCNC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)CC[C@@]4(C)[C@]3(C)CC[C@H]2C(C)(C)C1=O,C44H60FN3O4,26753.0
11556,MNI-caged-L-glutamate (trifluoroacetate salt),COc1ccc([N+](=O)[O-])c2c1CCN2C(=O)CC[C@H](N)C(=O)O.O=C(O)C(F)(F)F,C16H18F3N3O8,19532.0
11557,Oxysophocarpine,O=C1C=CC[C@@H]2[C@H]3CCC[N@+]4([O-])CCC[C@@H](CN12)[C@@H]34,C15H22N2O2,28305.0
11558,"1,3-Diheptadecanoyl-2-Oleoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCC,C55H104O6,27383.0
11559,"1,3-Dibutyryl-2-Oleoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCC)COC(=O)CCC,C29H52O6,26985.0
11560,Alaproclate (hydrochloride),CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1.Cl,C13H19Cl2NO2,27770.0
11561,ADL5859 (hydrochloride),CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3cccc(O)c32)cc1.Cl,C24H29ClN2O3,27796.0
11562,PSNCBAM-1,O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cccc(N3CCCC3)n2)c1,C22H21ClN4O,25855.0
11563,Folic Acid-d4,[2H]c1c([2H])c(C(=O)N[C@@H](CCC(=O)O)C(=O)O)c([2H])c([2H])c1NCc1c[nH]c2nc(N)nc(=O)c-2n1,C19H19N7O6,28485.0
11564,Guanosine,Nc1nc(=O)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2[nH]1,C10H13N5O5,27702.0
11565,SCH 527123,CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1,C21H23N3O5,27800.0
11566,Astilbin,C[C@@H]1O[C@@H](O[C@H]2C(=O)c3c(O)cc(O)cc3O[C@@H]2c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,C21H22O11,28267.0
11567,Benzamil (hydrochloride),Cl.N=C(NCc1ccccc1)NC(=O)c1nc(Cl)c(N)nc1N,C13H15Cl2N7O,14313.0
11568,"1,3-Dilignoceroyl Glycerol",CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCCCCCCCC,C51H100O5,26796.0
11569,Triamcinolone,C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F,C21H27FO6,28275.0
11570,MX1013,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(CC(=O)O)C(=O)CF,C18H23FN2O6,27904.0
11571,Rufloxacin (hydrochloride),CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2SCC4)CC1.Cl,C17H19ClFN3O3S,21413.0
11572,AZD 2098,COc1nccnc1NS(=O)(=O)c1cccc(Cl)c1Cl,C11H9Cl2N3O3S,27633.0
11573,Bilastine,CCOCCn1c(C2CCN(CCc3ccc(C(C)(C)C(=O)O)cc3)CC2)nc2ccccc21,C28H37N3O3,28375.0
11574,Aripiprazole-d8,[2H]C([2H])(Oc1ccc2c(c1)NC(=O)CC2)C([2H])([2H])C([2H])([2H])C([2H])([2H])N1CCN(c2cccc(Cl)c2Cl)CC1,C23H27Cl2N3O2,28487.0
11575,NOD-IN-1,CCOC(=O)c1cc2ccccc2n1S(=O)(=O)c1ccc(C)cc1,C18H17NO4S,28370.0
11576,CRT0066854,N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccccc1,C24H25N5S,28463.0
11577,Paritaprevir,Cc1cnc(C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@@]3(C(=O)NS(=O)(=O)C3CC3)NC(=O)[C@@H]3C[C@@H](Oc4nc5ccccc5c5ccccc45)CN3C2=O)cn1,C40H43N7O7S,28301.0
11578,Tizoxanide-d4,[2H]c1c([2H])c([2H])c(C(=O)Nc2ncc([N+](=O)[O-])s2)c(O)c1[2H],C10H7N3O4S,28533.0
11579,"1,2,3-Tri-13(E)-Docosenoyl Glycerol",CCCCCCCC/C=C/CCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC/C=C/CCCCCCCC)OC(=O)CCCCCCCCCCC/C=C/CCCCCCCC,C69H128O6,26991.0
11580,GHRP-6 (acetate),CC(=O)O.CC(=O)O.CC(=O)O.C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O,C52H68N12O12,27262.0
11581,Firocoxib,CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(S(C)(=O)=O)cc1,C17H20O5S,28286.0
11582,"L-Methionine-(S,R)-Sulfoximine",CS(=N)(=O)CC[C@H](N)C(=O)O,C5H12N2O3S,27608.0
11583,Testosterone Acetate,CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C21H30O3,26915.0
11584,Bz-IEGR-pNA (acetate),CC(=O)O.CC[C@H](C)[C@H](NC(=O)c1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc([N+](=O)[O-])cc1,C34H47N9O11,27567.0
11585,Flumazenil-d5,[2H]C([2H])([2H])C([2H])([2H])OC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2,C15H14FN3O3,28529.0
11586,N-methyl ortho-methyl Phenyl fentanyl (hydrochloride),Cc1ccccc1N(C(=O)c1ccccc1)C1CCN(C)CC1.Cl,C20H25ClN2O,28075.0
11587,Safinamide-d4,[2H]c1c([2H])c(OCc2cccc(F)c2)c([2H])c([2H])c1CN[C@@H](C)C(N)=O,C17H19FN2O2,28490.0
11588,Cholesterol ?-D-Glucoside,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)CC[C@]4(C)[C@H]3CC[C@]12C,C33H56O6,26713.0
11589,"1,3-Dilinoleoyl-2-Oleoyl Glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C57H100O6,27064.0
11590,Cholesteryl Stearate,CCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C45H80O2,26475.0
11591,Schisantherin B,C/C=C(/C)C(=O)O[C@H]1c2cc(OC)c(OC)c(OC)c2-c2c(cc3c(c2OC)OCO3)C[C@H](C)[C@]1(C)O,C28H34O9,26716.0
11592,ABX-1431,O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2ccc(C(F)(F)F)cc2N2CCCC2)CC1,C20H22F9N3O2,26023.0
11593,Reveromycin D,CCCCC[C@@]1(OC(=O)CCC(=O)O)CC[C@]2(CC[C@H](C)[C@@H](C/C=C(C)/C=C/[C@H](O)[C@@H](C)/C=C/C(=O)O)O2)O[C@H]1/C=C/C(C)=C/C(=O)O,C37H54O11,28101.0
11594,LysoFP-NH2,Nc1cc2c3c(cccc3c1)C(=O)N(CCN1CCOCC1)C2=O,C18H19N3O3,27023.0
11595,Nidulin,C/C=C(\C)c1c(Cl)c(OC)c(C)c2c1Oc1c(Cl)c(O)c(Cl)c(C)c1C(=O)O2,C20H17Cl3O5,27955.0
11596,Nogalamycin,COC(=O)[C@@H]1c2cc3c(c(O)c2[C@@H](O[C@@H]2O[C@@H](C)[C@H](OC)[C@@](C)(OC)[C@H]2OC)C[C@]1(C)O)C(=O)c1c(O)cc2c(c1C3=O)O[C@@H]1O[C@@]2(C)[C@H](O)[C@@H](N(C)C)[C@@H]1O,C39H49NO16,27995.0
11597,Senexin B,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,C27H26N6O,28459.0
11598,1-Palmitoyl-d3-2-hydroxy-sn-glycero-3-PC,[2H]C([2H])([2H])CCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C24H50NO7P,28229.0
11599,SRT 2104,Cc1nc(-c2cccnc2)sc1C(=O)Nc1ccccc1-c1cn2c(CN3CCOCC3)csc2n1,C26H24N6O2S2,28380.0
11600,"1,2-Dioctanoyl-3-Linoleoyl-rac-glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,C37H66O6,26930.0
11601,Tunicamycin 16:1 Mixture,CC(=O)N[C@H]1[C@@H](O[C@@H]2O[C@H](C[C@@H](O)[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)[C@H](O)[C@H](O)[C@H]2NC(=O)/C=C/CCCCCCCCCCC(C)C)O[C@H](CO)[C@@H](O)[C@@H]1O,C39H64N4O16,28357.0
11602,Pantoprazole-d6,[2H]C([2H])([2H])Oc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC([2H])([2H])[2H],C16H15F2N3O4S,28483.0
11603,Tunicamycin 15:1 Mixture,CC(=O)N[C@H]1[C@@H](O[C@@H]2O[C@H](C[C@@H](O)[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)[C@H](O)[C@H](O)[C@H]2NC(=O)/C=C/CCCCCCCCCC(C)C)O[C@H](CO)[C@@H](O)[C@@H]1O,C38H62N4O16,28356.0
11604,?8-Tetrahydrocannabivarin,CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C19H26O2,27322.0
11605,?8-Tetrahydrocannabivarin (CRM),CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C19H26O2,38795.0
11606,?8-Tetrahydrocannabivarin (Alt. Batch CRM),CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C19H26O2,41218.0
11607,Deethylindanomycin,CC/C(=C\C=C\[C@@H]1C=C[C@@H]2CCC[C@H]2[C@@H]1C(=O)c1ccc[nH]1)[C@@H]1O[C@@H]([C@@H](C)C(=O)O)CC[C@@H]1C,C29H39NO4,28089.0
11608,Atovaquone-d4,[2H]c1c([2H])c([2H])c2c(c1[2H])C(=O)C(O)=C([C@H]1CC[C@H](c3ccc(Cl)cc3)CC1)C2=O,C22H19ClO3,28491.0
11609,Sufugolix,CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)Cc2ccccc2)c(=O)n(-c2ccccc2)c(=O)n3Cc2c(F)cccc2F)cc1,C36H31F2N5O4S,27996.0
11610,Bacopasaponin C,CC(C)=C[C@@H]1CO[C@]23C[C@]4(CO2)[C@H](CC[C@@H]2[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](CO)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]24C)[C@H]3[C@@]1(C)O,C46H74O17,11820.0
11611,K252d,C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)[C@H](O)[C@H](O)[C@H]1O,C26H23N3O5,28469.0
11612,Lupulone,CC(C)=CCC1=C(O)C(C(=O)CC(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O,C26H38O4,28481.0
11613,Ivacaftor-d19,[2H]c1c(C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])c(O)cc(NC(=O)c2c[nH]c3ccccc3c2=O)c1C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H],C24H28N2O3,28539.0
11614,Florfenicol-d3,[2H]C([2H])([2H])S(=O)(=O)c1ccc([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)cc1,C12H14Cl2FNO4S,28538.0
11615,GLS1 Inhibitor,CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(c3cccnn3)C2)s1)c1ccccc1,C19H21N7O2S,28581.0
11616,N-methyl meta-methyl Phenyl fentanyl,Cc1cccc(N(C(=O)c2ccccc2)C2CCN(C)CC2)c1,C20H24N2O,28076.0
11617,Bacopaside II,CC(C)=C[C@@H]1CO[C@]23C[C@]4(CO2)[C@H](CC[C@@H]2[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](CO)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]24C)[C@H]3[C@@]1(C)O,C47H76O18,11822.0
11618,SGC3027,CC1=C(C)C(=O)C(C(C)(C)CC(=O)N(CCCCSC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)Cc2cccc(-c3ccc(Cl)cc3)c2)=C(C)C1=O,C41H47ClN6O6S,25325.0
11619,PHA-680632,CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1,C28H35N7O2,28381.0
11620,Tamsulosin-d4 (hydrochloride),Cl.[2H]C([2H])(N[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1)C([2H])([2H])Oc1ccccc1OCC,C20H29ClN2O5S,28486.0
11621,Clonidine-d4 (hydrochloride),Cl.[2H]C1([2H])N=C(Nc2c(Cl)cccc2Cl)NC1([2H])[2H],C9H10Cl3N3,28519.0
11622,MDMB-4en-PICA,C=CCCCn1cc(C(=O)N[C@H](C(=O)OC)C(C)(C)C)c2ccccc21,C21H28N2O3,28541.0
11623,1-Myristoyl-2-Oleoyl-3-Docosanoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC,C57H108O6,27382.0
11624,Thiorphan-d5,[2H]c1c([2H])c([2H])c(CC(CS)C(=O)NCC(=O)O)c([2H])c1[2H],C12H15NO3S,28692.0
11625,1-Hydroxyphenazine,Oc1cccc2nc3ccccc3nc12,C12H8N2O,28064.0
11626,Cerebroside C,CCCCCCCCCCCCCC/C=C/[C@@H](O)C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CC/C=C(\C)CCCCCCCCC,C43H79NO9,28590.0
11627,10-Methyldodec-2-en-4-olide,CCC(C)CCCCCC1C=CC(=O)O1,C13H22O2,28407.0
11628,Artemether-d3,[2H]C([2H])([2H])O[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,C16H26O5,28517.0
11629,Norfloxacin-d5,[2H]C([2H])([2H])C([2H])([2H])n1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,C16H18FN3O3,28521.0
11630,Tryptophol,OCCc1c[nH]c2ccccc12,C10H11NO,28404.0
11631,HAMNO,O=C1C=Cc2ccccc2/C1=C/Nc1ccccc1O,C17H13NO2,27631.0
11632,Streptogramin B,CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O,C45H54N8O10,28086.0
11633,Fraxin,COc1cc2ccc(=O)oc2c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c1O,C16H18O10,28217.0
11634,Bentazepam,O=C1CN=C(c2ccccc2)c2c(sc3c2CCCC3)N1,C17H16N2OS,27748.0
11635,Glecaprevir,CC(C)(C)[C@@H]1NC(=O)O[C@@H]2CCC[C@H]2OC/C=C/C(F)(F)c2nc3ccccc3nc2O[C@@H]2C[C@@H](C(=O)N[C@]3(C(=O)NS(=O)(=O)C4(C)CC4)C[C@H]3C(F)F)N(C2)C1=O,C38H46F4N6O9S,27934.0
11636,?8-THCA-A,CCCCCc1cc2c(c(O)c1C(=O)O)[C@@H]1CC(C)=CC[C@H]1C(C)(C)O2,C22H30O4,25271.0
11637,?8-THCA-A (exempt preparation),CCCCCc1cc2c(c(O)c1C(=O)O)[C@@H]1CC(C)=CC[C@H]1C(C)(C)O2,C22H30O4,35277.0
11638,?8-THCA-A (CRM),CCCCCc1cc2c(c(O)c1C(=O)O)[C@@H]1CC(C)=CC[C@H]1C(C)(C)O2,C22H30O4,28621.0
11639,"1,2-Dielaidoyl-3-Linoleoyl-rac-glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C/CCCCCCCC)OC(=O)CCCCCCC/C=C/CCCCCCCC,C57H102O6,27381.0
11640,Corticosterone-d8,[2H]C1=C2C([2H])([2H])C[C@@H]3[C@H]([C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4([2H])C(=O)C([2H])([2H])O)[C@@]2(C)CC([2H])([2H])C1=O,C21H30O4,28524.0
11641,Nitisinone-13C6,O=C(c1ccc(C(F)(F)F)cc1[N+](=O)[O-])[13CH]1[13C](=O)[13CH2][13CH2][13CH2][13C]1=O,C14H10F3NO5,28770.0
11642,Dihydromethysticin,COC1=CC(=O)O[C@@H](CCc2ccc3c(c2)OCO3)C1,C15H16O5,27644.0
11643,Dihydromethysticin (CRM),COC1=CC(=O)O[C@@H](CCc2ccc3c(c2)OCO3)C1,C15H16O5,41212.0
11644,Valdecoxib-d3,[2H]C([2H])([2H])c1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,C16H14N2O3S,28699.0
11645,Ketotifen-13C-d3,[2H][13C]([2H])([2H])N1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,C19H19NOS,28802.0
11646,INF39,C=C(Cc1ccccc1Cl)C(=O)OCC,C12H13ClO2,28476.0
11647,"1,2-Dipalmitoyl-3-Linoleoyl-rac-glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C53H98O6,27160.0
11648,1-Stearoyl-d35-2-hydroxy-sn-glycero-3-PC,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C26H54NO7P,28230.0
11649,BI-671800,CN(C)c1nc(Cc2ccc(NC(=O)c3ccc(C(F)(F)F)cc3)cc2)nc(N(C)C)c1CC(=O)O,C25H26F3N5O3,27638.0
11650,"1,3-Dipalmitoleoyl-2-11(Z)-Octadecenoyl Glycerol",CCCCCC/C=C\CCCCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCC)COC(=O)CCCCCCC/C=C\CCCCCC,C53H96O6,27380.0
11651,Amodiaquine-d10,[2H]C([2H])([2H])C([2H])([2H])N(Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O)C([2H])([2H])C([2H])([2H])[2H],C20H22ClN3O,28525.0
11652,Dasatinib N-oxide,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CC[N+]([O-])(CCO)CC2)n1,C22H26ClN7O3S,27845.0
11653,Dabrafenib-d9,[2H]C([2H])([2H])C(c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1)(C([2H])([2H])[2H])C([2H])([2H])[2H],C23H20F3N5O2S2,28797.0
11654,"1,2-Dipalmitoyl-3-Decanoyl-rac-glycerol",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C45H86O6,26933.0
11655,Iohexol-d5,[2H]C([2H])(O)C([2H])(O)C([2H])([2H])N(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,C19H26I3N3O9,28540.0
11656,AB-MECA,CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4ccc(N)cc4)ncnc32)[C@H](O)[C@@H]1O,C18H21N7O4,28415.0
11657,Piperoxan (hydrochloride),Cl.c1ccc2c(c1)OCC(CN1CCCCC1)O2,C14H20ClNO2,27629.0
11658,Cerevisterol,CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2C3=C[C@@H](O)[C@@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C28H46O3,28466.0
11659,Meropenem-d6,[2H]C([2H])([2H])N(C(=O)[C@@H]1C[C@H](SC2=C(C(=O)O)N3C(=O)[C@H]([C@@H](C)O)[C@H]3[C@H]2C)CN1)C([2H])([2H])[2H],C17H25N3O5S,28616.0
11660,Stiripentol-d9,[2H]C([2H])([2H])C(C(O)/C=C/c1ccc2c(c1)OCO2)(C([2H])([2H])[2H])C([2H])([2H])[2H],C14H18O3,28506.0
11661,1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PE,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)(O)OCCN,C21H44NO7P,27588.0
11662,Lenvatinib-d4,[2H]C1([2H])C(NC(=O)Nc2ccc(Oc3ccnc4cc(OC)c(C(N)=O)cc34)cc2Cl)C1([2H])[2H],C21H19ClN4O4,28615.0
11663,Pranlukast-d4,[2H]c1c([2H])c(C(=O)Nc2cccc3c(=O)cc(-c4nnn[nH]4)oc23)c([2H])c([2H])c1OCCCCc1ccccc1,C27H23N5O4,28709.0
11664,Prostaglandin D Synthase (hematopoietic-type) Inhibitor F092,O=C(Nc1ccc(N2CCCC2=O)cc1)c1cnc(-c2ccccn2)nc1,C20H17N5O2,28721.0
11665,6-Prenylindole,CC(C)=CCc1ccc2cc[nH]c2c1,C13H15N,28465.0
11666,Selank (acetate),CC(=O)O.C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,C35H61N11O11,27720.0
11667,Pimozide-d4,[2H]c1c([2H])c(C(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)c2ccc(F)cc2)c([2H])c([2H])c1F,C28H29F2N3O,28617.0
11668,MLS-1547,Oc1c(CN2CCN(c3ccccn3)CC2)cc(Cl)c2cccnc12,C19H19ClN4O,27648.0
11669,GR113808,Cn1cc(C(=O)OCC2CCN(CCNS(C)(=O)=O)CC2)c2ccccc21,C19H27N3O4S,28733.0
11670,"8(R),11(S)-DiHODE",CCCCC/C=C\[C@H](O)/C=C\[C@H](O)CCCCCCC(=O)O,C18H32O4,28584.0
11671,Nilutamide-d6,[2H]C([2H])([2H])C1(C([2H])([2H])[2H])NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,C12H10F3N3O4,28694.0
11672,Nitroxoline,O=[N+]([O-])c1ccc(O)c2ncccc12,C9H6N2O3,28391.0
11673,Chlamydocin,CC1(C)NC(=O)[C@H](CCCCCC(=O)[C@@H]2CO2)NC(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O,C28H38N4O6,28468.0
11674,Bezafibrate-d4,[2H]c1c([2H])c(C(=O)NCCc2ccc(OC(C)(C)C(=O)O)cc2)c([2H])c([2H])c1Cl,C19H20ClNO4,28526.0
11675,Sulfamethoxazole-d4,[2H]c1c([2H])c(S(=O)(=O)Nc2cc(C)on2)c([2H])c([2H])c1N,C10H11N3O3S,28618.0
11676,GSK2190915,CCOc1ccc(-c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4cc(OCc5ccc(C)cn5)ccc43)cc2)cn1,C38H43N3O4S,28600.0
11677,Gliovirin,COc1ccc([C@H]2SS[C@@]34C[C@]56O[C@H]5C=C[C@@H](O)[C@@H]6ON3C(=O)[C@@H]2NC4=O)c(O)c1OC,C20H20N2O8S2,28583.0
11678,"1,2-Dilinoleoyl-3-?-Linolenoyl-rac-glycerol",CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C57H96O6,27286.0
11679,Adefovir dipivoxil,CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C,C20H32N5O8P,28373.0
11680,"1,3-Dioleoyl-2-Lignoceroyl-rac-glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCCCC,C63H118O6,27384.0
11681,1-Linoleoyl-3-?-Linolenoyl-rac-glycerol,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C39H66O5,26829.0
11682,Vorasidenib,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,C14H13ClF6N6,28462.0
11683,ZLD1039,CCN(c1cc(-c2ccc(N3CCN(C)CC3)nc2)cc(C(=O)NCc2c3c(c(C)[nH]c2=O)CCCC3)c1C)C1CCOCC1,C36H48N6O3,19218.0
11684,Sulforhodamine 101 Sulfonyl Chloride,O=S(=O)([O-])c1cc(S(=O)(=O)Cl)ccc1-c1c2cc3c4c(c2[o+]c2c5c6c(cc12)CCCN6CCC5)CCCN4CCC3.O=S(=O)([O-])c1ccc(-c2c3cc4c5c(c3[o+]c3c6c7c(cc23)CCCN7CCC6)CCCN5CCC4)c(S(=O)(=O)Cl)c1,C62H58Cl2N4O12S4,28547.0
11685,Milbemycin A3 oxime,CC1=C[C@H]2C(=O)O[C@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C4\CO[C@H](/C1=N/O)[C@@]42O)O[C@@]1(CC[C@H](C)[C@@H](C)O1)C3,C31H43NO7,27967.0
11686,BMS 813160,CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O,C25H40N8O2,28421.0
11687,Bromadiolone,O=c1oc2ccccc2c(O)c1C(CC(O)c1ccc(-c2ccc(Br)cc2)cc1)c1ccccc1,C30H23BrO4,26854.0
11688,Aceclofenac,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,C16H13Cl2NO4,28620.0
11689,"1,2-Dielaidoyl-3-Stearoyl-rac-glycerol",CCCCCCCC/C=C/CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C/CCCCCCCC,C57H106O6,26934.0
11690,AZD 3839,NC1=N[C@@](c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21,C24H16F3N5,28388.0
11691,HLM006474,CCOc1ccc(C(Nc2ccccn2)c2ccc3ccc(C)nc3c2O)cc1C,C25H25N3O2,28276.0
11692,Sodium Ionophore VI,CCCCCCCCCCCCC(C)(C(=O)OCC1COCCOCCOCCO1)C(=O)OCC1COCCOCCOCCO1,C34H62O12,27754.0
11693,INCB 3344,CCO[C@H]1CN([C@H]2CC[C@@](O)(c3ccc4c(c3)OCO4)CC2)C[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,C29H34F3N3O6,28433.0
11694,D-Kynurenine,Nc1ccccc1C(=O)C[C@@H](N)C(=O)O,C10H12N2O3,28254.0
11695,GW 311616A,CC(C)[C@@H]1C(=O)N(S(C)(=O)=O)[C@@H]2CCN(C(=O)/C=C/CN3CCCCC3)[C@H]21.Cl,C19H32ClN3O4S,27957.0
11696,Quercetin 3-O-sophoroside,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,C27H30O17,28592.0
11697,Lomitapide-d8,[2H]C([2H])(N1CCC(NC(=O)c2ccccc2-c2ccc(C(F)(F)F)cc2)CC1)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1(C(=O)NCC(F)(F)F)c2ccccc2-c2ccccc21,C39H37F6N3O2,28764.0
11698,Procaterol (hydrochloride),CC[C@@H](NC(C)C)[C@@H](O)c1ccc(O)c2[nH]c(=O)ccc12.Cl,C16H23ClN2O3,28479.0
11699,Loganic Acid,C[C@@H]1[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C(C(=O)O)[C@H]2C[C@@H]1O,C16H24O10,28402.0
11700,Artesunate-d4,[2H]C([2H])(C(=O)O)C([2H])([2H])C(=O)O[C@@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,C19H28O8,28769.0
11701,Hexanoic Acid-d3,[2H]C([2H])([2H])CCCCC(=O)O,C6H12O2,28497.0
11702,Macitentan-d4,[2H]C([2H])(Oc1ncc(Br)cn1)C([2H])([2H])Oc1ncnc(NS(=O)(=O)NCCC)c1-c1ccc(Br)cc1,C19H20Br2N6O4S,28522.0
11703,NI-42,Cc1cc2cc(NS(=O)(=O)c3ccc(C#N)cc3)ccc2n(C)c1=O,C18H15N3O3S,28293.0
11704,PNU 100480,CC(=O)NC[C@H]1CN(c2ccc(N3CCSCC3)c(F)c2)C(=O)O1,C16H20FN3O3S,28395.0
11705,Demethylzeylasteral,C[C@@]1(C(=O)O)CC[C@]2(C)CC[C@]3(C)C4=CC(=O)c5c(cc(O)c(O)c5C=O)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,C29H36O6,28595.0
11706,Pirarubicin,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O[C@@H]2CCCCO2)[C@H](C)O1,C32H37NO12,28384.0
11707,4'-Demethylepipodophyllotoxin,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,C21H20O8,28393.0
11708,Deferiprone-d3,[2H]C([2H])([2H])n1ccc(=O)c(O)c1C,C7H9NO2,28702.0
11709,Aristolochic Acid C,O=C(O)c1cc2c(c3c1c([N+](=O)[O-])cc1ccc(O)cc13)OCO2,C16H9NO7,28505.0
11710,A286982,CC(=O)N1CCN(C(=O)/C=C/c2ccc(Sc3ccccc3C(C)C)c([N+](=O)[O-])c2)CC1,C24H27N3O4S,27646.0
11711,"meso-2,3-Dimercaptosuccinic Acid",O=C(O)[C@@H](S)[C@@H](S)C(=O)O,C4H6O4S2,28515.0
11712,LUF6000,Clc1ccc(Nc2nc3ccccc3c3[nH]c(C4CCCCC4)nc23)cc1Cl,C22H20Cl2N4,28437.0
11713,N-desmethyl Ivabradine (hydrochloride),COc1cc2c(cc1OC)CC(=O)N(CCCNC[C@H]1Cc3cc(OC)c(OC)cc31)CC2.Cl,C26H35ClN2O5,27808.0
11714,"1,2,3-Tri-10(Z)-Undecenoyl Glycerol",C=CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC=C)OC(=O)CCCCCCCCC=C,C36H62O6,26935.0
11715,2-Phenylaminoadenosine,Nc1nc(Nc2ccccc2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C16H18N6O4,28734.0
11716,Ceritinib-d7,[2H]C([2H])([2H])C([2H])(Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)C([2H])([2H])[2H],C28H36ClN5O3S,28768.0
11717,BMDB (hydrochloride),CCC(NCc1ccccc1)C(=O)c1ccc2c(c1)OCO2.Cl,C18H20ClNO3,24062.0
11718,1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PC,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C24H50NO7P,28153.0
11719,"Zonisamide-13C2,15N",[15NH2]S(=O)(=O)[13CH2][13c]1noc2ccccc21,C8H8N2O3S,28807.0
11720,HPA-12,CCCCCCCCCCCC(=O)N[C@@H](CO)C[C@H](O)c1ccccc1,C22H37NO3,28350.0
11721,Phenethyl 4-ANPP,c1ccc(CCN2CCC(N(CCc3ccccc3)c3ccccc3)CC2)cc1,C27H32N2,28386.0
11722,BMS 779788,CC(C)(O)c1cn(-c2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)c(C(C)(C)c2ccccc2Cl)n1,C28H29ClN2O3S,27339.0
11723,Aztreonam-d6,[2H]C([2H])([2H])C(O/N=C(\C(=O)N[C@@H]1C(=O)N(S(=O)(=O)O)[C@H]1C)c1csc(N)n1)(C(=O)O)C([2H])([2H])[2H],C13H17N5O8S2,28799.0
11724,"1,2,3-Trinervonoyl Glycerol",CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC,C75H140O6,26927.0
11725,C16 Sphingomyelin-d9 (d18:1/16:0-d9),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)N[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)[C@H](O)/C=C/CCCCCCCCCCCCC,C39H79N2O6P,27551.0
11726,Amenamevir,Cc1cccc(C)c1N(CC(=O)Nc1ccc(-c2ncon2)cc1)C(=O)C1CCS(=O)(=O)CC1,C24H26N4O5S,27921.0
11727,Derazantinib,COCCNCCc1cccc(Nc2ncc3c(n2)-c2ccccc2[C@H](c2ccccc2F)C3)c1,C29H29FN4O,27636.0
11728,"9,10-Dihydroxystearic Acid",CCCCCCCCC(O)C(O)CCCCCCCC(=O)O,C18H36O4,28612.0
11729,Tolcapone-d4,[2H]c1c([2H])c(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)c([2H])c([2H])c1C,C14H11NO5,28697.0
11730,Gefitinib-based PROTAC 3,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCOCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,C47H57ClFN7O8S,28597.0
11731,Hypocrellin B,COc1c2c3c4c(c(OC)c(=O)c5c(O)cc(OC)c(c6c(OC)cc(O)c(c1=O)c63)c54)C(C(C)=O)=C(C)C2,C30H24O9,28544.0
11732,Geniposidic Acid,O=C(O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2C(CO)=CC[C@H]12,C16H22O10,28409.0
11733,N6-Cyclohexyladenosine,OC[C@H]1O[C@@H](n2cnc3c(NC4CCCCC4)ncnc32)[C@H](O)[C@@H]1O,C16H23N5O4,28427.0
11734,17?-methyl-1-Testosterone,C[C@]12C=CC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H30O2,24537.0
11735,Pentadecanoic Acid-d3,[2H]C([2H])([2H])CCCCCCCCCCCCCC(=O)O,C15H30O2,28596.0
11736,Indacaterol-d3,[2H]C([2H])([2H])Cc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,C24H28N2O3,28886.0
11737,Carboxyamidotriazole,NC(=O)c1nnn(Cc2cc(Cl)c(C(=O)c3ccc(Cl)cc3)c(Cl)c2)c1N,C17H12Cl3N5O2,28732.0
11738,Ethacrynic Acid-d5,[2H]C([2H])([2H])C([2H])([2H])C(=C)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,C13H12Cl2O4,28537.0
11739,Peonidin 3-O-glucoside (chloride),COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)ccc1O.[Cl-],C22H23ClO11,28743.0
11740,GW843682X,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,C22H18F3N3O4S,28759.0
11741,Dieugenol,C=CCc1cc(OC)c(O)c(-c2cc(CC=C)cc(OC)c2O)c1,C20H22O4,27557.0
11742,Ponatinib-d8,[2H]C1([2H])N(C)C([2H])([2H])C([2H])([2H])N(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5cccnn45)c3)cc2C(F)(F)F)C1([2H])[2H],C29H27F3N6O,28905.0
11743,"1,2,3-Tritricosanoyl Glycerol",CCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCCC,C72H140O6,26929.0
11744,Quinidine-d3,[2H]C([2H])([2H])Oc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CC[N@@]3C[C@@H]4C=C)c2c1,C20H24N2O2,28884.0
11745,STX140,COc1cc2c(cc1OS(N)(=O)=O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OS(N)(=O)=O)CC[C@@H]12,C19H28N2O7S2,27863.0
11746,4-fluoro MDMB-BUTINACA 2'-isomer butanoic acid metabolite,CC(C)(C)[C@H](NC(=O)c1c2ccccc2nn1CCCCF)C(=O)O,C18H24FN3O3,28964.0
11747,IMR-1,CCOC(=O)COc1ccc(/C=C2/SC(=S)NC2=O)cc1OC,C15H15NO5S2,27920.0
11748,IDO-IN-3,NCCNc1nonc1/C(=N\c1ccc(F)c(Br)c1)NO,C11H12BrFN6O2,28432.0
11749,GW 766994,NC(=O)c1ccc(CNC(=O)NC[C@H]2CN(Cc3ccc(Cl)c(Cl)c3)CCO2)cc1,C21H24Cl2N4O3,28431.0
11750,Bromperidol,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,C21H23BrFNO2,26026.0
11751,BODIPY 503/512,CC1=CC(C)=[N+]2C1=Cc1ccc(CCC(=O)O)n1[B-]2(F)F,C14H15BF2N2O2,28800.0
11752,"1,3-Dioleoyl-2-Lauroyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCC,C51H94O6,27287.0
11753,"1,2-Distearoyl-3-Docosanoyl-rac-glycerol",CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC,C61H118O6,27288.0
11754,"Tranexamic Acid-13C2,15N",[15NH2][13CH2][C@H]1CC[C@H]([13C](=O)O)CC1,C8H15NO2,28804.0
11755,Palmitic Acid-13C (C1 labeled),CCCCCCCCCCCCCCC[13C](=O)O,C16H32O2,28749.0
11756,SR 27897,O=C(O)Cn1c(C(=O)Nc2nc(-c3ccccc3Cl)cs2)cc2ccccc21,C20H14ClN3O3S,28511.0
11757,"1,3-Diarachidonoyl Glycerol",CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(O)COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC,C43H68O5,26936.0
11758,Diarachidonin,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(O)COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC,C43H68O5,26928.0
11759,Abarelix (acetate),CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O.CC(=O)O,C74H99ClN14O16,28746.0
11760,BAY-545,CCn1c(=O)c2c(C)c(C(=O)N3CCC(O)CC3)sc2n(CCC(F)(F)F)c1=O,C18H22F3N3O4S,28420.0
11761,Cefradine,CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1,C16H19N3O4S,26060.0
11762,Cintirorgon,CC(C)(C[C@H]1CN(S(=O)(=O)c2cccc(C(F)(F)F)c2)c2cc(-c3cc(F)cc(OC(F)F)c3)ccc2O1)C(=O)O,C27H23F6NO6S,28425.0
11763,Cyproheptadine-d3,[2H]C([2H])([2H])N1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,C21H21N,29023.0
11764,"1,3-Dinervonoyl Glycerol",CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC,C51H96O5,26937.0
11765,Phomalactone,C/C=C/[C@@H]1OC(=O)C=C[C@@H]1O,C8H10O3,28854.0
11766,PF-04995274,OC1(CN2CCC(COc3noc4cccc(O[C@@H]5CCOC5)c34)CC2)CCOCC1,C23H32N2O6,28776.0
11767,PF-4840154,CC(C)CNc1nc(N2CCN(CC3CCCOC3)CC2)ncc1C(=O)NCc1ccccc1,C26H38N6O2,28915.0
11768,Lumiracoxib,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,C15H13ClFNO2,27645.0
11769,TMCB,CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2n1CC(=O)O,C11H9Br4N3O2,27652.0
11770,Gymnemic Acid I,C/C=C(\C)C(=O)O[C@H]1[C@H](O)[C@]2(COC(C)=O)[C@@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2CC1(C)C,C43H66O14,28495.0
11771,"1,3-Di-11(Z),14(Z),17(Z)-Eicosatrienoyl Glycerol",CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC,C43H72O5,26938.0
11772,4-Anilino-1-Boc-piperidine,CC(C)(C)OC(=O)N1CCC(Nc2ccccc2)CC1,C16H24N2O2,29119.0
11773,Gly-Arg-AMC (hydrochloride),Cc1cc(=O)oc2cc(NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)ccc12,C18H24N6O4,27580.0
11774,Decanoic Acid-d3,[2H]C([2H])([2H])CCCCCCCCC(=O)O,C10H20O2,28516.0
11775,Pironetin,C/C=C/C[C@H](C)[C@@H](OC)[C@@H](C)[C@H](O)C[C@H]1OC(=O)C=C[C@H]1CC,C19H32O4,28853.0
11776,N-(p-Tosyl)-GPR-pNA (acetate),CC(=O)O.Cc1ccc(S(=O)(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc2ccc([N+](=O)[O-])cc2)cc1,C28H38N8O9S,27568.0
11777,GKK1032B,C=C[C@@]1(C)C=C(C)[C@@H]2[C@@H]3[C@H](Oc4ccc(cc4)C[C@@H]4C(=O)NC(=O)[C@H]4C(=O)[C@H]31)[C@@H]1[C@@H](C)C[C@@H](C)C[C@]12C,C32H39NO4,28855.0
11778,1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC,CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC,C40H80NO7P,28348.0
11779,ASK1 Inhibitor 10,CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1.Cl.Cl,C21H23Cl2N5O,28512.0
11780,TP-238 (hydrochloride),CN(C)CCCOc1ccc(-c2cc(NCCCn3cccn3)nc(S(C)(=O)=O)n2)cc1.Cl,C22H31ClN6O3S,27254.0
11781,LH1306,COc1nc(OCc2cccc(-c3cccc(COc4ccc(CNCCNC(C)=O)c(OC)n4)c3C)c2C)ccc1CNCCNC(C)=O,C38H48N6O6,28727.0
11782,Troglitazone-d4,[2H]c1c([2H])c(OCC2(C)CCc3c(C)c(O)c(C)c(C)c3O2)c([2H])c([2H])c1CC1SC(=O)NC1=O,C24H27NO5S,28908.0
11783,Etravirine-d6,[2H]C([2H])([2H])c1cc(C#N)cc(C([2H])([2H])[2H])c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,C20H15BrN6O,28902.0
11784,Pulchinenoside A,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]12,C41H66O12,28545.0
11785,Ibudilast-d7,[2H]C([2H])([2H])C([2H])(C(=O)c1c(C(C)C)nn2ccccc12)C([2H])([2H])[2H],C14H18N2O,28876.0
11786,SAR131675,CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#C[C@@](C)(O)COC)nc21,C18H22N4O4,28385.0
11787,KT185,O=C(c1cccc(-c2ccc(-c3cn(C(=O)N4CCCCC4c4ccccc4)nn3)cc2)c1)N1CCCCC1,C32H33N5O2,19113.0
11788,MDMB-BUTINACA,CCCCn1nc(C(=O)N[C@H](C(=O)OC)C(C)(C)C)c2ccccc21,C19H27N3O3,28739.0
11789,TAK-220,CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(C)c(Cl)c2)CC1,C31H41ClN4O3,28448.0
11790,D-Pro-Phe-Arg-pNA (hydrochloride),Cl.Cl.N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCCN1)C(=O)Nc1ccc([N+](=O)[O-])cc1,C26H36Cl2N8O5,27569.0
11791,Bz-Nle-KRR-AMC (hydrochloride),CCCC[C@H](NC(=O)c1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc2c(C)cc(=O)oc2c1.Cl,C41H60N12O7(ClH)X,27710.0
11792,Z-D-Arg-Gly-Arg-pNA (hydrochloride),Cl.Cl.N=C(N)NCCC[C@H](NC(=O)CNC(=O)[C@@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1,C28H41Cl2N11O7,27583.0
11793,5-fluoro ADB 2'-indazole isomer,COC(=O)[C@@H](NC(=O)c1c2ccccc2nn1CCCCCF)C(C)(C)C,C20H28FN3O3,28962.0
11794,5-fluoro ADB 2'-indazole isomer butanoic acid metabolite,CC(C)(C)[C@H](NC(=O)c1c2ccccc2nn1CCCCCF)C(=O)O,C19H26FN3O3,28963.0
11795,3-hydroxy Heptadecanoic Acid,CCCCCCCCCCCCCCC(O)CC(=O)O,C17H34O3,28735.0
11796,5-fluoro MDMB-7-PAICA butanoic acid metabolite,CC(C)(C)[C@H](NC(=O)c1cn(CCCCCF)c2ncccc12)C(=O)O,C19H26FN3O3,28693.0
11797,Cimetidine-d3,[2H]C([2H])([2H])N/C(=N\CCSCc1nc[nH]c1C)NC#N,C10H16N6S,29050.0
11798,Prazosin-d8,[2H]C1([2H])N(C(=O)c2ccco2)C([2H])([2H])C([2H])([2H])N(c2nc(N)c3cc(OC)c(OC)cc3n2)C1([2H])[2H],C19H21N5O4,29094.0
11799,5-fluoro MDMB-PICA metabolite 4,CC(C)(C)[C@H](NC(=O)c1cn(CCCC(O)CF)c2ccccc12)C(=O)O,C20H27FN2O4,22395.0
11800,N-Oleoyl-L-phenylalanine,CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](Cc1ccccc1)C(=O)O,C27H43NO3,28921.0
11801,Levofloxacin-d8 (hydrochloride),Cl.[2H]C1([2H])N(C)C([2H])([2H])C([2H])([2H])N(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2OC[C@@H]4C)C1([2H])[2H],C18H21ClFN3O4,29080.0
11802,Capadenoson,N#Cc1c(N)nc(SCc2csc(-c3ccc(Cl)cc3)n2)c(C#N)c1-c1ccc(OCCO)cc1,C25H18ClN5O2S2,28422.0
11803,"1,2-Dioleoyl-3-?-Linolenoyl-rac-glycerol",CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C57H100O6,27378.0
11804,LSM-775 (maleate) (solution),CN1C[C@H](C(=O)N2CCOCC2)C=C2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)/C=C\C(=O)O,C24H27N3O6,28579.0
11805,1-Stearoyl-2-Palmitoyl-3-Oleoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C55H104O6,27290.0
11806,(+)-Abscisic Acid-d6,[2H]C1=C(C([2H])([2H])[2H])[C@](O)(/C=C/C(C)=C\C(=O)O)C(C)(C)C([2H])([2H])C1=O,C15H20O4,29093.0
11807,"1,2-Distearoyl-3-Linoleoyl-rac-glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC,C57H106O6,28179.0
11808,Cortexolone 17?-propionate,CCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,C24H34O5,28392.0
11809,OUL35,NC(=O)c1ccc(Oc2ccc(C(N)=O)cc2)cc1,C14H12N2O3,28845.0
11810,Eledoisin,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCC(=O)N1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O,C54H85N13O15S,28810.0
11811,Trametinib-13C-d3,[2H][13C]([2H])([2H])c1c(=O)n(C)c(Nc2ccc(I)cc2F)c2c(=O)n(C3CC3)c(=O)n(-c3cccc(NC(C)=O)c3)c12,C26H23FIN5O4,29144.0
11812,LM22B-10,OCCN(CCO)c1ccc(C(c2ccc(Cl)cc2)c2ccc(N(CCO)CCO)cc2)cc1,C27H33ClN2O4,29037.0
11813,AZD 1283,CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C,C23H26N4O5S,27649.0
11814,Genz-123346,CCCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2,C24H38N2O4,28500.0
11815,Dehydroascorbic Acid,O=C1O[C@H]([C@@H](O)CO)C(=O)C1=O,C6H6O6,29089.0
11816,Digalactosyldiacylglyceride (hydrogenated) (plant),CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CO[C@@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCCCC,C51H96O15,27373.0
11817,ABT-639,O=C(c1cc(S(=O)(=O)Nc2ccccc2F)c(F)cc1Cl)N1CCN2CCC[C@@H]2C1,C20H20ClF2N3O3S,28742.0
11818,Neohesperidin dihydrochalcone,COc1ccc(CCC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3OC3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)cc2O)cc1O,C28H36O15,28510.0
11819,Pentanoic Acid-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C5H10O2,28870.0
11820,Tenuigenin,CC1(C)CC[C@]2(C(=O)O)CCC3=C([C@@H](CCl)C[C@@H]4[C@@]5(C)C[C@H](O)[C@H](O)[C@@](C)(C(=O)O)[C@@H]5CC[C@@]34C)[C@@H]2C1,C30H45ClO6,28824.0
11821,Dihexanoin,CCCCCC(=O)OCC(O)COC(=O)CCCCC,C15H28O5,27293.0
11822,"1,2-Dioleoyl-3-Lauroyl-rac-glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C51H94O6,28548.0
11823,"1,2-Dipalmitoyl-3-Linoelaidoyl-rac-glycerol",CCCCC/C=C/C/C=C/CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C53H98O6,27292.0
11824,Deacetylanisomycin,COc1ccc(C[C@H]2NC[C@H](O)[C@H]2O)cc1,C12H17NO3,28067.0
11825,Steffimycin B,COc1cc(O)c2c(c1)C(=O)c1cc3c(c(O)c1C2=O)[C@@H](O[C@@H]1O[C@@H](C)[C@H](OC)[C@@H](O)[C@H]1OC)[C@H](OC)[C@](C)(O)C3=O,C29H32O13,28087.0
11826,Leucomycin A13,CCCCCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@H]2[C@H](N(C)C)[C@@H](O)[C@H](O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]3OC)O[C@@H]2C)C[C@@]1(C)O,C41H69NO14,28121.0
11827,CMS121,Oc1ccc(-c2cc(OC3CCCC3)c3ccccc3n2)cc1O,C20H19NO3,27085.0
11828,D-Glucosamine (hydrochloride),Cl.N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO,C6H14ClNO5,27055.0
11829,ABTS (ammonium salt),CCn1/c(=N/N=c2\sc3cc(S(=O)(=O)[O-])ccc3n2CC)sc2cc(S(=O)(=O)[O-])ccc21.[NH4+].[NH4+],C18H24N6O6S4,27317.0
11830,"1,2-Didocosanoyl-3-Myristoyl-rac-glycerol",CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC,C61H118O6,27277.0
11831,Captopril Disulfide,C[C@H](CSSC[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N1CCC[C@H]1C(=O)O,C18H28N2O6S2,28018.0
11832,Zelkovamycin,C/C=C1\NC(=O)C(CC)NC(=O)CNC(=O)C(C)(C(C)=O)NC(=O)C(Cc2c[nH]c3c(OC)cccc23)NC(=O)c2csc(n2)C(C)NC(=O)CN(C)C1=O,C36H45N9O9S,27753.0
11833,para-Bromofentanyl,CCC(=O)N(c1ccc(Br)cc1)C1CCN(CCc2ccccc2)CC1,C22H27BrN2O,27536.0
11834,Scopolamine N-butyl (bromide),CCCC[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12.[Br-],C21H30BrNO4,27223.0
11835,MI-3,CC(C)c1cc2c(N3CCN(C4=NCC(C)(C)S4)CC3)ncnc2s1,C18H25N5S2,27214.0
11836,Erythromycylamine,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](N)[C@H](C)[C@@H](O)[C@]1(C)O,C37H70N2O12,28098.0
11837,SU 5205,O=C1Nc2ccccc2/C1=C/c1ccc(F)cc1,C15H10FNO,27310.0
11838,Myricetrin,C[C@@H]1O[C@@H](Oc2c(-c3cc(O)c(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O,C21H20O12,26902.0
11839,Terlipressin (acetate),CC(=O)O.NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,C54H78N16O17S2,27027.0
11840,Nonanoic Acid methyl ester,CCCCCCCCC(=O)OC,C10H20O2,26719.0
11841,Kazusamycin B,CC(=C/C(C)C/C=C/C(C)=C/C(CO)C(=O)C(C)C(O)C(C)C/C(C)=C/C(=O)O)/C=C/C1OC(=O)C=CC1C,C32H46O7,28119.0
11842,Eprinomectin B1a,CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@H](NC(C)=O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C50H75NO14,28130.0
11843,Eprinomectin B1b,CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@H]1NC(C)=O,C49H73NO14,27994.0
11844,"1,2,3-Triheptanoyl Glycerol",CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,C24H44O6,28174.0
11845,Palovarotene,CC1(C)CCC(C)(C)c2cc(Cn3cccn3)c(/C=C/c3ccc(C(=O)O)cc3)cc21,C27H30N2O2,28460.0
11846,N6-Ethyladenosine,CCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C12H17N5O4,28428.0
11847,LY404187,CC(CNS(=O)(=O)C(C)C)c1ccc(-c2ccc(C#N)cc2)cc1,C19H22N2O2S,28741.0
11848,AZD 7648,Cc1cc2ncnn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C,C18H20N8O2,28598.0
11849,NSC 207895,CN1CCN(c2ccc([N+](=O)[O-])c3no[n+]([O-])c23)CC1,C11H13N5O4,27949.0
11850,AS1517499,NC(=O)c1cnc(NCCc2ccc(O)c(Cl)c2)nc1NCc1ccccc1,C20H20ClN5O2,29071.0
11851,Obafluorin,O=C(N[C@@H]1C(=O)O[C@@H]1Cc1ccc([N+](=O)[O-])cc1)c1cccc(O)c1O,C17H14N2O7,25731.0
11852,Bergapten,COc1c2ccoc2cc2oc(=O)ccc12,C12H8O4,26254.0
11853,Ginsenoside Rh1,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C,C36H62O9,27318.0
11854,Altrenogest,C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,C21H26O2,27218.0
11855,Sumatriptan-d6 (succinate),O=C(O)CCC(=O)O.[2H]C([2H])([2H])N(CCc1c[nH]c2ccc(CS(=O)(=O)NC)cc12)C([2H])([2H])[2H],C18H27N3O6S,28202.0
11856,Ceftiofur (hydrochloride),CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSC(=O)c3ccco3)CS[C@H]12)c1csc(N)n1.Cl,C19H18ClN5O7S3,27301.0
11857,Sotalol-d6 (hydrochloride),Cl.[2H]C([2H])([2H])C(NCC(O)c1ccc(NS(C)(=O)=O)cc1)C([2H])([2H])[2H],C12H21ClN2O3S,29097.0
11858,PD 117519,OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCc5ccccc54)ncnc32)[C@H](O)[C@@H]1O,C19H21N5O4,28444.0
11859,Anlotinib (hydrochloride),COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1.Cl,C23H23ClFN3O3,27655.0
11860,Swertiamarin,C=C[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C2C(=O)OCC[C@]21O,C16H22O10,27634.0
11861,Indole-3-propionic Acid,O=C(O)CCc1c[nH]c2ccccc12,C11H11NO2,28821.0
11862,LY2562175,Cn1cc(C(=O)O)c2ccc(N3CCC(OCc4c(-c5c(Cl)cccc5Cl)noc4C4CC4)CC3)cc21,C28H27Cl2N3O4,28912.0
11863,Balaglitazone,Cn1c(COc2ccc(CC3SC(=O)NC3=O)cc2)nc2ccccc2c1=O,C20H17N3O4S,28866.0
11864,Sulfapyridine,Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1,C11H11N3O2S,28619.0
11865,1-Palmitoyl-2-12-PAHSA-3-Oleoyl-sn-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCC(CCCCCC)OC(=O)CCCCCCCCCCCCCCC,C71H134O8,28233.0
11866,Sennoside B,O=C(O)c1cc(O)c2c(c1)[C@@H]([C@H]1c3cc(C(=O)O)cc(O)c3C(=O)c3c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cccc31)c1cccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c1C2=O,C42H38O20,28410.0
11867,TP-0903,CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1,C24H30ClN7O2S,28757.0
11868,Rubitecan,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c([N+](=O)[O-])cccc3nc2-1,C20H15N3O6,28956.0
11869,ONT-093,CCOC/C=C/c1ccc(-c2nc(-c3ccc(NC(C)C)cc3)c(-c3ccc(NC(C)C)cc3)[nH]2)cc1,C32H38N4O,28758.0
11870,Stearic Acid-13C,CCCCCCCCCCCCCCCCC[13C](=O)O,C18H36O2,28917.0
11871,Sulfamoxole,Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C,C11H13N3O3S,19537.0
11872,"L-006,235",CN1CCN(c2nc(-c3ccc(C(=O)NC4(C(=O)NCC#N)CCCCC4)cc3)cs2)CC1,C24H30N6O2S,28843.0
11873,Panaxatriol,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4[C@H](O)C[C@]23C)O1,C30H52O4,28835.0
11874,Anthralin,O=C1c2c(O)cccc2Cc2cccc(O)c21,C14H10O3,28371.0
11875,Biotin Tripeptide-1,NCCCC[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)C(=O)O,C24H38N8O6S,27153.0
11876,Caerulomycin A,COc1cc(/C=N/O)nc(-c2ccccn2)c1,C12H11N3O2,27625.0
11877,MDMB-CHMICA metabolite M2,CC(C)(C)[C@H](NC(=O)c1cn(CC2CCCCC2)c2ccccc12)C(=O)O,C22H30N2O3,19316.0
11878,Oroxylin A,COc1c(O)cc2oc(-c3ccccc3)cc(=O)c2c1O,C16H12O5,27363.0
11879,ALD-52 (solution),CCN(CC)C(=O)[C@@H]1C=C2c3cccc4c3c(cn4C(C)=O)C[C@H]2N(C)C1,C22H27N3O2,27818.0
11880,1-Lauroyl-2-Elaidoyl-3-Palmitoyl-rac-glycerol,CCCCCCCC/C=C/CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC,C49H92O6,26832.0
11881,Aurantioobtusin,COc1c(O)cc2c(c1O)C(=O)c1c(cc(C)c(O)c1OC)C2=O,C17H14O7,27481.0
11882,1-Linoleoyl-3-Palmitoyl-rac-glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCC,C37H68O5,28176.0
11883,6(5H)-Phenanthridinone,O=c1[nH]c2ccccc2c2ccccc12,C13H9NO,28730.0
11884,KDU691,CNC(=O)c1ccc(-c2cnc3cnc(C(=O)N(C)c4ccc(Cl)cc4)cn23)cc1,C22H18ClN5O2,29019.0
11885,DMH4,c1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)cc1,C24H24N4O2,27653.0
11886,Benznidazole,O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1,C12H12N4O3,29090.0
11887,2-fluoro Deschloronorketamine (hydrochloride),Cl.NC1(c2ccccc2F)CCCCC1=O,C12H15ClFNO,29118.0
11888,(-)-Nicotine,CN1CCC[C@H]1c1cccnc1,C10H14N2,29138.0
11889,PCI-29732,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCC1,C22H21N5O,29036.0
11890,Efaroxan (hydrochloride),CCC1(C2=NCCN2)Cc2ccccc2O1.Cl,C13H17ClN2O,29008.0
11891,8-Nitrotryptanthrin,O=C1c2cc([N+](=O)[O-])ccc2-n2c1nc1ccccc1c2=O,C15H7N3O4,28429.0
11892,AUT1,CC[C@H]1NC(=O)N(c2ccc(Oc3ccc(C)c(OC)c3)nc2)C1=O,C18H19N3O4,28599.0
11893,Urapidil (hydrochloride),COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1.Cl,C20H30ClN5O3,29004.0
11894,ZK 756326 (hydrochloride),Cl.Cl.OCCOCCN1CCN(Cc2cccc(Oc3ccccc3)c2)CC1,C21H30Cl2N2O3,28454.0
11895,Bufuralol-d9 (hydrochloride),Cl.[2H]C([2H])([2H])C(NCC(O)c1cc2cccc(CC)c2o1)(C([2H])([2H])[2H])C([2H])([2H])[2H],C16H24ClNO2,29081.0
11896,Octanoic Acid-d3,[2H]C([2H])([2H])CCCCCCC(=O)O,C8H16O2,28869.0
11897,BAY-1125976,NC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2n1,C23H21N5O,28913.0
11898,Hexestrol,CC[C@H](c1ccc(O)cc1)[C@@H](CC)c1ccc(O)cc1,C18H22O2,29003.0
11899,Fenbufen,O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1,C16H14O3,28851.0
11900,1-Undecanoyl-rac-glycerol,CCCCCCCCCCC(=O)OCC(O)CO,C14H28O4,28763.0
11901,MC1742,O=C(CCCCSc1nc(=O)cc(-c2ccc(-c3ccccc3)cc2)[nH]1)NO,C21H21N3O3S,29171.0
11902,AR-C 155858,Cc1n[nH]c(C)c1Cc1sc2c(c1C(=O)N1C[C@H](O)CO1)c(=O)n(C)c(=O)n2CC(C)C,C21H27N5O5S,14884.0
11903,Tiratricol,O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1,C14H9I3O4,28729.0
11904,Des(benzylpyridyl) Atazanavir,COC(=O)N[C@H](C(=O)NNC[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,C26H43N5O7,27372.0
11905,AMG-Tie2-1,CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)n1,C25H20F3N5O2,28850.0
11906,NSC 228155,O=[N+]([O-])c1ccc(Sc2cccc[n+]2[O-])c2nonc12,C11H6N4O4S,28856.0
11907,BV6,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCCCCCNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C1CCCCC1)C(c1ccccc1)c1ccccc1)C(c1ccccc1)c1ccccc1)C1CCCCC1,C70H96N10O8,28830.0
11908,6-Carboxytetramethylrhodamine,CN(C)c1ccc2c(-c3cc(C(=O)O)ccc3C(=O)[O-])c3ccc(N(C)C)cc3[o+]c2c1,C25H22N2O5,29046.0
11909,Mirodenafil (hydrochloride),CCCOc1ccc(S(=O)(=O)N2CCN(CCO)CC2)cc1-c1nc(=O)c2c([nH]1)c(CCC)cn2CC.Cl.Cl,C26H39Cl2N5O5S,29045.0
11910,Agarotetrol,O=c1cc(CCc2ccccc2)oc2c1[C@H](O)[C@@H](O)[C@@H](O)[C@@H]2O,C17H18O6,27662.0
11911,Decanoic Acid-d19,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C10H20O2,28871.0
11912,Avilamycin A,COC[C@H]1O[C@@H](OC2OC[C@@H]3O[C@]4(O[C@H]3[C@H]2OC(=O)C(C)C)O[C@H](C)[C@@](O)(C(C)=O)[C@@H]2OCO[C@H]24)[C@@H](OC)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](C)[C@H](OC)[C@H](O[C@H]2C[C@@]3(C)OC4(C[C@@H](O)[C@H](O[C@H]5C[C@@H](O)[C@H](OC(=O)c6c(C)c(Cl)c(O)c(Cl)c6OC)[C@@H](C)O5)[C@@H](C)O4)O[C@@H]3[C@@H](C)O2)[C@H]1O,C61H88Cl2O32,29135.0
11913,C6 Urea Ceramide,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)NCCCCCC,C25H50N2O3,25491.0
11914,trans-?-Viniferin,Oc1ccc(/C=C/c2cc(O)cc3c2[C@@H](c2cc(O)cc(O)c2)[C@H](c2ccc(O)cc2)O3)cc1,C28H22O6,25737.0
11915,LX2343,COc1ccc(Cl)cc1N(CC(=O)Nc1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1,C22H19ClN2O6S,27799.0
11916,4-Methyl-7-(2-nitrophenoxy)-2H-chromen-2-one,Cc1cc(=O)oc2cc(Oc3ccccc3[N+](=O)[O-])ccc12,C16H11NO5,28473.0
11917,MSDC-0602,COc1cccc(C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2)c1,C19H17NO5S,27829.0
11918,DL-AP4,NC(CCP(=O)(O)O)C(=O)O,C4H10NO5P,29011.0
11919,(R)-BAY-598,CCN(C(=O)CO)[C@@H]1CN(/C(=N\C#N)Nc2cccc(OC(F)F)c2)N=C1c1ccc(Cl)c(Cl)c1,C22H20Cl2F2N6O3,29174.0
11920,Cyantraniliprole,CNC(=O)c1cc(C#N)cc(C)c1NC(=O)c1cc(Br)nn1-c1ncccc1Cl,C19H14BrClN6O2,27309.0
11921,Cytisine,O=c1cccc2n1C[C@@H]1CNC[C@H]2C1,C11H14N2O,26437.0
11922,Tyrosol,OCCc1ccc(O)cc1,C8H10O2,27600.0
11923,BIBF 1202,CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(C(=O)O)ccc43)c3ccccc3)cc2)CC1,C30H31N5O4,27176.0
11924,Dansyl Chloride,CN(C)c1cccc2c(S(=O)(=O)Cl)cccc12,C12H12ClNO2S,27458.0
11925,Complanatuside,COc1cc(O)c2c(=O)c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(-c3ccc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3)oc2c1,C28H32O16,27295.0
11926,Orphenadrine (hydrochloride),Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl,C18H24ClNO,26391.0
11927,Siamycin I,CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H]2CSSC[C@@H]3NC(=O)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)O)NC(=O)[C@H](C(C)C)NC1=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC3=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N2,C97H131N23O26S4,27783.0
11928,TAN 420E,CO[C@H]1[C@@H](OC)C[C@H](C)[C@@H](OC)c2cc(O)cc(c2O)NC(=O)/C(C)=C/C=C/[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@@H]1C,C30H44N2O9,28120.0
11929,PAR3 (1-6) (human),[H]N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O,C29H45N9O8,27129.0
11930,Acetyl Pentapeptide-1,[H]N(C(C)=O)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C,C32H51N9O10,27261.0
11931,PAR4 (1-6) (human),[H]NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C,C28H41N7O9,27126.0
11932,RN-9893 (hydrochloride),CC(C)N1CCN(S(=O)(=O)c2ccc(NC(=O)c3ccc(C(F)(F)F)cc3[N+](=O)[O-])cc2)CC1.Cl,C21H24ClF3N4O5S,29172.0
11933,Piclamilast,COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC1CCCC1,C18H18Cl2N2O3,29170.0
11934,VX-765,CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C,C24H33ClN4O6,28825.0
11935,Morusin,CC(C)=CCc1c(-c2ccc(O)cc2O)oc2c3c(cc(O)c2c1=O)OC(C)(C)C=C3,C25H24O6,28857.0
11936,Saquinavir-d9,[2H]C([2H])([2H])C(NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)(C([2H])([2H])[2H])C([2H])([2H])[2H],C38H50N6O5,28906.0
11937,Kaurenoic Acid,C=C1C[C@@]23CC[C@@H]4[C@](C)(C(=O)O)CCC[C@@]4(C)[C@@H]2CC[C@H]1C3,C20H30O2,28957.0
11938,JNJ-38877605,Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1,C19H13F2N7,27650.0
11939,GLPG0974,C[C@]1(C(=O)N(CCCC(=O)O)Cc2cccc(Cl)c2)CCN1C(=O)c1csc2ccccc12,C25H25ClN2O4S,28108.0
11940,1-Stearoyl-2-Arachidonoyl-d11-sn-glycero-3-PE,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C43H78NO8P,27929.0
11941,1-Arachidoyl-2-Palmitoyl-3-Oleoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C57H108O6,28555.0
11942,1-Palmitoyl-2-11(Z)-Octadecenoyl-3-Oleoyl-rac-glycerol,CCCCCC/C=C\CCCCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCCCCCCCCCC,C55H102O6,28559.0
11943,OSS-128167,O=C(Nc1ccc(O)c(C(=O)O)c1)c1cccc(NC(=O)c2ccco2)c1,C19H14N2O6,29052.0
11944,CCT129202,CN(C)c1ccc(-c2nc3ncc(Cl)c(N4CCN(CC(=O)Nc5nccs5)CC4)c3[nH]2)cc1,C23H25ClN8OS,29053.0
11945,Triptorelin (trifluoroacetate salt),CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O.O=C(O)C(F)(F)F,C66H83F3N18O15,28613.0
11946,Difloxacin (hydrochloride),CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2)CC1.Cl,C21H20ClF2N3O3,29000.0
11947,iFSP1,Cc1ccc(-c2c(C#N)c(N)n3c(nc4ccccc43)c2C#N)cc1,C20H13N5,29483.0
11948,Disulfiram-d20,[2H]C([2H])([2H])C([2H])([2H])N(C(=S)SSC(=S)N(C([2H])([2H])C([2H])([2H])[2H])C([2H])([2H])C([2H])([2H])[2H])C([2H])([2H])C([2H])([2H])[2H],C10H20N2S4,28536.0
11949,Guanoclor,N=C(N)NNCCOc1c(Cl)cccc1Cl,C9H12Cl2N4O,27659.0
11950,Lomerizine (hydrochloride),COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC.Cl.Cl,C27H32Cl2F2N2O3,28374.0
11951,7-(?-Hydroxyethyl)theophylline,Cn1c(=O)c2c(ncn2CCO)n(C)c1=O,C9H12N4O3,28372.0
11952,Docosanoic Acid-d43,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C22H44O2,29075.0
11953,Troxerutin,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(OCCO)c(OCCO)c4)oc4cc(OCCO)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C33H42O19,27220.0
11954,TMI-005,CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCO)cc2)[C@H]1C(=O)NO,C17H22N2O6S2,29016.0
11955,Rose Bengal (sodium salt),O=C1OC2(c3cc(I)c([O-])c(I)c3Oc3c2cc(I)c([O-])c3I)c2c(Cl)c(Cl)c(Cl)c(Cl)c21.[Na+].[Na+],C20H2Cl4I4Na2O5,28829.0
11956,"1,3-Di-?-Linolenoyl Glycerol",CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC,C39H64O5,26940.0
11957,1-Myristoyl-2-Linoleoyl-3-Oleoyl-rac-glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCCCCCCCC,C53H96O6,28561.0
11958,Melittoside,OCC1=C[C@@H](O)[C@]2(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]12,C21H32O15,29035.0
11959,CTEP,Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(OC(F)(F)F)cc1,C19H13ClF3N3O,28773.0
11960,BAY 87-2243,Cc1cc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1ccnc(N2CCN(C3CC3)CC2)c1,C26H26F3N7O2,28626.0
11961,"1,2,3-Tripalmitoyl-d31 Glycerol",[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OCC(COC(=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])OC(=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H],C51H98O6,28593.0
11962,"Thymosin ?1 (human, mouse, rat, bovine)",CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(C)=O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O,C129H215N33O55,28748.0
11963,1-Palmitoyl-3-Arachidoyl-rac-glycerol,CCCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCC,C39H76O5,28557.0
11964,DWK-1339,COCCCc1ccc2oc(-c3ccc(OC)c(OC)c3)cc2c1,C20H22O4,27642.0
11965,1-Palmitoyl-3-Lauroyl-rac-glycerol,CCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCC,C31H60O5,28550.0
11966,1-Lauroyl-rac-glycerol,CCCCCCCCCCCC(=O)OCC(O)CO,C15H30O4,28170.0
11967,5-Carboxytetramethylrhodamine succinimidyl ester,CN(C)c1ccc2c(-c3ccc(C(=O)ON4C(=O)CCC4=O)cc3C(=O)[O-])c3ccc(N(C)C)cc3[o+]c2c1,C29H25N3O7,28509.0
11968,1-Myristoyl-2-Linoleoyl-3-Palmitoyl-rac-glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC,C51H94O6,28560.0
11969,Myristic Acid methyl ester-d27,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OC,C15H30O2,28594.0
11970,Gastrodin,OCc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,C13H18O7,28828.0
11971,Zopolrestat,O=C(O)Cc1nn(Cc2nc3cc(C(F)(F)F)ccc3s2)c(=O)c2ccccc12,C19H12F3N3O3S,29185.0
11972,4-Nitrophenyl-N-acetyl-?-D-glucosaminide,CC(=O)N[C@H]1[C@H](Oc2ccc([N+](=O)[O-])cc2)O[C@H](CO)[C@@H](O)[C@@H]1O,C14H18N2O8,28954.0
11973,Varlitinib,C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,C22H19ClN6O2S,27651.0
11974,1-Arachidoyl-2-Oleoyl-3-Palmitoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCC,C57H108O6,28556.0
11975,LB-100,CN1CCN(C(=O)C2C(C(=O)O)[C@H]3CC[C@@H]2O3)CC1,C13H20N2O4,29105.0
11976,IM-93,CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O,C21H28N4O2,28794.0
11977,2''-O-Galloylhyperin,O=C(O[C@H]1[C@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)O[C@H](CO)[C@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1,C28H24O16,29086.0
11978,Aristolochic Acid B,O=C(O)c1cc2c(c3c1c([N+](=O)[O-])cc1ccccc13)OCO2,C16H9NO6,28504.0
11979,Myristic Acid-d27,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C14H28O2,9003317.0
11980,Triflupromazine (hydrochloride),CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21.Cl,C18H20ClF3N2S,27610.0
11981,CKI-7 (hydrochloride),Cl.Cl.NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12,C11H14Cl3N3O2S,28268.0
11982,2-Cl-IB-MECA,CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@H](O)[C@@H]1O,C18H18ClIN6O4,27336.0
11983,Pentadecanoic Acid-d29,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C15H30O2,28081.0
11984,Phensuximide,CN1C(=O)CC(c2ccccc2)C1=O,C11H11NO2,27601.0
11985,"1,3-Dipalmitoyl-2-Oleoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC,C53H100O6,27066.0
11986,"1-Palmitoyl-d9-2,3-Dipalmitoyl-sn-glycerol",[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C51H98O6,27592.0
11987,4?-Hydroxywithanolide E,CC1=C(C)C(=O)O[C@@H]([C@](C)(O)[C@]2(O)CC[C@@]3(O)[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1,C28H38O8,27245.0
11988,CCT251236,Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1NC(=O)c1ccc2nc(OCCN3CCCC3)ccc2c1,C32H32N4O5,27788.0
11989,Leucinostatin A,CCC(=O)C[C@@H](O)C[C@@H](C)C[C@H](NC(=O)[C@@H]1C[C@H](C)CN1C(=O)/C=C/[C@@H](C)CC)C(=O)N[C@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)NCCC(=O)N[C@@H](C)CN(C)C)[C@H](O)C(C)C,C62H111N11O13,28190.0
11990,SR 3029,Fc1cccc(-n2cnc3c(NCc4nc5ccc(F)c(F)c5[nH]4)nc(N4CCOCC4)nc32)c1,C23H19F3N8O,27048.0
11991,Vortioxetine-d8,[2H]C1([2H])NC([2H])([2H])C([2H])([2H])N(c2ccccc2Sc2ccc(C)cc2C)C1([2H])[2H],C18H22N2S,28163.0
11992,Danshensu (sodium salt),O=C([O-])C(O)Cc1ccc(O)c(O)c1.[Na+],C9H9NaO5,27222.0
11993,para-bromo 4-ANPP,Brc1ccc(NC2CCN(CCc3ccccc3)CC2)cc1,C19H23BrN2,28216.0
11994,1-Octanoyl-rac-glycerol,CCCCCCCC(=O)OCC(O)CO,C11H22O4,26945.0
11995,Undecanoic Acid methyl ester,CCCCCCCCCCC(=O)OC,C12H24O2,26720.0
11996,Verrucofortine,C=CC(C)(C)[C@@]12C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)N3[C@@H]1N(C(C)=O)c1ccccc12,C24H31N3O3,28062.0
11997,ARN726,O=C(N[C@H]1CNC1=O)OCCCCC1CCCCC1,C14H24N2O3,24259.0
11998,AZD 3229,COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1,C24H26FN7O3,27908.0
11999,Xylometazoline (hydrochloride),Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1.Cl,C16H25ClN2,27797.0
12000,Heclin,CCc1ccc(/C=C/C(=O)Nc2ccc(C(C)=O)cc2)o1,C17H17NO3,26139.0
12001,Acetyl Octapeptide-3,[H]N(C(C)=O)[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(N)=O,C41H70N16O16S,27260.0
12002,1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PE,CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCCCCCCCCCC,C37H74NO7P,28349.0
12003,"1,2-Dimyristoyl-d54-sn-glycero-3-PC",[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H],C36H72NO8P,28753.0
12004,Mecillinam,CC1(C)S[C@@H]2[C@H](N=CN3CCCCCC3)C(=O)N2[C@H]1C(=O)O,C15H23N3O3S,9002008.0
12005,Sulfadimethoxine,COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1,C12H14N4O4S,28827.0
12006,CGP 71683 (hydrochloride),Cl.Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12,C26H30ClN5O2S,28778.0
12007,Palmitoyl Tripeptide-5 (trifluoroacetate salt),CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C.O=C(O)C(F)(F)F,C35H66F3N5O7,27565.0
12008,1-Lauroyl-2-Oleoyl-3-Palmitoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC,C49H92O6,28549.0
12009,CCT245737,N#Cc1cnc(Nc2cc(NC[C@H]3CNCCO3)c(C(F)(F)F)cn2)cn1,C16H16F3N7O,28775.0
12010,Trihexyphenidyl (hydrochloride),Cl.OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,C20H32ClNO,27643.0
12011,Rhein-8-glucoside,O=C(O)c1cc(O)c2c(c1)C(=O)c1cccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c1C2=O,C21H18O11,28844.0
12012,Corydaline,COc1cc2c(cc1OC)[C@H]1[C@@H](C)c3ccc(OC)c(OC)c3CN1CC2,C22H27NO4,27654.0
12013,Zanubrutinib,C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,C27H29N5O3,28924.0
12014,Cryogenine,COc1cc2c(cc1OC)[C@@H]1C[C@H](C[C@H]3CCCCN31)OC(=O)/C=C\c1ccc(O)c-2c1,C26H29NO5,25287.0
12015,Ac-LEVD-AFC,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1)C(C)C,C32H40F3N5O11,28809.0
12016,Rofecoxib-d5,[2H]c1c([2H])c([2H])c(C2=C(c3ccc(S(C)(=O)=O)cc3)COC2=O)c([2H])c1[2H],C17H14O4S,28900.0
12017,Leucettine L41,O=C1N=C(Nc2ccccc2)N/C1=C\c1ccc2c(c1)OCO2,C17H13N3O3,29225.0
12018,Derenofylline,O[C@H]1CC[C@H](Nc2nc(-c3ccccc3)nc3[nH]ccc23)CC1,C18H20N4O,27666.0
12019,ERB 041,C=Cc1cc(O)cc2nc(-c3ccc(O)c(F)c3)oc12,C15H10FNO3,28737.0
12020,Carubicin,CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(O)cccc1C3=O,C26H27NO10,27660.0
12021,Forsythoside B,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO[C@@H]3OC[C@](O)(CO)[C@H]3O)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,C34H44O19,29051.0
12022,NCGC00244536,O=C(NCCCc1ccccc1)c1cccc(-c2cc(O)c3ncccc3c2)c1,C25H22N2O2,18478.0
12023,AV-412,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1,C41H44ClFN6O7S2,29039.0
12024,Eticlopride (hydrochloride),CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O.Cl,C17H26Cl2N2O3,29112.0
12025,UNC2881,CCCCNc1ncc(C(=O)NCc2ccc(-n3ccnc3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,C25H33N7O2,29012.0
12026,"1,2-Dioleoyl-3-Docosanoyl-rac-glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C61H114O6,28863.0
12027,17?-hydroxy Pregnenolone,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,C21H32O3,29181.0
12028,BMS 214662,N#Cc1ccc2c(c1)CN(S(=O)(=O)c1cccs1)[C@H](Cc1ccccc1)CN2Cc1cnc[nH]1,C25H23N5O2S2,28713.0
12029,Methoxyfenozide,COc1cccc(C(=O)NN(C(=O)c2cc(C)cc(C)c2)C(C)(C)C)c1C,C22H28N2O3,29182.0
12030,Cyclosporin C,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,C62H111N11O13,29152.0
12031,Quazinone,C[C@@H]1C(=O)N=C2Nc3cccc(Cl)c3CN21,C11H10ClN3O,29151.0
12032,Rubusoside,C=C1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]2CC[C@]1(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C3,C32H50O13,29040.0
12033,Glumetinib,Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6cnn(C)c6)cn45)c3c2)cn1,C21H17N9O2S,28952.0
12034,"CP 376,395",CCC(CC)Nc1cc(C)nc(Oc2c(C)cc(C)cc2C)c1C,C21H30N2O,29188.0
12035,PEPA,NC(=O)COc1c(F)cc(SCCNS(=O)(=O)c2ccccc2)cc1F,C16H16F2N2O4S2,29190.0
12036,Clindamycin Palmitate (hydrochloride),CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC.Cl,C34H64Cl2N2O6S,29102.0
12037,Ginkgoneolic Acid,CCCCCCCCCCCCCc1cccc(O)c1C(=O)O,C20H32O3,27656.0
12038,JNK Inhibitor VII,CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2ccc(Nc3nccc(-c4cccnc4)n3)cc2)c1,C28H27N7O2,28831.0
12039,Fenticonazole (nitrate),Clc1ccc(C(Cn2ccnc2)OCc2ccc(Sc3ccccc3)cc2)c(Cl)c1.O=[N+]([O-])O,C24H21Cl2N3O4S,29002.0
12040,Agistatin D,CC[C@@H]1CC=C2OC=CC(=O)[C@]2(O)[C@@H]1O,C11H14O4,29169.0
12041,7-Azido-4-methylcoumarin,Cc1cc(=O)oc2cc(N=[N+]=[N-])ccc12,C10H7N3O2,28307.0
12042,N6-Methyladenosine,CNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C11H15N5O4,28833.0
12043,Hematoporphyrin (hydrochloride),CC1=C(CCC(=O)O)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5C(C)O)C(C)=C4C(C)O)c(C)c3CCC(=O)O.Cl.Cl,C34H38Cl2N4O6,28287.0
12044,"1,3-Distearoyl-2-Lauroyl Glycerol",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCC,C51H98O6,28552.0
12045,DOPR (hydrochloride),CCCc1cc(OC)c(CC(C)N)cc1OC.Cl,C14H24ClNO2,27747.0
12046,LAS101057,O=C(Nc1cnc(-c2ccncc2F)c(-c2cccnc2)n1)C1CC1,C18H14FN5O,28435.0
12047,CINPA1,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CN(CC)CC)c1ccccc1CC2,C23H29N3O3,29110.0
12048,26942,CCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCCC,C37H72O5,26942.0
12049,2-heptyl-3-hydroxy-4(1H)-Quinolone,CCCCCCCc1[nH]c2ccccc2c(=O)c1O,C16H21NO2,29186.0
12050,MK2a Inhibitor,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,C22H20FNO2,17325.0
12051,Nimorazole,O=[N+]([O-])c1cncn1CCN1CCOCC1,C9H14N4O3,29153.0
12052,CYM 5478,Cc1cc(C(=O)Cn2cc(C(F)(F)F)ccc2=O)c(C)n1Cc1ccccc1,C21H19F3N2O2,29024.0
12053,Pimodivir,O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,C20H19F2N5O2,29321.0
12054,Hesperetin-13C-d3,[2H][13C]([2H])([2H])Oc1ccc(C2CC(=O)c3c(O)cc(O)cc3O2)cc1O,C16H14O6,28806.0
12055,"2,4-difluoro U-48800 (hydrochloride)",CN(C)[C@@H]1CCCC[C@H]1N(C)C(=O)Cc1ccc(F)cc1F.Cl,C17H25ClF2N2O,29564.0
12056,Paclitaxel octadecanedioate,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCCCCCCCCCCCCCCCC(=O)O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,C65H83NO17,28635.0
12057,(E/Z)-Locostatin,C/C=C/C(=O)N1C(=O)OC[C@@H]1Cc1ccccc1,C14H15NO3,29092.0
12058,"3,5-Dinitrocatechol",O=[N+]([O-])c1cc(O)c(O)c([N+](=O)[O-])c1,C6H4N2O6,29180.0
12059,Netupitant-d6,[2H]C([2H])([2H])C(C(=O)N(C)c1cnc(N2CCN(C)CC2)cc1-c1ccccc1C)(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)C([2H])([2H])[2H],C30H32F6N4O,28901.0
12060,1-Myristoyl-rac-glycerol,CCCCCCCCCCCCCC(=O)OCC(O)CO,C17H34O4,28173.0
12061,FITM,CC(C)Nc1cc(-c2csc(N(C)C(=O)c3ccc(F)cc3)n2)ncn1,C18H18FN5OS,29219.0
12062,pNPS-DHA,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NS(=O)(=O)c1ccc([N+](=O)[O-])cc1,C28H36N2O5S,29507.0
12063,Cyclocytidine (hydrochloride),Cl.N=c1ccn2c(n1)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]12,C9H12ClN3O4,29014.0
12064,SM-164,CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCc4ccc(CCCCn5cc([C@@H](NC(=O)[C@@H]6CC[C@@H]7CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O,C62H84N14O6,28632.0
12065,Tolnaftate-d7,[2H]c1c([2H])c([2H])c2c([2H])c(OC(=S)N(C)c3cccc(C)c3)c([2H])c([2H])c2c1[2H],C19H17NOS,29048.0
12066,"1,2-Dipentadecanoyl-rac-glycerol",CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCC,C33H64O5,26941.0
12067,Ginsenoside Rc,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@@H](CO)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C53H90O22,29088.0
12068,"1,3-Distearoyl Glycerol",CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC,C39H76O5,26946.0
12069,Distearin,CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC,C39H76O5,27005.0
12070,DCP-Bio3,O=C1CCC(CCCOC(=O)NCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)C(=O)C1,C24H38N4O6S,28897.0
12071,DS-437,CCNC(=O)NCCSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,C15H23N7O4S,29476.0
12072,AZD 8835,CCn1nc(C2CCN(C(=O)CCO)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1,C22H31N9O3,29166.0
12073,"1,2-Dimyristoyl-rac-glycerol",CCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCC,C31H60O5,28171.0
12074,2-Coumaranone-1-L,Cc1cc(C)c(OC(=O)NC2C(=O)Oc3ccc(F)cc32)c(C)c1,C18H16FNO4,27389.0
12075,Pazufloxacin (mesylate),CS(=O)(=O)O.C[C@H]1COc2c(C3(N)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,C17H19FN2O7S,29249.0
12076,4-Nitrophenyl ?-L-rhamnopyranoside,C[C@@H]1O[C@@H](Oc2ccc([N+](=O)[O-])cc2)[C@H](O)[C@H](O)[C@H]1O,C12H15NO7,29195.0
12077,NE-CHMIMO,O=C(c1cccc2ccccc12)c1cn(CC2CCCCC2)c2ccccc12,C26H25NO,29301.0
12078,NMS-1286937,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1,C24H27F3N8O3,28762.0
12079,Prodan,CCC(=O)c1ccc2cc(N(C)C)ccc2c1,C15H17NO,27663.0
12080,2'-Deoxycytidine-5'-monophosphate,Nc1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)c(=O)n1,C9H14N3O7P,29340.0
12081,"1,2,3-Trimyristoleoyl Glycerol",CCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCC)OC(=O)CCCCCCC/C=C\CCCC,C45H80O6,26943.0
12082,GSK1904529A,CCc1cc(Nc2nccc(-c3c(-c4ccc(OC)c(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1,C44H47F2N9O5S,29155.0
12083,RTI-31,COC(=O)[C@H]1[C@@H](c2ccc(Cl)cc2)C[C@@H]2CC[C@H]1N2C,C16H20ClNO2,17977.0
12084,A 26771B,C[C@@H]1CCCCCCCCC[C@H](OC(=O)CCC(=O)O)C(=O)/C=C/C(=O)O1,C20H30O7,29593.0
12085,Nelfinavir-d3,[2H]C([2H])([2H])c1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,C32H45N3O4S,29416.0
12086,PKI-402,CCn1nnc2c(N3CCOCC3)nc(-c3ccc(NC(=O)Nc4ccc(C(=O)N5CCN(C)CC5)cc4)cc3)nc21,C29H34N10O3,27664.0
12087,Rifabutin-d7,[2H]C([2H])([2H])C([2H])(CN1CCC2(CC1)N=C1C(=C3NC(=O)/C(C)=C\C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)/C=C\O[C@@]4(C)Oc5c(C)c(O)c(c1c5C4=O)C3=O)N2)C([2H])([2H])[2H],C46H62N4O11,28904.0
12088,Diroximel Fumarate,COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O,C11H13NO6,29111.0
12089,6?-hydroxy Eplerenone,COC(=O)[C@H]1[C@H]2[C@@H]3CC[C@@]4(CCC(=O)O4)[C@@]3(C)C[C@H]3O[C@@]23[C@@]2(C)CCC(=O)C=C2[C@@H]1O,C24H30O7,28859.0
12090,Dehydrocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC(=O)[C@]12C,C24H34O5,29176.0
12091,BPTU,CC(C)(C)c1ccccc1Oc1ncccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1,C23H22F3N3O3,29444.0
12092,"1,2-Dipalmitoyl-d62-sn-glycero-3-PC",[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H],C40H80NO8P,28751.0
12093,AKP-11,CCCOc1ccc(-c2nc(-c3ccc4oc(C(N)(CO)CO)cc4c3)no2)cc1Cl,C22H22ClN3O5,27670.0
12094,Sitravatinib,COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)cc4F)c3s2)nc1,C33H29F2N5O4S,27338.0
12095,Tolfenamic Acid-d4,[2H]c1c([2H])c([2H])c(C(=O)O)c(Nc2cccc(Cl)c2C)c1[2H],C14H12ClNO2,28700.0
12096,Rehmannioside D,OCC1=C[C@@H](O)[C@]2(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]12,C27H42O20,29034.0
12097,Galbinic Acid,CC(=O)OCc1c(O)c2c(c3c1OC(=O)c1c(C)cc(O)c(C=O)c1O3)C(O)OC2=O,C20H14O11,29584.0
12098,BX-517,C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1ccc[nH]1,C15H14N4O2,29238.0
12099,Malabaricone C,O=C(CCCCCCCCc1ccc(O)c(O)c1)c1c(O)cccc1O,C21H26O5,29741.0
12100,NS 9283,N#Cc1cccc(-c2nc(-c3cccnc3)no2)c1,C14H8N4O,29189.0
12101,WAY-600,c1cncc(CN2CCC(n3ncc4c(N5CCOCC5)nc(-c5ccc6[nH]ccc6c5)nc43)CC2)c1,C28H30N8O,29214.0
12102,"1,2-Dioleoyl-3-Lauroyl-rac-glycerol-13C3",CCCCCCCC/C=C\CCCCCCCC(=O)O[13CH2][13CH]([13CH2]OC(=O)CCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C51H94O6,28755.0
12103,"1,2,3-Trilinoelaidoyl Glycerol",CCCCC/C=C/C/C=C/CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C/C/C=C/CCCCC)OC(=O)CCCCCCC/C=C/C/C=C/CCCCC,C57H98O6,26948.0
12104,Diallyl Tetrasulfide,C=CCSSSSCC=C,C6H10S4,29328.0
12105,"1,3-Distearoyl-2-Elaidoyl Glycerol",CCCCCCCC/C=C/CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC,C57H108O6,28864.0
12106,12-hydroxy Lauric Acid,O=C(O)CCCCCCCCCCCO,C12H24O3,28494.0
12107,(-)-Drimenol,CC1=CC[C@H]2C(C)(C)CCC[C@]2(C)[C@H]1CO,C15H26O,29428.0
12108,Bromopride,CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC,C14H22BrN3O2,29329.0
12109,BQR-695,CNC(=O)CNc1cnc2ccc(-c3ccc(OC)c(OC)c3)cc2n1,C19H20N4O3,27482.0
12110,Terbutaline,CC(C)(C)NCC(O)c1cc(O)cc(O)c1,C12H19NO3,29337.0
12111,Terpendole I,CC(C)(O)[C@H]1O[C@H]2CC[C@@]3(C)[C@@](O)(CC[C@H]4Cc5c([nH]c6ccccc56)[C@@]43C)[C@]23O[C@@H]3[C@@H]1O,C27H35NO5,29443.0
12112,Isoverbascoside,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](COC(=O)/C=C/c3ccc(O)c(O)c3)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,C29H36O15,29216.0
12113,"1,2-Dimyristoyl-3-Palmitoyl-rac-glycerol",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC,C47H90O6,28862.0
12114,9c(i472),CCOC(=O)c1[nH]c2cc(Cl)ccc2c1/C=C/C(=O)NCc1ccccc1OC,C22H21ClN2O4,28225.0
12115,Betaine,C[N+](C)(C)CC(=O)[O-],C5H11NO2,26814.0
12116,Demethoxyviridiol,C[C@@]12c3ccc4c(c3C(=O)c3occ(c31)[C@@H](O)C[C@H]2O)CCC4=O,C19H16O5,27953.0
12117,25C-NB4OMe (hydrochloride),COc1ccc(CNCCc2cc(OC)c(Cl)cc2OC)cc1.Cl,C18H23Cl2NO3,27337.0
12118,5?-Cholestane,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CCCC[C@]4(C)[C@H]3CC[C@]12C,C27H48,26763.0
12119,"1,2-Dibutyryl-3-Palmitoyl-rac-glycerol",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC,C27H50O6,27279.0
12120,"1,2,3-Tri-6(Z)-Octadecenoyl Glycerol",CCCCCCCCCCC/C=C\CCCCC(=O)OCC(COC(=O)CCCC/C=C\CCCCCCCCCCC)OC(=O)CCCC/C=C\CCCCCCCCCCC,C57H104O6,26895.0
12121,Oleic Acid-13C,CCCCCCCC/C=C\CCCCCCC[13C](=O)O,C18H34O2,27869.0
12122,CA-4948,Nc1ccc(-c2cccc(C(=O)Nc3cnc4nc(N5CCOCC5)oc4c3)n2)cn1,C21H19N7O3,27598.0
12123,Thymohydroquinone,Cc1cc(O)c(C(C)C)cc1O,C10H14O2,27558.0
12124,Talatisamine,CCN1C[C@]2(COC)CC[C@H](OC)C34C1C(C[C@@H]32)[C@@]1(O)C[C@H](OC)[C@H]2C[C@@H]4[C@@H]1[C@H]2O,C24H39NO5,27721.0
12125,"1,4-Benzoquinone",O=C1C=CC(=O)C=C1,C6H4O2,27560.0
12126,1-Pyrenesulfonic Acid (sodium salt),O=S(=O)([O-])c1ccc2ccc3cccc4ccc1c2c34.[Na+],C16H9NaO3S,27983.0
12127,Ganoderic Acid A,C[C@H](CC(=O)C[C@@H](C)[C@H]1C[C@H](O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O,C30H44O7,26674.0
12128,Ara-G,Nc1nc(=O)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O)c2[nH]1,C10H13N5O5,27984.0
12129,Dielaidin,CCCCCCCC/C=C/CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C/CCCCCCCC,C39H72O5,26979.0
12130,"1,3-Dielaidoyl Glycerol",CCCCCCCC/C=C/CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC/C=C/CCCCCCCC,C39H72O5,26939.0
12131,Kevetrin (hydrochloride),Cl.N#CCCCSC(=N)N,C5H10ClN3S,28288.0
12132,A01,Cc1ccnn1-c1ccc(C(=O)N2CCN(S(=O)(=O)c3ccc(Cl)c(C(F)(F)F)c3)CC2)cc1,C22H20ClF3N4O3S,26137.0
12133,SAR7334 (hydrochloride),Cl.Cl.N#Cc1ccc(O[C@@H]2c3ccccc3C[C@H]2N2CCC[C@@H](N)C2)c(Cl)c1,C21H24Cl3N3O,28292.0
12134,ACY-738,O=C(NO)c1cnc(NC2(c3ccccc3)CC2)nc1,C14H14N4O2,28282.0
12135,Schisandrin C,COc1c2c(cc3c1-c1c(cc4c(c1OC)OCO4)CC(C)C(C)C3)OCO2,C22H24O6,27475.0
12136,Stearic Acid-d2,[2H]C([2H])(CCCCCCCCCCCCCCCC)C(=O)O,C18H36O2,28150.0
12137,Lomefloxacin (hydrochloride),CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21.Cl,C17H20ClF2N3O3,28271.0
12138,Ciclesonide-d7,[2H]C([2H])([2H])C([2H])(C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C)C([2H])([2H])[2H],C32H44O7,28527.0
12139,1-Stearoyl-3-Arachidoyl-rac-glycerol,CCCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC,C41H80O5,27284.0
12140,KT172,COc1ccccc1-c1ccc(-c2cn(C(=O)N3CCCCC3Cc3ccccc3)nn2)cc1,C28H28N4O2,19112.0
12141,Diclazuril,N#CC(c1ccc(Cl)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl,C17H9Cl3N4O2,27047.0
12142,Lacidipine,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C,C26H33NO6,28270.0
12143,Caprooyl Tetrapeptide-3 (acetate),CC(=O)O.CCCCCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(N)=O,C26H47N9O5(C2H4O2)X,27154.0
12144,HhAntag,COc1cc(OC)cc(C(=O)Nc2ccc(Cl)c(-c3nc4ccc(N(C)C)cc4[nH]3)c2)c1,C24H23ClN4O3,28296.0
12145,Bilobetin,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1-c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,C31H20O10,27899.0
12146,3-Oxocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4CC(=O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H38O5,28403.0
12147,Fraxetin,COc1cc2ccc(=O)oc2c(O)c1O,C10H8O5,28011.0
12148,"1,2-Dipalmitoyl-3-Oleoyl-rac-glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C53H100O6,26878.0
12149,Cyclo(L-Pro-L-Val),CC(C)[C@@H]1NC(=O)[C@@H]2CCCN2C1=O,C10H16N2O2,27961.0
12150,Asperglaucide,CC(=O)OC[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1,C27H28N2O4,28499.0
12151,Precocene II,COc1cc2c(cc1OC)OC(C)(C)C=C2,C13H16O3,28480.0
12152,Finasteride-d9,[2H]C([2H])([2H])C(NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C)(C([2H])([2H])[2H])C([2H])([2H])[2H],C23H36N2O2,28482.0
12153,Paliperidone-d4,[2H]C([2H])(c1c(C)nc2n(c1=O)CCCC2O)C([2H])([2H])N1CCC(c2noc3cc(F)ccc23)CC1,C23H27FN4O3,28484.0
12154,Felbamate-d4,[2H]C([2H])(OC(N)=O)C(c1ccccc1)C([2H])([2H])OC(N)=O,C11H14N2O4,28489.0
12155,Sulfameter,COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1,C11H12N4O3S,27630.0
12156,Lasmiditan,CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1,C19H18F3N3O2,28369.0
12157,Azasetron (hydrochloride),CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21.Cl,C17H21Cl2N3O3,28383.0
12158,BP-1-102,CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)c(O)c1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F,C29H27F5N2O6S,28368.0
12159,Gemcitabine Elaidate,CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O,C27H43F2N3O5,28303.0
12160,"7,8-Dihydroneopterin",Nc1nc(=O)c2c([nH]1)NCC([C@H](O)[C@H](O)CO)=N2,C9H13N5O4,27606.0
12161,Cocaethylene (CRM),CCOC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C,C18H23NO4,28820.0
12162,Belizatinib,CC(C)NC(=O)[C@H]1CC[C@@H](n2c(NC(=O)c3ccc(F)cc3)nc3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1,C33H44FN5O3,28458.0
12163,"1,3-Dilinoleoyl-2-Docosahexaenoyl Glycerol",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C61H98O6,26984.0
12164,4-Methyl-7-(4-nitro-2-(trifluoromethyl)phenoxy)-2H-chromen-2-one,Cc1cc(=O)oc2cc(Oc3ccc([N+](=O)[O-])cc3C(F)(F)F)ccc12,C17H10F3NO5,28471.0
12165,"1,3-Dimyristoyl Glycerol",CCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCC,C31H60O5,26925.0
12166,Dimyristin,CCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCC,C31H60O5,26949.0
12167,Amprenavir-d4,[2H]c1c([2H])c(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CCOC2)c([2H])c([2H])c1N,C25H35N3O6S,28703.0
12168,.alpha.-methyl Serotonin (maleate),CC(N)Cc1c[nH]c2ccc(O)cc12.O=C(O)/C=C\C(=O)O,C15H18N2O5,28542.0
12169,Pleconaril,Cc1cc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)on1,C18H18F3N3O3,28461.0
12170,Dihydrocaffeic Acid,O=C(O)CCc1ccc(O)c(O)c1,C9H10O4,28390.0
12171,"1,2-Diarachidoyl-rac-glycerol",CCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCCCCCC,C43H84O5,26932.0
12172,Metoclopramide-d3,[2H]C([2H])([2H])Oc1cc(N)c(Cl)cc1C(=O)NCCN(CC)CC,C14H22ClN3O2,28885.0
12173,2-chloro-N6-Cyclopentyladenosine (hydrate),OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O,C15H20ClN5O4,28731.0
12174,2-chloro-N6-Cyclopentyladenosine,OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O,C15H20ClN5O4,36477.0
12175,A2AR Agonist-1,OC[C@H]1O[C@@H](n2cnc3c(NCCc4c[nH]c5ccccc45)ncnc32)[C@H](O)[C@@H]1O,C20H22N6O4,28414.0
12176,Crotonoside,Nc1[nH]c(=O)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C10H13N5O5,28219.0
12177,SMCC,O=C(ON1C(=O)CCC1=O)C1CCC(CN2C(=O)C=CC2=O)CC1,C16H18N2O6,28955.0
12178,Norwogonin,O=c1cc(-c2ccccc2)oc2c(O)c(O)cc(O)c12,C15H10O5,29227.0
12179,Flupirtine-d4 (hydrochloride),Cl.[2H]c1c([2H])c(CNc2ccc(NC(=O)OCC)c(N)n2)c([2H])c([2H])c1F,C15H18ClFN4O2,28695.0
12180,TLR7/8 Agonist 1 (hydrochloride),CCCCc1nc2c(N)nc3ccccc3c2n1Cc1ccc(CN)cc1.Cl.Cl,C22H27Cl2N5,28451.0
12181,1-Palmitoyl-d9-2-Palmitoyl-sn-glycero-3-PE,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCCCCCCCCCC,C37H74NO8P,28155.0
12182,GR79236,OC[C@H]1O[C@@H](n2cnc3c(N[C@H]4CCC[C@@H]4O)ncnc32)[C@H](O)[C@@H]1O,C15H21N5O5,28430.0
12183,Topotecan-d6,[2H]C([2H])([2H])N(Cc1c(O)ccc2nc3c(cc12)Cn1c-3cc2c(c1=O)COC(=O)[C@]2(O)CC)C([2H])([2H])[2H],C23H23N3O5,29082.0
12184,Pentagastrin,CSCC[C@H](NC(=O)[C@H](Cc1cc2ccccc2[nH]1)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,C37H49N7O9S,28546.0
12185,Daclatasvir-d6,[2H]C([2H])([2H])OC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC([2H])([2H])[2H])C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,C40H50N8O6,29077.0
12186,Chloroquine-d5 (phosphate),O=P(=O)OO.O=P(=O)OO.[2H]C([2H])([2H])C([2H])([2H])N(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.[HH].[HH],C18H30ClN3O8P2,29079.0
12187,"1,2-Dioleoyl-3-Myristoyl-rac-glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C53H98O6,27291.0
12188,SP-420,COCCOCCOc1ccc(C2=N[C@@](C)(C(=O)O)CS2)c(O)c1,C16H21NO6S,28498.0
12189,SRI-011381,O=C(NC1CCCCC1)N(Cc1ccccc1)CC1CCNCC1,C20H31N3O,28914.0
12190,"1,2-Dipalmitoleoyl-3-11(Z)-Octadecenoyl-rac-glycerol",CCCCCC/C=C\CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC,C53H96O6,27379.0
12191,SR 4370,CCCCNNC(=O)c1ccc(-c2cccc(F)c2F)cc1,C17H18F2N2O,25543.0
12192,CU-CPT9b,Cc1cc(-c2ccnc3cc(O)ccc23)ccc1O,C16H13NO2,28723.0
12193,HTMT (maleate),CC(CCCCC(=O)Nc1ccc(C(F)(F)F)cc1)NCCc1cnc[nH]1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,C27H33F3N4O9,29018.0
12194,"N,N-Dipropyldopamine (hydrobromide)",Br.CCCN(CCC)CCc1ccc(O)c(O)c1,C14H24BrNO2,28937.0
12195,DCP-Rho1,CCN(CC)c1ccc2c(-c3ccccc3C(=O)N3CCN(C(=O)OCCCC4CCC(=O)CC4=O)CC3)c3ccc(=[N+](CC)CC)cc-3oc2c1.[Cl-],C42H51ClN4O6,13194.0
12196,AMCA,Cc1c(CC(=O)O)c(=O)oc2cc(N)ccc12,C12H11NO4,29184.0
12197,GR148672X,Cc1cccc(N/N=C(\C(=O)c2cccs2)C(=O)C(F)(F)F)c1,C15H11F3N2O2S,28756.0
12198,AMN082,Cl.Cl.c1ccc(C(NCCNC(c2ccccc2)c2ccccc2)c2ccccc2)cc1,C28H30Cl2N2,28779.0
12199,RSV-604,O=C(Nc1ccccc1F)N[C@H]1N=C(c2ccccc2)c2ccccc2NC1=O,C22H17FN4O2,29041.0
12200,Dovitinib-d8,[2H]C1([2H])N(C)C([2H])([2H])C([2H])([2H])N(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)C1([2H])[2H],C21H21FN6O,28706.0
12201,CCR2-RA-[R],CC(=O)C1=C(O)C(=O)N(c2ccc(Cl)cc2F)[C@@H]1C1CCCCC1,C18H19ClFNO3,28423.0
12202,Biapenem,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)[O-])=C(SC3Cn4cnc[n+]4C3)[C@H](C)[C@H]12,C15H18N4O4S,28822.0
12203,Mitoxantrone-d8,[2H]C([2H])(O)C([2H])([2H])NCCNc1ccc(NCCNC([2H])([2H])C([2H])([2H])O)c2c1C(=O)c1c(O)ccc(O)c1C2=O,C22H28N4O6,29414.0
12204,Prenylamine,CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1,C24H27N,29430.0
12205,DH 97,CCCCC(=O)n1c(Cc2ccccc2)c(CCN)c2ccccc21,C22H26N2O,29522.0
12206,"6-Ethyl-2,7-dimethoxyjuglone",CCc1c(OC)cc2c(c1O)C(=O)C=C(OC)C2=O,C14H14O5,28049.0
12207,Talabostat (mesylate),CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O.CS(=O)(=O)O,C10H23BN2O6S,29007.0
12208,1-Palmitoyl-2-11(Z)-Octadecenoyl-3-Butyroyl-rac-glycerol,CCCCCC/C=C\CCCCCCCCCC(=O)OC(COC(=O)CCC)COC(=O)CCCCCCCCCCCCCCC,C41H76O6,28558.0
12209,"1,2-Dioctanoyl-3-Decanoyl-rac-glycerol",CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,C29H54O6,28554.0
12210,1-Stearoyl-2-Linoleoyl-3-Oleoyl-rac-glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC,C57H104O6,28562.0
12211,Nicotinamide N-oxide,NC(=O)c1ccc[n+]([O-])c1,C6H6N2O2,28441.0
12212,Tipranavir-d4,[2H]C([2H])(C)C([2H])([2H])[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,C31H33F3N2O5S,28907.0
12213,10-deacetyl Paclitaxel,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C,C45H49NO13,28503.0
12214,1-Myristoyl-3-Elaidoyl-rac-glycerol,CCCCCCCC/C=C/CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCC,C35H66O5,27289.0
12215,DAPH,O=C1NC(=O)c2cc(Nc3ccccc3)c(Nc3ccccc3)cc21,C20H15N3O2,29196.0
12216,Parecoxib (sodium salt),CCC(=O)[N-]S(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1.[Na+],C19H17N2NaO4S,29017.0
12217,Nicotiflorin,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C27H30O15,27392.0
12218,Ro 08-2750,Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C)c2cc1C=O,C13H10N4O3,28772.0
12219,Methysergide (maleate),CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1.O=C(O)/C=C\C(=O)O,C25H31N3O6,27658.0
12220,1-Palmitoyl-2-Arachidoyl-3-Oleoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC,C57H108O6,28553.0
12221,Coptisine (chloride),[Cl-].c1c2c(cc3c1OCO3)-c1cc3ccc4c(c3c[n+]1CC2)OCO4,C19H14ClNO4,28424.0
12222,BP-897,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1.Cl,C26H32ClN3O2,25831.0
12223,Cimaterol-d7,[2H]C([2H])([2H])C([2H])(NCC(O)c1ccc(N)c(C#N)c1)C([2H])([2H])[2H],C12H17N3O,28903.0
12224,"1,2-Dipalmitoyl-3-Elaidoyl-rac-glycerol",CCCCCCCC/C=C/CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C53H100O6,28865.0
12225,1-1(Z)-Hexadecenyl-2-Palmitoyl-d9-sn-glycero-3-PE,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)O[C@H](CO/C=C\CCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C37H74NO7P,27590.0
12226,Trihydroxycholestanoic Acid,CC(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C)C(=O)O,C27H46O5,26098.0
12227,MI-2,CCCc1cc2c(N3CCN(C4=NCC(C)(C)S4)CC3)ncnc2s1,C18H25N5S2,29218.0
12228,Voruciclib,CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccc(C(F)(F)F)cc4Cl)oc23)[C@@H]1CO,C22H19ClF3NO5,29085.0
12229,Agistatin E,CC[C@@H]1CC[C@]2(O)O[C@H]3CC(=O)[C@]2(O)[C@@H]1O3,C11H16O5,29211.0
12230,CZ415,CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)c3c(n2)C(C)(C)S(=O)(=O)C3)cc1,C22H29N5O4S,27668.0
12231,1-Arachidoyl-rac-glycerol,CCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO,C23H46O4,26947.0
12232,Pefloxacin (mesylate hydrate),CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21.CS(=O)(=O)O.O.O,C18H28FN3O8S,29103.0
12233,PKUMDL-LC-101-D04,Cl.NCCNS(=O)(=O)c1ccc(NC(=S)NC2CCCC2)cc1,C14H23ClN4O2S2,28966.0
12234,diABZI STING Agonist-1 (hydrochloride),CCn1nc(C)cc1C(=O)/N=c1\[nH]c2cc(C(N)=O)cc(OC)c2n1C/C=C/Cn1/c(=N/C(=O)c2cc(C)nn2CC)[nH]c2cc(C(N)=O)cc(OCCCN3CCOCC3)c21.Cl.Cl.Cl,C42H54Cl3N13O7,28054.0
12235,Dyclonine (hydrochloride),CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1.Cl,C18H28ClNO2,27667.0
12236,Fangchinoline,COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1C)Oc1c(O)c(OC)cc3c1[C@H](C2)N(C)CC3,C37H40N2O6,29243.0
12237,BMS 189961,CC1(C)CCC(C)(C)c2cc(C(O)C(=O)Nc3ccc(C(=O)O)cc3F)ccc21,C23H26FNO4,29380.0
12238,"1,2,3-Triheptadecanoyl Glycerol-d5",[2H]C([2H])(OC(=O)CCCCCCCCCCCCCCCC)C([2H])(OC(=O)CCCCCCCCCCCCCCCC)C([2H])([2H])OC(=O)CCCCCCCCCCCCCCCC,C54H104O6,28918.0
12239,2-deoxy-D-Ribose,O=CC[C@H](O)[C@H](O)CO,C5H10O4,29072.0
12240,(-)-Triptonide,CC(C)[C@]12O[C@H]1[C@@H]1O[C@@]13[C@@]1(C)CCC4=C(COC4=O)[C@@H]1C[C@@H]1O[C@@]13C2=O,C20H22O6,29156.0
12241,Phenylpyropene A,CC(=O)OC[C@@]1(C)[C@@H]2C[C@H](OC(C)=O)[C@@]3(C)Oc4cc(-c5ccccc5)oc(=O)c4[C@H](O)[C@@H]3[C@@]2(C)CC[C@@H]1OC(C)=O,C32H38O10,29594.0
12242,"1,2-Dimyristoyl-3-Lauroyl-rac-glycerol",CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC,C43H82O6,28861.0
12243,Azomycin,O=[N+]([O-])c1ncc[nH]1,C3H3N3O2,29395.0
12244,LH1307,CC(=O)NCCNCc1cc(C)c(OCc2cccc(-c3cccc(COc4cc(OCc5cncc(C#N)c5)c(CNCCNC(C)=O)cc4C)c3C)c2C)cc1OCc1cncc(C#N)c1,C54H58N8O6,28728.0
12245,"CP 471,474",CC(C)(NS(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1)C(=O)NO,C16H17FN2O5S,29442.0
12246,Talniflumate,O=C1OC(OC(=O)c2cccnc2Nc2cccc(C(F)(F)F)c2)c2ccccc21,C21H13F3N2O4,29623.0
12247,Ginsenoside Rb3,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C53H90O22,29005.0
12248,Malabaricone B,O=C(CCCCCCCCc1ccc(O)cc1)c1c(O)cccc1O,C21H26O4,29911.0
12249,JNJ-55511118,O=c1[nH]c2ccc(-c3c(Cl)cccc3OC(F)(F)F)cc2[nH]1,C14H8ClF3N2O2,29212.0
12250,Immethridine (hydrobromide),Br.Br.c1cc(Cc2cnc[nH]2)ccn1,C9H11Br2N3,29502.0
12251,DY 268,COc1cccc(Cn2cc(C(=O)Nc3ccc(C)c(S(=O)(=O)N4CCOCC4)c3)c(-c3ccc(C)cc3)n2)c1,C30H32N4O5S,29475.0
12252,Naftifine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])N(C/C=C/c1ccccc1)Cc1cccc2ccccc12,C21H22ClN,29413.0
12253,Ailanthone,C=C1[C@@H](O)[C@]2(O)OC[C@]34[C@H]2[C@@]2(C)[C@H](O)C(=O)C=C(C)[C@@H]2C[C@H]3OC(=O)C[C@@H]14,C20H24O7,29194.0
12254,Polyphyllin I,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](CO)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C44H70O16,29179.0
12255,Vandetanib-d6,[2H]C([2H])([2H])Oc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C([2H])([2H])[2H])CC1,C22H24BrFN4O2,28710.0
12256,Serotonin-d4 (hydrochloride),Cl.[2H]C([2H])(N)C([2H])([2H])c1c[nH]c2ccc(O)cc12,C10H13ClN2O,29415.0
12257,4-Hydroxymethamphetamine (hydrochloride),CNC(C)Cc1ccc(O)cc1.Cl,C10H16ClNO,9002128.0
12258,"3,3'-((2-Chlorophenyl)methylene)bis(4-hydroxy-2H-chromen-2-one)",O=c1oc2ccccc2c(O)c1C(c1ccccc1Cl)c1c(O)c2ccccc2oc1=O,C25H15ClO6,29864.0
12259,AMG 925,C[C@H]1CC[C@H](n2c3cnccc3c3cnc(Nc4ccc5c(n4)CCN(C(=O)CO)C5)nc32)CC1,C26H29N7O2,29245.0
12260,Sphingosine-1-phosphate-d7 (d18:1),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)COP(=O)(O)O,C18H38NO5P,10008121.0
12261,NAN-190,Br.COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1,C23H28BrN3O3,29314.0
12262,Lercanidipine (hydrochloride),COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1.Cl,C36H42ClN3O6,29104.0
12263,Phentolamine-d4 (hydrochloride),Cl.[2H]C1([2H])N=C(CN(c2ccc(C)cc2)c2cccc(O)c2)NC1([2H])[2H],C17H20ClN3O,29417.0
12264,ML-311,CCN1CCN(C(c2ccc(C(F)(F)F)cc2)c2ccc3cccnc3c2O)CC1,C23H24F3N3O,29445.0
12265,Nolatrexed (hydrochloride),Cc1ccc2[nH]c(N)nc(=O)c2c1Sc1ccncc1.Cl.Cl,C14H14Cl2N4OS,29247.0
12266,UK 371804,CC(C)(NS(=O)(=O)c1ccc2c(Cl)cnc(NC(=N)N)c2c1)C(=O)O,C14H16ClN5O4S,27225.0
12267,Maytansinol,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](O)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,C28H37ClN2O8,29228.0
12268,Octanoic Acid-d15,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C8H16O2,29074.0
12269,Saccharin 1-methylimidazole,Cn1ccnc1.O=C1NS(=O)(=O)c2ccccc21,C11H11N3O3S,29242.0
12270,NSC 781406,COc1ncc(-c2ccc3nccc(C#CCN4CCN(S(C)(=O)=O)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,C29H27F2N5O5S2,29226.0
12271,"1,2-Distearoyl-d70-sn-glycero-3-PC",[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H],C44H88NO8P,28752.0
12272,BMS 204352,COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21,C16H10ClF4NO2,29378.0
12273,(S)-3-N-Cbz-amino-succinimide,O=C1C[C@H](NC(=O)OCc2ccccc2)C(=O)N1,C12H12N2O4,28568.0
12274,5?-hydroxy Laxogenin,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC(=O)[C@@]5(O)C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C27H42O5,27665.0
12275,GNE-2861,COCCNc1nc2ccc(C#CC3(O)CCCCC3)cc2n1-c1ccnc(N)n1,C22H26N6O2,29458.0
12276,FG-7142,CNC(=O)c1cc2c(cn1)[nH]c1ccccc12,C13H11N3O,29183.0
12277,Bacopaside X,CC(C)=C[C@H]1C[C@](C)(O)[C@@H]2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](CO)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@@]34CO[C@@]2(C4)O1,C46H74O17,11851.0
12278,SKF 82958 (hydrobromide),Br.C=CCN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1,C19H21BrClNO2,29033.0
12279,Pluviatolide,COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc3c(c2)OCO3)ccc1O,C20H20O6,29582.0
12280,?-ethyl 2C-D (hydrochloride),CCC(N)Cc1cc(OC)c(C)cc1OC.Cl,C13H22ClNO2,26596.0
12281,"3,4-difluoro Isopropyl U-47700",CC(C)N(C(=O)c1ccc(F)c(F)c1)[C@@H]1CCCC[C@H]1N(C)C,C18H26F2N2O,29561.0
12282,"3,4-difluoro Propyl U-47700",CCCN(C(=O)c1ccc(F)c(F)c1)[C@@H]1CCCC[C@H]1N(C)C,C18H26F2N2O,29562.0
12283,"3,4-difluoro U-50488 (hydrochloride)",CN(C(=O)Cc1ccc(F)c(F)c1)[C@@H]1CCCC[C@H]1N1CCCC1.Cl,C19H27ClF2N2O,29566.0
12284,Norstictic Acid,Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(C)c(O)c3c(c1O2)C(O)OC3=O,C18H12O9,29581.0
12285,ABT-724 (hydrochloride),Cl.Cl.Cl.c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,C17H22Cl3N5,29506.0
12286,MK-8245,O=C(O)Cn1nnc(-c2cc(N3CCC(Oc4cc(F)ccc4Br)CC3)no2)n1,C17H16BrFN6O4,29421.0
12287,Columbianadin,C/C=C(/C)C(=O)OC(C)(C)[C@@H]1Cc2c(ccc3ccc(=O)oc23)O1,C19H20O5,27661.0
12288,SNS-062,O=C(CNc1cccc(Cl)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1,C19H21ClN6O,29200.0
12289,LDC-1267,CCOc1cn(-c2ccc(F)cc2C)nc1C(=O)Nc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)c(F)c1,C30H26F2N4O5,29459.0
12290,Coniferyl Alcohol,COc1cc(/C=C/CO)ccc1O,C10H12O3,29470.0
12291,Arjunolic Acid,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,C30H48O5,29438.0
12292,Cariprazine-d6,[2H]C([2H])([2H])N(C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)C([2H])([2H])[2H],C21H32Cl2N4O,29449.0
12293,Mavorixafor,NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,C21H27N5,28439.0
12294,Stachybotrysin B,CC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H](C)[C@]23Cc2c(O)cc(CO)c(C=O)c2O3)C1(C)C,C25H34O6,29583.0
12295,CPI-1189,CC(=O)Nc1ccc(C(=O)NC(C)(C)C)cc1,C13H18N2O2,29187.0
12296,CGP 7930,CC(C)(CO)Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1,C19H32O2,29429.0
12297,1-Heptadecanoyl-rac-glycerol,CCCCCCCCCCCCCCCCC(=O)OCC(O)CO,C20H40O4,28180.0
12298,Tecadenoson,OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCOC4)ncnc32)[C@H](O)[C@@H]1O,C14H19N5O5,28449.0
12299,GNE-493,CC(C)(O)c1cc2nc(-c3cnc(N)nc3)nc(N3CCOCC3)c2s1,C17H20N6O2S,29224.0
12300,Dityrosine (hydrochloride),Cl.Cl.NC(Cc1ccc(O)c(-c2cc(CC(N)C(=O)O)ccc2O)c1)C(=O)O,C18H22Cl2N2O6,27657.0
12301,8-M-PDOT,CCC(=O)NC1CCc2cccc(OC)c2C1,C14H19NO2,29521.0
12302,RGB-286638,COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1,C29H35N7O4,29499.0
12303,GSK256066,COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1,C27H26N4O5S,28012.0
12304,Ipratropium (bromide),CC(C)[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2.[Br-],C20H30BrNO3,29423.0
12305,KY 05009,Cc1ccc(C(=O)Nc2sc(Nc3ccccc3)nc2C(N)=O)cc1,C18H16N4O2S,29552.0
12306,Adomeglivant,Cc1cc(O[C@@H](CCC(F)(F)F)c2ccc(C(=O)NCCC(=O)O)cc2)cc(C)c1-c1ccc(C(C)(C)C)cc1,C32H36F3NO4,29668.0
12307,Erdosteine,O=C(O)CSCC(=O)NC1CCSC1=O,C8H11NO4S2,29177.0
12308,Tozadenant,COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12,C19H26N4O4S,28452.0
12309,Ginkgolide J,C[C@@H]1C(=O)O[C@H]2C[C@]34[C@@H]5OC(=O)[C@]3(O[C@@H]3OC(=O)[C@H](O)C34[C@H](C(C)(C)C)[C@H]5O)[C@]21O,C20H24O10,29163.0
12310,AMG 487,CCOc1ccc(-n2c([C@@H](C)N(Cc3cccnc3)C(=O)Cc3ccc(OC(F)(F)F)cc3)nc3ncccc3c2=O)cc1,C32H28F3N5O4,28416.0
12311,4-Fluoro-L-phenylalanine,N[C@@H](Cc1ccc(F)cc1)C(=O)O,C9H10FNO2,29178.0
12312,Berkeleylactone F,C[C@H]1OC(=O)/C=C/[C@@H](O)[C@@H](O)CCCCCCCC[C@@H]1O,C16H28O5,29592.0
12313,DiD (4-chlorobenzenesulfonate salt),CCCCCCCCCCCCCCCCCCN1/C(=C/C=C/C=C/C2=[N+](CCCCCCCCCCCCCCCCCC)c3ccccc3C2(C)C)C(C)(C)c2ccccc21.O=S(=O)([O-])c1ccc(Cl)cc1,C67H103ClN2O3S,29115.0
12314,Nepodin,CC(=O)c1c(C)cc2cccc(O)c2c1O,C13H12O3,27611.0
12315,NCS-382 (sodium salt),O=C([O-])/C=C1\CCCc2ccccc2C1O.[Na+],C13H13NaO3,29315.0
12316,EMPA,CCN(Cc1cccnc1)C(=O)CN(c1ccc(OC)nc1)S(=O)(=O)c1ccccc1C,C23H26N4O4S,29446.0
12317,CU-CPT9a,COc1ccc2c(-c3ccc(O)c(C)c3)ccnc2c1,C17H15NO2,28722.0
12318,Hypotaurine,NCCS(=O)O,C2H7NO2S,29614.0
12319,SMI-16a,CCCOc1ccc(/C=C2/SC(=O)NC2=O)cc1,C13H13NO3S,29456.0
12320,Opipramol,OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1,C23H29N3O,29471.0
12321,Evoxanthine,COc1c2c(cc3c1c(=O)c1ccccc1n3C)OCO2,C16H13NO4,29437.0
12322,NBI 74330,CCOc1ccc(-n2c([C@@H](C)N(Cc3cccnc3)C(=O)Cc3ccc(F)c(C(F)(F)F)c3)nc3ncccc3c2=O)cc1,C32H27F4N5O3,28442.0
12323,Imetit (hydrobromide),Br.Br.N=C(N)SCCc1cnc[nH]1,C6H12Br2N4S,29517.0
12324,Paquinimod,CCc1cccc2c1c(O)c(C(=O)N(CC)c1ccccc1)c(=O)n2C,C21H22N2O3,28443.0
12325,4-methoxy MiPT (hydrochloride),COc1cccc2[nH]cc(CCN(C)C(C)C)c12.Cl,C15H23ClN2O,29384.0
12326,DADLE,CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O,C29H39N5O7,28928.0
12327,SGC-iMLLT,C[C@H]1CCCN1Cc1nc2cc(NC(=O)c3ccc4c(cnn4C)c3)ccc2[nH]1,C22H24N6O,28113.0
12328,Phospho-Ginkgolic Acid,CCCCCCCCCCCCCCCc1cccc(OP(=O)(O)O)c1C(=O)O,C22H37O6P,29638.0
12329,Immepip (hydrobromide),Br.Br.c1ncc(CC2CCNCC2)[nH]1,C9H17Br2N3,29518.0
12330,Telotristat,Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1,C25H22ClF3N6O3,29424.0
12331,Tanshinone IIA sulfonate (sodium salt),Cc1c(S(=O)(=O)[O-])oc2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C.[Na+],C19H17NaO6S,29229.0
12332,LDC000067,COc1ccccc1-c1cc(Nc2cccc(CS(N)(=O)=O)c2)ncn1,C18H18N4O3S,29419.0
12333,SPI 112,O=C1Nc2ccc(S(=O)(=O)NCc3ccc(F)cc3)cc2/C1=N/Nc1cccc(C(=O)O)c1,C22H17FN4O5S,29474.0
12334,"(2R,6R)-Hydroxynorketamine (hydrochloride)",Cl.N[C@@]1(c2ccccc2Cl)CCC[C@@H](O)C1=O,C12H15Cl2NO2,19603.0
12335,AIM 100,c1ccc(-c2oc3ncnc(NC[C@@H]4CCCO4)c3c2-c2ccccc2)cc1,C23H21N3O2,29487.0
12336,DL-TBOA,N[C@H](C(=O)O)[C@H](OCc1ccccc1)C(=O)O,C11H13NO5,29632.0
12337,Despropionyl Remifentanil,COC(=O)CCN1CCC(Nc2ccccc2)(C(=O)OC)CC1,C17H24N2O4,9003390.0
12338,Risdiplam,Cc1cn2nc(-c3cc(=O)n4cc(N5CCNC6(CC6)C5)ccc4n3)cc(C)c2n1,C22H23N7O,29028.0
12339,"1,10-Phenanthroline (hydrate)",O.c1cnc2c(c1)ccc1cccnc12,C12H10N2O,28951.0
12340,Nomifensine,CN1Cc2c(N)cccc2C(c2ccccc2)C1,C16H18N2,29330.0
12341,Bisacodyl,CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1,C22H19NO4,28826.0
12342,"CP 94,253 (hydrochloride)",CCCOc1ccc2[nH]cc(C3=CCNCC3)c2n1.Cl,C15H20ClN3O,29486.0
12343,"3,4-difluoro-N-desmethyl U-47700 (hydrochloride)",CN[C@@H]1CCCC[C@H]1N(C)C(=O)c1ccc(F)c(F)c1.Cl,C15H21ClF2N2O,29560.0
12344,Gibberellic Acid,C=C1C[C@]23C[C@@]1(O)CC[C@H]2[C@@]12C=C[C@H](O)[C@@](C)(C(=O)O1)[C@H]2[C@@H]3C(=O)O,C19H22O6,29322.0
12345,Chlormadinone Acetate,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,C23H29ClO4,29392.0
12346,TP-3654,CC(C)(O)[C@H]1CC[C@H](Nc2ccc3ncc(-c4cccc(C(F)(F)F)c4)n3n2)CC1,C22H25F3N4O,29571.0
12347,"1,2,3-Trinonanoyl Glycerol",CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC)OC(=O)CCCCCCCC,C30H56O6,28177.0
12348,4-fluoro U-47931E,CN(C)[C@@H]1CCCC[C@H]1NC(=O)c1ccc(F)cc1,C15H21FN2O,29563.0
12349,Hydrocodone (bitartrate),COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C22H27NO9,22166.0
12350,DO264,FC(F)(F)Oc1ccc(Oc2ccnc(N3CCC(NC(=S)Nc4cccnc4)CC3)c2Cl)c(Cl)c1,C23H20Cl2F3N5O2S,29402.0
12351,1-Palmitoyl-2-Oleoyl-3-Arachidonoyl-rac-glycerol,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C57H100O6,29057.0
12352,C24:1 dihydro 1-Deoxyceramide (m18:0/24:1),CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)N[C@@H](C)[C@H](O)CCCCCCCCCCCCCCC,C42H83NO2,27562.0
12353,Prunetin,COc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1,C16H12O5,29432.0
12354,Bifeprunox (mesylate),CS(=O)(=O)O.O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,C25H27N3O5S,29523.0
12355,Ro 60-0175,C[C@H](N)Cn1ccc2cc(F)c(Cl)cc21.O=C(O)/C=C/C(=O)O,C15H16ClFN2O4,29520.0
12356,BMS 753,CC1(C)C(=O)C(C)(C)c2cc(C(=O)Nc3ccc(C(=O)O)cc3)ccc21,C21H21NO4,29493.0
12357,LY334370 (hydrochloride),CN1CCC(c2c[nH]c3ccc(NC(=O)c4ccc(F)cc4)cc23)CC1.Cl,C21H23ClFN3O,29481.0
12358,Hydrocortisone Acetate,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,C23H32O6,29390.0
12359,"1,3-Dipalmitoyl-2-Octanoyl Glycerol",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC,C43H82O6,29058.0
12360,IKD-8344,C[C@@H]([C@@H]1CC[C@@H](C)O1)[C@H]1C[C@@H]2CC[C@@H](O2)[C@@H](C)C(=O)C[C@@H]2CC[C@H](O2)[C@H](C)C(=O)O[C@@H]([C@@H](C)[C@@H]2CC[C@@H](C)O2)C[C@@H]2CC[C@@H](O2)[C@@H](C)C(=O)C[C@@H]2CC[C@H](O2)[C@H](C)C(=O)O1,C48H76O12,28194.0
12361,Bropirimine,Nc1nc(=O)c(Br)c(-c2ccccc2)[nH]1,C10H8BrN3O,29440.0
12362,BRL 44408 (maleate),CC1c2ccccc2CN1CC1=NCCN1.O=C(O)/C=C\C(=O)O,C17H21N3O4,29454.0
12363,Dimaprit (hydrochloride),CN(C)CCCSC(=N)N.Cl.Cl,C6H17Cl2N3S,29418.0
12364,TMI 1,CC#CCOc1ccc(S(=O)(=O)N2CCSC(C)(C)[C@@H]2C(=O)NO)cc1,C17H22N2O5S2,29713.0
12365,AZD 9272,N#Cc1cc(F)cc(-c2nc(-c3ccc(F)cn3)no2)c1,C14H6F2N4O,29717.0
12366,5-Heneicosylresorcinol,CCCCCCCCCCCCCCCCCCCCCc1cc(O)cc(O)c1,C27H48O2,30031.0
12367,Palmitic Acid-13C (C2 labeled),CCCCCCCCCCCCCC[13CH2]C(=O)O,C16H32O2,28916.0
12368,Decynium-22,CCN1/C(=C/c2ccc3ccccc3[n+]2CC)C=Cc2ccccc21.[I-],C23H23IN2,29494.0
12369,"N,N-Dimethylphenethylamine (hydrochloride)",CN(C)CCc1ccccc1.Cl,C10H16ClN,29754.0
12370,Terbutaline (hemisulfate),CC(C)(C)NCC(O)c1cc(O)cc(O)c1.CC(C)(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O,C24H40N2O10S,21292.0
12371,?9-THC Acetate,CCCCCc1cc(OC(C)=O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C23H32O3,29210.0
12372,?9-THC Acetate (CRM),CCCCCc1cc(OC(C)=O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C23H32O3,37914.0
12373,N-isopropyl Hexylone (hydrochloride),CCCCC(NC(C)C)C(=O)c1ccc2c(c1)OCO2.Cl,C16H24ClNO3,27076.0
12374,Dantrolene-d4,[2H]c1c([2H])c([N+](=O)[O-])c([2H])c([2H])c1-c1ccc(C=NN2CC(=O)NC2=O)o1,C14H10N4O5,29451.0
12375,BI-9627,CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1,C16H19F3N4O2,27640.0
12376,SCIO 469,C[C@@H]1CN(Cc2ccc(F)cc2)[C@@H](C)CN1C(=O)c1cc2c(C(=O)C(=O)N(C)C)cn(C)c2cc1Cl,C27H30ClFN4O3,29484.0
12377,Dapiprazole (hydrochloride),Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1.Cl,C19H28ClN5,29222.0
12378,Myrothecine A,CC(=O)[C@@]12CC/C=C/C(=O)O[C@@H]3C[C@H]4O[C@@H]5[C@@H]6C[C@@]4(O)[C@@]3(C)[C@]5(CC[C@@]6(C)O)COC(=O)/C=C(/CCO1)[C@H]2O,C29H38O10,28193.0
12379,Vortioxetine,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,C18H22N2S,30183.0
12380,N-3-oxo-decanoyl-L-Homoserine lactone,CCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O,C14H23NO4,13026.0
12381,ADB-BUTINACA,CCCCn1nc(C(=O)N[C@H](C(N)=O)C(C)(C)C)c2ccccc21,C18H26N4O2,29350.0
12382,ADB-BUTINACA (CRM),CCCCn1nc(C(=O)N[C@H](C(N)=O)C(C)(C)C)c2ccccc21,C18H26N4O2,40384.0
12383,Metonitazene,CCN(CC)CCn1c(Cc2ccc(OC)cc2)nc2cc([N+](=O)[O-])ccc21,C21H26N4O3,26398.0
12384,4-Dimethylamino-N-benzylcathinone (hydrochloride),CC(NCc1ccccc1)C(=O)c1ccc(N(C)C)cc1.Cl.Cl,C18H24Cl2N2O,28893.0
12385,PD 173212,CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)NC(C)(C)C)N(C)Cc1ccc(C(C)(C)C)cc1,C38H53N3O3,29447.0
12386,S26948,COC(=O)C(Cc1ccc(OCCn2c(=O)sc3cc(C(=O)c4ccccc4)ccc32)cc1)C(=O)OC,C28H25NO7S,29722.0
12387,Codeinone,COc1ccc2c3c1O[C@H]1C(=O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314,C18H19NO3,29917.0
12388,Suc-Ile-Glu(?-pip)-Gly-Arg-pNA (hydrochloride),CC[C@H](C)[C@H](NC(=O)CCC(=O)O)C(=O)N[C@@H](CCC(=O)N1CCCCC1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc([N+](=O)[O-])cc1.Cl,C34H53ClN10O10,27707.0
12389,BLX3887,O=C(Nc1ccc(F)cc1Cl)c1n[nH]c(Cl)c1Cl,C10H5Cl3FN3O,27391.0
12390,UAMC-3203 (hydrochloride),Cl.O=S(=O)(NCCN1CCNCC1)c1ccc(NC2CCCCC2)c(NCc2ccccc2)c1,C25H38ClN5O2S,29346.0
12391,Amthamine (hydrobromide),Br.Br.Cc1nc(N)sc1CCN,C6H13Br2N3S,29503.0
12392,A-1070722,COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1,C17H13F3N4O2,29783.0
12393,Bromodiphenhydramine (hydrochloride),CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1.Cl,C17H21BrClNO,29636.0
12394,AC-710,CCN1C(C)(C)CC(Oc2ccc(C(=O)Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2)CC1(C)C,C31H42N6O4,29498.0
12395,MLN8054,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,C25H15ClF2N4O2,27340.0
12396,ARN810,CC/C(=C(/c1ccc(/C=C/C(=O)O)cc1)c1ccc2[nH]ncc2c1)c1ccc(F)cc1Cl,C26H20ClFN2O2,29595.0
12397,Sophocarpine,O=C1C=CC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34,C15H22N2O,29598.0
12398,"N-(1-methylpentyl)-3,4-DMA (hydrochloride)",CCCCC(C)NC(C)Cc1ccc(OC)c(OC)c1.Cl,C17H30ClNO2,29859.0
12399,Tetracaine,CCCCNc1ccc(C(=O)OCCN(C)C)cc1,C15H24N2O2,30059.0
12400,IP7e,COCCOCc1ccc(-c2cc3onc(-c4ccccc4)c3c(=O)n2C)cc1,C23H22N2O4,29726.0
12401,Oxymorphone (hydrochloride),CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl,C17H20ClNO4,29435.0
12402,Wogonoside,COc1c(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,C22H20O11,29332.0
12403,Gliquidone,COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C,C27H33N3O6S,29596.0
12404,JT010,COCCCN(C(=O)CCl)c1nc(-c2ccc(OC)cc2)cs1,C16H19ClN2O3S,29732.0
12405,Phenazopyridine (hydrochloride),Cl.Nc1ccc(/N=N/c2ccccc2)c(N)n1,C11H12ClN5,29683.0
12406,GSK2982772,CN1C(=O)[C@@H](NC(=O)c2nnc(Cc3ccccc3)[nH]2)COc2ccccc21,C20H19N5O3,29230.0
12407,Hexylglutathione,CCCCCCSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,C16H29N3O6S,29695.0
12408,?-hydroxy Flualprazolam,OCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,C17H12ClFN4O,29206.0
12409,Ani 9,COc1ccccc1/C=N/NC(=O)COc1ccc(Cl)cc1C,C17H17ClN2O3,29733.0
12410,Merimepodib,COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1,C23H24N4O6,29351.0
12411,Brivudine,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/Br,C11H13BrN2O5,29448.0
12412,Quinacrine mustard (hydrochloride),COc1ccc2nc3cc(Cl)ccc3c(NC(C)CCCN(CCCl)CCCl)c2c1.Cl.Cl,C23H30Cl5N3O,29653.0
12413,BRD-9424,CCn1cc(NC(=S)Nc2cc(Cl)ccc2OC)c(C(N)=O)n1,C14H16ClN5O2S,29013.0
12414,5-Tricosylresorcinol,CCCCCCCCCCCCCCCCCCCCCCCc1cc(O)cc(O)c1,C29H52O2,30032.0
12415,RRx-001,O=C(CBr)N1CC([N+](=O)[O-])([N+](=O)[O-])C1,C5H6BrN3O5,28846.0
12416,YE 120,CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1,C16H9Cl2N3O,29720.0
12417,IT1t (hydrochloride),CC1(C)CN2C(CS/C(=N/C3CCCCC3)NC3CCCCC3)=CSC2=N1.Cl.Cl,C21H36Cl2N4S2,28434.0
12418,"1,3-Diarachidonoyl-2-Oleoyl Glycerol",CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C61H100O6,29232.0
12419,Phytanic Acid-d3,[2H]C([2H])([2H])C(CCCC(C)CCCC(C)CCCC(C)C)CC(=O)O,C20H40O2,29068.0
12420,JCP251,COc1oc(=O)c2cc(N)ccc2c1Cl,C10H8ClNO3,28712.0
12421,Boc-Lys(Ac)-AMC,CC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2c(C)cc(=O)oc2c1,C23H31N3O6,29682.0
12422,Chlorquinaldol,Cc1ccc2c(Cl)cc(Cl)c(O)c2n1,C10H7Cl2NO,29396.0
12423,Dihydrostreptomycin (sulfate),CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(=N)N)[C@@H](O)[C@@H]3NC(=N)N)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O,C21H43N7O16S,27879.0
12424,Maltopentaose,O=C[C@H](O)[C@@H](O)[C@H](O[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,C30H52O26,28456.0
12425,Zotarolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@H](n3cnnn3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,C52H79N5O12,29246.0
12426,Ro 41-0960,O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F,C13H8FNO5,29621.0
12427,Dyngo-4a,O=C(N/N=C/c1cc(O)c(O)cc1O)c1cc2ccccc2cc1O,C18H14N2O5,29479.0
12428,"CP 99,994 (hydrochloride)",COc1ccccc1CN[C@H]1CCCN[C@H]1c1ccccc1.Cl.Cl,C19H26Cl2N2O,27669.0
12429,5'-Deoxyadenosine,C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,C10H13N5O3,29619.0
12430,"1,2,3-Trioctanoyl Glycerol",CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,C27H50O6,26952.0
12431,ESI-05,Cc1ccc(S(=O)(=O)c2c(C)cc(C)cc2C)cc1,C16H18O2S,29702.0
12432,SB 222200,CC[C@H](NC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12)c1ccccc1,C26H24N2O,29422.0
12433,SKF 83566 (hydrobromide),Br.CN1CCc2cc(Br)c(O)cc2C(c2ccccc2)C1,C17H19Br2NO,29480.0
12434,MK-3903,Cc1ccc(Oc2nc3cc(Cl)c(-c4ccc(-c5ccccc5)cc4)cc3[nH]2)cc1C(=O)O,C27H19ClN2O3,29661.0
12435,"1,2,3-Trilinoleoyl Glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C57H98O6,26951.0
12436,L-Tryptophan,N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,C11H12N2O2,29600.0
12437,8-(3-Chlorostyryl)caffeine,Cn1c(=O)c2c(nc(/C=C/c3cccc(Cl)c3)n2C)n(C)c1=O,C16H15ClN4O2,29704.0
12438,Satratoxin G,CC1=CC2OC3CC4OC(=O)/C=C\C=C\C5(C(C)O)OCCC6(OC6C(=O)OCC2(CC1)C4(C)C31CO1)C5O,C29H36O10,9003415.0
12439,Penbutolol (hemisulfate),CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.O=S(=O)(O)O,C36H60N2O8S,29524.0
12440,Josamycin,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O,C42H69NO15,29606.0
12441,AZ 12216052,CCC(C)c1ccc(NC(=O)CSCc2ccc(Br)cc2)cc1,C19H22BrNOS,29460.0
12442,RJR 2429 (hydrochloride),Cl.Cl.c1cncc(C2CC3CCN2CC3)c1,C12H18Cl2N2,29745.0
12443,Dilazep (hydrochloride),COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC.Cl.Cl,C31H46Cl2N2O10,29761.0
12444,Asperuloside,CC(=O)OCC1=C[C@@H]2OC(=O)C3=CO[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H]1[C@@H]32,C18H22O11,29439.0
12445,LP-211,N#Cc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1,C30H34N4O,29659.0
12446,AZ3451,C[C@@H](C1CCCCC1)n1c(-c2cc3c(cc2Br)OCO3)nc2cc(C(=O)Nc3ccc(C#N)cc3)ccc21,C30H27BrN4O3,29671.0
12447,Hydromorphone (hydrochloride),CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5.Cl,C17H20ClNO3,26515.0
12448,Rupatadine (fumarate),Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1.O=C(O)/C=C/C(=O)O,C30H30ClN3O4,29478.0
12449,Filgotinib-d4,[2H]C1([2H])C(C(=O)Nc2nc3cccc(-c4ccc(CN5CCS(=O)(=O)CC5)cc4)n3n2)C1([2H])[2H],C21H23N5O3S,28875.0
12450,"2,5-Dihydroxycinnamic Acid phenethyl ester",O=C(/C=C/c1cc(O)ccc1O)OCCc1ccccc1,C17H16O4,29736.0
12451,"1,2,3-Trielaidoyl Glycerol",CCCCCCCC/C=C/CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C/CCCCCCCC)OC(=O)CCCCCCC/C=C/CCCCCCCC,C57H104O6,26950.0
12452,INH1,Cc1ccc(-c2csc(NC(=O)c3ccccc3)n2)c(C)c1,C18H16N2OS,29015.0
12453,Trichlormethiazide,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,C8H8Cl3N3O4S2,29331.0
12454,GLP-1R Agonist DMB,CC(C)(C)Nc1nc2cc(Cl)c(Cl)cc2nc1S(C)(=O)=O,C13H15Cl2N3O2S,29678.0
12455,Cyclo(RGDfK),N=C(N)NCCC[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O,C27H41N9O7,29514.0
12456,"N-(1,4-dimethylpentyl)-3,4-DMA (hydrochloride)",COc1ccc(CC(C)NC(C)CCC(C)C)cc1OC.Cl,C18H32ClNO2,29844.0
12457,Tiamulin-d10 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])([2H])N(CCSCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@]23CCC(=O)[C@H]2[C@@]1(C)[C@H](C)CC3)C([2H])([2H])C([2H])([2H])[2H],C28H48ClNO4S,29580.0
12458,KPT-276,O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)N1CC(F)(F)C1,C16H10F8N4O,29158.0
12459,Hexacosanoic Acid methyl ester-d3,[2H]C([2H])([2H])CCCCCCCCCCCCCCCCCCCCCCCCC(=O)OC,C27H54O2,28085.0
12460,L-Cysteinesulfinic Acid (hydrate),N[C@@H](CS(=O)O)C(=O)O.O,C3H9NO5S,29597.0
12461,CU CPT 22,CCCCCCOC(=O)c1cc(O)c(=O)c2c(O)c(O)c(OC)cc2c1,C19H22O7,15244.0
12462,Satratoxin H,CC1=C[C@H]2O[C@@H]3C[C@H]4OC(=O)/C=C\C=C\[C@]5([C@H](C)O)OCC/C(=C\C(=O)OC[C@@]2(CC1)[C@]4(C)[C@]31CO1)C5O,C29H36O9,30199.0
12463,4'-O-Methylresveratrol,COc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,C15H14O3,29106.0
12464,NS 8593 (hydrochloride),Cl.c1ccc2c(c1)CCC[C@H]2Nc1nc2ccccc2[nH]1,C17H18ClN3,29774.0
12465,"N-(1,4-dimethylpentyl)-4-Methoxyamphetamine (hydrochloride)",COc1ccc(CC(C)NC(C)CCC(C)C)cc1.Cl,C17H30ClNO,29857.0
12466,Propentofylline,CCCn1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2C,C15H22N4O3,29431.0
12467,Rec 15/2615 (hydrochloride),COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC.Cl.Cl,C26H35Cl2N5O5,27677.0
12468,Fruquintinib,CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12,C21H19N3O5,29425.0
12469,(R)-Ofloxacin,C[C@@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,C18H20FN3O4,29601.0
12470,FR901379,CCCCCCCCCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)c(OS(=O)(=O)O)c2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O,C51H82N8O21S,29648.0
12471,TB 21007,CC1(C)CC(=O)c2c(SCCO)sc(-c3nccs3)c2C1,C15H17NO2S3,27674.0
12472,ASP7657,O=C(NC[C@H]1CC[C@H](C(=O)O)CC1)c1cc(C(F)(F)F)cc2ccn(Cc3ccc4ccccc4n3)c12,C28H26F3N3O3,28578.0
12473,Destruxin B2,CC(C)C[C@H]1OC(=O)CCNC(=O)[C@H](C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C1=O,C29H49N5O7,30210.0
12474,Diaveridine,COc1ccc(Cc2cnc(N)nc2N)cc1OC,C13H16N4O2,29427.0
12475,ORG 12962 (hydrochloride),Cl.FC(F)(F)c1ccc(N2CCNCC2)nc1Cl,C10H12Cl2F3N3,27675.0
12476,1?-Acetoxypolygodial,CC(=O)O[C@@H]1CCC(C)(C)[C@@H]2CC=C(C=O)[C@H](C=O)[C@@]12C,C17H24O4,29901.0
12477,Carnaubadiol,C=C(C)[C@H](C)CC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1CC[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,C31H54O2,29728.0
12478,LY344864 (hydrochloride),CN(C)[C@@H]1CCc2[nH]c3ccc(NC(=O)c4ccc(F)cc4)cc3c2C1,C21H22FN3O,29496.0
12479,Garcinoic Acid,C/C(=C\CC/C(C)=C/CC[C@]1(C)CCc2cc(O)cc(C)c2O1)CC/C=C(\C)C(=O)O,C27H38O4,28122.0
12480,Drimendiol,CC1(C)CCC[C@]2(C)[C@@H](CO)C(CO)=CC[C@@H]12,C15H26O2,29820.0
12481,Azadirachtin B,C/C=C(\C)C(=O)O[C@@H]1C[C@H](O)[C@]23CO[C@H](C(=O)OC)[C@H]2[C@](C)([C@]24O[C@@]2(C)[C@H]2C[C@@H]4O[C@@H]4OC=C[C@@]42O)[C@H](O)[C@@H]2OC[C@@]1(C(=O)OC)[C@H]23,C33H42O14,29569.0
12482,Eleutheroside E,COc1cc([C@H]2OC[C@@H]3[C@@H]2CO[C@H]3c2cc(OC)c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)c2)cc(OC)c1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C34H46O18,29684.0
12483,Dihydronovobiocin,CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CCC(C)C)c4)c(=O)oc3c2C)OC1(C)C,C31H38N2O11,29649.0
12484,VUF 5574,COc1ccccc1NC(=O)Nc1nc(-c2cccnc2)nc2ccccc12,C21H17N5O2,27676.0
12485,Alphitonin,O=C1c2c(O)cc(O)cc2OC1(O)Cc1ccc(O)c(O)c1,C15H12O7,29716.0
12486,(5E)-7-Oxozeaenol,COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C/C[C@H](C)OC2=O,C19H22O7,29840.0
12487,1-Pentadecanoyl-rac-glycerol,CCCCCCCCCCCCCCC(=O)OCC(O)CO,C18H36O4,26959.0
12488,17(S)-HDHA-d5,[2H]C([2H])([2H])C([2H])([2H])/C=C\C[C@H](O)/C=C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C22H32O3,29797.0
12489,TAK-385,CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1,C29H27F2N7O5S,29512.0
12490,Methylspinazarin,Cc1cc(O)c2c(c1O)C(=O)C(O)=C(O)C2=O,C11H8O6,29898.0
12491,Berkeleylactone E,C[C@@H]1CCCCCCCCC[C@H](OC(=O)CCC(=O)O)[C@H](O)/C=C/C(=O)O1,C20H32O7,29826.0
12492,Radicinol,C/C=C/c1cc2c(c(=O)o1)[C@H](O)[C@@H](O)[C@H](C)O2,C12H14O5,29861.0
12493,SB-649868,Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccc(F)cc2)s1,C26H24FN3O3S,29477.0
12494,(E)-Guggulsterone,C/C=C1\C(=O)CC2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C,C21H28O2,10011296.0
12495,Multiflorenol,CC1(C)CC[C@]2(C)CC[C@]3(C)C4=CC[C@H]5C(C)(C)[C@@H](O)CC[C@]5(C)[C@H]4CC[C@@]3(C)[C@@H]2C1,C30H50O,29709.0
12496,ENPP1 Inhibitor C,Cc1nc2ncnn2c(N(C)C)c1Cc1cccc(N)c1,C15H18N6,29809.0
12497,Terrelumamide A,COC(=O)c1ccccc1NC(=O)[C@@H](NC(=O)c1cnc2c(n1)c(=O)[nH]c(=O)n2C)[C@@H](C)O,C20H20N6O7,29836.0
12498,"3,4-difluoro-N,N-didesmethyl U-47700 (trifluoroacetate salt)",CN(C(=O)c1ccc(F)c(F)c1)[C@@H]1CCCC[C@H]1N.O=C(O)C(F)(F)F,C16H19F5N2O3,29559.0
12499,"3,4-difluoro U-49900 (hydrochloride)",CCN(CC)[C@@H]1CCCC[C@H]1N(C)C(=O)c1ccc(F)c(F)c1.Cl,C18H27ClF2N2O,29565.0
12500,Polygodial pyridazine,CC1(C)CCC[C@]2(C)c3cnncc3CC[C@@H]12,C15H22N2,29900.0
12501,BMS-1001 (hydrochloride),Cc1cc(CN[C@H](CO)C(=O)O)c(OCc2cccc(C#N)c2)cc1OCc1cccc(-c2ccc3c(c2)OCCO3)c1C.Cl,C35H35ClN2O7,27891.0
12502,RO-3,COc1cc(Cc2cnc(N)nc2N)c(C(C)C)cc1OC,C16H22N4O2,29635.0
12503,Salazinic Acid,Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(CO)c(O)c3c(c1O2)C(O)OC3=O,C18H12O10,29885.0
12504,Tetrazolyl Glycine,NC(C(=O)O)c1nnn[nH]1,C3H5N5O2,28408.0
12505,Cilazapril,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O,C22H31N3O5,29777.0
12506,Teneligliptin (hydrobromide hydrate),Br.Br.Br.Br.Br.Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1.Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1.O,C44H65Br5N12O2S2(H2O)X,29515.0
12507,Cebranopadol,CN(C)[C@]1(c2ccccc2)CC[C@]2(CC1)OCCc1c3cc(F)ccc3[nH]c12,C24H27FN2O,29500.0
12508,"1,2-Dipalmitoyl-d6-rac-glycero-3-PC",[2H]C([2H])([2H])CCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC([2H])([2H])[2H],C40H80NO8P,28932.0
12509,AC480,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,C27H27FN8O3,29657.0
12510,Pirenzepine (hydrochloride),CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1.Cl.Cl,C19H23Cl2N5O2,29527.0
12511,"1,2-Dipalmitoyl-13C-sn-glycero-3-PC",CCCCCCCCCCCCCCC[13C](=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)O[13C](=O)CCCCCCCCCCCCCCC,C40H80NO8P,29133.0
12512,Dihydroergocristine (mesylate),CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O,C36H45N5O8S,29492.0
12513,Hypaconitine,COC[C@@]12CC[C@H](OC)C34C(C([C@H](OC)[C@@H]31)[C@]1(OC(C)=O)[C@@H]3[C@H]4C[C@@](O)([C@@H]3OC(=O)c3ccccc3)[C@@H](OC)[C@@H]1O)N(C)C2,C33H45NO10,29656.0
12514,DCEBIO,CCn1c(=O)[nH]c2cc(Cl)c(Cl)cc21,C9H8Cl2N2O,29426.0
12515,Coniferyl Ferulate,COc1cc(/C=C/COC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,C20H20O6,29620.0
12516,Kaempferide,COc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2O)cc1,C16H12O6,29673.0
12517,Zofenopril (calcium salt),CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)[O-].CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)[O-].[Ca+2],C44H44CaN2O8S4,29525.0
12518,Tasosartan,Cc1nc(C)c2c(n1)N(Cc1ccc(-c3ccccc3-c3nnn[nH]3)cc1)C(=O)CC2,C23H21N7O,29495.0
12519,SB-328437,COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12,C21H18N2O5,29677.0
12520,N-Nonyldeoxynojirimycin,CCCCCCCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,C15H31NO4,29698.0
12521,2?-methyl-5?-Androstan-17-one-3?-Glucuronide,C[C@@H]1C[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]32)C[C@@H]1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,C26H40O8,23088.0
12522,E2012,COc1cc(/C=C2\CCCN([C@@H](C)c3ccc(F)cc3)C2=O)ccc1-n1cnc(C)c1,C25H26FN3O2,29710.0
12523,SD 2590 (hydrochloride),COCCN1CCC(C(=O)NO)(S(=O)(=O)c2ccc(Oc3ccc(OC(F)(F)F)cc3)cc2)CC1.Cl,C22H26ClF3N2O7S,27680.0
12524,Zardaverine,COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F,C12H10F2N2O3,29685.0
12525,Senicapoc,NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1,C20H15F2NO,29679.0
12526,Pulsatilla Saponin D,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CC[C@]6(C(=O)O)CC[C@]45C)[C@]3(C)CO)OC[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C47H76O17,29455.0
12527,GRA Ex-25,CC(C)(C)[C@H]1CC[C@H](N(Cc2ccc(C(=O)NCCC(=O)O)cc2)C(=O)Nc2ccc(OC(F)(F)F)cc2)CC1,C29H36F3N3O5,29727.0
12528,5-Methoxyindole-3-acetic Acid,COc1ccc2[nH]cc(CC(=O)O)c2c1,C11H11NO3,14019.0
12529,S-Acetyl-L-glutathione,CC(=O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,C12H19N3O7S,29624.0
12530,Vicriviroc (maleate),COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C.O=C(O)/C=C\C(=O)O,C32H42F3N5O6,28453.0
12531,CK-666,Cc1[nH]c2ccccc2c1CCNC(=O)c1ccccc1F,C18H17FN2O,29038.0
12532,PKG Drug G1,Cc1[nH]c2ccccc2c1/C=C1\NC(=S)NC1=O,C13H11N3OS,29768.0
12533,Norcocaine (hydrochloride),COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2.Cl,C16H20ClNO4,28492.0
12534,C22 dihydro 1-Deoxyceramide (m18:0/22:0),CCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](C)[C@H](O)CCCCCCCCCCCCCCC,C40H81NO2,27018.0
12535,4-Methylumbelliferone,Cc1cc(=O)oc2cc(O)ccc12,C10H8O3,29603.0
12536,3?-OH-7-Oxocholenic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H36O4,29541.0
12537,Protonitazene (hydrochloride),CCCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1.Cl,C23H31ClN4O3,29381.0
12538,Protonitazene (hydrochloride) (exempt preparation),CCCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1.Cl,C23H31ClN4O3,38143.0
12539,3-TYP,c1cncc(-c2cnn[nH]2)c1,C7H6N4,29660.0
12540,Ganoderic Acid H,CC(=O)O[C@@H]1C(=O)C2=C(C(=O)CC3C2(C)CC[C@H](O)C3(C)C)C2(C)C(=O)CC(C(C)CC(=O)CC(C)C(=O)O)C12C,C32H44O9,29703.0
12541,Arginase Inhibitor 1,N[C@](CCCCB(O)O)(CCN1CCCCC1)C(=O)O,C13H27BN2O4,28418.0
12542,Trandolaprilat (hydrate),C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21.O,C22H32N2O6,29577.0
12543,Epimedin B,COc1ccc(-c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)cc1,C38H48O19,29694.0
12544,Eupatorin,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1O,C18H16O7,29599.0
12545,Ascorbyl Palmitate,CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O,C22H38O7,29604.0
12546,Isorhynchophylline,CC[C@H]1CN2CC[C@@]3(C(=O)Nc4ccccc43)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C22H28N2O4,29650.0
12547,Adarotene,O=C(O)/C=C/c1ccc(-c2ccc(O)c(C34CC5CC(CC(C5)C3)C4)c2)cc1,C25H26O3,29807.0
12548,Rafoxanide,O=C(Nc1ccc(Oc2ccc(Cl)cc2)c(Cl)c1)c1cc(I)cc(I)c1O,C19H11Cl2I2NO3,29616.0
12549,VU0240551,Cc1csc(NC(=O)CSc2ccc(-c3ccccc3)nn2)n1,C16H14N4OS2,29790.0
12550,Ethoprop,CCCSP(=O)(OCC)SCCC,C8H19O2PS2,27609.0
12551,Fenvalerate,CC(C)C(C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1)c1ccc(Cl)cc1,C25H22ClNO3,29399.0
12552,Filorexant,Cc1ccc(-c2ncccn2)c(C(=O)N2C[C@H](COc3ccc(F)cn3)CC[C@H]2C)c1,C24H25FN4O2,29490.0
12553,Upadacitinib,CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,C17H19F3N6O,29706.0
12554,NSC 15520,CC(C)C1=CC23CCC4C(C)(C(=O)O)CCCC4(C)C2CC1C(C(=O)O)C3C(=O)O,C24H34O6,26020.0
12555,Arundic Acid,CCCCCC[C@@H](CCC)C(=O)O,C11H22O2,29087.0
12556,Cytidine,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,C9H13N3O5,29602.0
12557,D13,O=C(N/N=C/c1cc(Br)cc(Br)c1O)c1ccc(Br)cc1,C14H9Br3N2O2,29818.0
12558,GR127935 (hydrochloride),COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1N1CCN(C)CC1.Cl,C29H32ClN5O3,29651.0
12559,OGG1-IN-O8,NNC(=O)c1sc2cccc(Cl)c2c1Cl,C9H6Cl2N2OS,29769.0
12560,Verinurad,CC(C)(Sc1ccncc1-c1ccc(C#N)c2ccccc12)C(=O)O,C20H16N2O2S,29667.0
12561,MT-DADMe-ImmA,CSC[C@H]1CN(Cc2c[nH]c3c(N)ncnc23)C[C@@H]1O,C13H19N5OS,29711.0
12562,BIBX1382,CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1,C18H19ClFN7,29630.0
12563,Notoginsenoside R1,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C,C47H80O18,29691.0
12564,Phillyrin,COc1ccc([C@@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2ccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)c2)cc1OC,C27H34O11,29654.0
12565,Decanoic Acid-d2,[2H]C([2H])(CCCCCCCC)C(=O)O,C10H20O2,29409.0
12566,PF-05105679,C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1,C26H21FN2O3,29489.0
12567,Debrisoquin (hemisulfate,N=C(N)N1CCc2ccccc2C1.O=S(=O)(O)O,C10H15N3O4S,29568.0
12568,Cenerimod,CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CO,C25H31N3O5,29665.0
12569,Crenigacestat,C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@@H]1C(=O)N(CCO)c2ncccc2-c2ccccc21,C22H23F3N4O4,27919.0
12570,"5,6-dimethyl-2-Thiouracil",Cc1[nH]c(=S)[nH]c(=O)c1C,C6H8N2OS,29821.0
12571,Norhyodeoxycholic Acid,C[C@H](CC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C23H38O4,9003440.0
12572,Harmane,Cc1nccc2c1[nH]c1ccccc12,C12H10N2,29613.0
12573,Purpurogallin,O=c1c(O)cccc2cc(O)c(O)c(O)c12,C11H8O5,29689.0
12574,Clothianidin,CN/C(=N\[N+](=O)[O-])NCc1cnc(Cl)s1,C6H8ClN5O2S,29605.0
12575,"5-(N,N-hexamethylene)-Amiloride",N=C(N)NC(=O)c1nc(Cl)c(N2CCCCCC2)nc1N,C12H18ClN7O,29788.0
12576,Betulonic Acid,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C30H46O3,29765.0
12577,Palmitoyl Tetrapeptide-7 (acetate),CC(=O)O.CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,C34H62N8O7(C2H4O2)X,27550.0
12578,Lazertinib,C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1,C30H34N8O3,29670.0
12579,L-Alanine,C[C@H](N)C(=O)O,C3H7NO2,29757.0
12580,Butyric Acid-d7,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O,C4H8O2,29408.0
12581,Citropten,COc1cc(OC)c2ccc(=O)oc2c1,C11H10O4,29338.0
12582,BHBM,Cc1ccccc1C(=O)N/N=C/c1cc(Br)ccc1O,C15H13BrN2O2,29817.0
12583,WNK-IN-11,CNc1nc(-c2cc(C(=O)N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cn2)cs1,C21H21Cl2N5OS,29676.0
12584,Radiprodil,O=C(Nc1ccc2[nH]c(=O)oc2c1)C(=O)N1CCC(Cc2ccc(F)cc2)CC1,C21H20FN3O4,29712.0
12585,Eact,COCCN(C(=O)c1cc(OC)c(OC)c(OC)c1)c1nc(-c2ccccc2)cs1,C22H24N2O5S,29791.0
12586,PF-06282999,COc1ccc(Cl)cc1-c1cc(=O)[nH]c(=S)n1CC(N)=O,C13H12ClN3O3S,28406.0
12587,Myristic Acid-13C,CCCCCCCCCCCCC[13C](=O)O,C14H28O2,29463.0
12588,CYR-101,O=C(CN1CCC(CN2Cc3ccccc3C2=O)CC1)c1ccc(F)cc1,C22H23FN2O2,29773.0
12589,Delamanid,C[C@]1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,C25H25F3N4O6,29697.0
12590,ADH-1,CC(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O,C22H34N8O6S2,29981.0
12591,OSI-930,O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12,C22H16F3N3O2S,29379.0
12592,Octanoic Acid-13C,CCCCCCC[13C](=O)O,C8H16O2,29461.0
12593,YH 239-EE,CCOC(=O)c1[nH]c2cc(Cl)ccc2c1C(C(=O)NC(C)(C)C)N(C=O)Cc1ccc(Cl)cc1,C25H27Cl2N3O4,27678.0
12594,ML-396,O=C(Nc1ccc(Oc2ccc(Cl)cn2)c(Cl)c1)c1ccccn1,C17H11Cl2N3O2,29167.0
12595,Cholic Acid anilide,C[C@H](CCC(=O)Nc1ccccc1)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C30H45NO4,26144.0
12596,VLX1570,C=CC(=O)N1CC/C(=C\c2ccc(F)c([N+](=O)[O-])c2)C(=O)/C(=C/c2ccc(F)c([N+](=O)[O-])c2)C1,C23H17F2N3O6,29721.0
12597,EPT,CCCN(CC)CCc1c[nH]c2ccccc12,C15H22N2,27323.0
12598,MMB-4en-PINACA,C=CCCCn1nc(C(=O)N[C@H](C(=O)OC)C(C)C)c2ccccc21,C19H25N3O3,29750.0
12599,NVP-CGM097,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2,C38H47ClN4O4,29519.0
12600,4-Amino-5-(bromomethyl)-2-methylpyrimidine (hydrobromide),Br.Br.Cc1ncc(CBr)c(N)n1,C6H10Br3N3,29839.0
12601,Strychnospermine,COc1ccc2c(c1)N(C(C)=O)[C@H]1[C@@H]3CO[C@H](C)[C@@H]4CN5CC[C@]21[C@@H]5C[C@H]34,C22H28N2O3,29988.0
12602,Karrikin 2,O=c1cc2ccocc-2o1,C7H4O3,29822.0
12603,Ethoxyquin Dimer,CCOc1ccc2c(c1)C(C)=CC(C)(C)N2c1cc(OCC)cc2c1NC(C)(C)C=C2C,C28H36N2O2,29823.0
12604,Nisoxetine (hydrochloride),CNCCC(Oc1ccccc1OC)c1ccccc1.Cl,C17H22ClNO2,29637.0
12605,Isotonitazene-d7,[2H]C([2H])([2H])C([2H])(Oc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1)C([2H])([2H])[2H],C23H30N4O3,29319.0
12606,Isotonitazene-d7 (CRM),[2H]C([2H])([2H])C([2H])(Oc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1)C([2H])([2H])[2H],C23H30N4O3,39682.0
12607,Vobtusine,COC(=O)C1=C2Nc3ccccc3[C@@]23CCN2C[C@]4(C[C@@H]5C[C@]67CCO[C@H]6CCN6CC[C@@]8(c9cccc(OC)c9N(C4)[C@@]58O)[C@@H]67)[C@@H]4OCC[C@]4(C1)[C@H]23,C43H50N4O6,30057.0
12608,Himandridine,COC(=O)C1=C2[C@@]3(O)CC4C[C@@H]5[C@H]3CC[C@H](C)N5[C@]24[C@@H]2CC[C@H](O)[C@H](OC)[C@H]2[C@@H]1OC(=O)c1ccccc1,C30H37NO7,30055.0
12609,Ligustrazine (hydrochloride),Cc1nc(C)c(C)nc1C.Cl,C8H12N2(ClH)X,29658.0
12610,C24 dihydro 1-Deoxyceramide (m18:0/24:0),CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](C)[C@H](O)CCCCCCCCCCCCCCC,C42H85NO2,27017.0
12611,Remdesivir,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)Oc1ccccc1,C27H35N6O8P,30354.0
12612,Seselin,CC1(C)C=Cc2c(ccc3ccc(=O)oc23)O1,C14H12O3,29930.0
12613,Dihydroeuphol,CC(C)CCC[C@@H](C)[C@@H]1CC[C@]2(C)C3=C(CC[C@@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1CC3,C30H52O,29944.0
12614,SS-208,O=C(NCCc1cc(C(=O)NO)no1)c1ccc(Cl)c(Cl)c1,C13H11Cl2N3O4,29128.0
12615,Betulinic Acid methyl ester,C=C(C)[C@@H]1CC[C@]2(C(=O)OC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C31H50O3,30066.0
12616,Xanthyletin,CC1(C)C=Cc2cc3ccc(=O)oc3cc2O1,C14H12O3,29929.0
12617,Himbadine,C[C@@H]1CC[C@H]2[C@H](C[C@@H]3C[C@@]2(O)C2=CC(=O)[C@H]4CCCC[C@@H]4[C@H]23)N1C,C21H31NO2,30043.0
12618,Himbosine,COC(=O)C1=C2[C@@]3(OC(C)=O)CC4C[C@@H]5[C@H]3CC[C@H](C)N5[C@]24[C@@H]2CC[C@H](OC(C)=O)[C@H](OC(=O)c3ccccc3)[C@H]2[C@@H]1OC(C)=O,C35H41NO10,30056.0
12619,Lepimectin A4,CC[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@H](OC(=O)/C(=N/OC)c3ccccc3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,C41H53NO10,30072.0
12620,Byssochlamic Acid,CCC[C@H]1CC2=C(C[C@@H](CC)CC3=C1C(=O)OC3=O)C(=O)OC2=O,C18H20O6,29908.0
12621,5-Aminoisotonitazene,CCN(CC)CCn1c(Cc2ccc(OC(C)C)cc2)nc2cc(N)ccc21,C23H32N4O,29318.0
12622,Penicinoline,O=C(O)c1c(-c2ccc[nH]2)[nH]c2ccccc2c1=O,C14H10N2O3,29932.0
12623,Sparsomycin,CSC[S@](=O)C[C@H](CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,C13H19N3O5S2,29934.0
12624,CPSI-1306,O=C(CC1CC(c2ccc(F)cc2F)=NO1)N1CCOCC1,C15H16F2N2O3,29905.0
12625,IT-143B,C/C=C(C)/C=C(\C)[C@H](O)[C@H](C)/C=C(C)/C=C/C/C(C)=C/Cc1nc(OC)c(OC)c(O)c1C,C28H41NO4,29960.0
12626,1cP-LSD (solution),CCN(CC)C(=O)[C@@H]1C=C2c3cccc4c3c(cn4C(=O)C3CC3)C[C@H]2N(C)C1,C24H29N3O2,30187.0
12627,4-hydroxy McPT (hydrochloride),CN(CCc1c[nH]c2cccc(O)c12)C1CC1.Cl,C14H19ClN2O,26499.0
12628,2-fluoro Viminol,CCC(C)N(CC(O)c1cccn1Cc1ccccc1F)C(C)CC,C21H31FN2O,27233.0
12629,Collinin,COc1c(OC/C=C(\C)CCC=C(C)C)ccc2ccc(=O)oc12,C20H24O4,29946.0
12630,Butyrolactone V,COC(=O)[C@]1(Cc2ccc3c(c2)C[C@H](O)C(C)(C)O3)OC(=O)C(O)=C1c1ccc(O)cc1,C24H24O8,29947.0
12631,(+)-Epoxysuberosin,COc1cc2oc(=O)ccc2cc1C[C@H]1OC1(C)C,C15H16O4,30042.0
12632,Monomethylsulochrin,COC(=O)c1cc(O)cc(OC)c1C(=O)c1c(O)cc(C)cc1OC,C18H18O7,29942.0
12633,Aszonapyrone A,C=C1CC[C@H]2[C@@](C)(CC[C@H]3C(C)(C)[C@@H](OC(C)=O)CC[C@]23C)[C@@H]1Cc1c(O)cc(C)oc1=O,C28H40O5,29940.0
12634,Streptimidone,C=C/C(C)=C/[C@H](C)C(=O)C[C@H](O)CC1CC(=O)NC(=O)C1,C16H23NO4,29984.0
12635,Sartorypyrone B,CC(=O)O[C@H]1C[C@]2(C)[C@H]3CC[C@]4(C)Oc5oc(C)cc(=O)c5C[C@H]4[C@]3(C)CC[C@H]2C(C)(C)[C@H]1OC(C)=O,C30H42O7,29949.0
12636,Banksialactone A,COc1cc(O)c2c(c1C)C(C)C(O)(CO)OC2=O,C13H16O6,30000.0
12637,Aspulvinone O,CC(C)=CCc1cc(/C=C2\OC(=O)C(c3cc(CC=C(C)C)c(O)cc3O)=C2O)ccc1O,C27H28O6,29959.0
12638,Leoidin,COC(=O)c1c(C)c2c(c(C)c1O)OC(=O)c1c(C)c(Cl)c(O)c(Cl)c1O2,C18H14Cl2O7,29939.0
12639,IT-143A,C/C=C(C)/C=C(\C)C(O)C(C)/C=C(C)/C=C(\C)C/C(C)=C/Cc1nc(OC)c(OC)c(O)c1C,C29H43NO4,30044.0
12640,Deoxygerfelin,Cc1cc(O)cc(Oc2cc(C)c(C(=O)O)c(O)c2)c1,C15H14O5,29931.0
12641,STING18,CC(C)(C)c1ccc(N2C(=O)c3cc(F)ccc3C(CC(=O)O)C2c2ccc3c(c2)OCCO3)cc1Cl,C29H27ClFNO5,28319.0
12642,Emestrin,COc1ccc2cc1Oc1cc(ccc1O)[C@H](O)[C@]13SS[C@@]4(C(=O)N1C)[C@H](O)C1=COC=CC(OC2=O)[C@H]1N4C3=O,C27H22N2O10S2,29970.0
12643,Territrem A,COc1cc(-c2cc3c(c(=O)o2)C[C@]2(O)[C@@]4(C)C(=O)C=CC(C)(C)[C@]4(O)CC[C@@]2(C)O3)cc2c1OCO2,C28H30O9,29941.0
12644,C24 1-Deoxyceramide (m18:1/24:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](C)NC(=O)CCCCCCCCCCCCCCCCCCCCCCC,C42H83NO2,27016.0
12645,Phenoxybenzamine-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(OCC(C)N(CCCl)Cc2ccccc2)c([2H])c1[2H],C18H23Cl2NO,29996.0
12646,Tropolone,O=c1cccccc1O,C7H6O2,29674.0
12647,Descarbamylnovobiocin,CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C,C30H35NO10,29971.0
12648,Asperfuran,C/C=C/C=C/[C@H]1Cc2cc(O)cc(O)c2O1,C13H14O3,29989.0
12649,"1,3-Diheptadecanoyl Glycerol",CCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCC,C37H72O5,26960.0
12650,Diheptadecanoin,CCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCC,C37H72O5,27002.0
12651,Mer-NF5003F,C[C@@H]1CC[C@H]2C(C)(C)[C@H](O)CC[C@]2(C)[C@@]12Cc1c(O)cc(C=O)c(C=O)c1O2,C23H30O5,29961.0
12652,Novobiocic Acid,CC(C)=CCc1cc(C(=O)Nc2c(O)c3ccc(O)c(C)c3oc2=O)ccc1O,C22H21NO6,29966.0
12653,"7,3',4'-Trihydroxyflavone",O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,C15H10O5,29880.0
12654,Chevalone E,Cc1cc(=O)c2c(o1)O[C@@]1(C)CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@@H]1C2,C26H38O4,29948.0
12655,Roccellic Acid,CCCCCCCCCCCC[C@@H](C(=O)O)[C@H](C)C(=O)O,C17H32O4,29909.0
12656,1-Deoxysphingosine (m18:1(4E)),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](C)N,C18H37NO,24687.0
12657,Oxcarbazepine-d4,[2H]c1c([2H])c([2H])c2c(c1[2H])C(=O)Cc1ccccc1N2C(N)=O,C15H12N2O2,29995.0
12658,Peiminine,C[C@H]1CC[C@@H]2N(C1)C[C@H]1[C@@H]3C[C@H]4[C@@H](CC(=O)[C@H]5C[C@@H](O)CC[C@@]54C)[C@@H]3CC[C@@H]1[C@]2(C)O,C27H43NO3,29618.0
12659,BPR1J-097,CN1CCN(c2ccc(C(=O)Nc3cc(-c4cccc(NS(=O)(=O)c5ccccc5)c4)[nH]n3)cc2)CC1,C27H28N6O3S,29805.0
12660,"3,4-dimethoxy-?-Pyrrolidinopropiophenone (hydrochloride)",COc1ccc(C(=O)C(C)N2CCCC2)cc1OC.Cl,C15H22ClNO3,30034.0
12661,Picamilon,O=C(O)CCCNC(=O)c1cccnc1,C10H12N2O3,29397.0
12662,CAY10761,S=c1[nH]nc(CCCc2n[nH]c(=S)o2)o1,C7H8N4O2S2,29865.0
12663,Brinzolamide-d5,[2H]C([2H])([2H])C([2H])([2H])N[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,C12H21N3O5S3,30006.0
12664,Phenyl U-47700 (hydrochloride),CN(C)[C@H]1CCCC[C@@H]1N(C(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1.Cl,C21H25Cl3N2O,30215.0
12665,1-Tridecanoyl-rac-glycerol,CCCCCCCCCCCCC(=O)OCC(O)CO,C16H32O4,26961.0
12666,Amitraz,Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1,C19H23N3,28852.0
12667,Yatein,COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc3c(c2)OCO3)cc(OC)c1OC,C22H24O7,29766.0
12668,Phenethyl 4-ANPP (hydrochloride),Cl.c1ccc(CCN2CCC(N(CCc3ccccc3)c3ccccc3)CC2)cc1,C27H33ClN2,30391.0
12669,YM-254890,C=C1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](C)C(=O)N[C@@H]([C@H](OC(=O)[C@@H](NC(C)=O)[C@H](O)C(C)C)C(C)C)C(=O)N(C)[C@@H]([C@@H](C)OC)C(=O)O[C@H](C)[C@H](NC(C)=O)C(=O)O[C@H](Cc2ccccc2)C(=O)N1C,C46H69N7O15,29735.0
12670,Acemetacin,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,C21H18ClNO6,29615.0
12671,PF-1022A,CC(C)C[C@H]1C(=O)O[C@H](Cc2ccccc2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](Cc2ccccc2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N1C,C52H76N4O12,29700.0
12672,14-Anhydrodigitoxigenin,C[C@]12CC[C@H](O)C[C@H]1CC[C@H]1C3=CC[C@H](C4=CC(=O)OC4)[C@@]3(C)CC[C@@H]12,C23H32O3,30439.0
12673,CXCR3 Antagonist 6c,CCNC(=O)N1CCCN(c2ccc(C(=O)NCCc3ccc(Cl)cc3Cl)cc2NC(=O)c2cccc(Cl)c2)CC1,C30H32Cl3N5O3,29731.0
12674,LY3000328,C=C(CC)C[C@H]1CCc2ccc(C3CCC(C4CCC4)CC3)cc2[C@@H]1CC(=C)c1ccc(C)cc1,C35H46,29729.0
12675,CBDB,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCC)cc1O,C20H28O2,29031.0
12676,CBDB (CRM),C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCC)cc1O,C20H28O2,32719.0
12677,N-3-hydroxybutyryl-L-Homoserine lactone,CC(O)CC(=O)N[C@H]1CCOC1=O,C8H13NO4,27691.0
12678,GS-441524,N#C[C@@]1(c2ccc3c(N)ncnn23)O[C@H](CO)[C@@H](O)[C@H]1O,C12H13N5O4,30469.0
12679,Azatadine (maleate),CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,C28H30N2O8,29758.0
12680,AG-528,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)N1CCc2ccccc21,C18H14N2O3,29666.0
12681,Daurisoline,COc1cc2c(cc1O)[C@@H](Cc1ccc(O)c(Oc3ccc(C[C@@H]4c5cc(OC)c(OC)cc5CCN4C)cc3)c1)N(C)CC2,C37H42N2O6,29628.0
12682,SLM6031434 (hydrochloride),CCCCCCCCOc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1C(F)(F)F.Cl,C22H31ClF3N5O2,30434.0
12683,C24:1 1-Deoxyceramide (m18:1/24:1(15Z)),CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)N[C@@H](C)[C@H](O)/C=C/CCCCCCCCCCCCC,C42H81NO2,30030.0
12684,SC144 (hydrochloride),Cl.O=C(NNc1nc2cc(F)ccc2n2cccc12)c1cnccn1,C16H12ClFN6O,29714.0
12685,Tolrestat,COc1ccc2c(C(=S)N(C)CC(=O)O)cccc2c1C(F)(F)F,C16H14F3NO3S,29693.0
12686,OSW-1,COc1ccc(C(=O)O[C@H]2[C@H](O[C@@H]3[C@@H](OC(C)=O)[C@H](O[C@H]4C[C@H]5[C@@H]6CC=C7C[C@@H](O)CC[C@]7(C)[C@H]6CC[C@]5(C)[C@@]4(O)[C@H](C)C(=O)CCC(C)C)OC[C@@H]3O)OC[C@@H](O)[C@@H]2O)cc1,C47H68O15,30310.0
12687,"1,2,3,4-Tetrahydrostaurosporine",CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6c(n2c5c31)CCCC6)C(=O)NC4,C28H30N4O3,29987.0
12688,Vitamin K1-d7,[2H]c1c([2H])c([2H])c2c(c1[2H])C(=O)C(C/C=C(\C)CCCC(C)CCCC(C)CCCC(C)C)=C(C([2H])([2H])[2H])C2=O,C31H46O2,29992.0
12689,Ecgonine (hydrochloride),CN1[C@H]2CC[C@@H]1[C@@H](C(=O)O)[C@@H](O)C2.Cl,C9H16ClNO3,23314.0
12690,S-Phenylcysteine,N[C@@H](CSc1ccccc1)C(=O)O,C9H11NO2S,29734.0
12691,CBDP,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCCCC)cc1O,C23H34O2,30169.0
12692,Almorexant-13C-d3,[2H][13C]([2H])([2H])NC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1,C29H31F3N2O3,29099.0
12693,20(S)-Protopanaxatriol,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@]12C,C30H52O4,29073.0
12694,IPSU,COc1ccnc(N2CCC3(CCCN(Cc4c[nH]c5ccccc45)C3=O)CC2)n1,C23H27N5O2,30007.0
12695,Nexinhib20,CC(C)(C)C(=O)/C(=C/c1cccc([N+](=O)[O-])c1)n1cncn1,C15H16N4O3,29899.0
12696,Alantolactone,C=C1C(=O)O[C@@H]2C[C@@]3(C)CCC[C@H](C)C3=C[C@H]12,C15H20O2,29762.0
12697,CAY10744,Oc1ccc(-c2cc(-c3ccccc3Cl)nc3c2Cc2c(O)cccc2-3)cc1,C24H16ClNO2,29802.0
12698,EZM2302,CNC[C@@H](O)COc1ccc(Cl)c(-c2nc(-c3c(C)noc3C)c(C)c(N3CC4(CCN(C(=O)OC)CC4)C3)n2)c1,C29H37ClN6O5,29954.0
12699,Phenelzine-d5 (sulfate),O=S(=O)(O)O.[2H]c1c([2H])c([2H])c(CCNN)c([2H])c1[2H],C8H14N2O4S,29645.0
12700,Ganoderenic Acid A,C/C(=C/C(=O)CC(C)C(=O)O)C1C[C@H](O)C2(C)C3=C(C(=O)CC12C)C1(C)CCC(=O)C(C)(C)C1C[C@@H]3O,C30H42O7,27685.0
12701,AZD 0364,COC[C@H]1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)nc2C(=O)N1Cc1ccc(F)c(F)c1,C24H24F2N8O2,29827.0
12702,Diazoxide-d3,[2H]C([2H])([2H])C1=NS(=O)(=O)c2cc(Cl)ccc2N1,C8H7ClN2O2S,29967.0
12703,Ursocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H40O5,29883.0
12704,Nimbin,COC(=O)C[C@H]1[C@]2(C)C3=C(C)[C@H](c4ccoc4)C[C@H]3O[C@@H]2[C@H](OC(C)=O)[C@@H]2[C@]1(C)C(=O)C=C[C@@]2(C)C(=O)OC,C30H36O9,29884.0
12705,Kocurin,C=C(NC(=O)C(=C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)C(=C)NC(=O)c1csc(-c2ccc3c(n2)-c2csc(n2)-c2csc(n2)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CSC(=N2)[C@H](Cc2ccccc2)NC(=O)c2csc(n2)[C@H](CC(N)=O)NC(=O)c2nc-3oc2C)n1)C(N)=O,C69H66N18O13S5,29125.0
12706,Estragole,C=CCc1ccc(OC)cc1,C10H12O,29824.0
12707,Oclacitinib-13C-d3,[2H][13C]([2H])([2H])N(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)NC)CC1,C15H23N5O2S,28808.0
12708,Indinavir-d6,[2H]c1nc([2H])c(C([2H])([2H])N2CCN(C[C@@H](O)C[C@@H](Cc3ccccc3)C(=O)N[C@H]3c4ccccc4C[C@H]3O)[C@H](C(=O)NC(C)(C)C)C2)c([2H])c1[2H],C36H47N5O4,29585.0
12709,CAY10748,CCn1nc(C)cc1C(=O)Nc1nc2cc(C(N)=O)cc(OCCCOC)c2n1CCCNC(=O)OCc1ccccc1,C30H37N7O6,30022.0
12710,Glycodehydrocholic Acid,C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC(=O)[C@]12C,C26H37NO6,29892.0
12711,Methyl 2-phenyl-2-(pyrrolidin-1-yl)acetate (hydrochloride),COC(=O)C(c1ccccc1)N1CCCC1.Cl,C13H18ClNO2,30228.0
12712,GLPG0492,CN1C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)[C@@]1(CO)c1ccccc1,C19H14F3N3O3,29938.0
12713,Karrikinolide,Cc1c2ccocc-2oc1=O,C8H6O3,29935.0
12714,Oosporein,CC1=C(O)C(=O)C(C2=C(O)C(=O)C(C)=C(O)C2=O)=C(O)C1=O,C14H10O8,29173.0
12715,15(R)-Prostaglandin F1?,CCCCC[C@@H](O)/C=C/[C@@H]1[C@@H](CCCCCCC(=O)O)[C@@H](O)C[C@H]1O,C20H36O5,29549.0
12716,Phe-Arg-?NA (hydrochloride),Cl.Cl.N=C(N)NCCC[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)Nc1ccc2ccccc2c1,C25H32Cl2N6O2,29511.0
12717,"2,3,4,5-Tetrachlorophenol",Oc1cc(Cl)c(Cl)c(Cl)c1Cl,C6H2Cl4O,29743.0
12718,1-(4-Bromophenyl)piperazine (hydrochloride),Brc1ccc(N2CCNCC2)cc1.Cl,C10H14BrClN2,30229.0
12719,Verrucarin A,CC1=C[C@H]2O[C@@H]3C[C@H]4OC(=O)/C=C/C=C/C(=O)OCC[C@@H](C)[C@H](O)C(=O)OC[C@@]2(CC1)[C@]4(C)[C@]31CO1,C27H34O9,29652.0
12720,(S)-CR8,CC[C@@H](CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1,C24H29N7O,29985.0
12721,AST-1306 (tosylate),C=CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1.Cc1ccc(S(=O)(=O)O)cc1,C31H26ClFN4O5S,29708.0
12722,Desvenlafaxine (succinate hydrate),CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O.O=C(O)CCC(=O)O,C20H33NO7,29855.0
12723,CAY10727,N=C(CCl)NCCCC1NC(=O)N(Cc2cccc(-c3ccccc3Cl)c2)C1=O,C21H22Cl2N4O2,26543.0
12724,Stavudine-13C-d3,[2H][13C]([2H])([2H])c1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,C10H12N2O4,28887.0
12725,Albiflorin,C[C@]12C[C@@H](O)[C@@H]3C[C@@]1(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@]3(COC(=O)c1ccccc1)C(=O)O2,C23H28O11,29744.0
12726,Cinazepam,O=C(O)CCC(=O)OC1N=C(c2ccccc2Cl)c2cc(Br)ccc2NC1=O,C19H14BrClN2O5,30208.0
12727,Urdamycin A,C[C@@H]1O[C@@H](O[C@@H]2C[C@H](c3ccc4c(c3O)C(=O)C3=C(C4=O)[C@@]4(O[C@H]5CC[C@H](O)[C@H](C)O5)C(=O)C[C@](C)(O)C[C@@]4(O)C=C3)O[C@H](C)[C@H]2O)CC[C@@H]1O[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1,C43H56O17,29510.0
12728,WYE-687,COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5cccnc5)CC4)c3n2)cc1,C28H32N8O3,29977.0
12729,Carbasalate Calcium,CC(=O)Oc1ccccc1C(=O)[O-].CC(=O)Oc1ccccc1C(=O)[O-].NC(N)=O.[Ca+2],C19H18CaN2O9,29806.0
12730,10-Norparvulenone,COc1cc2c(c(O)c1CO)C(=O)CCC2O,C12H14O5,29452.0
12731,CIM0216,Cc1cc(NC(=O)C(c2ccccc2)N2CCCc3ccccc32)no1,C21H21N3O2,27684.0
12732,7-hydroxy DPAT (hydrobromide),Br.CCCN(CCC)C1CCc2ccc(O)cc2C1,C16H26BrNO,29516.0
12733,CUMYL-CBMICA,CC(C)(NC(=O)c1cn(CC2CCC2)c2ccccc12)c1ccccc1,C23H26N2O,30207.0
12734,"1,5-Anhydro-D-glucitol",OC[C@H]1OC[C@H](O)[C@@H](O)[C@@H]1O,C6H12O5,29874.0
12735,Bevantolol (hydrochloride),COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC.Cl,C20H28ClNO4,29792.0
12736,Coumarin-Quinone Conjugate,CCN(CC)c1ccc2cc(C(=O)OCC3=C(C)C(=O)C(C)=C(C)C3=O)c(=O)oc2c1,C24H25NO6,29554.0
12737,Pregabalin methyl ester (hydrochloride),COC(=O)C[C@@H](CN)CC(C)C.Cl,C9H20ClNO2,30238.0
12738,Oleandrin,CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@@H](C5=CC(=O)OC5)[C@@H](OC(C)=O)C[C@]43O)C2)O[C@@H](C)[C@@H]1O,C32H48O9,29871.0
12739,CU-115,O=C(Nc1ccc(Oc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1)c1c(F)cccc1I,C21H11F7INO2,29815.0
12740,(1'S)-Dehydropestalotin,CCCC[C@H](O)c1cc(OC)cc(=O)o1,C11H16O4,29453.0
12741,Ethopropazine (hydrochloride),CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21.Cl,C19H25ClN2S,28493.0
12742,Ajmaline,CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)c5ccccc5C45C[C@@H]([C@H]2[C@H]5O)N3[C@@H]1O,C20H26N2O2,29962.0
12743,SJ000291942,CCc1ccc(OCC(=O)Nc2ccc(F)c([N+](=O)[O-])c2)cc1,C16H15FN2O4,29904.0
12744,Otilonium (bromide),CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1.[Br-],C29H43BrN2O4,29907.0
12745,Cycloaspeptide A,CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](C)NC(=O)c2ccccc2NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C1=O,C36H43N5O6,28744.0
12746,Variculanol,C=C1CC[C@H]2/C(C)=C/C[C@H]3[C@@H](C(C)C)[C@H](O)C[C@]3(C)[C@H](O)/C=C(\C)CC[C@@H]12,C25H40O2,29064.0
12747,Xanthoquinodin A1,COC(=O)[C@@]12Oc3cc4c(c(O)c3C(=O)C1=C(O)CC[C@@H]2O)[C@@H]1C=C[C@@]2(C4)C(=O)c3cc(C)cc(O)c3C(=O)C2=C1O,C31H24O11,28792.0
12748,Iso-Isariin B,CCCCC(C)C1CC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O1,C30H53N5O7,28791.0
12749,Losartan (potassium salt),CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[n-]2)cc1.[K+],C22H22ClKN6O,10006594.0
12750,Ginsenoside CK,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,C36H62O8,29926.0
12751,"Guanfacine-13C,15N3",[15NH]=[13C]([15NH2])[15NH]C(=O)Cc1c(Cl)cccc1Cl,C9H9Cl2N3O,30143.0
12752,JPH203,Nc1cc(COc2c(Cl)cc(C[C@H](N)C(=O)O)cc2Cl)c2oc(-c3ccccc3)nc2c1,C23H19Cl2N3O4,29715.0
12753,Phenindione,O=C1c2ccccc2C(=O)C1c1ccccc1,C15H10O2,30060.0
12754,Nocardamine,O=C1CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN1,C27H48N6O9,28745.0
12755,Ethynodiol Diacetate,C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C,C24H32O4,29854.0
12756,VUF8430 (hydrobromide),Br.Br.N=C(N)NCCSC(=N)N,C4H13Br2N5S,27682.0
12757,NNC-711 (hydrochloride),Cl.O=C(O)C1=CCCN(CCON=C(c2ccccc2)c2ccccc2)C1,C21H23ClN2O3,29687.0
12758,Xenopsin,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)O,C47H73N13O10,29968.0
12759,XMD8-85,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C,C25H29N7O2,29662.0
12760,"Stearic Acid-9,10-d2",[2H]C(CCCCCCCC)C([2H])CCCCCCCC(=O)O,C18H36O2,28868.0
12761,Desethylchloroquine,CCNCCCC(C)Nc1ccnc2cc(Cl)ccc12,C16H22ClN3,30113.0
12762,Nateglinide-d5,[2H]c1c([2H])c([2H])c(C[C@@H](NC(=O)[C@H]2CC[C@H](C(C)C)CC2)C(=O)O)c([2H])c1[2H],C19H27NO3,30151.0
12763,Amisulpride-d5,[2H]C([2H])([2H])C([2H])([2H])N1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,C17H27N3O4S,30075.0
12764,Cannabidivarinic Acid,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCC)c(C(=O)O)c1O,C20H26O4,9001575.0
12765,Cannabidivarinic Acid (CRM),C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCC)c(C(=O)O)c1O,C20H26O4,30245.0
12766,Cannabidivarinic Acid (Alt. Batch CRM),C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCC)c(C(=O)O)c1O,C20H26O4,42193.0
12767,16-Oxokahweol,C[C@@]12C=Cc3occc3[C@H]1CC[C@]13CC(=O)[C@H](CC[C@H]12)C3,C19H22O2,30117.0
12768,Fluticasone Furoate,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,C27H29F3O6S,29878.0
12769,HDAC8-IN-1,COc1ccc(/C=C/C(=O)NO)c(-c2ccc(-c3ccccc3)cc2)c1,C22H19NO3,28832.0
12770,Domperidone-d6,[2H]C([2H])(N1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)C([2H])([2H])C([2H])([2H])n1c(=O)[nH]c2ccccc21,C22H24ClN5O2,30152.0
12771,Isavuconazole-d4,[2H]c1c([2H])c(-c2csc([C@H](C)[C@](O)(Cn3cncn3)c3cc(F)ccc3F)n2)c([2H])c([2H])c1C#N,C22H17F2N5OS,30079.0
12772,AZ9482,N#Cc1cccnc1N1CCN(C(=O)c2cccc(Cc3n[nH]c(=O)c4ccccc34)c2)CC1,C26H22N6O2,30292.0
12773,Dienogest-d8,[2H]C1=C2CC[C@]3([2H])C(=C2CC([2H])([2H])C1=O)C([2H])([2H])C[C@@]1(C)[C@H]3CC[C@@]1(O)C([2H])([2H])C#N,C20H25NO2,30153.0
12774,Deoxy Donepezil (hydrochloride),COc1cc2c(cc1OC)CC(CC1CCN(Cc3ccccc3)CC1)C2.Cl,C24H32ClNO2,30045.0
12775,?5-Avenasterol,C/C=C(/CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,C29H48O,30154.0
12776,Germacrone,CC(C)=C1C/C=C(\C)CC/C=C(\C)CC1=O,C15H22O,30111.0
12777,4-Hydroxyhippuric Acid,O=C(O)CNC(=O)c1ccc(O)cc1,C9H9NO4,30115.0
12778,Glipizide-d11,[2H]C1([2H])C([2H])([2H])C([2H])([2H])C([2H])(NC(=O)NS(=O)(=O)c2ccc(CCNC(=O)c3cnc(C)cn3)cc2)C([2H])([2H])C1([2H])[2H],C21H27N5O4S,30074.0
12779,Budesonide-d8,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,C25H34O6,30046.0
12780,Galnon (trifluoroacetate salt),Cc1cc(=O)oc2cc(NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC3CCCCC3)NC(=O)OCC3c4ccccc4-c4ccccc43)ccc12.O=C(O)C(F)(F)F,C42H47F3N4O8,29925.0
12781,N-3-oxo-pentanoyl-L-Homoserine lactone,CCC(=O)CC(=O)N[C@H]1CCOC1=O,C9H13NO4,13201.0
12782,1-?-D-Arabinofuranosyluracil,O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)[nH]1,C9H12N2O6,29875.0
12783,IQ-1S (free acid),O/N=C1\c2ccccc2-c2nc3ccccc3nc21,C15H9N3O,29851.0
12784,4-deoxy Pyridoxine Phosphate,Cc1ncc(COP(=O)(O)O)c(C)c1O,C8H12NO5P,29973.0
12785,Hypocrellin A,COc1c2c3c4c(c(OC)c(=O)c5c(O)cc(OC)c(c6c(OC)cc(O)c(c1=O)c63)c54)C(C(C)=O)C(C)(O)C2,C30H26O10,29933.0
12786,Lauric Acid-13C,CCCCCCCCCCC[13C](=O)O,C12H24O2,29462.0
12787,?9-THCB,CCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C20H28O2,29306.0
12788,?9-THCB (CRM),CCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C20H28O2,33078.0
12789,(+)-Atenolol-d7,[2H]C([2H])([2H])C([2H])(NCC(O)COc1ccc(CC(N)=O)cc1)C([2H])([2H])[2H],C14H22N2O3,30018.0
12790,"8-Hydroxypyrene-1,3,6-trisulfonic Acid (sodium salt)",O=S(=O)([O-])c1cc(O)c2ccc3c(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c4ccc1c2c34.[Na+].[Na+].[Na+],C16H7Na3O10S3,30080.0
12791,"Myricetin 3,4'-di-O-?-glucopyranoside",O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2cc(O)c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c2)oc2cc(O)cc(O)c12,C27H30O18,30102.0
12792,Nitidine (chloride),COc1cc2c[n+](C)c3c4cc5c(cc4ccc3c2cc1OC)OCO5.[Cl-],C21H18ClNO4,29223.0
12793,4-Acetamidobutyric Acid,CC(=O)NCCCC(=O)O,C6H11NO3,29881.0
12794,KYA1797K,O=C([O-])CCN1C(=O)/C(=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)SC1=S.[K+],C17H11KN2O6S2,29221.0
12795,EVP-6124 (hydrochloride),Cl.O=C(N[C@H]1CN2CCC1CC2)c1cc2cccc(Cl)c2s1,C16H18Cl2N2OS,30073.0
12796,Doxepin-d3 (hydrochloride),Cl.[2H]C([2H])([2H])N(C)CC/C=C1\c2ccccc2COc2ccccc21,C19H22ClNO,30121.0
12797,Forsythoside A,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OCCc3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,C29H36O15,30110.0
12798,Toltrazuril sulfone,Cc1cc(-n2c(=O)[nH]c(=O)n(C)c2=O)ccc1Oc1ccc(S(=O)(=O)C(F)(F)F)cc1,C18H14F3N3O6S,29655.0
12799,Radezolid,CC(=O)NC[C@H]1CN(c2ccc(-c3ccc(CNCc4cnn[nH]4)cc3)c(F)c2)C(=O)O1,C22H23FN6O3,30092.0
12800,Diosmetin-d3,[2H]C([2H])([2H])Oc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1O,C16H12O6,30122.0
12801,VTP-27999 (trifluoroacetate salt),CN[C@H](CNC(=O)N1CCC[C@@H]([C@@H](OCCNC(=O)OC)c2cccc(Cl)c2)C1)C[C@H]1CCCOC1.O=C(O)C(F)(F)F,C28H42ClF3N4O7,27689.0
12802,17R(18S)-EpETE,CC[C@@H]1O[C@@H]1C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H30O3,28630.0
12803,Neridronic Acid,NCCCCCC(O)(P(=O)(O)O)P(=O)(O)O,C6H17NO7P2,29692.0
12804,Isodeoxycholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4CCCC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H40O4,29890.0
12805,Homoplantaginin,COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2oc(-c3ccc(O)cc3)cc(=O)c2c1O,C22H22O11,29853.0
12806,?7-Avenasterol,C/C=C(/CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,C29H48O,30155.0
12807,4-CPPC,O=C(O)c1cccc(-c2cc(C(=O)O)ncc2C(=O)O)c1,C14H9NO6,30068.0
12808,MK-4101,Cn1c(-c2ccccc2C(F)(F)F)nnc1C12CCC(c3noc(C4CC(F)(F)C4)n3)(CC1)CC2,C24H24F5N5O,29159.0
12809,Gypenoside IX,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C47H80O17,29705.0
12810,GMQ (hydrochloride),Cc1nc(NC(=N)N)nc2ccccc12.Cl,C10H12ClN5,29760.0
12811,ML-154,Cc1c(P(=S)(c2ccccc2)c2ccccc2)n2ccccc2[n+]1C/C=C/c1ccccc1.[Br-],C29H26BrN2PS,30200.0
12812,CAY10760,CCC(=O)N1N=C(c2c(-c3ccccc3)c3cc(Cl)ccc3[nH]c2=O)CC1c1ccc(OC)cc1,C28H24ClN3O3,30532.0
12813,Ilaprazole,COc1ccnc(CS(=O)c2nc3ccc(-n4cccc4)cc3[nH]2)c1C,C19H18N4O2S,30120.0
12814,QX-77,CC(=O)Nc1ccc(C2=Nc3ccc(Cl)cc3OC2)cc1,C16H13ClN2O2,29903.0
12815,MMG-0358,Oc1ccc(Cl)cc1-c1cnn[nH]1,C8H6ClN3O,29828.0
12816,14S(15R)-EET methyl ester,CCCCC[C@H]1O[C@H]1C/C=C\C/C=C\C/C=C\CCCC(=O)OC,C21H34O3,28631.0
12817,FR179642 (hydrate),C.C[C@@H](O)[C@@H]1NC(=O)[C@@H](N)C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)c(OS(=O)(=O)O)c2)NC(=O)[C@@H]2C[C@@H](O)CN2C1=O,C36H56N8O20S,29647.0
12818,?9-THCP,CCCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C23H34O2,30171.0
12819,?9-THCP (CRM),CCCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C23H34O2,33691.0
12820,?9-THCP (Alt. Batch CRM),CCCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C23H34O2,41267.0
12821,?-Pyrrolidinocyclohexanophenone (hydrochloride),Cl.O=C(c1ccccc1)C(C1CCCCC1)N1CCCC1,C18H26ClNO,30241.0
12822,Diphemanil (methyl sulfate),COS(=O)(=O)[O-].C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1,C21H27NO4S,30090.0
12823,C16 1-Deoxyceramide (m18:1/16:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](C)NC(=O)CCCCCCCCCCCCCCC,C34H67NO2,30029.0
12824,CAY10749,Nc1cc(C(F)(F)F)c(-c2nc3c(c(N4CCOCC4)n2)CCN(C(=O)c2cc(Cc4n[nH]c(=O)c5ccccc45)ccc2F)C3)cn1,C33H28F4N8O3,30058.0
12825,"1,2,3-Tristearoyl Glycerol-d105",[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OCC(COC(=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])OC(=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H],C57H110O6,28867.0
12826,Janthitrem A,C=C(C)[C@H]1O[C@H]2CC[C@@]3(C)[C@@](O)(CC[C@H]4Cc5c([nH]c6cc7c(cc56)[C@@H](O)[C@H]5C7=CC(C)(C)OC5(C)C)[C@@]43C)[C@]23O[C@@H]3[C@H]1O,C37H47NO6,30166.0
12827,V-9302,Cc1cccc(COc2ccccc2CN(CC[C@H](N)C(=O)O)Cc2ccccc2OCc2cccc(C)c2)c1,C34H38N2O4,27688.0
12828,1-Octanoyl-2-Decanoyl-3-Stearoyl-rac-glycerol,CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCC,C39H74O6,29237.0
12829,Fenobam (hydrate),CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1.O,C11H13ClN4O3,29759.0
12830,19S(20R)-EpDPA,CC[C@H]1O[C@H]1C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C22H32O3,28627.0
12831,Amifostine thiol (hydrochloride),Cl.Cl.NCCCNCCS,C5H16Cl2N2S,18612.0
12832,"1,2-Dipalmitoyl-3-Pentadecanoyl-rac-glycerol",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C50H96O6,29059.0
12833,"1,2-Dioleoyl-sn-glycero-3-PS (sodium salt)",CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OC[C@H](N)C(=O)O)OC(=O)CCCCCCC/C=C\CCCCCCCC.[Na+],C42H77NNaO10P,29983.0
12834,Isolithocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H40O3,29545.0
12835,"1,3-Distearoyl-2-Myristoyl Glycerol",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC,C53H102O6,28860.0
12836,"1,2-Distearoyl-3-Palmitoyl-rac-glycerol",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC,C55H106O6,28551.0
12837,Z944,CC(C)(C)NC(=O)CN1CCC(CNC(=O)c2cc(F)cc(Cl)c2)CC1,C19H27ClFN3O2,27679.0
12838,SID 3712249,N#Cc1c(N2CCCC2)nc(N)c2c(N)nc(N3CCCC3)cc12,C17H21N7,29723.0
12839,Australine (hydrochloride),Cl.OC[C@@H]1[C@@H](O)[C@H](O)[C@H]2[C@@H](O)CCN21,C8H16ClNO4,30051.0
12840,Bourgeonal,CC(C)(C)c1ccc(CCC=O)cc1,C13H18O,29965.0
12841,19R(20S)-EpDPA,CC[C@@H]1O[C@@H]1C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,C22H32O3,28628.0
12842,Avridine,CCCCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCCCC)CCCN(CCO)CCO,C43H90N2O2,30198.0
12843,N-Acetyl-DL-penicillamine,CC(=O)NC(C(=O)O)C(C)(C)S,C7H13NO3S,10010404.0
12844,4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone,CN(CCCC(=O)c1cccnc1)N=O,C10H13N3O2,16414.0
12845,p-Cresol sulfate (potassium salt),Cc1ccc(OS(=O)(=O)[O-])cc1.[K+],C7H7KO4S,29504.0
12846,Ro 5126766,CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F,C21H18FN5O5S,29197.0
12847,DPPI 1c (hydrochloride),Cl.N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CO)CCCC1,C14H21ClN4O2,30211.0
12848,CAY10742,Fc1ccc(Oc2ccc(-c3noc(-c4ccc5[nH]ccc5c4)n3)cc2)cc1,C22H14FN3O2,29800.0
12849,L-Threonine,C[C@@H](O)[C@H](N)C(=O)O,C4H9NO3,30194.0
12850,"N,O-Diacetyltyramine",CC(=O)NCCc1ccc(OC(C)=O)cc1,C12H15NO3,28738.0
12851,NHI 2,COC(=O)c1cc2c(C(F)(F)F)cc(-c3ccccc3)cc2n1O,C17H12F3NO3,30201.0
12852,"1,2-Dioleoyl-3-Arachidonoyl-rac-glycerol",CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C59H102O6,29234.0
12853,"1,3-Dioleoyl-2-Elaidoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C/CCCCCCCC,C57H104O6,29235.0
12854,Allantoin,NC(=O)N[C@H]1NC(=O)NC1=O,C4H6N4O3,30204.0
12855,Biotin-PEG4-NHS ester,O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)NCCOCCOCCOCCOCCC(=O)ON1C(=O)CCC1=O,C25H40N4O10S,29114.0
12856,"1,2-Dilauroyl-3-Myristoyl-rac-glycerol",CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCC,C41H78O6,29056.0
12857,"SL-651,498",Cn1c2ccc(F)cc2c2c(C(=O)N3CCCC3)cn(-c3ccccc3)c(=O)c21,C23H20FN3O2,22008.0
12858,Noscapine-13C-d3,[2H][13C]([2H])([2H])N1CCc2cc3c(c(OC)c2[C@@H]1[C@H]1OC(=O)c2c1ccc(OC)c2OC)OCO3,C22H23NO7,26679.0
12859,MDMB-ICA,COC(=O)[C@@H](NC(=O)c1c[nH]c2ccccc12)C(C)(C)C,C16H20N2O3,27249.0
12860,?-hydroxy Flubromazolam,OCc1nnc2n1-c1ccc(Br)cc1C(c1ccccc1F)=NC2,C17H12BrFN4O,26588.0
12861,"1,3-Dipalmitoyl-2-Myristoyl Glycerol",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC,C49H94O6,29054.0
12862,"8-Cyclopentyl-1,3-dimethylxanthine",Cn1c(=O)c2[nH]c(C3CCCC3)nc2n(C)c1=O,C12H16N4O2,29870.0
12863,D-Fructose-13C6,O=[13C]([13CH2]O)[13C@@H](O)[13C@H](O)[13C@H](O)[13CH2]O,C6H12O6,30071.0
12864,"1,2-Dioleoyl-3-Arachidoyl-rac-glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C59H110O6,29060.0
12865,Praziquantel-d11,[2H]C1([2H])C([2H])([2H])C([2H])([2H])C([2H])(C(=O)N2CC(=O)N3CCc4ccccc4C3C2)C([2H])([2H])C1([2H])[2H],C19H24N2O2,30237.0
12866,Gymnoascolide A,O=C1OCC(Cc2ccccc2)=C1c1ccccc1,C17H14O2,28585.0
12867,"1,3-Dipentadecanoyl Glycerol",CCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCC,C33H64O5,26994.0
12868,Dipentadecanoin,CCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCC,C33H64O5,27000.0
12869,1-Myristoyl-2-Oleoyl-3-Palmitoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC,C51H96O6,29233.0
12870,Bretylium (tosylate),CC[N+](C)(C)Cc1ccccc1Br.Cc1ccc(S(=O)(=O)[O-])cc1,C18H24BrNO3S,29979.0
12871,C-171,CCCCCCc1ccc(NC(=O)c2ccc([N+](=O)[O-])o2)cc1,C17H20N2O4,30159.0
12872,"L-368,899 (hydrochloride)",Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CC[C@H](C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1.Cl,C26H43ClN4O5S2,29868.0
12873,7-Biopterin,C[C@H](O)[C@H](O)c1cnc2c(=O)nc(N)nc-2[nH]1,C9H11N5O3,29819.0
12874,2-Methylcitric Acid,CC(C(=O)O)C(O)(CC(=O)O)C(=O)O,C7H10O7,29327.0
12875,Massarigenin C,C=C1OC(=O)[C@]2([C@H](C)C=CC(=O)[C@@H]2O)[C@H]1O,C11H12O5,29772.0
12876,BE-26263,CC1CC(=O)OC(C)Cc2cc(O)cc(O)c2C(=O)OC(C)CC(=O)OC(C)Cc2cc(O)cc(O)c2C(=O)OC(C)CC(=O)O1,C32H38O14,29070.0
12877,Fellutanine A,O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H]1Cc1c[nH]c2ccccc12,C22H20N4O2,29320.0
12878,1-Palmitoyl-rac-glycerol,CCCCCCCCCCCCCCCC(=O)OCC(O)CO,C19H38O4,26993.0
12879,CAY10755,C/C=C(\C)C1C(C)=CC2CC(C)CC3(O)C=C(CO)C(=O)C1(C)C23,C21H30O3,28464.0
12880,1-Palmitoyl-2-Oleoyl-3-Linolenoyl-rac-glycerol,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC,C55H98O6,29061.0
12881,Polygalasaponin F,C[C@@H]1O[C@@H](O[C@H]2[C@H](OC(=O)[C@]34CCC(C)(C)C[C@H]3C3=CC[C@@H]5[C@@]6(C)C[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@@](C)(CO)[C@@H]6CC[C@@]5(C)[C@]3(C)CC4)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O,C53H86O23,30064.0
12882,ThioGlo1,COC(=O)c1cc2c(ccc3ccc(OC)c(N4C(=O)C=CC4=O)c32)oc1=O,C20H13NO7,13235.0
12883,D-threo-Biopterin,C[C@@H](O)[C@H](O)c1c[nH]c2nc(N)nc(=O)c-2n1,C9H11N5O3,29986.0
12884,AS-2077715,CCC(C)CC(C)CCC1CCCC(c2c(O)c(C3C(O)C(O)C(O)C3O)cn(C)c2=O)O1,C25H41NO7,29775.0
12885,Cyperine,COc1cc(C)c(Oc2cc(C)cc(O)c2)c(O)c1,C15H16O4,29937.0
12886,16?-hydroxy Etiocholanolone,C[C@]12CC[C@@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)[C@H](O)C[C@@H]12,C19H30O3,27683.0
12887,Palmitoleic Acid-d13,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])/C=C\CCCCCCCC(=O)O,C16H30O2,27714.0
12888,C12 1-Deoxyceramide (m18:1/12:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](C)NC(=O)CCCCCCCCCCC,C30H59NO2,30028.0
12889,4-Chlorocathinone (hydrochloride),CC(N)C(=O)c1ccc(Cl)cc1.Cl,C9H11Cl2NO,30379.0
12890,Palifosfamide,O=P(O)(NCCCl)NCCCl,C4H11Cl2N2O2P,29887.0
12891,Pyrenocine A,C/C=C/C(=O)c1c(OC)cc(=O)oc1C,C11H12O4,29622.0
12892,9-Oxononanoic Acid,O=CCCCCCCCC(=O)O,C9H16O3,29882.0
12893,Oxythiamine (chloride hydrochloride),Cc1ncc(C[n+]2csc(CCO)c2C)c(=O)[nH]1.Cl.[Cl-],C12H17Cl2N3O2S,29953.0
12894,Phomosine D,COC(=O)c1c(C)c(Oc2cc(C)cc(O)c2CO)c(O)c(C)c1O,C18H20O7,28586.0
12895,EN6,C=CC(=O)Nc1cc(NC(=O)c2cnn(-c3ccccc3F)c2)ccc1F,C19H14F2N4O2,28715.0
12896,Dodecanoyl D-Sucrose,CCCCCCCCCCCC(=O)OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,C24H44O12,29982.0
12897,1-(3-Chloro-4-fluorophenyl)piperazine (hydrochloride),Cl.Fc1ccc(N2CCNCC2)cc1Cl,C10H13Cl2FN2,30230.0
12898,SL-164,Cc1cc(Cl)ccc1-n1c(C)nc2cccc(Cl)c2c1=O,C16H12Cl2N2O,28244.0
12899,Ralinepag,O=C(O)COC[C@H]1CC[C@H](COC(=O)N(c2ccccc2)c2ccc(Cl)cc2)CC1,C23H26ClNO5,30009.0
12900,Ilicicolin F,CC(=O)O[C@H]1CC(=O)[C@H](C)[C@@](C)(/C=C/C(C)=C/Cc2c(O)c(Cl)c(C)c(C=O)c2O)[C@@H]1C,C25H31ClO6,29850.0
12901,Carbolactone,C[C@@H]1C(=O)O[C@@H]2CC3=C(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]34C)[C@@H]3CC[C@H]1[C@@]23C,C24H36O3,29838.0
12902,SCH 60057,CC(C)=CCCC(C)(O)CCCC(C)(O)CCCC(C)(O)CCCC(C)(O)CCCC(C)(O)CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CO,C45H84O6,29239.0
12903,Monocerin,CCC[C@H]1C[C@H]2OC(=O)c3c(cc(OC)c(OC)c3O)[C@H]2O1,C16H20O6,29572.0
12904,Thiocoraline,CSC[C@H]1C(=O)SC[C@@H](NC(=O)c2nc3ccccc3cc2O)C(=O)NCC(=O)N(C)[C@H]2CSSC[C@@H](C(=O)N1C)N(C)C(=O)CNC(=O)[C@H](NC(=O)c1nc3ccccc3cc1O)CSC(=O)[C@H](CSC)N(C)C2=O,C48H56N10O12S6,29509.0
12905,Napyradiomycin A1,CC(C)=CCC/C(C)=C/C[C@@]12OC(C)(C)[C@H](Cl)C[C@]1(Cl)C(=O)c1c(O)cc(O)cc1C2=O,C25H30Cl2O5,29215.0
12906,Sporogen-AO 1,C=C(C)[C@@]12O[C@@H]1[C@@]1(C)C(=CC2=O)CC[C@@H](O)[C@@H]1C,C15H20O3,29576.0
12907,Acremine I,CC(C)(O)[C@H]1O[C@@H]1C1=CC(=O)[C@]2(C)O[C@@H]2[C@@H]1O,C12H16O5,29771.0
12908,Abacavir-d4,[2H]C1([2H])C(Nc2nc(N)nc3c2ncn3[C@H]2C=C[C@@H](CO)C2)C1([2H])[2H],C14H18N6O,30076.0
12909,DC_AC50,Nc1c(C(=O)Nc2c(F)cc(F)cc2Br)sc2nc3c(cc12)CCC3,C17H12BrF2N3OS,19283.0
12910,GR24,CC1=C[C@H](O/C=C2/C(=O)O[C@@H]3c4ccccc4C[C@H]23)OC1=O,C17H14O5,13210.0
12911,Maltononaose,O=C[C@H](O)[C@@H](O)[C@H](O[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O[C@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,C54H92O46,29918.0
12912,SM-324405,CCCCOc1nc(N)c2[nH]c(=O)n(Cc3cccc(CC(=O)OC)c3)c2n1,C19H23N5O4,29457.0
12913,Nalanthalide,C=C1CC[C@H]2[C@](C)(CCC=C(C)C)[C@@H](OC(C)=O)CC[C@]2(C)[C@@H]1Cc1c(OC)oc(C)c(C)c1=O,C30H44O5,29724.0
12914,Dehydrolithocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H38O3,29544.0
12915,22-NBD Cholesterol,C[C@H](CNc1ccc([N+](=O)[O-])c2nonc12)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C28H38N4O4,30136.0
12916,PSB-12379,O=P(O)(O)CP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(NCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O,C18H23N5O9P2,28446.0
12917,AUTEN-99,Br.C1=C(c2ccc(-c3ccccc3)cc2)SC2=NCCN12,C17H15BrN2S,30047.0
12918,E6005,CNc1nc(-c2cccc(NC(=O)c3ccc(C(=O)OC)cc3)c2)c2cc(OC)c(OC)cc2n1,C26H24N4O5,30203.0
12919,Hentriacontane,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,C31H64,29776.0
12920,Echinacoside,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,C35H46O20,29927.0
12921,"N-pyrrolidinyl-3,4-DMA (hydrochloride)",COc1ccc(CC(C)N2CCCC2)cc1OC.Cl,C15H24ClNO2,30611.0
12922,Clonostachydiol,C[C@@H]1OC(=O)/C=C/[C@@H](O)CC[C@H](C)OC(=O)/C=C/[C@H]1O,C14H20O6,29066.0
12923,Urdamycin B,C[C@@H]1O[C@@H](O[C@@H]2C[C@H](c3ccc4c(c3O)C(=O)c3ccc5c(c3C4=O)C(=O)C[C@](C)(O)C5)O[C@H](C)[C@H]2O)CC[C@@H]1O[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1,C37H44O13,29770.0
12924,Previridicatumtoxin,COc1cc(O)c2c(O)c3c(c(C/C=C(\C)CCC=C(C)C)c2c1)[C@H](O)[C@@]1(O)CC(O)=C(C(N)=O)C(=O)[C@@]1(O)C3=O,C30H33NO10,29069.0
12925,"1,2,3-Tri-10(Z)-Heptadecenoyl-rac-glycerol",CCCCCC/C=C\CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCC/C=C\CCCCCC,C54H98O6,26996.0
12926,"1,3-Ditridecanoyl Glycerol",CCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCC,C29H56O5,26995.0
12927,Ditridecanoin,CCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCC,C29H56O5,27001.0
12928,Methylophiopogonanone A,Cc1c(O)c(C)c2c(c1O)C(=O)[C@H](Cc1ccc3c(c1)OCO3)CO2,C19H18O6,30192.0
12929,4-(N-Boc-amino)piperidine,CC(C)(C)OC(=O)NC1CCNCC1,C10H20N2O2,30398.0
12930,Boc-L-Arg-OH,CC(C)(C)OC(=O)N[C@@H](CCCNC(=N)N)C(=O)O,C11H22N4O4,30448.0
12931,m-Methoxybenzamide,COc1cccc(C(N)=O)c1,C8H9NO2,30451.0
12932,ACTB-1003,COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1,C27H26F5N7O3,30069.0
12933,PD 318088,O=C(NOCC(O)CO)c1cc(Br)c(F)c(F)c1Nc1ccc(I)cc1F,C16H13BrF3IN2O4,30265.0
12934,N-Boc-L-Proline,CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)O,C10H17NO4,30386.0
12935,PD 168077 (maleate),Cc1cccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)c1.O=C(O)/C=C\C(=O)O,C24H26N4O5,29789.0
12936,(E)-Anethol,C/C=C/c1ccc(OC)cc1,C10H12O,29862.0
12937,Thioridazine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])N1CCCCC1CCN1c2ccccc2Sc2ccc(SC)cc21,C21H27ClN2S2,30239.0
12938,Tigogenin,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C27H44O3,30137.0
12939,BODIPY FL succinimide ester,CC1=CC(C)=[N+]2C1=Cc1ccc(CCC(=O)ON3C(=O)CCC3=O)n1[B-]2(F)F,C18H18BF2N3O4,29508.0
12940,Ciproxifan (maleate),O=C(O)/C=C\C(=O)O.O=C(c1ccc(OCCCc2cnc[nH]2)cc1)C1CC1,C20H22N2O6,29513.0
12941,Roquinimex,CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1,C18H16N2O3,30206.0
12942,5-deoxy-D-Ribose,C[C@@H](O)[C@@H](O)[C@@H](O)C=O,C5H10O4,30103.0
12943,Pramoxine (hydrochloride),CCCCOc1ccc(OCCCN2CCOCC2)cc1.Cl,C17H28ClNO3,30077.0
12944,Dipyridamole-d16,[2H]C([2H])(O)C([2H])([2H])N(c1nc(N2CCCCC2)c2nc(N(C([2H])([2H])C([2H])([2H])O)C([2H])([2H])C([2H])([2H])O)nc(N3CCCCC3)c2n1)C([2H])([2H])C([2H])([2H])O,C24H40N8O4,30138.0
12945,Isoconazole (nitrate),Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1.O=[N+]([O-])O,C18H15Cl4N3O4,30100.0
12946,Ramoplanin Complex,CC(C)C/C=C/C=C\C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]1C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@H](CCCN)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](c2ccc(O)cc2)C(=O)N[C@H](c2ccc(O)cc2)C(=O)NC([C@H](C)O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](CCCN)C(=O)N[C@@H](c2ccc(O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)cc2)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](c2ccc(O)cc2)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](c2ccc(O)c(Cl)c2)C(=O)O[C@@H]1C(N)=O.CC(C)CC/C=C/C=C\C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]1C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@H](CCCN)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](c2ccc(O)cc2)C(=O)N[C@H](c2ccc(O)cc2)C(=O)NC([C@H](C)O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](CCCN)C(=O)N[C@@H](c2ccc(O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)cc2)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](c2ccc(O)cc2)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](c2ccc(O)c(Cl)c2)C(=O)O[C@@H]1C(N)=O.CCC/C=C/C=C\C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]1C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@H](CCCN)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](c2ccc(O)cc2)C(=O)N[C@H](c2ccc(O)cc2)C(=O)NC([C@H](C)O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](CCCN)C(=O)N[C@@H](c2ccc(O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)cc2)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](c2ccc(O)cc2)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](c2ccc(O)c(Cl)c2)C(=O)O[C@@H]1C(N)=O,C357H462Cl3N63O120,28189.0
12947,Erythrodiol,CC1(C)CC[C@]2(CO)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,C30H50O2,30135.0
12948,Heptaminol,CC(N)CCCC(C)(C)O,C8H19NO,29879.0
12949,JBSNF-000088,COc1ccc(C(N)=O)cn1,C7H8N2O2,29920.0
12950,5-Phenyllevulinic Acid,O=C(O)CCC(=O)Cc1ccccc1,C11H12O3,28401.0
12951,2-Hydroxy-4-methoxybenzaldehyde,COc1ccc(C=O)c(O)c1,C8H8O3,30091.0
12952,"9(S),12(S),13(S)-TriHOME",CCCCC[C@H](O)[C@@H](O)/C=C/[C@@H](O)CCCCCCCC(=O)O,C18H34O5,10005143.0
12953,LOC14,O=C(C1CC1)N1CCN(Cn2sc3ccccc3c2=O)CC1,C16H19N3O2S,17766.0
12954,PYD-106,COC(=O)c1ccc(C2C(C(C)=O)=C(O)C(=O)N2CCc2c(C)[nH]c3ccccc23)cc1,C25H24N2O5,28837.0
12955,Eltenac,O=C(O)Cc1cscc1Nc1c(Cl)cccc1Cl,C12H9Cl2NO2S,27673.0
12956,Silodosin-d4,[2H]C([2H])(N[C@H](C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)C([2H])([2H])Oc1ccccc1OCC(F)(F)F,C25H32F3N3O4,30236.0
12957,Carviolin,COc1cc(CO)cc2c1C(=O)c1c(O)cc(O)cc1C2=O,C16H12O6,29634.0
12958,Hydroxysulochrin,COC(=O)c1cc(O)cc(OC)c1C(=O)c1c(O)cc(CO)cc1O,C17H16O8,29325.0
12959,Daldinone A,O=C1C[C@H]2[C@H]3CCC(=O)c4c(O)ccc(c43)[C@@]2(O)c2cccc(O)c21,C20H16O5,29501.0
12960,Zinnol,COc1c(C)c(O)cc(CO)c1CO,C10H14O4,29168.0
12961,Sporothriolide,C=C1C(=O)O[C@@H]2[C@H]1C(=O)O[C@@H]2CCCCCC,C13H18O4,29323.0
12962,Aranciamycin,CO[C@H]1[C@H](O[C@@H]2c3c(cc4c(c3O)C(=O)c3c(O)cccc3C4=O)C(=O)[C@@](C)(O)[C@H]2OC)O[C@@H](C)[C@H](O)[C@H]1O,C27H28O12,29575.0
12963,Mosapride (citrate),CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1.O=C(O)CC(O)(CC(=O)O)C(=O)O,C27H33ClFN3O10,30048.0
12964,MLN7243,NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ccnc3cc(-c4cccc(SC(F)(F)F)c4)nn23)[C@H](O)[C@@H]1O,C19H20F3N5O5S2,30108.0
12965,Suplatast (tosylate),CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1.Cc1ccc(S(=O)(=O)[O-])cc1,C23H33NO7S2,30316.0
12966,Coniferin,COc1cc(/C=C/CO)ccc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C16H22O8,30364.0
12967,Lapachol,CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O,C15H14O3,30190.0
12968,Sclareol,C=C[C@](C)(O)CC[C@@H]1[C@@]2(C)CCCC(C)(C)[C@@H]2CC[C@@]1(C)O,C20H36O2,30287.0
12969,Agomelatine-d6,[2H]C([2H])([2H])Oc1ccc2cccc(CCNC(=O)C([2H])([2H])[2H])c2c1,C15H17NO2,26447.0
12970,SKF 86002,Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,C16H12FN3S,30202.0
12971,Domiphen (bromide),CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1.[Br-],C22H40BrNO,30276.0
12972,Boc-NH-PEG3-OH,CC(C)(C)OC(=O)NCCOCCOCCO,C11H23NO5,30496.0
12973,Myxochelin A,O=C(NCCCC[C@@H](CO)NC(=O)c1cccc(O)c1O)c1cccc(O)c1O,C20H24N2O7,26422.0
12974,ITI214,CN1C(=O)c2c(nn(Cc3ccc(-c4cccc(F)n4)cc3)c2Nc2ccccc2)N2C1=N[C@@H]1CCC[C@@H]12.O=P(O)(O)O,C29H29FN7O5P,30376.0
12975,A-966492,NC(=O)c1cccc2nc(-c3ccc([C@@H]4CCCN4)cc3F)[nH]c12,C18H17FN4O,26378.0
12976,13-acetyl-9-Dihydrobaccatin III,CC(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)[C@@H](O)[C@H](OC(C)=O)C(=C1C)C2(C)C,C33H42O12,29701.0
12977,Elemicin,C=CCc1cc(OC)c(OC)c(OC)c1,C12H16O3,29394.0
12978,(4'-Hydroxy)phenoxybenzoic Acid,O=C(O)c1cccc(Oc2ccc(O)cc2)c1,C13H10O4,29891.0
12979,Etifoxine-13C-d3,[2H][13C]([2H])([2H])C1(c2ccccc2)OC(NCC)=Nc2ccc(Cl)cc21,C17H17ClN2O,30235.0
12980,JNJ-64619178,Nc1nc2cc(CC[C@H]3C[C@@H](n4ccc5c(N)ncnc54)[C@H](O)[C@@H]3O)ccc2cc1Br,C22H23BrN6O2,29231.0
12981,Sesquicillin A,C=C1CC[C@@H]2[C@@](C)(CCC=C(C)C)[C@H](OC(C)=O)CC[C@@]2(C)[C@H]1Cc1c(O)c(C)c(C)oc1=O,C29H42O5,29326.0
12982,K-41,CO[C@H]1CC[C@H](O[C@H]2[C@H](C)[C@@H]([C@H]3CC[C@H]([C@@H]4CC[C@H]([C@@]5(C)O[C@]6(O[C@H](C[C@@H]7O[C@](O)([C@@H](O)C(=O)O)[C@@H](C)[C@H](OC)[C@@]7(C)OC)C[C@@H](OC)[C@H]6C)[C@H](C)[C@H]5OC)O4)O3)O[C@](C)(O)[C@@H]2C)O[C@@H]1C,C48H82O18,29573.0
12983,Oxaline,C=CC(C)(C)[C@@]12C=C(OC)C(=O)N3/C(=C/c4cnc[nH]4)C(=O)N[C@]31N(OC)c1ccccc12,C24H25N5O4,29574.0
12984,Pericosine A,COC(=O)C1=C[C@H](O)[C@H](O)[C@H](O)[C@H]1Cl,C8H11ClO5,29633.0
12985,Dihydrotetrodecamycin,CC1OC(=O)C2=C1OC1C(O)C3(O)CCCCC3C(C)(C2=O)C1C,C18H24O6,29725.0
12986,"2,3,5-Trimethoxyamphetamine (hydrochloride)",COc1cc(CC(C)N)c(OC)c(OC)c1.Cl,C12H20ClNO3,25396.0
12987,Asapiprant,CC(C)Oc1ccc(S(=O)(=O)N2CCN(c3ccc(-c4ncco4)c(OCC(=O)O)c3)CC2)cc1,C24H27N3O7S,30008.0
12988,Papyracillic Acid,C=C1C(C)C(C)(O)OC12OC(=O)C=C2OC,C11H14O5,29324.0
12989,6-Chloro-3-indolyl-?-D-Glucuronide (cyclohexylammonium salt),NC1CCCCC1.O=C(O)[C@H]1O[C@@H](Oc2c[nH]c3cc(Cl)ccc23)[C@H](O)[C@@H](O)[C@@H]1O,C20H27ClN2O7,30131.0
12990,RGW 611,O=[N+]([O-])c1cn(CCN2CCOCC2)cn1,C9H14N4O3,30067.0
12991,Dendrobine,CC(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@@H]1CC[C@@H]3CN(C)[C@H]2[C@@]31C,C16H25NO2,26067.0
12992,YM-976,CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1,C17H16ClN3O,29529.0
12993,(E)-Ajoene,C=CCSS/C=C/CS(=O)CC=C,C9H14OS3,26242.0
12994,7-keto Lithocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H38O4,29546.0
12995,Dihydrochelerythrine,COc1ccc2c(c1OC)CN(C)c1c-2ccc2cc3c(cc12)OCO3,C21H19NO4,30118.0
12996,Colletodiol,C[C@@H]1C/C=C/C(=O)O[C@H](C)C[C@@H](O)[C@H](O)/C=C/C(=O)O1,C14H20O6,29945.0
12997,Isoliquiritin,O=C(/C=C/c1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)c1ccc(O)cc1O,C21H22O9,30270.0
12998,"(2R,3S)-N-Cbz-6-oxo-2,3-Diphenylmorpholine",O=C1CN(C(=O)OCc2ccccc2)[C@@H](c2ccccc2)[C@@H](c2ccccc2)O1,C24H21NO4,30497.0
12999,(+)-JQ1 PA,C#CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21,C22H20ClN5OS,30414.0
13000,BE-24566B,Cc1cc(O)cc2c1[C@H]1O[C@](C)(Cc3cc4c(c(O)c31)C(=O)c1c(O)cc(O)cc1C4(C)C)O2,C27H24O7,29955.0
13001,Deltorphin C (trifluoroacetate salt),CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)NCC(N)=O)C(C)C.O=C(O)C(F)(F)F,C39H53F3N8O12,30050.0
13002,Bruceine A,COC(=O)[C@@]12OC[C@]34[C@H]([C@@H](O)[C@@H]1O)[C@@]1(C)CC(=O)C(O)=C(C)[C@@H]1C[C@H]3OC(=O)[C@H](OC(=O)CC(C)C)[C@@H]24,C26H34O11,29936.0
13003,5-Bromouridine,O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1Br,C9H11BrN2O6,30457.0
13004,1-Amino-1-deoxy-D-fructose (hydrochloride),Cl.NCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO,C6H14ClNO5,30571.0
13005,Fmoc-Glu(OtBu)-Osu,CC(C)(C)OC(=O)CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)ON1C(=O)CCC1=O,C28H30N2O8,30545.0
13006,Stearic Acid-d4,[2H]C([2H])(CCCCCCCC)C([2H])([2H])CCCCCCCC(=O)O,C18H36O2,30549.0
13007,Ac-Gly-Lys-OMe (acetate),CC(=O)O.COC(=O)[C@H](CCCCN)NC(=O)CNC(C)=O,C13H25N3O6,30568.0
13008,Chlorophenol Red ?-D-Galactopyranoside,O=S1(=O)OC(c2ccc(O)c(Cl)c2)(c2ccc(O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)c(Cl)c2)c2ccccc21,C25H22Cl2O10S,29707.0
13009,Secoxyloganin,C=C[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C(C(=O)OC)[C@H]1CC(=O)O,C17H24O11,30267.0
13010,"1,3,4,6-Tetra-O-acetyl-2-azido-2-deoxy-?-D-Mannopyranose",CC(=O)OC[C@H]1O[C@H](OC(C)=O)[C@@H](N=[N+]=[N-])[C@@H](OC(C)=O)[C@@H]1OC(C)=O,C14H19N3O9,30542.0
13011,Boc-NH-PEG3 Acid,CC(C)(C)OC(=O)NCCOCCOCCOCC(=O)O,C13H25NO7,30536.0
13012,Pirmenol,C[C@@H]1CCC[C@H](C)N1CCCC(O)(c1ccccc1)c1ccccn1,C22H30N2O,29042.0
13013,Lafutidine,O=C(CS(=O)Cc1ccco1)NC/C=C\COc1cc(CN2CCCCC2)ccn1,C22H29N3O4S,30275.0
13014,H-Leu-OtBu (hydrochloride),CC(C)C[C@H](N)C(=O)OC(C)(C)C.Cl,C10H22ClNO2,30529.0
13015,Liquiritin,O=C1C[C@@H](c2ccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc2)Oc2cc(O)ccc21,C21H22O9,30263.0
13016,(-)-Isocorypalmine,COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2,C20H23NO4,29886.0
13017,Alrestatin,O=C(O)CN1C(=O)c2cccc3cccc(c23)C1=O,C14H9NO4,29888.0
13018,"1,2,3-Triundecanoyl Glycerol",CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCC,C36H68O6,27008.0
13019,Digitoxin,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,C41H64O13,27825.0
13020,Phenoxazine,c1ccc2c(c1)Nc1ccccc1O2,C12H9NO,29964.0
13021,Isocorydine,COc1ccc2c(c1O)-c1c(OC)c(OC)cc3c1[C@H](C2)N(C)CC3,C20H23NO4,30101.0
13022,Pinocembrin,O=C1C[C@@H](c2ccccc2)Oc2cc(O)cc(O)c21,C15H12O4,29852.0
13023,Enviroxime,CC(C)S(=O)(=O)n1c(N)nc2ccc(/C(=N/O)c3ccccc3)cc21,C17H18N4O3S,30552.0
13024,FLT3-IN-2,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cc1,C21H16ClF3N4,30070.0
13025,DL-Homocysteine,NC(CCS)C(=O)O,C4H9NO2S,30285.0
13026,Methylophiopogonanone B,COc1ccc(C[C@@H]2COc3c(C)c(O)c(C)c(O)c3C2=O)cc1,C19H20O5,30193.0
13027,Oleanolic Acid Acetate,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@]5(C(=O)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C,C32H50O4,29764.0
13028,Lipoxygenin,COc1ncccc1-c1cnc(OC)c(C(O)c2ccc3ccccc3c2)c1OC,C24H22N2O4,26310.0
13029,NGP-555,CCc1cc(Nc2nc(-c3ccc(-n4cnc(C)c4)c(F)c3)cs2)c(C)cc1C,C23H23FN4S,27918.0
13030,4-(Phenylcarbonyl)benzoic Acid,O=C(O)c1ccc(C(=O)c2ccccc2)cc1,C14H10O3,30407.0
13031,Ganoderic Acid B,C[C@H](CC(=O)C[C@@H](C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O,C30H44O7,30112.0
13032,Fmoc-Orn(Boc)-OH,CC(C)(C)OC(=O)NCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O,C25H30N2O6,30471.0
13033,F-14329,C/C=C/C[C@H](C)C[C@H](C)/C(O)=C1/C(=O)N[C@@H]([C@@H](O)c2ccc(O)cc2)C1=O,C21H27NO5,29999.0
13034,Schisanhenol,COc1cc2c(c(O)c1OC)-c1c(cc(OC)c(OC)c1OC)CC(C)C(C)C2,C23H30O6,30109.0
13035,MSC2530818,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,C18H17ClN4O,29669.0
13036,PF-05180999,Cc1nc(-c2cnn(C)c2-c2ccc(C(F)(F)F)cn2)c2c(N3CCC3)ncnn12,C19H17F3N8,30374.0
13037,2-Fluoro-4-iodo benzonitrile,N#Cc1ccc(I)cc1F,C7H3FIN,30483.0
13038,NAP 226-90,C[C@@H](c1cccc(O)c1)N(C)C,C10H15NO,30124.0
13039,12-keto Lithocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC(=O)[C@]12C,C24H38O4,29547.0
13040,Boc-Arg(Boc)2-OH,CC(C)(C)OC(=O)NC(=N)N(CCC[C@H](NC(=O)OC(C)(C)C)C(=O)O)C(=O)OC(C)(C)C,C21H38N4O8,30522.0
13041,KO947,O=C1Nc2cc3[nH]nc(-c4ccncc4)c3cc2CN1Cc1ccccc1,C21H17N5O,29213.0
13042,O-Propargyl-puromycin,C#CCOc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1,C24H29N7O5,15134.0
13043,ML-SA1,CC1CC(C)(C)N(C(=O)CN2C(=O)c3ccccc3C2=O)c2ccccc21,C22H22N2O3,29958.0
13044,Myristic Acid-d2,[2H]C([2H])(CCCCCCCCCCCC)C(=O)O,C14H28O2,29411.0
13045,Boc-Orn(Fmoc)-OH,CC(C)(C)OC(=O)N[C@@H](CCCNC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O,C25H30N2O6,30495.0
13046,L-Alanine methyl ester (hydrochloride),COC(=O)[C@H](C)N.Cl,C4H10ClNO2,30527.0
13047,DMA (hydrochloride),COc1ccc(-c2nc3ccc(-c4nc5ccc(N6CCN(C)CC6)cc5[nH]4)cc3[nH]2)cc1OC.Cl.Cl.Cl,C27H31Cl3N6O2,30416.0
13048,Onjisaponin B,COc1ccc(/C=C/C(=O)O[C@@H]2[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O[C@@H]3O[C@@H](C)[C@H](O[C@@H]4OC[C@@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@@H](O)[C@H]3O)[C@H](OC(=O)[C@]34CCC(C)(C)C[C@H]3C3=CC[C@@H]5[C@@]6(C)C[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@@](C)(C(=O)O)[C@@H]6CC[C@@]5(C)[C@]3(CO)CC4)O[C@@H]2C)cc1,C75H112O35,30521.0
13049,Dil,CCCCCCCCCCCCCCCCCCN1/C(=C/C=C/C2=[N+](CCCCCCCCCCCCCCCCCC)c3ccccc3C2(C)C)C(C)(C)c2ccccc21.[O-][Cl+3]([O-])([O-])[O-],C59H97ClN2O4,30423.0
13050,6-Chloro-2-fluoropurine,Fc1nc(Cl)c2[nH]cnc2n1,C5H2ClFN4,30481.0
13051,"1,2-Dinonadecanoyl-rac-glycerol",CCCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCCCCC,C41H80O5,27009.0
13052,Homodestcardin,CC[C@H](C)[C@@H]1NC(=O)[C@@H]2[C@@H](C)CCN2C(=O)[C@@H](CC(C)C)OC(=O)CCNC(=O)[C@H](C)N(C)C(=O)[C@H]([C@@H](C)CC)N(C)C1=O,C32H55N5O7,30052.0
13053,Decarestrictine A1,C[C@@H]1C[C@@H]2O[C@@H]2/C=C/[C@@H](O)CC(=O)O1,C10H14O4,29952.0
13054,Geraniin,O=C1OC2C3COC(=O)c4cc(O)c(O)c(O)c4-c4c(cc(O)c(O)c4O)C(=O)OC2C(OC(=O)c2cc(O)c(O)c4c2C2C1=CC(=O)C(O)(O4)C2(O)O)C(OC(=O)c1cc(O)c(O)c(O)c1)O3,C41H28O27,29924.0
13055,"N-ethyl-3,4-DMA (hydrochloride)",CCNC(C)Cc1ccc(OC)c(OC)c1.Cl,C13H22ClNO2,30482.0
13056,7-Bromoheptanoic Acid,O=C(O)CCCCCCBr,C7H13BrO2,30420.0
13057,Pseudoginsenoside F11,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3C[C@]4(C)[C@H](C[C@@H](O)[C@@H]5[C@@H]([C@]6(C)CC[C@H](C(C)(C)O)O6)CC[C@]54C)[C@@]4(C)CC[C@H](O)C(C)(C)[C@H]34)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C42H72O14,30222.0
13058,Pelargonidin 3-O-glucoside (chloride),OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O.[Cl-],C21H21ClO10,30224.0
13059,Bromoacetamido-PEG3-Boc-amine,CC(C)(C)OC(=O)NCCOCCOCCOCCNC(=O)CBr,C15H29BrN2O6,30554.0
13060,3-Acetylursolic Acid,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5[C@@H](C)[C@H](C)CC[C@]5(C(=O)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C,C32H50O4,30220.0
13061,PLX5622,COc1ncc(F)cc1CNc1ccc(Cc2c[nH]c3ncc(C)cc23)c(F)n1,C21H19F2N5O,28927.0
13062,2'-Deoxyguanosine (hydrate),Nc1nc(=O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)O3)c2[nH]1.O,C10H15N5O5,9002864.0
13063,MAK-683,Cc1ncccc1-c1cnc(NCc2c(F)ccc3c2CCO3)n2cnnc12,C20H17FN6O,29316.0
13064,CCK Octapeptide (sulfated),CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,C49H62N10O16S3,23371.0
13065,N-Glycolylneuraminic Acid,O=C(CO)N[C@@H]([C@@H](O)[C@H](O)[C@H](O)CO)[C@@H](O)CC(=O)C(=O)O,C11H19NO10,30283.0
13066,"2,3-Isopropylidene-D-ribonolactone",CC1(C)O[C@@H]2[C@@H](CO)OC(=O)[C@@H]2O1,C8H12O5,30479.0
13067,Boc-D-Leu-OSu,CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)ON1C(=O)CCC1=O,C15H24N2O6,30543.0
13068,Ethynylcytidine,C#C[C@@]1(O)[C@@H](CO)O[C@@H](n2ccc(N)nc2=O)[C@@H]1O,C11H13N3O5,27681.0
13069,"1,2,3-Trilignoceroyl Glycerol",CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCCCC,C75H146O6,29055.0
13070,N6-benzoyl-2'-Deoxyadenosine,O=C(Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1)c1ccccc1,C17H17N5O4,30262.0
13071,GSK356278,CCn1ncc2c(NC3CCOCC3)c(-c3nnc(Cc4sc(C)nc4C)o3)cnc21,C21H25N7O2S,30412.0
13072,Prostaglandin E1 isopropyl ester,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC(C)C,C23H40O5,9001729.0
13073,(Z)-9-Hexadecenol,CCCCCC/C=C\CCCCCCCCO,C16H32O,30462.0
13074,Lucidenic Acid A,C[C@H](CCC(=O)O)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O,C27H38O6,30372.0
13075,Ganoderenic Acid C,C/C(=C\C(=O)CC(C)C(=O)O)C1C[C@H](O)C2(C)C3=C(C(=O)CC12C)C1(C)CC[C@H](O)C(C)(C)C1C[C@@H]3O,C30H44O7,30366.0
13076,"6,7-Dihydro-5H-quinolin-8-one",O=C1CCCc2cccnc21,C9H9NO,30480.0
13077,Clorsulon,Nc1cc(C(Cl)=C(Cl)Cl)c(S(N)(=O)=O)cc1S(N)(=O)=O,C8H8Cl3N3O4S2,30288.0
13078,Strontium Ranelate,N#Cc1c(N(CC(=O)[O-])CC(=O)[O-])sc(C(=O)[O-])c1CC(=O)[O-].[Sr+2].[Sr+2],C12H6N2O8SSr2,30272.0
13079,Chloramine-T (hydrate),Cc1ccc(S(=O)(=O)[N-]Cl)cc1.O.[Na+],C7H7ClNNaO2S(H2O)X,30533.0
13080,Picroside II,COc1cc(C(=O)O[C@H]2[C@@H]3C=CO[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]3[C@@]3(CO)O[C@@H]23)ccc1O,C23H28O13,30319.0
13081,N-ethyl 2C-B (hydrochloride),CCNCCc1cc(OC)c(Br)cc1OC.Cl,C12H19BrClNO2,29387.0
13082,VS-5584 analog,CC(C)n1cnc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21,C16H20N8O,30324.0
13083,"3,5-Dihydroxybenzaldehyde",O=Cc1cc(O)cc(O)c1,C7H6O3,30445.0
13084,4-Nitrobenzeneboronic Acid,O=[N+]([O-])c1ccc(B(O)O)cc1,C6H6BNO4,30401.0
13085,Araloside A,CC1(C)CC[C@]2(C(=O)O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O[C@@H]7O[C@@H](CO)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,C47H74O18,30219.0
13086,14-dehydro Zymostenol,CC(C)CCC[C@@H](C)[C@H]1CC=C2C3=C(CC[C@@]21C)[C@@]1(C)CC[C@H](O)C[C@@H]1CC3,C27H44O,29534.0
13087,MDMB-BUTINACA butanoic acid metabolite,CCCCn1nc(C(=O)N[C@H](C(=O)O)C(C)(C)C)c2ccccc21,C18H25N3O3,28939.0
13088,Z-Lys-OH,NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O,C14H20N2O4,30460.0
13089,Sanggenone C,CC(C)=CC[C@]12Oc3cc(O)c([C@H]4C=C(C)C[C@H](c5ccc(O)cc5O)[C@H]4C(=O)c4ccc(O)cc4O)c(O)c3C(=O)[C@@]1(O)Oc1cc(O)ccc12,C40H36O12,30061.0
13090,"?-MSH (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)",CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C.O=C(O)C(F)(F)F,C79H110F3N21O21S,29923.0
13091,Ganoderic Acid C2,CC(CC(=O)CC(C)C1C[C@H](O)C2(C)C3=C(C(=O)CC12C)C1(C)CC[C@H](O)C(C)(C)C1CC3O)C(=O)O,C30H46O7,30371.0
13092,YL-109,COc1cc(-c2nc3ccccc3s2)ccc1O,C14H11NO2S,30290.0
13093,Boc-Glu-OBzl,CC(C)(C)OC(=O)N[C@@H](CCC(=O)O)C(=O)OCc1ccccc1,C17H23NO6,30464.0
13094,Prostaglandin J2-d4,[2H]C([2H])(/C=C\C[C@H]1C=CC(=O)[C@@H]1/C=C/[C@@H](O)CCCCC)C([2H])([2H])CC(=O)O,C20H30O4,19345.0
13095,BI-409306,O=c1nc(Cc2ccccn2)[nH]c2c1cnn2C1CCOCC1,C16H17N5O2,30375.0
13096,CAY10766,CC(C)(C)N1CCC(NC(=O)c2ccc(C(F)(F)F)cc2Cl)CC1,C17H22ClF3N2O,30604.0
13097,Moguisteine,CCOC(=O)CC(=O)N1CCSC1COc1ccccc1OC,C16H21NO5S,30362.0
13098,Remifentanil (oxalate),CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1.O=C(O)C(=O)O,C22H30N2O9,9003472.0
13099,CID-1375606,O=C(Nc1ccccc1)c1ccc(NC(=O)c2ccc(Cl)cc2Cl)cc1,C20H14Cl2N2O2,30422.0
13100,(S)-N-Boc-L-Homoserine ethyl ester,CCOC(=O)[C@H](CCO)NC(=O)OC(C)(C)C,C11H21NO5,30547.0
13101,Boc-Leu-Leu-OH,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C)C(=O)O,C17H32N2O5,30499.0
13102,Procyanidin,Oc1cc(O)c2c(c1)OC(c1ccc(O)c(O)c1)C(OC1(c3ccc(O)c(O)c3)Oc3cc(O)cc(O)c3C(O)C1O)C2,C30H26O13,29763.0
13103,Neotuberostemonine,CC[C@@H]1[C@H]2CCCCN3[C@H]2[C@@H](C[C@H]3[C@@H]2C[C@H](C)C(=O)O2)[C@H]2[C@@H]1OC(=O)[C@H]2C,C22H33NO4,30116.0
13104,"2,3,4-Tri-O-acetyl-?-D-Glucuronide methyl ester",COC(=O)[C@H]1O[C@@H](O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,C13H18O10,30540.0
13105,Cholenic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H38O3,29543.0
13106,Cefmetazole,CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21,C15H17N7O5S3,30269.0
13107,Irsogladine (maleate),Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O,C13H11Cl2N5O4,30223.0
13108,N?-Boc-D-Histidine,CC(C)(C)OC(=O)N[C@H](Cc1cnc[nH]1)C(=O)O,C11H17N3O4,30501.0
13109,N-(2-Aminoethyl)maleimide (trifluoroacetate salt),NCCN1C(=O)C=CC1=O.O=C(O)C(F)(F)F,C8H9F3N2O4,30530.0
13110,Myceliothermophin E,C/C=C(\C)[C@@H]1C(C)=C[C@]2(C)C[C@H](C)CC[C@H]2[C@@H]1C(=O)C1=C/C(=C/C(C)C)NC1=O,C26H37NO2,30053.0
13111,DL-3-n-Butylphthalide,CCCCC1OC(=O)c2ccccc21,C12H14O2,30284.0
13112,Gomisin J,COc1c(O)cc2c(c1OC)-c1c(cc(O)c(OC)c1OC)CC(C)C(C)C2,C22H28O6,30213.0
13113,Azido-dPEG7-amine,[N-]=[N+]=NCCOCCOCCOCCOCCOCCOCCOCCN,C16H34N4O7,30544.0
13114,Malotilate,CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1,C12H16O4S2,30266.0
13115,"4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline",COCCOc1cc2ncnc(Cl)c2cc1OCCOC,C14H17ClN2O4,30487.0
13116,TG100713,Nc1nc(N)c2nc(-c3cccc(O)c3)cnc2n1,C12H10N6O,30195.0
13117,(PEO)3-monoamine,NCCOCCOCCO,C6H15NO3,30426.0
13118,L-Glutamic Acid (ammonium salt),N.N[C@@H](CCC(=O)O)C(=O)O,C5H12N2O4,30377.0
13119,Fmoc-Asp(OtBu)-OSu,CC(C)(C)OC(=O)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)ON1C(=O)CCC1=O,C27H28N2O8,30537.0
13120,EIDD-1931,O=c1nc(NO)ccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C9H13N3O6,9002958.0
13121,Sodium Lauryl Sulfoacetate,CCCCCCCCCCCCOC(=O)CS(=O)(=O)[O-].[Na+],C14H27NaO5S,29906.0
13122,2'-Deoxycytidine (hydrochloride),Cl.Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,C9H14ClN3O4,30125.0
13123,Ac-Asp(OtBu)-OH,CC(=O)N[C@@H](CC(=O)OC(C)(C)C)C(=O)O,C10H17NO5,30539.0
13124,"1,4-Phenylenediacetic Acid",O=C(O)Cc1ccc(CC(=O)O)cc1,C10H10O4,30449.0
13125,Thymopentin,CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O,C30H49N9O9,30119.0
13126,Curdione,C/C1=C\CC[C@H](C)C(=O)C[C@@H](C(C)C)C(=O)C1,C15H24O2,30365.0
13127,Z-Leu-Leu-Leu-B(OH)2,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)B(O)O,C25H42BN3O6,10008311.0
13128,Cefditoren Pivoxil,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(/C=C\c3scnc3C)CS[C@H]12)c1csc(N)n1,C25H28N6O7S3,30315.0
13129,(-)-G-Lactone,O=C1C[C@@H]2C=CC[C@@H]2O1,C7H8O2,30488.0
13130,C22 Phytoceramide-d3 (t18:0/22:0-d3),[2H]C([2H])([2H])CCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC,C40H81NO4,9003465.0
13131,Pteryxin,C/C=C(/C)C(=O)O[C@@H]1c2c(ccc3ccc(=O)oc23)OC(C)(C)[C@@H]1OC(C)=O,C21H22O7,30320.0
13132,"2,3,5,6-Tetramethylpyrazine",Cc1nc(C)c(C)nc1C,C8H12N2,30281.0
13133,Phenol-13C6,O[13c]1[13cH][13cH][13cH][13cH][13cH]1,C6H6O,30526.0
13134,BTS,Cc1ccc(S(=O)(=O)NCc2ccccc2)cc1,C14H15NO2S,30099.0
13135,"6,9-Dichloro-1,2,3,4-tetrahydroacridine",Clc1ccc2c(Cl)c3c(nc2c1)CCCC3,C13H11Cl2N,30502.0
13136,PD 082106,O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\O,C16H10FN3O2,29719.0
13137,TBA-354,O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3)nc1)C2,C19H15F3N4O5,30317.0
13138,Azithromycin-13C-d3,[2H][13C]([2H])([2H])N(C)[C@H]1C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@]2(C)O)[C@@H]1O,C38H72N2O12,30653.0
13139,"2,5-Dihydroxybenzaldehyde",O=Cc1cc(O)ccc1O,C7H6O3,30268.0
13140,Methylhesperidin,COc1ccc(C2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1OC,C29H36O15,30049.0
13141,CNX-1351,CC(C)=CC(=O)CCC(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,C30H35N7O3S,30264.0
13142,Oleyl Alcohol,CCCCCCCC/C=C\CCCCCCCCO,C18H36O,30385.0
13143,Pulchinenoside B4,C=C(C)[C@@H]1CC[C@]2(C(=O)O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]12,C59H96O26,30271.0
13144,"4-(4,4,5,5-Tetramethyl-1,3,2-dioxaboran-2yl)aniline",CC1(C)OB(c2ccc(N)cc2)OC1(C)C,C12H18BNO2,30402.0
13145,N-acetyl-D-Leucine,CC(=O)N[C@H](CC(C)C)C(=O)O,C8H15NO3,30489.0
13146,Palmitic Acid-d5,[2H]C([2H])([2H])C([2H])([2H])CCCCCCCCCCCCCC(=O)O,C16H32O2,30557.0
13147,C26 Sphingomyelin (d18:1/26:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCC,C49H99N2O6P,9003457.0
13148,Deoxyarbutin,Oc1ccc(OC2CCCCO2)cc1,C11H14O3,21077.0
13149,N-hexanoyl-DL-Homoserine lactone,CCCCCC(=O)NC1CCOC1=O,C10H17NO3,10011197.0
13150,TLR7 Agonist 2,Cc1cc(COc2nc(N)nc3ccn(Cc4ccccn4)c23)no1,C17H16N6O2,28450.0
13151,Lenvatinib (mesylate),COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O.CS(=O)(=O)O,C22H23ClN4O7S,29832.0
13152,Palmatine (chloride),COc1cc2c(cc1OC)-c1cc3ccc(OC)c(OC)c3c[n+]1CC2.[Cl-],C21H22ClNO4,30318.0
13153,2-Chloroadenine,Nc1nc(Cl)nc2nc[nH]c12,C5H4ClN5,30474.0
13154,Aniline-13C6,N[13c]1[13cH][13cH][13cH][13cH][13cH]1,C6H7N,30523.0
13155,2-Amino-5-bromo-benzonitrile,N#Cc1cc(Br)ccc1N,C7H5BrN2,30454.0
13156,C22 Phytoceramide (t18:0/22:0),CCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC,C40H81NO4,9003464.0
13157,Carisoprodol,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,C12H24N2O4,30778.0
13158,"11?-13,14-dihydro-15-keto Prostaglandin F2?-d9",[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CC(=O)CC[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@@H]1O,C20H34O5,18787.0
13159,"2',3'-O-Isopropylideneguanosine",CC1(C)O[C@@H]2[C@H](O1)[C@@H](CO)O[C@H]2n1cnc2c(=O)nc(N)[nH]c21,C13H17N5O5,30476.0
13160,1-thio-?-D-Glucose Tetraacetate,CC(=O)OC[C@H]1O[C@@H](S)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,C14H20O9S,30446.0
13161,C22 Galactosylceramide (d18:1/22:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCCCCCC,C46H89NO8,9003458.0
13162,Bromobenzene-13C6,Br[13c]1[13cH][13cH][13cH][13cH][13cH]1,C6H5Br,30524.0
13163,Molnupiravir,CC(C)C(=O)OC[C@H]1O[C@@H](n2cc/c(=N\O)[nH]c2=O)[C@H](O)[C@@H]1O,C13H19N3O7,29586.0
13164,2-bromo Deschloroketamine,CNC1(c2ccccc2Br)CCCCC1=O,C13H16BrNO,30367.0
13165,11?-Prostaglandin F2?-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@@H]1O,C20H34O5,18788.0
13166,"13,14-dihydro-15-keto Prostaglandin E2-d9",[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CC(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,19348.0
13167,4-acetoxy MPT,CCCN(C)CCc1c[nH]c2cccc(OC(C)=O)c12,C16H22N2O2,26494.0
13168,CAY10762,O=c1c2ccccc2sn1CCc1ccccc1,C15H13NOS,30576.0
13169,O-Benzylhydroxylamine (hydrochloride),Cl.NOCc1ccccc1,C7H10ClNO,30528.0
13170,"13,14-dihydro-15-keto Prostaglandin D2-d9",[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CC(=O)CC[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H32O5,19334.0
13171,Arachidonic Acid-d5,[2H]C([2H])([2H])C([2H])([2H])CCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O2,9000477.0
13172,BINAP,c1ccc(P(c2ccccc2)c2ccc3ccccc3c2-c2c(P(c3ccccc3)c3ccccc3)ccc3ccccc23)cc1,C44H32P2,30399.0
13173,N-Fluorobenzenesulfonimide,O=S(=O)(c1ccccc1)N(F)S(=O)(=O)c1ccccc1,C12H10FNO4S2,30406.0
13174,15-keto Prostaglandin E2-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CC(=O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,C20H30O5,19350.0
13175,4-propanoyloxy DMT,CCC(=O)Oc1cccc2[nH]cc(CCN(C)C)c12,C15H20N2O2,29951.0
13176,"?-D-Ribofuranose 1,2,3,5-tetraacetate",CC(=O)OC[C@H]1O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O,C13H18O9,30408.0
13177,"L-655,708",CCOC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1cc(OC)ccc1-2,C18H19N3O4,30322.0
13178,Palmitelaidic Acid-d13,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])/C=C/CCCCCCCC(=O)O,C16H30O2,27713.0
13179,15-keto Prostaglandin E2-d4,[2H]C([2H])(/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/C(=O)CCCCC)C([2H])([2H])CC(=O)O,C20H30O5,19349.0
13180,Nitromethaqualone,COc1cc([N+](=O)[O-])ccc1-n1c(C)nc2ccccc2c1=O,C16H13N3O4,21840.0
13181,"1,1'-(Azodicarbonyl)dipiperidine",O=C(/N=N/C(=O)N1CCCCC1)N1CCCCC1,C12H20N4O2,30486.0
13182,Phenazine (methosulfate),COS(=O)(=O)[O-].C[n+]1c2ccccc2nc2ccccc21,C14H14N2O4S,30558.0
13183,"2-bromo-4,5-Dimethoxyphenethylamine (hydrochloride)",COc1cc(Br)c(CCN)cc1OC.Cl,C10H15BrClNO2,29386.0
13184,Manidipine-d4,[2H]C([2H])(OC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1)C([2H])([2H])N1CCN(C(c2ccccc2)c2ccccc2)CC1,C35H38N4O6,30768.0
13185,"N,N-dimethyl-3,4-DMA (hydrochloride)",COc1ccc(CC(C)N(C)C)cc1OC.Cl,C13H22ClNO2,30485.0
13186,"3,4-Dihydroxyamphetamine (hydrochloride)",CC(N)Cc1ccc(O)c(O)c1.Cl,C9H14ClNO2,30531.0
13187,Tankyrase-IN-2,CC(C)(O)c1ccc(-c2nc(=O)c3cc(F)cc(F)c3[nH]2)cc1,C17H14F2N2O2,29808.0
13188,2-Fluoroadenine,Nc1nc(F)nc2nc[nH]c12,C5H4FN5,30421.0
13189,L-Tyrosine amide,NC(=O)[C@@H](N)Cc1ccc(O)cc1,C9H12N2O2,30453.0
13190,1-Stearoyl-rac-glycerol-d40,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OC([2H])([2H])C([2H])(O)C([2H])([2H])O,C21H42O4,28919.0
13191,Methyl cyclohexanecarboxylate,COC(=O)C1CCCCC1,C8H14O2,30403.0
13192,Homatropine (hydrobromide),Br.CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2,C16H22BrNO3,30359.0
13193,Methyl 2-(1H-indazole-3-carboxamido)-3-methylbutanoate,COC(=O)[C@@H](NC(=O)c1n[nH]c2ccccc12)C(C)C,C14H17N3O3,25580.0
13194,4-fluoro ABUTINACA,O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(CCCCF)c2ccccc12,C22H28FN3O,30724.0
13195,JKE-1674,O=C(C(C[N+](=O)[O-])=NO)N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1,C20H20Cl2N4O4,30784.0
13196,4-hydroxy MALT,C=CCN(C)CCc1c[nH]c2cccc(O)c12,C14H18N2O,27257.0
13197,5-fluoro EMB-PICA,CCOC(=O)[C@@H](NC(=O)c1cn(CCCCCF)c2ccccc12)C(C)C,C21H29FN2O3,30769.0
13198,C26:1 Sphingomyelin (d18:1/26:1(17Z)),CCCCCCCC/C=C\CCCCCCCCCCCCCCCC(=O)N[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)[C@H](O)/C=C/CCCCCCCCCCCCC,C49H97N2O6P,9003459.0
13199,4-acetoxy MALT,C=CCN(C)CCc1c[nH]c2cccc(OC(C)=O)c12,C16H20N2O2,27256.0
13200,KUS121,Cc1cc(F)ccc1-c1ccc(/N=N/c2cc(S(=O)(=O)[O-])c3ccccc3c2N)cn1.[Na+],C22H16FN4NaO3S,30297.0
13201,C22 Glucosylceramide-d4 (d18:1/22:0-d4),[2H]C([2H])(CCCCCCCCC)C([2H])([2H])CCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC,C46H89NO8,9003462.0
13202,Peimine,C[C@H]1CC[C@@H]2N(C1)C[C@H]1[C@@H]3C[C@H]4[C@@H](C[C@H](O)[C@H]5C[C@@H](O)CC[C@@]54C)[C@@H]3CC[C@@H]1[C@]2(C)O,C27H45NO3,29963.0
13203,Succinimidyl 4-formylbenzoate,O=Cc1ccc(C(=O)ON2C(=O)CCC2=O)cc1,C12H9NO5,30477.0
13204,"N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine",COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)nc(NC(=O)C(C)C)[nH]c43)C[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,C35H37N5O7,30472.0
13205,Tropisetron-d5,[2H]c1[nH]c2c([2H])c([2H])c([2H])c([2H])c2c1C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)N2C,C17H20N2O2,30736.0
13206,Ziprasidone-d8,[2H]C1([2H])N(CCc2cc3c(cc2Cl)NC(=O)C3)C([2H])([2H])C([2H])([2H])N(c2nsc3ccccc23)C1([2H])[2H],C21H21ClN4OS,30737.0
13207,4-Phenyl-2-pyrrolidinone,O=C1CC(c2ccccc2)CN1,C10H11NO,30490.0
13208,Dacarbazine-d6,[2H]C([2H])([2H])N(/N=N/c1[nH]cnc1C(N)=O)C([2H])([2H])[2H],C6H10N6O,30771.0
13209,Atropine-d5,[2H]c1c([2H])c([2H])c(C(CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)c([2H])c1[2H],C17H23NO3,30734.0
13210,"3,4-Di-O-acetyl-L-fucal",CC(=O)O[C@@H]1[C@H](C)OC=C[C@@H]1OC(C)=O,C10H14O5,30864.0
13211,6-O-Sulfo-?-cyclodextrin (sodium salt),O=S(=O)([O-])OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8COS(=O)(=O)[O-])O[C@@H]7COS(=O)(=O)[O-])O[C@@H]6COS(=O)(=O)[O-])O[C@@H]5COS(=O)(=O)[O-])O[C@@H]4COS(=O)(=O)[O-])O[C@@H]3COS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],C42H63Na7O56S7,30168.0
13212,Hydroxyzine-d8 (hydrochloride),Cl.Cl.[2H]C1([2H])N(CCOCCO)C([2H])([2H])C([2H])([2H])N(C(c2ccccc2)c2ccc(Cl)cc2)C1([2H])[2H],C21H29Cl3N2O2,30739.0
13213,4-bromo-?-Pyrrolidinovalerophenone (hydrochloride),CCCC(C(=O)c1ccc(Br)cc1)N1CCCC1.Cl,C15H21BrClNO,19329.0
13214,Trifluoperazine-d3 (hydrochloride),Cl.Cl.[2H]C([2H])([2H])N1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,C21H26Cl2F3N3S,30718.0
13215,"2'-O-Monosuccinyladenosine-3',5'-cyclic monophosphate",Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1OC(=O)CCC(=O)O,C14H16N5O9P,30535.0
13216,Hydroxychlorodenafil,CCCc1nn(C)c2c(=O)nc(-c3cc(C(O)CCl)ccc3OCC)[nH]c12,C19H23ClN4O3,29998.0
13217,Dichlorphenamide-13C6,NS(=O)(=O)[13c]1[13cH][13c](Cl)[13c](Cl)[13c](S(N)(=O)=O)[13cH]1,C6H6Cl2N2O4S2,30719.0
13218,"9(E),11(E)-9-nitro Conjugated Linoleic Acid",CCCCCC/C=C/C=C(\CCCCCCCC(=O)O)[N+](=O)[O-],C18H31NO4,30160.0
13219,10-hydroxy Decanoic Acid,O=C(O)CCCCCCCCCO,C10H20O3,30458.0
13220,Spinorphin,CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(C)C,C45H64N8O10,29914.0
13221,N-[(3-(Anilinomethylene)-2-chloro-1-cyclohexen-1-yl)methylene]aniline (hydrochloride),Cl.ClC1=C(/C=N/c2ccccc2)CCC/C1=C\Nc1ccccc1,C20H20Cl2N2,30560.0
13222,2-Amino-6-chloropurine,Nc1nc(Cl)c2[nH]cnc2n1,C5H4ClN5,30400.0
13223,Nimodipine-d7,[2H]C([2H])([2H])C([2H])(OC(=O)C1=C(C)NC(C)=C(C(=O)OCCOC)C1c1cccc([N+](=O)[O-])c1)C([2H])([2H])[2H],C21H26N2O7,30720.0
13224,Cystinyl-bis-glycine,N[C@@H](CSSC[C@H](N)C(=O)NCC(=O)O)C(=O)NCC(=O)O,C10H18N4O6S2,30494.0
13225,5-fluoro AB-7-PAICA,CC(C)[C@H](NC(=O)c1cn(CCCCCF)c2ncccc12)C(N)=O,C18H25FN4O2,26646.0
13226,Carisoprodol-d7 (propyl-d7),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C(C)(COC(N)=O)COC(=O)NC(C)C,C12H24N2O4,30942.0
13227,Carisoprodol-d7 (propyl-d7) (CRM),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C(C)(COC(N)=O)COC(=O)NC(C)C,C12H24N2O4,19103.0
13228,tetranor-Prostaglandin E1,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCC(=O)O,C16H26O5,26702.0
13229,"9(E),11(E)-12-nitro Conjugated Linoleic Acid",CCCCCC/C(=C\C=C\CCCCCCCC(=O)O)[N+](=O)[O-],C18H31NO4,30834.0
13230,Benazepril-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(CC[C@H](N[C@H]2CCc3ccccc3N(CC(=O)O)C2=O)C(=O)OCC)c([2H])c1[2H],C24H29ClN2O5,30978.0
13231,Propylthiouracil-d5,[2H]C([2H])([2H])C([2H])([2H])Cc1cc(=O)[nH]c(=S)[nH]1,C7H10N2OS,30743.0
13232,3-Deazaadenosine (hydrochloride),Cl.Nc1nccc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C11H15ClN4O4,30969.0
13233,JKE-1716,O=C(CC(=NO)[N+](=O)[O-])N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1,C20H20Cl2N4O4,30786.0
13234,MIT-PZR,CCCCC(CC)CN1c2ccccc2Sc2cc(/C=c3\sc(=C(C#N)C#N)n(-c4ccccc4)c3=O)ccc21,C33H30N4OS2,28925.0
13235,Etonitazene,CCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1,C22H28N4O3,21824.0
13236,Etonitazene (exempt preparation),CCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1,C22H28N4O3,43514.0
13237,Fmoc-Lys-OH (hydrochloride),Cl.NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O,C21H25ClN2O4,30561.0
13238,5-fluoro EDMB-PICA,CCOC(=O)[C@@H](NC(=O)c1cn(CCCCCF)c2ccccc12)C(C)(C)C,C22H31FN2O3,30725.0
13239,Ebastine-d5,[2H]c1c([2H])c([2H])c(C(OC2CCN(CCCC(=O)c3ccc(C(C)(C)C)cc3)CC2)c2ccccc2)c([2H])c1[2H],C32H39NO2,30758.0
13240,Hydralazine-d4 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c2c(=NN)[nH]ncc2c1[2H],C8H9ClN4,30765.0
13241,3-fluoro Deschloroketamine (hydrochloride),CNC1(c2cccc(F)c2)CCCCC1=O.Cl,C13H17ClFNO,29756.0
13242,C-170,CCCCc1ccc(NC(=O)c2ccc([N+](=O)[O-])o2)cc1,C15H16N2O4,30157.0
13243,Talnetant,CC[C@H](NC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12)c1ccccc1,C25H22N2O2,29699.0
13244,Latanoprost amide,NC(=O)CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C23H35NO4,25245.0
13245,Carebastine-d5,[2H]c1c([2H])c([2H])c(C(OC2CCN(CCCC(=O)c3ccc(C(C)(C)C(=O)O)cc3)CC2)c2ccccc2)c([2H])c1[2H],C32H37NO4,30755.0
13246,17-phenyl trinor Prostaglandin F2? isopropyl amide,CC(C)NC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C26H39NO4,25242.0
13247,MMAF,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C,C39H65N5O8,30197.0
13248,Norcantharidin,O=C1OC(=O)[C@H]2[C@@H]1[C@@H]1CC[C@H]2O1,C8H8O4,28457.0
13249,PF-9366,CN(C)CCc1nnc2cc(-c3ccccc3)c3cc(Cl)ccc3n12,C20H19ClN4,30782.0
13250,Vilanterol-d4 (triphenylacetate),O=C(O)C(c1ccccc1)(c1ccccc1)c1ccccc1.[2H]C([2H])(OCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1)C([2H])([2H])OCc1c(Cl)cccc1Cl,C44H49Cl2NO7,30813.0
13251,Deschloroetizolam,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1,C17H16N4S,23107.0
13252,Coenzyme Q10-d6,[2H]C([2H])([2H])OC1=C(OC([2H])([2H])[2H])C(=O)C(C/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C)=C(C)C1=O,C59H90O4,30958.0
13253,Udenafil,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,C25H36N6O4S,30373.0
13254,PK-THPP,CCCC(=O)C1CCN(c2ncnc3c2CN(C(=O)c2ccc(-c4ccccc4)cc2)CC3)CC1,C29H32N4O2,29473.0
13255,2-hydroxy Atorvastatin (calcium salt),CC(C)c1c(C(=O)Nc2ccccc2O)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)[O-].CC(C)c1c(C(=O)Nc2ccccc2O)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)[O-].[Ca+2],C66H68CaF2N4O12,30974.0
13256,TG11-77 (hydrochloride),Cc1cc(C)nc(Nc2ncc(C(=O)NCCc3c(C)[nH]c4ccccc34)cn2)c1.Cl,C23H25ClN6O,30188.0
13257,SAHO2,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC[C@H](N)C(=O)O)[C@@H](O)[C@H]1O,C14H20N6O7S,28726.0
13258,Propylcathinone (hydrochloride),CCCNC(C)C(=O)c1ccccc1.Cl,C12H18ClNO,30941.0
13259,MOZ-IN-2,O=C(NNS(=O)(=O)c1ccccc1)c1cc(-c2ccnnc2)ccc1F,C17H13FN4O3S,27686.0
13260,Phenyl Cyclopentyl Ketone,O=C(c1ccccc1)C1CCCC1,C12H14O,31036.0
13261,Piclidenoson,CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O,C18H19IN6O4,28445.0
13262,SC-9,O=S(=O)(NCCCCCCc1ccccc1)c1cccc2c(Cl)cccc12,C22H24ClNO2S,30910.0
13263,Radotinib-d6,[2H]c1c([2H])c(C([2H])([2H])[2H])c(Nc2nccc(-c3cnccn3)n2)c([2H])c1C(=O)Nc1cc(-n2cnc(C)c2)cc(C(F)(F)F)c1,C27H21F3N8O,30767.0
13264,2-Fluorophenyl Cyclopentyl Ketone,O=C(c1ccccc1F)C1CCCC1,C12H13FO,31035.0
13265,D-Desthiobiotin,C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)O,C10H18N2O3,30418.0
13266,7-Methoxycoumarin,COc1ccc2ccc(=O)oc2c1,C10H8O3,30857.0
13267,Atranorin,COC(=O)c1c(C)cc(OC(=O)c2c(C)cc(O)c(C=O)c2O)c(C)c1O,C19H18O8,28106.0
13268,WZ8040,C=CC(=O)Nc1cccc(Sc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2Cl)c1,C24H25ClN6OS,30062.0
13269,Dimethylsildenafil,CCCc1nn(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CC(C)NC(C)C4)ccc3OCC)[nH]c12,C23H32N6O4S,30899.0
13270,"1,2,3-Trioctanoyl Glycerol-13C3",CCCCCCC[13C](=O)OCC(CO[13C](=O)CCCCCCC)O[13C](=O)CCCCCCC,C27H50O6,29464.0
13271,Garcinone D,COc1c(O)cc2oc3cc(O)c(CC=C(C)C)c(O)c3c(=O)c2c1CCC(C)(C)O,C24H28O7,30906.0
13272,N-Moc-MDMA,COC(=O)N(C)C(C)Cc1ccc2c(c1)OCO2,C13H17NO4,30231.0
13273,"1,3-Dioleoyl-2-Linoleoyl Glycerol",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC,C57H102O6,26972.0
13274,4-octynyl Itaconate,C#CCCCCCCOC(=O)CC(=C)C(=O)O,C13H18O4,28455.0
13275,Clotrimazole-d5,[2H]c1c([2H])c([2H])c(C(c2ccccc2)(c2ccccc2Cl)n2ccnc2)c([2H])c1[2H],C22H17ClN2,30717.0
13276,4'-hydroxy Nitazene,CCN(CC)CCn1c(Cc2ccc(O)cc2)nc2cc([N+](=O)[O-])ccc21,C20H24N4O3,30218.0
13277,Methamphetamine Methyl Carbamate,COC(=O)N(C)C(C)Cc1ccccc1,C12H17NO2,30300.0
13278,Oxaloacetic Acid,O=C(O)CC(=O)C(=O)O,C4H4O5,30280.0
13279,Clonitazene,CCN(CC)CCn1c(Cc2ccc(Cl)cc2)nc2cc([N+](=O)[O-])ccc21,C20H23ClN4O2,29642.0
13280,CN128,Cc1c(O)c(O)cc[n+]1[C@@H](CO)Cc1ccccc1,C15H18NO3,30833.0
13281,"3,4-Methylenedioxy-?-methylaminohexanophenone (hydrochloride)",CCCCC(NC)C(=O)c1ccc2c(c1)OCO2.Cl,C14H20ClNO3,29753.0
13282,Methoxyresorufin,COc1ccc2nc3ccc(=O)cc-3oc2c1,C13H9NO3,14852.0
13283,4-fluoro Phenibut (hydrochloride),Cl.NCC(CC(=O)O)c1ccc(F)cc1,C10H13ClFNO2,30232.0
13284,"7?,27-dihydroxy Cholesterol",C[C@@H](CO)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O3,20102.0
13285,7-Hydroxy-4-methyl-8-nitrocoumarin,Cc1cc(=O)oc2c([N+](=O)[O-])c(O)ccc12,C10H7NO5,30900.0
13286,Etofenamate-d4,[2H]c1c([2H])c([2H])c(C(=O)OCCOCCO)c(Nc2cccc(C(F)(F)F)c2)c1[2H],C18H18F3NO4,30745.0
13287,Nomegestrol,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,C21H28O3,30893.0
13288,McNA343,C[N+](C)(C)CC#CCOC(=O)Nc1cccc(Cl)c1.[Cl-],C14H18Cl2N2O2,30961.0
13289,Docosahexaenoic Acid-d5 methyl ester,[2H]C([2H])([2H])C([2H])([2H])/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC,C23H34O2,31125.0
13290,A6770,CC(=O)c1ncc(CO)[nH]1,C6H8N2O2,29972.0
13291,?-D-Glucose-1-phosphate (sodium salt hydrate),O=P([O-])([O-])O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O.[Na+].[Na+],C6H11Na2O9P,30566.0
13292,ZINC00881524,COc1ccc(CC(=O)Nc2nc3c(s2)CCc2ccccc2-3)cc1OC,C21H20N2O3S,30788.0
13293,Flunitazene (hydrochloride),CCN(CC)CCn1c(Cc2ccc(F)cc2)nc2cc([N+](=O)[O-])ccc21.Cl,C20H24ClFN4O2,30279.0
13294,Flunitazene (hydrochloride) (exempt preparation),CCN(CC)CCn1c(Cc2ccc(F)cc2)nc2cc([N+](=O)[O-])ccc21.Cl,C20H24ClFN4O2,40975.0
13295,ARV-771,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCCOCCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1,C49H60ClN9O7S2,21299.0
13296,Bimosiamose,O=C(O)Cc1cccc(-c2cc(CCCCCCc3ccc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c(-c4cccc(CC(=O)O)c4)c3)ccc2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)c1,C46H54O16,30878.0
13297,Deacetylforskolin,C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](O)[C@H](O)[C@@]2(C)O1,C20H32O6,11701.0
13298,Cefuroxime-d3,[2H]C([2H])([2H])O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,C16H16N4O8S,31163.0
13299,Argatroban-d3 (hydrochloride),[2H]C([2H])([2H])C1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1,C23H36N6O5S,25757.0
13300,NLRP3i,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1,C16H17ClN2O4S,30895.0
13301,Hydroxylupanine,O=C1CCC[C@@H]2[C@H]3C[C@@H](CN12)[C@@H]1C[C@@H](O)CCN1C3,C15H24N2O2,31171.0
13302,21-Deoxycortisol,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,C21H30O4,30873.0
13303,CU-32,COC(=O)c1nc(N)nc(Nc2ccc(I)cc2)n1,C11H10IN5O2,31029.0
13304,Doxazosin-d8 (hydrochloride),Cl.[2H]C1([2H])N(C(=O)C2COc3ccccc3O2)C([2H])([2H])C([2H])([2H])N(c2nc(N)c3cc(OC)c(OC)cc3n2)C1([2H])[2H],C23H26ClN5O5,30979.0
13305,UTP (sodium salt),O=c1ccn(C2OC(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)C(O)C2O)c(=O)[nH]1.[Na+].[Na+].[Na+],C9H12N2Na3O15P3,9003530.0
13306,Propiconazole-d7,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C1COC(Cn2cncn2)(c2ccc(Cl)cc2Cl)O1,C15H17Cl2N3O2,31177.0
13307,"6,7-Dimethylpterin",Cc1nc2c(=O)nc(N)nc-2[nH]c1C,C8H9N5O,30887.0
13308,SHS4121705,Oc1nc2nonc2nc1Nc1ccc(OC(F)(F)F)cc1,C11H6F3N5O3,31053.0
13309,Tolbutamide-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])NC(=O)NS(=O)(=O)c1ccc(C)cc1,C12H18N2O3S,30738.0
13310,DS44960156,O=C(O)c1ccc(C(=O)N2CCc3c(c(=O)oc4ccccc34)C2)cc1,C20H15NO5,28366.0
13311,N-acetyl-L-Cysteine ethyl ester,CCOC(=O)[C@H](CS)NC(C)=O,C7H13NO3S,30299.0
13312,15(S)-HEPE-d5,[2H]C([2H])([2H])C([2H])([2H])/C=C\C[C@H](O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H30O3,31221.0
13313,MDMB-4en-PINACA (CRM),C=CCCCn1nc(C(=O)N[C@H](C(=O)OC)C(C)(C)C)c2ccccc21,C20H27N3O3,30761.0
13314,MDMB-4en-PINACA,C=CCCCn1nc(C(=O)N[C@H](C(=O)OC)C(C)(C)C)c2ccccc21,C20H27N3O3,26097.0
13315,6-hydroxy Ramulosin,C[C@@H]1C[C@@H]2C[C@@H](O)CC(O)=C2C(=O)O1,C10H14O4,28587.0
13316,"2-(1,8-Naphthyridin-2-yl)phenol",Oc1ccccc1-c1ccc2cccnc2n1,C14H10N2O,30918.0
13317,Voxtalisib,CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21,C13H14N6O,30323.0
13318,Linoleic Acid-13C18,[13CH3][13CH2][13CH2][13CH2][13CH2]/[13CH]=[13CH]\[13CH2]/[13CH]=[13CH]\[13CH2][13CH2][13CH2][13CH2][13CH2][13CH2][13CH2][13C](=O)O,C18H32O2,31159.0
13319,Resolvin E4,CC/C=C\C[C@H](O)/C=C/C=C\C/C=C\C=C\[C@@H](O)CCCC(=O)O,C20H30O4,29590.0
13320,CU-76,COC(=O)c1nc(N)nc(Nc2cc(F)c(I)c(F)c2)n1,C11H8F2IN5O2,31030.0
13321,para-methyl AP-237 (hydrochloride),CCCC(=O)N1CCN(C/C=C/c2ccc(C)cc2)CC1.Cl,C18H27ClN2O,30744.0
13322,ML-209,COc1cc(O)c(C(CC(=O)N2C[C@H](C)C[C@H](C)C2)c2ccc3c(c2)OCO3)c(OC)c1,C25H31NO6,30164.0
13323,Clevudine,Cc1cn([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)c(=O)[nH]c1=O,C10H13FN2O5,30612.0
13324,CBGQ,CCCCCC1=CC(=O)C(C/C=C(\C)CCC=C(C)C)=C(O)C1=O,C21H30O3,30862.0
13325,Cerestat,CCc1cccc(N(C)C(=N)Nc2cccc3ccccc23)c1.Cl,C20H22ClN3,30966.0
13326,SB-200646 (hydrochloride),Cl.Cn1ccc2cc(NC(=O)Nc3cccnc3)ccc21,C15H15ClN4O,30973.0
13327,Cirsiliol,COc1cc2oc(-c3ccc(O)c(O)c3)cc(=O)c2c(O)c1OC,C17H14O7,30874.0
13328,Piribedil,c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1,C16H18N4O2,30321.0
13329,PDPEA,CCCCCCCCCCCCCCCc1cccc(OCC(=O)NCCO)c1,C25H43NO3,30956.0
13330,Enoximone,CSc1ccc(C(=O)c2[nH]c(=O)[nH]c2C)cc1,C12H12N2O2S,30868.0
13331,C16 Ganglioside GM2-d9 (d18:1/16:0-d9) (ammonium salt),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC.[NH4+],C65H120N4O26,31196.0
13332,SPRi 3,COCC(=O)NCCc1c(C)[nH]c2ccc(O)cc12,C14H18N2O3,30950.0
13333,TC HSD 21,COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Br)c3)SC2=S)cc1,C17H12BrNO3S2,29730.0
13334,ABP 688,CO/N=C1/C=C(C#Cc2cccc(C)n2)CCC1,C15H16N2O,30929.0
13335,2F-Peracetyl-Fucose,CC(=O)OC1O[C@@H](C)[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1F,C12H17FO7,30865.0
13336,Taleranol,C[C@H]1CCC[C@@H](O)CCCCCc2cc(O)cc(O)c2C(=O)O1,C18H26O5,28299.0
13337,AC-265347,Cc1ccc(C(C)(O)c2nc3ccccc3s2)c(C)c1,C17H17NOS,30937.0
13338,PF-04449613,C[C@H](c1nc(=O)c2cnn(C3CCOCC3)c2[nH]1)N1CC(Oc2ccccc2)C1,C21H25N5O3,30946.0
13339,BODIPY-Palmitate,CC1=CC(C)=[N+]2C1=C(CCCCCCCCCCCCCCC(=O)O)c1c(C)cc(C)n1[B-]2(F)F,C28H43BF2N2O2,26749.0
13340,Ketorolac (calcium salt),O=C(c1ccccc1)c1ccc2n1CCC2C(=O)[O-].O=C(c1ccccc1)c1ccc2n1CCC2C(=O)[O-].[Ca+2],C30H24CaN2O6,9003475.0
13341,Metodesnitazene (hydrochloride),CCN(CC)CCn1c(Cc2ccc(OC)cc2)nc2ccccc21.Cl,C21H28ClN3O,30035.0
13342,Metodesnitazene (hydrochloride) (exempt preparation),CCN(CC)CCn1c(Cc2ccc(OC)cc2)nc2ccccc21.Cl,C21H28ClN3O,43513.0
13343,(S)-DO271,FC(F)(F)Oc1ccc(Oc2ccnc(N3CCC[C@H](NC(=S)Nc4cccnc4)C3)c2Cl)c(Cl)c1,C23H20Cl2F3N5O2S,30038.0
13344,CGS 12066B,CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,C25H25F3N4O8,30623.0
13345,CLP 257,O=C1N=C(N2CCCCN2)S/C1=C\c1ccc(F)cc1O,C14H14FN3O2S,30948.0
13346,Nabumetone-d3,[2H]C([2H])([2H])Oc1ccc2cc(CCC(C)=O)ccc2c1,C15H16O2,30721.0
13347,TMN 355,O=C(NC(=O)c1c(F)cccc1Cl)NC1c2ccccc2-c2ccccc21,C21H14ClFN2O2,31155.0
13348,SAHO,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)CC[C@H](N)C(=O)O)[C@@H](O)[C@H]1O,C14H20N6O6S,28725.0
13349,CAY10767,Cc1cc(CNc2cccc(C(=O)O)c2)ccc1OCc1ccc(F)cc1,C22H20FNO3,30605.0
13350,C16 Ganglioside GM1-d9 (d18:1/16:0-d9) (ammonium salt),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC.[NH4+],C71H130N4O31,31195.0
13351,Bacopaside I,CC(C)=C[C@@H]1CO[C@]23C[C@]4(CO2)[C@H](CC[C@@H]2[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O[C@@H]7O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](CO)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]24C)[C@H]3[C@@]1(C)O,C46H74O20S,11821.0
13352,SR 3576,COc1cc(NC(=O)c2cccc(-n3cc(NC(=O)Nc4cccc(C)c4)cn3)c2)cc(OC)c1OC,C27H27N5O5,20215.0
13353,CDN1163,Cc1ccc2cccc(NC(=O)c3ccc(OC(C)C)cc3)c2n1,C20H20N2O2,31123.0
13354,Alarelin (acetate),CC(=O)O.CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,C60H86N16O16,30993.0
13355,Lycorine,O[C@H]1[C@H]2c3cc4c(cc3CN3CCC(=C[C@@H]1O)[C@H]23)OCO4,C16H17NO4,30650.0
13356,IMS 2186,COc1ccc(/C=C2\COc3ccc(C)cc3C2=O)cc1O,C18H16O4,31157.0
13357,Vatiquinone,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O,C29H44O3,26819.0
13358,Desethylchloroquine-d4,[2H]C([2H])(CC(C)Nc1ccnc2cc(Cl)ccc12)C([2H])([2H])NCC,C16H22ClN3,30907.0
13359,PD 180970,Cc1cc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)ccc1F,C21H15Cl2FN4O,30619.0
13360,Suprafenacine,Cc1ccc(/C=N/NC(=O)c2n[nH]c3c2CCCC3)cc1,C16H18N4O,31158.0
13361,3-Methyl-L-histidine,Cn1cncc1C[C@H](N)C(=O)O,C7H11N3O2,31165.0
13362,(-)-Rolipram,COc1ccc([C@@H]2CNC(=O)C2)cc1OC1CCCC1,C16H21NO3,31111.0
13363,"2,4-Dichlorobenzenesulfonyl Chloride",O=S(=O)(Cl)c1ccc(Cl)cc1Cl,C6H3Cl3O2S,30450.0
13364,Dinitolmide,Cc1c(C(N)=O)cc([N+](=O)[O-])cc1[N+](=O)[O-],C8H7N3O5,31138.0
13365,Halofantrine (hydrochloride),CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12.Cl,C26H31Cl3F3NO,30962.0
13366,Geranylgeranoic Acid,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/C(=O)O,C20H32O2,9003474.0
13367,HIF-2? Antagonist 2,O=[N+]([O-])c1c(Nc2cc(F)cc(Cl)c2)ccc2nonc12,C12H6ClFN4O3,16971.0
13368,Palmitoylcholine (chloride),CCCCCCCCCCCCCCCC(=O)OCC[N+](C)(C)C.[Cl-],C21H44ClNO2,9003456.0
13369,Broxaldine,Cc1ccc2c(Br)cc(Br)c(OC(=O)c3ccccc3)c2n1,C17H11Br2NO2,31113.0
13370,RCTR1,CC/C=C\C[C@H](O)/C=C/C=C\C=C\C=C\[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[C@@H](O)C/C=C\CCC(=O)O,C32H47N3O10S,24896.0
13371,TCS 21311,CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1,C27H25F3N4O4,30063.0
13372,Elaidyl Alcohol,CCCCCCCC/C=C/CCCCCCCCO,C18H36O,30459.0
13373,"(1R,3S)-3-Amino-cyclopentanol",N[C@H]1CC[C@@H](O)C1,C5H11NO,11357.0
13374,Protriptyline (hydrochloride),CNCCCC1c2ccccc2C=Cc2ccccc21.Cl,C19H22ClN,31179.0
13375,Mitiglinide (calcium salt),O=C([O-])[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1.O=C([O-])[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1.[Ca+2],C38H48CaN2O6,30693.0
13376,L-Ornithine (hydrochloride),Cl.NCCC[C@H](N)C(=O)O,C5H13ClN2O2,30779.0
13377,"(1S,3R)-3-Amino-cyclopentanol",N[C@@H]1CC[C@H](O)C1,C5H11NO,11356.0
13378,12-Bromododecanoic Acid,O=C(O)CCCCCCCCCCCBr,C12H23BrO2,30465.0
13379,Dropropizine,OCC(O)CN1CCN(c2ccccc2)CC1,C13H20N2O2,31110.0
13380,N106,COc1ccc(-c2nnc(Nc3nc4c(OC)cccc4s3)o2)cc1,C17H14N4O3S,30952.0
13381,Tenuifolin,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(CO)C(=CC[C@@H]4[C@@]5(C)C[C@H](O)[C@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@](C)(C(=O)O)[C@@H]5CC[C@]43C)[C@@H]2C1,C36H56O12,30617.0
13382,EML 425,Cc1cc(O)cc(C)c1C=C1C(=O)N(Cc2ccccc2)C(=O)N(Cc2ccccc2)C1=O,C27H24N2O4,30685.0
13383,Phillygenin,COc1cc([C@H]2OC[C@H]3[C@@H]2CO[C@H]3c2ccc(OC)c(OC)c2)ccc1O,C21H24O6,30698.0
13384,Corynoline,CN1Cc2c(ccc3c2OCO3)[C@@]2(C)[C@@H](O)Cc3cc4c(cc3[C@@H]12)OCO4,C21H21NO5,30712.0
13385,"Palmitic Acid-13C (C1, C2, C3, and C4 labeled)",CCCCCCCCCCCC[13CH2][13CH2][13CH2][13C](=O)O,C16H32O2,30550.0
13386,"L-732,138",CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc1cc(C(F)(F)F)cc(C(F)(F)F)c1,C22H18F6N2O3,30894.0
13387,Clinofibrate,CCC(C)(Oc1ccc(C2(c3ccc(OC(C)(CC)C(=O)O)cc3)CCCCC2)cc1)C(=O)O,C28H36O6,31109.0
13388,L-Proline,O=C(O)[C@@H]1CCCN1,C5H9NO2,30772.0
13389,CAIX Inhibitor S4,Cc1cc(C)cc(NC(=O)Nc2ccc(OS(N)(=O)=O)cc2)c1,C15H17N3O4S,31119.0
13390,"9(E),12(Z)-Octadecadienoic Acid",CCCCC/C=C\C/C=C/CCCCCCCC(=O)O,C18H32O2,10005146.0
13391,N-acetyl Desethylchloroquine-d4,[2H]C([2H])(CC(C)Nc1ccnc2cc(Cl)ccc12)C([2H])([2H])N(CC)C(C)=O,C18H24ClN3O,30908.0
13392,16F16,COC(=O)C1(C)c2[nH]c3ccccc3c2CCN1C(=O)CCl,C16H17ClN2O3,17770.0
13393,Amfenac (sodium salt hydrate),Nc1c(CC(=O)[O-])cccc1C(=O)c1ccccc1.O.[Na+],C15H14NNaO4,30627.0
13394,C16 Globotriaosylceramide-d9 (d18:1/16:0-d9),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC,C52H97NO18,31199.0
13395,Glycoursodeoxycholic Acid-d4,[2H]C1([2H])C[C@@]2(C)[C@H](C[C@H](O)[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)NCC(=O)O)CC[C@@H]32)C([2H])([2H])[C@@H]1O,C26H43NO5,31309.0
13396,Desethyl Hydroxychloroquine,CC(CCCNCCO)Nc1ccnc2cc(Cl)ccc12,C16H22ClN3O,31152.0
13397,Sphynolactone-7,CCCCOc1ccc(S(=O)(=O)N2CCN(C(=O)OC3C=C(C)C(=O)O3)CC2)cc1,C20H26N2O7S,26922.0
13398,Hydroxychloroquine O-Sulfate (sodium salt),CCN(CCCC(C)Nc1ccnc2cc(Cl)ccc12)CCOS(=O)(=O)[O-].[Na+],C18H25ClN3NaO4S,31231.0
13399,Arenobufagin,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2[C@H](O)C(=O)[C@]2(C)[C@@H](c3ccc(=O)oc3)CC[C@]12O,C24H32O6,30695.0
13400,Cannabidiolic Acid methyl ester,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)c(C(=O)OC)c1O,C23H32O4,28347.0
13401,(-)-6?-hydroxy Cannabidiol,C=C(C)[C@@H]1C[C@H](O)C(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O,C21H30O3,27576.0
13402,5-fluoro MMB-P7AICA,COC(=O)[C@@H](NC(=O)c1cn(CCCCCF)c2ncccc12)C(C)C,C19H26FN3O3,31189.0
13403,Cotrimoxazole,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,C24H29N7O6S,30781.0
13404,trans-Zeatin Riboside,C/C(=C\CNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)CO,C15H21N5O5,30747.0
13405,"L-701,324",O=c1[nH]c2cc(Cl)ccc2c(O)c1-c1cccc(Oc2ccccc2)c1,C21H14ClNO3,30687.0
13406,Cabotegravir-d5,[2H]C([2H])([2H])[C@@H]1N2C(=O)c3c(O)c(=O)c(C(=O)NCc4ccc(F)cc4F)cn3C[C@H]2OC1([2H])[2H],C19H17F2N3O5,31319.0
13407,Adefovir-d4,[2H]C([2H])(OCP(=O)(O)O)C([2H])([2H])n1cnc2c(N)ncnc21,C8H12N5O4P,31315.0
13408,N-Nitroso-N-methyl-4-Aminobutyric Acid,CN(CCCC(=O)O)N=O,C5H10N2O3,30911.0
13409,"1,2-O-Dihexadecyl-sn-glycerol",CCCCCCCCCCCCCCCCOC[C@H](CO)OCCCCCCCCCCCCCCCC,C35H72O3,17437.0
13410,Lauric Acid-d2,[2H]C([2H])(CCCCCCCCCC)C(=O)O,C12H24O2,29410.0
13411,Enclomiphene (citrate),CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O,C32H36ClNO8,30965.0
13412,YF-2,CCOc1cccc(OCCN(C)C)c1C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1,C20H22ClF3N2O3,31230.0
13413,Triflusal,CC(=O)Oc1cc(C(F)(F)F)ccc1C(=O)O,C10H7F3O4,30274.0
13414,"11(Z),14(Z)-Eicosadienoic Acid Ethanolamide",CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)NCCO,C22H41NO2,31024.0
13415,ZK 159222,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4(C(=O)OCCCC)CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,C32H48O5,9001925.0
13416,Indole-3-carboxaldehyde,O=Cc1c[nH]c2ccccc12,C9H7NO,31328.0
13417,"2',2'-Difluoro-2'-deoxyuridine",O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)[nH]1,C9H10F2N2O5,11689.0
13418,(S)-Pramipexole-d5 (hydrochloride),Cl.Cl.[2H]C([2H])([2H])C([2H])([2H])CN[C@H]1CCc2nc(N)sc2C1,C10H19Cl2N3S,31239.0
13419,Etherolenic Acid,CC/C=C\C=C\O/C=C/C=C\CCCCCCCC(=O)O,C18H28O3,10005123.0
13420,BIBF 1120 (esylate),CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,C33H39N5O7S,31082.0
13421,Nordeoxycholic Acid,C[C@H](CC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C23H38O4,30837.0
13422,3-fluoro PCP (hydrochloride),Cl.Fc1cccc(C2(N3CCCCC3)CCCCC2)c1,C17H25ClFN,31042.0
13423,666-15,Cl.NCCCOc1cc2ccccc2cc1C(=O)NCCOc1cc2ccccc2cc1C(=O)Nc1ccc(Cl)cc1O,C33H31Cl2N3O5,30780.0
13424,D-Phenylalanine,N[C@H](Cc1ccccc1)C(=O)O,C9H11NO2,31194.0
13425,Alloisolithocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H40O3,29542.0
13426,YS-49,Br.Oc1cc2c(cc1O)C(Cc1cccc3ccccc13)NCC2,C20H20BrNO2,30970.0
13427,Chaetoviridin A,CC[C@H](C)/C=C/C1=CC2=C(Cl)C(=O)[C@@]3(C)OC(=O)C(C(=O)[C@H](C)[C@@H](C)O)=C3C2=CO1,C23H25ClO6,31174.0
13428,Estradiol Cypionate,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1,C26H36O3,31105.0
13429,Creatinine,CN1CC(=O)N=C1N,C4H7N3O,31164.0
13430,(+)-Lupanine (perchlorate),O=C1CCC[C@@H]2[C@H]3C[C@@H](CN12)[C@@H]1CCCCN1C3.[O-][Cl+3]([O-])([O-])O,C15H25ClN2O5,31241.0
13431,Mizolastine,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,C24H25FN6O,9000566.0
13432,4-methyl PCP (hydrochloride),Cc1ccc(C2(N3CCCCC3)CCCCC2)cc1.Cl,C18H28ClN,32007.0
13433,ACHP,N#Cc1c(C2CCNCC2)cc(-c2c(O)cccc2OCC2CC2)nc1N,C21H24N4O2,14504.0
13434,eCF506,COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C,C26H38N8O3,19959.0
13435,Takinib,CCCn1c(NC(=O)c2cccc(C(N)=O)c2)nc2ccccc21,C18H18N4O2,24161.0
13436,AP-238 (hydrochloride),CCC(=O)N1C(C)CN(C/C=C/c2ccccc2)CC1C.Cl,C18H27ClN2O,31128.0
13437,1-Palmitoyl-2-Arachidonoyl-sn-glycero-3-PE,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C41H74NO8P,25660.0
13438,Mesoridazine,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,C21H26N2OS2,31370.0
13439,Teijin Compound 1 (hydrochloride),Cl.O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(Cc2ccc(Cl)cc2)C1,C21H22Cl2F3N3O2,30977.0
13440,Solanesol,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CO,C45H74O,30867.0
13441,JNJ-17203212,O=C(Nc1ccc(C(F)(F)F)cn1)N1CCN(c2ncccc2C(F)(F)F)CC1,C17H15F6N5O,30930.0
13442,"(3R,8S)-Falcarindiol",C=C[C@@H](O)C#CC#C[C@@H](O)/C=C\CCCCCCC,C17H24O2,30919.0
13443,Deslanoside,C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3C[C@@H](O)[C@]3(C)[C@@H](C5=CC(=O)OC5)CC[C@]43O)C2)C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1,C47H74O19,30872.0
13444,PF-998425,N#Cc1ccc([C@H]2CCCC[C@H]2O)cc1C(F)(F)F,C14H14F3NO,31442.0
13445,Glycodeoxycholic Acid-d4,[2H]C1([2H])C[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2C[C@H](O)[C@]2(C)[C@@H]([C@H](C)CCC(=O)NCC(=O)O)CC[C@@H]32)C([2H])([2H])[C@@H]1O,C26H43NO5,31310.0
13446,Thonzonium (bromide),CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1.[Br-],C32H55BrN4O,31253.0
13447,Brusatol,COC(=O)[C@@]12OC[C@]34[C@H]([C@@H](O)[C@@H]1O)[C@@]1(C)CC(=O)C(O)=C(C)[C@@H]1C[C@H]3OC(=O)[C@H](OC(=O)C=C(C)C)[C@@H]24,C26H32O11,30883.0
13448,NCL-00017509,C#Cc1nc(Nc2cccc(CC(N)=O)c2)nc2nc[nH]c12,C15H12N6O,31462.0
13449,N-Oleoyl Glutamine,CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](CCC(N)=O)C(=O)O,C23H42N2O4,28922.0
13450,MSA-2,COc1cc2cc(C(=O)CCC(=O)O)sc2cc1OC,C14H14O5S,30140.0
13451,(-)-11-nor-9-carboxy-?8-THC,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C(=O)O)C[C@@H]21,C21H28O4,25270.0
13452,(-)-11-nor-9-carboxy-?8-THC (CRM),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C(=O)O)C[C@@H]21,C21H28O4,34024.0
13453,CU-CPT4a,O=C(N[C@H](Cc1ccccc1)C(=O)O)c1sc2cc(F)ccc2c1Cl,C18H13ClFNO3S,30951.0
13454,Troxipide,COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC,C15H22N2O4,30616.0
13455,ERGi-USU,Oc1ccc2ccccc2c1/N=N/c1nccs1,C13H9N3OS,30875.0
13456,trans-2-Octenoyl-L-carnitine,CCCCC/C=C/C(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C,C15H27NO4,30995.0
13457,Calcein tetraethyl ester,CCOC(=O)CN(CC(=O)OCC)Cc1c(O)ccc2c1Oc1c(ccc(O)c1CN(CC(=O)OCC)CC(=O)OCC)C21OC(=O)c2ccccc21,C38H42N2O13,30754.0
13458,AF-DX 116,CCN(CC)CC1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc21,C24H31N5O2,30871.0
13459,ITE,COC(=O)c1csc(C(=O)c2c[nH]c3ccccc23)n1,C14H10N2O3S,25355.0
13460,?-hydroxy 2C-B (hydrochloride),COc1cc(C(O)CN)c(OC)cc1Br.Cl,C10H15BrClNO3,30520.0
13461,STO-609,O=C(O)c1cc2cccc3c(=O)n4c5ccccc5nc4c(c1)c23.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,C38H20N4O6,31358.0
13462,Glycolithocholic Acid-d4,[2H]C1([2H])C[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)NCC(=O)O)CC[C@@H]32)C([2H])([2H])[C@@H]1O,C26H43NO4,31308.0
13463,Ethosuximide-d5,[2H]C([2H])([2H])C([2H])([2H])C1(C)CC(=O)NC1=O,C7H11NO2,30759.0
13464,ML-334,O=C(O)[C@H]1CCCC[C@H]1C(=O)N1CCc2ccccc2[C@H]1CN1C(=O)c2ccccc2C1=O,C26H26N2O5,31439.0
13465,Esmolol-d7 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])(NCC(O)COc1ccc(CCC(=O)OC)cc1)C([2H])([2H])[2H],C16H26ClNO4,30727.0
13466,Mensacarcin,COc1cccc2c1[C@H](OC)[C@]13O[C@@]1(C2=O)[C@H](O)[C@H](C)[C@@](O)(C(=O)[C@@H]1O[C@H]1C)[C@@H]3O,C21H24O9,31438.0
13467,Aspyrone,C[C@@H]1O[C@H]1C1=C[C@H](O)[C@@H](C)OC1=O,C9H12O4,31389.0
13468,Ledipasvir-d6,[2H]C([2H])([2H])OC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1ncc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5nc([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC([2H])([2H])[2H])C(C)C)[nH]c5c4)ccc2-3)[nH]1)C(C)C,C49H54F2N8O6,31322.0
13469,L-Valacyclovir-d8 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])[C@]([2H])(N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21,C13H21ClN6O4,31479.0
13470,ACY-775,O=C(NO)c1cnc(NC2(c3cccc(F)c3)CCCCC2)nc1,C17H19FN4O2,29198.0
13471,Trimethylamine-d9 N-oxide,[2H]C([2H])([2H])[N+]([O-])(C([2H])([2H])[2H])C([2H])([2H])[2H],C3H9NO,31449.0
13472,PS-210,O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1,C19H15F3O5,30923.0
13473,Vosaroxin,CN[C@H]1CN(c2ccc3c(=O)c(C(=O)O)cn(-c4nccs4)c3n2)C[C@@H]1OC,C18H19N5O4S,30614.0
13474,"15-deoxy-?12,14-Prostaglandin D2-d4",[2H]C([2H])(/C=C\C[C@@H]1/C(=C\C=C\CCCCC)C(=O)C[C@@H]1O)C([2H])([2H])CC(=O)O,C20H30O4,19343.0
13475,RCGD 423,Brc1ccc(Nc2nc(-c3ccccc3)cs2)cc1,C15H11BrN2S,31420.0
13476,CHM-1,O=c1cc(-c2ccccc2F)[nH]c2cc3c(cc12)OCO3,C16H10FNO3,27647.0
13477,Remoxipride (hydrochloride),CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC.Cl,C16H24BrClN2O3,30971.0
13478,D-Serine,N[C@H](CO)C(=O)O,C3H7NO3,31197.0
13479,Cycloguanil-d6 (hydrochloride),Cl.[2H]C([2H])([2H])C1(C([2H])([2H])[2H])N=C(N)N=C(N)N1c1ccc(Cl)cc1,C11H15Cl2N5,31496.0
13480,Idronoxil,Oc1ccc(C2=Cc3ccc(O)cc3OC2)cc1,C15H12O3,30783.0
13481,Echinosporin,NC(=O)C1=C[C@H]2[C@@H]3C=C[C@@]2(O)C(=O)O[C@@H]3O1,C10H9NO5,31416.0
13482,TC-FPR 43,CC(C)c1c(NC(=O)Nc2ccc(Cl)cc2)c(=O)n(-c2ccccc2)n1C,C20H21ClN4O2,29804.0
13483,5-MMPA (hydrochloride),CNC(C)Cc1ccc(C)s1.Cl,C9H16ClNS,31292.0
13484,"15-deoxy-?12,14-Prostaglandin D2-d9",[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C/C=C/C=C1/C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,C20H30O4,19344.0
13485,4-Hydroxybenzyl Alcohol,OCc1ccc(O)cc1,C7H8O2,31209.0
13486,A-839977,Clc1cccc(-n2nnnc2NCc2ccccc2Oc2ccccn2)c1Cl,C19H14Cl2N6O,30934.0
13487,MB-05032,CC(C)Cc1sc(N)nc1-c1ccc(P(=O)(O)O)o1,C11H15N2O4PS,30924.0
13488,Famotidine-13C-d3,[2H]C([13C](=N)NS(N)(=O)=O)C([2H])([2H])SCc1csc(NC(=N)N)n1,C8H15N7O2S3,31493.0
13489,Proguanil,CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1,C11H16ClN5,30675.0
13490,Tebipenem Pivoxil,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(SC3CN(C4=NCCS4)C3)[C@H](C)[C@H]12,C22H31N3O6S2,30613.0
13491,SMIFH2,O=C1NC(=S)N(c2cccc(Br)c2)C(=O)/C1=C/c1ccco1,C15H9BrN2O3S,31517.0
13492,DSDP,O=C1[C@H]2CSC3(C(=O)c4ccccc4C3=O)N2C(=O)[C@H]2CSC3(C(=O)c4ccccc4C3=O)N12,C24H14N2O6S2,30156.0
13493,Dofequidar,O=C(C(c1ccccc1)c1ccccc1)N1CCN(CC(O)COc2cccc3ncccc23)CC1,C30H31N3O3,30925.0
13494,AQC,O=C(Nc1ccc2ncccc2c1)ON1C(=O)CCC1=O,C14H11N3O4,30877.0
13495,RMC-4550,Cc1nc(N2CCC3(CC2)CO[C@@H](C)[C@H]3N)c(CO)nc1-c1cccc(Cl)c1Cl,C21H26Cl2N4O2,31011.0
13496,A-1120,O=C(O)c1ccccc1NC(=O)N1CCC(c2ccccc2C(F)(F)F)CC1,C20H19F3N2O3,30921.0
13497,Chlorpyrifos-d10,[2H]C([2H])([2H])C([2H])([2H])OP(=S)(Oc1nc(Cl)c(Cl)cc1Cl)OC([2H])([2H])C([2H])([2H])[2H],C9H11Cl3NO3PS,30953.0
13498,SD-06,O=C(CO)N1CCC(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1,C20H20ClN5O2,30686.0
13499,Purine,c1ncc2[nH]cnc2n1,C5H4N4,30853.0
13500,"3,4-dichloro-N-cyclohexyl Methcathinone (hydrochloride)",CC(C(=O)c1ccc(Cl)c(Cl)c1)N(C)C1CCCCC1.Cl,C16H22Cl3NO,31150.0
13501,Choline (chloride),C[N+](C)(C)CCO.[Cl-],C5H14ClNO,31178.0
13502,Fluo-4 AM,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1ccc(C)cc1OCCOc1cc(-c2c3cc(F)c(=O)cc-3oc3cc(OCOC(C)=O)c(F)cc23)ccc1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O,C51H50F2N2O23,31143.0
13503,C-DIM8,Oc1ccc(C(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)cc1,C23H18N2O,30694.0
13504,SB-772077B (hydrochloride),CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl.Cl,C15H20Cl2N8O2,30975.0
13505,2-Amino-5-bromo-6-chloropyrazine,Nc1cnc(Br)c(Cl)n1,C4H3BrClN3,30917.0
13506,Norgestimate-d6,[2H]C1=C2C([2H])([2H])C[C@H]3[C@@H]4CC[C@](C#C)(OC(C)=O)[C@@]4(CC)CC[C@@H]3[C@@]2([2H])CC([2H])([2H])/C1=N\O,C23H31NO3,31176.0
13507,Melperone-d4 (hydrochloride),Cl.[2H]C1([2H])CC(C)CC([2H])([2H])N1CCCC(=O)c1ccc(F)cc1,C16H23ClFNO,31489.0
13508,BIMU 8,CC(C)n1c(=O)n(C(=O)N[C@H]2C[C@H]3CC[C@@H](C2)N3C)c2ccccc21.Cl,C19H27ClN4O2,30964.0
13509,Arterolane,CC(C)(N)CNC(=O)C[C@H]1CC[C@]2(CC1)OOC1(O2)[C@@H]2CC3CC(C[C@@H]1C3)C2,C22H36N2O4,30676.0
13510,Valrocemide,CCCC(CCC)C(=O)NCC(N)=O,C10H20N2O2,30909.0
13511,Faldaprevir-d6,[2H]C([2H])([2H])C(C(=O)Nc1nc(-c2cc(O[C@@H]3C[C@@H](C(=O)N[C@]4(C(=O)O)C[C@H]4C=C)N(C(=O)[C@@H](NC(=O)OC4CCCC4)C(C)(C)C)C3)c3ccc(OC)c(Br)c3n2)cs1)C([2H])([2H])[2H],C40H49BrN6O9S,31480.0
13512,Ferrozine (hydrate),O.O=S(=O)([O-])c1ccc(-c2nc(-c3ccccn3)nnc2-c2ccc(S(=O)(=O)O)cc2)cc1.[Na+],C20H15N4NaO7S2,31465.0
13513,LY272015,COc1ccc(CC2NCCc3c2[nH]c2ccc(C)cc32)cc1OC.Cl,C21H25ClN2O2,31471.0
13514,Buflomedil (hydrochloride),COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1.Cl,C17H26ClNO4,31184.0
13515,CD73-IN-1,NC(=O)c1cc(S(=O)(=O)Nc2ccc3cc(C4CC4)[nH]c3c2)ccc1O,C18H17N3O4S,30959.0
13516,Ascochin,C=C1OC(=O)c2c(O)cc(O)c(C=O)c2[C@@H]1C,C12H10O5,31450.0
13517,Abametapir,Cc1ccc(-c2ccc(C)cn2)nc1,C12H12N2,30684.0
13518,THZ1-R,CN(C)CCCC(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1,C31H30ClN7O2,31054.0
13519,Chlorotrianisene,COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1,C23H21ClO3,30361.0
13520,Afzelin,C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O,C21H20O10,31135.0
13521,BETP,CCS(=O)c1nc(-c2cccc(OCc3ccccc3)c2)cc(C(F)(F)F)n1,C20H17F3N2O2S,31116.0
13522,Colchicoside,COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2c(c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,C27H33NO11,11831.0
13523,4-methyl-?-Pyrrolidinoisohexanophenone (hydrochloride),Cc1ccc(C(=O)C(CC(C)C)N2CCCC2)cc1.Cl,C17H26ClNO,31013.0
13524,Ganglioside GD1a (bovine) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@]5(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O5)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[NH4+].[NH4+],C84H154N6O39,31591.0
13525,RS 102221 (hydrochloride),COc1cc(OC)c(C(=O)CCCCN2CCC3(CC2)NC(=O)NC3=O)cc1NS(=O)(=O)c1ccc(C(F)(F)F)cc1.Cl,C27H32ClF3N4O7S,31543.0
13526,Aurintricarboxylic Acid (ammonium salt),O=C([O-])C1=CC(=C(c2ccc(O)c(C(=O)[O-])c2)c2ccc(O)c(C(=O)[O-])c2)C=CC1=O.[NH4+].[NH4+].[NH4+],C22H23N3O9,30636.0
13527,Melicopine,O=C([O-])C1=CC(=C(c2ccc(O)c(C(=O)[O-])c2)c2ccc(O)c(C(=O)[O-])c2)C=CC1=O.[NH4+].[NH4+].[NH4+],C22H23N3O9,30636.0
13528,Dehydrocorydaline (chloride),COc1cc2c(cc1OC)-c1c(C)c3ccc(OC)c(OC)c3c[n+]1CC2.[Cl-],C22H24ClNO4,30972.0
13529,CAY10756,COc1nn(-c2cnccn2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,C19H19N9O2,30382.0
13530,Artefenomel,c1cc([C@H]2CC[C@]3(CC2)OOC2(O3)[C@@H]3CC4CC(C[C@@H]2C4)C3)ccc1OCCN1CCOCC1,C28H39NO5,30677.0
13531,Hydroxysafflor Yellow A,O=C(/C=C/c1ccc(O)cc1)C1=C(O)C(O)([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(O)=C([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1=O,C27H32O16,31204.0
13532,AS-2863619,Cc1nc2ccc(-n3c(-c4nonc4N)nc4cnccc43)cc2[nH]1.Cl.Cl,C16H14Cl2N8O,30976.0
13533,Metizolam,CCc1cc2c(s1)-n1cnnc1CN=C2c1ccccc1Cl,C16H13ClN4S,23111.0
13534,3-chloro PCP (hydrochloride),Cl.Clc1cccc(C2(N3CCCCC3)CCCCC2)c1,C17H25Cl2N,31475.0
13535,MMDPPA,CC(Cc1ccc2c(c1)OCO2)C(N)=O,C11H13NO3,31580.0
13536,Eurycomanone,C=C1[C@@H](O)[C@]2(O)OC[C@]34[C@H]2[C@@]2(C)[C@H](O)C(=O)C=C(C)[C@@H]2C[C@H]3OC(=O)[C@H](O)[C@@]14O,C20H24O9,30896.0
13537,7-Ethoxycoumarin,CCOc1ccc2ccc(=O)oc2c1,C11H10O3,31215.0
13538,Darunavir (ethanolate),CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1.CCO,C29H43N3O8S,31083.0
13539,ST1535,CCCCc1nc(N)c2nc(-n3nccn3)n(C)c2n1,C12H16N8,10611.0
13540,14-Deoxyandrographolide,C=C1CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1CCC1=CCOC1=O,C20H30O4,31140.0
13541,Fumitremorgin B,COc1ccc2c3c(n(CC=C(C)C)c2c1)[C@H](C=C(C)C)N1C(=O)[C@@H]2CCCN2C(=O)[C@]1(O)[C@H]3O,C27H33N3O5,31173.0
13542,Pikromycin,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)C[C@@H](C)C(=O)/C=C/[C@]1(C)O,C28H47NO8,31331.0
13543,Anthirine,C=C[C@@H](CO)[C@H]1CCN2CCc3c([nH]c4ccccc34)[C@@H]2C1,C19H24N2O,31343.0
13544,Triflumuron,O=C(NC(=O)c1ccccc1Cl)Nc1ccc(OC(F)(F)F)cc1,C15H10ClF3N2O3,30858.0
13545,Noracronycine,Cn1c2ccccc2c(=O)c2c(O)cc3c(c21)C=CC(C)(C)O3,C19H17NO3,31336.0
13546,AMB butanoic acid metabolite,CCCCCn1nc(C(=O)N[C@H](C(=O)O)C(C)C)c2ccccc21,C18H25N3O3,30302.0
13547,?-Butyrolactone-d6,[2H]C1([2H])OC(=O)C([2H])([2H])C1([2H])[2H],C4H6O2,31373.0
13548,1-Linoleoyl-2-hydroxy-sn-glycero-3-PC,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C26H50NO7P,17153.0
13549,"1,3,6,8-Pyrenetetrasulfonic Acid (sodium salt hydrate)",O.O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2ccc3c(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c4ccc1c2c43.[Na+].[Na+].[Na+].[Na+],C16H6Na4O12S4(H2O)X,29980.0
13550,"Methyl 3,4-Dihydroxyphenylacetate",COC(=O)Cc1ccc(O)cc1O,C9H10O4,30637.0
13551,Mahanimbine,CC(C)=CCC[C@@]1(C)C=Cc2c(c(C)cc3c2[nH]c2ccccc23)O1,C23H25NO,30897.0
13552,Gisadenafil (besylate),CCOc1ncc(S(=O)(=O)N2CCN(CC)CC2)cc1-c1nc(=O)c2nn(CCOC)c(CC)c2[nH]1.O=S(=O)(O)c1ccccc1,C29H39N7O8S2,31472.0
13553,Guaiazulene,Cc1ccc(C(C)C)cc2c(C)ccc1-2,C15H18,31506.0
13554,Bilaid A,CC(C)[C@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)O,C28H38N4O5,31242.0
13555,6-ECDCA,CC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12,C26H44O4,11031.0
13556,"5-Butyl-4-[2,3-difluoro-4-(phenylmethoxy)phenyl]-6-phenyl-2-pyrimidinamine",CCCCc1c(-c2ccccc2)nc(N)nc1-c1ccc(OCc2ccccc2)c(F)c1F,C27H25F2N3O,31338.0
13557,Bilaid B,CC(C)[C@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)O,C28H38N4O6,31244.0
13558,Bilaid C,CC(C)[C@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)O,C28H38N4O6,31246.0
13559,Meprednisone,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO,C22H28O5,30289.0
13560,Nefiracetam,Cc1cccc(C)c1NC(=O)CN1CCCC1=O,C14H18N2O2,31339.0
13561,Clotiazepam,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl,C16H15ClN2OS,27745.0
13562,9(S)-HETE-d8,[2H]C(/C=C(\[2H])[C@@]([2H])(O)C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCCC)=C(\[2H])CCCC(=O)O,C20H32O3,9003558.0
13563,CAY10770,O=C(O)CCCCCCCNn1nnc2ccccc21,C14H20N4O2,31216.0
13564,?-Methylamino-L-Alanine (hydrochloride),CNC[C@H](N)C(=O)O.Cl,C4H11ClN2O2,23287.0
13565,Xaliproden (hydrochloride),Cl.FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccccc4c3)CC2)c1,C24H23ClF3N,31468.0
13566,Nucleozin,Cc1onc(-c2ccccc2)c1C(=O)N1CCN(c2ccc([N+](=O)[O-])cc2Cl)CC1,C21H19ClN4O4,30363.0
13567,L-Homocysteine,N[C@@H](CCS)C(=O)O,C4H9NO2S,30852.0
13568,scyllo-Inositol,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,C6H12O6,31214.0
13569,5-Butyl-4-phenyl-6-[4-(phenylmethoxy)phenyl]-2-pyrimidinamine,CCCCc1c(-c2ccccc2)nc(N)nc1-c1ccc(OCc2ccccc2)cc1,C27H27N3O,31337.0
13570,9(R)-HETE-d8,[2H]C(/C=C(\[2H])[C@]([2H])(O)C/C([2H])=C(/[2H])C/C([2H])=C(/[2H])CCCCC)=C(\[2H])CCCC(=O)O,C20H32O3,9003557.0
13571,Bilaid A1,CC(C)[C@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@H](Cc1ccccc1)C(N)=O,C28H39N5O4,31243.0
13572,Reserpiline,COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)[C@H]3C[C@H]12,C23H28N2O5,31332.0
13573,Bilaid C1,CC(C)[C@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@H](Cc1ccccc1)C(N)=O,C28H39N5O5,31247.0
13574,ONC212,O=C1C2=C(CCN(Cc3ccccc3)C2)N2CCN=C2N1Cc1ccc(C(F)(F)F)cc1,C24H23F3N4O,30931.0
13575,MMDPPO,CC(C=NO)Cc1ccc2c(c1)OCO2,C11H13NO3,31579.0
13576,IFN-?-IFNAR-IN-1 (hydrochloride),CNCc1ccccc1Sc1cccc2ccccc12.Cl,C18H18ClNS,30960.0
13577,PF-04859989 (hydrochloride),Cl.N[C@H]1Cc2ccccc2N(O)C1=O,C9H11ClN2O2,31383.0
13578,4-cyano CUMYL-BUTCZCA,CC(C)(NC(=O)c1ccc2c(c1)c1ccccc1n2CCCCC#N)c1ccccc1,C27H27N3O,24429.0
13579,Cabergoline-d6,[2H]C([2H])([2H])N(CCCN(C(=O)NCC)C(=O)[C@@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(CC=C)C1)C([2H])([2H])[2H],C26H37N5O2,31690.0
13580,Hydroflumethiazide-13C-d2,[2H][13C]1([2H])Nc2cc(C(F)(F)F)c(S(N)(=O)=O)cc2S(=O)(=O)N1,C8H8F3N3O4S2,31608.0
13581,Rhodamine dithenoyl hydrazide,CCN(CC)c1ccc2c(c1)Oc1cc(N(CC)CC)ccc1C21c2ccccc2C(=O)N1N(C(=O)c1cccs1)C(=O)c1cccs1,C38H36N4O4S2,31095.0
13582,Labetalol-d5 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(CCC(C)NCC(O)c2ccc(O)c(C(N)=O)c2)c([2H])c1[2H],C19H25ClN2O3,31609.0
13583,5-Methoxycanthinone,COc1cc2nccc3c4ccccc4n(c1=O)c23,C15H10N2O2,31342.0
13584,Anagyrine,O=c1cccc2n1C[C@H]1C[C@@H]2CN2CCCC[C@H]12,C15H20N2O,31169.0
13585,Bilaid B1,CC(C)[C@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@H](Cc1ccc(O)cc1)C(N)=O,C28H39N5O5,31245.0
13586,AZ 7371,COc1ncnc(Cn2cc(C(=O)NCCO)c3ncc(C)cc32)c1C,C18H21N5O3,19310.0
13587,ABBV-744,CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1,C28H30FN3O4,30470.0
13588,Mobocertinib,C=CC(=O)Nc1cc(Nc2ncc(C(=O)OC(C)C)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,C32H39N7O4,31522.0
13589,Avanafil-13C-d3,[2H][13C]([2H])([2H])Oc1ccc(CNc2nc(N3CCC[C@H]3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,C23H26ClN7O3,31687.0
13590,Vapendavir-d5,[2H]C([2H])([2H])C([2H])([2H])Oc1noc2cc(OCCC3CCN(c4ccc(C)nn4)CC3)ccc12,C21H26N4O3,31320.0
13591,N-Phenylthiourea,NC(=S)Nc1ccccc1,C7H8N2S,30855.0
13592,Aclarubicin,CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC,C42H53NO15,15993.0
13593,WM-1119,O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1,C18H13F2N3O3S,30509.0
13594,?-Isopropylaminohexanophenone (hydrochloride),CCCCC(NC(C)C)C(=O)c1ccccc1.Cl,C15H24ClNO,31005.0
13595,Dihydrosanguinarine,CN1Cc2c(ccc3c2OCO3)-c2ccc3cc4c(cc3c21)OCO4,C20H15NO4,31139.0
13596,GNTI (hydrochloride),Cl.Cl.N=C(N)Nc1ccc2[nH]c3c(c2c1)C[C@@]1(O)[C@H]2Cc4ccc(O)c5c4[C@@]1(CCN2CC1CC1)[C@H]3O5,C27H31Cl2N5O3,31597.0
13597,Tormentic Acid,C[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@]1(C)O,C30H48O5,30696.0
13598,Allocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H40O5,30415.0
13599,Remdesivir-d4,[2H]C([2H])([2H])[C@]([2H])(N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)Oc1ccccc1)C(=O)OCC(CC)CC,C27H35N6O8P,30905.0
13600,Boceprevir-d9,[2H]C([2H])([2H])C(NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C)(C([2H])([2H])[2H])C([2H])([2H])[2H],C27H45N5O5,31461.0
13601,Dihydrophytol,CC(C)CCCC(C)CCCC(C)CCCC(C)CCO,C20H42O,31692.0
13602,"2-Amino-3,4-dimethyl-3H-imidazo[4,5-f]quinoline",Cc1cc2ncccc2c2nc(N)n(C)c12,C12H12N4,31509.0
13603,Polygalaxanthone III,COc1cc2c(=O)c3c(O)c([C@@H]4O[C@H](CO[C@@H]5OC[C@](O)(CO)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)c(O)cc3oc2cc1O,C25H28O15,30621.0
13604,PB 28 (hydrochloride),COc1cccc2c1CCCC2CCCN1CCN(C2CCCCC2)CC1.Cl.Cl,C24H40Cl2N2O,31742.0
13605,N-Boc Norketamine,CC(C)(C)OC(=O)NC1(c2ccccc2Cl)CCCCC1=O,C17H22ClNO3,9003560.0
13606,Isovitexin,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,C21H20O10,31212.0
13607,N-3-oxo-butyryl-L-Homoserine lactone,CC(=O)CC(=O)N[C@H]1CCOC1=O,C8H11NO4,13024.0
13608,(R)-Modafinil,NC(=O)C[S@@](=O)C(c1ccccc1)c1ccccc1,C15H15NO2S,29910.0
13609,Acetomycin,CC(=O)O[C@@H]1OC(=O)[C@](C)(C(C)=O)[C@@H]1C,C10H14O5,31410.0
13610,Ergosterol Peroxide,CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@]23C=C[C@]2(C[C@@H](O)CC[C@]12C)OO3,C28H44O3,30860.0
13611,PD 173955,CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1,C21H16Cl2N4OS,30618.0
13612,TRV-130 (hydrochloride),COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1.Cl,C22H31ClN2O2S,30624.0
13613,Dioctanoyl Glycol,CCCCCCCC(=O)OCCOC(=O)CCCCCCC,C18H34O4,31515.0
13614,Calcitonin (eel),CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O,C146H241N43O47S2,31487.0
13615,Gemcitabine monophosphate,Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)C2(F)F)c(=O)n1,C9H12F2N3O7P,31726.0
13616,Solasonine,C[C@@H]1CC[C@@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C45H73NO16,28111.0
13617,Laminin (925-933),CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NC(CCCNC(=N)N)C(=O)O,C40H62N12O14S,31141.0
13618,4'-O-Methylhonokiol,C=CCc1ccc(O)c(-c2ccc(OC)c(CC=C)c2)c1,C19H20O2,11089.0
13619,Nile Red,CCN(CC)c1ccc2nc3c4ccccc4c(=O)cc-3oc2c1,C20H18N2O2,30787.0
13620,RO5028442,CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21,C25H28ClN3O2,31452.0
13621,BMS 986142,Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O,C32H30F2N4O4,30927.0
13622,Difluorinated H2S Fluorescent Probe 1,Cc1cc(=O)oc2c(F)c(N=[N+]=[N-])c(F)cc12,C10H5F2N3O2,29835.0
13623,Ethyl 4-nitro-L-phenylalanine (hydrochloride),CCOC(=O)[C@@H](N)Cc1ccc([N+](=O)[O-])cc1.Cl,C11H15ClN2O4,30615.0
13624,Macranthoidin B,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CC[C@]6(C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O)CC[C@]45C)[C@]3(C)CO)OC[C@H](O)[C@@H]2O)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H]1O,C65H106O32,31533.0
13625,CNX-2006,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC4CN(CCF)C4)cc3OC)ncc2C(F)(F)F)c1,C26H27F4N7O2,30610.0
13626,BRL 15572,Cl.Cl.OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1,C25H29Cl3N2O,31191.0
13627,Propionylpromazine (hydrochloride),CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2.Cl,C20H25ClN2OS,31470.0
13628,Chrysosplenetin,COc1cc(-c2oc3cc(OC)c(OC)c(O)c3c(=O)c2OC)ccc1O,C19H18O8,30625.0
13629,Alachlor,CCc1cccc(CC)c1N(COC)C(=O)CCl,C14H20ClNO2,30854.0
13630,VCP171,Nc1scc(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1,C18H12F3NOS,30309.0
13631,MDMB-CHM7AICA,COC(=O)[C@@H](NC(=O)c1cn(CC2CCCCC2)c2ncccc12)C(C)(C)C,C22H31N3O3,31186.0
13632,D-Ornithine lactam,N[C@@H]1CCCNC1=O,C5H10N2O,31680.0
13633,(S)-Modafinil,NC(=O)C[S@](=O)C(c1ccccc1)c1ccccc1,C15H15NO2S,31565.0
13634,Nebularine,OC[C@H]1O[C@@H](n2cnc3cncnc32)[C@H](O)[C@@H]1O,C10H12N4O4,31329.0
13635,D-erythro/L-threo Lysosphingomyelin (d18:1),CCCCCCCCCCCCC/C=C/C(O)C(N)COP(=O)([O-])OCC[N+](C)(C)C,C23H49N2O5P,31557.0
13636,DQP1105,Cc1ccc2[nH]c(=O)c(C3=NN(C(=O)CCC(=O)O)C(c4ccc(Br)cc4)C3)c(-c3ccccc3)c2c1,C29H24BrN3O4,31121.0
13637,ZL0420,Cc1cc(/N=N/c2ccc3c(c2)CCC(=O)N3)c(N)cc1O,C16H16N4O2,30741.0
13638,MRTX-849,C=C(F)C(=O)N1CCN(c2nc(OC[C@@H]3CCCN3C)nc3c2CCN(c2cccc4cccc(Cl)c24)C3)C[C@@H]1CC#N,C32H35ClFN7O2,31440.0
13639,DL-Homocysteine thiolactone (hydrochloride),Cl.NC1CCSC1=O,C4H8ClNOS,31466.0
13640,ARN3236,COc1ccc(-c2c[nH]c3nccc(-c4ccsc4)c23)c(OC)c1,C19H16N2O2S,31457.0
13641,Icotinib,C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,C22H21N3O4,30093.0
13642,"2(E),4(Z)-Decadienoic Acid ethyl ester",CCCCC/C=C\C=C\C(=O)OCC,C12H20O2,30835.0
13643,5?-Dihydroprogesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C21H32O2,31505.0
13644,PLX51107,Cc1noc(C)c1-c1cnc2c(-c3ccc(C(=O)O)cc3)cn([C@@H](C)c3ccccn3)c2c1,C26H22N4O3,30742.0
13645,Hederasaponin B,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@]4(C)[C@H]5CC=C6[C@@H]7CC(C)(C)CC[C@]7(C(=O)O[C@@H]7O[C@H](CO[C@@H]8O[C@H](CO)[C@@H](O[C@@H]9O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@@H](O)[C@H](O)[C@H]7O)CC[C@@]6(C)[C@]5(C)CC[C@H]4C3(C)C)OC[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C59H96O25,30641.0
13646,TGN 020,O=C(Nc1nncs1)c1cccnc1,C8H6N4OS,30955.0
13647,AC-262536,N#Cc1ccc(N2[C@@H]3CC[C@H]2C[C@@H](O)C3)c2ccccc12,C18H18N2O,31598.0
13648,4-IBP,O=C(NC1CCN(Cc2ccccc2)CC1)c1ccc(I)cc1,C19H21IN2O,31518.0
13649,TAS 103 (hydrochloride),CN(C)CCNc1nc2cc(O)ccc2c2c1C(=O)c1ccccc1-2.Cl.Cl,C20H21Cl2N3O2,29869.0
13650,ODM-203,Cn1cc(-c2ccc3c(c2)ncn3-c2cc(NS(=O)(=O)C3CC3)cc(-c3ccc(F)cc3F)c2)cn1,C26H21F2N5O2S,31451.0
13651,(Des-Arg9)-Bradykinin,N=C(N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O,C44H61N11O10,31136.0
13652,Fuziline,CCN1C[C@]2(COC)CC[C@H](O)C34C1C([C@H](OC)[C@@H]32)[C@@]1(O)[C@@H](O)[C@H](OC)[C@H]2C[C@@H]4[C@@H]1C2O,C24H39NO7,30889.0
13653,Gibberellin A4,C=C1C[C@]23C[C@H]1CC[C@H]2[C@@]12CC[C@H](O)[C@@](C)(C(=O)O1)[C@H]2[C@@H]3C(=O)O,C19H24O5,31400.0
13654,Mometasone,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl,C22H28Cl2O4,31702.0
13655,Pyrvinium (pamoate),Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1.Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1.O=C([O-])c1cc2ccccc2c(Cc2c(O)c(C(=O)[O-])cc3ccccc23)c1O,C75H70N6O6,31546.0
13656,Cariprazine,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,C21H32Cl2N4O,31446.0
13657,D-DOPA,N[C@H](Cc1ccc(O)c(O)c1)C(=O)O,C9H11NO4,13249.0
13658,PSB-KD107,Cn1c(=O)c2c(nc3n2CCCN3CCc2c[nH]c3ccccc23)n(C)c1=O,C20H22N6O2,31393.0
13659,VUF 10166,CN1CCN(c2nc3ccccc3nc2Cl)CC1,C13H15ClN4,31423.0
13660,Oxfendazole,COC(=O)Nc1nc2ccc(S(=O)c3ccccc3)cc2[nH]1,C15H13N3O3S,29742.0
13661,IOWH-032,O=C(NCc1ccc(Oc2ccccc2)cc1)c1nc(-c2cc(Br)c(O)c(Br)c2)no1,C22H15Br2N3O4,30273.0
13662,Sobetirome,Cc1cc(OCC(=O)O)cc(C)c1Cc1ccc(O)c(C(C)C)c1,C20H24O4,30814.0
13663,18-Deoxyherboxidiene,CC[C@H](OC)[C@@H](C)[C@H]1O[C@]1(C)C[C@H](C)/C=C/C=C(\C)[C@H]1O[C@@H](CC(=O)O)CC[C@@H]1C,C25H42O5,29063.0
13664,TP-4748,CCOC(=O)c1occc1B(O)O,C7H9BO5,31459.0
13665,Docusate (sodium salt),CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)[O-].[Na+],C20H37NaO7S,30692.0
13666,Trimebutine,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,C22H29NO5,31574.0
13667,CLP 290,O=C1N=C(N2CCCCN2)S/C1=C\c1ccc(F)cc1OC(=O)N1CCCC1,C19H21FN4O3S,31448.0
13668,H3B-5942,CC/C(=C(/c1ccc(OCCNC/C=C/C(=O)N(C)C)cc1)c1ccc2[nH]ncc2c1)c1ccccc1,C31H34N4O2,31454.0
13669,2-O-?-D-Glucopyranosyl-L-ascorbic Acid,O=C1O[C@H]([C@@H](O)CO)C(O)=C1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C12H18O11,31402.0
13670,Alflutinib (mesylate),C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OCC(F)(F)F)nc1N(C)CCN(C)C.CS(=O)(=O)O,C29H35F3N8O5S,31473.0
13671,Bobcat 339,Nc1nc(=O)n(-c2cccc(-c3ccccc3)c2)cc1Cl,C16H12ClN3O,31453.0
13672,ZLY032,Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1COc1ccc2c(c1)OC[C@H]2CC(=O)O,C22H18F3NO4S,31485.0
13673,"7-Methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine",COc1c(OCCCN2CCOCC2)ccc2c1N=C(N)N1CCN=C21,C18H25N5O3,30944.0
13674,(+)-Baclofen (hydrochloride),Cl.NC[C@H](CC(=O)O)c1ccc(Cl)cc1,C10H13Cl2NO2,31595.0
13675,C188-9,COc1ccc(S(=O)(=O)Nc2cc(-c3c(O)ccc4ccccc34)c(O)c3ccccc23)cc1,C27H21NO5S,30928.0
13676,4-Methylaminoantipyrine (hydrochloride),CNc1c(C)n(C)n(-c2ccccc2)c1=O.Cl,C12H16ClN3O,31612.0
13677,PKC? Inhibitor Scramble Peptide,CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O,C37H65N9O13,31761.0
13678,Bofutrelvir,O=C[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)c1cc2ccccc2[nH]1,C25H32N4O4,31344.0
13679,GSK2018682,CC(C)Oc1ncc(-c2nc(-c3cccc4c3ccn4CCCC(=O)O)no2)cc1Cl,C22H21ClN4O4,31437.0
13680,BMS 1166,Cc1c(COc2cc(OCc3cccc(C#N)c3)c(CN3C[C@H](O)C[C@@H]3C(=O)O)cc2Cl)cccc1-c1ccc2c(c1)OCCO2,C36H33ClN2O7,31441.0
13681,"8(E),10(E),12(Z)-Octadecatrienoic Acid",CCCCC/C=C\C=C\C=C\CCCCCCC(=O)O,C18H30O2,30885.0
13682,Cannabielsoin,C=C(C)[C@@H]1CC[C@](C)(O)[C@H]2Oc3cc(CCCCC)cc(O)c3[C@@H]12,C21H30O3,21092.0
13683,Cannabielsoin (CRM),C=C(C)[C@@H]1CC[C@](C)(O)[C@H]2Oc3cc(CCCCC)cc(O)c3[C@@H]12,C21H30O3,36661.0
13684,RC363,CC(C)(C)c1cc(Sc2cccs2)cc(C(C)(C)C)c1O,C18H24OS2,31407.0
13685,Sphingomyelin (porcine RBC),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCCCCCCCCCC,C47H95N2O6P,31558.0
13686,VBIT-12,O=C(O)CNC(=O)C1(Nc2ccccc2)CCN(Cc2cccc3ccccc23)CC1,C25H27N3O3,31445.0
13687,(+)-?-Tocopherol,Cc1cc(O)cc2c1O[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC2,C27H46O2,31589.0
13688,Ganglioside GM1 (porcine) (ammonium salt),CCCCCCCCCCCCC/C=C/C(O)C(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(OC4OC(CO)C(O)C(O)C4O)C3NC(C)=O)C(OC3(C(=O)[O-])CC(O)C(NC(C)=O)C(C(O)C(O)CO)O3)C2O)C(O)C1O)NC(=O)CCCCCCCCCCCCCCCCC.[NH4+],C73H134N4O31,31551.0
13689,LXS-196,CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1,C22H23F3N8O,31455.0
13690,Cyclizine (hydrochloride),CN1CCN(C(c2ccccc2)c2ccccc2)CC1.Cl,C18H23ClN2,31190.0
13691,"2,6-Dichloropurine-9-?-D-riboside",OC[C@H]1O[C@@H](n2cnc3c(Cl)nc(Cl)nc32)[C@H](O)[C@@H]1O,C10H10Cl2N4O4,31405.0
13692,Belvarafenib,Cc1ccc2c(Nc3cccc(Cl)c3F)nccc2c1NC(=O)c1csc2c(N)ncnc12,C23H16ClFN6OS,31460.0
13693,ML-133 (hydrochloride),COc1ccc(CNCc2cccc3ccccc23)cc1.Cl,C19H20ClNO,31232.0
13694,2'-Deoxyinosine,O=c1nc[nH]c2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,C10H12N4O4,31507.0
13695,Amonafide,CN(C)CCN1C(=O)c2cccc3cc(N)cc(c23)C1=O,C16H17N3O2,31623.0
13696,GSK2983559,CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCOP(=O)(O)O,C21H23N4O7PS2,31458.0
13697,NMS-P715,CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2,C35H39F3N8O3,31613.0
13698,DS-1001b,CC(C)(C)N.Cc1cn(C(=O)c2c(-c3c(Cl)cc(Cl)cc3Cl)noc2C(C)(C)F)c2cccc(/C=C/C(=O)O)c12,C29H29Cl3FN3O4,31488.0
13699,Chebulic Acid,O=C(O)C[C@H](C(=O)O)[C@H]1c2c(cc(O)c(O)c2O)C(=O)O[C@@H]1C(=O)O,C14H12O11,11829.0
13700,MiPLA (solution),CC(C)N(C)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,C20H25N3O,31501.0
13701,INCB 057643,CN1C(=O)C(C)(C)Oc2c(-c3cn(C)c(=O)c4[nH]ccc34)cc(S(C)(=O)=O)cc21,C20H21N3O5S,31456.0
13702,Rasagiline-13C3 (mesylate),CS(=O)(=O)O.[13CH]#[13C][13CH2]N[C@@H]1CCc2ccccc21,C13H17NO3S,31688.0
13703,2'-MeCCPA,C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NC3CCCC3)nc(Cl)nc21,C16H22ClN5O4,30935.0
13704,Nicergoline,CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13,C24H26BrN3O3,31573.0
13705,Cimbuterol,CC(C)(C)NCC(O)c1ccc(N)c(C#N)c1,C13H19N3O,31743.0
13706,Cy3,CC[N+]1=C(/C=C/C=C2/N(CCCCCC(=O)O)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(C)c2cc(S(=O)(=O)[O-])ccc21,C31H38N2O8S2,30392.0
13707,Mpro Inhibitor 11b,O=C[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](Cc1cccc(F)c1)NC(=O)c1cc2ccccc2[nH]1,C25H25FN4O4,31345.0
13708,4-Hydroxyestradiol,C[C@]12CC[C@@H]3c4ccc(O)c(O)c4CC[C@H]3[C@@H]1CC[C@@H]2O,C18H24O3,31508.0
13709,Ganglioside GQ1b (porcine) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@]5(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]6(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O6)O5)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]4(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[NH4+].[NH4+].[NH4+].[NH4+],C106H194N10O55,31562.0
13710,L-Homoserine lactone (hydrochloride),Cl.N[C@H]1CCOC1=O,C4H8ClNO2,31492.0
13711,(S)-Crizotinib,C[C@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,C21H22Cl2FN5O,31114.0
13712,Chicago Sky Blue 6B,COc1cc(-c2ccc(/N=N/c3ccc4c(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c(N)c4c3O)c(OC)c2)ccc1/N=N/c1ccc2c(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c(N)c2c1O.[Na+].[Na+].[Na+].[Na+],C34H24N6Na4O16S4,31542.0
13713,Itopride (hydrochloride),COc1ccc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc1OC.Cl,C20H27ClN2O4,31183.0
13714,Ajmalicine,COC(=O)C1=CO[C@@H](C)[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,C21H24N2O3,31213.0
13715,N-Boc Ketamine,CN(C(=O)OC(C)(C)C)C1(c2ccccc2Cl)CCCCC1=O,C18H24ClNO3,9003561.0
13716,CCG-215022,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3ccccn3)c2)NC(=O)N1,C26H22FN7O3,31120.0
13717,Ropinirole-d7 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])N(CCC)CCc1cccc2c1CC(=O)N2,C16H25ClN2O,31689.0
13718,Antide (acetate),CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCNC(=O)c1cccnc1)C(=O)N[C@H](CCCCNC(=O)c1cccnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O.CC(=O)O,C84H112ClN17O16,31486.0
13719,AZD 5582,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H]1c2ccccc2C[C@H]1OCC#CC#CCO[C@@H]1Cc2ccccc2[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C1CCCCC1)C1CCCCC1,C58H78N8O8,30932.0
13720,GLX-351322,CCOC(=O)c1c(NC(=O)CN2CCN(C(=O)c3ccco3)CC2)sc2c1CCC2,C21H25N3O5S,31523.0
13721,Spiculisporic Acid,CCCCCCCCCC[C@H](C(=O)O)[C@]1(C(=O)O)CCC(=O)O1,C17H28O6,31334.0
13722,D-Lysine lactam,N[C@@H]1CCCCNC1=O,C6H12N2O,31684.0
13723,Ginsenoside F3,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2OC[C@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@]12C,C41H70O13,31409.0
13724,Sclareolide,CC1(C)CCC[C@]2(C)[C@H]3CC(=O)O[C@]3(C)CC[C@@H]12,C16H26O2,31371.0
13725,Resorufin (sodium salt),O=c1ccc2nc3ccc([O-])cc3oc-2c1.[Na+],C12H6NNaO3,30789.0
13726,MDMB-FUB7AICA,COC(=O)[C@@H](NC(=O)c1cn(Cc2ccc(F)cc2)c2ncccc12)C(C)(C)C,C22H24FN3O3,31187.0
13727,CENTA,O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3ccc([N+](=O)[O-])c(C(=O)O)c3)CS[C@H]12,C21H17N3O8S3,31534.0
13728,Solasodine,C[C@@H]1CC[C@@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C27H43NO2,28112.0
13729,?-Pyrrolidino-2-phenylacetophenone (hydrochloride),Cl.O=C(c1ccccc1)C(c1ccccc1)N1CCCC1,C18H20ClNO,31719.0
13730,CAY10746,CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1,C26H23N3O5,29814.0
13731,Cropropamide,C/C=C/C(=O)N(CCC)C(CC)C(=O)N(C)C,C13H24N2O2,30888.0
13732,Cilastatin-15N-d3,[2H]C([2H])(SCCCC/C=C(\NC(=O)[C@H]1CC1(C)C)C(=O)O)[C@]([2H])([15NH2])C(=O)O,C16H26N2O5S,29098.0
13733,NGI 1,Cc1cnc(NC(=O)c2cc(S(=O)(=O)N(C)C)ccc2N2CCCC2)s1,C17H22N4O3S2,31519.0
13734,trans-?-Farnesene,C=CC(=C)CC/C=C(\C)CCC=C(C)C,C15H24,31502.0
13735,N-p-Tosyl-Gly-Pro-Lys-pNA (acetate),CC(=O)O.Cc1ccc(S(=O)(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)Nc2ccc([N+](=O)[O-])cc2)cc1,C28H38N6O9S,31544.0
13736,Corynoxeine,C=C[C@H]1CN2CC[C@]3(C(=O)Nc4ccccc43)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C22H26N2O4,31403.0
13737,Ketamine hydroxylimine precursor (hydrochloride),C/N=C(/c1ccccc1Cl)C1(O)CCCC1.Cl,C13H17Cl2NO,22213.0
13738,AB-928,Cc1c(C#N)cccc1-c1cc(-c2cn(Cc3cccc(C(C)(C)O)n3)nn2)nc(N)n1,C23H22N8O,31444.0
13739,NUCC-390 (hydrochloride),CCCn1nc(C(=O)N2CCCCC2)c2c1CCC(NCCc1ccncc1)C2.Cl.Cl,C23H35Cl2N5O,30957.0
13740,Granisetron-d3,[2H]C([2H])([2H])n1nc(C(=O)N[C@H]2C[C@H]3CCC[C@@H](C2)N3C)c2ccccc21,C18H24N4O,31786.0
13741,Deoxycorticosterone Acetate,CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C23H32O4,30856.0
13742,Levobupivacaine (hydrochloride),CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl,C18H29ClN2O,31596.0
13743,RK-287107,O=c1nc(N2CCC3(CC2)CN(CCO)c2cc(F)cc(F)c23)[nH]c2c1CCCC2,C22H26F2N4O2,30998.0
13744,BKT 140,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c2ccc(F)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCNC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(N)=O)C(=O)N1)C(N)=O,C97H144FN33O19S2,30689.0
13745,L-Pyrohomoglutamic Acid,O=C1CCC[C@@H](C(=O)O)N1,C6H9NO3,31694.0
13746,N-Acetylmuramic Acid,CC(=O)N[C@@H](C=O)[C@@H](O[C@H](C)C(=O)O)[C@H](O)[C@H](O)CO,C11H19NO8,31330.0
13747,Ethiopropamine (hydrochloride),CCNC(C)Cc1cccs1.Cl,C9H16ClNS,31868.0
13748,Nandrolone Benzoate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2OC(=O)c1ccccc1,C25H30O3,31714.0
13749,Tioxolone,O=c1oc2cc(O)ccc2s1,C7H4O3S,31372.0
13750,LAMPA (solution),CCCN(C)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,C20H25N3O,31500.0
13751,Parvodicin C2,CCCCCCCCCCCC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(cc5)O3)NC(=O)[C@H](NC)c3ccc(O)c(c3)Oc3cc(O)c(Cl)c4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](C(=O)O)[C@@H](O)[C@@H]1O,C83H88Cl2N8O29,32542.0
13752,Quillaic Acid,CC1(C)CC[C@]2(C(=O)O)[C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(C=O)[C@@H]5CC[C@]43C)[C@@H]2C1,C30H46O5,31512.0
13753,PRX-08066,N#Cc1cc(CN2CCC(Nc3ncnc4sc(Cl)cc34)CC2)ccc1F,C19H17ClFN5S,31477.0
13754,Calcium D-Glucarate (hydrate),O.O.O.O.O=C([O-])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)[O-].[Ca+2],C6H16CaO12,31490.0
13755,Nimustine (hydrochloride),Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1.Cl,C9H14Cl2N6O2,31464.0
13756,"1,3-Diphenylurea",O=C(Nc1ccccc1)Nc1ccccc1,C13H12N2O,31323.0
13757,"L-778,123",N#Cc1ccc(Cn2cncc2CN2CCN(c3cccc(Cl)c3)C(=O)C2)cc1,C22H20ClN5O,32504.0
13758,PDD00017273,Cc1cc(Cn2c(=O)n(Cc3cnc(C)s3)c(=O)c3cc(S(=O)(=O)NC4(C)CC4)ccc32)n(C)n1,C23H26N6O4S2,19511.0
13759,Cyclo(L-His-L-Pro),O=C1N[C@@H](Cc2cnc[nH]2)C(=O)N2CCC[C@@H]12,C11H14N4O2,31172.0
13760,"2-(Isopentylamino)naphthalene-1,4-dione",CC(C)CCNC1=CC(=O)c2ccccc2C1=O,C15H17NO2,31107.0
13761,Cilostazol-d4,[2H]C1([2H])CCCC([2H])([2H])C1n1nnnc1CCCCOc1ccc2c(c1)CCC(=O)N2,C20H27N5O2,31790.0
13762,EMD 638683,CCc1c(C(=O)NNC(=O)C(O)c2cc(F)cc(F)c2)ccc(O)c1C,C18H18F2N2O4,31117.0
13763,RC574,CC(C)(C)c1cc([Se]c2cccs2)cc(C(C)(C)C)c1O,C18H24OSSe,31408.0
13764,THZ2,CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1,C31H28ClN7O2,31055.0
13765,Mozavaptan-d6,[2H]C([2H])([2H])N(C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21)C([2H])([2H])[2H],C27H29N3O2,31321.0
13766,Mefenamic Acid-d4,[2H]c1c([2H])c([2H])c(C(=O)O)c(Nc2cccc(C)c2C)c1[2H],C15H15NO2,31788.0
13767,SU 14813,Cc1[nH]c(/C=C2/C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,C23H27FN4O4,31514.0
13768,D-Pyroglutamic Acid,O=C1CC[C@H](C(=O)O)N1,C5H7NO3,31170.0
13769,Chelidonic Acid,O=C(O)c1cc(=O)cc(C(=O)O)o1,C7H4O6,31324.0
13770,ASP7663,CC(C)CN1C(=O)/C(=C/C(=O)O)c2cccc(F)c21,C14H14FNO3,31122.0
13771,Tetrahydrocannabivarinic Acid (CRM),CCCc1cc2c(c(O)c1C(=O)O)[C@@H]1C=C(C)CC[C@H]1C(C)(C)O2,C20H26O4,21259.0
13772,THCVA-A (Alt. Batch CRM),CCCc1cc2c(c(O)c1C(=O)O)[C@@H]1C=C(C)CC[C@H]1C(C)(C)O2,C20H26O4,41811.0
13773,RF9,N=C(N)NCCC[C@H](NC(=O)C12CC3CC(CC(C3)C1)C2)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,C26H38N6O3,31412.0
13774,Nisoldipine-d6,[2H]C([2H])([2H])C(COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-])C([2H])([2H])[2H],C20H24N2O6,31785.0
13775,Safranal,CC1=C(C=O)C(C)(C)CC=C1,C10H14O,31399.0
13776,Indole-3-carboxylic Acid,O=C(O)c1c[nH]c2ccccc12,C9H7NO2,31166.0
13777,"5,6-trans-Vitamin D3",C=C1CC[C@H](O)C/C1=C\C=C1/CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,C27H44O,31225.0
13778,JNJ-53718678,CS(=O)(=O)CCCn1c(Cn2c(=O)n(CC(F)(F)F)c3ccncc32)cc2cc(Cl)ccc21,C21H20ClF3N4O3S,31720.0
13779,Anethol,CC=Cc1ccc(OC)cc1,C10H12O,31398.0
13780,Eutylone-d5 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])([2H])NC(CC)C(=O)c1ccc2c(c1)OCO2,C13H18ClNO3,31629.0
13781,Eutylone-d5 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])C([2H])([2H])NC(CC)C(=O)c1ccc2c(c1)OCO2,C13H18ClNO3,40623.0
13782,Denudatine,C=C1[C@H]2CC[C@]3([C@@H]([C@H]2O)[C@@]24CCC[C@@]5(C)CN(CC)[C@@H]2[C@@H]3C[C@H]54)[C@@H]1O,C22H33NO2,30904.0
13783,4-IPP,Ic1cc(-c2ccccc2)ncn1,C10H7IN2,31770.0
13784,Cipargamin,C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12,C19H14Cl2FN3O,30678.0
13785,Blinin,CC(=O)OC[C@@]12CC[C@@H](C)[C@](C)(CCC3=CC(=O)OC3)[C@H]1C[C@H](O)C=C2CO,C22H32O6,30945.0
13786,AL-LAD (solution),C=CCN1C[C@H](C(=O)N(CC)CC)C=C2c3cccc4[nH]cc(c34)C[C@H]21,C22H27N3O,30442.0
13787,Phenprocoumon,CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O,C18H16O3,31730.0
13788,Cetilistat,CCCCCCCCCCCCCCCCOc1nc2ccc(C)cc2c(=O)o1,C25H39NO3,31622.0
13789,(R)-4-Amino-3-hydroxybutyric Acid,NC[C@H](O)CC(=O)O,C4H9NO3,31532.0
13790,Arg-Gly-Asp (trifluoroacetate salt),N=C(N)NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O.O=C(O)C(F)(F)F,C14H23F3N6O8,31369.0
13791,2-(1-(Thiophen-2-yl)ethylidene)hydrazinecarbothioamide,C/C(=N\NC(N)=S)c1cccs1,C7H9N3S2,31385.0
13792,Theobromine-d6,[2H]C([2H])([2H])n1cnc2c1c(=O)[nH]c(=O)n2C([2H])([2H])[2H],C7H8N4O2,9003565.0
13793,Furosemide-d5,[2H]c1oc(C([2H])([2H])Nc2cc(Cl)c(S(N)(=O)=O)cc2C(=O)O)c([2H])c1[2H],C12H11ClN2O5S,31789.0
13794,Remdesivir methylpropyl ester analog,CC(C)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)Oc1ccccc1,C25H31N6O8P,9003571.0
13795,Theophylline-d6,[2H]C([2H])([2H])n1c(=O)c2nc[nH]c2n(C([2H])([2H])[2H])c1=O,C7H8N4O2,9003566.0
13796,2-(2-Chlorophenyl)-2-hydroxycyclohexanone,O=C1CCCCC1(O)c1ccccc1Cl,C12H13ClO2,9003366.0
13797,Ectoine,CC1=NCC[C@@H](C(=O)O)N1,C6H10N2O2,31167.0
13798,Despropionyl meta-Chlorofentanyl,Clc1cccc(NC2CCN(CCc3ccccc3)CC2)c1,C19H23ClN2,32506.0
13799,Dronedarone-d6 (hydrochloride),Cl.[2H]C([2H])(Oc1ccc(C(=O)c2c(CCCC)oc3ccc(NS(C)(=O)=O)cc23)cc1)C([2H])([2H])C([2H])([2H])N(CCCC)CCCC,C31H45ClN2O5S,31787.0
13800,Miconazole-d5,[2H]C([2H])(OC([2H])(c1ccc(Cl)cc1Cl)C([2H])([2H])n1ccnc1)c1ccc(Cl)cc1Cl,C18H14Cl4N2O,31175.0
13801,D-Pyroaspartic Acid,O=C1C[C@H](C(=O)O)N1,C4H5NO3,31696.0
13802,Imidazole Ketone Erastin,CC(C)Oc1ccc(C(=O)Cn2ccnc2)cc1-n1c(CN2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O,C35H35ClN6O5,27088.0
13803,Aminooxyacetic Acid (hydrochloride),Cl.NOCC(=O)O.NOCC(=O)O,C4H11ClN2O6,28298.0
13804,Xanthine,O=c1[nH]c(=O)c2[nH]cnc2[nH]1,C5H4N4O2,31499.0
13805,Sucralose,OC[C@H]1O[C@H](O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1Cl,C12H19Cl3O8,31621.0
13806,Adiphenine (hydrochloride),CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1.Cl,C20H26ClNO2,31124.0
13807,L-Lysine lactam (hydrochloride),Cl.N[C@H]1CCCCNC1=O,C6H13ClN2O,31685.0
13808,D-Pyrohomoglutamic Acid,O=C1CCC[C@H](C(=O)O)N1,C6H9NO3,31693.0
13809,BD-AcAc2,C[C@@H](O)CCOC(=O)C[C@@H](C)O,C8H16O4,9003598.0
13810,GalNAc,CC(=O)N[C@@H](C=O)[C@@H](O)[C@@H](O)[C@H](O)CO,C8H15NO6,31728.0
13811,Cortisone,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,C21H28O5,30763.0
13812,JNJ-0966,COc1ccccc1Nc1nc(-c2sc(NC(C)=O)nc2C)cs1,C16H16N4O2S2,31781.0
13813,Pantothenate Kinase Inhibitor,CSc1cccc(NC(=O)CCc2c(C)nc3c4cccnc4nn3c2C)c1,C21H21N5OS,31002.0
13814,1-Palmitoyl-2-Docosahexaenoyl-sn-glycero-3-PC,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C46H80NO8P,31982.0
13815,"N,N-DMT (fumarate)",CN(C)CCc1c[nH]c2ccccc12.O=C(O)/C=C/C(=O)O,C16H20N2O4,9003568.0
13816,Timosaponin BII,C[C@@H](CC[C@@]1(O)O[C@H]2C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2[C@@H]1C)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C45H76O19,30644.0
13817,Quercetin 3-O-?-L-arabinopyranoside,O=c1c(O[C@@H]2OC[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,C20H18O11,30707.0
13818,Ganglioside GT1b (bovine) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@]5(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O5)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]4(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[NH4+].[NH4+].[NH4+],C95H174N8O47,31712.0
13819,Lersivirine,CCc1nn(CCO)c(CC)c1Oc1cc(C#N)cc(C#N)c1,C17H18N4O2,29497.0
13820,Theaflavin-3-gallate,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(=O)c2c(O)c(O)cc([C@H]3Oc4cc(O)cc(O)c4C[C@H]3O)c2c1)c1cc(O)c(O)c(O)c1,C36H28O16,31510.0
13821,Aflatoxin G1-13C17,[13CH3]O[13c]1[13cH][13c]2[13c]([13c]3o[13c](=O)[13c]4[13c]([13c]13)[13CH2][13CH2]O[13C]4=O)[13C@@H]1[13CH]=[13CH]O[13C@@H]1O2,C17H12O7,31262.0
13822,Ganglioside GD1a (porcine) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@]5(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O5)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC,C84H146N4O39,31707.0
13823,Ganglioside GM1 (ovine) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[NH4+],C73H134N4O31,31549.0
13824,Ganglioside GM1 (bovine) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[NH4+],C73H134N4O31,31548.0
13825,C18 Ganglioside GM1 (d18:1/18:0) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[NH4+],C73H134N4O31,42980.0
13826,Ganglioside GM3 (bovine buttermilk) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCCCCCCC.[NH4+],C64H121N3O21,31711.0
13827,Indigo Carmine,O=C1/C(=C2/Nc3ccc(S(=O)(=O)[O-])cc3C2=O)Nc2ccc(S(=O)(=O)[O-])cc21.[Na+].[Na+],C16H8N2Na2O8S2,31525.0
13828,Zearalenone-13C18,[13CH3][13C@H]1[13CH2][13CH2][13CH2][13C](=O)[13CH2][13CH2][13CH2]/[13CH]=[13CH]/[13c]2[13cH][13c](O)[13cH][13c](O)[13c]2[13C](=O)O1,C18H22O5,31288.0
13829,Dodecyl Gallate,CCCCCCCCCCCCOC(=O)c1cc(O)c(O)c(O)c1,C19H30O5,31401.0
13830,IL-4 Inhibitor,N#Cc1c(-c2ccc(O)c(O)c2)cc(-c2ccc(F)cc2)nc1N,C18H12FN3O2,32548.0
13831,"1,3,7-Trimethyluric Acid-d9",[2H]C([2H])([2H])n1c(=O)c2c([nH]c(=O)n2C([2H])([2H])[2H])n(C([2H])([2H])[2H])c1=O,C8H10N4O3,9003567.0
13832,Paraxanthine-d6,[2H]C([2H])([2H])n1c(=O)[nH]c2ncn(C([2H])([2H])[2H])c2c1=O,C7H8N4O2,9003564.0
13833,Cinanserin (hydrochloride),CN(C)CCCSc1ccccc1NC(=O)/C=C/c1ccccc1.Cl,C20H25ClN2OS,30729.0
13834,Ochratoxin A-13C20,[13CH3][13C@@H]1[13CH2][13c]2[13c](Cl)[13cH][13c]([13C](=O)N[13C@@H]([13CH2][13c]3[13cH][13cH][13cH][13cH][13cH]3)[13C](=O)O)[13c](O)[13c]2[13C](=O)O1,C20H18ClNO6,31295.0
13835,13C15-Nivalenol,[13CH3][13C]1=[13CH][13C@H]2O[13C@@H]3[13C@H](O)[13C@@H](O)[13C@]([13CH3])([13C@@]2([13CH2]O)[13C@H](O)[13C]1=O)[13C@]31[13CH2]O1,C15H20O7,31259.0
13836,5-methoxy-DL-Tryptophan,COc1ccc2[nH]cc(CC(N)C(=O)O)c2c1,C12H14N2O3,31222.0
13837,N1-Methylguanosine,Cn1c(N)nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1=O,C11H15N5O5,31737.0
13838,N-ethyl Pentylone-d5 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])([2H])NC(CCC)C(=O)c1ccc2c(c1)OCO2,C14H20ClNO3,30506.0
13839,Delsoline,CCN1C[C@]2(COC)CC[C@H](O)C34C1C(O)([C@@H](OC)[C@@H]32)[C@@]1(O)C[C@H](OC)[C@H]2C[C@@H]4[C@@H]1C2OC,C25H41NO7,31748.0
13840,"9(Z),11(E)-Conjugated Linoleic Acid (sodium salt)",CCCCCC/C=C/C=C\CCCCCCCC(=O)[O-].[Na+],C18H31NaO2,31552.0
13841,Olopatadine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])N(C)CC/C=C1\c2ccccc2COc2ccc(CC(=O)O)cc21,C21H24ClNO3,31918.0
13842,Poncirin,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)cc3O2)cc1,C28H34O14,31706.0
13843,3-Acetyldeoxy Nivalenol-13C17,[13CH3][13C](=O)O[13C@@H]1[13CH2][13C@]2([13CH3])[13C@@]3([13CH2]O)[13C@H](O)[13C](=O)[13C]([13CH3])=[13CH][13C@H]3O[13C@H]1[13C@@]21[13CH2]O1,C17H22O7,31258.0
13844,5-chloro Tryptamine (hydrochloride),Cl.NCCc1c[nH]c2ccc(Cl)cc12,C10H12Cl2N2,32707.0
13845,Fumonisin B2-13C34,[13CH3][13CH2][13CH2][13CH2][13C@@H]([13CH3])[13C@@H](O[13C](=O)[13CH2][13C@@H]([13CH2][13C](=O)O)[13C](=O)O)[13C@H]([13CH2][13C@@H]([13CH3])[13CH2][13CH2][13CH2][13CH2][13CH2][13CH2][13C@@H](O)[13CH2][13C@H](O)[13C@H]([13CH3])N)O[13C](=O)[13CH2][13C@@H]([13CH2][13C](=O)O)[13C](=O)O,C34H59NO14,31273.0
13846,Aflatoxin M1-13C17,[13CH3]O[13c]1[13cH][13c]2[13c]([13c]3o[13c](=O)[13c]4[13c]([13c]13)[13CH2][13CH2][13C]4=O)[13C@]1(O)[13CH]=[13CH]O[13C@@H]1O2,C17H12O7,31264.0
13847,STING Agonist 1a,COc1ccc2nc(Cl)c(-c3nnc4c(Cl)nc5ccccc5n34)cc2c1,C19H11Cl2N5O,32520.0
13848,CUMYL-CH-MeGACLONE,CC(C)(c1ccccc1)n1ccc2c(c1=O)c1ccccc1n2CC1CCCCC1,C27H30N2O,26432.0
13849,Octacosanoic Acid,CCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O,C28H56O2,31735.0
13850,"1,3-Di-o-tolylguanidine",Cc1ccccc1NC(=N)Nc1ccccc1C,C15H17N3,31736.0
13851,Erythrosin B,O=C1OC2(c3ccccc31)c1cc(I)c([O-])c(I)c1Oc1c2cc(I)c([O-])c1I.[Na+].[Na+],C20H6I4Na2O5,31722.0
13852,Benzphetamine (hydrochloride),C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1.Cl,C17H22ClN,32583.0
13853,HT-2 Toxin-13C22,[13CH3][13C](=O)O[13CH2][13C@]12[13CH2][13C@H](O[13C](=O)[13CH2][13CH]([13CH3])[13CH3])[13C]([13CH3])=[13CH][13C@H]1O[13C@@H]1[13C@H](O)[13C@@H](O)[13C@@]2([13CH3])[13C@]12[13CH2]O2,C22H32O8,31299.0
13854,Nanaomycin A,C[C@@H]1O[C@@H](CC(=O)O)CC2=C1C(=O)c1c(O)cccc1C2=O,C16H14O6,9001479.0
13855,Nandrolone Acetate,CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C,C20H28O3,31713.0
13856,Alyssin,CS(=O)CCCCCN=C=S,C7H13NOS2,31513.0
13857,Ginsenoside F1,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@]12C,C36H62O9,31137.0
13858,"3,4-Dihydroquinolin-2(1H)-one",O=C1CCc2ccccc2N1,C9H9NO,31701.0
13859,Gomisin D,COc1cc2c(c(OC)c1OC)-c1c3cc4c(c1OC[C@@H](C)[C@@](C)(O)C(=O)O[C@@H]2[C@@](C)(O)[C@@H](C)C3)OCO4,C28H34O10,30697.0
13860,Morroniside,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2[C@H](C)O[C@@H](O)C[C@H]12,C17H26O11,30711.0
13861,L-Ornithine lactam (hydrochloride),Cl.N[C@H]1CCCNC1=O,C5H11ClN2O,31683.0
13862,Aflatoxin B1-13C17,[13CH3]O[13c]1[13cH][13c]2[13c]([13c]3o[13c](=O)[13c]4[13c]([13c]13)[13CH2][13CH2][13C]4=O)[13C@@H]1[13CH]=[13CH]O[13C@@H]1O2,C17H12O6,31260.0
13863,GS-704277,C[C@H](NP(=O)(O)OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)C(=O)O,C15H19N6O8P,9003569.0
13864,Remdesivir isopropyl ester analog,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)Oc1ccccc1,C24H29N6O8P,9003635.0
13865,STING Agonist 12b,COc1ccc2[nH]c3c(C)c(C)ccc3c(=O)c2c1,C16H15NO2,32521.0
13866,3BDO,O=C1OC(COc2ccccc2[N+](=O)[O-])CC1Cc1ccccc1,C18H17NO5,29441.0
13867,ML-230,O=C(c1ccoc1)N1CCN(c2cc(-c3ccco3)nc3cc(-c4ccccc4)nn23)CC1,C25H21N5O3,32552.0
13868,Zeaxanthin Dipalmitate,CCCCCCCCCCCCCCCC(=O)O[C@@H]1CC(C)=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C[C@@H](OC(=O)CCCCCCCCCCCCCCC)CC2(C)C)C(C)(C)C1,C72H116O4,31703.0
13869,L-Phenylalanine,N[C@@H](Cc1ccccc1)C(=O)O,C9H11NO2,31498.0
13870,Alofanib,Cc1cc([N+](=O)[O-])c(NS(=O)(=O)c2cccc(C(=O)O)c2)cc1-c1cccnc1,C19H15N3O6S,31754.0
13871,4-deoxy Nivalenol-13C15,[13CH3][13C]1=[13CH][13C@H]2O[13C@@H]3[13C@H](O)[13CH2][13C@]([13CH3])([13C@@]2([13CH2]O)[13C@H](O)[13C]1=O)[13C@]31[13CH2]O1,C15H20O6,31249.0
13872,Aflatoxin G2-13C17,[13CH3]O[13c]1[13cH][13c]2[13c]([13c]3o[13c](=O)[13c]4[13c]([13c]13)[13CH2][13CH2]O[13C]4=O)[13C@@H]1[13CH2][13CH2]O[13C@@H]1O2,C17H14O7,31263.0
13873,Sulforhodamine B (sodium salt) (technical grade),CCN(CC)c1ccc2c(-c3ccc(S(=O)(=O)[O-])cc3S(=O)(=O)[O-])c3ccc(N(CC)CC)cc3[o+]c2c1.[Na+],C27H29N2NaO7S2,31539.0
13874,G6PDi-1,N#Cc1cc(Nc2ncc3c(n2)CCCCC3=O)cs1,C14H12N4OS,31484.0
13875,Sulfaclozine (sodium salt),Nc1ccc(S(=O)(=O)[N-]c2cncc(Cl)n2)cc1.[Na+],C10H8ClN4NaO2S,31223.0
13876,XD14,CCc1c(C(=O)Nc2cc(S(=O)(=O)N(CC)CC)ccc2O)[nH]c(C)c1C(C)=O,C20H27N3O5S,30740.0
13877,Zolazepam,Cc1nn(C)c2c1C(c1ccccc1F)=NCC(=O)N2C,C15H15FN4O,21128.0
13878,"3-Amino-2,6-Piperidinedione",NC1CCC(=O)NC1=O,C5H8N2O2,31698.0
13879,Thionordiazepam,S=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1,C15H11ClN2S,21988.0
13880,Aflatoxin B2-13C17,[13CH3]O[13c]1[13cH][13c]2[13c]([13c]3o[13c](=O)[13c]4[13c]([13c]13)[13CH2][13CH2][13C]4=O)[13C@@H]1[13CH2][13CH2]O[13C@@H]1O2,C17H14O6,31261.0
13881,4-methyl-?-Isopropylaminovalerophenone (hydrochloride),CCCC(NC(C)C)C(=O)c1ccc(C)cc1.Cl,C15H24ClNO,31008.0
13882,K22,O=C(N/C(=C\c1ccccc1)C(=O)N1CCC(O)(c2ccc(Br)cc2)CC1)c1ccccc1,C27H25BrN2O3,31578.0
13883,DL-Tryptophan,NC(Cc1c[nH]c2ccccc12)C(=O)O,C11H12N2O2,31210.0
13884,Valemetostat,Cc1cc(C)c(CNC(=O)c2cc(Cl)c3c(c2C)O[C@@](C)([C@H]2CC[C@H](N(C)C)CC2)O3)c(=O)[nH]1,C26H34ClN3O4,31674.0
13885,Chebulinic Acid,O=C(O)C[C@@H]1C(=O)O[C@H]2[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@@H](OC(=O)c3cc(O)c(O)c4c3[C@H]1[C@@H](O)C(=O)O4)[C@H](OC(=O)c1cc(O)c(O)c(O)c1)O[C@@H]2COC(=O)c1cc(O)c(O)c(O)c1,C41H32O27,32554.0
13886,Testosterone Hemisuccinate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2OC(=O)CCC(=O)O,C23H32O5,31716.0
13887,Dihydro K22,O=C(NC(Cc1ccccc1)C(=O)N1CCC(O)(c2ccc(Br)cc2)CC1)c1ccccc1,C27H27BrN2O3,31382.0
13888,ENPP1-IN-1,COc1ccc2c(-c3ccc(CNS(N)(=O)=O)cc3)ccnc2c1,C17H17N3O3S,31764.0
13889,Desethyl Hydroxychloroquine-d4,[2H]C([2H])(O)C([2H])([2H])NCCCC(C)Nc1ccnc2cc(Cl)ccc12,C16H22ClN3O,31162.0
13890,4-Nitrophenyl Palmitate,CCCCCCCCCCCCCCCC(=O)Oc1ccc([N+](=O)[O-])cc1,C22H35NO4,30870.0
13891,NVP-AAM077,CC(NC(c1cccc2[nH]c(=O)c(=O)[nH]c12)P(=O)(O)O)c1ccc(Br)cc1,C17H17BrN3O5P,30622.0
13892,Myristoyl Glycine,CCCCCCCCCCCCCC(=O)NCC(=O)O,C16H31NO3,30107.0
13893,Cy5-SE (triethylamine salt),CCN(CC)CC.CC[N+]1=C(/C=C/C=C/C=C2/N(CCCCCC(=O)ON3C(=O)CCC3=O)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(C)c2cc(S(=O)(=O)[O-])ccc21,C43H58N4O10S2,30387.0
13894,SSAA09E1,C/C(=N/NC(N)=S)c1cccs1,C7H9N3S2,32582.0
13895,Rilmenidine-d4,[2H]C1([2H])N=C(NC(C2CC2)C2CC2)OC1([2H])[2H],C10H16N2O,31691.0
13896,Vapendavir,CCOc1noc2cc(OCCC3CCN(c4ccc(C)nn4)CC3)ccc12,C21H26N4O3,30546.0
13897,Despropionyl para-Chlorofentanyl (hydrochloride),Cl.Clc1ccc(NC2CCN(CCc3ccccc3)CC2)cc1,C19H24Cl2N2,32514.0
13898,(R)-Aspartimide,N[C@@H]1CC(=O)NC1=O,C4H6N2O2,31699.0
13899,"N,N'-bis(2,3-Dihydroxybenzoyl)-O-L-seryl-L-dehydroalanine",C=C(NC(=O)c1cccc(O)c1O)C(=O)OC[C@H](NC(=O)c1cccc(O)c1O)C(=O)O,C20H18N2O10,31779.0
13900,"N,N'-bis(2,3-Dihydroxybenzoyl)-O-L-seryl-L-serine",O=C(N[C@@H](COC(=O)[C@H](CO)NC(=O)c1cccc(O)c1O)C(=O)O)c1cccc(O)c1O,C20H20N2O11,31778.0
13901,L-Cystine,N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O,C6H12N2O4S2,31727.0
13902,Spiro-Oxanthromicin A,Cc1ccc2c(c1O)C(=O)c1c(cc(O)c(C(=O)O)c1C)C21CC=C2c3cc(O)c(C(=O)O)c(C)c3C(=O)c3c(O)c(C)cc1c32,C36H26O10,32555.0
13903,2S-Eriodictyol,O=C1C[C@@H](c2ccc(O)c(O)c2)Oc2cc(O)cc(O)c21,C15H12O6,26803.0
13904,SR 12460,O=C(CNCCc1cc(F)cc(F)c1)Nc1ccc(Cl)cn1,C15H14ClF2N3O,31066.0
13905,4-methyl-N-Propylcathinone (hydrochloride),CCCNC(C)C(=O)c1ccc(C)cc1.Cl,C13H20ClNO,31529.0
13906,D-2-Aminoglutarimide (hydrochloride),Cl.N[C@@H]1CCC(=O)NC1=O,C5H9ClN2O2,31697.0
13907,D-Glucuronic Acid,O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(=O)O,C6H10O7,31531.0
13908,Succinobucol,CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(OC(=O)CCC(=O)O)c(C(C)(C)C)c1,C35H52O5S2,30886.0
13909,SR 12343,O=C(CNc1ccc(Cl)cn1)NCCc1cccc(Br)c1,C15H15BrClN3O,31031.0
13910,D-Glutamic Acid,N[C@H](CCC(=O)O)C(=O)O,C5H9NO4,31503.0
13911,Indole-3-pyruvic Acid,O=C(O)C(=O)Cc1c[nH]c2ccccc12,C11H9NO3,29876.0
13912,Bendamustine-d4 (hydrochloride),Cl.[2H]C([2H])(Cl)C([2H])([2H])N(CCCl)c1ccc2c(c1)nc(CCCC(=O)O)n2C,C16H22Cl3N3O2,31316.0
13913,PD-1-IN-17,C[C@@H](O)[C@H](N)c1nnc([C@H](CCC(N)=O)NC(=O)N[C@@H](CO)C(=O)O)o1,C13H22N6O7,32797.0
13914,CAY10773,O=C(Nc1cccc(CNc2ncnc3ccccc23)c1)Nc1ccc(Cl)c(Cl)c1,C22H17Cl2N5O,31806.0
13915,Camostat-d6 (hydrochloride),Cl.[2H]C([2H])([2H])N(C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1)C([2H])([2H])[2H],C20H23ClN4O5,30984.0
13916,1-Palmitoyl-2-13(S)-HpODE-sn-glycero-3-PC,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C=C\[C@H](CCCCC)OO,C42H80NO10P,31976.0
13917,Beauveriolide I,CCCC[C@H](C)[C@@H]1CC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@H](CC(C)C)C(=O)O1,C27H41N3O5,31774.0
13918,Amicoumacin B,CC(C)C[C@H](NC(=O)[C@@H](O)[C@@H](O)[C@@H](N)CC(=O)O)[C@@H]1Cc2cccc(O)c2C(=O)O1,C20H28N2O8,31777.0
13919,Benzyl-2-acetamido-2-deoxy-?-D-galactopyranoside,CC(=O)N[C@H]1[C@@H](OCc2ccccc2)O[C@H](CO)[C@H](O)[C@@H]1O,C15H21NO6,31747.0
13920,LY393558,CC(C)N1Cc2cc(S(C)(=O)=O)ccc2N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)S1(=O)=O,C26H31FN4O4S2,32775.0
13921,Nandrolone Propionate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C,C21H30O3,31715.0
13922,WB 4101 (hydrochloride),COc1cccc(OC)c1OCCNCC1COc2ccccc2O1.Cl,C19H24ClNO5,29528.0
13923,CAY10763,COc1cc(NC(=O)[C@@H](Cc2ccccc2)NC2=C/C(=N\O)c3ccccc3C2=O)cc(OC)c1,C27H25N3O5,30593.0
13924,GR159897,COC1(C[S@@](=O)c2ccccc2)CCN(CCc2c[nH]c3ccc(F)cc23)CC1,C23H27FN2O2S,32774.0
13925,5-fluoro AMT (hydrochloride),CC(N)Cc1c[nH]c2ccc(F)cc12.Cl,C11H14ClFN2,32728.0
13926,CUMYL-CB-MeGACLONE,CC(C)(c1ccccc1)n1ccc2c(c1=O)c1ccccc1n2CC1CCC1,C25H26N2O,31427.0
13927,E3330,CCCCCCCCC/C(=C\C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(=O)O,C21H30O6,32830.0
13928,Prochlorperazine-d8 (hydrochloride),Cl.Cl.[2H]C1([2H])N(C)C([2H])([2H])C([2H])([2H])N(CCCN2c3ccccc3Sc3ccc(Cl)cc32)C1([2H])[2H],C20H26Cl3N3S,31916.0
13929,CGP 60474,OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1,C18H18ClN5O,29631.0
13930,Umifenovir-d6 (hydrochloride),Cl.[2H]C([2H])([2H])N(Cc1c(O)c(Br)cc2c1c(C(=O)OCC)c(CSc1ccccc1)n2C)C([2H])([2H])[2H],C22H26BrClN2O3S,31494.0
13931,Beauvericin A,CC[C@H](C)[C@H]1OC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H](C(C)C)OC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H](C(C)C)OC(=O)[C@H](Cc2ccccc2)N(C)C1=O,C46H59N3O9,31773.0
13932,Butonitazene,CCCCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1,C24H32N4O3,30278.0
13933,Butonitazene (exempt preparation),CCCCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1,C24H32N4O3,38653.0
13934,Gemfibrozil-d6,[2H]C([2H])([2H])C(CCCOc1cc(C)ccc1C)(C(=O)O)C([2H])([2H])[2H],C15H22O3,31915.0
13935,CGS 9343B,CC1(CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)OCc2ccccc2-n2cccc21.O=C(O)/C=C\C(=O)O,C30H32N4O6,32844.0
13936,CAY10777,O=C(N/N=C/c1c[nH]c2ccccc12)c1nc2ccccc2s1,C17H12N4OS,32712.0
13937,Nicotinic Acid Mononucleotide,O=C([O-])c1ccc[n+]([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c1,C11H14NO9P,32883.0
13938,"(6R,S)-5,10-Methenyl-5,6,7,8-tetrahydrofolic Acid",Nc1nc(=O)c2c([nH]1)NC[C@@H]1C[N+](c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)[O-])cc3)=CN21,C20H21N7O6,31333.0
13939,ARN24139,O=C(Nc1cccc(OC(F)(F)F)c1)C1C(=O)N(c2ccccc2)C(=S)N(c2ccccc2)C1=O,C24H16F3N3O4S,31062.0
13940,BIIB068,Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1,C23H29N7O2,31619.0
13941,Clorprenaline (hydrochloride),CC(C)NCC(O)c1ccccc1Cl.Cl,C11H17Cl2NO,30360.0
13942,SB-216641 (hydrochloride),COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1OCCN(C)C.Cl,C28H31ClN4O4,32837.0
13943,MLN0905,Cc1ncc(CCCN(C)C)cc1Nc1ncc2c(n1)-c1ccc(C(F)(F)F)cc1NC(=S)C2,C24H25F3N6S,31115.0
13944,PDE4B Inhibitor,O=C(c1cc2cccnc2n1-c1ccc(Cl)c(Cl)c1)N1CC(F)(F)C1,C17H11Cl2F2N3O,32732.0
13945,PRGL493,CC(=O)NC1=Nc2nc3ccccc3n2C(c2cn(-c3ccccc3)nc2-c2ccc(C)o2)N1,C25H21N7O2,32748.0
13946,NSC 625987,COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12,C15H13NO2S,32843.0
13947,N-Isopropylbenzylamine (hydrochloride),CC(C)NCc1ccccc1.Cl,C10H16ClN,26305.0
13948,CCT031374 (hydrobromide),Br.O=C(CN1C2=NCCN2c2ccccc21)c1ccc(-c2ccccc2)cc1,C23H20BrN3O,32866.0
13949,Cy3-SE,CC[N+]1=C(/C=C/C=C2/N(CCCCCC(=O)ON3C(=O)CCC3=O)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(C)c2cc(S(=O)(=O)[O-])ccc21,C35H41N3O10S2,30393.0
13950,HTI 286,CN[C@H](C(=O)N[C@H](C(=O)N(C)[C@H](/C=C(\C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1,C27H43N3O4,32852.0
13951,11-Dehydrocorticosterone,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO,C21H28O4,32907.0
13952,AFUB7AICA 7'-azaindole isomer,O=C(NC12CC3CC(CC(C3)C1)C2)c1cnc2n(Cc3ccc(F)cc3)cccc1-2,C25H26FN3O,32989.0
13953,10-deacetyl-7-xylosyl Paclitaxel,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C,C50H57NO17,32955.0
13954,SB-332235,NS(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O,C13H10Cl3N3O4S,32869.0
13955,Tiagabine-d6 (hydrochloride),Cl.[2H]C([2H])([2H])c1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C([2H])([2H])[2H],C20H26ClNO2S2,30766.0
13956,SEP-0372814,Cc1ncc(C)n2nc([C@@H]3C[C@H]3c3nc4c5cccnc5ccn4c3C)nc12,C21H19N7,32836.0
13957,BX-430,CC(C)c1cc(Br)c(NC(=O)Nc2cccnc2)c(Br)c1,C15H15Br2N3O,32868.0
13958,Gavestinel (sodium salt),O=C(/C=C/c1c(C(=O)[O-])[nH]c2cc(Cl)cc(Cl)c12)Nc1ccccc1.[Na+],C18H11Cl2N2NaO3,32845.0
13959,UPF-648,O=C(O)[C@H]1C[C@@H]1C(=O)c1ccc(Cl)c(Cl)c1,C11H8Cl2O3,32860.0
13960,Muramyl Dipeptide,CC(=O)N[C@@H](C=O)[C@@H](O[C@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(=O)O)C(N)=O)[C@H](O)[C@H](O)CO,C19H32N4O11,30866.0
13961,Thioflavin T,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C.[Cl-],C17H19ClN2S,32553.0
13962,GGTI 2418,Cc1nc[nH]c1CN1CCN(C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](Cc2ccccc2)C1=O,C23H31N5O4,28714.0
13963,Micheliolide,C=C1C(=O)O[C@H]2[C@H]1CCC(C)=C1CC[C@@](C)(O)[C@@H]12,C15H20O3,25402.0
13964,Alclofenac,C=CCOc1ccc(CC(=O)O)cc1Cl,C11H11ClO3,29877.0
13965,R1487 (hydrochloride),Cl.Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21,C19H19ClF2N4O3,31478.0
13966,CU-T12-9,CNc1ccc([N+](=O)[O-])cc1-n1cnc(-c2ccc(C(F)(F)F)cc2)c1,C17H13F3N4O2,32867.0
13967,C3001a,Cc1ccc2nc(-c3ccc(NC(=O)[C@@H]4CC[C@H](C(=O)O)C4)cc3)sc2c1,C21H20N2O3S,31064.0
13968,"7,12-Dimethylbenz[a]anthracene",Cc1c2ccccc2c(C)c2c1ccc1ccccc12,C20H16,30383.0
13969,2-Nonylquinolin-4(1H)-one,CCCCCCCCCc1cc(=O)c2ccccc2[nH]1,C18H25NO,9003627.0
13970,ADTL-EI1712,NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2,C22H18Cl2N4O2S2,30602.0
13971,2-methyl DMT,Cc1[nH]c2ccccc2c1CCN(C)C,C13H18N2,29347.0
13972,EP4 Receptor Antagonist 1,C/C=C/c1nnn(Cc2ccc(C(F)(F)F)cc2)c1C(=O)N[C@@H](C)c1ccc(C(=O)O)cc1,C23H21F3N4O3,32722.0
13973,A-784168,O=C(Nc1ccc(S(=O)(=O)C(F)(F)F)cc1)C1=CCN(c2ncccc2C(F)(F)F)CC1,C19H15F6N3O3S,32855.0
13974,DMP 543,O=C1c2ccccc2C(Cc2ccnc(F)c2)(Cc2ccnc(F)c2)c2ccccc21,C26H18F2N2O,32849.0
13975,S 14506,COc1ccc2cccc(N3CCN(CCNC(=O)c4ccc(F)cc4)CC3)c2c1,C24H26FN3O2,32838.0
13976,AFUB7AICA,O=C(NC12CC3CC(CC(C3)C1)C2)c1cn(Cc2ccc(F)cc2)c2ncccc12,C25H26FN3O,31185.0
13977,A-770041,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C,C34H39N9O3,32854.0
13978,TGR-1202,CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F,C31H24F3N5O3,32877.0
13979,N-desethyl Etonitazene,CCNCCn1c(Cc2ccc(OCC)cc2)nc2cc([N+](=O)[O-])ccc21,C20H24N4O3,32512.0
13980,VU0152100,COc1ccc(CNC(=O)c2sc3nc(C)cc(C)c3c2N)cc1,C18H19N3O2S,32968.0
13981,?-methoxy 2C-B (hydrochloride),COc1cc(C(CN)OC)c(OC)cc1Br.Cl,C11H17BrClNO3,22055.0
13982,Acetoxyvalerenic Acid,CC(=O)O[C@@H]1CC(C)=C2[C@H]1[C@H](C)CC[C@H]2/C=C(\C)C(=O)O,C17H24O4,31516.0
13983,Tenapanor (hydrochloride),CN1Cc2c(Cl)cc(Cl)cc2[C@H](c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)c2)C1.Cl.Cl,C50H68Cl6N8O10S2,32875.0
13984,Iodophenpropit (hydrobromide),Br.Br.N=C(NCCc1ccc(I)cc1)SCCCc1cnc[nH]1,C15H21Br2IN4S,32850.0
13985,7-dechloro Griseofulvin,COC1=CC(=O)C[C@@H](C)[C@]12Oc1cc(OC)cc(OC)c1C2=O,C17H18O6,33116.0
13986,Tasimelteon-d5,[2H]C([2H])([2H])C([2H])([2H])C(=O)NC[C@@H]1C[C@H]1c1cccc2c1CCO2,C15H19NO2,31771.0
13987,ortho-Chlorofentanyl (hydrochloride),CCC(=O)N(c1ccccc1Cl)C1CCN(CCc2ccccc2)CC1.Cl,C22H28Cl2N2O,31040.0
13988,"3,4-Methylenedioxy-?-Pyrrolidinoisohexanophenone (hydrochloride)",CC(C)CC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1.Cl,C17H24ClNO3,32543.0
13989,Emeramide,O=C(NCCS)c1cccc(C(=O)NCCS)c1,C12H16N2O2S2,32889.0
13990,"CP 100,356 (hydrochloride)",COc1ccc(CCNc2nc(N3CCc4cc(OC)c(OC)cc4C3)c3cc(OC)c(OC)cc3n2)cc1OC.Cl,C31H37ClN4O6,32853.0
13991,Daunorubicinone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O,C21H18O8,32912.0
13992,Bisubstrate Inhibitor 78,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC[C@H](N)C(=O)O)Cc2ccc3ccccc3c2)[C@@H](O)[C@H]1O,C25H29N7O5,28567.0
13993,cis-ABCD,N[C@]1(C(=O)O)C[C@H](C(=O)O)C1,C6H9NO4,32966.0
13994,Fmoc-Cys(Trt)-OH,O=C(N[C@@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21,C37H31NO4S,32828.0
13995,Forchlorfenuron,O=C(Nc1ccccc1)Nc1ccnc(Cl)c1,C12H10ClN3O,32948.0
13996,Avatrombopag,O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1,C29H34Cl2N6O3S2,26535.0
13997,SB-399885 (hydrochloride),COc1ccc(S(=O)(=O)Nc2cc(Cl)cc(Cl)c2OC)cc1N1CCNCC1.Cl,C18H22Cl3N3O4S,32817.0
13998,Cy7,CC[N+]1=C(/C=C/C=C/C=C/C=C2\N(CCCCCC(=O)O)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(C)c2cc(S(=O)(=O)[O-])ccc21,C35H42N2O8S2,30395.0
13999,4-HQN,O=c1nc[nH]c2ccccc12,C8H6N2O,32821.0
14000,para-fluoro Methylaminorex,CC1N=C(N)OC1c1ccc(F)cc1,C10H11FN2O,26049.0
14001,Salicylic Acid,O=C(O)c1ccccc1O,C7H6O3,32991.0
14002,Tedizolid,Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](CO)OC4=O)cc3F)cn2)n1,C17H15FN6O3,32952.0
14003,1-Hydroxyanthraquinone,O=C1c2ccccc2C(=O)c2c(O)cccc21,C14H8O3,32905.0
14004,CGP 42112,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cccnc1)C(=O)O,C52H69N13O11,32874.0
14005,HUHS015,Cc1ccc2nc(-n3nc(C)c(Cc4ccccc4)c3O)[nH]c2c1,C19H18N4O,32915.0
14006,Procyclidine (hydrochloride),Cl.OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1,C19H30ClNO,33141.0
14007,GC376 (sodium salt),CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC1CCNC1=O)C(O)S(=O)(=O)[O-].[Na+],C21H30N3NaO8S,31469.0
14008,(-)-dehydro Griseofulvin,COC1=CC(=O)C=C(C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O,C17H15ClO6,33117.0
14009,"CP 316,819",CON(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2cc(Cl)ccc2[nH]1,C21H22ClN3O4,32856.0
14010,N-glycolyl-Ganglioside GM3 (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(=O)CO)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCCCCCCC.[NH4+],C64H121N3O22,33263.0
14011,IR 780,CCCN1/C(=C\C=C2/CCCC(/C=C/C3=[N+](CCC)c4ccccc4C3(C)C)=C2Cl)C(C)(C)c2ccccc21.[I-],C36H44ClIN2,31632.0
14012,Quetiapine-d8 (fumarate),O=C(O)/C=C/C(=O)O.[2H]C1([2H])N(CCOCCO)C([2H])([2H])C([2H])([2H])N(C2=Nc3ccccc3Sc3ccccc32)C1([2H])[2H],C25H29N3O6S,32946.0
14013,K-7174 (hydrochloride),COc1cc(/C=C/CCCN2CCCN(CCC/C=C/c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC.Cl.Cl,C33H50Cl2N2O6,32773.0
14014,2-Methylhexacosane,CCCCCCCCCCCCCCCCCCCCCCCCC(C)C,C27H56,9003585.0
14015,Olutasidenib,C[C@H](Nc1ccc(C#N)n(C)c1=O)c1cc2cc(Cl)ccc2[nH]c1=O,C18H15ClN4O2,30370.0
14016,Succinylcholine (chloride hydrate),C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.O.O.[Cl-].[Cl-],C14H34Cl2N2O6,32829.0
14017,5-methoxy MET,CCN(C)CCc1c[nH]c2ccc(OC)cc12,C14H20N2O,29349.0
14018,HM30181,COc1cc2c(cc1OC)CN(CCc1ccc(-n3nnc(-c4cc(OC)c(OC)cc4NC(=O)c4cc(=O)c5ccccc5o4)n3)cc1)CC2,C38H36N6O7,32873.0
14019,Cy2-SE,CC[n+]1c(/C=C/C=C2\Oc3ccccc3N2CCCCCC(=O)ON2C(=O)CCC2=O)oc2ccccc21.[I-],C29H30IN3O6,30394.0
14020,Sesamol,Oc1ccc2c(c1)OCO2,C7H6O3,32903.0
14021,2-deoxy-2-fluoro-D-Glucose,O=C[C@H](F)[C@@H](O)[C@H](O)[C@H](O)CO,C6H11FO5,33187.0
14022,BIX,N#CSCC(=O)c1ccc(O)c(O)c1,C9H7NO3S,32969.0
14023,"5,6-Dihydrouridine",O=C1CCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1,C9H14N2O6,32523.0
14024,Cannflavin A,COc1cc(-c2cc(=O)c3c(O)c(C/C=C(\C)CCC=C(C)C)c(O)cc3o2)ccc1O,C26H28O6,21970.0
14025,"9(S)-?6a,10a-THC (CRM)",CCCCCc1cc(O)c2c(c1)OC(C)(C)C1=C2C[C@@H](C)CC1,C21H30O2,33014.0
14026,"9(S)-?6a,10a-THC (Alt. Batch CRM)",CCCCCc1cc(O)c2c(c1)OC(C)(C)C1=C2C[C@@H](C)CC1,C21H30O2,42141.0
14027,ZM 449829,C=CC(=O)c1ccc2ccccc2c1,C13H10O,32820.0
14028,MLi-2,C[C@@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1,C21H25N5O2,19305.0
14029,"9(R)-?6a,10a-THC (CRM)",CCCCCc1cc(O)c2c(c1)OC(C)(C)C1=C2C[C@H](C)CC1,C21H30O2,33013.0
14030,LEI-401,O=C(NCC1CC1)c1cc(N2CC[C@H](O)C2)nc(N2CCC[C@@H](c3ccccc3)C2)n1,C24H31N5O2,31108.0
14031,Drostanolone Propionate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)[C@H](C)C[C@]4(C)[C@H]3CC[C@]12C,C23H36O3,32777.0
14032,SB-611812,CN(C)CCOc1cc(NS(=O)(=O)c2c(Cl)cc(C(F)(F)F)cc2Cl)ccc1Cl,C17H16Cl3F3N2O3S,33247.0
14033,Tauroursodeoxycholic Acid-d4 (sodium salt),[2H]C1([2H])C[C@@]2(C)[C@H](C[C@H](O)[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)[O-])CC[C@@H]32)C([2H])([2H])[C@@H]1O.[Na+],C26H44NNaO6S,32985.0
14034,Sitafloxacin,N[C@@H]1CN(c2c(F)cc3c(=O)c(C(=O)O)cn([C@@H]4C[C@@H]4F)c3c2Cl)CC12CC2,C19H18ClF2N3O3,32949.0
14035,BX-320,CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br,C23H31BrN8O3,31229.0
14036,Methimazole-d3,[2H]C([2H])([2H])n1cc[nH]c1=S,C4H6N2S,33278.0
14037,Sipatrigine,CN1CCN(c2ncc(-c3cc(Cl)cc(Cl)c3Cl)c(N)n2)CC1,C15H16Cl3N5,32963.0
14038,Dihydrofolic Acid,Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)=N2,C19H21N7O6,32750.0
14039,Phenytoin-d10,[2H]c1c([2H])c([2H])c(C2(c3c([2H])c([2H])c([2H])c([2H])c3[2H])NC(=O)NC2=O)c([2H])c1[2H],C15H12N2O2,33245.0
14040,MPC-6827 (hydrochloride),COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1.Cl,C17H18ClN3O,32872.0
14041,Lornoxicam-d4,[2H]c1nc(NC(=O)C2=C(O)c3sc(Cl)cc3S(=O)(=O)N2C)c([2H])c([2H])c1[2H],C13H10ClN3O4S2,33275.0
14042,Omadacycline,CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,C29H40N4O7,24932.0
14043,Maprotiline-d3 (hydrochloride),Cl.[2H]C([2H])([2H])NCCCC12CCC(c3ccccc31)c1ccccc12,C20H24ClN,33301.0
14044,Propafenone-d5 (hydrochloride),Cl.[2H]C([2H])(NCCC)C([2H])(O)C([2H])([2H])Oc1ccccc1C(=O)CCc1ccccc1,C21H28ClNO3,33293.0
14045,Perphenazine-d4,[2H]c1cc([2H])c2c(c1)Sc1cc([2H])c(Cl)c([2H])c1N2CCCN1CCN(CCO)CC1,C21H26ClN3OS,33298.0
14046,IC87201,Oc1c(Cl)cc(Cl)cc1CNc1ccc2nn[nH]c2c1,C13H10Cl2N4O,32973.0
14047,"6,2',4'-Trimethoxyflavone",COc1ccc(-c2cc(=O)c3cc(OC)ccc3o2)c(OC)c1,C18H16O5,33150.0
14048,MLN120B,COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C,C19H15ClN4O2,32819.0
14049,(-)-Physostigmine (salicylate),CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C.O=C(O)c1ccccc1O,C22H27N3O5,33106.0
14050,Cy7-SE,CC[N+]1=C(/C=C/C=C/C=C/C=C2/N(CCCCCC(=O)ON3C(=O)CCC3=O)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(C)c2cc(S(=O)(=O)[O-])ccc21,C39H45N3O10S2,30753.0
14051,GW 791343,Cc1ccc(CN2CCNCC2)cc1NC(=O)CNc1ccc(F)c(F)c1.Cl.Cl,C20H26Cl2F2N4O,32882.0
14052,7-Xylosyltaxol,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,C52H59NO18,32956.0
14053,Allylthiourea,C=CCNC(N)=S,C4H8N2S,30282.0
14054,UK 356618,Cc1cc(CCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)N[C@H](C)c2ccccc2)C(C)(C)C)ccc1-c1ccccc1,C34H43N3O4,32859.0
14055,(S)-WAY-100135 (hydrochloride),COc1ccccc1N1CCN(C[C@@H](C(=O)NC(C)(C)C)c2ccccc2)CC1.Cl.Cl,C24H35Cl2N3O2,32851.0
14056,4-(Trifluoromethyl) U-47700 (hydrochloride),CN(C)[C@@H]1CCCC[C@H]1N(C)C(=O)c1ccc(C(F)(F)F)cc1.Cl,C17H24ClF3N2O,26273.0
14057,"4-Androsten-11?-ol-3,17-dione",C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)C(=O)CC[C@@H]12,C19H26O3,30410.0
14058,Taurodeoxycholic Acid-d4 (sodium salt),[2H]C1([2H])C[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2C[C@H](O)[C@]2(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)[O-])CC[C@@H]32)C([2H])([2H])[C@@H]1O.[Na+],C26H44NNaO6S,32983.0
14059,HSGN-218,O=C(Nc1nnc(-c2cc(Cl)cc(Cl)c2)o1)c1ccc(SC(F)(F)F)cc1,C16H8Cl2F3N3O2S,32711.0
14060,IR 783,CC1(C)C(/C=C/C2=C(Cl)/C(=C/C=C3\N(CCCCS(=O)(=O)[O-])c4ccccc4C3(C)C)CCC2)=[N+](CCCCS(=O)(=O)[O-])c2ccccc21.[Na+],C38H46ClN2NaO6S2,31633.0
14061,MDK34597,Nc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,C19H17N5O2,33137.0
14062,TAK-981,Cc1sc(C(=O)c2cncnc2N[C@@H]2C[C@H](COS(N)(=O)=O)[C@@H](O)C2)cc1[C@@H]1NCCc2ccc(Cl)cc21,C25H28ClN5O5S2,32741.0
14063,SR 717 (lithium salt),O=C(Nc1cc(F)c(F)cc1C(=O)[O-])c1ccc(-n2ccnc2)nn1.[Li+],C15H8F2LiN5O3,31759.0
14064,33290,[2H][13C]([2H])([2H])n1nnc(-c2ccc(-c3ccc(N4C[C@H](CO)OC4=O)cc3F)cn2)n1,C17H15FN6O3,33290.0
14065,iBET-BD2,CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1,C23H27FN2O4,31766.0
14066,TFM,O=[N+]([O-])c1ccc(O)cc1C(F)(F)F,C7H4F3NO3,32870.0
14067,RO5166017,CCN(C[C@H]1COC(N)=N1)c1ccccc1,C12H17N3O,32972.0
14068,Flutolanil,CC(C)Oc1cccc(NC(=O)c2ccccc2C(F)(F)F)c1,C17H16F3NO2,33146.0
14069,AES-350,CC(C)(C)c1ccc(C(=O)Nc2ccc(C(=O)NO)cc2)cc1,C18H20N2O3,30607.0
14070,L-Azetidine-2-carboxylic Acid,O=C(O)[C@@H]1CCN1,C4H7NO2,33189.0
14071,CDDO-Im,CC1(C)CC[C@]2(C(=O)n3ccnc3)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,C34H43N3O3,31763.0
14072,Isopregnanolone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C21H34O2,32708.0
14073,Influenza Hemagglutinin Peptide (trifluoroacetate salt),CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O.O=C(O)C(F)(F)F,C55H68F3N9O19,33160.0
14074,Tucatinib,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,C26H24N8O2,31411.0
14075,Lanraplenib,Nc1cncc(-c2cn3ccnc3c(Nc3ccc(N4CCN(C5COC5)CC4)cc3)n2)n1,C23H25N9O,32518.0
14076,Pexacerfont,CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12,C18H24N6O,33221.0
14077,RU-521,Cc1nn(-c2nc3ccc(Cl)c(Cl)c3[nH]2)c(O)c1C1OC(=O)c2ccccc21,C19H12Cl2N4O3,31765.0
14078,Halicin,Nc1nnc(Sc2ncc([N+](=O)[O-])s2)s1,C5H3N5O2S3,30436.0
14079,AZD 3514,CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1,C25H32F3N7O2,33222.0
14080,Mesembrine,COc1ccc([C@@]23CCC(=O)C[C@@H]2N(C)CC3)cc1OC,C17H23NO3,21100.0
14081,S1RA (hydrochloride),Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1.Cl,C20H24ClN3O2,32729.0
14082,ADB-4en-PINACA,C=CCCCn1nc(C(=O)NC(C(N)=O)C(C)(C)C)c2ccccc21,C19H26N4O2,33205.0
14083,CAY10747,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)OCCCOC(=O)/C=C(\C#N)c4ccc(F)cc4)CC[C@]3(C)CC[C@]12C,C42H48FNO6,29915.0
14084,Carbazochrome,CN1CC(O)C2=CC(=NNC(N)=O)C(=O)C=C21,C10H12N4O3,32951.0
14085,Isoindigo,O=C1Nc2ccccc2C1=C1C(=O)Nc2ccccc21,C16H10N2O2,33208.0
14086,Erianin,COc1ccc(CCc2cc(OC)c(OC)c(OC)c2)cc1O,C18H22O5,32516.0
14087,11?-hydroxy Etiocholanolone,C[C@]12CC[C@@H](O)C[C@H]1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)C(=O)CC[C@@H]12,C19H30O3,33190.0
14088,Panaxadiol,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)O1,C30H52O3,33233.0
14089,GSK3987,COc1ccc(NC2=C(c3ccccc3)C(=O)N(Cc3ccccc3)C2=O)cc1,C24H20N2O3,30954.0
14090,Levodropropizine,OC[C@@H](O)CN1CCN(c2ccccc2)CC1,C13H20N2O2,32954.0
14091,5-chloro DMT (hydrochloride),CN(C)CCc1c[nH]c2ccc(Cl)cc12.Cl,C12H16Cl2N2,31044.0
14092,SGC-GAK-1,COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC,C18H17BrN2O3,33229.0
14093,FMK,Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1,C18H19FN4O2,9000887.0
14094,Nifuroxazide-d4,[2H]c1c([2H])c(C(=O)NN=Cc2ccc([N+](=O)[O-])o2)c([2H])c([2H])c1O,C12H9N3O5,33382.0
14095,Rizatriptan-d6 (benzoate salt),O=C(O)c1ccccc1.[2H]C([2H])([2H])N(CCc1c[nH]c2ccc(Cn3cncn3)cc12)C([2H])([2H])[2H],C22H25N5O2,33369.0
14096,Afoxolaner,O=C(CNC(=O)c1ccc(C2=NOC(c3cc(Cl)cc(C(F)(F)F)c3)(C(F)(F)F)C2)c2ccccc12)NCC(F)(F)F,C26H17ClF9N3O3,33317.0
14097,SBP-7455,COc1ccc(Nc2ncc(C(F)(F)F)c(NC3CC3)n2)cc1OC,C16H17F3N4O2,32988.0
14098,Guaifenesin-d3,[2H]C([2H])([2H])Oc1ccccc1OCC(O)CO,C10H14O4,33368.0
14099,JWH 184,CCCCCn1cc(Cc2ccc(C)c3ccccc23)c2ccccc21,C25H27N,32794.0
14100,"1,4-?-D-Xylopentaose",O=C[C@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H](O[C@@H]2OC[C@@H](O[C@@H]3OC[C@@H](O[C@@H]4OC[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,C25H42O21,33202.0
14101,Metaxalone-d6,[2H]C([2H])([2H])c1cc(OCC2CNC(=O)O2)cc(C([2H])([2H])[2H])c1,C12H15NO3,33377.0
14102,(+)-Secoisolariciresinol,COc1cc(C[C@H](CO)[C@@H](CO)Cc2ccc(O)c(OC)c2)ccc1O,C20H26O6,33155.0
14103,Luteolin 7-O-Glucuronide,O=C(O)[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(-c4ccc(O)c(O)c4)oc3c2)[C@H](O)[C@@H](O)[C@@H]1O,C21H18O12,33188.0
14104,PF-06928215,O=C(N[C@H]1CCCC[C@H]1C(=O)O)c1cnn2c(O)cc(-c3ccccc3)nc12,C20H20N4O4,32515.0
14105,"NG,NG-dimethyl-L-Arginine-d6 (hydrochloride)",Cl.Cl.[2H]C([2H])([2H])N(C(=N)NCCC[C@H](N)C(=O)O)C([2H])([2H])[2H],C8H20Cl2N4O2,33266.0
14106,A-867744,CCC(=O)c1cc(-c2ccc(Cl)cc2)n(-c2ccc(S(N)(=O)=O)cc2)c1C,C20H19ClN2O3S,32974.0
14107,Pirlindole-d4 (hydrochloride),Cl.[2H]C1([2H])NC2CCCc3c2n(c2ccc(C)cc32)C1([2H])[2H],C15H19ClN2,33375.0
14108,D-Amphetamine (hemisulfate),C[C@H](N)Cc1ccccc1.C[C@H](N)Cc1ccccc1.O=S(=O)(O)O,C18H28N2O4S,26204.0
14109,Nifenalol (hydrochloride),CC(C)NCC(O)c1ccc([N+](=O)[O-])cc1.Cl,C11H17ClN2O3,32944.0
14110,MK-2461,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,C24H25N5O5S,32964.0
14111,Tetrahydroxyquinone,O=C1C(O)=C(O)C(=O)C(O)=C1O,C6H4O6,32908.0
14112,DL-Malic Acid,O=C(O)CC(O)C(=O)O,C4H6O5,33310.0
14113,Quinapril-d5,[2H]c1c([2H])c([2H])c(CC[C@H](N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)O)C(=O)OCC)c([2H])c1[2H],C25H30N2O5,30735.0
14114,IRAK Inhibitor 6,COc1cc(N2CCOCC2)ccc1NC(=O)c1csc(-c2cccnc2)n1,C20H20N4O3S,33267.0
14115,CAY10771,CC(C)c1onc(-c2c(Cl)cccc2Cl)c1COc1ccc(CNc2ccc(CC(=O)O)cc2)c(Cl)c1,C28H25Cl3N2O4,31758.0
14116,CPYPP,O=C1NN(c2ccccc2)C(=O)/C1=C\C=C\c1ccccc1Cl,C18H13ClN2O2,17386.0
14117,NCB-0846,O[C@H]1CC[C@@H](Oc2cccc3cnc(Nc4ccc5nc[nH]c5c4)nc23)CC1,C21H21N5O2,33268.0
14118,Tetrahydroberberine,COc1ccc2c(c1OC)CN1CCc3cc4c(cc3C1C2)OCO4,C20H21NO4,33157.0
14119,Hexarelin,Cc1[nH]c2ccccc2c1C[C@@H](NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O,C47H58N12O6,30716.0
14120,Taurolithocholic Acid-d4 (sodium salt),[2H]C1([2H])C[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)[O-])CC[C@@H]32)C([2H])([2H])[C@@H]1O.[Na+],C26H44NNaO5S,32984.0
14121,Norethindrone-d6,[2H]C1=C2C([2H])([2H])C[C@@H]3[C@H](CC[C@@]4(C)[C@H]3CC[C@@]4(O)C#C)[C@@]2([2H])CC([2H])([2H])C1=O,C20H26O2,33277.0
14122,Hydroxycitric Acid (technical grade),O=C(O)CC(O)(C(=O)O)C(O)C(=O)O,C6H8O8,33191.0
14123,Benzoylmesaconine,COC[C@]12CN(C)C3C4[C@H](OC)[C@H]1C3([C@@H](OC)C[C@H]2O)[C@@H]1C[C@]2(O)C(OC(=O)c3ccccc3)[C@@H]1[C@]4(O)[C@@H](O)[C@@H]2OC,C31H43NO10,33238.0
14124,?-Cortol,C[C@]12CC[C@@H](O)C[C@H]1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)[C@H](O)CO,C21H36O5,33412.0
14125,17?-Hydroxyprogesterone,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,C21H30O3,33154.0
14126,Etilefrine (hydrochloride),CCNCC(O)c1cccc(O)c1.Cl,C10H16ClNO2,33249.0
14127,Diflucortolone 21-valerate,CCCCC(=O)OCC(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C27H36F2O5,33203.0
14128,"(6aR,9R)-?10-THC (CRM)",CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@@H](C)C=C21,C21H30O2,33011.0
14129,"(6aR,9R)-?10-THC (Alt. Batch CRM)",CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@@H](C)C=C21,C21H30O2,41814.0
14130,"7(S),10(S)-DiHOME",CCCCCCCCC(O)/C=C/C(O)CCCCCC(=O)O,C18H34O4,33447.0
14131,TNO155,C[C@@H]1OCC2(CCN(c3cnc(Sc4ccnc(N)c4Cl)c(N)n3)CC2)[C@@H]1N,C18H24ClN7OS,32525.0
14132,RU-24969 (succinate),COc1ccc2[nH]cc(C3=CCNCC3)c2c1.COc1ccc2[nH]cc(C3=CCNCC3)c2c1.O=C(O)CCC(=O)O,C32H38N4O6,33142.0
14133,Clitorin,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C33H40O19,33211.0
14134,Migrastatin,CO[C@H]1/C=C/CC/C=C/C(=O)O[C@H]([C@H](C)C(=O)CCCC2CC(=O)NC(=O)C2)/C(C)=C\[C@@H](C)[C@@H]1O,C27H39NO7,32885.0
14135,Bottromycin A2,COC(=O)C[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N/C1=N\CC(=O)N2CC[C@@H](C)[C@H]2C(=O)N[C@@H](C(C)C)C(=O)N[C@H]1C(C)(C)C)C(C)(C)C)[C@@H](C)c1ccccc1)c1nccs1,C42H62N8O7S,32921.0
14136,Acesulfame (potassium salt),CC1=CC(=O)[N-]S(=O)(=O)O1.[K+],C4H4KNO4S,33356.0
14137,INNO-8875,O=[N+]([O-])OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O,C15H20N6O6,33345.0
14138,TW9,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(C(=O)Nc3ccccc3N)cc1)c1nnc(C)n1-2,C32H28ClN7O2S,31588.0
14139,Gosogliptin,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1,C17H24F2N6O,33220.0
14140,2'-O-Methylcytidine,CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O,C10H15N3O5,33411.0
14141,Nifenazone,Cc1c(NC(=O)c2cccnc2)c(=O)n(-c2ccccc2)n1C,C17H16N4O2,33330.0
14142,D-(+)-Xylose,O=C[C@H](O)[C@@H](O)[C@H](O)CO,C5H10O5,33236.0
14143,NS 5806,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1c(Br)cc(Br)cc1-c1nnn[nH]1,C16H8Br2F6N6O,33226.0
14144,Ancymidol,COc1ccc(C(O)(c2cncnc2)C2CC2)cc1,C15H16N2O2,33311.0
14145,Aselacin C,CCCCCC=CC=CC(=O)CCCCCCCC(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H]1C(=O)NCCC(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](CO)C(=O)NCC(=O)O[C@@H]1C,C46H66N8O11,33163.0
14146,Aquastatin A,CCCCCCCCCCCCCCCc1cc(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)cc(O)c1C(=O)Oc1cc(C)c(C(=O)O)c(O)c1,C36H52O12,33253.0
14147,Cyproconazole,CC(C1CC1)C(O)(Cn1cncn1)c1ccc(Cl)cc1,C15H18ClN3O,32947.0
14148,Agonodepside B,C/C=C(\C)c1cc(O)c(C)c(O)c1C(=O)Oc1cc(/C(C)=C/C)c(C(=O)O)c(O)c1C,C24H26O7,32930.0
14149,Linearmycin A,C/C(=C\C=C\C=C\C=C\CC/C=C/C(C)[C@H](O)[C@@H](C)[C@H](O)/C=C/C=C/C=C/C=C/C=C/CC(O)C(C)C(=O)CC(O)C[C@H](O)C[C@H](O)/C=C/C[C@@H](O)C[C@H](O)C[C@@H](O)C[C@H](O)/C=C/CC(O)/C=C/C[C@H](O)C[C@H](O)CCCN)C(=O)O,C64H101NO16,33132.0
14150,Sparsentan,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)c(COCC)c1,C32H40N4O5S,33429.0
14151,20-Deoxyingenol,CC1=C[C@H]2C(=O)[C@]3(C=C(C)[C@H](O)[C@@]3(O)[C@@H]1O)[C@H](C)C[C@@H]1[C@H]2C1(C)C,C20H28O4,33225.0
14152,THCA-A,CCCCCc1cc2c(c(O)c1C(=O)O)[C@@H]1C=C(C)CC[C@H]1C(C)(C)O2,C22H30O4,33448.0
14153,THCA-A (Alt. Batch CRM),CCCCCc1cc2c(c(O)c1C(=O)O)[C@@H]1C=C(C)CC[C@H]1C(C)(C)O2,C22H30O4,41194.0
14154,Hortein,O=C1CCC(=O)c2c1c(O)c(O)c1c2-c2ccc(O)c3c(O)ccc-1c23,C20H12O6,33250.0
14155,Conglobatin C1,C/C1=C\CC[C@H](C)[C@H](Cc2cnco2)OC(=O)/C(C)=C/CC[C@H](C)[C@H](Cc2cnco2)OC1=O,C26H34N2O6,33256.0
14156,"7,12-Diketolithocholic Acid",C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC(=O)[C@]12C,C24H36O5,33416.0
14157,9-demethyl FR-901235,CC(=O)CC1(O)C(=O)c2c(O)cc(C)c3c(O)cc(O)c(c23)C1=O,C17H14O7,33135.0
14158,19-O-Acetylchaetoglobosin A,CC(=O)O[C@H]1C(=O)/C=C/C(=O)[C@@]23C(=O)N[C@@H](Cc4c[nH]c5ccccc45)[C@@H]2[C@H](C)[C@@]2(C)O[C@H]2[C@@H]3/C=C/C[C@H](C)/C=C/1C,C34H38N2O6,33164.0
14159,Aureonitol,C=C/C=C/[C@@H]1OC[C@H](/C=C/C=C/C)[C@H]1O,C13H18O2,32925.0
14160,Brorphine-d7,[2H]c1c([2H])c(C(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)C([2H])([2H])[2H])c([2H])c([2H])c1Br,C20H22BrN3O,31566.0
14161,Brorphine-d7 (exempt preparation),[2H]c1c([2H])c(C(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)C([2H])([2H])[2H])c([2H])c([2H])c1Br,C20H22BrN3O,38145.0
14162,Probetaenone I,CC[C@@H](C)[C@H]1C(C)=C[C@H]2C[C@@H](C)C[C@@H](C)[C@@H]2[C@@]1(C)C(=O)CCO,C21H36O2,33252.0
14163,Azilsartan-d5,[2H]C([2H])([2H])C([2H])([2H])Oc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,C25H20N4O5,33276.0
14164,Beclomethasone,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,C22H29ClO5,33196.0
14165,G150,Nc1ccc(-c2cc(Cl)c(Cl)c3[nH]c4c(c23)CN(C(=O)CO)CC4)cn1,C18H16Cl2N4O2,28318.0
14166,Isoguvacine (hydrochloride),Cl.O=C(O)C1=CCNCC1,C6H10ClNO2,33143.0
14167,NSC 19005,CN(CCc1ccccn1)CCc1ccccn1,C15H19N3,32898.0
14168,Pseudoprotodioscin,CC1=C(CC[C@@H](C)CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@H]2C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@@H]12,C51H82O21,33215.0
14169,Carbetocin (acetate),CC(=O)O.CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,C45H69N11O12S(C2H4O2)X,33234.0
14170,(+)-Sorokinianin,C=C1[C@H]([C@@H]2C[C@@H](O)C(=O)O2)[C@H]2[C@@H](C(C)C)CC[C@]1(C)[C@H]2CO,C18H28O4,33254.0
14171,"NG,NG-dimethyl-L-Arginine",CN(C)C(=N)NCCC[C@H](N)C(=O)O,C8H18N4O2,33576.0
14172,?-Rhodomycinone,CC[C@@]1(O)C[C@H](O)c2c(O)c3c(c(O)c2[C@H]1C(=O)OC)C(=O)c1cccc(O)c1C3=O,C22H20O9,32920.0
14173,Burnettramic Acid A,C[C@H](CCCCCCC/C=C/C[C@H](O)CCC[C@H](O)CCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C[C@H](C)/C(O)=C1\C(=O)[C@@H]2C[C@@H](O)CN2C1=O,C41H71NO12,33021.0
14174,Varioxepine A,CC(C)C1=C2N=C3OC=CC=C[C@@]34OC[C@H]3O[C@@]4(OC3(C)C)N2[C@@H](Cc2ccccc2)C(=O)N1,C26H29N3O5,32934.0
14175,Burnettramic Acid A aglycone,C[C@H](CCCCCCC/C=C/C[C@H](O)CCC[C@H](O)CCCCCCCO)C[C@H](C)/C(O)=C1\C(=O)[C@@H]2C[C@@H](O)CN2C1=O,C35H61NO7,33022.0
14176,Octopinic Acid,CC(NC(CCCN)C(=O)O)C(=O)O,C8H16N2O4,33093.0
14177,Actiphenol,Cc1cc(C)c(O)c(C(=O)CC2CC(=O)NC(=O)C2)c1,C15H17NO4,33119.0
14178,"WIN 66,306",CC(C)=CCc1cc([C@@H](O)[C@@H]2NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)CNC2=O)ccc1O,C41H52N8O9,33161.0
14179,Alternapyrone,CCC(C)/C=C(\C)CCCC(C)/C=C(C)/C=C(\C)CC(C)c1oc(=O)c(C)c(O)c1C,C28H44O3,33251.0
14180,Carbazomycin C,COc1ccc2[nH]c3c(C)c(C)c(OC)c(O)c3c2c1,C16H17NO3,33090.0
14181,Carbazomycin B,COc1c(C)c(C)c2[nH]c3ccccc3c2c1O,C15H15NO2,33089.0
14182,Monascuspiloin,C/C=C/C1=CC2=C(CO1)C(=O)[C@]1(C)OC(=O)[C@H](C(O)CCCCC)[C@H]1C2,C21H28O5,33098.0
14183,Callosobruchusic Acid,C/C(=C\C(=O)O)CCC[C@@H](C)C(=O)O,C10H16O4,32927.0
14184,Nafcillin-d5 (sodium salt),[2H]C([2H])([2H])C([2H])([2H])Oc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)[O-].[Na+],C21H21N2NaO5S,33468.0
14185,Neosartoricin,CC(=O)O[C@@H]1C(=O)c2c(c(CC=C(C)C)c3cc(O)cc(O)c3c2O)C[C@@]1(O)CC(=O)/C=C(/C)O,C26H28O9,33103.0
14186,Penicolinate B,COC(=O)c1ccc(CCCCCCCCCCc2ccc(C(=O)O)nc2)cn1,C23H30N2O4,32935.0
14187,Trypacidin,COC(=O)C1=CC(=O)C=C(OC)C12Oc1cc(C)cc(OC)c1C2=O,C18H16O7,33079.0
14188,Norfunalenone,Cc1cc(O)c2c3c(c(O)cc(O)c13)C(=O)C(O)=C2O,C14H10O6,32977.0
14189,Betulonaldehyde,C=C(C)[C@@H]1CC[C@]2(C=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C30H46O2,33042.0
14190,Kuwanon C,CC(C)=CCc1c(-c2ccc(O)cc2O)oc2c(CC=C(C)C)c(O)cc(O)c2c1=O,C25H26O6,33421.0
14191,N-(2-Azidoethyl)betulonamide,C=C(C)[C@@H]1CC[C@]2(C(=O)NCCN=[N+]=[N-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C32H50N4O2,33061.0
14192,Griseofulvic Acid,COc1cc(OC)c2c(c1Cl)O[C@@]1(C(=O)CC(=O)C[C@H]1C)C2=O,C16H15ClO6,33086.0
14193,"Betulin 3,28-diacetate",C=C(C)[C@@H]1CC[C@]2(COC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C34H54O4,33028.0
14194,Arcaine (sulfate),N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O,C6H18N6O4S,33284.0
14195,"2,3-Indolobetulin",C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)Cc6c([nH]c7ccccc67)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C36H51NO,33062.0
14196,Curvulinic Acid,CC(=O)c1c(O)cc(O)cc1CC(=O)O,C10H10O5,33094.0
14197,"2,3-Indolobetulinic glycine amide",C=C(C)[C@@H]1CC[C@]2(C(=O)NCC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)Cc6c([nH]c7ccccc67)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C38H52N2O3,33064.0
14198,BSH-IN-1,C[C@H](CCC(=O)CF)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C25H41FO3,30311.0
14199,3-Acetylbetulinaldehyde,C=C(C)[C@@H]1CC[C@]2(C=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C32H50O3,33051.0
14200,HY-17542,CC(=O)Nc1ccc(C)c(C(=O)N[C@H](C)c2cccc3ccccc23)c1,C22H22N2O2,33354.0
14201,Fluorescein 5(6)-isothiocyanate,O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2cc(N=C=S)ccc21.O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccc(N=C=S)cc21,C42H22N2O10S2,33264.0
14202,Chlorhexidine-d8 (hydrochloride),Cl.Cl.[2H]c1c([2H])c(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2c([2H])c([2H])c(Cl)c([2H])c2[2H])c([2H])c([2H])c1Cl,C22H32Cl4N10,33463.0
14203,NR-160,O=C(NO)c1ccc(CN(Cc2nnnn2Cc2ccccc2)C(=O)c2ccccc2C(F)(F)F)cc1,C25H21F3N6O3,31792.0
14204,Betulinic Aldehyde oxime,C=C(C)[C@@H]1CC[C@]2(C=NO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C30H49NO2,33027.0
14205,Sunset Yellow FCF,O=S(=O)([O-])c1ccc(N=Nc2c(O)ccc3cc(S(=O)(=O)[O-])ccc23)cc1.[Na+].[Na+],C16H10N2Na2O7S2,33257.0
14206,3-Oxobetulin Acetate,C=C(C)[C@@H]1CC[C@]2(COC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C32H50O3,33067.0
14207,20(S)-Protopanaxadiol,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,C30H52O3,33201.0
14208,Asperosaponin VI,CC1(C)CC[C@]2(C(=O)O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,C47H76O18,33206.0
14209,(E/Z)-Droloxifene,CCC(=C(c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1,C26H29NO2,33406.0
14210,1-Heptadecanoyl-2-hydroxy-sn-glycero-3-PC,CCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C25H52NO7P,33331.0
14211,Enoxacin-d8 (hydrochloride),Cl.[2H]C1([2H])NC([2H])([2H])C([2H])([2H])N(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3CC)C1([2H])[2H],C15H18ClFN4O3,33544.0
14212,C24 (2'(R)-hydroxy) Ceramide (d18:1/24:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)[C@H](O)CCCCCCCCCCCCCCCCCCCCCC,C42H83NO4,22527.0
14213,28-Aminobetulin,C=C(C)[C@@H]1CC[C@]2(CN)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C30H51NO,33050.0
14214,Flutamide-d7,[2H]C([2H])([2H])C([2H])(C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1)C([2H])([2H])[2H],C11H11F3N2O3,33541.0
14215,Methapyrilene (hydrochloride),CN(C)CCN(Cc1cccs1)c1ccccn1.Cl,C14H20ClN3S,33434.0
14216,Hexanoic Acid methyl ester,CCCCCC(=O)OC,C7H14O2,33675.0
14217,Sarpogrelate-d3 (hydrochloride),Cl.[2H]C([2H])([2H])Oc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O)c1,C24H32ClNO6,33472.0
14218,C24 (2'(S)-hydroxy) Ceramide (d18:1/24:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)[C@@H](O)CCCCCCCCCCCCCCCCCCCCCC,C42H83NO4,22526.0
14219,LY3381916,C[C@@H](NC(=O)c1ccc(F)cc1)c1ccc2c(c1)CCN2C(=O)C1CCOCC1,C23H25FN2O3,33178.0
14220,IMP-1710,C#Cc1cnc2[nH]cc(-c3cccc4c3CCN4C(=O)[C@@H]3CCCN3C#N)c2c1,C23H19N5O,31391.0
14221,Carbamazepine-d10,[2H]C1=C([2H])c2c([2H])c([2H])c([2H])c([2H])c2N(C(N)=O)c2c([2H])c([2H])c([2H])c([2H])c21,C15H12N2O,33486.0
14222,"28-acetyl-2,3-Indolobetulin",C=C(C)[C@@H]1CC[C@]2(COC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)Cc6c([nH]c7ccccc67)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C38H53NO2,33063.0
14223,Edicotinib,CC1(C)CC=C(c2nc(C3CC(C)(C)OC(C)(C)C3)ccc2NC(=O)c2ncc(C#N)[nH]2)CC1,C27H35N5O2,33347.0
14224,CBDH,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCCC)cc1O,C22H32O2,33351.0
14225,CBDH (CRM),C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCCC)cc1O,C22H32O2,34185.0
14226,Ibiglustat,CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)c1csc(-c2ccc(F)cc2)n1,C20H24FN3O2S,32878.0
14227,Tegoprazan,Cc1nc2cc(C(=O)N(C)C)cc(O[C@H]3CCOc4cc(F)cc(F)c43)c2[nH]1,C20H19F2N3O3,33243.0
14228,PACMA 31,C#CC(=O)N(c1ccc(OC)cc1OC)C(C(=O)NCC(=O)OCC)c1cccs1,C21H22N2O6S,32812.0
14229,Pemigatinib,CCN1C(=O)N(c2c(F)c(OC)cc(OC)c2F)Cc2c[nH]c3nc(CN4CCOCC4)cc-3c21,C24H27F2N5O4,33260.0
14230,Heptanoic Acid methyl ester,CCCCCCC(=O)OC,C8H16O2,33673.0
14231,5-fluoro CUMYL-PeGACLONE N-pentanoic acid metabolite,CC(C)(c1ccccc1)n1ccc2c(c1=O)c1ccccc1n2CCCCC(=O)O,C25H26N2O3,31284.0
14232,Isosorbide,O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2O,C6H10O4,33197.0
14233,3-Oxobetulin,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C30H48O2,33066.0
14234,GRL-0617,Cc1ccc(N)cc1C(=O)N[C@H](C)c1cccc2ccccc12,C20H20N2O,33348.0
14235,Betulin ditosylate,C=C(C)[C@@H]1CC[C@]2(COS(=O)(=O)c3ccc(C)cc3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OS(=O)(=O)c6ccc(C)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C44H62O6S2,33029.0
14236,"2,3-Indolobetulonic Acid",C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)Cc6c([nH]c7ccccc67)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C36H49NO2,33065.0
14237,"Phosphatidylinositol (plant, wheat germ) (sodium salt)",CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC.[Na+],C45H78NaO13P,33671.0
14238,Avobenzone-13C-d3,[2H][13C]([2H])([2H])Oc1ccc(C(=O)CC(=O)c2ccc(C(C)(C)C)cc2)cc1,C20H22O3,33367.0
14239,Cysteamine-d4 (hydrochloride),Cl.[2H]C([2H])(N)C([2H])([2H])S,C2H8ClNS,33297.0
14240,Nitrofurantoin-13C3,O=[13C]1[13CH2]N(/N=C/c2ccc([N+](=O)[O-])o2)[13C](=O)N1,C8H6N4O5,33296.0
14241,5-fluoro CUMYL-PeGACLONE N-(5-hydroxypentyl) metabolite,CC(C)(c1ccccc1)n1ccc2c(c1=O)c1ccccc1n2CCCCCO,C25H28N2O2,31283.0
14242,N-desmethyl Olanzapine,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCNCC1,C16H18N4S,33422.0
14243,Acremine F,CC(C)(O)/C=C/C1=C[C@H](O)[C@](C)(O)C[C@@H]1O,C12H20O4,33228.0
14244,Sphingosine (d16:1),CCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO,C16H33NO2,22356.0
14245,(+)-Anominine,C=C1CC[C@@]2(C)[C@H](C)CC[C@H](O)[C@@]2(CCC=C(C)C)[C@@H]1Cc1c[nH]c2ccccc12,C28H39NO,32923.0
14246,Talaromycesone A,CO[C@@]12c3c(C)cc(O)c4c(=O)oc(O)c(c34)C[C@@H]1[C@]13COC(=O)c4c(O)cc(C)c(c41)C(=O)[C@H]2[C@@H]3OC(C)=O,C29H24O11,32932.0
14247,Elsinochrome A,COc1c2c3c4c(c(OC)c(=O)c5c(O)cc(OC)c(c6c(OC)cc(O)c(c1=O)c63)c54)[C@H](C(C)=O)[C@H]2C(C)=O,C30H24O10,33072.0
14248,PCI 45227,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)C(O)CO)C1,C25H26N6O4,33560.0
14249,Savolitinib,C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21,C17H15N9,33332.0
14250,4-cyano MMB-BUTINACA,COC(=O)[C@@H](NC(=O)c1nn(CCCCC#N)c2ccccc12)C(C)C,C19H24N4O3,33334.0
14251,10(S)-HOME,CCCCCCCC[C@H](O)/C=C/CCCCCCC(=O)O,C18H34O3,33246.0
14252,Toloxatone,Cc1cccc(N2CC(CO)OC2=O)c1,C11H13NO3,33413.0
14253,Heptanoic Acid,CCCCCCC(=O)O,C7H14O2,33672.0
14254,?9-THCH,CCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C22H32O2,33352.0
14255,?9-THCH (CRM),CCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C22H32O2,34186.0
14256,Tryptamine-d4 (hydrochloride),Cl.[2H]C([2H])(N)C([2H])([2H])c1c[nH]c2ccccc12,C10H13ClN2,33538.0
14257,BAY-2402234,CCn1c(CO)nn(-c2cc(O[C@@H](C)C(F)(F)F)c(C(=O)Nc3c(F)cccc3Cl)cc2F)c1=O,C21H18ClF5N4O4,33259.0
14258,"CP 424,174",CC(C)c1cc(Cl)cc(C(C)C)c1NC(=O)NS(=O)(=O)c1cccc(C(C)(C)O)c1,C22H29ClN2O4S,29675.0
14259,CAY10774,O=C(O)[C@@H]1CCCCN1Cc1ccc(OCc2cccc(-c3ccccc3)c2Br)c(Br)c1,C26H25Br2NO3,32569.0
14260,Brimonidine,Brc1c(NC2=NCCN2)ccc2nccnc12,C11H10BrN5,33231.0
14261,Asiaticoside B,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)C[C@H]4C4=CC[C@@H]6[C@@]7(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]7[C@H](O)C[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,C48H78O20,33427.0
14262,Nylidrin,CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1,C19H25NO2,33232.0
14263,Ofloxacin-d8 (hydrochloride),Cl.[2H]C1([2H])N(C)C([2H])([2H])C([2H])([2H])N(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2OCC4C)C1([2H])[2H],C18H21ClFN3O4,33466.0
14264,"2,4,5-Trimethoxyamphetamine (hydrochloride)",COc1cc(OC)c(OC)cc1CC(C)N.Cl,C12H20ClNO3,33715.0
14265,APHS,CCCCC#CCSc1ccccc1OC(C)=O,C15H18O2S,70330.0
14266,ONO-7475,COc1cc2nccc(Oc3ccc(NC(=O)c4cc5c(n(-c6ccccc6)c4=O)CCCC5=O)nc3)c2cc1OC,C32H26N4O6,33258.0
14267,Chlormethiazole (hydrochloride),Cc1ncsc1CCCl.Cl,C6H9Cl2NS,33437.0
14268,(-)-Sweroside,C=C[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C2C(=O)OCC[C@H]21,C16H22O9,33454.0
14269,Albendazole-d7,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])Sc1ccc2[nH]c(NC(=O)OC)nc2c1,C12H15N3O2S,33542.0
14270,Tubermycin B,O=C(O)c1cccc2nc3ccccc3nc12,C13H8N2O2,33659.0
14271,Octahydrocurcumin,COc1cc(CCC(O)CC(O)CCc2ccc(O)c(OC)c2)ccc1O,C21H28O6,33686.0
14272,Chenodeoxycholic Acid 24-Acyl-?-D-Glucuronide,C[C@H](CCC(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C30H48O10,33227.0
14273,Sulfadiazine-d4,[2H]c1c([2H])c(S(=O)(=O)Nc2ncccn2)c([2H])c([2H])c1N,C10H10N4O2S,33605.0
14274,CY-09,O=C(O)c1ccc(C=C2SC(=S)N(Cc3cccc(C(F)(F)F)c3)C2=O)cc1,C19H12F3NO3S2,33353.0
14275,Carbazomycin D,COc1ccc2[nH]c3c(C)c(C)c(OC)c(OC)c3c2c1,C17H19NO3,33091.0
14276,Oxprenolol-d7,[2H]C([2H])([2H])C([2H])(NCC(O)COc1ccccc1OCC=C)C([2H])([2H])[2H],C15H23NO3,33274.0
14277,6-O-Demethyl Griseofulvin,COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(O)cc(OC)c1C2=O,C16H15ClO6,33118.0
14278,28-Deoxybetulin methyleneamine,C=C(C)[C@@H]1CC[C@]2(CCN)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C31H53NO,33060.0
14279,28-Acetylbetulin,C=C(C)[C@@H]1CC[C@]2(COC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C32H52O3,33052.0
14280,Betulonic Acid methyl ester,C=C(C)[C@@H]1CC[C@]2(C(=O)OC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C31H48O3,33054.0
14281,Aromadendrin,O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)cc2)[C@H]1O,C15H12O6,33402.0
14282,"5-bromo-N,N-DMT",CN(C)CCc1c[nH]c2ccc(Br)cc12,C12H15BrN2,31043.0
14283,Rebamipide-d4,[2H]c1c([2H])c(C(=O)NC(Cc2cc(=O)[nH]c3ccccc23)C(=O)O)c([2H])c([2H])c1Cl,C19H15ClN2O4,33543.0
14284,Acebilustat,O=C(O)c1ccc(CN2C[C@@H]3C[C@H]2CN3Cc2ccc(Oc3ccc(-c4ncco4)cc3)cc2)cc1,C29H27N3O4,33270.0
14285,RS 17053 (hydrochloride),CC(C)(Cc1c[nH]c2ccc(Cl)cc12)NCCOc1ccccc1OCC1CC1.Cl,C24H30Cl2N2O2,33548.0
14286,MF438,Cc1nnc(-c2ccc(N3CCC(Oc4ccccc4C(F)(F)F)CC3)nn2)s1,C19H18F3N5OS,33349.0
14287,7-Chlorokynurenic Acid,O=C(O)c1cc(O)c2ccc(Cl)cc2n1,C10H6ClNO3,33408.0
14288,Rebaudioside B,C=C1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)O)[C@@H]2CC[C@]1(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C3,C38H60O18,33199.0
14289,?-Pyrrolidinohexanophenone metabolite (hydrochloride),CCCCC(C(O)c1ccccc1)N1CCCC1.Cl,C16H26ClNO,31346.0
14290,C18 D-threo Ceramide (d18:1/18:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](CO)NC(=O)CCCCCCCCCCCCCCCCC,C36H71NO3,33676.0
14291,ITH15004,O=C(Cn1cnc2c(Cl)ncnc21)c1ccc(Cl)cc1Cl,C13H7Cl3N4O,33667.0
14292,Thimerosal,C[C][Hg]Sc1ccccc1C(=O)[O-].[Na+],C9H7HgNaO2S,33432.0
14293,Branebrutinib,CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1,C20H23FN4O2,33462.0
14294,MTP 131 (acetate),CC(=O)O.Cc1cc(O)cc(C)c1C[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,C32H49N9O5(C2H4O2)X,33302.0
14295,Cefprozil-d4,[2H]c1c([2H])c([C@@H](N)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(/C=C/C)CS[C@H]23)c([2H])c([2H])c1O,C18H19N3O5S,33639.0
14296,Rufinamide-15N-d2,[2H]C([2H])(c1c(F)cccc1F)n1cc(C([15NH2])=O)nn1,C10H8F2N4O,33539.0
14297,N-propionyl Norfentanyl,CCC(=O)N1CCC(N(C(=O)CC)c2ccccc2)CC1,C17H24N2O2,33492.0
14298,Ethionamide-d3,[2H]C([2H])([2H])Cc1cc(C(N)=S)ccn1,C8H10N2S,33636.0
14299,Ginkgotoxin,COCc1c(CO)cnc(C)c1O,C9H13NO3,33460.0
14300,7-Methoxyflavone,COc1ccc2c(=O)cc(-c3ccccc3)oc2c1,C16H12O3,33497.0
14301,TAS 205,Cn1cccc1C(=O)N1CCN(C(=O)Nc2ccc(N3CCC(C(=O)N4CCOCC4)CC3)cc2)CC1.O,C27H38N6O5,33261.0
14302,5?-Androst-16-en-3?-ol,C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C=CC[C@@H]12,C19H30O,33457.0
14303,para-fluoro Phenethyl 4-ANPP (hydrochloride),Cl.Fc1ccc(N(CCc2ccccc2)C2CCN(CCc3ccccc3)CC2)cc1,C27H32ClFN2,33565.0
14304,Fervenulin,Cn1c(=O)c2ncnnc2n(C)c1=O,C7H7N5O2,33499.0
14305,Methylatropine (bromide),C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2.[Br-],C18H26BrNO3,33433.0
14306,Sulfanilic Acid,Nc1ccc(S(=O)(=O)O)cc1,C6H7NO3S,33451.0
14307,L-Serine,N[C@@H](CO)C(=O)O,C3H7NO3,33561.0
14308,Isonanangenine B,CCCCCC(=O)O[C@@H]1C=C2C(=O)OC[C@]2(O)[C@@]2(C)[C@H](O)CCC(C)(C)[C@H]12,C21H32O6,33518.0
14309,1-BCP,O=C(c1ccc2c(c1)OCO2)N1CCCCC1,C13H15NO3,33428.0
14310,Tryptoquivaline D,CC(=O)O[C@H](c1nc2ccccc2c(=O)n1[C@@H]1C[C@]2(OC1=O)c1ccccc1N1C(=O)[C@H](C)N(O)[C@H]12)C(C)C,C28H28N4O7,33531.0
14311,Promestriene,CCCOc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OC)CC[C@@H]12,C22H32O2,33426.0
14312,Gadoleic Acid,CCCCCCCCCC/C=C\CCCCCCCC(=O)O,C20H38O2,33186.0
14313,Naphthol AS-E Phosphate,O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2cc1OP(=O)(O)O,C17H13ClNO5P,33602.0
14314,Nordihydrocapsaicin,COc1cc(CNC(=O)CCCCCC(C)C)ccc1O,C17H27NO3,33407.0
14315,Norethynodrel,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C,C20H26O2,33230.0
14316,AG-556,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCCc1ccccc1,C20H20N2O3,33335.0
14317,Trapidil,CCN(CC)c1cc(C)nc2ncnn12,C10H15N5,33496.0
14318,Efonidipine,CC1=C(C(=O)OCCN(Cc2ccccc2)c2ccccc2)C(c2cccc([N+](=O)[O-])c2)C(P2(=O)OCC(C)(C)CO2)=C(C)N1,C34H38N3O7P,33114.0
14319,Fenspiride-d5,[2H]c1c([2H])c([2H])c(CCN2CCC3(CC2)CNC(=O)O3)c([2H])c1[2H],C15H20N2O2,33711.0
14320,Pentalenic Acid,C[C@@H]1CC[C@H]2C(C(=O)O)=C[C@@H]3[C@@H](O)C(C)(C)C[C@@]132,C15H22O3,33532.0
14321,Griseofulvin-d3,[2H]C([2H])([2H])OC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O,C17H17ClO6,33366.0
14322,Nanangenine B,CCCCCC(=O)O[C@@H]1C=C2COC(=O)[C@]2(O)[C@@]2(C)[C@H](O)CCC(C)(C)[C@H]12,C21H32O6,33520.0
14323,Dihydropyrenophorin,C[C@@H]1CCC(=O)/C=C/C(=O)O[C@H](C)CC[C@H](O)/C=C/C(=O)O1,C16H22O6,33536.0
14324,AZD 7986,Cn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21,C23H24N4O4,33184.0
14325,Olanzapine Lactam Impurity,CC(=O)/C=C1\C(=O)Nc2ccccc2N=C1N1CCN(C)CC1,C17H20N4O2,33792.0
14326,MMB-FUBGACLONE,COC(=O)C(C(C)C)n1ccc2c(c1=O)c1ccccc1n2Cc1ccc(F)cc1,C24H23FN2O3,30770.0
14327,CM-272,COc1cc2c(NC3CCN(C)CC3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,C28H38N4O3,25948.0
14328,WS-12,COc1ccc(NC(=O)[C@@H]2C[C@H](C)CC[C@H]2C(C)C)cc1,C18H27NO2,30352.0
14329,Ticlopidine-d4 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(CN2CCc3sccc3C2)c(Cl)c1[2H],C14H15Cl2NS,33467.0
14330,ML-145,CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1,C24H22N2O5S2,33534.0
14331,Octanoic Acid,CCCCCCCC(=O)O,C8H16O2,33674.0
14332,PQR530,C[C@H]1COCCN1c1nc(-c2cnc(N)cc2C(F)F)nc(N2CCOCC2)n1,C18H23F2N7O2,28563.0
14333,ACU 4429 (hydrochloride),Cl.NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1,C16H26ClNO2,33242.0
14334,Previtamin D3,CC1=C(/C=C\C2=CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)CC1,C27H44O,33409.0
14335,Betulinic Acid propargyl ester,C#CCOC(=O)[C@]12CC[C@@H](C(=C)C)[C@@H]1[C@H]1CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2,C33H50O3,33030.0
14336,Betulinic glycine amide,CN1C(=O)c2ccccc2-n2c(nc3ccccc3c2=O)C1[C@@H](O)c1ccccc1,C24H19N3O3,33031.0
14337,"N,N-DMT N-oxide",C[N+](C)([O-])CCc1c[nH]c2ccccc12,C12H16N2O,33554.0
14338,3-Acetyl Betulin,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C32H52O3,33049.0
14339,4'-Acetyl Chrysomycin A,COc1cc2c(oc(=O)c3cc(C)cc(OC)c32)c2c([C@@H]3O[C@H](C)[C@H](OC(C)=O)[C@@](C)(O)[C@H]3O)ccc(O)c12,C29H30O10,33023.0
14340,Carbazomycin A,COc1c(C)c(C)c2[nH]c3ccccc3c2c1OC,C16H17NO2,33088.0
14341,Preterramide C,COC(=O)c1cc(OC)c(OC)c(OC)c1NC(=O)c1ccccc1NC(=O)c1cccnc1,C24H23N3O7,33097.0
14342,11-cis Retinol,CC1=C(/C=C/C(C)=C/C=C\C(C)=C\CO)C(C)(C)CCC1,C20H30O,33207.0
14343,3-Anilinopiperidine (hydrochloride),Cl.Cl.c1ccc(NC2CCCNC2)cc1,C11H18Cl2N2,9003735.0
14344,Emeguisin A,CC=C(C)c1cc(O)c(C)c2c1C(=O)Oc1c(C)c(O)c(Cl)c(C(C)=CC)c1O2,C23H23ClO5,32929.0
14345,Oasomycin B,C/C1=C\CC[C@H](C)[C@@H](O)[C@@H](C)[C@@H](O)CC/C=C/[C@H](C)[C@@H](O)/C=C/[C@H](C)[C@@H](O)/C(C)=C/[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)[C@H](O)C[C@@H](O)C[C@H](O)C[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)[C@H](O)C[C@@H](O)C[C@H](O)/C=C/C[C@@H]([C@H](C)[C@H]2CCC(=O)O2)OC1=O,C61H104O22,33019.0
14346,Linearmycin B,C/C(=C\C=C\C=C\C=C\C=C\CC/C=C/C(C)C(O)C(C)C(O)/C=C/C=C/C=C/C=C/C=C/CC(O)C(C)C(=O)CC(O)CC(O)CC(O)/C=C/CC(O)CC(O)CC(O)CC(O)/C=C/CC(O)/C=C/CC(O)CC(O)CCCN)C(=O)O,C66H103NO16,33133.0
14347,RIPA-56,CCC(C)(C)C(=O)N(O)Cc1ccccc1,C13H19NO2,33431.0
14348,CP21,CCn1ccc(=O)c(O)c1C,C8H11NO2,33318.0
14349,Erythromycin 2'-Propionate,CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,C40H71NO14,31739.0
14350,Tafenoquine,COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1,C24H28F3N3O3,30673.0
14351,Phomopsinamine,C=C(C)[C@@H]1NC(=O)[C@@H](NC)[C@@H](O)c2cc(Cl)c(O)c(c2)O[C@](C)(CC)[C@@H](C(=O)N2CC=C[C@H]2C(=O)N/C(C(N)=O)=C(\C)CC)NC1=O,C32H43ClN6O8,33588.0
14352,Remisporine B,COC(=O)[C@@]12O[C@](O)(C(=O)OC)[C@@H]3Cc4oc5cc(C)cc(O)c5c(=O)c4[C@@H](c4oc5cc(C)cc(O)c5c(=O)c41)[C@H]32,C30H24O12,31669.0
14353,Amycolatopsin B,COCCC[C@H]1O[C@@](O)([C@H](C)C2CC(OC)C(O)/C=C(C)/C=C(C)/C=C(\C)C(O[C@H]3O[C@H](C)[C@@H](OC)[C@H](O)[C@H]3O)C(C)/C=C(C)/C=C(OC)/C=C(\C)C(=O)O2)[C@H](OC)[C@@H](O)[C@]1(C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@@](C)(O)[C@H](O)[C@@H](C)O2)[C@@H](C)O1,C60H98O22,31677.0
14354,apo-Enterobactin,O=C(N[C@@H](COC(=O)[C@H](COC(=O)[C@H](CO)NC(=O)c1cccc(O)c1O)NC(=O)c1cccc(O)c1O)C(=O)O)c1cccc(O)c1O,C30H29N3O16,31760.0
14355,Sartorypyrone D,C=C1CC[C@H](O)C(C)(C)[C@@H]1CC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)oc1=O,C26H38O4,31676.0
14356,"7-Methoxy-9-methylfuro[2,3-b]-quinoline-4,5,8(9H)-trione",COC1=CC(=O)c2c(n(C)c3occc3c2=O)C1=O,C13H9NO5,31637.0
14357,Malolactomycin C,CNC(=N)NCCCCC/C=C(\C)CC(C)C1OC(=O)C(C)C(O)/C(C)=C/CC(O)C(C)C(O)CC(O)C(C)C(O)CCC(C)C(O)CC2(O)OC(CC(OC(=O)CC(=O)O)CC(O)CC(O)CC(O)C(C)C(O)/C=C/C=C/C1C)CC(O)C2O,C62H109N3O20,31673.0
14358,CBGB,CCCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1,C20H30O2,29109.0
14359,(S)-Canadine,COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,C20H21NO4,33805.0
14360,SM-102,CCCCCCCCCCCOC(=O)CCCCCN(CCO)CCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC,C44H87NO5,33474.0
14361,Circumdatin A,COC1=Cc2c(nc3n(c2=O)-c2ccc(OC)cc2C(=O)N2CCC[C@@H]32)OC=C1,C21H19N3O5,31436.0
14362,Piliformic Acid,CCCCC/C=C(/C(=O)O)C(C)C(=O)O,C11H18O4,31756.0
14363,Hodgkinsine B,CN1CC[C@]2(c3cccc4c3N[C@H]3N(C)CC[C@@]43[C@]34CCN(C)[C@H]3Nc3ccccc34)c3ccccc3N[C@H]12,C33H38N6,31421.0
14364,?-Carboline-1-carboxylic Acid,O=C(O)c1nccc2c1[nH]c1ccccc12,C12H8N2O2,31415.0
14365,Triamterene-d5,[2H]c1c([2H])c([2H])c(-c2nc3c(N)nc(N)nc3nc2N)c([2H])c1[2H],C12H11N7,33815.0
14366,4-hydroxy Estrone,C[C@]12CC[C@@H]3c4ccc(O)c(O)c4CC[C@H]3[C@@H]1CCC2=O,C18H22O3,33696.0
14367,4-Hydroxycanthin-6-one,O=c1cc(O)c2nccc3c4ccccc4n1c23,C14H8N2O2,31646.0
14368,Sydowinin B,COC(=O)c1c(O)ccc2oc3cc(CO)cc(O)c3c(=O)c12,C16H12O7,31670.0
14369,hemi-Oxanthromicin A,Cc1ccc2c(c1O)C(=O)c1c(cc(O)c(C(=O)O)c1C)C2(C)O,C18H16O6,31678.0
14370,"3,3'-Dithiodipropionic Acid di(N-hydroxysuccinimide ester)",O=C(CCSSCCC(=O)ON1C(=O)CCC1=O)ON1C(=O)CCC1=O,C14H16N2O8S2,33405.0
14371,Helicid,O=Cc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]2O)cc1,C13H16O7,33414.0
14372,Metronidazole Benzoate,Cc1ncc([N+](=O)[O-])n1CCOC(=O)c1ccccc1,C13H13N3O4,33316.0
14373,7-Methoxyisoflavone,COc1ccc2c(=O)c(-c3ccccc3)coc2c1,C16H12O3,33419.0
14374,Evocalcet,C[C@@H](N[C@H]1CCN(c2ccc(CC(=O)O)cc2)C1)c1cccc2ccccc12,C24H26N2O2,33346.0
14375,Diphenylpyraline,CN1CCC(OC(c2ccccc2)c2ccccc2)CC1,C19H23NO,33237.0
14376,KB-130015,Cc1oc2ccccc2c1Cc1cc(I)c(OCC(=O)O)c(I)c1,C18H14I2O4,33461.0
14377,Methocarbamol-d5,[2H]C([2H])(OC(N)=O)C([2H])(O)C([2H])([2H])Oc1ccccc1OC,C11H15NO5,33464.0
14378,Methyl Piliformate,CCCC/C=C/C(C(=O)OC)C(C)C(=O)O,C12H20O4,31757.0
14379,AZD 5991,Cc1c2c(nn1C)CSCc1cc(n(C)n1)CSc1cc(c3ccccc3c1)OCCCc1c(C(=O)O)n(C)c3c-2c(Cl)ccc13,C35H34ClN5O3S2,28926.0
14380,Hodgkinsine,CN1CC[C@]2(c3cccc4c3N[C@@H]3N(C)CC[C@]43[C@@]34CCN(C)[C@@H]3Nc3ccccc34)c3ccccc3N[C@H]12,C33H38N6,31413.0
14381,rac-trans-4-hydroxy Glyburide,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)N[C@H]2CC[C@H](O)CC2)cc1,C23H28ClN3O6S,33752.0
14382,Palmarumycin C3,O=C1c2c(O)ccc(O)c2C2(Oc3cccc4cccc(c34)O2)[C@@H]2O[C@H]12,C20H12O6,31447.0
14383,Fentanyl N-oxide,CCC(=O)N(c1ccccc1)C1CC[N+]([O-])(CCc2ccccc2)CC1,C22H28N2O2,9003288.0
14384,6-methoxy DMT,COc1ccc2c(CCN(C)C)c[nH]c2c1,C13H18N2O,33626.0
14385,Sitamaquine (tosylate),CCN(CC)CCCCCCNc1cc(OC)cc2c(C)ccnc12.Cc1ccc(S(=O)(=O)O)cc1,C28H41N3O4S,33590.0
14386,Isoreserpiline,COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)[C@@H]3C[C@H]12,C23H28N2O5,31641.0
14387,Norbaeocystin,NCCc1c[nH]c2cccc(OP(=O)(O)O)c12,C10H13N2O4P,31584.0
14388,Norbaeocystin (CRM),NCCc1c[nH]c2cccc(OP(=O)(O)O)c12,C10H13N2O4P,37764.0
14389,Alobresib,Cc1noc(C)c1-c1cc(C(O)(c2ccccn2)c2ccccn2)c2[nH]c(C3CC3)nc2c1,C26H23N5O2,30726.0
14390,Avrainvillamide,CC1(C)C=Cc2c(ccc3c2[N+]([O-])=C2C3=C[C@@]34NC(=O)C5(CCCN5C3=O)C[C@H]4C2(C)C)O1,C26H27N3O4,31655.0
14391,Batabulin (sodium salt),COc1ccc([N-]S(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1F.[Na+],C13H6F6NNaO3S,33487.0
14392,Amycolatopsin A,COCCC[C@H]1O[C@@](O)([C@H](C)C2CC(OC)C(O)/C=C(C)/C=C(C)/C=C(\C)C(O[C@H]3O[C@H](C)[C@@H](OC)[C@H](O)[C@H]3O)C(C)/C=C(CO)\C=C(OC)/C=C(\C)C(=O)O2)[C@H](OC)[C@@H](O)[C@]1(C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@@](C)(O)[C@H](O)[C@@H](C)O2)[C@@H](C)O1,C60H98O23,31672.0
14393,D-Homoserine lactone,N[C@@H]1CCOC1=O,C4H7NO2,31695.0
14394,KRP 297,COc1ccc(CC2SC(=O)NC2=O)cc1C(=O)NCc1ccc(C(F)(F)F)cc1,C20H17F3N2O4S,33699.0
14395,PF-06649751,Cc1cc(Oc2ncccc2C(F)(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C,C19H16F3N3O3,33556.0
14396,Porantherine,C[C@@]12CCC[C@@]34CCC[C@@H](C=C[C@H]1CC3)N42,C15H23N,31639.0
14397,4-Methylthiocanthin-6-one,CSc1cc(=O)n2c3ccccc3c3ccnc1c32,C15H10N2OS,31644.0
14398,Surfactin,CC(C)CCCCCCCCCC1CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1,C53H93N7O13,31620.0
14399,BMS-P5,COc1cc(C(=O)N2C[C@H](N)CC[C@@H]2C)cc2nc(-c3cc4cccnc4n3CC3CC3)n(C)c12,C27H32N6O2,33581.0
14400,TAS 115 (methanesulfonate),CNC(=O)c1cc2c(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)ccnc2cc1OC.CS(=O)(=O)O,C28H27FN4O7S2,33593.0
14401,Gestodene-d6,[2H]C1=C2C([2H])([2H])C[C@H]3[C@@H]4C=C[C@@](O)(C#C)[C@@]4(CC)CC[C@@H]3[C@@]2([2H])CC([2H])([2H])C1=O,C21H26O2,33819.0
14402,Vanoxonin,CC(=O)N(O)CCC[C@H](NC(=O)[C@@H](NC(=O)c1cccc(O)c1O)[C@@H](C)O)C(=O)O,C18H25N3O9,32931.0
14403,Ornidazole-d5,[2H]C([2H])(Cl)C([2H])(O)C([2H])([2H])n1c([N+](=O)[O-])cnc1C,C7H10ClN3O3,33810.0
14404,9-Methoxyellipticine,COc1ccc2[nH]c3c(C)c4ccncc4c(C)c3c2c1,C18H16N2O,31631.0
14405,Penipurdin A,COc1cc(O)cc2c1C(=O)c1c(O)cc(C[C@H](C)O)cc1C2=O,C18H16O6,31657.0
14406,Capromorelin (tartrate),CN1N=C2CCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)N)C[C@@]2(Cc2ccccc2)C1=O.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C32H41N5O10,33488.0
14407,Pyridindolol,OCc1cc2c([nH]c3ccccc32)c([C@@H](O)CO)n1,C14H14N2O3,32914.0
14408,(+)-Cannabidiol,C=C(C)[C@H]1CCC(C)=C[C@@H]1c1c(O)cc(CCCCC)cc1O,C21H30O2,9003416.0
14409,4-Hydroxycoumarin,O=c1cc(O)c2ccccc2o1,C9H6O3,33568.0
14410,BRD9876,CC(C)(C)c1ccc2cc(C#N)c(C#N)cc2c1,C16H14N2,33217.0
14411,cis-13-Octadecenoic Acid,CCCC/C=C\CCCCCCCCCCCC(=O)O,C18H34O2,33598.0
14412,2-methyl-5-methoxy DMT,COc1ccc2[nH]c(C)c(CCN(C)C)c2c1,C14H20N2O,32522.0
14413,Naftopidil-d5,[2H]C([2H])(Oc1cccc2ccccc12)C([2H])(O)C([2H])([2H])N1CCN(c2ccccc2OC)CC1,C24H28N2O3,33811.0
14414,Piperitone,CC1=CC(=O)C(C(C)C)CC1,C10H16O,33490.0
14415,Moexipril-d5,[2H]c1c([2H])c([2H])c(CC[C@H](N[C@@H](C)C(=O)N2Cc3cc(OC)c(OC)cc3C[C@H]2C(=O)O)C(=O)OCC)c([2H])c1[2H],C27H34N2O7,33814.0
14416,Bupivacaine (hydrochloride),CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl,C18H29ClN2O,31718.0
14417,C16 Galactosylceramide (d18:1/16:0),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCC,C40H77NO8,32600.0
14418,Methylchloroisothiazolinone/Methylisothiazolinone Mixture,Cn1sc(Cl)cc1=O.Cn1sccc1=O,C8H9ClN2O2S2,27470.0
14419,Methylketobemidone,CC(=O)C1(c2cccc(O)c2)CCN(C)CC1,C14H19NO2,33630.0
14420,DFHBI 1T,CC1=N/C(=C\c2cc(F)c(O)c(F)c2)C(=O)N1CC(F)(F)F,C13H9F5N2O2,33517.0
14421,Imidazole Propionate,O=C(O)CCc1cnc[nH]1,C6H8N2O2,33458.0
14422,"L-Tyrosine-13C9,15N",[15NH2][13C@@H]([13CH2][13c]1[13cH][13cH][13c](O)[13cH][13cH]1)[13C](=O)O,C9H11NO3,31256.0
14423,5-fluoro CUMYL-P7AICA N-pentanoic acid metabolite,CC(C)(NC(=O)c1cn(CCCCC(=O)O)c2ncccc12)c1ccccc1,C22H25N3O3,31749.0
14424,Hexanoic Acid-d5,[2H]C([2H])([2H])C([2H])([2H])CCCC(=O)O,C6H12O2,31248.0
14425,2-Naphthyl U-47700,CN(C)[C@@H]1CCCC[C@H]1N(C)C(=O)c1ccc2ccccc2c1,C20H26N2O,33872.0
14426,1-Palmitoyl-2-Docosahexaenoyl-sn-glycero-3-PE,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C43H74NO8P,33440.0
14427,TH1020,c1ccc(Cn2c(Sc3ncnc4c3sc3ncccc34)nnc2-c2ccncc2)cc1,C23H15N7S2,33553.0
14428,"(R,S)-N-Nitrosoanatabine",O=NN1CC=CCC1c1cccnc1,C10H11N3O,33851.0
14429,Kaempferol 3-O-galactoside,O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,C21H20O11,33747.0
14430,Histamine,NCCc1cnc[nH]1,C5H9N3,33828.0
14431,2-Ethylhexyl 4-methoxycinnamate,CCCCC(CC)COC(=O)C=Cc1ccc(OC)cc1,C18H26O3,33401.0
14432,SIH,O=C(NN=Cc1ccccc1O)c1ccncc1,C13H11N3O2,33314.0
14433,MRS1754,CCCn1c(=O)c2[nH]c(-c3ccc(OCC(=O)Nc4ccc(C#N)cc4)cc3)nc2n(CCC)c1=O,C26H26N6O4,33501.0
14434,Cevipabulin,CNCCCOc1cc(F)c(-c2c(Cl)nc3ncnn3c2N[C@@H](C)C(F)(F)F)c(F)c1,C18H18ClF5N6O,33224.0
14435,PTC-596,Cc1nc2ccc(F)cc2n1-c1nc(N)c(F)c(Nc2ccc(C(F)(F)F)cc2)n1,C19H13F5N6,33529.0
14436,TAS 0728,C=CC(=O)N1CCC[C@@H](n2nc(C(=O)Nc3ccc(CC(=O)N(C)C)c(C)c3C)c3c(N)ncnc32)C1,C26H32N8O3,33528.0
14437,Pentoxifylline-d6,[2H]C([2H])([2H])n1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2C([2H])([2H])[2H],C13H18N4O3,33244.0
14438,"CP 809,101 (hydrochloride)",Cl.Clc1cccc(COc2cncc(N3CCNCC3)n2)c1,C15H18Cl2N4O,33283.0
14439,Pregnanetriol,C[C@H](O)[C@@]1(O)CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,C21H36O3,33312.0
14440,Methazolamide-d6,[2H]C([2H])([2H])C(=O)/N=c1\sc(S(N)(=O)=O)nn1C([2H])([2H])[2H],C5H8N4O3S2,33933.0
14441,"5,7,8-Trimethoxydictamnine",COc1cc(OC)c2c(OC)c3ccoc3nc2c1OC,C15H15NO5,31418.0
14442,Rubiginone D2,COc1cccc2c1C(=O)c1ccc3c(c1C2=O)C(=O)[C@@H](O)[C@@H](C)[C@H]3O,C20H16O6,31463.0
14443,N-Methylcanadium (iodide),COc1ccc2c(c1OC)C[N+]1(C)CCc3cc4c(cc3[C@@H]1C2)OCO4.[I-],C21H24INO4,31654.0
14444,Stephacidin B,CC1(C)C=Cc2c(ccc3c2[N+]([O-])=C2C(C)(C)[C@@H]4CC56CCCN5C(=O)[C@]4(NC6=O)[C@@H]4N5C(=O)[C@@]67CCCN6C(=O)[C@]56[C@@H](C7)C(C)(C)c5c(c7ccc8c(c7n5O)C=CC(C)(C)O8)[C@H]6C234)O1,C52H54N6O8,31656.0
14445,Olomoucine II,CC[C@H](CO)Nc1nc(NCc2ccccc2O)c2ncn(C(C)C)c2n1,C19H26N6O2,33223.0
14446,Brotizolam,Cc1nnc2n1-c1sc(Br)cc1C(c1ccccc1Cl)=NC2,C15H10BrClN4S,27779.0
14447,Acetoxymethylketobemidone (hydrochloride),CC(=O)Oc1cccc(C2(C(C)=O)CCN(C)CC2)c1.Cl,C16H22ClNO3,29786.0
14448,ASTX029,COc1cc(F)cc([C@@H](CO)NC(=O)[C@@H](C)N2Cc3ccc(-c4nc(NC5CCOCC5)ncc4Cl)cc3C2=O)c1,C29H31ClFN5O5,33557.0
14449,4-Aminosalicylic Acid,Nc1ccc(C(=O)O)c(O)c1,C7H7NO3,33449.0
14450,para-fluoro 4-Anilinopiperidine (hydrochloride),Cl.Cl.Fc1ccc(NC2CCNCC2)cc1,C11H17Cl2FN2,33702.0
14451,BMS 986165,[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC,C20H22N8O3,33524.0
14452,Isothipendyl (hydrochloride),CC(CN1c2ccccc2Sc2cccnc21)N(C)C.Cl,C16H20ClN3S,33582.0
14453,iHAP1,COc1ccc(C(=O)N2c3ccccc3Sc3ccc(Cl)cc32)cc1,C20H14ClNO2S,33530.0
14454,3-keto Fusidic Acid,CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CCC(=O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O,C31H46O6,33855.0
14455,D-Aspartic Acid,N[C@H](CC(=O)O)C(=O)O,C4H7NO4,33494.0
14456,MW-150,CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4ccccc4c3)nn2)CC1,C24H23N5,33789.0
14457,LOXO-292,COc1ccc(CN2C3CC2CN(c2ccc(-c4cc(OCC(C)(C)O)cn5ncc(C#N)c45)cn2)C3)cn1,C29H31N7O3,33515.0
14458,Bipiperidinyl 4-ANPP,c1ccc(CCN2CCC(N3CCC(Nc4ccccc4)CC3)CC2)cc1,C24H33N3,33800.0
14459,BAY-1895344,C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3cc[nH]n3)c2n1,C20H21N7O,33603.0
14460,ASLAN003,COc1cccc(-c2cc(F)c(Nc3ncccc3C(=O)O)c(F)c2)c1,C19H14F2N2O3,33516.0
14461,BAY-293,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,C25H28N4O2S,33606.0
14462,Flubrotizolam,Cc1nnc2n1-c1sc(Br)cc1C(c1ccccc1F)=NC2,C15H10BrFN4S,28470.0
14463,Darifenacin-d4,[2H]C([2H])(c1ccc2c(c1)CCO2)C([2H])([2H])N1CCC(C(C(N)=O)(c2ccccc2)c2ccccc2)C1,C28H30N2O2,33701.0
14464,GSK2245035,CCC[C@H](C)Oc1nc(N)c2[nH]c(=O)n(CCCCCN3CCCCC3)c2n1,C20H34N6O2,33171.0
14465,Z-Lys-OBzl (benzenesulfonate),NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1.O=S(=O)(O)c1ccccc1,C27H32N2O7S,30916.0
14466,UNC0064-12,NCCCNc1ccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)cc1,C19H24N8,33555.0
14467,N-(1-Phenethyl-4-piperidyl)-N-phenethylpropanamide (hydrochloride),CCC(=O)N(CCc1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C24H33ClN2O,33801.0
14468,2-Hydroxyanthraquinone,O=C1c2ccccc2C(=O)c2cc(O)ccc21,C14H8O3,32906.0
14469,TVB-3166,Cc1cc(C)c(-c2n[nH]c(C)c2C)cc1C(=O)N1CC(c2ccc(C#N)cc2)C1,C24H24N4O,33533.0
14470,Telratolimod,CCCCCCCCCCCCCCCCCC(=O)NCCCCOn1c(CCCC)nc2c(N)nc3ccccc3c21,C36H59N5O2,33172.0
14471,LMB763,Cn1nc(C(=O)N(Cc2ccccc2)Cc2ccc(C(=O)O)cc2)c2c1-c1cc(Cl)ccc1OC2,C27H22ClN3O4,30184.0
14472,Testosterone-d3,[2H]C1([2H])C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@@]1([2H])O,C19H28O2,32986.0
14473,17-Epiestriol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@H]2O,C18H24O3,33601.0
14474,"(R,S)-hydroxy Ramelteon Metabolite M-II",CC(O)C(=O)NCC[C@@H]1CCc2ccc3c(c21)CCO3,C16H21NO3,33897.0
14475,Biotinyl hexylamine,NCCCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C16H30N4O2S,31226.0
14476,Sudan Red 7B,CCNc1ccc2ccccc2c1N=Nc1ccc(N=Nc2ccccc2)cc1,C24H21N5,33315.0
14477,WST-3,O=[N+]([O-])c1ccc(-[n+]2nc(-c3ccc(S(=O)(=O)[O-])cc3S(=O)(=O)[O-])nn2-c2ccc(I)cc2)c([N+](=O)[O-])c1.[Na+],C19H10IN6NaO10S2,30796.0
14478,Fursultiamine,CC(=C(CCO)SSCC1CCCO1)N(C=O)Cc1cnc(C)nc1N,C17H26N4O3S2,33456.0
14479,1-methyl-L-Tryptophan,Cn1cc(C[C@H](N)C(=O)O)c2ccccc21,C12H14N2O2,33313.0
14480,Hydroxy-PEG2 Acid,O=C(O)CCOCCOCCO,C7H14O5,30903.0
14481,Z-Lys-OMe (hydrochloride),COC(=O)[C@H](CCCCN)NC(=O)OCc1ccccc1.Cl,C15H23ClN2O4,30804.0
14482,Pamicogrel,CCOC(=O)Cn1cccc1-c1nc(-c2ccc(OC)cc2)c(-c2ccc(OC)cc2)s1,C25H24N2O4S,33514.0
14483,Ac-QPKK(Ac)-AMC,CC(=O)NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(C)=O)C(=O)Nc1ccc2c(C)cc(=O)oc2c1,C36H52N8O9,30790.0
14484,BIBP3226,N=C(N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1,C27H31N5O3,33210.0
14485,GW 406381,CCOc1ccc(-c2nn3ncccc3c2-c2ccc(S(C)(=O)=O)cc2)cc1,C21H19N3O3S,33895.0
14486,Arachidonyl Alcohol,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCO,C20H34O,32539.0
14487,LDN-27219,NNC(=O)CSc1nc2scc(-c3ccccc3)c2c(=O)n1-c1ccccc1,C20H16N4O2S2,32975.0
14488,AAA,O=C([O-])CC(NC(=O)CCCC/C=C\CCCCCCC/C=C\CCCCO)C(=O)[O-].[Na+].[Na+],C24H39NNa2O6,32733.0
14489,WST-1,O=[N+]([O-])c1ccc(-[n+]2nc(-c3ccc(S(=O)(=O)[O-])cc3S(=O)(=O)[O-])nn2-c2ccc(I)cc2)cc1.[Na+],C19H11IN5NaO8S2,31752.0
14490,SU 4942,O=C1Nc2ccccc2C1=Cc1ccc(Br)cc1,C15H10BrNO,32967.0
14491,"10,13-epoxy-11-methyl-Octadecadienoic Acid",CCCCCc1cc(C)c(CCCCCCCCC(=O)O)o1,C19H32O3,10009930.0
14492,Umbelliprenin,CC(C)=CCC/C(C)=C/CC/C(C)=C/COc1ccc2ccc(=O)oc2c1,C24H30O3,27894.0
14493,Clobetasol Propionate-d5,[2H]C([2H])([2H])C([2H])([2H])C(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C25H32ClFO5,33365.0
14494,Piroxicam-d3,[2H]C([2H])([2H])N1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,C15H13N3O4S,33248.0
14495,Marein,O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(O)c1O,C21H22O11,33213.0
14496,Cephalosporin C (zinc),CC(=O)OCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(=O)[O-])[C@H]2SC1.[Zn+2],C16H19N3O8SZn,33262.0
14497,N-Pyrrolidino Etonitazene,CCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN2CCCC2)cc1,C22H26N4O3,33169.0
14498,N-Pyrrolidino Etonitazene (CRM),CCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN2CCCC2)cc1,C22H26N4O3,42194.0
14499,Baloxavir Marboxil,COC(=O)OCOc1c2n(ccc1=O)N([C@@H]1c3ccccc3SCc3c1ccc(F)c3F)[C@@H]1COCCN1C2=O,C27H23F2N3O7S,33214.0
14500,Icariside I,COc1ccc(-c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2O)cc1,C27H30O11,33209.0
14501,Ganoderic Acid C1,C[C@H](CC(=O)C[C@@H](C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O,C30H42O7,33212.0
14502,Levobetaxolol (hydrochloride),CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1.Cl,C18H30ClNO3,33435.0
14503,Neosartoricin B,CC(C)=CCc1c2c(c(O)c3c(O)cc(O)cc13)C(=O)[C@@H](O)[C@](O)(CC(=O)/C=C(/C)O)C2,C24H26O8,33162.0
14504,Pyrenophorin,C[C@@H]1CCC(=O)/C=C/C(=O)O[C@H](C)CCC(=O)/C=C/C(=O)O1,C16H20O6,33502.0
14505,BQ-123,CC(C)C[C@@H]1NC(=O)[C@@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O,C31H42N6O7,19153.0
14506,Methylatropine (nitrate),C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2.O=[N+]([O-])[O-],C18H26N2O6,9002272.0
14507,WF-3681,O=C(O)CCC1OC(=O)C(O)=C1c1ccccc1,C13H12O5,33523.0
14508,AT2 Agonist C21,CCCCOC(=O)NS(=O)(=O)c1sc(CC(C)C)cc1-c1ccc(Cn2ccnc2)cc1,C23H29N3O4S2,33758.0
14509,CC-90009,O=C1CCC(N2Cc3cc(CNC(=O)C(F)(F)c4ccc(Cl)cc4)ccc3C2=O)C(=O)N1,C22H18ClF2N3O4,33692.0
14510,S-methyl-L-Cysteine,CSC[C@H](N)C(=O)O,C4H9NO2S,33452.0
14511,Noracetildenafil,CCCc1nn(C)c2c(=O)nc(-c3cc(C(=O)CN4CCN(C)CC4)ccc3OCC)[nH]c12,C24H32N6O3,9001803.0
14512,(+)-?9-THC,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@H]1CCC(C)=C[C@H]21,C21H30O2,33453.0
14513,(+)-?9-THC (exempt preparation),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@H]1CCC(C)=C[C@H]21,C21H30O2,34628.0
14514,(S)-Aspartimide,N[C@H]1CC(=O)NC1=O,C4H6N2O2,31700.0
14515,Karrikinolide 3-ethyl ester,CCOC(=O)c1c2ccocc-2oc1=O,C10H8O5,31675.0
14516,Aranciamycin A,CO[C@H]1[C@H](O[C@H]2C[C@](C)(O)Cc3cc4c(c(O)c32)C(=O)c2c(O)cccc2C4=O)O[C@@H](C)[C@H](O)[C@H]1O,C26H28O10,31659.0
14517,Floramultine,COc1cc2c3c(c1O)-c1c(cc(O)c(OC)c1OC)CC[C@@H]3N(C)CC2,C21H25NO5,31419.0
14518,5'-Thymidylic Acid (sodium salt),Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)([O-])[O-])O2)c(=O)[nH]c1=O.[Na+].[Na+],C10H13N2Na2O8P,33549.0
14519,Naringenin Chalcone,O=C(C=Cc1ccc(O)cc1)c1c(O)cc(O)cc1O,C15H12O5,33806.0
14520,(4-Carboxybutyl-d4)triphenylphosphonium (bromide),[2H]C([2H])(CC(=O)O)C([2H])([2H])C[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-],C23H24BrO2P,31254.0
14521,SB-204741,Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1,C14H14N4OS,32965.0
14522,PRN-1371,C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1,C26H30Cl2N6O4,33787.0
14523,CBGAQ,CCCCCC1=C(C(=O)O)C(=O)C(C/C=C(\C)CCC=C(C)C)=C(O)C1=O,C22H30O5,31772.0
14524,QD-394,CN1CCN(c2ccc(NC3=CC(=O)c4ncncc4C3=O)cc2)CC1,C19H19N5O2,31769.0
14525,CBDE,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CC)cc1O,C18H24O2,33847.0
14526,Pachymic Acid,C=C(CC[C@@H](C(=O)O)[C@H]1[C@H](O)C[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]1CC3)C(C)C,C33H52O5,33180.0
14527,Syringaldehyde,COc1cc(C=O)cc(OC)c1O,C9H10O4,33489.0
14528,Homocarnosine,NCCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,C10H16N4O3,33695.0
14529,?-Ketoglutaric Acid (sodium salt),O=C(O)CCC(=O)C(=O)O.[NaH],C5H6NaO5,9001828.0
14530,3-Methoxyphenylacetone,COc1cccc(CC(C)=O)c1,C10H12O2,9003643.0
14531,4-Fluorophenylacetone,CC(=O)Cc1ccc(F)cc1,C9H9FO,9003642.0
14532,2-Fluorophenylacetone,CC(=O)Cc1ccccc1F,C9H9FO,9003637.0
14533,"N,N-DMT (succinate)",CN(C)CCc1c[nH]c2ccccc12.O=C(O)CCC(=O)O,C16H22N2O4,33586.0
14534,Piericidin B,C/C=C(\C)[C@H](OC)[C@H](C)/C=C(C)/C=C/C/C(C)=C/Cc1nc(OC)c(OC)c(O)c1C,C26H39NO4,33721.0
14535,3-Fluorophenylacetone,CC(=O)Cc1cccc(F)c1,C9H9FO,9003638.0
14536,Isoalantolactone,C=C1C(=O)O[C@@H]2C[C@@]3(C)CCCC(=C)[C@@H]3C[C@H]12,C15H20O2,33838.0
14537,1-Stearoyl-2-Adrenoyl-sn-glycero-3-PC,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C48H88NO8P,33660.0
14538,COG133 (trifluoroacetate salt),CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C.O=C(O)C(F)(F)F,C99H182F3N37O21,33587.0
14539,Boc-D-Phe-Pro-OH,CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O,C19H26N2O5,31151.0
14540,Desmethyl Ofloxacin (hydrochloride),CC1COc2c(N3CCNCC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.Cl,C17H19ClFN3O4,33807.0
14541,HT-2157,O=C1C(=Nc2cccc(C(F)(F)F)c2)c2ccccc2N1c1ccccc1,C21H13F3N2O,33848.0
14542,Enrofloxacin-d5,[2H]C([2H])([2H])C([2H])([2H])N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1,C19H22FN3O3,33809.0
14543,NP19,Cc1c(COc2cc(OCc3cccc(C#N)c3)c(CNC(C)(C)C(=O)O)cc2Cl)cccc1-c1ccccc1,C33H31ClN2O4,31791.0
14544,Isocurcumenol,C=C1C[C@@]2(O)O[C@@]3(CC2=C(C)C)[C@@H](C)CC[C@@H]13,C15H22O2,30710.0
14545,Velneperit,CC(C)(C)S(=O)(=O)N[C@H]1CC[C@H](C(=O)Nc2ccc(C(F)(F)F)cn2)CC1,C17H24F3N3O3S,33850.0
14546,BCI-121,NC(=O)C1CCN(CC(=O)Nc2ccc(Br)cc2)CC1,C14H18BrN3O2,33854.0
14547,Lu AA33810,CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1,C19H25N3O2S3,32913.0
14548,CAY10784,O=C(Nc1ncc([N+](=O)[O-])s1)c1ccc(C(F)(F)F)cc1,C11H6F3N3O3S,34020.0
14549,Myrislignan,C=CCc1cc(OC)c(O[C@@H](C)[C@H](O)c2ccc(O)c(OC)c2)c(OC)c1,C21H26O6,33759.0
14550,L-Cysteine,N[C@@H](CS)C(=O)O,C3H7NO2S,33309.0
14551,Rosuvastatin lactone,CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H]1C[C@@H](O)CC(=O)O1,C22H26FN3O5S,33885.0
14552,(+)-Oxypeucedanin hydrate,CC(C)(O)[C@H](O)COc1c2ccoc2cc2oc(=O)ccc12,C16H16O6,33841.0
14553,Metipranolol,CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C,C17H27NO4,34089.0
14554,Pseudomonic Acid (lithium salt),C/C(=C\C(=O)OCCCCCCCCC(=O)[O-])CC1OCC(CC2OC2C(C)C(C)O)C(O)C1O.[Li+],C26H43LiO9,33271.0
14555,Dinotefuran,CN/C(=N\CC1CCOC1)N[N+](=O)[O-],C7H14N4O3,33802.0
14556,Ketamine-d4 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(C2(NC)CCCCC2=O)c(Cl)c1[2H],C13H17Cl2NO,15818.0
14557,Ketamine-d4 (hydrochloride) (CRM),Cl.[2H]c1c([2H])c([2H])c(C2(NC)CCCCC2=O)c(Cl)c1[2H],C13H17Cl2NO,39605.0
14558,DiBAC4(3),CCCCN1C(=O)C(=CC=CC2C(=O)N(CCCC)C(=O)N(CCCC)C2=O)C(=O)N(CCCC)C1=O,C27H40N4O6,33924.0
14559,Nuciferine,COc1cc2c3c(c1OC)-c1ccccc1C[C@H]3N(C)CC2,C19H21NO2,33839.0
14560,(S)-3-Thienylglycine,N[C@H](C(=O)O)c1ccsc1,C6H7NO2S,30912.0
14561,Allopurinol Riboside,O=c1nc[nH]c2c1cnn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C10H12N4O5,33459.0
14562,Gossypetin,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2c(O)c(O)cc(O)c12,C15H10O8,33840.0
14563,Tebuconazole-d9,[2H]C([2H])([2H])C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C(O)(CCc1ccc(Cl)cc1)Cn1cncn1,C16H22ClN3O,33287.0
14564,Roflumilast N-oxide,O=C(Nc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,C17H14Cl2F2N2O4,33975.0
14565,N-hydroxy Riluzole,ON=c1[nH]c2ccc(OC(F)(F)F)cc2s1,C8H5F3N2O2S,33999.0
14566,4-Pyridoxic Acid,Cc1ncc(CO)c(C(=O)O)c1O,C8H9NO4,33968.0
14567,Urolithin B,O=c1oc2cc(O)ccc2c2ccccc12,C13H8O3,33757.0
14568,AC-186,Oc1ccc(C2(c3ccccc3F)CCC(F)(F)CC2)cc1,C18H17F3O,33526.0
14569,Clofibric Acid-d4,[2H]c1c([2H])c(OC(C)(C)C(=O)O)c([2H])c([2H])c1Cl,C10H11ClO3,33612.0
14570,Eupalinolide A,C=C1C(=O)O[C@@H]2/C=C(\C)[C@@H](OC(C)=O)C/C=C(/COC(C)=O)C[C@@H](OC(=O)/C(C)=C/CO)[C@@H]12,C24H30O9,33808.0
14571,Ronidazole,Cn1c([N+](=O)[O-])cnc1COC(N)=O,C6H8N4O4,33071.0
14572,Cinnarizine-d8,[2H]C1([2H])N(CC=Cc2ccccc2)C([2H])([2H])C([2H])([2H])N(C(c2ccccc2)c2ccccc2)C1([2H])[2H],C26H28N2,33977.0
14573,Oxaprozin-d5,[2H]c1c([2H])c([2H])c(-c2oc(CCC(=O)O)nc2-c2ccccc2)c([2H])c1[2H],C18H15NO3,33279.0
14574,CAY10786,O=C(/C=C/CCc1ccccc1)c1cccs1,C15H14OS,33564.0
14575,"5,7-Dihydroxy-4-methylcoumarin",Cc1cc(=O)oc2cc(O)cc(O)c12,C10H8O4,33756.0
14576,"N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine",COc1ccc(C(OC[C@H]2O[C@@H](n3ccc(NC(=O)c4ccccc4)nc3=O)C[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,C37H35N3O7,30803.0
14577,Despropionyl Carfentanil,COC(=O)C1(Nc2ccccc2)CCN(CCc2ccccc2)CC1,C21H26N2O2,33866.0
14578,ONO-4059 (hydrochloride),CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1.Cl,C25H23ClN6O3,32818.0
14579,EDMB-PINACA,CCCCCn1nc(C(=O)N[C@H](C(=O)OCC)C(C)(C)C)c2ccccc21,C21H31N3O3,33663.0
14580,2-Methoxyphenylacetone,COc1ccccc1CC(C)=O,C10H12O2,9003639.0
14581,"5'-O-(4,4'-Dimethoxytrityl)thymidine",COc1ccc(C(OC[C@H]2O[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,C31H32N2O7,30802.0
14582,"N,N-Dimethylglycine (hydrochloride)",CN(C)CC(=O)O.Cl,C4H10ClNO2,33830.0
14583,Lithospermic Acid,O=C(/C=C/c1ccc(O)c2c1[C@H](C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,C27H22O12,33694.0
14584,Osilodrostat,N#Cc1ccc([C@H]2CCc3cncn32)c(F)c1,C13H10FN3,33928.0
14585,10-hydroxy Warfarin,CC(=O)C(O)C(c1ccccc1)c1c(O)c2ccccc2oc1=O,C19H16O5,33929.0
14586,(R)-Hydroxychloroquine (sulfate),CCN(CCO)CCC[C@@H](C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O,C18H28ClN3O5S,33442.0
14587,15-(6-nitroxyhexanoyl)-17-phenyl trinor Prostaglandin F2?,CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@H](CCc2ccccc2)OC(=O)CCCCCO[N+](=O)[O-])[C@H](O)C[C@@H]1O,C31H46N2O8,32791.0
14588,Capsiate,COc1cc(COC(=O)CCCC/C=C/C(C)C)ccc1O,C18H26O4,9002596.0
14589,Cholesteryl Acetate,CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C29H48O2,30816.0
14590,Marrubiin,C[C@@H]1C[C@H]2OC(=O)[C@@]3(C)CCC[C@@](C)([C@@H]23)[C@@]1(O)CCc1ccoc1,C20H28O4,33876.0
14591,L-3-n-Butylphthalide,CCCC[C@@H]1OC(=O)c2ccccc21,C12H14O2,9003759.0
14592,Phenylbutazone-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,C19H20N2O2,33978.0
14593,ROC-325,Cc1ccc(NCCN(C)CCNc2ccnc3cc(Cl)ccc23)c2c(=O)c3ccccc3sc12,C28H27ClN4OS,33566.0
14594,Tectoridin,COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2occ(-c3ccc(O)cc3)c(=O)c2c1O,C22H22O11,33969.0
14595,Periciazine,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,C21H23N3OS,33149.0
14596,CL2A-SN-38 (dichloroacetic acid salt),CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@@]3(CC)OC(=O)OCc1ccc(NC(=O)[C@H](CCCCN)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCn2cc(CNC(=O)C3CCC(CN4C(=O)C=CC4=O)CC3)nn2)cc1.O=C(O)C(Cl)Cl,C73H97N11O22(C2H2Cl2O2)X,33941.0
14597,Lauroylsarcosine (sodium salt),CCCCCCCCCCCC(=O)N(C)CC(=O)[O-].[Na+],C15H28NNaO3,33718.0
14598,Triacontanoic Acid,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O,C30H60O2,34032.0
14599,L-Gulose,O=C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO,C6H12O6,34049.0
14600,Voxilaprevir,CC[C@@H]1[C@@H]2CN(C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]3C[C@H]3CCCCC(F)(F)c3nc4ccc(OC)cc4nc3O2)[C@@H]1C(=O)N[C@]1(C(=O)NS(=O)(=O)C2(C)CC2)C[C@H]1C(F)F,C40H52F4N6O9S,33974.0
14601,Diquafosol (sodium salt),O=c1ccn([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1.[Na+].[Na+].[Na+].[Na+],C18H22N4Na4O23P4,33971.0
14602,EG00229 (trifluoroacetate salt),N=C(N)NCCC[C@H](NC(=O)c1sccc1NS(=O)(=O)c1cccc2nsnc12)C(=O)O.O=C(O)C(F)(F)F,C19H20F3N7O7S3,33937.0
14603,Carveol,C=C(C)C1CC=C(C)C(O)C1,C10H16O,33831.0
14604,NVS-ZP7-4,O=C1Nc2ccccc2C2(CCN(C[C@H](Cc3ccccc3)Nc3nc4ccc(F)cc4s3)CC2)N1,C28H28FN5OS,33773.0
14605,Racecadotril-d5,[2H]c1c([2H])c([2H])c(COC(=O)CNC(=O)C(CSC(C)=O)Cc2ccccc2)c([2H])c1[2H],C21H23NO4S,33893.0
14606,Isoflavone,O=c1c(-c2ccccc2)coc2ccccc12,C15H10O2,33964.0
14607,BPKDi,NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1,C21H28N6O,33707.0
14608,Sophoradin,O=C1CCC[C@@H]2[C@H]3CCCN4CCC[C@H](CN12)[C@@H]34,C15H24N2O,33087.0
14609,"N?,N?,N?-Trimethyllysine (chloride)",C[N+](C)(C)CCCC[C@H](N)C(=O)O.[Cl-],C9H21ClN2O2,33898.0
14610,?-Ketoglutaric Acid,O=C(O)CCC(=O)C(=O)O,C5H6O5,33693.0
14611,N-methyl Mescaline (hydrochloride),CNCCc1cc(OC)c(OC)c(OC)c1.Cl,C12H20ClNO3,30541.0
14612,Carvacrol,Cc1ccc(C(C)C)cc1O,C10H14O,33753.0
14613,Diphenidol-d10,[2H]C1([2H])N(CCCC(O)(c2ccccc2)c2ccccc2)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],C21H27NO,33979.0
14614,Ro 47-8634,CC(C)(C)c1ccc(S(=O)(=O)Nc2nc(-c3ncccn3)nc(OCCO)c2Oc2ccccc2O)cc1,C26H27N5O6S,34157.0
14615,Nicorandil-d4,[2H]c1nc([2H])c(C(=O)NCCO[N+](=O)[O-])c([2H])c1[2H],C8H9N3O4,33608.0
14616,?-Hydroxyisovaleric Acid,CC(C)(O)CC(=O)O,C5H10O3,34030.0
14617,Uvaol,C[C@H]1[C@H](C)CC[C@]2(CO)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,C30H50O2,33915.0
14618,N'-Nitrosonornicotine,O=NN1CCCC1c1cccnc1,C9H11N3O,34120.0
14619,Cannabinolic Acid (CRM),CCCCCc1cc2c(c(O)c1C(=O)O)-c1cc(C)ccc1C(C)(C)O2,C22H26O4,21734.0
14620,Cannabinolic Acid,CCCCCc1cc2c(c(O)c1C(=O)O)-c1cc(C)ccc1C(C)(C)O2,C22H26O4,37688.0
14621,Cannabinolic Acid (Alt. Batch CRM),CCCCCc1cc2c(c(O)c1C(=O)O)-c1cc(C)ccc1C(C)(C)O2,C22H26O4,41268.0
14622,Brombuterol (hydrochloride),CC(C)(C)NCC(O)c1cc(Br)c(N)c(Br)c1.Cl,C12H19Br2ClN2O,33592.0
14623,LYS-006 (hydrochloride),Cl.N[C@@H](CC(=O)O)Cn1nnc(-c2ccc(Oc3ncc(Cl)cc3F)cc2)n1,C16H15Cl2FN6O3,33706.0
14624,Hydroxy Desmethyl Bosentan,CC(C)(CO)c1ccc(S(=O)(=O)Nc2nc(-c3ncccn3)nc(OCCO)c2Oc2ccccc2O)cc1,C26H27N5O7S,34158.0
14625,Dehydroabietic Acid,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(C(=O)O)CCC[C@]21C,C20H28O2,33722.0
14626,Nepafenac-d5,[2H]c1c([2H])c([2H])c(C(=O)c2cccc(CC(N)=O)c2N)c([2H])c1[2H],C15H14N2O2,33717.0
14627,Histidine,N[C@@H](Cc1cnc[nH]1)C(=O)O,C6H9N3O2,33904.0
14628,Sinapyl Alcohol,COc1cc(C=CCO)cc(OC)c1O,C11H14O4,33916.0
14629,Etodolac Acyl Glucuronide,CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)OCC3,C23H29NO9,34072.0
14630,"4-chloro-N,N-Dimethylcathinone (hydrochloride)",CC(C(=O)c1ccc(Cl)cc1)N(C)C.Cl,C11H15Cl2NO,24432.0
14631,Brevilin A,C/C=C(/C)C(=O)O[C@H]1[C@@H]2[C@H](C)C(=O)O[C@@H]2C[C@@H](C)[C@@H]2C=CC(=O)[C@]21C,C20H26O5,33993.0
14632,Loxapine-d8,[2H]C1([2H])N(C)C([2H])([2H])C([2H])([2H])N(C2=Nc3ccccc3Oc3ccc(Cl)cc32)C1([2H])[2H],C18H18ClN3O,33537.0
14633,Tylvalosin (tartrate),CC[C@H]1OC(=O)C[C@@H](OC(C)=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C53H87NO19(C4H6O6)X,33849.0
14634,Althiomycin,COC1=CC(=O)N(C(=O)[C@H]2CSC(C(CO)NC(=O)c3csc(/C=N/O)n3)=N2)C1,C16H17N5O6S2,32887.0
14635,Bisucaberin,O=C1CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN1,C18H32N4O6,32890.0
14636,Pyridoxamine (hydrochloride),Cc1ncc(CO)c(CN)c1O.Cl.Cl,C8H14Cl2N2O2,33899.0
14637,Benanomicin A,COc1cc(O)c2c(c1)C(=O)c1c(cc3c(c1O)-c1c(cc(C)c(C(=O)N[C@H](C)C(=O)O)c1O)[C@H](O[C@@H]1O[C@H](C)[C@H](O)[C@H](O[C@@H]4OC[C@@H](O)[C@H](O)[C@H]4O)[C@H]1O)[C@H]3O)C2=O,C39H41NO19,32886.0
14638,Pamiparib,C[C@]12CCCN1CC1=NNC(=O)c3cc(F)cc4[nH]c2c1c34,C16H15FN4O,33182.0
14639,Altemicidin,CN1C=C(C(N)=O)[C@@H]2C[C@H](O)[C@@](NC(=O)CS(N)(=O)=O)(C(=O)O)[C@@H]2C1,C13H20N4O7S,32897.0
14640,Heparastatin,O=C(O)[C@H]1CN[C@H](NC(=O)C(F)(F)F)[C@@H](O)[C@H]1O,C8H11F3N2O5,32899.0
14641,(S)-Hydroxychloroquine (sulfate),CCN(CCO)CCC[C@H](C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O,C18H28ClN3O5S,33443.0
14642,Benastatin B,CCCCCc1cc2c(c(O)c1C(=O)O)-c1cc3c(c(O)c1CC2)C(=O)c1c(O)cc(O)cc1C3(C)C,C30H30O7,32893.0
14643,?-Naphthoflavone,O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12,C19H12O2,34040.0
14644,Norursodeoxycholic Acid,C[C@H](CC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C23H38O4,33925.0
14645,Mirtazapine N-oxide,C[N+]1([O-])CCN2c3ncccc3Cc3ccccc3C2C1,C17H19N3O,34214.0
14646,L-Norvaline,CCC[C@H](N)C(=O)O,C5H11NO2,34029.0
14647,Tribenoside,CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O,C29H34O6,33498.0
14648,Benastatin C,CCCCCc1cc(O)c2c(ccc3c(O)c4c(cc32)C(C)(C)c2cc(O)cc(O)c2C4=O)c1,C29H28O5,32894.0
14649,DMG-PEG(2000),CCCCCCCCCCCCCC(=O)OCC(COCCOC)OC(=O)CCCCCCCCCCCCC,C32H62O5(C2H4O)n,33945.0
14650,DMG-PEG(2000) (solution),CCCCCCCCCCCCCC(=O)OCC(COCCOC)OC(=O)CCCCCCCCCCCCC,C32H62O5(C2H4O)n,42746.0
14651,Isorhoifolin,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C27H30O14,34036.0
14652,Benzoylhypaconine,COC[C@@]12CC[C@H](OC)C34C(C([C@H](OC)[C@@H]31)[C@@]1(O)[C@@H](O)[C@H](OC)[C@@]3(O)C[C@@H]4[C@@H]1C3OC(=O)c1ccccc1)N(C)C2,C31H43NO9,34046.0
14653,TAS 116,CCc1cc(C(N)=O)ccc1-n1nc(C(C)C)c2c(-n3cnc(-c4cnn(C)c4)c3)ccnc21,C25H26N8O,33779.0
14654,Phosphoramide Mustard (cyclohexylammonium salt),NC1CCCCC1.NP(=O)(O)N(CCCl)CCCl,C10H24Cl2N3O2P,34078.0
14655,Tiopronin-d3,[2H]C([2H])([2H])C(S)C(=O)NCC(=O)O,C5H9NO3S,33376.0
14656,MI-463,Cc1c(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)ccc2[nH]c(C#N)cc12,C24H23F3N6S,33525.0
14657,Rilmenidine,C1COC(NC(C2CC2)C2CC2)=N1,C10H16N2O,32879.0
14658,Psychotridine,CN1CCC2(c3cccc4c3NC3N(C)CCC43c3cccc4c3NC3N(C)CCC43C34CCN(C)C3Nc3c(C56CCN(C)C5Nc5ccccc56)cccc34)c3ccccc3NC12,C55H62N10,31645.0
14659,Penicillamine-d3,[2H]C([2H])([2H])C(C)(S)[C@@H](N)C(=O)O,C5H11NO2S,33797.0
14660,IMP-1700,O=C(O)c1cn(C2CC2)c2cc(N3CCN(C(=S)Nc4ccc(C(F)(F)F)cc4)CC3)c(F)cc2c1=O,C25H22F4N4O3S,33724.0
14661,Heliquinomycin,COC(=O)c1cc2cc3c(c(O)c2c(=O)o1)O[C@@]1(Oc2c(O)c4c(c(O)c2[C@H]1O[C@H]1C[C@@H](OC)[C@@H](O)[C@H](C)O1)C(=O)C=C(OC)C4=O)[C@H](O)C3,C33H30O17,32922.0
14662,Oxanosine,Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)o1,C10H12N4O6,33503.0
14663,PON-PC,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=O,C33H64NO9P,9000463.0
14664,Meglutol,CC(O)(CC(=O)O)CC(=O)O,C6H10O5,33832.0
14665,Roxatidine-d10 (hemioxalate),O=C(O)C(=O)O.[2H]C1([2H])N(Cc2cccc(OCCCNC(=O)CO)c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H].[2H]C1([2H])N(Cc2cccc(OCCCNC(=O)CO)c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H],C36H54N4O10,34007.0
14666,Dynole 34-2,CCCCCCCCNC(=O)C(C#N)=Cc1cn(CCCN(C)C)c2ccccc12,C25H36N4O,34073.0
14667,Scopolin,COc1cc2ccc(=O)oc2cc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C16H18O9,33874.0
14668,Dopastin,C/C=C/C(=O)NC[C@H](C(C)C)N(O)N=O,C9H17N3O3,32896.0
14669,"22(S),23(S)-Homobrassinolide",CC[C@@H](C(C)C)[C@H](O)[C@@H](O)[C@@H](C)[C@H]1CC[C@H]2[C@@H]3COC(=O)[C@H]4C[C@H](O)[C@H](O)C[C@]4(C)[C@H]3CC[C@]12C,C29H50O6,32884.0
14670,Neospiramycin I,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O,C36H62N2O11,34060.0
14671,diABZI STING Agonist 3,CCn1nc(C)cc1C(=O)Nc1nc2cc(C(N)=O)ccc2n1C/C=C/Cn1c(NC(=O)c2cc(C)nn2CC)nc2cc(C(N)=O)cc(OCCCO)c21,C37H42N12O6,34082.0
14672,2-methoxy Estrone,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H24O3,34155.0
14673,rac-Desethyl Oxybutynin (hydrochloride),CCNCC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1.Cl,C20H28ClNO3,34262.0
14674,Ogerin,Nc1nc(NCc2ccccc2)nc(-c2ccccc2CO)n1,C17H17N5O,34228.0
14675,Dopamine 3-O-Sulfate,NCCc1ccc(O)c(OS(=O)(=O)O)c1,C8H11NO5S,34129.0
14676,DLin-MC3-DMA,CCCCC/C=C\C/C=C\CCCCCCCCC(CCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCN(C)C,C43H79NO2,34364.0
14677,Toosendanin,CC(=O)O[C@@H]1C[C@H](O)[C@@]23CO[C@@H](O)[C@]1(C)[C@@H]2C[C@@H](O)[C@]1(C)[C@@H]3C(=O)[C@H](OC(C)=O)[C@@]2(C)[C@H](c3ccoc3)C[C@H]3O[C@]321,C30H38O11,34042.0
14678,Nelociguat,COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N,C19H17FN8O2,34133.0
14679,3-epi-25-hydroxy Vitamin D3,C=C1CC[C@@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]12,C27H44O2,34200.0
14680,N-acetyl Norfentanyl,CCC(=O)N(c1ccccc1)C1CCN(C(C)=O)CC1,C16H22N2O2,33491.0
14681,"rac-1,2-bis-Palmitoyl-3-chloropropanediol",CCCCCCCCCCCCCCCC(=O)OCC(CCl)OC(=O)CCCCCCCCCCCCCCC,C35H67ClO4,9003677.0
14682,"Carbamazepine 10,11-epoxide",NC(=O)N1c2ccccc2C2OC2c2ccccc21,C15H12N2O2,33908.0
14683,(R)-(+)-Trityl glycidyl ether,c1ccc(C(OC[C@H]2CO2)(c2ccccc2)c2ccccc2)cc1,C22H20O2,34131.0
14684,5?-Tetrahydrocortisol,C[C@]12CC[C@@H](O)C[C@H]1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,C21H34O5,34195.0
14685,"CL 218,872",Cc1nnc2ccc(-c3cccc(C(F)(F)F)c3)nn12,C13H9F3N4,34037.0
14686,SR 318,Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1,C27H33N5O2,34233.0
14687,Didemnin B,CC[C@H](C)[C@H]1NC(=O)[C@@H](NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](C)O)[C@@H](C)OC(=O)[C@H](Cc2ccc(OC)cc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)C(=O)[C@H](C(C)C)OC(=O)C[C@@H]1O,C57H89N7O15,34063.0
14688,7-hydroxy Chlorpromazine (hydrochloride),CN(C)CCCN1c2ccc(O)cc2Sc2ccc(Cl)cc21.Cl,C17H20Cl2N2OS,33729.0
14689,RBN-2397,C[C@@H](COCCC(=O)N1CCN(c2ncc(C(F)(F)F)cn2)CC1)Nc1cn[nH]c(=O)c1C(F)(F)F,C20H23F6N7O3,33558.0
14690,Nimesulide-d5,[2H]c1c([2H])c([2H])c(Oc2cc([N+](=O)[O-])ccc2NS(C)(=O)=O)c([2H])c1[2H],C13H12N2O5S,33813.0
14691,MRTX-1257,C=CC(=O)N1CCN(c2nc(OC[C@@H]3CCCN3C)nc3c2CCN(c2cccc4cccc(C)c24)C3)C[C@@H]1CC#N,C33H39N7O2,33527.0
14692,Garenoxacin,C[C@H]1NCc2cc(-c3ccc4c(=O)c(C(=O)O)cn(C5CC5)c4c3OC(F)F)ccc21,C23H20F2N2O4,33599.0
14693,"5?-Androstane-3?,17?-diol",C[C@]12CC[C@@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,C19H32O2,33569.0
14694,?-NAAG,CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O,C11H16N2O8,33337.0
14695,Diprovocim-1,O=C(N[C@H]1C[C@@H]1c1ccccc1)[C@@H]1CN(C(=O)c2ccc(C(=O)N3C[C@@H](C(=O)N[C@H]4C[C@@H]4c4ccccc4)[C@H](C(=O)N[C@H]4C[C@@H]4c4ccccc4)C3)cc2)C[C@H]1C(=O)N[C@H]1C[C@@H]1c1ccccc1,C56H56N6O6,33174.0
14696,Oxfenicine,N[C@H](C(=O)O)c1ccc(O)cc1,C8H9NO3,33698.0
14697,Polygalacic Acid,CC1(C)CC[C@]2(C(=O)O)[C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,C30H48O6,30620.0
14698,"1,3,4,6-Tetra-O-acetyl-2-azido-2-deoxy-?-D-Glucopyranose",CC(=O)OC[C@H]1O[C@H](OC(C)=O)[C@H](N=[N+]=[N-])[C@@H](OC(C)=O)[C@@H]1OC(C)=O,C14H19N3O9,31153.0
14699,Z-(L-Arg)-AMC (hydrochloride),Cc1cc(=O)oc2cc(NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc3ccccc3)ccc12.Cl,C24H28ClN5O5,30797.0
14700,2-methyl-?-Ethylaminobutiophenone (hydrochloride),CCNC(CC)C(=O)c1ccccc1C.Cl,C13H20ClNO,31521.0
14701,Pipemidic Acid (hydrate),CCn1cc(C(=O)O)c(=O)c2cnc(N3CCNCC3)nc21.O.O.O,C14H23N5O6,33719.0
14702,Desoxymethyltestosterone,C[C@]12CC=CC[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H32O,25526.0
14703,4-Methoxyphenylacetone,COc1ccc(CC(C)=O)cc1,C10H12O2,9003644.0
14704,Resolvin E2,CC[C@@H](O)/C=C/C=C\C/C=C\C/C=C\C=C\[C@@H](O)CCCC(=O)O,C20H30O4,13827.0
14705,EFdA,C#C[C@]1(CO)O[C@@H](n2cnc3c(N)nc(F)nc32)C[C@@H]1O,C12H12FN5O3,33873.0
14706,GNE-6640,CCc1c(-c2ccc3[nH]ncc3c2)cnc(N)c1-c1ccc(O)cc1,C20H18N4O,33751.0
14707,Metacetamol,CC(=O)Nc1cccc(O)c1,C8H9NO2,33404.0
14708,1-Stearoyl-2-Adrenoyl-sn-glycero-3-PE,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C45H82NO8P,33661.0
14709,Dezocine,C[C@@]12CCCCC[C@@H](Cc3ccc(O)cc31)[C@@H]2N,C16H23NO,34093.0
14710,Roxadustat-d5,[2H]c1c([2H])c([2H])c(Oc2ccc3c(O)c(C(=O)NCC(=O)O)nc(C)c3c2)c([2H])c1[2H],C19H16N2O5,34235.0
14711,Vitamin K4,CC(=O)Oc1cc(C)c(OC(C)=O)c2ccccc12,C15H14O4,33970.0
14712,3?-Benzoyloxytropane (hydrochloride),CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1ccccc1)C2.Cl,C15H20ClNO2,33573.0
14713,Forphenicine,N[C@H](C(=O)O)c1ccc(C=O)c(O)c1,C9H9NO4,33504.0
14714,Benastatin A,CCCCCc1cc2ccc3c(O)c4c(cc3c2c(O)c1C(=O)O)C(C)(C)c1cc(O)cc(O)c1C4=O,C30H28O7,32892.0
14715,diABZI STING Agonist 2,CCn1nc(C)cc1C(=O)Nc1nc2cc(C(N)=O)ccc2n1CCCCn1c(NC(=O)c2cc(C)nn2CC)nc2cc(C(N)=O)ccc21,C34H38N12O4,34088.0
14716,Alisol A,C[C@H](C[C@H](O)[C@@H](O)C(C)(C)O)C1=C2C[C@H](O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,C30H50O5,34050.0
14717,Luteolin 7-O-Rutinoside,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)c(O)c5)oc4c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C27H30O15,34035.0
14718,Alpidem,CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12,C21H23Cl2N3O,34252.0
14719,N-3-hydroxydecanoyl-DL-Homoserine lactone,CCCCCCCC(O)CC(=O)NC1CCOC1=O,C14H25NO4,34217.0
14720,CP102,CCc1c(O)c(=O)ccn1CCO,C9H13NO3,33324.0
14721,7?-hydroxy-Dehydroepiandrosterone,C[C@]12CC[C@H](O)CC1=C[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H28O3,34268.0
14722,Tropacocaine (hydrochloride),CN1[C@@H]2CC[C@H]1C[C@H](OC(=O)c1ccccc1)C2.Cl,C15H20ClNO2,18063.0
14723,Bruceantin,COC(=O)[C@@]12OC[C@]34[C@H]([C@@H](O)[C@@H]1O)[C@@]1(C)CC(=O)C(O)=C(C)[C@@H]1C[C@H]3OC(=O)[C@H](OC(=O)/C=C(\C)C(C)C)[C@@H]24,C28H36O11,33973.0
14724,iso-LSD (solution),CCN(CC)C(=O)[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,C20H25N3O,34183.0
14725,GYKI 52466 (hydrochloride),CC1=NN=C(c2ccc(N)cc2)c2cc3c(cc2C1)OCO3.Cl,C17H16ClN3O2,34418.0
14726,"N,N-DMT-d4 (fumarate)",O=C(O)/C=C/C(=O)O.[2H]C([2H])(c1c[nH]c2ccccc12)C([2H])([2H])N(C)C,C16H20N2O4,34354.0
14727,Biotin sulfone,O=C(O)CCCC[C@H]1[C@H]2NC(=O)N[C@H]2CS1(=O)=O,C10H16N2O5S,34144.0
14728,Pregabalin Diacid Impurity,CC(C)CC(CC(=O)O)C(=O)O,C8H14O4,34150.0
14729,QLT0267,COc1ccc(N=Nc2c(N)n[nH]c2N)cc1,C10H12N6O,34309.0
14730,Nefazodone-d6 (hydrochloride),Cl.[2H]C([2H])(N1CCN(c2cccc(Cl)c2)CC1)C([2H])([2H])C([2H])([2H])n1nc(CC)n(CCOc2ccccc2)c1=O,C25H33Cl2N5O2,34264.0
14731,?-Glu-Leu,CC(C)C[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)O,C11H20N2O5,33923.0
14732,Benanomicin B,COc1cc(O)c2c(c1)C(=O)c1c(cc3c(c1O)-c1c(cc(C)c(C(=O)N[C@H](C)C(=O)O)c1O)[C@H](O[C@@H]1O[C@H](C)[C@H](N)[C@H](O[C@@H]4OC[C@@H](O)[C@H](O)[C@H]4O)[C@H]1O)[C@H]3O)C2=O,C39H42N2O18,32888.0
14733,DLin-KC2-DMA,CCCCC/C=C\C/C=C\CCCCCCCCC1(CCCCCCCC/C=C\C/C=C\CCCCC)OCC(CCN(C)C)O1,C43H79NO2,34363.0
14734,16-Epiestriol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@H](O)[C@@H]2O,C18H24O3,33455.0
14735,"1,4-D-Xylobiose",O=C[C@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O,C10H18O9,34031.0
14736,BDTX-189,C=CC(=O)Nc1cc2c(Nc3ccc(OCc4ccccn4)c(Cl)c3)ncnc2cc1OCCN1CCOCC1,C29H29ClN6O4,33932.0
14737,Netupitant N-oxide,Cc1ccccc1-c1cc(N2CC[N+](C)([O-])CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,C30H32F6N4O2,34005.0
14738,CVT-6883,CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(CC)c1=O,C21H21F3N6O2,33333.0
14739,Visnagin,COc1c2ccoc2cc2oc(C)cc(=O)c12,C13H10O4,34140.0
14740,SMU127,CCOC(=O)c1c(NC(=O)N2CCN(C)CC2)sc2c1CCC2,C16H23N3O3S,33147.0
14741,Terbuthylazine,CCNc1nc(Cl)nc(NC(C)(C)C)n1,C9H16ClN5,34192.0
14742,GKT136901,Cc1c2c(=O)n(-c3ccccc3Cl)[nH]c2cc(=O)n1Cc1ccccn1,C19H15ClN4O2,34205.0
14743,3-Indoxyl Phosphate (sodium salt),O=P([O-])([O-])Oc1c[nH]c2ccccc12.[Na+].[Na+],C8H6NNa2O4P,33936.0
14744,Lumisterol 3,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@@]4(C)[C@@H]3CC[C@]12C,C27H44O,34269.0
14745,Fluridone,Cn1cc(-c2ccccc2)c(=O)c(-c2cccc(C(F)(F)F)c2)c1,C19H14F3NO,33966.0
14746,trans-hydroxy Glimepiride,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](CO)CC3)cc2)C1=O,C24H34N4O6S,34278.0
14747,Picaridin-d3,[2H]C([2H])([2H])C(CC)OC(=O)N1CCCCC1CCO,C12H23NO3,34424.0
14748,AT-511,CNc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)Oc2ccccc2)[C@@H](O)[C@@]1(C)F,C24H33FN7O7P,33869.0
14749,CP94,CCc1c(O)c(=O)ccn1CC,C9H13NO2,33323.0
14750,Desmethylmoramide,O=C(N1CCCC1)C(CCN1CCOCC1)(c1ccccc1)c1ccccc1,C24H30N2O2,33884.0
14751,Xylotriose,O=C[C@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,C15H26O13,34033.0
14752,Ureidosuccinic Acid,NC(=O)NC(CC(=O)O)C(=O)O,C5H8N2O5,34126.0
14753,Ethylbenzyl-PeGACLONE,CCCCCn1c2ccccc2c2c(=O)n(C(CC)c3ccccc3)ccc21,C25H28N2O,9003353.0
14754,Norketamine-d4 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c(C2(N)CCCCC2=O)c(Cl)c1[2H],C12H15Cl2NO,15835.0
14755,Norketamine-d4 (hydrochloride) (CRM),Cl.[2H]c1c([2H])c([2H])c(C2(N)CCCCC2=O)c(Cl)c1[2H],C12H15Cl2NO,40383.0
14756,Methyprylon,CCC1(CC)C(=O)NCC(C)C1=O,C10H17NO2,9003645.0
14757,UGT8 Inhibitor 19,CNC(=O)c1csc2c(C(F)(F)F)cc(N3CCC(OC(=O)N[C@@H](C)COC(F)(F)F)CC3)nc12,C20H22F6N4O4S,32723.0
14758,Telavancin,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,C80H106Cl2N11O27P,18610.0
14759,Ethyl Gallate,CCOC(=O)c1cc(O)c(O)c(O)c1,C9H10O5,34193.0
14760,L-Leucine,CC(C)C[C@H](N)C(=O)O,C6H13NO2,34342.0
14761,GSK-A1,COc1ncc(-c2ccc3nc(N)n(-c4ccc(N5CCOCC5)cc4)c3c2)cc1S(=O)(=O)Nc1ccccc1F,C29H27FN6O4S,34502.0
14762,STX-64,NS(=O)(=O)Oc1ccc2c3c(c(=O)oc2c1)CCCCC3,C14H15NO5S,9003206.0
14763,SB-206553 (hydrochloride),Cl.Cn1ccc2cc3c(cc21)CCN3C(=O)Nc1cccnc1,C17H17ClN4O,34263.0
14764,CDPPB,N#Cc1cccc(C(=O)Nc2cc(-c3ccccc3)nn2-c2ccccc2)c1,C23H16N4O,34132.0
14765,Celecoxib Carboxylic Acid,NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(C(=O)O)cc2)cc1,C17H12F3N3O4S,34062.0
14766,BAY-1797,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,C20H17ClN2O4S,34229.0
14767,Nicotinamide-d4,[2H]c1nc([2H])c(C(N)=O)c([2H])c1[2H],C6H6N2O,34446.0
14768,Hederacoside D,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)C[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O[C@@H]8OC[C@H](O)[C@H](O)[C@H]8O)[C@@](C)(CO)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,C53H86O22,34202.0
14769,T-5342126,CCOc1ccc(OCC(O)CN(C)Cc2c(C)nn(Cc3ccccc3Cl)c2C)cc1,C25H32ClN3O3,33099.0
14770,7?-Thiomethylspironolactone,CS[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,C23H32O3S,34526.0
14771,Curcumin analog C1,COc1ccccc1/C=C/C(=O)/C=C/c1ccccc1OC,C19H18O3,34255.0
14772,Epipregnanolone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C21H34O2,34295.0
14773,2-hydroxy Estrone,C[C@]12CC[C@@H]3c4cc(O)c(O)cc4CC[C@H]3[C@@H]1CCC2=O,C18H22O3,34154.0
14774,7-hydroxy Methotrexate,CN(Cc1nc2c(N)nc(N)nc2[nH]c1=O)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,C20H22N8O6,33239.0
14775,MK-7246,CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1,C21H21FN2O4S,34208.0
14776,7-Methoxy-4-(trifluoromethyl)coumarin,COc1ccc2c(C(F)(F)F)cc(=O)oc2c1,C11H7F3O3,34398.0
14777,Zingibroside R1,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,C42H66O14,34130.0
14778,GDC-0575,N[C@@H]1CCCN(c2c(Br)cnc3[nH]cc(NC(=O)C4CC4)c23)C1,C16H20BrN5O,34300.0
14779,Cefquinome (sulfate),CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C[n+]3cccc4c3CCCC4)CS[C@H]12)c1csc(N)n1.O=S(=O)([O-])O,C23H26N6O9S3,34266.0
14780,AMG 510,C=CC(=O)N1CCN(c2nc(=O)n(-c3c(C)ccnc3C(C)C)c3nc(-c4c(O)cccc4F)c(F)cc23)C(C)C1,C30H30F2N6O3,29465.0
14781,Etiocholanolone,C[C@]12CC[C@@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H30O2,34501.0
14782,Apronal,C=CCC(C(=O)NC(N)=O)C(C)C,C9H16N2O2,34097.0
14783,EGTA,O=C(O)CN(CCOCCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,C14H24N2O10,33963.0
14784,Dolutegravir O-?-D-Glucuronide,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)c3C(=O)N12,C26H27F2N3O11,34509.0
14785,5-Feruloylquinic Acid,COc1cc(C=CC(=O)O[C@@H]2C[C@@](O)(C(=O)O)C[C@@H](O)[C@@H]2O)ccc1O,C17H20O9,34349.0
14786,K777,CN1CCN(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](/C=C/S(=O)(=O)c2ccccc2)CCc2ccccc2)CC1,C32H38N4O4S,19114.0
14787,9-Phenanthrol,Oc1cc2ccccc2c2ccccc12,C14H10O,15248.0
14788,EN219,O=C(CCl)N1N=C(c2ccc(Br)cc2)CC1c1ccc(Br)cc1,C17H13Br2ClN2O,33957.0
14789,4-oxo Cyclophosphamide,O=C1CCOP(=O)(N(CCCl)CCCl)N1,C7H13Cl2N2O3P,33976.0
14790,Maltose (hydrate),O.O=C[C@H](O)[C@@H](O)[C@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,C12H24O12,34239.0
14791,1-Oleoyl-2-hydroxy-sn-glycero-3-PC,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C26H52NO7P,20959.0
14792,Gossypin,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc(O)c12,C21H20O13,34142.0
14793,NAG-thiazoline,CC1=N[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]2S1,C8H13NO4S,34044.0
14794,Isobergapten,COc1cc2occc2c2oc(=O)ccc12,C12H8O4,34141.0
14795,Sulfo-NHS-Biotin,O=C1N[C@H]2[C@H](CS[C@H]2CCCCC(=O)ON2C(=O)CC(S(=O)(=O)[O-])C2=O)N1.[Na+],C14H18N3NaO8S2,33362.0
14796,Zoliflodacin,C[C@@H]1CN2c3c(cc4c(N5C(=O)OC[C@@H]5C)noc4c3F)CC3(C(=O)NC(=O)NC3=O)[C@H]2[C@H](C)O1,C22H22FN5O7,34203.0
14797,Psilocin-d10,[2H]C([2H])([2H])N(C([2H])([2H])[2H])C([2H])([2H])C([2H])([2H])c1c[nH]c2cccc(O)c12,C12H16N2O,31734.0
14798,Psilocin-d10 (CRM),[2H]C([2H])([2H])N(C([2H])([2H])[2H])C([2H])([2H])C([2H])([2H])c1c[nH]c2cccc(O)c12,C12H16N2O,37038.0
14799,Nav1.7 Blocker 52,CC(=O)Nc1cccc(Nc2ncnc(N3CCC(OCc4ccc(OC(F)(F)F)cc4)CC3)n2)c1C,C25H27F3N6O3,34477.0
14800,Nilvadipine-d4,[2H]c1c([2H])c(C2C(C(=O)OC(C)C)=C(C)NC(C#N)=C2C(=O)OC)c([2H])c([N+](=O)[O-])c1[2H],C19H19N3O6,33700.0
14801,Isoscopoletin,COc1cc2oc(=O)ccc2cc1O,C10H8O4,34117.0
14802,CD532,O=C(Nc1ccc(Nc2nccc(Nc3cc(C4CCCC4)[nH]n3)n2)cc1)Nc1cccc(C(F)(F)F)c1,C26H25F3N8O,17054.0
14803,Anle138b,Brc1cccc(-c2cc(-c3ccc4c(c3)OCO4)n[nH]2)c1,C16H11BrN2O2,34259.0
14804,N-desmethyl Eletriptan,O=S(=O)(CCc1ccc2[nH]cc(C[C@H]3CCCN3)c2c1)c1ccccc1,C21H24N2O2S,34302.0
14805,Loliolide,CC1(C)C[C@H](O)C[C@@]2(C)OC(=O)C=C12,C11H16O3,34196.0
14806,BAY-885,CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1,C25H28F3N7O2,34279.0
14807,Arhalofenate,CC(=O)NCCOC(=O)[C@H](Oc1cccc(C(F)(F)F)c1)c1ccc(Cl)cc1,C19H17ClF3NO4,34575.0
14808,Imidafenacin Metabolite M4,NC(=O)C(=O)NCCC(C(N)=O)(c1ccccc1)c1ccccc1,C18H19N3O3,34301.0
14809,N-Despropyl Ropinirole,CCCNCCc1cccc2c1CC(=O)N2,C13H18N2O,34156.0
14810,Hydroxydehydro Nifedipine Carboxylate,COC(=O)c1c(C)nc(CO)c(C(=O)O)c1-c1ccccc1[N+](=O)[O-],C16H14N2O7,34406.0
14811,TP-0463518,O=C(O)CNC(=O)C1=C(O)CCN(Cc2ccc(Oc3ccc(Cl)cc3)nc2)C1=O,C20H18ClN3O6,33788.0
14812,Ripretinib,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21,C24H21BrFN5O2,33782.0
14813,VER-246608,Cc1cnc(Cl)nc1-c1ccc(N(Cc2ccc(CNC(=O)C(F)F)cc2)C(=O)c2ccc(O)cc2O)cc1,C28H23ClF2N4O4,19182.0
14814,Hydroxetamine,CCNC1(c2cccc(O)c2)CCCCC1=O,C14H19NO2,33774.0
14815,2-Oxoadipic Acid,O=C(O)CCCC(=O)C(=O)O,C6H8O5,34574.0
14816,Phenanthrene,c1ccc2c(c1)ccc1ccccc12,C14H10,34284.0
14817,Eniluracil,C#Cc1c[nH]c(=O)[nH]c1=O,C6H4N2O2,34251.0
14818,trans-carboxy Glimepiride,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C(=O)O)CC3)cc2)C1=O,C24H32N4O7S,34277.0
14819,Tropinone,CN1C2CCC1CC(=O)C2,C8H13NO,34287.0
14820,AZ876,CC(C)(C)N1C(=O)C(Nc2ccc(N3CCCCC3)cc2)=C(c2ccccc2)S1(=O)=O,C24H29N3O3S,34413.0
14821,3-O-ethyl-L-Ascorbic Acid,CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO,C8H12O6,34139.0
14822,PTIQ,CCC(=O)N1CCc2cc(OC)c(O)cc2C1,C13H17NO3,33540.0
14823,6-hydroxy Etodolac,CCc1cc(O)cc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3,C17H21NO4,34211.0
14824,Moclobemide-d4,[2H]c1c([2H])c(C(=O)NCCN2CCOCC2)c([2H])c([2H])c1Cl,C13H17ClN2O2,34247.0
14825,Dipyanone (hydrochloride),CCC(=O)C(CC(C)N1CCCC1)(c1ccccc1)c1ccccc1.Cl,C23H30ClNO,33720.0
14826,FR900359,C=C1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](C)C(=O)N[C@@H]([C@H](OC(=O)[C@@H](NC(=O)CC)[C@H](O)C(C)C)C(C)C)C(=O)N(C)[C@@H]([C@@H](C)OC)C(=O)O[C@H](C(C)C)[C@H](NC(C)=O)C(=O)O[C@H](Cc2ccccc2)C(=O)N1C,C49H75N7O15,33666.0
14827,6-Methylmercaptopurine,CSc1ncnc2nc[nH]c12,C6H6N4S,34356.0
14828,P7C3-A20 analog,COc1cccc(NC[C@H](O)Cn2c3ccc(Br)cc3c3cc(Br)ccc32)c1,C22H20Br2N2O2,34412.0
14829,8-hydroxy Amoxapine,Oc1ccc2c(c1)N=C(N1CCNCC1)c1cc(Cl)ccc1O2,C17H16ClN3O2,29192.0
14830,N-Methyldeoxynojirimycin,CN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,C7H15NO4,34378.0
14831,1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)(O)O,C19H39O7P,33479.0
14832,Mapenterol (hydrochloride),CCC(C)(C)NCC(O)c1cc(Cl)c(N)c(C(F)(F)F)c1.Cl,C14H21Cl2F3N2O,34562.0
14833,meta-Topolin,Oc1cccc(CNc2ncnc3nc[nH]c23)c1,C12H11N5O,34122.0
14834,D-Arginine,N=C(N)NCCC[C@@H](N)C(=O)O,C6H14N4O2,34194.0
14835,Remimazolam (besylate),COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.O=S(=O)(O)c1ccccc1,C27H25BrN4O5S,31717.0
14836,Baeocystin,CNCCc1c[nH]c2cccc(OP(=O)(O)O)c12,C11H15N2O4P,31583.0
14837,Baeocystin (CRM),CNCCc1c[nH]c2cccc(OP(=O)(O)O)c12,C11H15N2O4P,37763.0
14838,SB-1317,CN1C/C=C/CCOc2cccc(c2)C2=CC=N/C(=N/c3cccc(c3)C1)N2,C23H24N4O,26817.0
14839,THPP-1,COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2,C23H21ClN6O3,34219.0
14840,GS-621763,CC(C)C(=O)OC[C@H]1O[C@](C#N)(c2ccc3c(N)ncnn23)[C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C,C24H31N5O7,34125.0
14841,K6PC-5,CCCCCCCC(=O)C(CCCCCC)C(=O)NC(CO)CO,C19H37NO4,34070.0
14842,1-Kestose,OC[C@H]1O[C@@](CO)(OC[C@@]2(O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O,C18H32O16,34346.0
14843,Biotin (S)-sulfoxide,O=C(O)CCCC[C@H]1[C@H]2NC(=O)N[C@H]2C[S@@]1=O,C10H16N2O4S,34145.0
14844,SM-16,Cc1cccc(-c2nc(C34CCC(C(N)=O)(CC3)CC4)[nH]c2-c2ccc3c(c2)OCO3)n1,C25H26N4O3,34061.0
14845,Dichlorvos-d6,[2H]C([2H])([2H])OP(=O)(OC=C(Cl)Cl)OC([2H])([2H])[2H],C4H7Cl2O4P,34517.0
14846,3-Methylglutaric Acid,CC(CC(=O)O)CC(=O)O,C6H10O4,34357.0
14847,16?-hydroxy Dehydroepiandrosterone,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)[C@H](O)C[C@@H]12,C19H28O3,34116.0
14848,MK-8617,COc1ccc(C(NC(=O)c2cnc(-c3cccnn3)[nH]c2=O)c2ccc(OC)cc2)cc1,C24H21N5O4,33790.0
14849,Hydroxy Celecoxib,NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(CO)cc2)cc1,C17H14F3N3O3S,33994.0
14850,AICA Ribonucleotide,NC(=O)c1ncn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c1N,C9H15N4O8P,33907.0
14851,Norpsilocin,CNCCc1c[nH]c2cccc(O)c12,C11H14N2O,23586.0
14852,Norpsilocin (CRM),CNCCc1c[nH]c2cccc(O)c12,C11H14N2O,37943.0
14853,Indoxyl Sulfate-d5 (potassium salt),[2H]c1[nH]c2c([2H])c([2H])c([2H])c([2H])c2c1OS(=O)(=O)[O-].[K+],C8H6KNO4S,34511.0
14854,L-Leu-AMC (hydrochloride),Cc1cc(=O)oc2cc(NC(=O)[C@@H](N)CC(C)C)ccc12.Cl,C16H21ClN2O3,34267.0
14855,N-Amidino-L-aspartic Acid,N=C(N)N[C@@H](CC(=O)O)C(=O)O,C5H9N3O4,34092.0
14856,BAY-985,C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1,C27H30F3N9O,34234.0
14857,ADL 08-0011 (hydrochloride),C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)O)CC[C@@]1(C)c1cccc(O)c1.Cl,C23H30ClNO3,34298.0
14858,Trimeperidine (hydrochloride),CCC(=O)OC1(c2ccccc2)CC(C)N(C)CC1C.Cl,C17H26ClNO2,9003647.0
14859,GSK1702934A,O=C(c1cc2c(s1)CCCCC2)N1CCC(n2c(=O)[nH]c3ccccc32)CC1,C22H25N3O2S,34576.0
14860,Thymol,Cc1ccc(C(C)C)c(O)c1,C10H14O,34496.0
14861,Sorafenib-d3,[2H]C([2H])([2H])NC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,C21H16ClF3N4O3,34487.0
14862,?-Cyperone,C=C(C)[C@@H]1CC[C@@]2(C)CCC(=O)C(C)=C2C1,C15H22O,34294.0
14863,ZL006,O=C(O)c1ccc(NCc2cc(Cl)cc(Cl)c2O)cc1O,C14H11Cl2NO4,34147.0
14864,Acetylthiocholine (iodide),CC(=O)SCC[N+](C)(C)C.[I-],C7H16INOS,34313.0
14865,Atreleuton,C[C@H](C#Cc1ccc(Cc2ccc(F)cc2)s1)N(O)C(N)=O,C16H15FN2O2S,28736.0
14866,D-Galacturonic Acid (hydrate),O.O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)O,C6H12O8,34416.0
14867,Dodecanoic Acid ingenol ester,CCCCCCCCCCCC(=O)O[C@@]12C[C@@H](C)[C@]34C=C(C)[C@H](O)[C@@]3(O)[C@H](O)C(CO)=C[C@@H](C4=O)[C@@H]1C2(C)C,C32H50O7,34213.0
14868,"1,3-Dielaidoyl-2-Oleoyl Glycerol",CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C/CCCCCCCC)COC(=O)CCCCCCC/C=C/CCCCCCCC,C57H104O6,29236.0
14869,19-Norandrostenedione,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CCC2=O,C18H24O2,34110.0
14870,Midodrine-d6 (hydrochloride),Cl.[2H]C([2H])([2H])Oc1ccc(OC([2H])([2H])[2H])c(C(O)CNC(=O)CN)c1,C12H19ClN2O4,33546.0
14871,MALT,C=CCN(C)CCc1c[nH]c2ccccc12,C14H18N2,26597.0
14872,Folitixorin,Nc1nc(=O)c2c([nH]1)NCC1CN(c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)CN21,C20H23N7O6,33967.0
14873,5-trans-17-phenyl trinor Prostaglandin F2?,O=C(O)CCC/C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,C23H32O5,9003836.0
14874,4-acetoxy EPT,CCCN(CC)CCc1c[nH]c2cccc(OC(C)=O)c12,C17H24N2O2,33512.0
14875,Nicotinuric Acid,O=C(O)CNC(=O)c1cccnc1,C8H8N2O3,34096.0
14876,MLN4760,CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(=O)O)C(=O)O,C19H23Cl2N3O4,31327.0
14877,Azelastine-13C-d3 (hydrochloride),Cl.[2H][13C]([2H])([2H])N1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1,C22H25Cl2N3O,33295.0
14878,Arsenobetaine,C[As+](C)(C)CC(=O)[O-],C5H11AsO2,34515.0
14879,Furazolidone,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,C8H7N3O5,34090.0
14880,MK-1903,O=C(O)c1n[nH]c2c1C[C@@H]1C[C@H]21,C8H8N2O2,34304.0
14881,Sulfatinib,Cc1cc2cc(Oc3ccnc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)n3)ccc2[nH]1,C24H28N6O3S,34206.0
14882,Aromadendrene,C=C1CC[C@@H]2[C@H]([C@@H]3[C@H](C)CC[C@@H]13)C2(C)C,C15H24,33829.0
14883,Mauritianin,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,C33H40O19,34326.0
14884,Xanthone,O=c1c2ccccc2oc2ccccc12,C13H8O2,34098.0
14885,Ilorasertib,Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,C25H21FN6O2S,34204.0
14886,Indapamide-13C-d3,[2H][13C]([2H])([2H])C1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,C16H16ClN3O3S,34244.0
14887,Orlistat-d3,[2H]C([2H])([2H])C(C)C[C@H](NC=O)C(=O)O[C@@H](CCCCCCCCCCC)C[C@@H]1OC(=O)[C@H]1CCCCCC,C29H53NO5,34361.0
14888,(S)-O-Desmethyl Naproxen,C[C@H](C(=O)O)c1ccc2cc(O)ccc2c1,C13H12O3,34199.0
14889,Opicapone,Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(-c2cc(O)c(O)c([N+](=O)[O-])c2)n1,C15H10Cl2N4O6,34253.0
14890,Gentisein,O=c1c2cc(O)ccc2oc2cc(O)cc(O)c12,C13H8O5,33877.0
14891,4-oxo Isotretinoin,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1=O,C20H26O3,34388.0
14892,Enarodustat,O=C(O)CNC(=O)c1c(O)cc(CCc2ccccc2)n2ncnc12,C17H16N4O4,33785.0
14893,3-Methylglutaconic Acid,CC(=CC(=O)O)CC(=O)O,C6H8O4,34055.0
14894,Pyrithyldione,CCC1(CC)C(=O)C=CNC1=O,C9H13NO2,34528.0
14895,1-(4-Chlorobenzhydryl)piperazine,Clc1ccc(C(c2ccccc2)N2CCNCC2)cc1,C17H19ClN2,34518.0
14896,AMG 548,Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O,C29H27N5O,34577.0
14897,Unifiram,O=C1CCC2CN(S(=O)(=O)c3ccc(F)cc3)CCN12,C13H15FN2O3S,34209.0
14898,AZ-GHS-22,CN1CCN(CCCS(=O)(=O)c2ccc3nc(NC(=O)NC(=O)c4cc(N5CCOCC5)ccc4Cl)sc3c2)CC1,C27H33ClN6O5S2,34611.0
14899,N-Ethylmaleimide,CCN1C(=O)C=CC1=O,C6H7NO2,19938.0
14900,2-(2-Aminoethyl)-3-(4-chlorophenyl)-3-hydroxyisoindol-1-one (hydrochloride),Cl.NCCN1C(=O)c2ccccc2C1(O)c1ccc(Cl)cc1,C16H16Cl2N2O2,34667.0
14901,BI-01383298,O=C(NCc1ccc(F)cc1)C1CCN(S(=O)(=O)c2cc(Cl)cc(Cl)c2)CC1,C19H19Cl2FN2O3S,24482.0
14902,Butenafine-13C-d3 (hydrochloride),Cl.[2H][13C]([2H])([2H])N(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12,C23H28ClN,34010.0
14903,PiPT,CCCN(CCc1c[nH]c2ccccc12)C(C)C,C16H24N2,33953.0
14904,PF-9601N,C#CCNCc1cc2cc(OCc3ccccc3)ccc2[nH]1,C19H18N2O,34258.0
14905,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,C14H23N3O10,33307.0
14906,DCPIB,CCCCC1(C2CCCC2)Cc2cc(OCCCC(=O)O)c(Cl)c(Cl)c2C1=O,C22H28Cl2O4,34064.0
14907,Fluorescamine,O=C1OC2(OC=C(c3ccccc3)C2=O)c2ccccc21,C17H10O4,34286.0
14908,"3?,5?,6?-Trihydroxycholanic Acid",C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@@H](O)[C@@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H40O5,19636.0
14909,Pilsicainide (hydrochloride),Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2.Cl,C17H25ClN2O,34242.0
14910,?-Guaiene,C=C(C)[C@@H]1CC[C@H](C)C2=C(C1)[C@@H](C)CC2,C15H24,34686.0
14911,4-Androstenediol,C[C@]12CC[C@H]3[C@@H](CCC4=C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,C19H30O2,34161.0
14912,Chrysoeriol,COc1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)ccc1O,C16H12O6,33395.0
14913,(-)-11-hydroxy-?8-THC,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(CO)C[C@@H]21,C21H30O3,29469.0
14914,(-)-11-hydroxy-?8-THC (CRM),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(CO)C[C@@H]21,C21H30O3,34023.0
14915,Hydroxy Lenalidomide,Nc1c(O)ccc2c1CN(C1CCC(=O)NC1=O)C2=O,C13H13N3O4,34491.0
14916,Dimethyl 2-ketoglutarate,COC(=O)CCC(=O)C(=O)OC,C7H10O5,28394.0
14917,Belinostat,O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO,C15H14N2O4S,34084.0
14918,(E/Z)-Belinostat,O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO,C15H14N2O4S,10004279.0
14919,O-Demethyl Apremilast,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1O,C21H22N2O7S,34216.0
14920,2C-I-FLY (hydrochloride),Cl.NCCc1c2c(c(I)c3c1OCC3)OCC2,C12H15ClINO2,31132.0
14921,Palonosetron N-oxide,O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1C[N+]2([O-])CCC1CC2,C19H24N2O2,34212.0
14922,9-hydroxy Stearic Acid,CCCCCCCCCC(O)CCCCCCCC(=O)O,C18H36O3,18016.0
14923,TRx0237 (mesylate),CN(C)c1ccc2c(c1)Sc1cc(N(C)C)ccc1N2.CS(=O)(=O)O.CS(=O)(=O)O,C18H27N3O6S3,34307.0
14924,1F-Fructofuranosylnystose,OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(O[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O,C30H52O26,34292.0
14925,TH257,CCCCN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1,C24H26N2O3S,34236.0
14926,Ophiopogonin D,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O)C[C@@H](O[C@@H]6O[C@H](C)[C@H](O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C44H70O16,34385.0
14927,Flavone,O=c1cc(-c2ccccc2)oc2ccccc12,C15H10O2,34028.0
14928,Olanzapine-related Compound B,Cc1cc2c(s1)Nc1ccccc1NC2=O,C12H10N2OS,33786.0
14929,DFB,Fc1cccc(C=NN=Cc2cccc(F)c2)c1,C14H10F2N2,34395.0
14930,Glycerophosphorylethanolamine (sodium salt),NCCOP(=O)([O-])OCC(O)CO.[Na+],C5H13NNaO6P,34460.0
14931,BL 918,O=C(Nc1ccc(F)cc1F)[C@H](NC(=S)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccccc1,C23H15F8N3OS,34303.0
14932,MK-7622,Cc1ccc(Cc2cc3c(=O)n([C@H]4CCCC[C@@H]4O)cnc3c3ccccc23)cn1,C25H25N3O2,34407.0
14933,AMK (hydrochloride),COc1ccc(N)c(C(=O)CCNC(C)=O)c1.Cl,C12H17ClN2O3,34688.0
14934,Methylnortestosterone,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,C19H28O2,34108.0
14935,3'-deoxy Thymidine,Cc1cn([C@H]2CC[C@@H](CO)O2)c(=O)[nH]c1=O,C10H14N2O4,33939.0
14936,Isopimaric Acid,C=C[C@@]1(C)CC[C@H]2C(=CC[C@@H]3[C@]2(C)CCC[C@@]3(C)C(=O)O)C1,C20H30O2,34544.0
14937,Norcholic Acid,C[C@H](CC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C23H38O5,34623.0
14938,O-Desethyl Sildenafil,CCCc1nn(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3O)[nH]c12,C20H26N6O4S,34733.0
14939,Deoxyuridine 5'-monophosphate (sodium salt),O=c1ccn(C2CC(O)C(COP(=O)([O-])[O-])O2)c(=O)[nH]1.[Na+].[Na+],C9H11N2Na2O8P,34314.0
14940,Sophoricoside,O=c1c(-c2ccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc2)coc2cc(O)cc(O)c12,C21H20O10,31203.0
14941,Glufosinate-d3 (hydrochloride),Cl.[2H]C([2H])([2H])P(=O)(O)CCC(N)C(=O)O,C5H13ClNO4P,34447.0
14942,O-Desmethyl Lacosamide,CC(=O)N[C@H](CO)C(=O)NCc1ccccc1,C12H16N2O3,34403.0
14943,"CP 93,129 (hydrochloride)",Cl.Cl.O=c1ccc2[nH]cc(C3=CCNCC3)c2[nH]1,C12H15Cl2N3O,34548.0
14944,2-O-(?-D-Glucopyranosyl)glycerol,OCC(CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C9H18O8,34492.0
14945,Hesperetin 7-O-glucoside,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O,C22H24O11,34545.0
14946,Acifran,CC1(c2ccccc2)OC(C(=O)O)=CC1=O,C12H10O4,34556.0
14947,Desmethyl Mirtazapine (hydrochloride),Cl.c1ccc2c(c1)Cc1cccnc1N1CCNCC21,C16H18ClN3,34261.0
14948,Fisetin-d5,[2H]c1cc2c(=O)c(O)c(-c3c([2H])c([2H])c(O)c(O)c3[2H])oc2c([2H])c1O,C15H10O6,34706.0
14949,GP-AMC (hydrobromide),Br.Cc1cc(=O)oc2cc(NC(=O)[C@@H]3CCCN3C(=O)CN)ccc12,C17H20BrN3O4,34458.0
14950,N-(3-Phenylpropionyl)glycine,O=C(O)CNC(=O)CCc1ccccc1,C11H13NO3,34392.0
14951,Cefalonium,NC(=O)c1cc[n+](CC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)Cc4cccs4)[C@H]3SC2)cc1,C20H18N4O5S2,34468.0
14952,Kaempferol 7-O-glucoside,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c12,C21H20O11,34347.0
14953,N-Nitroso Sarcosine-d3,[2H]C([2H])([2H])N(CC(=O)O)N=O,C3H6N2O3,34740.0
14954,PNU 112455A,Cl.Nc1cc(Nc2ccc(S(N)(=O)=O)cc2)ncn1,C10H12ClN5O2S,33438.0
14955,Deslorelin (acetate),CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,C64H83N17O12(C2H4O2)X,34041.0
14956,"Uracil-13C,15N2",O=c1cc[15nH][13c](=O)[15nH]1,C4H4N2O2,33997.0
14957,Benzetimide (hydrochloride),Cl.O=C1CCC(c2ccccc2)(C2CCN(Cc3ccccc3)CC2)C(=O)N1,C23H27ClN2O2,34527.0
14958,2-methyl AP-237-d7 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)N1CCN(CC=Cc2ccccc2)CC1C,C18H27ClN2O,31647.0
14959,2-methyl AP-237-d7 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)N1CCN(CC=Cc2ccccc2)CC1C,C18H27ClN2O,41813.0
14960,Lipid 5,CCCCCCCCCOC(=O)CCCCCCCN(CCO)CCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC,C44H87NO5,34372.0
14961,Escin Ia,C/C=C(\C)C(=O)O[C@H]1[C@H](OC(C)=O)[C@]2(CO)[C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2CC1(C)C,C55H86O24,34057.0
14962,GK921,C(#Cc1nc2ncccc2nc1OCCN1CCCC1)c1ccccc1,C21H20N4O,34359.0
14963,93-O17S,CCCCCCCCCCCCCCSCCOC(=O)CCN(CCCn1ccnc1)CCC(=O)OCCSCCCCCCCCCCCCCC,C44H83N3O4S2,34367.0
14964,Nepitrin,COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2oc(-c3ccc(O)c(O)c3)cc(=O)c2c1O,C22H22O12,34387.0
14965,Epimedin C,COc1ccc(-c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)cc1,C39H50O19,34375.0
14966,Indole-3-acetamide,NC(=O)Cc1c[nH]c2ccccc12,C10H10N2O,34374.0
14967,Poliumoside,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OCCc3ccc(O)c(O)c3)[C@H](O)[C@@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,C35H46O19,34389.0
14968,Yunaconitine,CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)C34C1C([C@H](OC)[C@@H]32)[C@@]1(OC(C)=O)C[C@H](OC)[C@@]2(O)C[C@@H]4[C@@H]1C2OC(=O)c1ccc(OC)cc1,C35H49NO11,34127.0
14969,Cefoselis (sulfate),CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cn3ccc(=N)n3CCO)CS[C@H]12)c1csc(N)n1.O=S(=O)(O)O,C19H24N8O10S3,34414.0
14970,Candesartan,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,C24H20N6O3,9003239.0
14971,"1,3-Benzodioxole-5,6-diamine (hydrochloride)",Cl.Cl.Nc1cc2c(cc1N)OCO2,C7H10Cl2N2O2,34308.0
14972,Trifluoperazine N-Glucuronide,C[N+]1([C@@H]2O[C@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]2O)CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,C27H32F3N3O6S,34299.0
14973,"1,2-Didocosahexaenoyl-sn-glycero-3-PC",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC,C52H80NO8P,10733.0
14974,NVP-BVU972,Cn1cc(-c2ccc3ncc(Cc4ccc5ncccc5c4)n3n2)cn1,C20H16N6,34495.0
14975,Alizapride-13C-d3 (hydrochloride),Cl.[2H][13C]([2H])([2H])Oc1cc2[nH]nnc2cc1C(=O)NCC1CCCN1CC=C,C16H22ClN5O2,33471.0
14976,(+)-N-3-Benzylnirvanol,CC[C@@]1(c2ccccc2)NC(=O)N(Cc2ccccc2)C1=O,C18H18N2O2,30097.0
14977,Phenethyl isothiocyanate,S=C=NCCc1ccccc1,C9H9NS,27804.0
14978,1-Androstenedione,C[C@]12C=CC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H26O2,34105.0
14979,Vicenin-2,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,C27H30O15,33403.0
14980,Triazolopyridinone,O=c1[nH]nc2ccccn12,C6H5N3O,34393.0
14981,SU 5201,O=C1Nc2ccccc2C1=Cc1ccc(Cl)c(Cl)c1,C15H9Cl2NO,34333.0
14982,Norethandrolone,CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,C20H30O2,34137.0
14983,Isoproterenol-d7 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])(NCC(O)c1ccc(O)c(O)c1)C([2H])([2H])[2H],C11H18ClNO3,34704.0
14984,Suberylglycine,O=C(O)CCCCCCC(=O)NCC(=O)O,C10H17NO5,34619.0
14985,DFHBI,CC1=N/C(=C\c2cc(F)c(O)c(F)c2)C(=O)N1C,C12H10F2N2O2,34555.0
14986,Epiandrosterone,C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H30O2,34164.0
14987,Spermidine-d6,[2H]C([2H])(N)C([2H])([2H])C([2H])([2H])NCCCCN,C7H19N3,34697.0
14988,N-Propionylglycine,CCC(=O)NCC(=O)O,C5H9NO3,34377.0
14989,DSR 6434,CCCCNc1nc(N)c2[nH]c(=O)n(Cc3ccc(OCCN(C)C)nc3)c2n1,C19H28N8O2,34331.0
14990,Tiliroside,O=C(/C=C/c1ccc(O)cc1)OC[C@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H](O)[C@@H]1O,C30H26O13,34493.0
14991,Famoxadone,CC1(c2ccc(Oc3ccccc3)cc2)OC(=O)N(Nc2ccccc2)C1=O,C22H18N2O4,34470.0
14992,LTI-291,CCCCCO[C@H]1CC[C@H](NC(=O)c2cnn3c(C)cc(C)nc23)CC1,C20H30N4O2,34305.0
14993,5-Androstenediol,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,C19H30O2,34159.0
14994,rac-5-carboxy Tolterodine,CC(C)N(CCC(c1ccccc1)c1cc(C(=O)O)ccc1O)C(C)C,C22H29NO3,34074.0
14995,SYP-5,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3cccs3)c2O)O1,C18H16O3S,33791.0
14996,"N,N'-Diphenethylurea",O=C(NCCc1ccccc1)NCCc1ccccc1,C17H20N2O,33580.0
14997,Gypenoside XVII,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C48H82O18,34514.0
14998,LCL-521,CCCCCCCCCCCCCC(=O)N[C@H](COC(=O)CN(C)C)[C@H](OC(=O)CN(C)C)c1ccc([N+](=O)[O-])cc1,C31H52N4O7,29738.0
14999,Kaempferol 3-neohesperidoside,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C27H30O15,34533.0
15000,Indibulin,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12,C22H16ClN3O2,34524.0
15001,Apiin,O=c1cc(-c2ccc(O)cc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@](O)(CO)[C@H]3O)cc(O)c12,C26H28O14,34596.0
15002,Prunin,O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c21,C21H22O10,34034.0
15003,Cicloprofen,CC(C(=O)O)c1ccc2c(c1)Cc1ccccc1-2,C16H14O2,33571.0
15004,Guanine,Nc1nc(=O)c2[nH]cnc2[nH]1,C5H5N5O,34248.0
15005,Triptophenolide,CC(C)c1ccc2c(c1O)CC[C@H]1C3=C(CC[C@]21C)C(=O)OC3,C20H24O3,34390.0
15006,VU0365114,O=C1C(=O)N(Cc2ccc(-c3ccccc3)cc2)c2ccc(OC(F)(F)F)cc21,C22H14F3NO3,33709.0
15007,N-Demethylvancomycin (hydrochloride),CCC[C@@H](N)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O.Cl,C64H72Cl3N9O24,34119.0
15008,Gardenoside,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]2[C@@H]1C=C[C@@]2(O)CO,C17H24O11,34381.0
15009,Piracetam-d6,[2H]C1([2H])C(=O)N(CC(N)=O)C([2H])([2H])C1([2H])[2H],C6H10N2O2,34241.0
15010,Naptalam,O=C(O)c1ccccc1C(=O)Nc1cccc2ccccc12,C18H13NO3,34285.0
15011,Tuberostemonine,CC[C@@H]1[C@H]2CCCCN3[C@H]2[C@H](C[C@H]3[C@@H]2C[C@H](C)C(=O)O2)[C@@H]2[C@H]1OC(=O)[C@H]2C,C22H33NO4,34457.0
15012,1-Methylinosine,Cn1cnc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1=O,C11H14N4O5,34461.0
15013,Tetrahydrocoptisine,c1cc2c(c3c1CC1c4cc5c(cc4CCN1C3)OCO5)OCO2,C19H17NO4,34603.0
15014,Hexamethylene bisacetamide,CC(=O)NCCCCCCNC(C)=O,C10H20N2O2,30859.0
15015,Descarbonyl Lacosamide,COC[C@@H](N)C(=O)NCc1ccccc1,C11H16N2O2,34380.0
15016,Prohexadione,CCC(=O)C1C(=O)CC(C(=O)O)CC1=O,C10H12O5,33922.0
15017,Gibberellin A1,C=C1C[C@]23C[C@@]1(O)CC[C@H]2[C@@]12CC[C@H](O)[C@@](C)(C(=O)O1)[C@H]2[C@@H]3C(=O)O,C19H24O6,34291.0
15018,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(=O)COCCOC,C31H63NO2(C2H4O)n,34336.0
15019,Psilocybin-d4,[2H]C([2H])(c1c[nH]c2cccc(OP(=O)(O)O)c12)C([2H])([2H])N(C)C,C12H17N2O4P,33760.0
15020,Psilocybin-d4 (CRM),[2H]C([2H])(c1c[nH]c2cccc(OP(=O)(O)O)c12)C([2H])([2H])N(C)C,C12H17N2O4P,35092.0
15021,Brilliant Black BN,CC(=O)Nc1ccc(S(=O)(=O)[O-])c2cc(S(=O)(=O)[O-])c(N=Nc3ccc(N=Nc4ccc(S(=O)(=O)[O-])cc4)c4ccc(S(=O)(=O)[O-])cc34)c(O)c12.[Na+].[Na+].[Na+].[Na+],C28H17N5Na4O14S4,34462.0
15022,Caudatin,CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](O)CC3=CC[C@]12O,C28H42O7,34585.0
15023,"7-Fluoro-2,1,3-benzoxadiazole-4-sulfonate (ammonium salt)",O=S(=O)([O-])c1ccc(F)c2nonc12.[NH4+],C6H6FN3O4S,34564.0
15024,BCIP (p-toluidine salt),Cc1ccc(N)cc1.O=P(O)(O)Oc1c[nH]c2ccc(Br)c(Cl)c12,C15H15BrClN2O4P,34423.0
15025,Shanzhiside methyl ester,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]2[C@@H]1[C@H](O)C[C@]2(C)O,C17H26O11,34047.0
15026,AA-861,CC1=C(C)C(=O)C(CCCCC#CCCCC#CCO)=C(C)C1=O,C21H26O3,13263.0
15027,Mestanolone,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H32O2,21485.0
15028,Stachyose (hydrate),O.OC[C@H]1O[C@H](OC[C@H]2O[C@H](OC[C@H]3O[C@H](O[C@]4(CO)O[C@H](CO)[C@@H](O)[C@@H]4O)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,C24H44O22,34322.0
15029,2-Chloro-4-nitrophenyl ?-D-maltotrioside,O=[N+]([O-])c1ccc(O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)c(Cl)c1,C24H34ClNO18,34459.0
15030,3-Methylxanthine,Cn1c(=O)[nH]c(=O)c2[nH]cnc21,C6H6N4O2,34288.0
15031,Dolutegravir M1,C[C@@H]1CCO[C@H]2Cn3cc(C(N)=O)c(=O)c(O)c3C(=O)N12,C13H15N3O5,34508.0
15032,3-Chlorophenmetrazine (hydrochloride),CC1NCCOC1c1cccc(Cl)c1.Cl,C11H15Cl2NO,33664.0
15033,Girard's Reagent P-d5,[2H]c1c([2H])c([2H])[n+](CC(=O)NN)c([2H])c1[2H].[Cl-],C7H10ClN3O,22005.0
15034,Flavoxate-d5,[2H]c1c([2H])c([2H])c(-c2oc3c(C(=O)OCCN4CCCCC4)cccc3c(=O)c2C)c([2H])c1[2H],C24H25NO4,33816.0
15035,Isocorynoxeine,C=C[C@H]1CN2CC[C@@]3(C(=O)Nc4ccccc43)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C22H26N2O4,34653.0
15036,Isorhamnetin 3-O-neohesperidoside,COc1cc(-c2oc3cc(O)cc(O)c3c(=O)c2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)ccc1O,C28H32O16,34604.0
15037,Octenidine (hydrochloride),CCCCCCCCN=c1ccn(CCCCCCCCCCn2ccc(=NCCCCCCCC)cc2)cc1.Cl.Cl,C36H64Cl2N4,34238.0
15038,Ganodermanontriol,C[C@H](CC[C@H](O)[C@](C)(O)CO)[C@H]1CC[C@@]2(C)C3=CC[C@H]4C(C)(C)C(=O)CC[C@]4(C)C3=CC[C@]12C,C30H48O4,34325.0
15039,SKLB1002,COc1cc2ncnc(Sc3nnc(C)s3)c2cc1OC,C13H12N4O2S2,34422.0
15040,Methandriol,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,C20H32O2,34135.0
15041,Sekikaic Acid,CCCc1cc(OC)cc(O)c1C(=O)Oc1c(OC)cc(CCC)c(C(=O)O)c1O,C22H26O8,13993.0
15042,7-Ethoxy-4-(trifluoromethyl)coumarin,CCOc1ccc2c(C(F)(F)F)cc(=O)oc2c1,C12H9F3O3,34610.0
15043,Rosin,OC[C@H]1O[C@@H](OC/C=C/c2ccccc2)[C@H](O)[C@@H](O)[C@@H]1O,C15H20O6,34383.0
15044,Glyphosate,O=C(O)CNCP(=O)(O)O,C3H8NO5P,28858.0
15045,IU1-47,Cc1cc(C(=O)CN2CCCCC2)c(C)n1-c1ccc(Cl)cc1,C19H23ClN2O,34095.0
15046,Norfluoxetine-d5 (hydrochloride),Cl.[2H]C([2H])(N)C([2H])([2H])C([2H])(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,C16H17ClF3NO,34742.0
15047,DL-o-Tyrosine,NC(Cc1ccccc1O)C(=O)O,C9H11NO3,33570.0
15048,GSK2795039,CC(C)n1cc(-c2ccc3c(c2)N(C)CC3)c2c(NS(=O)(=O)c3ccn(C)n3)ccnc21,C23H26N6O2S,33777.0
15049,Emodin 8-glucoside,Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c1C2=O,C21H20O10,34474.0
15050,Benzovindiflupyr,Cn1cc(C(=O)Nc2cccc3c2C2CCC3C2=C(Cl)Cl)c(C(F)F)n1,C18H15Cl2F2N3O,34595.0
15051,Incyclinide,NC(=O)C1=C(O)C[C@@H]2C[C@@H]3Cc4cccc(O)c4C(=O)C3=C(O)[C@]2(O)C1=O,C19H17NO7,34597.0
15052,EB 47 (hydrochloride),Cl.Cl.Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)N2CCN(CC(=O)Nc3cccc4c3CNC4=O)CC2)[C@@H](O)[C@H]1O,C24H29Cl2N9O6,34684.0
15053,Tetrahydrocortisone,C[C@]12CC[C@@H](O)C[C@H]1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,C21H32O5,34344.0
15054,L-Asparagine (hydrate),NC(=O)C[C@H](N)C(=O)O.O,C4H10N2O4,34519.0
15055,Podocarpusflavone A,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4O)c3o2)cc1,C31H20O10,34613.0
15056,Adenosine amine congener,NCCNC(=O)Cc1ccc(NC(=O)Cc2ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)cc1,C28H32N8O6,34394.0
15057,Ipidacrine,Nc1c2c(nc3c1CCC3)CCCC2,C12H16N2,34529.0
15058,AMCA N-succinimidyl ester,Cc1c(CC(=O)ON2C(=O)CCC2=O)c(=O)oc2cc(N)ccc12,C16H14N2O6,34668.0
15059,BRD6929,CC(=O)Nc1ccc(C(=O)Nc2cc(-c3cccs3)ccc2N)cc1,C19H17N3O2S,34149.0
15060,CBGP,CCCCCCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1,C23H36O2,30312.0
15061,Picosulfate (sodium salt hydrate),O.O=S(=O)([O-])Oc1ccc(C(c2ccc(OS(=O)(=O)[O-])cc2)c2ccccn2)cc1.[Na+].[Na+],C18H15NNa2O9S2,34566.0
15062,Ungeremine,Oc1cc2c3c(c1)c1cc4c(cc1c[n+]3CC2)OCO4,C16H12NO3,34549.0
15063,"5(6)-Carboxy-2',7'-dichlorofluorescein diacetate",CC(=O)Oc1cc2c(cc1Cl)C1(OC(=O)c3cc(C(=O)O)ccc31)c1cc(Cl)c(OC(C)=O)cc1O2.CC(=O)Oc1cc2c(cc1Cl)C1(OC(=O)c3ccc(C(=O)O)cc31)c1cc(Cl)c(OC(C)=O)cc1O2,C50H28Cl4O18,34692.0
15064,5-chloro-2-Thiothinone (hydrochloride),CNC(C)C(=O)c1ccc(Cl)s1.Cl,C8H11Cl2NOS,32544.0
15065,8-Oxycoptisine,O=c1c2c3c(ccc2cc2n1CCc1cc4c(cc1-2)OCO4)OCO3,C19H13NO5,34472.0
15066,SRT 3025 (hydrochloride),COCCCc1sc(-c2ccccc2)nc1C(=O)Nc1ccccc1-c1nc2cc(CN3CCCC3)cnc2s1.Cl,C31H32ClN5O2S2,34420.0
15067,5-Ethynyluridine,C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]c1=O,C11H12N2O6,34391.0
15068,"3,4,5-Trimethoxybenzoic Acid",COc1cc(C(=O)O)cc(OC)c1OC,C10H12O5,34750.0
15069,Quassin,COC1=C[C@@H](C)[C@@H]2C[C@H]3OC(=O)C[C@H]4C(C)=C(OC)C(=O)[C@H]([C@@]2(C)C1=O)[C@@]34C,C22H28O6,34382.0
15070,11(Z)-Docosenoic Acid,CCCCCCCCCC/C=C\CCCCCCCCCC(=O)O,C22H42O2,34582.0
15071,Deltaline,CCN1C[C@]2(C)CC[C@H](OC)C34C1C1(OCO[C@@]15C[C@H](OC)[C@H]1C[C@]3(O)[C@@H]5C1OC)[C@@H](OC(C)=O)[C@@H]42,C27H41NO8,34612.0
15072,D-(+)-Fucose,C[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O,C6H12O5,34343.0
15073,Dihydrokavain,COC1=CC(=O)O[C@@H](CCc2ccccc2)C1,C14H16O3,33822.0
15074,Dihydrokavain (CRM),COC1=CC(=O)O[C@@H](CCc2ccccc2)C1,C14H16O3,41815.0
15075,N-Benzyl Linoleamide,CCCCC/C=C\C/C=C\CCCCCCCC(=O)NCc1ccccc1,C25H39NO,33358.0
15076,Orcinol,Cc1cc(O)cc(O)c1,C7H8O2,34467.0
15077,4-Nitrophenyl Phosphate (sodium salt hydrate),O.O.O.O.O.O.O=[N+]([O-])c1ccc(OP(=O)([O-])[O-])cc1.[Na+].[Na+],C6H16NNa2O12P,34081.0
15078,Oxyberberine,COc1ccc2cc3n(c(=O)c2c1OC)CCc1cc2c(cc1-3)OCO2,C20H17NO5,34384.0
15079,"2,3,5,4'-Tetrahydroxyl-diphenylethylene 2-O-?-D-Glucoside",OC[C@H]1O[C@@H](Oc2c(O)cc(O)cc2/C=C/c2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O,C20H22O9,34594.0
15080,Bufotalin,CC(=O)O[C@H]1C[C@]2(O)[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1c1ccc(=O)oc1,C26H36O6,34466.0
15081,Perhydrofarnesyl Acetone,CC(=O)CCCC(C)CCCC(C)CCCC(C)C,C18H36O,33825.0
15082,Verbenalin,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]2[C@@H]1C(=O)C[C@@H]2C,C17H24O10,34663.0
15083,Dexloxiglumide,CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1,C21H30Cl2N2O5,34759.0
15084,N-Acetyl-DL-Aspartic Acid,CC(=O)NC(CC(=O)O)C(=O)O,C6H9NO5,34635.0
15085,N-Methylcytisine,CN1C[C@@H]2C[C@H](C1)c1cccc(=O)n1C2,C12H16N2O,34752.0
15086,Veratrosine,Cc1c([C@H](C)[C@@H]2NC[C@@H](C)C[C@H]2O)ccc2c1C[C@H]1[C@H]2CC=C2C[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)CC[C@@]21C,C33H49NO7,34617.0
15087,Methyl Diethyldithiocarbamate,CCN(CC)C(=S)SC,C6H13NS2,34379.0
15088,3-Hydroxypicolinic Acid,O=C(O)c1ncccc1O,C6H5NO3,34530.0
15089,Notoginsenoside Fe,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@@H](CO)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C,C47H80O17,34297.0
15090,Byakangelicin,COc1c2ccoc2c(OC[C@@H](O)C(C)(C)O)c2oc(=O)ccc12,C17H18O7,34600.0
15091,N?-Benzoyl-DL-Arginine-pNA (hydrochloride),Cl.N=C(N)NCCCC(NC(=O)c1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1,C19H23ClN6O4,33934.0
15092,GC7 (sulfate),N=C(N)NCCCCCCCN.O=S(=O)(O)O,C8H22N4O4S,34761.0
15093,BMS 1166 (hydrochloride),Cc1c(COc2cc(OCc3cccc(C#N)c3)c(CN3C[C@H](O)C[C@@H]3C(=O)O)cc2Cl)cccc1-c1ccc2c(c1)OCCO2.Cl,C36H34Cl2N2O7,27774.0
15094,7-ethyl Camptothecin,CCc1c2c(nc3ccccc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,C22H20N2O4,34607.0
15095,Chlorzoxazone-d3,[2H]c1c(Cl)c([2H])c2[nH]c(=O)oc2c1[2H],C7H4ClNO2,34237.0
15096,Silychristin,COc1cc([C@@H]2Oc3c(O)cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)cc3[C@H]2CO)ccc1O,C25H22O10,34658.0
15097,CAY17c,Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1OCCCCCC(=O)NO,C24H30N4O4S,31077.0
15098,12-hydroxy Stearic Acid,CCCCCCC(O)CCCCCCCCCCC(=O)O,C18H36O3,34558.0
15099,Corylifol A,CC(C)=CCC/C(C)=C/Cc1cc(-c2coc3cc(O)ccc3c2=O)ccc1O,C25H26O4,34616.0
15100,Maleimide-PEG2-AZD,O=C(CCN1C(=O)C=CC1=O)NCCOCCOCCC(=O)Nc1ccc(CCC(=O)N2CCC2=O)cc1,C26H32N4O8,20129.0
15101,UDP-?-D-Galactose (sodium salt),O=c1ccn([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1.[Na+].[Na+],C15H22N2Na2O17P2,34664.0
15102,Engeletin,C[C@@H]1O[C@@H](O[C@H]2C(=O)c3c(O)cc(O)cc3O[C@@H]2c2ccc(O)cc2)[C@H](O)[C@H](O)[C@H]1O,C21H22O10,34657.0
15103,5-hydroxy Flunixin,Cc1c(Nc2ncc(O)cc2C(=O)O)cccc1C(F)(F)F,C14H11F3N2O3,33930.0
15104,BAY-8002,O=C(Nc1ccccc1C(=O)O)c1cc(S(=O)(=O)c2ccccc2)ccc1Cl,C20H14ClNO5S,34231.0
15105,EX-229,Cc1ccc(Oc2nc3cc(Cl)c(-c4ccc5c(ccn5C)c4)cc3[nH]2)cc1C(=O)O,C24H18ClN3O3,34690.0
15106,O-desmethyl Brinzolamide (hydrochloride),CCN[C@H]1CN(CCCO)S(=O)(=O)c2sc(S(N)(=O)=O)cc21.Cl,C11H20ClN3O5S3,34276.0
15107,Pendimethalin,CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-],C13H19N3O4,34557.0
15108,Pendimethalin (CRM),CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-],C13H19N3O4,39352.0
15109,Byakangelicol,COc1c2ccoc2c(OC[C@H]2OC2(C)C)c2oc(=O)ccc12,C17H16O6,34571.0
15110,?-Ketoisocaproic Acid,CC(C)CC(=O)C(=O)O,C6H10O3,34749.0
15111,Psilocin-d6,[2H]C([2H])([2H])N(CCc1c[nH]c2cccc(O)c12)C([2H])([2H])[2H],C12H16N2O,34780.0
15112,L-Arginine-d7 (hydrochloride),Cl.[2H]C([2H])(NC(=N)N)C([2H])([2H])C([2H])([2H])[C@]([2H])(N)C(=O)O,C6H15ClN4O2,34834.0
15113,2-methyl-?-Pyrrolidinovalerophenone (hydrochloride),CCCC(C(=O)c1ccccc1C)N1CCCC1.Cl,C16H24ClNO,34397.0
15114,N-Nitroso Atenolol,CC(C)N(CC(O)COc1ccc(CC(N)=O)cc1)N=O,C14H21N3O4,34735.0
15115,GSK626616,O=C1N=C(Nc2c(Cl)cccc2Cl)S/C1=C\c1ccc2nccnc2c1,C18H10Cl2N4OS,34621.0
15116,Allocryptopine,COc1ccc2c(c1OC)CN(C)CCc1cc3c(cc1C(=O)C2)OCO3,C21H23NO5,34751.0
15117,Fraxinellone,CC1=C2C(=O)O[C@@H](c3ccoc3)[C@]2(C)CCC1,C14H16O3,34672.0
15118,Crassicauline A,CCN1C[C@]2(COC)CC[C@H](OC)C34C1C([C@H](OC)[C@@H]32)[C@@]1(OC(C)=O)C[C@H](OC)[C@@]2(O)C[C@@H]4[C@@H]1C2OC(=O)c1ccc(OC)cc1,C35H49NO10,34674.0
15119,Parbendazole,CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1,C13H17N3O2,34754.0
15120,1-(3-Chlorophenyl)biguanide (hydrochloride),Cl.N=C(N)NC(=N)Nc1cccc(Cl)c1,C8H11Cl2N5,34726.0
15121,(+)-?-Cadinene,CC1=C[C@@H]2C(=C(C)CC[C@H]2C(C)C)CC1,C15H24,34444.0
15122,CHIR98024,Nc1nc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-],C20H17Cl2N9O2,34872.0
15123,Eledoisin-related Peptide,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O,C34H58N8O6S,33115.0
15124,MS023,CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1,C17H25N3O,34786.0
15125,5-methoxy-N-methyl Tryptamine,CNCCc1c[nH]c2ccc(OC)cc12,C12H16N2O,28278.0
15126,Carbidopa-d3 (hydrate),O.[2H]c1c([2H])c(C[C@](C)(NN)C(=O)O)c([2H])c(O)c1O,C10H16N2O5,34884.0
15127,D-Glutamic Acid-d5,[2H]C([2H])(C(=O)O)C([2H])([2H])[C@@]([2H])(N)C(=O)O,C5H9NO4,34840.0
15128,Capsorubin,CC(/C=C/C=C(C)/C=C/C(=O)[C@]1(C)C[C@@H](O)CC1(C)C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C(=O)[C@]1(C)C[C@@H](O)CC1(C)C,C40H56O4,35115.0
15129,Carboxyphosphamide,NP(=O)(OCCC(=O)O)N(CCCl)CCCl,C7H15Cl2N2O4P,34052.0
15130,DL-Histidine-d3,[2H]C(N)(C(=O)O)C([2H])([2H])c1cnc[nH]1,C6H9N3O2,34841.0
15131,Ardisiacrispin A,CC1(C)[C@@H](O[C@@H]2OC[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3CC[C@]45OC[C@@]6(CC[C@](C)(C=O)C[C@H]64)[C@H](O)C[C@@]5(C)[C@]3(C)CC[C@@H]12,C52H84O22,34615.0
15132,13C6-4-Nitroaniline,N[13c]1[13cH][13cH][13c]([N+](=O)[O-])[13cH][13cH]1,C6H6N2O2,34858.0
15133,4-Acetamidobenzenesulfonamide,CC(=O)Nc1ccc(S(N)(=O)=O)cc1,C8H10N2O3S,34689.0
15134,rac-N-desmethyl Ivabradine-d6 (hydrochloride),Cl.[2H]C([2H])(NCC1Cc2cc(OC)c(OC)cc21)C([2H])([2H])C([2H])([2H])N1CCc2cc(OC)c(OC)cc2CC1=O,C26H35ClN2O5,34513.0
15135,Resolvin D2 n-3 DPA,CC/C=C\C[C@H](O)[C@H](O)/C=C/C=C/C=C\C=C\[C@@H](O)CCCCCC(=O)O,C22H34O5,34482.0
15136,3-Hydroxycoumarin,O=c1oc2ccccc2cc1O,C9H6O3,34815.0
15137,N-Nornuciferine,COc1cc2c3c(c1OC)-c1ccccc1C[C@H]3NCC2,C18H19NO2,34756.0
15138,C82,CCc1cc2c(=O)n(CC(=O)Nc3ccccc3OC)cnc2s1,C17H17N3O3S,33563.0
15139,MK-3697,COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2-c2nccs2)nc1OC,C23H21N5O3S,34718.0
15140,Obtusifolin,COc1c(O)c(C)cc2c1C(=O)c1c(O)cccc1C2=O,C16H12O5,34757.0
15141,Murrayone,C=C(C)C(=O)Cc1c(OC)ccc2ccc(=O)oc12,C15H14O4,34767.0
15142,Incensole Acetate,CC(=O)O[C@H]1CC/C(C)=C/CC/C(C)=C/C[C@]2(C(C)C)CC[C@@]1(C)O2,C22H36O3,34614.0
15143,Ribavirin-13C5,NC(=O)c1ncn([13C@@H]2O[13C@H]([13CH2]O)[13C@@H](O)[13C@H]2O)n1,C8H12N4O5,34882.0
15144,Levomefolate-13C-d3,[2H][13C]([2H])([2H])N1c2c([nH]c(N)nc2=O)NC[C@@H]1CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,C20H25N7O6,29579.0
15145,EC5026,CC[C@H](C)C(=O)N1CCC(NC(=O)Nc2ccc(OC(F)(F)F)c(F)c2)CC1,C18H23F4N3O3,33634.0
15146,N-(1-Benzyl-4-piperidyl)-N-benzylpropanamide (hydrochloride),CCC(=O)N(Cc1ccccc1)C1CCN(Cc2ccccc2)CC1.Cl,C22H29ClN2O,34593.0
15147,25-hydroxy Vitamin D2-d6,[2H]C([2H])([2H])C(O)([C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3/C[C@@H](O)CCC3=C)CCC[C@]12C)C([2H])([2H])[2H],C28H44O2,34853.0
15148,3-O-methyl Quercetin,COc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O,C16H12O7,29333.0
15149,Isoursodeoxycholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H40O4,34620.0
15150,IM-156 (acetate),CC(=O)O.N=C(NC(=N)N1CCCC1)Nc1ccc(OC(F)(F)F)cc1,C13H16F3N5O(C2H4O2)X,34763.0
15151,4F 4PP (oxalate),O=C(O)C(=O)O.O=C(c1ccc(F)cc1)C1CCN(CCCCc2ccccc2)CC1,C24H28FNO5,35005.0
15152,?-Fluvalinate,CC(C)[C@@H](Nc1ccc(C(F)(F)F)cc1Cl)C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1,C26H22ClF3N2O3,34520.0
15153,Salicyluric Acid,O=C(O)CNC(=O)c1ccccc1O,C9H9NO4,34813.0
15154,Ganoderic Acid DM,C/C(=C\CC[C@@H](C)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1CC3=O)C(=O)O,C30H44O4,34536.0
15155,Difelikefalin (trifluoroacetate salt),CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(C(=O)O)CC1.O=C(O)C(F)(F)F,C36H53N7O6(C2HF3O2)X,34542.0
15156,Metolazone-d7,[2H]c1c([2H])c([2H])c(C([2H])([2H])[2H])c(N2C(=O)c3cc(S(N)(=O)=O)c(Cl)cc3NC2C)c1[2H],C16H16ClN3O3S,34243.0
15157,9-Methyl-?-carboline,Cn1c2ccccc2c2ccncc21,C12H10N2,33583.0
15158,Saikosaponin C,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@H]3CC[C@]4(C)[C@H]5C=C[C@]67OC[C@@]8(CCC(C)(C)C[C@H]86)[C@@H](O)C[C@@]7(C)[C@]5(C)CC[C@H]4C3(C)C)O[C@@H]2CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,C48H78O17,34599.0
15159,3-Chlorocathinone (hydrochloride),CC(N)C(=O)c1cccc(Cl)c1.Cl,C9H11Cl2NO,33687.0
15160,2-Thiouracil,O=c1cc[nH]c(=S)[nH]1,C4H4N2OS,34747.0
15161,Sophoraflavanone G,C=C(C)[C@H](CC=C(C)C)Cc1c(O)cc(O)c2c1O[C@H](c1ccc(O)cc1O)CC2=O,C25H28O6,34755.0
15162,Wilforlide A,CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3CC=C4[C@@H]5C[C@@]6(C)C[C@H](OC6=O)[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,C30H46O3,34654.0
15163,PHY34,COc1cc2c(O[C@@H]3O[C@H](CO)[C@@H]4OC(C)(C)O[C@@H]4[C@H]3O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,C30H30O12,33584.0
15164,Uridine-5'-monophosphate (sodium salt hydrate),O.O=c1ccn([C@@H]2O[C@H](COP(=O)([O-])[O-])[C@@H](O)[C@H]2O)c(=O)[nH]1.[Na+].[Na+],C9H11N2Na2O9P(H2O)x,34525.0
15165,Songorine,C=C1[C@H]2C[C@@]3([C@@H]1O)[C@@H](CC2=O)[C@@]12[C@@H]4C[C@H]3[C@H]1N(CC)C[C@]4(C)CC[C@@H]2O,C22H31NO3,34601.0
15166,Faropenem (sodium salt hydrate),C[C@@H](O)[C@H]1C(=O)N2C(C(=O)[O-])=C([C@H]3CCCO3)S[C@H]12.C[C@@H](O)[C@H]1C(=O)N2C(C(=O)[O-])=C([C@H]3CCCO3)S[C@H]12.O.O.O.O.O.[Na+].[Na+],C24H38N2Na2O15S2,34507.0
15167,5-Carboxytetramethylrhodamine,CN(C)c1ccc2c(-c3ccc(C(=O)O)cc3C(=O)[O-])c3ccc(N(C)C)cc3[o+]c2c1,C25H22N2O5,34598.0
15168,8Br-HA,O=C(COc1ccc2c3c(c(=O)oc2c1Br)CCCC3)NO,C15H14BrNO5,34728.0
15169,Plitidepsin,CC[C@H](C)[C@H]1NC(=O)[C@@H](NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]2CCCN2C(=O)C(C)=O)[C@@H](C)OC(=O)[C@H](Cc2ccc(OC)cc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)C(=O)[C@H](C(C)C)OC(=O)C[C@@H]1O,C57H87N7O15,34053.0
15170,AH 7921-d3,[2H]c1c([2H])c(C(=O)NCC2(N(C)C)CCCCC2)c([2H])c(Cl)c1Cl,C16H22Cl2N2O,33723.0
15171,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCO)CCCCCCOC(=O)C(CCCCCC)CCCCCCCC,C48H95NO5,34337.0
15172,DSRM-3716,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCO)CCCCCCOC(=O)C(CCCCCC)CCCCCCCC,C48H95NO5,39517.0
15173,L-Threonine-d2,[2H][C@](C)(O)[C@]([2H])(N)C(=O)O,C4H9NO3,34828.0
15174,Arecaidine propargyl ester (hydrobromide),Br.C#CCOC(=O)C1=CCCN(C)C1,C10H14BrNO2,34568.0
15175,CCS-1477,CO[C@H]1CC[C@H](n2c([C@@H]3CCCC(=O)N3c3ccc(F)c(F)c3)nc3cc(-c4c(C)noc4C)ccc32)CC1,C30H32F2N4O3,34546.0
15176,Olivetol,CCCCCc1cc(O)cc(O)c1,C11H16O2,35202.0
15177,Simazine,CCNc1nc(Cl)nc(NCC)n1,C7H12ClN5,36491.0
15178,L-Asparagine-d3 (hydrate),O.[2H]C([2H])(C(N)=O)[C@]([2H])(N)C(=O)O,C4H10N2O4,34835.0
15179,Isopimpinellin,COc1c2ccoc2c(OC)c2oc(=O)ccc12,C13H10O5,34642.0
15180,Menthone,CC1CCC(C(C)C)C(=O)C1,C10H18O,34683.0
15181,L-Valine-d8,[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])[C@]([2H])(N)C(=O)O,C5H11NO2,34830.0
15182,L-Tryptophan-d5,[2H]c1[nH]c2c([2H])c([2H])c([2H])c([2H])c2c1C[C@H](N)C(=O)O,C11H12N2O2,34829.0
15183,SPA70,COc1ccc(OC)c(-n2nnc(S(=O)(=O)c3ccc(C(C)(C)C)cc3)c2C)c1,C21H25N3O4S,34490.0
15184,Cyclo(Phe-Pro),O=C1NC(Cc2ccccc2)C(=O)N2CCCC12,C14H16N2O2,34758.0
15185,"all-trans-13,14-Dihydroretinol",CC1=C(/C=C/C(C)=C/C=C/C(C)CCO)C(C)(C)CCC1,C20H32O,34873.0
15186,N-Nitroso Fluoxetine,CN(CCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1)N=O,C17H17F3N2O2,34879.0
15187,Acetophenazine (maleate),CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,C31H37N3O10S,34415.0
15188,Gitogenin,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O)[C@H](O)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C27H44O4,34681.0
15189,DL-Phenyl-d5-alanine,[2H]c1c([2H])c([2H])c(CC(N)C(=O)O)c([2H])c1[2H],C9H11NO2,34845.0
15190,Fenpropathrin,CC1(C)C(C(=O)OC(C#N)c2cccc(Oc3ccccc3)c2)C1(C)C,C22H23NO3,34478.0
15191,Grosvenorine,C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O,C33H40O19,34810.0
15192,Atipamezole,CCC1(c2cnc[nH]2)Cc2ccccc2C1,C14H16N2,34289.0
15193,L-Serine-13C3,N[13C@@H]([13CH2]O)[13C](=O)O,C3H7NO3,35126.0
15194,7?-Thiospironolactone,C[C@]12CCC(=O)C=C1C[C@@H](S)[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]21CCC(=O)O1,C22H30O3S,34868.0
15195,L-Proline-d3,[2H]C1([2H])CC[C@@]([2H])(C(=O)O)N1,C5H9NO2,34846.0
15196,Levistolide A,CCC/C=C1\OC(=O)C2=C1CC[C@H]1[C@H]3C=C4C(=O)O/C(=C\CCC)[C@@]4(CC3)[C@@H]21,C24H28O4,34386.0
15197,Isoleucine-d10,[2H]C([2H])([2H])C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])(N)C(=O)O,C6H13NO2,34842.0
15198,Acefylline,Cn1c(=O)c2c(ncn2CC(=O)O)n(C)c1=O,C9H10N4O4,33996.0
15199,PTC-028,Cc1nc2cc(F)c(F)cc2n1-c1cncc(Nc2ccc(C(F)(F)F)cc2)n1,C19H12F5N5,34471.0
15200,L-Aspartyl-L-phenylalanine,N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,C13H16N2O5,34197.0
15201,D-Biopterin,C[C@@H](O)[C@@H](O)c1c[nH]c2nc(N)nc(=O)c-2n1,C9H11N5O3,34201.0
15202,Triclabendazole-13C-d3,[2H][13C]([2H])([2H])Sc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1,C14H9Cl3N2OS,34011.0
15203,Coelenterazine hcp,O=c1c(Cc2ccccc2)nc2c(CC3CCCC3)[nH]c(-c3ccc(O)cc3)cn1-2,C25H25N3O2,34724.0
15204,Lumateperone (tosylate),CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12.Cc1ccc(S(=O)(=O)O)cc1,C31H36FN3O4S,34541.0
15205,2'-Deoxycytidine,Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,C9H13N3O4,34708.0
15206,SH-42,CC(=O)O[C@H]1CC[C@@]2(C)[C@@H](CC=C3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)COC=O)CC[C@@H]32)C1,C25H38O4,34677.0
15207,Tilmicosin-d3,[2H]C([2H])([2H])N(C)[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H](CCN3C[C@H](C)C[C@H](C)C3)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@H](CO[C@@H]3O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]3OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@@H]2C)O[C@H](C)[C@H]1O,C46H80N2O13,33545.0
15208,NSC 756093,COc1ccc2c(c1)N(CCO)C1=C(C(=O)OC1)C2c1ccccc1,C20H19NO4,35023.0
15209,Desacetylrifampicin,CO[C@H]1/C=C\O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](O)[C@@H]1C,C41H56N4O11,34817.0
15210,Disogluside,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C33H52O8,34746.0
15211,Decursinol,CC1(C)Oc2cc3oc(=O)ccc3cc2C[C@@H]1O,C14H14O4,34807.0
15212,Methylmethaqualone,Cc1ccc(-n2c(C)nc3ccccc3c2=O)c(C)c1,C17H16N2O,21839.0
15213,Gallein,O=C1OC2(c3ccccc31)c1ccc(O)c(O)c1Oc1c2ccc(O)c1O,C20H12O7,16344.0
15214,Alisol B,C[C@H](C[C@H](O)[C@H]1OC1(C)C)C1=C2C[C@H](O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,C30H48O4,34808.0
15215,L-Leucine-d10,[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])[C@]([2H])(N)C(=O)O,C6H13NO2,34843.0
15216,O-Des[2-aminoethyl]-O-carboxymethyl dehydroamlodipine,CCOC(=O)c1c(COCC(=O)O)nc(C)c(C(=O)OC)c1-c1ccccc1Cl,C20H20ClNO7,35213.0
15217,4-Hexylresorcinol,CCCCCCc1ccc(O)cc1O,C12H18O2,34824.0
15218,Harmol,Cc1nccc2c1[nH]c1cc(O)ccc12,C12H10N2O,33844.0
15219,680C91,Fc1ccc2c(/C=C/c3cccnc3)c[nH]c2c1,C15H11FN2,34823.0
15220,Bavachalcone,CC(C)=CCc1cc(C(=O)/C=C/c2ccc(O)cc2)c(O)cc1O,C20H20O4,34673.0
15221,Swertisin,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C22H22O10,34744.0
15222,N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 2-ethylbutyl ester,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(Oc1ccccc1)Oc1ccc([N+](=O)[O-])cc1,C21H27N2O7P,34748.0
15223,2-Thiocytidine,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=S)n1,C9H13N3O4S,34732.0
15224,3-methoxy Rolicyclidine (hydrochloride),COc1cccc(C2(N3CCCC3)CCCCC2)c1.Cl,C17H26ClNO,34638.0
15225,Heptabarbital,CCC1(C2=CCCCCC2)C(=O)NC(=O)NC1=O,C13H18N2O3,32706.0
15226,Dehydrowarfarin,CC(=O)/C=C(\c1ccccc1)c1c(O)c2ccccc2oc1=O,C19H14O4,33995.0
15227,Psilocybin-d10,[2H]C([2H])([2H])N(C([2H])([2H])[2H])C([2H])([2H])C([2H])([2H])c1c[nH]c2cccc(OP(=O)(O)O)c12,C12H17N2O4P,33761.0
15228,Psilocybin-d10 (exempt preparation),[2H]C([2H])([2H])N(C([2H])([2H])[2H])C([2H])([2H])C([2H])([2H])c1c[nH]c2cccc(OP(=O)(O)O)c12,C12H17N2O4P,40356.0
15229,"2,5-Dioxopyrrolidin-1-yl 4-(pyren-1-yl)butanoate",O=C(CCCc1ccc2ccc3cccc4ccc1c2c34)ON1C(=O)CCC1=O,C24H19NO4,34666.0
15230,2-(1-Piperazinyl)pyrimidine,c1cnc(N2CCNCC2)nc1,C8H12N4,34091.0
15231,Mofegiline (hydrochloride),Cl.NC/C(=C/F)CCc1ccc(F)cc1,C11H14ClF2N,35010.0
15232,CVT-2738,Cc1cccc(C)c1NC(=O)CN1CCNCC1,C14H21N3O,35003.0
15233,PD 166285,CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1,C26H27Cl2N5O2,26804.0
15234,DC661,CN(CCCCCCNc1ccnc2cc(Cl)ccc12)CCCCCCNc1ccnc2cc(Cl)ccc12,C31H39Cl2N5,34899.0
15235,N-Nitroso Clonidine,O=NN1CCN=C1Nc1c(Cl)cccc1Cl,C9H8Cl2N4O,34736.0
15236,Sardomozide (hydrochloride),Cl.Cl.N=C(N)N/N=C1\CCc2c(C(=N)N)cccc21,C11H16Cl2N6,34901.0
15237,"Cholesta-3,5-dien-7-one",CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C(=O)C=C4C=CCC[C@]4(C)[C@H]3CC[C@]12C,C27H42O,34320.0
15238,Methyl 4-hydroxycinnamate,COC(=O)/C=C/c1ccc(O)cc1,C10H10O3,35203.0
15239,Arteannuin B,C=C1C(=O)O[C@@]23[C@H]1CC[C@@H](C)[C@@H]2CC[C@@]1(C)O[C@@H]31,C15H20O3,33852.0
15240,Tepoxalin,COc1ccc(-n2nc(CCC(=O)N(C)O)cc2-c2ccc(Cl)cc2)cc1,C20H20ClN3O3,34849.0
15241,L-Asparagine,NC(=O)C[C@H](N)C(=O)O,C4H8N2O3,35022.0
15242,Val-Cit-PAB-OH,CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(CO)cc1,C18H29N5O4,34818.0
15243,Trabectedin,COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H]2[C@H]2c3c(cc(C)c(OC)c3O)C[C@@H]([C@@H]1O)N2C)OCO4,C39H43N3O11S,34662.0
15244,Mecysteine (hydrochloride),COC(=O)[C@@H](N)CS.Cl,C4H10ClNO2S,34847.0
15245,Meranzin,COc1ccc2ccc(=O)oc2c1C[C@@H]1OC1(C)C,C15H16O4,34743.0
15246,Blumeatin,COc1cc(O)c2c(c1)O[C@H](c1cc(O)cc(O)c1)CC2=O,C16H14O6,34809.0
15247,Regorafenib N-oxide,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)cc[n+]1[O-],C21H15ClF4N4O4,35101.0
15248,Chikusetsusaponin IVa,CC1(C)CC[C@]2(C(=O)O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,C42H66O14,34832.0
15249,1-Salicylate Glucuronide,O=C(O)c1ccccc1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,C13H14O9,34820.0
15250,Cirsimaritin,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1OC,C17H14O6,34498.0
15251,"1,2-Dioleoyl-sn-glycero-3-PA (sodium salt)",CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])O)OC(=O)CCCCCCC/C=C\CCCCCCCC.[Na+],C39H72NaO8P,34274.0
15252,Phellodendrine (chloride),COc1cc2c(cc1O)C[C@H]1c3cc(O)c(OC)cc3CC[N@@+]1(C)C2.[Cl-],C20H24ClNO4,34802.0
15253,93-O17O,CCCCCCCCCCCCCCOCCOC(=O)CCN(CCCn1ccnc1)CCC(=O)OCCOCCCCCCCCCCCCCC,C44H83N3O6,34366.0
15254,Lithospermoside,N#C/C=C1/C=C[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C14H19NO8,34771.0
15255,Paclitaxel C,CCCCCC(=O)N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C,C46H57NO14,34905.0
15256,L-Lysine-d3 (hydrochloride),Cl.[2H]C([2H])(N)CCC[C@]([2H])(N)C(=O)O,C6H15ClN2O2,34844.0
15257,Epiberberine,COc1cc2c(cc1OC)-c1cc3ccc4c(c3c[n+]1CC2)OCO4,C20H18NO4,34569.0
15258,ND-646,COc1ccccc1[C@H](Cn1c(=O)n(C(C)(C)C(N)=O)c(=O)c2c(C)c(-c3ncco3)sc21)OC1CCOCC1,C28H32N4O7S,34764.0
15259,Simazine-d10,[2H]C([2H])([2H])C([2H])([2H])Nc1nc(Cl)nc(NC([2H])([2H])C([2H])([2H])[2H])n1,C7H12ClN5,35209.0
15260,"3-(2,3-Dimethylphenyl)-2-methyl-4(3H)-quinazolinone",Cc1cccc(-n2c(C)nc3ccccc3c2=O)c1C,C17H16N2O,34174.0
15261,Saikosaponin B1,C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@]4(C)[C@@H]3C=CC3=C5CC(C)(C)CC[C@]5(CO)[C@@H](O)C[C@]34C)[C@]2(C)CO)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O,C42H68O13,34609.0
15262,Bupranolol,Cc1ccc(Cl)c(OCC(O)CNC(C)(C)C)c1,C14H22ClNO2,34902.0
15263,Sabutoclax,Cc1cc2c(C(=O)NCC(C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCC(C)c3ccccc3)c(O)c(O)cc2c1O,C42H40N2O8,34787.0
15264,"2-Amino-3,8-dimethylimidazo-[4,5-f]-quinoxaline",Cc1cnc2ccc3c(nc(N)n3C)c2n1,C11H11N5,34812.0
15265,3-methyl PCP (hydrochloride),Cc1cccc(C2(N3CCCCC3)CCCCC2)c1.Cl,C18H28ClN,34639.0
15266,Sildenafil Chlorosulfonyl,CCCc1nn(C)c2c(=O)nc(-c3cc(S(=O)(=O)Cl)ccc3OCC)[nH]c12,C17H19ClN4O4S,34760.0
15267,Halometasonel,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,C22H27ClF2O5,34848.0
15268,Bathophenanthroline,c1ccc(-c2ccnc3c2ccc2c(-c4ccccc4)ccnc23)cc1,C24H16N2,34811.0
15269,Metanephrine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])NCC(O)c1ccc(O)c(OC)c1,C10H16ClNO3,35207.0
15270,8-Azaadenosine,Nc1ncnc2c1nnn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C9H12N6O4,34622.0
15271,Ranaconitine,CCN1C[C@]2(OC(=O)c3ccccc3NC(C)=O)CC[C@H](OC)[C@]34[C@@H]2C[C@@](O)([C@@H]13)[C@@]1(O)C[C@H](OC)[C@H]2C[C@@H]4[C@]1(O)[C@H]2OC,C32H44N2O9,34774.0
15272,CC-92480,N#Cc1ccc(N2CCN(Cc3ccc(COc4cccc5c4CN([C@H]4CCC(=O)NC4=O)C5=O)cc3)CC2)c(F)c1,C32H30FN5O4,31065.0
15273,CBGM,CCCCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(OC)c1,C22H34O2,9003893.0
15274,4-Nitrophenyl ?-D-Glucopyranoside,O=[N+]([O-])c1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,C12H15NO8,35109.0
15275,TAK-285,CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,C26H25ClF3N5O3,29157.0
15276,Neferine,COc1ccc(C[C@@H]2c3cc(Oc4cc(C[C@H]5c6cc(OC)c(OC)cc6CCN5C)ccc4O)c(OC)cc3CCN2C)cc1,C38H44N2O6,34753.0
15277,BZO-POXIZID,CCCCCN1C(=O)/C(=N\NC(=O)c2ccccc2)c2ccccc21,C20H21N3O2,34795.0
15278,17(S)-HDoTE,CCCCC[C@H](O)/C=C/C=C\C/C=C\C/C=C\CCCCCC(=O)O,C22H36O3,34745.0
15279,Benzarone,CCc1oc2ccccc2c1C(=O)c1ccc(O)cc1,C17H14O3,34903.0
15280,LY2857785,CC(C)c1c2cc(-c3ccnc(N[C@H]4CC[C@H](NC5CCOCC5)CC4)n3)ccc2nn1C,C26H36N6O,34880.0
15281,PAR2 (1-6) amide (human) (trifluoroacetate salt),CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)C(C)C.O=C(O)C(F)(F)F,C30H55F3N8O9,35204.0
15282,Thermopsine,O=c1cccc2n1C[C@H]1C[C@@H]2CN2CCCC[C@@H]12,C15H20N2O,33853.0
15283,Avicularin,O=c1c(O[C@@H]2O[C@@H](CO)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,C20H18O11,33918.0
15284,CYM 50769,COc1ccc(Oc2c(Cl)cnn(C3c4ccccc4-c4ccccc43)c2=O)cc1,C24H17ClN2O3,34484.0
15285,Oroxin A,O=c1cc(-c2ccccc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c(O)c12,C21H20O10,34924.0
15286,GHB-d6 (sodium salt),[2H]C([2H])(O)C([2H])([2H])C([2H])([2H])C(=O)[O-].[Na+],C4H7NaO3,21924.0
15287,SNAP 94847,Cc1ccc(NC(=O)C(C)C)cc1C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1,C29H32F2N2O2,35105.0
15288,Brivaracetam,CCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1,C11H20N2O2,34685.0
15289,p-Cresol Glucuronide,Cc1ccc(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)cc1,C13H16O7,35113.0
15290,L-Alanine-d3,[2H]C([2H])([2H])[C@H](N)C(=O)O,C3H7NO2,34833.0
15291,IDO-IN-2,Cc1ccc(NC(=O)Nc2cc(-c3ccccc3-c3nnn[nH]3)ccc2N(CC(C)C)CC(C)C)cc1,C29H35N7O,34876.0
15292,O-Desmethyl-N-deschlorobenzoyl Indomethacin,Cc1[nH]c2ccc(O)cc2c1CC(=O)O,C11H11NO3,34581.0
15293,BRD3308,CC(=O)Nc1ccc(C(=O)Nc2ccc(F)cc2N)cc1,C15H14FN3O2,34875.0
15294,L-Methionine-d3,[2H]C([2H])([2H])SCC[C@H](N)C(=O)O,C5H11NO2S,34826.0
15295,Ramipril Diketopiperazine Acid,C[C@H]1C(=O)N2[C@@H](C[C@@H]3CCC[C@@H]32)C(=O)N1[C@@H](CCc1ccccc1)C(=O)O,C21H26N2O4,35001.0
15296,N-desethyl Brinzolamide (oxalate),COCCCN1C[C@H](N)c2cc(S(N)(=O)=O)sc2S1(=O)=O.O=C(O)C(=O)O,C12H19N3O9S3,34275.0
15297,Desmethyl Ranolazine,Cc1cccc(C)c1NC(=O)CN1CCN(CC(O)COc2ccccc2O)CC1,C23H31N3O4,35002.0
15298,N-Desbutyl Dronedarone (hydrochloride),CCCCNCCCOc1ccc(C(=O)c2c(CCCC)oc3ccc(NS(C)(=O)=O)cc23)cc1.Cl,C27H37ClN2O5S,34888.0
15299,Sarafloxacin-d8 (hydrochloride),Cl.[2H]C1([2H])NC([2H])([2H])C([2H])([2H])N(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2)C1([2H])[2H],C20H18ClF2N3O3,34226.0
15300,ARQ 621,C#CC[C@H](c1nc2cc(Cl)ccc2c(=O)n1Nc1ccccc1)N(CCCN)C(=O)c1cccc(Cl)c1F,C28H24Cl2FN5O2,34326.0
15301,2-Phenylmelatonin,COc1ccc2[nH]c(-c3ccccc3)c(CCNC(C)=O)c2c1,C19H20N2O2,35004.0
15302,Germacrene B,CC(C)=C1C/C=C(\C)CC/C=C(\C)CC1,C15H24,34907.0
15303,Mecloqualone,Cc1nc2ccccc2c(=O)n1-c1ccccc1Cl,C15H11ClN2O,21837.0
15304,7-epi-10-Deacetyltaxol,CC(=O)O[C@@]12CO[C@@H]1C[C@@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C,C45H49NO13,34296.0
15305,HS-1371,Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1,C24H24N4O,31033.0
15306,Skimmianine,COc1ccc2c(OC)c3ccoc3nc2c1OC,C14H13NO4,34643.0
15307,CPPG,NC(C(=O)O)(c1ccc(P(=O)(O)O)cc1)C1CC1,C11H14NO5P,34362.0
15308,Maduramicin (ammonium salt),CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)[O-])O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C.[NH4+],C47H83NO17,34270.0
15309,Simurosertib,Cc1n[nH]cc1-c1cc2[nH]c([C@@H]3CC4CCN3CC4)nc(=O)c2s1,C17H19N5OS,32519.0
15310,PTUPB,NS(=O)(=O)c1ccc(-n2nc(CCCNC(=O)Nc3ccc(C(F)(F)F)cc3)cc2-c2ccccc2)cc1,C26H24F3N5O3S,10897.0
15311,PD 404182,N=C1Sc2ccccc2C2=NCCCN12,C11H11N3S,34396.0
15312,N-Butyldeoxynojirimycin-d9 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])N1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,C10H22ClNO4,34852.0
15313,BAN ORL 24 (hydrochloride),Cl.Cl.O=C(NCCCN1CCC2(CC1)OCc1ccccc12)[C@H]1CCCN1Cc1ccccc1,C27H37Cl2N3O2,29485.0
15314,Psilocybin-d6,[2H]C([2H])([2H])N(CCc1c[nH]c2cccc(OP(=O)(O)O)c12)C([2H])([2H])[2H],C12H17N2O4P,34608.0
15315,Perillene,CC(C)=CCCc1ccoc1,C10H14O,35006.0
15316,Maropitant,COc1ccc(C(C)(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1,C32H40N2O,34816.0
15317,4-Methylumbelliferyl-?-D-Galactoside,Cc1cc(=O)oc2cc(O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)ccc12,C16H18O8,33920.0
15318,"3,6-Dimethoxy-9H-xanthen-9-one",COc1ccc2c(=O)c3ccc(OC)cc3oc2c1,C15H12O4,34806.0
15319,ACT-373898,CCCNS(=O)(=O)Nc1ncnc(OCC(=O)O)c1-c1ccc(Br)cc1,C15H17BrN4O5S,34916.0
15320,11-oxo Etiocholanolone,C[C@]12CC[C@@H](O)C[C@H]1CC[C@@H]1[C@@H]2C(=O)C[C@]2(C)C(=O)CC[C@@H]12,C19H28O3,35009.0
15321,8-Aminoclonazolam-d4,[2H]c1c([2H])c([2H])c(C2=NCc3nnc(C)n3-c3ccc(N)cc32)c(Cl)c1[2H],C17H14ClN5,34910.0
15322,CAY10781,O=C(O)Cc1cnc(-c2cccnc2)[nH]c1=O,C11H9N3O3,33778.0
15323,N-acetyl Lenalidomide,CC(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,C15H15N3O4,34421.0
15324,SC-43,N#Cc1ccc(Oc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)cc1,C21H13ClF3N3O2,34874.0
15325,Rosarin,OC[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC/C=C/c3ccccc3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H]1O,C20H28O10,35214.0
15326,D-Ornithine (hydrochloride),Cl.NCCC[C@@H](N)C(=O)O,C5H13ClN2O2,34887.0
15327,?9-Tetrahydrocannabiorcol,CC1=C[C@H]2c3c(O)cc(C)cc3OC(C)(C)[C@@H]2CC1,C17H22O2,33763.0
15328,Syringol,COc1cccc(OC)c1O,C8H10O3,34475.0
15329,2-Methylhippuric Acid,Cc1ccccc1C(=O)NCC(=O)O,C10H11NO3,34376.0
15330,4-acetoxy DMT (fumarate),CC(=O)Oc1cccc2[nH]cc(CCN(C)C)c12.O=C(O)/C=C/C(=O)O,C18H22N2O6,35188.0
15331,Taurine-d4,[2H]C([2H])(N)C([2H])([2H])S(=O)(=O)O,C2H7NO3S,35211.0
15332,17(R)-Protectin D1,CC/C=C\C[C@@H](O)/C=C\C=C\C=C\[C@H](O)C/C=C\C/C=C\CCC(=O)O,C22H32O4,34198.0
15333,Kanamycin B,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O,C18H37N5O10,34561.0
15334,Glycine-13C,N[13CH2]C(=O)O,C2H5NO2,35130.0
15335,N-Nitroso sarcosine,CN(CC(=O)O)N=O,C3H6N2O3,34734.0
15336,Tritylolmesartan Medoxomil,CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nnnn2C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1,C48H44N6O6,34854.0
15337,EPPTB,CCOc1cccc(NC(=O)c2ccc(N3CCCC3)c(C(F)(F)F)c2)c1,C20H21F3N2O2,34330.0
15338,1(R)-(Trifluoromethyl)oleyl alcohol,CCCCCCCC/C=C\CCCCCCC[C@@H](O)C(F)(F)F,C19H35F3O,31796.0
15339,GSK3368715 (hydrochloride),CCOCC1(COCC)CCC(c2n[nH]cc2CN(C)CCNC)CC1.Cl,C20H39ClN4O2,34886.0
15340,3-methyl Rolicyclidine (hydrochloride),Cc1cccc(C2(N3CCCC3)CCCCC2)c1.Cl,C17H26ClN,34637.0
15341,ONO-4817,CCOCOC[C@H](C[C@H](C)C(=O)NO)NC(=O)c1ccc(Oc2ccccc2)cc1,C22H28N2O6,34058.0
15342,Kaempferol 7-neohesperidoside,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)c(O)c(-c5ccc(O)cc5)oc4c3)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C27H30O15,34831.0
15343,"1,2-Dipropionyl-sn-glycero-3-PC",CCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CC,C14H28NO8P,32703.0
15344,Wee1 Inhibitor,O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21,C20H11ClN2O3,35391.0
15345,ADB-P7AICA,CCCCCn1cc(C(=O)N[C@H](C(N)=O)C(C)(C)C)c2cccnc21,C19H28N4O2,34352.0
15346,IAXO-102,CCCCCCCCCCCCCCO[C@H]1[C@@H](OC)O[C@H](CN)[C@@H](O)[C@@H]1OCCCCCCCCCCCCCC,C35H71NO5,34567.0
15347,(E/Z)-4-hydroxy Tamoxifen-d5,[2H]C([2H])([2H])C([2H])([2H])C(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,C26H29NO2,34232.0
15348,"3,5-Diiodo-L-thyronine",N[C@@H](Cc1cc(I)c(Oc2ccc(O)cc2)c(I)c1)C(=O)O,C15H13I2NO4,35212.0
15349,Withanone,CC1=C(C)C(=O)O[C@@H]([C@@H](C)[C@@]2(O)CC[C@H]3[C@@H]4[C@@H]5O[C@@H]5[C@@]5(O)CC=CC(=O)[C@]5(C)[C@H]4CC[C@@]32C)C1,C28H38O6,11804.0
15350,LC3-mHTT-IN-AN1,O=C1Nc2ccc(Br)cc2C1=Cc1cc(O)c(O)c(Br)c1,C15H9Br2NO3,34306.0
15351,5-methylthio DMT,CSc1ccc2[nH]cc(CCN(C)C)c2c1,C13H18N2S,35046.0
15352,Usaramine,C/C=C1\C[C@@H](C)[C@](O)(CO)C(=O)OCC2=CCN3CC[C@@H](OC1=O)[C@@H]23,C18H25NO6,34894.0
15353,Nifursol,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O,C12H7N5O9,35139.0
15354,Wilforgine,CC(=O)OCC12C(OC(C)=O)C(OC(C)=O)C3C(OC(C)=O)C14OC3(C)COC(=O)c1cccnc1CCC(C)C(=O)OC(C(OC(=O)c1ccoc1)C2OC(C)=O)C4(C)O,C41H47NO19,35029.0
15355,Kaempferol 3-glucuronide,O=C(O)[C@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H](O)[C@@H]1O,C21H18O12,34645.0
15356,BIBO-3304 (trifluoroacetate salt),N=C(N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F,C31H36F3N7O5,35205.0
15357,SEL120-34A  (hydrochloride),Cc1c(Br)c(Br)c2c3c1nc(N1CCNCC1)n3CCC2.Cl,C15H19Br2ClN4,27906.0
15358,desbutyl Lumefantrine,CCCCNCC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1,C26H24Cl3NO,24935.0
15359,Rosmanol,CC(C)c1cc2c(c(O)c1O)[C@@]13CCCC(C)(C)[C@@H]1[C@H](OC3=O)[C@H]2O,C20H26O5,35143.0
15360,Furanyl fentanyl-d5 (hydrochloride) (CRM),Cl.[2H]c1c([2H])c([2H])c(N(C(=O)c2ccco2)C2CCN(CCc3ccccc3)CC2)c([2H])c1[2H],C24H27ClN2O2,34769.0
15361,Tocofersolan,Cc1c(C)c2c(c(C)c1OC(=O)CCC(=O)OCCO)CCC(C)(CCCC(C)CCCC(C)CCCC(C)C)O2,C33H54O5(C2H4O)n,34661.0
15362,GT 949,COc1ccc2[nH]c(=O)c(C(c3nnnn3CCc3ccccc3)N3CCN(C4CCCCC4)CC3)cc2c1,C30H37N7O2,34552.0
15363,Scoulerine,COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(O)c3CN1CC2,C19H21NO4,35140.0
15364,SN-011,O=C(Nc1ccc(O)c(NS(=O)(=O)c2ccc(F)cc2)c1)c1ccc(-c2ccccc2)cc1,C25H19FN2O4S,34890.0
15365,Plecanatide (acetate),CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(N)=O)CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC2=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N1)C(=O)O,C67H108N18O28S4,33878.0
15366,Trimeprazine (tartrate),CC(CN(C)C)CN1c2ccccc2Sc2ccccc21.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C22H28N2O6S,33891.0
15367,5-hydroxy Indomethacin,Cc1c(CC(=O)O)c2cc(O)ccc2n1C(=O)c1ccc(Cl)cc1,C18H14ClNO4,34578.0
15368,Ciprofibrate-d6,[2H]C([2H])([2H])C(Oc1ccc(C2CC2(Cl)Cl)cc1)(C(=O)O)C([2H])([2H])[2H],C13H14Cl2O3,33917.0
15369,Aniline-d5,[2H]c1c([2H])c([2H])c(N)c([2H])c1[2H],C6H7N,35131.0
15370,Punicalin,O=CC(O)C(O)C1OC(=O)c2cc(O)c(O)c(O)c2-c2c(O)c(O)c3oc(=O)c4c(c(O)c(O)c5oc(=O)c2c3c54)-c2c(cc(O)c(O)c2O)C(=O)OCC1O,C34H22O22,33714.0
15371,SJ6986,O=C1CCC(N2C(=O)c3ccc(NS(=O)(=O)c4ccccc4OC(F)(F)F)cc3C2=O)C(=O)N1,C20H14F3N3O7S,34523.0
15372,Vitexin-4''-O-glucoside,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)c(O)cc(O)c12,C27H30O15,34923.0
15373,PT-141 (acetate),CC(=O)O.CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O,C52H72N14O12,35175.0
15374,Escin Ib,C/C=C(/C)C(=O)O[C@H]1[C@H](OC(C)=O)[C@]2(CO)[C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2CC1(C)C,C55H86O24,33926.0
15375,6-keto Lithocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC(=O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H38O4,35373.0
15376,JNJ-16259685,CO[C@H]1CC[C@@H](C(=O)c2ccc3nc4c(cc3c2)CCCO4)CC1,C20H23NO3,35377.0
15377,Baloxavir,O=C1c2c(O)c(=O)ccn2N([C@@H]2c3ccccc3SCc3c2ccc(F)c3F)[C@@H]2COCCN12,C24H19F2N3O4S,35125.0
15378,Shikalkin,CC(C)=CCC(O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,C16H16O5,34355.0
15379,Dehydrotumulosic Acid,C=C(CC[C@@H](C(=O)O)[C@H]1[C@H](O)C[C@@]2(C)C3=CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)C3=CC[C@]12C)C(C)C,C31H48O4,34938.0
15380,Zidebactam,O=C(NNC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O)[C@@H]1CCCNC1,C13H21N5O7S,30701.0
15381,AZD 5904,O=c1[nH]c(=S)n(C[C@H]2CCCO2)c2nc[nH]c12,C10H12N4O2S,33931.0
15382,Chlordiazepoxide,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,C16H14ClN3O,14261.0
15383,Chlordiazepoxide (CRM),CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,C16H14ClN3O,39680.0
15384,Enmetazobactam,Cn1cc[n+](C[C@@]2(C)[C@H](C(=O)[O-])N3C(=O)C[C@H]3S2(=O)=O)n1,C11H14N4O5S,30715.0
15385,Quercetin 3-O-?-D-xylopyranoside,O=c1c(O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,C20H18O11,35141.0
15386,Nicarbazine,Cc1cc(C)[nH]c(=O)n1.O=C(Nc1ccc([N+](=O)[O-])cc1)Nc1ccc([N+](=O)[O-])cc1,C19H18N6O6,35110.0
15387,ACT-709478,N#Cc1ccc(Cn2ccc(NC(=O)Cc3ccc(C4(C(F)(F)F)CC4)cc3)n2)nc1,C22H18F3N5O,25371.0
15388,Simvastatin Hydroxy Acid (ammonium salt),CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[NH4+],C25H43NO6,34883.0
15389,Periplogenin,C[C@]12CC[C@H](O)C[C@@]1(O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O,C23H34O5,35047.0
15390,AR231453,CC(C)c1noc(C2CCN(c3ncnc(Nc4ccc(S(C)(=O)=O)cc4F)c3[N+](=O)[O-])CC2)n1,C21H24FN7O5S,34898.0
15391,Siamenoside I,C[C@H](CC[C@@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)O)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4[C@@H](CC[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C4(C)C)[C@]3(C)[C@H](O)C[C@]12C,C54H92O24,34656.0
15392,?8-THC Acetate,CCCCCc1cc(OC(C)=O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C23H32O3,29209.0
15393,?8-THC Acetate (CRM),CCCCCc1cc(OC(C)=O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C23H32O3,37944.0
15394,Prim-O-Glucosylcimifugin,COc1c2c(cc3oc(CO[C@@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]4C)cc(=O)c13)O[C@H](C(C)(C)O)C2,C23H30O10,34921.0
15395,"3,4-Methylenedioxy-?-Cyclohexylaminopropiophenone (hydrochloride)",CC(NC1CCCCC1)C(=O)c1ccc2c(c1)OCO2.Cl,C16H22ClNO3,35165.0
15396,"3,4-Methylenedioxy-?-Cyclohexylaminopropiophenone (hydrochloride) (exempt preparation)",CC(NC1CCCCC1)C(=O)c1ccc2c(c1)OCO2.Cl,C16H22ClNO3,40413.0
15397,Atractylodin,C/C=C/C#CC#C/C=C/c1ccco1,C13H10O,35033.0
15398,"1,2-Dipalmitoyl-sn-glycero-3-EPC (chloride)",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(OCC)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC.[Cl-],C42H85ClNO8P,15099.0
15399,Licoflavone C,CC(C)=CCc1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,C20H18O5,35031.0
15400,"5-Formyl-5,6,7,8-tetrahydropteroic Acid (hydrochloride)",Cl.Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)O)cc1)N2C=O,C15H17ClN6O4,35717.0
15401,1-O-Acetylbritannilactone,C=C1C(=O)O[C@@H]2CC(C)=C([C@@H](C)CCCOC(C)=O)[C@@H](O)[C@H]12,C17H24O5,35137.0
15402,4-chloro Trazodone isomer (hydrochloride),Cl.O=c1n(CCCN2CCN(c3ccc(Cl)cc3)CC2)nc2ccccn12,C19H23Cl2N5O,35404.0
15403,Ramipril Diketopiperazine,CCOC(=O)[C@H](CCc1ccccc1)N1C(=O)[C@@H]2C[C@@H]3CCC[C@@H]3N2C(=O)[C@@H]1C,C23H30N2O4,34917.0
15404,?-Arbutin,OC[C@H]1O[C@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O,C12H16O7,35386.0
15405,(2S)-6-Prenylnaringenin,CC(C)=CCc1c(O)cc2c(c1O)C(=O)C[C@@H](c1ccc(O)cc1)O2,C20H20O5,35138.0
15406,Lotusine,COc1cc2c(cc1O)CC[N+](C)(C)[C@@H]2Cc1ccc(O)cc1,C19H24NO3,35136.0
15407,Chrysin 7-Glucuronide,O=C(O)[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(-c4ccccc4)oc3c2)[C@H](O)[C@@H](O)[C@@H]1O,C21H18O10,35034.0
15408,Sodium Orthovanadate,O=[V]([O-])([O-])[O-].[Na+].[Na+].[Na+],Na3O4V,34328.0
15409,Colupulone,CC(C)=CCC1=C(O)C(C(=O)C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O,C25H36O4,34048.0
15410,Flumequine-13C3,CC1CCc2cc(F)cc3c2n1c[13c]([13C](=O)O)[13c]3=O,C14H12FNO3,34006.0
15411,Biperiden-d5,[2H]c1c([2H])c([2H])c(C(O)(CCN2CCCCC2)C2CC3C=CC2C3)c([2H])c1[2H],C21H29NO,33469.0
15412,Gallic Acid-d2,[2H]c1c(O)c(O)c(O)c([2H])c1C(=O)O,C7H6O5,35132.0
15413,Brevifolincarboxylic Acid,O=C1CC(C(=O)O)c2c1oc(=O)c1cc(O)c(O)c(O)c21,C13H8O8,34922.0
15414,Ganoderic Acid G,CC(CC(=O)CC(C)C1CC(=O)C2(C)C3=C(C(=O)[C@@H](O)C12C)C1(C)CC[C@H](O)C(C)(C)C1C[C@@H]3O)C(=O)O,C30H44O8,34675.0
15415,Aprocitentan,NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,C16H14Br2N6O4S,34915.0
15416,Ganoderol B,C/C(=C\CC[C@@H](C)[C@H]1CC[C@@]2(C)C3=CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)C3=CC[C@]12C)CO,C30H48O2,34324.0
15417,Lappaconitine,CCN1C[C@]2(OC(=O)c3ccccc3NC(C)=O)CC[C@H](OC)[C@]34[C@@H]2C[C@@H]([C@@H]13)[C@@]1(O)C[C@H](OC)[C@H]2C[C@@H]4[C@]1(O)[C@H]2OC,C32H44N2O8,28747.0
15418,Tricyclene,CC1(C)C2CC3C(C2)C31C,C10H16,34290.0
15419,Thioacetazone,CC(=O)Nc1ccc(C=NNC(N)=S)cc1,C10H12N4OS,34589.0
15420,Eprazinone (hydrochloride),CCOC(CN1CCN(CC(C)C(=O)c2ccccc2)CC1)c1ccccc1.Cl.Cl,C24H34Cl2N2O2,28269.0
15421,Desisobutyryl Ciclesonide,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1C[C@H]1O[C@@H](C3CCCCC3)O[C@]12C(=O)CO,C28H38O6,34819.0
15422,L-Glutamine-d5,[2H]C([2H])(C(N)=O)C([2H])([2H])[C@]([2H])(N)C(=O)O,C5H10N2O3,34819.0
15423,Rizatriptan N-oxide,C[N+](C)([O-])CCc1c[nH]c2ccc(Cn3cncn3)cc12,C15H19N5O,35104.0
15424,GNE-317,COC1(c2sc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3c2C)COC1,C19H22N6O3S,27671.0
15425,N-Nitroso Metoprolol,COCCc1ccc(OCC(O)CN(N=O)C(C)C)cc1,C15H24N2O4,34738.0
15426,Dabigatran-d3,[2H]C([2H])([2H])n1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,C25H25N7O3,35704.0
15427,Irigenin,COc1cc(-c2coc3cc(O)c(OC)c(O)c3c2=O)cc(O)c1OC,C18H16O8,34676.0
15428,Ethephon,O=P(O)(O)CCCl,C2H6ClO3P,33562.0
15429,Mebicar,CN1C(=O)N(C)C2C1N(C)C(=O)N2C,C8H14N4O2,34606.0
15430,O-Phosphoethanolamine,NCCOP(=O)(O)O,C2H8NO4P,34636.0
15431,NVP-2,COC[C@@H](C)N[C@H]1CC[C@H](Nc2cc(-c3cccc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,C27H37ClN6O2,34725.0
15432,Desmethoxyyangonin,COc1cc(/C=C/c2ccccc2)oc(=O)c1,C14H12O3,23814.0
15433,Desmethoxyyangonin (CRM),COc1cc(/C=C/c2ccccc2)oc(=O)c1,C14H12O3,41214.0
15434,Dihydrocoumarin,O=C1CCc2ccccc2O1,C9H8O2,33495.0
15435,Desfuroylceftiofur,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CS)CS[C@H]12)c1csc(N)n1,C14H15N5O5S3,20360.0
15436,SB-242235,COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,C19H20FN5O,35117.0
15437,Carbinoxamine-d6 (maleate),O=C(O)/C=C\C(=O)O.[2H]C([2H])([2H])N(CCOC(c1ccc(Cl)cc1)c1ccccn1)C([2H])([2H])[2H],C20H23ClN2O5,34246.0
15438,Suberosin,COc1cc2oc(=O)ccc2cc1CC=C(C)C,C15H16O3,35035.0
15439,(E/Z)-Ajoene,C=CCSSC=CCS(=O)CC=C,C9H14OS3,34881.0
15440,Senkyunolide H,CCC/C=C1\OC(=O)C2=C1CC[C@@H](O)[C@H]2O,C12H16O4,35142.0
15441,?8-THCP,CCCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C23H34O2,30304.0
15442,?8-THCP (CRM),CCCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C23H34O2,42142.0
15443,Bendazac,O=C(O)COc1nn(Cc2ccccc2)c2ccccc12,C16H14N2O3,35127.0
15444,Phenetrazine (hydrochloride),CCC1NCCOC1c1ccccc1.Cl,C12H18ClNO,35144.0
15445,N-Nitroso Desloratadine-d4,[2H]C1([2H])CC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC([2H])([2H])N1N=O,C19H18ClN3O,34741.0
15446,Danicopan,CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(-c3cnc(C)nc3)cc12,C26H23BrFN7O3,32737.0
15447,5-methoxy MALT,C=CCN(C)CCc1c[nH]c2ccc(OC)cc12,C15H20N2O,34727.0
15448,AC-264613,C/C(=N\NC(=O)[C@@H]1C(=O)NC[C@H]1c1ccccc1)c1cccc(Br)c1,C19H18BrN3O2,28777.0
15449,BZO-CHMOXIZID,O=C(N/N=C1\C(=O)N(CC2CCCCC2)c2ccccc21)c1ccccc1,C22H23N3O2,34956.0
15450,Testosterone Propionate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C22H32O3,35191.0
15451,5-oxo Leukotriene B4,CCCCC/C=C\C[C@@H](O)/C=C/C=C/C=C\C(=O)CCCC(=O)O,C20H30O4,35416.0
15452,N-Nitroso Nebivolol,O=NN(CC(O)C1CCc2cc(F)ccc2O1)CC(O)C1CCc2cc(F)ccc2O1,C22H24F2N2O5,34739.0
15453,Levomedetomidine (hydrochloride),Cc1cccc([C@@H](C)c2cnc[nH]2)c1C.Cl,C13H17ClN2,35201.0
15454,Brevetoxin 3,C=C(CO)C[C@@H]1C[C@H](O)[C@]2(C)O[C@@H]3C[C@@H]4O[C@@H]5C[C@]6(C)O[C@]7(C)CC[C@@H]8O[C@@H]9C[C@]%10(C)O[C@@H]%11C(C)=CC(=O)O[C@H]%11C[C@H]%10O[C@H]9C[C@@H](C)[C@H]8O[C@H]7C[C@H]6O[C@@]5(C)CC=C[C@H]4O[C@H]3C[C@H]2O1,C50H72O14,34801.0
15455,Hirsuteine,C=C[C@H]1CN2CCc3c([nH]c4ccccc34)[C@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C22H26N2O3,34939.0
15456,8(Z)-Eicosenoic Acid methyl ester,CCCCCCCCCCC/C=C\CCCCCCC(=O)OC,C21H40O2,35428.0
15457,ADB-FUBIATA,CC(C)(C)[C@H](NC(=O)Cc1cn(Cc2ccc(F)cc2)c2ccccc12)C(N)=O,C23H26FN3O2,35059.0
15458,MDK35833,N#CCc1ccc(OCc2ccc(F)cc2)cc1,C15H12FNO,34332.0
15459,Boc-LGR-pNA (acetate),CC(=O)O.CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)Nc1ccc([N+](=O)[O-])cc1,C27H44N8O9,35176.0
15460,N-desmethyl Regorafenib N-oxide,NC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)cc[n+]1[O-],C20H13ClF4N4O4,35102.0
15461,S-2238 (hydrochloride),Cl.N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1,C27H37ClN8O5,34944.0
15462,JZP 430,CN(C(=O)Oc1nsnc1N1CCOCC1)C1CCCCCCC1,C16H26N4O3S,35383.0
15463,Ombrabulin (hydrochloride),COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO.Cl,C21H27ClN2O6,34897.0
15464,dBET6,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCCCCCCNC(=O)COc1cccc3c1C(=O)N(C1CCC(=O)NC1=O)C3=O)c1nnc(C)n1-2,C42H45ClN8O7S,35385.0
15465,Columbamine,COc1cc2c(cc1O)-c1cc3ccc(OC)c(OC)c3c[n+]1CC2,C20H20NO4,35032.0
15466,4-CF3-TPP-DC,CCCCCCCCCC[P+](c1ccc(C(F)(F)F)cc1)(c1ccc(C(F)(F)F)cc1)c1ccc(C(F)(F)F)cc1.[Br-],C31H33BrF9P,33513.0
15467,Rubiadin-1 methyl ether,COc1c(C)c(O)cc2c1C(=O)c1ccccc1C2=O,C16H12O4,34940.0
15468,Cytidine 5'-monophosphate,Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)n1,C9H14N3O8P,35116.0
15469,"1-(3,5-Di-tert-butyl-4-hydroxyphenyl)-1,2-ethanediol",CC(C)(C)c1cc(C(O)CO)cc(C(C)(C)C)c1O,C16H26O3,35440.0
15470,N-Nitroso Desloratadine,O=NN1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,C19H18ClN3O,34737.0
15471,C3,NC(=O)[C@@H]1CCN1Cc1ccc(OCc2cccc(F)c2)cc1,C18H19FN2O2,33166.0
15472,Enobosarm-d4,[2H]c1c([2H])c(OC[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c([2H])c([2H])c1C#N,C19H14F3N3O3,34687.0
15473,NF 023,O=C(Nc1cccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)c1)Nc1cccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],C35H20N4Na6O21S6,17234.0
15474,Dabigatran-13C-d3,[2H][13C]([2H])([2H])n1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,C25H25N7O3,35705.0
15475,Nandrolone Decanoate,CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C,C28H44O3,32546.0
15476,Iodixanol,CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,C35H44I6N6O15,35020.0
15477,Diphyllin,COc1cc2c(O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,C21H16O7,27826.0
15478,5-hydroxy Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncc(O)cn2)CC1,C21H31N5O3,34207.0
15479,Acenocoumarol-d4,[2H]c1c([2H])c([N+](=O)[O-])c([2H])c([2H])c1C(CC(C)=O)c1c(O)c2ccccc2oc1=O,C19H15NO6,35477.0
15480,SF11,CCOc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,C27H30N2O2S,33355.0
15481,Azaperone,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,C19H22FN3O,33775.0
15482,GLPG2938,CCOc1cc(NC(=O)NCc2cc(C)c(-c3cn(C)nc3C(F)(F)F)nn2)cc(C(F)(F)F)n1,C20H19F6N7O2,34318.0
15483,Indomethacin Acyl Glucuronide,COc1ccc2c(c1)c(CC(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)c(C)n2C(=O)c1ccc(Cl)cc1,C25H24ClNO10,34579.0
15484,Cl-Necrostatin-1,CN1C(=O)C(Cc2c[nH]c3c(Cl)cccc23)NC1=S,C13H12ClN3OS,11656.0
15485,1V-LSD (solution),CCCCC(=O)n1cc2c3c(cccc31)C1=C[C@@H](C(=O)N(CC)CC)CN(C)[C@@H]1C2,C25H33N3O2,35744.0
15486,Isoflupredone,C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F,C21H27FO5,35376.0
15487,1-Stearoyl-2-Eicosapentaenoyl-sn-glycero-3-PC,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C46H82NO8P,34995.0
15488,9(S)-?7-THC,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C=C[C@@H](C)C[C@@H]21,C21H30O2,34077.0
15489,9(S)-?7-THC (CRM),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C=C[C@@H](C)C[C@@H]21,C21H30O2,39317.0
15490,IRL 1620 (trifluoroacetate salt),CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC.O=C(O)C(F)(F)F,C88H118F3N17O29,30980.0
15491,L-Serine-d7,[2H]OC(=O)[C@@]([2H])(N([2H])[2H])C([2H])([2H])O[2H],C3H7NO3,34827.0
15492,VU0238429,COc1ccc(CN2C(=O)C(=O)c3cc(OC(F)(F)F)ccc32)cc1,C17H12F3NO4,34411.0
15493,LY433771,NC(=O)c1cccc2c1c1c(OCC(=O)O)cccc1n2CC1CCCCC1,C22H24N2O4,35406.0
15494,Indican,OC[C@H]1O[C@@H](Oc2c[nH]c3ccccc23)[C@H](O)[C@@H](O)[C@@H]1O,C14H17NO6,35417.0
15495,9(R)-?7-THC,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C=C[C@H](C)C[C@@H]21,C21H30O2,34076.0
15496,9(R)-?7-THC (CRM),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C=C[C@H](C)C[C@@H]21,C21H30O2,39187.0
15497,"7,4'-Dihydroxyflavone",O=c1cc(-c2ccc(O)cc2)oc2cc(O)ccc12,C15H10O4,35491.0
15498,Uridine-5'-monophosphate,O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1,C9H13N2O9P,35382.0
15499,BI-3406,COc1cc2nc(C)nc(N[C@H](C)c3cc(N)cc(C(F)(F)F)c3)c2cc1O[C@H]1CCOC1,C23H25F3N4O3,35261.0
15500,H-Gly-Pro-Hyp-OH (acetate),CC(=O)O.NCC(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)O,C14H23N3O7,35390.0
15501,6-methoxy-2-Naphthylacetic Acid,COc1ccc2cc(C(=O)O)ccc2c1,C12H10O3,35374.0
15502,?9-THC-ethyl,CCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C18H24O2,35049.0
15503,4-hydroxy TMT (iodide),C[N+](C)(C)CCc1c[nH]c2cccc(O)c12.[I-],C13H19IN2O,33670.0
15504,4-hydroxy TMT (iodide) (CRM),C[N+](C)(C)CCc1c[nH]c2cccc(O)c12.[I-],C13H19IN2O,38032.0
15505,"Somatostatin-14 (human, mouse, rat, porcine, bovine, ovine) (acetate)",CC(=O)O.C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O,C78H108N18O21S2,20809.0
15506,ABT-263-d8,[2H]C1([2H])OC([2H])([2H])C([2H])([2H])N(CC[C@H](CSc2ccccc2)Nc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CCC(C)(C)C5)CC4)cc3)cc2S(=O)(=O)C(F)(F)F)C1([2H])[2H],C47H55ClF3N5O6S3,34694.0
15507,7-Methylxanthine,Cn1cnc2[nH]c(=O)[nH]c(=O)c21,C6H6N4O2,34348.0
15508,"S-(1,2-Dichlorovinyl)-Cysteine (hydrochloride)",Cl.N[C@@H](CS/C(Cl)=C\Cl)C(=O)O,C5H8Cl3NO2S,33894.0
15509,ATN-161 (trifluoroacetate salt),CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O.O=C(O)C(F)(F)F,C25H36F3N9O10S,34056.0
15510,Akuammine,C/C=C1/CN2CC[C@@]34c5cc(O)ccc5N(C)[C@]35OC[C@@]4(C(=O)OC)[C@H]1C[C@H]25,C22H26N2O4,35149.0
15511,DL-Cystine-d4,[2H]C([2H])(SSC([2H])([2H])C(N)C(=O)O)C(N)C(=O)O,C6H12N2O4S2,30902.0
15512,Norpipanone (hydrochloride),CCC(=O)C(CCN1CCCCC1)(c1ccccc1)c1ccccc1.Cl,C23H30ClNO,35078.0
15513,Meglutol-d3,[2H]C([2H])([2H])C(O)(CC(=O)O)CC(=O)O,C6H10O5,30914.0
15514,Cyproterone Acetate,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,C24H29ClO4,16622.0
15515,IPG-4 AM,COCCOc1cc(-c2c3cc(CCC(=O)OCOC(C)=O)c(=O)c(Cl)c-3oc3c(Cl)c(OCOC(C)=O)c(CCC(=O)OCOC(C)=O)cc23)ccc1N1CCOc2cc(C)ccc2N2CCOCCOCCN(CCOCCOCC2)c2ccc(C)cc2OCC1,C67H79Cl2N3O21,35541.0
15516,M04,Cc1ccc(S(=O)(=O)c2nc(S(=O)(=O)C3CCCCC3)sc2N(C)C)cc1,C18H24N2O4S3,35454.0
15517,ING-2 AM,COc1cc(C)ccc1N1CCOCCOCCN(c2ccc(-c3c4cc(CCC(=O)OCOC(C)=O)c(=O)c(Cl)c-4oc4c(Cl)c(OCOC(C)=O)c(CCC(=O)OCOC(C)=O)cc34)cc2OC)CCOCC1,C53H60Cl2N2O18,24489.0
15518,BMS 345541 (hydrochloride),Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1.Cl,C14H18ClN5,16667.0
15519,IPG-2 AM,COc1cc(C)ccc1N1CCOCCOCCN(c2ccc(-c3c4cc(CCC(=O)OCOC(C)=O)c(=O)c(Cl)c-4oc4c(Cl)c(OCOC(C)=O)c(CCC(=O)OCOC(C)=O)cc34)cc2OC)CCOCCOCC1,C55H64Cl2N2O19,35540.0
15520,IPG-1 AM,COc1cc(C=O)ccc1N1CCOCCOCCN(c2ccc(-c3c4cc(CCC(=O)OCOC(C)=O)c(=O)c(Cl)c-4oc4c(Cl)c(OCOC(C)=O)c(CCC(=O)OCOC(C)=O)cc34)cc2OC)CCOCCOCC1,C55H62Cl2N2O20,35542.0
15521,Fluo-4 (potassium salt),Cc1ccc(N(CC(=O)[O-])CC(=O)[O-])c(OCCOc2cc(-c3c4cc(F)c(=O)cc-4oc4cc([O-])c(F)cc34)ccc2N(CC(=O)[O-])CC(=O)[O-])c1.[K+].[K+].[K+].[K+].[K+],C36H25F2K5N2O13,35765.0
15522,Ganoderic Acid N,CC(CC(=O)CC(C)(O)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O,C30H42O8,34323.0
15523,MN-18 N-(5-hydroxypentyl) metabolite,O=C(Nc1cccc2ccccc12)c1nn(CCCCCO)c2ccccc12,C23H23N3O2,35278.0
15524,OATD-01,C[C@H]1CN(C2CCN(c3nnc(N)[nH]3)CC2)[C@@H](Cc2ccc(Cl)cc2)CO1,C19H27ClN6O,35193.0
15525,N-Boc Norfentanyl,CCC(=O)N(c1ccccc1)C1CCN(C(=O)OC(C)(C)C)CC1,C19H28N2O3,36073.0
15526,2-(1-(4-Fluorobenzyl)-1H-indol-3-yl)acetic Acid,O=C(O)Cc1cn(Cc2ccc(F)cc2)c2ccccc12,C17H14FNO2,36015.0
15527,"2,5-DMA (hydrochloride)",COc1ccc(OC)c(CC(C)N)c1.Cl,C11H18ClNO2,34991.0
15528,"2,5-DMA (hydrochloride) (exempt preparation)",COc1ccc(OC)c(CC(C)N)c1.Cl,C11H18ClNO2,38144.0
15529,IPG-1 TMA,COc1cc(C=O)ccc1N1CCOCCOCCN(c2ccc(-c3c4cc(CCC(=O)[O-])c(=O)c(Cl)c-4oc4c(Cl)c([O-])c(CCC(=O)[O-])cc34)cc2OC)CCOCCOCC1.C[N+](C)(C)C.C[N+](C)(C)C.C[N+](C)(C)C,C58H83Cl2N5O14,35543.0
15530,Glycine-d5,[2H]OC(=O)C([2H])([2H])N([2H])[2H],C2H5NO2,34825.0
15531,Octapeptide-2,CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O,C42H78N12O14,35184.0
15532,"(3R,5R)-Rosuvastatin (calcium salt)",CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2],C44H54CaF2N6O12S2,35381.0
15533,"(R)-(-)-3,4-MDMA (hydrochloride)",CN[C@H](C)Cc1ccc2c(c1)OCO2.Cl,C11H16ClNO2,33956.0
15534,para-fluoro Norfentanyl,CCC(=O)N(c1ccc(F)cc1)C1CCNCC1,C14H19FN2O,35259.0
15535,?-hydroxy Etizolam,Cc1nnc2n1-c1sc(C(C)O)cc1C(c1ccccc1Cl)=NC2,C17H15ClN4OS,27780.0
15536,Brincidofovir,CCCCCCCCCCCCCCCCOCCCOP(=O)(O)CO[C@H](CO)Cn1ccc(N)nc1=O,C27H52N3O7P,35062.0
15537,2-Methylamino-5-chlorobenzophenone,CNc1ccc(Cl)cc1C(=O)c1ccccc1,C14H12ClNO,36069.0
15538,"3,4-Methylenedioxy-?-propylaminobutiophenone (hydrochloride)",CCCNC(CC)C(=O)c1ccc2c(c1)OCO2.Cl,C14H20ClNO3,30892.0
15539,5?-Androst-2-ene-17-one,C[C@]12CC=CC[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H28O,21302.0
15540,SOCLAC,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCl,C20H38ClNO3,9003928.0
15541,SACLAC,CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=O)CCl,C20H40ClNO3,9003926.0
15542,"1,4-Dicaffeoylquinic Acid",O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@H]1O,C25H24O12,33842.0
15543,"(6S)-5,6,7,8-tetrahydro-L-Biopterin (sulfate)",C[C@H](O)[C@H](O)[C@@H]1CNc2[nH]c(N)nc(=O)c2N1,C9H15N5O3,34671.0
15544,PROTAC(H-PGDS)-7,O=C1CCC(N2C(=O)c3cccc(N4CCN(C(=O)C5CCN(c6ccc(NC(=O)c7cnc(Oc8ccccc8)nc7)cc6)CC5)CC4)c3C2=O)C(=O)N1,C40H38N8O7,35561.0
15545,"(S)-(+)-3,4-MDMA (hydrochloride)",CN[C@@H](C)Cc1ccc2c(c1)OCO2.Cl,C11H16ClNO2,26333.0
15546,TAK-041,C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1,C18H15F3N4O3,36108.0
15547,2-Amino-3-(2-chlorobenzoyl)-5-ethylthiophene,CCc1cc(C(=O)c2ccccc2Cl)c(N)s1,C13H12ClNOS,36070.0
15548,SABRAC,CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=O)CBr,C20H40BrNO3,9003925.0
15549,DiFMUP,Cc1cc(=O)oc2c(F)c(OP(=O)(O)O)c(F)cc12,C10H7F2O6P,35500.0
15550,JX06,S=C(SSC(=S)N1CCOCC1)N1CCOCC1,C10H16N2O2S4,34850.0
15551,N-isopropyl Butylone (hydrochloride),CCC(NC(C)C)C(=O)c1ccc2c(c1)OCO2.Cl,C14H20ClNO3,35366.0
15552,4-hydroxy Atomoxetine,CNCC[C@@H](Oc1ccc(O)cc1C)c1ccccc1,C17H21NO2,34821.0
15553,O-desethyl Dapagliflozin,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,C19H21ClO6,36022.0
15554,COH000,COC(=O)C1=C(C(=O)OC)[C@@]2([C@@H](Cc3ccc(C)cc3)Nc3ccccc3)C=C[C@@H]1O2,C25H25NO5,34906.0
15555,Maytansine,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(C)=O)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,C34H46ClN3O10,36062.0
15556,SOBRAC,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CBr,C20H38BrNO3,9003927.0
15557,SU 0268,NC(=O)c1cccc(-c2ccc(S(=O)(=O)Nc3ccc4c(c3)N(C(=O)C3CC3)CCC4)cc2)c1,C26H25N3O4S,36064.0
15558,L6H21,COc1ccc(C(=O)/C=C/c2cccc(OC)c2OC)cc1,C18H18O4,35284.0
15559,IPG-2 TMA,COc1cc(C)ccc1N1CCOCCOCCN(c2ccc(-c3c4cc(CCC(=O)[O-])c(=O)c(Cl)c-4oc4c(Cl)c([O-])c(CCC(=O)[O-])cc34)cc2OC)CCOCCOCC1.C[N+](C)(C)C.C[N+](C)(C)C.C[N+](C)(C)C,C58H85Cl2N5O13,35533.0
15560,Fluo-2 AM,CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1ccc(C)cc1OCCOc1cc(-c2c3ccc(=O)cc-3oc3cc(OCOC(C)=O)ccc23)ccc1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O,C51H52N2O23,35758.0
15561,U-0124,CSC(N)=C(C#N)C(C#N)=C(N)SC,C8H10N4S2,34871.0
15562,TFC 007,O=C(Nc1ccc(N2CCC(C(=O)N3CCOCC3)CC2)cc1)c1cnc(Oc2ccccc2)nc1,C27H29N5O4,17971.0
15563,GR103691,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc(C(C)=O)cc3)cc2)CC1,C30H35N3O3,34870.0
15564,19-alkyne Cholesterol,C#C[C@]12CC[C@H](O)CC1=CC[C@H]1[C@@H]3CC[C@H]([C@H](C)CCCC(C)C)[C@@]3(C)CC[C@@H]12,C28H44O,16446.0
15565,PSB-CB5,O=C1/C(=C/c2cccc(OCc3ccc(Cl)cc3)c2)N=C2SCCCN12,C20H17ClN2O2S,35279.0
15566,Abrocitinib,CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1,C14H21N5O2S,34869.0
15567,Y-33075,C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1,C16H16N4O,35108.0
15568,EMD 534085,CN(C)CCNC(=O)NC[C@H]1CC[C@@H]2[C@H](O1)c1cc(C(F)(F)F)ccc1N[C@H]2c1ccccc1,C25H31F3N4O2,35719.0
15569,N'-Nitrosonornicotine-d4,[2H]c1nc([2H])c(C2CCCN2N=O)c([2H])c1[2H],C9H11N3O,35604.0
15570,Isotachysterol 3,CC1=C(/C=C/C2=C3CC[C@H]([C@H](C)CCCC(C)C)[C@@]3(C)CCC2)C[C@@H](O)CC1,C27H44O,35751.0
15571,N-acetyl Taurine,CC(=O)NCCS(=O)(=O)O,C4H9NO4S,35169.0
15572,LNT 1,O=c1c2sccc2n(CC2COc3ccccc3O2)c(=O)n1O,C15H12N2O5S,35803.0
15573,Acebutolol-d7,[2H]C([2H])([2H])C([2H])(NCC(O)COc1ccc(NC(=O)CCC)cc1C(C)=O)C([2H])([2H])[2H],C18H28N2O4,35557.0
15574,Roxatidine,O=C(CO)NCCCOc1cccc(CN2CCCCC2)c1,C17H26N2O3,36111.0
15575,Ambrisentan-d3,[2H]C([2H])([2H])OC(c1ccccc1)(c1ccccc1)C(Oc1nc(C)cc(C)n1)C(=O)O,C22H22N2O4,35558.0
15576,(S)-Tipifarnib,Cn1cncc1[C@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,C27H22Cl2N4O,35515.0
15577,BMS-299897,C[C@H](c1ccc(F)cc1CCCC(=O)O)N(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1,C24H21ClF3NO4S,35777.0
15578,FLT3-IN-3,N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1,C27H38N8O,36106.0
15579,Salicylic Acid-d4,[2H]c1c([2H])c([2H])c(C(=O)O)c(O)c1[2H],C7H6O3,35418.0
15580,21-Deoxycortisol-d8,[2H]C1=C2C([2H])([2H])C[C@@H]3[C@H]([C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)C([2H])([2H])[2H])[C@@]2(C)CC([2H])([2H])C1=O,C21H30O4,35556.0
15581,AHU377,CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O,C24H29NO5,36260.0
15582,Kynurenic Acid-d5,[2H]c1c([2H])c([2H])c2c(O)c([2H])c(C(=O)O)nc2c1[2H],C10H7NO3,36306.0
15583,Chlorpheniramine-d6 (maleate),O=C(O)/C=C\C(=O)O.[2H]C([2H])([2H])N(CCC(c1ccc(Cl)cc1)c1ccccn1)C([2H])([2H])[2H],C20H23ClN2O4,35767.0
15584,DPPE (fumarate),CCN(CC)CCOc1ccc(Cc2ccccc2)cc1.O=C(O)C=CC(=O)O,C23H29NO5,35360.0
15585,Sertraline-d3 (hydrochloride),Cl.[2H]C([2H])([2H])N[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,C17H18Cl3N,15857.0
15586,Methylmalonic Acid-d3,[2H]C([2H])([2H])C(C(=O)O)C(=O)O,C4H6O4,35232.0
15587,AT-001,O=C(O)Cc1nn(Cc2nc3cc(C(F)(F)F)ccc3s2)c(=O)c2nccnc12,C17H10F3N5O3S,36105.0
15588,cis-Zeatin,C/C(=C/CNc1ncnc2nc[nH]c12)CO,C10H13N5O,35549.0
15589,"2,3-Oxidosqualene",CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C=C(\C)CC/C=C(\C)CCC1OC1(C)C,C30H50O,36187.0
15590,"S,S-Hydroxybupropion (hydrochloride)",C[C@@H]1NC(C)(C)CO[C@@]1(O)c1cccc(Cl)c1.Cl,C13H19Cl2NO2,35718.0
15591,D-Iditol,OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO,C6H14O6,35597.0
15592,N-desethyl-N-methyl Vardenafil,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)[nH]n12,C22H30N6O4S,35435.0
15593,R162,C=CCc1ccc2c(c1O)C(=O)c1ccccc1C2=O,C17H12O3,30922.0
15594,(-)-Apomorphine (hydrochloride),CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl,C17H18ClNO2,34222.0
15595,RHPS4 (methyl sulfate),COS(=O)(=O)[O-].Cc1cc2c3c([n+](C)c4ccc(F)cc4c3c1)-c1cc(F)ccc1N2C,C23H20F2N2O4S,28543.0
15596,6?-hydroxy Prednisolone,C[C@]12C=CC(=O)C=C1[C@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,C21H28O6,35720.0
15597,Fluocortolone,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO,C22H29FO4,35246.0
15598,PF-06873600,C[C@@]1(O)CCC[C@H]1n1c(=O)c(C(F)F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21,C20H27F2N5O4S,35502.0
15599,CGP 36742,CCCCP(=O)(O)CCCN,C7H18NO2P,35495.0
15600,Takeda-6d,N#CC1(c2cccc(C(=O)Nc3cc(Oc4ccc5nc(NC(=O)C6CC6)sc5n4)ccc3F)c2Cl)CC1,C27H19ClFN5O3S,35754.0
15601,SR 57227A (hydrochloride),Cl.NC1CCN(c2cccc(Cl)n2)CC1,C10H15Cl2N3,35499.0
15602,Asoprisnil,COC[C@]1(OC)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(/C=N/O)cc3)C[C@@]21C,C28H35NO4,35170.0
15603,Dihydrojasmonic Acid,CCCCCC1C(=O)CCC1CC(=O)O,C12H20O3,35362.0
15604,Aldoxorubicin (hydrochloride),COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(CO)=NNC(=O)CCCCCN1C(=O)C=CC1=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,C37H43ClN4O13,35311.0
15605,?8-THCVA-A,CCCc1cc2c(c(O)c1C(=O)O)[C@@H]1CC(C)=CC[C@H]1C(C)(C)O2,C20H26O4,28580.0
15606,Cannabidiol monomethyl ether,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1OC,C22H32O2,35712.0
15607,CBDBA,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCC)c(C(=O)O)c1O,C21H28O4,29032.0
15608,O-Phospho-L-Threonine,C[C@@H](OP(=O)(O)O)[C@H](N)C(=O)O,C4H10NO6P,35057.0
15609,Tetrahydrocannabivarin-d5 (CRM),[2H]C([2H])([2H])C([2H])([2H])Cc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C19H26O2,35017.0
15610,2'-Deoxyuridine-d2,[2H]c1c([2H])n([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,C9H12N2O5,36323.0
15611,Olmesartan-d6,[2H]C([2H])([2H])C(O)(c1nc(CCC)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c1C(=O)O)C([2H])([2H])[2H],C24H26N6O3,36324.0
15612,Dansyl Amide,CN(C)c1cccc2c(S(N)(=O)=O)cccc12,C12H14N2O2S,36149.0
15613,CB-1158,NC(CCCCB(O)O)(C(=O)O)C1CCN(Cc2ccc(Cl)cc2Cl)CC1,C18H27BCl2N2O4,27297.0
15614,Lansoprazole N-oxide,Cc1c(OCC(F)(F)F)cc[n+]([O-])c1CS(=O)c1nc2ccccc2[nH]1,C16H14F3N3O3S,35427.0
15615,Fluorescein diacetate,CC(=O)Oc1ccc2c(c1)Oc1cc(OC(C)=O)ccc1C21OC(=O)c2ccccc21,C24H16O7,35701.0
15616,DL-erythro-PDMP (hydrochloride),CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@@H](O)c1ccccc1.Cl,C23H39ClN2O3,22676.0
15617,MHY553,Oc1ccc(-c2nc3ccccc3s2)c(O)c1,C13H9NO2S,36088.0
15618,PF-3450074,Cc1[nH]c2ccccc2c1CC(=O)N[C@@H](Cc1ccccc1)C(=O)N(C)c1ccccc1,C27H27N3O2,36107.0
15619,Carazolol-d7,[2H]C([2H])([2H])C([2H])(NCC(O)COc1cccc2[nH]c3ccccc3c12)C([2H])([2H])[2H],C18H22N2O2,35560.0
15620,BRD0639,Cc1ccc(NC(=O)[C@H](C)n2ncc(Cl)cc2=O)cc1S(=O)(=O)NCCc1ccccn1,C21H22ClN5O4S,35625.0
15621,PF-07321332,CC(C)(C)[C@H](NC(=O)C(F)(F)F)C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@H](C#N)C[C@@H]1CCNC1=O)C2(C)C,C23H32F3N5O4,35257.0
15622,Nitrazepam,O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1,C15H11N3O3,16196.0
15623,GSK 417651A,COc1ccc(Nc2nc(C(=O)N3CCc4ccccc4C3)cs2)cc1,C20H19N3O2S,15268.0
15624,2-Chloroadenosine 5-triphosphate (sodium salt),Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],C10H11ClN5Na4O13P3,34978.0
15625,1-Isothiocyanato-6-(methylsulfenyl)-hexane,CSCCCCCCN=C=S,C8H15NS2,35595.0
15626,Hygromycin A,CC(=O)[C@H]1O[C@@H](Oc2ccc(/C=C(\C)C(=O)N[C@@H]3[C@H](O)[C@@H](O)[C@H]4OCO[C@H]4[C@@H]3O)cc2O)[C@@H](O)[C@@H]1O,C23H29NO12,35565.0
15627,"6,8-Difluoro-7-hydroxy-4-methylcoumarin",Cc1cc(=O)oc2c(F)c(O)c(F)cc12,C10H6F2O3,36017.0
15628,"6,7,4'-Trihydroxyisoflavone",O=c1c(-c2ccc(O)cc2)coc2cc(O)c(O)cc12,C15H10O5,35405.0
15629,CB-6644,CCOc1cc(F)c(Cl)cc1C(=O)NCC(C)(C)CC(=O)Nc1c(COC)n2n(c1=O)-c1ccccc1CCC2,C29H34ClFN4O5,36125.0
15630,4'-chloro Deschloroalprazolam,Cc1nnc2n1-c1ccccc1C(c1ccc(Cl)cc1)=NC2,C17H13ClN4,36057.0
15631,Blasticidin S,CN(CC[C@H](N)CC(=O)N[C@H]1C=C[C@H](n2ccc(N)nc2=O)O[C@@H]1C(=O)O)C(=N)N,C17H26N8O5,35252.0
15632,Lamotrigine N2-oxide,Nc1nc(N)[n+]([O-])nc1-c1cccc(Cl)c1Cl,C9H7Cl2N5O,35524.0
15633,"3',4'-Dihydroxyflavone",O=c1cc(-c2ccc(O)c(O)c2)oc2ccccc12,C15H10O4,35226.0
15634,Oxiracetam,NC(=O)CN1CC(O)CC1=O,C6H10N2O3,26030.0
15635,Rabeprazole sulfone,COCCCOc1ccnc(CS(=O)(=O)c2nc3ccccc3[nH]2)c1C,C18H21N3O4S,35076.0
15636,Pantoprazole sulfone N-oxide,COc1cc[n+]([O-])c(CS(=O)(=O)c2nc3ccc(OC(F)F)cc3[nH]2)c1OC,C16H15F2N3O6S,35199.0
15637,7-Hydroxyflavone,O=c1cc(-c2ccccc2)oc2cc(O)ccc12,C15H10O3,36071.0
15638,Thymidine-d4,[2H]c1c(C([2H])([2H])[2H])c(=O)[nH]c(=O)n1[C@H]1C[C@H](O)[C@@H](CO)O1,C10H14N2O5,36322.0
15639,PAP-1,O=c1ccc2c(OCCCCOc3ccccc3)c3ccoc3cc2o1,C21H18O5,30105.0
15640,Talaporfin (sodium salt),C=Cc1c(C)c2cc3nc(c(CC(=O)N[C@@H](CC(=O)[O-])C(=O)[O-])c4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CC)c(C)c4C(=O)[O-])[C@@H](CCC(=O)[O-])[C@@H]3C.[Na+].[Na+].[Na+].[Na+],C38H37N5Na4O9,35722.0
15641,MK-212 (hydrochloride),Cl.Clc1cncc(N2CCNCC2)n1,C8H12Cl2N4,36089.0
15642,Pramiracetam,CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C,C14H27N3O2,26031.0
15643,Dictamnine,COc1c2ccccc2nc2occc12,C12H9NO2,34646.0
15644,Lidocaine-d10,[2H]C([2H])([2H])C([2H])([2H])N(CC(=O)Nc1c(C)cccc1C)C([2H])([2H])C([2H])([2H])[2H],C14H22N2O,35066.0
15645,5?-Androstan-3?-ol,C[C@@]12CCC[C@H]1[C@@H]1CC[C@H]3C[C@@H](O)CC[C@]3(C)[C@H]1CC2,C19H32O,34719.0
15646,Cochineal,Cc1c(C(=O)O)c(O)cc2c1C(=O)c1c(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c(O)c1C2=O,C22H20O13,35334.0
15647,Fluindione,O=C1c2ccccc2C(=O)C1c1ccc(F)cc1,C15H9FO2,34966.0
15648,Lumogallion,O=S(=O)(O)c1cc(Cl)cc(/N=N/c2ccc(O)cc2O)c1O,C12H9ClN2O6S,35596.0
15649,6-Methylmercaptopurine-d3,[2H]C([2H])([2H])Sc1ncnc2nc[nH]c12,C6H6N4S,36321.0
15650,BMS 270394,CC1(C)CCC(C)(C)c2cc([C@@H](O)C(=O)Nc3ccc(C(=O)O)cc3F)ccc21,C23H26FNO4,35576.0
15651,"2-Bromo-3',4'-(methylenedioxy)propiophenone",CC(Br)C(=O)c1ccc2c(c1)OCO2,C10H9BrO3,35350.0
15652,Dopamine 4-O-Sulfate,NCCc1ccc(OS(=O)(=O)O)c(O)c1,C8H11NO5S,36085.0
15653,10-acetyl Docetaxel,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,C45H55NO15,34497.0
15654,Linuron,CON(C)C(=O)Nc1ccc(Cl)c(Cl)c1,C9H10Cl2N2O2,36205.0
15655,Glycocyamine,N=C(N)NCC(=O)O,C3H7N3O2,35792.0
15656,"(1R,4R)-N-desmethyl Sertraline (hydrochloride)",Cl.N[C@@H]1CC[C@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,C16H16Cl3N,35741.0
15657,Uridine-d2,[2H]c1c([2H])n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]c1=O,C9H12N2O6,36317.0
15658,Dopamine-d4 (hydrochloride),Cl.[2H]C([2H])(N)C([2H])([2H])c1ccc(O)c(O)c1,C8H12ClNO2,36309.0
15659,CM10,C=CCc1cccc(CNc2nc3ccccc3n2CCC)c1O,C20H23N3O,36186.0
15660,Hypoxanthine-d4,[2H]c1nc(=O)c2c(nc([2H])n2[2H])n1[2H],C5H4N4O,36330.0
15661,Nicorandil N-oxide,O=C(NCCO[N+](=O)[O-])c1ccc[n+]([O-])c1,C8H9N3O5,35415.0
15662,Remerin,CN1CCc2cc3c(c4c2[C@H]1Cc1ccccc1-4)OCO3,C18H17NO2,36035.0
15663,L-Glutamic Acid ?-p-Nitroanilide (hydrate),N[C@@H](CCC(=O)Nc1ccc([N+](=O)[O-])cc1)C(=O)O.O,C11H15N3O6,36209.0
15664,MCC950 (sodium salt),CC(C)(O)c1coc(S(=O)(=O)[N-]C(=O)Nc2c3c(cc4c2CCC4)CCC3)c1.[Na+],C20H23N2NaO5S,34762.0
15665,4-Aminobenzylphosphonic Acid,Nc1ccc(CP(=O)(O)O)cc1,C7H10NO3P,36029.0
15666,MF766,O=C(O)c1ccc(C2(NC(=O)c3cccc4ccn(Cc5ccc(C(F)(F)F)cc5)c34)CC2)cc1,C27H21F3N2O3,36076.0
15667,Fluazinam,O=[N+]([O-])c1cc(C(F)(F)F)c(Cl)c([N+](=O)[O-])c1Nc1ncc(C(F)(F)F)cc1Cl,C13H4Cl2F6N4O4,36221.0
15668,Cytidine-d2,[2H]c1c(N)nc(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1[2H],C9H13N3O5,36320.0
15669,SBI-425,COc1ccc(Cl)cc1S(=O)(=O)Nc1cncc(C(N)=O)c1,C13H12ClN3O4S,34626.0
15670,Pyridoxal (hydrochloride),Cc1ncc(CO)c(C=O)c1O.Cl,C8H10ClNO3,35379.0
15671,Nipecotic Acid,O=C(O)C1CCCNC1,C6H11NO2,36126.0
15672,2-Aminotetralin,NC1CCc2ccccc2C1,C10H13N,35544.0
15673,Cytosine-d2,[2H]c1nc(=O)[nH]c(N)c1[2H],C4H5N3O,36319.0
15674,Perfluorodecanesulfonic Acid,O=S(=O)(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C10HF21O3S,34990.0
15675,"Dexamethasone 9,11-epoxide",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]34O[C@H]4C[C@]2(C)[C@@]1(O)C(=O)CO,C22H28O5,36161.0
15676,Vanillin,COc1cc(C=O)ccc1O,C8H8O3,36422.0
15677,L-Alloisoleucine,CC[C@@H](C)[C@H](N)C(=O)O,C6H13NO2,34904.0
15678,Hydroxymethyl Tolperisone (hydrochloride),CC(CN1CCCCC1)C(=O)c1ccc(CO)cc1.Cl,C16H24ClNO2,35578.0
15679,"N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]-4-pyridinecarboxamide",Cc1ccc(-c2csc(NC(=O)c3ccncc3)n2)c(C)c1,C17H15N3OS,36050.0
15680,5-Hydroxyindole,Oc1ccc2[nH]ccc2c1,C8H7NO,36431.0
15681,L-319,CCCCCC/C=C\COC(=O)CCCCCCCC(CCCCCCCC(=O)OC/C=C\CCCCCC)OC(=O)CCCN(C)C,C41H75NO6,35051.0
15682,2-bromo 17?-Estradiol,C[C@]12CC[C@@H]3c4cc(Br)c(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,C18H23BrO2,9002145.0
15683,6-Chrysenamine,Nc1cc2c3ccccc3ccc2c2ccccc12,C18H13N,35780.0
15684,5(Z)-Dodecenoic Acid,CCCCCC/C=C\CCCC(=O)O,C12H22O2,35910.0
15685,3-methoxy PCMo (hydrochloride),COc1cccc(C2(N3CCOCC3)CCCCC2)c1.Cl,C17H26ClNO2,19785.0
15686,Biliverdin (technical grade),C=CC1=C(C)/C(=C/C2=N/C(=C\c3[nH]c(/C=C4\NC(=O)C(C)=C4C=C)c(C)c3CCC(=O)O)C(CCC(=O)O)=C2C)NC1=O,C33H34N4O6,36337.0
15687,3?-hydroxy Pravastatin (sodium salt),CC[C@H](C)C(=O)O[C@H]1CC=CC2=C[C@@H](O)[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21.[NaH],C23H36NaO7,35748.0
15688,D-Mannosamine (hydrochloride),Cl.N[C@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO,C6H14ClNO5,36231.0
15689,Centrinone,COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCOCC1,C26H25F2N7O6S2,24684.0
15690,Cephacetrile,CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CC#N)[C@H]2SC1,C13H13N3O6S,36269.0
15691,FPL 55712,CCCc1c(OCC(O)COc2ccc3c(=O)cc(C(=O)[O-])oc3c2CCC)ccc(C(C)=O)c1O.[Na+],C27H29NaO9,35433.0
15692,Glycolithocholic Acid 3-sulfate (sodium salt),C[C@H](CCC(=O)NCC(=O)[O-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@]12C.[Na+].[Na+],C26H41NNa2O7S,35298.0
15693,Daltroban,O=C(O)Cc1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1,C16H16ClNO4S,14061.0
15694,Sulthiame,NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1,C10H14N2O4S2,36271.0
15695,Homocitrulline,NC(=O)NCCCC[C@H](N)C(=O)O,C7H15N3O3,34980.0
15696,Sparstolonin B,O=c1occ2c3c(ccc(O)c13)Oc1ccc(O)cc1-2,C15H8O5,33080.0
15697,ZZW-115,CN(C)CCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1.Cl.Cl.Cl,C24H34Cl3F3N4S,34974.0
15698,Perseitol,OCC(O)C(O)C(O)C(O)C(O)CO,C7H16O7,36445.0
15699,Mitoquinone (mesylate),COC1=C(OC)C(=O)C(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)=C(C)C1=O.CS(=O)(=O)[O-],C38H47O7PS,29317.0
15700,Mitoquinol,COc1c(O)c(C)c(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c(O)c1OC.CS(=O)(=O)[O-],C38H49O7PS,89950.0
15701,O-Desmethyl Mebeverine Acid,CCN(CCCC(=O)O)C(C)Cc1ccc(O)cc1,C15H23NO3,35523.0
15702,?-Cembrenediol,C/C1=C/[C@H](O)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,C20H34O2,36042.0
15703,Aristolochic Acid D,COc1cc(O)cc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3,C17H11NO8,35492.0
15704,Thujopsene,CC1=CC[C@]2(C)CCCC(C)(C)[C@@]23C[C@@H]13,C15H24,35270.0
15705,Larixyl Acetate,C=C[C@@](C)(O)CC[C@H]1C(=C)C[C@H](OC(C)=O)[C@H]2C(C)(C)CCC[C@]12C,C22H36O3,35309.0
15706,?9-THCPA-A (CRM),CCCCCCCc1cc2c(c(O)c1C(=O)O)[C@@H]1C=C(C)CC[C@H]1C(C)(C)O2,C24H34O4,36239.0
15707,PSP,CC1(C)CC(/C=C/c2ccc3cc(OC(=O)c4cc([N+](=O)[O-])ccc4F)ccc3c2)=CC(=C(C#N)C#N)C1,C30H22FN3O4,35589.0
15708,Totarol,CC(C)c1c(O)ccc2c1CC[C@H]1C(C)(C)CCC[C@]21C,C20H30O,26412.0
15709,Chlorphine,CC(c1ccc(Cl)cc1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1,C20H22ClN3O,36301.0
15710,8-hydroxy Mirtazapine,CN1CCN2c3ncc(O)cc3Cc3ccccc3C2C1,C17H19N3O,35443.0
15711,Z-Gly-Pro-pNA,O=C(NCC(=O)N1CCC[C@H]1C(=O)Nc1ccc([N+](=O)[O-])cc1)OCc1ccccc1,C21H22N4O6,36135.0
15712,"L-694,247",CS(=O)(=O)Nc1ccc(Cc2noc(-c3ccc4[nH]cc(CCN)c4c3)n2)cc1,C20H21N5O3S,35475.0
15713,Fenhexamid,CC1(C(=O)Nc2ccc(O)c(Cl)c2Cl)CCCCC1,C14H17Cl2NO2,36222.0
15714,Guanosine 5'-[?-thio]triphosphate (lithium salt),Nc1nc(=O)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)S)[C@@H](O)[C@H]3O)c2[nH]1.[LiH],C10H16LiN5O13P3S,35098.0
15715,YIL 781 (hydrochloride),Cc1nc2ccc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1.Cl,C24H29ClFN3O2,29217.0
15716,(-)-?-Sesquiphellandrene,C=C1C=C[C@@H]([C@@H](C)CCC=C(C)C)CC1,C15H24,35749.0
15717,4-hydroxy Omeprazole sulfide,COc1ccc2nc(SCc3ncc(C)c(O)c3C)[nH]c2c1,C16H17N3O2S,35448.0
15718,Koumine,C=C[C@@]12CN(C)[C@H]3C[C@]14C(=Nc1ccccc14)[C@H]1C[C@@H]2[C@@H]3CO1,C20H22N2O,36210.0
15719,Glycidyl Palmitate,CCCCCCCCCCCCCCCC(=O)OCC1CO1,C19H36O3,9003681.0
15720,L-Kynurenine-d4,[2H]c1cc([2H])c(N)c(C(=O)C([2H])([2H])[C@H](N)C(=O)O)c1,C10H12N2O3,36307.0
15721,Cholesteryl Nervonate,CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C51H90O2,26471.0
15722,Clobetasone Propionate,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@@]21C,C25H30ClFO5,35747.0
15723,Cerberin,CO[C@@H]1[C@@H](O)[C@H](C)O[C@@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@@H](C5=CC(=O)OC5)CC[C@]43O)C2)[C@H]1OC(C)=O,C32H48O9,35582.0
15724,2-hydroxy Oleic Acid,CCCCCCCC/C=C\CCCCCCC(O)C(=O)O,C18H34O3,36044.0
15725,Catechol,Oc1ccccc1O,C6H6O2,34791.0
15726,DL-threo-?-Hydroxyaspartic Acid,N[C@H](C(=O)O)[C@H](O)C(=O)O,C4H7NO5,35274.0
15727,Trestolone Acetate,CC(=O)O[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@]12C)[C@H]1CCC(=O)C=C1C[C@H]3C,C21H30O3,31974.0
15728,SUN11602,Cc1c(C)c(NCC(=O)N(C)C2CCN(Cc3ccc(C(N)=O)cc3)CC2)c(C)c(C)c1N,C26H37N5O2,36572.0
15729,PD 168568 (hydrochloride),Cc1ccc(N2CCN(CCC3NC(=O)c4ccccc43)CC2)cc1C.Cl.Cl,C22H29Cl2N3O,35483.0
15730,Soticlestat,O=C(c1cccnc1-c1ccncc1)N1CCC(O)(Cc2ccccc2)CC1,C23H23N3O2,34928.0
15731,Nirvanol,CCC1(c2ccccc2)NC(=O)NC1=O,C11H12N2O2,21733.0
15732,Iomeprol,CN(C(=O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,C17H22I3N3O8,36397.0
15733,"CP 226,269",Fc1ccc2[nH]c(CN3CCN(c4ccccn4)CC3)cc2c1,C18H19FN4,36493.0
15734,Stobadine,Cc1ccc2c(c1)[C@H]1CN(C)CC[C@H]1N2,C13H18N2,36082.0
15735,3?-Cholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H40O5,36447.0
15736,TS-011,ON/C=N/c1ccc(N2CCOCC2)c(Cl)c1,C11H14ClN3O2,9002862.0
15737,PFM01,CC(C)CN1C(=O)/C(=C/c2ccc(O)cc2)SC1=S,C14H15NO2S2,36574.0
15738,Rhoifolin,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C27H30O14,35583.0
15739,SIB 1757,Cc1ccc(O)c(/N=N/c2ccccc2)n1,C12H11N3O,35442.0
15740,Glycyl-L-Glutamine (hydrate),NCC(=O)N[C@@H](CCC(N)=O)C(=O)O.O,C7H15N3O5,35058.0
15741,LF3,NS(=O)(=O)c1ccc(NC(=S)N2CCN(C/C=C/c3ccccc3)CC2)cc1,C20H24N4O2S2,36164.0
15742,Mofezolac,COc1ccc(-c2noc(CC(=O)O)c2-c2ccc(OC)cc2)cc1,C19H17NO5,34102.0
15743,7-hydroxy Etodolac,CCc1c(O)ccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3,C17H21NO4,34071.0
15744,6-Chloropurine Riboside,OC[C@H]1O[C@@H](n2cnc3c(Cl)ncnc32)[C@H](O)[C@@H]1O,C10H11ClN4O4,36002.0
15745,Xylotetraose,O=C[C@H](O)[C@@H](O)[C@@H](CO)OC1OC[C@@H](O[C@@H]2OC[C@@H](O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,C20H34O17,35387.0
15746,Difethialone,O=c1sc2ccccc2c(O)c1C1CC(c2ccc(-c3ccc(Br)cc3)cc2)Cc2ccccc21,C31H23BrO2S,36225.0
15747,2-Methyl-2-thiazoline-4-carboxylic Acid (sodium salt),CC1=NC(C(=O)[O-])CS1.[Na+],C5H6NNaO2S,34419.0
15748,Palmitoyl Alkyne-Coenzyme A,C#CCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O,C37H62N7O17P3S,36470.0
15749,Desethoxy Quetiapine (hydrochloride),Cl.Cl.OCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,C19H23Cl2N3OS,35410.0
15750,Enocitabine,CCCCCCCCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,C31H55N3O6,36538.0
15751,Anhydroecgonine methyl ester,COC(=O)C1=CC[C@@H]2CC[C@H]1N2C,C10H15NO2,17979.0
15752,Chenodeoxycholic Acid 3-Glucuronide,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O)CC[C@]4(C)[C@H]3CC[C@]12C,C30H48O10,36289.0
15753,DOT1L-IN-4,COc1nc(Nc2cc(S(C)(=O)=O)ccc2N[C@@H](c2cccc3c2OC(F)(F)O3)c2ncccc2Cl)nc(N2CCNCC2)n1,C28H27ClF2N8O5S,36456.0
15754,Cytosine,Nc1ccnc(=O)[nH]1,C4H5N3O,36219.0
15755,Deoxypodophyllotoxin,COc1cc([C@@H]2c3cc4c(cc3C[C@H]3COC(=O)[C@@H]32)OCO4)cc(OC)c1OC,C22H22O7,36434.0
15756,"3,4-dehydro Cilostazol",O=c1ccc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2[nH]1,C20H25N5O2,35075.0
15757,4-Hydroxyquinoline,Oc1ccnc2ccccc12,C9H7NO,35064.0
15758,Cannabinol Acetate,CCCCCc1cc(OC(C)=O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2,C23H28O3,36412.0
15759,Orphine,CC(c1ccccc1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1,C20H23N3O,36303.0
15760,3-hydroxy methyl Cefuroxime,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CO)CS[C@H]12)c1ccco1,C15H15N3O7S,35079.0
15761,Sulfamethazine-d4,[2H]c1c([2H])c(S(=O)(=O)Nc2nc(C)cc(C)n2)c([2H])c([2H])c1N,C12H14N4O2S,36575.0
15762,CBDPA (CRM),C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCCCC)c(C(=O)O)c1O,C24H34O4,36237.0
15763,Rhodojaponin III,CC1(C)[C@H]2O[C@H]2[C@H]2[C@](C)(O)[C@@H]3CC[C@@H]4[C@@H](O)[C@@]3(C[C@@H](O)[C@@]21O)C[C@@]4(C)O,C20H32O6,36345.0
15764,?-Cortolone,C[C@]12CC[C@@H](O)C[C@H]1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)[C@@H](O)CO,C21H34O5,35609.0
15765,SN-38 Glucuronide,CCc1c2c(nc3ccc(O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,C28H28N2O11,35642.0
15766,3-Epideoxycholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H40O4,34984.0
15767,Apricitabine,Nc1ccn([C@H]2CO[C@@H](CO)S2)c(=O)n1,C8H11N3O3S,36037.0
15768,2-Methylbutyrylglycine,CCC(C)C(=O)NCC(=O)O,C7H13NO3,36379.0
15769,ADB-BINACA,CC(C)(C)C(NC(=O)c1nn(Cc2ccccc2)c2ccccc12)C(N)=O,C21H24N4O2,18757.0
15770,Bazedoxifene N-oxide,Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCC[N+]3([O-])CCCCCC3)cc2)c2ccc(O)cc12,C30H34N2O4,35072.0
15771,Sennidin A,O=C(O)c1cc(O)c2c(c1)[C@H]([C@@H]1c3cccc(O)c3C(=O)c3c(O)cc(C(=O)O)cc31)c1cccc(O)c1C2=O,C30H18O10,35237.0
15772,Safinamide Acid,C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(=O)O,C17H18FNO3,35084.0
15773,3-Methoxytyrosine,COc1cc(CC(N)C(=O)O)ccc1O,C10H13NO4,36443.0
15774,Benoxaprofen,CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1,C16H12ClNO3,36001.0
15775,1-Methylpseudouridine,Cn1cc([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]c1=O,C10H14N2O6,35401.0
15776,14-methyl Pentadecanoic Acid,CC(C)CCCCCCCCCCCCC(=O)O,C16H32O2,36459.0
15777,16-Ketoestradiol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC(=O)[C@@H]2O,C18H22O3,36033.0
15778,"7,4'-Di-O-methylapigenin",COc1ccc(-c2cc(=O)c3c(O)cc(OC)cc3o2)cc1,C17H14O5,35388.0
15779,4-methoxy Estrone,COc1c(O)ccc2c1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H24O3,36041.0
15780,13C17-Mycophenolic Acid,[13CH3]O[13c]1[13c]([13CH3])[13c]2[13c]([13c](O)[13c]1[13CH2][13CH]=[13C]([13CH3])[13CH2][13CH2][13C](=O)O)[13C](=O)O[13CH2]2,C17H20O6,36359.0
15781,Galgravin,COc1ccc([C@H]2O[C@@H](c3ccc(OC)c(OC)c3)[C@H](C)[C@@H]2C)cc1OC,C22H28O5,35431.0
15782,Valsartan Acid,O=C(O)c1ccc(-c2ccccc2-c2nnn[nH]2)cc1,C14H10N4O2,35361.0
15783,12-methyl Tridecanoic Acid,CC(C)CCCCCCCCCCC(=O)O,C14H28O2,36461.0
15784,MDL 800,COC(=O)c1cc(NS(=O)(=O)c2cc(Cl)cc(Cl)c2)ccc1S(=O)(=O)Nc1cc(Br)c(F)cc1C,C21H16BrCl2FN2O6S2,35528.0
15785,Digoxigenin Bisdigitoxoside,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CC[C@@H]5[C@@H]4C[C@@H](O)[C@]4(C)[C@@H](C6=CC(=O)OC6)CC[C@]54O)C3)O[C@@H]2C)C[C@H](O)[C@@H]1O,C35H54O11,35356.0
15786,rac-Hesperetin-d3,[2H]C([2H])([2H])Oc1ccc(C2CC(=O)c3c(O)cc(O)cc3O2)cc1O,C16H14O6,35802.0
15787,ELOVL1-27,O=C(Nc1ccn(-c2ccnc(F)c2)n1)C1(c2ccccc2F)CC1,C18H14F2N4O,35323.0
15788,Sphinganine (d16:0 branched),CC(C)CCCCCCCCCCC[C@@H](O)[C@@H](N)CO,C17H37NO2,36503.0
15789,Chenodeoxycholic Acid (sodium salt),CC(CCC(=O)[O-])C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C.[Na+],C24H39NaO4,35346.0
15790,Albendazole sulfone,CCCS(=O)(=O)c1ccc2nc(NC(=O)OC)[nH]c2c1,C12H15N3O4S,35445.0
15791,Loxoprofen (sodium salt),CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1.[NaH],C15H18NaO3,35088.0
15792,trans-10-hydroxy Nortriptyline,CNCC/C=C1\c2ccccc2CC(O)c2ccccc21,C19H21NO,36660.0
15793,Monodocosanoin,CCCCCCCCCCCCCCCCCCCCCC(=O)OC(CO)CO.CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO,C50H100O8,36515.0
15794,PF-6260933,Nc1ccc(-c2cnc(N)c(-c3ccc(Cl)cc3)c2)cn1,C16H13ClN4,29220.0
15795,AF38469,Cc1cccc(NC(=O)c2ccc(C(F)(F)F)cc2C(=O)O)n1,C15H11F3N2O3,35530.0
15796,6-Deoxypenciclovir,Nc1ncc2ncn(CCC(CO)CO)c2n1,C10H15N5O2,35602.0
15797,cis-10-hydroxy Nortriptyline,CNCC/C=C1/c2ccccc2CC(O)c2ccccc21,C19H21NO,36659.0
15798,Aposcopolamine,C=C(C(=O)O[C@@H]1C[C@@H]2[C@H]3O[C@H]3[C@H](C1)N2C)c1ccccc1,C17H19NO3,36689.0
15799,Primin,CCCCCC1=CC(=O)C=C(OC)C1=O,C12H16O3,35441.0
15800,D-Tetrahydropalmatine,COc1cc2c(cc1OC)[C@H]1Cc3ccc(OC)c(OC)c3CN1CC2,C21H25NO4,35577.0
15801,BDA-366,CCN(CC)C[C@@H](O)CNc1ccc(NC[C@H]2CO2)c2c1C(=O)c1ccccc1C2=O,C24H29N3O4,35420.0
15802,Flavokawain A,COc1ccc(/C=C/C(=O)c2c(O)cc(OC)cc2OC)cc1,C18H18O5,36083.0
15803,Flavokawain A (CRM),COc1ccc(/C=C/C(=O)c2c(O)cc(OC)cc2OC)cc1,C18H18O5,40957.0
15804,N-Nitrosomethylisopropylamine,CC(C)N(C)N=O,C4H10N2O,36220.0
15805,FIT-039,Fc1ccc(N2CCCCC2)c(NC(=S)c2ccncc2)c1,C17H18FN3S,36555.0
15806,Choline-d9 (chloride),[2H]C([2H])([2H])[N+](CCO)(C([2H])([2H])[2H])C([2H])([2H])[2H].[Cl-],C5H14ClNO,36454.0
15807,Hydroxymetronidazole,O=[N+]([O-])c1cnc(CO)n1CCO,C6H9N3O4,35249.0
15808,UCLA gp130 2,Fc1ccc(Nc2nc(-c3ccccc3)cs2)cc1,C15H11FN2S,35551.0
15809,Uracil-d4,[2H]c1c([2H])n([2H])c(=O)n([2H])c1=O,C4H4N2O2,36318.0
15810,3-Aminosalicylic Acid,Nc1cccc(C(=O)O)c1O,C7H7NO3,36543.0
15811,6-Methylpterin,Cc1c[nH]c2nc(N)nc(=O)c-2n1,C7H7N5O,35380.0
15812,20(R)-Ginsenoside Rh1,CC(C)=CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C,C36H62O9,35493.0
15813,YQ-128,C#CCNS(=O)(=O)c1ccc(CCN(Cc2cc(Cl)ccc2OCCC)C(=O)Cc2ccsc2)cc1,C27H29ClN2O4S2,36451.0
15814,?8-iso-THC,C=C(C)[C@@H]1CC[C@]2(C)C[C@H]1c1c(O)cc(CCCCC)cc1O2,C21H30O2,33864.0
15815,?8-iso-THC (CRM),C=C(C)[C@@H]1CC[C@]2(C)C[C@H]1c1c(O)cc(CCCCC)cc1O2,C21H30O2,39000.0
15816,Desmethyl Sibutramine (hydrochloride),CNC(CC(C)C)C1(c2ccc(Cl)cc2)CCC1.Cl,C16H25Cl2N,35073.0
15817,SB-243213 (hydrochloride),Cc1cc2c(cc1C(F)(F)F)N(C(=O)Nc1ccc(Oc3cccnc3C)nc1)CC2.Cl.Cl,C22H21Cl2F3N4O2,36217.0
15818,N-desmethyl Galantamine,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCNC2,C16H19NO3,35074.0
15819,Etiocholanedione,C[C@]12CCC(=O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,C19H28O2,34358.0
15820,Fulvestrant 9-sulfone,C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O,C32H47F5O4S,35070.0
15821,5-Androstenetriol,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1C[C@@H](O)[C@@H]2O,C19H30O3,35273.0
15822,Clindamycin (hydrochloride hydrate),CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1.Cl.O,C18H36Cl2N2O6S,35581.0
15823,12-O-Methylcarnosic Acid,COc1c(C(C)C)cc2c(c1O)[C@@]1(C(=O)O)CCCC(C)(C)[C@@H]1CC2,C21H30O4,36175.0
15824,TVB-2640,Cc1nnc(-c2cc(C(=O)N3CCC(c4ccc(C#N)cc4)CC3)c(C)cc2C2CCC2)[nH]1,C27H29N5O,35703.0
15825,N?-Benzoyl-L-Arginine-pNA (hydrochloride),Cl.N=C(N)NCCC[C@H](NC(=O)c1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1,C19H23ClN6O4,36331.0
15826,N-Nitrosodibutylamine,CCCCN(CCCC)N=O,C8H18N2O,35474.0
15827,2-Methoxy-4-methylphenol,COc1cc(C)ccc1O,C8H10O2,36533.0
15828,3'-Hydroxygenkwanin,COc1cc(O)c2c(=O)cc(-c3ccc(O)c(O)c3)oc2c1,C16H12O6,36150.0
15829,"3,5,6,7,8,3',4'-Heptamethoxyflavone",COc1ccc(-c2oc3c(OC)c(OC)c(OC)c(OC)c3c(=O)c2OC)cc1OC,C22H24O9,36475.0
15830,Pantoprazole N-oxide,COc1cc[n+]([O-])c(CS(=O)c2nc3ccc(OC(F)F)cc3[nH]2)c1OC,C16H15F2N3O5S,35449.0
15831,Apatinib-d8,[2H]C1([2H])C([2H])([2H])C([2H])([2H])C(C#N)(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)C1([2H])[2H],C24H23N5O,35055.0
15832,3-chloro-L-Tyrosine,N[C@@H](Cc1ccc(O)c(Cl)c1)C(=O)O,C9H10ClNO3,35753.0
15833,GSK369796 (hydrochloride),CC(C)(C)NCc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O.Cl.Cl,C20H24Cl3N3O,36061.0
15834,Omeprazole N-oxide,COc1ccc2nc(S(=O)Cc3c(C)c(OC)c(C)c[n+]3[O-])[nH]c2c1,C17H19N3O4S,35430.0
15835,BAY-179,c1ccc2oc(-c3csc(C4CCN(Cc5nc6ncccc6[nH]5)CC4)n3)cc2c1,C23H21N5OS,36657.0
15836,Aristolone,C[C@@H]1CCCC2=CC(=O)[C@@H]3[C@@H](C3(C)C)[C@]21C,C15H22O,36157.0
15837,2-NP-AOZ,O=C1OCCN1/N=C/c1ccccc1[N+](=O)[O-],C10H9N3O4,35575.0
15838,Thymine-d4,[2H]c1[nH]c(=O)[nH]c(=O)c1C([2H])([2H])[2H],C5H6N2O2,36329.0
15839,"4',7-Di-O-methylnaringenin",COc1ccc([C@@H]2CC(=O)c3c(O)cc(OC)cc3O2)cc1,C17H16O5,36190.0
15840,Fluorphine,CC(c1ccc(F)cc1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1,C20H22FN3O,36302.0
15841,Lipid 29,CCCCCCCCC(CC)OC(=O)CCCCCCCN(CCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC)CCCNc1c(NC)c(=O)c1=O,C52H97N3O6,35337.0
15842,ELN484228,O=S(=O)(Nc1ccc(F)cc1)c1ccccc1,C12H10FNO2S,29398.0
15843,Inosine,O=c1nc[nH]c2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C10H12N4O5,34373.0
15844,MIK665,COc1ccccc1-c1nccc(COc2ccccc2CC(Oc2ncnc3sc(-c4ccc(F)cc4)c(-c4ccc(OCCN5CCN(C)CC5)c(Cl)c4C)c23)C(=O)O)n1,C47H44ClFN6O6S,36404.0
15845,Genkwanin,COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1,C16H12O5,35229.0
15846,3'-Deoxy-3'-fluorothymidine,Cc1cn([C@H]2C[C@H](F)[C@@H](CO)O2)c(=O)[nH]c1=O,C10H13FN2O4,36519.0
15847,3-Epiursolic Acid,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,C30H48O3,36528.0
15848,3-Methoxycatechol,COc1cccc(O)c1O,C7H8O3,36535.0
15849,DHODH-IN 11,N#C/C(=N\O)C(=O)Nc1ccc(-c2ccccc2)cc1,C15H11N3O2,36159.0
15850,Trifolirhizin,OC[C@H]1O[C@@H](Oc2ccc3c(c2)OC[C@H]2c4cc5c(cc4O[C@@H]32)OCO5)[C@H](O)[C@@H](O)[C@@H]1O,C22H22O10,34655.0
15851,Bacitracin A (technical grade),CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1,C66H103N17O16S,36252.0
15852,2'-C-?-Methylguanosine,C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(=O)nc(N)[nH]c21,C11H15N5O5,36548.0
15853,Meclizine N-oxide,Cc1cccc(C[N+]2([O-])CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1,C25H27ClN2O,35054.0
15854,Tumulosic Acid,C=C(CC[C@@H](C(=O)O)[C@H]1[C@H](O)C[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,C31H50O4,36021.0
15855,(-)-Syringaresinol di-O-glucoside,COc1cc([C@@H]2OC[C@@H]3[C@H]2CO[C@H]3c2cc(OC)c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)c2)cc(OC)c1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C34H46O18,36672.0
15856,4'-Demethylpodophyllotoxin,COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,C21H20O8,36481.0
15857,Aticaprant,Cc1cc(C)cc([C@@H]2CCCN2Cc2ccc(Oc3ccc(C(N)=O)cc3F)cc2)c1,C26H27FN2O2,35464.0
15858,"3-hydroxy-9,10-Dimethoxypterocarpan",COc1ccc2c(c1OC)O[C@H]1c3ccc(O)cc3OC[C@@H]21,C17H16O5,36152.0
15859,ZD 7155 (hydrochloride),CCc1cc2c(c(CC)n1)CCC(=O)N2Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1.Cl,C26H27ClN6O,36576.0
15860,Valtrate,CC(=O)OCC1=CO[C@@H](OC(=O)CC(C)C)[C@H]2C1=C[C@H](OC(=O)CC(C)C)[C@]21CO1,C22H30O8,36522.0
15861,"1,1,1,1-Kestohexose",OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O,C36H62O31,36591.0
15862,3-oxo Deoxycholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4CC(=O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H38O4,35227.0
15863,4-Hydroxyphenylacetylglycine,O=C(O)CNC(=O)Cc1ccc(O)cc1,C10H11NO4,36488.0
15864,O-desmethyl Galantamine,CN1CC[C@@]23C=C[C@H](O)C[C@@H]2Oc2c(O)ccc(c23)C1,C16H19NO3,35080.0
15865,Atractylenolide II,C=C1CCC[C@]2(C)C[C@@H]3OC(=O)C(C)=C3C[C@@H]12,C15H20O2,36173.0
15866,AT-130,COc1ccccc1/C(Br)=C(\NC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)N1CCCCC1,C22H22BrN3O5,35453.0
15867,Darifenacin N-oxide,NC(=O)C(c1ccccc1)(c1ccccc1)C1CC[N+]([O-])(CCc2ccc3c(c2)CCO3)C1,C28H30N2O3,35083.0
15868,CRT0036521,O=C(O)c1cccc(S(=O)(=O)N2CCc3ccccc3C2)c1,C16H15NO4S,36600.0
15869,"3'-Azido-2',3'-dideoxyuridine",[N-]=[N+]=N[C@H]1C[C@H](n2ccc(=O)[nH]c2=O)O[C@@H]1CO,C9H11N5O4,36544.0
15870,Octocrylene,CCCCC(CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1,C24H27NO2,35461.0
15871,Corydine,COc1cc2c3c(c1O)-c1c(ccc(OC)c1OC)C[C@@H]3N(C)CC2,C20H23NO4,35028.0
15872,Dexamethasone Palmitate,CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C38H59FO6,35451.0
15873,Desalkylgidazepam,O=C1CN=C(c2ccccc2)c2cc(Br)ccc2N1,C15H11BrN2O,36608.0
15874,Desalkylgidazepam (CRM),O=C1CN=C(c2ccccc2)c2cc(Br)ccc2N1,C15H11BrN2O,40621.0
15875,BAY-1816032,COc1cnccc1Nc1nc(-c2nn(Cc3c(F)cc(OCCO)cc3F)c3ccccc23)ncc1OC,C27H24F2N6O4,35095.0
15876,Metformin hydroxy analog 2,CN(C)C(=N)NC(N)=O,C4H10N4O,36316.0
15877,Pyropheophorbide a methyl ester,C=Cc1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)OC)[C@@H]3C,C34H36N4O3,36512.0
15878,DSM 265,Cc1cc(Nc2ccc(S(F)(F)(F)(F)F)cc2)n2nc(C(C)(F)F)nc2n1,C14H12F7N5S,30680.0
15879,Kinetin Riboside,OC[C@H]1O[C@@H](n2cnc3c(NCc4ccco4)ncnc32)[C@H](O)[C@@H]1O,C15H17N5O5,36570.0
15880,LCS3,O=C(Nc1ccc(Cl)cc1)c1ccc([N+](=O)[O-])o1,C11H7ClN2O4,36636.0
15881,Coclaurine,COc1cc2c(cc1O)[C@H](Cc1ccc(O)cc1)NCC2,C17H19NO3,35716.0
15882,6-Aminopenicillanic Acid,CC1(C)S[C@@H]2[C@H](N)C(=O)N2[C@H]1C(=O)O,C8H12N2O3S,34494.0
15883,3-Acetylaconitine,CCN1C[C@]2(COC)[C@H](OC(C)=O)C[C@H](OC)C34C1C([C@H](OC)[C@@H]32)[C@@]1(OC(C)=O)[C@@H](O)[C@H](OC)[C@@]2(O)C[C@@H]4[C@@H]1C2OC(=O)c1ccccc1,C36H49NO12,36155.0
15884,TACA,NC/C=C/C(=O)O,C4H7NO2,35217.0
15885,Procyanidin B4,Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)[C@@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,C30H26O12,36398.0
15886,"3,5-Bis(4-nitrophenoxy)benzoic Acid",O=C(O)c1cc(Oc2ccc([N+](=O)[O-])cc2)cc(Oc2ccc([N+](=O)[O-])cc2)c1,C19H12N2O8,36553.0
15887,"N6,N6-Dimethyladenosine",CN(C)c1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C12H17N5O4,35348.0
15888,Cytarabine 5'-monophosphate,Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]2O)c(=O)n1,C9H14N3O8P,36496.0
15889,Pyrrolnitrin,O=[N+]([O-])c1c(Cl)cccc1-c1c[nH]cc1Cl,C10H6Cl2N2O2,35099.0
15890,MRTX-1133,C#Cc1c(F)ccc2cc(O)cc(-c3ncc4c(N5CC6CCC(C5)N6)nc(OC[C@@]56CCCN5C[C@H](F)C6)nc4c3F)c12,C33H31F3N6O2,36413.0
15891,"5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein (hydrochloride)",Cl.O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccc(Nc3nc(Cl)nc(Cl)n3)cc21,C23H13Cl3N4O5,34080.0
15892,Cycleanine,COc1cc2c3c(c1OC)Oc1ccc(cc1)C[C@@H]1c4c(cc(OC)c(OC)c4Oc4ccc(cc4)C[C@H]3N(C)CC2)CCN1C,C38H42N2O6,36020.0
15893,Clinodiside A,CC1(C)CC[C@@]2(CO)C(=C3C=C[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@@H]2O)C1,C48H78O19,36200.0
15894,N-desmethyl Asenapine,Clc1ccc2c(c1)[C@H]1CNC[C@@H]1c1ccccc1O2,C16H14ClNO,35085.0
15895,Abafungin,Cc1ccc(Oc2ccccc2-c2csc(NC3=NCCCN3)n2)c(C)c1,C21H22N4OS,35465.0
15896,"5?-Cholanic Acid-3,6-dione",C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC(=O)[C@H]4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H36O4,36184.0
15897,Robinetin,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)ccc12,C15H10O7,35272.0
15898,"9(E),12(E)-Linoleic Acid ethyl ester",CCCCC/C=C/C/C=C/CCCCCCCC(=O)OCC,C20H36O2,36551.0
15899,CCT020312,CCN(CC)CCC(=O)N1N=C(c2c(-c3ccccc3)c3cc(Br)ccc3[nH]c2=O)CC1c1ccc(Br)cc1,C31H30Br2N4O2,36577.0
15900,3-(3-Hydroxyphenyl)-3-hydroxypropanoic Acid,O=C(O)CC(O)c1cccc(O)c1,C9H10O4,35548.0
15901,3-Methylsalicylic Acid,Cc1cccc(C(=O)O)c1O,C8H8O3,36536.0
15902,CAY10788,COC(=O)c1cccc(OCc2ccc3ccccc3n2)c1,C18H15NO3,35324.0
15903,Etheroleic Acid,CCCC/C=C/O/C=C/C=C\CCCCCCCC(=O)O,C18H30O3,10005119.0
15904,NDI-091143,COC(=O)c1cc(Cl)c(O)c(S(=O)(=O)Nc2cc(-c3ccccc3)c(F)cc2F)c1,C20H14ClF2NO5S,36054.0
15905,L-Pyroglutamic Acid,O=C1CC[C@@H](C(=O)O)N1,C5H7NO3,36531.0
15906,Iguratimod,CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1,C17H14N2O6S,35529.0
15907,Dynarrestin,CCOC(=O)c1sc(Nc2ccc(F)cc2F)nc1-c1ccc(N(CC)CC)cc1,C22H23F2N3O2S,35527.0
15908,Mitochonic Acid 5,O=C(CC(C(=O)O)c1c[nH]c2ccccc12)c1ccc(F)cc1F,C18H13F2NO3,35702.0
15909,X-?-Gal,OC[C@H]1O[C@H](Oc2c[nH]c3ccc(Br)c(Cl)c23)[C@H](O)[C@@H](O)[C@H]1O,C14H15BrClNO6,36095.0
15910,CYM 2503,Cc1cc(=O)[nH]c2cc(NC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)[C@H](CC3CCCCC3)NC(=O)OCC3c4ccccc4-c4ccccc43)ccc12,C45H55N5O7,36590.0
15911,"24,25-epoxy Cholesterol",C[C@H](CCC1OC1(C)C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H44O2,25966.0
15912,11?-Hydroxyprogesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,C21H30O3,36031.0
15913,1-hydroxy Ibuprofen,CC(C(=O)O)c1ccc(C(O)C(C)C)cc1,C13H18O3,36295.0
15914,Desmethylflutiazepam,CCc1cc2c(s1)NC(=O)CN=C2c1ccccc1F,C15H13FN2OS,36747.0
15915,3'-hydroxy Puerarin,O=c1c(-c2ccc(O)c(O)c2)coc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12,C21H20O10,36771.0
15916,Erlotinib (hydrochloride),C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl,C22H24ClN3O4,35517.0
15917,3-demethyl Colchicine,COc1c(O)cc2c(c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,C21H23NO6,35238.0
15918,Cyclamidomycin,NC(=O)/C=C/C1=NCCC1,C7H10N2O,36387.0
15919,N-Desmethyltrimipramine,CNCC(C)CN1c2ccccc2CCc2ccccc21,C19H24N2,34982.0
15920,CBNQ,CCCCCC1=CC(=O)C2=C(OC(C)(C)c3ccc(C)cc32)C1=O,C21H24O3,30863.0
15921,8(R)-hydroxy-9(R)-Hexahydrocannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C[C@@H](O)[C@H](C)C[C@@H]21,C21H32O3,36250.0
15922,35600,COc1cc(-c2oc3cc(O)cc(O)c3c(=O)c2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)ccc1O,C22H22O12,35600.0
15923,Carfenazine,CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,C24H31N3O2S,36486.0
15924,Ipronidazole,[C][C]([C])c1n[c]c([N+](=O)[O-])n1[C],C7N3O2,35082.0
15925,Oxotremorine (sesquifumarate),O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C1CCCN1CC#CCN1CCCC1.O=C1CCCN1CC#CCN1CCCC1,C36H48N4O14,35707.0
15926,3-Isomangostin,COc1c(O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)CCC(C)(C)O4,C24H26O6,36484.0
15927,Desmethyl Carvedilol,Oc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,C23H24N2O4,35411.0
15928,CBGH,CCCCCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1,C22H34O2,33396.0
15929,8(S)-hydroxy-9(S)-Hexahydrocannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C[C@H](O)[C@@H](C)C[C@@H]21,C21H32O3,36249.0
15930,Harmalol (hydrochloride hydrate),CC1=NCCc2c1[nH]c1cc(O)ccc21.Cl.O.O,C12H17ClN2O3,36090.0
15931,ARC 239 (hydrochloride),COc1ccccc1N1CCN(CCN2C(=O)c3ccccc3C(C)(C)C2=O)CC1.Cl.Cl,C24H31Cl2N3O3,36218.0
15932,2'-Deoxyadenosine-5'-O-diphosphate (sodium salt),Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](COP(=O)([O-])OP(=O)([O-])[O-])O1.[Na+].[Na+].[Na+],C10H12N5Na3O9P2,36195.0
15933,?-Glucogallin,O=C(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)c1cc(O)c(O)c(O)c1,C13H16O10,36010.0
15934,"cis-9,10-Epoxyoctadecanoic Acid",CCCCCCCC[C@H]1O[C@H]1CCCCCCCC(=O)O,C18H34O3,36442.0
15935,BAY-1436032,C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1,C26H30F3N3O3,35709.0
15936,CB-103,CC(C)(C)c1ccc(Oc2ccc(N)cn2)cc1,C15H18N2O,36293.0
15937,Rhamnocitrin,COc1cc(O)c2c(=O)c(O)c(-c3ccc(O)cc3)oc2c1,C16H12O6,36272.0
15938,TC-I 2000,O=C(Nc1ccc(F)cc1)N1CCc2ccccc2C1c1ccc(C(F)(F)F)cc1,C23H18F4N2O,35463.0
15939,3-Allylphenol,C=CCc1cccc(O)c1,C9H10O,36492.0
15940,3-Hydroxy-4-methyl-2(5H)-thiophenone,CC1=C(O)C(=O)SC1,C5H6O2S,36290.0
15941,N-Acetyl-L-thyroxine,CC(=O)N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,C17H13I4NO5,35197.0
15942,N-desmethyl Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCNCC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,C28H29N7O,16947.0
15943,AZD 2716,C[C@H](Cc1cccc(-c2cc(Cc3ccccc3)ccc2C(N)=O)c1)C(=O)O,C24H23NO3,35067.0
15944,Benomyl,CCCCNC(=O)n1c(NC(=O)OC)nc2ccccc21,C14H18N4O3,34634.0
15945,N-desmethyl Sildenafil (citrate),CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCNCC4)ccc3OCC)nc12.O=C(O)CC(O)(CC(=O)O)C(=O)O,C27H36N6O11S,10010587.0
15946,LQZ-7I,Fc1ccc(Nc2nc3ccccc3nc2Nc2ccc(F)cc2)cc1,C20H14F2N4,36602.0
15947,Kumatakenin,COc1cc(O)c2c(=O)c(OC)c(-c3ccc(O)cc3)oc2c1,C17H14O6,35514.0
15948,Obidoxime (chloride),O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1.[Cl-].[Cl-],C14H16Cl2N4O3,36587.0
15949,Ac4ManNAz,CC(=O)OC[C@H]1OC(OC(C)=O)[C@@H](NC(=O)CN=[N+]=[N-])[C@@H](OC(C)=O)[C@@H]1OC(C)=O,C16H22N4O10,36283.0
15950,Scopoline,CN1[C@@H]2C[C@@H]3C[C@H]1[C@H](O)[C@H]2O3,C8H13NO2,35301.0
15951,p-Nitrophenyl ?-D-Galactopyranoside,O=[N+]([O-])c1ccc(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)cc1,C12H15NO8,36160.0
15952,Agrimol B,CCCC(=O)c1c(O)c(Cc2c(O)c(Cc3c(O)c(C)c(OC)c(C(=O)CCC)c3O)c(O)c(C(=O)[C@@H](C)CC)c2O)c(O)c(C)c1OC,C37H46O12,34996.0
15953,Gypsogenic Acid,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(C(=O)O)[C@@H]5CC[C@]43C)[C@@H]2C1,C30H46O5,36025.0
15954,MS1943,Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(N4CCN(CCNC(=O)CC56CC7CC(CC(C7)C5)C6)CC4)nc3)cc3c2cnn3C(C)C)c(=O)[nH]1,C42H54N8O3,35466.0
15955,Carbostyril 124,Cc1cc(=O)[nH]c2cc(N)ccc12,C10H10N2O,34967.0
15956,Capsaicin-d3,[2H]C([2H])([2H])Oc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,C18H27NO3,34695.0
15957,3-Butylidenephthalide,CCCC=C1OC(=O)c2ccccc21,C12H12O2,34983.0
15958,Dihydronarwedine,COc1ccc2c3c1O[C@H]1CC(=O)CC[C@@]31CCN(C)C2,C17H21NO3,35409.0
15959,Valproic Acid,CCCC(CCC)C(=O)O,C8H16O2,35739.0
15960,F1063-0967,Cc1ccc(C=C2SC(=S)N(CCCCCC(=O)Nc3ccc(C(=O)O)c(O)c3)C2=O)cc1,C24H24N2O5S2,36115.0
15961,Piperacetazine,CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,C24H30N2O2S,35220.0
15962,BC-1618,OC(COc1ccc(C(F)(F)F)cc1)CN(Cc1ccccc1)Cc1ccccc1,C24H24F3NO2,36136.0
15963,Coluracetam,Cc1oc2nc3c(c(NC(=O)CN4CCCC4=O)c2c1C)CCCC3,C19H23N3O3,26032.0
15964,GRL-0496,O=C(Oc1cncc(Cl)c1)c1cccc2[nH]ccc12,C14H9ClN2O2,36114.0
15965,?-D-Glutamylglycine (trifluoroacetate salt),N[C@H](CCC(=O)NCC(=O)O)C(=O)O.O=C(O)C(F)(F)F,C9H13F3N2O7,36278.0
15966,Tubercidin,Nc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C11H14N4O4,35834.0
15967,9-Anthracenecarboxylic Acid,O=C(O)c1c2ccccc2cc2ccccc12,C15H10O2,36180.0
15968,Exatecan (mesylate),CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](N)CC3.CS(=O)(=O)O,C25H26FN3O7S,35452.0
15969,N-Nitroso-N-methylaniline,CN(N=O)c1ccccc1,C7H8N2O,35563.0
15970,Ginkgolic Acid C17:1,CCCCCC/C=C\CCCCCCCCCc1cccc(O)c1C(=O)O,C24H38O3,35737.0
15971,Lupenone,C=C(C)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C30H48O,35335.0
15972,Clindamycin Phosphate,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,C18H34ClN2O8PS,35611.0
15973,Ampicillin (hydrate),CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O.O.O.O,C16H25N3O7S,35740.0
15974,Glyphosine,O=C(O)CN(CP(=O)(O)O)CP(=O)(O)O,C4H11NO8P2,14299.0
15975,N-Boc Sitagliptin,CC(C)(C)OC(=O)N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,C21H23F6N5O3,35312.0
15976,AA92593,COc1ccc(S(=O)(=O)N2CCCCC2)cc1C,C13H19NO3S,35836.0
15977,1-Cinnamoylpyrrolidine,O=C(/C=C/c1ccccc1)N1CCCC1,C13H15NO,36483.0
15978,Nilotinib (hydrochloride hydrate),Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1.Cl.O,C28H25ClF3N7O2,36628.0
15979,Genipin 1-gentiobioside,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2C(CO)=CC[C@H]12,C23H34O15,35621.0
15980,CADD522,O=C(O)C1C2C=CC(C2)C1C(=O)Nc1ccc(Cl)c(Cl)c1,C15H13Cl2NO3,36679.0
15981,ELOVL1-22,c1ccc([C@H]2CN(c3cc(O[C@H]4C[C@@H](n5cccn5)C4)ncn3)CCO2)cc1,C21H23N5O2,36142.0
15982,Lefamulin,C=C[C@]1(C)C[C@@H](OC(=O)CS[C@@H]2CC[C@@H](N)C[C@H]2O)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,C28H45NO5S,36285.0
15983,Vanillin 4-O-?-D-Glucoside,COc1cc(C=O)ccc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C14H18O8,35908.0
15984,Qstatin,O=S(=O)(c1ccc(Br)s1)n1cccn1,C7H5BrN2O2S2,36609.0
15985,Miltirone,CC(C)C1=Cc2ccc3c(c2C(=O)C1=O)CCCC3(C)C,C19H22O2,36663.0
15986,Reuterin,O=CCCO,C3H6O2,36300.0
15987,rac-Benpyrine,O=C1CC(Nc2ncnc3nc[nH]c23)CN1Cc1ccccc1,C16H16N6O,36680.0
15988,LY345899,Nc1nc(=O)c2c([nH]1)NCC1CN(c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)C(=O)N21,C20H21N7O7,36627.0
15989,BI-2545,O=C(NC[C@@H]1[C@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@@H]12)c1ccc2nn[nH]c2c1,C23H19F6N5O3,24285.0
15990,Stearic Acid glycidyl ester-d5,[2H]C([2H])(OC(=O)CCCCCCCCCCCCCCCCC)C1([2H])OC1([2H])[2H],C21H40O3,36839.0
15991,Desipramine-d4 (hydrochloride),Cl.[2H]c1cc([2H])c2c(c1)CCc1cc([2H])cc([2H])c1N2CCCNC,C18H23ClN2,36849.0
15992,D-Arabinose,O=C[C@@H](O)[C@H](O)[C@H](O)CO,C5H10O5,35700.0
15993,DMPE-MPEG(2000),CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)OCCOC)OC(=O)CCCCCCCCCCCCC,C35H68NO10P(C2H4O)n,34649.0
15994,Isosinensetin,COc1ccc(-c2cc(=O)c3c(OC)cc(OC)c(OC)c3o2)cc1OC,C20H20O7,36009.0
15995,9-ING-41,Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc3c(cc21)OCO3,C22H13FN2O5,36629.0
15996,IRAK Inhibitor 1,c1cc(NC2CCNCC2)nc(-c2cnc3ccccn23)c1,C17H19N5,36637.0
15997,Renin Fluorogenic Substrate,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)NCCNc1cccc2c(S(=O)(=O)O)cccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(=O)N[C@@H](CCCCNC(=O)c1ccc(N=Nc2ccc(N(C)C)cc2)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C,C109H156N32O21S,10006906.0
15998,S6K-18,CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1,C17H18N4O3S,36624.0
15999,Avoralstat,C=Cc1cc(C(=O)Nc2ccc(C(=N)N)cc2)c(-c2ccc(C(=O)NCC3CC3)nc2C(=O)O)cc1OC,C28H27N5O5,35610.0
16000,Estrone 3-sulfate (sodium salt),C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)[O-])cc4CC[C@H]3[C@@H]1CCC2=O.[Na+],C18H21NaO5S,36989.0
16001,Oleic Acid-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCC/C=C\CCCCCCCC(=O)O,C18H34O2,24659.0
16002,Heptacosanoic Acid,CCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O,C27H54O2,36163.0
16003,GPX4 Inhibitor 26a,O=C(NCCc1ccccc1)C(c1csc2ccccc12)N(C(=O)CCl)c1ccc(-c2cnco2)cc1,C29H24ClN3O3S,35408.0
16004,2-Stearoyl-sn-glycero-3-PC,CCCCCCCCCCCCCCCCCC(=O)O[C@H](CO)COP(=O)([O-])OCC[N+](C)(C)C,C26H54NO7P,35308.0
16005,O-Desmethylangolensin,CC(C(=O)c1ccc(O)cc1O)c1ccc(O)cc1,C15H14O4,36435.0
16006,Necrosulfonamide-d4,[2H]c1c([2H])c(S(=O)(=O)Nc2nccnc2OC)c([2H])c([2H])c1NC(=O)C=Cc1ccc([N+](=O)[O-])s1,C18H15N5O6S2,34702.0
16007,PF-04753299,C[C@@](CCc1ccc(-c2ccccc2)cc1)(C(=O)NO)S(C)(=O)=O,C18H21NO4S,36502.0
16008,1-Carboxycyclohexaneacetic Acid,O=C(O)CC1(C(=O)O)CCCCC1,C9H14O4,36046.0
16009,Gusacitinib,N#CCC1CCN(c2nc(Nc3ccc(N4CCC(O)CC4)cc3)c3c(=O)[nH]ncc3n2)CC1,C24H28N8O2,36554.0
16010,Urobilin (hydrochloride),CCC1=C(C)[C@@H](CC2=N/C(=C\c3[nH]c(C[C@H]4NC(=O)C(C)=C4CC)c(C)c3CCC(=O)O)C(CCC(=O)O)=C2C)NC1=O.Cl,C33H43ClN4O6,36508.0
16011,Aficamten,CCc1nc(-c2ccc3c(c2)CC[C@H]3NC(=O)c2cnn(C)c2)no1,C18H19N5O2,36304.0
16012,Liarozole,Clc1cccc(C(c2ccc3nc[nH]c3c2)n2ccnc2)c1,C17H13ClN4,29491.0
16013,L-Phenylalanine-13C6,N[C@@H](C[13c]1[13cH][13cH][13cH][13cH][13cH]1)C(=O)O,C9H11NO2,35195.0
16014,4-Chloroindole-3-acetic Acid,O=C(O)Cc1c[nH]c2cccc(Cl)c12,C10H8ClNO2,35534.0
16015,Acridine,c1ccc2nc3ccccc3cc2c1,C13H9N,35607.0
16016,Protectin D1 methyl ester,CC/C=C\C[C@H](O)/C=C\C=C\C=C\[C@H](O)C/C=C\C/C=C\CCC(=O)OC,C23H34O4,36746.0
16017,5-bromo-3-indolyl-?-D-Galactopyranoside,OC[C@H]1O[C@@H](Oc2c[nH]c3ccc(Br)cc23)[C@H](O)[C@@H](O)[C@H]1O,C14H16BrNO6,35299.0
16018,NS 3623,O=C(Nc1cccc(C(F)(F)F)c1)Nc1ccc(Br)cc1-c1nnn[nH]1,C15H10BrF3N6O,34992.0
16019,2-Hydroxyadipic Acid,O=C(O)CCCC(O)C(=O)O,C6H10O5,36482.0
16020,Ascorbyl Tetraisopalmitate,CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC,C70H128O10,36275.0
16021,Cannabidiol diacetate,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(OC(C)=O)cc(CCCCC)cc1OC(C)=O,C25H34O4,36424.0
16022,Tulobuterol (hydrochloride),CC(C)(C)NCC(O)c1ccccc1Cl.Cl,C12H19Cl2NO,35562.0
16023,Lansoprazole sulfone N-oxide,Cc1c(OCC(F)(F)F)cc[n+]([O-])c1CS(=O)(=O)c1nc2ccccc2[nH]1,C16H14F3N3O4S,35450.0
16024,RG3039,Nc1nc(N)c2c(OCC3CCN(Cc4c(Cl)cccc4Cl)CC3)cccc2n1,C21H23Cl2N5O,36589.0
16025,8-Chloroadenosine,Nc1ncnc2c1nc(Cl)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C10H12ClN5O4,35766.0
16026,9(S)-HHC,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@H](C)C[C@@H]21,C21H32O2,27501.0
16027,9(S)-Hexahydrocannabinol (CRM),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@H](C)C[C@@H]21,C21H32O2,37942.0
16028,PEG diamine,NCCOCCOCCN,C4H12N2O(C2H4O)n,21174.0
16029,Alisol C Monoacetate,CC(=O)O[C@@H](C[C@@H](C)C1=C2C[C@H](O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1=O)[C@H]1OC1(C)C,C32H48O6,35823.0
16030,16-methyl Stearic Acid,CCC(C)CCCCCCCCCCCCCCC(=O)O,C19H38O2,36476.0
16031,Stercobilin (hydrochloride),CC[C@H]1[C@H](Cc2[nH]c(/C=C3\N=C(C[C@@H]4NC(=O)[C@H](CC)[C@H]4C)C(C)=C3CCC(=O)O)c(CCC(=O)O)c2C)NC(=O)[C@@H]1C.Cl,C33H46N4O6(ClH)X,36509.0
16032,3-Aminocatechol,Nc1cccc(O)c1O,C6H7NO2,36366.0
16033,Phenylarsine Oxide,O=[As]c1ccccc1,C6H5AsO,35525.0
16034,Oleuropein aglycone,C/C=C1/[C@H](O)OC=C(C(=O)OC)[C@H]1CC(=O)OCCc1ccc(O)c(O)c1,C19H22O8,35547.0
16035,Albendazole sulfone-d3,[2H]C([2H])([2H])OC(=O)Nc1nc2ccc(S(=O)(=O)CCC)cc2[nH]1,C12H15N3O4S,35129.0
16036,BAY-1082439,COc1c(OC[C@H](O)CN2CCOCC2)ccc2c1N=C(NC(=O)c1cccnc1C)N1CCN=C21,C25H30N6O5,35456.0
16037,BLU-782,CCOC1(c2ccc(-c3cc4c(N5CCN(C(=O)O[C@@H]6CCOC6)CC5)ccnn4c3)nc2)CCN(C(C)C)CC1,C31H42N6O4,35490.0
16038,CD38 Inhibitor 1,COCCO[C@H]1CC[C@H](Nc2cc(=O)n(C)c3ccc(-c4cncs4)cc23)CC1,C22H27N3O3S,35532.0
16039,Phytanic Acid methyl ester,COC(=O)CC(C)CCCC(C)CCCC(C)CCCC(C)C,C21H42O2,10007422.0
16040,N-?-Benzoyl-L-Argininamide (hydrochloride),Cl.N=C(N)NCCC[C@H](NC(=O)c1ccccc1)C(N)=O,C13H20ClN5O2,35015.0
16041,Harmalol,CC1=NCCc2c1[nH]c1cc(O)ccc21,C12H12N2O,35145.0
16042,Flunixin-d3,[2H]C([2H])([2H])c1c(Nc2ncccc2C(=O)O)cccc1C(F)(F)F,C14H11F3N2O2,35056.0
16043,Fluetizolam,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1F,C17H15FN4S,36236.0
16044,20(R)-Protopanaxatriol,CC(C)=CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@]12C,C30H52O4,36530.0
16045,D-(+)-Cellopentaose,O=C[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,C30H52O26,35300.0
16046,2''-O-?-L-Galactopyranosylorientin,O=c1cc(-c2ccc(O)c(O)c2)oc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@H]3O[C@@H](CO)[C@@H](O)[C@@H](O)[C@@H]3O)c(O)cc(O)c12,C27H30O16,36156.0
16047,Bullatine B,CCN1C[C@]2(COC)CC[C@H](O)C34C1C([C@H](OC)[C@@H]32)[C@@]1(O)C[C@H](OC)[C@H]2C[C@@H]4[C@@H]1C2O,C24H39NO6,36170.0
16048,10-Shogaol,CCCCCCCCCC=CC(=O)CCc1ccc(O)c(OC)c1,C21H32O3,36171.0
16049,"10,11-dihydro-10,11-dihydroxy Carbamazepine",NC(=O)N1c2ccccc2C(O)C(O)c2ccccc21,C15H14N2O3,35436.0
16050,NV-5138,CC(C)(C[C@H](N)C(=O)O)C(F)F,C7H13F2NO2,35482.0
16051,Piribedil N-oxide,[O-][N+]1(Cc2ccc3c(c2)OCO3)CCN(c2ncccn2)CC1,C16H18N4O3,36328.0
16052,"1,1'-Ethylidene-bis-(L-tryptophan)",CC(n1cc(C[C@H](N)C(=O)O)c2ccccc21)n1cc(C[C@H](N)C(=O)O)c2ccccc21,C24H26N4O4,35804.0
16053,D-?-Tocopheryl Quinone,CC1=C(C)C(=O)C(CC[C@](C)(O)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C1=O,C29H50O3,35365.0
16054,Belotecan (hydrochloride),CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C.Cl,C25H28ClN3O4,35488.0
16055,2-Phenylacetamide,NC(=O)Cc1ccccc1,C8H9NO,36364.0
16056,3-Hydroxyflavone,O=c1c(O)c(-c2ccccc2)oc2ccccc12,C15H10O3,35333.0
16057,10-Formyltetrahydrofolate (sodium salt) (technical grade),Nc1nc(=O)c2c([nH]1)NCC(CN(C=O)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1)N2.[Na+].[Na+],C20H21N7Na2O7,35763.0
16058,DL-Homocystine,NC(CCSSCCC(N)C(=O)O)C(=O)O,C8H16N2O4S2,36223.0
16059,Fosfomycin (calcium salt),C[C@@H]1O[C@@H]1P(=O)([O-])[O-].[Ca+2],C3H5CaO4P,35535.0
16060,1-Octen-3-ol,C=CC(O)CCCCC,C8H16O,35550.0
16061,Remdesivir O-desphosphate acetonide,CC1(C)O[C@H]2[C@@H](O1)[C@](C#N)(c1ccc3c(N)ncnn13)O[C@@H]2CO,C15H17N5O4,36673.0
16062,Norquetiapine,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,C17H17N3S,36687.0
16063,DSPE-mPEG(550),CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)OCCOC)OC(=O)CCCCCCCCCCCCCCCCC,C43H84NO10P(C2H4O)n,34651.0
16064,DX3-213B,CC(C)S(=O)(=O)c1ccc(S(=O)(=O)N2CCC[C@@H](C(=O)N3CCC(F)(F)CC3)C2)cc1,C20H28F2N2O5S2,36783.0
16065,Stercobilinogen (technical grade),CCC1C(=O)NC(Cc2[nH]c(Cc3[nH]c(CC4NC(=O)C(C)C4CC)c(C)c3CCC(=O)O)c(CCC(=O)O)c2C)C1C,C33H48N4O6,36510.0
16066,Linoleic Acid glycidyl ester,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC1CO1,C21H36O3,36840.0
16067,N-acetyl-S-(trichlorovinyl)-L-Cysteine,CC(=O)N[C@@H](CSC(Cl)=C(Cl)Cl)C(=O)O,C7H8Cl3NO3S,35086.0
16068,5-Hydroxyisatin,O=C1Nc2ccc(O)cc2C1=O,C8H5NO3,36383.0
16069,Hexocannabitriol,C=C1CC[C@@H](C(=C)C)[C@H](c2c(O)cc(CCCCC)cc2O)[C@H]1O,C21H30O3,36829.0
16070,Hypaphorine,C[N+](C)(C)[C@@H](Cc1c[nH]c2ccccc12)C(=O)[O-],C14H18N2O2,35228.0
16071,Carbutamide,CCCCNC(=O)NS(=O)(=O)c1ccc(N)cc1,C11H17N3O3S,35552.0
16072,GSK189254A,CNC(=O)c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1,C21H25N3O2,36705.0
16073,TRPM4-IN-5,O=C(COc1ccccc1Cl)Nc1cc(Cl)ccc1C(=O)O,C15H11Cl2NO4,36019.0
16074,BLT-1,CCCCCCC1CCCC1=NNC(N)=S,C12H23N3S,34989.0
16075,Montelukast,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,C35H36ClNO3S,35779.0
16076,ICI 63197,CCCn1c(=O)c(C)cn2nc(N)nc12,C9H13N5O,35538.0
16077,?9-THC methyl ether,CCCCCc1cc(OC)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C22H32O2,36348.0
16078,PF-00835231,COc1cccc2[nH]c(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C(=O)CO)cc12,C24H32N4O6,36047.0
16079,Lipoamide,NC(=O)CCCCC1CCSS1,C8H15NOS2,35336.0
16080,"L,L-Dityrosine",N[C@@H](Cc1ccc(O)c(-c2cc(C[C@H](N)C(=O)O)ccc2O)c1)C(=O)O,C18H20N2O6,35746.0
16081,VTX-27,CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2Cl)CCN1,C20H24ClFN6O,36938.0
16082,Ponatinib (hydroachloride),Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12.Cl,C29H28ClF3N6O,35778.0
16083,306Oi10,CC(C)CCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C,C59H115N3O8,36698.0
16084,Isomeranzin,COc1ccc2ccc(=O)oc2c1CC(=O)C(C)C,C15H16O4,35827.0
16085,Paederosidic Acid,CSC(=O)OCC1=C[C@H](O)[C@@H]2C(C(=O)O)=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]12,C18H24O12S,35363.0
16086,Dodecyltrimethylammonium (bromide),CCCCCCCCCCCC[N+](C)(C)C.[Br-],C15H34BrN,37009.0
16087,Ophthalmic Acid,CC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,C11H19N3O6,35343.0
16088,Rhosin (hydrochloride),Cl.N[C@H](Cc1c[nH]c2ccccc12)C(=O)N/N=C/c1ccc2nccnc2c1,C20H19ClN6O,36415.0
16089,Ractopamine (hydrochloride),CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1.Cl,C18H24ClNO3,27613.0
16090,Plerixafor,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,C28H54N8,35579.0
16091,Ononetin,COc1ccc(CC(=O)c2ccc(O)cc2O)cc1,C15H14O4,35813.0
16092,Saponarin,O=c1cc(-c2ccc(O)cc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,C27H30O15,35805.0
16093,"3,3'-Dipropylthiadicarbocyanine (iodide)",CCCN1/C(=C\C=C\C=C\c2sc3ccccc3[n+]2CCC)Sc2ccccc21.[I-],C25H27IN2S2,36308.0
16094,Rebaudioside M,C=C1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]2CC[C@]1(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C3,C56H90O33,35239.0
16095,2-Amino-3-hydroxy-3-methylbutyrate,CC(C)(O)C(N)C(=O)O,C5H11NO3,36381.0
16096,"8(Z),11(Z),14(Z)-Octadecatrienoic Acid ethyl ester",CCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)OCC,C20H34O2,36843.0
16097,1-Oleoyl-2-Lauroyl-3-Palmitoyl-rac-glycerol,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCC,C49H92O6,36859.0
16098,Psilocin (hemifumarate),CN(C)CCc1c[nH]c2cccc(O)c12.CN(C)CCc1c[nH]c2cccc(O)c12.O=C(O)/C=C/C(=O)O,C28H36N4O6,36971.0
16099,(-)-11-hydroxy-?8-Tetrahydrocannabivarin,CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(CO)C[C@@H]21,C19H26O3,36630.0
16100,(-)-11-hydroxy-?8-Tetrahydrocannabivarin (exempt preparation),CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(CO)C[C@@H]21,C19H26O3,38185.0
16101,AG-636,Cc1ccccc1-c1ccc(-c2cc(C(=O)O)c3c(c2)nnn3C)cc1,C21H17N3O2,36122.0
16102,3-Hydroxyphenylacetic Acid,O=C(O)Cc1cccc(O)c1,C8H8O3,36436.0
16103,S-99,CC(C)Nc1cc(C(F)(F)F)cc2nc(NC(=O)c3cccnc3)nn12,C16H15F3N6O,36607.0
16104,9(R)-Hexahydrocannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@@H](C)C[C@@H]21,C21H32O2,27500.0
16105,Eriodictyol 7-O-glucoside,O=C1C[C@@H](c2ccc(O)c(O)c2)Oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c21,C21H22O11,36003.0
16106,L-Carnitine-d9 (chloride),[2H]C([2H])([2H])[N+](C[C@H](O)CC(=O)O)(C([2H])([2H])[2H])C([2H])([2H])[2H].[Cl-],C7H16ClNO3,37029.0
16107,Sphingosine-1-Phosphate Lyase Fluorogenic Substrate,[NH3+][C@@H](COP(=O)([O-])O)[C@H](O)CCOc1ccc2ccc(=O)oc2c1,C14H18NO8P,13238.0
16108,Brazilein,O=C1C=C2CC3(O)COc4cc(O)ccc4C3=C2C=C1O,C16H12O5,36736.0
16109,11-hydroxy Cannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(CO)cc1-2,C21H26O3,34591.0
16110,Temozolomide Acid,Cn1nnc2c(C(=O)O)ncn2c1=O,C6H5N5O3,35800.0
16111,Sulisobenzone,COc1cc(O)c(C(=O)c2ccccc2)cc1S(=O)(=O)O,C14H12O6S,35225.0
16112,Epifriedelanol,C[C@H]1[C@@H](O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@@]2(C)CC[C@@]2(C)[C@@H]3CC(C)(C)CC[C@]3(C)CC[C@]12C,C30H52O,36148.0
16113,Licogliflozin (mixed isomers),CCc1ccc([C@@H]2O[C@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)cc1Cc1ccc2c(c1)OCCO2,C23H28O7,35772.0
16114,12-Epinapelline,C=C1[C@H]2C[C@@]3([C@@H]1O)[C@@H](C[C@H]2O)[C@@]12[C@@H]4C[C@H]3[C@H]1N(CC)C[C@]4(C)CC[C@@H]2O,C22H33NO3,36550.0
16115,Anethole Trithione,COc1ccc(-c2cc(=S)ss2)cc1,C10H8OS3,35397.0
16116,Nithiamide,CC(=O)Nc1ncc([N+](=O)[O-])s1,C5H5N3O3S,36006.0
16117,Dimidium (bromide),C[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[Br-],C20H18BrN3,35816.0
16118,"5,6-Dihydrouracil",O=C1CCNC(=O)N1,C4H6N2O2,36438.0
16119,DLin-DMA,CCCCC/C=C\C/C=C\CCCCCCCCOCC(CN(C)C)OCCCCCCCC/C=C\C/C=C\CCCCC,C41H77NO2,36701.0
16120,PPTN (hydrochloride),Cl.O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1,C29H25ClF3NO2,36854.0
16121,5-fluoro AMB metabolite 6,CC(C)[C@H](NC(=O)c1nn(CCCCC(=O)O)c2ccccc12)C(=O)O,C18H23N3O5,37058.0
16122,Ensitrelvir (fumarate),Cn1cnc(Cn2c(=O)[nH]/c(=N\c3cc4cn(C)nc4cc3Cl)n(Cc3cc(F)c(F)cc3F)c2=O)n1.O=C(O)/C=C/C(=O)O,C26H21ClF3N9O6,35844.0
16123,N4-Acetylcytidine,CC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,C11H15N3O6,35219.0
16124,HA-15,CC(=O)Nc1nc(-c2cccc(NS(=O)(=O)c3cccc4c(N(C)C)cccc34)c2)cs1,C23H22N4O3S2,35775.0
16125,AFUBIATA,O=C(Cc1cn(Cc2ccc(F)cc2)c2ccccc12)NC12CC3CC(CC(C3)C1)C2,C27H29FN2O,36992.0
16126,"3,29-Dibenzoyl Rarounitriol",CC1(C)[C@H](OC(=O)c2ccccc2)CC[C@]2(C)C3=C([C@@H](O)C[C@@H]12)[C@@]1(C)CC[C@@]2(C)CC[C@@](C)(COC(=O)c4ccccc4)C[C@H]2[C@]1(C)CC3,C44H58O5,36158.0
16127,YM-155 (chloride),COCCn1c2c([n+](Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O.[Cl-],C20H19ClN4O3,36827.0
16128,"5,7-Dichlorothiazolo[5,4-d]pyrimidine",Clc1nc(Cl)c2ncsc2n1,C5HCl2N3S,36489.0
16129,2-keto-D-Gluconic Acid (calcium salt),O=C([O-])C(=O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])C(=O)[C@@H](O)[C@H](O)[C@H](O)CO.[Ca+2],C12H18CaO14,35622.0
16130,.delta.8-THC-C8,CCCCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C24H36O2,35422.0
16131,?8-THC-C8 (exempt preparation),CCCCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C24H36O2,38149.0
16132,9(R)-Hexahydrocannabiphorol,CCCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@@H](C)C[C@@H]21,C23H36O2,36346.0
16133,Febrifugine (hydrochloride),Cl.Cl.O=C(C[C@H]1NCCC[C@@H]1O)Cn1cnc2ccccc2c1=O,C16H21Cl2N3O3,37044.0
16134,(Arg)9 (trifluoroacetate salt),N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O.O=C(O)C(F)(F)F,C56H111F3N36O12,36714.0
16135,N-Methyl-4-pyridone-5-carboxamide,Cn1ccc(=O)c(C(N)=O)c1,C7H8N2O2,36684.0
16136,Aminoethyl-SS-Propionic Acid,NCCSSCCC(=O)O,C5H11NO2S2,35501.0
16137,Techtochrysin,COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,C16H12O4,35791.0
16138,4-Methoxyphenyl-?-D-Glucopyranoside,COc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,C13H18O7,35818.0
16139,Darusentan,COc1cc(OC)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c2ccccc2)n1,C22H22N2O6,36034.0
16140,DC-05,OC(CNCCc1c[nH]c2ccccc12)Cn1c2ccccc2c2ccccc21,C25H25N3O,36584.0
16141,ML-792,NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ncncc2C(=O)c2ccn(Cc3cccc(Br)c3)n2)C[C@@H]1O,C21H23BrN6O5S,36820.0
16142,AZD 3293,CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(N=C(C)C(N)=N2)[C@]2(CC[C@H](OC)CC2)C3)c1,C26H28N4O,24934.0
16143,CTP354,[2H]C([2H])([2H])C(c1cc2nnc(-c3cc(F)ccc3F)n2nc1OCc1ncnn1C)(C([2H])([2H])[2H])C([2H])([2H])[2H],C19H19F2N7O,36618.0
16144,Danicamtiv,Cn1cc(S(=O)(=O)[C@@](C)(F)C2CCN(C(=O)Nc3ccon3)CC2)c(C(F)F)n1,C16H20F3N5O4S,36875.0
16145,Cephalotaxine,COC1=C[C@]23CCCN2CCc2cc4c(cc2[C@@H]3[C@@H]1O)OCO4,C18H21NO4,36521.0
16146,Desvaleryl Valsartan,CC(C)[C@H](NCc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)C(=O)O,C19H21N5O2,35634.0
16147,Amlodipine (besylate),CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl.O=S(=O)(O)c1ccccc1,C26H31ClN2O8S,14886.0
16148,Norelgestromin,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC,C21H29NO2,35243.0
16149,Neoglycyrol,COc1c(CC=C(C)C)c(O)cc2oc(=O)c3c4ccc(O)cc4oc3c12,C21H18O6,36525.0
16150,PKC? Inhibitor,O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1,C24H21N5O2,35494.0
16151,"2',3'-Dideoxyuridine",O=c1ccn([C@H]2CC[C@@H](CO)O2)c(=O)[nH]1,C9H12N2O4,36494.0
16152,CH-FUBIATA,O=C(Cc1cn(Cc2ccc(F)cc2)c2ccccc12)NC1CCCCC1,C23H25FN2O,37054.0
16153,7-Benzyloxy-4-(trifluoromethyl)coumarin,O=c1cc(C(F)(F)F)c2ccc(OCc3ccccc3)cc2o1,C17H11F3O3,35721.0
16154,LATS-IN-1,O=C(/N=c1\sccn1Cc1ccccc1)c1c[nH]c2ncccc12,C18H14N4OS,36623.0
16155,ILK-IN-2,CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1,C30H30F3N5O,36674.0
16156,AMOZ,NN1CC(CN2CCOCC2)OC1=O,C8H15N3O3,36480.0
16157,C12-200,CCCCCCCCCCC(O)CN(CCN1CCN(CCN(CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC)CC1)CCN(CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC,C70H145N5O5,36699.0
16158,Bryostatin 1,CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3,C47H68O17,14802.0
16159,Mono-11(Z)-eicosenoin,CCCCCCCC/C=C\CCCCCCCCCC(=O)OC(CO)CO.CCCCCCCC/C=C\CCCCCCCCCC(=O)OCC(O)CO,C46H88O8,36860.0
16160,SJB2-043,O=C1c2ccccc2C(=O)c2oc(-c3ccccc3)nc21,C17H9NO3,36605.0
16161,UDP-GalNAc (sodium salt),CC(=O)N[C@H]1[C@@H](OP(=O)([O-])OP(=O)([O-])OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)O[C@H](CO)[C@H](O)[C@@H]1O.[Na+].[Na+],C17H25N3Na2O17P2,36506.0
16162,ASTX660,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nc(CO)c(Cc4ccc(F)cc4)cc32)[C@@H](CN2CCOC[C@H]2C)CN1,C30H42FN5O3,36619.0
16163,Continentalic Acid,C=C[C@]1(C)C=C2CC[C@H]3[C@@](C)(CCC[C@@]3(C)C(=O)O)[C@@H]2CC1,C20H30O2,35240.0
16164,2'-Acetylacteoside,CC(=O)O[C@H]1[C@H](OCCc2ccc(O)c(O)c2)O[C@H](CO)[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O,C31H38O16,36511.0
16165,QN523,O=C(Nc1cccc2cccnc12)c1cnccn1,C14H10N4O,37123.0
16166,TSPC,N#Cc1nccnc1S(=O)(=O)c1cccs1,C9H5N3O2S2,35837.0
16167,PD-1/PD-L1 Inhibitor 3 (trifluoroacetate salt),CCCC[C@H]1C(=O)N(C)[C@@H](CCCC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccccc2)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N1C.O=C(O)C(F)(F)F,C89H126N24O18S(C2HF3O2)X,36719.0
16168,GSK8612,Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCc2ccc(S(N)(=O)=O)cc2)n1,C17H17BrF3N7O2S,28813.0
16169,Benproperine (phosphate),CC(COc1ccccc1Cc1ccccc1)N1CCCCC1.O=P(O)(O)O,C21H30NO5P,35776.0
16170,Pulmatin,Cc1cc(O)c2c(c1)C(=O)c1cccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c1C2=O,C21H20O9,36343.0
16171,Dipipanone (hydrochloride),CCC(=O)C(CC(C)N1CCCCC1)(c1ccccc1)c1ccccc1.Cl,C24H32ClNO,20144.0
16172,YSK05,CCCCC/C=C\C/C=C\CCCCCCCCOC1(OCCCCCCCC/C=C\C/C=C\CCCCC)CCN(C)CC1,C42H77NO2,35786.0
16173,Loratadine N-oxide,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3ccc[n+]([O-])c32)CC1,C22H23ClN2O3,35244.0
16174,Galantamine (hydrobromide),Br.COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,C17H22BrNO3,35247.0
16175,BRM/BRG1 ATP Inhibitor 1,O=C(Nc1cc(C(F)F)ns1)Nc1cc(F)ncc1CO,C11H9F3N4O2S,36138.0
16176,Dabigatran etexilate (mesylate),CCCCCCOC(=O)NC(=N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1.CS(=O)(=O)O,C35H45N7O8S,35248.0
16177,6?-Methylprednisolone 21-acetate,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,C24H32O6,35799.0
16178,21-Deoxycortisone,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C,C21H28O4,35236.0
16179,Dopamine,NCCc1ccc(O)c(O)c1,C8H11NO2,36532.0
16180,10-oxo-12(Z)-Octadecenoic Acid,CCCCC/C=C\CC(=O)CCCCCCCCC(=O)O,C18H32O3,36977.0
16181,Rhamnopterin,CC(O)C(O)C(O)c1c[nH]c2nc(N)nc(=O)c-2n1,C10H13N5O4,35254.0
16182,AZD 7325,CCCNC(=O)c1nnc2c(-c3c(F)cccc3OC)cccc2c1N,C19H19FN4O2,36449.0
16183,D-Val-Leu-Lys-pNA,CC(C)C[C@H](NC(=O)[C@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)Nc1ccc([N+](=O)[O-])cc1,C23H38N6O5,36580.0
16184,Citrulline,NC(=O)NCCC[C@H](N)C(=O)O,C6H13N3O3,35648.0
16185,Acebutolol,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,C18H28N2O4,36534.0
16186,Epigoitrin,C=C[C@@H]1CNC(=S)O1,C5H7NOS,35620.0
16187,Myricetin 3-galactoside,O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,C21H20O13,36467.0
16188,Poloxin,CC1=CC(=O)C(C(C)C)=C/C1=N/OC(=O)c1ccccc1C,C18H19NO3,36018.0
16189,N-desmethyl Azelastine,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCNCC1,C21H22ClN3O,35429.0
16190,Desglymidodrine,COc1ccc(OC)c(C(O)CN)c1,C10H15NO3,35608.0
16191,3-hydroxy-4-Methoxyphenethylamine (hydrochloride),COc1ccc(CCN)cc1O.Cl,C9H14ClNO2,36012.0
16192,Ceapin-A7,O=C(Nc1cnn(Cc2ccc(C(F)(F)F)cc2C(F)(F)F)c1)c1cc(-c2ccco2)on1,C20H12F6N4O3,36113.0
16193,"6(Z),9(Z),12(Z),15(Z)-Hexadecatetraenoic Acid ethyl ester",C=CC/C=C\C/C=C\C/C=C\CCCCC(=O)OCC,C18H28O2,36842.0
16194,Dofetilide N-oxide,C[N+]([O-])(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,C19H27N3O6S2,36294.0
16195,3-Methyladipic Acid,CC(CCC(=O)O)CC(=O)O,C7H12O4,36452.0
16196,Fustin,O=C1c2ccc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@H]1O,C15H12O6,36273.0
16197,Ethylene Glycol monododecyl ether,CCCCCCCCCCCCOCCO,C14H30O2,36857.0
16198,Ginkgolide K,CC1=C2[C@@H](OC1=O)[C@H](O)[C@]13[C@H]4C[C@@H](C(C)(C)C)[C@]15[C@@H](OC(=O)[C@@H]5O)O[C@@]23C(=O)O4,C20H22O9,35304.0
16199,1-Dehydrocorticosterone 21-acetate,CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,C23H30O5,36298.0
16200,7-Demethylsuberosin,CC(C)=CCc1cc2ccc(=O)oc2cc1O,C14H14O3,35282.0
16201,TCL053,CCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCC)(COC(=O)CCCCCCC/C=C\CCCC)COC(=O)CCCN(C)C,C53H95NO8,37045.0
16202,Ranitidine S-oxide,CN/C(=C\[N+](=O)[O-])NCCS(=O)Cc1ccc(CN(C)C)o1,C13H22N4O4S,35412.0
16203,N-Nitrosomethylethylamine,CCN(C)N=O,C3H8N2O,36074.0
16204,1-(2-Methoxyphenyl)piperazine (hydrochloride),COc1ccccc1N1CCNCC1.Cl,C11H17ClN2O,37139.0
16205,7-(Diethylamino)coumarin-3-carboxylic Acid,CCN(CC)c1ccc2cc(C(=O)O)c(=O)oc2c1,C14H15NO4,35396.0
16206,BRD6989,CC1CCc2nc(N)c(C#N)c(-c3cccnc3)c2C1,C16H16N4,35358.0
16207,Sorafenib (tosylate),CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1,C28H24ClF3N4O6S,35612.0
16208,2-NP-AHD,O=C1CN(/N=C/c2ccccc2[N+](=O)[O-])C(=O)N1,C10H8N4O4,36500.0
16209,Divarin,CCCc1cc(O)cc(O)c1,C9H12O2,37183.0
16210,Hexahydrohippuric Acid,O=C(O)CNC(=O)C1CCCCC1,C9H15NO3,36386.0
16211,Oseltamivir Acid methyl ester,CCC(CC)O[C@@H]1C=C(C(=O)OC)C[C@H](N)[C@H]1NC(C)=O,C15H26N2O4,36556.0
16212,Hexadecanedioic Acid,O=C(O)CCCCCCCCCCCCCCC(=O)O,C16H30O4,36000.0
16213,7-keto Deoxycholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H38O5,35264.0
16214,BI-4394,CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1,C24H22N4O5,36855.0
16215,dBET57,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCNc1cccc3c1C(=O)N(C1CCC(=O)NC1=O)C3=O)c1nnc(C)n1-2,C34H31ClN8O5S,36626.0
16216,Gemigliptin (tartrate),N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1CC(F)(F)CCC1=O.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C22H25F8N5O8,36016.0
16217,Cannabigerol dimethyl ether,CCCCCc1cc(OC)c(C/C=C(\C)CCC=C(C)C)c(OC)c1,C23H36O2,37052.0
16218,N-acetyl-L-Glutamine,CC(=O)N[C@@H](CCC(N)=O)C(=O)O,C7H12N2O4,35398.0
16219,Esmolol Acid (hydrochloride),CC(C)NCC(O)COc1ccc(CCC(=O)O)cc1.Cl,C15H24ClNO4,35295.0
16220,Ro 0335,N#Cc1cc(Cl)cc(Oc2c(Br)ccc(CC(=O)Nc3ccc(S(N)(=O)=O)cc3Cl)c2F)c1,C21H13BrCl2FN3O4S,36124.0
16221,Berbamine (hydrochloride),COc1cc2c3cc1Oc1c(OC)c(OC)cc4c1[C@@H](Cc1ccc(O)c(c1)Oc1ccc(cc1)C[C@@H]3N(C)CC2)N(C)CC4.Cl.Cl,C37H42Cl2N2O6,35593.0
16222,Hetacillin,CC1(C)S[C@@H]2[C@H](N3C(=O)[C@@H](c4ccccc4)NC3(C)C)C(=O)N2[C@H]1C(=O)O,C19H23N3O4S,35643.0
16223,4-oxo Retinoic Acid,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1=O,C20H26O3,35819.0
16224,Ipronidazole-d3,[2H]C([2H])([2H])n1c([N+](=O)[O-])[c]nc1C(C)C,C7H10N3O2,37194.0
16225,Coumarin 7,CCN(CC)c1ccc2cc(-c3nc4ccccc4[nH]3)c(=O)oc2c1,C20H19N3O2,35762.0
16226,LSN2814617,CC(C)(C)c1nnc2n1CCC(c1nc(-c3ccc(F)cc3)no1)C2,C18H20FN5O,33607.0
16227,N-acetyl-L-Isoleucine,CC[C@H](C)[C@H](NC(C)=O)C(=O)O,C8H15NO3,35545.0
16228,Isolariciresinol,COc1cc([C@H]2c3cc(O)c(OC)cc3C[C@@H](CO)[C@@H]2CO)ccc1O,C20H24O6,36032.0
16229,Alfuzosin-d7,[2H]C1([2H])OC([2H])(C(=O)NCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)C([2H])([2H])C1([2H])[2H],C19H27N5O4,34999.0
16230,N-acetyl-L-Ornithine,CC(=O)N[C@@H](CCCN)C(=O)O,C7H14N2O3,36092.0
16231,"10-oxo-12(Z),15(Z)-Octadecadienoic Acid",CC/C=C\C/C=C\CC(=O)CCCCCCCCC(=O)O,C18H30O3,36976.0
16232,3-Iodo-2-propynyl Butylcarbamate,CCCCNC(=O)OCC#CI,C8H12INO2,36028.0
16233,RBN-012759,O=c1nc(CS[C@H]2CC[C@H](O)CC2)[nH]c2cc(OCC3CC3)cc(F)c12,C19H23FN2O3S,36137.0
16234,Quinaprilat,C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O,C23H26N2O5,36007.0
16235,COTC,CC=CC(=O)OCC1=C[C@@H](O)[C@@H](O)[C@@H](O)C1=O,C11H14O6,36408.0
16236,E3 Ligand-Linker Conjugate 3,NCCCCNC(=O)COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,C19H22N4O6,36666.0
16237,VcMMAE,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCCCCN2C(=O)C=CC2=O)C(C)C)cc1)C(C)C,C68H105N11O15,35646.0
16238,cKK-E12,CCCCCCCCCCC(O)CN(CCCCC1NC(=O)C(CCCCN(CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC)NC1=O)CC(O)CCCCCCCCCC,C60H120N4O6,36700.0
16239,"Kisspeptin-10 (mouse, rat)",CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,C63H83N17O15,14036.0
16240,Lamotrigine-d3,[2H]c1c([2H])c(Cl)c(Cl)c(-c2nnc(N)nc2N)c1[2H],C9H7Cl2N5,37196.0
16241,exo-THC (CRM),C=C1CC[C@@H]2[C@@H](C1)c1c(O)cc(CCCCC)cc1OC2(C)C,C21H30O2,36898.0
16242,exo-THC (Alt. Batch CRM),C=C1CC[C@@H]2[C@@H](C1)c1c(O)cc(CCCCC)cc1OC2(C)C,C21H30O2,41216.0
16243,L-Thyroxine-N-methylamide,CNC(=O)[C@@H](N)Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1,C16H14I4N2O3,35606.0
16244,AZD 0865,Cc1cccc(C)c1CNc1cc(C(=O)NCCO)cn2c(C)c(C)nc12,C21H26N4O2,36805.0
16245,KDM5-C70,CCOC(=O)c1ccnc(CNCC(=O)N(CC)CCN(C)C)c1,C17H28N4O3,36817.0
16246,E4CPG,CCC(N)(C(=O)O)c1ccc(C(=O)O)cc1,C11H13NO4,36667.0
16247,Cetirizine N-oxide,O=C(O)COCC[N+]1([O-])CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,C21H25ClN2O4,36013.0
16248,A2764 (hydrochloride),CCN(CC)CCOc1ccc(Cl)c2cccnc12.Cl.Cl,C15H21Cl3N2O,36943.0
16249,Desalkylgidazepam-d5,[2H]c1c([2H])c([2H])c(C2=NCC(=O)Nc3ccc(Br)cc32)c([2H])c1[2H],C15H11BrN2O,37215.0
16250,Desalkylgidazepam-d5 (CRM),[2H]c1c([2H])c([2H])c(C2=NCC(=O)Nc3ccc(Br)cc32)c([2H])c1[2H],C15H11BrN2O,40622.0
16251,E3 Ligase Ligand 2,O=C1CCC(N2C(=O)c3cccc(O)c3C2=O)C(=O)N1,C13H10N2O5,36664.0
16252,"3,3'-Sulfinyldipropanoic Acid",O=C(O)CCS(=O)CCC(=O)O,C6H10O5S,37214.0
16253,Propiverine (hydrochloride),CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1.Cl,C23H30ClNO3,36049.0
16254,AM92016 (hydrochloride),CN(CCc1ccc(Cl)c(Cl)c1)CC(O)COc1ccc(NS(C)(=O)=O)cc1.Cl,C19H25Cl3N2O4S,36803.0
16255,Isovaleryl-DL-carnitine-d9 (chloride),[2H]C([2H])([2H])[N+](CC(CC(=O)O)OC(=O)CC(C)C)(C([2H])([2H])[2H])C([2H])([2H])[2H].[Cl-],C12H24ClNO4,37213.0
16256,NVP-AEW541,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,C27H29N5O,33946.0
16257,L-Albizziin,NC(=O)NC[C@H](N)C(=O)O,C4H9N3O3,36665.0
16258,Stearic Acid glycidyl ester,CCCCCCCCCCCCCCCCCC(=O)OCC1CO1,C21H40O3,36838.0
16259,Suc-Ala-Ala-Ala-pNA,C[C@H](NC(=O)CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)Nc1ccc([N+](=O)[O-])cc1,C19H25N5O8,36478.0
16260,CB-096,COc1cc(-c2nc3ccc([N+](=O)[O-])cc3[nH]2)ccc1O,C14H11N3O4,36407.0
16261,Acetyl-CoA Synthase Inhibitor,COCCNC(=O)Nc1ccc2nc(-c3cccs3)c(-c3cccs3)nc2c1,C20H18N4O2S2,36023.0
16262,AMG 333,O=C(O)c1ccc(C(=O)N[C@@H](c2ccc(OC(F)(F)F)c(F)c2)c2ncccc2F)nc1,C20H12F5N3O4,36825.0
16263,Ferristatin II,Nc1ccc(N=Nc2ccc(-c3ccc(N=Nc4c(S(=O)(=O)[O-])cc5cc(S(=O)(=O)[O-])c(N=Nc6ccccc6)c(O)c5c4N)cc3)cc2)c(N)c1.[Na+].[Na+],C34H25N9Na2O7S2,36621.0
16264,ALK Inhibitor 2,CNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2OC)ncc1Cl,C23H28ClN7O3S,36823.0
16265,MSX-130,c1ccc(-c2nc(-c3ccc(-c4nc(-c5ccccc5)c(-c5ccccc5)[nH]4)cc3)[nH]c2-c2ccccc2)cc1,C36H26N4,36804.0
16266,Mebeverine Acid,CCN(CCCC(=O)O)C(C)Cc1ccc(OC)cc1,C16H25NO3,35498.0
16267,Cannabiphorol,CCCCCCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2,C23H30O2,37006.0
16268,Lipid C24,CCCCCCCCCCC(CCCCCCCC)COC(=O)CCN(CCCCN1CCN(C)CC1)CCC(=O)OCC(CCCCCCCC)CCCCCCCCCC,C55H109N3O4,37122.0
16269,CUMYL-NBMINACA,CC(C)(NC(=O)c1nn(CC2CC3CCC2C3)c2ccccc12)c1ccccc1,C25H29N3O,34908.0
16270,1-Docosahexaenoyl-2-hydroxy-sn-glycero-3-PC,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C30H50NO7P,37340.0
16271,Amisulpride N-oxide,CC[N+]1([O-])CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,C17H27N3O5S,35447.0
16272,Ethopabate,CCOc1cc(NC(C)=O)ccc1C(=O)OC,C12H15NO4,36079.0
16273,Fadraciclib,CC[C@H](Nc1nc(NCc2cnc(C)cc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O,C21H31N7O,36119.0
16274,MELK-8a (hydrochloride),CN1CCN(c2ccc(-n3cc(-c4ccncc4OCC4CCNCC4)cn3)cc2)CC1.Cl,C25H33ClN6O,37025.0
16275,L-Tryptophanamide (hydrochloride),Cl.NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12,C11H14ClN3O,35769.0
16276,Cucurbitacin D,CC(C)(O)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C[C@H](O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C,C30H44O7,36172.0
16277,2'-O-Methyl-5-methyluridine,CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cc(C)c(=O)[nH]c1=O,C11H16N2O6,35357.0
16278,"(R,S)-Anatabine-d4",[2H]c1nc([2H])c(C2CC=CCN2)c([2H])c1[2H],C10H12N2,37198.0
16279,ETC-206,N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)cn23)cc1,C25H20N4O2,36501.0
16280,SEN-12333,O=C(CCCCN1CCOCC1)Nc1ccc(-c2cccnc2)cc1,C20H25N3O2,36123.0
16281,BO-264,COc1ccc(-c2cc(Nc3ccnc(N4CCOCC4)n3)on2)cc1,C18H19N5O3,36611.0
16282,4-chloro Modafinil,NC(=O)CS(=O)C(c1ccccc1)c1ccc(Cl)cc1,C15H14ClNO2S,37091.0
16283,WAY-169916,C=CCn1nc(-c2ccc(O)cc2O)c2cccc(C(F)(F)F)c21,C17H13F3N2O2,35842.0
16284,GLS4,CCOC(=O)C1=C(CN2CCOCC2)N=C(c2nccs2)NC1c1ccc(F)cc1Br,C21H22BrFN4O3S,35843.0
16285,Ractopamine-d3 (hydrochloride),Cl.[2H]C([2H])(NC(C)CCc1ccc(O)cc1)C([2H])(O)c1ccc(O)cc1,C18H24ClNO3,37207.0
16286,RG-7090,Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1,C18H13ClFN3,36806.0
16287,Clindamycin-d3 (hydrochloride),Cl.[2H]C([2H])([2H])N1C[C@H](CCC)C[C@H]1C(=O)N[C@@H]([C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O)[C@H](C)Cl,C18H34Cl2N2O5S,35424.0
16288,FOY-251,CS(=O)(=O)O.N=C(N)Nc1ccc(C(=O)Oc2ccc(CC(=O)O)cc2)cc1,C17H19N3O7S,36051.0
16289,Sulfadoxin-d4,[2H]c1c([2H])c(S(=O)(=O)Nc2ncnc(OC)c2OC)c([2H])c([2H])c1N,C12H14N4O4S,37200.0
16290,6?-Methylprednisolone 21-hemisuccinate (sodium salt),C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)O)[C@@]2(C)C=CC(=O)C=C12.[NaH],C26H34NaO8,35742.0
16291,PBD-150,COc1ccc(NC(=S)NCCCn2ccnc2)cc1OC,C15H20N4O2S,36112.0
16292,5-hydroxy Indole-3-acetic Acid-d6,[2H]c1[nH]c2c([2H])c([2H])c(O)c([2H])c2c1C([2H])([2H])C(=O)O,C10H9NO3,37199.0
16293,IQA,O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12,C17H12N2O3,35223.0
16294,2-Nitroamino-2-imidazoline,O=[N+]([O-])NC1=NCCN1,C3H6N4O2,36036.0
16295,(-)-11-nor-9-carboxy-?8-THC-d3,[2H]C([2H])([2H])CCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C(=O)O)C[C@@H]21,C21H28O4,37041.0
16296,N-methyl Tyramine (hydrochloride),CNCCc1ccc(O)cc1.Cl,C9H14ClNO,35233.0
16297,"(9,10a)-syn-?6a,7-THC",CCCCCc1cc(O)c2c(c1)OC(C)(C)C1=CC[C@@H](C)C[C@H]12,C21H30O2,37047.0
16298,Dimethylfraxetin,COc1cc2ccc(=O)oc2c(OC)c1OC,C12H12O5,36485.0
16299,PTP1B-IN-2,COC(=O)CN(c1ccc(CN(c2ccc(OCc3ccc(C)cc3)c(C(=O)OC)c2)S(=O)(=O)Cc2ccccc2)cc1)S(C)(=O)=O,C34H36N2O9S2,36824.0
16300,LC10,CCCCCCCCCCN(CCCCCCCCCC)CCNC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C46H86N2O2,37000.0
16301,I-CBP112,CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OC[C@H]2CCCN(C)C2)C1,C27H36N2O5,36811.0
16302,"1,2-Dioleoyl-sn-glycero-3-EPC (chloride)",CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(OCC)OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC.[Cl-],C46H89ClNO8P,36473.0
16303,Avacopan,Cc1ccc(NC(=O)[C@H]2CCCN(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC3CCCC3)cc2)cc1C(F)(F)F,C33H35F4N3O2,36639.0
16304,2-Aminoflubendazole,Nc1nc2ccc(C(=O)c3ccc(F)cc3)cc2[nH]1,C14H10FN3O,35444.0
16305,2-bromo LSD (solution),CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]c(Br)c(c34)C[C@H]2N(C)C1,C20H24BrN3O,36791.0
16306,2-bromo LSD,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]c(Br)c(c34)C[C@H]2N(C)C1,C20H24BrN3O,40633.0
16307,Norpropranolol (hydrochloride),Cl.NCC(O)COc1cccc2ccccc12,C13H16ClNO2,36011.0
16308,AF64394,CC(C)Oc1cc(Cl)ccc1CNc1cc(-c2ccccc2)nc2ncnn12,C21H20ClN5O,36826.0
16309,N-hydroxylamine Dapsone,Nc1ccc(S(=O)(=O)c2ccc(NO)cc2)cc1,C12H12N2O3S,35446.0
16310,FB23-2,Cc1noc(C)c1-c1cc(Cl)c(Nc2ccccc2C(=O)NO)c(Cl)c1,C18H15Cl2N3O3,36606.0
16311,Emavusertib,Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1,C24H25N7O5,36845.0
16312,Elexacaftor,Cc1nn(C)cc1S(=O)(=O)NC(=O)c1ccc(-n2ccc(OCC(C)(C)C(F)(F)F)n2)nc1N1C[C@@H](C)CC1(C)C,C26H34F3N7O4S,35307.0
16313,JTE-607,CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(Cl)c(OCCN2CCN(C)CC2)c(Cl)c1O.Cl.Cl,C25H33Cl4N3O5,36942.0
16314,TM-N1324,Cc1nn(-c2ncnc3nc[nH]c23)c2c1C(c1ccc(F)cc1Cl)CC(=O)N2,C18H13ClFN7O,37208.0
16315,Perphenazine Sulfoxide,O=S1c2ccccc2N(CCCN2CCN(CCO)CC2)c2cc(Cl)ccc21,C21H26ClN3O2S,35801.0
16316,Thiocolchicoside,COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2c(c1OC)-c1ccc(SC)c(=O)cc1[C@@H](NC(C)=O)CC2,C27H33NO10S,35821.0
16317,Nalfurafine (hydrochloride),CN(C(=O)/C=C/c1ccoc1)[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5.Cl,C28H33ClN2O5,36795.0
16318,Vericiguat,COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncc(F)cc23)nc1N,C19H16F2N8O2,35253.0
16319,LTURM 34,O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,C24H18N2O3S,35571.0
16320,NN-390,CC(C)N(Cc1ccc(C(=O)NO)cc1)S(=O)(=O)c1cc(F)c(F)c(F)c1F,C17H16F4N2O4S,36564.0
16321,Huperzine B,CC1=C[C@H]2Cc3[nH]c(=O)ccc3[C@]3(C1)NCCC[C@H]23,C16H20N2O,35629.0
16322,Pirtobrutinib,COc1ccc(F)cc1C(=O)NCc1ccc(-c2nn([C@@H](C)C(F)(F)F)c(N)c2C(N)=O)cc1,C22H21F4N5O3,36775.0
16323,Pyrene,c1cc2ccc3cccc4ccc(c1)c2c34,C16H10,35168.0
16324,3-Hydroxy-4-methoxyacetophenone,COc1ccc(C(C)=O)cc1O,C9H10O3,36801.0
16325,1-Oleoyl-2-Linoleoyl-rac-glycerol,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(CO)COC(=O)CCCCCCC/C=C\CCCCCCCC,C39H70O5,37241.0
16326,N-Pyrrolidino Protonitazene,CCCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN2CCCC2)cc1,C23H28N4O3,37456.0
16327,Cannabigerolic Acid monomethyl ether,CCCCCc1cc(OC)c(C/C=C(\C)CCC=C(C)C)c(O)c1C(=O)O,C23H34O4,37039.0
16328,Glycyl-L-Proline (trifluoroacetate salt),NCC(=O)N1CCC[C@H]1C(=O)O.O=C(O)C(F)(F)F,C9H13F3N2O5,36182.0
16329,306-O12B-3,CCCCCCCCSSCCOC(=O)CCNCCCN(C)CCCN(CCC(=O)OCCSSCCCCCCCC)CCC(=O)OCCSSCCCCCCCC,C46H91N3O6S6,37096.0
16330,U-0521,CC(C)C(=O)c1ccc(O)c(O)c1,C10H12O3,36314.0
16331,N1-Acetylputrescine,CC(=O)NCCCCN,C6H14N2O,37185.0
16332,Triazavirin,CSc1nc2[n-]nc([N+](=O)[O-])c(=O)n2n1.O.O.[Na+],C5H7N6NaO5S,36052.0
16333,6-Acetylcodeine,COc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341,C20H23NO4,17048.0
16334,IXA4,Cc1ccc(OCCN(C)C(=O)Cn2cc(NC(=O)CCOc3ccccc3)cn2)cc1,C24H28N4O4,36788.0
16335,Coblopasvir,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)c4c3OCO4)cc2)[nH]1)C(C)C,C41H50N8O8,36779.0
16336,CUMYL-INACA,CC(C)(NC(=O)c1n[nH]c2ccccc12)c1ccccc1,C17H17N3O,37055.0
16337,Tetrahydroepiberberine,COc1cc2c(cc1OC)C1Cc3ccc4c(c3CN1CC2)OCO4,C20H21NO4,36177.0
16338,BzF,N[C@@H](Cc1ccc(C(=O)c2ccccc2)cc1)C(=O)O,C16H15NO3,36168.0
16339,1-1(Z)-Octadecenyl-2-Docosahexaenoyl-sn-glycero-3-PE,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](CO/C=C\CCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C45H78NO7P,37138.0
16340,AZM475271,COc1ccc(Cl)c(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1,C23H27ClN4O3,37378.0
16341,SHIN 1,Cc1n[nH]c2c1C(c1cc(CO)cc(-c3ccccc3)c1)(C(C)C)C(C#N)=C(N)O2,C24H24N4O2,35715.0
16342,306-O12B,CCCCCCCCSSCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCSSCCCCCCCC)CCC(=O)OCCSSCCCCCCCC)CCC(=O)OCCSSCCCCCCCC,C59H115N3O8S8,37549.0
16343,Velaresol,O=Cc1c(O)cccc1OCCCCC(=O)O,C12H14O5,37190.0
16344,Euscaphic Acid,C[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@]1(C)O,C30H48O5,36162.0
16345,Yamogenin,C[C@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C27H42O3,36008.0
16346,FOXM1 Inhibitor III,Nc1c(C(=O)Nc2ccc(F)cc2)sc2nc(-c3cccs3)cc(C(F)(F)F)c12,C19H11F4N3OS2,36932.0
16347,NS 638,Nc1nc2cc(C(F)(F)F)ccc2n1Cc1ccc(Cl)cc1,C15H11ClF3N3,37193.0
16348,Samatasvir,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2ccc(-c3csc4c(-c5ccc(-c6cnc([C@@H]7CCCN7C(=O)[C@H](NC(=O)OC)c7ccccc7)[nH]6)cc5)csc34)cc2[nH]1)C(C)C,C47H48N8O6S2,36776.0
16349,Cyclouridine,O=c1ccn2c(n1)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]12,C9H10N2O5,35271.0
16350,Crebanine,COc1ccc2c(c1OC)C[C@@H]1c3c(cc4c(c3-2)OCO4)CCN1C,C20H21NO4,36176.0
16351,ML-382,CCOc1ccccc1NC(=O)c1ccccc1NS(=O)(=O)C1CC1,C18H20N2O4S,36668.0
16352,Iloperidone-d3,[2H]C([2H])([2H])Oc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,C24H27FN2O4,35194.0
16353,LP-01,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCC(OCCCCCCCC)OCCCCCCCC)COC(=O)OCCCN(CC)CC,C50H93NO9,37278.0
16354,n-Propane Residual Solvent (CRM)n-Propane Residual Solvent (CRM),CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCC(OCCCCCCCC)OCCCCCCCC)COC(=O)OCCCN(CC)CC,C50H93NO9,38278.0
16355,Brequinar (sodium salt),Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)[O-].[Na+],C23H14F2NNaO2,36183.0
16356,5-chloro AMT,CC(N)Cc1c[nH]c2ccc(Cl)cc12,C11H13ClN2,35183.0
16357,Pantoic Acid,CC(C)(CO)[C@@H](O)C(=O)O,C6H12O4,36685.0
16358,AP20187,CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)NCC(CNC(=O)COc2cccc([C@@H](CCc3ccc(OC)c(OC)c3)OC(=O)[C@@H]3CCCCN3C(=O)[C@@H](CC)c3cc(OC)c(OC)c(OC)c3)c2)CN(C)C)c1)c1cc(OC)c(OC)c(OC)c1,C82H107N5O20,36808.0
16359,"2-methyl-1,2,3,4-Tetrahydro-?-carboline",CN1CCc2c([nH]c3ccccc23)C1,C12H14N2,35039.0
16360,2-Chloro-N-methyl-N-(4-nitrophenyl)acetamide,CN(C(=O)CCl)c1ccc([N+](=O)[O-])cc1,C9H9ClN2O3,35536.0
16361,C53,CC1(C)C(=O)N(Cc2c(F)cccc2Cl)c2cc(C(=O)NCc3c(F)cc(F)cc3F)ccc21,C25H19ClF4N2O2,37354.0
16362,JNJ-303,CC(C)(Oc1ccc(Cl)cc1)C(=O)NC1C2CC3CC1CC(NS(C)(=O)=O)(C3)C2,C21H29ClN2O4S,37345.0
16363,"Bradykinin (human, mouse, rat, bovine) (acetate)",CC(=O)O.N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)O,C50H73N15O11(C2H4O2)n,37408.0
16364,Tesofensine,CCOC[C@@H]1[C@@H](c2ccc(Cl)c(Cl)c2)C[C@@H]2CC[C@H]1N2C,C17H23Cl2NO,35224.0
16365,9A1P9,CCCCCCCCCOP(=O)(O)OCCN(CCCCCCCC)CCCCCCCC,C27H58NO4P,37276.0
16366,3-Methylnordiazepam,CC1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O,C16H13ClN2O,37518.0
16367,2-Methoxyhydroquinone,COc1cc(O)ccc1O,C7H8O3,36537.0
16368,Chlorphenesin,OCC(O)COc1ccc(Cl)cc1,C9H11ClO3,36169.0
16369,Timosaponin AI,C[C@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C33H54O8,36174.0
16370,Taraxasterol Acetate,C=C1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]2[C@@H]1C,C32H52O2,36131.0
16371,80-O16B,CCCCCCCCCCCCSSCCOC(=O)CCN(CCCN(C)C)CCC(=O)OCCSSCCCCCCCCCCCC,C39H78N2O4S4,37564.0
16372,TPX-0022,CCN1Cc2c(ccc(F)c2C#N)O[C@@H](C)CNC(=O)c2c(N)nn3ccc1nc23,C20H20FN7O2,36118.0
16373,Dipsacoside B,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CC[C@]6(C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O)CC[C@]45C)[C@]3(C)CO)OC[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C53H86O22,35624.0
16374,NG-497,CCOc1ccc(-c2cc(OC)cc(C(=O)OC(C)C)n2)cc1,C18H21NO4,36886.0
16375,"2,4'-Dibromoacetophenone",O=C(CBr)c1ccc(Br)cc1,C8H6Br2O,37358.0
16376,Quercetin 3-O-?-D-Glucose-7-O-?-D-Gentiobioside,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c12,C33H40O22,36130.0
16377,SBI-553,COc1ccccc1C1CCN(c2nc(C3(F)CC3)nc3ccc(N(C)CCO)cc23)CC1,C26H31FN4O2,36782.0
16378,Inflammasome Inhibitor 4b,Cc1cc(C)cc([N-]C(=O)NS(=O)(=O)c2cc(C(C)(C)O)co2)c1.[Na+],C16H19N2NaO5S,37030.0
16379,HCV-IN-31,CNc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@]1(C)F,C12H17FN6O3,36778.0
16380,LOR253,Cc1[nH]c2ccc(F)cc2c1-c1nc2c3cccnc3c3ncccc3c2[nH]1,C22H14FN5,36773.0
16381,PKC? Inhibitor (hydrochloride),Cl.NCC1CCC(CNc2nc(NCc3ccccc3OC(F)(F)F)ncc2[N+](=O)[O-])CC1,C20H26ClF3N6O3,36165.0
16382,Pagoclone,CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1,C23H22ClN3O2,27749.0
16383,2-(N-Methylperfluorooctanesulfonamido)acetic Acid,CN(CC(=O)O)S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C11H6F17NO4S,37262.0
16384,Gingerenone A,COc1cc(CC/C=C/C(=O)CCc2ccc(O)c(OC)c2)ccc1O,C21H24O5,36841.0
16385,Ceftizoxime (sodium salt),CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=CCS[C@H]12)c1csc(N)n1.[Na+],C13H12N5NaO5S2,36093.0
16386,Pep2-8,CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O,C83H110N16O24,36923.0
16387,(-)-Pinoresinol,COc1cc([C@@H]2OC[C@@H]3[C@H]2CO[C@H]3c2ccc(O)c(OC)c2)ccc1O,C20H22O6,36850.0
16388,1-1(Z)-Octadecenyl-2-Arachidonoyl-sn-glycero-3-PC,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](CO/C=C\CCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C46H84NO7P,37132.0
16389,Anagliptin,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1,C19H25N7O2,36188.0
16390,Sunifiram,CCC(=O)N1CCN(C(=O)c2ccccc2)CC1,C14H18N2O2,35018.0
16391,?8-THCB,CCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C20H28O2,30303.0
16392,?8-THCB (exempt preparation),CCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C20H28O2,37898.0
16393,PKM2 Inhibitor,CC1=C(CSC(=S)N2CCCCC2)C(=O)c2ccccc2C1=O,C18H19NO2S2,36815.0
16394,N-desmethyl Diltiazem (hydrochloride),CNCCN1C(=O)[C@H](OC(C)=O)[C@H](c2ccc(OC)cc2)Sc2ccccc21.Cl,C21H25ClN2O4S,34977.0
16395,Bayogenin,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,C30H48O5,35822.0
16396,Isobutyryl-L-carnitine (chloride),CC(C)C(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C11H22ClNO4,37103.0
16397,3-Amino-5-hydroxybenzoic Acid,Nc1cc(O)cc(C(=O)O)c1,C7H7NO3,35831.0
16398,12-Tridecenoic Acid,C=CCCCCCCCCCCC(=O)O,C13H24O2,37601.0
16399,Ganglioside GD1b (bovine) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]4(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC,C84H146N4O39,31708.0
16400,VU0119498,O=C1C(=O)N(Cc2ccc(Br)cc2)c2ccccc21,C15H10BrNO2,36132.0
16401,Ganglioside GQ1b (bovine) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@]5(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]6(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O6)O5)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]4(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC,C106H178N6O55,31561.0
16402,"9,10-Dimethoxypterocarpan-3-O-?-D-glucoside",COc1ccc2c(c1OC)O[C@H]1c3ccc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3OC[C@@H]21,C23H26O10,36192.0
16403,Forphenicinol,N[C@H](C(=O)O)c1ccc(CO)c(O)c1,C9H11NO4,36392.0
16404,AZD 4205,COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1,C25H31N9O2,36622.0
16405,Ovalbumin (257-264) (chicken) (trifluoroacetate salt),CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O.O=C(O)C(F)(F)F,C47H75F3N10O15,36882.0
16406,Tirucallol,CC(C)=CCC[C@H](C)[C@@H]1CC[C@]2(C)C3=C(CC[C@@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1CC3,C30H50O,35623.0
16407,NT1-O14B,CCCCCCCCCCSSCCOC(=O)CCN(CCC(=O)OCCSSCCCCCCCCCC)CCc1c[nH]c2ccccc12,C40H68N2O4S4,37095.0
16408,(+)-?8-THC,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@H]1CC=C(C)C[C@H]21,C21H30O2,35329.0
16409,1-1(Z)-Octadecenyl-2-Arachidonoyl-sn-glycero-3-PE,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](CO/C=C\CCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C43H78NO7P,37137.0
16410,Gartanin,CC(C)=CCc1c(O)c(CC=C(C)C)c2oc3c(O)ccc(O)c3c(=O)c2c1O,C23H24O6,35631.0
16411,"2H,2H,3H,3H-Perfluorohexanoic Acid",O=C(O)CCC(F)(F)C(F)(F)C(F)(F)F,C6H5F7O2,37230.0
16412,"1,3-Dimethyluric Acid",Cn1c(=O)c2[nH]c(=O)[nH]c2n(C)c1=O,C7H8N4O3,36167.0
16413,Emvododstat,COc1ccc([C@H]2c3[nH]c4ccc(Cl)cc4c3CCN2C(=O)Oc2ccc(Cl)cc2)cc1,C25H20Cl2N2O3,36877.0
16414,OVN73571,CC(=O)N[C@H]1[C@@H](OC[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O,C32H36N2O13,36858.0
16415,RAMB4,O=C1C(=Cc2ccc(Cl)c(Cl)c2)CNCC1=Cc1ccc(Cl)c(Cl)c1,C19H13Cl4NO,36936.0
16416,N-Formylmethionine,CSCC[C@H](NC=O)C(=O)O,C6H11NO3S,35594.0
16417,Saikosaponin F,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@H]3CC[C@]4(C)[C@H]5CC=C6[C@@H]7CC(C)(C)CC[C@]7(CO)[C@@H](O)C[C@@]6(C)[C@]5(C)CC[C@H]4C3(C)C)O[C@@H]2CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,C48H80O17,35626.0
16418,Alisol F,C[C@@H]1C[C@@H]([C@@H](O)C(C)(C)O)O[C@H]2C[C@@]3(C)C(=C12)C[C@H](O)[C@H]1[C@@]2(C)CCC(=O)C(C)(C)[C@@H]2CC[C@@]13C,C30H48O5,35627.0
16419,n-Dodecyl-?-D-Glucopyranoside,CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C18H36O6,36030.0
16420,BNC-105,COc1cc(C(=O)c2c(C)oc3c(O)c(OC)ccc23)cc(OC)c1OC,C20H20O7,36930.0
16421,AA26-8,O=C(N1CCCC1)n1ccnn1,C7H10N4O,36937.0
16422,LSD (CRM),CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,C20H25N3O,35189.0
16423,LSD,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,C20H25N3O,37037.0
16424,Pexiganan (acetate),CC(=O)O.[H]NCCCC[C@H](NC(=O)[C@H](CCCCN[H])NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN[H])NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN[H])NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN[H])NC(=O)[C@H](CCCCN[H])NC(=O)[C@H](C)NC(=O)[C@H](CCCCN[H])NC(=O)[C@H](CCCCN[H])NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN[H])NC(=O)CNC(=O)[C@@H](NC(=O)CN[H])[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(N)=O,C122H210N32O22(C2H4O2)X,36924.0
16425,Salvigenin,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1,C18H16O6,35632.0
16426,CBDVQ,C=C(C)[C@@H]1CCC(C)=C[C@H]1C1=C(O)C(=O)C(CCC)=CC1=O,C19H24O3,36872.0
16427,8-chloro Caffeine,Cn1c(=O)c2c(nc(Cl)n2C)n(C)c1=O,C8H9ClN4O2,35817.0
16428,CHMFL-BMX-078,C=CC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3C)c(NC)n2)ccc1C,C33H35N7O6,36828.0
16429,CL4H6,CCCCCCCC/C=C\CCCCCCCC(=O)OCCCCCCC(O)(CCCCCCOC(=O)CCCCCCC/C=C\CCCCCCCC)CCCCN(CCC)CCC,C59H113NO5,37279.0
16430,Rimiducid,CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)NCCNC(=O)COc2cccc([C@@H](CCc3ccc(OC)c(OC)c3)OC(=O)[C@@H]3CCCCN3C(=O)[C@@H](CC)c3cc(OC)c(OC)c(OC)c3)c2)c1)c1cc(OC)c(OC)c(OC)c1,C78H98N4O20,35303.0
16431,Entecavir,C=C1[C@H](CO)[C@@H](O)C[C@@H]1n1cnc2c(=O)nc(N)[nH]c21,C12H15N5O3,36926.0
16432,1-O-Caffeoylquinic Acid,O=C(C=Cc1ccc(O)c(O)c1)O[C@]1(C(=O)O)C[C@@H](O)[C@H](O)[C@H](O)C1,C16H18O9,36189.0
16433,Androsin,COc1cc(C(C)=O)ccc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C15H20O8,36191.0
16434,Lysipressin (acetate),CC(=O)O.NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,C48H69N13O14S2,37430.0
16435,Phosphatidylserine (bovine),CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC([NH3+])C(=O)O)OC(=O)CCCCCCC/C=C\CCCCCCCC,C42H78NO10P,24341.0
16436,"L-Glutathione, oxidized",N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O,C20H32N6O12S2,35825.0
16437,Piperazine Erastin,CC(C)Oc1ccc(CN2CCNCC2)cc1-n1c(CN2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O,C35H41ClN6O4,36934.0
16438,Sphingomyelin (bovine buttermilk),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCCCCCCCCC,C46H93N2O6P,31559.0
16439,Ziyuglycoside I,C[C@@H]1CC[C@]2(C(=O)O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@]1(C)O,C41H66O13,37320.0
16440,KPT-6566,CC(C)(C)c1ccc(S(=O)(=O)N=C2C=C(SCC(=O)O)C(=O)c3ccccc32)cc1,C22H21NO5S2,37308.0
16441,1-1(Z)-Octadecenyl-2-Docosahexaenoyl-sn-glycero-3-PC,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](CO/C=C\CCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C48H84NO7P,37134.0
16442,4-tert-Octylphenol monoethoxylate,CC(C)(C)CC(C)(C)c1ccc(OCCO)cc1,C16H26O2,37366.0
16443,ATX-100,CCCCCCCC(CCCCCCC)OC(=O)CCCN(CCCC(=O)OC(CCCCCCC)CCCCCCC)C(=O)SCCCN(C)C,C44H86N2O5S,36935.0
16444,Malachite Green (chloride),CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccccc2)cc1.[Cl-],C23H25ClN2,37395.0
16445,DL-Sulforaphane Glutathione,CS(=O)CCCCNC(=S)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,C16H28N4O7S3,34731.0
16446,CBD-C8,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCCCCC)cc1O,C24H36O2,35432.0
16447,MK-0591,CC(C)(C)Sc1c(CC(C)(C)C(=O)O)n(Cc2ccc(Cl)cc2)c2ccc(OCc3ccc4ccccc4n3)cc12,C34H35ClN2O3S,37322.0
16448,Biotin-VAD-FMK,COC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)C(C)C)C(=O)CF,C30H49FN6O8S,24305.0
16449,1-1(Z)-Hexadecenyl-2-Arachidonoyl-sn-glycero-3-PC,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](CO/C=C\CCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C44H80NO7P,34182.0
16450,10-methyl Lauric Acid,CCC(C)CCCCCCCCC(=O)O,C13H26O2,36504.0
16451,Cyclobutyl fentanyl (hydrochloride),Cl.O=C(C1CCC1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C24H31ClN2O,22389.0
16452,Frangulin A,Cc1cc(O)c2c(c1)C(=O)c1cc(O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)cc(O)c1C2=O,C21H20O9,36087.0
16453,ALEPH (hydrochloride),COc1cc(SC)c(OC)cc1CC(C)N.Cl,C12H20ClNO2S,23818.0
16454,1-1(Z)-Octadecenyl-2-Adrenoyl-sn-glycero-3-PE,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](CO/C=C\CCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C45H82NO7P,37136.0
16455,Lactoyl Phenylalanine,C[C@H](O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,C12H15NO4,37304.0
16456,JPH203 (hydrochloride),Cl.Cl.Nc1cc(COc2c(Cl)cc(C[C@H](N)C(=O)O)cc2Cl)c2oc(-c3ccccc3)nc2c1,C23H21Cl4N3O4,36053.0
16457,rac-Mono(ethylhexyl) Phthalate,CCCCC(CC)COC(=O)c1ccccc1C(=O)O,C16H22O4,35605.0
16458,T-1095,COC(=O)OC[C@H]1O[C@@H](Oc2cc(C)cc(O)c2C(=O)CCc2ccc3occc3c2)[C@H](O)[C@@H](O)[C@@H]1O,C26H28O11,37284.0
16459,Arnicolide D,C=C(C)C(=O)O[C@H]1[C@@H]2[C@H](C)C(=O)O[C@@H]2C[C@@H](C)[C@@H]2C=CC(=O)[C@]21C,C19H24O5,36193.0
16460,Flucloxacillin (sodium salt),Cc1onc(-c2c(F)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)[O-].[Na+],C19H16ClFN3NaO5S,35241.0
16461,Pentadecafluorooctanoic Acid,O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C8HF15O2,37232.0
16462,ENPP1 Inhibitor 43,CCC(Sc1nc(N)nc2nc[nH]c12)C(=O)Nc1ccc(O)c(OC)c1,C16H18N6O3S,36836.0
16463,ISP-I-28,CCCCCCC(O)CCCCCCCCC[C@@H](O)[C@H](O)C(N)(CO)CO,C21H45NO5,9004082.0
16464,Betahistine-d3 (hydrochloride),Cl.Cl.[2H]C([2H])([2H])NCCc1ccccn1,C8H14Cl2N2,35559.0
16465,113-O12B,CCCCCCCCSSCCOC(=O)CCN(CCC(=O)OCCSSCCCCCCCC)CCN(C)CCN(CCC(=O)OCCSSCCCCCCCC)CCC(=O)OCCSSCCCCCCCC,C57H111N3O8S8,37671.0
16466,4'-fluoro Diazepam,CN1C(=O)CN=C(c2ccc(F)cc2)c2cc(Cl)ccc21,C16H12ClFN2O,37116.0
16467,Arimoclomol,[O-][n+]1cccc(/C(Cl)=N/OC[C@H](O)CN2CCCCC2)c1,C14H20ClN3O3,37368.0
16468,ENPP3 Inhibitor 4t,O=C(Nc1ccc(OS(=O)(=O)c2ccc(OC(F)(F)F)cc2)cc1)c1ccccc1,C20H14F3NO5S,37646.0
16469,ENPP3 Inhibitor 4g,Cc1ccc(C(=O)Nc2ccc(OS(=O)(=O)c3ccc(OC(F)(F)F)cc3)cc2)cc1,C21H16F3NO5S,37647.0
16470,Isomenthone,CC(C)[C@@H]1CC[C@H](C)CC1=O,C10H18O,35063.0
16471,Sarolaner,CS(=O)(=O)CC(=O)N1CC2(C1)OCc1cc(C3=NO[C@@](c4cc(Cl)c(F)c(Cl)c4)(C(F)(F)F)C3)ccc12,C23H18Cl2F4N2O5S,37321.0
16472,MRS1845,C#CCN1C(C)=C(C(=O)OC)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OCC)=C1C,C21H22N2O6,36814.0
16473,BCP-T.A.,C#Cc1nc(C(=O)N2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)cs1,C23H19Cl2N3OS,37659.0
16474,Propacetamol (hydrochloride),CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1.Cl,C14H21ClN2O3,36134.0
16475,PEG(2000)-DSPE (sodium salt),CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCCNC(=O)OCCOC)OC(=O)CCCCCCCCCCCCCCCCC.[Na+],C45H87NNaO11P,37148.0
16476,Ethylparaben,CCOC(=O)c1ccc(O)cc1,C9H10O3,37357.0
16477,Deferitrin,C[C@]1(C(=O)O)CSC(c2ccc(O)cc2O)=N1,C11H11NO4S,33328.0
16478,Camelliaside A,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C33H40O20,35628.0
16479,L-Arginine-13C6 (hydrochloride),Cl.N=[13C](N)N[13CH2][13CH2][13CH2][13C@H](N)[13C](=O)O,C6H15ClN4O2,9004088.0
16480,N-Succinimidyl-S-acetylthioacetate,CC(=O)SCC(=O)ON1C(=O)CCC1=O,C8H9NO5S,36928.0
16481,5-fluoro 7-APAICA,O=C(NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3)c1cn(CCCCCF)c2ncccc12,C23H30FN3O,23021.0
16482,5-methoxy DMT (succinate),COc1ccc2[nH]cc(CCN(C)C)c2c1.O=C(O)CCC(=O)O,C17H24N2O5,37552.0
16483,"1,2,3,4-Tetrahydro-?-carboline",c1ccc2c3c([nH]c2c1)CNCC3,C11H12N2,35038.0
16484,Perfluorobutylsulfonamide,NS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C4H2F9NO2S,37365.0
16485,GCN2-IN-1,c1nn(C2CCOCC2)cc1Nc1ncc2nnn(-c3ccc4cn[nH]c4c3)c2n1,C19H18N10O,36027.0
16486,L-Isoleucine-13C6,[13CH3][13CH2][13C@H]([13CH3])[13C@H](N)[13C](=O)O,C6H13NO2,9004090.0
16487,STM2457,O=C(NCc1cn2cc(CNCC3CCCCC3)ccc2n1)c1cc(=O)n2ccccc2n1,C25H28N6O2,34280.0
16488,MeTC7,CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC1[C@]23C=C[C@]2(C[C@@H](OC(=O)CBr)CC[C@]12C)n1c(=O)n(C)c(=O)n13,C32H48BrN3O4,37338.0
16489,TD52,C#Cc1cccc(Nc2nc3ccccc3nc2Nc2cccc(C#C)c2)c1,C24H16N4,37744.0
16490,AG-270,COc1ccc(-c2c(Nc3ccccn3)[nH]c3c(C4=CCCCC4)c(-c4ccccc4)nn3c2=O)cc1,C30H27N5O2,36246.0
16491,STAT3 Inhibitor 4m,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCCc4cccs4)CC[C@]3(C)CC[C@]12C,C35H45NO3S,37352.0
16492,Odevixibat,CCCCC1(CCCC)CN(c2ccccc2)c2cc(SC)c(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(=O)O)c3ccc(O)cc3)cc2S(=O)(=O)N1,C37H48N4O8S2,35344.0
16493,CAY10790,O=C(O)c1cccc(OCc2ccc3ccccc3n2)c1,C17H13NO3,35326.0
16494,Pentadecanoyl-L-carnitine (chloride),CCCCCCCCCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C22H44ClNO4,37677.0
16495,?8-THC methyl ether,OCc1cccc(OCc2ccc3ccccc3n2)c1,C17H15NO2,36793.0
16496,CAY10789,OCc1cccc(OCc2ccc3ccccc3n2)c1,C17H15NO2,35325.0
16497,Dabrafenib (mesylate),CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1.CS(=O)(=O)O,C24H24F3N5O5S3,35251.0
16498,Chamazulene,CCc1ccc(C)c2ccc(C)c-2c1,C14H16,36072.0
16499,5-O-Demethylnobiletin,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)c(OC)c3o2)cc1OC,C20H20O8,35230.0
16500,2'-Deoxyguanosine-5'-O-triphosphate (sodium salt),Nc1nc(=O)c2ncn([C@H]3C[C@H](O)[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O3)c2[nH]1.[Na+].[Na+].[Na+],C10H13N5Na3O13P3,35771.0
16501,LEI-110,O=C(CCCc1ccccc1)C(=O)NCCc1ccc(Oc2ccc(C(F)(F)F)cn2)cc1,C25H23F3N2O3,36789.0
16502,Solanidine,C[C@H]1CC[C@@H]2[C@@H](C)[C@H]3[C@H](C[C@H]4[C@@H]5CC=C6C[C@@H](O)CC[C@]6(C)[C@H]5CC[C@]34C)N2C1,C27H43NO,36433.0
16503,Orotidine,O=C(O)c1cc(=O)[nH]c(=O)n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,C10H12N2O8,36401.0
16504,LCS-1,Cc1cccc(-n2ncc(Cl)c(Cl)c2=O)c1,C11H8Cl2N2O,35231.0
16505,N-formyl-2-Aminophenol,O=CNc1ccccc1O,C7H7NO2,36802.0
16506,JI-101,COc1ccc(Br)cc1NC(=O)Nc1cccc2c1ccn2Cc1ccnc(N)c1,C22H20BrN5O2,36405.0
16507,1-Methylxanthine,Cn1c(=O)[nH]c2nc[nH]c2c1=O,C6H6N4O2,35245.0
16508,Trimipramine N-oxide,CC(CN1c2ccccc2CCc2ccccc21)C[N+](C)(C)[O-],C20H26N2O,35414.0
16509,(+)-Sparteine,C1CCN2C[C@H]3C[C@H](CN4CCCC[C@@H]34)[C@H]2C1,C15H26N2,36400.0
16510,Hydrocortisone Aceponate,CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,C26H36O7,35359.0
16511,Desthiazolylmethyl Ritonavir,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@@H]2OC(=O)N[C@H]2Cc2ccccc2)C(C)C)cs1,C33H43N5O4S,36299.0
16512,ONO-8590580,Cc1c(F)c(Nc2ccc(-c3cn(C)cn3)cn2)cc2c1ncn2CC1CC1,C21H21FN6,35297.0
16513,Butyl 4-hydroxybenzoate,CCCCOC(=O)c1ccc(O)cc1,C11H14O3,36797.0
16514,"2',3'-Dideoxyadenosine",Nc1ncnc2c1ncn2[C@H]1CC[C@@H](CO)O1,C10H13N5O2,36662.0
16515,S-Methyl-D-penicillamine,CSC(C)(C)[C@@H](N)C(=O)O,C6H13NO2S,36297.0
16516,Monoacetylcadaverine (hydrochloride),CC(=O)NCCCCCN.Cl,C7H17ClN2O,35275.0
16517,D-Arabinitol,OC[C@@H](O)C(O)[C@H](O)CO,C5H12O5,33826.0
16518,"N2,N2-Dimethylguanosine",CN(C)c1nc(=O)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2[nH]1,C12H17N5O5,35347.0
16519,Aripiprazole N-oxide,O=C1CCc2ccc(OCCCC[N+]3([O-])CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,C23H27Cl2N3O3,35296.0
16520,Montbretin A,C[C@@H]1O[C@@H](O[C@@H]2CO[C@@H](Oc3c(O)cc(-c4oc5cc(O)cc(O)c5c(=O)c4O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O[C@@H]4O[C@H](COC(=O)/C=C/c5ccc(O)c(O)c5)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,C53H64O33,30651.0
16521,?-azido-C6 Ceramide,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCN=[N+]=[N-],C24H46N4O3,37650.0
16522,VV116,[2H]c1cc([C@]2(C#N)O[C@H](COC(=O)C(C)C)[C@@H](OC(=O)C(C)C)[C@H]2OC(=O)C(C)C)n2ncnc(N)c12,C24H31N5O7,37745.0
16523,?9-THC-C8,CCCCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C24H36O2,35081.0
16524,?9-THC-C8 (exempt preparation),CCCCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C24H36O2,38148.0
16525,trans-Petroselinic Acid methyl ester,CCCCCCCCCCC/C=C/CCCCC(=O)OC,C19H36O2,36670.0
16526,3-(3-Hydroxyphenyl)propionic Acid sulfate,O=C(O)CCc1cccc(OS(=O)(=O)O)c1,C9H10O6S,9004103.0
16527,"DL-3,4-Dihydroxyphenyl glycol",OCC(O)c1ccc(O)c(O)c1,C8H10O4,11708.0
16528,3-amino-L-Tyrosine (hydrochloride),Cl.Cl.Nc1cc(C[C@H](N)C(=O)O)ccc1O,C9H14Cl2N2O3,36310.0
16529,Pentoxyresorufin,CCCCCOc1ccc2nc3ccc(=O)cc-3oc2c1,C17H17NO3,14853.0
16530,"Aripiprazole N,N-dioxide",O=C1CCc2ccc(OCCCC[N+]3([O-])CC[N+]([O-])(c4cccc(Cl)c4Cl)CC3)cc2N1,C23H27Cl2N3O4,35496.0
16531,Minosaminomycin,CC(C)CC(NC(=O)NC(CC1CN=C(N)N1)C(=O)NC1C(O)C(O)C(OC2OC(C)C(N)CC2N)C(O)C1O)C(=O)O,C25H46N8O10,36406.0
16532,YKL-05-099,COc1ccc(N2C(=O)N(c3c(C)cccc3Cl)Cc3cnc(Nc4ccc(C5CCN(C)CC5)cc4OC)nc32)nc1,C32H34ClN7O3,36116.0
16533,GDC-046,O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cccc1Cl,C16H13Cl2N3O2,36601.0
16534,Tegobuvir,Fc1ccccc1-c1nc2ccn(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)nn3)cc-2n1,C25H14F7N5,36603.0
16535,4-Chloroethamphetamine (hydrochloride),CCNC(C)Cc1ccc(Cl)cc1.Cl,C11H17Cl2N,36647.0
16536,3-O-demethyl Thiocolchicine,COc1c(O)cc2c(c1OC)-c1ccc(SC)c(=O)cc1[C@@H](NC(C)=O)CC2,C21H23NO5S,35497.0
16537,"(R,S)-3,5-DHPG",NC(C(=O)O)c1cc(O)cc(O)c1,C8H9NO4,35912.0
16538,Finerenone,CCOc1ncc(C)c2c1[C@H](c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,C21H22N4O3,36086.0
16539,Triazolomethylindole-3-acetic Acid,O=C(O)Cc1c[nH]c2ccc(Cn3cncn3)cc12,C13H12N4O2,35103.0
16540,Homobrassinolide,CC[C@@H](C(C)C)C(O)C(O)[C@@H](C)[C@H]1CC[C@H]2[C@@H]3COC(=O)[C@H]4C[C@H](O)[C@H](O)C[C@]4(C)[C@H]3CC[C@]12C,C29H50O6,36038.0
16541,Galactaric Acid,O=C(O)[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(=O)O,C6H10O8,36206.0
16542,Noroxycodone-d3 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])Oc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)NCC[C@]314,C17H20ClNO4,36792.0
16543,LSD (L-hemitartrate) (solution),CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1.CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1.O=C(O)[C@H](O)[C@@H](O)C(=O)O,C44H56N6O8,37663.0
16544,L-Cysteine-15N-d3,[2H]C([2H])(S)[C@]([2H])([15NH2])C(=O)O,C3H7NO2S,34838.0
16545,Salvinorin A-d3,[2H]C([2H])([2H])C(=O)O[C@H]1C[C@@H](C(=O)OC)[C@]2(C)CC[C@H]3C(=O)O[C@H](c4ccoc4)C[C@]3(C)[C@H]2C1=O,C23H28O8,36410.0
16546,1-Stearoyl-2-Eicosapentaenoyl-sn-glycero-3-PE,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C43H76NO8P,37702.0
16547,Prinomastat,CC1(C)SCCN(S(=O)(=O)c2ccc(Oc3ccncc3)cc2)[C@H]1C(=O)NO,C18H21N3O5S2,37699.0
16548,OF-02,CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CCCCC1NC(=O)C(CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)NC1=O)CC(O)CCCCCC/C=C\C/C=C\CCCCC,C84H152N4O6,37652.0
16549,Lipid A9,CCCCCCCCC(=O)N(CCCN(C)C)C(CCCCCCCCC(=O)OCC(CCCC)CCCCCC)CCCCCCCCC(=O)OCC(CCCC)CCCCCC,C57H112N2O5,37667.0
16550,(R)-HTS-3,CN(C)[C@@H](CNC(=O)c1cc(F)cc(F)c1)c1ccccc1,C17H18F2N2O,37563.0
16551,Perfluorononanoic Acid,O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C9HF17O2,37250.0
16552,Perfluoroheptanoic Acid,O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C7HF13O2,37247.0
16553,ENPP3 Inhibitor,Cc1ccc(-c2nnc(Nc3ccc(S(N)(=O)=O)cc3)c3ccccc23)cc1S(N)(=O)=O,C21H19N5O4S2,37760.0
16554,Heptafluorobutyric Acid,O=C(O)C(F)(F)C(F)(F)C(F)(F)F,C4HF7O2,37234.0
16555,Fumonisin B1-13C34,[13CH3][13CH2][13CH2][13CH2][13C@@H]([13CH3])[13C@@H](O[13C](=O)[13CH2][13C@@H]([13CH2][13C](=O)O)[13C](=O)O)[13C@H]([13CH2][13C@@H]([13CH3])[13CH2][13C@H](O)[13CH2][13CH2][13CH2][13CH2][13C@@H](O)[13CH2][13C@H](O)[13C@H]([13CH3])N)O[13C](=O)[13CH2][13C@@H]([13CH2][13C](=O)O)[13C](=O)O,C34H59NO15,31272.0
16556,KAS 08,O=C(c1ccc([N+](=O)[O-])cc1)N1CCc2cc(S(=O)(=O)N3C[C@H](c4ccccc4)NC3=O)ccc21,C24H20N4O6S,36474.0
16557,Jun9-72-2,C[C@H](c1cccc2ccccc12)N(C)Cc1ccc(O)cc1,C20H21NO,37195.0
16558,Creatine Phosphate (sodium salt hydrate),CN(CC(=O)O)C(=N)NP(=O)([O-])[O-].O.[Na+].[Na+],C4H10N3Na2O6P,37803.0
16559,Losartan Azide,CCCCc1nc(Cl)c(CN=[N+]=[N-])n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,C22H22ClN9,37387.0
16560,Alphenal,C=CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,C13H12N2O3,26918.0
16561,2BAct,O=C(COc1ccc(Cl)c(F)c1)NC12CC(NC(=O)c3cnc(C(F)F)cn3)(C1)C2,C19H16ClF3N4O3,37788.0
16562,S-Sulfocysteine,N[C@@H](CSS(=O)(=O)O)C(=O)O,C3H7NO5S2,34559.0
16563,STD1T,NC(=O)c1c(NC(=O)COCc2cc(-c3cccs3)on2)sc2c1CCCC2,C19H19N3O4S2,37791.0
16564,Perfluorodecanoic Acid,O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C10HF19O2,37244.0
16565,Calcium Ionophore II,O=C(COCC(=O)N(C1CCCCC1)C1CCCCC1)N(C1CCCCC1)C1CCCCC1,C28H48N2O3,37707.0
16566,AS-2717638,COc1cc2c(C(=O)N3CCCCC3)cn(-c3noc4ccc(C)cc34)c(=O)c2cc1OC,C25H25N3O5,37787.0
16567,MRK-016,Cc1cc(-c2nncc3c(C(C)(C)C)c(OCc4ncnn4C)nn23)no1,C17H20N8O2,36656.0
16568,ORG 41841,COc1cccc(-c2nc(SC)nc3sc(C(=O)NC(C)(C)C)c(N)c23)c1,C19H22N4O2S2,37724.0
16569,JNJ-37822681 (hydrochloride),Cl.Cl.Fc1ccc(CN2CCC(Nc3ccc(C(F)(F)F)nn3)CC2)cc1F,C17H19Cl2F5N4,37428.0
16570,8?-hydroxy-?9-THC,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C[C@@H](O)C(C)=C[C@@H]21,C21H30O3,37635.0
16571,8?-hydroxy-?9-THC (exempt preparation),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C[C@@H](O)C(C)=C[C@@H]21,C21H30O3,39794.0
16572,"(5Z,2E)-CU-3",O=C1/C(=C/C=C/c2ccco2)SC(=S)N1NS(=O)(=O)c1ccccc1,C16H12N2O4S3,37770.0
16573,Trotabresib,Cn1cc(-c2cc(S(C)(=O)=O)ccc2OCC2CC2)c2ccccc2c1=O,C21H21NO4S,36292.0
16574,ADB-INACA,CC(C)(C)[C@H](NC(=O)c1n[nH]c2ccccc12)C(N)=O,C14H18N4O2,37729.0
16575,?4(8)-iso-THC,CCCCCc1cc(O)c2c(c1)O[C@]1(C)CCC(=C(C)C)[C@H]2C1,C21H30O2,33863.0
16576,Northebaine,COC1=CC=C2[C@H]3Cc4ccc(OC)c5c4[C@@]2(CCN3)[C@H]1O5,C18H19NO3,37237.0
16577,(R)-Norketamine (hydrochloride),Cl.N[C@@]1(c2ccccc2Cl)CCCCC1=O,C12H15Cl2NO,37821.0
16578,(S)-Norketamine (hydrochloride),Cl.N[C@]1(c2ccccc2Cl)CCCCC1=O,C12H15Cl2NO,37822.0
16579,11-nor-9(S)-carboxy-Hexahydrocannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@H](C(=O)O)C[C@@H]21,C21H30O4,36356.0
16580,11-nor-9(S)-carboxy-Hexahydrocannabinol (CRM),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@H](C(=O)O)C[C@@H]21,C21H30O4,42203.0
16581,CTS-1027,O=C(NO)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1,C19H20ClNO6S,33219.0
16582,"2H,2H,3H,3H-Perfluorooctanoic Acid",O=C(O)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C8H5F11O2,37270.0
16583,AVE-0991,CCNC(=O)NS(=O)(=O)c1sc(CC(C)C)cc1-c1ccc(Cn2c(-c3ccccc3)nc(OC)c2C=O)cc1,C29H32N4O5S2,37837.0
16584,Tolterodine Dimer,Cc1ccc(O)c(C(CCN(CCC(c2ccccc2)c2cc(C)ccc2O)C(C)C)c2ccccc2)c1,C35H41NO2,37389.0
16585,"8,9-Dihydrocannabidiol",CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(C)C)c(O)c1,C21H32O2,36349.0
16586,Perfluorohexanoic Acid,O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C6HF11O2,37249.0
16587,"1,2-Diarachidonoyl-sn-glycero-3-PE",CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC,C45H74NO8P,37531.0
16588,Latanoprost tris(triethylsilyl) ether,CC[Si](CC)(CC)O[C@@H](CCc1ccccc1)CC[C@@H]1[C@@H](C/C=C\CCCC(=O)OC(C)C)[C@@H](O[Si](CC)(CC)CC)C[C@H]1O[Si](CC)(CC)CC,C44H82O5Si3,37396.0
16589,ortho-CBNQ,CCCCCC1=CC2=C(C(=O)C1=O)c1cc(C)ccc1C(C)(C)O2,C21H24O3,37874.0
16590,Cannabinol ethyl,CCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2,C18H20O2,9003767.0
16591,Imidacloprid Impurity 1,O=[N+]([O-])N=C1N(Cc2ccc(Cl)nc2)CCN1Cc1ccc(Cl)nc1,C15H14Cl2N6O2,37382.0
16592,STOML3 Inhibitor OB-1,CCOC(=O)c1c(-c2ccccc2)oc2ccc(Oc3c([N+](=O)[O-])ncn3C)cc12,C21H17N3O6,37584.0
16593,Corynantheidine,CC[C@@H]1CN2CCc3c([nH]c4ccccc34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C22H28N2O3,37859.0
16594,7-Ketositosterol,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C(=O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,C29H48O2,37189.0
16595,LM-10,Fc1ccc2c(/C=C/c3nnn[nH]3)c[nH]c2c1,C11H8FN5,36291.0
16596,Cannabibutol,CCCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2,C20H24O2,29303.0
16597,Oleic Acid-13C5,CCCCCCCC/C=C\[13CH2][13CH2]CCC[13CH2][13CH2][13C](=O)O,C18H34O2,9004089.0
16598,GK241,CCCCCCCCCCCCCCC(=O)C(=O)N[C@H](C(=O)O)C(C)C,C21H39NO4,37689.0
16599,Ethyl Mycophenolate,CCOC(=O)CC/C(C)=C/Cc1c(O)c2c(c(C)c1OC)COC2=O,C19H24O6,35065.0
16600,Rabeprazole Sulfide,COCCCOc1ccnc(CSc2nc3ccccc3[nH]2)c1C,C18H21N3O2S,36276.0
16601,Y-33075 (hydrochloride),C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1.Cl,C16H17ClN4O,36216.0
16602,11-nor-9(R)-carboxy-Hexahydrocannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@@H](C(=O)O)C[C@@H]21,C21H30O4,36355.0
16603,11-nor-9(R)-carboxy-Hexahydrocannabinol (CRM),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@@H](C(=O)O)C[C@@H]21,C21H30O4,41816.0
16604,Mevalonate (lithium salt),CC(O)(CCO)CC(=O)O.[LiH],C6H12LiO4,37476.0
16605,V-125,CCN(c1ccc(C(=O)O)cn1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,C23H30N2O2,37532.0
16606,5-Aminofluorescein,Nc1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21,C20H13NO5,36270.0
16607,CAY10792,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)OCCCn4cc([N+](=O)[O-])nc4Cl)CC[C@]3(C)CC[C@]12C,C35H44ClN3O6,37353.0
16608,iso-AL-LAD (solution),C=CCN1C[C@@H](C(=O)N(CC)CC)C=C2c3cccc4[nH]cc(c34)C[C@H]21,C22H27N3O,37661.0
16609,"1,2-Dielaidoyl-3-Palmitoyl-rac-glycerol",CCCCCCCC/C=C/CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C/CCCCCCCC,C55H102O6,37437.0
16610,BPH-1358,Cl.Cl.O=C(Nc1cccc(C2=NCCN2)c1)c1ccc(-c2ccc(C(=O)Nc3cccc(C4=NCCN4)c3)cc2)cc1,C32H30Cl2N6O2,37402.0
16611,CTPI-2,O=C(O)c1ccccc1NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1,C13H9ClN2O6S,36933.0
16612,"4,6,4'-Trihydroxy-3'-methoxyaurone",COc1cc(/C=C2\Oc3cc(O)cc(O)c3C2=O)ccc1O,C16H12O6,37937.0
16613,Ensitrelvir,Cn1cnc(Cn2c(=O)[nH]/c(=N\c3cc4cn(C)nc4cc3Cl)n(Cc3cc(F)c(F)cc3F)c2=O)n1,C22H17ClF3N9O2,37945.0
16614,AA3-DLin,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCCN1CCN(CCOC(=O)CCCCCCC/C=C\C/C=C\CCCCC)CC1,C44H78N2O4,37903.0
16615,4-acetoxy TMT (iodide),CC(=O)Oc1cccc2[nH]cc(CC[N+](C)(C)C)c12.[I-],C15H21IN2O2,33669.0
16616,DMHCA,C[C@H](CCC(=O)N(C)C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C26H43NO2,37712.0
16617,N-Acetyl-L-phenylalanine,CC(=O)N[C@@H](Cc1ccccc1)C(=O)O,C11H13NO3,36253.0
16618,Cannabihexol,CCCCCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2,C22H28O2,33444.0
16619,Parishin B,O=C(O)CC(O)(CC(=O)OCc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)OCc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,C32H40O19,36296.0
16620,Eleclazine,O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1,C21H16F3N3O3,36227.0
16621,Indole-3-lactic Acid,O=C(O)C(O)Cc1c[nH]c2ccccc12,C11H11NO3,37534.0
16622,"5-(3',4'-Dihydroxyphenyl)-?-Valerolactone",O=C1CCC(Cc2ccc(O)c(O)c2)O1,C11H12O4,36690.0
16623,"1H,1H,2H,2H-Perfluorooctanesulfonic Acid",O=S(=O)(O)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C8H5F13O3S,37260.0
16624,2-Amino-2'-chloro-5-nitrobenzophenone,Nc1ccc([N+](=O)[O-])cc1C(=O)c1ccccc1Cl,C13H9ClN2O3,37885.0
16625,2-Amino-5-nitrobenzophenone,Nc1ccc([N+](=O)[O-])cc1C(=O)c1ccccc1,C13H10N2O3,37876.0
16626,Clotizolam,Cc1nnc2n1-c1sc(Cl)cc1C(c1ccccc1Cl)=NC2,C15H10Cl2N4S,34448.0
16627,8?-hydroxy-exo-THC,C=C1C[C@H]2c3c(O)cc(CCCCC)cc3OC(C)(C)[C@@H]2C[C@H]1O,C21H30O3,37766.0
16628,8?-hydroxy-exo-THC (exempt preparation),C=C1C[C@H]2c3c(O)cc(CCCCC)cc3OC(C)(C)[C@@H]2C[C@H]1O,C21H30O3,39796.0
16629,Flumatinib,Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1,C29H29F3N8O,36226.0
16630,Aeruginascin (CRM),C[N+](C)(C)CCc1c[nH]c2cccc(OP(=O)([O-])O)c12,C13H19N2O4P,37762.0
16631,Cypenamine (hydrochloride),Cl.NC1CCCC1c1ccccc1,C11H16ClN,34111.0
16632,3?-hydroxy-7-oxo-5-Cholestenoic Acid-d3,[2H]C([2H])([2H])C(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C(=O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)O,C27H42O4,29539.0
16633,7-[1-(1H)-Tetrazolylacetamido]desacetoxycephalosporanic Acid,CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cn3cnnn3)[C@H]2SC1,C11H12N6O4S,36228.0
16634,Erbstatin,O=CN/C=C/c1cc(O)ccc1O,C9H9NO3,37706.0
16635,Caerulein (acetate),CC(=O)O.CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,C60H77N13O23S2,24408.0
16636,Perfluorobutanesulfonic Acid,O=S(=O)(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C4HF9O3S,37243.0
16637,Perfluorotridecanoic Acid,O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C13HF25O2,37256.0
16638,BAMEA-O16B,CCCCCCCCCCCCSSCCOC(=O)CCNCCN(C)CCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC,C56H111N3O6S6,37439.0
16639,Dextromethorphan,COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,C18H25NO,11157.0
16640,ARUK3001185,FC(F)(F)c1c(Cl)ccc(-n2ccnn2)c1Cl,C9H4Cl2F3N3,37113.0
16641,COMC,C/C=C/C(=O)OCC1=CCCCC1=O,C11H14O3,37736.0
16642,Nitemazepam,CN1C(=O)C(O)N=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21,C16H13N3O4,37051.0
16643,Perfluorooctanesulfonic Acid,O=S(=O)(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C8HF17O3S,37233.0
16644,Perfluorododecanoic Acid,O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C12HF23O2,37245.0
16645,Heptadecanoyl-L-carnitine (chloride),CCCCCCCCCCCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C24H48ClNO4,37934.0
16646,2-Amino-5-chlorobenzophenone,Nc1ccc(Cl)cc1C(=O)c1ccccc1,C13H10ClNO,37875.0
16647,?8-THCH,CCCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C22H32O2,33392.0
16648,113-O16B,CCCCCCCCCCCCSSCCOC(=O)CCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC,C73H143N3O8S8,37831.0
16649,Minoxidil Sulfate,N=c1cc(N2CCCCC2)nc(N)n1OS(=O)(=O)O,C9H15N5O4S,36084.0
16650,Eicosapentaenoic Acid-d5 ethyl ester,[2H]C([2H])([2H])C([2H])([2H])/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC,C22H34O2,37972.0
16651,Meprobamate,CCCC(C)(COC(N)=O)COC(N)=O,C9H18N2O4,15894.0
16652,2-Amino-2'-fluoro-5-nitrobenzophenone,Nc1ccc([N+](=O)[O-])cc1C(=O)c1ccccc1F,C13H9FN2O3,37887.0
16653,IC8,CCCCCCCCCCCCC(O)CN(CCCN1CCN(CCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CC1)CC(O)CCCCCCCCCCCC,C66H136N4O4,37986.0
16654,Seco Rapamycin (sodium salt),CO[C@@H](C[C@@H]1CC[C@@H](C)[C@](O)(C(=O)C(=O)N2CCCC[C@H]2C(=O)[O-])O1)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)/C=C/[C@H](C)C[C@@H]1CC[C@@H](O)[C@H](OC)C1.[Na+],C51H78NNaO13,16158.0
16655,4-acetoxy NMT (hydrochloride),CNCCc1c[nH]c2cccc(OC(C)=O)c12.Cl,C13H17ClN2O2,36352.0
16656,VK-II-86,COc1ccccc1OCCNCC(O)CCOc1cccc2[nH]c3ccccc3c12,C25H28N2O4,36677.0
16657,Mescaline-d4 (hydrochloride),Cl.[2H]C([2H])(N)C([2H])([2H])c1cc(OC)c(OC)c(OC)c1,C11H18ClNO3,34432.0
16658,Mescaline-d4 (hydrochloride) (CRM),Cl.[2H]C([2H])(N)C([2H])([2H])c1cc(OC)c(OC)c(OC)c1,C11H18ClNO3,38456.0
16659,Ursodeoxycholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H40O4,31016.0
16660,Lipid A6,CCCCCCC#CCCOC(=O)CCCCCCCC(CCCCCCCC(=O)OCCC#CCCCCCC)OC(=O)CCCN(C)C,C43H75NO6,35052.0
16661,PPZ-A10,CCCCCCCCCCN(CCCCCCCCCC)CCC(=O)NCCCN1CCN(CCCNC(=O)CCN(CCCCCCCCCC)CCCCCCCCCC)CC1,C56H114N6O2,9004144.0
16662,Deschloroclotizolam,Cc1nnc2n1-c1sc(Cl)cc1C(c1ccccc1)=NC2,C15H11ClN4S,34449.0
16663,246C10,CCCCCCCCCCC(O)CN(CCCN1CCN(CCCN(CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC)CC1)CC(O)CCCCCCCCCC,C58H120N4O4,37907.0
16664,2-Amino-5-bromo-2'-fluorobenzophenone,Nc1ccc(Br)cc1C(=O)c1ccccc1F,C13H9BrFNO,37936.0
16665,"2,8-Quinolinediol",O=c1ccc2cccc(O)c2[nH]1,C9H7NO2,36376.0
16666,(-)-7-nor-7-carboxy Cannabidiol,C=C(C)[C@@H]1CCC(C(=O)O)=C[C@H]1c1c(O)cc(CCCCC)cc1O,C21H28O4,21637.0
16667,(?)-7-nor-7-carboxy Cannabidiol (CRM),C=C(C)[C@@H]1CCC(C(=O)O)=C[C@H]1c1c(O)cc(CCCCC)cc1O,C21H28O4,41184.0
16668,Docosahexaenoic Acid-d5 ethyl ester,[2H]C([2H])([2H])C([2H])([2H])/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCC,C24H36O2,37971.0
16669,DL-Pyroglutamic Acid,O=C1CCC(C(=O)O)N1,C5H7NO3,36375.0
16670,3-(4-Hydroxyphenyl)lactic Acid,O=C(O)C(O)Cc1ccc(O)cc1,C9H10O4,36367.0
16671,N-acetyl-DL-Tryptophan,CC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O,C13H14N2O3,36399.0
16672,Phentermine,CC(C)(N)Cc1ccccc1,C10H15N,38010.0
16673,"2-Amino-2',5-dichlorobenzophenone",Nc1ccc(Cl)cc1C(=O)c1ccccc1Cl,C13H9Cl2NO,37886.0
16674,Desalkylquazepam,Fc1ccccc1C1=NCC(=S)Nc2ccc(Cl)cc21,C15H10ClFN2S,38119.0
16675,Fmoc-1-Methyl-L-histidine,Cn1cnc(C[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)c1,C22H21N3O4,36312.0
16676,Mirabegron Impurity 6,Nc1ccc(CCNC[C@H](O)c2ccccc2)cc1,C16H20N2O,36315.0
16677,Tetrahydrocannabivarin Acetate,CCCc1cc(OC(C)=O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C21H28O3,37958.0
16678,Tetrahydrocannabivarin Acetate (exempt preparation),CCCc1cc(OC(C)=O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C21H28O3,39444.0
16679,?8-THCQ,CCCCCC1=CC(=O)C2=C(OC(C)(C)[C@@H]3CC=C(C)C[C@@H]23)C1=O,C21H28O3,30844.0
16680,"2,3-Diaminonaphthalene",Nc1cc2ccccc2cc1N,C10H10N2,36265.0
16681,NIBR17,COc1ccc(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)cn1,C18H20N8O2,37312.0
16682,Ketanserin,O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,C22H22FN3O3,37984.0
16683,MKC8866,COc1cc2c(C)c(CC(=O)N3CCOCC3)c(=O)oc2c(C=O)c1O,C18H19NO7,37332.0
16684,5Br-INACA,NC(=O)c1n[nH]c2ccc(Br)cc12,C8H6BrN3O,37881.0
16685,N-acetyl-2-Aminophenol,CC(=O)Nc1ccccc1O,C8H9NO2,35829.0
16686,2-Amino-5-bromobenzophenone,Nc1ccc(Br)cc1C(=O)c1ccccc1,C13H10BrNO,37935.0
16687,LNP023 (hydrochloride),CCO[C@H]1CCN(Cc2c(OC)cc(C)c3[nH]ccc23)[C@H](c2ccc(C(=O)O)cc2)C1.Cl,C25H31ClN2O4,37291.0
16688,VAF347,FC(F)(F)c1ccc(Nc2nccc(-c3cccc(Cl)c3)n2)cc1,C17H11ClF3N3,37328.0
16689,1-(2-Amino-3-hydroxyphenyl)ethanone,CC(=O)c1cccc(O)c1N,C8H9NO2,36416.0
16690,2'-O-Methyluridine,CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O,C10H14N2O6,36520.0
16691,Allolithocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H40O3,38158.0
16692,FSEN1,COc1ccc(N2CCN(Cc3cn4c(-c5ccc(Br)cc5)nnc4s3)CC2)cc1,C22H22BrN5OS,38025.0
16693,CAY10795,Cn1ccc2cc(-c3cnc4ccc(C(=O)N5CCCCC5)cc4n3)ccc2c1=O,C24H22N4O2,37981.0
16694,WHI-P97,COc1cc2ncnc(Nc3cc(Br)c(O)c(Br)c3)c2cc1OC,C16H13Br2N3O3,36385.0
16695,Methylprotodioscin,CO[C@]1(CC[C@@H](C)CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@H]2C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2[C@@H]1C,C52H86O22,36344.0
16696,2-Methoxy-4-vinylphenol,C=Cc1ccc(O)c(OC)c1,C9H10O2,36427.0
16697,3-(3-Hydroxyphenyl)propanoic Acid,O=C(O)CCc1cccc(O)c1,C9H10O3,36268.0
16698,AM0902,Cn1cnc2ncn(Cc3nc(CCc4ccc(Cl)cc4)no3)c(=O)c21,C17H15ClN6O2,37290.0
16699,Rhyncophylline,CC[C@H]1CN2CC[C@]3(C(=O)Nc4ccccc43)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C22H28N2O4,37946.0
16700,CA77.1,CC(=O)Nc1ccc(-c2cnc3cc(Cl)ccc3n2)cc1,C16H12ClN3O,37300.0
16701,TT3,CCCCCCCCCCCCN(CCCCCCCCCCCC)CCCNC(=O)c1cc(C(=O)NCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC)cc(C(=O)NCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC)c1,C90H174N6O3,37909.0
16702,Bequinostatin C,CCCCCc1cc2ccc3c(O)c4c(cc3c2c(O)c1C(=O)O)C(=O)c1cc(O)cc(O)c1C4=O,C28H22O8,37773.0
16703,98N12-5,CCCCCCCCCCCCNC(=O)CCN(CCNCCN(CCC(=O)NCCCCCCCCCCCC)CCN(CCC(=O)NCCCCCCCCCCCC)CCC(=O)NCCCCCCCCCCCC)CCC(=O)NCCCCCCCCCCCC,C81H163N9O5,37651.0
16704,Bequinostatin A,CCCCCc1cc2c(c(O)c1C(=O)O)-c1cc3c(c(O)c1C(O)C2)C(=O)c1c(O)cc(O)cc1C3=O,C28H24O9,37772.0
16705,Pyrimorph,CC(C)(C)c1ccc(C(=CC(=O)N2CCOCC2)c2ccnc(Cl)c2)cc1,C22H25ClN2O2,37286.0
16706,6-epi COTC,C/C=C/C(=O)OCC1=C[C@@H](O)[C@@H](O)[C@H](O)C1=O,C11H14O6,37746.0
16707,SI-113,OCCNc1nc(NCCc2ccccc2)c2cnn(C=Cc3ccccc3)c2n1,C23H24N6O,37384.0
16708,2-(N-Ethylperfluorooctanesulfonamido)acetic Acid,CCN(CC(=O)O)S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C12H8F17NO4S,37363.0
16709,Fluostatin B,CC1C(=O)c2cc(O)c3c(c2C(O)C1O)C(=O)c1cccc(O)c1-3,C18H14O6,37771.0
16710,CRT0273750,C[C@H](NC(=O)CCc1nc2cccnc2n1Cc1ccc(OC(F)(F)F)cc1)c1ccc(Cl)cc1,C25H22ClF3N4O2,20904.0
16711,Creatine Phosphate,CN(CC(=O)O)C(=N)NP(=O)(O)O,C4H10N3O5P,35598.0
16712,M1001,O=S1(=O)N=C(Nc2ccccc2N2CCCC2)c2ccccc21,C17H17N3O2S,37393.0
16713,ETP-46321,CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1,C20H27N9O3S,37330.0
16714,Tomatine,C[C@H]1CC[C@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C50H83NO21,16024.0
16715,MPO-IN-28,COc1ccc2c(C)nc(NC(=N)N)nc2c1,C11H13N5O,37192.0
16716,Pimpinellin,COc1c(OC)c2occc2c2oc(=O)ccc12,C13H10O5,36274.0
16717,SKLB23bb,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1OCCCC(=O)NO,C21H24N4O4,37242.0
16718,Celgosivir,CCCC(=O)O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O,C12H21NO5,36526.0
16719,CFMTI,Cc1c(-c2ccc3c(c2)CN(C2CC2)C3=O)nnn1-c1cccnc1F,C19H16FN5O,37546.0
16720,UC2288,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cn2)CC1,C20H18ClF6N3O2,37380.0
16721,ICEC0942 (hydrochloride),CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12.Cl,C22H31ClN6O,30997.0
16722,L-Lysine (hydrochloride),Cl.NCCCC[C@H](N)C(=O)O,C6H15ClN2O2,36455.0
16723,5-methyl-2'-O-Methylcytidine,CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cc(C)c(N)nc1=O,C11H17N3O5,37908.0
16724,RO9021,Cc1ccc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)nc1C,C18H25N7O,37543.0
16725,p-Carboxyphenyl Sulfate,O=C(O)c1ccc(OS(=O)(=O)O)cc1,C7H6O6S,9004155.0
16726,ER-819762,CCN1C(=O)N2Cc3cc(OC)cc(OC)c3[C@@H](C)C=C2C12CCN(Cc1cc(C)cc(C)c1)CC2,C30H39N3O3,10531.0
16727,"PtdIns-(5)-P1 (1,2-dihexanoyl) (sodium salt)",CCCCCC(=O)OC[C@H](COP(=O)([O-])O[C@H]1[C@H](O)[C@@H](OP(=O)([O-])O)[C@H](O)[C@@H](O)[C@H]1O)OC(=O)CCCCC.[Na+].[Na+],C21H38Na2O16P2,10008050.0
16728,2-Methylglutaric Acid,CC(CCC(=O)O)C(=O)O,C6H10O4,36440.0
16729,2-Hydroxyisocaproic Acid,CC(C)CC(O)C(=O)O,C6H12O3,36439.0
16730,MBQ-167,CCn1c2ccccc2c2cc(-n3nncc3-c3ccccc3)ccc21,C22H18N4,35437.0
16731,KIN101,CS(=O)(=O)Oc1ccc2c(=O)c(-c3ccc(Br)cc3)coc2c1,C16H11BrO5S,37429.0
16732,Eosin Y (sodium salt),O=C1OC2(c3ccccc31)c1cc(Br)c([O-])c(Br)c1Oc1c2cc(Br)c([O-])c1Br.[Na+].[Na+],C20H6Br4Na2O5,36335.0
16733,Bongkrekic Acid,CO[C@H](C/C=C\C=C\CC/C=C/C[C@H](C)/C=C/C(=C\C(=O)O)CC(=O)O)/C(C)=C\C=C(/C)C(=O)O,C28H38O7,38230.0
16734,TMB,Cc1cc(-c2cc(C)c(N)c(C)c2)cc(C)c1N,C16H20N2,36361.0
16735,L-Pipecolic Acid,O=C(O)[C@@H]1CCCCN1,C6H11NO2,36313.0
16736,ERX-41,CC(C)COc1cc(C(=O)Nc2ccc(C(=O)N[C@H]3CC[C@H](C)CC3)cc2OCC(C)C)ccc1NC(=O)c1ccc([N+](=O)[O-])c(OCCO)c1,C38H48N4O9,37726.0
16737,OF-C4-Deg-Lin,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCCCCN(CCCCOC(=O)CCCCCCC/C=C\C/C=C\CCCCC)CCCCC1NC(=O)C(CCCCN(CCCCOC(=O)CCCCCCC/C=C\C/C=C\CCCCC)CCCCOC(=O)CCCCCCC/C=C\C/C=C\CCCCC)NC1=O,C100H176N4O10,37856.0
16738,DUBs-IN-2,CCON=C1c2ccccc2-c2nc(C#N)c(C#N)nc21,C15H9N5O,36229.0
16739,Q203,CCc1nc2ccc(Cl)cn2c1C(=O)NCc1ccc(N2CCC(c3ccc(OC(F)(F)F)cc3)CC2)cc1,C29H28ClF3N4O2,37323.0
16740,Pafuramidine,CONC(=N)c1ccc(-c2ccc(-c3ccc(C(=N)NOC)cc3)o2)cc1,C20H20N4O3,36669.0
16741,"3?,7?-Dihydroxycholest-5-enoic Acid-d3",[2H]C([2H])([2H])C(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)O,C27H44O4,29538.0
16742,Diphenylterazine,O=c1c(Cc2ccccc2)nc2c(-c3ccccc3)[nH]c(-c3ccccc3)cn1-2,C25H19N3O,37334.0
16743,TRC051384,O=C(NCCN1CCOCC1)Nc1ccc(C(=O)/C=C/c2cccc(N3CCOCC3)n2)cc1,C25H31N5O4,29199.0
16744,3-Phenyllactic Acid,O=C(O)C(O)Cc1ccccc1,C9H10O3,36365.0
16745,4-Methylcatechol,Cc1ccc(O)c(O)c1,C7H8O2,36429.0
16746,cis-9-Heptadecenoic Acid,CCCCCCC/C=C\CCCCCCCC(=O)O,C17H32O2,36254.0
16747,"1,2-Dioleoyl-3(S)-trimethylammoniumpropane (chloride)",CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](C[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC.[Cl-],C42H80ClNO4,38195.0
16748,JWH 181,CCCCCn1c(C)c(C(=O)c2ccc(CCC)c3ccccc23)c2ccccc21,C28H31NO,38120.0
16749,Palmitic Acid-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)O,C16H32O2,37061.0
16750,Ehp Inhibitor-2,Nc1c(-c2cccc(O)c2)cnc2c(-c3cccnc3)cnn12,C17H13N5O,37582.0
16751,Dihydrothymine,CC1CNC(=O)NC1=O,C5H8N2O2,37187.0
16752,"2,3,7,8-Tetrachlorodibenzo-p-dioxin",Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2,C12H4Cl4O2,38392.0
16753,2'-Hydroxyacetophenone,CC(=O)c1ccccc1O,C8H8O2,37418.0
16754,5-(3-Aminoallyl)-2'-deoxyuridine-5'-O-triphosphate (sodium salt),NC/C=C/c1cn([C@H]2C[C@H](O)[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O2)c(=O)[nH]c1=O.[Na+].[Na+].[Na+].[Na+],C12H16N3Na4O14P3,38361.0
16755,Hinokiflavone,O=c1cc(-c2ccc(Oc3c(O)cc4oc(-c5ccc(O)cc5)cc(=O)c4c3O)cc2)oc2cc(O)cc(O)c12,C30H18O10,36338.0
16756,FIDAS-3,CN(C)c1ccc(/C=C/c2c(F)cccc2F)cc1,C16H15F2N,37716.0
16757,11-hydroxy-9(S)-Hexahydrocannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@H](CO)C[C@@H]21,C21H32O3,36354.0
16758,5-Ph-IAA,O=C(O)Cc1c[nH]c2ccc(-c3ccccc3)cc12,C16H13NO2,38161.0
16759,2-Amino-5-chloro-2'-fluorobenzophenone,Nc1ccc(Cl)cc1C(=O)c1ccccc1F,C13H9ClFNO,37939.0
16760,Verdiperstat,CC(C)OCCn1c(=S)[nH]c(=O)c2[nH]ccc21,C11H15N3O2S,37333.0
16761,Adenosine 5'-methylenediphosphate (sodium salt),Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])CP(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+],C11H14N5Na3O9P2,38359.0
16762,10?-hydroxy-?8-THC,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)[C@H](O)[C@@H]21,C21H30O3,38022.0
16763,Syrosingopine,CCOC(=O)Oc1c(OC)cc(C(=O)O[C@@H]2C[C@@H]3CN4CCc5c([nH]c6cc(OC)ccc56)[C@H]4C[C@@H]3[C@H](C(=O)OC)[C@H]2OC)cc1OC,C35H42N2O11,36402.0
16764,10?-hydroxy-exo-THC,C=C1CC[C@@H]2[C@H](c3c(O)cc(CCCCC)cc3OC2(C)C)[C@H]1O,C21H30O3,38020.0
16765,10074-A4,O=C1CSC(=O)N1CC(O)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21,C18H14Cl2N2O3S,37486.0
16766,Cyazofamid,Cc1ccc(-c2c(Cl)nc(C#N)n2S(=O)(=O)N(C)C)cc1,C13H13ClN4O2S,24044.0
16767,L-Methionine Sulfoxide,CS(=O)CC[C@H](N)C(=O)O,C5H11NO3S,36255.0
16768,Carbaethopendecine (bromide),CCCCCCCCCCCCCCC(C(=O)OCC)[N+](C)(C)C.[Br-],C21H44BrNO2,37482.0
16769,11-hydroxy-9(R)-Hexahydrocannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@@H](CO)C[C@@H]21,C21H32O3,36353.0
16770,Hispidol,O=C1/C(=C/c2ccc(O)cc2)Oc2cc(O)ccc21,C15H10O4,37373.0
16771,1-Stearoyl-2-Oleoyl-sn-glycero-3-PC,CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C44H86NO8P,37967.0
16772,"6',7'-epoxy Cannabigerol",CCCCCc1cc(O)c(C/C=C(\C)CCC2OC2(C)C)c(O)c1,C21H32O3,37967.0
16773,N-propyl Buphedrone (hydrochloride),CCCNC(CC)C(=O)c1ccccc1.Cl,C13H20ClNO,38240.0
16774,Ciclotizolam,Clc1ccccc1C1=NCc2nnc(C3CCCCC3)n2-c2sc(Br)cc21,C20H18BrClN4S,37999.0
16775,KDM4D-IN-1,Cc1nn2c([nH]c(=O)c3cccnc32)c1C#N,C11H7N5O,37431.0
16776,Norpsilocin-d4,[2H]C([2H])(NC)C([2H])([2H])c1c[nH]c2cccc(O)c12,C11H14N2O,37127.0
16777,Norpsilocin-d4 (CRM),[2H]C([2H])(NC)C([2H])([2H])c1c[nH]c2cccc(O)c12,C11H14N2O,41287.0
16778,2-Methylthioadenosine triphosphate (sodium salt),CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])[C@@H](O)[C@H]3O)c2n1.[Na+].[Na+].[Na+].[Na+],C11H14N5Na4O13P3S,21418.0
16779,(2-Amino-5-bromophenyl)(pyridin-2-yl)methanone,Nc1ccc(Br)cc1C(=O)c1ccccn1,C12H9BrN2O,37940.0
16780,4-fluoro AB-BUTINACA,CC(C)[C@H](NC(=O)c1nn(CCCCF)c2ccccc12)C(N)=O,C17H23FN4O2,37657.0
16781,?8-Tetrahydrocannabiorcol,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C)cc1OC2(C)C,C17H22O2,33762.0
16782,AZD 1390,CC(C)n1c(=O)n(C)c2cnc3cc(F)c(-c4ccc(OCCCN5CCCCC5)nc4)cc3c21,C27H32FN5O2,36498.0
16783,Salvinorin A (CRM),COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@H](c3ccoc3)C[C@]21C,C23H28O8,38208.0
16784,NS 13001,Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1,C17H16ClN7,37317.0
16785,"2,3,7,8-Tetrachlorodibenzofuran",Clc1cc2oc3cc(Cl)c(Cl)cc3c2cc1Cl,C12H4Cl4O,38393.0
16786,1-Stearoyl-2-Oleoyl-sn-glycero-3-PE,CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C41H80NO8P,38153.0
16787,4-(2-Acetoxyacetyl)phenyl acetate,CC(=O)OCC(=O)c1ccc(OC(C)=O)cc1,C12H12O5,37888.0
16788,3-hydroxy Flubromazepam,O=C1Nc2ccc(Br)cc2C(c2ccccc2F)=NC1O,C15H10BrFN2O2,37849.0
16789,LOC1886,COc1cccc2[nH]c(C(=O)n3ccnc3)cc12,C13H11N3O2,38026.0
16790,Propylparaben,CCCOC(=O)c1ccc(O)cc1,C10H12O3,37417.0
16791,?8-THC-ethyl,CCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C18H24O2,37954.0
16792,Cyano-myracrylamide,C=CC(=O)N(CC#N)CCCCCCCCCCCCCC,C19H34N2O,35155.0
16793,N-Methylphenethylamine (hydrochloride),CNCCc1ccccc1.Cl,C9H14ClN,38261.0
16794,Galanthamine N-oxide,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CC[N@@+](C)([O-])C2,C17H21NO4,35413.0
16795,Ermanin,COc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2OC)cc1,C17H14O6,37535.0
16796,Lormetazepam,CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21,C16H12Cl2N2O2,21989.0
16797,5-Formyluracil,O=Cc1c[nH]c(=O)[nH]c1=O,C5H4N2O3,36523.0
16798,5-Bromopentanoic Acid-d4,[2H]C([2H])(CBr)C([2H])([2H])CC(=O)O,C5H9BrO2,30913.0
16799,JK-P3,COc1ccc(C(=O)Nc2cc(-c3ccccc3)[nH]n2)cc1OC,C18H17N3O3,37555.0
16800,FL-411,Cc1cc(-c2nc(=O)c3c4c(sc3[nH]2)CN(C)CC4)cc(C)c1O,C18H19N3O2S,37547.0
16801,FTI-276 (trifluoroacetate salt),CSCC[C@H](NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1)C(=O)O.O=C(O)C(F)(F)F,C23H28F3N3O5S2,10011661.0
16802,Nandrolone Phenylpropionate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2OC(=O)CCc1ccccc1,C27H34O3,9002212.0
16803,"2',3'-Dideoxyadenosine-5'-O-triphosphate (sodium salt)",Nc1ncnc2c1ncn2[C@H]1CC[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O1.[Na+].[Na+].[Na+].[Na+],C10H12N5Na4O11P3,38373.0
16804,BAY-218,C[C@@H](CO)NC(=O)c1cc(-c2ccc(Cl)cc2)nn(-c2cccc(F)c2)c1=O,C20H17ClFN3O3,37583.0
16805,Methylsuccinic Acid,CC(CC(=O)O)C(=O)O,C5H8O4,36430.0
16806,CK1-IN-1,Fc1ccc(-c2nc(-c3ccc4ccccc4c3F)[nH]c2-c2ccncc2)cc1,C24H15F2N3,37313.0
16807,Delgocitinib,C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2,C16H18N6O,38307.0
16808,CID-44216842,COc1cccc(C2=NN(c3ccc(S(N)(=O)=O)cc3)C(c3ccc(Br)cc3)C2)c1,C22H20BrN3O3S,37775.0
16809,Nicotinic Acid,O=C(O)c1cccnc1,C6H5NO2,37416.0
16810,VU0134992 (hydrochloride),CC(C)c1ccc(OCC(=O)NC2CC(C)(C)NC(C)(C)C2)c(Br)c1.Cl,C20H32BrClN2O2,37299.0
16811,E6446 (hydrochloride),Cl.Cl.c1cc(-c2nc3ccc(OCCCN4CCCC4)cc3o2)ccc1OCCCN1CCCC1,C27H37Cl2N3O3,37296.0
16812,Ethylene Oxide Residual Solvent (CRM),C1CO1,C2H4O,38277.0
16813,"3,4-Dihydroxymandelic Acid",O=C(O)C(O)c1ccc(O)c(O)c1,C8H8O5,36369.0
16814,Kisspeptin-234 (trifluoroacetate salt),CC(=O)N[C@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O.O=C(O)C(F)(F)F,C63H78N18O13(C2HF3O2)X,35633.0
16815,4-Acetylphenol,CC(=O)c1ccc(O)cc1,C8H8O2,35636.0
16816,4-hydroxy DALT,C=CCN(CC=C)CCc1c[nH]c2cccc(O)c12,C16H20N2O,34789.0
16817,Furosine (hydrochloride),Cl.Cl.N[C@@H](CCCCNCC(=O)c1ccco1)C(=O)O,C12H20Cl2N2O4,38527.0
16818,7?-Hydroxy-3-oxocholest-4-enoic Acid-d3,[2H]C([2H])([2H])C(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)CC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)O,C27H42O4,29537.0
16819,2'-deoxy NAD+ (sodium salt),NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3O)[C@@H](O)[C@H]2O)c1.[Na+],C21H26N7NaO13P2,38386.0
16820,"1,4-DPCA ethyl ester",CCOC(=O)c1c[nH]c2c(ccc3cccnc32)c1=O,C15H12N2O3,38334.0
16821,Metapristone,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(NC)cc3)C[C@@]21C,C28H33NO2,36380.0
16822,HCKFWW (trifluoroacetate salt),C=CC(=O)N1CC2(CC(n3nc(-c4ccc5c(cnn5C)c4)c(-c4c(Cl)c(C)cc5[nH]ncc45)c3C)C2)C1,C29H28ClN7O,38157.0
16823,Necrostatin-34,Cc1ccc(C2CC(=O)NC(SCC(=O)Nc3nccs3)=C2C#N)cc1,C18H16N4O2S2,37735.0
16824,1-Palmitoyl-2-Pyropheophorbide a-sn-glycero-3-PC,C=Cc1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C)[C@@H]3C,C57H82N5O9P,38430.0
16825,LP-935509,COc1ncccc1-c1cnn2ccc(N3CCN(C(=O)OC(C)C)CC3)nc12,C20H24N6O3,37283.0
16826,TDI-10229,Cc1c(Cc2ccccc2)c(-c2cc(Cl)nc(N)n2)nn1C,C16H16ClN5,37674.0
16827,MF094,CC(C)(C)NS(=O)(=O)c1cccc2c(NC(=O)[C@H](Cc3ccccc3)NC(=O)C3CCCCC3)cccc12,C30H37N3O4S,37774.0
16828,Phenylacetylglycine,O=C(O)CNC(=O)Cc1ccccc1,C10H11NO3,36368.0
16829,DRB18,Cc1ccc(CNc2ccc(Cl)cc2NCc2ccc(C)c(O)c2)cc1O,C22H23ClN2O2,38217.0
16830,"2',3'-cyclic NADP+ (sodium salt)",NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@@H]4OP(=O)([O-])O[C@@H]43)[C@@H](O)[C@H]2O)c1.[Na+].[Na+],C21H24N7Na2O16P3,38388.0
16831,Lentztrehalose B,CC(C)=CCO[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@@H]1CO,C17H30O11,37733.0
16832,SGC-SMARCA-BRDVIII,CC(C)(C)OC(=O)N1CCN(c2cc(-c3ccccc3O)nnc2N)CC1,C19H25N5O3,33567.0
16833,Chroman 1,COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCN(C)C)CO2,C24H28N4O4,38248.0
16834,Salvinorin B ethoxymethyl ether,CCOCO[C@H]1C[C@@H](C(=O)OC)[C@]2(C)CC[C@H]3C(=O)O[C@H](c4ccoc4)C[C@]3(C)[C@H]2C1=O,C24H32O8,38171.0
16835,DL-Tyrosine,NC(Cc1ccc(O)cc1)C(=O)O,C9H11NO3,36460.0
16836,ML-198,C#Cc1ccc(NC(=O)c2cnn3c(C)cc(C)nc23)cc1,C17H14N4O,37755.0
16837,"MDMB-INACA 3,3-dimethylbutanoic acid metabolite",CC(C)(C)[C@H](NC(=O)c1n[nH]c2ccccc12)C(=O)O,C14H17N3O3,38151.0
16838,Methyl Mycophenolate,COC(=O)CC/C(C)=C/Cc1c(O)c2c(c(C)c1OC)COC2=O,C18H22O6,38397.0
16839,Undecanedioic Acid,O=C(O)CCCCCCCCCC(=O)O,C11H20O4,36465.0
16840,Lentztrehalose A,CC(C)(O)[C@@H](O)CO[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@@H]1CO,C17H32O13,37732.0
16841,CFM 4,O=C1N(Cc2ccccc2Cl)c2ccccc2C12NN=C(c1ccccc1)S2,C22H16ClN3OS,36780.0
16842,"2,3,4,7,8-Pentachlorodibenzofuran",Clc1cc2oc3c(Cl)c(Cl)c(Cl)cc3c2cc1Cl,C12H3Cl5O,38626.0
16843,"17?-Estradiol-2,4,16,16-d4 3-sulfate (sodium salt)",[2H]c1cc2c(c([2H])c1OS(=O)(=O)[O-])CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC([2H])([2H])[C@@H]2O.[Na+],C18H23NaO5S,38627.0
16844,JNJ-10229570,COc1ccccc1-c1nc(=Nc2ccccc2)sn1-c1ccccc1OC,C22H19N3O2S,37768.0
16845,Sulfuretin,O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)ccc21,C15H10O5,36569.0
16846,"2,3,4,6,7,8-Hexachlorodibenzofuran",Clc1cc2c(oc3c(Cl)c(Cl)c(Cl)cc32)c(Cl)c1Cl,C12H2Cl6O,38623.0
16847,"1,2,3,7,8-Pentachlorodibenzofuran",Clc1cc2oc3cc(Cl)c(Cl)c(Cl)c3c2cc1Cl,C12H3Cl5O,38625.0
16848,Fz25,C[C@]12CC[C@@H]3c4ccc(OCc5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@]2(O)c1cnn[nH]1,C27H31N3O2,37752.0
16849,DL-Dapoxetine (hydrochloride),CN(C)C(CCOc1cccc2ccccc12)c1ccccc1.Cl,C21H24ClNO,37915.0
16850,NEDD8 Inhibitor M22,Clc1ccc(CCNC2CCN(Cc3ccccc3)CC2)c(Cl)c1,C20H24Cl2N2,37756.0
16851,Photoclick Cholesterol,C#CCCCCOC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC4(N=N4)[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C30H46N2O3,24528.0
16852,GNE-618,O=C(NCc1ccc(S(=O)(=O)c2cccc(C(F)(F)F)c2)cc1)c1cnc2[nH]ncc2c1,C21H15F3N4O3S,37223.0
16853,ZM 522,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)c6ccc(F)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C37H51FO4,37904.0
16854,ACBI1,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)c(OCCOc2ccc(CN3CCN(c4cc(-c5ccccc5O)nnc4N)CC3)cc2)c1,C49H58FN9O7S,36612.0
16855,"1,2,3,4,7,8-Hexachlorodibenzofuran",Clc1cc2oc3c(Cl)c(Cl)c(Cl)c(Cl)c3c2cc1Cl,C12H2Cl6O,38619.0
16856,5-Dibromomethyl Anastrozole,CC(C)(C#N)c1cc(C(Br)Br)cc(C(C)(C)C#N)c1,C15H16Br2N2,36024.0
16857,Triciribine Phosphate,CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23,C13H17N6O7P,37985.0
16858,Ethyl HDFP,CCCCCCCCCCCCCCCCP(=O)(F)OCC,C18H38FO2P,38209.0
16859,Trilaciclib (hydrochloride),CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1.Cl.Cl,C24H32Cl2N8O,37297.0
16860,CaMKII-IN-1,Cc1c(Cl)cccc1S(=O)(=O)Nc1nc(NCCc2ccccc2)nc2c1CN(Cc1ccccc1)CC2,C29H30ClN5O2S,37303.0
16861,2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone,CC(C)(O)C(=O)c1ccc(OCCO)cc1,C12H16O4,36428.0
16862,PGS-IN-1,CC(C)(C)c1cc(/C=C2\CCOC2=O)cc(C(C)(C)C)c1O,C19H26O3,37666.0
16863,GL67,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)N(CCCN)CCCCNCCCN)CC[C@]4(C)[C@H]3CC[C@]12C,C38H70N4O2,34371.0
16864,Chlorazanil (hydrochloride),Cl.Nc1ncnc(Nc2ccc(Cl)cc2)n1,C9H9Cl2N5,37238.0
16865,3-hydroxy Xylazine,Cc1ccc(O)c(C)c1NC1=NCCCS1,C12H16N2OS,38354.0
16866,DOG-IM4,CCCCCCCC/C=C\CCCCCCCCOCC(COCCOCCOCCOCCNC(=O)c1c[nH]cn1)OCCCCCCCC/C=C\CCCCCCCC,C51H95N3O7,37441.0
16867,"1,2,3,4,6,7,8-Heptachlorodibenzofuran",Clc1cc2c(oc3c(Cl)c(Cl)c(Cl)c(Cl)c32)c(Cl)c1Cl,C12HCl7O,38617.0
16868,"1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin",Clc1cc2c(c(Cl)c1Cl)Oc1c(cc(Cl)c(Cl)c1Cl)O2,C12H2Cl6O2,38596.0
16869,"1,2,3,6,7,8-Hexachlorodibenzofuran",Clc1cc2c(oc3cc(Cl)c(Cl)c(Cl)c32)c(Cl)c1Cl,C12H2Cl6O,38621.0
16870,Lipid 14,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCCCN(CCCCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCOC(=O)CCCN(C)C,C56H110N2O6,38589.0
16871,Cordysinin C/D,CC(O)c1nccc2c1[nH]c1ccccc12,C13H12N2O,38207.0
16872,ODM-207,COc1cc2c(cc1-c1c(C)noc1C)cc(C)c(=O)n2Cc1ccccn1,C22H21N3O3,37757.0
16873,8(R)-hydroxy-9(S)-Hexahydrocannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C[C@@H](O)[C@@H](C)C[C@@H]21,C21H32O3,36251.0
16874,Bergaptol,O=c1ccc2c(O)c3ccoc3cc2o1,C11H6O4,38742.0
16875,SAR125844,O=C(NCCN1CCOCC1)Nc1nc2ccc(Sc3nnc4ccc(-c5ccc(F)cc5)nn34)cc2s1,C25H23FN8O2S2,37542.0
16876,3'-Deoxyuridine,O=c1ccn([C@@H]2O[C@H](CO)C[C@H]2O)c(=O)[nH]1,C9H12N2O5,36547.0
16877,Cho-es-Lys,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)OCCCCCCOC(=O)[C@@H]([NH3+])CCCC[NH3+])CC[C@]4(C)[C@H]3CC[C@]12C.O=C([O-])C(F)(F)F.O=C([O-])C(F)(F)F,C44H72F6N2O9,37337.0
16878,1P-MiPLA (solution),CCC(=O)n1cc2c3c(cccc31)C1=C[C@@H](C(=O)N(C)C(C)C)CN(C)[C@@H]1C2,C23H29N3O2,38498.0
16879,Fasoracetam,O=C1CC[C@H](C(=O)N2CCCCC2)N1,C10H16N2O2,37239.0
16880,C13-112-tetra-tail,CCCCCCCCCCCC(O)CN(CCOCCOCCN(CC(O)CCCCCCCCCCC)CC(O)CCCCCCCCCCC)CC(O)CCCCCCCCCCC,C58H120N2O6,38329.0
16881,"1,2,3,4,7,8,9-Heptachlorodibenzofuran",Clc1cc2oc3c(Cl)c(Cl)c(Cl)c(Cl)c3c2c(Cl)c1Cl,C12HCl7O,38618.0
16882,C-87,O=C1/C(=N/Nc2ccc(Cl)c([N+](=O)[O-])c2)C(c2ccccc2)=NN1c1nc(-c2ccccc2)cs1,C24H15ClN6O3S,36578.0
16883,Salcaprozate (sodium salt),O=C([O-])CCCCCCCNC(=O)c1ccccc1O.[Na+],C15H20NNaO4,36505.0
16884,STING Agonist 23,O=C(NCCCCCNC(=O)c1ccc([N+](=O)[O-])o1)c1ccc([N+](=O)[O-])o1,C15H16N4O8,38345.0
16885,"1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin",Clc1cc2c(c(Cl)c1Cl)Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1O2,C12HCl7O2,38597.0
16886,Moperone,Cc1ccc(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1,C22H26FNO2,21968.0
16887,10(R)-hydroxy-9(S)-Hexahydrocannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@H](C)[C@@H](O)[C@@H]21,C21H32O3,38272.0
16888,"1,2-Dimyristoyl-3-dimethylammonium-propane",CCCCCCCCCCCCCC(=O)OCC(CN(C)C)OC(=O)CCCCCCCCCCCCC,C33H65NO4,38310.0
16889,L202,CCCCCCCCCCC(CCCCCCCCC(=O)OCCC(CCCCC)CCCCC)COC(=O)C1CCN(C)CC1,C41H79NO4,37841.0
16890,Lipid CL1,CCCCC/C=C\CCCC(CCC/C=C\CCCCC)C(CCC/C=C\CCCCC)OC(=O)CCCCN(C)C,C39H73NO2,38320.0
16891,"N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid methyl ester",COC(=O)C1=C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O1,C12H19NO8,36529.0
16892,Poloppin,O=C(O)CCc1ccc(-c2ccc(Br)cc2)n1-c1ccccc1C(F)(F)F,C20H15BrF3NO2,38330.0
16893,AMG 458,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1,C30H29N5O5,36213.0
16894,NSC 232003,CC(NO)=C1C=NC(=O)NC1=O,C6H7N3O3,38523.0
16895,Corey Lactone Benzoate,O=C1C[C@@H]2[C@@H](CO)[C@H](OC(=O)c3ccccc3)C[C@@H]2O1,C15H16O5,10007983.0
16896,"1,2,3,7,8-Pentachlorodibenzo-p-dioxin",Clc1cc2c(cc1Cl)Oc1c(cc(Cl)c(Cl)c1Cl)O2,C12H3Cl5O2,38599.0
16897,EIDD-2749,O=c1ccn([C@@H]2O[C@](F)(CO)[C@@H](O)[C@H]2O)c(=O)[nH]1,C9H11FN2O6,38249.0
16898,"1,2-Dipalmitoyl-3-dimethylammonium-propane",CCCCCCCCCCCCCCCC(=O)OCC(CN(C)C)OC(=O)CCCCCCCCCCCCCCC,C37H73NO4,38311.0
16899,10(S)-hydroxy-9(R)-Hexahydrocannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@@H](C)[C@H](O)[C@@H]21,C21H32O3,38273.0
16900,9-keto Tafluprost,CC(C)OC(=O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/C(F)(F)COc1ccccc1,C25H32F2O5,9000349.0
16901,Thymine,Cc1c[nH]c(=O)[nH]c1=O,C5H6N2O2,38749.0
16902,N8-Acetylspermidine (hydrochloride),CC(=O)NCCCCNCCCN.Cl.Cl,C9H23Cl2N3O,37434.0
16903,Melengestrol Acetate,C=C1C[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@@]1(OC(C)=O)C(C)=O,C25H32O4,35471.0
16904,"3,5-Diiodo-L-tyrosine",N[C@@H](Cc1cc(I)c(O)c(I)c1)C(=O)O,C9H9I2NO3,36266.0
16905,Amphotericin B methyl ester,COC(=O)[C@H]1[C@@H]2C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@@H]1O)O2,C48H75NO17,36342.0
16906,"4,5-Desisopropylidene Topiramate",CC1(C)O[C@H]2[C@H](O)[C@H](O)CO[C@@]2(COS(N)(=O)=O)O1,C9H17NO8S,35071.0
16907,Thio-NAD,NC(=S)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1,C21H27N7O13P2S,36466.0
16908,9-keto Latanoprost,CC(C)OC(=O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1,C26H38O5,9000350.0
16909,5-(3'-Hydroxyphenyl)-?-Valerolactone,O=C1CCC(Cc2cccc(O)c2)O1,C11H12O3,38519.0
16910,Eprobemide,O=C(NCCCN1CCOCC1)c1ccc(Cl)cc1,C14H19ClN2O2,36604.0
16911,N-Phenethyl-N-phenylpropionamide,CCC(=O)N(CCc1ccccc1)c1ccccc1,C17H19NO,38752.0
16912,Asaraldehyde,COc1cc(OC)c(OC)cc1C=O,C10H12O4,36798.0
16913,1-Palmitoyl-2-Oleoyl-sn-glycero-3-PE,CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C39H76NO8P,20067.0
16914,"5,6-Dimethylbenzimidazole",Cc1cc2nc[nH]c2cc1C,C9H10N2,36437.0
16915,?-Glycerophosphate (sodium salt hydrate),O.O.O.O.O.O=P([O-])([O-])OC(CO)CO.[Na+].[Na+],C3H17Na2O11P,38367.0
16916,Dianhydrogalactitol,O[C@H]([C@H](O)[C@@H]1CO1)[C@H]1CO1,C6H10O4,37705.0
16917,PK11000,CS(=O)(=O)c1ncc(Cl)c(C(=O)O)n1,C6H5ClN2O4S,37306.0
16918,1V209,COCCOc1nc(N)c2[nH]c(=O)n(Cc3ccc(C(=O)O)cc3)c2n1,C16H17N5O5,38318.0
16919,Fmoc-L-Alanine,C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O,C18H17NO4,36457.0
16920,"N-[1-(2,3-Di(9-octadecenoyloxy)propyl]-N,N,N-trimethylammonium (chloride)",CCCCCCCCC=CCCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCCC=CCCCCCCCC.[Cl-],C42H84ClNO2,38592.0
16921,LY2365109 (hydrochloride),CN(CCOc1ccc(-c2ccc3c(c2)OCO3)cc1C(C)(C)C)CC(=O)O.Cl,C22H28ClNO5,37427.0
16922,Pyraclostrobin,COC(=O)N(OC)c1ccccc1COc1ccn(-c2ccc(Cl)cc2)n1,C19H18ClN3O4,37533.0
16923,6-Thioguanosine,Nc1nc(=S)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2[nH]1,C10H13N5O4S,36539.0
16924,Seralutinib,COc1ccc(-c2cncc(N[C@@H](C)c3cccc(NC(=O)c4cncc(C)c4)c3)n2)cc1OC,C27H27N5O3,37754.0
16925,DT2216,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCC(=O)N2CCN(CC[C@H](CSc3ccccc3)Nc3ccc(S(=O)(=O)NC(=O)c4ccc(N5CCN(CC6=C(c7ccc(Cl)cc7)CCC(C)(C)C6)CC5)cc4)cc3S(=O)(=O)C(F)(F)F)CC2)C(C)(C)C)cc1,C77H96ClF3N10O10S4,37311.0
16926,Besifovir,Nc1ncc2ncn(CC3(OCP(=O)(O)O)CC3)c2n1,C10H14N5O4P,37570.0
16927,"1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin",Clc1cc2c(c(Cl)c1Cl)Oc1cc(Cl)c(Cl)c(Cl)c1O2,C12H2Cl6O2,38595.0
16928,4-fluoro MDMB-BUTINACA-d4,[2H]c1c([2H])c([2H])c2c(c(C(=O)N[C@H](C(=O)OC)C(C)(C)C)nn2CCCCF)c1[2H],C19H26FN3O3,37890.0
16929,4-fluoro MDMB-BUTINACA-d4 (exempt preparation),[2H]c1c([2H])c([2H])c2c(c(C(=O)N[C@H](C(=O)OC)C(C)(C)C)nn2CCCCF)c1[2H],C19H26FN3O3,43498.0
16930,"1,2,3,4,7,8-Hexachlorodibenzo-p-dioxin",Clc1cc2c(cc1Cl)Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1O2,C12H2Cl6O2,38594.0
16931,PNU 159682,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H]2[C@H](O[C@@H]3[C@@H](OC)OCCN32)[C@H](C)O1,C32H35NO13,37370.0
16932,"Trehalose 6,6'-Dibehenate",CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,C56H106O13,37911.0
16933,Ethyl-?-D-Glucuronide,CCO[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,C8H14O7,22271.0
16934,Longdaysin,CC(C)n1cnc2c(NCc3cccc(C(F)(F)F)c3)ncnc21,C16H16F3N5,36706.0
16935,NB-598,CCN(C/C=C/C#CC(C)(C)C)Cc1cccc(OCc2cc(-c3ccsc3)cs2)c1,C27H31NOS2,14912.0
16936,OF-Deg-Lin,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCCN(CCCCC1NC(=O)C(CCCCN(CCOC(=O)CCCCCCC/C=C\C/C=C\CCCCC)CCOC(=O)CCCCCCC/C=C\C/C=C\CCCCC)NC1=O)CCOC(=O)CCCCCCC/C=C\C/C=C\CCCCC,C92H160N4O10,37853.0
16937,5-(3-Aminoallyl)uridine-5'-O-triphosphate (sodium salt),NC/C=C/c1cn([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])[C@@H](O)[C@H]2O)c(=O)[nH]c1=O.[Na+].[Na+].[Na+].[Na+],C12H16N3Na4O15P3,38423.0
16938,Siremadlin,COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,C26H24Cl2N6O4,38516.0
16939,8-Chloroadenosine-5'-triphosphate (sodium salt),Nc1ncnc2c1nc(Cl)n2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],C10H11ClN5Na4O13P3,38448.0
16940,Senkyunolide I,CCC/C=C1\OC(=O)C2=C1CC[C@H](O)[C@H]2O,C12H16O4,35649.0
16941,2-Chloroadenosine-5'-O-diphosphate (sodium salt),Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+],C10H11ClN5Na3O10P2,38447.0
16942,SSYA10-001,C=CCn1c(CSc2ccccc2[N+](=O)[O-])n[nH]c1=S,C12H12N4O2S2,38324.0
16943,3-Deoxyaconitine,CCN1C[C@]2(COC)CC[C@H](OC)C34C1C([C@H](OC)[C@@H]32)[C@@]1(OC(C)=O)[C@@H](O)[C@H](OC)[C@@]2(O)C[C@@H]4[C@@H]1C2OC(=O)c1ccccc1,C34H47NO10,36151.0
16944,"1,2-Dioleoyl-3(R)-trimethylammoniumpropane (chloride)",CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](C[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC.[Cl-],C42H80ClNO4,38194.0
16945,Thiophanate-methyl,COC(=O)NC(=S)Nc1ccccc1NC(=S)NC(=O)OC,C12H14N4O4S2,35402.0
16946,"1,2,3,4,6,7,8,9-Octachlorodibenzo-p-dioxin",Clc1c(Cl)c(Cl)c2c(c1Cl)Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1O2,C12Cl8O2,38598.0
16947,Clobazam,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,C16H13ClN2O2,14262.0
16948,Anecortave Acetate,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3=CC[C@@]21C,C23H30O5,36441.0
16949,Fimasartan,CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,C27H31N7OS,36524.0
16950,DiZPK,CC1(CCCNC(=O)NCCCC[C@H](N)C(=O)O)N=N1,C12H23N5O3,37191.0
16951,Cinnamoylglycine,O=C(O)CNC(=O)C=Cc1ccccc1,C11H11NO3,36378.0
16952,5-methoxy DMT (fumarate),COc1ccc2[nH]cc(CCN(C)C)c2c1.O=C(O)/C=C/C(=O)O,C17H22N2O5,35025.0
16953,?-Sitostenone,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,C29H48O,36703.0
16954,ML-188,CC(C)(C)NC(=O)[C@@H](c1cccnc1)N(C(=O)c1ccco1)c1ccc(C(C)(C)C)cc1,C26H31N3O3,37346.0
16955,5-Nitro-2-(bromoacetamido)benzophenone,O=C(CBr)Nc1ccc([N+](=O)[O-])cc1C(=O)c1ccccc1,C15H11BrN2O4,38114.0
16956,Phenylglycine,NC(C(=O)O)c1ccccc1,C8H9NO2,37186.0
16957,5-methoxy DMT-d4,[2H]C([2H])(c1c[nH]c2ccc(OC)cc12)C([2H])([2H])N(C)C,C13H18N2O,38748.0
16958,5-methoxy DMT-d4 (CRM),[2H]C([2H])(c1c[nH]c2ccc(OC)cc12)C([2H])([2H])N(C)C,C13H18N2O,39186.0
16959,CHM-FUBIATA,O=C(Cc1cn(Cc2ccc(F)cc2)c2ccccc12)NCC1CCCCC1,C24H27FN2O,38205.0
16960,Reparixin,CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1,C14H21NO3S,17350.0
16961,TTAPE-Me,C[N+](C)(C)CCOc1ccc(C(=C(c2ccc(OCC[N+](C)(C)C)cc2)c2ccc(OCC[N+](C)(C)C)cc2)c2ccc(OCC[N+](C)(C)C)cc2)cc1.[Br-].[Br-].[Br-].[Br-],C46H68Br4N4O4,36068.0
16962,iso-Hexahydrocannabinol,CCCCCc1cc(O)c2c(c1)O[C@]1(C)CC[C@@H](C(C)C)[C@H]2C1,C21H32O2,37851.0
16963,2-Iminobiotin (hydrobromide),Br.N=C1N[C@H]2[C@H](CS[C@H]2CCCCC(=O)O)N1,C10H18BrN3O2S,38919.0
16964,8-bromo NAD+ (sodium salt),NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4c(Br)nc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1.[Na+],C21H25BrN7NaO14P2,38475.0
16965,DSG-mPEG(2000),CCCCCCCCCCCCCCCCCC(=O)OCC(COCCOC)OC(=O)CCCCCCCCCCCCCCCCC,C40H78O5(C2H4O)n,37800.0
16966,Lipid A4,CCCCCCCCCCC(O)CN(CCOCCN(CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC)CCN1CCN(CCOCCN(CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC)CC1,C74H153N5O7,38351.0
16967,AZD 9291DA,COc1cc(N(C)CCN(C)C)c(N)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,C25H31N7O,35570.0
16968,AA147,Cc1ccc(O)c(NC(=O)CCc2ccccc2)c1,C16H17NO2,27143.0
16969,Supinoxin,COc1cc(OC)cc(N2CCN(C(=O)Nc3nc4cc(F)ccc4nc3OC)CC2)c1,C22H24FN5O4,36573.0
16970,"2,6-Xylidine (hydrochloride)",Cc1cccc(C)c1N.Cl,C8H12ClN,38856.0
16971,Lipid 222,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCCCN(CCCCO)CCCCCCCCOC(=O)C(CCCCCC)CCCCCCCC,C52H103NO5,38338.0
16972,Gambogenic Acid,CC(C)=CCC/C(C)=C/Cc1c(O)c(CC=C(C)C)c2c(c1O)C(=O)C1=C[C@@H]3C[C@H]4C(C)(C)O[C@@](C/C=C(/C)C(=O)O)(C3=O)[C@@]14O2,C38H46O8,35638.0
16973,C14-SPM,CCCCCCCCCCCCC(O)CN(CCCCN(CCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC,C94H194N4O6,38785.0
16974,Romifidine (hydrochloride),Cl.Fc1cccc(Br)c1NC1=NCCN1,C9H10BrClFN3,38581.0
16975,LAU-0901,CC1=C(C(=O)OCCOc2ccc(Cl)c(Cl)c2)C(C)C(C(=O)OC(CN2CCOCC2)CN2CCOCC2)=C(C)N1,C29H39Cl2N3O7,38414.0
16976,Boc-D-1-Nal-OH,CC(C)(C)OC(=O)N[C@H](Cc1cccc2ccccc12)C(=O)O,C18H21NO4,36545.0
16977,8-Bu(3-yne)T-NAD+ (sodium salt),C#CCCSc1nc2c(N)ncnc2n1[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])OC[C@H]2O[C@@H]([n+]3cccc(C(N)=O)c3)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O.[Na+],C25H30N7NaO14P2S,38477.0
16978,MSAB,COC(=O)c1cccc(NS(=O)(=O)c2ccc(C)cc2)c1,C15H15NO4S,36497.0
16979,IMR-1A,COc1cc(C=C2SC(=S)NC2=O)ccc1OCC(=O)O,C13H11NO5S2,37432.0
16980,SP-8356,COc1cc(/C=C/C2=CC(=O)[C@H]3C[C@@H]2C3(C)C)cc(O)c1O,C18H20O4,37481.0
16981,Hirsutine,CC[C@H]1CN2CCc3c([nH]c4ccccc34)[C@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C22H28N2O3,36403.0
16982,"2,3-dinor-8-iso Prostaglandin F1?",CCCCC[C@H](O)/C=C/[C@@H]1[C@H](CCCCC(=O)O)[C@@H](O)C[C@H]1O,C18H32O5,15290.0
16983,ML-417,COc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,C22H25N3O3,36582.0
16984,IWP-O1,O=C(Cn1nnc(-c2ccncc2)c1-c1ccccc1)Nc1ccc(-c2ccccc2)cn1,C26H20N6O,38418.0
16985,Nigerose,O=C[C@H](O)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)CO,C12H22O11,37419.0
16986,PF-249,COc1nc(N(C)C)ccc1-c1cc2c(C(=O)O)c[nH]c2cc1Cl,C17H16ClN3O3,38416.0
16987,"3,6'-Disinapoylsucrose",COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(CO)O[C@H](CO)[C@@H](O)[C@@H]3OC(=O)/C=C/c3cc(OC)c(O)c(OC)c3)[C@H](O)[C@@H](O)[C@@H]2O)cc(OC)c1O,C34H42O19,35640.0
16988,PfDHODH-IN-1,N#CC(C(=O)Nc1ccc(C(F)(F)F)cc1)=C(O)C1CC1,C14H11F3N2O2,37728.0
16989,Cosan-528,Cc1cc(Br)ccc1NC(=O)CCl,C9H9BrClNO,37537.0
16990,1-Palmitoyl-2-hydroxy-sn-glycero-3-PA,CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)(O)O,C19H39O7P,10010094.0
16991,"1,2,3,4,6,7,8,9-Octachlorodibenzofuran",Clc1c(Cl)c(Cl)c2c(oc3c(Cl)c(Cl)c(Cl)c(Cl)c32)c1Cl,C12Cl8O,38624.0
16992,8-butylthio NAD+ (sodium salt),CCCCSc1nc2c(N)ncnc2n1C1OC(COP(=O)([O-])OP(=O)([O-])OCC2OC([n+]3cccc(C(N)=O)c3)C(O)C2O)C(O)C1O.[Na+],C25H34N7NaO14P2S,38476.0
16993,Steviolbioside,C=C1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)O)[C@@H]2CC[C@]1(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C3,C32H50O13,36513.0
16994,BIBF 0775,CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1,C31H34N4O2,37777.0
16995,Emamectin B1 (benzoate salt),CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@H](NC)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CN[C@@H]1[C@H](C)O[C@@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)C[C@@H]1OC.O=C(O)c1ccccc1,C104H154N2O28,36201.0
16996,Safinamide Metabolite NW 1689,O=C(O)c1ccc(OCc2cccc(F)c2)cc1,C14H11FO3,35395.0
16997,Bortezomib Impurity A,NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1,C14H14N4O2,36499.0
16998,TD-4208,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1,C35H43N5O4,36549.0
16999,Purine riboside-5'-O-triphosphate (sodium salt),O=P([O-])([O-])OP(=O)([O-])OP(=O)([O-])OC[C@H]1O[C@@H](n2cnc3cncnc32)[C@H](O)[C@@H]1O.[Na+].[Na+].[Na+].[Na+],C10H11N4Na4O13P3,38491.0
17000,Pseudotropine,CN1[C@@H]2CC[C@H]1C[C@H](O)C2,C8H15NO,36166.0
17001,hVEGF-IN-1,CCN(CC)CCOc1ccc(Nc2nc(-c3ccccc3NC(=O)CCN3CCN(C)CC3)nc3ccccc23)cc1,C34H43N7O2,37550.0
17002,NCT-58,COc1cc(NC(=O)c2ccc3c(c2OC)C=CC(C)(C)O3)ccc1OCCC1CCCCN1,C27H34N2O5,38325.0
17003,Isocytosine,Nc1nccc(=O)[nH]1,C4H5N3O,38510.0
17004,6-PPD-Q,CC(C)CC(C)NC1=CC(=O)C(Nc2ccccc2)=CC1=O,C18H22N2O2,38247.0
17005,Sp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt),Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO[P@](=O)([S-])OP(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+],C10H12N5Na3O9P2S,38534.0
17006,IRAK4 Inhibitor 1,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c2c1,C19H23N5O,37548.0
17007,LEE011 (succinate),CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1.O=C(O)CCC(=O)O,C27H36N8O5,36414.0
17008,BAMB-4,Cc1ccc(C(=O)Nc2noc3ccccc23)cc1,C15H12N2O2,36583.0
17009,Tolebrutinib,C=CC(=O)N1CCC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)nccc32)C1,C26H25N5O3,37723.0
17010,Rp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt),Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO[P@@](=O)([S-])OP(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+],C10H12N5Na3O9P2S,38533.0
17011,6-PPD,CC(C)CC(C)Nc1ccc(Nc2ccccc2)cc1,C18H24N2,38246.0
17012,Clopidogrel-related Compound B (hydrochloride),COC(=O)C(c1ccccc1Cl)N1CCc2ccsc2C1.Cl,C16H17Cl2NO2S,36507.0
17013,Alitame,C[C@@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)NC1C(C)(C)SC1(C)C,C14H25N3O4S,36267.0
17014,HM43239,Cc1ccc2c(-c3nc(Nc4cc(CN5C[C@@H](C)N[C@@H](C)C5)cc(C5CC5)c4)ncc3Cl)c[nH]c2c1,C29H33ClN6,37737.0
17015,GPX4 24,COC(=O)[C@H]1Cc2c([nH]c3ccccc23)[C@H](c2ccc(S(C)(=O)=O)cc2)N1C(=O)CCl,C22H21ClN2O5S,38428.0
17016,8-Aminoadenosine-5'-O-triphosphate (sodium salt),Nc1ncnc2c1nc(N)n2C1OC(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])C(O)C1O.[Na+].[Na+].[Na+].[Na+],C10H13N6Na4O13P3,38539.0
17017,Naloxonazine (hydrochloride),C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5.Cl.Cl,C38H44Cl2N4O6,21950.0
17018,5-methoxy NiPT,COc1ccc2[nH]cc(CCNC(C)C)c2c1,C14H20N2O,35267.0
17019,Lentztrehalose C,CC(C)(O)[C@H]1CO[C@H]2[C@H](O1)[C@@H](O)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)O[C@@H]2CO,C17H30O12,37734.0
17020,5-Heptylresorcinol,CCCCCCCc1cc(O)cc(O)c1,C13H20O2,38858.0
17021,1cP-MiPLA (solution),CC(C)N(C)C(=O)[C@@H]1C=C2c3cccc4c3c(cn4C(=O)C3CC3)C[C@H]2N(C)C1,C24H29N3O2,39013.0
17022,"5?-Pregnane-3?,20?-diol",C[C@H](O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C21H36O2,38890.0
17023,"3(Z),6(Z),9(Z),12(Z),15(Z)-Octadecapentaenoic Acid",CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC(=O)O,C18H26O2,10009731.0
17024,PF-3644022,Cc1ccc(-c2ccc3c(ccc4sc5c(c43)NC[C@@H](C)NC5=O)n2)cn1,C21H18N4OS,19185.0
17025,Parathyroid Hormone (1-34) (rat) (acetate),CC(=O)O.[H]NCCCC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)N[H])C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN[H])C(=O)N[C@@H](CCCCN[H])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C,C182H295N55O50S2,36861.0
17026,Merafloxacin,CCNCC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CC)c3c2F)C1,C19H23F2N3O3,37709.0
17027,ATX-001,CCCCCC/C=C\COC(=O)CCCCCCCN(CCCCCCCC(=O)OC/C=C\CCCCCC)C(=O)CSCCN(C)C,C40H74N2O5S,39037.0
17028,Dendrogenin A,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@@H](NCCc4cnc[nH]4)[C@@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C32H55N3O2,37975.0
17029,Sulfane Sulfur Probe 4,O=C(Oc1ccc2c(c1)Oc1cc(OC(=O)c3ccccc3S)ccc1C21OC(=O)c2ccccc21)c1ccccc1S,C34H20O7S2,37921.0
17030,Dibenzofuran-4-carboxylic Acid,O=C(O)c1cccc2c1oc1ccccc12,C13H8O3,36681.0
17031,RS 25344 (hydrochloride),Cl.O=c1c2cccnc2n(-c2cccc([N+](=O)[O-])c2)c(=O)n1Cc1ccncc1,C19H14ClN5O4,37793.0
17032,N-formyl 4-ANPP,O=CN(c1ccccc1)C1CCN(CCc2ccccc2)CC1,C20H24N2O,38863.0
17033,GSK1940029,Cc1c(C(=O)Nc2ccc(CO)cc2)nnn1Cc1ccc(Cl)c(Cl)c1,C18H16Cl2N4O2,36704.0
17034,Pencycuron,O=C(Nc1ccccc1)N(Cc1ccc(Cl)cc1)C1CCCC1,C19H21ClN2O,36127.0
17035,Spiromesifen-d9,[2H]C([2H])([2H])C(CC(=O)OC1=C(c2c(C)cc(C)cc2C)C(=O)OC12CCCC2)(C([2H])([2H])[2H])C([2H])([2H])[2H],C23H30O4,39033.0
17036,Riluzole,Nc1nc2ccc(OC(F)(F)F)cc2s1,C8H5F3N2OS,35833.0
17037,Tapinarof,CC(C)c1c(O)cc(/C=C/c2ccccc2)cc1O,C17H18O2,36527.0
17038,Ravidasvir (hydrochloride),COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc3cc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)ccc3c2)[nH]1)C(C)C.Cl.Cl,C42H52Cl2N8O6,37794.0
17039,4-Hydroxyindole-3-acetic Acid,O=C(O)Cc1c[nH]c2cccc(O)c12,C10H9NO3,33632.0
17040,APS6-45,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(F)(C(F)(F)F)C(F)(F)F)ccc3F)cc2)ccn1,C23H16F8N4O3,38417.0
17041,8-propylthio NAD+ (sodium salt),CCCSc1nc2c(N)ncnc2n1[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])OC[C@H]2O[C@@H]([n+]3cccc(C(N)=O)c3)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O.[Na+],C24H32N7NaO14P2S,38488.0
17042,Zapnometinib,O=C(O)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,C13H7ClF2INO2,38517.0
17043,Indole-3-acetic Acid-d5,[2H]c1[nH]c2c([2H])c([2H])c([2H])c([2H])c2c1CC(=O)O,C10H9NO2,38894.0
17044,Biotin-Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CCCC[C@@H]5SC[C@@H]6NC(=O)N[C@@H]65)CC[C@]4(C)[C@H]3CC[C@]12C,C37H60N2O3S,38852.0
17045,Quarfloxin,CN1CCC[C@H]1CCNC(=O)c1cn2c3c(c(N4CCC(c5cnccn5)C4)c(F)cc3c1=O)Oc1cc3ccccc3cc1-2,C35H33FN6O3,36552.0
17046,PMX-53 (trifluoroacetate salt),CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CC2CCCCC2)NC(=O)[C@@H]2CCCN2C1=O.O=C(O)C(F)(F)F,C47H65N11O7(C2HF3O2)X,35840.0
17047,"2,6-Xylidine-d6 (hydrochloride)",Cl.[2H]C([2H])([2H])c1cccc(C([2H])([2H])[2H])c1N,C8H12ClN,38920.0
17048,Oxamyl-d6,[2H]C([2H])([2H])N(C(=O)/C(=N/OC(=O)NC)SC)C([2H])([2H])[2H],C7H13N3O3S,39031.0
17049,SH5-07,CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)NO)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F,C29H28F5N3O5S,36818.0
17050,"2,2'-Bisnaloxone",C=CCN1CC[C@]23c4c5cc(-c6cc7c8c(c6O)O[C@H]6C(=O)CC[C@@]9(O)[C@@H](C7)N(CC=C)CC[C@]869)c(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,C38H40N2O8,36678.0
17051,Dopamine D3 Receptor Agonist 13a,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,C22H33Cl2N3O2,38382.0
17052,Myristyl Nicotinate,CCCCCCCCCCCCCCOC(=O)c1cccnc1,C20H33NO2,37714.0
17053,Tricin,COc1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc(OC)c1O,C17H14O7,35835.0
17054,4-(Trifluoromethyl)nicotinic Acid,O=C(O)c1cnccc1C(F)(F)F,C7H4F3NO2,36479.0
17055,Senaparib,O=C(c1cc(Cn2c(=O)[nH]c(=O)c3c(F)cccc32)ccc1F)N1CCN(c2ncccn2)CC1,C24H20F2N6O3,37722.0
17056,17?-Estradiol-d3,[2H]C1([2H])C[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]2(C)[C@@]1([2H])O,C18H24O2,38974.0
17057,GSK2200150A,c1cc2c(s1)CCOC21CCN(Cc2ccc3c(c2)OCCO3)CC1,C20H23NO3S,36620.0
17058,AP1189 (acetate),CC(=O)O.N=C(N)NN=CC=Cc1cccn1-c1ccccc1[N+](=O)[O-],C16H18N6O4,37400.0
17059,C14-4,CCCCCCCCCCCCC(O)CN(CCOCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CCN1CCN(CCOCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CC1,C84H173N5O7,38942.0
17060,Xylazine-d6,[2H]C([2H])([2H])c1cccc(C([2H])([2H])[2H])c1NC1=NCCCS1,C12H16N2S,38353.0
17061,Xylazine-d6 (CRM),[2H]C([2H])([2H])c1cccc(C([2H])([2H])[2H])c1NC1=NCCCS1,C12H16N2S,39184.0
17062,MD2-TLR4-I,O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl,C22H14Cl2N4O,38328.0
17063,GMX1777,COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N=C(NC#N)NCCCCCCOc2ccc(Cl)cc2)cc1.[Cl-],C30H43Cl2N5O8,38798.0
17064,pythiDC,O=C(O)c1ccc(-c2ncc(C(=O)O)s2)nc1,C10H6N2O4S,37392.0
17065,4-Allylcatechol,C=CCc1ccc(O)c(O)c1,C9H10O2,36542.0
17066,12-oxo-9(Z)-Dodecenoic Acid,O=CC/C=C\CCCCCCCC(=O)O,C12H20O3,37713.0
17067,Fmoc-Arg(Pbf)-OH,Cc1c(C)c(S(=O)(=O)NC(=N)NCCC[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)c(C)c2c1OC(C)(C)C2,C34H40N4O7S,36458.0
17068,A12-Iso5-2DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCCN(C)C,C45H85N3O2,38586.0
17069,Melagatran,N=C(N)c1ccc(CNC(=O)[C@@H]2CCN2C(=O)[C@H](NCC(=O)O)C2CCCCC2)cc1,C22H31N5O4,9002300.0
17070,(+)-Muscarine (tosylate),C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O.Cc1ccc(S(=O)(=O)[O-])cc1,C16H27NO5S,38853.0
17071,4A3-SC8,CCCCCCCCSCC(C)C(=O)OCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCOC(=O)C(C)CSCCCCCCCC)CCC(=O)OCCOC(=O)C(C)CSCCCCCCCC)CCC(=O)OCCOC(=O)C(C)CSCCCCCCCC,C75H139N3O16S4,38155.0
17072,Zofenoprilat,C[C@H](CS)C(=O)N1C[C@@H](Sc2ccccc2)C[C@H]1C(=O)O,C15H19NO3S2,38124.0
17073,THJ2201 N-(5-hydroxypentyl) metabolite,O=C(c1cccc2ccccc12)c1nn(CCCCCO)c2ccccc12,C23H22N2O2,9003736.0
17074,"Lipid 2,2(8,8) 4C CH3",CCCCCC/C=C\COC(=O)CN(CC(=O)OC(CCCCCCCC)CCCCCCCC)C(=O)SCCCCN(C)C,C37H70N2O5S,37910.0
17075,Bufotenidine (iodide),C[N+](C)(C)CCc1c[nH]c2ccc(O)cc12.[I-],C13H19IN2O,37638.0
17076,Spirotetramat-d5,[2H]C([2H])([2H])C([2H])([2H])OC(=O)OC1=C(c2cc(C)ccc2C)C(=O)N[C@]12CC[C@@H](OC)CC2,C21H27NO5,39032.0
17077,Ambroxol-d5 (hydrochloride),Cl.[2H]C1([2H])C[C@H](NCc2cc(Br)cc(Br)c2N)CC([2H])([2H])[C@@]1([2H])O,C13H19Br2ClN2O,38335.0
17078,AZD 8797,CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2ccccc2)nc2nc(N)sc12,C19H25N5OS2,28419.0
17079,1-Arachidoyl-2-hydroxy-sn-glycero-3-PC,CCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C28H58NO7P,38303.0
17080,Osalmid,O=C(Nc1ccc(O)cc1)c1ccccc1O,C13H11NO3,38513.0
17081,MMG-11,CCOC(=O)c1ccc(CC(=O)c2ccc(O)c(O)c2O)o1,C15H14O7,38787.0
17082,Devazepide,CN1C(=O)[C@@H](NC(=O)c2cc3ccccc3[nH]2)N=C(c2ccccc2)c2ccccc21,C25H20N4O2,38509.0
17083,Ala-D-?-Glu-Lys-D-Ala-D-Ala (trifluoroacetate salt),C[C@H](N)C(=O)N[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)O)C(=O)O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,C24H38F6N6O12,36453.0
17084,AP-1,COc1cc(N2CCN(C(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,C39H40ClN9O8S,38875.0
17085,Tiopronin-Cysteine Disulfide,CC(SSC[C@H](N)C(=O)O)C(=O)NCC(=O)O,C8H14N2O5S2,39020.0
17086,Guanosine 5'-[?-thio]triphosphate (sodium salt),Nc1nc(=O)c2ncn(C3OC(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[S-])C(O)C3O)c2[nH]1.[Na+].[Na+].[Na+].[Na+],C10H12N5Na4O13P3S,38565.0
17087,8-Methoxymethyl-3-isobutyl-1-methylxanthine,COCc1nc2c([nH]1)c(=O)n(C)c(=O)n2CC(C)C,C12H18N4O3,39151.0
17088,Lipid III-45,CCCCCCC(CCCC)C(=O)OCCCCCCCCCN(CCCO)CCCCCCCCCOC(=O)C(CCCC)CCCCCC,C45H89NO5,39243.0
17089,Dimethoate-d6,[2H]C([2H])([2H])OP(=S)(OC([2H])([2H])[2H])SCC(=O)NC,C5H12NO3PS2,39260.0
17090,YK-009,CCCCCCCCCCOC(=O)CCCN(CCO)CCCCCC(=O)OCC(CCCCCCCC)CCCCCCCC,C40H79NO5,38282.0
17091,Cedazuridine,O=C1N[C@H](O)CCN1[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,C9H14F2N2O5,38767.0
17092,Dimethyldimyristylammonium (bromide),CCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCC.[Br-],C30H64BrN,38870.0
17093,Blarcamesine,CN(C)CC1CCOC1(c1ccccc1)c1ccccc1,C19H23NO,36812.0
17094,SCR130,O=C1NC(=S)NC(=O)C12N=C(c1ccc(Cl)cc1)CC2c1ccc(Cl)cc1,C19H13Cl2N3O2S,37779.0
17095,Malathion-d6,[2H]C([2H])([2H])OP(=S)(OC([2H])([2H])[2H])SC(CC(=O)OCC)C(=O)OCC,C10H19O6PS2,39262.0
17096,ZLY28,O=C(O)C1(c2cccc(-c3ccc(OCc4c(-c5c(Cl)cccc5Cl)noc4C4CC4)cc3)c2)CC1,C29H23Cl2NO4,38864.0
17097,TG2-179-1,Cc1sc(NC(=O)CSc2nnc(-c3ccc(Cl)cc3)o2)c(C#N)c1-c1ccc(F)cc1,C22H14ClFN4O2S2,38874.0
17098,Pyridaben-d13,[2H]c1c([2H])c(C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])c([2H])c([2H])c1CSc1cnn(C(C)(C)C)c(=O)c1Cl,C19H25ClN2OS,39259.0
17099,Imazalil-d5 (sulfate),O=S(=O)(O)O.[2H]C([2H])=C([2H])C([2H])([2H])OC(Cn1ccnc1)c1ccc(Cl)cc1Cl,C14H16Cl2N2O5S,39261.0
17100,11-nor-9-carboxy Cannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C(=O)O)cc1-2,C21H24O4,34592.0
17101,Dihydrocannabielsoin,CCCCCc1cc(O)c2c(c1)O[C@H]1[C@@H]2[C@H](C(C)C)CC[C@]1(C)O,C21H32O3,39021.0
17102,SZM-1209,CCS(=O)(=O)NC1CCC(C(=O)Nc2nc3cc(F)c(Oc4ccc(F)c(NC(=O)Cc5cccc(C(F)(F)F)c5)c4)cc3s2)CC1,C31H29F5N4O5S2,38494.0
17103,p-methyl-N-salicyloyl Tryptamine,Cc1ccc(C(=O)NCCc2c[nH]c3ccccc23)c(O)c1,C18H18N2O2,38958.0
17104,Carmagerol,CCCCCc1cc(O)c(C/C=C(\C)CCC(O)C(C)(C)O)c(O)c1,C21H34O4,38000.0
17105,Cannabigerol diacetate,CCCCCc1cc(OC(C)=O)c(C/C=C(\C)CCC=C(C)C)c(OC(C)=O)c1,C25H36O4,39145.0
17106,OC2-K3-E10,CCCCCCCCC(O)CN(CCCNC(=O)CCN(CCO)CCC(=O)NCCCN(CC(O)CCCCCCCC)CC(O)CCCCCCCC)CC(O)CCCCCCCC,C54H111N5O7,38243.0
17107,Cannabidivarin diacetate,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(OC(C)=O)cc(CCC)cc1OC(C)=O,C23H30O4,39148.0
17108,CL4F8-6,CCCCCCC(CCCCCC)C(=O)OCCCCCCC(O)(CCCCCCOC(=O)C(CCCCCC)CCCCCC)CCCCN(CCC)CCC,C51H101NO5,38802.0
17109,Methyl Parathion-d6,[2H]C([2H])([2H])OP(=S)(Oc1ccc([N+](=O)[O-])cc1)OC([2H])([2H])[2H],C8H10NO5PS,37894.0
17110,Lipid Catechol,CCCCCCCCCCCCCCOP(=O)(OCCCCCCCCCCCCCC)C(NCCN(CC)CC)c1ccc(O)c(O)c1,C41H79N2O5P,38665.0
17111,Lipid 8,CCCCC/C=C\C/C=C\CCCCCCCCN(CCCCCCCC/C=C\C/C=C\CCCCC)CCOC(=O)CCCN(C)C,C44H82N2O2,38746.0
17112,KIN1148,O=C(Nc1nc2ccc3scnc3c2s1)c1ccc2ccccc2c1,C19H11N3OS2,38980.0
17113,(+)-cis-Cannabidiol,C=C(C)[C@@H]1CCC(C)=C[C@@H]1c1c(O)cc(CCCCC)cc1O,C21H30O2,38947.0
17114,Tauro-Obeticholic Acid (sodium salt),CCC1C(O)C2C3CCC(C(C)CCC(=O)NCCS(=O)(=O)[O-])C3(C)CCC2C2(C)CCC(O)CC12.[Na+],C28H48NNaO6S,38878.0
17115,AA-T3A-C12,CCCCCCCCCCC(O)CN(CCCN(CCCNC(=O)c1ccc(OC)cc1)CCCN(CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC,C65H126N4O6,38648.0
17116,"1(R),2(S)-epoxy Cannabidiol",C=C(C)[C@@H]1CC[C@@]2(C)O[C@H]2[C@H]1c1c(O)cc(CCCCC)cc1O,C21H30O3,39024.0
17117,Abnormal Cannabidivarin,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(O)cc1CCC,C19H26O2,38873.0
17118,Cypermethrin-d5,[2H]c1c([2H])c([2H])c(Oc2cccc(C(C#N)OC(=O)C3C(C=C(Cl)Cl)C3(C)C)c2)c([2H])c1[2H],C22H19Cl2NO3,39265.0
17119,R-268712,Cc1cccc(-c2n[nH]cc2-c2ccc(F)c(-c3cnn(CCO)c3)c2)n1,C20H18FN5O,36810.0
17120,13(Z)-Docosenoic Acid (sodium salt),CCCCCCCC/C=C\CCCCCCCCCCCC(=O)[O-].[Na+],C22H41NaO2,38975.0
17121,Ornipressin (acetate),CC(=O)O.NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,C47H67N13O14S2,36716.0
17122,DC-LC3in-D5,O=C1CC(c2cccc(Cl)c2Cl)CC(=O)C1=CNCCN1CCOCC1,C19H22Cl2N2O3,38339.0
17123,UNC8153 (trifluoroacetate salt),NCCCCCCNC(=O)c1ccc(NC(=O)c2ccc(CN(C(=O)c3ccc4c(c3)OCC(=O)N4)C3CC3)cc2)cc1.O=C(O)C(F)(F)F,C35H38F3N5O7,38932.0
17124,ortho-methyl 4-Anilino-1-Boc-piperidine,Cc1ccccc1NC1CCN(C(=O)OC(C)(C)C)CC1,C17H26N2O2,39001.0
17125,SIBA,CC(C)CSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,C14H21N5O3S,38758.0
17126,1-Linoleoyl-2-hydroxy-sn-glycero-3-PA (sodium salt),CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@@H](O)COP(=O)(O)O.[NaH],C21H39NaO7P,38309.0
17127,CMP8,O=C1CCC2(Cc3ccc(Cl)cc3)Cc3cc(O)ccc3C2=C1c1ccc(OCCN2CCCCC2)cc1,C33H34ClNO3,36585.0
17128,D159687,COc1ccc(Cc2ccc(NC(N)=O)cc2)cc1-c1cccc(Cl)c1,C21H19ClN2O2,38778.0
17129,"PtdIns-(4,5)-P2 (1,2-dioctanoyl)",CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@H]1O)OC(=O)CCCCCCC,C25H49O19P3,39270.0
17130,Lysergol,CN1C[C@H](CO)C=C2c3cccc4[nH]cc(c34)C[C@H]21,C16H18N2O,11717.0
17131,2''-O-Rhamnosylicariside II,COc1ccc(-c2oc3c(CC=C(C)C)c(O)cc(O)c3c(=O)c2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)cc1,C33H40O14,36487.0
17132,ZZL-7,COC(=O)[C@@H](NC(=O)[C@H](C)NC(C)=O)C(C)C,C11H20N2O4,38645.0
17133,?9-THCQ,CCCCCC1=CC(=O)C2=C(OC(C)(C)[C@@H]3CCC(C)=C[C@@H]23)C1=O,C21H28O3,30845.0
17134,Coblopasvir (hydrochloride),COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)c4c3OCO4)cc2)[nH]1)C(C)C.Cl.Cl,C41H52Cl2N8O8,38793.0
17135,5-fluoro MMB-PICA butanoic acid metabolite,CC(C)[C@H](NC(=O)c1cn(CCCCCF)c2ccccc12)C(=O)O,C19H25FN2O3,31267.0
17136,MH 148,CC1(C)C(/C=C/C2=C(Cl)/C(=C/C=C3\N(CCCCCC(=O)O)c4ccccc4C3(C)C)CCC2)=[N+](CCCCCC(=O)O)c2ccccc21.[Br-],C42H52BrClN2O4,31634.0
17137,4-Nitrophenyl ?-D-Glucuronide,O=C(O)[C@H]1O[C@@H](Oc2ccc([N+](=O)[O-])cc2)[C@H](O)[C@@H](O)[C@@H]1O,C12H13NO9,38756.0
17138,RM 133-3,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC(C/C=C\CCCCCCCCOC(=O)CCN(CCCN(CC)CC)CCC(=O)OCCCCCCCC/C=C\CC(CCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)CCCCCC,C89H150N2O8,38917.0
17139,Adenosine-5'-O-(3-thiotriphosphate) (sodium salt),Nc1ncnc2c1ncn2C1OC(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[S-])C(O)C1O.[Na+].[Na+].[Na+].[Na+],C10H12N5Na4O12P3S,38635.0
17140,"Thymidine-5'-O-(?,?-methylene)diphosphate (sodium salt)",Cc1cn(C2CC(O)C(COP(=O)([O-])CP(=O)([O-])[O-])O2)c(=O)[nH]c1=O.[Na+].[Na+].[Na+],C11H15N2Na3O10P2,38571.0
17141,N6-[(6-Aminohexyl)carbamoylmethyl]-ADP,NCCCCCCNC(=O)CNc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,C18H31N7O11P2,38402.0
17142,PF-05221304,COc1cc(C(=O)N2CCC3(CC2)CC(=O)c2c(cnn2C(C)C)C3)cc(-c2ccc(C(=O)O)cc2)n1,C28H30N4O5,36856.0
17143,para-methyl 4-Anilino-1-Boc-piperidine,Cc1ccc(NC2CCN(C(=O)OC(C)(C)C)CC2)cc1,C17H26N2O2,39026.0
17144,GSK3484862,CCc1c(C#N)c(S[C@@H](C(N)=O)c2ccccc2)nc(N(C)C)c1C#N,C19H19N5OS,38897.0
17145,Cannabidiol-d3 (CRM),[2H]C([2H])([2H])CCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(O)c1,C21H30O2,33075.0
17146,Ensifentrine,COc1cc2c(cc1OC)-c1c/c(=N\c3c(C)cc(C)cc3C)n(CCNC(N)=O)c(=O)n1CC2,C26H31N5O4,38761.0
17147,ALC-0315 analogous-1,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCCCN(CCO)CCCCCCCCOC(=O)C(CCCCCC)CCCCCCCC,C50H99NO5,38591.0
17148,Z-CITCO,Clc1ccc(-c2nc3sccn3c2/C=N\OCc2ccc(Cl)c(Cl)c2)cc1,C19H12Cl3N3OS,39172.0
17149,Centhaquin,Cc1cccc(N2CCN(CCc3ccc4ccccc4n3)CC2)c1,C22H25N3,36929.0
17150,Mastoparan X (trifluoroacetate salt),CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC.O=C(O)C(F)(F)F,C75H127F3N20O17S,36903.0
17151,MR2938,COc1cc(OC)c2c(=O)nc(-c3ccc(N4CCN(C)CC4)cc3)[nH]c2c1,C21H24N4O3,39035.0
17152,POMHEX,CC(C)(C)C(=O)OCOP(=O)(OCOC(=O)C(C)(C)C)C1CCCN(O)C1=O,C17H30NO9P,33390.0
17153,Lipid 10,CCCCC/C=C\C/C=C\CCCCCCCCN(CCCCCCCC/C=C\C/C=C\CCCCC)CCOC(=O)CCN1CCN(C)CC1,C46H85N3O2,38705.0
17154,Hydroxy Ipronidazole-d3,[2H]C([2H])([2H])n1c([N+](=O)[O-])cnc1C(C)(C)O,C7H11N3O3,39166.0
17155,2-(2-Chlorophenyl)-2-nitrocyclohexanone,O=C1CCCCC1(c1ccccc1Cl)[N+](=O)[O-],C12H12ClNO3,38251.0
17156,DORI,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(C[N+](C)(C)CCO)OC(=O)CCCCCCC/C=C\CCCCCCCC.[Br-],C43H82BrNO5,38981.0
17157,Prostaglandin E2 Inhibitor 3,O=C(Nc1nnc(-c2ccc(-c3cccc(O)c3)cc2)s1)c1ccccc1Br,C21H14BrN3O2S,38316.0
17158,STING Agonist 12L,C#Cc1cc(NC(=O)c2ccc(-c3ccnnc3)nn2)c(C(=O)O)cc1F,C18H10FN5O3,38344.0
17159,"3,4-Methylenedioxycathinone (hydrochloride)",CC(N)C(=O)c1ccc2c(c1)OCO2.Cl,C10H12ClNO3,16688.0
17160,AVN-101 (hydrochloride),Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1.Cl,C21H25ClN2,38791.0
17161,Xylazine (hydrochloride),Cc1cccc(C)c1NC1=NCCCS1.Cl,C12H17ClN2S,36692.0
17162,Biotin Sphingosine,N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C28H52N4O4S,39291.0
17163,2-(cyclohexylmethyl)-Plumbagin,O=C1C(CC2CCCCC2)=CC(=O)c2c(O)cccc21,C17H18O3,39143.0
17164,BHD,NNC(=O)c1ccc(-c2nn(Cc3ccc(Cl)cc3Cl)c3ccccc23)cc1,C21H16Cl2N4O,38962.0
17165,4'-Chlorodiazepam,CN1C(=O)CN=C(c2ccc(Cl)cc2)c2cc(Cl)ccc21,C16H12Cl2N2O,23105.0
17166,"1-Aminoguanosine-3',5'-monophosphate (sodium salt)",Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)([O-])O[C@H]3[C@H]2O)c(=O)n1N.[Na+],C10H12N6NaO7P,38638.0
17167,Cannabivarinselsoin,C=C(C)[C@@H]1CC[C@](C)(O)[C@H]2Oc3cc(CCC)cc(O)c3[C@@H]12,C19H26O3,29305.0
17168,Abacavir,Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1,C14H18N6O,36925.0
17169,?-Secretase Inhibitor 11,Nc1ccc(N2CCOCC2)c2nonc12,C10H12N4O2,38524.0
17170,Flavokawain C,COc1cc(O)c(C(=O)/C=C/c2ccc(O)cc2)c(OC)c1,C17H16O5,39393.0
17171,Flavokawain C (CRM),COc1cc(O)c(C(=O)/C=C/c2ccc(O)cc2)c(OC)c1,C17H16O5,42197.0
17172,Nicotinamide riboside (chloride),NC(=O)c1ccc[n+]([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1.[Cl-],C11H15ClN2O5,36941.0
17173,meta-methyl 4-Anilino-1-Boc-piperidine,Cc1cccc(NC2CCN(C(=O)OC(C)(C)C)CC2)c1,C17H26N2O2,39025.0
17174,"Cinnamyl-3,4-dihydroxy-?-Cyanocinnamate",N#C/C(=C\c1ccc(O)c(O)c1)C(=O)OC/C=C/c1ccccc1,C19H15NO4,10858.0
17175,Asulam,COC(=O)NS(=O)(=O)c1ccc(N)cc1,C8H10N2O4S,37902.0
17176,Vimseltinib,Cc1nc(-c2cnc(NC(C)C)n(C)c2=O)ccc1Oc1ccnc(-c2cnn(C)c2)c1,C23H25N7O2,38783.0
17177,Acequinocyl (CRM),CCCCCCCCCCCCC1=C(OC(C)=O)C(=O)c2ccccc2C1=O,C24H32O4,39353.0
17178,C12-113,CCCCCCCCCCC(O)CN(CCN(C)CCN(CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC,C53H111N3O4,39335.0
17179,VH 032 Linker 6,C#CCOCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,C31H42N4O7S,38898.0
17180,"1,2-Dipalmitoyl-3-trimethylammoniumpropane (chloride)",CCCCCCCCCCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC.[Cl-],C38H76ClNO4,38907.0
17181,Paraquat (chloride),C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-],C12H14Cl2N2,38521.0
17182,Perfluoropentanoic Acid,O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C5HF9O2,37254.0
17183,"3,4-Methylenedioxypropiophenone",CCC(=O)c1ccc2c(c1)OCO2,C10H10O3,39438.0
17184,Papaverine (hydrochloride),COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC.Cl,C20H22ClNO4,39361.0
17185,Khasianine,C[C@@H]1CC[C@@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C39H63NO11,38762.0
17186,BMS 502,Cn1c(=O)c([N+](=O)[O-])c(N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c2nc(C#N)ccc21,C27H22F2N6O3,39303.0
17187,AR-9281,CC(=O)N1CCC(NC(=O)NC23C[C@H]4C[C@@H](C2)C[C@@H](C3)C4)CC1,C18H29N3O2,38346.0
17188,"N-Hexadecyl-N,N-dimethylhexadecan-1-aminium (bromide)",CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC.[Br-],C34H72BrN,38871.0
17189,(-)-Eburnamonine,CC[C@]12CCCN3CCc4c(n(c5ccccc45)C(=O)C1)[C@@H]32,C19H22N2O,37569.0
17190,7?-hydroxy-3-oxo-5?-Cholan-24-oic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C24H38O4,38159.0
17191,8-Geranyloxypsoralen,CC(C)=CCC/C(C)=C/COc1c2occc2cc2ccc(=O)oc12,C21H22O4,35167.0
17192,6-(Dimethylamino)purine,CN(C)c1ncnc2nc[nH]c12,C7H9N5,38963.0
17193,HUP-55,Cc1nc(CCCc2ccccc2)oc1N1CCC[C@H]1C#N,C18H21N3O,39117.0
17194,Perfluoro-4-methoxybutanoic Acid,O=C(O)C(F)(F)C(F)(F)C(F)(F)OC(F)(F)F,C5HF9O3,37269.0
17195,FGTI-2734,Cn1cncc1CN(CCN(CC1CCCCC1)S(=O)(=O)c1ccccn1)c1ccc(C#N)cc1F,C26H31FN6O2S,37694.0
17196,Fenpyroximate (CRM),Cc1nn(C)c(Oc2ccccc2)c1C=NOCc1ccc(C(=O)OC(C)(C)C)cc1,C24H27N3O4,39356.0
17197,Chlormequat (chloride) (CRM),C[N+](C)(C)CCCl.[Cl-],C5H13Cl2N,39360.0
17198,Oleoyl-L-carnitine (chloride),CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C25H48ClNO4,39014.0
17199,Lipid AX4,CCCCCCC(CCCC)C(=O)OCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCOC(=O)C(CCCC)CCCCCC)CCC(=O)OCCCCOC(=O)C(CCCC)CCCCCC)CCC(=O)OCCCCOC(=O)C(CCCC)CCCCCC,C83H155N3O16,39070.0
17200,Creatine (hydrate),CN(CC(=O)O)C(=N)N.O,C4H11N3O3,36940.0
17201,Estriol 16?-(?-D-Glucuronide),C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)[C@@H]2O,C24H32O9,39140.0
17202,Pararosaniline (hydrochloride),Cl.N=C1C=CC(=C(c2ccc(N)cc2)c2ccc(N)cc2)C=C1,C19H18ClN3,38901.0
17203,N-methyl Perfluorooctanesulfonamide,CNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C9H4F17NO2S,37264.0
17204,Enterobactin,O=C(N[C@H]1COC(=O)[C@@H](NC(=O)c2cccc(O)c2O)COC(=O)[C@@H](NC(=O)c2cccc(O)c2O)COC1=O)c1cccc(O)c1O,C30H27N3O15,33394.0
17205,"1H,1H,2H,2H-Perfluorodecanesulfonic Acid",O=S(=O)(O)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C10H5F17O3S,37259.0
17206,"1H,1H,2H,2H-Perfluorohexanesulfonic Acid",O=S(=O)(O)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C6H5F9O3S,37261.0
17207,Cudetaxestat,CCCn1cc(-n2c(Cl)c(Sc3cccc(C(=O)O)c3F)c3ccc(Cl)c(F)c32)cn1,C21H15Cl2F2N3O2S,38789.0
17208,Perfluoro-3-methoxypropanoic Acid,O=C(O)C(F)(F)C(F)(F)OC(F)(F)F,C4HF7O3,37268.0
17209,Arylpiperazine 5k,O=C(CN1CCN(c2ccc(F)cn2)CC1)Nc1nc2c(s1)CCCC2,C18H22FN5OS,38135.0
17210,7-Acetoxy-4-methylcoumarin,CC(=O)Oc1ccc2c(C)cc(=O)oc2c1,C12H10O4,38909.0
17211,MTDB-Alkyne,C#CCNC(=O)c1ccccc1NC(=O)N1CCCN(Cc2csc(C)n2)CC1,C21H25N5O2S,38926.0
17212,8-Bromo-2'-deoxyadenosine-5'-O-triphosphate (sodium salt),Nc1ncnc2c1nc(Br)n2[C@H]1C[C@H](O)[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O1.[Na+].[Na+].[Na+].[Na+],C10H11BrN5Na4O12P3,38661.0
17213,Rp-2'-Deoxyguanosine-5'-O-(1-thiotriphosphate) (sodium salt),Nc1nc(=O)c2ncn([C@H]3C[C@H](O)[C@@H](CO[P@@](=O)([S-])OP(=O)([O-])OP(=O)([O-])[O-])O3)c2[nH]1.[Na+].[Na+].[Na+].[Na+],C10H12N5Na4O12P3S,38668.0
17214,KRP 203,Cl.NC(CO)(CO)CCc1ccc(Sc2cccc(Oc3ccccc3)c2)cc1Cl,C23H25Cl2NO3S,10010426.0
17215,FX11,CCCc1c(O)c(O)c(C(=O)O)c2cc(Cc3ccccc3)c(C)cc12,C22H22O4,38518.0
17216,M-3258,O=C(N[C@@H](Cc1coc2ccccc12)B(O)O)[C@@H]1C[C@H]2CC[C@@H]1O2,C17H20BNO5,38160.0
17217,1-Palmitoyl-d9-2-Arachidonoyl-sn-glycero-3-PC,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC,C44H80NO8P,38384.0
17218,4-Hydroxyphenylglyoxylic Acid,O=C(O)C(=O)c1ccc(O)cc1,C8H6O4,38121.0
17219,Ceforanide,NCc1ccccc1CC(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3CC(=O)O)CS[C@H]12,C20H21N7O6S2,36075.0
17220,A011,C[C@H](c1ccccc1)n1nnc2cnc3ccc(-c4ccc(OCCCN(C)C)nc4)cc3c21,C27H28N6O,39183.0
17221,(R)-2-(3-(2-Ethoxyphenoxy)piperidin-1-yl)pyrimidine-5-carboxylic Acid,CCOc1ccccc1O[C@@H]1CCCN(c2ncc(C(=O)O)cn2)C1,C18H21N3O4,39257.0
17222,RCB-4-8,CCCCCCC#CCOC(=O)OC(C/C=C\CCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCC/C=C\CC(CCCCCC)OC(=O)OCC#CCCCCCC)CCN(CC)CC)CCCCCC,C68H120N2O10,38803.0
17223,5-Methylcytosine,Cc1cnc(=O)[nH]c1N,C5H7N3O,38741.0
17224,Glutaurine,N[C@@H](CCC(=O)NCCS(=O)(=O)O)C(=O)O,C7H14N2O6S,39586.0
17225,6-Chloropurine,Clc1ncnc2nc[nH]c12,C5H3ClN4,38879.0
17226,Beclomethasone Dipropionate,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C,C28H37ClO7,38880.0
17227,Acenaphthene-d10,[2H]c1c([2H])c2c3c(c([2H])c([2H])c([2H])c3c1[2H])C([2H])([2H])C2([2H])[2H],C12H10,38968.0
17228,UCB 9260,Cc1ccc(C)c(Cn2c(C(O)c3ccncc3)nc3ccc(-c4cnn(C)c4)cc32)c1,C26H25N5O,37336.0
17229,Naltriben (mesylate),CS(=O)(=O)O.Oc1ccc2c3c1O[C@H]1c4oc5ccccc5c4C[C@@]4(O)[C@@H](C2)N(CC2CC2)CC[C@]314,C27H29NO7S,38979.0
17230,ThioLox,CCCCNC(=O)c1cc(-c2ccccc2)sc1N,C15H18N2OS,38946.0
17231,Amitriptyline-d3 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])N(C)CCC=C1c2ccccc2CCc2ccccc21,C20H24ClN,19033.0
17232,Pheniramine (maleate),CN(C)CCC(c1ccccc1)c1ccccn1.O=C(O)/C=C\C(=O)O,C20H24N2O4,39473.0
17233,Cardiolipin (16:0/16:0/16:0/16:0),CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC(O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,C73H142O17P2,39175.0
17234,2-Chloro-L-phenylalanine,N[C@@H](Cc1ccccc1Cl)C(=O)O,C9H10ClNO2,38972.0
17235,MTDB,CCOC(=O)c1ccccc1NC(=O)N1CCCN(Cc2csc(C)n2)CC1,C20H26N4O3S,39462.0
17236,Tianeptine Metabolite MC5,CN1c2ccccc2C(NCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O,C19H21ClN2O4S,36694.0
17237,Ripasudil (hydrochloride hydrate),C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12.Cl.O.O,C15H23ClFN3O4S,19920.0
17238,Flavokawain 1i,COc1cc(O)c(C(=O)/C=C/c2cccc3ccccc23)c(OC)c1,C21H18O4,39394.0
17239,C12-SPM,CCCCCCCCCCC(O)CN(CCCCN(CCCN(CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC)CCCN(CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC,C82H170N4O6,38784.0
17240,3'-O-Methylguanosine-5'-O-triphosphate (sodium salt),CO[C@H]1[C@@H](O)[C@H](n2cnc3c(=O)nc(N)[nH]c32)O[C@@H]1COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+],C11H14N5Na4O14P3,38688.0
17241,ABD-F,NS(=O)(=O)c1ccc(F)c2nonc12,C6H4FN3O3S,38892.0
17242,Hexafluoropropylene Oxide Dimer Acid,O=C(O)C(F)(OC(F)(F)C(F)(F)C(F)(F)F)C(F)(F)F,C6HF11O3,37266.0
17243,KY 19382,CON=C1C(=C2C(=O)Nc3cc(Cl)c(Cl)cc32)Nc2ccccc21,C17H11Cl2N3O2,37579.0
17244,"4-(Acetyloxy)-N,N-dimethyl-?-oxo-1H-indole-3-acetamide",CC(=O)Oc1cccc2[nH]cc(C(=O)C(=O)N(C)C)c12,C14H14N2O4,39002.0
17245,"2H,2H,3H,3H-Perfluorodecanoic Acid",O=C(O)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C10H5F15O2,37271.0
17246,GBR 13069 (hydrochloride),Cl.Cl.Fc1ccc(C(OCCN2CCN(CC=Cc3ccccc3)CC2)c2ccc(F)cc2)cc1,C28H32Cl2F2N2O,38903.0
17247,Beclomethasone 17-Propionate,CCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C,C25H33ClO6,38884.0
17248,Perfluorohexanesulfonic Acid,O=S(=O)(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C6HF13O3S,37248.0
17249,"2-Heptyl-4,6-dihydroxybenzoic Acid",CCCCCCCc1cc(O)cc(O)c1C(=O)O,C14H20O4,38859.0
17250,Sabizabulin,COc1cc(C(=O)c2cnc(-c3c[nH]c4ccccc34)[nH]2)cc(OC)c1OC,C21H19N3O4,38525.0
17251,Ingliforib,O=C(N[C@@H](Cc1ccccc1)[C@@H](O)C(=O)N1C[C@@H](O)[C@@H](O)C1)c1cc2cc(Cl)ccc2[nH]1,C23H24ClN3O5,38419.0
17252,Limonin 17-?-D-Glucopyranoside,CC1(C)O[C@H]2CC(=O)OC[C@]23[C@H]2CC[C@@](C)([C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c4ccoc4)[C@@]4(O[C@@H]4C(=O)O)[C@]2(C)C(=O)C[C@@H]13,C32H42O14,39147.0
17253,SN-001,COc1ccc(NC(=O)c2ccc(-c3ccccc3)cc2)cc1NS(=O)(=O)c1ccc(F)cc1,C26H21FN2O4S,38899.0
17254,Moexiprilat,COc1cc2c(cc1OC)CN(C(=O)[C@H](C)N[C@@H](CCc1ccccc1)C(=O)O)[C@H](C(=O)O)C2,C25H30N2O7,38047.0
17255,Cilazaprilat,O=C(O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O,C20H27N3O5,38118.0
17256,BI-187004,N#Cc1ccc2c(c1)[C@H]1CCCN(C(=O)c3ccc4nc[nH]c4c3)[C@H]1C2,C21H18N4O,38786.0
17257,JAK Inhibitor 31,Cc1cc(Nc2ncc(C)c(N3CC(CC#N)(N4CCN(C)CC4)C3)n2)sn1,C19H26N8S,39387.0
17258,Retigabine (hydrochloride),CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N.Cl.Cl,C16H20Cl2FN3O2,39309.0
17259,N-didesmethyl Loperamide,NC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,C27H29ClN2O2,39559.0
17260,XY-4,CCCCCCCCCCCCCCCC(=O)O[C@H](COP(=O)(O)O)C(F)F,C19H37F2O6P,39273.0
17261,?8-THC Glucuronide,CCCCCc1cc(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21,C27H38O8,38961.0
17262,Perfluorononanesulfonic Acid (sodium salt),O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.[Na+],C9F19NaO3S,38908.0
17263,5-methoxy Tryptamine (hydrochloride),COc1ccc2[nH]cc(CCN)c2c1.Cl,C11H15ClN2O,36784.0
17264,Malathion-d10,[2H]C([2H])([2H])C([2H])([2H])OC(=O)CC(SP(=S)(OC)OC)C(=O)OC([2H])([2H])C([2H])([2H])[2H],C10H19O6PS2,39561.0
17265,Captan-d6,[2H]C1=C([2H])C([2H])([2H])C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2C1([2H])[2H],C9H8Cl3NO2S,39577.0
17266,Diazinon-d10,[2H]C([2H])([2H])C([2H])([2H])OP(=S)(Oc1cc(C)nc(C(C)C)n1)OC([2H])([2H])C([2H])([2H])[2H],C12H21N2O3PS,39556.0
17267,Carbofuran-d3,[2H]C([2H])([2H])NC(=O)Oc1cccc2c1OC(C)(C)C2,C12H15NO3,39558.0
17268,AMX12006,C[C@H](NC(=O)c1c(Nc2cccc(C(F)(F)F)c2)c2ccccc2n1C)c1ccc(C(=O)O)cc1,C26H22F3N3O3,39027.0
17269,C18,COc1cc(N(C(=O)CCl)c2ccc3c(c2)OCCO3)cc(OC)c1F,C18H17ClFNO5,39432.0
17270,Acetamiprid-d3,[2H]C([2H])([2H])N(Cc1ccc(Cl)nc1)C(C)=NC#N,C10H11ClN4,39565.0
17271,Methomyl-d3,[2H]C([2H])([2H])NC(=O)ON=C(C)SC,C5H10N2O2S,39576.0
17272,Fenoxycarb-d3,[2H]C([2H])([2H])COC(=O)NCCOc1ccc(Oc2ccccc2)cc1,C17H19NO4,39598.0
17273,UCL-TRO-1938,CCN1CCN(c2ccc(Nc3cc(Nc4cccc5c4N(C(C)=O)CC5)ccn3)cc2)CC1,C27H32N6O,39118.0
17274,Acequinocyl-d25,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C1=C(OC(C)=O)C(=O)c2ccccc2C1=O,C24H32O4,39589.0
17275,Acephate-d3,[2H]C([2H])([2H])C(=O)NP(=O)(OC)SC,C4H10NO3PS,39579.0
17276,EP4 Antagonist 14,O=C(O)c1ccc(CNC(=O)c2c3ccccc3nn2Cc2ccc(C(F)(F)F)cc2)cc1,C24H18F3N3O3,38427.0
17277,AB-680,C[C@H](Nc1cc(Cl)nc2c1cnn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O)c1ccccc1F,C20H24ClFN4O9P2,32798.0
17278,Griselimycin,CC(=O)N(C)[C@H](C(=O)N1C[C@H](C)C[C@H]1C(=O)N(C)[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N2C[C@H](C)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N2CCC[C@H]2C(=O)N(C)[C@H](CC(C)C)C(=O)NCC(=O)O[C@@H]1C)C(C)C,C57H96N10O12,39306.0
17279,Spiroxamine-d4,[2H]C1([2H])CC(C(C)(C)C)CC([2H])([2H])C12OCC(CN(CC)CCC)O2,C18H35NO2,39604.0
17280,2-(Chloromethyl)-3-(2-methylphenyl)quinazolin-4(3H)-one,Cc1ccccc1-n1c(CCl)nc2ccccc2c1=O,C16H13ClN2O,34173.0
17281,12?-Hydroxyisocholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@@H](O)[C@]12C,C24H40O5,39638.0
17282,7-keto Dehydroepiandrosterone Acetate,CC(=O)O[C@H]1CC[C@@]2(C)C(=CC(=O)[C@@H]3[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]32)C1,C21H28O4,39489.0
17283,Ethoprop-d6,[2H]C([2H])([2H])CCSP(=O)(OCC)SCCC([2H])([2H])[2H],C8H19O2PS2,39601.0
17284,Tegatrabetan,C[C@@H]1C[C@H](C)CN(S(=O)(=O)c2ccc3c(c2)C(=NO)c2cc(S(=O)(=O)N4C[C@H](C)C[C@H](C)C4)ccc2C3=NO)C1,C28H36N4O6S2,37423.0
17285,Glabrol,CC(C)=CCc1cc([C@@H]2CC(=O)c3ccc(O)c(CC=C(C)C)c3O2)ccc1O,C25H28O4,37367.0
17286,S-(N-Methylsulfinylbutylthiocarbamoyl)-L-cysteine,CS(=O)CCCCNC(=S)SC[C@H](N)C(=O)O,C9H18N2O3S3,39555.0
17287,Cyclobenzaprine N-oxide,C[N+](C)([O-])CCC=C1c2ccccc2C=Cc2ccccc21,C20H21NO,36691.0
17288,GSK547,N#Cc1cc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)ncn1,C20H18F2N6O,37347.0
17289,FB23,Cc1noc(C)c1-c1cc(Cl)c(Nc2ccccc2C(=O)O)c(Cl)c1,C18H14Cl2N2O3,37383.0
17290,"CP 346,086",O=C(Nc1ccc2c(c1)CCN(Cc1nnc[nH]1)C2)c1ccccc1-c1ccc(C(F)(F)F)cc1,C26H22F3N5O,39156.0
17291,Paulownin,O[C@]12CO[C@H](c3ccc4c(c3)OCO4)[C@H]1CO[C@@H]2c1ccc2c(c1)OCO2,C20H18O7,37287.0
17292,Sulfosuccinimidyl 3-[[2-(Biotinamido)ethyl]dithio]propionate (sodium salt),O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)NCCSSCCC(=O)ON1C(=O)CC(S(=O)(=O)[O-])C1=O.[Na+],C19H27N4NaO9S4,39537.0
17293,Propoxur-d3,[2H]C([2H])([2H])NC(=O)Oc1ccccc1OC(C)C,C11H15NO3,39582.0
17294,Imidacloprid-d4,[2H]C1([2H])N=C(N[N+](=O)[O-])N(Cc2ccc(Cl)nc2)C1([2H])[2H],C9H10ClN5O2,39549.0
17295,(R)-(-)-Metalaxyl-d6,[2H]C([2H])([2H])c1cccc(C([2H])([2H])[2H])c1N(C(=O)COC)[C@H](C)C(=O)OC,C15H21NO4,39575.0
17296,Phosmet-d6,[2H]C([2H])([2H])OP(=S)(OC([2H])([2H])[2H])SCN1C(=O)c2ccccc2C1=O,C11H12NO4PS2,39569.0
17297,S-72,Cc1ccc(S(=O)(=O)Nc2cc(C(=O)NCc3cnn(C)c3)ccc2C)cc1,C20H22N4O3S,39083.0
17298,Dioleyldimethylammonium (chloride),CCCCCCCC/C=C\CCCCCCCC[N+](C)(C)CCCCCCCC/C=C\CCCCCCCC.[Cl-],C38H76ClN,38797.0
17299,8(S)-hydroxy-9(R)-Hexahydrocannabinol,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C[C@H](O)[C@H](C)C[C@@H]21,C21H32O3,36248.0
17300,33-BCRP Inhibitor,[N-]=[N+]=Nc1ccc(Nc2nc(-c3ccncc3)nc3ccccc23)cc1,C19H13N7,39403.0
17301,Palustric Acid,CC(C)C1=CC2=C(CC1)[C@@]1(C)CCC[C@@](C)(C(=O)O)[C@@H]1CC2,C20H30O2,39136.0
17302,1P-ETH-LAD (solution),CCC(=O)n1cc2c3c(cccc31)C1=C[C@@H](C(=O)N(CC)CC)CN(CC)[C@@H]1C2,C24H31N3O2,39805.0
17303,Imidafenacin,Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1,C20H21N3O,37420.0
17304,m-Coumaric Acid,O=C(O)C=Cc1cccc(O)c1,C9H8O3,37236.0
17305,3-Hydroxyhippuric Acid,O=C(O)CNC(=O)c1cccc(O)c1,C9H9NO4,37240.0
17306,Piperonyl Butoxide-d9,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])OCCOCCOCc1cc2c(cc1CCC)OCO2,C19H30O5,39581.0
17307,AZD 4573,CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1,C22H28ClN5O2,33306.0
17308,Elacestrant (hydrochloride),CCNCCc1ccc(CN(CC)c2cc(OC)ccc2[C@@H]2CCc3cc(O)ccc3C2)cc1.Cl.Cl,C30H40Cl2N2O2,37298.0
17309,"1,2-Dimyristoyl-3-trimethylammoniumpropane (chloride)",CCCCCCCCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC.[Cl-],C34H68ClNO4,38906.0
17310,AOH1996,COc1cccc(Oc2ccccc2NC(=O)CNC(=O)c2cccc3ccccc23)c1,C26H22N2O4,39526.0
17311,Polymyxin B2 (sulfate),CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.O=S(=O)(O)O,C55H96N16O13(H2O4S)X,39720.0
17312,MDMB-PICA,CCCCCn1cc(C(=O)N[C@H](C(=O)OC)C(C)(C)C)c2ccccc21,C21H30N2O3,39729.0
17313,"1-(2,6-Xylyl)-2-thiourea",Cc1cccc(C)c1NC(N)=S,C9H12N2S,39373.0
17314,(-)-Levamisole,c1ccc([C@H]2CN3CCSC3=N2)cc1,C11H12N2S,33972.0
17315,Ethyl-?-D-Glucuronide-d5,[2H]C([2H])([2H])C([2H])([2H])O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,C8H14O7,22273.0
17316,para-fluoro 4-Anilino-1-Boc-piperidine,CC(C)(C)OC(=O)N1CCC(Nc2ccc(F)cc2)CC1,C16H23FN2O2,39539.0
17317,CHIR99021 (hydrochloride),Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1.Cl,C22H19Cl3N8,39176.0
17318,2-Bromo-4'-methylpropiophenone,Cc1ccc(C(=O)C(C)Br)cc1,C10H11BrO,39486.0
17319,PI-1840,CCCc1ccc(OCC(=O)N(Cc2nc(-c3cccnc3)no2)C(C)C)cc1,C22H26N4O3,37331.0
17320,ML-202,COc1cccc(Cn2ncc3c4sc(S(C)=O)cc4n(C)c3c2=O)c1,C18H17N3O3S2,37326.0
17321,2-n-Dodecylfuran,CCCCCCCCCCCCc1ccco1,C16H28O,39269.0
17322,Shield-1,CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(OCCN2CCOCC2)c1)c1cc(OC)c(OC)c(OC)c1,C42H56N2O10,37325.0
17323,Polymyxin E2 (sulfate),CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.O=S(=O)(O)O,C52H100N16O17S,39721.0
17324,Cannabifuran,CCCCCc1cc(O)c2c(c1)oc1c(C)ccc(C(C)C)c12,C21H26O2,21108.0
17325,TH263,O=C(NCc1ccccc1)c1ccc(S(=O)(=O)NCc2ccccc2)cc1,C21H20N2O3S,37295.0
17326,4-fluoro MBZP,CN1CCN(Cc2ccc(F)cc2)CC1,C12H17FN2,39382.0
17327,"1,2-Stearoyl-3-trimethylammoniumpropane (chloride)",CCCCCCCCCCCCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC.[Cl-],C42H84ClNO4,37404.0
17328,"4-(3,4-Difluorobenzo)curcumin",COc1cc(/C=C/C(=O)C(=Cc2ccc(F)c(F)c2)C(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,C28H22F2O6,39271.0
17329,Mogrol,C[C@H](CC[C@@H](O)C(C)(C)O)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4[C@@H](CC[C@H](O)C4(C)C)[C@]3(C)[C@H](O)C[C@]12C,C30H52O4,39253.0
17330,Balovaptan,CN1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1,C22H24ClN5O,37329.0
17331,BRD0705,CC[C@@]1(c2ccccc2)C2=C(CC(C)(C)CC2=O)Nc2n[nH]cc21,C20H23N3O,37314.0
17332,5-methoxy DMT N-oxide,COc1ccc2[nH]cc(CC[N+](C)(C)[O-])c2c1,C13H18N2O2,34927.0
17333,BTSA1,O=C1C(=NNc2nccs2)C(c2ccccc2)=NN1c1nc(-c2ccccc2)cs1,C21H14N6OS2,37305.0
17334,Glucosamine Cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CCC(=O)N[C@H]5C(O)O[C@H](CO)[C@@H](O)[C@@H]5O)CC[C@]4(C)[C@H]3CC[C@]12C,C37H61NO8,39446.0
17335,Dooku1,Clc1cccc(Cl)c1CSc1nnc(-c2ccc[nH]2)o1,C13H9Cl2N3OS,39161.0
17336,BC-11 (hydrobromide),Br.N=C(N)SCc1ccc(B(O)O)cc1,C8H12BBrN2O2S,39522.0
17337,NPD-2975,CC(C)c1n[nH]c2c(=O)[nH]c(-c3ccc(F)cc3)nc12,C14H13FN4O,39466.0
17338,Eicosapentaenoyl-L-carnitine (chloride),CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],C27H44ClNO4,9003924.0
17339,Fluostatin A (sodium salt),Cc1cc(=O)c2c(cc([O-])c3c4c(O)cccc4c(=O)c32)c1=O.[Na+],C18H9NaO5,38913.0
17340,Tri-Salicylic Acid,O=C(Oc1ccccc1C(=O)Oc1ccccc1C(=O)O)c1ccccc1O,C21H14O7,37348.0
17341,MDMB-PINACA,CCCCCn1nc(C(=O)N[C@H](C(=O)OC)C(C)(C)C)c2ccccc21,C20H29N3O3,39730.0
17342,Polymyxin E1 (sulfate),CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.O=S(=O)(O)O,C53H102N16O17S,39718.0
17343,Festinavir,C#C[C@@]1(CO)C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1,C12H12N2O4,37668.0
17344,DMU2139,COc1ccc2cc(C(=O)C=Cc3cccnc3)ccc2c1,C19H15NO2,37301.0
17345,Cyfluthrin-d6,[2H]C([2H])([2H])C1(C([2H])([2H])[2H])C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1ccc(F)c(Oc2ccccc2)c1,C22H18Cl2FNO3,39600.0
17346,Inecalcitol,C[C@H](CC#CC(C)(C)O)[C@H]1CC[C@@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C,C26H40O3,37288.0
17347,Fumagillol,CO[C@@H]1[C@H](O)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C,C16H26O4,39766.0
17348,DKM 2-93,COc1ccc(CNC(=O)CCl)cc1OC,C11H14ClNO3,37293.0
17349,JPC0323,CCCCCCCC/C=C\CCCCCCCC(=O)NC(CO)(CO)CO,C22H43NO4,39470.0
17350,Naloxone benzoylhydrazone,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=NNC(=O)c2ccccc2)CC[C@@]3(O)[C@H]1C5,C26H27N3O4,39827.0
17351,SR 4835,Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1,C21H20Cl2N10O,39158.0
17352,N-propyl Ephenidine (hydrochloride),CCCNC(Cc1ccccc1)c1ccccc1.Cl,C17H22ClN,39449.0
17353,Bactobolamine,C[C@]1(C(Cl)Cl)OC(=O)C2=C(O)C[C@@H](O)[C@H](O)[C@H]2[C@H]1N,C11H15Cl2NO5,38896.0
17354,Mepivacaine-d3,[2H]C([2H])([2H])N1CCCCC1C(=O)Nc1c(C)cccc1C,C15H22N2O,39812.0
17355,5-Methoxycarbonylamino-N-acetyltryptamine,COC(=O)Nc1ccc2[nH]cc(CCNC(C)=O)c2c1,C14H17N3O3,39553.0
17356,Plipastatin A1,CCCCCCCCCCCCC[C@@H](O)CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](CCCN)C(=O)N[C@H]1Cc2ccc(cc2)OC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]([C@@H](C)O)NC1=O,C72H110N12O20,38916.0
17357,test,CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(N)c(=O)oc3c2C)OC1(C)C.Cl,C19H25ClN2O9,123456.0
17358,XL092,CNC(=O)c1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)ccnc2cc1OC,C29H25FN4O5,37749.0
17359,cKK-E15,CCCCCCCCCCCCCC(O)CN(CCCCC1NC(=O)C(CCCCN(CC(O)CCCCCCCCCCCCC)CC(O)CCCCCCCCCCCCC)NC1=O)CC(O)CCCCCCCCCCCCC,C72H144N4O6,38211.0
17360,(-)-?-Thujone,CC(C)[C@]12CC(=O)[C@H](C)[C@H]1C2,C10H16O,39792.0
17361,DNCA,CCCCCCCC/C=C\CCCCCCCCOCC(CNC(=O)Cn1ccc(N)nc1=O)OCCCCCCCC/C=C\CCCCCCCC,C45H82N4O4,38554.0
17362,L-2-Aminobutyric Acid,CC[C@H](N)C(=O)O,C4H9NO2,38750.0
17363,PF-9363,COc1cccc(OC)c1S(=O)(=O)Nc1noc2cc(Cn3cccn3)cc(OC)c12,C20H20N4O6S,37778.0
17364,AZD 7507,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCN(CCO)CC1,C23H27FN6O3,37485.0
17365,JG-98,CCn1c(=O)/c(=C2\Sc3cc(Cl)ccc3N2C)s/c1=C\c1scc[n+]1Cc1ccccc1.[Cl-],C24H21Cl2N3OS3,38337.0
17366,3-keto Ursolic Acid,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,C30H46O3,37364.0
17367,S-Geranylgeranyl-L-glutathione,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,C30H49N3O6S,9004116.0
17368,Fezolinetant,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1,C16H15FN6OS,39523.0
17369,DTHIB,O=C(Nc1ccc(F)cc1)Nc1ccc(Cl)c([N+](=O)[O-])c1,C13H9ClFN3O3,37433.0
17370,Thiacloprid-d4,[2H]C1([2H])SC(=NC#N)N(Cc2ccc(Cl)nc2)C1([2H])[2H],C10H9ClN4S,39573.0
17371,Ethanol Residual Solvent (CRM),CCO,C2H6O,39476.0
17372,306Oi9-cis2,CCCCCC/C=C\COC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC/C=C\CCCCCC)CCC(=O)OC/C=C\CCCCCC)CCC(=O)OC/C=C\CCCCCC,C55H99N3O8,39557.0
17373,Cefpirome (sulfate),CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C[n+]3cccc4c3CCC4)CS[C@H]12)c1csc(N)n1.O=S(=O)([O-])O,C22H24N6O9S3,37398.0
17374,L-Ascorbic Acid 6-stearate,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O,C24H42O7,39142.0
17375,"5,7-Dimethoxyflavone",COc1cc(OC)c2c(=O)cc(-c3ccccc3)oc2c1,C17H14O4,37361.0
17376,Perfluorotetradecanoic Acid,O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C14HF27O2,37255.0
17377,NBQX,NS(=O)(=O)c1cccc2c1c([N+](=O)[O-])cc1[nH]c(=O)c(=O)[nH]c12,C12H8N4O6S,38281.0
17378,PZ-2891,CC(C)c1ccc(CC(=O)N2CCN(c3ccc(C#N)nn3)CC2)cc1,C20H23N5O,37309.0
17379,CL097,CCOCc1nc2c(N)nc3ccccc3c2[nH]1,C13H14N4O,39513.0
17380,LY2334737,CCCC(CCC)C(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,C17H25F2N3O5,37425.0
17381,Pirozadil,COc1cc(C(=O)OCc2cccc(COC(=O)c3cc(OC)c(OC)c(OC)c3)n2)cc(OC)c1OC,C27H29NO10,37292.0
17382,SLB1122168,CCCCCCCCCCc1ccc2nc(NC[C@H]3CCNC3)oc2c1.Cl,C22H36ClN3O,39427.0
17383,GN44028,c1ccc2c(c1)Cc1c(Nc3ccc4c(c3)OCCO4)n[nH]c1-2,C18H15N3O2,37289.0
17384,Trimetazidine-d8 (hydrochloride),Cl.Cl.[2H]C1([2H])NC([2H])([2H])C([2H])([2H])N(Cc2ccc(OC)c(OC)c2OC)C1([2H])[2H],C14H24Cl2N2O3,39810.0
17385,SM-102 N-oxide,CCCCCCCCCCCOC(=O)CCCCC[N+]([O-])(CCO)CCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC,C44H87NO6,39636.0
17386,Iturin A-2,CCCCCCCCCCC[C@@H]1CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N2CCC[C@H]2C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N1,C48H74N12O14,38911.0
17387,Betaxolol-d7 (hydrochloride),Cl.[2H]C([2H])([2H])C([2H])(NCC(O)COc1ccc(CCOCC2CC2)cc1)C([2H])([2H])[2H],C18H30ClNO3,39815.0
17388,Mitraciliatine,CC[C@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C23H30N2O4,39856.0
17389,NIK SMI1,COc1cc(C(N)=O)nc(-c2cccc(C#C[C@]3(O)CCN(C)C3=O)c2)c1,C20H19N3O4,37750.0
17390,ML-SA5,CN(C)S(=O)(=O)c1ccc(S(=O)(=O)Nc2cccc(Cl)c2N2CCCCC2)cc1,C19H24ClN3O4S2,38326.0
17391,JPC0323 Oleate,CCCCCCCC/C=C\CCCCCCCC(=O)NC(CO)(CO)COC(=O)CCCCCCC/C=C\CCCCCCCC,C40H75NO5,39833.0
17392,Pridopidine,CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1,C15H23NO2S,38302.0
17393,STING Agonist D61,CCn1nc(C)cc1C(=O)Nc1nc2cc(C(N)=O)cc(OC)c2n1CCCNc1ncc(-c2ccccc2C(F)(F)F)o1,C29H29F3N8O4,38706.0
17394,4-Methylumbelliferyl-?-L-Fucopyranoside,Cc1cc(=O)oc2cc(O[C@@H]3O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]3O)ccc12,C16H18O7,39552.0
17395,JQAD1,C[C@H](N(Cc1ccc(F)cc1)C(=O)CN1C(=O)O[C@@]2(CCc3cc(NC(=O)CCCCCCCCCCCNc4ccc5c(c4)C(=O)N(C4CCC(=O)NC4=O)C5=O)ccc32)C1=O)C(F)(F)F,C48H52F4N6O9,39566.0
17396,Ferroptocide,C[C@@H]1CC[C@@]23C[C@H](O)C(=O)[C@@]2(O)[C@]1(C)[C@H](OC(=O)CCl)C[C@@H](C1=CCn2c(=O)n(-c4ccccc4)c(=O)n2C1)[C@@H]3C,C30H36ClN3O7,39005.0
17397,Ankaflavin,C/C=C/C1=CC2=C(CO1)C(=O)[C@]1(C)OC(=O)[C@H](C(=O)CCCCCCC)[C@H]1C2,C23H30O5,39546.0
17398,Propionic Acid-d5,[2H]C([2H])([2H])C([2H])([2H])C(=O)O,C3H6O2,39159.0
17399,Ezeprogind (sulfate),CC(C)CN(CCCN1CCN(CCCNc2nc3ccccc3[nH]2)CC1)CC(C)C.O=S(=O)(O)O.O=S(=O)(O)O,C25H48N6O8S2,37401.0
17400,Mycro 3,CCOC(=O)c1cnn(-c2ccccc2)c1NC(=O)c1cc2nc(-c3ccco3)cc(C(F)(F)Cl)n2n1,C24H17ClF2N6O4,37767.0
17401,?-hydroxy Triazolam,OCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,C17H12Cl2N4O,39390.0
17402,?-hydroxy Triazolam (CRM),OCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,C17H12Cl2N4O,40187.0
17403,?9-THC Glucuronide,CCCCCc1cc(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C27H38O8,39623.0
17404,SSE1806,O=C1CCCC2=C1C(c1cccc([N+](=O)[O-])c1)c1cc3c(cc1N2)OCCO3,C21H18N2O5,39780.0
17405,Bictegravir (sodium salt),O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c([O-])c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2.[Na+],C21H17F3N3NaO5,37488.0
17406,D-(-)-Quinic Acid,O=C(O)[C@]1(O)C[C@@H](O)[C@@H](O)[C@H](O)C1,C7H12O6,30212.0
17407,Tauro-d4-ursodeoxycholic Acid,[2H]C([2H])(NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C([2H])([2H])S(=O)(=O)O,C26H45NO6S,39851.0
17408,C16 dihydro Ceramide-d9 (d18:0/16:0-d9),[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC,C34H69NO3,39389.0
17409,Imeglimin (hydrochloride),C[C@@H]1N=C(N)N=C(N(C)C)N1.Cl,C6H13N5(ClH)X,37556.0
17410,N-butyl Pentedrone (hydrochloride),CCCCNC(CCC)C(=O)c1ccccc1.Cl,C15H24ClNO,39234.0
17411,GW 806742X,CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1,C25H22F3N7O4S,37541.0
17412,6-hydroxy Buspirone,O=C1CC2(CCCC2)C(O)C(=O)N1CCCCN1CCN(c2ncccn2)CC1,C21H31N5O3,39807.0
17413,Pemoline,NC1=NC(=O)C(c2ccccc2)O1,C9H8N2O2,14208.0
17414,Cyclobenzaprine-d6 (hydrochloride),Cl.[2H]C([2H])([2H])N(CCC=C1c2ccccc2C=Cc2ccccc21)C([2H])([2H])[2H],C20H22ClN,39834.0
17415,TDTBPP,CC(C)(C)c1ccc(OP(=O)(Oc2ccc(C(C)(C)C)cc2C(C)(C)C)Oc2ccc(C(C)(C)C)cc2C(C)(C)C)c(C(C)(C)C)c1,C42H63O4P,39138.0
17416,?-Sitosterol-D-glucoside,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,C35H60O6,11906.0
17417,AZ 304,COc1ccc2c(Nc3cc(NC(=O)c4cccc(C(C)(C)C#N)c4)ccc3C)ncnc2c1,C27H25N5O2,37580.0
17418,Fulacimstat,Cn1c(=O)oc2cc(-n3cc(C(=O)O)c(=O)n([C@@H]4CCc5c4cccc5C(F)(F)F)c3=O)ccc21,C23H16F3N3O6,37731.0
17419,D-Penicillamine,CC(C)(S)[C@@H](N)C(=O)O,C5H11NO2S,23955.0
17420,Chlorphenesin Carbamate,NC(=O)OCC(O)COc1ccc(Cl)cc1,C10H12ClNO4,39252.0
17421,CGP 55845 (hydrochloride),C[C@H](NC[C@H](O)CP(=O)(O)Cc1ccccc1)c1ccc(Cl)c(Cl)c1.Cl,C18H23Cl3NO3P,21912.0
17422,(+)-Praeruptorin B,C/C=C(/C)C(=O)O[C@H]1c2c(ccc3ccc(=O)oc23)OC(C)(C)[C@H]1OC(=O)/C(C)=C\C,C24H26O7,37536.0
17423,Chonglou Saponin VII,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@@]1(O)[C@@H]2C,C51H82O21,39251.0
17424,ICA 110381,O=C(Nc1ccc(Cl)nc1)c1ccc(Cl)cc1,C12H8Cl2N2O,37294.0
17425,GSK25,CC1=C(C(=O)Nc2cc3cn[nH]c3cc2F)C(c2ccc(Cl)cc2F)NC(c2ccnc(Cl)c2)=N1,C24H16Cl2F2N6O,39163.0
17426,GeA-69,CC(=O)Nc1ccccc1-c1cccc2c1[nH]c1ccccc12,C20H16N2O,39533.0
17427,CU-CPT17e,O=[N+]([O-])c1ccc(COc2cc3c(cc2OCc2ccc([N+](=O)[O-])cc2)OC2(C=C3)CCOCC2)cc1,C27H24N2O8,39534.0
17428,PI4KIII? Inhibitor 3,Cc1ccc(NC(=O)N2CCN(c3nc(N)nc4sc(-c5cccnc5)nc34)CC2)cc1,C22H22N8OS,39530.0
17429,2'-Deoxy-5-fluorocytidine,Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,C9H12FN3O4,37477.0
17430,AZD 5597,CN[C@H]1CCN(C(=O)c2ccc(Nc3ncc(F)c(-c4cnc(C)n4C(C)C)n3)cc2)C1,C23H28FN7O,38526.0
17431,Promethazine Sulfoxide,CC(CN1c2ccccc2S(=O)c2ccccc21)N(C)C,C17H20N2OS,39547.0
17432,DIMBOA,COc1ccc2c(c1)OC(O)C(=O)N2O,C9H9NO5,39647.0
17433,TRi-1,COc1ccc([N+](=O)[O-])c(S(=O)(=O)c2ccc(Cl)cc2)n1,C12H9ClN2O5S,31307.0
17434,Defensamide,CCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)OC,C16H23NO4,37318.0
17435,DIM-C-pPhCO2Me,COC(=O)c1ccc(C(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)cc1,C25H20N2O2,37540.0
17436,J27644,O=C(NO)c1ccc(Cn2c(=O)[nH]c(=O)c3cccc(Cl)c32)cc1,C16H12ClN3O4,39469.0
17437,GX-674,Nc1nc2ccc(-c3cc(Cl)ccc3Oc3cc(F)c(S(=O)(=O)Nc4ncns4)cc3F)cc2[nH]1,C21H13ClF2N6O3S2,39677.0
17438,(E)-KPT-330,O=C(/C=C/n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1,C17H11F6N7O,39562.0
17439,CTB,CCOc1ccccc1C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1,C16H13ClF3NO2,37480.0
17440,FEN1-IN-4,O=c1c2ccccc2n(CC2CC2)c(=O)n1O,C12H12N2O3,37790.0
17441,Bax Channel Blocker,OC(CN1CCNCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21,C19H21Br2N3O,37538.0
17442,Cardiolipin (14:1/14:1/14:1/14:1) (sodium salt),CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC(O)COP(=O)([O-])OC[C@@H](COC(=O)CCCCCCC/C=C\CCCC)OC(=O)CCCCCCC/C=C\CCCC)OC(=O)CCCCCCC/C=C\CCCC.[Na+].[Na+],C65H116Na2O17P2,39280.0
17443,Ocinaplon,O=C(c1ccccn1)c1cnn2c(-c3ccncc3)ccnc12,C17H11N5O,37478.0
17444,Tetramyristoylcardiolipin (ammonium salt),CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC(O)COP(=O)([O-])OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC.[NH4+].[NH4+],C65H132N2O17P2,37277.0
17445,Isopaynantheine,C=C[C@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C23H28N2O4,39879.0
17446,(E/Z)-IT-603,COc1cc(Br)cc(C=C2NC(=S)NC2=O)c1O,C11H9BrN2O3S,37792.0
17447,Carbaryl-d7,[2H]c1c([2H])c([2H])c2c(OC(=O)NC)c([2H])c([2H])c([2H])c2c1[2H],C12H11NO2,39550.0
17448,AB-INACA,CC(C)[C@H](NC(=O)c1n[nH]c2ccccc12)C(N)=O,C13H16N4O2,39400.0
17449,BD 750,Oc1c2c(nn1-c1nc3ccccc3s1)CCCC2,C14H13N3OS,37574.0
17450,(-)-Terpinen-4-ol,CC1=CC[C@@](O)(C(C)C)CC1,C10H18O,38964.0
17451,FT113,O=C(c1ccc(-c2nc3ccc(F)cc3o2)cc1)N1CCN(C(=O)C2(O)CC2)CC1,C22H20FN3O4,37545.0
17452,DLin-MC4-DMA,CCCCC/C=C\C/C=C\CCCCCCCCC(CCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCN(C)C,C44H81NO2,39732.0
17453,4-Trehalosamine,N[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@@H]1CO,C12H23NO10,40229.0
17454,L-Arabinitol,OC[C@H](O)C(O)[C@@H](O)CO,C5H12O5,38882.0
17455,DPCPX,CCCn1c(=O)c2nc(C3CCCC3)[nH]c2n(CCC)c1=O,C16H24N4O2,21972.0
17456,C18 Ceramide-1-phosphate (d18:1/18:0) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])O)NC(=O)CCCCCCCCCCCCCCCCC.[NH4+],C36H75N2O6P,39228.0
17457,BSJ-4-116,CC(C)S(=O)(=O)c1ccccc1Nc1nc(N[C@@H]2CCCN(CCCCCCCNC(=O)COc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)ncc1Cl,C40H49ClN8O8S,39564.0
17458,M2N12,Cc1ccc(Cn2cc(CNC3=C(Cl)C(=O)c4cccnc4C3=O)nn2)cc1,C20H16ClN5O2,37391.0
17459,MIPS521,Nc1scc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1C(=O)c1ccc(Cl)cc1,C19H10ClF6NOS,37776.0
17460,RVX-297,COc1cc(OC)c2c(=O)nc(-c3cc(C)c(OCCN4CCCC4)c(C)c3)[nH]c2c1,C24H29N3O4,38777.0
17461,GSK840,CNC(=O)c1ccc2c(c1)ncn2-c1ccc(CC(=O)OC(C)(C)C)cc1,C21H23N3O3,35661.0
17462,S 2101,Cl.N[C@@H]1C[C@H]1c1cc(F)cc(F)c1OCc1ccccc1,C16H16ClF2NO,19802.0
17463,PPACK (hydrochloride),Cl.Cl.N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)CCl,C21H33Cl3N6O3,37489.0
17464,IAJD249,CCCCCCCCOCC(COCCCCCCCC)(COCCCCCCCC)COC(=O)CCCN1CCN(CCO)CC1,C39H78N2O6,39689.0
17465,Ganoderiol F,C[C@H](CCC=C(CO)CO)[C@H]1CC[C@@]2(C)C3=CC[C@H]4C(C)(C)C(=O)CC[C@]4(C)C3=CC[C@]12C,C30H46O3,39775.0
17466,Pocapavir,COc1ccc(OCc2ccc(COc3c(Cl)cccc3Cl)cc2)c(Cl)c1,C21H17Cl3O3,37349.0
17467,AZD 7624,CNCCOc1ccccc1C1(Nc2nccn(-c3cc(C(=O)NC4CC4)cc(F)c3C)c2=O)CC1,C27H30FN5O3,27690.0
17468,Vanillic Acid,COc1cc(C(=O)O)ccc1O,C8H8O4,39643.0
17469,Hexetidine,CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1,C21H45N3,38755.0
17470,INCB 086550,Cc1c(Nc2nccc3cc(CN4CC[C@@H](O)C4)cnc23)cccc1-c1cccc(-c2nc3cc(CN4CC[C@@H](C(=O)O)C4)cc(C#N)c3o2)c1C,C41H39N7O4,38781.0
17471,BMS 663068,COc1cnc(-n2cnc(C)n2)c2c1c(C(=O)C(=O)N1CCN(C(=O)c3ccccc3)CC1)cn2COP(=O)(O)O,C25H26N7O8P,37708.0
17472,DMU2105,O=C(C=Cc1ccc2ccccc2c1)c1cccnc1,C18H13NO,38522.0
17473,BNTX (maleate),O=C(O)/C=C\C(=O)O.O=C1/C(=C/c2ccccc2)C[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,C31H31NO8,39829.0
17474,Eldecalcitol,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)[C@@H](OCCCO)[C@@H]1O,C30H50O5,33713.0
17475,Isopropylphenidine (hydrochloride),CC(C)NC(Cc1ccccc1)c1ccccc1.Cl,C17H22ClN,39455.0
17476,VU0661013,Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)[C@H](C)CN(c2cn(C)c4ccc(C(=O)O)cc24)C3=O)cc(C)c1Cl,C39H39Cl2N5O4,39524.0
17477,Procyanidin A1,Oc1cc(O)c2c(c1)O[C@@]1(c3ccc(O)c(O)c3)Oc3cc(O)c4c(c3[C@@H]2[C@H]1O)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C4,C30H24O12,38893.0
17478,SGC-CK2-1,CCC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C,C20H21N7O,34103.0
17479,"4-Nonylphenol-2,3,5,6-d4",[2H]c1c([2H])c(CCCCCCCCC)c([2H])c([2H])c1O,C15H24O,39497.0
17480,Conagenin,C[C@@H]([C@@H](C)O)[C@@H](O)C(=O)N[C@@](C)(CO)C(=O)O,C10H19NO6,40222.0
17481,MOMIPP,COc1ccc2[nH]c(C)c(/C=C/C(=O)c3ccncc3)c2c1,C18H16N2O2,39671.0
17482,DNPH1i,OC[C@H]1O[C@@H](n2cnc3c(NCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O,C17H19N5O4,38531.0
17483,"L-745,870 (hydrochloride)",Cl.Cl.Cl.Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,C18H22Cl4N4,37586.0
17484,C-02,O=C1CCC(N2C(=O)c3cccc(NCCCCNC(=O)c4nn(Cc5ccc(Cl)cc5Cl)c5ccccc45)c3C2=O)C(=O)N1,C32H28Cl2N6O5,39384.0
17485,2-p-Toluidinylnaphthylene-6-sulfonate (sodium salt),Cc1ccc(Nc2ccc3cc(S(=O)(=O)[O-])ccc3c2)cc1.[Na+],C17H14NNaO3S,37140.0
17486,RA-2,O=C(OCc1cccc(COC(=O)c2ccc(O)c(F)c2)c1)c1ccc(O)c(F)c1,C22H16F2O6,39567.0
17487,7-Methyl-6-mercaptopurine,Cn1cnc2[nH]cnc(=S)c21,C6H6N4S,39655.0
17488,Atrazine-d5,[2H]C([2H])([2H])C([2H])([2H])Nc1nc(Cl)nc(NC(C)C)n1,C8H14ClN5,39551.0
17489,DOPE-mPEG(2000) (ammonium salt),CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCCNC(=O)OCCOC)OC(=O)CCCCCCC/C=C\CCCCCCCC.[NH4+],C43H83N2O10P(C2H4O)n,37405.0
17490,NAS-181,C1=C(CN2CCOCC2)COc2c1cccc2OC[C@H]1CNCCO1.CS(=O)(=O)O.CS(=O)(=O)O,C21H34N2O10S2,39191.0
17491,11?-hydroxy Testosterone,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,C19H28O3,38301.0
17492,6-O-Methylreticulol,COc1cc2cc(C)oc(=O)c2c(O)c1OC,C12H12O5,40221.0
17493,Cyclazodone,O=C1N=C(NC2CC2)OC1c1ccccc1,C12H12N2O2,22764.0
17494,PAMAM Dendrimer G1.5 Carboxylate (sodium salt) (water solution),O=C([O-])CCN(CCNC(=O)CCN(CCNC(=O)CCN(CCC(=O)NCCN(CCC(=O)NCCN(CCC(=O)[O-])CCC(=O)[O-])CCC(=O)NCCN(CCC(=O)[O-])CCC(=O)[O-])CCN(CCC(=O)NCCN(CCC(=O)NCCN(CCC(=O)[O-])CCC(=O)[O-])CCC(=O)NCCN(CCC(=O)[O-])CCC(=O)[O-])CCC(=O)NCCN(CCC(=O)NCCN(CCC(=O)[O-])CCC(=O)[O-])CCC(=O)NCCN(CCC(=O)[O-])CCC(=O)[O-])CCC(=O)NCCN(CCC(=O)[O-])CCC(=O)[O-])CCC(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],C110H176N26Na16O44,39106.0
17495,Dlin-MC2-DMA,CCCCC/C=C\C/C=C\CCCCCCCCC(CCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCN(C)C,C42H77NO2,39731.0
17496,1-Phenylethylamine (hydrochloride),CC(N)c1ccccc1.Cl,C8H12ClN,39897.0
17497,YCH1899,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCn2c(nnc2-c2ccc(Br)o2)C1,C25H18BrFN6O3,39737.0
17498,JHU37160,CCN1CCN(C2=Nc3cc(Cl)ccc3Nc3c(F)cccc32)CC1,C19H20ClFN4,39531.0
17499,Phellopterin,COc1c2ccoc2c(OCC=C(C)C)c2oc(=O)ccc12,C17H16O5,38965.0
17500,"5,7,3',4',5'-Pentamethoxyflavone",COc1cc(OC)c2c(=O)cc(-c3cc(OC)c(OC)c(OC)c3)oc2c1,C20H20O7,39820.0
17501,N-ethyl Perfluorooctanesulfonamidoethanol,CCN(CCO)S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C12H10F17NO3S,37916.0
17502,PK68,CC(=O)Nc1nc2ccc(-c3cnc(C)c(NC(=O)OC4CCCCC4)c3)cc2s1,C22H24N4O3S,36653.0
17503,ST1936,Cc1[nH]c2ccc(Cl)cc2c1CCN(C)C,C13H17ClN2,39811.0
17504,Metixene (hydrochloride hydrate),CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1.Cl.O,C20H26ClNOS,39825.0
17505,CAY10799 (potassium salt),CCCC(O)CCC(=O)C1=C([O-])CCC1=O.[K+],C12H17KO4,40227.0
17506,MD2-IN-1,COc1ccc(C(=O)C=Cc2cc(OC)c(OC)c(OC)c2)cc1OC,C20H22O6,38323.0
17507,1-Palmitoyl-sn-glycerol,CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO,C19H38O4,39468.0
17508,Puromycin,COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1,C22H29N7O5,35841.0
17509,(R)-(4-Bromophenyl)(phenyl)methanamine,N[C@H](c1ccccc1)c1ccc(Br)cc1,C13H12BrN,37310.0
17510,RP 70676,Cc1cc(C)n(CCCCCSc2nc(-c3ccccc3)c(-c3ccccc3)[nH]2)n1,C25H28N4S,39529.0
17511,ARRY-382,Cc1cccc(Cn2nc(C3CC3)c3c(NC(=O)c4cnc5cc(OCCN6CCN(C)CC6)ccn45)cccc32)n1,C32H36N8O2,38796.0
17512,PAMAM Dendrimer G0-NH2 (water solution),NCCNC(=O)CCN(CCC(=O)NCCN)CCN(CCC(=O)NCCN)CCC(=O)NCCN,C22H48N10O4,39053.0
17513,Spirapril (hydrochloride),CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2.Cl,C22H31ClN2O5S2,39278.0
17514,PAMAM Dendrimer G0.5 Carboxylate (sodium salt) (water solution),O=C([O-])CCN(CCNC(=O)CCN(CCC(=O)NCCN(CCC(=O)[O-])CCC(=O)[O-])CCN(CCC(=O)NCCN(CCC(=O)[O-])CCC(=O)[O-])CCC(=O)NCCN(CCC(=O)[O-])CCC(=O)[O-])CCC(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],C46H72N10Na8O20,39104.0
17515,Pralsetinib,CO[C@]1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CC[C@H](c2nc(C)cc(Nc3cc(C)[nH]n3)n2)CC1,C27H32FN9O2,33181.0
17516,Lixisenatide (acetate),CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O,C217H351N61O67S,39739.0
17517,Aminorex,NC1=NCC(c2ccccc2)O1,C9H10N2O,22762.0
17518,Belzutifan,CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F,C17H12F3NO4S,39652.0
17519,NCT-02,Cc1cnc(NC(=O)Cc2coc3cc4c(cc23)CCC4)s1,C17H16N2O2S,39568.0
17520,1-Stearoyl-sn-glycerol,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO,C21H42O4,39519.0
17521,N-ethyl Perfluorooctanesulfonamide,CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C10H6F17NO2S,37263.0
17522,PAMAM Dendrimer G1.0 Amine (water solution),NCCNC(=O)CCN(CCNC(=O)CCN(CCC(=O)NCCN(CCC(=O)NCCN)CCC(=O)NCCN)CCN(CCC(=O)NCCN(CCC(=O)NCCN)CCC(=O)NCCN)CCC(=O)NCCN(CCC(=O)NCCN)CCC(=O)NCCN)CCC(=O)NCCN,C62H128N26O12,39054.0
17523,B-973B,C[C@H](NC(=O)CCc1ccc(F)c(F)c1)c1cncc(N2CCN(c3ccccn3)CC2)n1,C24H26F2N6O,38790.0
17524,Juglanin,O=c1c(O[C@@H]2O[C@@H](CO)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,C20H18O10,39824.0
17525,Cytogenin,COc1cc(O)c2c(=O)oc(CO)cc2c1,C11H10O5,40220.0
17526,Perfluorooctanesulfonamide,NS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C8H2F17NO2S,37258.0
17527,C25-140,Cc1nn(-c2ccc3nnc(C)n3n2)c(C)c1CCC(=O)N1CCC(Cc2ccccc2)CC1,C26H31N7O,39669.0
17528,Mebendazole-d8,[2H]c1c([2H])c([2H])c(C(=O)c2ccc3nc(NC(=O)OC([2H])([2H])[2H])[nH]c3c2)c([2H])c1[2H],C16H13N3O3,40232.0
17529,Ganoderenic Acid D,C/C(=C\C(=O)CC(C)C(=O)O)C1CC(=O)C2(C)C3=C(C(=O)CC12C)C1(C)CCC(=O)C(C)(C)C1C[C@@H]3O,C30H40O7,39774.0
17530,852A,CCc1nc2c(N)nc3ccccc3c2n1CCCCNS(C)(=O)=O,C17H23N5O2S,39512.0
17531,Erysolin,CS(=O)(=O)CCCCN=C=S,C6H11NO2S2,39661.0
17532,"10-Chloroestra-1,4-diene-3,17-dione",C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43Cl)[C@@H]1CCC2=O,C18H21ClO2,39758.0
17533,NCI 126224,COC(=O)C(=Cc1ccccc1[N+](=O)[O-])C(=O)OC,C12H11NO6,39520.0
17534,11-A-M,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CC12CC3CC(CC(C3)C1)C2)COC(=O)OCCCN(CC)CC,C42H71NO7,39458.0
17535,Meptazinol (hydrochloride),CCC1(c2cccc(O)c2)CCCCN(C)C1.Cl,C15H24ClNO,39657.0
17536,CT3,N#Cc1ncn(CC(=O)N2Cc3ccc(-c4cc(F)cnc4C(F)(F)F)cc3C2)n1,C19H12F4N6O,39416.0
17537,PF-04979064,Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1,C24H26N6O3,39527.0
17538,4-Hydroxyphenylpropionylglycine,O=C(O)CNC(=O)CCc1ccc(O)cc1,C11H13NO4,36389.0
17539,GYKI 53655,CNC(=O)N1N=C(c2ccc(N)cc2)c2cc3c(cc2CC1C)OCO3.Cl,C19H21ClN4O3,39842.0
17540,(+)-Naproxen (sodium salt),COc1ccc2cc([C@H](C)C(=O)[O-])ccc2c1.[Na+],C14H13NaO3,37554.0
17541,Antrodin A,CC(C)=CCOc1ccc(C2=C(CC(C)C)C(=O)OC2=O)cc1,C19H22O4,36094.0
17542,NP-118809,O=C(CC(c1ccccc1)c1ccccc1)N1CCN(C(c2ccccc2)c2ccccc2)CC1,C32H32N2O,37539.0
17543,Homosildenafil,CCCc1nn(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]c12,C23H32N6O4S,38891.0
17544,Desacetylcinobufagin,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)[C@@H](O)[C@H]3O[C@]132,C24H32O5,39822.0
17545,G6PD Activator AG1,c1ccc2c(CCNCCSSCCNCCc3c[nH]c4ccccc34)c[nH]c2c1,C24H30N4S2,39675.0
17546,Clazamycin A (hydrochloride),Cl.N=C1C=C[C@]2(O)C[C@H](Cl)CN12,C7H10Cl2N2O,40224.0
17547,HR68,CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)Nc1ccncc1,C22H19ClN2O3,39855.0
17548,RECTAS,Clc1nc(NCc2ccco2)c2[nH]cnc2n1,C10H8ClN5O,38322.0
17549,Sulfo-Cyanine 5.5,CC[N+]1=C(C=CC=CC=C2N(CCCCCC(=O)O)c3ccc4c(S(=O)(=O)O)cc(S(=O)(=O)O)cc4c3C2(C)C)C(C)(C)c2c1ccc1c(S(=O)(=O)[O-])cc(S(=O)(=O)O)cc21,C41H44N2O14S4,37369.0
17550,NS 3861,CN1C2C=C(c3sccc3Br)CC1CC2,C12H14BrNS,37406.0
17551,IAJD93,CCCCC(CC)COCC(COCC(CC)CCCC)(COCC(CC)CCCC)COC(=O)CCCN1CCN(CCO)CC1,C39H78N2O6,39688.0
17552,L-Valine,CC(C)[C@H](N)C(=O)O,C5H11NO2,38709.0
17553,Glutaminase C Inhibitor 11,O=C(Cc1cccc(Oc2ccccc2)c1)Nc1nnc(N[C@@H]2CCN(c3cccnn3)C2)s1,C24H23N7O2S,39883.0
17554,Cannabigerobutolic Acid,CCCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1C(=O)O,C21H30O4,29136.0
17555,Ganodermanondiol,C[C@H](CC[C@H](O)C(C)(C)O)[C@H]1CC[C@@]2(C)C3=CC[C@H]4C(C)(C)C(=O)CC[C@]4(C)C3=CC[C@]12C,C30H48O3,39776.0
17556,AT-511 (hemisulfate),CNc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)Oc2ccccc2)[C@@H](O)[C@@]1(C)F.O=S(=O)(O)O,C24H35FN7O11PS,33870.0
17557,IMM-H007,CC(=O)OC[C@H]1O[C@@H](n2cnc3c(Nc4cccc(O)c4)ncnc32)[C@H](OC(C)=O)[C@@H]1OC(C)=O,C22H23N5O8,38774.0
17558,1-Palmitoyl-2-Oleoyl-sn-glycero-3-PS (sodium salt),CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OC[C@H]([NH3+])C(=O)[O-].[Na+],C40H75NNaO10P,20068.0
17559,Indole-3-acetonitrile,N#CCc1c[nH]c2ccccc12,C10H8N2,38751.0
17560,BDW568,COC(=O)CSc1nnc2c3c(C)c(C)sc3ncn12,C12H12N4O2S2,39708.0
17561,4-Nitrophenyl ?-D-Xylopyranoside,O=[N+]([O-])c1ccc(O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)cc1,C11H13NO7,38883.0
17562,4-Biphenylacetic Acid,O=C(O)Cc1ccc(-c2ccccc2)cc1,C14H12O2,38116.0
17563,Azaribine,CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O,C14H17N3O9,40131.0
17564,Sofpironium (bromide),CCOC(=O)C[N+]1(C)CC[C@@H](OC(=O)[C@](O)(c2ccccc2)C2CCCC2)C1.[Br-],C22H32BrNO5,38794.0
17565,De-Boc-Cabazitaxel,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](N)c3ccccc3)C(C)=C1C2(C)C,C40H49NO12,40116.0
17566,BMS 963272,Cc1ccc(C2=C(c3nnn[nH]3)C(=O)N[C@@](c3ccc(OCCCC(F)(F)F)cc3)(C(F)(F)F)C2)cc1,C24H21F6N5O2,34981.0
17567,Nucleic Acid Dye Green I,CCCN(CCCN(C)C)c1cc(C=C2Sc3ccccc3N2C)c2ccccc2[n+]1-c1ccccc1.[Cl-],C32H37ClN4S,35669.0
17568,SBI-115,CCS(=O)(=O)c1ncc(Cl)c(C(=O)Oc2cccc(C)c2)n1,C14H13ClN2O4S,39168.0
17569,UK122 (trifluoroacetate salt),N=C(N)c1ccc(/C=C2/N=C(c3ccccc3)OC2=O)cc1.O=C(O)C(F)(F)F,C19H14F3N3O4,9001218.0
17570,Col003,O=Cc1cc(Cc2ccccc2)cc([N+](=O)[O-])c1O,C14H11NO4,39528.0
17571,CK7,Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1,C14H12N6O2S,39153.0
17572,9322-O16B,CCCCCCCCCCCCSSCCOC(=O)CCN(CCCn1ccnc1C)CCC(=O)OCCSSCCCCCCCCCCCC,C41H77N3O4S4,40208.0
17573,Cholic Acid-24-13C,C[C@H](CC[13C](=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C24H40O5,40288.0
17574,"5-(4'-(Azidomethyl)(1,1'-biphenyl)-2-yl)-2H-tetrazole",[N-]=[N+]=NCc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,C14H11N7,38780.0
17575,244cis,CCCCCC/C=C\COC(=O)CCCCCCCCN(CCCCCCCCC(=O)OC/C=C\CCCCCC)CCN1CCN(CCCCCCCCC(=O)OC/C=C\CCCCCC)CC1,C60H111N3O6,39284.0
17576,Mandipropamid,C#CCOc1ccc(CCNC(=O)C(OCC#C)c2ccc(Cl)cc2)cc1OC,C23H22ClNO4,40129.0
17577,12-oxo Stearic Acid,CCCCCCC(=O)CCCCCCCCCCC(=O)O,C18H34O3,40259.0
17578,6?-hydroxy Triamcinolone acetonide,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@@H](O)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,C24H31FO7,40122.0
17579,Neurofibrillary Tangle BODIPY (600/710 nm),CN(C)c1ccc(/C=C/C2=CC3=C4C=CC=[N+]4[B-](F)(F)n4ccc(c43)C=C2)cc1,C23H20BF2N3,40243.0
17580,Notopterol,CC(C)=CC(O)C/C(C)=C/COc1c2ccoc2cc2oc(=O)ccc12,C21H22O5,39268.0
17581,G0-C14 analog,CCCCCCCCCCCCC(O)CN(CCNC(=O)CCN(CCC(=O)NCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CCN(CCC(=O)NCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CCC(=O)NCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC,C134H272N10O12,40194.0
17582,Desmethylclotiazepam Uncyclized Intermediate (hydrochloride),CCc1cc(C(=O)c2ccccc2Cl)c(NC(=O)CN)s1.Cl,C15H16Cl2N2O2S,39920.0
17583,Fluphenazine decanoate,CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,C32H44F3N3O2S,39903.0
17584,BUTINACA,CCCCn1nc(C(N)=O)c2ccccc21,C12H15N3O,40096.0
17585,BPN14770,O=C(O)Cc1ccc(Cc2cc(-c3cccc(Cl)c3)nc(C(F)(F)F)c2)cc1,C21H15ClF3NO2,34075.0
17586,Hydroxy Darunavir,CC(C)(O)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,C27H37N3O8S,40225.0
17587,Mianserin (hydrochloride),CN1CCN2c3ccccc3Cc3ccccc3C2C1.Cl,C18H21ClN2,39378.0
17588,MCP110,COc1cc(CN(CCc2ccccn2)C(=O)CCCCc2ccccc2)ccc1OCc1ccccc1,C33H36N2O3,37725.0
17589,TC LPA5 4,COc1cccc(-n2nc(C(=O)O)cc2-c2ccc(C3CCCCC3)c(Cl)c2)c1,C23H23ClN2O3,17719.0
17590,Cardiolipin (16:0/18:1/16:0/18:1) (sodium salt),CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC(O)COP(=O)([O-])OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC.[Na+].[Na+],C77H144Na2O17P2,39282.0
17591,GSK963,CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1,C14H18N2O,39900.0
17592,EC330,C#CC(F)(F)[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(C4CC4)cc3)C[C@@]21C,C30H32F2O2,37551.0
17593,UNC7145,CC(C)N(Cc1ccc(C(=O)Nc2ccncn2)cc1)C(=O)c1ccc2c(c1)OCC(=O)N2,C24H23N5O4,40166.0
17594,Acetazolamide-d3,[2H]C([2H])([2H])C(=O)Nc1nnc(S(N)(=O)=O)s1,C4H6N4O3S2,40125.0
17595,Aloenin,COc1cc(-c2c(C)cc(O)cc2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)oc(=O)c1,C19H22O10,35859.0
17596,Di-tert-butyl (((S)-1-(tert-butoxy)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)carbamoyl)-L-glutamate,CC(C)(C)OC(=O)CC[C@H](NC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C,C27H42N2O8,39619.0
17597,L-Azidohomoalanine (hydrochloride),Cl.[N-]=[N+]=NCC[C@H](N)C(=O)O,C4H9ClN4O2,11786.0
17598,"Cholesterol-3,4-13C2",CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4[13CH2][13C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O,40278.0
17599,Colneleic Acid,CCCCC/C=C\C=C\OCCCCCCCCC.O=CO,C19H36O3,10005076.0
17600,Aspartyl-alanyl-diketopiperazine,C[C@@H]1NC(=O)[C@H](CC(=O)O)NC1=O,C7H10N2O4,37715.0
17601,C13-112-tri-tail,CCCCCCCCCCCC(O)CNCCOCCOCCN(CC(O)CCCCCCCCCCC)CC(O)CCCCCCCCCCC,C45H94N2O5,38383.0
17602,Benzydamine (hydrochloride),CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12.Cl,C19H24ClN3O,39808.0
17603,3-(4-Chloro-2-methylphenyl)-2-methyl-4(3H)-quinazolinone,Cc1cc(Cl)ccc1-n1c(C)nc2ccccc2c1=O,C16H13ClN2O,40204.0
17604,Harpagoside,C[C@]1(OC(=O)/C=C/c2ccccc2)C[C@@H](O)[C@]2(O)C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]21,C24H30O11,38967.0
17605,TDI-11861,Nc1nc(Cl)cc(-c2nn(C(F)F)cc2Cc2ccccc2OCCN2CCOC[C@H]2CO)n1,C22H25ClF2N6O3,39922.0
17606,GR94800,CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)c1ccccc1)C(N)=O,C49H61N9O8,38773.0
17607,Valerenic Acid,CC1=C2[C@H](/C=C(\C)C(=O)O)CC[C@@H](C)[C@H]2CC1,C15H22O2,40113.0
17608,(+)-Longifolene,C=C1[C@H]2CC[C@@H]3[C@H]2C(C)(C)CCC[C@]13C,C15H24,37362.0
17609,N-acetyl-L-Alanine,CC(=O)N[C@@H](C)C(=O)O,C5H9NO3,37360.0
17610,WDR5-MYC Probe 12,Cc1cc(=O)c(C(=O)NCc2c(F)cc(-c3cccc(S(=O)(=O)F)c3)cc2F)nn1-c1ccccc1,C25H18F3N3O4S,39304.0
17611,N6F11,O=C1NC(CCl)=NC2C=C(c3ccc(Cl)cc3)SC12,C13H10Cl2N2OS,39919.0
17612,PD-1/PD-L1 Inhibitor N11,CC(C)(CO)NCc1cnc2c(N3CCc4c(-c5ccccc5)cccc43)ncnc2c1,C26H27N5O,39663.0
17613,Fumonisin B4,CCCC[C@@H](C)[C@@H](OC(=O)C[C@@H](CC(=O)O)C(=O)O)[C@H](C[C@@H](C)CCCCCCCC[C@H](O)[C@H](C)N)OC(=O)C[C@@H](CC(=O)O)C(=O)O,C34H59NO13,35683.0
17614,SB-4,Brc1ccc(CSc2nc3ccccc3o2)cc1,C14H10BrNOS,37748.0
17615,SLU-10482,O=C(Cc1ccc(F)c(C(F)(F)F)c1)N1CCN(c2ccc3nncn3n2)CC1,C18H16F4N6O,39375.0
17616,WIC1,CCN1CCN(c2ccc(NC(=O)c3cc4ccccc4oc3=O)cc2)CC1,C22H23N3O3,39574.0
17617,CCMI,Cc1cc(C(=CNc2ccc(Cl)cc2)C(=O)Nc2ccc(Cl)cc2)on1,C19H15Cl2N3O2,37571.0
17618,Dihydrocurcumin,COc1cc(/C=C/C(O)=C/C(=O)CCc2ccc(O)c(OC)c2)ccc1O,C21H22O6,39823.0
17619,Cardiolipin (18:1/18:1/18:1/18:1) (sodium salt),CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC(O)COP(=O)([O-])OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC.[Na+].[Na+],C81H148Na2O17P2,14045.0
17620,DUN41875,Cc1c(C(=O)Nc2ccn(C)n2)ncn1Cc1cccc(C(F)(F)F)c1,C17H16F3N5O,37151.0
17621,ARV-110,N#Cc1ccc(O[C@H]2CC[C@H](NC(=O)c3ccc(N4CCC(CN5CCN(c6cc7c(cc6F)C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)CC4)nn3)CC2)cc1Cl,C41H43ClFN9O6,39662.0
17622,S1PL-IN-31,C[C@@H]1CN(c2nnc(Cc3ccccc3)c3ccc(Cl)cc23)CCN1c1ccc(C#N)cn1,C26H23ClN6,39826.0
17623,Foroxymithine,CC(=O)N[C@@H](CCCN(O)C=O)C(=O)N[C@@H](CO)C(=O)N(O)CCC[C@@H]1NC(=O)[C@H](CCCN(O)C=O)NC1=O,C22H37N7O11,40228.0
17624,CYY292,COc1cc(Nc2ncc(C)c(Nc3ccc4cn[nH]c4c3)n2)ccc1N1CCN(C)CC1,C24H28N8O,39831.0
17625,MK-8722,O[C@@H]1CO[C@H]2[C@@H]1OC[C@H]2Oc1nc2nc(-c3ccc(-c4ccccc4)cc3)c(Cl)cc2[nH]1,C24H20ClN3O4,37578.0
17626,Perfluoroheptanesulfonic Acid,O=S(=O)(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C7HF15O3S,37246.0
17627,GBR 12783 (hydrochloride),C(=Cc1ccccc1)CN1CCN(CCOC(c2ccccc2)c2ccccc2)CC1.Cl.Cl,C28H34Cl2N2O,35662.0
17628,"8(4'-bromophenyl)-1,3,5,7-tetramethyl-BODIPY",CC1=CC(C)=[N+]2C1=C(c1ccc(Br)cc1)c1c(C)cc(C)n1[B-]2(F)F,C19H18BBrF2N2,40123.0
17629,inS3-54-A18,O=C1C(=Cc2ccc(Cl)cc2)C=C(c2ccccc2)N1c1ccc(O)cc1,C23H16ClNO2,39678.0
17630,Perfluorohexanesulfonamide,NS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C6H2F13NO2S,38306.0
17631,SN-38-d3,[2H]C([2H])([2H])Cc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,C22H20N2O5,40133.0
17632,Perfluoropentanesulfonic Acid,O=S(=O)(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C5HF11O3S,37253.0
17633,Aldicarb-d3,[2H]C([2H])([2H])NC(=O)ON=CC(C)(C)SC,C7H14N2O2S,39580.0
17634,Ganciclovir (sodium salt),Nc1nc([O-])c2ncn(COC(CO)CO)c2n1.[Na+],C9H12N5NaO4,37487.0
17635,HWL-088,Cc1ccccc1-c1cccc(COc2ccc(OCC(=O)O)c(F)c2)c1,C22H19FO4,30227.0
17636,WS5,CCOC(=O)CNC(=O)[C@@H]1C[C@H](C)CC[C@H]1C(C)C,C15H27NO3,38763.0
17637,?8-THCPA-A,CCCCCCCc1cc2c(c(O)c1C(=O)O)[C@@H]1CC(C)=CC[C@H]1C(C)(C)O2,C24H34O4,39461.0
17638,9-O-desmethyl Mitragynine,CC[C@@H]1CN2CCc3c([nH]c4cccc(O)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C22H28N2O4,27540.0
17639,4-Methylphenmetrazine (hydrochloride),Cc1ccc(C2OCCNC2C)cc1.Cl,C12H18ClNO,35151.0
17640,Biotin Sulfoxide,O=C(O)CCCC[C@H]1[C@H]2NC(=O)N[C@H]2CS1=O,C10H16N2O4S,40172.0
17641,Benzydamine-d6 (hydrochloride),Cl.[2H]C([2H])([2H])N(CCCOc1nn(Cc2ccccc2)c2ccccc12)C([2H])([2H])[2H],C19H24ClN3O,40112.0
17642,BZAD-01,N=C(NCc1ccccc1C(F)(F)F)c1ccc(OC(F)(F)F)cc1,C16H12F6N2O,38788.0
17643,RAD150,Cc1c(N[C@@H](c2nnc(-c3ccc(C#N)cc3)o2)[C@H](C)OC(=O)c2ccccc2)ccc(C#N)c1Cl,C27H20ClN5O3,39173.0
17644,Inavolisib,C[C@H](Nc1ccc2c(c1)OCCn1cc(N3C(=O)OC[C@H]3C(F)F)nc1-2)C(N)=O,C18H19F2N5O4,37576.0
17645,"7(Z),10(Z),13(Z)-Hexadecatrienoic Acid",CC/C=C\C/C=C\C/C=C\CCCCCC(=O)O,C16H26O2,10005156.0
17646,Methohexital (exempt preparation),C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,C14H18N2O3,39997.0
17647,306-N16B,CCCCCCCCCCCCSSCCNC(=O)CCN(CCCN(C)CCCN(CCC(=O)NCCSSCCCCCCCCCCCC)CCC(=O)NCCSSCCCCCCCCCCCC)CCC(=O)NCCSSCCCCCCCCCCCC,C75H151N7O4S8,37927.0
17648,Dihydromyristicin,CCCc1cc(OC)c2c(c1)OCO2,C11H14O3,39272.0
17649,"1,2-Dioleoyl-3-trimethylammoniumpropane (methyl sulfate)",CCCCCCCC/C=C\CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC.COS(=O)(=O)[O-],C43H83NO8S,38905.0
17650,Normetanephrine (hydrochloride),COc1cc(C(O)CN)ccc1O.Cl,C9H14ClNO3,38792.0
17651,Silydianin,COc1cc([C@@H]2[C@H]3CO[C@@]4(O)C(=O)[C@@H]2C=C([C@H]2Oc5cc(O)cc(O)c5C(=O)[C@@H]2O)[C@@H]34)ccc1O,C25H22O10,39248.0
17652,Strophanthidin,C[C@]12CC[C@H]3[C@@H](CC[C@]4(O)C[C@@H](O)CC[C@]34C=O)[C@@]1(O)CC[C@@H]2C1=CC(=O)OC1,C23H32O6,39244.0
17653,Taraxasterol,C=C1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]2[C@@H]1C,C30H50O,39245.0
17654,FerroLOXIN-1,Fc1cccc(-n2cc(-c3ccccc3)nc2NCc2ccc(C(F)(F)F)c(F)c2)c1,C23H16F5N3,39325.0
17655,N-acetyl-L-Glutamic Acid,CC(=O)N[C@@H](CCC(=O)O)C(=O)O,C7H11NO5,37359.0
17656,Dehydrocannabifuran,C=C(C)c1ccc(C)c2oc3cc(CCCCC)cc(O)c3c12,C21H24O2,39782.0
17657,SLF1081851 (hydrochloride),CCCCCCCCCCc1ccc(-c2noc(CCCN)n2)cc1.Cl,C21H34ClN3O,37150.0
17658,D-(-)-Tagatose,O=C(CO)[C@@H](O)[C@@H](O)[C@H](O)CO,C6H12O6,39233.0
17659,Cnicin,C=C1C(=O)O[C@@H]2/C=C(\CO)CC/C=C(\C)C[C@H](OC(=O)C(=C)[C@@H](O)CO)[C@@H]12,C20H26O7,38969.0
17660,Orforglipron,Cc1cc(-n2nc3c(c2-n2ccn(-c4ccc5c(cnn5C)c4F)c2=O)[C@H](C)N(C(=O)c2cc4cc([C@H]5CCOC(C)(C)C5)ccc4n2[C@@]2(c4noc(=O)[nH]4)C[C@@H]2C)CC3)cc(C)c1F,C48H48F2N10O5,39741.0
17661,Rilmazolam,CN(C)C(=O)c1nc2n(n1)-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,C19H15Cl2N5O,39863.0
17662,Voclosporin,C=C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,C63H111N11O12,39719.0
17663,Nifuratel,CSCC1CN(N=Cc2ccc([N+](=O)[O-])o2)C(=O)O1,C10H11N3O5S,40119.0
17664,Di-tert-butyl (((S)-6-amino-1-(tert-butoxy)-1-oxohexan-2-yl)carbamoyl)-L-glutamate,CC(C)(C)OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCN)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C,C24H45N3O7,39616.0
17665,Lacto-N-tetraose,CC(=O)N[C@H]1[C@H](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]([C@H](O)[C@@H](O)C=O)[C@H](O)CO)[C@@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,C26H45NO21,39034.0
17666,5-O-Methylvisammioside,COc1c2c(cc3oc(C)cc(=O)c13)O[C@H](C(C)(C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C2,C22H28O10,39250.0
17667,Isosteviol,C[C@@]12CC[C@@H]3[C@@](CC[C@H]4[C@@]3(C)CCC[C@@]4(C)C(=O)O)(CC1=O)C2,C20H30O3,36916.0
17668,Heraclenin,CC1(C)O[C@@H]1COc1c2occc2cc2ccc(=O)oc12,C16H14O5,39146.0
17669,18-hydroxy Oleoyl Leucine-d7,[2H]C([2H])([2H])C([2H])(C[C@H](NC(=O)CCCCCCC/C=C\CCCCCCCCO)C(=O)O)C([2H])([2H])[2H],C24H45NO4,9004331.0
17670,JHU37152,CCN1CCN(C2=Nc3cc(Cl)ccc3Nc3cccc(F)c32)CC1,C19H20ClFN4,39532.0
17671,?9-THCP Acetate,CCCCCCCc1cc(OC(C)=O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,C25H36O3,37968.0
17672,"L-838,417",Cn1ncnc1COc1nn2c(-c3cc(F)ccc3F)nnc2cc1C(C)(C)C,C19H19F2N7O,22007.0
17673,Fmoc-Thr(GalNAc(Ac)3-?-D)-OH,CC(=O)N[C@H]1[C@@H](O[C@H](C)[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O,C33H38N2O13,38759.0
17674,"1-(2,3-Dichlorophenyl)urea",NC(=O)Nc1cccc(Cl)c1Cl,C7H6Cl2N2O,39160.0
17675,DU-14,CCCCCCCCCCCCCC(=O)NCCc1ccc(OS(N)(=O)=O)cc1,C22H38N2O4S,39665.0
17676,?8-THCBA-A,CCCCc1cc2c(c(O)c1C(=O)O)[C@@H]1CC(C)=CC[C@H]1C(C)(C)O2,C21H28O4,39460.0
17677,?8-THCBA-A (exempt preparation),CCCCc1cc2c(c(O)c1C(=O)O)[C@@H]1CC(C)=CC[C@H]1C(C)(C)O2,C21H28O4,41301.0
17678,"N,N-Dimethyl-L-tryptophan (hydrochloride)",CN(C)[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.Cl,C13H17ClN2O2,35114.0
17679,Deterenol (hydrochloride),CC(C)NCC(O)c1ccc(O)cc1.Cl,C11H18ClNO2,39583.0
17680,Maribavir,CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O,C15H19Cl2N3O4,39650.0
17681,N-methyl Cyclazodone,CN(C1=NC(=O)C(c2ccccc2)O1)C1CC1,C13H14N2O2,27947.0
17682,TK05,COc1ccc(C(=O)c2ccc(C(=O)c3ccc(N(CC4CC4)c4ccc(Cl)cc4)cn3)cc2C(=O)O)cc1,C31H25ClN2O5,19793.0
17683,Apocarotenal,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(\C)C=O)C(C)(C)CCC1,C30H40O,37231.0
17684,N-desmethyl Rilmazolam,CNC(=O)c1nc2n(n1)-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,C18H13Cl2N5O,39864.0
17685,Rucaparib (camsylate),CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)O)C(=O)C2.CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,C29H34FN3O5S,40218.0
17686,MB-07811,Cc1cc(OC[P@@]2(=O)OCC[C@@H](c3cccc(Cl)c3)O2)cc(C)c1Cc1ccc(O)c(C(C)C)c1,C28H32ClO5P,30670.0
17687,?v?5 Integrin-IN-1,O=C(O)C[C@H](C(=O)N1CC[C@@H](CCC2=CC=C3CCCN=C3N2)C1)c1cccc(C(F)(F)F)c1,C25H28F3N3O3,39733.0
17688,INCB 13739,Cc1c(Cl)cccc1S(=O)(=O)N1CCC[C@H](C(=O)NC2CCCCC2)C1,C19H27ClN2O3S,40223.0
17689,(R)-ErSO,O=C1Nc2c(C(F)(F)F)cccc2[C@@]1(c1ccc(O)cc1)c1ccc(OC(F)(F)F)cc1,C22H13F6NO3,35684.0
17690,CL15F6,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCC(O)(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCOC(=O)C1CCN(C)CC1,C56H107NO7,40345.0
17691,"2,3-Dihydrobenzofuran",c1ccc2c(c1)CCO2,C8H8O,39945.0
17692,12-keto Chenodeoxycholic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC(=O)[C@]12C,C24H38O5,30838.0
17693,Mogroside IIIe,C[C@H](CC[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)O)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4[C@@H](CC[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C4(C)C)[C@]3(C)[C@H](O)C[C@]12C,C48H82O19,39286.0
17694,N4-Acetyl-2'-O-methylcytidine,CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1ccc(NC(C)=O)nc1=O,C12H17N3O6,40285.0
17695,DUPA(OtBu)-OH,CC(C)(C)OC(=O)CC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C,C23H40N2O9,39617.0
17696,Formosanin C,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,C51H82O20,40236.0
17697,Negletein,COc1cc2oc(-c3ccccc3)cc(=O)c2c(O)c1O,C16H12O5,38971.0
17698,"7(Z),10(Z),13(Z)-Hexadecatrienoic acid methyl ester",CC/C=C\C/C=C\C/C=C\CCCCCC(=O)OC,C17H28O2,10005161.0
17699,Perfluoropropanesulfonic Acid,O=S(=O)(O)C(F)(F)C(F)(F)C(F)(F)F,C3HF7O3S,38156.0
17700,PFI-90,O=C(NNc1ccccn1)c1ccccn1,C11H10N4O,40120.0
17701,IRAK4 Inhibitor 28,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,C21H31N5O2,40167.0
17702,R-6890,CC(c1ccc(Cl)cc1)N1CCC2(CC1)C(=O)NCN2c1ccccc1,C21H24ClN3O,39967.0
17703,Linzagolix,COc1cc(F)c(-n2c(=O)[nH]c3csc(C(=O)O)c3c2=O)cc1OCc1c(OC)ccc(F)c1F,C22H15F3N2O7S,39654.0
17704,5-Amino-6-(D-ribitylamino)uracil (hydrochloride),Nc1c(NC[C@H](O)[C@H](O)[C@H](O)CO)[nH]c(=O)[nH]c1=O,C9H16N4O6,39898.0
17705,7-Aminocephalosporanic Acid,CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](N)[C@H]2SC1,C10H12N2O5S,35824.0
17706,VL422,CCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCC(=O)OCC(COC(=O)CCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC)COC(=O)OCCCN(CC)CC,C62H117NO11,39874.0
17707,LGD 3303,CCc1c(C)c2c3c(Cl)cc(=O)[nH]c3ccc2n1CC(F)(F)F,C16H14ClF3N2O,40143.0
17708,Senexin A,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,C17H14N4,30291.0
17709,Soyasapogenol B,CC1(C)C[C@@H](O)[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,C30H50O3,40270.0
17710,4-methoxy-5-Hydroxycanthin-6-one,COc1c(O)c(=O)n2c3ccccc3c3ccnc1c32,C15H10N2O3,40234.0
17711,TAS 6417,C=CC(=O)N[C@H]1C=C(C)c2c(-c3cnc4ccccc4c3)c3c(N)ncnc3n2C1,C23H20N6O,27911.0
17712,Eupafolin,COc1c(O)cc2oc(-c3ccc(O)c(O)c3)cc(=O)c2c1O,C16H12O7,40138.0
17713,LY294002 (hydrochloride),Cl.O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,C19H18ClNO3,39171.0
17714,N2-Isobutyryl Guanosine,CC(C)C(=O)Nc1nc(=O)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2[nH]1,C14H19N5O6,40283.0
17715,ULK-101,O=C(N[C@@H](C1CC1)C(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(F)cc4)cnc23)cs1,C22H16F4N4OS,40403.0
17716,GNF-362,C[C@@H]1CN(Cc2c[nH]nc2-c2ccc(C#N)cc2)CCN1c1ccc(C(F)(F)F)cn1,C22H21F3N6,35866.0
17717,PF-06826647,Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](C#N)C4)c3)n2)cn1,C20H17N9,37577.0
17718,BDE 47,Brc1ccc(Oc2ccc(Br)cc2Br)c(Br)c1,C12H6Br4O,39232.0
17719,Dexmedetomidine,Cc1cccc([C@H](C)c2cnc[nH]2)c1C,C13H16N2,39544.0
17720,Acetylshikonin,CC(=O)O[C@H](CC=C(C)C)C1=CC(=O)c2c(O)ccc(O)c2C1=O,C18H18O6,40144.0
17721,Stearic Acid-d5,[2H]C([2H])([2H])C([2H])([2H])CCCCCCCCCCCCCCCC(=O)O,C18H36O2,9000455.0
17722,Fluorofenidone,Cc1ccc(=O)n(-c2cccc(F)c2)c1,C12H10FNO,39651.0
17723,N-trans-Caffeoyltyramine,O=C(/C=C/c1ccc(O)c(O)c1)NCCc1ccc(O)cc1,C17H17NO4,40340.0
17724,Imidaprilat,C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O,C18H23N3O6,38046.0
17725,1-Docosahexaenoyl-rac-glycerol,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCC(O)CO,C25H38O4,35871.0
17726,STING PROTAC SP23,O=C(/C=C/C(=O)Nc1ccc(NC(=O)c2ccc([N+](=O)[O-])o2)cc1)NCCCCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,C34H33N7O10,39274.0
17727,N6-Methyl-2'-deoxyadenosine,CNc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,C11H15N5O3,40407.0
17728,Rosavin,O[C@@H]1[C@@H](O)[C@H](OC/C=C/c2ccccc2)O[C@H](CO[C@@H]2OC[C@H](O)[C@H](O)[C@H]2O)[C@H]1O,C20H28O10,39839.0
17729,16-Oxocafestol,CC12CCc3occc3C1CCC13CC(=O)C(CCC12)C3,C19H24O2,39940.0
17730,Promethazine-d4 (hydrochloride),Cl.[2H]c1cc([2H])c2c(c1)Sc1cc([2H])cc([2H])c1N2CC(C)N(C)C,C17H21ClN2S,40321.0
17731,Isoastragaloside I,CC(=O)O[C@H]1[C@H](O[C@H]2CC[C@]34C[C@]35CC[C@]3(C)[C@@H]([C@@]6(C)CC[C@@H](C(C)(C)O)O6)[C@@H](O)C[C@@]3(C)[C@@H]5C[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]4C2(C)C)OC[C@@H](OC(C)=O)[C@@H]1O,C45H72O16,40279.0
17732,Mitochondrial Fusion Promoter M1,CC(=NNc1c(Cl)cc(Cl)cc1Cl)c1cc(Cl)ccc1O,C14H10Cl4N2O,39909.0
17733,?-Ionone Acid,CC1=C(/C=C/C(=O)O)C(C)(C)CCC1,C12H18O2,9004321.0
17734,N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys (trifluoroacetate salt),CCCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O.O=C(O)C(F)(F)F,C45H66F3N7O11,35865.0
17735,GCN2iB,COc1ncc(Cl)cc1S(=O)(=O)Nc1ccc(F)c(C#Cc2cnc(N)nc2)c1F,C18H12ClF2N5O3S,35897.0
17736,U-99194 (maleate),CCCN(CCC)C1Cc2cc(OC)c(OC)cc2C1.O=C(O)/C=C\C(=O)O,C21H31NO6,35854.0
17737,Diltiazem-d3 (hydrochloride),Cl.[2H]C([2H])([2H])C(=O)O[C@H]1C(=O)N(CCN(C)C)c2ccccc2S[C@H]1c1ccc(OC)cc1,C22H27ClN2O4S,39981.0
17738,"8(Z),11(Z),14(Z)-Heptadecatrienal",CC/C=C\C/C=C\C/C=C\CCCCCCC=O,C17H28O,10005154.0
17739,Astragaloside II,CC(=O)O[C@H]1[C@H](O[C@H]2CC[C@]34C[C@]35CC[C@]3(C)[C@@H]([C@@]6(C)CC[C@@H](C(C)(C)O)O6)[C@@H](O)C[C@@]3(C)[C@@H]5C[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]4C2(C)C)OC[C@@H](O)[C@@H]1O,C43H70O15,40139.0
17740,Stearda,CCCCCCCCCCCCCCCCCC(=O)NCCc1ccc(O)c(O)c1,C26H45NO3,38973.0
17741,X-82,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)N[C@H]1CCN(C(=O)N(C)C)C1,C23H26FN5O3,38765.0
17742,D-(+)-Ribonic Acid ?-lactone,O=C1O[C@H](CO)[C@@H](O)[C@H]1O,C5H8O5,39293.0
17743,Annaosanchun,C[C@@]12CCC[C@H]1[C@@H]1C[C@@H](O)[C@@]3(O)C[C@@H](O)CC[C@]3(C)[C@H]1CC2,C19H32O3,37572.0
17744,MMB-ICA,COC(=O)[C@@H](NC(=O)c1c[nH]c2ccccc12)C(C)C,C15H18N2O3,39951.0
17745,NBD-Pen,CCCCCC1(C)CC(Nc2ccc([N+](=O)[O-])c3nonc23)CC(C)(C)N1[O],C19H28N5O4,25806.0
17746,2'-Fluoro-2'-deoxyadenosine,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1F,C10H12FN5O3,39923.0
17747,4-Acetamido Antipyrine,CC(=O)Nc1c(C)n(C)n(-c2ccccc2)c1=O,C13H15N3O2,40308.0
17748,Coumarin 6,CCN(CC)c1ccc2cc(-c3nc4ccccc4s3)c(=O)oc2c1,C20H18N2O2S,40214.0
17749,Vincristine-d3,[2H]C([2H])([2H])C(=O)O[C@@H]1[C@]2(CC)C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[N@](CCc8c6[nH]c6ccccc86)C[C@](O)(CC)C7)c(OC)cc5N(C=O)[C@H]4[C@@]1(O)C(=O)OC)[C@@H]32,C46H56N4O10,34512.0
17750,(Z)-Capsaicin,COc1cc(CNC(=O)CCCC/C=C\C(C)C)ccc1O,C18H27NO3,39929.0
17751,"7-(p-Methoxybenzylamino)-4-nitrobenz-2,1,3-oxadiazole",COc1ccc(CNc2ccc([N+](=O)[O-])c3nonc23)cc1,C14H12N4O4,39668.0
17752,Apigenin-7-O-(2G-rhamnosyl)gentiobioside,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C33H40O19,35893.0
17753,MT-802,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCN(CCOCCOCC(=O)Nc2ccc3c(c2)C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,C41H41N9O8,36581.0
17754,cRIPGBM,Cc1n(Cc2ccccc2)c2c([n+]1Cc1ccc(F)cc1)C(=O)c1ccccc1C2=O.[Cl-],C26H20ClFN2O2,38115.0
17755,"Mebhydroline (1,5-naphthalenedisulfonate)",CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1.CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1.O=S(=O)(O)c1cccc2c(S(=O)(=O)O)cccc12,C48H48N4O6S2,40281.0
17756,ONC206,O=C1C2=C(CCN(Cc3ccccc3)C2)N2CCN=C2N1Cc1ccc(F)cc1F,C23H22F2N4O,36777.0
17757,IR-117-17,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCCCCCC(O)C(CCCCOC(=O)CCCCCCC/C=C\C/C=C\CCCCC)CNCCCN(CCCC)CCCC,C59H110N2O5,40420.0
17758,Ombuin,COc1cc(O)c2c(=O)c(O)c(-c3ccc(OC)c(O)c3)oc2c1,C17H14O7,40217.0
17759,PF-06651600,C=CC(=O)N1CC(Nc2ncnc3[nH]ccc23)CC[C@@H]1C,C15H19N5O,21054.0
17760,Lipid C-1,CCCCCCCCCCCOC(=O)CCCCCN(CCCO)CCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC,C45H89NO5,39975.0
17761,Ethyl 2-phenylacetoacetate,CCOC(=O)C(C(C)=O)c1ccccc1,C12H14O3,39487.0
17762,(S)-C12-200,CCCCCCCCCC[C@H](O)CN(CCN1CCN(CCN(C[C@@H](O)CCCCCCCCCC)C[C@@H](O)CCCCCCCCCC)CC1)CCN(C[C@@H](O)CCCCCCCCCC)C[C@@H](O)CCCCCCCCCC,C70H145N5O5,38885.0
17763,"5,7,3',4'-Tetramethoxyflavone",COc1cc(OC)c2c(=O)cc(-c3ccc(OC)c(OC)c3)oc2c1,C19H18O6,40272.0
17764,GR89696 (fumarate),COC(=O)N1CCN(C(=O)Cc2ccc(Cl)c(Cl)c2)C(CN2CCCC2)C1.O=C(O)/C=C/C(=O)O,C23H29Cl2N3O7,40145.0
17765,RMC-4630,Cc1nc(N2CCC3(CC2)CO[C@@H](C)[C@H]3N)c(CO)nc1Sc1ccnc(N)c1Cl,C20H27ClN6O2S,38772.0
17766,Metoclopramide,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,C14H22ClN3O2,39844.0
17767,N-Phenethylnoroxymorphone,O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CCc2ccccc2)[C@H]1O5,C24H25NO4,35677.0
17768,Obeldesivir,CC(C)C(=O)OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O,C16H19N5O5,40404.0
17769,8-Desoxygartanin,CC(C)=CCc1c(O)c(CC=C(C)C)c2oc3c(O)cccc3c(=O)c2c1O,C23H24O5,40275.0
17770,D-Pantethine,CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO,C22H42N4O8S2,39137.0
17771,AZD 4604,COC[C@H](C(=O)Nc1cccc2c(-c3nc(Nc4cccc(S(C)(=O)=O)c4F)ncc3F)c[nH]c12)N1CCN(C)CC1,C28H31F2N7O4S,39890.0
17772,Lipid C3,CCCCCCCCCCCCCCC(O)CN(CCN1CCN(CC(CN(CC(O)CCCCCCCCCCCCCC)CC(O)CCCCCCCCCCCCCC)OCC)CC1)CC(CN(CC(O)CCCCCCCCCCCCCC)CC(O)CCCCCCCCCCCCCC)OCC,C96H197N5O7,39516.0
17773,Docosahexaenoyl Serinol,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NC(CO)CO,C25H39NO3,35678.0
17774,5-Aminothalidomide,Nc1ccc2c(c1)C(=O)N(C1CCC(=O)NC1=O)C2=O,C13H11N3O4,39514.0
17775,Sinapaldehyde,COc1cc(/C=C/C=O)cc(OC)c1O,C11H12O4,40267.0
17776,DAR-4M,CNc1ccc(-c2c3ccc(=[N+](C)C)cc-3oc3cc(N(C)C)ccc23)c(C(=O)[O-])c1N,C25H26N4O3,27897.0
17777,"2,3-Dichlorobiphenyl",Clc1cccc(-c2ccccc2)c1Cl,C12H8Cl2,35886.0
17778,Semaglutide,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C,C187H291N45O59,40231.0
17779,Artemitin,COc1ccc(-c2oc3cc(OC)c(OC)c(O)c3c(=O)c2OC)cc1OC,C20H20O8,40269.0
17780,TCH-165,CCOC(=O)[C@]1(c2ccccc2)N=C(c2ccc(OC)cc2)N(Cc2ccccc2)[C@@H]1c1ccc(NCc2ccccc2)cc1,C39H37N3O3,40454.0
17781,1-10(Z)-Heptadecenoyl-2-hydroxy-sn-glycero-3-PE,CCCCCC/C=C\CCCCCCCCC(=O)OC[C@@H](O)COP(=O)(O)OCCN,C22H44NO7P,35672.0
17782,Valproic Acid-d4,[2H]C([2H])(CC)C(C(=O)[O-])C([2H])([2H])CC,C8H15O2,39966.0
17783,?9-THCBA-A (exempt preparation),CCCCc1cc2c(c(O)c1C(=O)O)[C@@H]1C=C(C)CC[C@H]1C(C)(C)O2,C21H28O4,39959.0
17784,?9-THCBA-A,CCCCc1cc2c(c(O)c1C(=O)O)[C@@H]1C=C(C)CC[C@H]1C(C)(C)O2,C21H28O4,29309.0
17785,PCO371,Cc1cc(N2C(=O)NC(=O)C2(C)C)cc(C)c1CCS(=O)(=O)N1CCC2(CC1)NC(c1ccc(OC(F)(F)F)cc1)=NC2=O,C29H32F3N5O6S,39182.0
17786,"3,3'-Diethyloxacarbocyanine (iodide)",CCN1C(=CC=Cc2oc3ccccc3[n+]2CC)Oc2ccccc21.[I-],C21H21IN2O2,39456.0
17787,N4-benzoyl-2'-Deoxycytidine,O=C(Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1)c1ccccc1,C16H17N3O5,39934.0
17788,Bruceine D,CC1=CC(=O)[C@@H](O)[C@]2(C)[C@H]3[C@@H](O)[C@H](O)[C@@]4(C)OC[C@@]35[C@@H](C[C@@H]12)OC(=O)[C@H](O)[C@]54O,C20H26O9,40140.0
17789,"4',5,7-Trimethoxyflavone",COc1ccc(-c2cc(=O)c3c(OC)cc(OC)cc3o2)cc1,C18H16O5,40271.0
17790,MA-0204,Cc1cnc(-c2ccc(OC(F)(F)F)cc2)n1Cc1ccccc1OCCC[C@@H](C)CC(=O)O,C25H27F3N2O4,26025.0
17791,16-carboxy Mitragynine,CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)O,C22H28N2O4,27538.0
17792,Desipramine (hydrochloride) (CRM),CNCCCN1c2ccccc2CCc2ccccc21.Cl,C18H23ClN2,19105.0
17793,Desipramine (hydrochloride),CNCCCN1c2ccccc2CCc2ccccc21.Cl,C18H23ClN2,15304.0
17794,Semaglutide (sodium salt),CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C.[NaH],C187H291N45NaO59,40170.0
17795,GSK843,Cc1cc(-c2cnc(N)c3c(-c4ccc5scnc5c4)csc23)n(C)n1,C19H15N5S2,39835.0
17796,HOE 32021,COc1ccc(-c2nc3ccc(-c4nc5ccc(N6CCN(C)CC6)cc5[nH]4)cc3[nH]2)cc1,C26H26N6O,39912.0
17797,SAINT C-18,CCCCCCCC/C=C\CCCCCCCCC(CCCCCCCC/C=C\CCCCCCCC)c1cc[n+](C)cc1.[Cl-],C43H78ClN,39709.0
17798,Gitoxin,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)[C@@H](O)C[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,C41H64O14,38888.0
17799,2'-Fluoro-2'-deoxy-arabino-Cytidine,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)c(=O)n1,C9H12FN3O4,39935.0
17800,Acetylharpagide,CC(=O)O[C@@]1(C)C[C@@H](O)[C@]2(O)C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]21,C17H26O11,39930.0
17801,3'-Deoxy-3'-fluoroguanosine,Nc1nc(=O)c2ncn([C@@H]3O[C@H](CO)[C@@H](F)[C@H]3O)c2[nH]1,C10H12FN5O4,35699.0
17802,Promethazine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])N(C)C(C)CN1c2ccccc2Sc2ccccc21,C17H21ClN2S,38299.0
17803,Promethazine-d3 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])N(C)C(C)CN1c2ccccc2Sc2ccccc21,C17H21ClN2S,39606.0
17804,Raddeanin A,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC=C7[C@@H]8CC(C)(C)CC[C@]8(C(=O)O)CC[C@@]7(C)[C@]6(C)CC[C@H]5C4(C)C)OC[C@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C47H76O16,40235.0
17805,SC-13,CCCn1c(=O)c2sccc2n(Cc2cccc(NC(=O)Cc3ccccc3)c2)c1=O,C24H23N3O3S,39717.0
17806,Rosuvastatin EP Impurity A (calcium salt),CC(C)c1nc(N(C)S(=O)(=O)CC(C)(C)O)nc(-c2ccc(F)cc2)c1/C=C/C(O)CC(O)CC(=O)[O-].CC(C)c1nc(N(C)S(=O)(=O)CC(C)(C)O)nc(-c2ccc(F)cc2)c1/C=C/C(O)CC(O)CC(=O)[O-].[Ca+2],C50H66CaF2N6O14S2,35686.0
17807,DCLK1-IN-1,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2CC(F)(F)F,C26H28F3N7O2,40448.0
17808,N4-benzoyl-Cytidine,O=C(Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1)c1ccccc1,C16H17N3O6,35698.0
17809,5-Iodouridine,O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1I,C9H11IN2O6,35697.0
17810,Acetyl-DL-carnitine (chloride),CC(=O)OC(CC(=O)O)C[N+](C)(C)C.[Cl-],C9H18ClNO4,31015.0
17811,5-Iodo-2'-deoxycytidine,Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I,C9H12IN3O4,35696.0
17812,4E2RCat,O=C(O)c1cc(-c2ccc(C=C3SC(=S)N(Cc4ccccc4)C3=O)o2)ccc1Cl,C22H14ClNO4S2,35894.0
17813,N-Methylnuciferine (iodide),COc1cc2c3c(c1OC)-c1ccccc1C[C@H]3[N+](C)(C)CC2.[I-],C20H24INO2,40276.0
17814,PDIC-NS,CS(=O)(=O)[O-].CS(=O)(=O)[O-].C[NH+](C)CCN1C(=O)c2cc(Cl)c3c4c(Cl)cc5c6c(cc(Cl)c(c7c(Cl)cc(c2c37)C1=O)c64)C(=O)N(CC[NH+](C)C)C5=O,C34H32Cl4N4O10S2,40481.0
17815,Aureobasidin A,CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C(C)C)N(C)C(=O)[C@@H]([C@H](C)CC)OC(=O)[C@H](C(C)(C)O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N(C)C1=O,C60H92N8O11,39722.0
17816,2-Hydroxyethylflurazepam,O=C1CN=C(c2ccccc2F)c2cc(Cl)ccc2N1CCO,C17H14ClFN2O2,40185.0
17817,2-Hydroxyethylflurazepam (CRM),O=C1CN=C(c2ccccc2F)c2cc(Cl)ccc2N1CCO,C17H14ClFN2O2,40620.0
17818,KAT8 Inhibitor 19,CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1ccc[nH]1,C16H13N3O3,38977.0
17819,KHS-101,CC(C)CNc1ccnc(NCc2csc(-c3ccccc3)n2)n1,C18H21N5S,37544.0
17820,Adenylosuccinic Acid,O=C(O)C[C@H](Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O)C(=O)O,C14H18N5O11P,29696.0
17821,BODIPY 480/508-Cholesteryl Linoleate,CCCCC/C=C\C/C=C\CCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCC5=C6C(C)=CC(C)=[N+]6[B-](F)(F)n6c(C)cc(C)c65)[C@@]4(C)CC[C@@H]32)C1,C54H81BF2N2O2,39684.0
17822,Nordiazepam Uncyclized Intermediate (hydrochloride),Cl.NCC(=O)Nc1ccc(Cl)cc1C(=O)c1ccccc1,C15H14Cl2N2O2,35679.0
17823,Typhaneoside,COc1cc(-c2oc3cc(O)cc(O)c3c(=O)c2O[C@@H]2O[C@H](CO[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)ccc1O,C34H42O20,38970.0
17824,GNE-140,O=C1N[C@](c2ccc(N3CCOCC3)cc2)(c2ccsc2)CC(O)=C1Sc1ccccc1Cl,C25H23ClN2O3S2,39015.0
17825,Obovatol,C=CCc1ccc(Oc2cc(CC=C)cc(O)c2O)cc1,C18H18O3,27553.0
17826,RR6,CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)Cc1ccccc1,C16H23NO4,9001411.0
17827,Anthraflavic Acid,O=C1c2ccc(O)cc2C(=O)c2ccc(O)cc21,C14H8O4,39246.0
17828,1-O-Dodecyl-rac-glycerol,CCCCCCCCCCCCOCC(O)CO,C15H32O3,17441.0
17829,HOE 33187,CN1CCN(c2ccc3nc(-c4ccc5nc(-c6ccccc6)[nH]c5c4)[nH]c3c2)CC1,C25H24N6,40147.0
17830,Cardiolipin (18:0/18:0/18:0/18:0) (sodium salt),CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC(O)COP(=O)([O-])OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC.[Na+].[Na+],C81H156Na2O17P2,39283.0
17831,"CP 105,696",O=C(O)C1(c2ccc3c(c2)OC[C@H](Cc2ccc(-c4ccccc4)cc2)[C@H]3O)CCCC1,C28H28O4,17620.0
17832,Difamilast,CCOc1ccccc1C(=O)NCc1coc(-c2ccc(OC(F)F)c(OC(C)C)c2)n1,C23H24F2N2O5,39664.0
17833,Ebio1,O=C(Nc1ccc2c3c(cccc13)CC2)c1ccc(F)cc1,C19H14FNO,40604.0
17834,"5,6,7-Trimethoxyflavone",COc1cc2oc(-c3ccccc3)cc(=O)c2c(OC)c1OC,C18H16O5,40289.0
17835,FT709,Cc1nc2c([C@H](O)C(=O)N3CC4=C(C3)CN(S(=O)(=O)c3cnc5c(c3)OCCO5)C4)cccc2o1,C23H22N4O7S,39971.0
17836,ZK 824859,CC[C@@H](Oc1nc(Oc2cccc(-c3cccc(CN)c3)c2)c(F)cc1F)C(=O)O,C22H20F2N2O4,37789.0
17837,SEN-177,Cn1cnnc1C1CCN(c2ncccc2-c2ccc(F)nc2)CC1,C18H19FN6,40449.0
17838,Vilanterol (triphenylacetate),O=C(O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O,C44H49Cl2NO7,39536.0
17839,C3-K2-E14,CCCCCCCCCCCCC(O)CN(CCNC(=O)CCN(CCC)CCC(=O)NCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC,C69H141N5O6,39323.0
17840,Artepillin C,CC(C)=CCc1cc(/C=C/C(=O)O)cc(CC=C(C)C)c1O,C19H24O3,35666.0
17841,TNT-b10,CCCCCCCCCCC(O)CN(C)CCn1c(=O)n(CCN(C)CC(O)CCCCCCCCCC)c(=O)n(CCN(C)CC(O)CCCCCCCCCC)c1=O,C48H96N6O6,39294.0
17842,BGJ398 (phosphate),CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O,C26H34Cl2N7O7P,39292.0
17843,HOE-S 785026,CN1CCN(c2ccc3nc(-c4ccc5nc(-c6cccc(O)c6)[nH]c5c4)[nH]c3c2)CC1,C25H24N6O,40148.0
17844,9(R)-Hexahydrocannabinol methyl ether,CCCCCc1cc(OC)c2c(c1)OC(C)(C)[C@@H]1CC[C@@H](C)C[C@@H]21,C22H34O2,40412.0
17845,Bifendate,COC(=O)c1cc(OC)c2c(c1-c1c(C(=O)OC)cc(OC)c3c1OCO3)OCO2,C20H18O10,39926.0
17846,N-Benzylcyclohexylamine (hydrochloride),Cl.c1ccc(CNC2CCCCC2)cc1,C13H20ClN,40410.0
17847,FMF-04-159-2,CN(C)C/C=C/C(=O)Nc1cccc(S(=O)(=O)N2CCC(NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cc(Cl)cc3Cl)CC2)c1,C28H30Cl3N7O5S,39989.0
17848,HOE 32020,CN1CCN(c2ccc3nc(-c4ccc5nc(-c6ccc(Cl)cc6)[nH]c5c4)[nH]c3c2)CC1,C25H23ClN6,39910.0
17849,1T-LSD (solution),CCN(CC)C(=O)[C@@H]1C=C2c3cccc4c3c(cn4C(=O)c3cccs3)C[C@H]2N(C)C1,C25H27N3O2S,40712.0
17850,Caffeic Acid dimethyl ether,COc1ccc(C=CC(=O)O)cc1OC,C11H12O4,39933.0
17851,PF-07304814,COc1cccc2[nH]c(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C(=O)COP(=O)(O)O)cc12,C24H33N4O9P,37026.0
17852,N-demethyl Promethazine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])NC(C)CN1c2ccccc2Sc2ccccc21,C16H19ClN2S,39871.0
17853,PDIC-NN,CN(C)CCN1C(=O)c2cc(Cl)c3c4c(Cl)cc5c6c(cc(Cl)c(c7c(Cl)cc(c2c37)C1=O)c64)C(=O)N(CCN(C)C)C5=O,C32H24Cl4N4O4,40664.0
17854,DL-Dithiothreitol,O[C@H](CS)[C@H](O)CS,C4H10O2S2,35885.0
17855,Bz-RS-ISer(3-Ph)-OMe,COC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1,C17H17NO4,40291.0
17856,2-epi-Fialuridine,O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2F)cc1I,C9H10FIN2O5,39924.0
17857,Erinacine A,CC(C)C1=C2C3=CC=C(C=O)C[C@H](O[C@@H]4OC[C@@H](O)[C@H](O)[C@H]4O)[C@]3(C)CC[C@@]2(C)CC1,C25H36O6,38352.0
17858,Ethacridine (lactate),CC(O)C(=O)O.CCOc1ccc2nc3cc(N)ccc3c(N)c2c1,C18H21N3O4,40282.0
17859,AKOS B018304,O=C1NC(=S)SC1=Cc1ccccc1[N+](=O)[O-],C10H6N2O3S2,35694.0
17860,Auxinole,Cc1ccc(C(=O)CC(C(=O)O)c2c[nH]c3ccccc23)c(C)c1,C20H19NO3,40334.0
17861,WQ 1,O=C1CC(C2CCN(Cc3ccccc3)CC2)Sc2ccccc21,C21H23NOS,40462.0
17862,Procodazole,O=C(O)CCc1nc2ccccc2[nH]1,C10H10N2O2,39931.0
17863,Viaminate,CCOC(=O)c1ccc(NC(=O)/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)cc1,C29H37NO3,40118.0
17864,THPTA,OCCCn1cc(CN(Cc2cn(CCCO)nn2)Cc2cn(CCCO)nn2)nn1,C18H30N10O3,35670.0
17865,p-Nitrophenyl Sulfate (potassium salt),O=[N+]([O-])c1ccc(OS(=O)(=O)[O-])cc1.[K+],C6H4KNO6S,35691.0
17866,Enfumafungin,CC(=O)O[C@@H]1C[C@]23C4=CC[C@@]5(C)[C@H](C(=O)O)[C@@](C)([C@H](C)C(C)C)CC[C@]5(C)[C@H]4CC[C@H]2[C@@](C)(COC3O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C38H60O12,39742.0
17867,4-methoxy BZP (hydrochloride),COc1ccc(CN2CCNCC2)cc1.Cl.Cl,C12H20Cl2N2O,40370.0
17868,PF-05190457,Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1,C29H32N6OS,40142.0
17869,1-Myristoyl-2-Linoleoyl-sn-glycero-3-PC,CCCCC/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,C40H76NO8P,35674.0
17870,Lipid 50,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCC(CCCCCC)OC(=O)NCCN1CCCC1,C56H98N2O8,39877.0
17871,8-Shogaol,CCCCCCCC=CC(=O)CCc1ccc(O)c(OC)c1,C19H28O3,40273.0
17872,Usmarapride (oxalate),COCCCN1CCC(c2nnc(-c3nn(C(C)C)c4ccccc34)o2)CC1.O=C(O)C(=O)O,C23H31N5O6,35867.0
17873,?-phenyl GHB (sodium salt),O=C([O-])CC(CO)c1ccccc1.[Na+],C10H11NaO3,37820.0
17874,L-Abrine,CN[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,C12H14N2O2,34914.0
17875,BI-1467335,CC(C)(C)NC(=O)c1ccc(OC/C(=C/F)CN)cc1.Cl,C15H22ClFN2O2,30672.0
17876,Isopteropodine,COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CC[C@@]4(C(=O)Nc5ccccc54)[C@@H]3C[C@H]12,C21H24N2O4,40237.0
17877,Ouabain (hydrate),C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O.O,C29H46O13,14319.0
17878,ARQ 531,O=C(c1ccc(Oc2ccccc2)cc1Cl)c1c[nH]c2ncnc(N[C@@H]3CC[C@@H](CO)OC3)c12,C25H23ClN4O4,30165.0
17879,XIE62-1004,Cl.OCCNCc1ccc(OCc2ccccc2)c(OCc2ccccc2)c1,C23H26ClNO3,40446.0
17880,Betamethasone Dipropionate,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C28H37FO7,39499.0
17881,AZ1 USP25/28 Inhibitor,OCCNCc1cc(Br)ccc1OCc1ccc(F)c(C(F)(F)F)c1,C17H16BrF4NO2,40335.0
17882,Buspirone-d8 (hydrochloride),Cl.[2H]C([2H])(N1CCN(c2ncccn2)CC1)C([2H])([2H])C([2H])([2H])C([2H])([2H])N1C(=O)CC2(CCCC2)CC1=O,C21H32ClN5O2,40435.0
17883,D-Glucurone,O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O,C6H8O6,40301.0
17884,Perfluoroundecanoic Acid,O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C11HF21O2,37257.0
17885,eIF2? Activator 2,O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1,C21H20F6N2O2,40130.0
17886,Borofalan,N[C@@H](Cc1ccc([10B](O)O)cc1)C(=O)O,C9H12BNO4,38760.0
17887,DZD9008,C=CC(=O)Nc1cc(Nc2nccc(Nc3cc(Cl)c(F)cc3C(C)(C)O)n2)c(OC)cc1N1CC[C@H](N(C)C)C1,C29H35ClFN7O3,38900.0
17888,MRTX-0902,Cc1c(C#N)cccc1[C@@H](C)Nc1nnc(C)c2cnc(N3CCOCC3)cc12,C22H24N6O,38578.0
17889,A1-28,CCCCCCCCCCCCSSCCOC(=O)CCNCCCN(C)CCCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC,C58H115N3O6S6,39590.0
17890,Tectorigenin,COc1c(O)cc2occ(-c3ccc(O)cc3)c(=O)c2c1O,C16H12O6,35680.0
17891,Metrizoic Acid,CC(=O)Nc1c(I)c(C(=O)O)c(I)c(N(C)C(C)=O)c1I,C12H11I3N2O4,38512.0
17892,VH 032 Linker 1,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCN)C(C)(C)C)cc1.Cl,C30H46ClN5O7S,26148.0
17893,ABX-464,FC(F)(F)Oc1ccc(Nc2ccc3cccc(Cl)c3n2)cc1,C16H10ClF3N2O,39515.0
17894,Eurycomalactone,CC1=CC(=O)[C@@H](O)[C@@]2(C)[C@H]1CC(=O)[C@@]1(C)[C@H]3C(=O)O[C@H]([C@@H]3C)[C@H](O)[C@@H]12,C19H24O6,39016.0
17895,Demoxepam,O=C1C[N+]([O-])=C(c2ccccc2)c2cc(Cl)ccc2N1,C15H11ClN2O2,21937.0
17896,D-Ala-D-Ala,C[C@@H](N)C(=O)N[C@H](C)C(=O)O,C6H12N2O3,39648.0
17897,2'-O-(2-Methoxyethyl)adenosine,COCCO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(N)ncnc21,C13H19N5O5,40443.0
17898,Cefotiam hexetil (hydrochloride),CC(OC(=O)OC1CCCCC1)OC(=O)C1=C(CSc2nnnn2CCN(C)C)CS[C@@H]2[C@H](NC(=O)Cc3csc(N)n3)C(=O)N12.Cl.Cl,C27H39Cl2N9O7S3,39538.0
17899,5-Bromo-2'-deoxycytidine,Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Br,C9H12BrN3O4,40644.0
17900,3-azido-7-hydroxy Coumarin,[2H]C([2H])([2H])CC(=O)C(CC(C)N(C([2H])([2H])[2H])C([2H])([2H])[2H])(c1ccccc1)c1ccccc1,C21H27NO,10596.0
17901,Paliperidone Palmitate,CCCCCCCCCCCCCCCC(=O)OC1CCCn2c1nc(C)c(CCN1CCC(c3noc4cc(F)ccc34)CC1)c2=O,C39H57FN4O4,39644.0
17902,"Hydrochlorothiazide-3,3-d2",[2H]C1([2H])Nc2cc(Cl)c(S(N)(=O)=O)cc2S(=O)(=O)N1,C7H8ClN3O4S2,39983.0
17903,Dienestrol,CC=C(C(=CC)c1ccc(O)cc1)c1ccc(O)cc1,C18H18O2,38954.0
17904,CS 2164,COc1ccc2c(Oc3ccc4c(C(=O)Nc5ccccc5N)cccc4c3)ccnc2c1,C27H21N3O3,38766.0
17905,Melitracen (hydrochloride),CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21.Cl,C21H26ClN,40117.0
17906,P276-00 (hydrochloride),CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl,C21H21Cl2NO5,39845.0
17907,10-(Phosphonooxy)-1-decanole,O=P(O)(O)OCCCCCCCCCCO,C10H23O5P,9004346.0
17908,m-isobutyl Ibuprofen,CC(C)Cc1cccc(C(C)C(=O)O)c1,C13H18O2,40127.0
17909,Pterin,Nc1nc2[nH]ccnc-2c(=O)n1,C6H5N5O,39503.0
17910,Zasocitinib,CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12,C23H24N8O3,35682.0
17911,Picrocrocin,CC1=C(C=O)C(C)(C)C[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1,C16H26O7,39914.0
17912,MYCi975,Cn1nc(C(F)(F)F)cc1-c1ccc(OCc2ccc(Cl)cc2)c(-c2ccc(Cl)c(C(F)(F)F)c2)c1O,C25H16Cl2F6N2O2,39622.0
17913,15(R)-HODE,CCCC(O)C/C=C\C/C=C\CCCCCCCC(=O)O,C18H32O3,38710.0
17914,"(1S,4S)-N-desmethyl Sertraline (hydrochloride)",Cl.N[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,C16H16Cl3N,15916.0
17915,PL1,CCCCCC(CC)OC(=O)CCCCCCCCN(CCCCCCCCC(=O)OC(CC)CCCCC)CCCN(CCCCCCCCC(=O)OC(CC)CCCCC)CCCOP(=O)(OCC)OCC,C61H121N2O10P,38647.0
17916,Atogepant,C[C@@H]1[C@H](c2c(F)ccc(F)c2F)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F,C29H23F6N5O3,35899.0
17917,viFSP1,COc1ccc(N2CC(=O)C(c3nc(C)cs3)=C2N)c(OC)c1,C16H17N3O3S,39927.0
17918,Fluzoparib,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCn2nc(C(F)(F)F)nc2C1,C22H16F4N6O2,36671.0
17919,(1S)-(-)-?-Pinene,CC1=CC[C@H]2C[C@@H]1C2(C)C,C10H16,35693.0
17920,CL075,CCCc1nc2c(N)nc3ccccc3c2s1,C13H13N3S,37686.0
17921,MCU i4,CCOC(=O)c1cnc2ccc(C)cc2c1Nc1ccc(N(CC)CC)cc1,C23H27N3O2,39993.0
17922,Spinosin,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C28H32O15,40216.0
17923,AA43279,COc1ccc(-c2cc(N)c(C(N)=O)s2)cc1,C12H12N2O2S,40428.0
17924,"9(S),12(S),13(S)-TriHODE",CC/C=C\CC(O)C(O)/C=C/C(O)CCCCCCCC(=O)O,C18H32O5,38950.0
17925,Lorazepam-d4 (CRM),[2H]c1c([2H])c([2H])c(C2=NC(O)C(=O)Nc3ccc(Cl)cc32)c(Cl)c1[2H],C15H10Cl2N2O2,18728.0
17926,Lorazepam-d4,[2H]c1c([2H])c([2H])c(C2=NC(O)C(=O)Nc3ccc(Cl)cc32)c(Cl)c1[2H],C15H10Cl2N2O2,40658.0
17927,Lifitegrast (sodium salt),CS(=O)(=O)c1cccc(C[C@H](NC(=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc4ccoc4c2)C3)C(=O)[O-])c1.[Na+],C29H23Cl2N2NaO7S,40427.0
17928,HIV-1 Integrase Inhibitor,[N-]=[N+]=NCc1cccc(C(=O)C=C(O)C(=O)O)c1,C11H9N3O4,38779.0
17929,FTT5,CCCCCC(CC)OC(=O)CCCCCCCCN(CCCCCCCCC(=O)OC(CC)CCCCC)CCCNC(=O)c1cc(C(=O)NCCCN(CCCCCCCCC(=O)OC(CC)CCCCC)CCCCCCCCC(=O)OC(CC)CCCCC)cc(C(=O)NCCCN(CCCCCCCCC(=O)OC(CC)CCCCC)CCCCCCCCC(=O)OC(CC)CCCCC)c1,C120H222N6O15,37413.0
17930,Loxoprofen-SRS,C[C@H](C(=O)O)c1ccc(C[C@H]2CCC[C@@H]2O)cc1,C15H20O3,38122.0
17931,BAY-2416964,C[C@@H](CO)NC(=O)c1cc(-c2ccc(Cl)cc2)nn(-c2cnn(C)c2)c1=O,C18H18ClN5O3,36939.0
17932,Lipoxamycin (hemisulfate),CC(C)CCCC(=O)CCCCCCC(=O)CCN(O)C(=O)[C@@H](N)CO.CC(C)CCCC(=O)CCCCCCC(=O)CCN(O)C(=O)[C@@H](N)CO.O=S(=O)(O)O,C38H74N4O14S,37747.0
17933,Phenylethyl 3-methylcaffeate,COc1cc(C=CC(=O)OCCc2ccccc2)ccc1O,C18H18O4,39152.0
17934,?DBCO-NHS ester,O=C(CCC(=O)N1Cc2ccccc2C#Cc2ccccc21)ON1C(=O)CCC1=O,C23H18N2O5,40461.0
17935,3'-O-Methylguanosine,CO[C@H]1[C@@H](O)[C@H](n2cnc3c(=O)nc(N)[nH]c32)O[C@@H]1CO,C11H15N5O5,40292.0
17936,Doxylamine-d5 (succinate),O=C(O)CCC(=O)O.[2H]c1c([2H])c([2H])c(C(C)(OCCN(C)C)c2ccccn2)c([2H])c1[2H],C21H28N2O5,40674.0
17937,4-Methylaminorex,CC1N=C(N)OC1c1ccccc1,C10H12N2O,13982.0
17938,V-0219 (hydrochloride),Cl.FC(F)(F)c1ccc(-c2noc(CN3CCCC(CN4CCOCC4)C3)n2)cc1,C20H26ClF3N4O2,39740.0
17939,N-sec-butyl Pentedrone (hydrochloride),CCCC(NC(C)CC)C(=O)c1ccccc1.Cl,C15H24ClNO,39237.0
17940,DOSPA (hydrochloride),CCCCCCCC/C=C\CCCCCCCCOCC(C[N+](C)(C)CCNC(=O)C(CCCNCCCN)NCCCN)OCCCCCCCC/C=C\CCCCCCCC.Cl.Cl.Cl.Cl.[Cl-],C54H115Cl5N6O3,38585.0
17941,Sulfo-SMCC,O=C(ON1C(=O)CC(S(=O)(=O)[O-])C1=O)C1CCC(CN2C(=O)C=CC2=O)CC1.[Na+],C16H17N2NaO9S,35692.0
17942,CXCR2-IN-1,CN1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1,C19H20Cl2FN3O4S,28426.0
17943,Clenbuterol-d9,[2H]C([2H])([2H])C(NCC(O)c1cc(Cl)c(N)c(Cl)c1)(C([2H])([2H])[2H])C([2H])([2H])[2H],C12H18Cl2N2O,40816.0
17944,NS 3728,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1ccc(Br)cc1-c1nnn[nH]1,C16H9BrF6N6O,39988.0
17945,4-Aminodiphenylamine,Nc1ccc(Nc2ccccc2)cc1,C12H12N2,40726.0
17946,2'-Fluoro-2'-deoxy-arabino-Uridine,O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)c(=O)[nH]1,C9H11FN2O5,40303.0
17947,Ritalinic Acid (hydrochloride) (CRM),Cl.O=C(O)C(c1ccccc1)C1CCCCN1,C13H18ClNO2,40261.0
17948,DPPD-Q,O=C1C=C(Nc2ccccc2)C(=O)C=C1Nc1ccccc1,C18H14N2O2,40826.0
17949,10?-hydroxy Naltrexone,O=C1CC[C@@]2(O)[C@H]3[C@@H](O)c4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,C20H23NO5,40442.0
17950,Nedometinib,Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c2cccnc21,C17H16FIN4O3,40465.0
17951,Dimethylamino-Micheliolide,CC1=C2CC[C@@](C)(O)[C@@H]2[C@H]2OC(=O)[C@@H](CN(C)C)[C@@H]2CC1,C17H27NO3,25499.0
17952,IM21.7c,CCCCCCCCCCCCCCCCCCC(CCCCCCCCCCCCCCCCCC)CCCCC(CCC(C)CCCC(C)C)[n+]1ccn(CCCC)c1.[Cl-],C59H117ClN2,39637.0
17953,Ethidium (bromide),CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[Br-],C21H20BrN3,39132.0
17954,Lamevudine,C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc2c(N)ncnc21,C12H16N4O4,39925.0
17955,6-PPD-Q-d5,[2H]c1c([2H])c([2H])c(NC2=CC(=O)C(NC(C)CC(C)C)=CC2=O)c([2H])c1[2H],C18H22N2O2,40784.0
17956,OPPD,CCCCCCC(C)Nc1ccc(Nc2ccccc2)cc1,C20H28N2,40732.0
17957,N-Propionitrile Chlorphine (hydrochloride),CC(c1ccc(Cl)cc1)N1CCC(n2c(=O)n(CCC#N)c3ccccc32)CC1.Cl,C23H26Cl2N4O,40326.0
17958,N-demethyl Promethazine (hydrochloride),CNC(C)CN1c2ccccc2Sc2ccccc21.Cl,C16H19ClN2S,39870.0
17959,Lipid M,CCCCCCCCCOC(=O)CCCCCCCN(CCO)CCCCCCCOC(=O)C(CCCCCCCC)CCCCCCCC,C44H87NO5,38775.0
17960,7-Deaza-7-iodo-2'-deoxyguanosine,Nc1nc(=O)c2c(I)cn([C@H]3C[C@H](O)[C@@H](CO)O3)c2[nH]1,C11H13IN4O4,40643.0
17961,Dapoxetine-d7 (hydrochloride),Cl.[2H]c1c([2H])c([2H])c2c(OCC[C@@H](c3ccccc3)N(C)C)c([2H])c([2H])c([2H])c2c1[2H],C21H24ClNO,40762.0
17962,Tandospirone,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1,C21H29N5O2,40436.0
17963,5R(6S)-EET,CCCCC/C=C\C/C=C\C/C=C\C[C@@H]1O[C@@H]1CCCC(=O)O,C20H32O3,9004343.0
17964,14S(15R)-EET,CCCCC[C@H]1O[C@H]1C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O3,9004352.0
17965,SRI-37330,CS(=O)(=O)NCC1CCCN(c2ncnc3ccc(C(F)(F)F)cc23)C1,C16H19F3N4O2S,31638.0
17966,Scopolamine,CN1[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12,C17H21NO4,40307.0
17967,IPN60090,CNC(=O)c1cn(C[C@H](F)CCc2ccc(NC(=O)Cc3cc(OC4CC(F)(F)C4)cc(C)n3)nn2)nn1,C24H27F3N8O3,35855.0
17968,SET2,CCCN(C)c1cc(C(F)(F)F)nc(SCCC(=O)NCc2ccco2)n1,C17H21F3N4O2S,40360.0
17969,Dimenhydrinate,CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O,C24H28ClN5O3,39977.0
17970,Acanthoside B,COc1cc([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2cc(OC)c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)c2)cc(OC)c1O,C28H36O13,40280.0
17971,?-Funaltrexamine (hydrochloride),COC(=O)/C=C/C(=O)N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5.Cl,C25H31ClN2O6,39901.0
17972,HBC 530,CN(CCO)c1ccc(C=C(C#N)c2ccc(C#N)cc2)cc1,C19H17N3O,40295.0
17973,9CCN,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CCCCCCCC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C,C36H60O4,40739.0
17974,FA16,CN(C)S(=O)(=O)c1ccc(N2CCC(Cn3c(C(F)(F)F)nc4ccccc43)CC2)cc1,C22H25F3N4O2S,40499.0
17975,CGP 20712A,CS(=O)(=O)O.Cn1cc(C(F)(F)F)nc1-c1ccc(OCC(O)CNCCOc2ccc(O)c(C(N)=O)c2)cc1,C24H29F3N4O8S,40765.0
17976,Amylmetacresol,CCCCCc1ccc(C)cc1O,C12H18O,40290.0
17977,Hispolon,CC(=O)/C=C(O)/C=C/c1ccc(O)c(O)c1,C12H12O4,38415.0
17978,3-Chlorogentisyl Alcohol,OCc1cc(O)cc(Cl)c1O,C7H7ClO3,40663.0
17979,Pomalidomide 4'-PEG5-amine (hydrochloride),Cl.NCCOCCOCCOCCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,C25H37ClN4O9,39987.0
17980,PF-06650833,CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12,C18H20FN3O4,28397.0
17981,OT-82,O=C(NCCCc1cn[nH]c1)c1ccc(-c2ccncc2)c(C#Cc2ccc(F)cc2)c1,C26H21FN4O,38782.0
17982,4-Hydroxy-1-(2-phenylethyl)piperidine,OC1CCN(CCc2ccccc2)CC1,C13H19NO,40440.0
17983,14R(15S)-EET,CCCCC[C@@H]1O[C@@H]1C/C=C\C/C=C\C/C=C\CCCC(=O)O,C20H32O3,9004351.0
17984,5S(6R)-EET,CCCCC/C=C\C/C=C\C/C=C\C[C@H]1O[C@H]1CCCC(=O)O,C20H32O3,9004349.0
17985,11R(12S)-EET,CCCCC/C=C\C[C@@H]1O[C@@H]1C/C=C\C/C=C\CCCC(=O)O,C20H32O3,9004344.0
17986,"(3?,4?,17?)-17-(2-Pyridinylmethyl)androst-5-ene-3,4,17-triol",C[C@]12CC[C@H](O)[C@H](O)C1=CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]2(O)Cc1ccccn1,C25H35NO3,40438.0
17987,TH-1760,O=C(c1ccc2[nH]ccc2c1)N1CCN(S(=O)(=O)c2ccc3[nH]c(=O)oc3c2)CC1,C20H18N4O5S,40469.0
17988,5-Formyl-2'-deoxyuridine,O=Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,C10H12N2O6,40306.0
17989,Maackiain,Oc1ccc2c(c1)OC[C@H]1c3cc4c(cc3O[C@@H]21)OCO4,C16H12O5,40215.0
17990,CPS2,Cc1ccsc1C(=O)n1nc(Nc2ccc(S(=O)(=O)NCCOCc3cn(CCOCCOCCNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)nn3)cc2)nc1N,C38H42N12O10S2,40457.0
17991,PF-00489791,CCOCCn1nc(C(=O)NS(C)(=O)=O)c2nc(N(C)CC)nc(Nc3cc(C)ccn3)c21,C20H28N8O4S,40464.0
17992,Pomalidomide 4'-alkylC6-amine (hydrochloride),Cl.NCCCCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,C19H25ClN4O4,39985.0
17993,Bepotastine,O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1,C21H25ClN2O3,39932.0
17994,WM-3835,Cc1cc(-c2ccccc2)cc(C(=O)NNS(=O)(=O)c2cccc(O)c2)c1F,C20H17FN2O4S,40296.0
17995,para-Methylaminorex,Cc1ccc(C2CN=C(N)O2)cc1,C10H12N2O,40507.0
17996,exo-Tetrahydrocannabivarin,C=C1CC[C@@H]2[C@@H](C1)c1c(O)cc(CCC)cc1OC2(C)C,C19H26O2,40402.0
17997,exo-Tetrahydrocannabivarin (exempt preparation),C=C1CC[C@@H]2[C@@H](C1)c1c(O)cc(CCC)cc1OC2(C)C,C19H26O2,43493.0
17998,4-Hydroxyphenylpyruvic Acid,O=C(O)C(=O)Cc1ccc(O)cc1,C9H8O4,38508.0
17999,"2,3-Dihydroxybenzoic Acid",O=C(O)c1cccc(O)c1O,C7H6O4,35635.0
18000,Methamphetamine Ethyl Carbamate,CCOC(=O)N(C)C(C)Cc1ccccc1,C13H19NO2,40333.0
18001,Cruzain-IN-1,CCn1cnc2c(Nc3cc(F)cc(F)c3)nc(C#N)nc21,C14H10F2N6,37350.0
18002,N-Desmethyltamoxifen (hydrochloride),CC/C(=C(\c1ccccc1)c1ccc(OCCNC)cc1)c1ccccc1.Cl,C25H28ClNO,40673.0
18003,80-O18,CCCCCCCCCCCCCCCCCCOC(=O)CCN(CCCN(C)C)CCC(=O)OCCCCCCCCCCCCCCCCCC,C47H94N2O4,40611.0
18004,GMB 475,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOc2ccc(-c3cc(Nc4ccc(OC(F)(F)F)cc4)ncn3)cc2)C(C)(C)C)cc1,C43H46F3N7O7S,40463.0
18005,Rosamultin,C[C@@H]1CC[C@]2(C(=O)O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@]1(C)O,C36H58O10,39939.0
18006,GSK199 analog (hydrochloride),CCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)cc(OC)c3n2C)cc2ccccc21.Cl,C25H30ClN5O2,40866.0
18007,4-Hydroxydiphenylamine,Oc1ccc(Nc2ccccc2)cc1,C12H11NO,40730.0
18008,N-Benzylmethcathinone (hydrochloride),CC(C(=O)c1ccccc1)N(C)Cc1ccccc1.Cl,C17H20ClNO,40723.0
18009,ICA 27243,O=C(Nc1ccc(Cl)nc1)c1ccc(F)c(F)c1,C12H7ClF2N2O,40827.0
18010,Pentylone-d3 (hydrochloride),Cl.[2H]C([2H])([2H])NC(CCC)C(=O)c1ccc2c(c1)OCO2,C13H18ClNO3,35689.0
18011,Pentylone-d3 (hydrochloride) (CRM),Cl.[2H]C([2H])([2H])NC(CCC)C(=O)c1ccc2c(c1)OCO2,C13H18ClNO3,40615.0
18012,CP-4,CC[N+](CC)=c1ccc2c(-c3ccccc3C(=O)O)c3c(oc-2c1)-c1ccc(N)cc1CC3,C28H27N2O3,39984.0
18013,?8-iso-Tetrahydrocannabivarin,C=C(C)[C@@H]1CC[C@]2(C)C[C@H]1c1c(O)cc(CCC)cc1O2,C19H26O2,40474.0
18014,Chondroitin Sulfate A (sodium salt),CC(=O)N[C@@H]1[C@@H](O[C@H]2O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]2O)[C@@H](OS(=O)(=O)[O-])[C@@H](CO)O[C@H]1O.[Na+],C14H22NNaO15S,37801.0
18015,SIL Lipid,CCCCCCCCCCCCOC(=O)CCN(C)CCN(CCN(C)CCC(=O)OCCCCCCCCCCCC)CCN(C)CCC(=O)OCCCCCCCCCCCC,C54H108N4O6,40801.0
18016,Laninamivir octanoate,CCCCCCCC(=O)OC[C@@H](O)[C@@H](OC)[C@@H]1OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]1NC(C)=O,C21H36N4O8,40850.0
18017,E12CA1A3,CCCCCCCCCCC(COC(=O)C(CCCCCC)CCCCCCCC)OC(=O)CCCN(C)C,C34H67NO4,40415.0
18018,(-)-11-hydroxy-?9-THC,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(CO)=C[C@@H]21,C21H30O3,14239.0
18019,GP 2a,Cc1ccc2c(c1)Cc1c(C(=O)NC3CCCCC3)nn(-c3ccc(Cl)cc3Cl)c1-2,C24H23Cl2N3O,40761.0
18020,Mechercharmycin A,C=C1NC(=O)[C@H](C(C)C)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)c2nc(oc2-c2ccccc2)-c2coc(n2)-c2csc(n2)-c2coc(n2)-c2coc1n2,C35H32N8O7S,40868.0
18021,GS-444217,O=C(Nc1cccc(-c2nncn2C2CC2)c1)c1cc(-n2cnc(C3CC3)c2)ccn1,C23H21N7O,40757.0
18022,BPR0912,CCc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#Cc2ccc(C(F)(F)F)cc2)s1,C30H25Cl2F3N4OS,10678.0
18023,5-Acetamide-Butenolide,CC(=O)NC1C=CC(=O)O1,C6H7NO3,40867.0
18024,DTPD,Cc1ccccc1Nc1ccc(Nc2ccccc2C)cc1,C20H20N2,40756.0
18025,Enramycin A,CC(C)CCCC/C=C/C=C\C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@H](CCCN)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](c2ccc(O)cc2)C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CCCNC(N)=O)C(=O)N[C@H](C[C@@H]2CN=C(N)N2)C(=O)N[C@@H](c2ccc(O)cc2)C(=O)N[C@H](CO)C(=O)N[C@@H](c2cc(Cl)c(O)c(Cl)c2)C(=O)NCC(=O)N[C@@H](C[C@@H]2CN=C(N)N2)C(=O)N[C@H](C)C(=O)N[C@@H](c2ccc(O)cc2)C(=O)O[C@@H]1C,C107H138Cl2N26O31,40847.0
18026,5-methoxy Pyrrolidinyltryptamine,COc1ccc2[nH]cc(CCN3CCCC3)c2c1,C15H20N2O,35512.0
18027,MDK8582,CCc1c(C(=O)C(N)=O)c2c(OCC(N)=O)cccc2n1Cc1ccccc1,C21H21N3O4,37307.0
18028,Cladosporin,C[C@H]1CCC[C@H](C[C@H]2Cc3cc(O)cc(O)c3C(=O)O2)O1,C16H20O5,40864.0
18029,Pinaverium (bromide),COc1cc(Br)c(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)cc1OC.[Br-],C26H41Br2NO4,40653.0
18030,Butin,O=C1CC(c2ccc(O)c(O)c2)Oc2cc(O)ccc21,C15H12O5,40268.0
18031,"CP 339,818 (hydrochloride)",CCCCCN=c1ccn(Cc2ccccc2)c2ccccc12.Cl,C21H25ClN2,40766.0
18032,ML-162-yne,C#CCOc1ccc(N(C(=O)CCl)C(C(=O)NCCc2ccccc2)c2cccs2)cc1Cl,C25H22Cl2N2O3S,40783.0
18033,Verrucarin J,CC1=C[C@H]2O[C@@H]3C[C@H]4OC(=O)/C=C\C=C\C(=O)OCC/C(C)=C/C(=O)OC[C@@]2(CC1)[C@]4(C)[C@]31CO1,C27H32O8,40815.0
18034,AKI-603,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc([N+](=O)[O-])cc3)n2)n[nH]1,C19H23N9O2,40840.0
18035,6?-hydroxy Paclitaxel-d5,[2H]c1c([2H])c([2H])c(C(=O)N[C@@H](c2ccccc2)[C@@H](O)C(=O)O[C@H]2C[C@@]3(O)[C@@H](OC(=O)c4ccccc4)[C@@H]4[C@]5(OC(C)=O)CO[C@@H]5[C@@H](O)[C@H](O)[C@@]4(C)C(=O)[C@H](OC(C)=O)C(=C2C)C3(C)C)c([2H])c1[2H],C47H51NO15,40926.0
18036,6-Mercaptopurine Riboside,OC[C@H]1O[C@@H](n2cnc3c(=S)nc[nH]c32)[C@H](O)[C@@H]1O,C10H12N4O4S,40331.0
18037,PEO-IAA,O=C(CC(C(=O)O)c1c[nH]c2ccccc12)c1ccccc1,C18H15NO3,40665.0
18038,SAR439859,O=C(O)c1ccc2c(c1)CCCC(c1ccc(Cl)cc1Cl)=C2c1ccc(O[C@H]2CCN(CCCF)C2)cc1,C31H30Cl2FNO3,40748.0
18039,ASP2905,Fc1ccc(Nc2nc(NCc3ncccn3)nc(Nc3ccccc3)n2)cc1,C20H17FN8,40780.0
18040,2-Chlorophenyl Cyclopentyl Ketone,O=C(c1ccccc1Cl)C1CCCC1,C12H13ClO,39809.0
18041,NVS-STG2,COc1cc(C(=O)O)ccc1NCc1ccc(C2(C(C)(C)C)OCC(C)(C)CO2)cc1,C25H33NO5,40159.0
18042,BAY-4931,CCc1ccc(-c2nc3cc(NC(=O)c4cc([N+](=O)[O-])ccc4Cl)ccc3o2)cc1,C22H16ClN3O4,40668.0
18043,GSK620,CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O,C18H19N3O3,36139.0
18044,Cinerubin B,CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@@H]4O[C@H]5CC(=O)[C@H](C)O[C@H]5O[C@@H]4[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)ccc(O)c2C3=O)[C@H]1C(=O)OC,C42H51NO16,40865.0
18045,AJ2-30,CCn1c2ccccc2c2cc(CNc3nc4ccccc4n3C)ccc21,C23H22N4,40667.0
18046,IACS-13909,CC1(N)CCN(c2cnc3c(-c4cccc(Cl)c4Cl)n[nH]c3n2)CC1,C17H18Cl2N6,40654.0
18047,Aspinolide B,C/C=C/C(=O)O[C@H]1/C=C/[C@@H](O)[C@@H](O)CCC(=O)O[C@@H]1C,C14H20O6,40873.0
18048,DTPD-Q,Cc1ccccc1NC1=CC(=O)C(Nc2ccccc2C)=CC1=O,C20H18N2O2,40612.0
18049,GSK329,CNc1cc(Oc2c(Cl)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2Cl)ncn1,C19H14Cl2F3N5O2,40666.0
18050,C14-O2,CCCCCCCCCCCCC(O)CN(CCOCCOCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CCN1CCN(CCOCCOCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CC1,C88H181N5O9,40805.0
18051,8R(9S)-EET,CCCCC/C=C\C/C=C\C[C@@H]1O[C@@H]1C/C=C\CCCC(=O)O,C20H32O3,9004347.0
18052,2'-Fluoro-2'-deoxyuridine,O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2F)c(=O)[nH]1,C9H11FN2O5,40302.0
18053,Isomitraphylline,COC(=O)C1=CO[C@@H](C)[C@H]2CN3CC[C@@]4(C(=O)Nc5ccccc54)[C@@H]3C[C@H]12,C21H24N2O4,39452.0
18054,Elobixibat,CCCCC1(CCCC)CN(c2ccccc2)c2cc(SC)c(OCC(=O)N[C@@H](C(=O)NCC(=O)O)c3ccccc3)cc2S(=O)(=O)C1,C36H45N3O7S2,30658.0
18055,UNC6934,O=C1COc2cc(C(=O)N(Cc3ccc(C(=O)Nc4ccncn4)cc3)C3CC3)ccc2N1,C24H21N5O4,28814.0
18056,Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH,CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O)C(=O)OC(C)(C)C,C64H101N5O16,40707.0
18057,"3,4,6-Tri-O-acetyl-D-glucal",CC(=O)OC[C@H]1OC=C[C@@H](OC(C)=O)[C@@H]1OC(C)=O,C12H16O7,39976.0
18058,Enramycin B,CCC(C)CCCC/C=C/C=C\C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@H](CCCN)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](c2ccc(O)cc2)C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CCCNC(N)=O)C(=O)N[C@H](C[C@@H]2CN=C(N)N2)C(=O)N[C@@H](c2ccc(O)cc2)C(=O)N[C@H](CO)C(=O)N[C@@H](c2cc(Cl)c(O)c(Cl)c2)C(=O)NCC(=O)N[C@@H](C[C@@H]2CN=C(N)N2)C(=O)N[C@H](C)C(=O)N[C@@H](c2ccc(O)cc2)C(=O)O[C@@H]1C,C108H140Cl2N26O31,40848.0
18059,Lipid U-101,CCCCCCCCC(CCCCCC)COC(=O)CCCCCN(CCCCCC(=O)OCC(CCCCCC)CCCCCCCC)CCCN(CCO)CCO,C51H102N2O6,40902.0
18060,"CP 93,129",O=c1ccc2[nH]cc(C3=CCNCC3)c2[nH]1,C12H13N3O,40817.0
18061,BMS 986299,CCN(Cc1nc2c(N)nc3cc(-c4cc[nH]n4)ccc3c2[nH]1)C(C)=O,C18H19N7O,40652.0
18062,PROTAC RAF Degrader 1,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(N5CCN(CC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCc6ccc(-c7scnc7C)cc6)C(C)(C)C)CC5)cc4)cc23)c1F,C51H57F2N9O7S2,40967.0
18063,Arecaidine but-2-ynyl ester (tosylate),CC#CCOC(=O)C1=CCCN(C)C1.Cc1ccc(S(=O)(=O)O)cc1,C18H23NO5S,39816.0
18064,SMIP004,CCCCc1ccc(NC(C)=O)c(C)c1,C13H19NO,40645.0
18065,Menin-MLL Inhibitor 20,CC(C)(C)OC(=O)N[C@@H]1CCCN(Cc2ccnc(C(=O)Nc3ccc(-c4cc5c(N6CCOCC6)ncnc5[nH]4)cc3)c2)C1,C33H40N8O4,40782.0
18066,NX-2127,NC(=O)c1ncc(N2CCCCC2)nc1Nc1ccc(C2CCN(C[C@@H]3CCN(c4ccc5c(c4)C(=O)N(C4CCC(=O)NC4=O)C5=O)C3)CC2)cc1,C39H45N9O5,40785.0
18067,ERD-308,CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(-c2scnc2C)cc1)C(C)(C)C)CCOc1ccc(C(=O)c2c(-c3ccc(O)cc3)sc3cc(O)ccc23)cc1,C55H65N5O9S2,33388.0
18068,trans-Indole-3-acrylic Acid,O=C(O)/C=C/c1c[nH]c2ccccc12,C11H9NO2,40655.0
18069,para-methoxy-2-amino Benzamidoxime,COc1ccc(N)c(C(=N)NO)c1,C8H11N3O2,9004402.0
18070,IPPD,CC(C)Nc1ccc(Nc2ccccc2)cc1,C15H18N2,40725.0
18071,C16 ?-Glucosylceramide (d18:1/16:0) (synthetic),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCC,C40H77NO8,40274.0
18072,Lipid 88,CCCCCCC(CCCC)COC(=O)OCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCOC(=O)OCC(CCCC)CCCCCC)CCC(=O)OCCOC(=O)OCC(CCCC)CCCCCC)CCC(=O)OCCOC(=O)OCC(CCCC)CCCCCC,C79H147N3O20,40493.0
18073,LMT-28,C=C(CCCCC)[C@@H](O)[C@H](C)C(=O)N1C(=O)OC[C@@H]1C(C)C,C17H29NO4,40837.0
18074,(-)-Narwedine,COc1ccc2c3c1O[C@H]1CC(=O)C=C[C@@]31CCN(C)C2,C17H19NO3,40744.0
18075,A17,CC(C)[C@@H](CO)NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@@H](OC=O)C[C@@H]4C[C@H](OC=O)CC[C@]4(C)[C@H]3CC[C@]12C,C31H51NO6,39686.0
18076,11S(12R)-EET,CCCCC/C=C\C[C@H]1O[C@H]1C/C=C\C/C=C\CCCC(=O)O,C20H32O3,9004348.0
18077,DSPE-PEG(2000) Cyanur (ammonium salt),CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCCNC(=O)OCCOCCNc1nc(Cl)nc(Cl)n1)OC(=O)CCCCCCCCCCCCCCCCC.[NH4+],C47H89Cl2N6O10P(C2H4O)n,37797.0
18078,Voriconazole-d3 N-oxide,[2H]C([2H])([2H])[C@@H](c1nc[n+]([O-])cc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,C16H14F3N5O2,40332.0
18079,PDIC-NC,CN(C)CCN1C(=O)c2cc(Cl)c3c4c(Cl)cc5c6c(cc(Cl)c(c7c(Cl)cc(c2c37)C1=O)c64)C(=O)N(CCN(C)C)C5=O.Cl.Cl,C32H26Cl6N4O4,40818.0
18080,KYP-2047,N#C[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CCCc1ccccc1,C20H25N3O2,39180.0
18081,Vipoglanstat,Cn1c(Nc2c(Cl)ccc(CNC(=O)C(C)(C)C)c2Cl)nc2cc(C(=O)N[C@H]3CC[C@H](C(F)(F)F)CC3)c(OCC(F)F)cc21,C30H34Cl2F5N5O3,37925.0
18082,6-Deoxy-8-O-methylrabelomycin,COc1cccc2c1C(=O)c1ccc3c(c1C2=O)C(=O)C[C@](C)(O)C3,C20H16O5,40662.0
18083,IZ-Chol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)NCCCn5ccnc5)CC[C@]4(C)[C@H]3CC[C@]12C,C34H55N3O2,40963.0
18084,1A-116,Cc1cc(C)cc(NC(=N)Nc2ccccc2C(F)(F)F)c1,C16H16F3N3,40781.0
18085,CNDAC (hydrochloride),Cl.N#C[C@H]1[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O,C10H13ClN4O4,40672.0
18086,GPX4 16,N#Cc1ccc(C(=O)/C=C/c2ccccc2Oc2ccccc2C=O)cc1,C23H15NO3,40498.0
18087,GSK3039294,O=C(OCOC(=O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(=O)OCOC(=O)OC1CCOCC1)OC1CCOCC1,C30H44N2O14,36559.0
18088,Gefapixant,COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1S(N)(=O)=O,C14H19N5O4S,40825.0
18089,2-Hydroxyethylflurazepam-d4 (CRM),[2H]c1c([2H])c([2H])c(C2=NCC(=O)N(CCO)c3ccc(Cl)cc32)c(F)c1[2H],C17H14ClFN2O2,40619.0
18090,MPLA,CCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCC)CC(=O)N[C@H]1[C@H](OC[C@H]2O[C@H](O)[C@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H]2O)O[C@H](CO)[C@@H](OP(=O)([O-])O)[C@@H]1OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC.[NH4+],C96H184N3O22P,25998.0
18091,Propiverine N-oxide,CCCOC(C(=O)OC1CC[N+](C)([O-])CC1)(c1ccccc1)c1ccccc1,C23H29NO4,41013.0
18092,2-Methyl-1-butanol,CCC(C)CO,C5H12O,40330.0
18093,Bhimanone,CC(=O)C[C@@H]1C[C@H](O)c2c(O)cccc2C1=O,C13H14O4,40910.0
18094,Fenazaquin,CC(C)(C)c1ccc(CCOc2ncnc3ccccc23)cc1,C20H22N2O,38881.0
18095,"1,2-Hexadecanediol",CCCCCCCCCCCCCCC(O)CO,C16H34O2,17445.0
18096,4?-Phorbol,CC1=C[C@H]2[C@@]3(O)[C@H](C)[C@@H](O)[C@]4(O)[C@H]([C@@H]3C=C(CO)C[C@@]2(O)C1=O)C4(C)C,C20H28O6,40905.0
18097,GSK199 (hydrochloride),CCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)cc(OC)c3n2C)cc2cccnc21.Cl,C24H29ClN6O2,17489.0
18098,TASP0277308,CCn1c(Oc2cccc(N3CCN(C)CC3)c2)nnc1[C@@H](C)NS(=O)(=O)c1ccc(Cl)c(Cl)c1,C23H28Cl2N6O3S,11340.0
18099,Questin,COc1cc(O)cc2c1C(=O)c1c(O)cc(C)cc1C2=O,C16H12O5,40904.0
18100,?-Valerobetaine,C[N+](C)(C)CCCCC(=O)[O-],C8H17NO2,37092.0
18101,Ac4GalNAz,CC(=O)OC[C@H]1OC(OC(C)=O)[C@H](NC(=O)CN=[N+]=[N-])[C@@H](OC(C)=O)[C@H]1OC(C)=O,C16H22N4O10,39653.0
18102,Hydroxyfasudil,O=c1[nH]ccc2c(S(=O)(=O)N3CCCNCC3)cccc12,C14H17N3O3S,40814.0
18103,Phytantriol,CC(C)CCCC(C)CCCC(C)CCCC(C)(O)C(O)CO,C20H42O3,40742.0
18104,Ganglioside GM1 (bovine) (sodium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[Na+],C73H130N3NaO31,41206.0
18105,THCA-A-d3 (CRM),[2H]C([2H])([2H])CCCCc1cc2c(c(O)c1C(=O)O)[C@@H]1C=C(C)CC[C@H]1C(C)(C)O2,C22H30O4,37042.0
18106,p38? MAPK-IN-1,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)cc2)cc1,C27H35N5O3,40839.0
18107,VTP-50469,CC(C)N(C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(CCN(C[C@H]3CC[C@H](NS(C)(=O)=O)CC3)CC2)C1)C(C)C,C32H47FN6O4S,40759.0
18108,Ionizable Lipid 4,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COC(=O)OCCCN(CC)CC,C48H85NO7,40496.0
18109,Fedotozine (tartrate),CC[C@](COCc1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C.O=C(O)[C@@H](O)[C@H](O)C(=O)O,C26H37NO10,22189.0
18110,Soyasaponin II,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3[C@H](O[C@H]4CC[C@@]5(C)[C@@H](CC[C@]6(C)[C@@H]5CC=C5[C@@H]7CC(C)(C)C[C@@H](O)[C@]7(C)CC[C@]56C)[C@@]4(C)CO)O[C@H](C(=O)O)[C@@H](O)[C@@H]3O)OC[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,C47H76O17,40661.0
18111,Camellianin A,CC(=O)OC[C@H]1O[C@@H](Oc2cc(O)cc3oc(-c4ccc(O)cc4)cc(=O)c23)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O,C29H32O15,37575.0
18112,NE52-QQ57,CCc1nn2c(C)cc(C)nc2c1Cc1ccc(-c2nnc(C3CCNCC3)o2)cc1,C24H28N6O,40647.0
18113,4-Nitrodiphenylamine,O=[N+]([O-])c1ccc(Nc2ccccc2)cc1,C12H10N2O2,40729.0
18114,"N,N'-Diphenyl-1,4-phenylenediamine",c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1,C18H16N2,40727.0
18115,Liriodendrin,COc1cc([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2cc(OC)c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)c2)cc(OC)c1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C34H46O18,40743.0
18116,Ganglioside GD1b (porcine brain) (ammonium salt),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]4(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC.[NH4+].[NH4+],C84H154N6O39,31593.0
18117,Giemsa Stain,CN(C)c1ccc2nc3ccc(=[NH2+])cc-3sc2c1.[Cl-],C14H14ClN3S,38336.0
18118,IPPD-Q,CC(C)NC1=CC(=O)C(Nc2ccccc2)=CC1=O,C15H16N2O2,40829.0
18119,Delorazepam Uncyclized Intermediate (hydrochloride),Cl.NCC(=O)Nc1ccc(Cl)cc1C(=O)c1ccccc1Cl,C15H13Cl3N2O2,35688.0
18120,Tanzawaic Acid B,C[C@H]1C[C@@H](C)[C@@H]2[C@@H](/C=C/C=C/C(=O)O)[C@@H](C)C=C[C@H]2C1,C18H26O2,40909.0
18121,2-((2-Hydroxypropionyl)amino)benzamide,CC(O)C(=O)Nc1ccccc1C(N)=O,C10H12N2O3,40915.0
18122,20-O-Acetylingenol-3-angelate,C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(COC(C)=O)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C,C27H36O7,39904.0
18123,Eosin Y,O=C1OC2(c3ccccc31)c1cc(Br)c(O)c(Br)c1Oc1c2cc(Br)c(O)c1Br,C20H8Br4O5,40128.0
18124,Raptinal,O=CC1(C2(C=O)c3ccccc3-c3ccccc32)c2ccccc2-c2ccccc21,C28H18O2,39131.0
18125,Glycerol Phenylbutyrate,O=C(CCCc1ccccc1)OCC(COC(=O)CCCc1ccccc1)OC(=O)CCCc1ccccc1,C33H38O6,40832.0
18126,Semaglutide Side Chain,CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)C(=O)OC(C)(C)C,C43H79N3O13,40746.0
18127,DG-041,Cc1cn(Cc2ccc(Cl)cc2Cl)c2c(/C=C/C(=O)NS(=O)(=O)c3cc(Cl)c(Cl)s3)cc(F)cc12,C23H15Cl4FN2O3S2,13234.0
18128,Suzetrigine,COc1c([C@H]2[C@H](C(=O)Nc3ccnc(C(N)=O)c3)O[C@@](C)(C(F)(F)F)[C@H]2C)ccc(F)c1F,C21H20F5N3O4,40799.0
18129,AbK,CC1(CCOC(=O)NCCCC[C@H](N)C(=O)O)N=N1,C11H20N4O4,38895.0
18130,Tri-GalNAc COOH,CC(=O)N[C@H]1[C@H](OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)(COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)NC(=O)CCOCCOCCOCCOCCOCCC(=O)O)O[C@H](CO)[C@H](O)[C@@H]1O,C75H134N10O35,40934.0
18131,TG89,Cc1cnc(Nc2cccc(CN3CCOCC3)c2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,C26H34N6O3S,39162.0
18132,PFI-653,O=C(c1cnc(NCc2cnccn2)nc1)N1CCC2(CCOCC2)C1,C18H22N6O2,40955.0
18133,Drostanolone Enanthate,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)[C@H](C)C[C@]4(C)[C@H]3CC[C@]12C,C27H44O3,40656.0
18134,Eribulin,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C,C40H59NO11,17351.0
18135,GW 870086,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C1C(C)(C)C1(C)C)C(=O)OCC#N,C31H39F2NO6,40786.0
18136,Iprodione,CC(C)NC(=O)N1CC(=O)N(c2cc(Cl)cc(Cl)c2)C1=O,C13H13Cl2N3O3,38877.0
18137,A2793,CCOC(=O)COc1ccc(Cl)c2cccnc12,C13H12ClNO3,41081.0
18138,Lipid DIM1,CCCCCCCCCCC(O)CN(CCCO[C@H]1CO[C@@H]2[C@H]1OC[C@H]2OCCCN(CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC,C60H120N2O8,40512.0
18139,Resorcinol Monoacetate (technical grade),CC(=O)Oc1cccc(O)c1,C8H8O3,39019.0
18140,Cholesteryl Butyrate,CCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1,C31H52O2,40950.0
18141,Lipid 2-10,CCCCCCCC(=O)N(CCCN(C)C)C(CCCCCCCCC(=O)OC(CCCCCC)CCCCCC)CCCCCCCCC(=O)OC(CCCCCC)CCCCCC,C58H114N2O5,40811.0
18142,Coumarin 478,O=c1oc2c3c4c(cc2c2c1CCC2)CCCN4CCC3,C18H19NO2,40754.0
18143,Sapacitabine,CCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N)c(=O)n1,C26H42N4O5,27321.0
18144,Lipid HTO12,CCCCCCCCCCCCC(O)CN(CCO)CCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC,C41H83NO4,41202.0
18145,Ziyuglycoside II,C[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@]1(C)O,C35H56O8,40831.0
18146,GDC-1971,N[C@@H]1c2ccccc2OC12CCN(c1cnc3c(N4CCCc5ncccc54)n[nH]c3n1)CC2,C25H26N8O,39884.0
18147,Mps1-IN-3,COc1cc(N2CCC(O)CC2)ccc1Nc1nc(Nc2ccccc2S(=O)(=O)C(C)C)c2[nH]cnc2n1,C26H31N7O4S,41029.0
18148,Val-Cit-PAB-MMAE,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](N)C(C)C)cc1)C(C)C,C58H94N10O12,41048.0
18149,Pomiferin,CC(C)=CCc1c2c(c3occ(-c4ccc(O)c(O)c4)c(=O)c3c1O)C=CC(C)(C)O2,C25H24O6,35861.0
18150,FDW028,CCc1ccc(CNc2nc3nc(CNCc4ccccc4)cc(O)n3n2)cc1,C22H24N6O,39543.0
18151,SGC-STK17B-1,O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12,C16H10N2O2S3,41126.0
18152,VH 032,CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,C24H32N4O4S,39982.0
18153,MK-8719,CCNC1=N[C@@H]2[C@@H](O)[C@H](O)[C@@H](C(F)F)O[C@@H]2S1,C9H14F2N2O3S,34054.0
18154,CPPD-Q,O=C1C=C(NC2CCCCC2)C(=O)C=C1Nc1ccccc1,C18H20N2O2,40828.0
18155,Lucitanib (hydrochloride),CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12.Cl.Cl,C26H27Cl2N3O4,37711.0
18156,KL1333,CC(C)c1nc2c([nH]1)-c1ccccc1C(=O)C2=O,C14H12N2O2,39670.0
18157,"(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (hydrochloride)",Cl.N[C@@H]1C[C@H]1c1ccc(F)c(F)c1,C9H10ClF2N,41102.0
18158,BL 1249,c1ccc(-c2nnn[nH]2)c(Nc2cccc3c2CCCC3)c1,C17H17N5,37426.0
18159,Clerosterol,C=C(C)[C@@H](CC)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C29H48O,35862.0
18160,Escitalopram (oxalate),CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21.O=C(O)C(=O)O,C22H23FN2O5,39841.0
18161,Mazdutide,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(N)=O,C210H322N46O67,40971.0
18162,AZD 5462,COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)O)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)NCC1(C)CCC1,C30H41FN2O6,40956.0
18163,N4-Methylcytidine,CNc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,C10H15N3O5,40907.0
18164,Picoxystrobin,CO/C=C(/C(=O)OC)c1ccccc1COc1cccc(C(F)(F)F)n1,C18H16F3NO4,39545.0
18165,KMH-233,CNC(=O)COc1ccc(-c2c(C#N)c(NC(=O)c3cccc(C[C@H](N)C(=O)O)c3)n3c(nc4ccccc43)c2C#N)cc1,C32H25N7O5,31032.0
18166,Cannabiorcol,Cc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2,C17H18O2,9003766.0
18167,NDSB-256-4T,CC(C)(C)c1cc[n+](CCCS(=O)(=O)[O-])cc1,C12H19NO3S,17443.0
18168,MMRi62,Oc1c(C(Nc2ccccn2)c2cccc(Cl)c2Cl)ccc2cccnc12,C21H15Cl2N3O,40841.0
18169,Dihydrobipolaroxin,C=C(C=O)[C@]1(O)C[C@@]2(C)C(=CC1=O)C=C[C@H](O)[C@@H]2C,C15H18O4,40916.0
18170,"L-742,001 (hydrochloride)",Cl.O=C(O)C(O)=CC(=O)C1(Cc2ccc(Cl)cc2)CCN(Cc2ccccc2)CC1,C23H25Cl2NO4,40920.0
18171,GSK2850163,Cc1ccc(CNC(=O)N2CCC[C@]3(CCN(Cc4ccc(Cl)c(Cl)c4)C3)C2)cc1,C24H29Cl2N3O,40917.0
18172,"8,9-Dihydrocannabidivarin",CCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(C)C)c(O)c1,C19H28O2,41062.0
18173,TP-060,CC(C)(O)c1ccc(N2Cc3c(ccnc3-c3ccc(F)cc3OCC(F)(F)F)C2=O)cc1,C24H20F4N2O3,41127.0
18174,iCRT3,CCc1ccc(-c2nc(CSCC(=O)NCCc3ccccc3)c(C)o2)cc1,C23H26N2O2S,40836.0
18175,2-(Morpholin-4-yl)ethane-1-sulfonamide,NS(=O)(=O)CCN1CCOCC1,C6H14N2O3S,40952.0
18176,4-Nitrosodiphenylamine,O=Nc1ccc(Nc2ccccc2)cc1,C12H10N2O,40731.0
18177,"1,2-Dipalmitoyl-sn-glycero-3-PC-d9",[2H]C([2H])([2H])[N+](CCOP(=O)([O-])OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)(C([2H])([2H])[2H])C([2H])([2H])[2H],C40H80NO8P,41203.0
18178,Takeda-103A,CCCn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccncn1,C24H23F2N7O,41027.0
18179,AH 10639 (phosphate),CC(C)c1nc2nc(N)nc(N)c2nc1C(C)C.O=P(O)(O)O,C12H21N6O4P,41043.0
18180,8RK64,N#CN1CC[C@H](C(=O)Nc2nc3c(s2)CN(C(=O)CN=[N+]=[N-])CC3)C1,C14H16N8O2S,41148.0
18181,2-Bromo-4'-chloropropiophenone,CC(Br)C(=O)c1ccc(Cl)cc1,C9H8BrClO,40861.0
18182,cyclo-Cannabigerol,CCCCCc1cc(O)c2c(c1)OC(C(C)(O)CCC=C(C)C)C2,C21H32O3,37956.0
18183,Borussertib,C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1,C36H32N6O3,33387.0
18184,"Cholyl-1,3-diaminopropane",C[C@H](CCC(=O)NCCCN)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C27H48N2O4,40898.0
18185,Chenodeoxycholyl-putrescine,C[C@H](CCC(=O)NCCCCN)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C28H50N2O3,40896.0
18186,NEO2734,Cc1cc(-c2ccc3nc(C4CCOCC4)n(CCOC(F)(F)F)c3c2)cn(C)c1=O,C22H24F3N3O3,41030.0
18187,BGG463,CC(=O)Nc1cc(Oc2ccc3c(C(=O)Nc4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)cccc3c2)ncn1,C30H29F3N6O3,41146.0
18188,JNJ-9350,O=C(NCCCn1ccnc1)c1cc2nc(-c3ccccc3)cc(-c3ccccc3)n2n1,C25H22N6O,41171.0
18189,Cimlanod,Cc1ccc(S(=O)(=O)NO)o1,C5H7NO4S,40660.0
18190,Cholyl-cadaverine,C[C@H](CCC(=O)NCCCCCN)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C29H52N2O4,40897.0
18191,Linderalactone,C/C1=C\CCC2=C[C@@H](OC2=O)c2c(C)coc2C1,C15H16O3,35641.0
18192,"Thymine-13C5,15N2",[13CH3][13c]1[13cH][15nH][13c](=O)[15nH][13c]1=O,C5H6N2O2,41172.0
18193,AT-1,CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)SCCCCCCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21,C48H58ClN9O5S3,33265.0
18194,LSN3318839,C[C@H](c1c(Cl)ccc(C2CC2)c1Cl)n1cnc2cnc(-c3ccccc3[C@@H](C)C(=O)O)cc21,C26H23Cl2N3O2,41245.0
18195,Cholyl-putrescine,C[C@H](CCC(=O)NCCCCN)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C28H50N2O4,40899.0
18196,7-PPD-Q,CC(C)CCC(C)NC1=CC(=O)C(Nc2ccccc2)=CC1=O,C19H24N2O2,40610.0
18197,Chenodeoxycholyl-cadaverine,C[C@H](CCC(=O)NCCCCCN)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C29H52N2O3,40895.0
18198,Aranidipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-],C19H20N2O7,40813.0
18199,GalNAc-L96,COc1ccc(C(OC[C@@H]2C[C@@H](OC(=O)CCC(=O)O)CN2C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2NC(C)=O)(COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2NC(C)=O)COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2NC(C)=O)(c2ccccc2)c2ccc(OC)cc2)cc1,C121H179N11O45,40455.0
18200,DOTATATE (acetate),CC(=O)O.C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(=O)O,C67H94N14O21S2,41054.0
18201,GalNac-L96 (triethylamine salt),CCN(CC)CC.COc1ccc(C(OC[C@@H]2C[C@@H](OC(=O)CCC(=O)O)CN2C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2NC(C)=O)(COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2NC(C)=O)COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2NC(C)=O)(c2ccccc2)c2ccc(OC)cc2)cc1,C127H194N12O45,40456.0
18202,Ralmitaront,CCc1[nH]nc(C(=O)Nc2ccc([C@H]3CNCCO3)cc2)c1C,C17H22N4O2,41111.0
18203,9-cis-Retinol,CC1=C(/C=C/C(C)=C\C=C\C(C)=C\CO)C(C)(C)CCC1,C20H30O,41345.0
18204,BAY-1161909,COc1cc(S(C)(=O)=O)ccc1Nc1nc2ccc(-c3ccc(NC(=O)[C@H](C)c4ccc(F)cc4)cc3)cn2n1,C29H26FN5O4S,41108.0
18205,CDKI-73,CNc1nc(C)c(-c2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2F)s1,C15H15FN6O2S2,41099.0
18206,Fumarate hydratase-IN-1,CCOC(=O)[C@@]12CCCC=C1N(Cc1ccc(-c3ccccc3)cc1)C(=O)[C@H]2CC(=O)NC,C27H30N2O4,39275.0
18207,BI-749327,Nc1ccc(C2CCN(C(=O)c3ccc(Oc4ccc(C(F)(F)F)cc4)cc3)CC2)nn1,C23H21F3N4O2,39672.0
18208,Alborixin,CC[C@@H]1O[C@@H]([C@]2(C)C[C@@H](C)[C@](O)([C@]3(C)CC[C@@H]([C@@H](O)[C@]4(O)O[C@H](C[C@@]5(O)O[C@@H]([C@@H](C)[C@H](O)C[C@@H]6O[C@H]([C@@H](C)C(=O)O)[C@@H](C)C[C@H]6C)CC[C@@H]5C)[C@@H](C)C[C@H]4C)O3)O2)CC[C@@]1(C)O,C48H84O14,40933.0
18209,Verrucarin H,CC1=CC2OC3CC4OC(=O)C=CC=CC5OC(CC(C)=CC(=O)OCC2(CC1)C4(C)C31CO1)OC5C,C29H36O8,40936.0
18210,BAY-2433334,CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(-c2cc(Cl)ccc2-n2cc(C(F)(F)F)nn2)cc1=O,C26H21ClF4N6O4,41101.0
18211,LD003,CCCCC/C=C\C/C=C\CCCCCCCCOC(=O)CCC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,C44H65FO8,41278.0
18212,PT2385,CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)C(F)(F)C2,C17H12F3NO4S,21325.0
18213,Muvalaplin,O=C(O)[C@@H](Cc1cccc(CN(Cc2cccc(C[C@H](C(=O)O)[C@H]3CCNC3)c2)Cc2cccc(C[C@H](C(=O)O)[C@H]3CCNC3)c2)c1)[C@@H]1CCNC1,C42H54N4O6,39746.0
18214,"Cytosine-13C,15N2",Nc1cc[15n][13c](=O)[15nH]1,C4H5N3O,41122.0
18215,Noribogaine (hydrochloride),CC[C@H]1C[C@@H]2C[C@H]3c4[nH]c5ccc(O)cc5c4CC[N@@](C2)[C@@H]13.Cl,C19H25ClN2O,40090.0
18216,"L-168,049",CCCOc1ccc(Br)cc1-c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1,C24H20BrClN2O,41112.0
18217,MRS1220,O=C(Cc1ccccc1)Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12,C21H14ClN5O2,41015.0
18218,VU534,Cc1cc(C)c2sc(NC(=O)C3CCN(S(=O)(=O)c4ccc(F)cc4)CC3)nc2c1,C21H22FN3O3S2,39744.0
18219,Golotimod (trifluoroacetate salt),N[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)O.O=C(O)C(F)(F)F,C18H20F3N3O7,40833.0
18220,Zelasudil,Cn1nc(-c2ccc(C(=O)NCC(F)F)cc2)nc1Nc1ccc2[nH]ncc2c1C1CC1,C22H21F2N7O,41163.0
18221,Proxymetacaine (hydrochloride),CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N.Cl,C16H27ClN2O3,39840.0
18222,Akt-I-1,CN(C)CC(C)(C)CNc1nn2c(-c3ccccc3)nnc2cc1C1CCC1,C22H30N6,41016.0
18223,MBP146-78,CN1CCC(c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)CC1,C21H22FN3,41083.0
18224,UCSF924,Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1,C20H22N2O2,41317.0
18225,TG-46,Cc1cnc(Nc2ccc(CN3CCOCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,C26H34N6O3S,41123.0
18226,GNE-490,Cc1nc(N)ncc1-c1nc(N2CCOCC2)c2sc(C(C)(C)O)cc2n1,C18H22N6O2S,41120.0
18227,TL12-186,CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCNC(=O)CNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2)ncc1Cl,C44H51ClN10O9S,40970.0
18228,JNJ-42226314,O=C(c1ccc2c(ccn2-c2ccc(F)cc2)c1)N1CC(N2CCN(C(=O)c3nccs3)CC2)C1,C26H24FN5O2S,41115.0
18229,SGC-AAK1-1,CCN(CC)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1,C21H25N5O3S,41118.0
18230,Homogentisic Acid lactone,O=C1Cc2cc(O)ccc2O1,C8H6O3,41254.0
18231,Ferroptosis Inducer 24,O=C(/C=C/c1ccccc1)OCCc1c[nH]c2ccccc12,C19H17NO2,41201.0
18232,N-Ethylmethamphetamine (hydrochloride),CCN(C)C(C)Cc1ccccc1.Cl,C12H20ClN,14526.0
18233,MI-2-2,CC1(C)CN=C(N2CCN(c3ncnc4sc(CC(F)(F)F)cc34)CC2)S1,C17H20F3N5S2,41109.0
18234,TASP0415914,CC(=O)Nc1nc(C)c(-c2nc(N3CCCC(O)C3)no2)s1,C13H17N5O3S,41145.0
18235,(+)-Fenfluramine (hydrochloride),CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1.Cl,C12H17ClF3N,39830.0
18236,SGC6870,Cc1cc(C)cc([C@@H]2c3cc(C)ccc3NC(=O)CN2C(=O)c2ccc(Br)s2)c1,C23H21BrN2O2S,33712.0
18237,Communesin B,C/C=C/C=C/C(=O)N1CC[C@@]23c4ccccc4N[C@@H]4N(C)c5cccc6c5[C@@]42CC[N@@]([C@@H]13)[C@@H]6[C@H]1OC1(C)C,C32H36N4O2,40935.0
18238,NVS-BPTF-1,Cc1c(Nc2ccc(S(=O)(=O)N3CCN(C)CC3)cc2F)nc2ccc(-c3cnn(C4CC4)c3)cn2c1=O,C26H28FN7O3S,41164.0
18239,ARN25062,FC(F)(F)c1cccc(Nc2cc(-c3ccccc3)nc(C3CCNCC3)n2)c1,C22H21F3N4,39615.0
18240,2-Hydroxypropyl Octadecanoate,CCCCCCCCCCCCCCCCCC(=O)OCC(C)O,C21H42O3,41151.0
18241,Ophiobolin H,CC(C)=C/C=C\[C@H](C)[C@H]1CC[C@]2(C)C[C@H]3[C@H]4/C(=C\C[C@@H]12)CO[C@@]4(O)C[C@@]3(C)O,C25H38O3,40937.0
18242,Surfen (hydrochloride),Cc1cc(N)c2cc(NC(=O)Nc3ccc4nc(C)cc(N)c4c3)ccc2n1.Cl.Cl,C21H22Cl2N6O,26670.0
18243,2-Hydroxypropyl Hexadecanoate,CCCCCCCCCCCCCCCC(=O)OCC(C)O,C19H38O3,41150.0
18244,BAY-069,Cc1ccccc1Oc1cc(-n2c(=O)cc(C(F)(F)F)[nH]c2=O)c2ccccc2c1Cl,C22H14ClF3N2O3,41149.0
18245,WLB-89462,CCc1ncc(-c2cc(C)no2)c(C2CCN(CC(=O)N3CCOCC3)CC2)n1,C21H29N5O3,39736.0
18246,PXS-5505 (hydrochloride),Cl.Cl.NC/C=C(\F)CS(=O)(=O)c1cccc2cccnc12,C13H15Cl2FN2O2S,39857.0
18247,DDO-5936,Cc1cc(C)c(S(=O)(=O)N(CC(=O)O)c2ccc(Nc3ccnc(N4CCCC4)n3)cc2)c(C)c1,C25H29N5O4S,41040.0
18248,TP-0472993,CC(=O)N1CCC(COc2ccc(-c3cc[nH]n3)nc2)CC1,C16H20N4O2,39757.0
18249,ETH-LAD (solution),CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(CC)C1,C21H27N3O,41271.0
18250,Direct Red 80,O=C(Nc1ccc2c(O)c(N=Nc3ccc(N=Nc4ccc(S(=O)(=O)[O-])cc4)cc3S(=O)(=O)[O-])c(S(=O)(=O)[O-])cc2c1)Nc1ccc2c(O)c(N=Nc3ccc(N=Nc4ccc(S(=O)(=O)[O-])cc4)cc3S(=O)(=O)[O-])c(S(=O)(=O)[O-])cc2c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],C45H26N10Na6O21S6,39535.0
18251,BTTAA,CC(C)(C)n1cc(CN(Cc2cn(CC(=O)O)nn2)Cc2cn(C(C)(C)C)nn2)nn1,C19H30N10O2,41089.0
18252,Heptaminol (hydrochloride),CC(N)CCCC(C)(C)O.Cl,C8H20ClNO,40849.0
18253,C12-TLRa,CCCCCCCCCCC(O)CN(Cc1ccc(Cn2c(CCCC)nc3c(N)nc4ccccc4c32)cc1)CC(O)CCCCCCCCCC,C46H73N5O2,41338.0
18254,Pridinol (hydrochloride),Cl.OC(CCN1CCCCC1)(c1ccccc1)c1ccccc1,C20H26ClNO,36056.0
18255,TP-021,O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1,C20H20ClN3O5,41315.0
18256,A1874,COc1cc(C(=O)NCCOCCOCCOCCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F,C58H62Cl3F2N9O7S,40842.0
18257,N-Cholyl-L-Leucine,CC(C)C[C@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C)C(=O)O,C30H51NO6,40930.0
18258,HM03,COc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(O)c(CN4CCN(C)CC4)c3)c2c1,C26H27ClN4O2,40908.0
18259,S49076 (hydrochloride),Cl.O=C1Nc2ccc(CN3C(=O)CSC3=O)cc2/C1=C/c1cc(CN2CCOCC2)c[nH]1,C22H23ClN4O4S,41173.0
18260,BAY-390,O[C@]1(C(F)(F)F)CCCC[C@H]1Nc1ccc(F)cc1,C13H15F4NO,41313.0
18261,Dimethindene (maleate),CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1.O=C(O)/C=C\C(=O)O,C24H28N2O4,40649.0
18262,NSC 44625,Nc1cc(C(F)(F)F)c(S(N)(=O)=O)cc1S(N)(=O)=O,C7H8F3N3O4S2,40985.0
18263,SNDX-5613,CCN(C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(CCN(C[C@H]3CC[C@H](NS(=O)(=O)CC)CC3)CC2)C1)C(C)C,C32H47FN6O4S,40758.0
18264,Guanine-15N5,[15NH2]c1[15n]c(=O)c2[15nH]c[15n]c2[15nH]1,C5H5N5O,41180.0
18265,Oleacein,C/C=C(/C=O)[C@@H](CC=O)CC(=O)OCCc1ccc(O)c(O)c1,C17H20O6,40719.0
18266,Bayer 18,CC(C)(C)NC(=O)Nc1cccc(Nc2ncc(F)c(NC(C)(C)CO)n2)c1,C19H27FN6O2,41124.0
18267,6-ECDCA-d4,[2H]C1([2H])C[C@@]2(C)[C@H]([C@@H](CC)[C@@H](O)[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]32)C([2H])([2H])[C@@H]1O,C26H44O4,39007.0
18268,2'-O-(2-Methoxyethyl)guanosine,COCCO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(=O)nc(N)[nH]c21,C13H19N5O6,40444.0
18269,Heroin-d9,[2H]C([2H])([2H])C(=O)Oc1ccc2c3c1O[C@H]1[C@@H](OC(=O)C([2H])([2H])[2H])C=C[C@H]4[C@@H](C2)N(C([2H])([2H])[2H])CC[C@@]341,C21H23NO5,40095.0
18270,Heroin-d9 (exempt preparation),[2H]C([2H])([2H])C(=O)Oc1ccc2c3c1O[C@H]1[C@@H](OC(=O)C([2H])([2H])[2H])C=C[C@H]4[C@@H](C2)N(C([2H])([2H])[2H])CC[C@@]341,C21H23NO5,42070.0
18271,Vardenafil (CRM),CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,C23H32N6O4S,41134.0
18272,GSK215,CNC(=O)c1ccccc1Nc1cc(Nc2ccc(N3CCN(CC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)c4ccc(-c5scnc5C)cc4)C(C)(C)C)CC3)cc2OC)ncc1C(F)(F)F,C50H59F3N10O6S,40835.0
18273,AMG 1,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,C31H29FN4O5,41226.0
18274,ADU-S100,Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2CO[P@@](=O)([S-])O[C@@H]3[C@H](O)[C@@H](CO[P@@](=O)([S-])O[C@H]2[C@H]1O)O[C@H]3n1cnc2c(N)ncnc21.[Na+].[Na+],C20H22N10Na2O10P2S2,27901.0
18275,Oleocanthal,C/C=C(/C=O)[C@@H](CC=O)CC(=O)OCCc1ccc(O)cc1,C17H20O5,17496.0
18276,Cholesteryl Palmitate-d7,[2H]C([2H])([2H])C([2H])(CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CCCCCCCCCCCCCCC)CC[C@]4(C)[C@H]3CC[C@]12C)C([2H])([2H])[2H],C43H76O2,9000422.0
18277,Survodutide,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)C1(NC(=O)[C@@H](N)Cc2c[nH]cn2)CCC1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCNC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(N)=O,C192H289N47O61,40972.0
18278,Calicheamicin ?1,CCN[C@H]1CO[C@@H](O[C@H]2[C@H](O[C@H]3C#C/C=C\C#C[C@]4(O)CC(=O)C(NC(=O)OC)=C3/C4=C\CSSSC)O[C@H](C)[C@@H](NO[C@H]3C[C@H](O)[C@H](SC(=O)c4c(C)c(I)c(O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](OC)[C@H]5O)c(OC)c4OC)[C@@H](C)O3)[C@@H]2O)C[C@@H]1OC,C55H74IN3O21S4,40830.0
18279,PFI-6,CN(C)C(=O)c1ccc(-c2cc(C(=O)N[C@@H]3CCc4ccccc43)no2)cc1O,C22H21N3O4,41162.0
18280,Cipepofol,CC(C)c1cccc([C@H](C)C2CC2)c1O,C14H20O,40951.0
18281,Norfluoxetine (oxalate) (CRM),NCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1.O=C(O)C(=O)O,C18H18F3NO5,35884.0
18282,BVT 14225,CCN(CC)C(=O)Cc1csc(NS(=O)(=O)c2cccc(Cl)c2C)n1,C16H20ClN3O3S2,41224.0
18283,DDR-TRK-1,Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)CN(c3cncnc3)C[C@@H]4C)cc(C(F)(F)F)c2)cn1,C26H23F3N6O,41321.0
18284,N-Cholyl-L-Alanine,C[C@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C)C(=O)O,C27H45NO6,40928.0
18285,BAY-826,Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1,C26H19F5N6OS,41365.0
18286,Lurasidone (hydrochloride) (CRM),Cl.O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1,C28H37ClN4O2S,41305.0
18287,Utreglutide,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)C(C)(C)NC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C,C191H298N46O58,41275.0
18288,JNJ-39758979,CC(C)c1cc(N2CC[C@@H](N)C2)nc(N)n1,C11H19N5,41084.0
18289,Megastigmatrienone (mixed isomers),CC=CC=C1C(C)=CC(=O)CC1(C)C,C13H18O,38754.0
18290,Oxybuprocaine (hydrochloride),CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N.Cl,C17H29ClN2O3,39978.0
18291,Boc-Dap-NE,CO[C@H]([C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)[C@@H]1CCCN1C(=O)OC(C)(C)C,C23H36N2O5,41222.0
18292,Pantothenate-AMC,Cc1cc(=O)oc2cc(NC(=O)CCNC(=O)[C@H](O)C(C)(C)CO)ccc12,C19H24N2O6,9004463.0
18293,Lipid 29d,CCCCC/C=C\C/C=C\CCCCCCCC(=O)Nc1sc2c(c1C(=O)NCCCN(C)C)CCN(C(=O)CCCCCCC/C=C\C/C=C\CCCCC)C2,C49H82N4O3S,40913.0
18294,PHA-408,CN1CCN(c2cc(C(=O)Nc3ccc4c(c3)-c3c(c(C(N)=O)nn3-c3ccc(F)cc3)CC4)c(Cl)cn2)CC1,C29H27ClFN7O2,41279.0
18295,ABT-100,Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1,C27H19F3N4O3,41355.0
18296,3-Methoxymethamphetamine (hydrochloride),CNC(C)Cc1cccc(OC)c1.Cl,C11H18ClNO,24011.0
18297,Ambenonium (chloride),CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl.[Cl-].[Cl-],C28H42Cl4N4O2,40845.0
18298,N-butyl Lithocholic Acid,CCCCOC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C28H48O3,41397.0
18299,di-coupled CBDP,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCCCC)c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c1O,C33H48O2,41323.0
18300,Azadiradione,CC(=O)O[C@@H]1C[C@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@H]2CC[C@]3(C)C(=CC(=O)[C@H]3c3ccoc3)[C@@]21C,C28H34O5,37063.0
18301,NNC-0640,CS(=O)(=O)c1cccc(NC(=O)N(Cc2ccc(C(=O)Nc3nnn[nH]3)cc2)c2ccc(C3CCCCC3)cc2)c1,C29H31N7O4S,41234.0
18302,BI-639667,CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1,C22H18FN5O3S,41523.0
18303,NT-0796,CC(C)OC(=O)[C@@H](Cc1ncccn1)OC(=O)Nc1c2c(cc3c1CCC3)CCC2,C23H27N3O4,41237.0
18304,IB-96212,CCCC1(O)C(O)C(C)C/C=C\C=C\C(CC(C)O)CCC2OC3(CCC(C)C(C(C)C(O)CC)O3)C(C)C(OC(=O)/C=C/C(C)C(O)C(C)C(O)C(OC3CCC(O)C(C)O3)C(O)C(O)C1O)C2C,C54H94O16,40938.0
18305,2N12B,CCCCCCCCSSCCOC(=O)CCN(C)CCN(CCC(=O)OCCSSCCCCCCCC)CCC(=O)OCCSSCCCCCCCC,C42H82N2O6S6,41094.0
18306,ARD-2128,CC1(C)[C@H](NC(=O)c2ccc(N3CCN(CC4CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)cc2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1,C45H50ClN7O6,40964.0
18307,Allobarbital,C=CCC1(CC=C)C(=O)NC(=O)NC1=O,C10H12N2O3,22010.0
18308,MRSA Antibiotic 1,O=C(COc1ccc(Cl)cc1Cl)Nc1cc(Cl)ccc1C(=O)O,C15H10Cl3NO4,40432.0
18309,SAG 21k,CN[C@H]1CC[C@H](N(Cc2cc(-c3ccncc3)ccc2OC)C(=O)c2sc3c(F)ccc(F)c3c2Cl)CC1,C29H28ClF2N3O2S,41121.0
18310,Bisantrene,C(=NNC1=NCCN1)c1c2ccccc2c(C=NNC2=NCCN2)c2ccccc12,C22H22N8,40986.0
18311,CCT369260,C[C@@H]1CN(c2ncc(Cl)c(Nc3ccc4c(c3)n(CCC(C)(C)O)c(=O)n4C)n2)C[C@H](C)C1(F)F,C24H31ClF2N6O2,41314.0
18312,Capzimin Dimer,O=C(NCCc1nccs1)c1cnc2c(SSc3cccc4cc(C(=O)NCCc5nccs5)cnc34)cccc2c1,C30H24N6O2S4,41364.0
18313,Bamadutide,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)CC)C(=O)O,C200H313N51O63,41269.0
18314,BI-99179,CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1,C23H25N3O3,41307.0
18315,GSM2,COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,C25H22F4N6O2,41322.0
18316,"Uracil-13C4,15N2",O=[13c]1[13cH][13cH][15nH][13c](=O)[15nH]1,C4H4N2O2,41125.0
18317,?-Glucuronidase Inhibitor,CCOc1ccc(NC(=S)N(CCO)Cc2cc3cc(C)cc(C)c3[nH]c2=O)cc1,C23H27N3O3S,41228.0
18318,Taccalonolide AJ,CC(=O)O[C@H]1[C@H]2[C@H]([C@@H]3[C@@H](O)[C@@H]4[C@H]([C@H](C)[C@H]5O[C@]56OC(=O)[C@@](C)(O)[C@]46C)[C@@]3(C)[C@H]1OC(C)=O)[C@@H](O)C(=O)[C@H]1C[C@@H]3O[C@@H]3[C@H](OC(C)=O)[C@]21C,C34H44O14,41223.0
18319,oxLig-1 (technical grade),CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C(=O)C=C4C[C@@H](OC(=O)CCCCCCCC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C,C36H58O5,40740.0
18320,CID-5157334,O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1)c1ccc(Cl)cc1Cl,C19H14Cl2N2O3S,41677.0
18321,TP-024,Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O,C19H16F4N4O,41144.0
18322,GalNac-L96 analog,COc1ccc(C(OC[C@@H]2C[C@@H](O)CN2C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2NC(C)=O)(COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2NC(C)=O)COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2NC(C)=O)(c2ccccc2)c2ccc(OC)cc2)cc1,C117H175N11O42,39994.0
18323,SGC-CLK-1,COc1cc(Nc2nccc(-c3cnn4nc(OC)ccc34)n2)cc(C(F)(F)F)c1,C19H15F3N6O2,41311.0
18324,SYM 2081,C[C@H](C[C@H](N)C(=O)O)C(=O)O,C6H11NO4,41348.0
18325,TP-004,Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12,C17H16F3N5O,41368.0
18326,Bromhexine,CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1,C14H20Br2N2,37900.0
18327,YHS-12,CCCCCCCCCCCCN(CCCCCCCCCCCC)CCNC(=O)/C=C/C(=O)NCCN(CCCCCCCCCCCC)CCCCCCCCCCCC,C56H112N4O2,40510.0
18328,PS-47,O=C(O)/C=C(\CCc1ccc(Cl)cc1)c1ccccc1,C17H15ClO2,41116.0
18329,Lotiglipron (hydrochloride),C[C@]1(c2ccc(Cl)cn2)Oc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4C[C@@H]4CCO4)CC3)c2O1.Cl,C31H32Cl2N4O5,41227.0
18330,Homer,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCNC(=O)c2ccc(-c3ccc(N4CCN(C)CC4)c(NC(=O)c4c[nH]c(=O)cc4C(F)(F)F)c3)cc2)C(C)(C)C)cc1,C52H60F3N9O7S,41325.0
18331,Esaxerenone,Cc1c(C(=O)Nc2ccc(S(C)(=O)=O)cc2)cn(CCO)c1-c1ccccc1C(F)(F)F,C22H21F3N2O4S,41082.0
18332,GLP-1R Agonist 2,C[C@H]1CN(c2cccc(OCc3ccc(Cl)cc3F)n2)CCN1Cc1nc2ccc(C(=O)O)cc2n1C[C@@H]1CCO1,C30H31ClFN5O4,41319.0
18333,Gelsevirine,C=C[C@]12CN(C)[C@@H]3[C@H]4CO[C@H](C[C@H]41)[C@]1(C(=O)N(OC)c4ccccc41)[C@@H]32,C21H24N2O3,39749.0
18334,Z-FF-FMK,O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)CF)OCc1ccccc1,C27H27FN2O4,41026.0
18335,Taccalonolide A,CC(=O)O[C@@H]1[C@H]2[C@H]3[C@H]([C@H](OC(C)=O)[C@H](OC(C)=O)[C@]2(C)[C@@H]2[C@@H]1[C@]1(C)C(=C[C@H]2C)OC(=O)[C@@]1(C)O)[C@]1(C)[C@H](C[C@@H]2O[C@@H]2[C@@H]1OC(C)=O)C(=O)[C@@H]3O,C36H46O14,40798.0
18336,N-desmethyl Enzalutamide,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(N)=O)c(F)c1,C20H14F4N4O2S,41025.0
18337,Taccalonolide B,CC(=O)O[C@H]1[C@H]2[C@H]([C@@H]3[C@@H](O)[C@@H]4[C@H]([C@H](C)C=C5OC(=O)[C@@](C)(O)[C@@]54C)[C@@]3(C)[C@H]1OC(C)=O)[C@@H](O)C(=O)[C@H]1C[C@@H]3O[C@@H]3[C@H](OC(C)=O)[C@]21C,C34H44O13,41098.0
18338,Dotinurad,O=C(c1cc(Cl)c(O)c(Cl)c1)N1CS(=O)(=O)c2ccccc21,C14H9Cl2NO4S,41014.0
18339,UNC0321,COc1cc2c(NC3CCN(C)CC3)nc(N3CCCN(C)CC3)nc2cc1OCCOCCN(C)C,C27H45N7O3,41100.0
18340,Vitamin K3-d8,[2H]C1=C(C([2H])([2H])[2H])C(=O)c2c([2H])c([2H])c([2H])c([2H])c2C1=O,C11H8O2,41285.0
18341,Saikosaponin B2,C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@]4(C)[C@@H]3C=CC3=C5CC(C)(C)CC[C@]5(CO)[C@H](O)C[C@]34C)[C@]2(C)CO)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O,C42H68O13,39936.0
18342,rac-X77,CC(C)(C)c1ccc(N(C(=O)c2cnc[nH]2)C(C(=O)NC2CCCCC2)c2cccnc2)cc1,C27H33N5O2,40779.0
18343,RA-9,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CNC/C1=C\c1ccc([N+](=O)[O-])cc1,C19H15N3O5,40838.0
18344,Cholestyramine,CCC(C)C.CCC(CC(CC)c1ccc(C[N+](C)(C)C)cc1)c1ccccc1.[Cl-],C7H18Cl(C21H28N)n,37827.0
18345,(R)-AS-1,C[C@H](C(=O)NCc1ccccc1)N1C(=O)CCC1=O,C14H16N2O3,41673.0
18346,L-369,CCCCCC(CCCCC)CCOC(=O)CCCCCCCC(CCCCCCCC(=O)OCCC(CCCCC)CCCCC)OC(=O)CCCN(C)C,C49H95NO6,41232.0
18347,Lumazine,O=c1nc2[nH]ccnc-2c(=O)[nH]1,C6H4N4O2,38300.0
18348,L82-G17,O=c1[nH]ncc(NN=Cc2cccc(O)c2)c1Cl,C11H9ClN4O2,41041.0
18349,Lin28 Inhibitor LI71,CCOc1cccc2c1N[C@@H](c1ccc(C(=O)O)cc1)[C@H]1CC=C[C@@H]21,C21H21NO3,41039.0
18350,ML-137,Cn1cc(-c2ccc(CN3C(=O)C(=O)c4ccccc43)c(F)c2)cn1,C19H14FN3O2,40918.0
18351,MTK 458,FC(F)(F)c1cc2c(N[C@@H]3CCCc4ccccc43)ncnc2[nH]1,C17H15F3N4,41391.0
18352,"N,N?-Diferuloylputrescine",COc1cc(C=CC(=O)NCCCCNC(=O)C=Cc2ccc(O)c(OC)c2)ccc1O,C24H28N2O6,41436.0
18353,DT-109,CC(C)C[C@H](NC(=O)CNC(=O)CN)C(=O)O,C10H19N3O4,41219.0
18354,?-MSH (human),[H]NCCCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N[H])C(=O)N[C@@H](CCCCN[H])C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O[H])cc1)C(=O)N[C@@H](CCC/N=C(/N)N[H])C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn([H])cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC/N=C(/N)N[H])C(=O)N[C@@H](Cc1cn([H])c2ccccc12)C(=O)NCC(=O)N[C@@H](CO[H])C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN[H])C(=O)N[C@@H](CC(=O)O)C(=O)O,C118H174N34O35S,41549.0
18355,SNT-207707 (hydrochloride),CC(C)CCN(CCC(C)C)C(=O)c1ccc2nc(-c3ccc(C#N)cc3)c(CCCN3CCCC3)n2c1.Cl,C32H44ClN5O,41524.0
18356,Laninamivir,CO[C@@H]([C@@H]1OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]1NC(C)=O)[C@H](O)CO,C13H22N4O7,39139.0
18357,C23 Phytoceramide (t18:0/23:0),CCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC,C41H83NO4,9004471.0
18358,BAY-474,CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1,C17H15N5,41451.0
18359,N-Ethyltryptamine (hemifumarate),CCNCCc1c[nH]c2ccccc12.CCNCCc1c[nH]c2ccccc12.O=C(O)/C=C/C(=O)O,C28H36N4O4,32598.0
18360,(-)-11-nor-9-carboxy-?9-THC (CRM),CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C(=O)O)=C[C@@H]21,C21H28O4,40600.0
18361,Taspoglutide (acetate),CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C,C154H236N40O47,41258.0
18362,Paroxetine (maleate) (CRM),Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1.O=C(O)/C=C\C(=O)O,C23H24FNO7,40969.0
18363,3-methyl-?-Pyrrolidinovalerophenone (hydrochloride),CCCC(C(=O)c1cccc(C)c1)N1CCCC1.Cl,C16H24ClNO,40482.0
18364,exo-Tetrahydrocannabiphorol,C=C1CC[C@@H]2[C@@H](C1)c1c(O)cc(CCCCCCC)cc1OC2(C)C,C23H34O2,41136.0
18365,exo-THCP (exempt preparation),C=C1CC[C@@H]2[C@@H](C1)c1c(O)cc(CCCCCCC)cc1OC2(C)C,C23H34O2,43497.0
18366,Ropidoxuridine,O=c1ncc(I)cn1[C@H]1C[C@H](O)[C@@H](CO)O1,C9H11IN2O4,41220.0
18367,Acoramidis (hydrochloride),Cc1n[nH]c(C)c1CCCOc1cc(C(=O)O)ccc1F.Cl,C15H18ClFN2O3,41536.0
18368,Undecylenoyl Phenylalanine,C=CCCCCCCCCC(=O)N[C@@H](Cc1ccccc1)C(=O)O,C20H29NO3,41467.0
18369,HPG1860,COc1cc(C(=O)O)cc2sc(N3CCN(Cc4c(-c5c(Cl)cccc5Cl)noc4C4CC4)C[C@H]3C)nc12,C27H26Cl2N4O4S,39481.0
18370,Bisphenol A-?-D-Glucuronide,CC(C)(c1ccc(O)cc1)c1ccc(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)cc1.CC(C)(c1ccc(O)cc1)c1ccc(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)cc1,C42H48O16,35857.0
18371,DUPA,O=C(O)CC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O,C11H16N2O9,19501.0
18372,ECPLA,CCN(C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1)C1CC1,C21H25N3O,27773.0
18373,(+)-Biotin-PEG3-amine,NCCOCCOCCOCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,C18H34N4O5S,30534.0
18374,PF-07104091,COCc1cc(C(=O)Nc2cc([C@H]3CC[C@@H](OC(=O)NC(C)C)C3)n[nH]2)n(C)n1,C19H28N6O4,41356.0
18375,BMS 649,CC1(C)CCC(C)(C)c2cc(C3(c4ccc(C(=O)O)cc4)OCCO3)ccc21,C24H28O4,30037.0
18376,MRTX-1719,Cn1ncc(-c2ccc3c(=O)[nH]nc(CN)c3c2)c1-c1c(F)c(Cl)cc(OC2CC2)c1C#N,C23H18ClFN6O2,36563.0
18377,GSK778,COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1,C30H33N5O3,41280.0
18378,MU1210,Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1,C22H16N4O,41308.0
18379,3-oxo-2-Phenylbutanamide,CC(=O)C(C(N)=O)c1ccccc1,C10H11NO2,28359.0
18380,Hydroxytyrosol Acetate,CC(=O)OCCc1ccc(O)c(O)c1,C10H12O4,41665.0
18381,K03861,CN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4ccnc(N)n4)cc3)cc2C(F)(F)F)CC1,C24H26F3N7O2,19921.0
18382,USP8-IN-2,COc1ccc(Cl)cc1NC(=S)NC1CCN(c2cccc(C(F)(F)F)n2)CC1,C19H20ClF3N4OS,41599.0
18383,RO27-3225 (trifluoroacetate salt),CCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N(C)CC(N)=O.O=C(O)C(F)(F)F,C41H53F3N12O8,41558.0
18384,Norastemizole,Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc32)cc1,C19H21FN4,41828.0
18385,Curzerene,C=C[C@@]1(C)Cc2occ(C)c2C[C@@H]1C(=C)C,C15H20O,35828.0
18386,Isoxicam,Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1,C14H13N3O5S,41340.0
18387,MRK-740,COc1cc(OC)cc(-c2noc(N3CCN(C)C4(CCN(c5ccnc(C)c5)CC4)C3)n2)c1,C25H32N6O3,26387.0
18388,BBT594,CC(=O)Nc1cc(Oc2ccc3c(c2)CCN3C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)ncn1,C28H30F3N7O3,41359.0
18389,GLP-1R Modulator L7-028,O=C(Nc1cccc(C(=O)N2CCCCC2)c1)c1cccc(OC2CCCC2)c1,C24H28N2O3,41246.0
18390,DUB-IN-3,C=CCON=C1c2ccccc2-c2nc(C#N)c(C#N)nc21,C16H9N5O,41594.0
18391,C8 Ceramide-mPEG(2000),C=CCON=C1c2ccccc2-c2nc(C#N)c(C#N)nc21,C16H9N5O,41594.0
18392,PKN3 Inhibitor Compound 16,COc1cc(Nc2ccnc3cc(I)ccc23)cc(OC)c1OC,C18H17IN2O3,41437.0
18393,Napirimus,Cn1cc(C(=O)c2cccc3ccccc23)cc1C(=O)O,C17H13NO3,41873.0
18394,Raloxifene,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,C28H27NO4S,41845.0
18395,5-methoxy Tryptamine-d4,[2H]C([2H])(N)C([2H])([2H])c1c[nH]c2ccc(OC)cc12,C11H14N2O,40901.0
18396,7-methyl DMT,Cc1cccc2c(CCN(C)C)c[nH]c12,C13H18N2,41684.0
18397,TP-040,CC1CCN(c2ccnc(NCc3cn(C)cn3)n2)CC1,C15H22N6,41375.0
18398,Glucagon Receptor Antagonist 3,CCCc1c(C(C)C)nc(C(C)C)c([C@@H](C)O)c1-c1ccc(F)cc1O,C22H30FNO2,41243.0
18399,5-Hydroxymethylcytidine,Nc1nc(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1CO,C10H15N3O6,40745.0
18400,Atrasentan (hydrochloride),CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1.Cl,C29H39ClN2O6,31238.0
18401,N2-Isobutyryl-2'-deoxyguanosine,CC(C)C(=O)Nc1nc(=O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)O3)c2[nH]1,C14H19N5O5,40284.0
18402,DBPR108,CC(C)(CC(=O)N1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,C16H25FN4O2,41117.0
18403,CP-LC-0867,CCCCCCCCCCC(CCCCCCCC)C(=O)NC(CCSCCC(=O)OCC(CC)CCCC)C(=O)NCCN(C)C,C39H77N3O4S,41926.0
18404,CP-LC-1143,CCCCC/C=C\C/C=C\CCCCCCCCOC(=O)CCSCCC(NC(=O)C(CCCCCC)CCCCCCCC)C(=O)NCCN(C)C,C45H85N3O4S,41927.0
18405,BAY-850,COc1cc(Cl)c(C(=O)N[C@@H](CN[C@H]2CC[C@@H](N)CC2)Cc2ccc(C#N)cc2)cc1-c1ccc(CN[C@H](C)c2ccc(C)cc2)o1,C38H44ClN5O3,23422.0
18406,DSPE-PEG(2000) Maleimide,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)COCCOCCNC(=O)CCN1C(=O)C=CC1=O)OC(=O)CCCCCCCCCCCCCCCCC,C54H98N3O14P,42013.0
18407,DPTN (hydrochloride),Cc1cc(C)cc(-c2nc(NC(=O)c3cccnc3)sc2-c2ccncc2)c1.Cl.Cl,C22H20Cl2N4OS,41540.0
18408,?-keto Phentermine (hydrochloride),CC(C)(N)C(=O)c1ccccc1.Cl,C10H14ClNO,40802.0
18409,Cathine (hydrochloride),C[C@H](N)[C@@H](O)c1ccccc1.Cl,C9H14ClNO,9004461.0
18410,UNC7467,O=C(O)c1ccc2noc(-c3ccc(-c4ccccc4)cc3)c2c1,C20H13NO3,41597.0
18411,CGamF,C[C@H](CCC(=O)NCC(=O)Nc1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C46H54N2O10,40792.0
18412,IHCH-7079,COc1ccccc1CCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCN3C,C23H29N3O,41988.0
18413,JG-2016,CCc1cc2c(cc1Cl)nc1c(=O)[nH]c(=O)nc-1n2CCOCC(C)C,C18H21ClN4O3,41876.0
18414,Cannabinerol,CCCCCc1cc(O)c(C/C=C(/C)CCC=C(C)C)c(O)c1,C21H32O2,20499.0
18415,SBI-797812,O=C(NCc1ccncc1)Nc1ccc(S(=O)(=O)N2CC3CCC(C2)O3)cc1,C19H22N4O4S,41526.0
18416,BI-3802,CNC(=O)COc1cc2cc(Nc3nc(N4C[C@H](C)C[C@H](C)C4)ncc3Cl)ccc2n(C)c1=O,C24H29ClN6O3,41731.0
18417,Moronic Acid,CC1(C)C=C2[C@H]3CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)O)CC1,C30H46O3,30654.0
18418,4-Anilino-1-Cbz-piperidine,O=C(OCc1ccccc1)N1CCC(Nc2ccccc2)CC1,C19H22N2O2,41653.0
18419,Parsaclisib,CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(F)c1[C@@H]1CNC(=O)C1,C20H22ClFN6O2,29784.0
18420,Tocainide,Cc1cccc(C)c1NC(=O)C(C)N,C11H16N2O,41592.0
18421,NVP-DKY709,O=C1CCC(N2Cc3cc(C4CCN(Cc5ccccc5)CC4)ccc3C2=O)C(=O)N1,C25H27N3O3,41295.0
18422,AZD 1656,COC[C@H](C)Oc1cc(Oc2cnc(C(=O)N3CCC3)cn2)cc(C(=O)Nc2cnc(C)cn2)c1,C24H26N6O5,41839.0
18423,(R)-RP 6306,Cc1cc2c(C(N)=O)c(N)n(-c3c(C)ccc(O)c3C)c2nc1C,C18H20N4O2,41738.0
18424,RP 6306,Cc1cc2c(C(N)=O)c(N)n(-c3c(C)ccc(O)c3C)c2nc1C,C18H20N4O2,41732.0
18425,Dxd,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(=O)CO)CC3,C26H24FN3O6,41699.0
18426,Lucitanib,CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12,C26H25N3O4,41711.0
18427,AG-13958,Cc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2F)n(C)n1,C26H22FN7O,41352.0
18428,SB-02024,C[C@@H]1COCCN1c1cc(N2CCCC[C@@H]2C(F)(F)F)[nH]c(=O)c1,C16H22F3N3O2,41231.0
18429,"Chymotrypsin Substrate II, Fluorogenic",Cc1cc(=O)oc2cc(NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CCC(=O)O)ccc12,C34H39N5O9,41593.0
18430,1-Palmitoyl-2-13(S)-HODE-sn-glycero-3-PC,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C=C\[C@@H](O)CCCCC,C42H80NO9P,41445.0
18431,PF-06648671,Cc1cn(-c2ccc3n(c2=O)CCN([C@@H](C)[C@@H]2CC[C@H](c4cc(F)c(Cl)cc4C(F)(F)F)O2)C3=O)cn1,C25H23ClF4N4O3,41893.0
18432,N-Boc-4-piperidone,CC(C)(C)OC(=O)N1CCC(=O)CC1,C10H17NO3,41652.0
18433,Dersimelagon,COC[C@H]1CN(C(=O)[C@]2(F)CN(C3CCCC3)C[C@H]2c2ccc(OC)cc2)C[C@@H]1c1ccc(C(F)(F)F)cc1N1CCC(C(=O)O)CC1,C36H45F4N3O5,41468.0
18434,(R)-ZINC3573,CN(C)[C@@H]1CCN(c2cc(-c3ccccc3)nc3ccnn23)C1,C18H21N5,41312.0
18435,Decanoyl-L-carnitine-d9 (chloride),[2H]C([2H])([2H])[N+](C[C@H](CC(=O)O)OC(=O)CCCCCCCCC)(C([2H])([2H])[2H])C([2H])([2H])[2H].[Cl-],C17H34ClNO4,40352.0
18436,(R)-SKBG-1,COc1ccc(CNC(=O)[C@H]2CN(C(=O)CCl)CCN2S(=O)(=O)c2ccc(OC)cc2)cc1,C22H26ClN3O6S,42091.0
18437,BAY-0069,CCc1ccc(-c2nc3cc(NC(=O)c4cc([N+](=O)[O-])ccc4Br)ccc3o2)cc1,C22H16BrN3O4,41525.0
18438,Lipid N2-3L,CCCCCCCC/C=C\CCCCCCCC(=O)OCCN(CCOC(=O)NCCCN(CCO)CCO)CCOC(=O)C(CCCCCC)CCCCCCCC,C48H93N3O8,40911.0
18439,T3-CLK,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1,C28H30N6O2,41309.0
18440,6-CFSE,O=C(ON1C(=O)CCC1=O)c1ccc2c(c1)C1(OC2=O)c2ccc(O)cc2Oc2cc(O)ccc21,C25H15NO9,41342.0
18441,ADB-4en-PINACA-d4,[2H]c1c([2H])c([2H])c2c(c(C(=O)N[C@H](C(N)=O)C(C)(C)C)nn2CCCC=C)c1[2H],C19H26N4O2,41434.0
18442,GSK-F1,COc1ncc(-c2ccc3nc(N)n(-c4ccccc4C(F)(F)F)c(=O)c3c2)cc1S(=O)(=O)Nc1ccc(F)cc1F,C27H18F5N5O4S,41366.0
18443,GSK5182,CN(C)CCOc1ccc(/C(=C(/CCCO)c2ccccc2)c2ccc(O)cc2)cc1,C27H31NO3,19097.0
18444,ZG-2033,COc1cc(Nc2nsc3ccccc23)cc(OC)c1,C15H14N2O2S,41672.0
18445,Alloisolithocholic Acid-d4,[2H]C1([2H])C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@H]4[C@@H]3CC[C@H]2C([2H])([2H])[C@H]1O,C24H40O3,41155.0
18446,4-Azido-L-phenylalanine,[N-]=[N+]=Nc1ccc(C[C@H](N)C(=O)O)cc1,C9H10N4O2,41697.0
18447,ARUK2001607,Cc1cc2c(Nc3ccc(S(C)(=O)=O)cc3)ncnc2s1,C14H13N3O2S2,41527.0
18448,A-1596586,COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1,C29H27F2NO7,41316.0
18449,Ellagic Acid,O=C(Nc1ccc(I)cc1F)c1cc(F)ccc1O,C13H8F2INO2,41521.0
18450,Isoorotidine,O=C(O)c1cc(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1,C10H12N2O8,40981.0
18451,Tenalisib,CC[C@H](Nc1ncnc2nc[nH]c12)c1oc2ccccc2c(=O)c1-c1cccc(F)c1,C23H18FN5O2,30949.0
18452,DPTIP (hydrochloride),COc1cc(-c2nc(-c3ccccc3)c(-c3cccs3)[nH]2)cc(OC)c1O.Cl,C21H19ClN2O3S,41681.0
18453,2-oxo-3-hydroxy LSD (solution),CCN(CC)C(=O)[C@@H]1C=C2c3cccc4c3C(O)(C[C@H]2N(C)C1)C(=O)N4,C20H25N3O3,41933.0
18454,BAY-3827,CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12,C27H25FN6O,41448.0
18455,JNJ-38158471,CCNC(=O)Nc1ccc(Oc2ncnc(N)c2C=NOC)cc1Cl,C15H17ClN6O3,41361.0
18456,7-acetyl Paclitaxel,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](OC(C)=O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,C49H53NO15,39288.0
18457,THAL-SNS-032,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCN(CC(=O)NCCOCCOCCOCCNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)s2)o1,C40H52N8O10S2,40958.0
18458,Delphinidin-3-O-rutinoside (chloride),C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc4c(O)cc(O)cc4[o+]c3-c3cc(O)c(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O.[Cl-],C27H31ClO16,33552.0
18459,Cryptosporiopsin A,COc1cc(O)c(Cl)c2c1C(=O)O[C@H](C)CCC(=O)CC/C=C/C(=O)C2,C19H21ClO6,40919.0
18460,RX-518,C=CC(=O)Nc1cccc(-c2cccc3cnc(Nc4ccc(N5CCN(CCO)CC5)c(F)c4F)nc23)c1,C29H28F2N6O2,40922.0
18461,DLin-MeOH,CCCCC/C=C\C/C=C\CCCCCCCCC(O)CCCCCCCC/C=C\C/C=C\CCCCC,C37H68O,41432.0
18462,ACP-105,Cc1c(N2[C@@H]3CC[C@H]2C[C@@](C)(O)C3)ccc(C#N)c1Cl,C16H19ClN2O,40146.0
18463,JQKD82 (hydrochloride),CCN(CCN(C)C)C(=O)CNCc1cc(C(=O)Oc2ccc(OC(C)C)cc2OC(C)C)ccn1.Cl.Cl.Cl,C27H43Cl3N4O5,41542.0
18464,EM12-SO2F,O=C1CCC(N2Cc3ccc(S(=O)(=O)F)cc3C2=O)C(=O)N1,C13H11FN2O5S,41446.0
18465,JNJ-1013,COc1cc(N2CCC(OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)c3ccc(-c4scnc4C)cc3)C(C)(C)C)CC2)ccc1NC(=O)c1cccc(-c2cc[nH]n2)n1,C46H55N9O7S,41740.0
18466,Ecnoglutide,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C,C194H304N48O61,41272.0
18467,Desmethyl Carfentanil,CCC(=O)N(c1ccccc1)C1(C(=O)O)CCN(CCc2ccccc2)CC1,C23H28N2O3,31705.0
18468,Masofaniten,CC(C)(c1ccc(OCc2ccnc(NS(C)(=O)=O)n2)cc1)c1cc(Cl)c(OCCCl)c(C#N)c1,C24H24Cl2N4O4S,41670.0
18469,Zunsemetinib,Cc1cnc(-c2ccnc(C(C)(C)O)n2)cc1-n1c(C)cc(OCc2ncc(F)cc2F)c(Cl)c1=O,C25H22ClF2N5O3,41863.0
18470,119-23,CCCCCCCC/C=C\CCCCCCCC(=O)OCCCCCC(C(=O)NC12CC3CC(CC(C3)C1)C2)N(CCCN(C)C)C(=O)CCCCCCC/C=C\CCCCCCCC,C58H105N3O4,41386.0
18471,USP8-IN-1,COc1ccc(N2CCN(C(=S)Nc3ccc([N+](=O)[O-])cc3)CC2)c(N)c1,C18H21N5O3S,41598.0
18472,YKL-06-061,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCC1)C(=O)N(c1c(C)cccc1C)C2,C30H37N7O2,41721.0
18473,N-Cbz Norfentanyl,CCC(=O)N(c1ccccc1)C1CCN(C(=O)OCc2ccccc2)CC1,C22H26N2O3,41654.0
18474,LNP023,CCO[C@H]1CCN(Cc2c(OC)cc(C)c3[nH]ccc23)[C@H](c2ccc(C(=O)O)cc2)C1,C25H30N2O4,41833.0
18475,DNL343,O=C(COc1ccc(Cl)cc1)NC12CC(c3nnc([C@H]4C[C@@H](OC(F)(F)F)C4)o3)(C1)C2,C20H19ClF3N3O4,41674.0
18476,Calcium Influx Inducer Compound 634,CCOC(=O)c1c(NS(=O)(=O)c2cccc3nsnc23)sc(C)c1C,C15H15N3O4S3,41986.0
18477,Lophophine (hydrochloride),COc1cc(CCN)cc2c1OCO2.Cl,C10H14ClNO3,40538.0
18478,Fmoc-Tyr(PO3H2)-OH,O=C(N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)O)OCC1c2ccccc2-c2ccccc21,C24H22NO8P,41973.0
18479,K-604 (hydrochloride),CSc1cc(C)nc(SC)c1NC(=O)CN1CCN(CCSc2nc3ccccc3[nH]2)CC1.Cl.Cl,C23H32Cl2N6OS3,41119.0
18480,1-Stearoyl-2-Docosahexaenoyl-sn-glycero-3-PE,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[NH3+],C45H78NO8P,41382.0
18481,FHD-286,COC[C@H](NC(=O)c1ccn(S(C)(=O)=O)c1)C(=O)Nc1nc(-c2cccc(N3C[C@@H](C)O[C@@H](C)C3)n2)cs1,C24H30N6O6S2,41864.0
18482,Z-Prolyl-prolinal,CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C=O,C15H24N2O4,41535.0
18483,BI SF3 (hydrochloride),Cl.NCc1n[nH]c2ccc(Cl)cc12,C8H9Cl2N3,41113.0
18484,USP8-IN-3,O=[N+]([O-])c1ccc(NC(=S)NC2CCN(c3cccc(C(F)(F)F)n3)CC2)cc1,C18H18F3N5O2S,41600.0
18485,Acoramidis,Cc1n[nH]c(C)c1CCCOc1cc(C(=O)O)ccc1F,C15H17FN2O3,41522.0
18486,Iprindole,CN(C)CCCn1c2c(c3ccccc31)CCCCCC2,C19H28N2,41664.0
18487,Emodepside,CC(C)C[C@H]1C(=O)O[C@H](Cc2ccc(N3CCOCC3)cc2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](Cc2ccc(N3CCOCC3)cc2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N1C,C60H90N6O14,41247.0
18488,RMC-6236,CCn1c(-c2cc(N3CCN(C)CC3)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1csc(n1)C[C@H](NC(=O)[C@H]1C[C@@H]1C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2,C44H58N8O5S,41982.0
18489,BAY-899,O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1,C25H19F2N5O2,41716.0
18490,CS 2100,CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1,C25H23N3O4S,14396.0
18491,PTX80,CN(C)CCCS(=O)(=O)N1C/C(=C\c2ccc(C#N)cc2)C(=O)/C(=C/c2ccc(C#N)cc2)C1,C26H26N4O3S,41676.0
18492,VH 032 amide C7 Acid,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCC(=O)O)C(C)(C)C)cc1,C31H44N4O6S,40447.0
18493,N-Palmitoyl Phenylalanine,CCCCCCCCCCCCCCCC(=O)N[C@@H](Cc1ccccc1)C(=O)O,C25H41NO3,20066.0
18494,9(10)-Nitrooleate,CCCCCCCC/C(=C\CCCCCCCC(=O)O)[N+](=O)[O-].CCCCCCCC/C=C(\CCCCCCCC(=O)O)[N+](=O)[O-],C36H66N2O8,33896.0
18495,Tradipitant,O=C(c1ccccc1Cl)c1cccnc1-c1nnn(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1-c1ccncc1,C28H16ClF6N5O,41831.0
18496,Semaglutide Main Chain (9-37),[H]NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[H])NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O[H])cc1)NC(=O)[C@H](CO[H])NC(=O)[C@H](CO[H])NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO[H])NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)N[H])[C@@H](C)O[H])[C@@H](C)O[H])C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cn([H])c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC/N=C(/N)N[H])C(=O)NCC(=O)N[C@@H](CCC/N=C(/N)N[H])C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC,C142H216N38O45,40788.0
18497,N-Lithocholyl-L-Leucine,CC(C)C[C@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)O,C30H51NO4,40931.0
18498,DUB-IN-1,N#Cc1nc2c(nc1C#N)-c1ccccc1C2=NOCc1ccccc1,C20H11N5O,41737.0
18499,BTMPS,CC1(C)CC(OC(=O)CCCCCCCCC(=O)OC2CC(C)(C)NC(C)(C)C2)CC(C)(C)N1,C28H52N2O4,42192.0
18500,BTMPS (CRM),CC1(C)CC(OC(=O)CCCCCCCCC(=O)OC2CC(C)(C)NC(C)(C)C2)CC(C)(C)N1,C28H52N2O4,42332.0
18501,Sergliflozin A,COc1ccc(Cc2ccccc2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,C20H24O7,14342.0
18502,Ozenoxacin,CNc1ncc(-c2ccc3c(=O)c(C(=O)O)cn(C4CC4)c3c2C)cc1C,C21H21N3O3,41837.0
18503,N-Cbz-4-piperidone,O=C1CCN(C(=O)OCc2ccccc2)CC1,C13H15NO3,37355.0
18504,WYneC,C#CCCC(=O)C=P(c1ccccc1)(c1ccccc1)c1ccccc1,C24H21OP,42009.0
18505,KSQ-4279,COc1ncnc(C2CC2)c1-c1ncc2cnn(Cc3ccc(-c4nc(C(F)(F)F)cn4C(C)C)cc3)c2n1,C27H25F3N8O,41862.0
18506,Fenclofenac,O=C(O)Cc1ccccc1Oc1ccc(Cl)cc1Cl,C14H10Cl2O3,41709.0
18507,Reldesemtiv,NC(=O)c1ccn(-c2cnc(NC[C@]3(c4ncccc4F)C[C@H](F)C3)nc2)c1,C19H18F2N6O,41840.0
18508,"LCL-161, phenol",C[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2cccc(O)c2)cs1)C1CCCCC1)N(C)C(=O)OC(C)(C)C,C31H42N4O6S,40358.0
18509,MFZ 10-7,Cc1cccc(C#Cc2cc(F)cc(C#N)c2)n1,C15H9FN2,42024.0
18510,Lipid 7-1,CC/C=C\CCCCOC(CCC(=O)OCCCCCCN(CCO)CCCCCCCC(=O)OCCCCCCCCC)OCCCC/C=C\CC,C45H85NO7,41304.0
18511,(+)-?-Tocopherol Acetate,CC(=O)Oc1c(C)c(C)c2c(c1C)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2,C31H52O3,31795.0
18512,(+)-?-Tocopherol Acetate (CRM),CC(=O)Oc1c(C)c(C)c2c(c1C)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2,C31H52O3,42624.0
18513,7rh,CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1,C30H29F3N6O,41861.0
18514,HP661,Cc1c(C(=O)N2CCN(Cc3ccc(OCC(F)(F)F)cc3)CC2)nnn1Cc1ccc(C(=O)Nc2ccc(C(F)(F)F)cc2)nc1,C31H29F6N7O3,38927.0
18515,Atopaxar (hydrobromide),Br.CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OC)c(C(C)(C)C)c1)C2,C29H39BrFN3O5,41395.0
18516,Betazole (hydrochloride),Cl.Cl.NCCc1cc[nH]n1,C5H11Cl2N3,41712.0
18517,Imirestat,O=C1NC(=O)C2(N1)c1cc(F)ccc1-c1ccc(F)cc12,C15H8F2N2O2,41829.0
18518,SLU-PP-332,O=C(NN=Cc1ccc2ccccc2c1)c1ccc(O)cc1,C18H14N2O2,41719.0
18519,CCR2 Antagonist,CSc1ccc(C(=O)N[C@@H]2CCCC[C@@H]2NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)NC(C)C)cc1,C28H34F3N5O4S,19542.0
18520,SIS17,CCCCCCCCCCCCCCCCNNC(=O)c1cccs1,C21H38N2OS,41360.0
18521,BDP9066,c1cc(-c2c[nH]c3nccc(N4CCC[C@@]5(CCCCN5)C4)c23)ncn1,C20H24N6,26264.0
18522,LY3295668,Cc1cc(Nc2ccc(F)c(C[C@@]3(C(=O)O)CCN(Cc4cccc(Cl)c4F)[C@H](C)C3)n2)n[nH]1,C24H26ClF2N5O2,27914.0
18523,PRI-724,C[C@H]1[C@H]2N(C(=O)CN(C)N2C(=O)NCc2ccccc2)[C@@H](Cc2ccc(OP(=O)(O)O)cc2)C(=O)N1Cc1cccc2cccnc12,C33H35N6O7P,41728.0
18524,GDC-6036,C=CC(=O)N1CCN(c2nc(OCC3CCCN3C)nc3c(F)c(-c4nc(N)cc(C)c4C(F)(F)F)c(Cl)cc23)C(C)C1,C29H32ClF4N7O2,41852.0
18525,Erinacine C,CC(C)C1=C2[C@H]3CC=C(CO)[C@H]4O[C@H]5[C@@H](OC[C@@H](O)[C@@H]5O)O[C@@H]4[C@]3(C)CC[C@@]2(C)CC1,C25H38O6,40079.0
18526,ZINC69391,Cc1cc(C)nc(NC(=N)Nc2ccccc2C(F)(F)F)n1,C14H14F3N5,41860.0
18527,SP-13786,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,C17H14F2N4O2,41857.0
18528,JC2-11,COc1cc(/C=C/C(=O)c2ccc(OC)c(F)c2)ccc1O,C17H15FO4,41595.0
18529,Inaxaplin,O=C(CCc1c(-c2ccc(F)cc2)[nH]c2c(F)cc(F)cc12)N[C@@H]1C(=O)NC[C@H]1O,C21H18F3N3O3,40852.0
18530,PF-06835919,C[C@H]1CCN1c1nc(N2C[C@@H]3[C@@H](CC(=O)O)[C@@H]3C2)cc(C(F)(F)F)n1,C16H19F3N4O2,41842.0
18531,Benzquinamide (hydrochloride),CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(C)=O.Cl,C22H33ClN2O5,41713.0
18532,LMTK3 Inhibitor C28,FC(F)(F)Oc1cccc(-c2cnc3ccc(-c4ccncc4)nn23)c1,C18H11F3N4O,41877.0
18533,LCQ-908,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(Nc4ccc(C(F)(F)F)nc4)cn3)cc2)CC1,C25H24F3N3O2,42025.0
18534,2-TEDC,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)OCCc1cccs1,C16H13NO4S,41872.0
18535,N-[(4-Aminophenyl)methyl]adenosine,Nc1ccc(CNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1,C17H20N6O4,28417.0
18536,DSPE-PEG(2000)-DBCO,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCCNC(=O)OCCOCCNC(=O)CCC(=O)N1Cc2ccccc2C#Cc2ccccc21)OC(=O)CCCCCCCCCCCCCCCCC.[NH4+],C63H103N4O12P(C2H4O)n,37798.0
18537,Dovitinib (lactate),CC(O)C(=O)O.CC(O)C(=O)O.CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,C27H33FN6O7,41394.0
18538,PS-10,O=S(=O)(c1ccc(O)cc1O)N1Cc2cc(O)cc(O)c2C1,C14H13NO6S,42068.0
18539,GSK1482160,CN1C(=O)CC[C@H]1C(=O)NCc1cccc(C(F)(F)F)c1Cl,C14H14ClF3N2O2,41980.0
18540,ECC5004,C[C@H]1c2c(nn(-c3ccc(F)c(C4CC4)c3)c2-n2ccn(-c3ccc4c(cnn4C)c3F)c2=O)CCN1C(=O)c1cc2cc([C@@H]3CCOC(C)(C)C3)ccn2c1C1(c2noc(=O)[nH]2)CC1,C48H46F2N10O5,41324.0
18541,exo-Tetrahydrocannabivarin methyl ether,C=C1CC[C@@H]2[C@@H](C1)c1c(OC)cc(CCC)cc1OC2(C)C,C20H28O2,42161.0
18542,Pro-GA,COC(=O)CCCC(=O)N[C@@H](C)C(=O)OCOC(C)=O,C12H19NO7,42353.0
18543,Deschlorodiazepam,CN1C(=O)CN=C(c2ccccc2)c2ccccc21,C16H14N2O,40790.0
18544,Omidenepag (free acid),O=C(O)CNc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)n1,C23H22N6O4S,41045.0
18545,Lisuride (maleate),CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1.O=C(O)/C=C\C(=O)O,C24H30N4O5,36140.0
18546,BTT3033,CN(c1ccc(NC(=O)Nc2ccccc2)cc1)S(=O)(=O)c1cnn(-c2ccc(F)cc2)c1,C23H20FN5O3S,42119.0
18547,Macimorelin (acetate),CC(=O)O.CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)NC=O,C28H34N6O5,41886.0
18548,"N1,N11-Diethylnorspermine (hydrochloride)",CCNCCCNCCCNCCCNCC.Cl.Cl.Cl.Cl,C13H36Cl4N4,41393.0
18549,Fananserin,O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1,C23H24FN3O2S,33216.0
18550,GSK180,O=C(O)CCn1c(=O)oc2cc(Cl)c(Cl)cc21,C10H7Cl2NO4,19217.0
18551,Trifluralin,CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-],C13H16F3N3O4,35476.0
18552,PQA-18,CC(C)=CCOC(=O)c1cc(OCC=C(C)C)c2cccc(OCC=C(C)C)c2n1,C25H31NO4,42351.0
18553,M-110,CCC(=NNC(=O)c1ccnc(NCCCN2CCOCC2)c1)c1ccc(Cl)cc1O,C22H28ClN5O3,39165.0
18554,Mitragynine Pseudoindoxyl,CC[C@@H]1CN2CCC3(Nc4cccc(OC)c4C3=O)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C23H30N2O5,20033.0
18555,Alkyne-tagged Dopamine (hydrochloride),C#CCNCCc1ccc(O)c(O)c1.Cl,C11H14ClNO2,42358.0
18556,Phepropeptin B,CC(C)C[C@@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,C40H56N6O6,10008109.0
18557,FHT-2344,COC[C@H](NC(=O)c1ccn(S(C)(=O)=O)c1)C(=O)Nc1nc(-c2cccc(-c3ccn(C)n3)c2)cs1,C23H24N6O5S2,42043.0
18558,"8?,9?-epoxy Hexahydrocannabinol",CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C[C@@H]3O[C@]3(C)C[C@@H]21,C21H30O3,42021.0
18559,Rupintrivir,CCOC(=O)/C=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)c1cc(C)on1)C(C)C)Cc1ccc(F)cc1,C31H39FN4O7,41543.0
18560,AQW-051,Cc1ccc(-c2ccc(O[C@H]3CN4CCC3CC4)cn2)cc1,C19H22N2O,41851.0
18561,PG-931,CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C1=O,C59H85N15O11,41551.0
18562,Poseltinib,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccoc23)c1,C26H26N6O3,37324.0
18563,ML-401,O=C(/C=C/c1ccc(Br)cc1)N1CCN(Cc2ccc(Cl)cc2)CC1,C20H20BrClN2O,41450.0
18564,WYneO,C#CCOC(=O)C[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-],C23H20BrO2P,42011.0
18565,Dendrophenol,COc1cc(CCc2cc(OC)c(O)c(OC)c2)ccc1O,C17H20O5,42115.0
18566,Santalol,C/C(=C/CC[C@]1(C)C2CC3[C@H](C2)C31C)CO.C=C1[C@@H]2CC[C@@H](C2)[C@@]1(C)CC/C=C(/C)CO,C30H48O2,41891.0
18567,ARV-766,COc1cc(O[C@H]2C(C)(C)[C@H](NC(=O)c3ccc(N4CCC(CN5CCN(c6ccc(C(=O)N[C@H]7CCC(=O)NC7=O)c(F)c6)CC5)CC4)cc3)C2(C)C)ccc1C#N,C45H54FN7O6,41985.0
18568,WYneN,C#CCNC(=O)C[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-],C23H21BrNOP,42010.0
18569,BI-87G3,O=[N+]([O-])c1cnc(Sc2nc3ccccc3s2)s1,C10H5N3O2S3,42045.0
18570,Lavendamycin,Cc1c(C(=O)O)nc(-c2ccc3c(n2)C(=O)C(N)=CC3=O)c2[nH]c3ccccc3c12,C22H14N4O4,42360.0
18571,GSK3? Inhibitor 1,O=C1Nc2ccccc2/C1=C/c1ccccn1,C14H10N2O,42107.0
18572,EN4,C=CC(=O)NCc1ccc(C(=O)Nc2ccccc2Oc2ccc(OCC)cc2)cc1,C25H24N2O4,33473.0
18573,DC-U4106,Cc1n[nH]c(C)c1Oc1c(O)cc(O)c2c(=O)cc(-c3ccc(N4CCN(c5ccccn5)CC4)cc3)oc12,C29H27N5O5,41723.0
18574,Pyrotinib (maleate),CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,C40H39ClN6O11,42108.0
18575,"8?,9?-Epoxyhexahydrocannabinol",CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C[C@H]3O[C@@]3(C)C[C@@H]21,C21H30O3,42022.0
18576,Phepropeptin C,CC[C@H](C)[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC1=O,C38H60N6O6,10008110.0
18577,Phepropeptin A,CC(C)C[C@@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,C37H58N6O6,10008108.0
18578,Omidenepag Isopropyl,CC(C)OC(=O)CNc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)n1,C26H28N6O4S,41046.0
18579,Apararenone,CC1(C)Oc2cc(NS(C)(=O)=O)ccc2N(c2ccc(F)cc2)C1=O,C17H17FN2O4S,30671.0
18580,Werner Syndrome RecQ Helicase-IN-2,CCc1c(N2CCN(C(=O)c3ncnc(C)c3O)CC2)c(=O)n2nc(C3=CCOCC3)nc2n1CC(=O)Nc1ccc(C(F)(F)F)cc1C,C32H34F3N9O5,41678.0
18581,Palazestrant,CCCN1CC(Oc2ccc([C@@H]3c4[nH]c5ccccc5c4C[C@@H](C)N3CC(C)(C)F)cc2)C1,C28H36FN3O,41843.0
18582,3-hydroxy Desalkylflurazepam,O=C1Nc2ccc(Cl)cc2C(c2ccccc2F)=NC1O,C15H10ClFN2O2,42202.0
18583,TC 13172,Cn1c(=O)c2c(nc(S(C)(=O)=O)n2C)n(CC#Cc2cccc(O)c2)c1=O,C17H16N4O5S,31034.0
18584,DBCO-amine,NCCC(=O)N1Cc2ccccc2C#Cc2ccccc21,C18H16N2O,41895.0
18585,PSB-KK1445,Cn1c(=O)c2c(nc(NCCc3c[nH]c4ccccc34)n2Cc2ccc(F)cc2)n(C)c1=O,C24H23FN6O2,42093.0
18586,Retrorsine,C/C=C1/C[C@@H](C)[C@](O)(CO)OC(=O)CC2=CCN3CC[C@@H](OC1=O)[C@@H]23,C18H25NO6,42027.0
18587,Robenacoxib,CCc1ccc(Nc2c(F)c(F)cc(F)c2F)c(CC(=O)O)c1,C16H13F4NO2,42218.0
18588,5-Maleimido-pentanoic NHS ester,O=C(CCCCN1C(=O)C=CC1=O)ON1C(=O)CCC1=O,C13H14N2O6,41900.0
18589,Boc-FLFLF,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,C44H59N5O8,39673.0
18590,DYRK1A Inhibitor Compound 11,CN(C)c1nccc(-c2cnn3ncccc23)n1,C12H12N6,41715.0
18591,PTI-125 (hydrochloride),CN1CCC2(CC1)NCC(=O)N2Cc1ccccc1.Cl.Cl,C15H23Cl2N3O,41859.0
18592,PROTAC CRBN Degrader-1,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCCCCOCCOCCCCCOCC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)C(C)(C)C)cc1,C53H72N8O13S,41878.0
18593,Darodipine,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1cccc2nonc12,C19H21N3O5,41667.0
18594,GLN-1062,COc1ccc2c3c1O[C@H]1C[C@@H](OC(=O)c4ccccc4)C=C[C@@]31CCN(C)C2,C24H25NO4,41855.0
18595,RA-375,O=C(CCl)N[C@@H](Cc1ccccc1)C(=O)N1C/C(=C\c2ccc([N+](=O)[O-])cc2)C(=O)/C(=C/c2ccc([N+](=O)[O-])cc2)C1,C30H25ClN4O7,41541.0
18596,(S)-SKBG-1,COc1ccc(CNC(=O)[C@@H]2CN(C(=O)CCl)CCN2S(=O)(=O)c2ccc(OC)cc2)cc1,C22H26ClN3O6S,42092.0
18597,PCsBu (hydrochloride),CCC(C)NC1(c2ccccc2)CCCCC1.Cl,C16H26ClN,42031.0
18598,KDS-0071,O=C(Nc1cn2c(-c3ccc(CN4CCS(=O)(=O)CC4)c(F)c3)cccc2n1)C1CC1,C22H23FN4O3S,41996.0
18599,"6,6-Dimethyl-3-(4-methylbenzoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-amine",Cc1ccc(C(=O)c2c(N)sc3c2CCC(C)(C)C3)cc1,C18H21NOS,42175.0
18600,PAZ-417,Cc1cccc(-c2ccc3c(c2)c(C(=O)C(=O)O)cn3Cc2ccc(C(C)(C)C)cc2)c1,C28H27NO3,42122.0
18601,PD 176252,COc1ccc(C2(CNC(=O)[C@](C)(Cc3c[nH]c4ccccc34)NC(=O)Nc3ccc([N+](=O)[O-])cc3)CCCCC2)nc1,C32H36N6O5,42037.0
18602,BMS 986260,N#Cc1cnc2ccc(-c3c(-c4ccc(F)c(Cl)c4)ncn3CCO)nn12,C18H12ClFN6O,42042.0
18603,Fmoc-?-Alanine,O=C(O)CCNC(=O)OCC1c2ccccc2-c2ccccc21,C18H17NO4,41969.0
18604,Methylliberine,COc1nc2c(c(=O)n1C)n(C)c(=O)n2C,C9H12N4O3,42071.0
18605,3-hydroxy Desalkylgidazepam,O=C1Nc2ccc(Br)cc2C(c2ccccc2)=NC1O,C15H11BrN2O2,42258.0
18606,Methyl Salicylate-d4,[2H]c1c([2H])c([2H])c(C(=O)OC)c(O)c1[2H],C8H8O3,42145.0
18607,GAPDH Inhibitor Compound F8,c1cc(OCC2CO2)cc(-c2nnc(-c3cccc(OCC4CO4)c3)o2)c1,C20H18N2O5,42090.0
18608,DBCO-acid,O=C(O)CCC(=O)N1Cc2ccccc2C#Cc2ccccc21,C19H15NO3,41894.0
18609,RP 6685,Nc1ccc(C#CCN(C(=O)Cc2ncc(C(F)(F)F)cc2C(F)(F)F)c2ccc(F)cc2)nn1,C22H14F7N5O,42127.0
18610,Fosravuconazole (L-lysine ethanolate),CCO.C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@@](Cn1cncn1)(OCOP(=O)(O)O)c1ccc(F)cc1F.NCCCC[C@H](N)C(=O)O,C31H40F2N7O8PS,42133.0
18611,BMS 466442,COC(=O)[C@H](Cc1cn(Cc2ccccc2)cn1)NC(=O)c1cc2cc(OC)c(OCc3ccccc3)cc2[nH]1,C31H30N4O5,42075.0
18612,MAPK13 Inhibitor Compound 61,Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Oc2ccncc2)cc1,C20H23N5O2,42121.0
18613,KU-0058948,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCCNCC1,C21H21FN4O2,42098.0
18614,JNJ-42847922,Cc1cc(C)nc(N2CC3CN(C(=O)c4c(F)cccc4-n4nccn4)CC3C2)n1,C21H22FN7O,41854.0
18615,YH-306,O=C(Cc1ccc(O)cc1)N1CCc2c([nH]c3ccccc23)C1,C19H18N2O2,41874.0
18616,"6,6?-Trehalose Dioleate",CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,C48H86O13,42212.0
18617,NecroX-7,O=S1(=O)CCN(Cc2cc(NC3CCOCC3)c3[nH]c(-c4ccccc4)cc3c2)CC1,C24H29N3O3S,42135.0
18618,Moracin M,Oc1cc(O)cc(-c2cc3ccc(O)cc3o2)c1,C14H10O4,42221.0
18619,CNBSF,O=[N+]([O-])c1ccc(Cl)c(S(=O)(=O)F)c1,C6H3ClFNO4S,42355.0
18620,Dihydroartemisinin (mixed isomers),C[C@@H]1CC[C@H]2[C@@H](C)C(O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,C15H24O5,41908.0
18621,ECSI#6,O=CNC(Cc1ccc2c(c1)OCO2)Cc1ccc2c(c1)OCO2,C18H17NO5,42250.0
18622,Werner Syndrome RecQ Helicase-IN-4,CCc1c(N2CCN(C(=O)c3ncccc3O)CC2)c(=O)n2nc(C3=CCOCC3)nc2n1CC(=O)Nc1ccc(C(F)(F)F)cc1C,C32H33F3N8O5,41679.0
18623,Emraclidine,Cc1cc(C)c2c(n1)CN(C(=O)CC1CN(c3ccnc(C(F)(F)F)c3)C1)C2,C20H21F3N4O,42125.0
18624,KOTX1,CCc1cnccc1C(=O)Nc1cc2c(cc1F)NC(=O)CC2,C17H16FN3O2,42249.0
18625,RX-3117,Nc1ccn([C@@H]2C(F)=C(CO)[C@@H](O)[C@H]2O)c(=O)n1,C10H12FN3O4,27922.0
18626,5'-hydroxy-9(R)-Hexahydrocannabinol,C[C@@H]1CC[C@@H]2[C@@H](C1)c1c(O)cc(CCCCCO)cc1OC2(C)C,C21H32O3,41349.0
18627,Deschlorodemethyldiazepam,O=C1CN=C(c2ccccc2)c2ccccc2N1,C15H12N2O,40789.0
18628,FX-909,CS(=O)(=O)c1ccc(C#N)cc1-c1cc(=O)c2c(F)cc(F)cc2[nH]1,C17H10F2N2O3S,41452.0
18629,ASP5878,COc1cc(OC)c(F)c(COc2cnc(Nc3cnn(CCO)c3)nc2)c1F,C18H19F2N5O4,41841.0
18630,USP28-IN-4,CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccc4c(c3)CNC4)c2)c(Cl)c1,C22H18Cl2N2O3S,41604.0
18631,MCI-INI-3,COC(=O)c1cc(-c2ccc3c(c2)OCO3)nc2cc(-c3ccccc3)nn12,C21H15N3O4,42077.0
18632,LSZ-102,CC(F)(F)c1cc(F)ccc1-c1sc2cc(O)ccc2c1Oc1ccc(/C=C/C(=O)O)cc1,C25H17F3O4S,41834.0
18633,VL285,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](C(C)C)N2Cc3ccccc3C2=O)cc1,C29H32N4O4S,41538.0
18634,Cannabinerolic Acid,CCCCCc1cc(O)c(C/C=C(/C)CCC=C(C)C)c(O)c1C(=O)O,C22H32O4,20500.0
18635,Minaprine (hydrochloride),Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl.Cl,C17H24Cl2N4O,41710.0
18636,VX-984,[2H]c1nc(C)nc([2H])c1-c1cc(NC[C@@H](C)c2cccc3c(C(=O)NC)ccnc23)ncn1,C23H23N7O,42072.0
18637,Campesterol,CC(C)[C@H](C)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,C28H48O,41695.0
18638,SQ-609,OC1CCN(CC2CCN(CC34CC5CC(CC(C5)C3)C4)CC2)CC1,C22H38N2O,41875.0
18639,Nandrolone Cypionate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1,C26H38O3,41907.0
18640,Spongosine,COc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1,C11H15N5O5,41832.0
18641,Lirafugratinib,C=C(C)C(=O)Nc1ccc(-c2c(-c3ccc(Oc4nccc(C)n4)c(F)c3)c3c(N)ncnc3n2C)cc1,C28H24FN7O2,40940.0
18642,"1,2,3-Trioleoyl Glycerol-d5",[2H]C([2H])(OC(=O)CCCCCCC/C=C\CCCCCCCC)C([2H])(OC(=O)CCCCCCC/C=C\CCCCCCCC)C([2H])([2H])OC(=O)CCCCCCC/C=C\CCCCCCCC,C57H104O6,41987.0
18643,TrkB Agonist Prodrug R13,CNC(=O)Oc1ccc2c(=O)cc(-c3ccccc3)oc2c1OC(=O)NC,C19H16N2O6,42074.0
18644,(S)-Reticuline,COc1ccc(C[C@H]2c3cc(O)c(OC)cc3CCN2C)cc1O,C19H23NO4,42219.0
18645,Terguride,CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,C20H28N4O,42028.0
18646,Lodenafil,CCCc1nn(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CCO)CC4)ccc3OCC)[nH]c12,C23H32N6O5S,42220.0
18647,TCS 46b,O=c1[nH]c2ccc(C#CCN3CCC(Cc4ccccc4)CC3)cc2[nH]1,C22H23N3O,42123.0
18648,FLLL31,COc1ccc(/C=C/C(=O)C(C)(C)C(=O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,C25H28O6,42233.0
18649,Verosudil,CN(C)C(C(=O)Nc1ccc2c(=O)[nH]ccc2c1)c1ccsc1,C17H17N3O2S,42234.0
18650,CM-4620,Cc1cccc(F)c1C(=O)Nc1cnc(-c2cc3c(cc2Cl)OC(F)(F)O3)cn1,C19H11ClF3N3O3,41977.0
18651,Metapramine,CNC1Cc2ccccc2N(C)c2ccccc21,C16H18N2,42033.0
18652,Prostaglandin D2 Inhibitor,COc1nc(NCCc2ccc(Cl)cc2Cl)cc(-c2cccc(C(C)(C)C(=O)O)c2)n1,C23H23Cl2N3O3,42095.0
18653,Lipid A,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)C(CC)CO,C48H95NO5,41708.0
18654,Orcinol Glucoside,Cc1cc(O)cc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c1,C13H18O7,42365.0
18655,Atractylon,C=C1CCC[C@]2(C)Cc3occ(C)c3C[C@@H]12,C15H20O,37568.0
18656,Coumarin 343,O=C(O)c1cc2cc3c4c(c2oc1=O)CCCN4CCC3,C16H15NO4,41970.0
18657,N-Lithocholyl-L-Alanine,C[C@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)O,C27H45NO4,40929.0
18658,Actinobolin (hemisulfate),C[C@H](N)C(=O)N[C@@H]1[C@H]2C(=C(O)C[C@@H](O)[C@@H]2O)C(=O)O[C@@H]1C.C[C@H](N)C(=O)N[C@@H]1[C@H]2C(=C(O)C[C@@H](O)[C@@H]2O)C(=O)O[C@@H]1C.O=S(=O)(O)O,C26H42N4O16S,42359.0
18659,BAY 60-2770,O=C(O)CCCCN(CCc1cc(F)ccc1OCc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)Cc1ccc(C(=O)O)cc1,C35H33F4NO5,20077.0
18660,Phepropeptin D,CC[C@H](C)[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC1=O,C41H58N6O6,10008111.0
18661,Vofopitant,COc1ccc(-n2nnnc2C(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1,C21H23F3N6O,42029.0
18662,GSK467,O=c1nc(Oc2cnn(Cc3ccccc3)c2)[nH]c2cnccc12,C17H13N5O2,42103.0
18663,MMV390048,CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)c2)cc1,C18H14F3N3O2S,41835.0
18664,EM-12-FS,O=C1CCC(N2Cc3ccc(OS(=O)(=O)F)cc3C2=O)C(=O)N1,C13H11FN2O6S,41983.0
18665,Endosidin 5,Cc1ccc2cc(C)c(NN=Cc3c[nH]c4ccccc34)nc2c1,C20H18N4,41328.0
18666,AZD 0095,Cc1nc2nc(C)c(O[C@@H]3CCN(c4ccc(-c5ccc(CN6CCOCC6)nn5)cc4)C3)c(C)n2n1,C27H32N8O2,42134.0
18667,Sisunatovir,NCc1ccc2c(c1)nc(CN1C(=O)C3(CC3)c3ccc(F)cc31)n2CCCC(F)(F)F,C23H22F4N4O,42124.0
18668,SB-505124 (hydrochloride),Cc1cccc(-c2nc(C(C)(C)C)[nH]c2-c2ccc3c(c2)OCO3)n1.Cl,C20H22ClN3O2,42056.0
18669,C16 MPEG(2000) Ceramide (d18:1/16:0),*OCCOC(=O)CCC(=O)OC[C@H](NC(=O)CCCCCCCCCCCCCCC)[C@H](O)/C=C/CCCCCCCCCCCCC,C38H70NO6(C2H4O)n,41955.0
18670,IMB-808,CN(CC(=O)Nc1ccc(F)c(F)c1F)C(=O)c1ccc2c(c1)OCCO2,C18H15F3N2O4,42448.0
18671,GSK973,CNC(=O)c1cc(C(=O)N[C@H]2[C@@H]3COC[C@@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1,C23H23FN2O4,42057.0
18672,KEA1-97,Fc1ccc(-c2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)cc1,C15H9Cl2FN4,42049.0
18673,Paltusotine,N#Cc1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O,C27H22F2N4O,42041.0
18674,DMX-5084,COCCOc1ccc(-c2cn(-c3ccccc3)c3[nH]cnc(=O)c23)cc1,C21H19N3O3,42334.0
18675,Martinostat,CN(Cc1ccc(/C=C/C(=O)NO)cc1)CC12CC3CC(CC(C3)C1)C2,C22H30N2O2,42100.0
18676,NPD4928,COc1ccc2[nH]cc(CCNC(=O)COc3cc4c(c5oc(=O)c(C)c(C)c35)CCC(C)(C)O4)c2c1,C29H32N2O6,36598.0
18677,Ac-IEPD-AFC,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1,C32H38F3N5O11,42179.0
18678,Glutaminase-IN-1,O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)[se]2)nn1,C26H24F3N7O3Se,42339.0
18679,Nalmefene (hydrochloride),C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5.Cl,C21H26ClNO3,28266.0
18680,Metronidazole Impurity G,Cc1ncc([N+](=O)[O-])n1CC(=O)O,C6H7N3O4,42291.0
18681,diABZI STING Agonist-1,CCn1nc(C)cc1C(=O)Nc1nc2cc(C(N)=O)cc(OC)c2n1C/C=C/Cn1c(NC(=O)c2cc(C)nn2CC)nc2cc(C(N)=O)cc(OCCCN3CCOCC3)c21,C42H51N13O7,42079.0
18682,DFSX-2,CCOC(=O)c1cn(-c2nc(N)c(F)cc2F)c2cc(N3CC(OC(=O)C(C)C)C3)c(F)cc2c1=O,C24H23F3N4O5,41981.0
18683,TTA-A2,C[C@@H](NC(=O)Cc1ccc(C2CC2)cc1)c1ccc(OCC(F)(F)F)cn1,C20H21F3N2O2,42236.0
18684,RAD51-IN-17,O=c1c2ccccc2nc(/C=C/c2cccnc2)n1Cc1ccc(Cl)cc1,C22H16ClN3O,42253.0
18685,Fmoc-L-Cys(Mmt)-OH,COc1ccc(C(SC[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)(c2ccccc2)c2ccccc2)cc1,C38H33NO5S,42177.0
18686,SMBA1,O=[N+]([O-])c1ccc2c(c1)C(=Cc1ccccc1O)c1ccccc1-2,C20H13NO3,42247.0
18687,Erinacine B,CC(C)C1=C2[C@H]3CC=C(C=O)[C@H]4O[C@H]5[C@@H](OC[C@@H](O)[C@@H]5O)O[C@@H]4[C@]3(C)CC[C@@]2(C)CC1,C25H36O6,40078.0
18688,Ppc-1,COc1cc(C(=O)OCC=C(C)C)nc2c(OCC=C(C)C)cccc12,C21H25NO4,42352.0
18689,Navoximod,O[C@H](C[C@H]1c2c(F)cccc2-c2cncn21)[C@H]1CC[C@H](O)CC1,C18H21FN2O2,28440.0
18690,4-Amino-D-phenylalanine,Nc1ccc(C[C@@H](N)C(=O)O)cc1,C9H12N2O2,41971.0
18691,Quetiapine Sulfoxide,O=S1c2ccccc2N=C(N2CCN(CCOCCO)CC2)c2ccccc21,C21H25N3O3S,42035.0
18692,1-1(Z)-Hexadecenyl-2-hydroxy-sn-glycero-3-PC,CCCCCCCCCCCCCC/C=C\OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C,C24H50NO6P,41465.0
18693,PHA-543613,O=C(N[C@@H]1CN2CCC1CC2)c1cc2ccoc2cn1,C15H17N3O2,42222.0
18694,SB-657510,COc1cc(Br)c(S(=O)(=O)Nc2ccc(Cl)c(O[C@@H]3CCN(C)C3)c2)cc1OC,C19H22BrClN2O5S,42321.0
18695,1-Methyl-3-amino-4-cyanopyrazole,Cn1cc(C#N)c(N)n1,C5H6N4,42224.0
18696,FX12,COC(=O)C1=Cc2ccccc2S1(=O)=O,C10H8O4S,42089.0
18697,AZD 3458,CC(=O)Nc1nc(C)c(-c2cc3c(c(S(C)(=O)=O)c2)C(=O)N([C@@H](C)C2CC2)C3)s1,C20H23N3O4S2,42104.0
18698,"2-Amino-9H-pyrido[2,3-b]indole",Nc1ccc2c(n1)[nH]c1ccccc12,C11H9N3,42114.0
18699,Tiglyl Glycine,C/C=C(\C)C(=O)NCC(=O)O,C7H11NO3,41836.0
18700,AMG 511,COc1ncc(Nc2ncc([C@@H](C)N3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,C22H28FN9O3S,41853.0
18701,Insulin Sensitizer C59,O=C(Nc1cc(Cl)c(Cl)cn1)C12CC3CC(CC(C3)C1)C2,C16H18Cl2N2O,42129.0
18702,Fluorescent Brightener 28,O=S(=O)([O-])c1cc(Nc2nc(Nc3ccccc3)nc(N(CCO)CCO)n2)ccc1C=Cc1ccc(Nc2nc(Nc3ccccc3)nc(N(CCO)CCO)n2)cc1S(=O)(=O)[O-].[Na+].[Na+],C40H42N12Na2O10S2,41995.0
18703,AG-045572,COc1cc(OC)c(NC(=O)c2ccc(Cc3cc4c(cc3C)C(C)(C)CCC4(C)C)o2)c(OC)c1,C30H37NO5,42244.0
18704,GR46611,COc1ccc(CNC(=O)C=Cc2ccc3[nH]cc(CCN(C)C)c3c2)cc1,C23H27N3O2,42235.0
18705,AZD 4320,CN(CCO)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F,C45H48ClF3N4O7S3,41978.0
18706,ZD 4190,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1,C19H16BrFN6O2,42248.0
18707,"3,4-MDMA-d5 (hydrochloride)",Cl.[2H]C(c1ccc2c(c1)OCO2)C([2H])(C)NC([2H])([2H])[2H],C11H16ClNO2,42148.0
18708,TPX-0046,C[C@@H]1CNC(=O)c2cnn3cc4c(nc23)N(Cc2cc(F)cnc2O1)[C@H]1CCC[C@H]1O4,C21H21FN6O3,41990.0
18709,MSD-M1PAM,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1,C22H20N4O3,41358.0
18710,GLPG1205,O=c1nc(OC[C@@H]2COCCO2)cc2n1CCc1cc(C#CC3CC3)ccc1-2,C22H22N2O4,33185.0
18711,Oxybenzone,COc1ccc(C(=O)c2ccccc2)c(O)c1,C14H12O3,42170.0
18712,DSPE-PEG(2000)-Biotin,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)COCCOCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)OC(=O)CCCCCCCCCCCCCCCCC,C57H107N4O13PS,41914.0
18713,CDK2 Inhibitor 73,NS(=O)(=O)c1ccc(Nc2nc(-c3cccc(-c4ccccc4)c3)c3[nH]cnc3n2)cc1,C23H18N6O2S,42335.0
18714,BSJ-04-132,CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CCCCNC(=O)COc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)cn3)nc2n1C1CCCC1,C42H49N11O7,41248.0
18715,UTL-5g,Cc1cc(C(=O)Nc2ccc(Cl)cc2Cl)no1,C11H8Cl2N2O2,42242.0
18716,BIA,Nc1ccccc1C(=O)/C=C/c1cccc([N+](=O)[O-])c1,C15H12N2O3,42217.0
18717,BMY 14802 (hydrochloride),Cl.OC(CCCN1CCN(c2ncc(F)cn2)CC1)c1ccc(F)cc1,C18H23ClF2N4O,42264.0
18718,Quipazine (maleate),O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O.c1ccc2nc(N3CCNCC3)ccc2c1,C21H23N3O8,42262.0
18719,2-BFI (hydrochloride),Cl.c1ccc2oc(C3=NCCN3)cc2c1,C11H11ClN2O,42338.0
18720,"9?,10?-Epoxyhexahydrocannabinol",CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@]3(C)O[C@@H]3[C@@H]21,C21H30O3,39972.0
18721,EN450,C=CC(=O)Nc1cc(S(=O)(=O)N(C)C)ccc1Cl,C11H13ClN2O3S,42326.0
18722,Butylcathinone (hydrochloride),CCCCNC(C)C(=O)c1ccccc1.Cl,C13H20ClNO,42470.0
18723,PRN-1008,CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1,C36H40FN9O3,42239.0
18724,GS-9901,N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1,C22H17ClFN9O,42105.0
18725,"2,2',6-Tribromobisphenol A",CC(C)(c1ccc(O)c(Br)c1)c1cc(Br)c(O)c(Br)c1,C15H13Br3O2,9004566.0
18726,LNP GalNAc Ligand 1 (trifluoroacetate salt),CC(=O)N[C@H]1[C@H](OCCCCC(=O)NCCCNC(=O)CCOCC(N)(COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2NC(C)=O)COCCC(=O)NCCCNC(=O)CCCCO[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2NC(C)=O)O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O.O=C(O)C(F)(F)F,C81H129F3N10O38,38952.0
18727,H3B-8800,C/C(=C\C=C\[C@@H](C)c1ccccn1)[C@H]1OC(=O)C[C@H](O)CC[C@@](C)(O)[C@@H](OC(=O)N2CCN(C)CC2)/C=C/[C@@H]1C,C31H45N3O6,42106.0
18728,Usp22i-S02,N#Cc1c2c(c(Nc3ccccc3)n3c1nc1ccccc13)CCCC2,C22H18N4,42130.0
18729,RMC-6291,CCn1c(-c2cccnc2[C@H](C)OC)c2c3cc(ccc31)N1CCO[C@@H](C[C@H](NC(=O)[C@H](C(C)C)N(C)C(=O)C3(F)CCN(C(=O)C#CC(C)(C)N(C)C)CC3)C(=O)N3CCC[C@H](N3)C(=O)OCC(C)(C)C2)C1,C55H78FN9O8,42174.0
18730,Taminadenant,Nc1nc(-n2cccn2)nc(-n2cccn2)c1Br,C10H8BrN7,32799.0
18731,LY456236 (hydrochloride),COc1ccc(Nc2ncnc3ccc(OC)cc23)cc1.Cl,C16H16ClN3O2,42263.0
18732,Rifamycin S,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C(=O)C=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O,C37H45NO12,42178.0
18733,Deferitazole,COCCOCCOCCOc1cccc(C2=N[C@@](C)(C(=O)O)CS2)c1O,C18H25NO7S,33329.0
18734,C-82,C[C@H]1[C@H]2N(C(=O)CN(C)N2C(=O)NCc2ccccc2)[C@@H](Cc2ccc(O)cc2)C(=O)N1Cc1cccc2cccnc12,C33H34N6O4,42038.0
18735,TBBPA monosulfate,CC(C)(c1cc(Br)c(O)c(Br)c1)c1cc(Br)c(OS(=O)(=O)O)c(Br)c1,C15H12Br4O5S,9004565.0
18736,BU 224 (hydrochloride),Cl.c1ccc2nc(C3=NCCN3)ccc2c1,C12H12ClN3,42451.0
18737,"L-371,257",COc1cc(OC2CCN(C(C)=O)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1,C28H33N3O6,42436.0
18738,B7-CD28 Interaction Inhibitor,Cn1ncc2c3[nH]n(-c4ccc(F)cc4)c(=O)c3c(-c3cccc(C(F)(F)F)c3)nc21,C21H13F4N5O,42398.0
18739,HS-38,CC(Sc1nc(=O)c2cnn(-c3cccc(Cl)c3)c2[nH]1)C(N)=O,C14H12ClN5O2S,42246.0
18740,RMC-7977,CCn1c(-c2cc(N3CCN(C4CC4)CC3)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1csc(n1)C[C@H](NC(=O)[C@H]1[C@@H]3COC[C@@H]31)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2,C47H60N8O6S,42185.0
18741,UR-144,CCCCCn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc21,C21H29NO,11502.0
18742,PE154,CCN(CC)c1ccc2c(c1)OC(=O)C(=CNc1ccc(CC(=O)NNc3c4c(nc5ccccc35)CCCC4)cc1)C2=O,C35H35N5O4,42396.0
18743,SB-9200,CO[C@@H]1[C@H](OP(=O)(OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)C[C@@H]2O)SCOC(=O)OC(C)C)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O,C25H34N7O13PS,42317.0
18744,ZED-1227,CCC(CC)CNC(=O)Cn1cccc(NC(=O)[C@H](CC/C=C/C(=O)OC)NC(=O)c2cncn2C)c1=O,C26H36N6O6,42333.0
18745,AG-9,COc1ccc(C=C(C#N)C#N)cc1,C11H8N2O,42420.0
18746,ATC 0175,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)c(F)c3)CC2)nc2ccccc12.Cl,C23H26ClF2N5O,42376.0
18747,RIPK2 Inhibitor OD36 (hydrochloride),Cl.Clc1cc2cc(c1)-c1cnn3c1NC(=NCCOCCO2)C=C3,C16H16Cl2N4O2,42171.0
18748,5-BDBD,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,C17H11BrN2O2,42034.0
18749,2-Amino-2-(p-tolyl)acetic Acid,Cc1ccc(C(N)C(=O)O)cc1,C9H11NO2,42294.0
18750,Pyribencarb,COC(=O)NCc1cc(/C(C)=N/OCc2cccc(C)n2)ccc1Cl,C18H20ClN3O3,42362.0
18751,Oxatomide,O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,C27H30N4O,42288.0
18752,TAK-994,CC(C)(O)C(=O)N1CC[C@H](NS(C)(=O)=O)[C@@H]1Cc1cccc(-c2cc(F)cc(F)c2)c1F,C22H25F3N2O4S,42336.0
18753,FAM Azide 6-isomer,[N-]=[N+]=NCCCNC(=O)c1ccc2c(c1)C1(OC2=O)c2ccc(O)cc2Oc2cc(O)ccc21,C24H18N4O6,42389.0
18754,TGN 073,O=S(=O)(Nc1ncccc1OCc1ccccc1)c1ccccc1,C18H16N2O3S,42086.0
18755,5-Hexynoic Acid,C#CCCCC(=O)O,C6H8O2,35507.0
18756,4?-Methoxyflavonol,COc1ccc(-c2oc3ccccc3c(=O)c2O)cc1,C16H12O4,42424.0
18757,INF 4E,C=C(C(=O)OCC)C(O)c1ccccc1Cl,C12H13ClO3,42315.0
18758,ZM 226600,CC(O)(C(=O)Nc1ccc(S(=O)(=O)c2ccccc2)cc1)C(F)(F)F,C16H14F3NO4S,42440.0
18759,Co 102862,NC(=O)NN=Cc1ccc(Oc2ccc(F)cc2)cc1,C14H12FN3O2,42437.0
18760,T807,Fc1ccc(-c2ccc3c(c2)[nH]c2ccncc23)cn1,C16H10FN3,42289.0
18761,3-Methylindole,Cc1c[nH]c2ccccc12,C9H9N,39231.0
18762,MK-3207,O=C(CN1C(=O)C2(CCCC2)NC[C@H]1c1cc(F)cc(F)c1)Nc1ccc2c(c1)C[C@@]1(C2)C(=O)Nc2ncccc21,C31H29F2N5O3,42490.0
18763,JNJ-10191584 (maleate),CN1CCN(C(=O)c2nc3ccc(Cl)cc3[nH]2)CC1.O=C(O)/C=C\C(=O)O,C17H19ClN4O5,42265.0
18764,Dauricine,COc1cc2c(cc1OC)[C@@H](Cc1ccc(Oc3cc(C[C@@H]4c5cc(OC)c(OC)cc5CCN4C)ccc3O)cc1)N(C)CC2,C38H44N2O6,42364.0
18765,THJ2201 N-pentanoic acid metabolite,O=C(O)CCCCn1nc(C(=O)c2cccc3ccccc23)c2ccccc21,C23H20N2O3,42427.0
18766,exo-THC methyl ether,C=C1CC[C@@H]2[C@@H](C1)c1c(OC)cc(CCCCC)cc1OC2(C)C,C22H32O2,40537.0
18767,Oroxin B,O=c1cc(-c2ccccc2)oc2cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)c(O)c(O)c12,C27H30O15,42489.0
18768,CFT-7455,O=C1CC[C@H](N2C(=O)c3cccc4c(Cc5ccc(CN6CCOCC6)cc5)ccc2c34)C(=O)N1,C28H27N3O4,42053.0
18769,GSK3685032,CCc1c(C#N)c(S[C@@H](C(N)=O)c2ccccc2)nc(N2CCC(N)CC2)c1C#N,C22H24N6OS,41882.0
18770,WAY-181187,NCCc1cn(S(=O)(=O)c2c(Cl)nc3sccn23)c2ccccc12,C15H13ClN4O2S2,23461.0
18771,ICI 89406,N#Cc1ccccc1OCC(O)CNCCNC(=O)Nc1ccccc1,C19H22N4O3,42370.0
18772,FAUC-213,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,C18H19ClN4,42322.0
18773,Doxycycline (hydrate),C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O,C22H26N2O9,35830.0
18774,2-Methylmethcathinone-d3 (hydrochloride),Cl.[2H]C([2H])([2H])NC(C)C(=O)c1ccccc1C,C11H16ClNO,42462.0
18775,GNF-4877,CC(C)Oc1ccc(F)c(-c2cnc(N)c(C(=O)Nc3cnccc3N3CCC[C@@H](C(=O)O)C3)n2)c1,C25H27FN6O4,42538.0
18776,BJJF078,C=CC(=O)NC1CCN(S(=O)(=O)c2cccc3c(NC(=O)c4ccc(OC)c(OC)c4)cccc23)CC1,C27H29N3O6S,42397.0
18777,K114,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(Br)c2)cc1,C22H17BrO2,34218.0
18778,TC-F 2,CCn1c(=O)n([C@H]2CCCN(c3nccc(-c4cc5ccccc5o4)n3)C2)c2ccccc21,C26H25N5O2,42395.0
18779,AMZ30,N#C/C(=C\c1cccn1S(=O)(=O)c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1ccc(F)cc1,C19H12FN3O6S2,42052.0
18780,CVN293,Nc1nonc1-c1nc2cccc(F)c2n1Cc1cccnn1,C14H10FN7O,40983.0
18781,EGFR-IN-7,COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(C)cc1Nc1ncc(Br)c(Nc2ccc3nccnc3c2P(C)(C)=O)n1,C32H41BrN9O2P,42214.0
18782,OX04528,[O-][n+]1cc(O)cc(CCCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1,C16H13F6NO2,42377.0
18783,RGD-targeted Proapoptotic Peptide,[H]NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN[H])NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN[H])NC(=O)[C@H](CCCCN[H])NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN[H])NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN[H])NC(=O)CNC(=O)CNC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](C)N[H])C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCC/N=C(/N)N[H])NC2=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)C(=O)O,C116H199N35O31S4,42136.0
18784,DL-Cysteine,NC(CS)C(=O)O,C3H7NO2S,41968.0
18785,Crocin II,CC(/C=C/C=C(\C)C(=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)=C\C=C\C=C(C)\C=C\C=C(/C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O,C38H54O19,42485.0
18786,4-Fluoroaniline-d4,[2H]c1c([2H])c(F)c([2H])c([2H])c1N,C6H6FN,42441.0
18787,2-DI-1-ASP,CN(C)c1ccc(C=Cc2cccc[n+]2C)cc1.[I-],C16H19IN2,42328.0
18788,1-1(Z)-Octadecenyl-2-hydroxy-sn-glycero-3-PE,CCCCCCCCCCCCCCCC/C=C\OC[C@@H](O)COP(=O)([O-])OCC[NH3+],C23H48NO6P,41466.0
18789,K579,CC1(NCC(=O)N2CCC[C@H]2C#N)CCN(c2ncccn2)CC1,C17H24N6O,42505.0
18790,PD 81723,Cc1sc(N)c(C(=O)c2cccc(C(F)(F)F)c2)c1C,C14H12F3NOS,42371.0
18791,TCN 237 (hydrochloride),Cl.Cl.Oc1ccc2[nH]c(CN3CCC(Cc4ccccc4F)CC3)nc2c1,C20H24Cl2FN3O,42266.0
18792,"2,4-Dinitrobenzenesulfonic Acid (sodium salt)",O=[N+]([O-])c1ccc(S(=O)(=O)[O-])c([N+](=O)[O-])c1.[Na+],C6H3N2NaO7S,42630.0
18793,"Nonafluoro-3,6-dioxaheptanoic Acid",O=C(O)C(F)(F)OC(F)(F)C(F)(F)OC(F)(F)F,C5HF9O4,37917.0
18794,Compound C22,CCOC(=O)c1cnn(-c2ccc(Cl)cc2)c1NS(=O)(=O)c1cccc(Cl)c1,C18H15Cl2N3O4S,42343.0
18795,N-ethyl Nitrazepam,CCN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21,C17H15N3O3,41870.0
18796,VT103,CNS(=O)(=O)c1ccc(Nc2ccc(C(F)(F)F)cc2)c(-c2cn(C)cn2)c1,C18H17F3N4O2S,42327.0
18797,KI-696,COc1cc([C@@H](CC(=O)O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)cc2nnn(C)c12,C28H30N4O6S,42039.0
18798,Rezivertinib,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1OCCN(C)C,C27H30N6O3,42537.0
18799,SB-218795,COC(=O)[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1,C25H20N2O3,42373.0
18800,Narlaprevir,CCCC[C@H](NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1,C36H61N5O7S,42487.0
18801,Cdk9 Inhibitor,Cc1ccc(Nc2cc(-c3cccc(N4C(=O)c5ccccc5C4=O)c3)ncn2)cc1NS(C)(=O)=O,C26H21N5O4S,42512.0
18802,?Z-FA-FMK,CC(NC(=O)C(Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)CF,C21H23FN2O4,42444.0
18803,3-O-Methylgallic Acid,COc1cc(C(=O)O)cc(O)c1O,C8H8O5,42530.0
18804,VPS34-IN-19,CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1,C21H25N7O,41357.0
18805,Sermorelin (acetate),CC(=O)O.[H]N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)CC,C151H250N44O44S,36696.0
18806,CJ-033466,Cc1cn2c(N)c(Cl)cc(C(=O)NCC3CCN(CC(C)C)CC3)c2n1,C19H28ClN5O,42394.0
18807,TR-107,N#Cc1cccc(CN2CCc3ncn(Cc4ccc(Cl)cc4)c(=O)c3C2)c1,C22H19ClN4O,42445.0
18808,Lanoconazole,N#C/C(=C1/SCC(c2ccccc2Cl)S1)n1ccnc1,C14H10ClN3S2,42532.0
18809,Ciwujianoside B,C=C1CC[C@]2(C(=O)O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,C58H92O25,42502.0
18810,Lipid U 105,CCCCCCCCC(CCCCCCCC)OC(=O)CCCCCN(CCCCCC(=O)OC(CCCCCCCC)CCCCCCCC)CCCN(CCO)CCO,C53H106N2O6,41944.0
18811,Sirpiglenastat,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)C=[N+]=[N-])C(=O)OC(C)C,C22H27N5O5,41293.0
18812,Medetomidine-d3 (hydrochloride),Cl.[2H]C([2H])([2H])C(c1cnc[nH]1)c1cccc(C)c1C,C13H17ClN2,41734.0
18813,SKF 89976A (hydrochloride),Cl.O=C(O)C1CCCN(CCC=C(c2ccccc2)c2ccccc2)C1,C22H26ClNO2,42449.0
18814,"MDMB-PICA 3,3-dimethylbutanoic acid metabolite",CCCCCn1cc(C(=O)N[C@H](C(=O)O)C(C)(C)C)c2ccccc21,C20H28N2O3,42703.0
18815,JBI-589,Cc1c(-c2cc3ccccc3n2Cc2ccc(F)cc2)nc2cc(C(=O)N3CCC[C@@H](N)C3)ccn12,C29H28FN5O,42126.0
18816,SCH 546738,CC[C@H]1CN(c2nc(N)c(C(N)=O)nc2Cl)CCN1C1CCN(Cc2ccc(Cl)cc2)CC1,C23H31Cl2N7O,28447.0
18817,NNC 05-2090 (hydrochloride),COc1ccccc1C1(O)CCN(CCCn2c3ccccc3c3ccccc32)CC1.Cl,C27H31ClN2O2,42491.0
18818,GLPG2534,N#Cc1ccc(-n2cnc3cc(OCCOCCO)c(NC4CCOCC4)nc32)nc1,C21H24N6O4,42048.0
18819,(?)-8-Prenylnaringenin,CC(C)=CCc1c(O)cc(O)c2c1O[C@H](c1ccc(O)cc1)CC2=O,C20H20O5,37906.0
18820,BI-3231,CCn1c(=O)c(C)cn(Cc2nnc(-c3ccc(F)c(O)c3F)s2)c1=O,C16H14F2N4O3S,41147.0
18821,Corosolic Acid ?,CCCOC(=O)[C@]12CC[C@@H](C)[C@H](C)[C@H]1C1=CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2,C33H54O4,42738.0
18822,NBI 98782,COc1cc2c(cc1OC)[C@H]1C[C@@H](O)[C@H](CC(C)C)CN1CC2,C19H29NO3,42116.0
18823,Corypalmine,COc1cc2c(cc1O)CCN1Cc3c(ccc(OC)c3OC)CC21,C20H23NO4,42467.0
18824,Dipraglurant,Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1,C16H12FN3,42535.0
18825,SB-FI-26,O=C(O)[C@H]1[C@@H](c2ccccc2)[C@H](C(=O)Oc2cccc3ccccc23)[C@@H]1c1ccccc1,C28H22O4,41182.0
18826,ZA3-Ep10,CCCCCCCCC(O)CN(CCC(=O)NCC[N+](C)(C)CCCS(=O)(=O)[O-])CCN(CCN(CC(O)CCCCCCCC)CC(O)CCCCCCCC)CCN(CC(O)CCCCCCCC)CC(O)CCCCCCCC,C66H138N6O9S,40764.0
18827,"3,4-MDiPA (hydrochloride)",CC(C)NC(C)Cc1ccc2c(c1)OCO2.Cl,C13H20ClNO2,42415.0
18828,PF-06821497,COc1cc(C)[nH]c(=O)c1CN1CCc2c(Cl)cc([C@H](OC)C3COC3)c(Cl)c2C1=O,C22H24Cl2N2O5,42500.0
18829,?-Piperidinohexanophenone (hydrochloride),CCCCC(C(=O)c1ccccc1)N1CCCCC1.Cl,C17H26ClNO,42574.0
18830,"L-152,804",CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3ccccc32)C(=O)C1,C23H26O4,42504.0
18831,6-Trehalose Monooleate,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,C30H54O12,42211.0
18832,4-hydroxy Tryptophol,OCCc1c[nH]c2cccc(O)c12,C10H11NO2,33633.0
18833,JP-2-196,COc1ccc(C(=O)C=CC(=O)N2CCNCC2)cc1.O=C(O)C(F)(F)F,C17H19F3N2O5,42342.0
18834,Cocaethylene-d3,[2H]C([2H])([2H])N1[C@H]2CC[C@@H]1[C@@H](C(=O)OCC)[C@@H](OC(=O)c1ccccc1)C2,C18H23NO4,18038.0
18835,503O13,CCCCCCCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCCCCCCC)CCN(C)CCCN(C)CCN(CCC(=O)OCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCC,C73H144N4O8,38628.0
18836,BML-260,O=C(O)c1ccc(N2C(=O)C(=Cc3ccccc3)SC2=S)cc1,C17H11NO3S2,42442.0
18837,Inarigivir (ammonium salt),CO[C@@H]1[C@H](OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)C[C@@H]2O)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O.N,C20H29N8O10PS,42216.0
18838,"?9?,10?-epoxy Hexahydrocannabinol",CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@@]3(C)O[C@H]3[C@@H]21,C21H30O3,42023.0
18839,?Lyso-Monosialoganglioside GM3 (synthetic),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O,C41H74N2O20,42762.0
18840,Butamirate (citrate),CCC(C(=O)OCCOCCN(CC)CC)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O,C24H37NO10,42561.0
18841,ART558,Cc1cccc(N(C)C(=O)[C@@H]2[C@H](O)CCN2c2nc(C)cc(C(F)(F)F)c2C#N)c1,C21H21F3N4O2,42324.0
18842,Soyasaponin Ba,CC1(C)C[C@@H](O)[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,C48H78O19,42534.0
18843,"2,4,6-Trinitrobenzenesulphonic Acid",O=[N+]([O-])c1cc([N+](=O)[O-])c(S(=O)(=O)O)c([N+](=O)[O-])c1,C6H3N3O9S,9004605.0
18844,Octyl Gallate,CCCCCCCCOC(=O)c1cc(O)c(O)c(O)c1,C15H22O5,42586.0
18845,PF-02545920,Cn1cc(-c2ccc(OCc3ccc4ccccc4n3)cc2)c(-c2ccncc2)n1,C25H20N4O,42047.0
18846,C26 Ceramide (d18:1/26:0) (synthetic),CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCC,C44H87NO3,42978.0
18847,Bz 423,CN1C(=O)C(Cc2ccc3ccccc3c2)N=C(c2ccc(O)cc2)c2cc(Cl)ccc21,C27H21ClN2O2,42608.0
18848,Iclepertin,C[C@@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1C[C@@H]2C[C@]2(c2cc(C(F)(F)F)on2)C1)C(F)(F)F,C20H18F6N2O5S,41729.0
18849,NAcM-OPT,CCCCN1CCC(N(Cc2ccccc2)C(=O)Nc2ccc(Cl)c(Cl)c2)CC1,C23H29Cl2N3O,42379.0
18850,BC13,COc1cc(OC)c2c(=O)nc(-c3ccc(C(=O)N4CC5(CCN(c6ncc7c(C)cc(=O)n(C8CCCC8)c7n6)CC5)C4)cc3)[nH]c2c1,C37H39N7O5,42704.0
18851,77PD,CC(C)CCC(C)Nc1ccc(NC(C)CCC(C)C)cc1,C20H36N2,42602.0
18852,SLX-4090,COc1cccc(C(=O)Nc2ccc3c(c2)CCN(C(=O)Oc2ccccc2)C3)c1-c1ccc(C(F)(F)F)cc1,C31H25F3N2O4,41979.0
18853,DS18561882,Cc1c(N2CCN(C)[C@@H](C)C2)ccc2c3c(c(=O)oc12)CN(C(=O)c1ccc(NS(C)(=O)=O)c(OC(F)(F)F)c1)CC3,C28H31F3N4O6S,33860.0
18854,PSB-06126,Nc1c(S(=O)(=O)[O-])cc(Nc2cccc3ccccc23)c2c1C(=O)c1ccccc1C2=O.[Na+],C24H15N2NaO5S,42173.0
18855,??Psilocybin Analytical Reference Standard,C[NH+](C)CCc1c[nH]c2cccc(OP(=O)([O-])O)c12,C12H17N2O4P,39698.0
18856,Triamcinolone hexacetonide,CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,C30H41FO7,42600.0
18857,DCZ0415,O=C1C2C3C=CC(C4CC34)C2C(=O)N1c1ccc(Cc2ccncc2)cc1,C23H20N2O2,42513.0
18858,Grayanotoxin III,CC1(C)[C@@H](O)C[C@H]2[C@](C)(O)[C@@H]3CC[C@@H]4[C@@H](O)[C@@]3(C[C@@H](O)[C@@]21O)C[C@@]4(C)O,C20H34O6,42645.0
18859,5?-Cholestan-3-one,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C27H46O,42284.0
18860,TC-DAPK6,O=C1OC(C=Cc2ccccc2)=NC1=Cc1cccnc1,C17H12N2O2,42378.0
18861,Dilauryl thiodipropionate,CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC,C30H58O4S,42578.0
18862,nor-Orphine,O=c1[nH]c2ccccc2n1C1CCNCC1,C12H15N3O,37339.0
18863,Ethylbromazolam,CCc1nnc2n1-c1ccc(Br)cc1C(c1ccccc1)=NC2,C18H15BrN4,42723.0
18864,7-hydroxy Mitragynine-d3,[2H]C([2H])([2H])Oc1cccc2c1[C@@]1(O)CCN3C[C@@H](CC)[C@@H](/C(=C\OC)C(=O)OC)C[C@H]3C1=N2,C23H30N2O5,42292.0
18865,Anti-NASH Agent 1,CNc1ccc(C(=O)C=Cc2cc(C)c(OC(C)(C)C(=O)OC(C)(C)C)c(C)c2)cc1,C26H33NO4,42614.0
18866,TOAC,CC1(C)CC(N)(C(=O)O)CC(C)(C)N1[O],C10H19N2O3,42097.0
18867,TL02-59,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(Oc4ncnc5cc(OC)c(OC)cc45)c3)cc2C(F)(F)F)CC1,C32H34F3N5O4,42729.0
18868,Evatanepag,CC(C)(C)c1ccc(CN(Cc2cccc(OCC(=O)O)c2)S(=O)(=O)c2cccnc2)cc1,C25H28N2O5S,42727.0
18869,2'-O-Methylisoliquiritigenin,COc1cc(O)ccc1C(=O)C=Cc1ccc(O)cc1,C16H14O4,36490.0
18870,2-Methylcathinone (hydrochloride),Cc1ccccc1C(=O)C(C)N.Cl,C10H14ClNO,42713.0
18871,JHU083,CCOC(=O)[C@H](CCC(=O)C=[N+]=[N-])NC(=O)[C@@H](N)CC(C)C,C14H24N4O4,40642.0
18872,MitoPeDPP,[I-].c1ccc(P(c2ccc(OCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)cc2)c2ccc3c4cccc5cccc(c6cccc2c63)c54)cc1,C53H41IOP2,41727.0
18873,HIF-2? Translation Inhibitor 76,COC(=O)c1sccc1NN=C(C#N)S(C)(=O)=O,C9H9N3O4S2,42446.0
18874,CCPD,c1cc(NC2CCCCC2)ccc1NC1CCCCC1,C18H28N2,42610.0
18875,ZP3022,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,C199H294N48O61S,42636.0
18876,Carbonate Ionophore VII,CCCCCCCCN(CCCCCCCC)C(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(=O)c5ccc(C(=O)C(F)(F)F)cc5)CC[C@]4(C)[C@H]3C[C@H](OC(=O)c3ccc(C(=O)C(F)(F)F)cc3)[C@]12C,C58H79F6NO7,42078.0
18877,Polymyxin B Nonapeptide (trifluoroacetate salt),CC(C)C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@@H](N)[C@@H](C)O)CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC1=O.O=C(O)C(F)(F)F,C45H75F3N14O13,42533.0
18878,RA-0002034,CCOc1ccccc1-c1cc(C(=O)NC/C=C/S(C)(=O)=O)n[nH]1,C16H19N3O4S,42186.0
18879,"1,2-Dierucoyl-sn-glycero-3-PE",CCCCCCCC/C=C\CCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC,C49H94NO8P,41090.0
18880,NVR 3-778,O=C(Nc1cc(F)c(F)c(F)c1)c1ccc(F)c(S(=O)(=O)N2CCC(O)CC2)c1,C18H16F4N2O4S,42725.0
18881,"1,2-Diheptadecanoyl-sn-glycero-3-PE",CCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCC,C39H78NO8P,38319.0
18882,10(R)-hydroxy Stearic Acid,CCCCCCCC[C@@H](O)CCCCCCCCC(=O)O,C18H36O3,42929.0
18883,NVP-LCQ195,CS(=O)(=O)N1CCC(NC(=O)c2n[nH]cc2NC(=O)c2c(Cl)cccc2Cl)CC1,C17H19Cl2N5O4S,42728.0
18884,nor-Butylone (hydrochloride),CCC(N)C(=O)c1ccc2c(c1)OCO2.Cl,C11H14ClNO3,42708.0
18885,NBC,CCCCN(CCCC)C1=[S][Ni+2]2([S]=C(N(CCCC)CCCC)[S-]2)[S-]1,C18H36N2NiS4,42583.0
18886,N-Palmitoyl-L-Serine (sodium salt),CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)[O-].[Na+],C19H36NNaO4,25677.0
18887,(-)-Gossypol (acetate),CC(=O)O.Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,C32H34O10,42421.0
18888,BBD,O=[N+]([O-])c1ccc(NCc2ccccc2)c2nonc12,C13H10N4O3,42897.0
18889,DSPE-mPEG(1000),CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)OCCOC)OC(=O)CCCCCCCCCCCCCCCCC,C43H84NO10P(C2H4O)n,42638.0
18890,DSPE-MPEG(5000),CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)OCCOC)OC(=O)CCCCCCCCCCCCCCCCC,C43H84NO10P(C2H4O)n,43359.0
18891,Lipid I97,CCCCCCCCC(CCCCCC)COC(=O)CCCC(=O)OCC(C)(C)[C@@H](OC(=O)CCCC(=O)OCC(CCCCCC)CCCCCCCC)C(=O)NCCC(=O)OCCN(C)C,C55H102N2O11,42607.0
18892,Timapiprant (sodium salt),Cc1c(Cc2ccc3ccccc3n2)c2cc(F)ccc2n1CC(=O)[O-].[Na+],C21H16FN2NaO2,42734.0
18893,VZ 185,COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN1CCN(CCCCCOc2cc(-c3scnc3C)ccc2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,C53H67FN8O8S,41454.0
18894,TG53,COc1ccc(Cl)cc1C(=O)Nc1ccc(Nc2nc(C)cc(N(C)C)n2)cc1,C21H22ClN5O2,42514.0
18895,ART812,Cc1cc(C(F)(F)F)cc(N2C(=O)[C@@H](O)[C@@H](O)[C@H]2C(=O)N(C)c2ccc(F)c(Cl)c2)n1,C19H16ClF4N3O4,42904.0
18896,L-012 (sodium salt),Nc1c(-c2ccccc2)nc(Cl)c2c([O-])n[nH]c(=O)c12.[Na+],C13H8ClN4NaO2,39908.0
18897,n-Decyl-?-D-Glucopyranoside,CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C16H32O6,42722.0
18898,THIQ,O=C(N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCC(Cn2cncn2)(C2CCCCC2)CC1)[C@H]1Cc2ccccc2CN1,C33H41ClN6O2,24303.0
18899,ARB-272572,Cc1c(NC(=O)c2ccc(CNCCO)cn2)cccc1-c1cccc(NC(=O)c2ccc(CNCCO)cn2)c1C,C32H36N6O4,42547.0
18900,SP100030,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cnc(Cl)nc1C(F)(F)F,C14H5ClF9N3O,42898.0
18901,Lipid PPz-2R1,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN1CCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CC1,C48H94N2O4,43160.0
18902,N-methyl-N-Propylcathinone (hydrochloride),CCCN(C)C(C)C(=O)c1ccccc1.Cl,C13H20ClNO,42468.0
18903,3-Methylcathinone (hydrochloride),Cc1cccc(C(=O)C(C)N)c1.Cl,C10H14ClNO,42714.0
18904,DS-3801b,Cc1cc(N(C)C(=O)[C@H]2CC[C@H](Oc3cccc(CO)c3)CC2)ccc1CN1CCN[C@@H](C)C1,C28H39N3O3,42548.0
18905,2-hydroxy Oleic Acid-d17,[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C=CCCCCCCC(O)C(=O)O,C18H34O3,9004307.0
18906,FGIN-1-43,CCCCCCN(CCCCCC)C(=O)Cc1c(-c2ccc(Cl)cc2)[nH]c2ccc(Cl)cc12,C28H36Cl2N2O,42245.0
18907,AZ 13705339,CCS(=O)(=O)c1cc(Nc2ncc(F)c(N(Cc3ccccc3C#N)c3cc(CO)ccc3C)n2)ccc1N1CCN(C)CC1,C33H36FN7O3S,42087.0
18908,Mitoguazone,CC(C=NNC(=N)N)=NNC(=N)N,C5H12N8,33803.0
18909,N-isopropyl Buphedrone (hydrochloride),CCC(NC(C)C)C(=O)c1ccccc1.Cl,C13H20ClNO,42474.0
18910,1588-A4,CC(C)(C)OC(=O)N1CCN(c2ncnc3c(F)c(Br)c(Cl)cc23)CC1,C17H19BrClFN4O2,42439.0
18911,Cbz-Gly-Pro-AMC,Cc1cc(=O)oc2cc(NC(=O)[C@@H]3CCCN3C(=O)CNC(=O)OCc3ccccc3)ccc12,C25H25N3O6,42320.0
18912,3-Methylmethcathinone-d3 (hydrochloride),Cl.[2H]C([2H])([2H])NC(C)C(=O)c1cccc(C)c1,C11H16ClNO,35394.0
18913,LRE1,Nc1nc(Cl)cc(N(Cc2cccs2)C2CC2)n1,C12H13ClN4S,42438.0
18914,AMG 009,CCCCNC(=O)c1ccc(Oc2ccc(CC(=O)O)cc2OC)c(NS(=O)(=O)c2ccc(Cl)cc2Cl)c1,C26H26Cl2N2O7S,42392.0
18915,TAK-653,CC1=CN2CCS(=O)(=O)N=C2C(c2ccc(OC3CCCCC3)cc2)=N1,C19H23N3O3S,42187.0
18916,Isoleucine,CCC(C)C(N)C(=O)O,C6H13NO2,41562.0
18917,"2,3-Dimercaptopropanesulfonate (sodium salt hydrate)",O.O=S(=O)([O-])CC(S)CS.[Na+],C3H9NaO4S3,39521.0
18918,KCC009,O=C(N[C@@H](Cc1ccc(O)cc1)C(=O)NCC1CC(Br)=NO1)OCc1ccccc1,C21H22BrN3O5,42453.0
18919,A-582941,CN1CC2CN(c3ccc(-c4ccccc4)nn3)CC2C1.Cl.Cl,C17H22Cl2N4,42375.0
18920,Cannabiripsol,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC[C@](C)(O)[C@@H](O)[C@@H]21,C21H32O4,21728.0
18921,Ralaniten,CC(C)(c1ccc(OC[C@H](O)CO)cc1)c1ccc(OC[C@H](O)CCl)cc1,C21H27ClO5,42391.0
18922,Perfluorohexyloctane,CCCCCCCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C14H17F13,40490.0
18923,Lipid 1 HG3,CCCCCCCCCCC(CCCCCCCCCC)OC(=O)CCCCCCCC(CCCCCCC)OC(=O)CCCN(C)C,C43H85NO4,9004529.0
18924,nor-Pentylone (hydrochloride),CCCC(N)C(=O)c1ccc2c(c1)OCO2.Cl,C12H16ClNO3,42709.0
18925,Benzoic Acid,O=C(O)c1ccccc1,C7H6O2,43179.0
18926,YL-939,C1=C(c2nc(-c3cnn(C4CCNCC4)c3)cn3cc(-c4ccccc4)nc23)CCOC1,C25H26N6O,38006.0
18927,TL4-12,CNc1cc(Oc2cc(C(=O)Nc3cc(N4CCN(C)CC4)cc(C(F)(F)F)c3)ccc2C)ncn1,C25H27F3N6O2,42907.0
18928,DL-Pipecolic Acid-d9,[2H]C1([2H])NC([2H])(C(=O)O)C([2H])([2H])C([2H])([2H])C1([2H])[2H],C6H11NO2,43070.0
18929,TM2-115,COc1cc2c(NC3CCN(C)CC3)nc(N3CCCN(C)CC3)nc2cc1OCc1ccccc1,C28H38N6O2,42901.0
18930,Fentanyl methylene homolog (hydrochloride),CCC(=O)N(Cc1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl,C23H31ClN2O,43031.0
18931,NBD-Hydrazine,NNc1ccc([N+](=O)[O-])c2nonc12,C6H5N5O3,42611.0
18932,Ulifloxacin,CC1Sc2c(C(=O)O)c(=O)c3cc(F)c(N4CCNCC4)cc3n21,C16H16FN3O3S,38123.0
18933,OICR-0547,O=C(Nc1cc(-c2cccc(CN3CCOCC3)c2)ccc1N1CCOCC1)c1c[nH]c(=O)cc1C(F)(F)F,C28H29F3N4O4,18180.0
18934,MDK1088,CN(Cc1ccccc1)C(=O)C1CCCN(Cc2ccc(C(F)(F)F)cc2)C1,C22H25F3N2O,37394.0
18935,"9(E),12(Z)-Tetradecadienyl Acetate",C/C=C\C/C=C/CCCCCCCCOC(C)=O,C16H28O2,42895.0
18936,"5?-Cholestane-3?,7?,12?,25-tetrol",C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,C27H48O4,42577.0
18937,?Salbutamol-d3,[2H]C([2H])(O)c1cc(C([2H])(O)CNC(C)(C)C)ccc1O,C13H21NO3,43118.0
18938,AMG 2850,C[C@H](NC(=O)N1CCc2cccnc2[C@H]1c1ccc(C(F)(F)F)cc1)C(F)(F)F,C19H17F6N3O,42906.0
18939,SPHINX,Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccc2N2CCOCC2)o1,C17H17F3N2O3,42958.0
18940,Etomidate Acid,C[C@H](c1ccccc1)n1cncc1C(=O)O,C12H12N2O2,43013.0
18941,H-?-Ala-AMC (trifluoroacetate salt),Cc1cc(=O)oc2cc(NC(=O)CCN)ccc12.O=C(O)C(F)(F)F,C15H15F3N2O5,42913.0
18942,Casopitant (mesylate),CC(=O)N1CCN([C@H]2CCN(C(=O)N(C)[C@H](C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@@H](c3ccc(F)cc3C)C2)CC1.CS(=O)(=O)O,C31H39F7N4O5S,42910.0
18943,Fmoc-Tyr(tBu)-OH,CC(C)(C)Oc1ccc(C[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)cc1,C28H29NO5,42581.0
18944,SSE15206,COc1cc(C2CC(c3ccccc3)=NN2C(N)=S)cc(OC)c1OC,C19H21N3O3S,42961.0
18945,HS-276,CCCn1c(NC(=O)c2cccc(C(N)=O)c2)nc2ccc(CN3CCCCC3)cc21,C24H29N5O2,43026.0
18946,O-Acetyl-L-Homoserine (hydrochloride),CC(=O)OCC[C@H](N)C(=O)O.Cl,C6H12ClNO4,41714.0
18947,9-Chlorohexadecafluoro-3-oxanone-1-sulfonic Acid (potassium,O=S(=O)([O-])C(F)(F)C(F)(F)OC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Cl.[K+],C8ClF16KO4S,42909.0
18948,UH15-38,CN1CCN(c2cccc(Nc3cc4c(cn3)cc(-c3cccc(O)c3)c(=O)n4C)c2)CC1,C26H27N5O2,41056.0
18949,Befetupitant,Cc1ccccc1-c1cc(N2CCOCC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,C29H29F6N3O2,43004.0
18950,Vanillylmandelic Acid,COc1cc(C(O)C(=O)O)ccc1O,C9H10O5,42992.0
18951,Poly(I:C) (sodium salt),Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)n1.O=c1nc[nH]c2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O.[NaH],C19H27N7NaO16P2,42916.0
18952,ML-402,Cc1cc(Cl)ccc1OCCNC(=O)c1cccs1,C14H14ClNO2S,42962.0
18953,Dodecyl-D-Glucopyranoside,CCCCCCCCCCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C18H36O6,42721.0
18954,Noroxymorphone (hydrochloride) (CRM),Cl.O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3)[C@H]1O5,C16H18ClNO4,41701.0
18955,JH-X-119-01,C=CC(=O)Nc1cccc(C(=O)Nc2ccc(NC(=O)c3cccc(-c4cc[nH]n4)n3)cc2)c1,C25H20N6O3,43041.0
18956,E10i-494,CC(C)CCCCCCCCCCC(O)CN(CCOCCN(CC(O)CCCCCCCCCCC(C)C)CC(O)CCCCCCCCCCC(C)C)CCN1CCN(CCOCCN(CC(O)CCCCCCCCCCC(C)C)CC(O)CCCCCCCCCCC(C)C)CC1,C89H183N5O7,43084.0
18957,MTX-531,C[C@@H](Nc1ncnc2ccc(-c3cnc(Cl)c(NS(C)(=O)=O)c3)cc12)c1ccccc1,C22H20ClN5O2S,43038.0
18958,N-desethyl Etodesnitazene,CCNCCn1c(Cc2ccc(OCC)cc2)nc2ccccc21,C20H25N3O,42226.0
18959,ZINC40099027,COc1ccc(C2CCCN2C(=O)Nc2cc(C(F)(F)F)ccc2N2CCOCC2)cc1,C23H26F3N3O3,42956.0
18960,4-NDQ,O=[N+]([O-])c1cc[n+]([O-])c2ccccc12,C9H6N2O3,42994.0
18961,12-Nitrolinoleate,CCCCC/C=C(\C/C=C\CCCCCCCC(=O)O)[N+](=O)[O-],C18H31NO4,10007623.0
18962,Tinoridine (hydrochloride),CCOC(=O)c1c(N)sc2c1CCN(Cc1ccccc1)C2.Cl,C17H21ClN2O2S,42963.0
18963,UCB 9608,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4c3cnn4C)[C@@H](C)C2)c(C)c1,C20H26N8O2,43027.0
18964,BLU-945,CO[C@@H]1CCN(c2nccc(Nc3cc4c(C(C)C)ccc(N5C[C@H](CS(C)(=O)=O)[C@H]5C)c4cn3)n2)C[C@@H]1F,C28H37FN6O3S,43015.0
18965,Y134,CC(C)N1CCN(c2ccc(C(=O)c3c(-c4ccc(O)cc4)sc4cc(O)ccc34)cc2)CC1,C28H28N2O3S,42393.0
18966,GPX4 Activator 2,COc1ccc(NCc2cccn2-c2nnc(N3CCN(C)CC3)s2)c(OC)c1,C20H26N6O2S,43195.0
18967,VU6005649,COc1ccc(-c2c(C)nn3c(C(F)(F)F)cc(C)nc23)c(F)c1F,C16H12F5N3O,43138.0
18968,Larazotide (acetate),CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C,C34H59N9O12,43008.0
18969,Cathepsin Inhibitor 1,Cn1nc(C(C)(C)C)cc1C(=O)N[C@@H](Cc1cccc(Cl)c1)C(=O)NCC#N,C20H24ClN5O2,28790.0
18970,Demethyleneberberine,COc1ccc2cc3[n+](cc2c1OC)CCc1cc(O)c(O)cc1-3,C19H18NO4,43099.0
18971,Isopropoxate,CC(C)OC(=O)c1cncn1[C@H](C)c1ccccc1,C15H18N2O2,43012.0
18972,?16-Dehydroprogesterone,CC(=O)C1=CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C21H28O2,43057.0
18973,MS049,CNCCN1CCC(OCc2ccccc2)CC1,C15H24N2O,41105.0
18974,1-Methylnicotinamide (iodide),C[n+]1cccc(C(N)=O)c1.[I-],C7H9IN2O,43076.0
18975,Despropionyl Bezitramide,N#CC(CCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)(c1ccccc1)c1ccccc1,C28H28N4O,43337.0
18976,Zolpidic Acid,Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)O)cc1,C17H16N2O2,43000.0
18977,(+)-Propoxate,CCCOC(=O)c1cncn1[C@H](C)c1ccccc1,C15H18N2O2,43011.0
18978,84-B10,COc1ccc(Oc2ccc(C(F)(F)F)cc2NC(=O)CC(CC(=O)O)c2ccccc2)cc1,C25H22F3NO5,43187.0
18979,21-deacetoxy Deflazacort,CC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C,C23H29NO4,43019.0
18980,PT-179,O=C1CCC(N2C(=O)c3ccc(N4CCOCC4)cc3C2=O)C(=O)N1,C17H17N3O5,43028.0
18981,CB-65,O=C(NC1CCCCC1)c1cn(CCN2CCOCC2)c2cc(Cl)ccc2c1=O,C22H28ClN3O3,43106.0
18982,Metoprine,Cc1nc(N)nc(N)c1-c1ccc(Cl)c(Cl)c1,C11H10Cl2N4,43098.0
18983,NF 1819,O=C1[C@H](c2ccc(F)cc2)[C@@H](c2ccc3c(c2)OCO3)N1C1CCN(C(=O)n2cncn2)CC1,C24H22FN5O4,43142.0
18984,MEK Inhibitor,CNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1cccc(CN(C)C)c1)c1ccccc1,C26H26N4O2,43190.0
18985,4'-hydroxy Desnitazene,CCN(CC)CCn1c(Cc2ccc(O)cc2)nc2ccccc21,C20H25N3O,39321.0
18986,TH10785,c1ccc2c(NC3CCCCC3)nc(C3CC3)nc2c1,C17H21N3,43043.0
18987,PSMA11,O=C(O)CCc1ccc(O)c(CN(CCN(CC(=O)O)Cc2cc(CCC(=O)NCCCCCC(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)ccc2O)CC(=O)O)c1,C44H62N6O17,42984.0
18988,W1131,O=C(Nc1ccc(-c2cnc3cc(C4=CCNCC4)ccn23)cc1)c1ccc([N+](=O)[O-])o1,C23H19N5O4,42902.0
18989,GRP94 Inhibitor 1,CC(C)c1ccc(-c2ccc(N[C@H]3CC[C@H](O)CC3)c(C(N)=O)c2)cc1,C22H28N2O2,43140.0
18990,NTNCB (hydrochloride),Cl.O=[N+]([O-])c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1,C25H34ClN3O4S,43216.0
18991,GPX4 9i,C#Cc1nc(C(=O)N(c2ccc(-c3cnco3)cc2)C(C(=O)NC(C)(C)C)c2csc3ccccc23)cs1,C29H24N4O3S2,43114.0
18992,Nahlsgen,COP(=O)(CCC(N)C(=O)O)Oc1cccc(CC(=O)O)c1,C13H18NO7P,43172.0
18993,GW 542573X,COc1ccccc1NC(=O)OCC1CCN(C(=O)OC(C)(C)C)CC1,C19H28N2O5,43213.0
18994,Monomethyl Itaconate,C=C(CC(=O)OC)C(=O)O,C6H8O4,43263.0
18995,Hygromycin B,CN[C@H]1C[C@@H](N)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@@H]3OC4(O[C@H]23)O[C@H]([C@@H](N)CO)[C@H](O)[C@H](O)[C@H]4O)[C@@H]1O,C20H37N3O13,36462.0
18996,BX-513 (hydrochloride),Cl.N#CC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,C28H30Cl2N2O,42733.0
18997,MeOSuc-Ala-Ala-Pro-Ala-CMK,COC(=O)CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)CCl,C20H31ClN4O7,42456.0
18998,10(S)-hydroxy-12(Z)-Octadecenoic Acid,CCCCC/C=C\C[C@@H](O)CCCCCCCCC(=O)O,C18H34O3,43087.0
18999,Corynoxine B,CC[C@@H]1CN2CC[C@]3(C(=O)Nc4ccccc43)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,C22H28N2O4,27827.0
19000,Oxypaeoniflorin,C[C@@]12C[C@@]3(O)O[C@@H](O1)[C@]1(COC(=O)c4ccc(O)cc4)[C@H]3C[C@@]12O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C23H28O12,42363.0
19001,SMI-6860766,O=C(C=CNc1ccc(Br)cc1Cl)c1ccccc1,C15H11BrClNO,42960.0
19002,"514O6,10",CCCCCCCCC(CCCCCC)COC(=O)CCN(CCC(=O)OCC(CCCCCC)CCCCCCCC)CCN(CC)CCCN(CC)CCN(CCC(=O)OCC(CCCCCC)CCCCCCCC)CCC(=O)OCC(CCCCCC)CCCCCCCC,C87H172N4O8,42917.0
19003,GPR3 Agonist 2,FC(F)(F)Oc1ccc2c(c1)[I+]c1ccccc1-2.O=S(=O)([O-])C(F)(F)F,C14H7F6IO4S,42616.0
19004,HPH-15,CC(C)(C)SCCNC(=S)c1cccc(C(=S)NCCSC(C)(C)C)n1,C19H31N3S4,42819.0
19005,SC-10,CCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12,C17H22ClNO2S,42947.0
19006,Hexestrol-d6,[2H]C([2H])(C)C([2H])(c1ccc(O)cc1)C([2H])(c1ccc(O)cc1)C([2H])([2H])C,C18H22O2,43149.0
19007,N-acetyl-L-Leucine,CC(=O)N[C@@H](CC(C)C)C(=O)O,C8H15NO3,42889.0
19008,ML-418,CC(C)OC(=O)NC1CCN(Cc2cc(Cl)c3cccnc3c2O)CC1,C19H24ClN3O3,43042.0
19009,(S)-HDAC-42,CC(C)[C@H](C(=O)Nc1ccc(C(=O)NO)cc1)c1ccccc1,C18H20N2O3,13277.0
19010,(?)-Volinanserin,COc1cccc([C@@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC,C22H28FNO3,42955.0
19011,Sesquicannabigerolic Acid,CCCCCc1cc(O)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(O)c1C(=O)O,C27H40O4,37846.0
19012,Clorazepate (potassium hydrate),O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.O[K].[K+],C16H11ClK2N2O4,14264.0
19013,Idazoxan (hydrochloride),Cl.c1ccc2c(c1)OCC(C1=NCCN1)O2,C11H13ClN2O2,41310.0
19014,DT-061,O=S(=O)(N[C@@H]1CCC[C@H](N2c3ccccc3Oc3ccccc32)[C@H]1O)c1ccc(OC(F)(F)F)cc1,C25H23F3N2O5S,42118.0
19015,Ocaperidone,Cc1nc2c(C)cccn2c(=O)c1CCN1CCC(c2noc3cc(F)ccc23)CC1,C24H25FN4O2,42946.0
19016,SCH 221510,Cc1ccccc1C(c1ccccc1C)N1[C@@H]2CC[C@H]1C[C@](O)(c1ccccc1)C2,C28H31NO,43181.0
19017,Radulone A,CC1=C2CC[C@]2(C)[C@]23OC[C@@](C)(C=C2C1=O)[C@@H]3O,C15H18O3,40939.0
19018,Fertirelin,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,C55H76N16O12,42967.0
19019,KT474,Cn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(C#CCOC3CCN(C[C@H]4CC[C@H](n5cc(NC(=O)c6cnn7ccc(N8C[C@H]9C[C@@H]8CO9)nc67)c(C(F)F)n5)CC4)CC3)c21,C44H49F2N11O6,41053.0
19020,CX-08005,CCCCCCCCCCCCCCOc1ccccc1NC(=O)c1ccccc1C(=O)O,C28H39NO4,42730.0
19021,Fenadiazole,Oc1ccccc1-c1nnco1,C8H6N2O2,43305.0
19022,Eszopiclone,CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,C17H17ClN6O3,21530.0
19023,TMPO,CC1(C)C=[N+]([O-])C(C)(C)C1,C8H15NO,20625.0
19024,STF-1084,COc1cc2ncnc(N3CCC(CCP(=O)(O)O)CC3)c2cc1OC,C17H24N3O5P,30440.0
19025,Tobramycin (sulfate),NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O,C18H43N5O21S3,41453.0
19026,LLY-284,Nc1ncnc2c1ccn2[C@@H]1O[C@H]([C@@H](O)c2ccccc2)[C@@H](O)[C@H]1O,C17H18N4O4,43141.0
19027,Methisosildenafil,CCCc1nn(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4C[C@@H](C)N[C@@H](C)C4)ccc3OCC)[nH]c12,C23H32N6O4S,43101.0
19028,Pemafibrate,CC[C@@H](Oc1cccc(CN(CCCOc2ccc(OC)cc2)c2nc3ccccc3o2)c1)C(=O)O,C28H30N2O6,22004.0
19029,24-methylene Cholesterol,C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,C28H46O,41696.0
19030,Cyclotraxin B,CSCC[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC1=O,C48H73N13O17S3,42991.0
19031,A-1899,COc1ccc(CC(=O)NCc2ccccc2-c2ccccc2C(=O)NCc2ccc(F)cc2F)cc1,C30H26F2N2O3,43018.0
19032,TC JL 37,N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1,C17H11ClF2N4O2,43110.0
19033,Citreorosein,O=C1c2cc(O)cc(O)c2C(=O)c2c(O)cc(CO)cc21,C15H10O6,43199.0
19034,JD5037,CC(C)[C@H](/N=C(/NS(=O)(=O)c1ccc(Cl)cc1)N1C[C@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O,C27H27Cl2N5O3S,12053.0
19035,Caleprunin B,COc1cc2cc(C(C)=O)oc2cc1OC,C12H12O4,42954.0
19036,TG 100-115,Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1,C18H14N6O2,10010512.0
19037,"N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxymethylcytidine-cyanoethyl phosphoramidite",COc1ccc(C(OC[C@H]2O[C@@H](n3cc(C)c(NC(=O)c4ccccc4)nc3=O)C[C@@H]2OP(OCCC#N)N(C(C)C)C(C)C)(c2ccccc2)c2ccc(OC)cc2)cc1,C47H54N5O8P,43272.0
19038,MAO-A Inhibitor 1,Oc1ccc(/C=C/c2cc(O)cc(O)c2O)cc1,C14H12O4,43319.0
19039,Axitinib (AG 013736),CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=N[NH]3)\C=C\C4=CC=CC=N4,C22H18N4OS,S1005
19040,Roxadustat (FG-4592),CC1=NC(=C(O)C2=C1C=C(OC3=CC=CC=C3)C=C2)C(=O)NCC(O)=O,C19H16N2O5,S1007
19041,Selumetinib (AZD6244),C[N]1C=NC2=C(F)C(=C(C=C12)C(=O)NOCCO)NC3=CC=C(Br)C=C3Cl,C17H15BrClFN4O3,S1008
19042,Nintedanib (BIBF 1120),COC(=O)C1=CC=C\2C(=C1)NC(=O)C2=C(NC3=CC=C(C=C3)N(C)C(=O)CN4CCN(C)CC4)/C5=CC=CC=C5,C31H33N5O4,S1010
19043,Afatinib (BIBW2992),CN(C)C/C=C/C(=O)NC1=CC2=C(NC3=CC=C(F)C(=C3)Cl)N=CN=C2C=C1OC4CCOC4,C24H25ClFN5O3,S1011
19044,Bortezomib (PS-341),CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)B(O)O,C19H25BN4O4,S1013
19045,Bosutinib (SKI-606),COC1=C(Cl)C=C(Cl)C(=C1)NC2=C(C=NC3=CC(=C(OC)C=C23)OCCCN4CCN(C)CC4)C#N,C26H29Cl2N5O3,S1014
19046,Dasatinib (BMS-354825),CC1=NC(=CC(=N1)N2CCN(CCO)CC2)NC3=NC=C(S3)C(=O)NC4=C(Cl)C=CC=C4C,C22H26ClN7O2S,S1021
19047,"Ridaforolimus (Deforolimus, MK-8669)",COC1CC(CCC1O[P](C)(C)=O)CC(C)C2CC(=O)C(C)\C=C(C)\C(O)C(OC)C(=O)C(C)CC(C)/C=C/C=C/C=C(C)/C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N4CCCCC4C(=O)O2)OC,C53H84NO14P,S1022
19048,Gefitinib (ZD1839),COC1=C(OCCCN2CCOCC2)C=C3C(=NC=NC3=C1)NC4=CC=C(F)C(=C4)Cl,C22H24ClFN4O3,S1025
19049,Imatinib (STI571) Mesylate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CC=CN=C5.C[S](O)(=O)=O,C29H31N7O.CH4SO3,S1026
19050,Lapatinib (GW-572016) Ditosylate,CC1=CC=C(C=C1)[S](O)(=O)=O.CC2=CC=C(C=C2)[S](O)(=O)=O.C[S](=O)(=O)CCNCC3=CC=C(O3)C4=CC=C5N=CN=C(NC6=CC=C(OCC7=CC=CC(=C7)F)C(=C6)Cl)C5=C4,C29H26ClFN4O4S.2C7H8O3S,S1028
19051,Lenalidomide (CC-5013),NC1=C2CN(C3CCC(=O)NC3=O)C(=O)C2=CC=C1,C13H13N3O3,S1029
19052,Panobinostat (LBH589),CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C3=C([NH]1)C=CC=C3,C21H23N3O2,S1030
19053,Nilotinib (AMN-107),CC1=C[N](C=N1)C2=CC(=CC(=C2)C(F)(F)F)NC(=O)C3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,S1033
19054,Pazopanib HCl (GW786034 HCl),Cl.C[N]1N=C2C=C(C=CC2=C1C)N(C)C3=NC(=NC=C3)NC4=CC=C(C)C(=C4)[S](N)(=O)=O,C21H23N7O2S.HCl,S1035
19055,Rapamycin (AY-22989),COC1CC(CCC1O)CC(C)C2CC(=O)C(C)\C=C(/C)C(O)C(OC)C(=O)C(C)CC(C)/C=C/C=C/C=C(C)/C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N4CCCCC4C(=O)O2)OC,C51H79NO13,S1039
19056,Sorafenib (BAY 43-9006) tosylate,CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2.CC4=CC=C(C=C4)[S](O)(=O)=O,C21H16ClF3N4O3.C7H8O3S,S1040
19057,Sunitinib (SU11248) malate,CCN(CC)CCNC(=O)C1=C(C)[NH]C(=C1C)/C=C/2C(=O)NC3=CC=C(F)C=C23.OC(CC(O)=O)C(O)=O,C22H27FN4O2.C4H6O5,S1042
19058,Temsirolimus (CCI-779),COC1CC(CCC1OC(=O)C(C)(CO)CO)CC(C)C2CC(=O)C(C)\C=C(C)\C(O)C(OC)C(=O)C(C)CC(C)/C=C/C=C/C=C(C)/C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N4CCCCC4C(=O)O2)OC,C56H87NO16,S1044
19059,Vorinostat (SAHA),ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,C14H20N2O3,S1047
19060,Entinostat (MS-275),NC1=CC=CC=C1NC(=O)C2=CC=C(CNC(=O)OCC3=CN=CC=C3)C=C2,C21H20N4O3,S1053
19061,Enzastaurin (LY317615),C[N]1C=C(C2=CC=CC=C12)C3=C(C(=O)NC3=O)C4=C[N](C5CCN(CC5)CC6=NC=CC=C6)C7=CC=CC=C47,C32H29N5O2,S1055
19062,Olaparib (AZD2281),FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5,C24H23FN4O3,S1060
19063,Masitinib (AB1010),CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(=C(C)C=C3)NC4=NC(=CS4)C5=CC=CN=C5,C28H30N6OS,S1064
19064,Crizotinib (PF-02341066),CC(OC1=C(N)N=CC(=C1)C2=C[N](N=C2)C3CCNCC3)C4=C(Cl)C=CC(=C4Cl)F,C21H22Cl2FN5O,S1068
19065,(S)-crizotinib,CC(OC1=C(N)N=CC(=C1)C2=C[N](N=C2)C3CCNCC3)C4=C(Cl)C=CC(=C4Cl)F,C21H22Cl2FN5O,S7505
19066,Vismodegib (GDC-0449),C[S](=O)(=O)C1=CC=C(C(=C1)Cl)C(=O)NC2=CC(=C(Cl)C=C2)C3=NC=CC=C3,C19H14Cl2N2O3S,S1082
19067,Belinostat (PXD101),ONC(=O)/C=C/C1=CC(=CC=C1)[S](=O)(=O)NC2=CC=CC=C2,C15H14N2O4S,S1085
19068,Rucaparib (AG-014699) phosphate,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=CC(=CC(=C34)[NH]2)F.O[P](O)(O)=O,C19H18FN3O.H3PO4,S1098
19069,Cabozantinib (BMS-907351),COC1=CC2=C(C=C1OC)C(=CC=N2)OC3=CC=C(NC(=O)C4(CC4)C(=O)NC5=CC=C(F)C=C5)C=C3,C28H24FN3O5,S1119
19070,Everolimus (RAD001),COC1CC(CCC1OCCO)CC(C)C2CC(=O)C(C)\C=C(C)\C(O)C(OC)C(=O)C(C)CC(C)/C=C/C=C/C=C(C)/C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N4CCCCC4C(=O)O2)OC,C53H83NO14,S1120
19071,Ivacaftor (VX-770),CC(C)(C)C1=CC(=C(NC(=O)C2=CNC3=C(C=CC=C3)C2=O)C=C1O)C(C)(C)C,C24H28N2O3,S1144
19072,Docetaxel (RP56976),CC(=O)OC12COC1CC(O)C3(C)C2C(OC(=O)C4=CC=CC=C4)C5(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(=C(C(O)C3=O)C5(C)C)C,C43H53NO14,S1148
19073,Paclitaxel (NSC 125973),CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)C4=CC=CC=C4)C5(O)CC(OC(=O)C(O)C(NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(=C1C5(C)C)C,C47H51NO14,S1150
19074,Capecitabine (RO 09-1978),CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2OC(C)C(O)C2O,C15H22FN3O6,S1156
19075,Pretomanid (PA-824),[O-][N+](=O)C1=C[N]2CC(COC2=N1)OCC3=CC=C(OC(F)(F)F)C=C3,C14H12F3N3O5,S1162
19076,Lenvatinib (E7080),COC1=C(C=C2C(=CC=NC2=C1)OC3=CC(=C(NC(=O)NC4CC4)C=C3)Cl)C(N)=O,C21H19ClN4O4,S1164
19077,Valproic Acid (NSC 93819) sodium salt,CCCC(CCC)C(=O)O[Na],C8H15NaO2,S1168
19078,Regorafenib (BAY 73-4506),CNC(=O)C1=CC(=CC=N1)OC2=CC(=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)F,C21H15ClF4N4O3,S1178
19079,Danoprevir (ITMN-191),CC(C)(C)OC(=O)NC1CCCCC\C=C/C2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)N[S](=O)(=O)C6CC6,C35H46FN5O9S,S1183
19080,Ritonavir (ABT-538),CC(C)C(NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)NC(CC(O)C(CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4,C37H48N6O5S2,S1185
19081,Anastrozole (ZD-1033),CC(C)(C#N)C1=CC(=CC(=C1)C[N]2C=NC=N2)C(C)(C)C#N,C17H19N5,S1188
19082,Aprepitant (MK-0869),CC(OC1OCCN(CC2=NNC(=O)N2)C1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,C23H21F7N4O3,S1189
19083,Bicalutamide (ICI-176334),CC(O)(C[S](=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC=C(C#N)C(=C2)C(F)(F)F,C18H14F4N2O4S,S1190
19084,Fulvestrant (ICI-182780),CC12CCC3C(C(CCCCCCCCC[S](=O)CCCC(F)(F)C(F)(F)F)CC4=C3C=CC(=C4)O)C1CCC2O,C32H47F5O3S,S1191
19085,Raltitrexed,CN(CC1=CC2=C(C=C1)N=C(C)NC2=O)C3=CC=C(S3)C(=O)NC(CCC(O)=O)C(O)=O,C21H22N4O6S,S1192
19086,Thalidomide (K17),O=C1CCC(N2C(=O)C3=C(C=CC=C3)C2=O)C(=O)N1,C13H10N2O4,S1193
19087,Exemestane (FCE 24304),CC12CCC3C(CC(=C)C4=CC(=O)C=CC34C)C1CCC2=O,C20H24O2,S1196
19088,Finasteride,CC(C)(C)NC(=O)C1CCC2C3CCC4NC(=O)C=CC4(C)C3CCC12C,C23H36N2O2,S1197
19089,Cladribine (RWJ 26251),NC1=NC(=NC2=C1N=C[N]2C3CC(O)C(CO)O3)Cl,C10H12ClN5O3,S1199
19090,Decitabine (NSC 127716),NC1=NC(=O)N(C=N1)C2CC(O)C(CO)O2,C8H12N4O4,S1200
19091,Dutasteride,CC12CCC3C(CCC4NC(=O)C=CC34C)C1CCC2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F,C27H30F6N2O2,S1202
19092,Melatonin (NSC 113928),COC1=CC2=C([NH]C=C2CCNC(C)=O)C=C1,C13H16N2O2,S1204
19093,Bisoprolol fumarate,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1.OC(=O)\C=C\C(O)=O,C22H35NO8,S1206
19094,Tivozanib (AV-951),COC1=CC2=C(C=C1OC)C(=CC=N2)OC3=CC=C(NC(=O)NC4=NOC(=C4)C)C(=C3)Cl,C22H19ClN4O5,S1207
19095,Doxorubicin (Adriamycin) HCl,Cl.COC1=C2C(=O)C3=C(C(=C4CC(O)(CC(OC5CC(N)C(O)C(C)O5)C4=C3O)C(=O)CO)O)C(=O)C2=CC=C1,C27H29NO11.HCl,S1208
19096,Epirubicin (IMI 28) HCl,Cl.COC1=C2C(=O)C3=C(C(=C4CC(O)(CC(OC5CC(N)C(O)C(C)O5)C4=C3O)C(=O)CO)O)C(=O)C2=CC=C1,C27H29NO11.HCl,S1223
19097,"Fluorouracil (5-Fluorouracil, 5-FU)",FC1=CNC(=O)NC1=O,C4H3FN2O2,S1209
19098,Methotrexate (CL-14377),CN(CC1=NC2=C(N)N=C(N)N=C2N=C1)C3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O,C20H22N8O5,S1210
19099,Bendamustine (SDX105) HCl,Cl.C[N]1C(=NC2=CC(=CC=C12)N(CCCl)CCCl)CCCC(O)=O,C16H21Cl2N3O2.HCl,S1212
19100,Nelarabine,COC1=NC(=NC2=C1N=C[N]2C3OC(CO)C(O)C3O)N,C11H15N5O5,S1213
19101,Bleomycin (NSC125066) sulfate,CC(O)C(NC(=O)C(C)C(O)C(C)NC(=O)C(NC(=O)C1=C(C)C(=NC(=N1)C(CC(N)=O)NCC(N)C(N)=O)N)C(OC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(OC(N)=O)C3O)C4=C[NH]C=N4)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C.O[S]([O-])(=O)=O,C55H85N17O25S4,S1214
19102,Clofarabine,NC1=C2N=C[N](C3OC(CO)C(O)C3F)C2=NC(=N1)Cl,C10H11ClFN5O3,S1218
19103,Dacarbazine (NSC-45388),CN(C)N=NC1=C(N=C[NH]1)C(N)=O,C6H10N6O,S1221
19104,Dexrazoxane HCl (ICRF-187),Cl.CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,C11H16N4O4.HCl,S1222
19105,Etoposide (VP-16),COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(OC4OC5COC(C)OC5C(O)C4O)C6=C2C=C7OCOC7=C6,C29H32O13,S1225
19106,Raloxifene HCl,Cl.OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=C(S2)C=C(O)C=C5,C28H27NO4S.HCl,S1227
19107,Fludarabine Phosphate,NC1=NC(=NC2=C1N=C[N]2C3OC(CO[P](O)(O)=O)C(O)C3O)F,C10H13FN5O7P,S1229
19108,Topotecan (NSC609699) HCl,Cl.CCC1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC(=C(CN(C)C)C5=C4)O)C2=O,C23H23N3O5.HCl,S1231
19109,2-Methoxyestradiol (2-MeOE2),COC1=C(O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,C19H26O3,S1233
19110,Letrozole (CGS 20267),N#CC1=CC=C(C=C1)C([N]2C=NC=N2)C3=CC=C(C=C3)C#N,C17H11N5,S1235
19111,Temozolomide (CCRG 81045),CN1N=NC2=C(N=C[N]2C1=O)C(N)=O,C6H6N6O2,S1237
19112,Tamoxifen (ICI 46474),CC/C(C1=CC=CC=C1)=C(C2=CC=CC=C2)/C3=CC=C(OCCN(C)C)C=C3.OC(=O)CC(O)(CC(O)=O)C(O)=O,C26H29NO,S1238
19113,Tamoxifen (ICI 46474) Citrate,CC/C(C1=CC=CC=C1)=C(C2=CC=CC=C2)/C3=CC=C(OCCN(C)C)C=C3.OC(=O)CC(O)(CC(O)=O)C(O)=O,C26H29NO.C6H8O7,S1972
19114,Vincristine (NSC-67574) sulfate,CCC1(O)CC2CN(CCC3=C([NH]C4=C3C=CC=C4)C(C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)C7C(O)(C(OC(C)=O)C8(CC)C=CCN9CCC67C89)C(=O)OC)C1.O[S](O)(=O)=O,C46H58N4O14S,S1241
19115,Agomelatine (S20098),COC1=CC2=C(CCNC(C)=O)C=CC=C2C=C1,C15H17NO2,S1243
19116,Latrepirdine 2HCl,Cl.Cl.CN1CCC2=C(C1)C3=C(C=CC(=C3)C)[N]2CCC4=CC=C(C)N=C4,C21H25N3.2HCl,S1245
19117,Leflunomide (HWA486),CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,C12H9F3N2O2,S1247
19118,Enzalutamide (MDV3100),CNC(=O)C1=C(F)C=C(C=C1)N2C(=S)N(C(=O)C2(C)C)C3=CC=C(C#N)C(=C3)C(F)(F)F,C21H16F4N4O2S,S1250
19119,Dienogest,CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(O)CC#N,C20H25NO2,S1251
19120,Entecavir Hydrate,O.NC1=NC(=O)C2=C(N1)[N](C=N2)C3CC(O)C(CO)C3=C,C12H15N5O3.H2O,S1252
19121,Nepafenac,NC(=O)CC1=CC=CC(=C1N)C(=O)C2=CC=CC=C2,C15H14N2O2,S1255
19122,Rufinamide,NC(=O)C1=C[N](CC2=C(F)C=CC=C2F)N=N1,C10H8F2N4O,S1256
19123,Posaconazole (SCH 56592),CCC(C(C)O)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(C5)(C[N]6C=NC=N6)C7=CC=C(F)C=C7F)C=C4,C37H42F2N8O4,S1257
19124,Prasugrel,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C3CC3)C4=CC=CC=C4F)S1,C20H20FNO3S,S1258
19125,Ramelteon,CCC(=O)NCCC1CCC2=CC=C3OCCC3=C12,C16H21NO2,S1259
19126,Cinacalcet (AMG-073) HCl,Cl.CC(NCCCC1=CC(=CC=C1)C(F)(F)F)C2=CC=CC3=C2C=CC=C3,C22H22F3N.HCl,S1260
19127,Celecoxib (SC 58635),CC1=CC=C(C=C1)C2=CC(=N[N]2C3=CC=C(C=C3)[S](N)(=O)=O)C(F)(F)F,C17H14F3N3O2S,S1261
19128,Vemurafenib (PLX4032),CCC[S](=O)(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(C=C23)C4=CC=C(Cl)C=C4,C23H18ClF2N3O3S,S1267
19129,Acarbose,CC1OC(OC2C(O)C(O)C(OC2CO)OC3C(O)C(O)C(O)OC3CO)C(O)C(O)C1NC4C=C(CO)C(O)C(O)C4O,C25H43NO18,S1271
19130,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(O)=O)[C]45CC6[CH2][CH](C[CH]([CH2]6)C4)C5,C28H28O3,S1276
19131,Altretamine,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,S1278
19132,Amisulpride,CCN1CCCC1CNC(=O)C2=CC(=C(N)C=C2OC)[S](=O)(=O)CC,C17H27N3O4S,S1280
19133,Aniracetam,COC1=CC=C(C=C1)C(=O)N2CCCC2=O,C12H13NO3,S1281
19134,Artemisinin,CC1CCC2C(C)C(=O)OC3OC4(C)CCC1C23OO4,C15H22O5,S1282
19135,Asenapine maleate,CN1CC2C(C1)C3=C(OC4=C2C=CC=C4)C=CC(=C3)Cl.OC(=O)\C=C/C(O)=O,C17H16ClNO.C4H4O4,S1283
19136,Benazepril HCl,Cl.CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=C(C=CC=C3)N(CC(O)=O)C2=O,C24H28N2O5.HCl,S1284
19137,Budesonide,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(O1)C(=O)CO,C25H34O6,S1286
19138,Bumetanide,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)[S](N)(=O)=O,C17H20N2O5S,S1287
19139,Carmofur,CCCCCCNC(=O)N1C=C(F)C(=O)NC1=O,C11H16FN3O3,S1289
19140,Cetirizine DiHCl,Cl.Cl.OC(=O)COCCN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3,C21H25ClN2O3.2HCl,S1291
19141,Levocetirizine Dihydrochloride,Cl.Cl.OC(=O)COCCN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3,C21H25ClN2O3.2HCl,S4849
19142,Cilnidipine (FRC-8653),COCCOC(=O)C1=C(C)NC(=C(C1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC\C=C\C3=CC=CC=C3)C,C27H28N2O7,S1293
19143,Cilostazol (OPC-13013),O=C1CCC2=C(N1)C=CC(=C2)OCCCCC3=NN=N[N]3C4CCCCC4,C20H27N5O2,S1294
19144,Floxuridine (NSC 27640),OCC1OC(CC1O)N2C=C(F)C(=O)NC2=O,C9H11FN2O5,S1299
19145,Tegafur (FT-207),FC1=CN(C2CCCO2)C(=O)NC1=O,C8H9FN2O3,S1300
19146,Ifosfamide (NSC109724),ClCCN[P]1(=O)OCCCN1CCCl,C7H15Cl2N2O2P,S1302
19147,Megestrol Acetate,CC(=O)OC1(CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC12C)C(C)=O,C24H32O4,S1304
19148,Mercaptopurine (6-MP),S=C1N=CNC2=C1[NH]C=N2,C5H4N4S,S1305
19149,Costunolide,CC/1=C\CC\C(=C\C2OC(=O)C(=C)C2CC1)C,C15H20O2,S1319
19150,Dexamethasone (MK-125),CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,C22H29FO5,S1322
19151,Betamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,C22H29FO5,S1500
19152,Doxazosin Mesylate,COC1=C(OC)C=C2C(=NC(=NC2=C1)N3CCN(CC3)C(=O)C4COC5=C(O4)C=CC=C5)N.C[S](O)(=O)=O,C23H25N5O5.CH4O3S,S1324
19153,Edaravone,CC1=NN(C(=O)C1)C2=CC=CC=C2,C10H10N2O,S1326
19154,Etodolac,CCC1=CC=CC2=C1[NH]C3=C2CCOC3(CC)CC(O)=O,C17H21NO3,S1328
19155,Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,C11H14N2O4,S1330
19156,Fluconazole (UK 49858),OC(C[N]1C=NC=N1)(C[N]2C=NC=N2)C3=C(F)C=C(F)C=C3,C13H12F2N6O,S1331
19157,Flumazenil (RO 15-1788),CCOC(=O)C1=C2CN(C)C(=O)C3=CC(=CC=C3[N]2C=N1)F,C15H14FN3O3,S1332
19158,Fluoxetine (Lilly 110140) HCl,Cl.CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2,C17H18F3NO.HCl,S1333
19159,Flupirtine maleate,CCOC(=O)NC1=C(N)N=C(NCC2=CC=C(F)C=C2)C=C1.OC(=O)\C=C\C(O)=O,C15H17FN4O2.C4H4O4,S1334
19160,Fluvoxamine (DU-23000) maleate,COCCCCC(=N\OCCN)/C1=CC=C(C=C1)C(F)(F)F.OC(=O)\C=C/C(O)=O,C19H25F3N2O6,S1336
19161,Gatifloxacin,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(=C1N3CCNC(C)C3)F)C4CC4,C19H22FN3O4,S1340
19162,Genistein (NPI 031L),OC1=CC=C(C=C1)C2=COC3=C(C(=CC(=C3)O)O)C2=O,C15H10O5,S1342
19163,Glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)[S](=O)(=O)NC(=O)NC3CCC(C)CC3)C1=O,C24H34N4O5S,S1344
19164,Ivermectin (MK-933),CCC(C)C1OC2(CCC1C)CC3CC(C\C=C(C)\C(OC4CC(OC)C(OC5CC(OC)C(O)C(C)O5)C(C)O4)C(C)\C=C\C=C\6COC7C(O)C(=CC(C(=O)O3)C67O)C)O2,C48H74O14,S1351
19165,Lansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1C[S](=O)C2=NC3=CC=CC=C3[NH]2,C16H14F3N3O2S,S1354
19166,Levetiracetam (UCB-L059),CCC(N1CCCC1=O)C(N)=O,C8H14N2O2,S1356
19167,Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,C14H22N2O,S1357
19168,Loratadine (SCH29851),CCOC(=O)N1CCC(CC1)=C2C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3,C22H23ClN2O2,S1358
19169,Losartan Potassium (DuP 753),[KH].CCCCC1=NC(=C(CO)[N]1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=N[NH]4)Cl,C22H23ClKN6O,S1359
19170,Amonafide,CN(C)CCN1C(=O)C2=C3C(=CC=C2)C=C(N)C=C3C1=O,C16H17N3O2,S1367
19171,Acitretin,COC1=CC(=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(=C1C)C)C,C21H26O3,S1368
19172,Daptomycin (LY146032),CCCCCCCCCC(=O)NC(CC1=C[NH]C2=C1C=CC=C2)C(=O)NC(CC(N)=O)C(=O)NC(CC(O)=O)C(=O)NC3C(C)OC(=O)C(CC(=O)C4=CC=CC=C4N)NC(=O)C(NC(=O)C(CO)NC(=O)CNC(=O)C(CC(O)=O)NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(CCCN)NC(=O)CNC3=O)C(C)CC(O)=O,C72H101N17O26,S1373
19173,Doripenem Hydrate,O.CC(O)C1C2C(C)C(=C(N2C1=O)C(O)=O)SC3CNC(CN[S](N)(=O)=O)C3,C15H24N4O6S2.H2O,S1374
19174,Gestodene,CCC12CCC3C(CCC4=CC(=O)CCC34)C1C=CC2(O)C#C,C21H26O2,S1376
19175,Drospirenone,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C)C4C6CC6C57CCC(=O)O7,C24H30O3,S1377
19176,Ruxolitinib (INCB018424),N#CCC(C1CCCC1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4,C17H18N6,S1378
19177,S-Ruxolitinib (INCB018424),N#CCC(C1CCCC1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4,C17H18N6,S2902
19178,Isotretinoin,CC1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1,C20H28O2,S1379
19179,Lopinavir (ABT-378),CC(C)C(N1CCCNC1=O)C(=O)NC(CC(O)C(CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4,C37H48N4O5,S1380
19180,Meropenem,CC(O)C1C2C(C)C(=C(N2C1=O)C(O)=O)SC3CNC(C3)C(=O)N(C)C,C17H25N3O5S,S1381
19181,Mianserin HCl,Cl.CN1CCN2C(C1)C3=C(CC4=C2C=CC=C4)C=CC=C3,C18H20N2.HCl,S1382
19182,Mosapride Citrate,CCOC1=CC(=C(Cl)C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(F)C=C3)N.OC(=O)CC(O)(CC(O)=O)C(O)=O,C21H25ClFN3O3.C6H8O7,S1385
19183,Nafamostat mesilate (FUT-175),C[S](O)(=O)=O.C[S](O)(=O)=O.NC(=N)NC1=CC=C(C=C1)C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(N)=N,C19H17N5O2.2CH4O3S,S1386
19184,Naftopidil DiHCl,Cl.Cl.COC1=CC=CC=C1N2CCN(CC2)CC(O)COC3=C4C=CC=CC4=CC=C3,C24H28N2O3.2HCl,S1387
19185,Omeprazole,COC1=CC=C2[NH]C(=NC2=C1)[S](=O)CC3=C(C)C(=C(C)C=N3)OC,C17H19N3O3S,S1389
19186,Ondansetron HCl,Cl.C[N]1C2=C(C(=O)C(CC2)C[N]3C=CN=C3C)C4=CC=CC=C14,C18H19N3O.HCl,S1390
19187,Oxcarbazepine,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2,C15H12N2O2,S1391
19188,Pirarubicin (NSC-333054),COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(CC(O)(CC4OC5CC(N)C(OC6CCCCO6)C(C)O5)C(=O)CO)C(=C3C2=O)O,C32H37NO12,S1393
19189,Pizotifen Malate,CN1CCC(CC1)=C2C3=C(CCC4=C2C=CC=C4)SC=C3.OC(CC(O)=O)C(O)=O,C19H21NS.C4H6O5,S1394
19190,Resveratrol (SRT501),OC1=CC=C(C=C1)\C=C\C2=CC(=CC(=C2)O)O,C14H12O3,S1396
19191,Rocuronium Bromide,[Br-].CC(=O)OC1C(CC2C3CCC4CC(O)C(CC4(C)C3CCC12C)N5CCOCC5)[N+]6(CCCC6)CC=C,C32H53N2O4.Br,S1397
19192,Stavudine (d4T),CC1=CN(C2OC(CO)C=C2)C(=O)NC1=O,C10H12N2O4,S1398
19193,Tenofovir (GS 1278) Disoproxil Fumarate,CC(C)OC(=O)OCO[P](=O)(COC(C)C[N]1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C.OC(=O)/C=C/C(O)=O,C19H30N5O10P.C4H4O4,S1400
19194,Tenofovir,CC(C[N]1C=NC2=C(N)N=CN=C12)OC[P](O)(O)=O,C9H14N5O4P,S1401
19195,Tigecycline (GAR-936),CN(C)C1C2CC3CC4=C(C(=C(NC(=O)CNC(C)(C)C)C=C4N(C)C)O)C(=O)C3=C(O)C2(O)C(=O)C(=C1O)C(N)=O,C29H39N5O8,S1403
19196,Trilostane,CC12CCC3C(CCC45OC4C(=C(CC35C)C#N)O)C1CCC2O,C20H27NO3,S1404
19197,Vecuronium Bromide,[Br-].CC(=O)OC1CC2CCC3C(CCC4(C)C3CC(C4OC(C)=O)[N+]5(C)CCCCC5)C2(C)CC1N6CCCCC6,C34H57N2O4.Br,S1405
19198,Bimatoprost,CCNC(=O)CCC\C=C/CC1C(O)CC(O)C1/C=C/C(O)CCC2=CC=CC=C2,C25H37NO4,S1407
19199,Linezolid (PNU-100766),CC(=O)NCC1CN(C(=O)O1)C2=CC=C(N3CCOCC3)C(=C2)F,C16H20FN3O4,S1408
19200,Alfuzosin HCl,Cl.COC1=C(OC)C=C2C(=NC(=NC2=C1)N(C)CCCNC(=O)C3CCCO3)N,C19H27N5O4.HCl,S1409
19201,Clopidogrel (SR-25990C) Bisulfate,COC(=O)C(N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3.O[S](O)(=O)=O,C16H16ClNO2S.H2SO4,S1415
19202,Ranolazine 2HCl,Cl.Cl.COC1=CC=CC=C1OCC(O)CN2CCN(CC2)CC(=O)NC3=C(C)C=CC=C3C,C24H33N3O4.2HCl,S1425
19203,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(O)=O,C27H36N2O4,S1426
19204,Rolipram (ZK-62711),COC1=C(OC2CCCC2)C=C(C=C1)C3CNC(=O)C3,C16H21NO3,S1430
19205,S-(+)-Rolipram,COC1=C(OC2CCCC2)C=C(C=C1)C3CNC(=O)C3,C16H21NO3,S2127
19206,Sildenafil Citrate,CCCC1=N[N](C)C2=C1N=C(NC2=O)C3=CC(=CC=C3OCC)[S](=O)(=O)N4CCN(C)CC4.OC(=O)CC(O)(CC(O)=O)C(O)=O,C22H30N6O4S.C6H8O7,S1431
19207,Sumatriptan Succinate,CN[S](=O)(=O)CC1=CC=C2[NH]C=C(CCN(C)C)C2=C1.OC(=O)CCC(O)=O,C14H21N3O2S.C4H6O4,S1432
19208,Tamsulosin hydrochloride,CCOC1=C(OCCNC(C)CC2=CC=C(OC)C(=C2)[S](N)(=O)=O)C=CC=C1,C20H28N2O5S.HCl,S1435
19209,Tizanidine HCl,Cl.ClC1=C(NC2=NCCN2)C3=NSN=C3C=C1,C9H8ClN5S.HCl,S1437
19210,Topiramate,CC1(C)OC2COC3(CO[S](N)(=O)=O)OC(C)(C)OC3C2O1,C12H21NO8S,S1438
19211,Tranilast (SB 252218),COC1=C(OC)C=C(\C=C\C(=O)NC2=CC=CC=C2C(O)=O)C=C1,C18H17NO5,S1439
19212,Venlafaxine HCl,Cl.COC1=CC=C(C=C1)C(CN(C)C)C2(O)CCCCC2,C17H27NO2.HCl,S1441
19213,Voriconazole (UK-109496),CC(C1=NC=NC=C1F)C(O)(C[N]2C=NC=N2)C3=CC=C(F)C=C3F,C16H14F3N5O,S1442
19214,Zileuton (A-64077),CC(N(O)C(N)=O)C1=CC2=CC=CC=C2S1,C11H12N2O2S,S1443
19215,Ziprasidone HCl,Cl.ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=C4C=CC=C5,C21H21ClN4OS.HCl,S1444
19216,Zonisamide,N[S](=O)(=O)CC1=NOC2=CC=CC=C12,C8H8N2O3S,S1445
19217,Tipifarnib (R115777),C[N]1C=NC=C1C(N)(C2=CC=C(Cl)C=C2)C3=CC4=C(C=C3)N(C)C(=O)C=C4C5=CC(=CC=C5)Cl,C27H22Cl2N4O,S1453
19218,Atazanavir (BMS-232632) Sulfate,COC(=O)NC(C(=O)NC(CC1=CC=CC=C1)C(O)CN(CC2=CC=C(C=C2)C3=NC=CC=C3)NC(=O)C(NC(=O)OC)C(C)(C)C)C(C)(C)C.O[S](O)(=O)=O,C38H52N6O7.H2SO4,S1457
19219,Neflamapimod (VX-745),FC1=CC(=C(SC2=NN3C=NC(=O)C(=C3C=C2)C4=C(Cl)C=CC=C4Cl)C=C1)F,C19H9Cl2F2N3OS,S1458
19220,Moxifloxacin (BAY12-8039) HCl,Cl.COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(=C1N3CC4CCCNC4C3)F)C5CC5,C21H24FN3O4.HCl,S1465
19221,Doxercalciferol,CC(C)C(C)/C=C/C(C)C1CCC2C(/CCCC12C)=C/C=C/3CC(O)CC(O)C3=C,C28H44O2,S1467
19222,Alfacalcidol,CC(C)CCCC(C)C1CCC2/C(CCCC12C)=C\C=C3/CC(O)CC(O)C3=C,C27H44O2,S1468
19223,Safinamide Mesylate,CC(NCC1=CC=C(OCC2=CC(=CC=C2)F)C=C1)C(N)=O.C[S](O)(=O)=O,C17H19FN2O2.CH4O3S,S1472
19224,Daclatasvir (BMS-790052),COC(=O)NC(C(C)C)C(=O)N1CCCC1C2=NC=C([NH]2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C([NH]5)C6CCCN6C(=O)C(NC(=O)OC)C(C)C,C40H50N8O6,S1482
19225,Iloperidone,COC1=C(OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)C=CC(=C1)C(C)=O,C24H27FN2O4,S1483
19226,HMN-214,COC1=CC=C(C=C1)[S](=O)(=O)N(C(C)=O)C2=C(C=CC=C2)\C=C\C3=CC=[N+]([O-])C=C3,C22H20N2O5S,S1485
19227,Naratriptan HCl,Cl.CN[S](=O)(=O)CCC1=CC=C2[NH]C=C(C3CCN(C)CC3)C2=C1,C17H25N3O2S.HCl,S1488
19228,Ponatinib (AP24534),CN1CCN(CC1)CC2=C(C=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CN=C5C=CC=N[N]45)C=C2)C(F)(F)F,C29H27F3N6O,S1490
19229,Fludarabine (NSC 118218),NC1=NC(=NC2=C1N=C[N]2C3OC(CO)C(O)C3O)F,C10H12FN5O4,S1491
19230,Pralatrexate (NSC 754230),NC1=NC(=C2N=C(CC(CC#C)C3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O)C=NC2=N1)N,C23H23N7O5,S1497
19231,Cefaclor,O.NC(C(=O)NC1C2SCC(=C(N2C1=O)C(O)=O)Cl)C3=CC=CC=C3,C15H14ClN3O4S.H2O,S1499
19232,Mycophenolate mofetil (RS-61443),COC1=C(C)C2=C(C(=O)OC2)C(=C1C\C=C(C)\CCC(=O)OCCN3CCOCC3)O,C23H31NO7,S1501
19233,Dyphylline,CN1C(=O)N(C)C2=C([N](CC(O)CO)C=N2)C1=O,C10H14N4O4,S1504
19234,Aztreonam,CC1C(NC(=O)\C(=N/OC(C)(C)C(O)=O)C2=CSC(=N2)N)C(=O)N1[S](O)(=O)=O,C13H17N5O8S2,S1505
19235,Alprostadil,CCCCCC(O)/C=C/C1C(O)CC(=O)C1CCCCCCC(O)=O,C20H34O5,S1508
19236,Lactulose,OCC(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)C(=O)CO,C12H22O11,S1511
19237,Tadalafil (IC351),CN1CC(=O)N2C(CC3=C([NH]C4=C3C=CC=C4)C2C5=CC=C6OCOC6=C5)C1=O,C22H19N3O4,S1512
19238,Cyclosporine,CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,C62H111N11O12,S1514
19239,Cyclosporin A (NSC 290193),CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,C62H111N11O12,S2286
19240,Natamycin,CC1C/C=C/C=C/C=C/C=C/C(CC2OC(O)(CC(O)CC3OC3/C=C/C(=O)O1)CC(O)C2C(O)=O)OC4OC(C)C(O)C(N)C4O,C33H47NO13,S1517
19241,Quizartinib (AC220),CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=C[N]4C(=N3)SC5=CC(=CC=C45)OCCN6CCOCC6,C29H32N6O4S,S1526
19242,Telaprevir (VX-950),CCCC(NC(=O)C1C2CCCC2CN1C(=O)C(NC(=O)C(NC(=O)C3=NC=CN=C3)C4CCCCC4)C(C)(C)C)C(=O)C(=O)NC5CC5,C36H53N7O6,S1538
19243,Saxagliptin (BMS-477118),NC(C(=O)N1C(CC2CC12)C#N)[C]34CC5[CH2]C(C[C](O)(C5)C3)C4,C18H25N3O2,S1540
19244,Febuxostat,CC(C)COC1=C(C=C(C=C1)C2=NC(=C(S2)C(O)=O)C)C#N,C16H16N2O3S,S1547
19245,Dapagliflozin (BMS-512148),CCOC1=CC=C(CC2=CC(=CC=C2Cl)C3OC(CO)C(O)C(O)C3O)C=C1,C21H25ClO6,S1548
19246,Nebivolol hydrochloride (R-65824),Cl.OC(CNCC(O)C1CCC2=C(O1)C=CC(=C2)F)C3CCC4=CC(=CC=C4O3)F,C22H25F2NO4.HCl,S1549
19247,Pimobendan,COC1=CC=C(C=C1)C2=NC3=CC(=CC=C3[NH]2)C4=NNC(=O)CC4C,C19H18N4O2,S1550
19248,Delafloxacin (ABT-492),NC1=C(F)C=C(F)C(=N1)N2C=C(C(O)=O)C(=O)C3=CC(=C(N4CC(O)C4)C(=C23)Cl)F,C18H12ClF3N4O4,S1553
19249,Lumacaftor (VX-809),CC1=C(N=C(NC(=O)C2(CC2)C3=CC4=C(OC(F)(F)O4)C=C3)C=C1)C5=CC=CC(=C5)C(O)=O,C24H18F2N2O5,S1565
19250,Pomalidomide (CC-4047),NC1=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=CC=C1,C13H11N3O4,S1567
19251,Tazarotene,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(SCCC3(C)C)C=C2,C21H21NO2S,S1569
19252,Fasudil (HA-1077) HCl,Cl.O=[S](=O)(N1CCCNCC1)C2=C3C=CN=CC3=CC=C2,C14H17N3O2S.HCl,S1573
19253,Sulfasalazine (NSC 667219),OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)[S](=O)(=O)NC3=CC=CC=N3,C18H14N4O5S,S1576
19254,Candesartan (CV-11974),CCOC1=NC2=C([N]1CC3=CC=C(C=C3)C4=CC=CC=C4C5=N[NH]N=N5)C(=CC=C2)C(O)=O,C24H20N6O3,S1578
19255,Bestatin (NK421),CC(C)CC(NC(=O)C(O)C(N)CC1=CC=CC=C1)C(O)=O,C16H24N2O4,S1591
19256,Apixaban (BMS 562247-01),COC1=CC=C(C=C1)[N]2N=C(C(N)=O)C3=C2C(=O)N(CC3)C4=CC=C(C=C4)N5CCCCC5=O,C25H25N5O4,S1593
19257,Reserpine,COC1C(CC2CN3CCC4=C([NH]C5=C4C=CC(=C5)OC)C3CC2C1C(=O)OC)OC(=O)C6=CC(=C(OC)C(=C6)OC)OC,C33H40N2O9,S1601
19258,Furosemide (NSC 269420),N[S](=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,C12H11ClN2O5S,S1603
19259,Olmesartan Medoxomil,CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)C(=O)OCC5=C(C)OC(=O)O5)C(C)(C)O,C29H30N6O6,S1604
19260,Cefdinir,NC1=NC(=CS1)C(=N/O)/C(=O)NC2C3SCC(=C(N3C2=O)C(O)=O)C=C,C14H13N5O5S2,S1605
19261,Clotrimazole,ClC1=C(C=CC=C1)C([N]2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4,C22H17ClN2,S1606
19262,Rizatriptan Benzoate,CN(C)CCC1=C[NH]C2=C1C=C(C[N]3C=NC=N3)C=C2.OC(=O)C4=CC=CC=C4,C22H25N5O2,S1607
19263,Pyridostigmine Bromide,[Br-].CN(C)C(=O)OC1=C[N+](=CC=C1)C,C9H13BrN2O2,S1608
19264,Methimazole,CN1C=CNC1=S,C4H6N2S,S1609
19265,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)[S](N)(=O)=O)Cl,C16H16ClN3O3S,S1610
19266,Cefoperazone,CCN1CCN(C(=O)NC(C(=O)NC2C3SCC(=C(N3C2=O)C(O)=O)CSC4=NN=N[N]4C)C5=CC=C(O)C=C5)C(=O)C1=O,C25H27N9O8S2,S1611
19267,Silodosin,CC(CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC3=CC=CC=C3OCC(F)(F)F,C25H32F3N3O4,S1613
19268,Riluzole (PK 26124),NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2,C8H5F3N2OS,S1614
19269,Sulfameter,COC1=CN=C(N[S](=O)(=O)C2=CC=C(N)C=C2)N=C1,C11H12N4O3S,S1618
19270,Prilocaine,CCCNC(C)C(=O)NC1=C(C)C=CC=C1,C13H20N2O,S1619
19271,Darunavir Ethanolate,CCO.CC(C)CN(CC(O)C(CC1=CC=CC=C1)NC(=O)OC2COC3OCCC23)[S](=O)(=O)C4=CC=C(N)C=C4,C27H37N3O7S.C2H5OH,S1620
19272,Prednisone (NSC-10023),CC12CC(=O)C3C(CCC4=CC(=O)C=CC34C)C1CCC2(O)C(=O)CO,C21H26O5,S1622
19273,Ethinyl Estradiol,CC12CCC3C(CCC4=CC(=CC=C34)O)C1CCC2(O)C#C,C20H24O2,S1625
19274,Naproxen Sodium,[Na+].COC1=CC=C2C=C(C=CC2=C1)C(C)C([O-])=O,C14H13NaO3,S1626
19275,Nitazoxanide (NSC 697855),CC(=O)OC1=C(C=CC=C1)C(=O)NC2=NC=C(S2)[N+]([O-])=O,C12H9N3O5S,S1627
19276,Triamcinolone Acetonide,CC1(C)OC2CC3C4CCC5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(O1)C(=O)CO,C24H31FO6,S1628
19277,Orlistat (Ro 18-0647),CCCCCCCCCCCC(CC1OC(=O)C1CCCCCC)OC(=O)C(CC(C)C)NC=O,C29H53NO5,S1629
19278,Allopurinol,O=C1N=CN=C2NNC=C12,C5H4N4O,S1630
19279,Allopurinol Sodium,[Na+].O=C1NC=NC2=C1C=N[NH]2,C5H4N4NaO,S1631
19280,Zafirlukast (ICI-204219),COC1=CC(=CC=C1CC2=C[N](C)C3=C2C=C(NC(=O)OC4CCCC4)C=C3)C(=O)N[S](=O)(=O)C5=CC=CC=C5C,C31H33N3O6S,S1633
19281,Erythromycin,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O,C37H67NO13,S1635
19282,Amphotericin B,CC1OC(OC/2CC3OC(O)(CC(O)CC(O)C(O)CCC(O)CC(O)CC(=O)OC(C)C(C)C(O)C(C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C2)CC(O)C3C(O)=O)C(O)C(N)C1O,C47H73NO17,S1636
19283,Ibuprofen (NSC 256857),CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,C13H18O2,S1638
19284,(R)-(-)-Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,C13H18O2,S5899
19285,Amprenavir (VX-478),CC(C)CN(CC(O)C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)[S](=O)(=O)C3=CC=C(N)C=C3,C25H35N3O6S,S1639
19286,Albendazole (SKF-62979),CCCSC1=CC=C2N=C(NC(=O)OC)[NH]C2=C1,C12H15N3O2S,S1640
19287,Chlorothiazide,N[S](=O)(=O)C1=C(Cl)C=C2N=CN[S](=O)(=O)C2=C1,C7H6ClN3O4S2,S1641
19288,Ursodiol,CC(CCC(O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C,C24H40O4,S1643
19289,Chenodeoxycholic Acid,CC(CCC(O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C,C24H40O4,S1843
19290,Nitrofural,NC(=O)N/N=C/C1=CC=C(O1)[N+]([O-])=O,C6H6N4O4,S1644
19291,Ketoprofen,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2,C16H14O3,S1645
19292,S-(+)-Ketoprofen,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2,C16H14O3,S5192
19293,Ketorolac,OC(=O)C1CC[N]2C1=CC=C2C(=O)C3=CC=CC=C3,C15H13N1O3,S1646
19294,Adenosine,NC1=NC=NC2=C1N=C[N]2C3OC(CO)C(O)C3O,C10H13N5O4,S1647
19295,Zolmitriptan,CN(C)CCC1=C[NH]C2=C1C=C(CC3COC(=O)N3)C=C2,C16H21N3O2,S1649
19296,Telbivudine,CC1=CN(C2CC(O)C(CO)O2)C(=O)NC1=O,C10H14N2O5,S1651
19297,Thymidine (NSC 21548),CC1=CN(C2CC(O)C(CO)O2)C(=O)NC1=O,C10H14N2O5,S4803
19298,Monobenzone,OC1=CC=C(OCC2=CC=CC=C2)C=C1,C13H12O2,S1652
19299,Tretinoin (NSC 122758),CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1,C20H28O2,S1653
19300,Phenylbutazone,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,C19H20N2O2,S1654
19301,Ezetimibe (SCH-58235),OC(CCC1C(N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4,C24H21F2NO3,S1655
19302,Enalaprilat Dihydrate,O.O.CC(NC(CCC1=CC=CC=C1)C(O)=O)C(=O)N2CCCC2C(O)=O,C18H24N2O5.2H2O,S1657
19303,Dofetilide,CN(CCOC1=CC=C(N[S](C)(=O)=O)C=C1)CCC2=CC=C(N[S](C)(=O)=O)C=C2,C19H27N3O5S2,S1658
19304,Isradipine,COC(=O)C1=C(C)NC(=C(C1C2=CC=CC3=NON=C23)C(=O)OC(C)C)C,C19H21N3O5,S1662
19305,Estrone,CC12CCC3C(CCC4=CC(=CC=C34)O)C1CCC2=O,C18H22O2,S1665
19306,Flucytosine,NC1=NC(=O)NC=C1F,C4H4FN3O,S1666
19307,Trichlormethiazide,N[S](=O)(=O)C1=C(Cl)C=C2NC(N[S](=O)(=O)C2=C1)C(Cl)Cl,C8H8Cl3N3O4S2,S1667
19308,Loteprednol etabonate,CCOC(=O)OC1(CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C)C(=O)OCCl,C24H31ClO7,S1669
19309,Aminophylline,CN1C(=O)N(C)C2=C([NH]C=N2)C1=O.CN3C(=O)N(C)C4=C([NH]C=N4)C3=O.NCCN,C16H24N10O4,S1673
19310,Lubiprostone,CCCCC(F)(F)C(=O)CCC1C(O)CC(=O)C1CCCCCCC(O)=O,C20H32F2O5,S1675
19311,Amorolfine HCl,Cl.CCC(C)(C)C1=CC=C(CC(C)CN2CC(C)OC(C)C2)C=C1,C21H35NO.HCl,S1676
19312,Chloramphenicol,OCC(NC(=O)C(Cl)Cl)C(O)C1=CC=C(C=C1)[N+]([O-])=O,C11H12Cl2N2O5,S1677
19313,Flurbiprofen,CC(C(O)=O)C1=CC(=C(C=C1)C2=CC=CC=C2)F,C15H13FO2,S1679
19314,Mesalamine (5-ASA),NC1=CC=C(O)C(=C1)C(O)=O,C7H7NO3,S1681
19315,Ipratropium Bromide,[Br-].CC(C)[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,C20H30BrNO3,S1683
19316,Sulfanilamide,NC1=CC=C(C=C1)[S](N)(=O)=O,C6H8N2O2S,S1685
19317,Betamethasone Dipropionate,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,C28H37FO7,S1688
19318,Meprednisone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO,C22H28O5,S1689
19319,Betamethasone Valerate,CCCCC(=O)OC1(C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC12C)C(=O)CO,C27H37FO6,S1690
19320,Praziquantel,O=C1CN(CC2N1CCC3=CC=CC=C23)C(=O)C4CCCCC4,C19H24N2O2,S1691
19321,Busulfan (NSC-750),C[S](=O)(=O)OCCCCO[S](C)(=O)=O,C6H14O6S2,S1692
19322,Carbamazepine,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3,C15H12N2O,S1693
19323,Hydrocortisone (NSC 10483),CC12CCC(=O)C=C1CCC3C4CCC(O)(C(=O)CO)C4(C)CC(O)C23,C21H30O5,S1696
19324,Desonide,CC1(C)OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(O1)C(=O)CO,C24H32O6,S1701
19325,Didanosine,OCC1CCC(O1)[N]2C=NC3=C2N=CNC3=O,C10H12N4O3,S1702
19326,Divalproex Sodium,[Na+].CCCC(CCC)C(O)=O.CCCC(CCC)C([O-])=O,C8H16O2.C8H15O2.Na,S1703
19327,Emtricitabine (BW 1592),NC1=NC(=O)N(C=C1F)C2CSC(CO)O2,C8H10FN3O3S,S1704
19328,Progesterone (NSC 9704),CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C21H30O2,S1705
19329,Lamivudine (BCH-189),NC1=NC(=O)N(C=C1)C2CSC(CO)O2,C8H11N3O3S,S1706
19330,Estradiol,CC12CCC3C(CCC4=C3C=CC(=C4)O)C1CCC2O,C18H24O2,S1709
19331,Alpha-Estradiol,CC12CCC3C(CCC4=C3C=CC(=C4)O)C1CCC2O,C18H24O2,S5910
19332,Deferasirox (ICL-670),OC(=O)C1=CC=C(C=C1)[N]2N=C(N=C2C3=CC=CC=C3O)C4=CC=CC=C4O,C21H15N3O4,S1712
19333,Piroxicam,CN1C(=C(O)C2=C(C=CC=C2)[S]1(=O)=O)C(=O)NC3=NC=CC=C3,C15H13N3O4S,S1713
19334,Gemcitabine (LY-188011),NC1=NC(=O)N(C=C1)C2OC(CO)C(O)C2(F)F,C9H11F2N3O4,S1714
19335,Glipizide,CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)[S](=O)(=O)NC(=O)NC3CCCCC3,C21H27N5O4S,S1715
19336,Glyburide (Glibenclamide),COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)[S](=O)(=O)NC(=O)NC3CCCCC3,C23H28ClN3O5S,S1716
19337,Fomepizole,CC1=C[NH]N=C1,C4H6N2,S1717
19338,Adefovir Dipivoxil (GS 0840),CC(C)(C)C(=O)OCO[P](=O)(COCC[N]1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C,C20H32N5O8P,S1718
19339,Zalcitabine,NC1=NC(=O)N(C=C1)C2CCC(CO)O2,C9H13N3O3,S1719
19340,Azathioprine,C[N]1C=NC(=C1SC2=C3[NH]C=NC3=NC=N2)[N+]([O-])=O,C9H7N7O2S,S1721
19341,Indomethacin (NSC-77541),COC1=CC=C2[N](C(=C(CC(O)=O)C2=C1)C)C(=O)C3=CC=C(Cl)C=C3,C19H16ClNO4,S1723
19342,Terbinafine,CN(C\C=C\C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,C21H25N,S1725
19343,Levonorgestrel,CCC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C,C21H28O2,S1727
19344,Norgestrel,CCC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C,C21H28O2,S5709
19345,Gemfibrozil,CC1=CC(=C(C)C=C1)OCCCC(C)(C)C(O)=O,C15H22O3,S1729
19346,Indapamide,CC1CC2=C(C=CC=C2)N1NC(=O)C3=CC=C(Cl)C(=C3)[S](N)(=O)=O,C16H16ClN3O3S,S1730
19347,Mitotane,ClC(Cl)C(C1=CC=C(Cl)C=C1)C2=C(Cl)C=CC=C2,C14H10Cl4,S1732
19348,Methylprednisolone (NSC-19987),CC1CC2C3CCC(O)(C(=O)CO)C3(C)CC(O)C2C4(C)C=CC(=O)C=C14,C22H30O5,S1733
19349,Meloxicam,CN1C(=C(O)C2=C(C=CC=C2)[S]1(=O)=O)C(=O)NC3=NC=C(C)S3,C14H13N3O4S2,S1734
19350,Mesna,[Na+].[O-][S](=O)(=O)CCS,C2H5NaO3S2,S1735
19351,Methocarbamol,COC1=C(OCC(O)COC(N)=O)C=CC=C1,C11H15NO5,S1736
19352,Prednisolone (NSC-9900),CC12CC(O)C3C(CCC4=CC(=O)C=CC34C)C1CCC2(O)C(=O)CO,C21H28O5,S1737
19353,Telmisartan,CCCC1=NC2=C(C=C(C=C2C)C3=NC4=C(C=CC=C4)[N]3C)[N]1CC5=CC=C(C=C5)C6=CC=CC=C6C(O)=O,C33H30N4O2,S1738
19354,Thiabendazole,[NH]1C2=C(C=CC=C2)N=C1C3=CSC=N3,C10H7N3S,S1739
19355,Guaifenesin,COC1=C(OCC(O)CO)C=CC=C1,C10H14O4,S1740
19356,Rifabutin (LM427),COC1\C=C\OC2(C)OC3=C(C2=O)C4=C(C(=C3C)O)C(=O)C(=C5NC6(CCN(CC6)CC(C)C)N=C45)NC(=O)/C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C,C46H62N4O11,S1741
19357,Nevirapine (NSC 641530),CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2C4CC4,C15H14N4O,S1742
19358,Esomeprazole magnesium,[Mg++].COC1=CC2=C([N-]C(=N2)[S](=O)CC3=C(C)C(=C(C)C=N3)OC)C=C1.COC4=CC5=C([N-]C(=N5)[S](=O)CC6=NC=C(C)C(=C6C)OC)C=C4,C34H36MgN6O6S2,S1743
19359,Nicotinic Acid,OC(=O)C1=CC=CN=C1,C6H5NO2,S1744
19360,Nimodipine,COCCOC(=O)C1=C(C)NC(=C(C1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)C)C,C21H26N2O7,S1747
19361,Nisoldipine,COC(=O)C1=C(C)NC(=C(C1C2=CC=CC=C2[N+]([O-])=O)C(=O)OCC(C)C)C,C20H24N2O6,S1748
19362,Octocrylene,CCCCC(CC)COC(=O)C(C#N)=C(C1=CC=CC=C1)C2=CC=CC=C2,C24H27NO2,S1750
19363,Oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C2=CC=CC=C2,C22H31NO3,S1754
19364,Enoxacin,CCN1C=C(C(O)=O)C(=O)C2=CC(=C(N=C12)N3CCNCC3)F,C15H17FN4O3,S1756
19365,Pitavastatin (NK-104) calcium,[Ca++].OC(CC(O)C=CC1=C(C2=CC=C(F)C=C2)C3=CC=CC=C3N=C1C4CC4)CC([O-])=O.OC(CC(O)C=CC5=C(C6=CC=C(F)C=C6)C7=CC=CC=C7N=C5C8CC8)CC([O-])=O,C50H46CaF2N2O8,S1759
19366,Rifapentine,COC1\C=C\OC2(C)OC3=C(C2=O)C4=C(O)C(=C(NC(=O)\C(=C\C=C\C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C)C(=C4C(=C3C)O)O)\C=N\N5CCN(CC5)C6CCCC6,C47H64N4O12,S1760
19367,Suprofen,CC(C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2,C14H12O3S,S1761
19368,Pyrazinamide,NC(=O)C1=NC=CN=C1,C5H5N3O,S1762
19369,Quetiapine (ICI-204636) fumarate,OCCOCCN1CCN(CC1)C2=NC3=CC=CC=C3SC4=C2C=CC=C4.OCCOCCN5CCN(CC5)C6=NC7=CC=CC=C7SC8=C6C=CC=C8.OC(=O)\C=C\C(O)=O,C46H54N6O8S2,S1763
19370,Rifampin (NSC-113926),COC1\C=C\OC2(C)OC3=C(C2=O)C4=C(O)C(=C(NC(=O)\C(=C\C=C\C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C)C(=C4C(=C3C)O)O)\C=N\N5CCN(C)CC5,C43H58N4O12,S1764
19371,Cefditoren Pivoxil,CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)\C=C/C3=C(C)N=CS3)C4=CSC(=N4)N,C25H28N6O7S3,S1768
19372,Sulfadiazine,NC1=CC=C(C=C1)[S](=O)(=O)NC2=NC=CC=N2,C10H10N4O2S,S1770
19373,Chlorprothixene,CN(C)CC/C=C1/C2=CC=CC=C2SC3=C1C=C(Cl)C=C3,C18H18ClNS,S1771
19374,Oxytetracycline (Terramycin),CN(C)C1C2C(O)C3C(=C(O)C4=C(C=CC=C4O)C3(C)O)C(=O)C2(O)C(=O)C(=C1O)C(N)=O,C22H24N2O9,S1773
19375,Thioguanine (NSC 752),NC1=NC(=S)C2=C(N1)N=C[NH]2,C5H5N5S,S1774
19376,Thiotepa,S=[P](N1CC1)(N2CC2)N3CC3,C6H12N3PS,S1775
19377,Toremifene Citrate (NK 622),CN(C)CCOC1=CC=C(C=C1)\C(=C(CCCl)/C2=CC=CC=C2)C3=CC=CC=C3.OC(=O)CC(O)(CC(O)=O)C(O)=O,C32H36ClNO8,S1776
19378,Ethionamide,CCC1=NC=CC(=C1)C(N)=S,C8H10N2S,S1777
19379,Trifluridine (NSC 75520),OCC1OC(CC1O)N2C=C(C(=O)NC2=O)C(F)(F)F,C10H11F3N2O5,S1778
19380,Azacitidine (5-Azacytidine),NC1=NC(=O)N(C=N1)C2OC(CO)C(O)C2O,C8H12N4O5,S1782
19381,Vidarabine,NC1=C2N=C[N](C3OC(CO)C(O)C3O)C2=NC=N1,C10H13N5O4,S1784
19382,Verteporfin (CL 318952),COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(=C([NH]4)C=C5N=C(C=C1[NH]2)C(=C5C)CCC(O)=O)C=C)C6=CC=C(C(C(=O)OC)C36C)C(=O)OC,C41H42N4O8,S1786
19383,Teniposide,COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(OC4OC5COC(OC5C(O)C4O)C6=CC=CS6)C7=CC8=C(OCO8)C=C27,C32H32O13S,S1787
19384,Tetrabenazine (Xenazine),COC1=CC2=C(C=C1OC)C3CC(=O)C(CC(C)C)CN3CC2,C19H27NO3,S1789
19385,Rifaximin,COC1\C=C\OC2(C)OC3=C(C2=O)C4=C(C(=C3C)O)C(=C(NC(=O)\C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C)C5=C4N=C6C=C(C)C=C[N]56)O,C43H51N3O11,S1790
19386,Bacitracin Zinc,[Zn++].CCC(C)C(N)C1=NCC(S1)C(=O)NC(CC(C)C)C(=O)NC(CCC([O-])=O)C(=O)NC(C(C)CC)C(=O)NC2CCCCNC(=O)C(CC(N)=O)NC(=O)C(CC([O-])=O)NC(=O)C(CC3=C[NH]C=N3)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(NC(=O)C(CCCN)NC2=O)C(C)CC,C66H101N17O16SZn,S1791
19387,Simvastatin (MK 733),CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C12,C25H38O5,S1792
19388,Ramipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(O)=O,C23H32N2O5,S1793
19389,Fenofibrate (NSC-281319),CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2,C20H21ClO4,S1794
19390,Ranolazine,COC1=CC=CC=C1OCC(O)CN2CCN(CC2)CC(=O)NC3=C(C)C=CC=C3C,C24H33N3O4,S1799
19391,Ranitidine Hydrochloride,Cl.CNC(/NCCSCC1=CC=C(CN(C)C)O1)=C\[N+]([O-])=O,C13H22N4O3S.HCl,S1801
19392,Acetylcholine Chloride,[Cl-].CC(=O)OCC[N+](C)(C)C,C7H16NO2.Cl,S1805
19393,Acipimox,CC1=CN=C(C=[N+]1[O-])C(O)=O,C6H6N2O3,S1806
19394,Aciclovir (BW 248U),NC1=NC2=C(N=C[N]2COCCO)C(=O)N1,C8H11N5O3,S1807
19395,Nifedipine (BAY-a-1040),COC(=O)C1=C(C)NC(=C(C1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC)C,C17H18N2O6,S1808
19396,Amiloride (MK-870) HCl,Cl.NC(=N)NC(=O)C1=NC(=C(N)N=C1N)Cl,C6H8ClN7O.HCl,S1811
19397,Amlodipine Besylate,CCOC(=O)C1=C(COCCN)NC(=C(C1C2=C(Cl)C=CC=C2)C(=O)OC)C.O[S](=O)(=O)C3=CC=CC=C3,C20H25ClN2O5.C6H6O3S,S1813
19398,Levamlodipine Besylate,CCOC(=O)C1=C(COCCN)NC(=C(C1C2=C(Cl)C=CC=C2)C(=O)OC)C.O[S](=O)(=O)C3=CC=CC=C3,C20H25ClN2O5.C6H6O3S,E0826
19399,Chlorpheniramine Maleate,CN(C)CCC(C1=CC=C(Cl)C=C1)C2=NC=CC=C2.OC(=O)\C=C/C(O)=O,C16H19ClN2.C4H4O4,S1816
19400,Clofibrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1,C12H15ClO3,S1820
19401,Fenoprofen Calcium,[Ca++].CC(C([O-])=O)C1=CC(=CC=C1)OC2=CC=CC=C2.CC(C([O-])=O)C3=CC(=CC=C3)OC4=CC=CC=C4,C30H26CaO6,S1823
19402,Erdosteine,OC(=O)CSCC(=O)NC1CCSC1=O,C8H11NO4S2,S1825
19403,Betaxolol HCl,Cl.CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,C18H29NO3.HCl,S1827
19404,Levobetaxolol HCl,Cl.CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,C18H29NO3.HCl,S4085
19405,Proparacaine HCl,Cl.CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,C16H26N2O3.HCl,S1828
19406,Pranlukast,O=C(NC1=CC2=C(C=C1)C(=O)C=C(O2)C3=NN=N[NH]3)C4=CC=C(OCCCCC5=CC=CC=C5)C=C4,C27H23N5O4,S1829
19407,Oxfendazole,COC(=O)NC1=NC2=C([NH]1)C=C(C=C2)[S](=O)C3=CC=CC=C3,C15H13N3O3S,S1830
19408,Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC2=C3C(=CC=C2)[NH]C4=C3C=CC=C4,C24H26N2O4,S1831
19409,Atracurium Besylate,COC1=CC=C(CC2C3=CC(=C(OC)C=C3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]4(C)CCC5=CC(=C(OC)C=C5C4CC6=CC=C(OC)C(=C6)OC)OC)OC)C=C1OC.[O-][S](=O)(=O)C7=CC=CC=C7.[O-][S](=O)(=O)C8=CC=CC=C8,C53H72N2O12.2(C6H5O3S),S1832
19410,Cisatracurium Besylate,COC1=CC=C(CC2C3=CC(=C(OC)C=C3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]4(C)CCC5=CC(=C(OC)C=C5C4CC6=CC=C(OC)C(=C6)OC)OC)OC)C=C1OC.[O-][S](=O)(=O)C7=CC=CC=C7.[O-][S](=O)(=O)C8=CC=CC=C8,C53H72N2O12.2C6H5O3S,S2113
19411,Butoconazole nitrate,O[N+]([O-])=O.ClC1=CC=C(CCC(C[N]2C=CN=C2)SC3=C(Cl)C=CC=C3Cl)C=C1,C19H17Cl3N2S.HNO3,S1833
19412,Azithromycin (CP-62993),CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(O)CC(C)CN(C)C(C)C(O)C1(C)O,C38H72N2O12,S1835
19413,Albendazole Oxide,CCC[S](=O)C1=CC2=C(C=C1)N=C(NC(=O)OC)[NH]2,C12H15N3O3S,S1836
19414,Chloroxine,OC1=C(Cl)C=C(Cl)C2=C1N=CC=C2,C9H5Cl2NO,S1839
19415,Lomustine,ClCCN(N=O)C(=O)NC1CCCCC1,C9H16ClN3O2,S1840
19416,Cimetidine,CNC(NCCSCC1=C(C)[NH]C=N1)=NC#N,C10H16N6S,S1845
19417,Clemastine (HS-592) fumarate,CN1CCCC1CCOC(C)(C2=CC=CC=C2)C3=CC=C(Cl)C=C3.OC(=O)\C=C\C(O)=O,C21H26ClNO.C4H4O4,S1847
19418,Curcumin,COC1=CC(=CC=C1O)/C=C/C(O)=C/C(=O)/C=C/C2=CC(=C(O)C=C2)OC,C21H20O6,S1848
19419,Daidzein,OC1=CC=C(C=C1)C2=COC3=CC(=CC=C3C2=O)O,C15H10O4,S1849
19420,Bifonazole,C1=CC=C(C=C1)C([N]2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4,C22H18N2,S1854
19421,Pefloxacin Mesylate,CCN1C=C(C(O)=O)C(=O)C2=CC(=C(C=C12)N3CCN(C)CC3)F.C[S](O)(=O)=O,C17H20FN3O3.CH4O3S,S1855
19422,Metoprolol Tartrate,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1.COCCC2=CC=C(OCC(O)CNC(C)C)C=C2.OC(C(O)C(O)=O)C(O)=O,2C15H25NO3.C4H6O6,S1856
19423,Dienestrol,C/C=C(C1=CC=C(O)C=C1)/C(=C/C)C2=CC=C(O)C=C2,C18H18O2,S1858
19424,Diethylstilbestrol,CCC(/C1=CC=C(O)C=C1)=C(CC)\C2=CC=C(O)C=C2,C18H20O2,S1859
19425,Diltiazem HCl,Cl.COC1=CC=C(C=C1)C2SC3=C(C=CC=C3)N(CCN(C)C)C(=O)C2OC(C)=O,C22H26N2O4S.HCl,S1865
19426,Diphenhydramine HCl,Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,C17H21NO.HCl,S1866
19427,Dapoxetine HCl,Cl.CN(C)C(CCOC1=C2C=CC=CC2=CC=C1)C3=CC=CC=C3,C21H23NO.HCl,S1869
19428,Valaciclovir HCl,Cl.CC(C)C(N)C(=O)OCCOC[N]1C=NC2=C1N=C(N)NC2=O,C13H20N6O4.HCl,S1876
19429,Ganciclovir (BW 759),NC1=NC2=C(N=C[N]2COC(CO)CO)C(=O)N1,C9H13N5O4,S1878
19430,Roxatidine Acetate HCl,Cl.CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2,C19H28N2O4.HCl,S1880
19431,Protionamide,CCCC1=NC=CC(=C1)C(N)=S,C9H12N2S,S1881
19432,Idoxuridine,OCC1OC(CC1O)N2C=C(I)C(=O)NC2=O,C9H11IN2O5,S1883
19433,Sparfloxacin,CC1CN(CC(C)N1)C2=C(F)C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(O)=O,C19H22F2N4O3,S1884
19434,Felodipine,CCOC(=O)C1=C(C)NC(=C(C1C2=CC=CC(=C2Cl)Cl)C(=O)OC)C,C18H19Cl2NO4,S1885
19435,Deflazacort,CC(=O)OCC(=O)C12N=C(C)OC1CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC23C,C25H31NO6,S1888
19436,Nizatidine,CNC(/NCCSCC1=CSC(=N1)CN(C)C)=C/[N+]([O-])=O,C12H21N5O2S2,S1890
19437,Carbidopa,CC(CC1=CC(=C(O)C=C1)O)(NN)C(O)=O,C10H14N2O4,S1891
19438,Valsartan (CGP-48933),CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=N[NH]N=N3)C(C(C)C)C(O)=O,C24H29N5O3,S1894
19439,Dipyridamole (NSC 515776),OCCN(CCO)C1=NC2=C(N=C(N=C2N3CCCCC3)N(CCO)CCO)C(=N1)N4CCCCC4,C24H40N8O4,S1895
19440,Potassium Iodide,[K+].[I-],K+I-,S1897
19441,Tropisetron HCl,Cl.CN1C2CCC1CC(C2)OC(=O)C3C=NC4=CC=CC=C34,C17H20N2O2.HCl,S1898
19442,Nicotinamide (NSC 13128),NC(=O)C1=CC=CN=C1,C6H6N2O,S1899
19443,Vitamin B12,CC(CNC(=O)CCC1(C)C(CC(N)=O)C2N=C1/C(=C/3N=C(/C=C/4N=C(/C(=C/5[N-]C2(C)C(C)(CC(N)=O)C5CCC(N)=O)C)C(C)(CC(N)=O)C4CCC(N)=O)C(C)(C)C3CCC(N)=O)C)O[P]([O-])(=O)OC6C(O)C(OC6CO)[N]7C=NC8=C7C=C(C)C(=C8)C.[Co++]C#N,C63H88CoN14O14P,S1902
19444,Diclofenac Sodium,[Na+].[O-]C(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1,C14H10Cl2NNaO2,S1903
19445,Avobenzone,COC1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)C(C)(C)C,C20H22O3,S1904
19446,Amlodipine,CCOC(=O)C1=C(COCCN)NC(=C(C1C2=C(Cl)C=CC=C2)C(=O)OC)C,C20H25ClN2O5,S1905
19447,Metronidazole,CC1=NC=C([N]1CCO)[N+]([O-])=O,C6H9N3O3,S1907
19448,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,C11H11F3N2O3,S1908
19449,Fluvastatin (XU-62-320) Sodium,[Na+].CC(C)[N]1C2=C(C=CC=C2)C(=C1\C=C\C(O)CC(O)CC([O-])=O)C3=CC=C(F)C=C3,C24H25FNNaO4,S1909
19450,Tioconazole,ClC1=CC=C(C(C[N]2C=CN=C2)OCC3=C(Cl)SC=C3)C(=C1)Cl,C16H13Cl3N2OS,S1910
19451,Tropicamide,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,C17H20N2O2,S1913
19452,Pregnenolone,CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,C21H32O2,S1914
19453,Sulfamethoxazole,CC1=CC(=NO1)N[S](=O)(=O)C2=CC=C(N)C=C2,C10H11N3O3S,S1915
19454,Sulfisoxazole,CC1=NOC(=C1C)N[S](=O)(=O)C2=CC=C(N)C=C2,C11H13N3O3S,S1916
19455,Crystal Violet,[Cl-].CN(C)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(C)C)=C3C=CC(C=C3)=[N+](C)C,C25H30ClN3,S1917
19456,Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3,C21H23ClFNO2,S1920
19457,Phenindione,O=C1C(C2=CC=CC=C2)C(=O)C3=CC=CC=C13,C15H10O2,S1921
19458,Alibendol,COC1=CC(=CC(=C1O)C(=O)NCCO)CC=C,C13H17NO4,S1928
19459,Triamcinolone,CC12CC(O)C3(F)C(CCC4=CC(=O)C=CC34C)C1CC(O)C2(O)C(=O)CO,C21H27FO6,S1933
19460,Nystatin (Fungicidin),CC1OC(=O)CC(O)CC(O)CC(O)CCC(O)C(O)CC2(O)CC(O)C(C(CC(OC3OC(C)C(O)C(N)C3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/C(C)C(O)C1C)O2)C(O)=O,C53H85NO20,S1934
19461,Isoniazid,NNC(=O)C1=CC=NC=C1,C6H7N3O,S1937
19462,Levofloxacin,CC1COC2=C(N3CCN(C)CC3)C(=CC4=C2N1C=C(C(O)=O)C4=O)F,C18H20FN3O4,S1940
19463,Ofloxacin,CC1COC2=C(N3CCN(C)CC3)C(=CC4=C2N1C=C(C(O)=O)C4=O)F,C18H20FN3O4,S1463
19464,Enalapril Maleate,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(O)=O.OC(=O)\C=C/C(O)=O,C20H28N2O5.C4H4O4,S1941
19465,Menadione (NSC 4170),CC1=CC(=O)C2=CC=CC=C2C1=O,C11H8O2,S1949
19466,Metformin HCl,Cl.CN(C)C(=N)NC(N)=N,C4H11N5.HCl,S1950
19467,Methoxsalen,COC1=C2OC=CC2=CC3=C1OC(=O)C=C3,C12H8O4,S1952
19468,Miconazole Nitrate,O[N+]([O-])=O.ClC1=CC=C(COC(C[N]2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(=C1)Cl,C18H14Cl4N2O.HNO3,S1956
19469,Sulfamethizole,CC1=NN=C(N[S](=O)(=O)C2=CC=C(N)C=C2)S1,C9H10N4O2S2,S1957
19470,Sulbactam,CC1(C)C(N2C(CC2=O)[S]1(=O)=O)C(O)=O,C8H11NO5S,S1958
19471,Tolfenamic Acid,CC1=C(Cl)C=CC=C1NC2=C(C=CC=C2)C(O)=O,C14H12ClNO2,S1959
19472,Pranoprofen,CC(C(O)=O)C1=CC2=C(OC3=NC=CC=C3C2)C=C1,C15H13NO3,S1960
19473,Sulphadimethoxine,COC1=CC(=NC(=N1)OC)N[S](=O)(=O)C2=CC=C(N)C=C2,C12H14N4O4S,S1962
19474,Rimantadine,CC(N)[C]12C[CH]3[CH2]C([CH2][CH](C3)C1)C2,C12H21N,S1964
19475,Primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,C12H14N2O2,S1965
19476,Nefiracetam,CC1=CC=CC(=C1NC(=O)CN2CCCC2=O)C,C14H18N2O2,S1969
19477,Nicorandil,[O-][N+](=O)OCCNC(=O)C1=CC=CN=C1,C8H9N3O4,S1971
19478,Cyclocytidine HCl,Cl.OCC1OC2C(OC3=NC(=N)C=CN23)C1O,C9H12ClN3O4,S1973
19479,Meglumine,CNCC(O)C(O)C(O)C(O)CO,C7H17NO5,S1974
19480,Aripiprazole,ClC1=CC=CC(=C1Cl)N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2,C23H27Cl2N3O2,S1975
19481,Methscopolamine,[Br-].C[N+]1(C)C2CC(CC1C3OC23)OC(=O)C(CO)C4=CC=CC=C4,C18H24BrNO4,S1978
19482,Amiodarone (NSC 85442) HCl,Cl.CCCCC1=C(C(=O)C2=CC(=C(OCCN(CC)CC)C(=C2)I)I)C3=C(O1)C=CC=C3,C25H29I2NO3.HCl,S1979
19483,Adenine HCl,Cl.NC1=NC=NC2=C1N=C[NH]2,C5H5N5.HCl,S1983
19484,Mometasone furoate,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C5=CC=CO5)C(=O)CCl,C27H30Cl2O6,S1987
19485,Propylthiouracil,CCCC1=CC(=O)NC(=S)N1,C7H10N2OS,S1988
19486,Capsaicin(Vanilloid),COC1=C(O)C=CC(=C1)CNC(=O)CCCC\C=C\C(C)C,C18H27NO3,S1990
19487,Fluticasone propionate,CCC(=O)OC1(C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C)C(=O)SCF,C25H31F3O5S,S1992
19488,Lacidipine,CCOC(=O)C1=C(C)NC(=C(C1C2=C(C=CC=C2)\C=C\C(=O)OC(C)(C)C)C(=O)OCC)C,C26H33NO6,S1994
19489,Elvitegravir (JTK-303),COC1=CC2=C(C=C1CC3=C(F)C(=CC=C3)Cl)C(=O)C(=CN2C(CO)C(C)C)C(O)=O,C23H23ClFNO5,S2001
19490,Maraviroc (UK-427857),CC(C)C1=NN=C(C)[N]1C2CC3CCC(C2)N3CCC(NC(=O)C4CCC(F)(F)CC4)C5=CC=CC=C5,C29H41F2N5O,S2003
19491,Raltegravir (MK-0518),CN1C(=O)C(=C(N=C1C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3)O,C20H21FN6O5,S2005
19492,Pyrimethamine,CCC1=NC(=NC(=C1C2=CC=C(Cl)C=C2)N)N,C12H13ClN4,S2006
19493,Sulindac,CC1=C(CC(O)=O)C2=C(C=CC(=C2)F)\C1=C/C3=CC=C(C=C3)[S](C)=O,C20H17FO3S,S2007
19494,Pramipexole 2HCl Monohydrate,O.Cl.Cl.CCCNC1CCC2=C(C1)SC(=N2)N,C10H17N3S.2HCl.H2O,S2011
19495,Suplatast Tosylate,CCOCC(O)COC1=CC=C(NC(=O)CC[S+](C)C)C=C1.CC2=CC=C(C=C2)[S]([O-])(=O)=O,C23H33NO7S2,S2015
19496,Mirtazapine,CN1CCN2C(C1)C3=C(CC4=C2N=CC=C4)C=CC=C3,C17H19N3,S2016
19497,Benidipine HCl,Cl.COC(=O)C1=C(C)NC(=C(C1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC3CCCN(C3)CC4=CC=CC=C4)C,C28H31N3O6.HCl,S2017
19498,Formoterol Hemifumarate,COC1=CC=C(CC(C)NCC(O)C2=CC=C(O)C(=C2)NC=O)C=C1.COC3=CC=C(CC(C)NCC(O)C4=CC=C(O)C(=C4)NC=O)C=C3.OC(=O)\C=C\C(O)=O,C19H24N2O4.1/2C4H4O4,S2020
19499,Chlormezanone,CN1C(C2=CC=C(Cl)C=C2)[S](=O)(=O)CCC1=O,C11H12ClNO3S,S2021
19500,Ketotifen Fumarate,CN1CCC(CC1)=C2C3=C(CC(=O)C4=C2C=CS4)C=CC=C3.OC(=O)\C=C\C(O)=O,C19H19NOS.C4H4O4,S2024
19501,Urapidil HCl,Cl.COC1=CC=CC=C1N2CCN(CCCNC3=CC(=O)N(C)C(=O)N3C)CC2,C20H29N5O3.HCl,S2025
19502,Diclazuril,ClC1=CC=C(C=C1)C(C#N)C2=C(Cl)C=C(C=C2Cl)N3N=CC(=O)NC3=O,C17H9Cl3N4O2,S2028
19503,Uridine,OCC1OC(C(O)C1O)N2C=CC(=O)NC2=O,C9H12N2O6,S2029
19504,Flunarizine 2HCl,Cl.Cl.FC1=CC=C(C=C1)C(N2CCN(CC2)C\C=C\C3=CC=CC=C3)C4=CC=C(F)C=C4,C26H26F2N2.2HCl,S2030
19505,Fenticonazole Nitrate,O[N+]([O-])=O.ClC1=CC=C(C(C[N]2C=CN=C2)OCC3=CC=C(SC4=CC=CC=C4)C=C3)C(=C1)Cl,C24H20Cl2N2OS.HNO3,S2031
19506,Rebamipide,OC(=O)C(CC1=CC(=O)NC2=C1C=CC=C2)NC(=O)C3=CC=C(Cl)C=C3,C19H15ClN2O4,S2032
19507,Aspartame,COC(=O)C(CC1=CC=CC=C1)NC(=O)C(N)CC(O)=O,C14H18N2O5,S2036
19508,Candesartan Cilexetil,CCOC1=NC2=C([N]1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=N[NH]5)C(=CC=C2)C(=O)OC(C)OC(=O)OC6CCCCC6,C33H34N6O6,S2037
19509,Phentolamine Mesylate,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.C[S](O)(=O)=O,C17H19N3O.CH4O3S,S2038
19510,Nimesulide,C[S](=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O,C13H12N2O5S,S2040
19511,Dyclonine HCl,Cl.CCCCOC1=CC=C(C=C1)C(=O)CCN2CCCCC2,C18H27NO2.HCl,S2041
19512,Cyproterone Acetate,CC(=O)OC1(CCC2C3C=C(Cl)C4=CC(=O)C5CC5C4(C)C3CCC12C)C(C)=O,C24H29ClO4,S2042
19513,Memantine HCl,Cl.CC12C[CH]3CC(C)([CH2]1)C[C](N)(C3)C2,C12H21N.HCl,S2043
19514,Cyproheptadine HCl,Cl.CN1CCC(CC1)=C2C3=C(C=CC=C3)C=CC4=C2C=CC=C4,C21H21N.HCl,S2044
19515,Doxifluridine,CC1OC(C(O)C1O)N2C=C(F)C(=O)NC2=O,C9H11FN2O5,S2045
19516,Pioglitazone HCl,Cl.CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1,C19H20N2O3S.HCl,S2046
19517,Captopril,CC(CS)C(=O)N1CCCC1C(O)=O,C9H15NO3S,S2051
19518,Oxytetracycline Dihydrate,O.O.CN(C)C1C2C(O)C3C(=C(O)C2(O)C(=O)C(=C1O)C(N)=O)C(=O)C4=C(O)C=CC=C4C3(C)O,C22H24N2O9.2H2O,S2052
19519,Cytidine,NC1=NC(=O)N(C=C1)C2OC(CO)C(O)C2O,C9H13N3O5,S2053
19520,Cytarabine (U-19920A),NC1=NC(=O)N(C=C1)C2OC(CO)C(O)C2O,C9H13N3O5,S1648
19521,Orphenadrine Citrate,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2C.OC(=O)CC(O)(CC(O)=O)C(O)=O,C18H23NO.C6H8O7,S2054
19522,Gimeracil,OC1=CC(=O)NC=C1Cl,C5H4ClNO2,S2055
19523,Cyclophosphamide (NSC-26271) Monohydrate,O.ClCCN(CCCl)[P]1(=O)NCCCO1,C7H15Cl2N2O2P.H2O,S2057
19524,Tolnaftate,CN(C(=S)OC1=CC=C2C=CC=CC2=C1)C3=CC(=CC=C3)C,C19H17NOS,S2058
19525,Terazosin HCl Dihydrate,O.O.Cl.COC1=CC2=C(C=C1OC)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N,C19H25N5O4.HCl.2H2O,S2059
19526,Bromhexine HCl,Cl.CN(CC1=CC(=CC(=C1N)Br)Br)C2CCCCC2,C14H20Br2N2.HCl,S2060
19527,Lovastatin (MK-803),CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C12,C24H36O5,S2061
19528,Tiopronin,CC(S)C(=O)NCC(O)=O,C5H9NO3S,S2062
19529,Balofloxacin,CNC1CCCN(C1)C2=C(OC)C3=C(C=C2F)C(=O)C(=CN3C4CC4)C(O)=O,C20H24FN3O4,S2064
19530,Lafutidine,O=C(C[S](=O)CC1=CC=CO1)NC\C=C/COC2=CC(=CC=N2)CN3CCCCC3,C22H29N3O4S,S2065
19531,Moxonidine,COC1=NC(=NC(=C1NC2=NCCN2)Cl)C,C9H12ClN5O,S2066
19532,Ozagrel HCl,Cl.OC(=O)/C=C/C1=CC=C(C[N]2C=CN=C2)C=C1,C13H12N2O2.HCl,S2067
19533,Argatroban (MCI-9038),CC1CCN(C(C1)C(O)=O)C(=O)C(CCCNC(N)=N)N[S](=O)(=O)C2=CC=CC3=C2NCC(C)C3,C23H36N6O5S,S2069
19534,Prulifloxacin (NM441),CC1SC2=C(C(O)=O)C(=O)C3=CC(=C(C=C3N12)N4CCN(CC4)CC5=C(C)OC(=O)O5)F,C21H20FN3O6S,S2071
19535,Seratrodast(AA-2414),CC1=C(C)C(=O)C(=C(C)C1=O)C(CCCCCC(O)=O)C2=CC=CC=C2,C22H26O4,S2072
19536,Rosiglitazone (BRL-49653) HCl,Cl.CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C3=CC=CC=N3,C18H19N3O3S.HCl,S2075
19537,Atorvastatin Calcium,[Ca++].CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C([N]1CCC(O)CC(O)CC([O-])=O)C3=CC=C(F)C=C3)C4=CC=CC=C4.CC(C)C5=C(C(=O)NC6=CC=CC=C6)C(=C([N]5CCC(O)CC(O)CC([O-])=O)C7=CC=C(F)C=C7)C8=CC=CC=C8,2(C33H34FN2O5).Ca,S2077
19538,Famotidine,NC(=N)NC1=NC(=CS1)CSCCC(=N)N[S](N)(=O)=O,C8H15N7O2S3,S2078
19539,Moexipril HCl,Cl.CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(OC)C=C3CC2C(O)=O)OC,C27H34N2O7.HCl,S2079
19540,Clevidipine Butyrate,CCCC(=O)OCOC(=O)C1=C(C)NC(=C(C1C2=CC=CC(=C2Cl)Cl)C(=O)OC)C,C21H23Cl2NO6,S2080
19541,Adiphenine HCl,Cl.CCN(CC)CCOC(=O)C(C1=CC=CC=C1)C2=CC=CC=C2,C20H25NO2.HCl,S2082
19542,Procaterol HCl,Cl.CCC(NC(C)C)C(O)C1=CC=C(O)C2=C1C=CC(=O)N2,C16H22N2O3.HCl,S2083
19543,Duloxetine HCl,Cl.CNCCC(OC1=C2C=CC=CC2=CC=C1)C3=CC=CS3,C18H19NOS.HCl,S2084
19544,Trimebutine,CCC(COC(=O)C1=CC(=C(OC)C(=C1)OC)OC)(N(C)C)C2=CC=CC=C2,C22H29NO5,S2085
19545,Ivabradine HCl,Cl.COC1=CC2=C(CC(=O)N(CCCN(C)CC3CC4=CC(=C(OC)C=C34)OC)CC2)C=C1OC,C27H36N2O5.HCl,S2086
19546,Rivastigmine Tartrate,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C.OC(C(O)C(O)=O)C(O)=O,C14H22N2O2.C4H6O6,S2087
19547,Dexmedetomidine HCl,Cl.CC(C1=CN=C[NH]1)C2=CC=CC(=C2C)C,C13H16N2.HCl,S2090
19548,Betaxolol,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,C18H29NO3,S2091
19549,Detomidine HCl,Cl.CC1=C(C)C(=CC=C1)CC2=C[NH]C=N2,C12H14N2.HCl,S2092
19550,Almotriptan Malate,CN(C)CCC1=C[NH]C2=CC=C(C[S](=O)(=O)N3CCCC3)C=C12.OC(CC(O)=O)C(O)=O,C17H25N3O2S.C4H6O5,S2096
19551,Ambrisentan,COC(C(OC1=NC(=CC(=N1)C)C)C(O)=O)(C2=CC=CC=C2)C3=CC=CC=C3,C22H22N2O4,S2097
19552,Bexarotene (LGD1069),CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(O)=O)C(C)(C)CCC2(C)C,C24H28O2,S2098
19553,Temocapril HCl,Cl.CCOC(=O)C(CCC1=CC=CC=C1)NC2CSC(CN(CC(O)=O)C2=O)C3=CC=CS3,C23H28N2O5S2.HCl,S2099
19554,Gabexate Mesylate,CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1.C[S](O)(=O)=O,C16H23N3O4.CH4O3S,S2101
19555,Rasagiline Mesylate,C[S](O)(=O)=O.C#CCNC1CCC2=CC=CC=C12,C12H13N.CH4O3S,S2102
19556,Naltrexone HCl,Cl.OC1=CC=C2CC3N(CCC45C(OC1=C24)C(=O)CCC35O)CC6CC6,C20H23NO4.HCl,S2103
19557,Levosulpiride,CCN1CCCC1CNC(=O)C2=C(OC)C=CC(=C2)[S](N)(=O)=O,C15H23N3O4S,S2104
19558,Sulpiride,CCN1CCCC1CNC(=O)C2=C(OC)C=CC(=C2)[S](N)(=O)=O,C15H23N3O4S,S4655
19559,Pantoprazole,COC1=C(OC)C(=NC=C1)C[S](=O)C2=NC3=CC=C(OC(F)F)C=C3[NH]2,C16H15F2N3O4S,S2105
19560,Flunixin Meglumin,CNCC(O)C(O)C(O)C(O)CO.CC1=C(C=CC=C1NC2=NC=CC=C2C(O)=O)C(F)(F)F,C14H11F3N2O2.C7H17NO5,S2108
19561,Imidapril HCl,Cl.CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(CN(C)C2=O)C(O)=O,C20H27N3O6.HCl,S2109
19562,Lapatinib (GW-572016),C[S](=O)(=O)CCNCC1=CC=C(O1)C2=CC=C3N=CN=C(NC4=CC=C(OCC5=CC=CC(=C5)F)C(=C4)Cl)C3=C2,C29H26ClFN4O4S,S2111
19563,Dronedarone HCl,Cl.CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C2=C(CCCC)OC3=CC=C(N[S](C)(=O)=O)C=C23,C31H44N2O5S.HCl,S2114
19564,Conivaptan HCl,Cl.CC1=NC2=C([NH]1)C3=C(C=CC=C3)N(CC2)C(=O)C4=CC=C(NC(=O)C5=C(C=CC=C5)C6=CC=CC=C6)C=C4,C32H26N4O2.HCl,S2116
19565,Ibutilide Fumarate,CCCCCCCN(CC)CCCC(O)C1=CC=C(N[S](C)(=O)=O)C=C1.CCCCCCCN(CC)CCCC(O)C2=CC=C(N[S](C)(=O)=O)C=C2.OC(=O)\C=C\C(O)=O,(C20H36N2O3S)2.C4H4O4,S2118
19566,Probucol,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(O)C(=C2)C(C)(C)C)C(C)(C)C,C31H48O2S2,S2119
19567,Arbidol HCl,Cl.CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br,C22H25BrN2O3S.HCl,S2120
19568,Dextrose,OCC(O)C(O)C(O)C(O)C=O,C6H12O6,S2123
19569,Xylose,OCC(O)C(O)C(O)C=O,C5H10O5,S2124
19570,D-Ribose,OCC(O)C(O)C(O)C=O,C5H10O5,S5544
19571,L-Xylose,OCC(O)C(O)C(O)C=O,C5H10O5,S5830
19572,L-(+)-Arabinose,OCC(O)C(O)C(O)C=O,C5H10O5,S6346
19573,Mestranol,COC1=CC2=C(C=C1)C3CCC4(C)C(CCC4(O)C#C)C3CC2,C21H26O2,S2125
19574,Naftopidil,COC1=CC=CC=C1N2CCN(CC2)CC(O)COC3=C4C=CC=CC4=CC=C3,C24H28N2O3,S2126
19575,Bazedoxifene (WAY-140424) HCl,Cl.CC1=C([N](CC2=CC=C(OCCN3CCCCCC3)C=C2)C4=CC=C(O)C=C14)C5=CC=C(O)C=C5,C30H34N2O3.HCl,S2128
19576,Atropine sulfate monohydrate,O.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN4C5CCC4CC(C5)OC(=O)C(CO)C6=CC=CC=C6.O[S](O)(=O)=O,2(C17H23NO3).H2O.H2SO4,S2130
19577,Roflumilast (B9302-107),FC(F)OC1=CC=C(C=C1OCC2CC2)C(=O)NC3=C(Cl)C=NC=C3Cl,C17H14Cl2F2N2O3,S2131
19578,Sonidegib (NVP-LDE225),CC1CN(CC(C)O1)C2=CC=C(NC(=O)C3=C(C)C(=CC=C3)C4=CC=C(OC(F)(F)F)C=C4)C=N2,C26H26F3N3O3,S2151
19579,Dabigatran (BIBR-1048) etexilate,CCCCCCOC(=O)N=C(N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)[N]2C)C=C1,C34H41N7O5,S2154
19580,Tebipenem Pivoxil,CC(O)C1C2C(C)C(=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)SC3CN(C3)C4=NCCS4,C22H31N3O6S2,S2159
19581,Bazedoxifene (TSE-424) acetate,CC(O)=O.CC1=C([N](CC2=CC=C(OCCN3CCCCCC3)C=C2)C4=CC=C(O)C=C14)C5=CC=C(O)C=C5,C30H34N2O3.C2H4O2,S2167
19582,Rosuvastatin (ZD4522) calcium,[Ca++].CC(C)C1=C(\C=C\C(O)CC(O)CC([O-])=O)C(=NC(=N1)N(C)[S](C)(=O)=O)C2=CC=C(F)C=C2.CC(C)C3=C(\C=C\C(O)CC(O)CC([O-])=O)C(=NC(=N3)N(C)[S](C)(=O)=O)C4=CC=C(F)C=C4,C22H28FN3O6S.1/2Ca,S2169
19583,Telotristat Etiprate (LX 1606 Hippurate),CCOC(=O)C(N)CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=CC=C(Cl)C=C3[N]4C=CC(=N4)C)C(F)(F)F.OC(=O)CNC(=O)C5=CC=CC=C5,C27H26ClF3N6O3.C9H9NO3,S2173
19584,Dichlorphenamide,N[S](=O)(=O)C1=CC(=C(Cl)C(=C1)[S](N)(=O)=O)Cl,C6H6Cl2N2O4S2,S2177
19585,Ixazomib (MLN2238),CC(C)CC(NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B(O)O,C14H19BCl2N2O4,S2180
19586,Ixazomib Citrate (MLN9708) Analogue,CC(C)CC(NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B2OC(=O)CC(CC(O)=O)(O2)C(O)=O,C20H23BCl2N2O9,S2181
19587,Infigratinib (BGJ398),CCN1CCN(CC1)C2=CC=C(NC3=NC=NC(=C3)N(C)C(=O)NC4=C(Cl)C(=CC(=C4Cl)OC)OC)C=C2,C26H31Cl2N7O3,S2183
19588,Phenprocoumon,CCC(C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3OC2=O,C18H16O3,S2188
19589,Aliskiren Hemifumarate,COCCCOC1=C(OC)C=CC(=C1)CC(CC(N)C(O)CC(C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C.COCCCOC2=C(OC)C=CC(=C2)CC(CC(N)C(O)CC(C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C.OC(=O)\C=C\C(O)=O,C30H53N3O6.1/2C4H4O4,S2199
19590,Irinotecan (CPT-11) HCl Trihydrate,O.O.O.Cl.CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CCC(CC6)N7CCCCC7)C=C15)C(O)(CC)C(=O)OC4,C33H38N4O6.HCl.3H2O,S2217
19591,Momelotinib (CYT387),O=C(NCC#N)C1=CC=C(C=C1)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4,C23H22N6O2,S2219
19592,Idelalisib,CCC(NC1=C2N=C[NH]C2=NC=N1)C3=NC4=CC=CC(=C4C(=O)N3C5=CC=CC=C5)F,C22H18FN7O,S2226
19593,Eltrombopag (SB497115) Olamine,CC1=CC=C(C=C1C)N2N=C(C)C(=N/NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(O)=O)/C2=O.NCCO.NCCO,C29H36N6O6,S2229
19594,Esomeprazole sodium,COC1=CC=C2[N]([Na])C(=NC2=C1)[S](=O)CC3=NC=C(C)C(=C3C)OC,C17H18N3O3S.Na,S2233
19595,Abiraterone Acetate (CB7630),CC(=O)OC1CCC2(C)C3CCC4(C)C(CC=C4C5=CC=CN=C5)C3CC=C2C1,C26H33NO2,S2246
19596,(-)-Epigallocatechin Gallate,OC1=CC2=C(CC(OC(=O)C3=CC(=C(O)C(=C3)O)O)C(O2)C4=CC(=C(O)C(=C4)O)O)C(=C1)O,C22H18O11,S2250
19597,4-Methylumbelliferone (4-MU),CC1=CC(=O)OC2=C1C=CC(=C2)O,C10H8O3,S2256
19598,Esculin,OCC1OC(OC2=C(O)C=C3OC(=O)C=CC3=C2)C(O)C(O)C1O,C15H16O9,S2258
19599,Amygdalin,OCC1OC(OCC2OC(OC(C#N)C3=CC=CC=C3)C(O)C(O)C2O)C(O)C(O)C1O,C20H27NO11,S2260
19600,Andrographolide,CC1(CO)C(O)CCC2(C)C(C\C=C\3C(O)COC3=O)C(=C)CCC12,C20H30O5,S2261
19601,Apigenin (LY 080400),OC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(O)C=C3O,C15H10O5,S2262
19602,Arbutin,OCC1OC(OC2=CC=C(O)C=C2)C(O)C(O)C1O,C12H16O7,S2263
19603,alpha-Arbutin,OCC1OC(OC2=CC=C(O)C=C2)C(O)C(O)C1O,C12H16O7,S5112
19604,Artemether,COC1OC2OC3(C)CCC4C(C)CCC(C1C)C24OO3,C16H26O5,S2264
19605,Artesunate (WR-256283),CC1CCC2C(C)C(OC3OC4(C)CCC1C23OO4)OC(=O)CCC(O)=O,C19H28O8,S2265
19606,Asiatic Acid,CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(CO)C5CCC34C)C2C1C)C(O)=O,C30H48O5,S2266
19607,Baicalein,OC1=C(O)C(=C2C(=O)C=C(OC2=C1)C3=CC=CC=C3)O,C15H10O5,S2268
19608,Baicalin (NSC-661431),OC1C(O)C(OC(C1O)C(O)=O)OC2=C(O)C(=C3C(=O)C=C(OC3=C2)C4=CC=CC=C4)O,C21H18O11,S2269
19609,Bergenin,COC1=C(O)C2=C(C=C1O)C(=O)OC3C(O)C(O)C(CO)OC23,C14H16O9,S2270
19610,Berberine chloride (NSC 646666),[Cl-].COC1=CC=C2C=C3C4=C(CC[N+]3=CC2=C1OC)C=C5OCOC5=C4,C20H18NO4.Cl,S2271
19611,Caffeic Acid,OC(=O)/C=C/C1=CC=C(O)C(=C1)O,C9H8O4,S2277
19612,Chlorogenic Acid,OC1CC(O)(CC(OC(=O)\C=C\C2=CC(=C(O)C=C2)O)C1O)C(O)=O,C16H18O9,S2280
19613,Cinchonidine,OC(C1CC2CCN1CC2C=C)C3=CC=NC4=CC=CC=C34,C19H22N2O,S2282
19614,Cinchonine(LA40221),OC(C1CC2CCN1CC2C=C)C3=CC=NC4=CC=CC=C34,C19H22N2O,S2283
19615,Colchicine (NSC 757),COC1=CC=C2C(=CC1=O)C(CCC3=C2C(=C(OC)C(=C3)OC)OC)NC(C)=O,C22H25NO6,S2284
19616,Cytisine,O=C1C=CC=C2C3CNCC(C3)CN12,C11H14N2O,S2287
19617,Daidzin,OCC1OC(OC2=CC3=C(C=C2)C(=O)C(=CO3)C4=CC=C(O)C=C4)C(O)C(O)C1O,C21H20O9,S2289
19618,Dihydroartemisinin (DHA),CC1CCC2C(C)C(O)OC3OC4(C)CCC1C23OO4,C15H24O5,S2290
19619,DL-Carnitine HCl,[Cl-].C[N+](C)(C)CC(O)CC(O)=O,C7H15NO3.HCl,S2293
19620,D-Carnitine hydrochloride,[Cl-].C[N+](C)(C)CC(O)CC(O)=O,C7H16ClNO3,S5874
19621,L-Carnitine hydrochloride,[Cl-].C[N+](C)(C)CC(O)CC(O)=O,C7H16ClNO3,S5922
19622,Emodin,CC1=CC2=C(C(=C1)O)C(=O)C3=C(C=C(O)C=C3O)C2=O,C15H10O5,S2295
19623,Enoxolone,CC1(C)C(O)CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(O)=O,C30H46O4,S2296
19624,Glycyrrhetinic acid,CC1(C)C(O)CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(O)=O,C30H46O4,S6456
19625,Formononetin,COC1=CC=C(C=C1)C2=COC3=C(C=CC(=C3)O)C2=O,C16H12O4,S2299
19626,Ferulic Acid,COC1=CC(=CC=C1O)\C=C\C(O)=O,C10H10O4,S2300
19627,Glycyrrhizin (NSC 167409),CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(O)=O)OC6OC(C(O)C(O)C6OC7OC(C(O)C(O)C7O)C(O)=O)C(O)=O,C42H62O16,S2302
19628,Gossypol Acetate,CC(C)C1=C2C=C(C)C(=C(O)C2=C(C=O)C(=C1O)O)C3=C(O)C4=C(C=C3C)C(=C(O)C(=C4C=O)O)C(C)C.CC(O)=O,C32H34O10,S2303
19629,Gramine,CN(C)CC1=C[NH]C2=C1C=CC=C2,C11H14N2,S2304
19630,Hesperetin,COC1=CC=C(C=C1O)C2CC(=O)C3=C(O)C=C(O)C=C3O2,C16H14O6,S2308
19631,Hesperidin,COC1=CC=C(C=C1O)C2CC(=O)C3=C(O)C=C(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)C=C3O2,C28H34O15,S2309
19632,Honokiol (NSC 293100),OC1=C(CC=C)C=C(C=C1)C2=CC(=CC=C2O)CC=C,C18H18O2,S2310
19633,Hyodeoxycholic acid (HDCA),CC(CCC(O)=O)C1CCC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C,C24H40O4,S2311
19634,Kaempferol (NSC 407289),OC1=CC=C(C=C1)C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2,C15H10O6,S2314
19635,Kinetin,C(NC1=NC=NC2=C1[NH]C=N2)C3=CC=CO3,C10H9N5O,S2316
19636,L-(+)-Rhamnose Monohydrate,O.CC1OC(O)C(O)C(O)C1O,C6H12O5.H2O,S2317
19637,α-L-Rhamnose monohydrate,O.CC1OC(O)C(O)C(O)C1O,C6H12O5.H2O,S3887
19638,Lappaconitine,CCN1CC2(CCC(OC)C34C2CC(C13)C5(O)CC(OC)C6CC4C5(O)C6OC)OC(=O)C7=CC=CC=C7NC(C)=O,C32H44N2O8,S2318
19639,Luteolin,OC1=CC(=C2C(=O)C=C(OC2=C1)C3=CC=C(O)C(=C3)O)O,C15H10O6,S2320
19640,Magnolol,OC1=C(C=C(CC=C)C=C1)C2=CC(=CC=C2O)CC=C,C18H18O2,S2321
19641,(+)-Matrine,O=C1CCCC2C3CCCN4CCCC(CN12)C34,C15H24N2O,S2322
19642,Sophoridine,O=C1CCCC2C3CCCN4CCCC(CN12)C34,C15H24N2O,S3895
19643,Morin Hydrate,O.OC1=CC=C(C(=C1)O)C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2,C15H10O7.H2O,S2325
19644,Nalidixic acid,CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2,C12H12N2O3,S2328
19645,Naringin,CC1OC(OC2C(O)C(O)C(CO)OC2OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC=C(O)C=C5)O)C(O)C(O)C1O,C27H32O14,S2329
19646,Neohesperidin Dihydrochalcone (Nhdc),COC1=C(O)C=C(CCC(=O)C2=C(O)C=C(OC3OC(CO)C(O)C(O)C3OC4OC(C)C(O)C(O)C4O)C=C2O)C=C1,C28H36O15,S2331
19647,Neohesperidin,COC1=CC(=CC(=C1)C2CC(=O)C3=C(O)C=C(OC4OC(CO)C(O)C(O)C4OC5OC(C)C(O)C(O)C5O)C=C3O2)O,C28H34O15,S2332
19648,Oleanolic Acid,CC1(C)CC(C2CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1)C(O)=O,C30H48O3,S2334
19649,Orotic acid (6-Carboxyuracil),OC(=O)C1=CC(=O)NC(=O)N1,C5H4N2O4,S2336
19650,Osthole,COC1=CC=C2C=CC(=O)OC2=C1CC=C(C)C,C15H16O3,S2337
19651,Oxymatrine,[O-][N+]12CCCC3CN4C(CCCC4=O)C(CCC1)C23,C15H24N2O2,S2338
19652,Paeonol,COC1=CC(=C(C=C1)C(C)=O)O,C9H10O3,S2339
19653,(-)-Parthenolide,CC/1=C\CCC2(C)OC2C3OC(=O)C(=C)C3CC1,C15H20O3,S2341
19654,Piperine,O=C(\C=C\C=C\C1=CC2=C(OCO2)C=C1)N3CCCCC3,C17H19NO3,S2344
19655,Puerarin,OCC1OC(OC2=C(O)C=CC3=C2OC=C(C3=O)C4=CC=C(O)C=C4)C(O)C(O)C1O,C21H20O9,S2346
19656,Quercetin Dihydrate,O.O.OC1=CC(=C2C(=O)C(=C(OC2=C1)C3=CC=C(O)C(=C3)O)O)O,C15H10O7.2H2O,S2347
19657,Rotenone (Barbasco),COC1=CC2=C(C=C1OC)C3C(CO2)OC4=C(C=CC5=C4CC(O5)C(C)=C)C3=O,C23H22O6,S2348
19658,Rutaecarpine,O=C1N2CCC3=C([NH]C4=C3C=CC=C4)C2=NC5=C1C=CC=C5,C18H13N3O,S2349
19659,Rutin,CC1OC(OCC2OC(OC3=C(OC4=C(C(=CC(=C4)O)O)C3=O)C5=CC(=C(O)C=C5)O)C(O)C(O)C2O)C(O)C(O)C1O,C27H30O16,S2350
19660,Rutin hydrate,CC1OC(OCC2OC(OC3=C(OC4=C(C(=CC(=C4)O)O)C3=O)C5=CC(=C(O)C=C5)O)C(O)C(O)C2O)C(O)C(O)C1O,C27H30O16.xH2O,S6264
19661,Salicin,OCC1OC(OC2=CC=CC=C2CO)C(O)C(O)C1O,C13H18O7,S2351
19662,Sclareol,CC1(C)CCCC2(C)C1CCC(C)(O)C2CCC(C)(O)C=C,C20H36O2,S2354
19663,Silibinin (NSC 651520),COC1=CC(=CC=C1O)C2OC3=CC(=CC=C3OC2CO)C4OC5=CC(=CC(=C5C(=O)C4O)O)O,C25H22O10,S2357
19664,Silymarin,COC1=CC(=CC=C1O)C2OC3=CC=C(C=C3OC2CO)C4OC5=C(C(=CC(=C5)O)O)C(=O)C4O,C25H22O10,S2358
19665,Sinomenine,COC1=CC2C3CC4=C(C(=C(OC)C=C4)O)C2(CCN3C)CC1=O,C19H23NO4,S2359
19666,Synephrine,CNCC(O)C1=CC=C(O)C=C1,C9H13NO2,S2362
19667,Tanshinone I,CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C(C)C=CC=C34,C18H12O3,S2364
19668,Tanshinone IIA,CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C,C19H18O3,S2365
19669,Taxifolin (Dihydroquercetin),OC1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC(=C(O)C=C3)O,C15H12O7,S2366
19670,Troxerutin,CC1OC(OCC2OC(OC3=C(OC4=CC(=CC(=C4C3=O)O)OCCO)C5=CC(=C(OCCO)C=C5)OCCO)C(O)C(O)C2O)C(O)C(O)C1O,C33H42O19,S2369
19671,Ursolic Acid,CC1CC(C2CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(O)=O,C30H48O3,S2370
19672,Yohimbine HCl,Cl.COC(=O)C1C(O)CCC2CN3CCC4=C([NH]C5=C4C=CC=C5)C3CC12,C21H26N2O3.HCl,S2373
19673,5-hydroxytryptophan (5-HTP),NC(CC1=C[NH]C2=CC=C(O)C=C12)C(O)=O,C11H12N2O3,S2374
19674,L-5-Hydroxytryptophan,NC(CC1=C[NH]C2=CC=C(O)C=C12)C(O)=O,C11H12N2O3,S4769
19675,Aloin,OCC1OC(C(O)C(O)C1O)C2C3=C(C(=CC=C3)O)C(=O)C4=C2C=C(CO)C=C4O,C21H22O9,S2375
19676,Ammonium Glycyrrhizinate,N.CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(O)=O)OC6OC(C(O)C(O)C6OC7OC(C(O)C(O)C7O)C(O)=O)C(O)=O,C42H62O16.NH3,S2376
19677,Ammonium Glycyrrhizate,N.CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(O)=O)OC6OC(C(O)C(O)C6OC7OC(C(O)C(O)C7O)C(O)=O)C(O)=O,C42H65NO16,S9143
19678,Butylscopolamine Bromide,[Br-].CCCC[N+]1(C)C2CC(CC1C3OC23)OC(=O)C(CO)C4=CC=CC=C4,C21H30NO4.Br,S2378
19679,Dioscin,CC1CCC2(OC1)OC3CC4C5CC=C6CC(CCC6(C)C5CCC4(C)C3C2C)OC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7OC9OC(C)C(O)C(O)C9O,C45H72O16,S2379
19680,Diosmetin,COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O)C=C(O)C=C3O2,C16H12O6,S2380
19681,D-Mannitol,OCC(O)C(O)C(O)C(O)CO,C6H14O6,S2381
19682,Sorbitol,OCC(O)C(O)C(O)C(O)CO,C6H14O6,S2393
19683,Evodiamine,CN1C2N(CCC3=C2[NH]C4=CC=CC=C34)C(=O)C5=C1C=CC=C5,C19H17N3O,S2382
19684,Gastrodin,OCC1OC(OC2=CC=C(CO)C=C2)C(O)C(O)C1O,C13H18O7,S2383
19685,Hematoxylin,OC1=CC2=C(C=C1O)C3C4=C(OCC3(O)C2)C(=C(O)C=C4)O,C16H14O6,S2384
19686,Indirubin (NSC 105327),O=C1NC2=CC=CC=C2\C1=C3/NC4=C(C=CC=C4)C3=O,C16H10N2O2,S2386
19687,Lappaconite HBr,Br.CCN1CC2(CCC(OC)C34C2CC(C13)C5(O)CC(OC)C6CC4C5(O)C6OC)OC(=O)C7=C(NC(C)=O)C=CC=C7,C32H44N2O8.HBr,S2387
19688,L-carnitine,C[N+](C)(C)CC(O)CC([O-])=O,C7H15NO3,S2388
19689,DL-Carnitine,C[N+](C)(C)CC(O)CC([O-])=O,C7H15NO3,S5937
19690,Naringin Dihydrochalcone,CC1OC(OC2C(O)C(O)C(CO)OC2OC3=CC(=C(C(=O)CCC4=CC=C(O)C=C4)C(=C3)O)O)C(O)C(O)C1O,C27H34O14,S2389
19691,Polydatin,OCC1OC(OC2=CC(=CC(=C2)\C=C\C3=CC=C(O)C=C3)O)C(O)C(O)C1O,C20H22O8,S2390
19692,Quercetin (NSC 9221),OC1=CC(=C2C(=O)C(=C(OC2=C1)C3=CC=C(O)C(=C3)O)O)O,C15H10O7,S2391
19693,Salidroside,OCC1OC(OCCC2=CC=C(O)C=C2)C(O)C(O)C1O,C14H20O7,S2396
19694,Palmatine chloride,[Cl-].COC1=CC=C2C=C3C4=C(CC[N+]3=CC2=C1OC)C=C(OC)C(=C4)OC,C21H22NO4.Cl,S2397
19695,Sodium Danshensu,[Na+].OC(CC1=CC(=C(O)C=C1)O)C([O-])=O,C9H9O5.Na,S2401
19696,Tetrandrine (NSC-77037),COC1=CC=C2CC3N(C)CCC4=CC(=C(OC)C(=C34)OC5=C(OC)C=C6CCN(C)C(CC7=CC=C(OC1=C2)C=C7)C6=C5)OC,C38H42N2O6,S2403
19697,10-Deacetylbaccatin-III,CC(=O)OC12COC1CC(O)C3(C)C2C(OC(=O)C4=CC=CC=C4)C5(O)CC(O)C(=C(C(O)C3=O)C5(C)C)C,C29H36O10,S2409
19698,Paeoniflorin (NSC 178886),CC12CC3(O)OC(O1)C4(COC(=O)C5=CC=CC=C5)C3CC24OC6OC(CO)C(O)C(O)C6O,C23H28O11,S2410
19699,Geniposide,COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)C3C1CC=C3CO,C17H24O10,S2411
19700,Ipriflavone (Osteofix),CC(C)OC1=CC=C2C(=C1)OC=C(C2=O)C3=CC=CC=C3,C18H16O3,S2422
19701,(S)-10-Hydroxycamptothecin,CCC1(O)C(=O)OCC2=C1C=C3N(CC4=CC5=CC(=CC=C5N=C34)O)C2=O,C20H16N2O5,S2423
19702,Rotundine,COC1=CC2=C(C=C1OC)C3CC4=CC=C(OC)C(=C4CN3CC2)OC,C21H25NO4,S2437
19703,Synephrine HCl,Cl.CNCC(O)C1=CC=C(O)C=C1,C9H13NO2.HCl,S2438
19704,Guanosine,NC1=NC2=C(N=C[N]2C3OC(CO)C(O)C3O)C(=O)N1,C10H13N5O5,S2439
19705,Inosine,OCC1OC(C(O)C1O)[N]2C=NC3=C2N=CNC3=O,C10H12N4O5,S2442
19706,Tolbutamide (HLS 831),CCCCNC(=O)N[S](=O)(=O)C1=CC=C(C)C=C1,C12H18N2O3S,S2443
19707,Levosimendan,CC1CC(=O)NN=C1C2=CC=C(NN=C(C#N)C#N)C=C2,C14H12N6O,S2446
19708,Equol,OC1=CC=C(C=C1)C2COC3=CC(=CC=C3C2)O,C15H14O3,S2450
19709,Amantadine HCl,Cl.N[C]12CC3[CH2][CH](C[CH]([CH2]3)C1)C2,C10H17N.HCl,S2451
19710,Amfebutamone (Bupropion) HCl,Cl.CC(NC(C)(C)C)C(=O)C1=CC=CC(=C1)Cl,C13H18ClNO.HCl,S2452
19711,Bupivacaine HCl,Cl.CCCCN1CCCCC1C(=O)NC2=C(C)C=CC=C2C,C18H28N2O.HCl,S2454
19712,Levobupivacaine HCl,Cl.CCCCN1CCCCC1C(=O)NC2=C(C)C=CC=C2C,C18H28N2O.HCl,S4061
19713,Bethanechol chloride,[Cl-].CC(C[N+](C)(C)C)OC(N)=O,C7H17N2O2.Cl,S2455
19714,Chlorpromazine HCl,Cl.CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2,C17H19ClN2S.HCl,S2456
19715,Clindamycin HCl,Cl.CCCC1CC(N(C)C1)C(=O)NC(C(C)Cl)C2OC(SC)C(O)C(O)C2O,C18H33ClN2O5S.HCl,S2457
19716,Clonidine HCl,Cl.ClC1=C(NC2=NCCN2)C(=CC=C1)Cl,C9H9Cl2N3.HCl,S2458
19717,Clozapine,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(=C3)Cl,C18H19ClN4,S2459
19718,Pramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,C10H17N3S,S2460
19719,Domperidone,ClC1=CC2=C(C=C1)N(C3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2,C22H24ClN5O2,S2461
19720,Estriol,CC12CCC3C(CCC4=CC(=CC=C34)O)C1CC(O)C2O,C18H24O3,S2466
19721,Famciclovir,CC(=O)OCC(CC[N]1C=NC2=CN=C(N)N=C12)COC(C)=O,C14H19N5O4,S2467
19722,Fenbendazole,COC(=O)NC1=NC2=C([NH]1)C=C(SC3=CC=CC=C3)C=C2,C15H13N3O2S,S2468
19723,Fluocinolone Acetonide,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(O1)C(=O)CO,C24H30F2O6,S2470
19724,Gallamine Triethiodide,[I-].[I-].[I-].CC[N+](CC)(CC)CCOC1=C(OCC[N+](CC)(CC)CC)C(=CC=C1)OCC[N+](CC)(CC)CC,C30H60I3N3O3,S2471
19725,Hexestrol,CCC(C(CC)C1=CC=C(O)C=C1)C2=CC=C(O)C=C2,C18H22O2,S2473
19726,Imatinib (STI571),CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CC=CN=C5,C29H31N7O,S2475
19727,Lincomycin HCl,Cl.CCCC1CC(N(C)C1)C(=O)NC(C(C)O)C2OC(SC)C(O)C(O)C2O,C18H34N2O6S.HCl,S2479
19728,Loperamide HCl,Cl.CN(C)C(=O)C(CCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4,C29H33ClN2O2.HCl,S2480
19729,Manidipine,COC(=O)C1=C(C)NC(=C(C1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5)C,C35H38N4O6,S2481
19730,Manidipine 2HCl,Cl.Cl.COC(=O)C1=C(C)NC(=C(C1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5)C,C35H38N4O6.2HCl,S2482
19731,Milrinone,CC1=C(C=C(C#N)C(=O)N1)C2=CC=NC=C2,C12H9N3O,S2484
19732,Mitoxantrone (NSC-301739) 2HCl,Cl.Cl.OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(=C3C2=O)O,C22H29ClN4O6.2HCl,S2485
19733,Moroxydine HCl,Cl.NC(=N)NC(=N)N1CCOCC1,C6H13N5O.HCl,S2486
19734,Mycophenolic acid,COC1=C(C)C2=C(C(=C1C\C=C(/C)CCC(O)=O)O)C(=O)OC2,C17H20O6,S2487
19735,Nateglinide,CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(O)=O,C19H27NO3,S2489
19736,Nitrendipine,CCOC(=O)C1=C(C)NC(=C(C1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC)C,C18H20N2O6,S2491
19737,Novobiocin Sodium (NSC 2382),[Na+].COC1C(OC(N)=O)C(O)C(OC2=CC=C3C(=C(NC(=O)C4=CC=C([O-])C(=C4)CC=C(C)C)C(=O)OC3=C2C)O)OC1(C)C,C31H35N2O11.Na,S2492
19738,Olanzapine,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3,C17H20N4S,S2493
19739,Olopatadine HCl,Cl.CN(C)CC\C=C/1C2=C(COC3=C1C=C(CC(O)=O)C=C3)C=CC=C2,C21H23NO3.HCl,S2494
19740,Ozagrel,OC(=O)/C=C/C1=CC=C(C[N]2C=CN=C2)C=C1,C13H12N2O2,S2496
19741,Pancuronium dibromide,[Br-].[Br-].CC(=O)OC1CC2CCC3C(CCC4(C)C3CC(C4OC(C)=O)[N+]5(C)CCCCC5)C2(C)CC1[N+]6(C)CCCCC6,C35H60N2O4.2Br,S2497
19742,Phenoxybenzamine HCl,Cl.CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,C18H22ClNO.HCl,S2499
19743,Propafenone HCl,CCCNCC(O)COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2,C21H27NO3.HCl,S2500
19744,Propafenone,CCCNCC(O)COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2,C21H27NO3,S5789
19745,Pyrantel Pamoate,CN1CCCN=C1\C=C\C2=CC=CS2.OC(=O)C3=CC4=CC=CC=C4C(=C3O)CC5=C6C=CC=CC6=CC(=C5O)C(O)=O,C23H16O6.C11H14N2S,S2501
19746,Quinine HCl Dihydrate,O.O.Cl.COC1=CC2=C(C=C1)N=CC=C2C(O)C3CC4CCN3CC4C=C,C20H24N2O2.HCl.2H2O,S2502
19747,Racecadotril,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2,C21H23NO4S,S2503
19748,Ribavirin (ICN-1229),NC(=O)C1=N[N](C=N1)C2OC(CO)C(O)C2O,C8H12N4O5,S2504
19749,Rosiglitazone (BRL-49653) maleate,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C3=NC=CC=C3.OC(=O)\C=C/C(O)=O,C18H19N3O3S.C4H4O4,S2505
19750,Roxithromycin,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(O)CC(C)C(=N/OCOCCOC)/C(C)C(O)C1(C)O,C41H76N2O15,S2506
19751,Scopolamine (LSM-4015) HBr,Br.CN1C2CC(CC1C3OC23)OC(=O)C(CO)C4=CC=CC=C4,C17H21NO4.HBr,S2508
19752,Sotalol HCl,Cl.CC(C)NCC(O)C1=CC=C(N[S](C)(=O)=O)C=C1,C12H20N2O3S.HCl,S2509
19753,Spectinomycin 2HCl,Cl.Cl.CNC1C(O)C(NC)C2OC3(O)C(OC(C)CC3=O)OC2C1O,C14H24N2O7.2HCl,S2510
19754,Sulfadoxine,COC1=C(OC)C(=NC=N1)N[S](=O)(=O)C2=CC=C(N)C=C2,C12H14N4O4S,S2511
19755,Tenoxicam,CN1C(=C(O)C2=C(C=CS2)[S]1(=O)=O)C(=O)NC3=CC=CC=N3,C13H11N3O4S2,S2512
19756,Vardenafil HCl Trihydrate,O.O.O.Cl.CCCC1=NC(=C2[N]1N=C(NC2=O)C3=CC(=CC=C3OCC)[S](=O)(=O)N4CCN(CC)CC4)C,C23H32N6O4S.HCl.3H2O,S2515
19757,Xylazine HCl,Cl.CC1=C(NC2=NCCCS2)C(=CC=C1)C,C12H16N2S.HCl,S2516
19758,Maprotiline HCl,Cl.CNCCCC12CCC(C3=CC=CC=C13)C4=C2C=CC=C4,C20H23N.HCl,S2517
19759,Naphazoline HCl,Cl.C1CN=C(CC2=C3C=CC=CC3=CC=C2)N1,C14H14N2.HCl,S2519
19760,Epinephrine bitartrate,CNCC(O)C1=CC(=C(O)C=C1)O.OC(C(O)C(O)=O)C(O)=O,C9H13NO3.C4H6O6,S2521
19761,Phenytoin Sodium,[Na+].[O-]C1=NC(=O)C(N1)(C2=CC=CC=C2)C3=CC=CC=C3,C15H11N2NaO2,S2524
19762,Phenytoin,O=C1NC(=O)C(N1)(C2=CC=CC=C2)C3=CC=CC=C3,C15H12N2O2,S2525
19763,Ciclopirox,CC1=CC(=O)N(O)C(=C1)C2CCCCC2,C12H17NO2,S2528
19764,Dopamine HCl,Cl.NCCC1=CC(=C(O)C=C1)O,C8H11NO2.HCl,S2529
19765,L-Ascorbyl 6-palmitate,CCCCCCCCCCCCCCCC(=O)OCC(O)C1OC(=O)C(=C1O)O,C22H38O7,S2532
19766,Ritodrine HCl,Cl.CC(NCCC1=CC=C(O)C=C1)C(O)C2=CC=C(O)C=C2,C17H21NO3.HCl,S2533
19767,Isoconazole nitrate,O[N+]([O-])=O.ClC1=CC=C(C(C[N]2C=CN=C2)OCC3=C(Cl)C=CC=C3Cl)C(=C1)Cl,C18H14Cl4N2O.HNO3,S2534
19768,Econazole nitrate,O[N+]([O-])=O.ClC1=CC=C(COC(C[N]2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C=C1,C18H15Cl3N2O.HNO3,S2535
19769,Miconazole,ClC1=CC=C(COC(C[N]2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C(=C1)Cl,C18H14Cl4N2O,S2536
19770,Secnidazole,CC(O)C[N]1C(=NC=C1[N+]([O-])=O)C,C7H11N3O3,S2537
19771,Clomipramine HCl,Cl.CN(C)CCCN1C2=C(CCC3=C1C=C(Cl)C=C3)C=CC=C2,C19H23ClN2.HCl,S2541
19772,Ceftiofur HCl,Cl.CO/N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(O)=O)CSC(=O)C3=CC=CO3)C4=CSC(=N4)N,C19H17N5O7S3.HCl,S2543
19773,Tiotropium Bromide hydrate,O.[Br-].C[N+]1(C)C2CC(CC1C3OC23)OC(=O)C(O)(C4=CC=CS4)C5=CC=CS5,C19H22NO4S2.Br.xH2O,S2547
19774,Trospium chloride,[Cl-].OC(C(=O)OC1CC2CCC(C1)[N+]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5,C25H30NO3.Cl,S2549
19775,Sulbactam sodium,[Na+].CC1(C)C(N2C(CC2=O)[S]1(=O)=O)C([O-])=O,C8H10NO5S.Na,S2551
19776,Azelastine HCl,Cl.CN1CCCC(CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O,C22H24ClN3O.HCl,S2552
19777,5-Aminolevulinic acid HCl,Cl.NCC(=O)CCC(O)=O,C5H9NO3.HCl,S2553
19778,Daphnetin,OC1=CC=C2C=CC(=O)OC2=C1O,C9H6O4,S2554
19779,Clarithromycin,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(CC(C)C(=O)C(C)C(O)C1(C)O)OC,C38H69NO13,S2555
19780,Rosiglitazone (BRL 49653),CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C3=CC=CC=N3,C18H19N3O3S,S2556
19781,Terbinafine HCl,Cl.CN(C\C=C\C#CC(C)(C)C)CC1=CC=CC2=C1C=CC=C2,C21H25N.HCl,S2557
19782,Cortisone acetate,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC12C,C23H30O6,S2559
19783,Clomifene citrate,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)/C2=CC=CC=C2)/C3=CC=CC=C3.OC(=O)CC(O)(CC(O)=O)C(O)=O,C26H28ClNO.C6H8O7,S2561
19784,Cloxacillin Sodium,O.[Na+].CC1=C(C(=O)NC2C3SC(C)(C)C(N3C2=O)C([O-])=O)C(=NO1)C4=CC=CC=C4Cl,C19H19ClN3NaO6S,S2564
19785,Amoxicillin Sodium,[Na+].CC1(C)SC2C(NC(=O)C(N)C3=CC=C(O)C=C3)C(=O)N2C1C([O-])=O,C16H18N3O5S.Na,S2565
19786,Isoprenaline (NCI-C55630) HCl,Cl.CC(C)NCC(O)C1=CC=C(O)C(=C1)O,C11H17NO3.HCl,S2566
19787,Medroxyprogesterone acetate (NSC-26386),CC1CC2C(CCC3(C)C2CCC3(OC(C)=O)C(C)=O)C4(C)CCC(=O)C=C14,C24H34O4,S2567
19788,Phenylephrine (NCI-C55641) HCl,Cl.CNCC(O)C1=CC(=CC=C1)O,C9H13NO2.HCl,S2569
19789,Prednisolone Acetate,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,C23H30O6,S2570
19790,Tetracaine HCl,Cl.CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,C15H24N2O2.HCl,S2573
19791,Tetracycline HCl,Cl.CN(C)C1C2CC3C(=C(O)C2(O)C(=O)C(=C1O)C(N)=O)C(=O)C4=C(O)C=CC=C4C3(C)O,C22H24N2O8.HCl,S2574
19792,Xylometazoline HCl,Cl.CC1=C(CC2=NCCN2)C(=CC(=C1)C(C)(C)C)C,C16H24N2.HCl,S2576
19793,Phenacetin,CCOC1=CC=C(NC(C)=O)C=C1,C10H13NO2,S2577
19794,Zidovudine,CC1=CN(C2CC(N=[N+]=[N-])C(CO)O2)C(=O)NC1=O,C10H13N5O4,S2579
19795,Quinapril HCl,Cl.CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=C(CC2C(O)=O)C=CC=C3,C25H30N2O5.HCl,S2581
19796,Thiamphenicol,C[S](=O)(=O)C1=CC=C(C=C1)C(O)C(CO)NC(=O)C(Cl)Cl,C12H15Cl2NO5S,S2583
19797,Clobetasol propionate,CCC(=O)OC1(C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC12C)C(=O)CCl,C25H32ClFO5,S2584
19798,Brompheniramine hydrogen maleate,CN(C)CCC(C1=CC=C(Br)C=C1)C2=CC=CC=N2.OC(=O)\C=C/C(O)=O,C16H19BrN2.C4H4,S2585
19799,Dimethyl Fumarate,COC(=O)\C=C\C(=O)OC,C6H8O4,S2586
19800,Miglitol,OCCN1CC(O)C(O)C(O)C1CO,C8H17NO5,S2589
19801,Pioglitazone (AD-4833),CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1,C19H20N2O3S,S2590
19802,Tolvaptan,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(O)C4=C3C=CC(=C4)Cl)C,C26H25ClN2O3,S2593
19803,Clindamycin palmitate HCl,Cl.CCCCCCCCCCCCCCCC(=O)OC1C(O)C(O)C(OC1SC)C(NC(=O)C2CC(CCC)CN2C)C(C)Cl,C34H63ClN2O6S.HCl,S2596
19804,L-Thyroxine,NC(CC1=CC(=C(OC2=CC(=C(O)C(=C2)I)I)C(=C1)I)I)C(O)=O,C15H11I4NO4,S2599
19805,Gliclazide,CC1=CC=C(C=C1)[S](=O)(=O)NC(=O)NN2CC3CCCC3C2,C15H21N3O3S,S2601
19806,Acemetacin,COC1=CC2=C(C=C1)[N](C(=C2CC(=O)OCC(O)=O)C)C(=O)C3=CC=C(Cl)C=C3,C21H18ClNO6,S2602
19807,Tioxolone,OC1=CC=C2SC(=O)OC2=C1,C7H4O3S,S2603
19808,Idebenone,COC1=C(OC)C(=O)C(=C(C)C1=O)CCCCCCCCCCO,C19H30O5,S2605
19809,Mifepristone (RU486),CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(CC12C)C5=CC=C(C=C5)N(C)C,C29H35NO2,S2606
19810,Buflomedil HCl,Cl.COC1=CC(=C(C(=O)CCCN2CCCC2)C(=C1)OC)OC,C17H25NO4.HCl,S2607
19811,Fluocinonide,CC(=O)OCC(=O)C12OC(C)(C)OC1CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC23C,C26H32F2O7,S2608
19812,Inulin,OCC1OC(OC2(CO)OC(CO)C(O)C2O)C(O)C(O)C1O,C6nH10n+2O5n+1,S2609
19813,Sucrose,OCC1OC(OC2(CO)OC(CO)C(O)C2O)C(O)C(O)C1O,C12H22O11,S3598
19814,Lonidamine (AF-1890),OC(=O)C1=N[N](CC2=C(Cl)C=C(Cl)C=C2)C3=CC=CC=C13,C15H10Cl2N2O2,S2610
19815,Ethisterone,CC12CCC(=O)C=C1CCC3C2CCC4(C)C3CCC4(O)C#C,C21H28O2,S2611
19816,Clorsulon,NC1=CC(=C(C=C1[S](N)(=O)=O)[S](N)(=O)=O)C(Cl)=C(Cl)Cl,C8H8Cl3N3O4S2,S2613
19817,Noradrenaline bitartrate monohydrate,O.NCC(O)C1=CC(=C(O)C=C1)O.OC(C(O)C(O)=O)C(O)=O,C8H11NO3.C4H6O6.H2O,S2615
19818,Fostamatinib (R788),COC1=C(OC)C(=CC(=C1)NC2=NC=C(F)C(=N2)NC3=CC=C4OC(C)(C)C(=O)N(CO[P](O)(O)=O)C4=N3)OC,C23H26FN6O9P,S2625
19819,Clinofibrate,CCC(C)(OC1=CC=C(C=C1)C2(CCCCC2)C3=CC=C(OC(C)(CC)C(O)=O)C=C3)C(O)=O,C28H36O6,S2664
19820,Ciprofibrate,CC(C)(OC1=CC=C(C=C1)C2CC2(Cl)Cl)C(O)=O,C13H14Cl2O3,S2665
19821,Dolutegravir (GSK1349572),CC1CCOC2CN3C=C(C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)C(=C3C(=O)N12)O,C20H19F2N3O5,S2667
19822,Trametinib (GSK1120212),CN1C(=O)C(=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC4=CC=C(I)C=C4F)C5=CC(=CC=C5)NC(C)=O)C,C26H23FIN5O4,S2673
19823,Ibrutinib (PCI-32765),NC1=C2C(=NC=N1)[N](N=C2C3=CC=C(OC4=CC=CC=C4)C=C3)C5CCCN(C5)C(=O)C=C,C25H24N6O2,S2680
19824,Tirbanibulin,O=C(CC1=CC=C(C=N1)C2=CC=C(OCCN3CCOCC3)C=C2)NCC4=CC=CC=C4,C26H29N3O3,S2700
19825,Nilvadipine,COC(=O)C1=C(NC(=C(C1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)C)C)C#N,C19H19N3O6,S2721
19826,Dacomitinib (PF-00299804),COC1=C(NC(=O)/C=C/CN2CCCCC2)C=C3C(=NC=NC3=C1)NC4=CC(=C(F)C=C4)Cl,C24H25ClFN5O2,S2727
19827,Fedratinib (TG101348),CC1=C(NC2=CC=CC(=C2)[S](=O)(=O)NC(C)(C)C)N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=C1,C27H36N6O3S,S2736
19828,Niraparib (MK-4827),NC(=O)C1=CC=CC2=C[N](N=C12)C3=CC=C(C=C3)C4CCCNC4,C19H20N4O,S2741
19829,Canagliflozin (JNJ 28431754),CC1=C(CC2=CC=C(S2)C3=CC=C(F)C=C3)C=C(C=C1)C4OC(CO)C(O)C(O)C4O,C24H25FO5S,S2760
19830,Alectinib (CH5424802),CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C)(C)C5=C(C2=O)C6=CC=C(C=C6[NH]5)C#N,C30H34N4O2,S2762
19831,MK-2048,CCN1CC(C)[N]2C(=C(O)C3=C2C(=NN(CC4=CC=C(F)C(=C4)Cl)C3=O)C(=O)NC)C1=O,C21H21ClFN5O4,S2765
19832,Laquinimod,CCN(C(=O)C1=C(O)C2=C(C=CC=C2Cl)N(C)C1=O)C3=CC=CC=C3,C19H17ClN2O3,S2787
19833,Tofacitinib (CP-690550),CC1CCN(CC1N(C)C2=C3C=C[NH]C3=NC=N2)C(=O)CC#N,C16H20N6O,S2789
19834,Istradefylline,CCN1C(=O)N(CC)C2=C([N](C)C(=N2)\C=C\C3=CC=C(OC)C(=C3)OC)C1=O,C20H24N4O4,S2790
19835,Torcetrapib,CCOC(=O)N1C(CC)CC(N(CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)C(=O)OC)C3=C1C=CC(=C3)C(F)(F)F,C26H25F9N2O4,S2792
19836,Sofosbuvir (GS-7977),CC(C)OC(=O)C(C)N[P](=O)(OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O)OC3=CC=CC=C3,C22H29FN3O9P,S2794
19837,Lonafarnib (SCH66336),NC(=O)N1CCC(CC1)CC(=O)N2CCC(CC2)C3C4=C(CCC5=C3C(=CC(=C5)Cl)Br)C=C(Br)C=N4,C27H31Br2ClN4O2,S2797
19838,Dabrafenib (GSK2118436),CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(F)C(=CC=C3)N[S](=O)(=O)C4=C(F)C=CC=C4F,C23H20F3N5O2S2,S2807
19839,MPEP,CC1=NC(=CC=C1)C#CC2=CC=CC=C2,C14H11N,S2809
19840,Alpelisib (BYL719),CC1=C(SC(=N1)NC(=O)N2CCCC2C(N)=O)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,C19H22F3N5O2S,S2814
19841,Clindamycin,CCCC1CC(N(C)C1)C(=O)NC(C(C)Cl)C2OC(SC)C(O)C(O)C2O,C18H33ClN2O5S,S2830
19842,Apalutamide (ARN-509),CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C23CCC3)C4=CN=C(C#N)C(=C4)C(F)(F)F,C21H15F4N5O2S,S2840
19843,Baricitinib (INCB028050),CC[S](=O)(=O)N1CC(CC#N)(C1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4,C16H17N7O2S,S2851
19844,Carfilzomib (PR-171),CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN2CCOCC2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC(C)C)C(=O)C4(C)CO4,C40H57N5O7,S2853
19845,Alogliptin (SYR-322) benzoate,CN1C(=O)C=C(N2CCCC(N)C2)N(CC3=CC=CC=C3C#N)C1=O,C18H21N5O2.C7H6O2,S2868
19846,Alogliptin,CN1C(=O)C=C(N2CCCC(N)C2)N(CC3=CC=CC=C3C#N)C1=O,C18H21N5O2,S5365
19847,Camostat Mesilate,CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1.C[S](O)(=O)=O,C20H22N4O5.CH4O3S,S2874
19848,Prucalopride,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(N)C3=C2OCC3)Cl,C18H26ClN3O3,S2875
19849,4-Aminohippuric Acid,NC1=CC=C(C=C1)C(=O)NCC(O)=O,C9H10N2O3,S2883
19850,Acesulfame Potassium,[KH].CC1=CC(=O)N[S](=O)(=O)O1,C4H5NO4S.K,S2884
19851,Cobicistat (GS-9350),CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,C40H53N7O5S2,S2900
19852,Lumiracoxib,CC1=CC=C(NC2=C(Cl)C=CC=C2F)C(=C1)CC(O)=O,C15H13ClFNO2,S2903
19853,Pirfenidone (S-7701),CC1=CN(C(=O)C=C1)C2=CC=CC=C2,C12H11NO,S2907
19854,Icotinib (BPI-2009H),C#CC1=CC(=CC=C1)NC2=NC=NC3=C2C=C4OCCOCCOCCOC4=C3,C22H21N3O4,S2922
19855,Carbazochrome sodium sulfonate (AC-17),[Na+].CN1C(CC2=C\C(=N\NC(N)=O)C(=O)C=C12)[S]([O-])(=O)=O,C10H11N4NaO5S,S3000
19856,Clevudine,CC1=CN(C2OC(CO)C(O)C2F)C(=O)NC1=O,C10H13FN2O5,S3001
19857,Rivaroxaban (BAY 59-7939),ClC1=CC=C(S1)C(=O)NCC2CN(C(=O)O2)C3=CC=C(C=C3)N4CCOCC4=O,C19H18ClN3O5S,S3002
19858,Prostaglandin E2 (PGE2),CCCCCC(O)/C=C/C1C(O)CC(=O)C1C\C=C/CCCC(O)=O,C20H32O5,S3003
19859,Paroxetine HCl,Cl.FC1=CC=C(C=C1)C2CCNCC2COC3=CC4=C(OCO4)C=C3,C19H20FNO3.HCl,S3005
19860,Zaltoprofen,CC(C(O)=O)C1=CC2=C(SC3=CC=CC=C3C(=O)C2)C=C1,C17H14O3S,S3008
19861,Pazopanib,C[N]1N=C2C=C(C=CC2=C1C)N(C)C3=NC(=NC=C3)NC4=CC=C(C)C(=C4)[S](N)(=O)=O,C21H23N7O2S,S3012
19862,Amoxicillin,CC1(C)SC2C(NC(=O)C(N)C3=CC=C(O)C=C3)C(=O)N2C1C(O)=O,C16H19N3O5S,S3015
19863,Aspirin (NSC 27223),CC(=O)OC1=C(C=CC=C1)C(O)=O,C9H8O4,S3017
19864,Niflumic acid,OC(=O)C1=CC=CN=C1NC2=CC=CC(=C2)C(F)(F)F,C13H9F3N2O2,S3018
19865,Ciclopirox ethanolamine,CC1=CC(=O)N(O)C(=C1)C2CCCCC2.NCCO,C12H17NO2.C2H7NO,S3019
19866,Rimonabant (SR141716),CC1=C([N](N=C1C(=O)NN2CCCCC2)C3=CC=C(Cl)C=C3Cl)C4=CC=C(Cl)C=C4,C22H21Cl3N4O,S3021
19867,Cabazitaxel (XRP6258),COC1CC2OCC2(OC(C)=O)C3C(OC(=O)C4=CC=CC=C4)C5(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(=C(C(OC)C(=O)C13C)C5(C)C)C,C45H57NO14,S3022
19868,Bufexamac,CCCCOC1=CC=C(CC(=O)NO)C=C1,C12H17NO3,S3023
19869,Lamotrigine,NC1=NC(=C(N=N1)C2=CC=CC(=C2Cl)Cl)N,C9H7Cl2N5,S3024
19870,Fenoprofen calcium hydrate,O.O.CC(C(=O)O[Ca]OC(=O)C(C)C1=CC=CC(=C1)OC2=CC=CC=C2)C3=CC=CC(=C3)OC4=CC=CC=C4,C30H30CaO8,S3027
19871,Niclosamide (BAY2353),OC1=CC=C(Cl)C=C1C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O,C13H8Cl2N2O4,S3030
19872,Linagliptin (BI-1356),CC#CC[N]1C(=NC2=C1C(=O)N(CC3=NC4=CC=CC=C4C(=N3)C)C(=O)N2C)N5CCCC(N)C5,C25H28N8O2,S3031
19873,Vildagliptin (LAF-237),O[C]12CC3[CH2]C(C1)C[C](C3)(C2)NCC(=O)N4CCCC4C#N,C17H25N3O2,S3033
19874,Daunorubicin (RP 13057) HCl,Cl.COC1=C2C(=O)C3=C(C(=C4CC(O)(CC(OC5CC(N)C(O)C(C)O5)C4=C3O)C(C)=O)O)C(=O)C2=CC=C1,C27H29NO10.HCl,S3035
19875,Pravastatin sodium,[Na+].CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC([O-])=O)C12,C23H35O7.Na,S3036
19876,Bepotastine Besilate,OC(=O)CCCN1CCC(CC1)OC(C2=CC=C(Cl)C=C2)C3=NC=CC=C3.O[S](=O)(=O)C4=CC=CC=C4,C21H25ClN2O3.C6H6O3S,S3037
19877,Fosaprepitant dimeglumine salt,CNCC(O)C(O)C(O)C(O)CO.CNCC(O)C(O)C(O)C(O)CO.CC(OC1OCCN(CC2=NN(C(=O)N2)[P](O)(O)=O)C1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,C23H22F7N4O6P.2C7H17NO5,S3038
19878,Rofecoxib,C[S](=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,C17H14O4S,S3043
19879,Cinepazide maleate,COC1=C(OC)C(=CC(=C1)/C=C/C(=O)N2CCN(CC2)CC(=O)N3CCCC3)OC.OC(=O)\C=C/C(O)=O,C22H31N3O5.C4H4O4,S3045
19880,Azilsartan,CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NC(=O)ON5)C(O)=O,C25H20N4O5,S3046
19881,Otilonium Bromide,[Br-].CCCCCCCCOC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)OCC[N+](C)(CC)CC,C29H43BrN2O4,S3047
19882,Bosentan Hydrate,O.COC1=CC=CC=C1OC2=C(OCCO)N=C(N=C2N[S](=O)(=O)C3=CC=C(C=C3)C(C)(C)C)C4=NC=CC=N4,C27H29N5O6S.H2O,S3051
19883,Rupatadine Fumarate,CC1=CN=CC(=C1)CN2CCC(CC2)=C3C4=CC=C(Cl)C=C4CCC5=CC=CN=C35.OC(=O)\C=C\C(O)=O,C26H26ClN3.C4H4O4,S3052
19884,Azelnidipine,CC(C)OC(=O)C1=C(C)NC(=C(C1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC3CN(C3)C(C4=CC=CC=C4)C5=CC=CC=C5)N,C33H34N4O6,S3053
19885,Alverine Citrate,CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2.OC(=O)CC(O)(CC(O)=O)C(O)=O,C20H27N.C6H8O7,S3054
19886,Azilsartan Medoxomil,CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NC(=O)ON5)C(=O)OCC6=C(C)OC(=O)O6,C30H24N4O8,S3057
19887,Medetomidine HCl,Cl.CC(C1=C[NH]C=N1)C2=C(C)C(=CC=C2)C,C13H16N2.HCl,S3060
19888,Epinephrine HCl,Cl.CNCC(O)C1=CC=C(O)C(=C1)O,C9H13NO3.HCl,S3061
19889,Diclofenac Potassium,[K+].[O-]C(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl,C14H10Cl2KNO2,S3062
19890,Diclofenac Diethylamine,CCNCC.OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl,C14H11Cl2NO2.C4H11N,S3063
19891,Naloxone HCl,Cl.OC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5CC=C)C=C1,C19H21NO4.HCl,S3066
19892,Chlorhexidine 2HCl,Cl.Cl.ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1,C22H30Cl2N10.2HCl,S3067
19893,Vanillin,COC1=CC(=CC=C1O)C=O,C8H8O3,S3071
19894,Chlorthalidone,N[S](=O)(=O)C1=CC(=CC=C1Cl)C2(O)NC(=O)C3=C2C=CC=C3,C14H11ClN2O4S,S3074
19895,Tazobactam,CC1(C[N]2C=CN=N2)C(N3C(CC3=O)[S]1(=O)=O)C(O)=O,C10H12N4O5S,S3077
19896,Beclomethasone dipropionate,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC12C,C28H37ClO7,S3078
19897,Atovaquone,OC1=C(C2CCC(CC2)C3=CC=C(Cl)C=C3)C(=O)C4=C(C=CC=C4)C1=O,C22H19ClO3,S3079
19898,Etravirine (TMC125),CC1=CC(=CC(=C1OC2=C(Br)C(=NC(=N2)NC3=CC=C(C=C3)C#N)N)C)C#N,C20H15BrN6O,S3080
19899,Ulipristal Acetate (CDB 2914),CN(C)C1=CC=C(C=C1)C2CC3(C)C(CCC3(OC(C)=O)C(C)=O)C4CCC5=CC(=O)CCC5=C24,C30H37NO4,S3081
19900,Indacaterol Maleate,CCC1=CC2=C(CC(C2)NCC(O)C3=CC=C(O)C4=C3C=CC(=O)N4)C=C1CC.OC(=O)\C=C/C(O)=O,C24H28N2O3.C4H4O4,S3083
19901,2-Thiouracil,O=C1NC(=S)NC=C1,C4H4N2OS,S3100
19902,Moguisteine,CCOC(=O)CC(=O)N1CCSC1COC2=CC=CC=C2OC,C16H21NO5S,S3104
19903,Nadifloxacin,CC1CCC2=C3N1C=C(C(O)=O)C(=O)C3=CC(=C2N4CCC(O)CC4)F,C19H21FN2O4,S3105
19904,Pidotimod,OC(=O)C1CSCN1C(=O)C2CCC(=O)N2,C9H12N2O4S,S3106
19905,Pyridoxine HCl,Cl.CC1=C(O)C(=C(CO)C=N1)CO,C8H11NO3.HCl,S3113
19906,Vitamin C,OCC(O)C1OC(=O)C(=C1O)O,C6H8O6,S3114
19907,Sulfathiazole,NC1=CC=C(C=C1)[S](=O)(=O)NC2=NC=CS2,C9H9N3O2S2,S3116
19908,Oxybutynin hydrochloride,Cl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C2=CC=CC=C2,C22H31NO3.HCl,S3117
19909,Doxepin HCl,Cl.CN(C)CC\C=C1/C2=CC=CC=C2COC3=C1C=CC=C3,C19H21NO.HCl,S3120
19910,Ornidazole,CC1=NC=C([N]1CC(O)CCl)[N+]([O-])=O,C7H10ClN3O3,S3121
19911,Dexamethasone Acetate,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(C)=O,C24H31FO6,S3124
19912,Trimethoprim,COC1=C(OC)C(=CC(=C1)CC2=CN=C(N)N=C2N)OC,C14H18N4O3,S3129
19913,Biotin (Vitamin B7),OC(=O)CCCCC1SCC2NC(=O)NC12,C10H16N2O3S,S3130
19914,Sulfamerazine,CC1=NC(=NC=C1)N[S](=O)(=O)C2=CC=C(N)C=C2,C11H12N4O2S,S3132
19915,Sulfamethazine,CC1=NC(=NC(=C1)C)N[S](=O)(=O)C2=CC=C(N)C=C2,C12H14N4O2S,S3133
19916,Sodium salicylate,[NaH].OC(=O)C1=CC=CC=C1O,C7H6O3.Na,S3137
19917,Methylthiouracil,CC1=CC(=O)NC(=S)N1,C5H6N2OS,S3138
19918,Milnacipran HCl,Cl.CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,C15H22N2O.HCl,S3140
19919,Levomilnacipran Hydrochloride,Cl.CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,C15H23ClN2O,S5693
19920,Darifenacin HBr,Br.NC(=O)C(C1CCN(CCC2=CC=C3OCCC3=C2)C1)(C4=CC=CC=C4)C5=CC=CC=C5,C28H30N2O2.HBr,S3144
19921,Entacapone,CCN(CC)C(=O)\C(=C\C1=CC(=C(O)C(=C1)O)[N+]([O-])=O)C#N,C14H15N3O5,S3147
19922,Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=CC(=CC=C4C3CCC12C)O,C23H32O3,S3149
19923,Articaine HCl,Cl.CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC,C13H20N2O3S.HCl,S3150
19924,Gliquidone,COC1=CC2=C(C=C1)C(C)(C)C(=O)N(CCC3=CC=C(C=C3)[S](=O)(=O)NC(=O)NC4CCCCC4)C2=O,C27H33N3O6S,S3151
19925,Levalbuterol tartrate,CC(C)(C)NCC(O)C1=CC=C(O)C(=C1)CO.CC(C)(C)NCC(O)C2=CC=C(O)C(=C2)CO.OC(C(O)C(O)=O)C(O)=O,C30H48N2O12,S3153
19926,Butenafine HCl,Cl.CN(CC1=CC=C(C=C1)C(C)(C)C)CC2=C3C=CC=CC3=CC=C2,C23H27N.HCl,S3154
19927,Mepivacaine HCl,Cl.CN1CCCCC1C(=O)NC2=C(C)C=CC=C2C,C15H22N2O.HCl,S3155
19928,Ethynodiol diacetate,CC(=O)OC1CCC2C3CCC4(C)C(CCC4(OC(C)=O)C#C)C3CCC2=C1,C24H32O4,S3160
19929,Sertaconazole nitrate,O[N+]([O-])=O.ClC1=CC=C(C(C[N]2C=CN=C2)OCC3=CSC4=C(Cl)C=CC=C34)C(=C1)Cl,C20H15Cl3N2OS.HNO3,S3161
19930,Tylosin tartrate,CCC1OC(=O)CC(O)C(C)C(OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(C2O)N(C)C)C(CC=O)CC(C)C(=O)\C=C\C(=C\C1COC4OC(C)C(O)C(OC)C4OC)C.OC(C(O)C(O)=O)C(O)=O,C46H77NO17.C4H6O6,S3162
19931,Benztropine mesylate,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.C[S](O)(=O)=O,C21H25NO.CH4SO3,S3163
19932,Altrenogest,CC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(O)CC=C,C21H26O2,S3167
19933,Ampicillin sodium,[Na+].CC1(C)SC2C(NC(=O)C(N)C3=CC=CC=C3)C(=O)N2C1C([O-])=O,C16H18N3NaO4S,S3170
19934,Anagrelide HCl,Cl.ClC1=CC=C2NC3=NC(=O)CN3CC2=C1Cl,C10H7Cl2N3O.HCl,S3172
19935,Antipyrine,CN1N(C(=O)C=C1C)C2=CC=CC=C2,C11H12N2O,S3173
19936,Atomoxetine HCl,Cl.CNCCC(OC1=CC=CC=C1C)C2=CC=CC=C2,C17H21NO.HCl,S3175
19937,Betahistine 2HCl,Cl.Cl.CNCCC1=NC=CC=C1,C8H12N2.2HCl,S3176
19938,Brinzolamide,CCNC1CN(CCCOC)[S](=O)(=O)C2=C1C=C(S2)[S](N)(=O)=O,C12H21N3O5S3,S3178
19939,Carbenicillin disodium,[Na+].[Na+].CC1(C)SC2C(NC(=O)C(C([O-])=O)C3=CC=CC=C3)C(=O)N2C1C([O-])=O,C17H16N2Na2O6S,S3179
19940,Eletriptan HBr,Br.CN1CCCC1CC2=C[NH]C3=C2C=C(CC[S](=O)(=O)C4=CC=CC=C4)C=C3,C22H26N2O2S.HBr,S3180
19941,Flumequine,CC1CCC2=C3N1C=C(C(O)=O)C(=O)C3=CC(=C2)F,C14H12FNO3,S3181
19942,Amitriptyline HCl,Cl.CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C13,C20H23N.HCl,S3183
19943,Adrenalone HCl,Cl.CNCC(=O)C1=CC(=C(O)C=C1)O,C9H11NO3.HCl,S3185
19944,Azatadine dimaleate,CN1CCC(CC1)=C2C3=CC=CC=C3CCC4=CC=CN=C24.OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O,C20H22N2.2C4H4O4,S3186
19945,Ropinirole HCl,Cl.CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2,C16H24N2O.HCl,S3189
19946,Ticarcillin sodium,[NaH].[NaH].CC1(C)SC2C(NC(=O)C(C(O)=O)C3=CSC=C3)C(=O)N2C1C(O)=O,C15H16N2O6S2.2Na,S3193
19947,Azlocillin sodium salt,[NaH].CC1(C)SC2C(NC(=O)C(NC(=O)N3CCNC3=O)C4=CC=CC=C4)C(=O)N2C1C(O)=O,C20H23N5O6S.Na,S3195
19948,Reboxetine mesylate,CCOC1=C(OC(C2CNCCO2)C3=CC=CC=C3)C=CC=C1.C[S](O)(=O)=O,C19H23NO3.CH4O3S,S3199
19949,Triflusal,CC(=O)OC1=CC(=CC=C1C(O)=O)C(F)(F)F,C10H7F3O4,S3200
19950,Trifluoperazine 2HCl,Cl.Cl.CN1CCN(CCCN2C3=C(SC4=CC=C(C=C24)C(F)(F)F)C=CC=C3)CC1,C21H24F3N3S.2HCl,S3201
19951,Catharanthine,CCC1=CC2CN3CCC4=C([NH]C5=CC=CC=C45)C(C2)(C13)C(=O)OC,C21H24N2O2,S3202
19952,Iopromide,COCC(=O)NC1=C(I)C(=C(I)C(=C1I)C(=O)N(C)CC(O)CO)C(=O)NCC(O)CO,C18H24I3N3O8,S3207
19953,Fexofenadine HCl,Cl.CC(C)(C(O)=O)C1=CC=C(C=C1)C(O)CCCN2CCC(CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4,C32H39NO4.HCl,S3208
19954,Moclobemide (Ro 111163),ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2,C13H17ClN2O2,S3212
19955,Triptolide (PG490),CC(C)C12OC1C3OC34C5(C)CCC6=C(COC6=O)C5CC7OC47C2O,C20H24O6,S3604
19956,Fangchinoline,COC1=C2OC3=CC=C(CC4N(C)CCC5=C4C=C(OC6=C(O)C(=CC7=C6C(CC(=C2)C=C1)N(C)CC7)OC)C(=C5)OC)C=C3,C37H40N2O6,S3606
19957,Berbamine dihydrochloride,Cl.Cl.COC1=CC2=C3C=C1OC4=C(OC)C(=CC5=C4C(CC6=CC(=C(O)C=C6)OC7=CC=C(CC3N(C)CC2)C=C7)N(C)CC5)OC,C37H40N2O6.2HCl,S3609
19958,(+)-Fangchinoline,COC1=C2OC3=CC=C(CC4N(C)CCC5=C4C=C(OC6=C7C(CC(=C2)C=C1)N(C)CCC7=CC(=C6O)OC)C(=C5)OC)C=C3,C37H40N2O6,S3611
19959,Rosmarinic acid,OC(=O)C(CC1=CC=C(O)C(=C1)O)OC(=O)\C=C\C2=CC=C(O)C(=C2)O,C18H16O8,S3612
19960,Dehydrocostus Lactone,C=C1CCC2C(OC(=O)C2=C)C3C1CCC3=C,C15H18O2,S3615
19961,Asiaticoside,CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(CO)C5CCC34C)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O,C48H78O19,S3616
19962,Acetylspiramycin (ASPM),COC1C(CC(=O)OC(C)C/C=C/C=C/C(OC2CCC(C(C)O2)N(C)C)C(C)CC(CC=O)C1OC3OC(C)C(OC4CC(C)(O)C(O)C(C)O4)C(C3O)N(C)C)OC(C)=O,C45H76N2O15,S3618
19963,Pazufloxacin mesylate,CC1COC2=C(C(=CC3=C2N1C=C(C(O)=O)C3=O)F)C4(N)CC4.C[S](O)(=O)=O,C16H15FN2O4.CH4O3S,S3621
19964,Diammonium Glycyrrhizinate,N.N.CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(O)=O)OC6OC(C(O)C(O)C6OC7OC(C(O)C(O)C7O)C(O)=O)C(O)=O,C42H62O16.2H3N,S3622
19965,Ceftibuten dihydrate,O.O.NC1=NC(=CS1)C(=C/CC(O)=O)/C(=O)NC2C3SCC=C(N3C2=O)C(O)=O,C15H18N4O8S2,S3623
19966,Tyramine,NCCC1=CC=C(O)C=C1,C8H11NO,S3625
19967,Tryptamine,NCCC1=C[NH]C2=CC=CC=C12,C10H12N2,S3627
19968,Medroxyprogesterone,CC1CC2C(CCC3(C)C2CCC3(O)C(C)=O)C4(C)CCC(=O)C=C14,C22H32O3,S3635
19969,Cefpirome sulfate,CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C([O-])=O)C[N+]3=CC=CC4=C3CCC4)C5=CSC(=N5)N.O[S](O)(=O)=O,C22H23N6O5S2.HO4S,S3637
19970,Cefamandole nafate,[Na+].C[N]1N=NN=C1SCC2=C(N3C(SC2)C(NC(=O)C(OC=O)C4=CC=CC=C4)C3=O)C([O-])=O,C19H17N6O6S2.Na,S3638
19971,Tacrine hydrochloride hydrate,NC1=C2C=CC=CC2=NC3=C1CCCC3,C13H14N2.xHCl.xH2O,S3639
19972,Methoxyphenamine Hydrochloride,Cl.CNC(C)CC1=CC=CC=C1OC,C11H17N.HCl,S3640
19973,Osalmid,OC1=CC=C(NC(=O)C2=C(O)C=CC=C2)C=C1,C13H11NO3,S3641
19974,Amitraz,CN(C=NC1=CC=C(C)C=C1C)C=NC2=CC=C(C)C=C2C,C19H23N3,S3643
19975,Sulfamonomethoxine,COC1=NC=NC(=C1)N[S](=O)(=O)C2=CC=C(N)C=C2,C11H12N4O3S,S3644
19976,Kitasamycin,COC1C(O)CC(=O)OC(C)C/C=C/C=C/C(O)C(C)CC(CC=O)C1OC2OC(C)C(OC3CC(C)(O)C(OC(=O)CC(C)C)C(C)O3)C(C2O)N(C)C,C40H67NO14,S3645
19977,Mafenide Acetate,CC(O)=O.NCC1=CC=C(C=C1)[S](N)(=O)=O,C7H10N2O2S.C2H4O2,S3647
19978,Amlexanox (AA-673),CC(C)C1=CC2=C(OC3=NC(=C(C=C3C2=O)C(O)=O)N)C=C1,C16H14N2O4,S3648
19979,Tauroursodeoxycholic Acid (TUDCA),CC(CCC(=O)NCC[S](O)(=O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C,C26H45NO6S,S3654
19980,Taurochenodeoxycholic acid,CC(CCC(=O)NCC[S](O)(=O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C,C26H45NO6S,S3865
19981,Cefepime Dihydrochloride Monohydrate,O.Cl.Cl.CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C([O-])=O)C[N+]3(C)CCCC3)C4=CSC(=N4)N,C19H25N6O5S2.HCl.Cl.H2O,S3655
19982,Piribedil,C1OC2=CC=C(CN3CCN(CC3)C4=NC=CC=N4)C=C2O1,C16H18N4O2,S3656
19983,Promestriene,CCCOC1=CC2=C(C=C1)C3CCC4(C)C(CCC4C3CC2)OC,C22H32O2,S3657
19984,Fludrocortisone acetate,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3(F)C(O)CC12C,C23H31FO6,S3659
19985,Afloqualone,CC1=C(C=CC=C1)N2C(=O)C3=C(C=CC(=C3)N)N=C2CF,C16H14FN3O,S3663
19986,Ilaprazole,COC1=CC=NC(=C1C)C[S](=O)C2=NC3=C([NH]2)C=C(C=C3)[N]4C=CC=C4,C19H18N4O2S,S3666
19987,Thymopentin,CC(C)C(NC(=O)C(CC(O)=O)NC(=O)C(CCCCN)NC(=O)C(N)CCCNC(N)=N)C(=O)NC(CC1=CC=C(O)C=C1)C(O)=O,C30H49N9O9,S3668
19988,Carmustine,ClCCNC(=O)N(CCCl)N=O,C5H9Cl2N3O2,S3669
19989,Quinestrol,CC12CCC3C(CCC4=C3C=CC(=C4)OC5CCCC5)C1CCC2(O)C#C,C25H32O2,S3671
19990,Cefonicid sodium,[Na+].[Na+].OC(C(=O)NC1C2SCC(=C(N2C1=O)C([O-])=O)CSC3=NN=N[N]3C[S]([O-])(=O)=O)C4=CC=CC=C4,C18H16N6O8S3.2Na,S3672
19991,Sulfaphenazole,NC1=CC=C(C=C1)[S](=O)(=O)NC2=CC=N[N]2C3=CC=CC=C3,C15H14N4O2S,S3673
19992,Levamlodipine,CCOC(=O)C1=C(COCCN)NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C,C20H25ClN2O5,S3674
19993,Umbelliferone,OC1=CC2=C(C=C1)C=CC(=O)O2,C9H6O3,S3675
19994,Carbendazim,COC(=O)NC1=NC2=C([NH]1)C=CC=C2,C9H9N3O2,S3676
19995,Cinnamic acid,OC(=O)/C=C/C1=CC=CC=C1,C9H8O2,S3677
19996,Vitamin E Acetate,CC(C)CCCC(C)CCCC(C)CCCC1(C)CCC2=C(C)C(=C(C)C(=C2O1)C)OC(C)=O,C31H52O3,S3681
19997,DL-α-tocopherol acetate,CC(C)CCCC(C)CCCC(C)CCCC1(C)CCC2=C(C)C(=C(C)C(=C2O1)C)OC(C)=O,C31H52O3,E0191
19998,Methacholine chloride,[Cl-].CC(C[N+](C)(C)C)OC(C)=O,C8H18NO2.Cl,S3684
19999,Urea,NC(N)=O,CH4N2O,S3687
20000,Ethidium bromide,[Br-].CC[N+]1=C2C=C(N)C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N,C21H20N3.Br,S3689
20001,Pargyline hydrochloride,Cl.CN(CC#C)CC1=CC=CC=C1,C11H13N.HCl,S3690
20002,"2,6-Dihydroxypurine",O=C1NC(=O)C2=C(N1)N=C[NH]2,C5H4N4O2,S3693
20003,Glucosamine hydrochloride,Cl.NC1C(O)OC(CO)C(O)C1O,C6H13NO5.HCl,S3694
20004,Mafenide hydrochloride,Cl.NCC1=CC=C(C=C1)[S](N)(=O)=O,C7H10N2O2S.HCl,S3697
20005,Nortriptyline hydrochloride,Cl.CNCCC=C1C2=C(CCC3=C1C=CC=C3)C=CC=C2,C19H21N.HCl,S3698
20006,Benactyzine hydrochloride,Cl.CCN(CC)CCOC(=O)C(O)(C1=CC=CC=C1)C2=CC=CC=C2,C20H25NO3.HCl,S3701
20007,Phenethyl alcohol,OCCC1=CC=CC=C1,C8H10O,S3703
20008,4-Methylbenzylidene camphor,CC1=CC=C(C=C1)\C=C/2C3CCC(C)(C2=O)C3(C)C,C18H22O,S3704
20009,Chlorobutanol,CC(C)(O)C(Cl)(Cl)Cl,C4H7Cl3O,S3705
20010,Sarpogrelate hydrochloride,Cl.COC1=CC=CC(=C1)CCC2=C(OCC(CN(C)C)OC(=O)CCC(O)=O)C=CC=C2,C24H31NO6.HCl,S3706
20011,Ethopabate,CCOC1=CC(=CC=C1C(=O)OC)NC(C)=O,C12H15NO4,S3707
20012,Sulfachloropyridazine,NC1=CC=C(C=C1)[S](=O)(=O)NC2=CC=C(Cl)N=N2,C10H9ClN4O2S,S3708
20013,Furagin,[O-][N+](=O)C1=CC=C(O1)/C=C/C=N/N2CC(=O)NC2=O,C10H8N4O5,S3709
20014,Carbasalate Calcium,CC(=O)OC1=C(C=CC=C1)C(=O)O[Ca]OC(=O)C2=C(OC(C)=O)C=CC=C2.NC(N)=O,C18H14O8.CH4N2O.Ca,S3711
20015,Moxidectin,CO\N=C1/CC2(CC3CC(C\C=C(C)\CC(C)/C=C/C=C/4COC5C(O)C(=CC(C(=O)O3)C45O)C)O2)OC(C1C)\C(C)=C\C(C)C,C37H53NO8,S3713
20016,Lifitegrast,C[S](=O)(=O)C1=CC=CC(=C1)CC(NC(=O)C2=C(Cl)C=C3CN(CCC3=C2Cl)C(=O)C4=CC=C5C=COC5=C4)C(O)=O,C29H24Cl2N2O7S,S3714
20017,Flibanserin,FC(F)(F)C1=CC=CC(=C1)N2CCN(CC2)CCN3C(=O)NC4=C3C=CC=C4,C20H21F3N4O,S3716
20018,Topiroxostat,N#CC1=NC=CC(=C1)C2=N[NH]C(=N2)C3=CC=NC=C3,C13H8N6,S3719
20019,Elafibranor,CSC1=CC=C(C=C1)C(=O)\C=C\C2=CC(=C(OC(C)(C)C(O)=O)C(=C2)C)C,C22H24O4S,S3720
20020,Isavuconazole,CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(O)(C[N]3C=NC=N3)C4=CC(=CC=C4F)F,C22H17F2N5OS,S3722
20021,Ramosetron Hydrochloride,Cl.C[N]1C=C(C(=O)C2CCC3=C(C2)[NH]C=N3)C4=C1C=CC=C4,C17H17N3O.HCl,S3723
20022,Velpatasvir,COCC1CC(N(C1)C(=O)C(NC(=O)OC)C2=CC=CC=C2)C3=NC=C([NH]3)C4=CC=C5C(=C4)COC6=C5C=C7C=CC8=C(N=C([NH]8)C9CCC(C)N9C(=O)C(NC(=O)OC)C(C)C)C7=C6,C49H54N8O8,S3724
20023,Selexipag,CC(C)N(CCCCOCC(=O)N[S](C)(=O)=O)C1=NC(=C(N=C1)C2=CC=CC=C2)C3=CC=CC=C3,C26H32N4O4S,S3726
20024,Vilanterol Trifenate,OCC1=CC(=CC=C1O)C(O)CNCCCCCCOCCOCC2=C(Cl)C=CC=C2Cl.OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5,C24H33Cl2NO5.C20H16O2,S3727
20025,Grazoprevir,COC1=CC2=NC3=C(CCCCCC4CC4OC(=O)NC(C(=O)N5CC(CC5C(=O)NC6(CC6C=C)C(=O)N[S](=O)(=O)C7CC7)O3)C(C)(C)C)N=C2C=C1,C38H50N6O9S,S3728
20026,Iron sucrose,[Fe+3].[Fe+3].OC(C(O)C(O)C([O-])=O)C(O)C([O-])=O.OC(C(O)C(O)C([O-])=O)C(O)C([O-])=O.OC(C(O)C(O)C([O-])=O)C(O)C([O-])=O,C18H24Fe2O24,S3729
20027,Metaxalone,CC1=CC(=CC(=C1)C)OCC2CNC(=O)O2,C12H15NO3,S3730
20028,Tipiracil hydrochloride,Cl.ClC1=C(CN2CCCC2=N)NC(=O)NC1=O,C9H11ClN4O2.HCl,S3731
20029,Avibactam sodium,[Na+].NC(=O)C1CCC2CN1C(=O)N2O[S]([O-])(=O)=O,C7H10N3O6.Na,S3732
20030,Boceprevir,CC(C)(C)NC(=O)NC(C(=O)N1CC2C(C1C(=O)NC(CC3CCC3)C(=O)C(N)=O)C2(C)C)C(C)(C)C,C27H45N5O5,S3733
20031,Umeclidinium bromide,[Br-].OC(C1=CC=CC=C1)(C2=CC=CC=C2)C34CC[N+](CCOCC5=CC=CC=C5)(CC3)CC4,C29H34NO2.Br,S3735
20032,Travoprost,CC(C)OC(=O)CCC\C=C/CC1C(O)CC(O)C1\C=C\C(O)COC2=CC(=CC=C2)C(F)(F)F,C26H35F3O6,S3738
20033,Calcipotriene,CC(\C=C\C(O)C1CC1)C2CCC3/C(CCCC23C)=C/C=C\4CC(O)CC(O)C4=C,C27H40O3,S3739
20034,Benznidazole,[O-][N+](=O)C1=NC=C[N]1CC(=O)NCC2=CC=CC=C2,C12H12N4O3,S3741
20035,Cholic acid,CC(CCC(O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,C24H40O5,S3742
20036,Balsalazide disodium,O.O.[Na+].[Na+].OC1=CC=C(C=C1C([O-])=O)N=NC2=CC=C(C=C2)C(=O)NCCC([O-])=O,C17H13N3O6.2H2O.2Na,S3745
20037,Lumefantrine,CCCCN(CCCC)CC(O)C1=CC(=CC\2=C1C3=C(C=C(Cl)C=C3)C2=C/C4=CC=C(Cl)C=C4)Cl,C30H32Cl3NO,S3746
20038,Levothyroxine sodium,[Na+].NC(CC1=CC(=C(OC2=CC(=C(O)C(=C2)I)I)C(=C1)I)I)C([O-])=O,C15H10I4NO4.Na,S3747
20039,Sodium benzoate,[Na+].[O-]C(=O)C1=CC=CC=C1,C7H5O2.Na,S3750
20040,Quinidine hemisulfate hydrate,O.O.COC1=CC2=C(C=C1)N=CC=C2C(O)C3CC4CCN3CC4C=C.COC5=CC6=C(C=C5)N=CC=C6C(O)C7CC8CCN7CC8C=C.O[S](O)(=O)=O,C20H24N2O2.1/2H2SO4.H2O,S3751
20041,4-Hydroxybenzoic acid,OC(=O)C1=CC=C(O)C=C1,C7H6O3,S3754
20042,Methyl salicylate,COC(=O)C1=C(O)C=CC=C1,C8H8O3,S3756
20043,Sinomenine hydrochloride,Cl.COC1=C(O)C2=C(CC3C4C=C(OC)C(=O)CC24CCN3C)C=C1,C19H23NO4.HCl,S3758
20044,Norcantharidin,O=C1OC(=O)C2C3CCC(O3)C12,C8H8O4,S3759
20045,Cinnamaldehyde,O=C\C=C\C1=CC=CC=C1,C9H8O,S3763
20046,Tanshinone IIA sulfonate sodium,[Na+].CC1=C(OC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C)[S]([O-])(=O)=O,C19H17O6S.Na,S3766
20047,Palmatine,COC1=CC2=C(C=C1OC)C3=CC4=C(C=[N+]3CC2)C(=C(OC)C=C4)OC,C21H22NO4,S3769
20048,5-Hydroxymethylfurfural,OCC1=CC=C(O1)C=O,C6H6O3,S3772
20049,Tyrosol,OCCC1=CC=C(O)C=C1,C8H10O2,S3773
20050,Dehydroandrographolide Succinate Potasium Salt,[K+].CC1(COC(=O)CCC([O-])=O)C(CCC2(C)C1CCC(=C)C2\C=C\C3=CCOC3=O)OC(=O)CCC(O)=O,C28H35O10.K,S3774
20051,Ligustrazine hydrochloride,Cl.CC1=NC(=C(C)N=C1C)C,C8H12N2.HCl,S3775
20052,Sophoricoside,OCC1OC(OC2=CC=C(C=C2)C3=COC4=C(C(=CC(=C4)O)O)C3=O)C(O)C(O)C1O,C21H20O10,S3776
20053,cis-Anethole,COC1=CC=C(\C=C\C)C=C1,C10H12O,S3779
20054,Trans-Anethole,COC1=CC=C(\C=C\C)C=C1,C10H12O,S3990
20055,Ginkgolide C,CC1C(=O)OC2C(O)C34C5OC(=O)C3(OC6OC(=O)C(O)C46C(C5O)C(C)(C)C)C12O,C20H24O11,S3781
20056,Echinacoside,CC1OC(OC2C(O)C(OCCC3=CC(=C(O)C=C3)O)OC(COC4OC(CO)C(O)C(O)C4O)C2OC(=O)\C=C\C5=CC=C(O)C(=C5)O)C(O)C(O)C1O,C35H46O20,S3783
20057,Notoginsenoside R1,CC(C)=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(CC34C)OC6OC(CO)C(O)C(O)C6OC7OCC(O)C(O)C7O,C47H80O18,S3785
20058,Carvacrol,CC(C)C1=CC=C(C)C(=C1)O,C10H14O,S3788
20059,Succinic acid,OC(=O)CCC(O)=O,C4H6O4,S3791
20060,Palmitic acid,CCCCCCCCCCCCCCCC(O)=O,C16H32O2,S3794
20061,Helicide,OCC1OC(OC2=CC=C(C=O)C=C2)C(O)C(O)C1O,C13H16O7,S3797
20062,Gentisic acid,OC(=O)C1=C(O)C=CC(=C1)O,C7H6O4,S3799
20063,Trigonelline Hydrochloride,[Cl-].C[N+]1=CC(=CC=C1)C(O)=O,C7H8NO2.Cl,S3802
20064,Stevioside,CC12CCCC(C)(C1CCC34CC(=C)C(CCC23)(C4)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O,C38H60O18,S3805
20065,Dehydroandrographolide,CC1(CO)C(O)CCC2(C)C(C\C=C3/C=COC3=O)C(=C)CCC12,C20H28O4,S3807
20066,Imperatorin,CC(C)=CCOC1=C2OC(=O)C=CC2=CC3=C1OC=C3,C16H14O4,S3809
20067,Scutellarin,OC1C(O)C(OC(C1O)C(O)=O)OC2=CC3=C(C(=O)C=C(O3)C4=CC=C(O)C=C4)C(=C2O)O,C21H18O12,S3810
20068,Ginsenoside Re,CC1OC(OC2C(O)C(O)C(CO)OC2OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C1O,C48H82O18,S3811
20069,Monocrotaline,CC1C(=O)OC2CCN3CC=C(COC(=O)C(C)(O)C1(C)O)C23,C16H23NO6,S3812
20070,Harmine hydrochloride,Cl.COC1=CC2=C(C=C1)C3=CC=NC(=C3[NH]2)C,C13H12N2O.HCl,S3817
20071,Quercitrin,CC1OC(OC2=C(OC3=C(C(=CC(=C3)O)O)C2=O)C4=CC(=C(O)C=C4)O)C(O)C(O)C1O,C21H20O11,S3824
20072,Loganin,COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)C3C(C)C(O)CC13,C17H26O10,S3835
20073,Isoquercitrin,OCC1OC(OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(O)C=C4)O)C(O)C(O)C1O,C21H20O12,S3842
20074,Madecassoside,CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(CO)C5C(O)CC34C)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O,C48H78O20,S3843
20075,Eupatilin,COC1=CC=C(C=C1OC)C2=CC(=O)C3=C(O2)C=C(O)C(=C3O)OC,C18H16O7,S3846
20076,Panaxatriol,CC1(C)CCCC(C)(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C,C30H52O4,S3847
20077,D-Galactose,OCC1OC(O)C(O)C(O)C1O,C6H12O6,S3849
20078,D-Mannose,OCC1OC(O)C(O)C(O)C1O,C6H12O6,S5763
20079,Glucosamine sulfate,NC(C=O)C(O)C(O)C(O)CO.O[S](O)(=O)=O,C6H13NO5.H2SO4,S3850
20080,Camphor,CC1(C)C2CCC1(C)C(=O)C2,C10H16O,S3851
20081,(+)-Camphor,CC1(C)C2CCC1(C)C(=O)C2,C10H16O,S4516
20082,Tetrahydropalmatine hydrochloride,Cl.COC1=C(OC)C2=C(CC3N(CCC4=C3C=C(OC)C(=C4)OC)C2)C=C1,C21H25NO4.HCl,S3854
20083,Allantoin,NC(=O)NC1NC(=O)NC1=O,C4H6N4O3,S3856
20084,Lawsone,OC1=CC(=O)C2=C(C=CC=C2)C1=O,C10H6O3,S3858
20085,Galanthamine,COC1=C2OC3CC(O)C=CC34CCN(C)CC(=C24)C=C1,C17H21NO3,S3866
20086,Harmine,COC1=CC2=C(C=C1)C3=CC=NC(=C3[NH]2)C,C13H12N2O,S3868
20087,D-Pinitol,COC1C(O)C(O)C(O)C(O)C1O,C7H14O6,S3870
20088,Guaiacol,COC1=C(O)C=CC=C1,C7H8O2,S3872
20089,Indigo,O=C1\C(NC2=C1C=CC=C2)=C\3NC4=C(C=CC=C4)C3=O,C16H10N2O2,S3876
20090,Scopoletin,COC1=CC2=C(OC(=O)C=C2)C=C1O,C10H8O4,S3881
20091,Protopine,CN1CCC2=C(C=C3OCOC3=C2)C(=O)CC4=C(C1)C5=C(OCO5)C=C4,C20H19NO5,S3883
20092,Pyrogallol,OC1=C(O)C(=CC=C1)O,C6H6O3,S3885
20093,Arteether,CCOC1OC2OC3(C)CCC4C(C)CCC(C1C)C24OO3,C17H28O5,S3889
20094,Isopsoralen,O=C1OC2=C(C=C1)C=CC3=C2C=CO3,C11H6O3,S3892
20095,Bornyl acetate,CC(=O)OC1CC2CCC1(C)C2(C)C,C12H20O2,S3893
20096,Hydroxy Camptothecine,CCC1(O)C(=O)OCC2=C1C=C3N(CC4=CC5=C(C=CC(=C5)O)N=C34)C2=O,C20H16N2O5,S3898
20097,Hederagenin,CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(CO)C5CCC34C)C2C1)C(O)=O,C30H48O4,S3899
20098,Astragaloside IV,CC(C)(O)C1CCC(C)(O1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O,C41H68O14,S3901
20099,Bulleyaconi cine A,CCN1CC2(CCC(OC)C34C5CC6(O)C(CC(OC(C)=O)(C(C(OC)C23)C14)C5C6C(=O)C7=CC=C(OC)C=C7)OC)COC,C35H49NO9,S3907
20100,Catalpol,OCC1OC(OC2OC=CC3C(O)C4OC4(CO)C23)C(O)C(O)C1O,C15H22O10,S3909
20101,α-Hederin,CC1OC(OC2C(O)C(O)COC2OC3CCC4(C)C(CCC5(C)C4CC=C6C7CC(C)(C)CCC7(CCC56C)C(O)=O)C3(C)CO)C(O)C(O)C1O,C41H66O12,S3914
20102,Hederacoside C,CC1OC(OC2C(O)C(O)C(OCC3OC(OC(=O)C45CCC(C)(C)CC4C6=CCC7C8(C)CCC(OC9OCC(O)C(O)C9OC%10OC(C)C(O)C(O)C%10O)C(C)(CO)C8CCC7(C)C6(C)CC5)C(O)C(O)C3O)OC2CO)C(O)C(O)C1O,C59H96O26,S3919
20103,Lathyrol,CC1CC2(O)C(C1O)C(O)C(=C)CCC3C(\C=C(C)\C2=O)C3(C)C,C20H30O4,S3921
20104,Ginsenoside Rg1,CC(C)=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(CC34C)OC6OC(CO)C(O)C(O)C6O,C42H72O14,S3923
20105,Ginsenoside Rb1,CC(C)=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C,C54H92O23,S3924
20106,(-)-Epicatechin gallate,OC1=CC2=C(CC(OC(=O)C3=CC(=C(O)C(=C3)O)O)C(O2)C4=CC=C(O)C(=C4)O)C(=C1)O,C22H18O10,S3925
20107,Forsythin,COC1=CC=C(C=C1OC)C2OCC3C2COC3C4=CC(=C(OC5OC(CO)C(O)C(O)C5O)C=C4)OC,C27H34O11,S3926
20108,Swertiamarin,OCC1OC(OC2OC=C3C(=O)OCCC3(O)C2C=C)C(O)C(O)C1O,C16H22O10,S3927
20109,Liquiritin,OCC1OC(OC2=CC=C(C=C2)C3CC(=O)C4=C(O3)C=C(O)C=C4)C(O)C(O)C1O,C21H22O9,S3930
20110,Nonivamide,CCCCCCCCC(=O)NCC1=CC(=C(O)C=C1)OC,C17H27NO3,S3935
20111,Valproic acid (VPA),CCCC(CCC)C(O)=O,C8H16O2,S3944
20112,L-Cycloserine,NC1CONC1=O,C3H6N2O2,S3945
20113,D-Cycloserine,NC1CONC1=O,C3H6N2O2,S1998
20114,Maltitol,OCC(O)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO,C12H24O11,S3950
20115,Lactitol,OCC(O)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO,C12H24O11,S5368
20116,Tannic acid,OC1=CC(=CC(=C1O)O)C(=O)OC2=C(O)C(=CC(=C2)C(=O)OCC3OC(OC(=O)C4=CC(=C(O)C(=C4)O)OC(=O)C5=CC(=C(O)C(=C5)O)O)C(OC(=O)C6=CC(=C(O)C(=C6)O)OC(=O)C7=CC(=C(O)C(=C7)O)O)C(OC(=O)C8=CC(=C(O)C(=C8)O)OC(=O)C9=CC(=C(O)C(=C9)O)O)C3OC(=O)C%10=CC(=C(O)C(=C%10)O)OC(=O)C%11=CC(=C(O)C(=C%11)O)O)O,C76H52O46,S3951
20117,Tetramethylpyrazine,CC1=NC(=C(C)N=C1C)C,C8H12N2,S3956
20118,Gamma-Oryzanol,COC1=CC(=CC=C1O)/C=C/C(=O)OC2CCC34CC35CCC6(C)C(CCC6(C)C5CCC4C2(C)C)C(C)CCC=C(C)C,C40H58O4,S3957
20119,(+)-Borneol,CC1(C)C2CCC1(C)C(O)C2,C10H18O,S3959
20120,(-)-Borneol,CC1(C)C2CCC1(C)C(O)C2,C10H18O,S3977
20121,Vanillyl Butyl Ether,CCCCOCC1=CC(=C(O)C=C1)OC,C12H18O3,S3965
20122,Nifuratel,CSCC1CN(\N=C\C2=CC=C(O2)[N+]([O-])=O)C(=O)O1,C10H11N3O5S,S3966
20123,Flavone,O=C1C=C(OC2=C1C=CC=C2)C3=CC=CC=C3,C15H10O2,S3967
20124,Histamine,NCCC1=C[NH]C=N1,C5H9N3,S3968
20125,Veratric acid,COC1=C(OC)C=C(C=C1)C(O)=O,C9H10O4,S3969
20126,Vindoline,CCC12C=CCN3CCC4(C(N(C)C5=C4C=CC(=C5)OC)C(O)(C1OC(C)=O)C(=O)OC)C23,C25H32N2O6,S3970
20127,Fusidine,CC1C(O)CCC2(C)C1CCC3(C)C2C(O)CC4\C(C(CC34C)OC(C)=O)=C(/CCC=C(C)C)C(O)=O,C31H48O6,S3971
20128,(+)-Catechin hydrate,OC1CC2=C(OC1C3=CC(=C(O)C=C3)O)C=C(O)C=C2O,C15H14O6.xH2O,S3974
20129,(+)-Catechin,OC1CC2=C(OC1C3=CC(=C(O)C=C3)O)C=C(O)C=C2O,C15H14O6,S4722
20130,(-)Epicatechin,OC1CC2=C(OC1C3=CC(=C(O)C=C3)O)C=C(O)C=C2O,C15H14O6,S4723
20131,Protocatechuic acid,OC(=O)C1=CC(=C(O)C=C1)O,C7H6O4,S3975
20132,Zinc Undecylenate,[Zn++].[O-]C(=O)CCCCCCCCC=C.[O-]C(=O)CCCCCCCCC=C,C22H38O4Zn,S3979
20133,Pyridoxine,CC1=NC=C(CO)C(=C1O)CO,C8H11NO3,S3980
20134,Batyl alcohol,CCCCCCCCCCCCCCCCCCOCC(O)CO,C21H44O3,S3982
20135,Caryophyllene oxide,CC1(C)CC2C1CCC3(C)OC3CCC2=C,C15H24O,S3983
20136,Nordihydroguaiaretic acid (NDGA),CC(CC1=CC=C(O)C(=C1)O)C(C)CC2=CC=C(O)C(=C2)O,C18H22O4,S3984
20137,Methyl 4-hydroxybenzoate,COC(=O)C1=CC=C(O)C=C1,C8H8O3,S3985
20138,L-Arabinose,OC1COC(O)C(O)C1O,C5H10O5,S3986
20139,D(-)-Arabinose,OC1COC(O)C(O)C1O,C5H10O5,S5134
20140,L-Tryptophan,NC(CC1=C[NH]C2=C1C=CC=C2)C(O)=O,C11H12N2O2,S3987
20141,Theophylline-7-acetic acid,CN1C(=O)N(C)C2=C([N](CC(O)=O)C=N2)C1=O,C9H10N4O4,S3988
20142,D-(+)-Trehalose dihydrate,O.O.OCC1OC(OC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O,C12H22O11.2H2O,S3992
20143,Guaiazulene,CC(C)C1=CC2=C(C)C=CC2=C(C)C=C1,C15H18,S3995
20144,Thioctic acid,OC(=O)CCCCC1CCSS1,C8H14O2S2,S3996
20145,(+)-α-Lipoic acid,OC(=O)CCCCC1CCSS1,C8H14O2S2,S3998
20146,Oxaceprol,CC(=O)N1CC(O)CC1C(O)=O,C7H11NO4,S3997
20147,α-santonin,CC1C2CCC3(C)C=CC(=O)C(=C3C2OC1=O)C,C15H18O3,S3999
20148,Pergolide Mesylate,CCCN1CC(CSC)CC2C1CC3=C[NH]C4=C3C2=CC=C4.C[S](O)(=O)=O,C20H30N2O3S2,S4000
20149,Cabozantinib malate,COC1=CC2=C(C=C1OC)C(=CC=N2)OC3=CC=C(NC(=O)C4(CC4)C(=O)NC5=CC=C(F)C=C5)C=C3.OC(CC(O)=O)C(O)=O,C28H24FN3O5.C4H6O5,S4001
20150,Sitagliptin phosphate monohydrate,O.NC(CC(=O)N1CC[N]2C(=NN=C2C(F)(F)F)C1)CC3=C(F)C=C(F)C(=C3)F.O[P](O)(O)=O,C16H15F6N5O.H3PO4.H2O,S4002
20151,Lithocholic acid,CC(CCC(O)=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,C24H40O3,S4003
20152,Ethambutol 2HCl,Cl.Cl.CCC(CO)NCCNC(CC)CO,C10H24N2O2.2HCl,S4004
20153,Pentamidine isethionate,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1.OCC[S](O)(=O)=O.OCC[S](O)(=O)=O,C19H24N4O2.2C2H6O4S,S4007
20154,Mirabegron,NC1=NC(=CS1)CC(=O)NC2=CC=C(CCNCC(O)C3=CC=CC=C3)C=C2,C21H24N4O2S,S4009
20155,Acebutolol HCl,Cl.CCCC(=O)NC1=CC(=C(OCC(O)CNC(C)C)C=C1)C(C)=O,C18H28N2O4.HCl,S4010
20156,Ampiroxicam,CCOC(=O)OC(C)OC1=C(N(C)[S](=O)(=O)C2=C1C=CC=C2)C(=O)NC3=NC=CC=C3,C20H21N3O7S,S4011
20157,Desloratadine,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4,C19H19ClN2,S4012
20158,Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,C17H23NO3,S4014
20159,Atropine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,C17H23NO3,S4713
20160,Allylthiourea,NC(=S)NCC=C,C4H8N2S,S4017
20161,Sennoside B,OCC1OC(OC2=CC=CC3=C2C(=O)C4=C(O)C=C(C=C4C3C5C6=C(C(=O)C7=C(O)C=C(C=C57)C(O)=O)C(=CC=C6)OC8OC(CO)C(O)C(O)C8O)C(O)=O)C(O)C(O)C1O,C42H38O20,S4018
20162,Sennoside A,OCC1OC(OC2=CC=CC3=C2C(=O)C4=C(O)C=C(C=C4C3C5C6=C(C(=O)C7=C(O)C=C(C=C57)C(O)=O)C(=CC=C6)OC8OC(CO)C(O)C(O)C8O)C(O)=O)C(O)C(O)C1O,C42H38O20,S4033
20163,Avanafil,COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N3CCCC3CO)C(=O)NCC4=NC=CC=N4)C=C1,C23H26ClN7O3,S4019
20164,Sodium Picosulfate,[Na+].[Na+].[O-][S](=O)(=O)OC1=CC=C(C=C1)C(C2=CC=C(O[S]([O-])(=O)=O)C=C2)C3=CC=CC=N3,C18H15NO8S2.2Na,S4020
20165,Tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(=C2)[N+]([O-])=O)O,C14H11NO5,S4021
20166,Probenecid,CCCN(CCC)[S](=O)(=O)C1=CC=C(C=C1)C(O)=O,C13H19NO4S,S4022
20167,Procaine HCl,Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,C13H20N2O2.HCl,S4023
20168,Homatropine Methylbromide,[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C3=CC=CC=C3,C17H24NO3.Br,S4024
20169,Homatropine Bromide,Br.CN1C2CCC1CC(C2)OC(=O)C(O)C3=CC=CC=C3,C16H21NO3.HBr,S4025
20170,Hydroxyzine 2HCl,Cl.Cl.OCCOCCN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3,C21H27ClN2O2.2HCl,S4026
20171,Aclidinium Bromide,[Br-].OC(C(=O)OC1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C4=CC=CS4)C5=CC=CS5,C26H30NO4S2.Br,S4031
20172,Diphemanil Methylsulfate,CO[S]([O-])(=O)=O.C[N+]1(C)CC[C](CC1)=[C](C2=CC=CC=C2)C3=CC=CC=C3,C20H24N.CH3O4S,S4034
20173,Doxapram HCl,O.Cl.CCN1CC(CCN2CCOCC2)C(C1=O)(C3=CC=CC=C3)C4=CC=CC=C4,C24H30N2O2.HCl.H2O,S4037
20174,Dibucaine HCl,Cl.CCCCOC1=CC(=C2C=CC=CC2=N1)C(=O)NCCN(CC)CC,C20H29N3O2.HCl,S4038
20175,Methazolamide,CN1N=C(SC1=NC(C)=O)[S](N)(=O)=O,C5H8N4O3S2,S4039
20176,Norethindrone,CC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C,C20H26O2,S4040
20177,Olsalazine Sodium,[Na+].[Na+].OC1=CC=C(C=C1C([O-])=O)N=NC2=CC=C(O)C(=C2)C([O-])=O,C14H8N2O6.2Na,S4041
20178,Nafcillin Sodium,O.CCOC1=C(C(=O)NC2C3SC(C)(C)C(N3C2=O)C(=O)O[Na])C4=C(C=CC=C4)C=C1,C21H21N2O5S.H2O.Na,S4042
20179,Tetrahydrozoline HCl,Cl.C1CC(C2=NCCN2)C3=CC=CC=C3C1,C13H16N2.HCl,S4043
20180,Toltrazuril,CN1C(=O)NC(=O)N(C1=O)C2=CC(=C(OC3=CC=C(SC(F)(F)F)C=C3)C=C2)C,C18H14F3N3O4S,S4044
20181,Pheniramine Maleate,CN(C)CCC(C1=CC=CC=C1)C2=NC=CC=C2.OC(=O)\C=C/C(O)=O,C16H20N2.C4H4O4,S4045
20182,Estradiol Cypionate,CC12CCC3C(CCC4=CC(=CC=C34)O)C1CCC2OC(=O)CCC5CCCC5,C26H36O3,S4046
20183,Bisacodyl,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(OC(C)=O)C=C2)C3=CC=CC=N3,C22H19NO4,S4047
20184,Carbimazole,CCOC(=O)N1C=CN(C)C1=S,C7H10N2O2S,S4048
20185,Valdecoxib,CC1=C(C2=CC=C(C=C2)[S](N)(=O)=O)C(=NO1)C3=CC=CC=C3,C16H14N2O3S,S4049
20186,Valganciclovir HCl,Cl.CC(C)C(N)C(=O)OCC(CO)OCN1C=NC2C1N=C(N)NC2=O,C14H22N6O5.HCl,S4050
20187,Nabumetone,COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1,C15H16O2,S4051
20188,Sertraline HCl,Cl.CNC1CCC(C2=CC=C(Cl)C(=C2)Cl)C3=C1C=CC=C3,C17H17Cl2N.HCl,S4053
20189,Spironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C)C3CCC4(C)C(CCC45CCC(=O)O5)C13,C24H32O4S,S4054
20190,Retapamulin,CC1CCC23CCC(=O)C2C1(C)C(CC(C)(C=C)C(O)C3C)OC(=O)CSC4CC5CCC(C4)N5C,C30H47NO4S,S4056
20191,Methyclothiazide,CN1C(CCl)NC2=CC(=C(C=C2[S]1(=O)=O)[S](N)(=O)=O)Cl,C9H11Cl2N3O4S2,S4057
20192,Ropivacaine HCl,Cl.CCCN1CCCCC1C(=O)NC2=C(C)C=CC=C2C,C17H26N2O.HCl,S4058
20193,Sodium Nitroprusside Dihydrate,[Na+].[Na+].O=N[Fe--](C#N)(C#N)(C#N)(C#N)C#N,C5H4FeN6Na2O3,S4059
20194,Erythromycin Ethylsuccinate,CCOC(=O)CCC(=O)OC1C(CC(C)OC1OC2C(C)C(OC3CC(C)(OC)C(O)C(C)O3)C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)C(=O)C(C)CC2(C)O)N(C)C,C43H75NO16,S4060
20195,Ronidazole,C[N]1C(=NC=C1[N+]([O-])=O)COC(N)=O,C6H8N4O4,S4062
20196,Escitalopram Oxalate,CN(C)CCCC1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3.OC(=O)C(O)=O,C20H21FN2O.C2H2O4,S4064
20197,Guanabenz Acetate,CC(O)=O.NC(=N)N/N=C/C1=C(Cl)C=CC=C1Cl,C8H8Cl2N4.C2H4O2,S4065
20198,Tinidazole,CC[S](=O)(=O)CC[N]1C(=NC=C1[N+]([O-])=O)C,C8H13N3O4S,S4068
20199,Guanidine HCl,Cl.NC(N)=N,CH5N3.HCl,S4070
20200,Griseofulvin,COC1=CC(=C2C(=O)C3(OC2=C1Cl)C(C)CC(=O)C=C3OC)OC,C17H17ClO6,S4071
20201,Decamethonium Bromide,[Br-].[Br-].C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,C16H38N2.2Br,S4072
20202,Sodium 4-Aminosalicylate,[Na+].NC1=CC(=C(C=C1)C([O-])=O)O,C7H7NO3.2H2O.Na,S4073
20203,Zinc Pyrithione,O1N2C=CC=CC2=[SH][Zn]13ON4C=CC=CC4=[SH]3,C10H8N2O2S2Zn,S4075
20204,Propranolol HCl,Cl.CC(C)NCC(O)COC1=CC=CC2=CC=CC=C12,C16H21NO2.HCl,S4076
20205,S(-)-Propranolol hydrochloride,Cl.CC(C)NCC(O)COC1=CC=CC2=CC=CC=C12,C16H22ClNO2,S5981
20206,Mequinol,COC1=CC=C(O)C=C1,C7H8O2,S4077
20207,Mefenamic Acid,CC1=C(C)C(=CC=C1)NC2=CC=CC=C2C(O)=O,C15H15NO2,S4078
20208,Ticagrelor,CCCSC1=NC2=C(N=N[N]2C3CC(OCCO)C(O)C3O)C(=N1)NC4CC4C5=CC(=C(F)C=C5)F,C23H28F2N6O4S,S4079
20209,Triamterene,NC1=NC2=C(N=C(C3=CC=CC=C3)C(=N2)N)C(=N1)N,C12H11N7,S4080
20210,Sulfacetamide Sodium,[Na+].CC(=O)[N-][S](=O)(=O)C1=CC=C(N)C=C1,C8H10N2O3S.Na,S4081
20211,Spiramycin,COC1C(O)CC(=O)OC(C)C/C=C/C=C/C(OC2CCC(C(C)O2)N(C)C)C(C)CC(CC=O)C1OC3OC(C)C(OC4CC(C)(O)C(O)C(C)O4)C(C3O)N(C)C,C43H74N2O14,S4082
20212,Lomerizine 2HCl,Cl.Cl.COC1=C(OC)C(=C(CN2CCN(CC2)C(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4)C=C1)OC,C27H30F2N2O3.2HCl,S4084
20213,Loxapine Succinate,CN1CCN(CC1)C2=NC3=C(OC4=C2C=C(Cl)C=C4)C=CC=C3.OC(=O)CCC(O)=O,C18H18ClN3O.C4H6O4,S4086
20214,Flumethasone,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,C22H28F2O5,S4088
20215,Diflorasone,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,C22H28F2O5,S5360
20216,Halobetasol Propionate,CCC(=O)OC1(C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C)C(=O)CCl,C25H31ClF2O5,S4089
20217,Fenspiride HCl,Cl.O=C1NCC2(CCN(CCC3=CC=CC=C3)CC2)O1,C15H20N2O2.HCl,S4090
20218,Ifenprodil Tartrate,CC(C(O)C1=CC=C(O)C=C1)N2CCC(CC2)CC3=CC=CC=C3.CC(C(O)C4=CC=C(O)C=C4)N5CCC(CC5)CC6=CC=CC=C6.OC(C(O)C(O)=O)C(O)=O,2(C21H27NO2).C4H6O6,S4091
20219,Pramoxine HCl,Cl.CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,C17H27NO3.HCl,S4092
20220,Difluprednate,CCCC(=O)OC1(CCC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C)C(=O)COC(C)=O,C27H34F2O7,S4095
20221,Droperidol,FC1=CC=C(C=C1)C(=O)CCCN2CCC(=CC2)N3C(=O)NC4=C3C=CC=C4,C22H22FN3O2,S4096
20222,Halcinonide,CC1(C)OC2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)C2(O1)C(=O)CCl,C24H32ClFO5,S4098
20223,Dexlansoprazole,CC1=C(C[S](=O)C2=NC3=C([NH]2)C=CC=C3)N=CC=C1OCC(F)(F)F,C16H14F3N3O2S,S4099
20224,Esmolol HCl,Cl.COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,C16H25NO4.HCl,S4100
20225,Voglibose,OCC(CO)NC1CC(O)(CO)C(O)C(O)C1O,C10H21NO7,S4101
20226,Eprosartan Mesylate,CCCCC1=NC=C(\C=C(CC2=CC=CS2)\C(O)=O)[N]1CC3=CC=C(C=C3)C(O)=O.C[S](O)(=O)=O,C23H24N2O4S.CH4O3S,S4102
20227,Diminazene Aceturate,CC(=O)NCC(O)=O.CC(=O)NCC(O)=O.NC(=N)C1=CC=C(NN=NC2=CC=C(C=C2)C(N)=N)C=C1,C14H15N7.2C4H7NO3,S4104
20228,Closantel Sodium,[Na+].CC1=C(NC(=O)C2=CC(=CC(=C2[O-])I)I)C=C(Cl)C(=C1)C(C#N)C3=CC=C(Cl)C=C3,C22H13Cl2I2N2O2.Na,S4105
20229,Closantel,CC1=C(NC(=O)C2=CC(=CC(=C2O)I)I)C=C(Cl)C(=C1)C(C#N)C3=CC=C(Cl)C=C3,C22H14Cl2I2N2O2,S4106
20230,Clofazimine,CC(C)N=C1C=C2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)N=C2C=C1NC5=CC=C(Cl)C=C5,C27H22Cl2N4,S4107
20231,Estradiol Benzoate,CC12CCC3C(CCC4=CC(=CC=C34)OC(=O)C5=CC=CC=C5)C1CCC2O,C25H28O3,S4110
20232,Dicloxacillin Sodium,O.CC1=C(C(=O)NC2C3SC(C)(C)C(N3C2=O)C(=O)O[Na])C(=NO1)C4=C(Cl)C=CC=C4Cl,C19H17Cl2N3O5S.H2O.Na,S4111
20233,Desvenlafaxine Succinate hydrate,O.CN(C)CC(C1=CC=C(O)C=C1)C2(O)CCCCC2.OC(=O)CCC(O)=O,C16H25NO2.C4H6O4.H2O,S4112
20234,Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C2(O)CCCCC2,C16H25NO2,S4113
20235,Triclabendazole,CSC1=NC2=C([NH]1)C=C(Cl)C(=C2)OC3=C(Cl)C(=CC=C3)Cl,C14H9Cl3N2OS,S4114
20236,Histamine 2HCl,Cl.Cl.NCCC1=C[NH]C=N1,C5H9N3.2HCl,S4118
20237,Pefloxacin Mesylate Dihydrate,O.O.CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCN(C)CC3)C(=C2)F.C[S](O)(=O)=O,C17H20FN3O3.CH4O3S.2H2O,S4119
20238,Sulconazole Nitrate,O[N+]([O-])=O.ClC1=CC=C(CSC(C[N]2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C=C1,C18H15Cl3N2S.HNO3,S4120
20239,Tilmicosin,CCC1OC(=O)CC(O)C(C)C(OC2OC(C)C(O)C(C2O)N(C)C)C(CCN3CC(C)CC(C)C3)CC(C)C(=O)\C=C\C(=C\C1COC4OC(C)C(O)C(OC)C4OC)C,C46H80N2O13,S4122
20240,Timolol Maleate,CC(C)(C)NCC(O)COC1=NSN=C1N2CCOCC2.OC(=O)\C=C/C(O)=O,C13H24N4O3S.C4H4O4,S4123
20241,Tolazoline HCl,Cl.C1CN=C(CC2=CC=CC=C2)N1,C10H12N2.HCl,S4124
20242,Sodium Phenylbutyrate,[Na]OC(=O)CCCC1=CC=CC=C1,C10H11O2.Na,S4125
20243,Troxipide,COC1=C(OC)C(=CC(=C1)C(=O)NC2CCCNC2)OC,C15H22N2O4,S4128
20244,Levodropropizine,OCC(O)CN1CCN(CC1)C2=CC=CC=C2,C13H20N2O2,S4131
20245,Dropropizine,OCC(O)CN1CCN(CC1)C2=CC=CC=C2,C13H20N2O2,S4138
20246,Clorprenaline HCl,Cl.CC(C)NCC(O)C1=CC=CC=C1Cl,C11H16ClNO.HCl,S4135
20247,Carprofen,CC(C(O)=O)C1=CC2=C(C=C1)C3=C([NH]2)C=CC(=C3)Cl,C15H12ClNO2,S4136
20248,Cyclizine 2HCl,Cl.Cl.CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3,C18H22N2.2HCl,S4139
20249,Dinitolmide,CC1=C(C=C(C=C1[N+]([O-])=O)[N+]([O-])=O)C(N)=O,C8H7N3O5,S4141
20250,Pentoxyverine Citrate,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C2=CC=CC=N2)C(C)C.O[P](O)(O)=O,C20H31NO3.C6H8O7,S4143
20251,Azithromycin Dihydrate,O.O.CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(O)CC(C)CN(C)C(C)C(O)C1(C)O,C38H72N2O12.2H2O,S4147
20252,Ampicillin Trihydrate,O.O.O.CC1(C)SC2C(NC(=O)C(N)C3=CC=CC=C3)C(=O)N2C1C(O)=O,C16H19N3O4S.3H2O,S4148
20253,Amfenac Sodium Monohydrate,O.[Na+].NC1=C(C=CC=C1CC([O-])=O)C(=O)C2=CC=CC=C2,C15H12NO3.H2O.Na,S4149
20254,Penfluridol,OC1(CCN(CCCC(C2=CC=C(F)C=C2)C3=CC=C(F)C=C3)CC1)C4=CC(=C(Cl)C=C4)C(F)(F)F,C28H27ClF5NO,S4151
20255,Ethamsylate,CCNCC.OC1=CC=C(O)C(=C1)[S](O)(=O)=O,C6H6O5S.C4H11N,S4152
20256,Chlorzoxazone,ClC1=CC2=C(OC(=O)N2)C=C1,C7H4ClNO2,S4155
20257,Bezafibrate,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O,C19H20ClNO4,S4159
20258,Penicillin G Sodium,[Na+].CC1(C)SC2C(NC(=O)CC3=CC=CC=C3)C(=O)N2C1C([O-])=O,C16H18N2O4S.Na,S4160
20259,Benzoic Acid,OC(=O)C1=CC=CC=C1,C7H6O2,S4161
20260,Benzethonium Chloride,[Cl-].CC(C)(C)CC(C)(C)C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1,C27H42NO2.Cl,S4162
20261,Doxycycline Hyclate (WC2031),O.Cl.Cl.CCO.CC1C2C(O)C3C(N(C)C)C(=C(C(N)=O)C(=O)C3(O)C(=C2C(=O)C4=C(O)C=CC=C14)O)O.CC5C6C(O)C7C(N(C)C)C(=C(C(N)=O)C(=O)C7(O)C(=C6C(=O)C8=C(O)C=CC=C58)O)O,C22H24N2O8.1/2C2H6O.HCl.1/2H2O,S4163
20262,Doxofylline,CN1C(=O)N(C)C2=C([N](CC3OCCO3)C=N2)C1=O,C11H14N4O4,S4164
20263,Benzydamine HCl,Cl.CN(C)CCCOC1=N[N](CC2=CC=CC=C2)C3=CC=CC=C13,C19H23N3O.HCl,S4165
20264,Chlorpropamide,CCCNC(=O)N[S](=O)(=O)C1=CC=C(Cl)C=C1,C10H13ClN2O3S,S4166
20265,Cyromazine,NC1=NC(=NC(=N1)N)NC2CC2,C6H10N6,S4167
20266,Teriflunomide,C/C(O)=C(C#N)/C(=O)NC1=CC=C(C=C1)C(F)(F)F,C12H9F3N2O2,S4169
20267,Coumarin,O=C1OC2=C(C=CC=C2)C=C1,C9H6O2,S4170
20268,Choline Chloride,[Cl-].C[N+](C)(C)CCO,C5H14NO.Cl,S4171
20269,Cetylpyridinium Chloride,[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1,C21H38N.Cl,S4172
20270,1-Hexadecanol,CCCCCCCCCCCCCCCCO,C16H34O,S4173
20271,Sulfaguanidine,NC(=N)N[S](=O)(=O)C1=CC=C(N)C=C1,C7H10N4O2S,S4175
20272,Trometamol,NC(CO)(CO)CO,C4H11NO3,S4176
20273,Uracil,O=C1NC=CC(=O)N1,C4H4N2O2,S4177
20274,Climbazole,CC(C)(C)C(=O)C(OC1=CC=C(Cl)C=C1)[N]2C=CN=C2,C15H17ClN2O2,S4178
20275,Mezlocillin Sodium,[Na+].CC1(C)SC2C(NC(=O)C(NC(=O)N3CCN(C3=O)[S](C)(=O)=O)C4=CC=CC=C4)C(=O)N2C1C([O-])=O,C21H25N5O8S2.Na,S4179
20276,Nicardipine HCl,Cl.COC(=O)C1=C(C)NC(=C(C1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3)C,C26H29N3O6.HCl,S4181
20277,Nifuroxazide,OC1=CC=C(C=C1)C(=O)N/N=C/C2=CC=C(O2)[N+]([O-])=O,C12H9N3O5,S4182
20278,Penciclovir,NC1=NC(=O)C2=C(N1)[N](CCC(CO)CO)C=N2,C10H15N5O3,S4184
20279,Tiratricol,OC(=O)CC1=CC(=C(OC2=CC=C(O)C(=C2)I)C(=C1)I)I,C14H9I3O4,S4185
20280,Domiphen Bromide,[Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1,C22H40NO.Br,S4186
20281,Salicylanilide,OC1=CC=CC=C1C(=O)NC2=CC=CC=C2,C13H11NO2,S4187
20282,Sasapyrine,OC(=O)C1=CC=CC=C1OC(=O)C2=CC=CC=C2O,C14H10O5,S4188
20283,Cyclandelate,CC1CC(CC(C)(C)C1)OC(=O)C(O)C2=CC=CC=C2,C17H24O3,S4189
20284,Cinchophen,OC(=O)C1=C2C=CC=CC2=NC(=C1)C3=CC=CC=C3,C16H11NO2,S4190
20285,Betamipron,OC(=O)CCNC(=O)C1=CC=CC=C1,C10H11NO3,S4191
20286,Chlorquinaldol,CC1=CC=C2C(=CC(=C(O)C2=N1)Cl)Cl,C10H7Cl2NO,S4192
20287,Broxyquinoline,OC1=C2N=CC=CC2=C(Br)C=C1Br,C9H5Br2NO,S4195
20288,Ethacridine lactate monohydrate,O.CCOC1=CC2=C(N)C3=CC=C(N)C=C3N=C2C=C1.CC(O)C(O)=O,C15H15N3O.C3H6O3.H2O,S4196
20289,Bemegride,CCC1(C)CC(=O)NC(=O)C1,C8H13NO2,S4197
20290,Tolperisone HCl,Cl.CC(CN1CCCCC1)C(=O)C2=CC=C(C)C=C2,C16H23NO.HCl,S4200
20291,Florfenicol,C[S](=O)(=O)C1=CC=C(C=C1)C(O)C(CF)NC(=O)C(Cl)Cl,C12H14Cl2FNO4S,S4201
20292,Verapamil (CP-16533-1) HCl,Cl.COC1=CC=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC=C(OC)C(=C2)OC)C=C1OC,C27H38N2O4.HCl,S4202
20293,Furaltadone HCl,Cl.[O-][N+](=O)C1=CC=C(O1)/C=N/N2CC(CN3CCOCC3)OC2=O,C13H16N4O6.HCl,S4203
20294,Isosorbide,OC1COC2C(O)COC12,C6H10O4,S4204
20295,Clofibric Acid,CC(C)(OC1=CC=C(Cl)C=C1)C(O)=O,C10H11ClO3,S4207
20296,Chromocarb,OC(=O)C1=CC(=O)C2=CC=CC=C2O1,C10H6O4,S4208
20297,Benzocaine,CCOC(=O)C1=CC=C(N)C=C1,C9H11NO2,S4210
20298,Dirithromycin,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(O)CC(C)C4NC(COCCOC)OC(C4C)C1(C)O,C42H78N2O14,S4213
20299,Sucralose,OCC1OC(OC2(CCl)OC(CCl)C(O)C2O)C(O)C(O)C1Cl,C12H19Cl3O8,S4214
20300,Valnemulin HCl,Cl.CC(C)C(N)C(=O)NCC(C)(C)SCC(=O)OC1CC(C)(C=C)C(O)C(C)C23CCC(C)C1(C)C2C(=O)CC3,C31H52N2O5S.HCl,S4216
20301,Liothyronine Sodium,[Na+].NC(CC1=CC(=C(OC2=CC=C(O)C(=C2)I)C(=C1)I)I)C([O-])=O,C15H12I3NO4.Na,S4217
20302,Azaperone,FC1=CC=C(C=C1)C(=O)CCCN2CCN(CC2)C3=CC=CC=N3,C19H22FN3O,S4219
20303,Benzbromarone,CCC1=C(C(=O)C2=CC(=C(O)C(=C2)Br)Br)C3=C(O1)C=CC=C3,C17H12Br2O3,S4221
20304,Piperacillin Sodium,[Na+].CCN1CCN(C(=O)NC(C(=O)NC2C3SC(C)(C)C(N3C2=O)C([O-])=O)C4=CC=CC=C4)C(=O)C1=O,C23H27N5O7S.Na,S4222
20305,Mevastatin,CCC(C)C(=O)OC1CCC=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C12,C23H34O5,S4223
20306,Erythritol,OCC(O)C(O)CO,C4H10O4,S4224
20307,Mexiletine HCl,Cl.CC(N)COC1=C(C)C=CC=C1C,C11H17NO.HCl,S4225
20308,Fidaxomicin,CCC1\C=C(C)/C(O)C\C=C\C=C(COC2OC(C)C(OC(=O)C3=C(CC)C(=C(O)C(=C3O)Cl)Cl)C(O)C2OC)\C(=O)OC(C\C=C(C)\C=C(C)\C1OC4OC(C)(C)C(OC(=O)C(C)C)C(O)C4O)C(C)O,C52H74Cl2O18,S4227
20309,Fluorometholone Acetate,CC1CC2C3CCC(OC(C)=O)(C(C)=O)C3(C)CC(O)C2(F)C4(C)C=CC(=O)C=C14,C24H31FO5,S4228
20310,Oxybuprocaine HCl,Cl.CCCCOC1=CC(=CC=C1N)C(=O)OCCN(CC)CC,C17H28N2O3.HCl,S4229
20311,Oxaprozin,OC(=O)CCC1=NC(=C(O1)C2=CC=CC=C2)C3=CC=CC=C3,C18H15NO3,S4230
20312,Pilocarpine HCl,Cl.CCC1C(COC1=O)CC2=CN=C[N]2C,C11H16N2O2.HCl,S4231
20313,Phenazopyridine HCl,Cl.NC1=NC(=C(C=C1)N=NC2=CC=CC=C2)N,C11H11N5.HCl,S4235
20314,Primaquine Diphosphate,COC1=CC(=C2N=CC=CC2=C1)NC(C)CCCN.O[P](O)(O)=O.O[P](O)(O)=O,C15H21N3O.2H3O4P,S4237
20315,Cepharanthine,COC1=C2OC3=CC=C(CC4N(C)CCC5=C4C(=C6OCOC6=C5)OC7=C(OC)C=C8CCN(C)C(CC(=C2)C=C1)C8=C7)C=C3,C37H38N2O6,S4238
20316,Bergapten,COC1=C2C=COC2=CC3=C1C=CC(=O)O3,C12H8O4,S4239
20317,Doxylamine Succinate,CN(C)CCOC(C)(C1=CC=CC=C1)C2=CC=CC=N2.OC(=O)CCC(O)=O,C17H22N2O.C4H6O4,S4240
20318,Cetrimonium Bromide (CTAB),[Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C,C19H42N.Br,S4242
20319,Deoxycorticosterone acetate,CC(=O)OCC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C23H32O4,S4243
20320,Serotonin HCl,Cl.NCCC1=C[NH]C2=CC=C(O)C=C12,C10H12N2O.HCl,S4244
20321,Tranylcypromine (2-PCPA) HCl,Cl.NC1CC1C2=CC=CC=C2,C9H12ClN,S4246
20322,Prucalopride Succinate,COCCCN1CCC(CC1)NC(=O)C2=C3OCCC3=C(N)C(=C2)Cl.OC(=O)CCC(O)=O,C18H26ClN3O3.C4H6O4,S4247
20323,Bromfenac Sodium,[Na+].NC1=C(C=CC=C1CC([O-])=O)C(=O)C2=CC=C(Br)C=C2,C15H11BrNO3.Na,S4248
20324,Flopropione,CCC(=O)C1=C(O)C=C(O)C=C1O,C9H10O4,S4249
20325,Sulfamethoxypyridazine,COC1=NN=C(N[S](=O)(=O)C2=CC=C(N)C=C2)C=C1,C11H12N4O3S,S4250
20326,Epinastine HCl,Cl.NC1=NCC2N1C3=CC=CC=C3CC4=CC=CC=C24,C16H15N3.HCl,S4253
20327,Quinacrine 2HCl,Cl.Cl.CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC3=CC(=CC=C13)Cl,C23H30ClN3O.2HCl,S4255
20328,Buspirone HCl,Cl.O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4,C21H31N5O2.HCl,S4256
20329,Alizapride HCl,Cl.COC1=CC2=C(C=C1C(=O)NCC3CCCN3CC=C)N=N[NH]2,C16H21N5O2.HCl,S4257
20330,Luliconazole,ClC1=CC=C(C2CSC(/S2)=C(C#N)\[N]3C=CN=C3)C(=C1)Cl,C14H9Cl2N3S2,S4258
20331,Vilazodone HCl,Cl.NC(=O)C1=CC2=C(O1)C=CC(=C2)N3CCN(CCCCC4=C[NH]C5=C4C=C(C=C5)C#N)CC3,C26H27N5O2.HCl,S4259
20332,Tamibarotene,CC1(C)CCC(C)(C)C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(O)=O,C22H25NO3,S4260
20333,Efaproxiral Sodium,[Na+].CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(OC(C)(C)C([O-])=O)C=C2)C,C20H23NO4.Na,S4263
20334,Etofibrate,CC(C)(OC1=CC=C(Cl)C=C1)C(=O)OCCOC(=O)C2=CC=CN=C2,C18H18ClNO5,S4264
20335,Nicaraven,CC(CNC(=O)C1=CN=CC=C1)NC(=O)C2=CN=CC=C2,C15H16N4O2,S4265
20336,Brimonidine Tartrate,OC(C(O)C(O)=O)C(O)=O.BrC1=C2N=CC=NC2=CC=C1NC3=NCCN3,C15H16BrN5O6,S4266
20337,Diacerein,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C=C(C=C3OC(C)=O)C(O)=O)C2=O,C19H12O8,S4267
20338,Flufenamic acid,OC(=O)C1=CC=CC=C1NC2=CC=CC(=C2)C(F)(F)F,C14H10F3NO2,S4268
20339,Vinorelbine ditartrate (KW-2307),CCC1=CC2CN(C1)CC3=C([NH]C4=C3C=CC=C4)C(C2)(C(=O)OC)C5=C(OC)C=C6N(C)C7C(O)(C(OC(C)=O)C8(CC)C=CCN9CCC7(C89)C6=C5)C(=O)OC.OC(C(O)C(O)=O)C(O)=O.OC(C(O)C(O)=O)C(O)=O,C45H54N4O8.2C4H6O6,S4269
20340,Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O,C19H25NOS,S4274
20341,Bambuterol HCl,Cl.CN(C)C(=O)OC1=CC(=CC(=C1)OC(=O)N(C)C)C(O)CNC(C)(C)C,C18H29N3O5.HCl,S4277
20342,Carteolol HCl,Cl.CC(C)(C)NCC(O)COC1=C2CCC(=O)NC2=CC=C1,C16H25ClN2O3,S4278
20343,Demeclocycline HCl,Cl.CN(C)C1C2CC3C(O)C4=C(Cl)C=CC(=C4C(=O)C3=C(O)C2(O)C(=O)C(=C1O)C(N)=O)O,C21H21ClN2O8.HCl,S4279
20344,Meclofenoxate (Centrophenoxine) HCl,Cl.CN(C)CCOC(=O)COC1=CC=C(Cl)C=C1,C12H17Cl2NO3,S4280
20345,Tasimelteon,CCC(=O)NCC1CC1C2=C3CCOC3=CC=C2,C15H19NO2,S4281
20346,Nelfinavir (AG 1343) Mesylate,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(O)CN3CC4CCCCC4CC3C(=O)NC(C)(C)C.C[S](O)(=O)=O,C33H49N3O7S2,S4282
20347,Cyclobenzaprine HCl,Cl.CN(C)CCC=C1C2=C(C=CC=C2)C=CC3=C1C=CC=C3,C20H22ClN,S4283
20348,Chloroprocaine HCl,Cl.CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1,C13H20Cl2N2O2,S4284
20349,Ospemifene,OCCOC1=CC=C(C=C1)\C(=C(\CCCl)C2=CC=CC=C2)C3=CC=CC=C3,C24H23ClO2,S4285
20350,Anidulafungin (LY303366),CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(O)C(O)NC(=O)C5C(O)C(C)CN5C(=O)C(NC(=O)C(NC(=O)C6CC(O)CN6C(=O)C(NC4=O)C(C)O)C(O)C(O)C7=CC=C(O)C=C7)C(C)O,C58H73N7O17,S4286
20351,Chloroambucil,OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl,C14H19Cl2NO2,S4288
20352,Metoclopramide HCl,Cl.CCN(CC)CCNC(=O)C1=CC(=C(N)C=C1OC)Cl,C14H23Cl2N3O2,S4289
20353,Labetalol HCl,Cl.CC(CCC1=CC=CC=C1)NCC(O)C2=CC(=C(O)C=C2)C(N)=O,C19H25ClN2O3,S4291
20354,Diphenidol HCl,Cl.OC(CCCN1CCCCC1)(C2=CC=CC=C2)C3=CC=CC=C3,C21H28ClNO,S4292
20355,Promethazine HCl,Cl.CC(CN1C2=CC=CC=C2SC3=C1C=CC=C3)N(C)C,C17H21ClN2S,S4293
20356,Procainamide HCl,Cl.CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,C13H22ClN3O,S4294
20357,Meclofenamate Sodium,CC1=C(Cl)C(=C(Cl)C=C1)NC2=CC=CC=C2C(=O)O[Na],C14H11Cl2NO2.Na,S4295
20358,Salmeterol Xinafoate,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC2=CC=CC=C2.OC(=O)C3=C(O)C4=CC=CC=C4C=C3,C36H45NO7,S4296
20359,Mupirocin,CC(O)C(C)C1OC1CC2COC(C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)C(O)C2O,C26H44O9,S4297
20360,Dicoumarol,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC4=CC=CC=C14,C19H12O6,S4299
20361,(R)-(+)-Atenolol HCl,Cl.CC(=O)OC1CN2CCC1CC2,C9H16ClNO2,S4301
20362,Aceclidine HCl,Cl.CC(=O)OC1CN2CCC1CC2,C9H16ClNO2,S4376
20363,9-Aminoacridine,NC1=C2C=CC=CC2=NC3=CC=CC=C13,C13H10N2,S4303
20364,Anisindione,COC1=CC=C(C=C1)C2C(=O)C3=C(C=CC=C3)C2=O,C16H12O3,S4304
20365,Anisotropine Methylbromide,[Br-].CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C,C17H32BrNO2,S4305
20366,Auranofin,CCP(|[Au]SC1OC(COC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O)(CC)CC,C20H34AuO9PS,S4307
20367,Benzthiazide,N[S](=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC3=CC=CC=C3)N[S]2(=O)=O,C15H14ClN3O4S3,S4308
20368,Bromocriptine Mesylate,CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4CC5=C(Br)[NH]C6=C5C(=CC=C6)C4=C3)(OC2(O)C7CCCN7C1=O)C(C)C.C[S](O)(=O)=O,C32H40BrN5O5.CH4O3S,S4309
20369,Carbadox,COC(=O)N/N=C/C1=[N+]([O-])C2=C(C=CC=C2)[N+](=C1)[O-],C11H10N4O4,S4312
20370,Clopamide,CC1CCCC(C)N1NC(=O)C2=CC=C(Cl)C(=C2)[S](N)(=O)=O,C14H20ClN3O3S,S4316
20371,Clorgyline HCl,Cl.CN(CCCOC1=CC=C(Cl)C=C1Cl)CC#C,C13H15Cl2NO.HCl,S4317
20372,Disopyramide Phosphate,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C2=NC=CC=C2)C(C)C.O[P](O)(O)=O,C21H32N3O5P,S4322
20373,Ethoxzolamide,CCOC1=CC=C2N=C(SC2=C1)[S](N)(=O)=O,C9H10N2O3S2,S4326
20374,Isoetharine Mesylate,CCC(NC(C)C)C(O)C1=CC=C(O)C(=C1)O.C[S](O)(=O)=O,C14H25NO6S,S4330
20375,Meclocycline Sulfosalicylate,CN(C)C1C2C(O)C3C(=C)C4=C(C(=CC=C4Cl)O)C(=O)C3=C(O)C2(O)C(=O)C(=C1O)C(N)=O.OC(=O)C5=C(O)C=CC(=C5)[S](O)(=O)=O,C22H21ClN2O8.C7H6O6S,S4331
20376,Medrysone,CC1CC2C3CCC(C(C)=O)C3(C)CC(O)C2C4(C)CCC(=O)C=C14,C22H32O3,S4332
20377,Mesoridazine Besylate,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)[S](C)=O.O[S](=O)(=O)C5=CC=CC=C5,C27H32N2O4S3,S4334
20378,Metaproterenol Sulfate,CC(C)NCC(O)C1=CC(=CC(=C1)O)O.CC(C)NCC(O)C2=CC(=CC(=C2)O)O.O[S](O)(=O)=O,C22H36N2O10S,S4335
20379,Metaraminol Bitartrate,CC(N)C(O)C1=CC=CC(=C1)O.OC(C(O)C(O)=O)C(O)=O,C13H19NO8,S4336
20380,Methoxamine HCl,Cl.COC1=CC(=C(OC)C=C1)C(O)C(C)N,C11H17NO3.HCl,S4338
20381,Meticrane,CC1=C(C=C2C(=C1)CCC[S]2(=O)=O)[S](N)(=O)=O,C10H13NO4S2,S4339
20382,Oxethazaine,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC2=CC=CC=C2,C28H41N3O3,S4343
20383,Oxprenolol HCl,Cl.CC(C)NCC(O)COC1=CC=CC=C1OCC=C,C15H23NO3.HCl,S4344
20384,Pentoxifylline,C[N]1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C,C13H18N4O3,S4345
20385,Procyclidine HCl,Cl.OC(CCN1CCCC1)(C2CCCCC2)C3=CC=CC=C3,C19H30ClNO,S4349
20386,Ractopamine HCl,Cl.CC(CCC1=CC=C(O)C=C1)NCC(O)C2=CC=C(O)C=C2,C18H24ClNO3,S4351
20387,Terfenadine,CC(C)(C)C1=CC=C(C=C1)C(O)CCCN2CCC(CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4,C32H41NO2,S4353
20388,Thiostrepton,CCC(C)C1NC2C=CC3=C(C=C(N=C3C2O)C(=O)OC(C)C4NC(=O)C5=CSC(=N5)C(NC(=O)C6CSC(=N6)\C(NC(=O)C(NC(=O)C7=CSC(=N7)C8(CCC(=NC8C9=CSC4=N9)C%10=NC(=CS%10)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC1=O)C(C)O)=C\C)C(C)(O)C(C)O)C(C)O,C72H85N19O18S5,S4354
20389,Tacrine HCl,Cl.NC1=C2C=CC=CC2=NC3=C1CCCC3,C13H14N2.HCl,S4357
20390,Pimozide,FC1=CC=C(C=C1)C(CCCN2CCC(CC2)N3C(=O)NC4=CC=CC=C34)C5=CC=C(F)C=C5,C28H29F2N3O,S4358
20391,Cinoxacin,CCN1N=C(C(O)=O)C(=O)C2=C1C=C3OCOC3=C2,C12H10N2O5,S4361
20392,Glafenine HCl,Cl.OCC(O)COC(=O)C1=CC=CC=C1NC2=CC=NC3=CC(=CC=C23)Cl,C19H18Cl2N2O4,S4362
20393,Phthalylsulfacetamide,CC(=O)N[S](=O)(=O)C1=CC=C(NC(=O)C2=C(C=CC=C2)C(O)=O)C=C1,C16H14N2O6S,S4365
20394,Pinacidil,O.CC(NC(NC1=CC=NC=C1)=NC#N)C(C)(C)C,C13H19N5.H2O,S4366
20395,Suxibuzone,CCCCC1(COC(=O)CCC(O)=O)C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,C24H26N2O6,S4367
20396,Carbenoxolone Sodium,[Na+].[Na+].CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C([O-])=O)OC(=O)CCC([O-])=O,C34H48Na2O7,S4368
20397,Dicyclomine HCl,Cl.CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,C19H36ClNO2,S4373
20398,Mepenzolate Bromide,[Br-].C[N+]1(C)CCC(CC1)OC(=O)C(O)(C2=CC=CC=C2)C3=CC=CC=C3,C21H26BrNO3,S4375
20399,Imipramine HCl,Cl.CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2,C19H25ClN2,S4377
20400,Proadifen HCl,Cl.CCCC(C(=O)OCCN(CC)CC)(C1=CC=CC=C1)C2=CC=CC=C2,C23H32ClNO2,S4381
20401,Pyrilamine Maleate,COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1.OC(=O)\C=C/C(O)=O,C17H23N3O1.C4H4O4,S4382
20402,Fosfomycin Tromethamine,CC1OC1[P](O)(O)=O.NC(CO)(CO)CO,C7H18NO7P,S4385
20403,Bendroflumethiazide,N[S](=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)N[S]2(=O)=O)C=C1C(F)(F)F,C15H14F3N3O4S2,S4387
20404,Bentiromide,OC(=O)C1=CC=C(NC(=O)C(CC2=CC=C(O)C=C2)NC(=O)C3=CC=CC=C3)C=C1,C23H20N2O5,S4388
20405,Bephenium Hydroxynaphthoate,C[N+](C)(CCOC1=CC=CC=C1)CC2=CC=CC=C2.OC3=C(C=C4C=CC=CC4=C3)C([O-])=O,C28H29NO4,S4389
20406,Camylofin Chlorhydrate,Cl.Cl.CCN(CC)CCNC(C(=O)OCCC(C)C)C1=CC=CC=C1,C19H34Cl2N2O2,S4391
20407,Cephapirin Sodium,[Na+].CC(=O)OCC1=C(N2C(SC1)C(NC(=O)CSC3=CC=NC=C3)C2=O)C([O-])=O,C17H16N3O6S2.Na,S4393
20408,Clofoctol,CC(C)(C)CC(C)(C)C1=CC(=C(O)C=C1)CC2=CC=C(Cl)C=C2Cl,C21H26Cl2O,S4394
20409,Digoxigenin,CC12CCC(O)CC1CCC3C2CC(O)C4(C)C(CCC34O)C5=CC(=O)OC5,C23H34O5,S4396
20410,Oxeladin Citrate,CCN(CC)CCOCCOC(=O)C(CC)(CC)C1=CC=CC=C1.OC(=O)CC(O)(CC(O)=O)C(O)=O,C20H33NO3.C6H8O7,S4402
20411,Pasiniazid,NNC(=O)C1=CC=NC=C1.NC2=CC(=C(C=C2)C(O)=O)O,C6H7N3O.C7H7NO3,S4404
20412,Pindolol,CC(C)NCC(O)COC1=C2C=C[NH]C2=CC=C1,C14H20N2O2,S4406
20413,Sodium 4-aminohippurate,[Na+].NC1=CC=C(C=C1)C(=O)NCC([O-])=O,C9H9N2NaO3,S4414
20414,Misoprostol,CCCCC(C)(O)C/C=C/C1C(O)CC(=O)C1CCCCCCC(=O)OC,C22H38O5,S4415
20415,Trimipramine Maleate,CC(CN(C)C)CN1C2=C(CCC3=CC=CC=C13)C=CC=C2.OC(=O)\C=C/C(O)=O,C24H30N2O4,S4416
20416,Mefloquine HCl,Cl.OC(C1CCCCN1)C2=CC(=NC3=C(C=CC=C23)C(F)(F)F)C(F)(F)F,C17H17ClF6N2O,S4420
20417,Eltrombopag,CC1=CC=C(C=C1C)N2N=C(C)C(=N/NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(O)=O)/C2=O,C25H22N4O4,S4502
20418,Calcium D-Panthotenate,CC(C)(CO)C(O)C(=O)NCCC(=O)O[Ca]OC(=O)CCNC(=O)C(O)C(C)(C)CO,C18H32CaN2O10,S4503
20419,6-Mercaptopurine (6-MP) Monohydrate,O.S=C1N=CNC2=C1[NH]C=N2,C5H6N4OS,S4504
20420,Vinblastine (NSC-49842) sulfate,CCC1(O)CC2CN(CCC3=C([NH]C4=CC=CC=C34)C(C2)(C(=O)OC)C5=C(OC)C=C6N(C)C7C(O)(C(OC(C)=O)C8(CC)C=CCN9CCC7(C89)C6=C5)C(=O)OC)C1.O[S](O)(=O)=O,C46H58N4O9.H2SO4,S4505
20421,Acetazolamide,CC(=O)NC1=NN=C(S1)[S](N)(=O)=O,C4H6N4O3S2,S4506
20422,17-Hydroxyprogesterone,CC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C21H30O3,S4507
20423,4-Aminoantipyrine,CN1N(C2=CC=CC=C2)C(=O)C(=C1C)N,C11H13N3O,S4509
20424,4-Aminobenzoic acid,NC1=CC=C(C=C1)C(O)=O,C7H7NO2,S4510
20425,Aceglutamide,CC(=O)NC(CCC(N)=O)C(O)=O,C7H12N2O4,S4512
20426,Acetylleucine,CC(C)CC(NC(C)=O)C(O)=O,C8H15NO3,S4514
20427,Ademetionine disulfate tosylate,C[S+](CCC(N)C([O-])=O)CC1OC(C(O)C1O)[N]2C=NC3=C(N)N=CN=C23.CC4=CC=C(C=C4)[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O,C22H34N6O16S4,S4515
20428,Cefotaxime sodium,[Na+].CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C([O-])=O)COC(C)=O)C3=CSC(=N3)N,C16H17N5O7S2.Na,S4517
20429,Chloroxylenol,CC1=CC(=CC(=C1Cl)C)O,C8H9ClO,S4518
20430,2-Aminoheptane,CCCCCC(C)N,C7H17N,S4520
20431,DEET,CCN(CC)C(=O)C1=CC(=CC=C1)C,C12H17NO,S4521
20432,Dehydroacetic acid,CC(=O)C1C(=O)OC(=CC1=O)C,C8H8O4,S4522
20433,2-Ethoxybenzamide,CCOC1=C(C=CC=C1)C(N)=O,C9H11NO2,S4524
20434,Ethylparaben,CCOC(=O)C1=CC=C(O)C=C1,C9H10O3,S4525
20435,Fenbufen,OC(=O)CCC(=O)C1=CC=C(C=C1)C2=CC=CC=C2,C16H14O3,S4526
20436,Fenofibric acid,CC(C)(OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2)C(O)=O,C17H15ClO4,S4527
20437,Furazolidone,[O-][N+](=O)C1=CC=C(O1)\C=N\N2CCOC2=O,C8H7N3O5,S4528
20438,i-Inositol,OC1C(O)C(O)C(O)C(O)C1O,C6H12O6,S4530
20439,Iopamidol,CC(O)C(=O)NC1=C(I)C(=C(I)C(=C1I)C(=O)NC(CO)CO)C(=O)NC(CO)CO,C17H22I3N3O8,S4532
20440,6-Acetamidohexanoic acid,CC(=O)NCCCCCC(O)=O,C8H15NO3,S4534
20441,Methylene Blue,[Cl-].CN(C)C1=CC2=C(C=C1)N=C3C=CC(C=C3S2)=[N+](C)C,C16H18ClN3S,S4535
20442,Nitrofurantoin,[O-][N+](=O)C1=CC=C(O1)/C=N/N2CC(=O)NC2=O,C8H6N4O5,S4536
20443,Pantoprazole sodium,[Na+].COC1=CC=NC(=C1OC)C[S](=O)C2=NC3=C([N-]2)C=CC(=C3)OC(F)F,C16H14F2N3NaO4S,S4538
20444,Salicylic acid,OC(=O)C1=C(O)C=CC=C1,C7H6O3,S4539
20445,Triclosan,OC1=CC(=CC=C1OC2=CC=C(Cl)C=C2Cl)Cl,C12H7Cl3O2,S4541
20446,Trihexyphenidyl hydrochloride,Cl.OC(CCN1CCCCC1)(C2CCCCC2)C3=CC=CC=C3,C20H31NO.HCl,S4542
20447,Trimetazidine dihydrochloride,Cl.Cl.COC1=C(OC)C(=C(CN2CCNCC2)C=C1)OC,C14H22N2O3.2HCl,S4543
20448,Urethane,CCOC(N)=O,C3H7NO2,S4544
20449,Xylitol,OCC(O)C(O)C(O)CO,C5H12O5,S4546
20450,8-Hydroxyquinoline,OC1=CC=CC2=CC=CN=C12,C9H7NO,S4547
20451,Aminoguanidine hydrochloride,Cl.NNC(N)=N,CH6N4.HCl,S4548
20452,Azelaic acid,OC(=O)CCCCCCCC(O)=O,C9H16O4,S4550
20453,Bithionol,OC1=C(Cl)C=C(Cl)C=C1SC2=C(O)C(=CC(=C2)Cl)Cl,C12H6Cl4O2S,S4552
20454,Bronopol,OCC(Br)(CO)[N+]([O-])=O,C3H6BrNO4,S4553
20455,Carzenide,N[S](=O)(=O)C1=CC=C(C=C1)C(O)=O,C7H7NO4S,S4556
20456,Citiolone,CC(=O)NC1CCSC1=O,C6H9NO2S,S4558
20457,Cloxiquine,OC1=CC=C(Cl)C2=CC=CN=C12,C9H6ClNO,S4559
20458,Danthron,OC1=CC=CC2=C1C(=O)C3=C(O)C=CC=C3C2=O,C14H8O4,S4561
20459,Dehydrocholic acid,CC(CCC(O)=O)C1CCC2C3C(CC(=O)C12C)C4(C)CCC(=O)CC4CC3=O,C24H34O5,S4562
20460,Diatrizoic acid,CC(=O)NC1=C(I)C(=C(I)C(=C1I)NC(C)=O)C(O)=O,C11H9I3N2O4,S4563
20461,Diethylcarbamazine citrate,CCN(CC)C(=O)N1CCN(C)CC1.OC(=O)CC(O)(CC(O)=O)C(O)=O,C10H21N3O.C6H8O7,S4564
20462,Diiodohydroxyquinoline,OC1=C(I)C=C(I)C2=CC=CN=C12,C9H5I2NO,S4565
20463,DL-Panthenol,CC(C)(CO)C(O)C(=O)NCCCO,C9H19NO4,S4566
20464,D panthenol,CC(C)(CO)C(O)C(=O)NCCCO,C9H19NO4,S4695
20465,Ethylvanillin,CCOC1=C(O)C=CC(=C1)C=O,C9H10O3,S4568
20466,Fluphenazine dihydrochloride,Cl.Cl.OCCN1CCN(CCCN2C3=C(SC4=CC=C(C=C24)C(F)(F)F)C=CC=C3)CC1,C22H26F3N3OS.2HCl,S4569
20467,Halothane,FC(F)(F)C(Cl)Br,C2HBrClF3,S4570
20468,Hexylresorcinol,CCCCCCC1=C(O)C=C(O)C=C1,C12H18O2,S4571
20469,Sulfabenzamide,NC1=CC=C(C=C1)[S](=O)(=O)NC(=O)C2=CC=CC=C2,C13H12N2O3S,S4576
20470,Terpin hydrate,O.CC(C)(O)C1CCC(C)(O)CC1,C10H20O2.H2O,S4577
20471,Tyloxapol,CC1=CC(=CC(=C1OCCO)CC2=C(OCCO)C(=CC(=C2)C(C)(C)CC(C)(C)C)CC3=C(OCCO)C=CC(=C3)C(C)(C)CC(C)(C)C)C(C)(C)CC(C)(C)C,(C14H22O.C2H4O.CH2O)x,S4578
20472,Triacetin,CC(=O)OCC(COC(C)=O)OC(C)=O,C9H14O6,S4581
20473,Butamben,CCCCOC(=O)C1=CC=C(N)C=C1,C11H15NO2,S4583
20474,Butylparaben,CCCCOC(=O)C1=CC=C(O)C=C1,C11H14O3,S4584
20475,Succinylsulfathiazole,OC(=O)CCC(=O)NC1=CC=C(C=C1)[S](=O)(=O)NC2=NC=CS2,C13H13N3O5S2,S4585
20476,Pentylenetetrazol,C1CC[N]2N=NN=C2CC1,C6H10N4,S4587
20477,Docusate Sodium,[Na+].CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)[S]([O-])(=O)=O,C20H37O7S.Na,S4588
20478,Amodiaquine dihydrochloride dihydrate,O.O.Cl.Cl.CCN(CC)CC1=CC(=CC=C1O)NC2=C3C=CC(=CC3=NC=C2)Cl,C20H22ClN3O.2HCl.2H2O,S4589
20479,Dithranol,OC1=CC=CC2=C1C(=O)C3=C(C2)C=CC=C3O,C14H10O3,S4590
20480,Nitroxoline,OC1=CC=C(C2=CC=CN=C12)[N+]([O-])=O,C9H6N2O3,S4591
20481,Chlormadinone acetate,CC(=O)OC1(CCC2C3C=C(Cl)C4=CC(=O)CCC4(C)C3CCC12C)C(C)=O,C23H29ClO4,S4593
20482,Cephalothin sodium,[Na+].CC(=O)OCC1=C(N2C(SC1)C(NC(=O)CC3=CC=CS3)C2=O)C([O-])=O,C16H15N2NaO6S2,S4594
20483,Cefazolin Sodium,[Na+].CC1=NN=C(SCC2=C(N3C(SC2)C(NC(=O)C[N]4C=NN=N4)C3=O)C([O-])=O)S1,C14H14N8O4S3.Na,S4595
20484,Cefixime,NC1=NC(=CS1)C(=N/OCC(O)=O)/C(=O)NC2C3SCC(=C(N3C2=O)C(O)=O)C=C,C16H15N5O7S2,S4596
20485,Lercanidipine hydrochloride,Cl.COC(=O)C1=C(C)NC(=C(C1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4)C,C36H41N3O6.HCl,S4597
20486,Benzyl benzoate,O=C(OCC1=CC=CC=C1)C2=CC=CC=C2,C14H12O2,S4599
20487,Benzyl alcohol,OCC1=CC=CC=C1,C7H8O,S4600
20488,Clioquinol,OC1=C(I)C=C(Cl)C2=CC=CN=C12,C9H5ClINO,S4601
20489,Gallic acid,OC(=O)C1=CC(=C(O)C(=C1)O)O,C7H6O5,S4603
20490,Levofloxacin hydrate,CC1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(=C2N4CCN(C)CC4)F,C18H20FN3O4.1/2H2O,S4604
20491,"2,2′-Dihydroxy-4-methoxybenzophenone",COC1=CC(=C(C=C1)C(=O)C2=C(O)C=CC=C2)O,C14H12O4,S4607
20492,Diflunisal,OC(=O)C1=C(O)C=CC(=C1)C2=C(F)C=C(F)C=C2,C13H8F2O3,S4609
20493,Mebendazole,COC(=O)NC1=NC2=C([NH]1)C=CC(=C2)C(=O)C3=CC=CC=C3,C16H13N3O3,S4610
20494,Dapson,NC1=CC=C(C=C1)[S](=O)(=O)C2=CC=C(N)C=C2,C12H12N2O2S,S4612
20495,Fenoldopam mesylate,C[S](O)(=O)=O.OC1=CC=C(C=C1)C2CNCCC3=C(Cl)C(=C(O)C=C23)O,C16H16ClNO3.CH4O3S,S4618
20496,Itopride hydrochloride,Cl.COC1=CC=C(C=C1OC)C(=O)NCC2=CC=C(OCCN(C)C)C=C2,C20H26N2O4.HCl,S4619
20497,Cefuroxime sodium,[Na+].CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C([O-])=O)COC(N)=O)C3=CC=CO3,C16H16N4O8S.Na,S4620
20498,"3,4-Diaminopyridine",NC1=C(N)C=NC=C1,C5H7N3,S4622
20499,Methylbenactyzine Bromide,[Br-].CC[N+](C)(CC)CCOC(=O)C(O)(C1=CC=CC=C1)C2=CC=CC=C2,C21H28NO3.Br,S4623
20500,"5,5-Dimethyloxazolidine-2,4-dione",CC1(C)OC(=O)NC1=O,C5H7NO3,S4624
20501,Alcaftadine,CN1CCC(CC1)=C2C3=C(CC[N]4C(=CN=C24)C=O)C=CC=C3,C19H21N3O,S4625
20502,(+/-)-Sulfinpyrazone,O=C1C(CC[S](=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4,C23H20N2O3S,S4628
20503,Chlorotrianisene,COC1=CC=C(C=C1)C(Cl)=C(C2=CC=C(OC)C=C2)C3=CC=C(OC)C=C3,C23H21ClO3,S4629
20504,Diazoxide,CC1=NC2=CC=C(Cl)C=C2[S](=O)(=O)N1,C8H7ClN2O2S,S4630
20505,Prochlorperazine dimaleate salt,CN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1.OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O,C20H24ClN3S.C8H8O8,S4631
20506,Isosorbide Mononitrate,OC1COC2C(COC12)O[N+]([O-])=O,C6H9NO6,S4633
20507,Sodium sulfadiazine,NC1=CC=C(C=C1)[S](=O)(=O)N([Na])C2=NC=CC=N2,C10H10N4O2S.Na,S4634
20508,Cyproheptadine hydrochloride sesquihydrate,O.O.O.Cl.Cl.CN1CCC(CC1)=C2C3=CC=CC=C3C=CC4=CC=CC=C24.CN5CCC(CC5)=C6C7=CC=CC=C7C=CC8=CC=CC=C68,C21H21N.HCl.3/2H2O,S4635
20509,Teneligliptin hydrobromide,CC1=N[N](C2=CC=CC=C2)C(=C1)N3CCN(CC3)C4CNC(C4)C(=O)N5CCSC5,C22H30N6OS.5/2HBr,S4636
20510,Prasugrel Hydrochloride,Cl.CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C3CC3)C4=C(F)C=CC=C4)S1,C20H20FNO3S.HCl,S4637
20511,Desogestrel,CCC12CC(=C)C3C(CCC4=CCCCC34)C1CCC2(O)C#C,C22H30O,S4638
20512,Lesinurad,OC(=O)CSC1=NN=C(Br)[N]1C2=C3C=CC=CC3=C(C=C2)C4CC4,C17H14BrN3O2S,S4640
20513,Tedizolid Phosphate,C[N]1N=NC(=N1)C2=NC=C(C=C2)C3=CC=C(C=C3F)N4CC(CO[P](O)(O)=O)OC4=O,C17H16FN6O6P,S4641
20514,Ciclesonide,CC(C)C(=O)OCC(=O)C12OC(OC1CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC23C)C6CCCCC6,C32H44O7,S4646
20515,Cefmenoxime hydrochloride,Cl.CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(O)=O)CSC3=NN=N[N]3C)C4=CSC(=N4)N.CO\N=C(/C(=O)NC5C6SCC(=C(N6C5=O)C(O)=O)CSC7=NN=N[N]7C)C8=CSC(=N8)N,C32H34N18O10S6.HCl,S4647
20516,Dantrolene sodium hemiheptahydrate,CCC1CN2CCC1CC2C(O)C3=C4C=C(OC)C=CC4=NC=C3,C14H9N4O5.7/2H2O.Na,S4648
20517,Hydroquinidine,CCC1CN2CCC1CC2C(O)C3=C4C=C(OC)C=CC4=NC=C3,C20H26N2O2,S4658
20518,Atipamezole hydrochloride,Cl.CCC1(CC2=C(C1)C=CC=C2)C3=C[NH]C=N3,C14H16N2.HCl,S4649
20519,Atipamezole,CCC1(CC2=C(C1)C=CC=C2)C3=CN=C[NH]3,C14H16N2,S4650
20520,Etoricoxib,CC1=NC=C(C=C1)C2=NC=C(Cl)C=C2C3=CC=C(C=C3)[S](C)(=O)=O,C18H15ClN2O2S,S4651
20521,Sulisobenzone,COC1=CC(=C(C=C1[S](O)(=O)=O)C(=O)C2=CC=CC=C2)O,C14H12O6S,S4652
20522,Parecoxib,CCC(=O)N[S](=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3,C19H18N2O4S,S4656
20523,Eslicarbazepine Acetate,CC(=O)OC1CC2=C(C=CC=C2)N(C(N)=O)C3=C1C=CC=C3,C17H16N2O3,S4657
20524,Glycopyrrolate,[Br-].C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)C3=CC=CC=C3,C19H28NO3.Br,S4660
20525,Tiagabine hydrochloride,Cl.CC1=C(SC=C1)C(=CCCN2CCCC(C2)C(O)=O)C3=C(C)C=CS3,C20H25NO2S2.HCl,S4661
20526,Atazanavir,COC(=O)NC(C(=O)NC(CC1=CC=CC=C1)C(O)CN(CC2=CC=C(C=C2)C3=NC=CC=C3)NC(=O)C(NC(=O)OC)C(C)(C)C)C(C)(C)C,C38H52N6O7,S4662
20527,Fusidate Sodium,[Na+].CC1C(O)CCC2(C)C1CCC3(C)C2C(O)CC4\C(C(CC34C)OC(C)=O)=C(/CCC=C(C)C)C([O-])=O,C31H47O6.Na,S4663
20528,Molsidomine,CCOC(=O)[N-]C1=C[N+](=NO1)N2CCOCC2,C9H14N4O4,S4664
20529,Rabeprazole sodium,COCCCOC1=C(C)C(=NC=C1)C[S](=O)C2=NC3=CC=CC=C3[N]2[Na],C18H20N3O3S.Na,S4665
20530,Sivelestat sodium tetrahydrate,O.O.O.O.[Na+].CC(C)(C)C(=O)OC1=CC=C(C=C1)[S](=O)(=O)NC2=CC=CC=C2C(=O)NCC([O-])=O,C20H21N2O7S.4H2O.Na,S4666
20531,Lidocaine hydrochloride,Cl.CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,C14H22N2O.HCl,S4667
20532,Benzocaine hydrochloride,Cl.CCOC(=O)C1=CC=C(N)C=C1,C9H11NO2.HCl,S4669
20533,Dimenhydrinate,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.CN3C(=O)N(C)C4=C([NH]C(=N4)Cl)C3=O,C24H28ClN5O3,S4672
20534,Etonogestrel,CCC12CC(=C)C3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C,C22H28O2,S4673
20535,Hydroxyprogesterone caproate,CCCCCC(=O)OC1(CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C)C(C)=O,C27H40O4,S4674
20536,Gluconolactone,OCC1OC(=O)C(O)C(O)C1O,C6H10O6,S4676
20537,Povidone iodine,CCC(C)N1CCCC1=O,(C6H9NO)x.xI2,S4678
20538,Terazosin HCl,Cl.COC1=CC2=C(C=C1OC)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N,C19H25N5O4.HCl,S4679
20539,Loxoprofen,CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1,C15H18O3,S4682
20540,Sildenafil Mesylate,CCCC1=N[N](C)C2=C1N=C(NC2=O)C3=CC(=CC=C3OCC)[S](=O)(=O)N4CCN(C)CC4.C[S](O)(=O)=O,C22H30N6O4S.xCH4O3S,S4683
20541,Efavirenz,FC(F)(F)C1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC3CC3,C14H9ClF3NO2,S4685
20542,Vitamin E,CC(C)CCCC(C)CCCC(C)CCCC1(C)CCC2=C(C)C(=C(C)C(=C2O1)C)O,C29H50O2,S4686
20543,(±)-α-Tocopherol,CC(C)CCCC(C)CCCC(C)CCCC1(C)CCC2=C(C)C(=C(C)C(=C2O1)C)O,C29H50O2,S6104
20544,Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,C14H22N2O2,S4687
20545,Deoxycholic acid,CC(CCC(O)=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C,C24H40O4,S4689
20546,Escin,C\C=C(C)/C(=O)OC1C(OC(C)=O)C2(CO)C(O)CC3(C)C(=CCC4C5(C)CCC(OC6OC(C(OC7OC(CO)C(O)C(O)C7O)C(O)C6OC8OC(CO)C(O)C(O)C8O)C(O)=O)C(C)(CO)C5CCC34C)C2CC1(C)C,C55H86O24,S4690
20547,Oxybenzone,COC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O,C14H12O3,S4691
20548,Succimer,OC(=O)C(S)C(S)C(O)=O,C4H6O4S2,S4692
20549,Guanfacine Hydrochloride,Cl.NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,C9H9Cl2N3O.HCl,S4693
20550,CarbinoxaMine Maleate,CN(C)CCOC(C1=CC=C(Cl)C=C1)C2=NC=CC=C2.OC(=O)\C=C/C(O)=O,C16H19ClN2O.C4H4O4,S4696
20551,Saxagliptin hydrate,O.NC(C(=O)N1C(CC2CC12)C#N)[C]34CC5[CH2]C(C[C](O)(C5)C3)C4,C18H25N3O2.H2O,S4697
20552,Vitamin K1,CC(C)CCCC(C)CCCC(C)CCC/C(C)=C/CC1=C(C)C(=O)C2=C(C=CC=C2)C1=O,C31H46O2,S4698
20553,Etretinate,CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=C(OC)C=C1C)C,C23H30O3,S4699
20554,2-Deoxy-D-glucose (2-DG),OCC1OC(O)CC(O)C1O,C6H12O5,S4701
20555,Eugenol,COC1=C(O)C=CC(=C1)CC=C,C10H12O2,S4706
20556,Oleic Acid,CCCCCCCC\C=C/CCCCCCCC(O)=O,C18H34O2,S4707
20557,Latanoprost,CC(C)OC(=O)CCC\C=C/CC1C(O)CC(O)C1CCC(O)CCC2=CC=CC=C2,C26H40O5,S4709
20558,Esculetin,OC1=CC2=C(C=CC(=O)O2)C=C1O,C9H6O4,S4711
20559,(-)-Menthol,CC(C)C1CCC(C)CC1O,C10H20O,S4714
20560,DL-Menthol,CC(C)C1CCC(C)CC1O,C10H20O,S5868
20561,Menthol,CC(C)C1CCC(C)CC1O,C10H20O,E4112
20562,Evans Blue,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(O)C4=C(N)C(=CC(=C4C=C3)[S](=O)(=O)O[Na])[S](=O)(=O)O[Na])C)N=NC5=C(O)C6=C(N)C(=CC(=C6C=C5)[S](=O)(=O)O[Na])[S](=O)(=O)O[Na],C34H24N6O14S4.4Na,S4716
20563,Isatin,O=C1NC2=C(C=CC=C2)C1=O,C8H5NO2,S4717
20564,Acetylcholine iodide,[I-].CC(=O)OCC[N+](C)(C)C,C7H16NO2.I,S4718
20565,Cefotaxime,CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(O)=O)COC(C)=O)C3=CSC(=N3)N,C16H17N5O7S2,S4720
20566,Benzenesulfonamide,N[S](=O)(=O)C1=CC=CC=C1,C6H7NO2S,S4725
20567,Lauric Acid,CCCCCCCCCCCC(O)=O,C12H24O2,S4726
20568,Cinnarizine,C1CN(CCN1C\C=C\C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4,C26H28N2,S4727
20569,Perphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4)CC1,C21H26ClN3OS,S4731
20570,Retigabine,CCOC(=O)NC1=CC=C(NCC2=CC=C(F)C=C2)C=C1N,C16H18FN3O2,S4733
20571,Retigabine 2HCl,Cl.Cl.CCOC(=O)NC1=CC=C(NCC2=CC=C(F)C=C2)C=C1N,C16H18FN3O2.2HCl,S4734
20572,Salvianolic acid B,OC(=O)C(CC1=CC(=C(O)C=C1)O)OC(=O)/C=C/C2=CC=C(O)C3=C2C(C(O3)C4=CC=C(O)C(=C4)O)C(=O)OC(CC5=CC=C(O)C(=C5)O)C(O)=O,C36H30O16,S4735
20573,Trapidil,CCN(CC)C1=CC(=NC2=NC=N[N]12)C,C10H15N5,S4736
20574,Psoralen,O=C1OC2=C(C=C1)C=C3C=COC3=C2,C11H6O3,S4737
20575,Anethole trithione,COC1=CC=C(C=C1)C2=CC(=S)SS2,C10H8OS3,S4744
20576,Ondansetron Hydrochloride Dihydrate,O.O.Cl.C[N]1C2=C(C(=O)C(CC2)C[N]3C=CN=C3C)C4=C1C=CC=C4,C18H19N3O.HCl.2H2O,S4748
20577,Citalopram HBr,Br.CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3,C20H21FN2O.HBr,S4749
20578,Sulfacetamide sodium salt hydrate,O.CC(=O)N([Na])[S](=O)(=O)C1=CC=C(N)C=C1,C8H9N2O3S.H2O.Na,S4750
20579,Cisapride hydrate,O.COC1CN(CCCOC2=CC=C(F)C=C2)CCC1NC(=O)C3=CC(=C(N)C=C3OC)Cl,C23H29ClFN3O4.H2O,S4751
20580,Corticosterone (NSC-9705),CC12CC(O)C3C(CCC4=CC(=O)CCC34C)C1CCC2C(=O)CO,C21H30O4,S4752
20581,Ganoderic acid A,CC(CC(=O)CC(C)C(O)=O)C1CC(O)C2(C)C3=C(C(=O)CC12C)C4(C)CCC(=O)C(C)(C)C4CC3O,C30H44O7,S4753
20582,Betulin,CC(=C)C1CCC2(CO)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C12,C30H50O2,S4754
20583,p-Coumaric Acid,OC(=O)\C=C\C1=CC=C(O)C=C1,C9H8O3,S4759
20584,Melibiose,OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O,C12H22O11,S4768
20585,alpha-Asarone,COC1=CC(=C(\C=C\C)C=C1OC)OC,C12H16O3,S4772
20586,Menadiol Diacetate,CC(=O)OC1=C2C=CC=CC2=C(OC(C)=O)C(=C1)C,C15H14O4,S4779
20587,Benzyl isothiocyanate,S=C=NCC1=CC=CC=C1,C8H7NS,S4783
20588,L-α-Phosphatidylcholine,C[N+](C)(C)CCO[P]([O-])(=O)OCC(COC(=O)[R])OC(=O)[R],C10H18LNO8PR2,S4788
20589,5-Acetylsalicylic acid,CC(=O)C1=CC(=C(O)C=C1)C(O)=O,C9H8O4,S4789
20590,N-Acetylneuraminic acid,CC(=O)NC1C(O)CC(O)(OC1C(O)C(O)CO)C(O)=O,C11H19NO9,S4792
20591,Nicergoline,COC12CC(COC(=O)C3=CN=CC(=C3)Br)CN(C)C1CC4=C[N](C)C5=CC=CC2=C45,C24H26BrN3O3,S4797
20592,Ceftizoxime,CO\N=C(C(=O)NC1C2SCC=C(N2C1=O)C(O)=O)\C3=CSC(=N3)N,C13H13N5O5S2,S4812
20593,Cefuroxime axetil,CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(=O)OC(C)OC(C)=O)COC(N)=O)C3=CC=CO3,C20H22N4O10S,S4813
20594,L-Cysteine HCl,Cl.NC(CS)C(O)=O,C3H7NO2S.ClH,S4815
20595,Diatrizoate sodium,[Na+].CC(=O)NC1=C(I)C(=C(I)C(=C1I)NC(C)=O)C([O-])=O,C11H8I3N2O4.Na,S4816
20596,Atenolol,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,C14H22N2O3,S4817
20597,Saccharin,O=C1N[S](=O)(=O)C2=C1C=CC=C2,C7H5NO3S,S4819
20598,Diastase,0,0,S4820
20599,Lanolin,0,0,S5106
20600,Casanthranol,0,C26H44NNaO7RS,S5132
20601,Arabic gum,0,0,S5580
20602,Insulin (human),0,C257H383N65O77S6,S6955
20603,Gramicidin,0,0,E2970
20604,Melanin,0,0,E4013
20605,Eprinomectin,0,,S3591
20606,Hypromellose,0,,S4444
20607,Maltose,OCC(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)C(O)C=O,C12H22O11,S4830
20608,Lactose,OCC(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)C(O)C=O,C12H22O11,S6047
20609,Piperonyl butoxide,CCCCOCCOCCOCC1=CC2=C(OCO2)C=C1CCC,C19H30O5,S4831
20610,Tolmetin,C[N]1C(=CC=C1C(=O)C2=CC=C(C)C=C2)CC(O)=O,C15H15NO3,S4832
20611,Cefoxitin sodium,[Na+].COC1(NC(=O)CC2=CC=CS2)C3SCC(=C(N3C1=O)C([O-])=O)COC(N)=O,C16H16N3O7S2.Na,S4833
20612,Propantheline bromide,[Br-].CC(C)[N+](C)(CCOC(=O)C1C2=C(OC3=CC=CC=C13)C=CC=C2)C(C)C,C23H30NO3.Br,S4834
20613,Aceclofenac,OC(=O)COC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1,C16H13Cl2NO4,S4835
20614,Nilutamide,CC1(C)NC(=O)N(C2=CC=C(C(=C2)C(F)(F)F)[N+]([O-])=O)C1=O,C12H10F3N3O4,S4836
20615,Ibudilast,CC(C)C(=O)C1=C2C=CC=C[N]2N=C1C(C)C,C14H18N2O,S4837
20616,Acotiamide hydrochloride,O.O.O.Cl.COC1=CC(=C(C=C1OC)C(=O)NC2=NC(=CS2)C(=O)NCCN(C(C)C)C(C)C)O,C21H30N4O5S.HCl.3H2O,S4838
20617,Mosapride,CCOC1=CC(=C(Cl)C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(F)C=C3)N,C21H25ClFN3O3,S4839
20618,Laurocapram,CCCCCCCCCCCCN1CCCCCC1=O,C18H35NO,S4841
20619,Potassium acetate,CC(=O)O[K],C2H3O2.K,S4843
20620,Cefcapene Pivoxil Hydrochloride,O.Cl.CC\C=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)COC(N)=O)C3=CSC(=N3)N,C23H29N5O8S2.HCl.H2O,S4844
20621,Rabeprazole,COCCCOC1=C(C)C(=NC=C1)C[S](=O)C2=NC3=C([NH]2)C=CC=C3,C18H21N3O3S,S4845
20622,Meropenem Trihydrate,O.O.O.CC(O)C1C2C(C)C(=C(N2C1=O)C(O)=O)SC3CNC(C3)C(=O)N(C)C,C17H25N3O5S.3H2O,S4846
20623,Faropenem Sodium,[Na+].CC(O)C1C2SC(=C(N2C1=O)C([O-])=O)C3CCCO3,C12H14NO5S.Na,S4847
20624,Dalbavancin,CNC1C(=O)NC2CC3=CC=C(OC4=C(OC5OC(C(O)C(O)C5NC(=O)CCCCCCCCC(C)C)C(O)=O)C6=CC(=C4)C(NC(=O)C(NC2=O)C7=CC(=CC(=C7Cl)O)OC8=CC=C1C=C8O)C(=O)NC9C(=O)NC(C(O)C%10=CC(=C(O6)C=C%10)Cl)C(=O)NC(C(=O)NCCCN(C)C)C%11=C(C(=CC(=C%11)O)OC%12OC(CO)C(O)C(O)C%12O)C%13=CC9=CC=C%13O)C=C3,C88H100Cl2N10O28,S4848
20625,Flucloxacillin sodium,[Na+].CC1=C(C(=O)NC2C3SC(C)(C)C(N3C2=O)C([O-])=O)C(=NO1)C4=C(F)C=CC=C4Cl,C19H16ClFN3O5S.Na,S4850
20626,Tafluprost,CC(C)OC(=O)CCC\C=C/CC1C(O)CC(O)C1/C=C/C(F)(F)COC2=CC=CC=C2,C25H34F2O5,S4851
20627,Gadopentetate Dimeglumine,CNCC(O)C(O)C(O)C(O)CO.CNCC(O)C(O)C(O)C(O)CO.OC(=O)CN1CCN2CCN(CC(O)=O)CC(=O)O[Gd](OC(=O)C2)OC(=O)C1,C14H18GdN3O10.2C7H17NO5.2H,S4852
20628,Ecabet sodium,[Na+].CC(C)C1=CC2=C(C=C1[S]([O-])(=O)=O)C3(C)CCCC(C)(C3CC2)C(O)=O,C20H27O5S.Na,S4853
20629,Bedaquiline fumarate,COC1=C(C=C2C=C(Br)C=CC2=N1)C(C3=CC=CC=C3)C(O)(CCN(C)C)C4=C5C=CC=CC5=CC=C4.OC(=O)\C=C\C(O)=O,C32H31BrN2O2.C4H4O4,S4854
20630,Iproniazid,CC(C)NNC(=O)C1=CC=NC=C1,C9H13N3O,S4856
20631,TriacetonaMine,CC1(C)CC(=O)CC(C)(C)N1,C9H17NO,S4859
20632,Indole-3-carboxylic acid,OC(=O)C1=C[NH]C2=C1C=CC=C2,C9H7NO2,S4860
20633,Squalene,CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(C)\CC\C=C(C)\CCC=C(C)C,C30H50,S4862
20634,Cefetamet pivoxil hydrochloride,Cl.CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)C)C3=CSC(=N3)N,C20H25N5O7S2.HCl,S4865
20635,Nicarbazin,CC1=NC(=NC(=C1)C)O.[O-][N+](=O)C2=CC=C(NC(=O)NC3=CC=C(C=C3)[N+]([O-])=O)C=C2,C13H10N4O5.C6H8N2O,S4866
20636,Propacetamol hydrochloride,Cl.CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1,C14H20N2O3.HCl,S4867
20637,Xanthinol Nicotinate,CN(CCO)CC(O)C[N]1C=NC2=C1C(=O)N(C)C(=O)N2C.OC(=O)C3=CC=CN=C3,C13H21N5O4.C6H5NO2,S4868
20638,Sulfamethoxazole sodium,CC1=CC(=NO1)N([Na])[S](=O)(=O)C2=CC=C(N)C=C2,C10H10N3O3S.Na,S4869
20639,Cefodizime Sodium,[Na+].[Na+].CO/N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C([O-])=O)CSC3=NC(=C(CC([O-])=O)S3)C)C4=CSC(=N4)N,C20H18N6O7S4.2Na,S4870
20640,Pyridoxal 5-phosphate monohydrate,O.CC1=NC=C(CO[P](O)(O)=O)C(=C1O)C=O,C8H10NO6P.H2O,S4871
20641,Cefazedone,CC1=NN=C(SCC2=C(N3C(SC2)C(NC(=O)CN4C=C(Cl)C(=O)C(=C4)Cl)C3=O)C(O)=O)S1,C18H15Cl2N5O5S3,S4874
20642,Cephapirin Benzathine,CC(=O)OCC1=C(N2C(SC1)C(NC(=O)CSC3=CC=NC=C3)C2=O)C(O)=O.CC(=O)OCC4=C(N5C(SC4)C(NC(=O)CSC6=CC=NC=C6)C5=O)C(O)=O.C(CNCC7=CC=CC=C7)NCC8=CC=CC=C8,C50H54N8O12S4,S4875
20643,Robenidine Hydrochloride,Cl.ClC1=CC=C(C=C1)\C=N\NC(=N)N\N=C\C2=CC=C(Cl)C=C2,C15H13Cl2N5.HCl,S4876
20644,Eperisone hydrochloride,Cl.CCC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2,C17H25NO.HCl,S4877
20645,Neticonazole Hydrochloride,Cl.CCCCCOC1=CC=CC=C1C(=C\SC)/[N]2C=CN=C2,C17H22N2OS.HCl,S4878
20646,Cefathiamidine,CC(C)NC(SCC(=O)NC1C2SCC(=C(N2C1=O)C(O)=O)COC(C)=O)=NC(C)C,C19H28N4O6S2,S4880
20647,Calcium Dobesilate,OC1=CC=C(O)C(=C1)[S]([O-])(=O)=O,C6H5O5S.1/2Ca,S4881
20648,Lynestrenol,CC12CCC3C(CCC4=CCCCC34)C1CCC2(O)C#C,C20H28O,S4883
20649,Taurolidine,O=[S]1(=O)CCN(CN1)CN2CC[S](=O)(=O)NC2,C7H16N4O4S2,S4885
20650,Menbutone,COC1=C2C=CC=CC2=C(C=C1)C(=O)CCC(O)=O,C15H14O4,S4886
20651,Perospirone hydrochloride,Cl.O=C1C2CCCCC2C(=O)N1CCCCN3CCN(CC3)C4=NSC5=C4C=CC=C5,C23H30N4O2S.HCl,S4889
20652,Bifendate,COC(=O)C1=CC(=C2OCOC2=C1C3=C(C=C(OC)C4=C3OCO4)C(=O)OC)OC,C20H18O10,S4890
20653,Cytosine,NC1=NC(=O)NC=C1,C4H5N3O,S4893
20654,D-Glucurone,OC1OC2C(O)C(=O)OC2C1O,C6H8O6,S4894
20655,Elagolix Sodium,[Na+].COC1=C(F)C(=CC=C1)C2=C(C)N(CC3=C(F)C=CC=C3C(F)(F)F)C(=O)N(CC(NCCCC([O-])=O)C4=CC=CC=C4)C2=O,C32H29F5N3O5.Na,S4896
20656,Sulfogaiacol,[K+].COC1=CC(=CC=C1O)[S]([O-])(=O)=O,C7H7O5S.K,S4899
20657,Propiverine hydrochloride,Cl.CCCOC(C(=O)OC1CCN(C)CC1)(C2=CC=CC=C2)C3=CC=CC=C3,C23H29NO3.ClH,S4931
20658,Proxyphylline,CC(O)C[N]1C=NC2=C1C(=O)N(C)C(=O)N2C,C10H14N4O3,S4932
20659,Asunaprevir (BMS-650032),COC1=C2C=CC(=CC2=C(OC3CC(N(C3)C(=O)C(NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NC4(CC4C=C)C(=O)N[S](=O)(=O)C5CC5)N=C1)Cl,C35H46ClN5O9S,S4935
20660,cis-Aconitic acid,OC(=O)CC(=C/C(O)=O)/C(O)=O,C6H6O6,S4939
20661,Maltol,CC1=C(O)C(=O)C=CO1,C6H6O3,S4940
20662,Farnesol,CC(C)=CCCC(/C)=C/CCC(/C)=C/CO,C15H26O,S4941
20663,Nonanoic acid,CCCCCCCCC(O)=O,C9H18O2,S4949
20664,Fumaric acid,OC(=O)\C=C\C(O)=O,C4H4O4,S4952
20665,Usnic acid,CC(=O)C1C(=O)C=C2OC3=C(C(=C(C)C(=C3C(C)=O)O)O)C2(C)C1=O,C18H16O7,S4953
20666,Benzamidine HCl,Cl.NC(=N)C1=CC=CC=C1,C7H9ClN2,S4956
20667,Linalool,CC(C)=CCCC(C)(O)C=C,C10H18O,S4957
20668,Glycocholic acid,CC(CCC(=O)NCC(O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,C26H43NO6,S4958
20669,Lactobionic acid,OCC(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)C(O)C(O)=O,C12H22O12,S4964
20670,Tropine,CN1C2CCC1CC(O)C2,C8H15NO,S4969
20671,Buparvaquone,CC(C)(C)C1CCC(CC1)CC2=C(O)C(=O)C3=C(C=CC=C3)C2=O,C21H26O3,S4971
20672,Iminostilbene,N1C2=C(C=CC=C2)C=CC3=CC=CC=C13,C14H11N,S4973
20673,Fimasartan,CCCCC1=NC(=C(CC(=S)N(C)C)C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[NH]4)C,C27H31N7OS,S4975
20674,Sulfalene (SMPZ),COC1=C(N[S](=O)(=O)C2=CC=C(N)C=C2)N=CC=N1,C11H12N4O3S,S4976
20675,Efonidipine,CC1=C(C(C2=CC(=CC=C2)[N+]([O-])=O)C(=C(C)N1)[P]3(=O)OCC(C)(C)CO3)C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5,C34H38N3O7P,S4977
20676,Azathramycin,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(O)CC(C)CNC(C)C(O)C1(C)O,C37H70N2O12,S4978
20677,Anamorelin,CN(C)N(C)C(=O)C1(CCCN(C1)C(=O)C(CC2=C[NH]C3=C2C=CC=C3)NC(=O)C(C)(C)N)CC4=CC=CC=C4,C31H42N6O3,S4980
20678,Sorbic acid,C/C=C/C=C/C(O)=O,C6H8O2,S4983
20679,Tiamulin fumarate,CCN(CC)CCSCC(=O)OC1CC(C)(C=C)C(O)C(C)C23CCC(C)C1(C)C2C(=O)CC3.OC(=O)\C=C\C(O)=O,C28H47NO4S.C4H4O4,S4988
20680,Valpromide,CCCC(CCC)C(N)=O,C8H17NO,S4991
20681,Methylcobalamin,C[Co+]N1\C2=C(C)/C3=N\C(=C/C4=NC(=C(C)/C5=NC(C(CC(N)=O)C5(C)CCC(=O)NCC(C)O[P]([O-])(=O)OC6C(O)C(OC6CO)[N]7C=NC8=C7C=C(C)C(=C8)C)C1(C)C(C)(CC(N)=O)C2CCC(N)=O)\C(CCC(N)=O)C4(C)C)C(CCC(N)=O)C3(C)CC(N)=O,C63H91CoN13O14P,S4994
20682,Tavaborole (AN-2690),OB1OCC2=CC(=CC=C12)F,C7H6BFO2,S4996
20683,Avermectin B1,CCC(C)C1OC2(CC3CC(C\C=C(C)\C(OC4CC(OC)C(OC5CC(OC)C(O)C(C)O5)C(C)O4)C(C)\C=C\C=C\6COC7C(O)C(=CC(C(=O)O3)C67O)C)O2)C=CC1C,C48H72O14,S4999
20684,Tofacitinib (CP-690550) Citrate,CC1CCN(CC1N(C)C2=C3C=C[NH]C3=NC=N2)C(=O)CC#N.OC(=O)CC(O)(CC(O)=O)C(O)=O,C16H20N6O.C6H8O7,S5001
20685,Fingolimod (FTY720) HCl,Cl.CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,C19H33NO2.HCl,S5002
20686,Tacrolimus (FK506),COC1CC(CCC1O)\C=C(C)\C2OC(=O)C3CCCCN3C(=O)C(=O)C4(O)OC(C(CC(C)C/C(=C/C(CC=C)C(=O)CC(O)C2C)C)OC)C(CC4C)OC,C44H69NO12,S5003
20687,Pimecrolimus,CCC1/C=C(C)/CC(C)CC(OC)C2OC(O)(C(C)CC2OC)C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)C(O)CC1=O)/C(C)=C/C4CCC(Cl)C(C4)OC,C43H68ClNO11,S5004
20688,Cefotiam hydrochloride,Cl.Cl.CN(C)CC[N]1N=NN=C1SCC2=C(N3C(SC2)C(NC(=O)CC4=CSC(=N4)N)C3=O)C(O)=O,C18H23N9O4S3.2HCl,S5005
20689,Teprenone,CC(C)=CCC/C(C)=C/CC\C(C)=C\CC\C(C)=C\CCC(C)=O,C23H38O,S5006
20690,Delamanid,CC1(COC2=CC=C(C=C2)N3CCC(CC3)OC4=CC=C(OC(F)(F)F)C=C4)C[N]5C=C(N=C5O1)[N+]([O-])=O,C25H25F3N4O6,S5007
20691,Brivudine,OCC1OC(CC1O)N2C=C(\C=C\Br)C(=O)NC2=O,C11H13BrN2O5,S5009
20692,Indometacin Sodium,O.O.O.COC1=CC2=C(C=C1)[N](C(=C2CC(=O)O[Na])C)C(=O)C3=CC=C(Cl)C=C3,C19H21ClNNaO7,S5010
20693,Octenidine Dihydrochloride,Cl.Cl.CCCCCCCCN=C1C=CN(CCCCCCCCCCN2C=CC(C=C2)=NCCCCCCCC)C=C1,C36H62N4.2HCl,S5012
20694,Ioversol,OCCN(C(=O)CO)C1=C(I)C(=C(I)C(=C1I)C(=O)NCC(O)CO)C(=O)NCC(O)CO,C18H24I3N3O9,S5013
20695,Crisaborole (AN2728),OB1OCC2=CC(=CC=C12)OC3=CC=C(C=C3)C#N,C14H10BNO3,S5014
20696,Simeprevir (TMC435),COC1=C(C)C2=NC(=CC(=C2C=C1)OC3CC4C(C3)C(=O)N(C)CCCC\C=C/C5CC5(NC4=O)C(=O)N[S](=O)(=O)C6CC6)C7=NC(=CS7)C(C)C,C38H47N5O7S2,S5015
20697,Isoprinosine,CC(O)CN(C)C.CC(O)CN(C)C.CC(O)CN(C)C.CC(=O)NC1=CC=C(C=C1)C(O)=O.CC(=O)NC2=CC=C(C=C2)C(O)=O.CC(=O)NC3=CC=C(C=C3)C(O)=O.OCC4OC(C(O)C4O)[N]5C=NC6=C5N=CNC6=O,C10H12N4O5.3C9H9NO3.3C5H13NO,S5016
20698,Oxyclozanide,OC1=C(Cl)C=C(Cl)C=C1NC(=O)C2=C(O)C(=CC(=C2Cl)Cl)Cl,C13H6Cl5NO3,S5017
20699,Indobufen,CCC(C(O)=O)C1=CC=C(C=C1)N2CC3=C(C=CC=C3)C2=O,C18H17NO3,S5019
20700,Tilorone dihydrochloride,Cl.Cl.CCN(CC)CCOC1=CC2=C(C=C1)C3=C(C=C(OCCN(CC)CC)C=C3)C2=O,C25H34N2O3.2HCl,S5020
20701,Nadolol,CC(C)(C)NCC(O)COC1=CC=CC2=C1CC(O)C(O)C2,C17H27NO4,S5023
20702,Efinaconazole,CC(N1CCC(=C)CC1)C(O)(C[N]2C=NC=N2)C3=CC=C(F)C=C3F,C18H22F2N4O,S5025
20703,Mebeverine Hydrochloride,Cl.CCN(CCCCOC(=O)C1=CC=C(OC)C(=C1)OC)C(C)CC2=CC=C(OC)C=C2,C25H35NO5.HCl,S5027
20704,Etofylline,CN1C(=O)N(C)C2=C([N](CCO)C=N2)C1=O,C9H12N4O3,S5029
20705,Dihydralazine sulphate,N\N=C1/NN\C(=N/N)C2=C1C=CC=C2.O[S](O)(=O)=O,C8H10N6.H2SO4,S5030
20706,Mephenesin,CC1=C(OCC(O)CO)C=CC=C1,C10H14O3,S5032
20707,Terconazole,CC(C)N1CCN(CC1)C2=CC=C(OCC3COC(C[N]4C=NC=N4)(O3)C5=CC=C(Cl)C=C5Cl)C=C2,C26H31Cl2N5O3,S5033
20708,Melitracen hydrochloride,Cl.CN(C)CC[CH]=[C]1C2=C(C=CC=C2)[C](C)(C)C3=C1C=CC=C3,C21H25N.HCl,S5034
20709,Phenazine methosulfate,CO[S]([O-])(=O)=O.C[N+]1=C2C=CC=CC2=NC3=CC=CC=C13,C13H11N2.CH3O4S,S5037
20710,Valethamate Bromide,[Br-].CCC(C)C(C(=O)OCC[N+](C)(CC)CC)C1=CC=CC=C1,C19H32BrNO2,S5038
20711,Tiamulin,CCN(CC)CCSCC(=O)OC1CC(C)(C=C)C(O)C(C)C23CCC(C)C1(C)C2C(=O)CC3,C28H47NO4S,S5040
20712,Difloxacin hydrochloride,Cl.CN1CCN(CC1)C2=CC3=C(C=C2F)C(=O)C(=CN3C4=CC=C(F)C=C4)C(O)=O,C21H19F2N3O3.HCl,S5041
20713,Bevantolol hydrochloride,Cl.COC1=C(OC)C=C(CCNCC(O)COC2=CC=CC(=C2)C)C=C1,C20H27NO4.HCl,S5042
20714,Benorylate,CC(=O)NC1=CC=C(OC(=O)C2=C(OC(C)=O)C=CC=C2)C=C1,C17H15NO5,S5043
20715,Clonixin,CC1=C(NC2=C(C=CC=N2)C(O)=O)C=CC=C1Cl,C13H11ClN2O2,S5046
20716,Thiocolchicoside,COC1=C(OC)C2=C(CCC(NC(C)=O)C3=CC(=O)C(=CC=C23)SC)C=C1OC4OC(CO)C(O)C(O)C4O,C27H33NO10S,S5049
20717,Granisetron,CN1C2CCCC1CC(C2)NC(=O)C3=N[N](C)C4=C3C=CC=C4,C18H24N4O,S5052
20718,Imazalil,ClC1=CC=C(C(C[N]2C=CN=C2)OCC=C)C(=C1)Cl,C14H14Cl2N2O,S5053
20719,Rifamycin sodium salt,[Na+].COC1/C=C/OC2(C)OC3=C(C2=O)C4=C(C(=C3C)O)C(=C(NC(=O)\C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(C1C)C(=O)OC)C)C=C4[O-])O,C37H46NNaO12,S5054
20720,Milbemycin Oxime,CC1C(OC2(CC1)CC3CC(C/C=C(C)/CC(C)\C=C\C=C\4COC5/C(=N/O)C(=CC(C(=O)O3)C45O)C)O2)[R],C30H40NO7R2,S5055
20721,Dinoprost tromethamine,CCCCCC(O)/C=C/C1C(O)CC(O)C1C\C=C/CCCC(O)=O.NC(CO)(CO)CO,C20H34O5.C4H11NO3,S5056
20722,Revaprazan Hydrochloride,Cl.CC1N(CCC2=C1C=CC=C2)C3=NC(=NC(=C3C)C)NC4=CC=C(F)C=C4,C22H23FN4.HCl,S5058
20723,Pixantrone Maleate,NCCNC1=CC=C(NCCN)C2=C1C(=O)C3=C(C=NC=C3)C2=O.OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O,C17H19N5O2.2C4H4O4,S5059
20724,Metadoxine,CC1=C(O)C(=C(CO)C=N1)CO.OC(=O)C2CCC(=O)N2,C8H11NO3.C5H7NO3,S5060
20725,Daclatasvir Dihydrochloride,Cl.Cl.COC(=O)NC(C(C)C)C(=O)N1CCCC1C2=NC=C([NH]2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C([NH]5)C6CCCN6C(=O)C(NC(=O)OC)C(C)C,C40H50N8O6.2HCl,S5062
20726,Trelagliptin succinate,CN1C(=O)C=C(N2CCCC(N)C2)N(CC3=CC(=CC=C3C#N)F)C1=O.OC(=O)CCC(O)=O,C18H20FN5O2.C4H6O4,S5063
20727,Ganciclovir sodium,[Na+].NC1=NC2=C(N=C[N]2COC(CO)CO)C(=N1)[O-],C9H12N5NaO4,S5065
20728,Pramipexole dihydrochloride,Cl.Cl.CCCNC1CCC2=C(C1)SC(=N2)N,C10H17N3S.2HCl,S5066
20729,Losartan,CCCCC1=NC(=C(CO)[N]1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=N[NH]4)Cl,C22H23ClN6O,S5067
20730,Dabrafenib Mesylate,CC(C)(C)C1=NC(=C(S1)C2=CC=NC(=N2)N)C3=C(F)C(=CC=C3)N[S](=O)(=O)C4=C(F)C=CC=C4F.C[S](O)(=O)=O,C23H20F3N5O2S2.CH4O3S,S5069
20731,Mupirocin calcium,O.O.CC(O)C(C)C1OC1CC2COC(C\C(C)=C\C(=O)OCCCCCCCCC(=O)O[Ca]OC(=O)CCCCCCCCOC(=O)\C=C(C)\CC3OCC(CC4OC4C(C)C(C)O)C(O)C3O)C(O)C2O,C52H86CaO18.2H2O,S5070
20732,Duloxetine,CNCCC(OC1=CC=CC2=CC=CC=C12)C3=CC=CS3,C18H19NOS,S5071
20733,Donepezil,COC1=CC2=C(C=C1OC)C(=O)C(CC3CCN(CC3)CC4=CC=CC=C4)C2,C24H29NO3,S5073
20734,Argatroban Monohydrate,O.CC1CCN(C(C1)C(O)=O)C(=O)C(CCCNC(N)=N)N[S](=O)(=O)C2=CC=CC3=C2NCC(C)C3,C23H36N6O5S.H2O,S5074
20735,Acotiamide,COC1=C(OC)C=C(C(=O)NC2=NC(=CS2)C(=O)NCCN(C(C)C)C(C)C)C(=C1)O,C21H30N4O5S,S5075
20736,Xipamide,CC1=C(NC(=O)C2=CC(=C(Cl)C=C2O)[S](N)(=O)=O)C(=CC=C1)C,C15H15ClN2O4S,S5076
20737,Regorafenib (BAY-734506) Monohydrate,O.CNC(=O)C1=NC=CC(=C1)OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C(=C2)F,C21H15ClF4N4O3.H2O,S5077
20738,Osimertinib mesylate,COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CC=C4)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C.C[S](O)(=O)=O,C29H37N7O5S,S5078
20739,Sitagliptin,NC(CC(=O)N1CC[N]2C(=NN=C2C(F)(F)F)C1)CC3=C(F)C=C(F)C(=C3)F,C16H15F6N5O,S5079
20740,Ceforanide,NCC1=CC=CC=C1CC(=O)NC2C3SCC(=C(N3C2=O)C(O)=O)CSC4=NN=N[N]4CC(O)=O,C20H21N7O6S2,S5081
20741,Vitamin K2,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=C(C)C(=O)C2=C(C=CC=C2)C1=O,C31H40O2,S5082
20742,Lentinan,O(C1C(O)C(CO)OC(OCC2OC(OC3C(O)C(CO)OC(OC4C(O)C(COC5OC(CO)C(O)C(O)C5O)OC(OC6C(O)C(OC(CO)C6O)[*])C4O)C3O)C(O)C(OC7OC(CO)C(O)C(O)C7O)C2O)C1O)[*],C42H70O35R2,S5083
20743,Carbazochrome,CN1CC(O)C2=C\C(=N\NC(N)=O)C(=O)C=C12,C10H12N4O3,S5084
20744,Azamethiphos,CO[P](=O)(OC)SCN1C(=O)OC2=C1N=CC(=C2)Cl,C9H10ClN2O5PS,S5085
20745,p-Anisaldehyde,COC1=CC=C(C=O)C=C1,C8H8O2,S5086
20746,Geranyl acetate,CC(=O)OC/C=C(C)/CCC=C(C)C,C12H20O2,S5091
20747,Febantel,COCC(=O)NC1=C(C=CC(=C1)SC2=CC=CC=C2)N=C(NC(=O)OC)NC(=O)OC,C20H22N4O6S,S5092
20748,Rafoxanide,OC1=C(I)C=C(I)C=C1C(=O)NC2=CC(=C(OC3=CC=C(Cl)C=C3)C=C2)Cl,C19H11Cl2I2NO3,S5093
20749,SulfadiMethoxine sodium,COC1=NC(=NC(=C1)N([Na])[S](=O)(=O)C2=CC=C(N)C=C2)OC,C12H13N4O4S.Na,S5096
20750,Pralidoxime Iodide,[I-].C[N+]1=C(C=CC=C1)\C=N\O,C7H9N2O.I,S5100
20751,Stachyose,O.O.O.O.OCC1OC(OCC2OC(OCC3OC(OC4(CO)OC(CO)C(O)C4O)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O,C24H42O21.4H2O,S5102
20752,Proanthocyanidins,OC1C(O)C(OC2CC3=C(OC2C4=CC=C(O)C(=C4)O)C=C(O)C=C3O)(OC5=C1C(=CC(=C5)O)O)C6=CC=C(O)C(=C6)O,C30H26O13,S5105
20753,Tylosin,CCC1OC(=O)CC(O)C(C)C(OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(C2O)N(C)C)C(CC=O)CC(C)C(=O)/C=C/C(=C/C1COC4OC(C)C(O)C(OC)C4OC)C,C46H77NO17,S5108
20754,Ademetionine,C[S+](CCC(N)C([O-])=O)CC1OC(C(O)C1O)[N]2C=NC3=C2N=CN=C3N,C15H22N6O5S,S5109
20755,Propyl gallate,CCCOC(=O)C1=CC(=C(O)C(=C1)O)O,C10H12O5,S5113
20756,Hydroquinine,CCC1CN2CCC1CC2C(O)C3=CC=NC4=C3C=C(OC)C=C4,C20H26N2O2,S5114
20757,Doramectin,COC1CC(OC(C)C1O)OC2C(C)OC(CC2OC)OC\3C(C)/C=C/C=C/4COC5C(O)C(=CC(C(=O)OC6CC(C/C=C3C)OC7(C6)OC(C(C)C=C7)C8CCCCC8)C45O)C,C50H74O14,S5117
20758,Phytol,CC(C)CCCC(C)CCCC(C)CCC\C(C)=C\CO,C20H40O,S5121
20759,Aleuritic Acid,OCCCCCCC(O)C(O)CCCCCCCC(O)=O,C16H32O5,S5126
20760,Taurocholic acid sodium salt hydrate,[Na+].CC(CCC(=O)NCC[S]([O-])(=O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,C26H45NO7S.xH2O.Na,S5130
20761,Taurocholic acid sodium salt,[Na+].CC(CCC(=O)NCC[S]([O-])(=O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,C26H45NO7S.Na,E0154
20762,Citral,CC(C)=CCCC(/C)=C/C=O,C10H16O,S5138
20763,Pyrithioxin,CC1=NC=C(CSSCC2=CN=C(C)C(=C2CO)O)C(=C1O)CO,C16H20N2O4S2,S5141
20764,Citropten,COC1=CC2=C(C=CC(=O)O2)C(=C1)OC,C11H10O4,S5143
20765,Protoporphyrin IX,CC1=C2[NH]C(=C1CCC(O)=O)C=C3N=C(C=C4N=C(C=C5[NH]C(=C2)C(=C5C)C=C)C(=C4C)C=C)C(=C3CCC(O)=O)C,C34H34N4O4,S5145
20766,Raffinose,OCC1OC(OCC2OC(OC3(CO)OC(CO)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O,C18H32O16,S5155
20767,Thymol,CC(C)C1=CC=C(C)C=C1O,C10H14O,S5157
20768,Doxycycline,CC1C2C(O)C3C(N(C)C)C(=C(C(N)=O)C(=O)C3(O)C(=C2C(=O)C4=C1C=CC=C4O)O)O,C22H24N2O8,S5159
20769,7-Methoxycoumarin,COC1=CC2=C(C=CC(=O)O2)C=C1,C10H8O3,S5163
20770,Chlorotetracycline,CN(C)C1C2CC3C(=C(O)C2(O)C(=O)C(=C1O)C(N)=O)C(=O)C4=C(C(=CC=C4O)Cl)C3(C)O,C22H23ClN2O8,S5164
20771,Benzyl cinnamate,O=C(OCC1=CC=CC=C1)/C=C/C2=CC=CC=C2,C16H14O2,S5167
20772,Kojic acid,OCC1=CC(=O)C(=CO1)O,C6H6O4,S5174
20773,Fructose,OCC(O)C(O)C(O)C(=O)CO,C6H12O6,S5176
20774,Naproxen,COC1=CC2=CC=C(C=C2C=C1)C(C)C(O)=O,C14H14O3,S5177
20775,Ropivacaine Mesilate,CCCN1CCCCC1C(=O)NC2=C(C)C=CC=C2C.C[S](O)(=O)=O,C18H30N2O4S,S5179
20776,Diaveridine,COC1=C(OC)C=C(CC2=CN=C(N)N=C2N)C=C1,C13H16N4O2,S5200
20777,Sulbutiamine,CC(C)C(=O)OCCC(/SS\C(CCOC(=O)C(C)C)=C(C)/N(CC1=C(N)N=C(C)N=C1)C=O)=C(C)/N(CC2=CN=C(C)N=C2N)C=O,C32H46N8O6S2,S5203
20778,Nilotinib hydrochloride,Cl.CC1=C[N](C=N1)C2=CC(=CC(=C2)C(F)(F)F)NC(=O)C3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CC=CN=C5,C28H22F3N7O.HCl,S5205
20779,Benzylpenicillin potassium,[K+].CC1(C)SC2C(NC(=O)CC3=CC=CC=C3)C(=O)N2C1C([O-])=O,C16H17N2O4S.K,S5206
20780,Ciprofloxacin hydrochloride hydrate,O.Cl.OC(=O)C1=CN(C2CC2)C3=C(C=C(F)C(=C3)N4CCNCC4)C1=O,C17H18FN3O3.HCl.H2O,S5208
20781,Enoxacin Sesquihydrate,CCN1C=C(C(O)=O)C(=O)C2=C1N=C(N3CCNCC3)C(=C2)F,C15H17FN4O3.3/2H2O,S5209
20782,Sulfamethazine Sodium Salt,CC1=CC(=NC(=N1)N([Na])[S](=O)(=O)C2=CC=C(N)C=C2)C,C12H13N4O2S.Na,S5210
20783,4-Aminosalicylic acid,NC1=CC(=C(C=C1)C(O)=O)O,C7H7NO3,S5211
20784,Imidazolidinyl Urea,OCN1C(NC(=O)NCNC(=O)NC2N(CO)C(=O)NC2=O)C(=O)NC1=O,C11H16N8O8,S5212
20785,Piroctone Olamine,CC(CC1=CC(=CC(=O)N1O)C)CC(C)(C)C.NCCO,C14H23NO2.C2H7NO,S5213
20786,Imidocarb dipropionate,CCC(O)=O.CCC(O)=O.O=C(NC1=CC=CC(=C1)C2=NCCN2)NC3=CC=CC(=C3)C4=NCCN4,C19H20N6O.2C3H6O2,S5214
20787,Abacavir (1592U89),NC1=NC2=C(N=C[N]2C3CC(CO)C=C3)C(=N1)NC4CC4,C14H18N6O,S5215
20788,Arformoterol Tartrate,COC1=CC=C(CC(C)NCC(O)C2=CC(=C(O)C=C2)NC=O)C=C1.OC(C(O)C(O)=O)C(O)=O,C23H30N2O10,S5217
20789,Coluracetam,CC1=C(C)C2=C(O1)N=C3CCCCC3=C2NC(=O)CN4CCCC4=O,C19H23N3O3,S5222
20790,Adrafinil,ONC(=O)C[S](=O)C(C1=CC=CC=C1)C2=CC=CC=C2,C15H15NO3S,S5224
20791,Erythromycin thiocyanate,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O.SC#N,C37H67NO13.CHNS,S5227
20792,Minoxidil sulphate,NC1=NC(=CC(=N)N1O[S](O)(=O)=O)N2CCCCC2,C9H15N5O4S,S5228
20793,Isosorbide dinitrate,[O-][N+](=O)OC1COC2C(COC12)O[N+]([O-])=O,C6H8N2O8,S5229
20794,Fenretinide (NSC 374551),CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(=O)NC2=CC=C(O)C=C2)C(C)(C)CCC1,C26H33NO2,S5233
20795,Nintedanib Ethanesulfonate Salt,CC[S](O)(=O)=O.COC(=O)C1=CC2=C(C=C1)C(/C(=O)N2)=C(NC3=CC=C(C=C3)N(C)C(=O)CN4CCN(C)CC4)\C5=CC=CC=C5,C31H33N5O4.C2H6O3S,S5234
20796,Solifenacin (YM905),O=C(OC1CN2CCC1CC2)N3CCC4=C(C=CC=C4)C3C5=CC=CC=C5,C23H26N2O2,S5238
20797,Paroxetine mesylate,C[S](O)(=O)=O.FC1=CC=C(C=C1)C2CCNCC2COC3=CC=C4OCOC4=C3,C19H20FNO3.CH4O3S,S5239
20798,Lenvatinib (E7080) Mesylate,COC1=C(C=C2C(=CC=NC2=C1)OC3=CC(=C(NC(=O)NC4CC4)C=C3)Cl)C(N)=O.C[S](O)(=O)=O,C21H19ClN4O4.CH4O3S,S5240
20799,Lapatinib ditosylate monohydrate,O.CC1=CC=C(C=C1)[S](O)(=O)=O.CC2=CC=C(C=C2)[S](O)(=O)=O.C[S](=O)(=O)CCNCC3=CC=C(O3)C4=CC5=C(C=C4)N=CN=C5NC6=CC(=C(OCC7=CC(=CC=C7)F)C=C6)Cl,C43H44ClFN4O11S3,S5241
20800,Ruxolitinib Phosphate,O[P](O)(O)=O.N#CCC(C1CCCC1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4,C17H18N6.H3O4P,S5243
20801,Raltegravir potassium,[K+].CN1C(=O)C(=C(N=C1C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3)[O-],C20H20FN6O5.K,S5245
20802,Entecavir,NC1=NC(=O)C2=C(N1)[N](C=N2)C3CC(O)C(CO)C3=C,C12H15N5O3,S5246
20803,Selamectin,COC1CC(OC(C)C1O)OC/2C(C)\C=C\C=C\3COC4/C(=N/O)C(=CC(C(=O)OC5CC(C\C=C2C)OC6(CCC(C)C(O6)C7CCCCC7)C5)C34O)C,C43H63NO11,S5247
20804,Darunavir,CC(C)CN(CC(O)C(CC1=CC=CC=C1)NC(=O)OC2COC3OCCC23)[S](=O)(=O)C4=CC=C(N)C=C4,C27H37N3O7S,S5250
20805,Cisapride (R 51619),COC1CN(CCCOC2=CC=C(F)C=C2)CCC1NC(=O)C3=C(OC)C=C(N)C(=C3)Cl,C23H29ClFN3O4,S5253
20806,Dasatinib hydrochloride,Cl.CC1=NC(=CC(=N1)NC2=NC=C(S2)C(=O)NC3=C(C)C=CC=C3Cl)N4CCN(CCO)CC4,C22H27Cl2N7O2S,S5254
20807,Nicardipine,COC(=O)C1=C(C)NC(=C(C1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3)C,C26H29N3O6,S5255
20808,Benproperine phosphate,CC(COC1=C(CC2=CC=CC=C2)C=CC=C1)N3CCCCC3.O[P](O)(O)=O,C21H27NO.H3O4P,S5256
20809,Doxapram,CCN1CC(CCN2CCOCC2)C(C1=O)(C3=CC=CC=C3)C4=CC=CC=C4,C24H30N2O2,S5257
20810,Revefenacin,CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(CN5CCC(CC5)C(N)=O)C=C4,C35H43N5O4,S5258
20811,Ufenamate,CCCCOC(=O)C1=CC=CC=C1NC2=CC(=CC=C2)C(F)(F)F,C18H18F3NO2,S5261
20812,Stiripentol,CC(C)(C)C(O)/C=C/C1=CC=C2OCOC2=C1,C14H18O3,S5266
20813,Canrenone,CC12CCC(=O)C=C1C=CC3C2CCC4(C)C3CCC45CCC(=O)O5,C22H28O3,S5273
20814,Tedizolid (TR-700),C[N]1N=NC(=N1)C2=CC=C(C=N2)C3=C(F)C=C(C=C3)N4CC(CO)OC4=O,C17H15FN6O3,S5278
20815,Fendiline hydrochloride,Cl.CC(NCCC(C1=CC=CC=C1)C2=CC=CC=C2)C3=CC=CC=C3,C23H25N.HCl,S5279
20816,Dapiprazole Hydrochloride,Cl.CC1=C(C=CC=C1)N2CCN(CC2)CCC3=NN=C4CCCC[N]34,C19H27N5.HCl,S5281
20817,Lactitol monohydrate,O.OCC(O)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO,C12H24O11.H2O,S5282
20818,Adenosine 5'-monophosphate monohydrate,O.NC1=NC=NC2=C1N=C[N]2C3OC(CO[P](O)(O)=O)C(O)C3O,C10H14N5O7P.H2O,S5284
20819,Ramatroban,OC(=O)CC[N]1C2=C(CC(CC2)N[S](=O)(=O)C3=CC=C(F)C=C3)C4=CC=CC=C14,C21H21FN2O4S,S5286
20820,Estropipate,CC12CCC3C(CCC4=C3C=CC(=C4)O[S](O)(=O)=O)C1CCC2=O.C5CNCCN5,C22H32N2O5S,S5288
20821,Ceftezole,OC(=O)C1=C(CSC2C(NC(=O)C[N]3C=NN=N3)C(=O)N12)CSC4=NN=CS4,C13H12N8O4S3,S5289
20822,sulfaisodimidine,CC1=CC(=NC(=N1)C)N[S](=O)(=O)C2=CC=C(N)C=C2,C12H14N4O2S,S5291
20823,Diazolidinyl urea,OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O,C8H14N4O7,S5292
20824,Nimustine Hydrochloride,Cl.CC1=NC=C(CNC(=O)N(CCCl)N=O)C(=N1)N,C9H13ClN6O2.HCl,S5293
20825,Cephalotin acid,CC(=O)OCC1=C(N2C(SC1)C(NC(=O)CC3=CC=CS3)C2=O)C(O)=O,C16H16N2O6S2,S5294
20826,Lincomycin Hydrochloride Monohydrate,O.Cl.CCCC1CC(N(C)C1)C(=O)NC(C(C)O)C2OC(SC)C(O)C(O)C2O,C18H34N2O6S.HCl.H2O,S5295
20827,Vidarabine monohydrate,O.NC1=NC=NC2=C1N=C[N]2C3OC(CO)C(O)C3O,C10H13N5O4.H2O,S5297
20828,Amoxicillin trihydrate,O.O.O.CC1(C)SC2C(NC(=O)C(N)C3=CC=C(O)C=C3)C(=O)N2C1C(O)=O,C16H19N3O5S.3H2O,S5298
20829,Tosufloxacin p-Toluenesulfonate Hydrate,O.CC1=CC=C(C=C1)[S](O)(=O)=O.NC2CCN(C2)C3=NC4=C(C=C3F)C(=O)C(=CN4C5=CC=C(F)C=C5F)C(O)=O,C19H15F3N4O3.C7H8O3S.H2O,S5299
20830,Carglumic Acid,NC(=O)NC(CCC(O)=O)C(O)=O,C6H10N2O5,S5301
20831,6-Methoxy-2-naphthoic acid,COC1=CC2=CC=C(C=C2C=C1)C(O)=O,C12H10O3,S5302
20832,Bromisoval,CC(C)C(Br)C(=O)NC(N)=O,C6H11BrN2O2,S5305
20833,Propyphenazone (4-Isopropylantipyrine),CC(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O,C14H18N2O,S5309
20834,Pyridoxal phosphate,CC1=NC=C(CO[P](O)(O)=O)C(=C1O)C=O,C8H10NO6P,S5311
20835,Pyridoxal 5′-phosphate hydrate,CC1=NC=C(CO[P](O)(O)=O)C(=C1O)C=O,C8H10NO6P.xH2O,S6115
20836,Octinoxate,CCCCC(CC)COC(=O)C=CC1=CC=C(OC)C=C1,C18H26O3,S5320
20837,Sodium gualenate,[Na+].CC(C)C1=CC=C(C)C2=C(C=C(C)C2=C1)[S]([O-])(=O)=O,C15H17O3S.Na,S5322
20838,Nitisinone,[O-][N+](=O)C1=CC(=CC=C1C(=O)C2C(=O)CCCC2=O)C(F)(F)F,C14H10F3NO5,S5325
20839,Dolasetron,O=C1CN2C3CC(CC2CC1C3)OC(=O)C4=C[NH]C5=C4C=CC=C5,C19H20N2O3,S5326
20840,Meisoindigo,CN1C(=O)/C(C2=C1C=CC=C2)=C3/C(=O)NC4=CC=CC=C34,C17H12N2O2,S5327
20841,Gamithromycin,CCCN1CC(C)C(O)C(C)(O)C(CC)OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(O)CC1C,C40H76N2O12,S5328
20842,Ceftezole sodium,[Na+].[O-]C(=O)C1=C(CSC2C(NC(=O)C[N]3C=NN=N3)C(=O)N12)CSC4=NN=CS4,C13H11N8O4S3.Na,S5331
20843,Sulbenicillin Sodium,[Na+].[Na+].CC1(C)SC2C(NC(=O)C(C3=CC=CC=C3)[S]([O-])(=O)=O)C(=O)N2C1C([O-])=O,C16H16N2O7S2.2Na,S5333
20844,4-Allylanisole,COC1=CC=C(CC=C)C=C1,C10H12O,S5339
20845,Metroprolol succinate,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1.COCCC2=CC=C(OCC(O)CNC(C)C)C=C2.OC(=O)CCC(O)=O,C34H56N2O10,S5341
20846,Vanillic acid,COC1=C(O)C=CC(=C1)C(O)=O,C8H8O4,S5343
20847,Nerolidol,CC(C)=CCC/C(C)=C/CCC(C)(O)C=C,C15H26O,S5345
20848,Cefpodoxime proxetil,COCC1=C(N2C(SC1)C(NC(=O)C(=N/OC)\C3=CSC(=N3)N)C2=O)C(=O)OC(C)OC(=O)OC(C)C,C21H27N5O9S2,S5350
20849,Cefmetazole sodium,[Na+].COC1(NC(=O)CSCC#N)C2SCC(=C(N2C1=O)C([O-])=O)CSC3=NN=N[N]3C,C15H16N7O5S3.Na,S5351
20850,Cefminox Sodium,[Na+].COC1(NC(=O)CSCC(N)C(O)=O)C2SCC(=C(N2C1=O)C([O-])=O)CSC3=NN=N[N]3C,C16H20N7O7S3.Na,S5352
20851,Cefpiramide sodium,[Na+].C[N]1N=NN=C1SCC2=C(N3C(SC2)C(NC(=O)C(NC(=O)C4=C(O)C=C(C)N=C4)C5=CC=C(O)C=C5)C3=O)C([O-])=O,C25H23N8NaO7S2,S5353
20852,Ceftiofur,CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(O)=O)CSC(=O)C3=CC=CO3)C4=CSC(=N4)N,C19H17N5O7S3,S5356
20853,Safinamide,CC(NCC1=CC=C(OCC2=CC=CC(=C2)F)C=C1)C(N)=O,C17H19FN2O2,S5357
20854,Regadenoson,CNC(=O)C1=C[N](N=C1)C2=NC3=C(N=C[N]3C4OC(CO)C(O)C4O)C(=N2)N,C15H18N8O5,S5358
20855,Butoconazole,ClC1=CC=C(CCC(C[N]2C=CN=C2)SC3=C(Cl)C=CC=C3Cl)C=C1,C19H17Cl3N2S,S5359
20856,Bendazac,OC(=O)COC1=N[N](CC2=CC=CC=C2)C3=C1C=CC=C3,C16H14N2O3,S5361
20857,Pikamilone,OC(=O)CCCNC(=O)C1=CN=CC=C1,C10H12N2O3,S5363
20858,Fipronil,NC1=C(C(=N[N]1C2=C(Cl)C=C(C=C2Cl)C(F)(F)F)C#N)[S](=O)C(F)(F)F,C12H4Cl2F6N4OS,S5366
20859,Ethyl Oleate,CCCCCCCC\C=C/CCCCCCCC(=O)OCC,C20H38O2,S5367
20860,Ethoxyquin,CCOC1=CC2=C(NC(C)(C)C=C2C)C=C1,C14H19NO,S5369
20861,Ajmaline,CCC1C(O)N2C3CC1C4C(O)C5(CC24)C3N(C)C6=CC=CC=C56,C20H26N2O2,S5371
20862,Methyl Aminolevulinate Hydrochloride,Cl.COC(=O)CCC(=O)CN,C6H12ClNO3,S5372
20863,Dibutyl phthalate,CCCCOC(=O)C1=C(C=CC=C1)C(=O)OCCCC,C16H22O4,S5377
20864,Dimethyl phthalate,COC(=O)C1=C(C=CC=C1)C(=O)OC,C10H10O4,S5378
20865,Imidafenacin,CC1=NC=C[N]1CCC(C(N)=O)(C2=CC=CC=C2)C3=CC=CC=C3,C20H21N3O,S5385
20866,Betrixaban,COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC3=CC=C(Cl)C=N3,C23H22ClN5O3,S5388
20867,Betrixaban maleate,COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC3=CC=C(Cl)C=N3.OC(=O)\C=C/C(O)=O,C23H22ClN5O3.C4H4O4,S5389
20868,Mepivacaine,CN1CCCCC1C(=O)NC2=C(C)C=CC=C2C,C15H22N2O,S5392
20869,Cyclofenil,CC(=O)OC1=CC=C(C=C1)[C](=[C]2CC[CH2]CC2)C3=CC=C(OC(C)=O)C=C3,C23H24O4,S5393
20870,Tizoxanide,OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+]([O-])=O,C10H7N3O4S,S5394
20871,Phenolphthalein,OC1=CC=C(C=C1)C2(OC(=O)C3=C2C=CC=C3)C4=CC=C(O)C=C4,C20H14O4,S5395
20872,Chlorhexidine,ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1,C22H30Cl2N10,S5397
20873,Nefazodone hydrochloride,Cl.CCC1=NN(CCCN2CCN(CC2)C3=CC(=CC=C3)Cl)C(=O)N1CCOC4=CC=CC=C4,C25H33Cl2N5O2,S5398
20874,Chlorprothixene hydrochloride,Cl.CN(C)CC\C=C/1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2,C18H19Cl2NS,S5399
20875,Tegaserod Maleate,CCCCCNC(=N)N/N=C/C1=C[NH]C2=C1C=C(OC)C=C2.OC(=O)\C=C/C(O)=O,C16H23N5O.C4H4O4,S5401
20876,Dasabuvir (ABT-333),COC1=C(C=C(C=C1C2=CC3=CC=C(N[S](C)(=O)=O)C=C3C=C2)N4C=CC(=O)NC4=O)C(C)(C)C,C26H27N3O5S,S5402
20877,Ombitasvir (ABT-267),COC(=O)NC(C(C)C)C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(NC(=O)C6CCCN6C(=O)C(NC(=O)OC)C(C)C)C=C5,C50H67N7O8,S5403
20878,Paritaprevir (ABT-450),CC1=NC=C(N=C1)C(=O)NC2CCCCC\C=C/C3CC3(NC(=O)C4CC(CN4C2=O)OC5=NC6=C(C=CC=C6)C7=C5C=CC=C7)C(=O)N[S](=O)(=O)C8CC8,C40H43N7O7S,S5404
20879,Propylparaben,CCCOC(=O)C1=CC=C(O)C=C1,C10H12O3,S5405
20880,Sultamicillin Tosylate,CC1=CC=C(C=C1)[S](O)(=O)=O.CC2(C)SC3CC(=O)N3C2C(=O)OCOC(=O)C4N5C(C(NC(=O)C(N)C6=CC=CC=C6)C5=O)[S](=O)(=O)C4(C)C,C32H38N4O12S3,S5406
20881,Squalane,CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C,C30H62,S5407
20882,Chloramphenicol sodium succinate,[Na+].OC(C(COC(=O)CCC([O-])=O)NC(=O)C(Cl)Cl)C1=CC=C(C=C1)[N+]([O-])=O,C15H15Cl2N2O8.Na,S5410
20883,Sultamicillin,CC1(C)SC2C(NC(=O)C(N)C3=CC=CC=C3)C(=O)N2C1C(=O)OCOC(=O)C4N5C(CC5=O)[S](=O)(=O)C4(C)C,C25H30N4O9S2,S5411
20884,Ertugliflozin,CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)C34OCC(CO)(O3)C(O)C(O)C4O)C=C1,C22H25ClO7,S5413
20885,Diflucortolone valerate,CCCCC(=O)OCC(=O)C1C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,C27H36F2O5,S5414
20886,Metyrapone,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2,C14H14N2O,S5416
20887,Parecoxib Sodium,CCC(=O)N([Na])[S](=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3,C19H17N2NaO4S,S5418
20888,"1,4-Cineole",CC(C)C12CCC(C)(CC1)O2,C10H18O,S5419
20889,Clindamycin alcoholate,O.Cl.CCCC1CC(N(C)C1)C(=O)NC(C(C)Cl)C2OC(SC)C(O)C(O)C2O,C18H33ClN2O5S.HCl.H2O,S5420
20890,Carbaryl,CNC(=O)OC1=C2C=CC=CC2=CC=C1,C12H11NO2,S5424
20891,Promazine hydrochloride,Cl.CN(C)CCCN1C2=CC=CC=C2SC3=C1C=CC=C3,C17H20N2S.HCl,S5428
20892,Metoprolol,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,C15H25NO3,S5430
20893,Quinacrine Dihydrochloride Dihydrate,O.O.Cl.Cl.CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC3=CC(=CC=C13)Cl,C23H30ClN3O.2HCl.2H2O,S5435
20894,Berberine Sulfate,COC1=C(OC)C2=C(C=C1)C=C3C4=C(CC[N+]3=C2)C=C5OCOC5=C4.O[S]([O-])(=O)=O,C20H18NO4.HO4S,S5440
20895,Triprolidine Hydrochloride,O.Cl.CC1=CC=C(C=C1)\C(=C/CN2CCCC2)C3=NC=CC=C3,C19H22N2.HCl.H2O,S5447
20896,Sofalcone,CC(C)=CCOC1=CC=C(/C=C/C(=O)C2=C(OCC(O)=O)C=C(OCC=C(C)C)C=C2)C=C1,C27H30O6,S5450
20897,Sanguinarine chloride,[Cl-].C[N+]1=CC2=C3OCOC3=CC=C2C4=CC=C5C=C6OCOC6=CC5=C14,C20H14NO4.Cl,S5452
20898,Hyperoside,OCC1OC(OC2=C(OC3=C(C(=CC(=C3)O)O)C2=O)C4=CC(=C(O)C=C4)O)C(O)C(O)C1O,C21H20O12,S5453
20899,Saikosaponin D,CC1OC(OC2CCC3(C)C(CCC4(C)C3C=CC56OCC7(CCC(C)(C)CC57)C(O)CC46C)C2(C)CO)C(O)C(OC8OC(CO)C(O)C(O)C8O)C1O,C42H68O13,S5454
20900,Saikosaponin A,CC1OC(OC2CCC3(C)C(CCC4(C)C3C=CC56OCC7(CCC(C)(C)CC57)C(O)CC46C)C2(C)CO)C(O)C(OC8OC(CO)C(O)C(O)C8O)C1O,C42H68O13,S5466
20901,Curculigoside,COC1=C(C(=O)OCC2=CC(=CC=C2OC3OC(CO)C(O)C(O)C3O)O)C(=CC=C1)OC,C22H26O11,S5457
20902,Verbascoside,CC1OC(OC2C(O)C(OCCC3=CC=C(O)C(=C3)O)OC(CO)C2OC(=O)\C=C\C4=CC=C(O)C(=C4)O)C(O)C(O)C1O,C29H36O15,S5458
20903,Aucubin,OCC1OC(OC2OC=CC3C(O)C=C(CO)C23)C(O)C(O)C1O,C15H22O9,S5459
20904,Vitexin-2-O-rhaMnoside,CC1OC(OC2C(O)C(O)C(CO)OC2C3=C(O)C=C(O)C4=C3OC(=CC4=O)C5=CC=C(O)C=C5)C(O)C(O)C1O,C27H30O14,S5460
20905,Pivmecillinam hydrochloride,Cl.CC(C)(C)C(=O)OCOC(=O)C1N2C(SC1(C)C)C(N=CN3CCCCCC3)C2=O,C21H33N3O5S.HCl,S5473
20906,Rolapitant,CC(OCC1(CCC2(CCC(=O)N2)CN1)C3=CC=CC=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,C25H26F6N2O2,S5476
20907,Gefarnate,CC(C)=CCC/C(C)=C/CC\C(C)=C\CCC(=O)OC\C=C(C)\CCC=C(C)C,C27H44O2,S5477
20908,Dantrolene sodium,[Na+].[O-]C1=NC(=O)CN1/N=C/C2=CC=C(O2)C3=CC=C(C=C3)[N+]([O-])=O,C14H9N4NaO5,S5478
20909,Cloperastine hydrochloride,Cl.ClC1=CC=C(C=C1)C(OCCN2CCCCC2)C3=CC=CC=C3,C20H24ClNO.HCl,S5479
20910,Clidinium Bromide,[Br-].C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(C3=CC=CC=C3)C4=CC=CC=C4,C22H26NO3.Br,S5480
20911,Molindone hydrochloride,Cl.CCC1=C(C)[NH]C2=C1C(=O)C(CC2)CN3CCOCC3,C16H24N2O2.HCl,S5481
20912,Prilocaine hydrochloride,Cl.CCCNC(C)C(=O)NC1=CC=CC=C1C,C13H20N2O.HCl,S5482
20913,Tribenzagan Hydrochloride,Cl.COC1=C(OC)C(=CC(=C1)C(=O)NCC2=CC=C(OCCN(C)C)C=C2)OC,C21H28N2O5.HCl,S5483
20914,Rimantadine Hydrochloride,Cl.CC(N)[C]12C[CH]3C[CH]([CH2]C([CH2]3)C1)C2,C12H21N.HCl,S5484
20915,Desipramine Hydrochloride,Cl.CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2,C18H22N2.HCl,S5485
20916,Fluorometholone,CC1CC2C3CCC(O)(C(C)=O)C3(C)CC(O)C2(F)C4(C)C=CC(=O)C=C14,C22H29FO4,S5486
20917,Cefoperazone sodium,[Na+].CCN1CCN(C(=O)NC(C(=O)NC2C3SCC(=C(N3C2=O)C([O-])=O)CSC4=NN=N[N]4C)C5=CC=C(O)C=C5)C(=O)C1=O,C25H26N9NaO8S2,S5487
20918,Fluorescein,OC1=CC2=C(C=C1)C3(OC(=O)C4=C3C=CC=C4)C5=C(O2)C=C(O)C=C5,C20H12O5,S5488
20919,Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C2=NC=CC=C2)C(C)C,C21H29N3O,S5490
20920,Lomefloxacin,CCN1C=C(C(O)=O)C(=O)C2=C1C(=C(N3CCNC(C)C3)C(=C2)F)F,C17H19F2N3O3,S5491
20921,Econazole,ClC1=CC=C(COC(C[N]2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1,C18H15Cl3N2O,S5492
20922,Atropine sulfate,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN4C5CCC4CC(C5)OC(=O)C(CO)C6=CC=CC=C6.O[S](O)(=O)=O,C34H46N2O6.H2SO4,S5493
20923,Salbutamol,CC(C)(C)NCC(O)C1=CC=C(O)C(=C1)CO,C13H21NO3,S5494
20924,Iopanoic acid,CCC(CC1=C(I)C=C(I)C(=C1I)N)C(O)=O,C11H12I3NO2,S5497
20925,Betahistine mesylate,CNCCC1=CC=CC=N1.C[S](O)(=O)=O.C[S](O)(=O)=O,C8H12N2.2CH4O3S,S5498
20926,Amodiaquine hydrochloride,Cl.Cl.CCN(CC)CC1=CC(=CC=C1O)NC2=C3C=CC(=CC3=NC=C2)Cl,C20H22ClN3O.2HCl,S5500
20927,Hydrocortisone acetate,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC12C,C23H32O6,S5501
20928,Ilaprazole sodium,COC1=C(C)C(=NC=C1)C[S](=O)C2=NC3=C(C=CC(=C3)[N]4C=CC=C4)[N]2[Na],C19H17N4NaO2S,S5502
20929,O-Acetyl-L-carnitine hydrochloride,[Cl-].CC(=O)OC(CC(O)=O)C[N+](C)(C)C,C9H18ClNO4,S5503
20930,Ropivacaine,CCCN1CCCCC1C(=O)NC2=C(C)C=CC=C2C,C17H26N2O,S5504
20931,2’-deoxyuridine,OCC1OC(CC1O)N2C=CC(=O)NC2=O,C9H12N2O5,S5505
20932,Trimebutine maleate,CCC(COC(=O)C1=CC(=C(OC)C(=C1)OC)OC)(N(C)C)C2=CC=CC=C2.OC(=O)\C=C/C(O)=O,C26H33NO9,S5507
20933,Penicillin G Procaine,O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.CC2(C)SC3C(NC(=O)CC4=CC=CC=C4)C(=O)N3C2C(O)=O,C16H18N2O4S.C13H20N2O2.H2O,S5515
20934,Salmeterol,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC2=CC=CC=C2,C25H37NO4,S5527
20935,Acetophenone,CC(=O)C1=CC=CC=C1,C8H8O,S5528
20936,Geraniol,CC(C)=CCC\C(C)=C\CO,C10H18O,S5530
20937,Doripenem,CC(O)C1C2C(C)C(=C(N2C1=O)C(O)=O)SC3CNC(CN[S](N)(=O)=O)C3,C15H24N4O6S2,S5531
20938,Erythromycin estolate,CCCCCCCCCCCCO[S](O)(=O)=O.CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3OC(=O)CC)N(C)C)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O,C52H97NO18S,S5532
20939,Moxifloxacin,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(=C1N3CC4CCCNC4C3)F)C5CC5,C21H24FN3O4,S5535
20940,Tizanidine,ClC1=C(NC2=NCCN2)C3=NSN=C3C=C1,C9H8ClN5S,S5537
20941,Tropisetron,CN1C2CCC1CC(C2)OC(=O)C3=C[NH]C4=C3C=CC=C4,C17H20N2O2,S5538
20942,Olprinone,CC1=C(C=C(C#N)C(=O)N1)C2=C[N]3C=CN=C3C=C2,C14H10N4O,S5539
20943,Landiolol hydrochloride,Cl.CC1(C)OCC(COC(=O)CCC2=CC=C(OCC(O)CNCCNC(=O)N3CCOCC3)C=C2)O1,C25H39N3O8.HCl,S5540
20944,Dimetridazole,C[N]1C(=NC=C1[N+]([O-])=O)C,C5H7N3O2,S5541
20945,"1, 10-Phenanthroline monohydrate",O.C1=CC2=C(N=C1)C3=C(C=CC=N3)C=C2,C12H8N2.H2O,S5543
20946,Sulfacetamide,CC(=O)N[S](=O)(=O)C1=CC=C(N)C=C1,C8H10N2O3S,S5546
20947,Hydroxylammonium chloride,Cl.NO,HCl.H3NO,S5547
20948,Ethyl gallate,CCOC(=O)C1=CC(=C(O)C(=C1)O)O,C9H10O5,S5550
20949,Amenamevir,CC1=C(N(CC(=O)NC2=CC=C(C=C2)C3=NOC=N3)C(=O)C4CC[S](=O)(=O)CC4)C(=CC=C1)C,C24H26N4O5S,S5552
20950,Kasugamycin hydrochloride,Cl.CC1OC(OC2C(O)C(O)C(O)C(O)C2O)C(N)CC1NC(=N)C(O)=O,C14H25N3O9.HCl,S5553
20951,Lanatoside C,CC1OC(CC(O)C1OC2CC(O)C(OC3CC(OC(C)=O)C(OC4OC(CO)C(O)C(O)C4O)C(C)O3)C(C)O2)OC5CCC6(C)C(CCC7C6CC(O)C8(C)C(CCC78O)C9=CC(=O)OC9)C5,C49H76O20,S5554
20952,Pamabrom,CN1C(=O)N(C)C2=C([NH]C(=N2)Br)C1=O.CC(C)(N)CO,C7H7BrN4O2.C4H11NO,S5555
20953,(-)-Sparteine Sulfate,O.O.O.O.O.O[S](O)(=O)=O.C1CCN2CC3CC(CN4CCCCC34)C2C1,C15H26N2.H2SO4.5H2O,S5556
20954,D-Pantothenate Sodium,[Na+].CC(C)(CO)C(O)C(=O)NCCC([O-])=O,C9H16NO5.Na,S5558
20955,Tetrahydropalmatine,COC1=C(OC)C=C2C3CC4=CC=C(OC)C(=C4CN3CCC2=C1)OC,C21H25NO4,S5559
20956,Midecamycin,CCC(=O)OC1CC(=O)OC(C)C/C=C/C=C/C(O)C(C)CC(CC=O)C(OC2OC(C)C(OC3CC(C)(O)C(OC(=O)CC)C(C)O3)C(C2O)N(C)C)C1OC,C41H67NO15,S5560
20957,Ethacrynic Acid,CCC(=C)C(=O)C1=C(Cl)C(=C(OCC(O)=O)C=C1)Cl,C13H12Cl2O4,S5561
20958,2-Hydroxybenzyl alcohol,OCC1=CC=CC=C1O,C7H8O2,S5562
20959,Thioridazine hydrochloride,Cl.CSC1=CC2=C(SC3=CC=CC=C3N2CCC4CCCCN4C)C=C1,C21H26N2S2.HCl,S5563
20960,Xylazine,CC1=C(NC2=NCCCS2)C(=CC=C1)C,C12H16N2S,S5564
20961,Triflupromazine hydrochloride,Cl.CN(C)CCCN1C2=C(SC3=CC=C(C=C13)C(F)(F)F)C=CC=C2,C18H20ClF3N2S,S5565
20962,Dapagliflozin propanediol monohydrate,O.CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)C3OC(CO)C(O)C(O)C3O)C=C1.CC(O)CO,C21H25ClO6.C3H8O2.H2O,S5566
20963,Tocofersolan,CC(C)CCCC(C)CCCC(C)CCCC1(C)CCC2=C(C)C(=C(C)C(=C2O1)C)OC(=O)CCC(=O)OCCO,(C2H4O)nC33H54O5,S5568
20964,Tilmicosin phosphate,CCC1OC(=O)CC(O)C(C)C(OC2OC(C)C(O)C(C2O)N(C)C)C(CCN3CC(C)CC(C)C3)CC(C)C(=O)\C=C\C(=C\C1COC4OC(C)C(O)C(OC)C4OC)C.O[P](O)(O)=O,C46H80N2O13.H3O4P,S5573
20965,Olmesartan,CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=N[NH]4)C(O)=O)C(C)(C)O,C24H26N6O3,S5581
20966,Cytarabine hydrochloride,Cl.NC1=NC(=O)N(C=C1)C2OC(CO)C(O)C2O,C9H13N3O5.HCl,S5582
20967,Cinnamyl acetate,CC(=O)OC/C=C/C1=CC=CC=C1,C11H12O2,S5583
20968,Citronellal,CC(CCC=C(C)C)CC=O,C10H18O,S5585
20969,Vitamin A,CC(=C/CO)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C,C20H30O,S5592
20970,α-Terpineol,CC1=CCC(CC1)C(C)(C)O,C10H18O,S5594
20971,(1R)-(-)-Menthyl acetate,CC(C)C1CCC(C)CC1OC(C)=O,C12H22O2,S5597
20972,Sodium cholate,[Na+].CC(CCC([O-])=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,C24H39O5.Na,S5599
20973,Diphenylamine Hydrochloride,Cl.N(C1=CC=CC=C1)C2=CC=CC=C2,C12H12ClN,S5604
20974,(+)-Longifolene,CC1(C)CCCC2(C)C3CCC(C13)C2=C,C15H24,S5614
20975,Hippuric acid,OC(=O)CNC(=O)C1=CC=CC=C1,C9H9NO3,S5618
20976,Betahistine,CNCCC1=NC=CC=C1,C8H12N2,S5619
20977,Cilastatin,CC1(C)CC1C(=O)N\C(=C/CCCCSCC(N)C(O)=O)C(O)=O,C16H26N2O5S,S5621
20978,Bedaquiline,COC1=NC2=CC=C(Br)C=C2C=C1C(C3=CC=CC=C3)C(O)(CCN(C)C)C4=CC=CC5=CC=CC=C45,C32H31BrN2O2,S5623
20979,Ammonium lactate,[NH4+].CC(O)C([O-])=O,C3H9NO3,S5625
20980,Benzalkonium chloride,[Cl-].CCCCCC[N+](C)(C)CC1=CC=CC=C1,C15H26ClNR,S5626
20981,Amsacrine hydrochloride,Cl.COC1=CC(=CC=C1NC2=C3C=CC=CC3=NC4=C2C=CC=C4)N[S](C)(=O)=O,C21H20ClN3O3S,S5627
20982,Cefotiam Hexetil Hydrochloride,Cl.Cl.CC(OC(=O)OC1CCCCC1)OC(=O)C2=C(CSC3C(NC(=O)CC4=CSC(=N4)N)C(=O)N23)CSC5=NN=N[N]5CCN(C)C,C27H39Cl2N9O7S3,S5637
20983,Cefozopran hydrochloride,Cl.CO/N=C(C(=O)NC1C2SCC(=C(N2C1=O)C([O-])=O)C[N+]3=C4C=CC=N[N]4C=C3)/C5=NSC(=N5)N,C19H18ClN9O5S2,S5638
20984,Rhodamine B,[Cl-].CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(C=C3O2)=[N+](CC)CC)C4=C(C=CC=C4)C(O)=O,C28H31ClN2O3,S5641
20985,Emedastine Difumarate,CCOCC[N]1C2=C(C=CC=C2)N=C1N3CCCN(C)CC3.OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O,C17H26N4O.2C4H4O4,S5647
20986,Iguratimod,C[S](=O)(=O)NC1=CC2=C(C=C1OC3=CC=CC=C3)C(=O)C(=CO2)NC=O,C17H14N2O6S,S5648
20987,Hydroxyzine pamoate,OCCOCCN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3.OC(=O)C4=C(O)C(=C5C=CC=CC5=C4)CC6=C7C=CC=CC7=CC(=C6O)C(O)=O,C44H43ClN2O8,S5649
20988,Dexrazoxane,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,C11H16N4O4,S5651
20989,Elbasvir,COC(=O)NC(C(C)C)C(=O)N1CCCC1C2=NC=C([NH]2)C3=CC4=C(C=C3)C5=CC6=C(C=CC(=C6)C7=CN=C([NH]7)C8CCCN8C(=O)C(NC(=O)OC)C(C)C)[N]5C(O4)C9=CC=CC=C9,C49H55N9O7,S5652
20990,Indigo carmine,[Na+].[Na+].[O-][S](=O)(=O)C1=CC2=C(NC(/C2=O)=C\3NC4=C(C=C(C=C4)[S]([O-])(=O)=O)C3=O)C=C1,C16H8N2Na2O8S2,S5653
20991,Indacaterol,CCC1=CC2=C(CC(C2)NCC(O)C3=CC=C(O)C4=C3C=CC(=O)N4)C=C1CC,C24H28N2O3,S5654
20992,Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C2(O)CCCCC2,C17H27NO2,S5655
20993,Diphenylpyraline hydrochloride,Cl.CN1CCC(CC1)OC(C2=CC=CC=C2)C3=CC=CC=C3,C19H24ClNO,S5656
20994,Ertapenem sodium,[Na+].CC(O)C1C2C(C)C(=C(N2C1=O)C([O-])=O)SC3CNC(C3)C(=O)NC4=CC(=CC=C4)C(O)=O,C22H24N3NaO7S,S5657
20995,Omeprazole Sodium,COC1=CC2=C(C=C1)[N]([Na])C(=N2)[S](=O)CC3=NC=C(C)C(=C3C)OC,C17H18N3NaO3S,S5658
20996,Emedastine,CCOCC[N]1C2=C(C=CC=C2)N=C1N3CCCN(C)CC3,C17H26N4O,S5659
20997,Tiaprofenic acid,CC(C(O)=O)C1=CC=C(S1)C(=O)C2=CC=CC=C2,C14H12O3S,S5661
20998,Ranitidine,CNC(/NCCSCC1=CC=C(CN(C)C)O1)=C\[N+]([O-])=O,C13H22N4O3S,S5662
20999,Minaprine dihydrochloride,Cl.Cl.CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3,C17H24Cl2N4O,S5663
21000,Orphenadrine Hydrochloride,Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2C,C18H24ClNO,S5664
21001,Drofenine Hydrochloride,Cl.CCN(CC)CCOC(=O)C(C1CCCCC1)C2=CC=CC=C2,C20H32ClNO2,S5665
21002,Moxisylyte hydrochloride,Cl.CC(C)C1=C(OCCN(C)C)C=C(C)C(=C1)OC(C)=O,C16H26ClNO3,S5666
21003,Fruquintinib (HMPL-013),CNC(=O)C1=C(C)OC2=CC(=CC=C12)OC3=C4C=C(OC)C(=CC4=NC=N3)OC,C21H19N3O5,S5667
21004,Isoxsuprine hydrochloride,Cl.CC(COC1=CC=CC=C1)NC(C)C(O)C2=CC=C(O)C=C2,C18H24ClNO3,S5669
21005,Chloropyramine hydrochloride,Cl.CN(C)CCN(CC1=CC=C(Cl)C=C1)C2=CC=CC=N2,C16H21Cl2N3,S5670
21006,Mivacurium chloride,[Cl-].[Cl-].COC1=CC2=C(C=C1OC)C(CC3=CC(=C(OC)C(=C3)OC)OC)[N+](C)(CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]4(C)CCC5=C(C=C(OC)C(=C5)OC)C4CC6=CC(=C(OC)C(=C6)OC)OC)CC2,C58H80Cl2N2O14,S5673
21007,Dolasetron Mesylate,C[S](O)(=O)=O.O=C1CN2C3CC(CC2CC1C3)OC(=O)C4=C[NH]C5=C4C=CC=C5,C20H24N2O6S,S5679
21008,(-)-Verbenone,CC1=CC(=O)C2CC1C2(C)C,C10H14O,S5680
21009,Methyl linolenate,CC\C=C/C/C=C\C\C=C/CCCCCCCC(=O)OC,C19H32O2,S5682
21010,Isoproterenol sulfate dihydrate,O.O.CC(C)NCC(O)C1=CC=C(O)C(=C1)O.CC(C)NCC(O)C2=CC=C(O)C(=C2)O.O[S](O)(=O)=O,C22H40N2O12S,S5683
21011,Desoximetasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,C22H29FO4,S5685
21012,Mexenone,COC1=CC(=C(C=C1)C(=O)C2=CC=C(C)C=C2)O,C15H14O3,S5692
21013,Isopropamide Iodide,[I-].CC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C2=CC=CC=C2)C(C)C,C23H33IN2O,S5697
21014,Ketorolac tromethamine salt,NC(CO)(CO)CO.OC(=O)C1CC[N]2C1=CC=C2C(=O)C3=CC=CC=C3,C19H24N2O6,S5698
21015,Phthalylsulfathiazole,OC(=O)C1=C(C=CC=C1)C(=O)NC2=CC=C(C=C2)[S](=O)(=O)NC3=NC=CS3,C17H13N3O5S2,S5700
21016,Alvimopan dihydrate (LY246736 dihydrate),O.O.CC1CN(CCC1(C)C2=CC=CC(=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(O)=O,C25H36N2O6,S5701
21017,Fenipentol,CCCCC(O)C1=CC=CC=C1,C11H16O,S5702
21018,Carvedilol Phosphate,COC1=C(OCCNCC(O)COC2=CC=CC3=C2C4=C([NH]3)C=CC=C4)C=CC=C1.O[P](O)(O)=O,C24H29N2O8P.1/2H2O,S5703
21019,Raceanisodamine,CN1C2CC(O)C1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,C17H23NO4,S5705
21020,Ambroxol,NC1=C(Br)C=C(Br)C=C1CNC2CCC(O)CC2,C13H18Br2N2O,S5710
21021,Pravastatin,CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC(O)=O)C12,C23H36O7,S5713
21022,lurasidone,O=C1C2C3CCC(C3)C2C(=O)N1CC4CCCCC4CN5CCN(CC5)C6=NSC7=CC=CC=C67,C28H36N4O2S,S5714
21023,Atorvastatin,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C([N]1CCC(O)CC(O)CC(O)=O)C3=CC=C(F)C=C3)C4=CC=CC=C4,C33H35FN2O5,S5715
21024,Abemaciclib (LY2835219),CCN1CCN(CC1)CC2=CN=C(NC3=NC=C(F)C(=N3)C4=CC(=C5N=C(C)[N](C(C)C)C5=C4)F)C=C2,C27H32F2N8,S5716
21025,Acetohexamide,CC(=O)C1=CC=C(C=C1)[S](=O)(=O)NC(=O)NC2CCCCC2,C15H20N2O4S,S5717
21026,Acrivastine,CC1=CC=C(C=C1)C(=C\CN2CCCC2)/C3=CC=CC(=N3)\C=C\C(O)=O,C22H24N2O2,S5718
21027,Ceftizoxime sodium,[Na+].CO\N=C(/C(=O)NC1C2SCC=C(N2C1=O)C([O-])=O)C3=CSC(=N3)N,C13H12N5NaO5S2,S5719
21028,Glecaprevir,CC(C)(C)C1NC(=O)OC2CCCC2OC\C=C\C(F)(F)C3=NC4=C(C=CC=C4)N=C3OC5CC(N(C5)C1=O)C(=O)NC6(CC6C(F)F)C(=O)N[S](=O)(=O)C7(C)CC7,C38H46F4N6O9S,S5720
21029,Oxantel Pamoate,CN1CCCN=C1\C=C\C2=CC(=CC=C2)O.OC(=O)C3=C(O)C(=C4C=CC=CC4=C3)CC5=C6C=CC=CC6=CC(=C5O)C(O)=O,C36H32N2O7,S5722
21030,Dichlorophen,OC1=CC=C(Cl)C=C1CC2=CC(=CC=C2O)Cl,C13H10Cl2O2,S5724
21031,Pempidine,CN1C(C)(C)CCCC1(C)C,C10H21N,S5725
21032,Triiodothyronine,NC(CC1=CC(=C(OC2=CC=C(O)C(=C2)I)C(=C1)I)I)C(O)=O,C15H12I3NO4,S5726
21033,Tetryzoline,C1CC(C2=NCCN2)C3=C(C1)C=CC=C3,C13H16N2,S5727
21034,Delapril Hydrochloride,Cl.CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(O)=O)C2CC3=C(C2)C=CC=C3,C26H33ClN2O5,S5728
21035,Fosfosal,OC(=O)C1=C(O[P](O)(O)=O)C=CC=C1,C7H7O6P,S5729
21036,Alimemazine Tartrate,CC(CN(C)C)CN1C2=CC=CC=C2SC3=C1C=CC=C3.CC(CN(C)C)CN4C5=CC=CC=C5SC6=C4C=CC=C6.OC(C(O)C(O)=O)C(O)=O,C40H50N4O6S2,S5730
21037,Sebacic acid,OC(=O)CCCCCCCCC(O)=O,C10H18O4,S5732
21038,Stearic acid,CCCCCCCCCCCCCCCCCC(O)=O,C18H36O2,S5733
21039,Midodrine hydrochloride,Cl.COC1=CC=C(OC)C(=C1)C(O)CNC(=O)CN,C12H19ClN2O4,S5734
21040,Midodrine,COC1=CC=C(OC)C(=C1)C(O)CNC(=O)CN,C12H18N2O4,S5735
21041,Benzathine penicilline,CC1(C)SC2C(NC(=O)CC3=CC=CC=C3)C(=O)N2C1C(O)=O.CC4(C)SC5C(NC(=O)CC6=CC=CC=C6)C(=O)N5C4C(O)=O.C(CNCC7=CC=CC=C7)NCC8=CC=CC=C8,C48H56N6O8S2,S5736
21042,Diclofenac Epolamine,OCCN1CCCC1.OC(=O)CC2=C(NC3=C(Cl)C=CC=C3Cl)C=CC=C2,C20H24Cl2N2O3,S5737
21043,Nebivolol,OC(CNCC(O)C1CCC2=CC(=CC=C2O1)F)C3CCC4=C(O3)C=CC(=C4)F,C22H25F2NO4,S5739
21044,Palonosetron,O=C1N(CC2CCCC3=C2C1=CC=C3)C4CN5CCC4CC5,C19H24N2O,S5740
21045,Quetiapine,OCCOCCN1CCN(CC1)C2=NC3=CC=CC=C3SC4=C2C=CC=C4,C21H25N3O2S,S5741
21046,Deferoxamine mesylate (Ba 33112),CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN.C[S](O)(=O)=O,C26H52N6O11S,S5742
21047,γ-Linolenic acid,CCCCC\C=C/C/C=C\C\C=C/CCCCC(O)=O,C18H30O2,S5743
21048,Morantel tartrate,CN1CCCN=C1/C=C/C2=C(C)C=CS2.OC(C(O)C(O)=O)C(O)=O,C16H22N2O6S,S5747
21049,Chlorpromazine,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2,C17H19ClN2S,S5749
21050,DL-Norepinephrine hydrochloride,Cl.NCC(O)C1=CC(=C(O)C=C1)O,C8H12ClNO3,S5750
21051,Norepinephrine hydrochloride,Cl.NCC(O)C1=CC(=C(O)C=C1)O,C8H11NO3.ClH,E2944
21052,Abametapir,CC1=CN=C(C=C1)C2=CC=C(C)C=N2,C12H12N2,S5752
21053,Baricitinib phosphate,CC[S](=O)(=O)N1CC(CC#N)(C1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4.O[P](O)(O)=O,C16H20N7O6PS,S5754
21054,Isoeugenol,COC1=C(O)C=CC(=C1)\C=C\C,C10H12O2,S5757
21055,Methyl linoleate,CCCCC/C=C\C\C=C/CCCCCCCC(=O)OC,C19H34O2,S5759
21056,Citric acid,OC(=O)CC(O)(CC(O)=O)C(O)=O,C6H8O7,S5761
21057,Methyl Oleate,CCCCCCCC\C=C/CCCCCCCC(=O)OC,C19H36O2,S5762
21058,Sodium Dehydrocholate,[Na+].CC(CCC([O-])=O)C1CCC2C3C(CC(=O)C12C)C4(C)CCC(=O)CC4CC3=O,C24H33NaO5,S5765
21059,Alfuzosin,COC1=CC2=NC(=NC(=C2C=C1OC)N)N(C)CCCNC(=O)C3CCCO3,C19H27N5O4,S5766
21060,Aliskiren,COCCCOC1=C(OC)C=CC(=C1)CC(CC(N)C(O)CC(C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C,C30H53N3O6,S5767
21061,Fenoterol hydrobromide,Br.CC(CC1=CC=C(O)C=C1)NCC(O)C2=CC(=CC(=C2)O)O,C17H22BrNO4,S5768
21062,Fenoterol,CC(CC1=CC=C(O)C=C1)NCC(O)C2=CC(=CC(=C2)O)O,C17H21NO4,S5769
21063,Proflavine,NC1=CC2=NC3=CC(=CC=C3C=C2C=C1)N,C13H11N3,S5776
21064,Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,C16H25NO4,S5778
21065,Trimetazidine,COC1=CC=C(CN2CCNCC2)C(=C1OC)OC,C14H22N2O3,S5779
21066,Prazosin,COC1=CC2=NC(=NC(=C2C=C1OC)N)N3CCN(CC3)C(=O)C4=CC=CO4,C19H21N5O4,S5780
21067,Raloxifene,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=C(S2)C=C(O)C=C5,C28H27NO4S,S5781
21068,Doxazosin,COC1=CC2=C(C=C1OC)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=C(O4)C=CC=C5)N,C23H25N5O5,S5782
21069,Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC2(CC2)CC(O)=O)C3=CC=CC(=C3)\C=C\C4=CC=C5C=CC(=CC5=N4)Cl,C35H36ClNO3S,S5783
21070,Vancomycin,CNC(CC(C)C)C(=O)NC1C(O)C2=CC(=C(OC3=C(OC4OC(CO)C(O)C(O)C4OC5CC(C)(N)C(O)C(C)O5)C6=CC(=C3)C(NC(=O)C(CC(N)=O)NC1=O)C(=O)NC7C(=O)NC(C(O)C8=CC(=C(O6)C=C8)Cl)C(=O)NC(C(O)=O)C9=C(C(=CC(=C9)O)O)C%10=C(O)C=CC7=C%10)C=C2)Cl,C66H75Cl2N9O24,S5784
21071,Dronedarone,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C2=C(CCCC)OC3=C2C=C(N[S](C)(=O)=O)C=C3,C31H44N2O5S,S5787
21072,Rasagiline,C#CCNC1CCC2=C1C=CC=C2,C12H13N,S5795
21073,Alprenolol hydrochloride,Cl.CC(C)NCC(O)COC1=CC=CC=C1CC=C,C15H24ClNO2,S5802
21074,Allopregnanolone,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,C21H34O2,S5805
21075,Relugolix,CONC(=O)NC1=CC=C(C=C1)C2=C(CN(C)C)C3=C(S2)N(CC4=C(F)C=CC=C4F)C(=O)N(C3=O)C5=NN=C(OC)C=C5,C29H27F2N7O5S,S5808
21076,Choline Fenofibrate,CC(C)(OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2)C([O-])=O.C[N+](C)(C)CCO,C22H28ClNO5,S5812
21077,Pyrvinium,CN(C)C1=CC2=CC=C(/C=C/C3=C(C)[N](C(=C3)C)C4=CC=CC=C4)[N+](=C2C=C1)C.CN(C)C5=CC6=CC=C(/C=C/C7=C(C)[N](C(=C7)C)C8=CC=CC=C8)[N+](=C6C=C5)C.OC9=C(CC%10=C(O)C(=CC%11=C%10C=CC=C%11)C([O-])=O)C%12=C(C=CC=C%12)C=C9C([O-])=O,C75H70N6O6,S5816
21078,Linoleic acid,CCCCC/C=C\C\C=C/CCCCCCCC(O)=O,C18H32O2,S5821
21079,L-Pyroglutamic acid,OC(=O)C1CCC(=O)N1,C5H7NO3,S5823
21080,Citronellyl acetate,CC(CCOC(C)=O)CCC=C(C)C,C12H22O2,S5827
21081,Cabergoline,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=C[NH]C4=C3C2=CC=C4)N(CC=C)C1,C26H37N5O2,S5842
21082,Cinitapride Hydrogen Tartrate,CCOC1=CC(=C(C=C1C(=O)NC2CCN(CC2)CC3CCC=CC3)[N+]([O-])=O)N.OC(C(O)C(O)=O)C(O)=O,C25H36N4O10,S5843
21083,Ethacrynate Sodium,[Na+].CCC(=C)C(=O)C1=C(Cl)C(=C(OCC([O-])=O)C=C1)Cl,C13H11Cl2NaO4,S5847
21084,Frovatriptan Succinate,CNC1CCC2=C(C1)C3=C([NH]2)C=CC(=C3)C(N)=O.OC(=O)CCC(O)=O,C18H23N3O5,S5848
21085,Xylometazoline,CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C,C16H24N2,S5854
21086,Trazodone,ClC1=CC(=CC=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2,C19H22ClN5O,S5857
21087,Vilazodone,NC(=O)C1=CC2=C(O1)C=CC(=C2)N3CCN(CCCCC4=C[NH]C5=C4C=C(C=C5)C#N)CC3,C26H27N5O2,S5858
21088,Sancycline,CN(C)C1C2CC3CC4=C(C(=CC=C4)O)C(=O)C3=C(O)C2(O)C(=O)C(=C1O)C(N)=O,C21H22N2O7,S5859
21089,Lercanidipine,COC(=O)C1=C(C)NC(=C(C1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4)C,C36H41N3O6,S5861
21090,Metoclopramide,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(=C1)Cl,C14H22ClN3O2,S5862
21091,Metronidazole Benzoate,CC1=NC=C([N]1CCOC(=O)C2=CC=CC=C2)[N+]([O-])=O,C13H13N3O4,S5863
21092,Cortisone,CC12CCC(=O)C=C1CCC3C4CCC(O)(C(=O)CO)C4(C)CC(=O)C23,C21H28O5,S5869
21093,Trans-Tranilast,COC1=C(OC)C=C(\C=C\C(=O)NC2=C(C=CC=C2)C(O)=O)C=C1,C18H17NO5,S5871
21094,Estradiol dipropionate,CCC(=O)OC1CCC2C3CCC4=C(C=CC(=C4)OC(=O)CC)C3CCC12C,C24H32O4,S5872
21095,Scopolamine HBr trihydrate,O.O.O.Br.CN1C2CC(CC1C3OC23)OC(=O)C(CO)C4=CC=CC=C4,C17H28BrNO7,S5873
21096,Hodostin,CO[S]([O-])(=O)=O.CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,C13H22N2O6S,S5886
21097,Khellin,COC1=C2OC(=CC(=O)C2=C(OC)C3=C1OC=C3)C,C14H12O5,S5887
21098,Edrophonium chloride,[Cl-].CC[N+](C)(C)C1=CC=CC(=C1)O,C10H16ClNO,S5900
21099,Canagliflozin hemihydrate,O.CC1=C(CC2=CC=C(S2)C3=CC=C(F)C=C3)C=C(C=C1)C4OC(CO)C(O)C(O)C4O.CC5=C(CC6=CC=C(S6)C7=CC=C(F)C=C7)C=C(C=C5)C8OC(CO)C(O)C(O)C8O,C48H52F2O11S2,S5901
21100,Anagliptin,CC1=N[N]2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N,C19H25N7O2,S5909
21101,Bictegravir,OC1=C2N(CC3OC4CCC(C4)N3C2=O)C=C(C(=O)NCC5=C(F)C=C(F)C=C5F)C1=O,C21H18F3N3O5,S5911
21102,Cyclopentolate Hydrochloride,Cl.CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(O)CCCC2,C17H26ClNO3,S5921
21103,Celiprolol hydrochloride,Cl.CCN(CC)C(=O)NC1=CC(=C(OCC(O)CNC(C)(C)C)C=C1)C(C)=O,C20H34ClN3O4,S5923
21104,Olanexidine Hydrochloride semihydrate,Cl.CCCCCCCCNC(=N)NC(=N)NCC1=CC=C(Cl)C(=C1)Cl,C17H29Cl3N5O0.5,S5924
21105,Olodaterol hydrochloride,Cl.COC1=CC=C(CC(C)(C)NCC(O)C2=C3OCC(=O)NC3=CC(=C2)O)C=C1,C21H27ClN2O5,S5925
21106,Pitolisant hydrochloride,Cl.ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1,C17H27Cl2NO,S5926
21107,Proguanil,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1,C11H16ClN5,S5927
21108,Alvimopan,CC1CN(CCC1(C)C2=CC=CC(=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(O)=O,C25H32N2O4,S5935
21109,Cefazolin,CC1=NN=C(SCC2=C(N3C(SC2)C(NC(=O)C[N]4C=NN=N4)C3=O)C(O)=O)S1,C14H14N8O4S3,S5936
21110,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=C(C=CC=C3)N(CC(O)=O)C2=O,C24H28N2O5,S5938
21111,Bendamustine (SDX105),C[N]1C(=NC2=C1C=CC(=C2)N(CCCl)CCCl)CCCC(O)=O,C16H21Cl2N3O2,S5939
21112,Bepotastine,OC(=O)CCCN1CCC(CC1)OC(C2=CC=C(Cl)C=C2)C3=CC=CC=N3,C21H25ClN2O3,S5940
21113,Bromhexine,CN(CC1=CC(=CC(=C1N)Br)Br)C2CCCCC2,C14H20Br2N2,S5943
21114,Butenafine,CN(CC1=CC=C(C=C1)C(C)(C)C)CC2=CC=CC3=C2C=CC=C3,C23H27N,S5944
21115,Amodiaquine,CCN(CC)CC1=CC(=CC=C1O)NC2=CC=NC3=C2C=CC(=C3)Cl,C20H22ClN3O,S5948
21116,Fingolimod,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,C19H33NO2,S5950
21117,Cefoxitin,COC1(NC(=O)CC2=CC=CS2)C3SCC(=C(N3C1=O)C(O)=O)COC(N)=O,C16H17N3O7S2,S5951
21118,Baloxavir marboxil,COC(=O)OCOC1=C2N(C=CC1=O)N(C3COCCN3C2=O)C4C5=C(CSC6=C4C=CC=C6)C(=C(F)C=C5)F,C27H23F2N3O7S,S5952
21119,Ataluren (PTC124),OC(=O)C1=CC=CC(=C1)C2=NOC(=N2)C3=CC=CC=C3F,C15H9FN2O3,S6003
21120,Imidazole,[NH]1C=CN=C1,C3H4N2,S6006
21121,Bisphenol A,CC(C)(C1=CC=C(O)C=C1)C2=CC=C(O)C=C2,C15H16O2,S6007
21122,Sodium L-lactate,[Na+].CC(O)C([O-])=O,C3H5NaO3,S6010
21123,Acetamide,CC(N)=O,C2H5NO,S6011
21124,Isonicotinic acid,OC(=O)C1=CC=NC=C1,C6H5NO2,S6014
21125,Benzylcetyldimethylammonium chloride hydrate,[Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1,C25H46ClN,S6015
21126,2-Naphthol,OC1=CC=C2C=CC=CC2=C1,C10H8O,S6035
21127,Dibutyl sebacate,CCCCOC(=O)CCCCCCCCC(=O)OCCCC,C18H34O4,S6041
21128,(+)-(S)-Carvone,CC(=C)C1CC=C(C)C(=O)C1,C10H14O,S6049
21129,Saccharin sodium salt hydrate,[Na+].O=C1[N-][S](=O)(=O)C2=C1C=CC=C2,C7H4NNaO3S.xH2O,S6052
21130,Phenylglyoxylic acid,OC(=O)C(=O)C1=CC=CC=C1,C8H6O3,S6053
21131,(S)-(−)-Limonene,CC(=C)C1CCC(=CC1)C,C10H16,S6055
21132,β-Caryophyllene,CC/1=C\CCC(=C)C2CC(C)(C)C2CC1,C15H24,S6058
21133,Congo Red,[Na+].[Na+].NC1=C2C=CC=CC2=C(C=C1N=NC3=CC=C(C=C3)C4=CC=C(C=C4)N=NC5=CC(=C6C=CC=CC6=C5N)[S]([O-])(=O)=O)[S]([O-])(=O)=O,C32H22N6Na2O6S2,S6065
21134,"2,4-dichlorobenzyl alcohol",OCC1=C(Cl)C=C(Cl)C=C1,C7H6Cl2O,S6067
21135,Doxycycline monohydrate,O.CC1C2C(O)C3C(N(C)C)C(=C(C(N)=O)C(=O)C3(O)C(=C2C(=O)C4=C1C=CC=C4O)O)O,C22H26N2O9,S6068
21136,Diclofenac acid,OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1,C14H11Cl2NO2,S6073
21137,2-Methylhexanoic acid,CCCCC(C)C(O)=O,C7H14O2,S6079
21138,Terpinen-4-ol,CC(C)C1(O)CCC(=CC1)C,C10H18O,S6118
21139,Maltotriose,OCC1OC(OC2C(O)C(O)C(OC2CO)OC3C(O)C(O)C(O)OC3CO)C(O)C(O)C1O,C18H32O16,S6121
21140,(±)-α-Bisabolol,CC(C)=CCCC(C)(O)C1CCC(=CC1)C,C15H26O,S6136
21141,Levomenol,CC(C)=CCCC(C)(O)C1CCC(=CC1)C,C15H26O,E4499
21142,Acid Red 27,[Na+].[Na+].[Na+].OC1=C(C=C2C=C(C=CC2=C1N=NC3=C4C=CC=CC4=C(C=C3)[S]([O-])(=O)=O)[S]([O-])(=O)=O)[S]([O-])(=O)=O,C20H11N2Na3O10S3,S6152
21143,Brucine sulfate heptahydrate,O.O.O.O.O.O.O.COC1=CC2=C(C=C1OC)C34CCN5CC6=CCOC7CC(=O)N2C3C7C6CC45.COC8=CC9=C(C=C8OC)C%10%11CCN%12CC%13=CCOC%14CC(=O)N9C%10C%14C%13CC%11%12.O[S](O)(=O)=O,C46H68N4O19S,S6172
21144,Amylmetacresol,CCCCCC1=C(O)C=C(C)C=C1,C12H18O,S6173
21145,p-Toluenesulfonic acid monohydrate,O.CC1=CC=C(C=C1)[S](O)(=O)=O,C7H10O4S,S6188
21146,Acid Yellow 36,[Na+].[O-][S](=O)(=O)C1=CC(=CC=C1)N=NC2=CC=C(NC3=CC=CC=C3)C=C2,C18H14N3NaO3S,S6189
21147,Dimethylamine hydrochloride,Cl.CNC,C2H8ClN,S6197
21148,Butylated hydroxytoluene,CC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C,C15H24O,S6202
21149,Levulinic acid,CC(=O)CCC(O)=O,C5H8O3,S6207
21150,Ethanolamine hydrochloride,Cl.NCCO,C2H8ClNO,S6210
21151,Phthalic acid,OC(=O)C1=CC=CC=C1C(O)=O,C8H6O4,S6215
21152,o-Toluic acid,CC1=C(C=CC=C1)C(O)=O,C8H8O2,S6217
21153,Sodium lauryl sulfate,[Na+].CCCCCCCCCCCCO[S]([O-])(=O)=O,C12H25NaO4S,S6218
21154,Methyl cinnamate,COC(=O)/C=C/C1=CC=CC=C1,C10H10O2,S6221
21155,Triethyl citrate,CCOC(=O)CC(O)(CC(=O)OCC)C(=O)OCC,C12H20O7,S6223
21156,Methyl nicotinate,COC(=O)C1=CC=CN=C1,C7H7NO2,S6231
21157,Methylamine hydrochloride,Cl.CN,CH6ClN,S6232
21158,Tartaric acid,OC(C(O)C(O)=O)C(O)=O,C4H6O6,S6233
21159,DL-Tartaric acid,OC(C(O)C(O)=O)C(O)=O,C4H6O6,S2997
21160,D-(-)-Tartaric acid,OC(C(O)C(O)=O)C(O)=O,C4H6O6,S3134
21161,Pentadecanoic acid,CCCCCCCCCCCCCCC(O)=O,C15H30O2,S6234
21162,Sodium dehydroacetate,[Na+].CC(=O)C1=C([O-])C=C(C)OC1=O,C8H7NaO4,S6235
21163,L-Lactic acid,CC(O)C(O)=O,C3H6O3,S6250
21164,Terephthalic acid,OC(=O)C1=CC=C(C=C1)C(O)=O,C8H6O4,S6251
21165,N-Acetylglucosamine,CC(=O)NC(C=O)C(O)C(O)C(O)CO,C8H15NO6,S6257
21166,"1,2-Propanediol",CC(O)CO,C3H8O2,S6258
21167,Ammonium formate,NOC=O,CH5NO2,S6262
21168,Glycolic acid,OCC(O)=O,C2H4O3,S6272
21169,(−)-β-Pinene,CC1(C)C2CCC(=C)C1C2,C10H16,S6275
21170,Sodium Thiocyanate,[Na]SC#N,CNNaS,S6281
21171,Tetraethylammonium bromide,[Br-].CC[N+](CC)(CC)CC,C8H20BrN,S6284
21172,Chlorhexidine diacetate,CC(O)=O.CC(O)=O.ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1,C26H38Cl2N10O4,S6288
21173,Octanoic acid,CCCCCCCC(O)=O,C8H16O2,S6296
21174,N-Acetyl-L-tyrosine,CC(=O)NC(CC1=CC=C(O)C=C1)C(O)=O,C11H13NO4,S6316
21175,5-Methoxytryptamine,COC1=CC2=C([NH]C=C2CCN)C=C1,C11H14N2O,S6324
21176,Ethyl maltol,CCC1=C(O)C(=O)C=CO1,C7H8O3,S6335
21177,D-Glucuronic acid,OC(C=O)C(O)C(O)C(O)C(O)=O,C6H10O7,S6343
21178,Glucosamine,NC(C=O)C(O)C(O)C(O)CO,C6H13NO5,S6400
21179,2-Aminoethanethiol,NCCS,C2H7NS,S6402
21180,Chloramine-T,CC1=CC=C(C=C1)[S](=O)(=O)N([Na])Cl,C7H7ClNNaO2S,S6403
21181,Salicylamide,NC(=O)C1=C(O)C=CC=C1,C7H7NO2,S6404
21182,Octisalate,CCCCC(CC)COC(=O)C1=C(O)C=CC=C1,C15H22O3,S6405
21183,Tulobuterol hydrochloride,Cl.CC(C)(C)NCC(O)C1=C(Cl)C=CC=C1,C12H19Cl2NO,S6407
21184,Zucapsaicin,COC1=C(O)C=CC(=C1)CNC(=O)CCCC\C=C/C(C)C,C18H27NO3,S6409
21185,Clemizole,ClC1=CC=C(C[N]2C(=NC3=C2C=CC=C3)CN4CCCC4)C=C1,C19H20ClN3,S6410
21186,Nimorazole,[O-][N+](=O)C1=CN=C[N]1CCN2CCOCC2,C9H14N4O3,S6411
21187,Diroximel Fumarate,COC(=O)\C=C\C(=O)OCCN1C(=O)CCC1=O,C11H13NO6,S6421
21188,Cevimeline HCl hemihydrate,Cl.CC1OC2(CS1)CN3CCC2CC3,C10H18ClNOS.1/2H2O,S6432
21189,Udenafil,CCCOC1=CC=C(C=C1C2=NC(=O)C3=C(N2)C(=N[N]3C)CCC)[S](=O)(=O)NCCC4CCCN4C,C25H36N6O4S,S6433
21190,Mequitazine,C1CN2CCC1C(C2)CN3C4=C(SC5=C3C=CC=C5)C=CC=C4,C20H22N2S,S6435
21191,Talniflumate,FC(F)(F)C1=CC(=CC=C1)NC2=C(C=CC=N2)C(=O)OC3OC(=O)C4=C3C=CC=C4,C21H13F3N2O4,S6439
21192,Halazone,OC(=O)C1=CC=C(C=C1)[S](=O)(=O)N(Cl)Cl,C7H5Cl2NO4S,S6440
21193,Riboflavin Tetrabutyrate,CCCC(=O)OCC(OC(=O)CCC)C(OC(=O)CCC)C(CN1C2=C(C=C(C)C(=C2)C)N=C3C(=O)NC(=O)N=C13)OC(=O)CCC,C33H44N4O10,S6441
21194,Chlorphenesin,OCC(O)COC1=CC=C(Cl)C=C1,C9H11ClO3,S6442
21195,Chromium picolinate,[Cr+3]|1|2|3(|[O-]C(=O)C4=N|1C=CC=C4)(|[O-]C(=O)C5=N|2C=CC=C5)|[O-]C(=O)C6=N|3C=CC=C6,C18H12CrN3O6,S6443
21196,Triclocarban,ClC1=CC=C(NC(=O)NC2=CC=C(Cl)C(=C2)Cl)C=C1,C13H9Cl3N2O,S6444
21197,Carazolol,CC(C)NCC(O)COC1=CC=CC2=C1C3=C([NH]2)C=CC=C3,C18H22N2O2,S6447
21198,Ibuprofen piconol,CC(C)CC1=CC=C(C=C1)C(C)C(=O)OCC2=NC=CC=C2,C19H23NO2,S6448
21199,Apronal,CC(C)C(CC=C)C(=O)NC(N)=O,C9H16N2O2,S6450
21200,Delavirdine mesylate,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=C([NH]3)C=CC(=C4)N[S](C)(=O)=O.C[S](O)(=O)=O,C23H32N6O6S2,S6452
21201,Bicyclol,COC(=O)C1=CC(=C2OCOC2=C1C3=C4OCOC4=C(OC)C=C3CO)OC,C19H18O9,S6453
21202,Docosahexaenoic Acid,CC\C=C/C/C=C\C\C=C/C/C=C\C\C=C/C/C=C\CCC(O)=O,C22H32O2,S6454
21203,Clebopride malate,COC1=C(C=C(Cl)C(=C1)N)C(=O)NC2CC[NH+](CC2)CC3=CC=CC=C3.OC(CC(O)=O)C([O-])=O,C24H30ClN3O7,S6455
21204,Flurbiprofen Axetil,CC(OC(C)=O)OC(=O)C(C)C1=CC=C(C(=C1)F)C2=CC=CC=C2,C19H19FO4,S6457
21205,Nifurtimox,CC1C[S](=O)(=O)CCN1\N=C\C2=CC=C(O2)[N+]([O-])=O,C10H13N3O5S,S6459
21206,Permethrin,CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3,C21H20Cl2O3,S6461
21207,Amezinium (methylsulfate),COC1=[N+](N=CC(=C1)N)C2=CC=CC=C2.CO[S]([O-])(=O)=O,C12H15N3O5S,S6462
21208,Tafamidis,OC(=O)C1=CC=C2N=C(OC2=C1)C3=CC(=CC(=C3)Cl)Cl,C14H7Cl2NO3,S6465
21209,Fosfluconazole,O[P](O)(=O)OC(C[N]1C=NC=N1)(C[N]2C=NC=N2)C3=C(F)C=C(F)C=C3,C13H13F2N6O4P,S6467
21210,Trandolapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(O)=O,C24H34N2O5,S6468
21211,Thonzylamine,COC1=CC=C(CN(CCN(C)C)C2=NC=CC=N2)C=C1,C16H22N4O,S6469
21212,Fluralaner,CC1=CC(=CC=C1C(=O)NCC(=O)NCC(F)(F)F)C2=NOC(C2)(C3=CC(=CC(=C3)Cl)Cl)C(F)(F)F,C22H17Cl2F6N3O3,S6470
21213,Tinoridine hydrochloride,Cl.CCOC(=O)C1=C(N)SC2=C1CCN(CC3=CC=CC=C3)C2,C17H21ClN2O2S,S6472
21214,Pinaverium bromide,[Br-].COC1=C(OC)C=C(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)C(=C1)Br,C26H41Br2NO4,S6473
21215,Eicosapentaenoic Acid,CC/C=C\C\C=C/C/C=C\C\C=C/C/C=C\CCCC(O)=O,C20H30O2,S6476
21216,Fipexide hydrochloride,Cl.ClC1=CC=C(OCC(=O)N2CCN(CC2)CC3=CC=C4OCOC4=C3)C=C1,C20H22Cl2N2O4,S6478
21217,uridine triacetate,CC(=O)OCC1OC(C(OC(C)=O)C1OC(C)=O)N2C=CC(=O)NC2=O,C15H18N2O9,S6484
21218,fluticasone furoate,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)C5=CC=CO5)C(=O)SCF,C27H29F3O6S,S6487
21219,Doravirine (MK-1439),CN1C(=O)NN=C1CN2C=CC(=C(OC3=CC(=CC(=C3)C#N)Cl)C2=O)C(F)(F)F,C17H11C1F3N5O3,S6492
21220,Mitapivat,O=C(N1CCN(CC1)CC2CC2)C3=CC=C(N[S](=O)(=O)C4=C5N=CC=CC5=CC=C4)C=C3,C24H26N4O3S,S6508
21221,Clobetasone butyrate,CCCC(=O)OC1(C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(=O)CC12C)C(=O)CCl,C26H32ClFO5,S6587
21222,Methylprednisolone hemisuccinate,CC1CC2C3CCC(O)(C(=O)COC(=O)CCC(O)=O)C3(C)CC(O)C2C4(C)C=CC(=O)C=C14,C26H34O8,S6588
21223,Hydrocortisone butyrate,CCCC(=O)OC1(CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC12C)C(=O)CO,C25H36O6,S6590
21224,(±)-Equol,OC1=CC=C(C=C1)C2COC3=C(C2)C=CC(=C3)O,C15H14O3,S6601
21225,Cyclothiazide,N[S](=O)(=O)C1=CC2=C(NC(N[S]2(=O)=O)C3CC4CC3C=C4)C=C1Cl,C14H16ClN3O4S2,S6611
21226,Fursultiamine,CC1=NC=C(CN(C=O)/C(C)=C(CCO)/SSCC2CCCO2)C(=N1)N,C17H26N4O3S2,S6614
21227,AP26113-analog (ALK-IN-1),COC1=CC(=CC=C1NC2=NC=C(Cl)C(=N2)NC3=CC=CC=C3[P](C)(C)=O)N4CCC(CC4)N(C)C,C26H34ClN6O2P,S7000
21228,Binimetinib (MEK162),C[N]1C=NC2=C1C=C(C(=O)NOCCO)C(=C2F)NC3=C(F)C=C(Br)C=C3,C17H15BrF2N4O3,S7007
21229,Duvelisib (IPI-145),CC(NC1=NC=NC2=C1N=C[NH]2)C3=CC4=CC=CC(=C4C(=O)N3C5=CC=CC=C5)Cl,C22H17ClN6O,S7028
21230,Tezacaftor (VX-661),CC(C)(CO)C1=CC2=CC(=C(F)C=C2[N]1CC(O)CO)NC(=O)C3(CC3)C4=CC=C5OC(F)(F)OC5=C4,C26H27F3N2O6,S7059
21231,Tepotinib (EMD 1214063),CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC=CC(=C3)CN4N=C(C=CC4=O)C5=CC(=CC=C5)C#N,C29H28N6O2,S7067
21232,Cilengitide trifluoroacetate,CC(C)C1N(C)C(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(O)=O)NC(=O)CNC(=O)C(CCCNC(N)=N)NC1=O.OC(=O)C(F)(F)F,C29H41F3N8O9,S7077
21233,Ceritinib (LDK378),CC(C)OC1=C(NC2=NC(=C(Cl)C=N2)NC3=C(C=CC=C3)[S](=O)(=O)C(C)C)C=C(C)C(=C1)C4CCNCC4,C28H36ClN5O3S,S7083
21234,Zotarolimus (ABT-578),COC1CC(CCC1[N]2C=NN=N2)CC(C)C3CC(=O)C(C)/C=C(C)/C(O)C(OC)C(=O)C(C)CC(C)/C=C/C=C/C=C(C)/C(CC4CCC(C)C(O)(O4)C(=O)C(=O)N5CCCCC5C(=O)O3)OC,C52H79N5O12,S7091
21235,Tovorafenib (MLN2480),CC(NC(=O)C1=C(Cl)C(=NC=N1)N)C2=NC=C(S2)C(=O)NC3=NC=C(Cl)C(=C3)C(F)(F)F,C17H12Cl2F3N7O2S,S7121
21236,Marimastat (BB-2516),CNC(=O)C(NC(=O)C(CC(C)C)C(O)C(=O)NO)C(C)(C)C,C15H29N3O5,S7156
21237,Abemaciclib mesylate (LY2835219),CCN1CCN(CC1)CC2=CC=C(NC3=NC(=C(F)C=N3)C4=CC(=C5N=C(C)[N](C(C)C)C5=C4)F)N=C2.C[S](O)(=O)=O,C27H32F2N8.CH4O3S,S7158
21238,Glasdegib (PF-04449913),CN1CCC(CC1C2=NC3=CC=CC=C3[NH]2)NC(=O)NC4=CC=C(C=C4)C#N,C21H22N6O,S7160
21239,Siponimod (BAF312),CCC1=CC(=CC=C1CN2CC(C2)C(O)=O)\C(C)=N\OCC3=CC=C(C4CCCCC4)C(=C3)C(F)(F)F,C29H35F3N2O3,S7179
21240,Olverembatinib dimesylate (HQP1351),CN1CCN(CC1)CC2=C(C=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CC5=C([NH]N=C5)N=C4)C=C2)C(F)(F)F.C[S](O)(=O)=O.C[S](O)(=O)=O,C29H27F3N6O.2CH4O3S,S7194
21241,Selinexor (KPT-330),FC(F)(F)C1=CC(=CC(=C1)C2=N[N](\C=C/C(=O)NNC3=CN=CC=N3)C=N2)C(F)(F)F,C17H11F6N7O,S7252
21242,Edoxaban tosylate Monohydrate,O.CN(C)C(=O)C1CCC(NC(=O)C(=O)NC2=CC=C(Cl)C=N2)C(C1)NC(=O)C3=NC4=C(CN(C)CC4)S3.CC5=CC=C(C=C5)[S](O)(=O)=O,C24H30ClN7O4S.C7H8O3S.H2O,S7280
21243,Rociletinib (CO-1686),COC1=C(NC2=NC=C(C(=N2)NC3=CC=CC(=C3)NC(=O)C=C)C(F)(F)F)C=CC(=C1)N4CCN(CC4)C(C)=O,C27H28F3N7O3,S7284
21244,Osimertinib (AZD9291),COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CC=C4)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C,C28H33N7O2,S7297
21245,Rilpivirine,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)/C=C/C#N,C22H18N6,S7303
21246,Sorafenib (BAY 43-9006),CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2,C21H16ClF3N4O3,S7397
21247,Ascomycin (FK520),CCC1/C=C(C)/CC(C)CC(OC)C2OC(O)(C(C)CC2OC)C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)C(O)CC1=O)\C(C)=C\C4CCC(O)C(C4)OC,C43H69NO12,S7411
21248,Puromycin (CL13900) 2HCl,Cl.Cl.COC1=CC=C(CC(N)C(=O)NC2C(O)C(OC2CO)[N]3C=NC4=C3N=CN=C4N(C)C)C=C1,C22H29N7O5.2HCl,S7417
21249,Ribociclib (LEE011),CN(C)C(=O)C1=CC2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2[N]1C5CCCC5,C23H30N8O,S7440
21250,Triapine,NC(=S)N/N=C/C1=NC=CC=C1N,C7H9N5S,S7470
21251,Trelagliptin,CN1C(=O)C=C(N2CCCC(N)C2)N(CC3=CC(=CC=C3C#N)F)C1=O,C18H20FN5O2,S7513
21252,Lorlatinib (PF-6463922),CC1OC2=C(N)N=CC(=C2)C3=C(C#N)[N](C)N=C3CN(C)C(=O)C4=C1C=C(F)C=C4,C21H19FN6O2,S7536
21253,Erythromycin Cyclocarbonate,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(O)CC(C)C(=O)C(C)C4OC(=O)OC14C,C38H65NO14,S7550
21254,Darolutamide (ODM-201),CC(O)C1=CC(=N[NH]1)C(=O)NC(C)C[N]2C=CC(=N2)C3=CC(=C(C=C3)C#N)Cl,C19H19ClN6O2,S7559
21255,Ledipasvir (GS5885),COC(=O)NC(C(C)C)C(=O)N1C2CCC(C2)C1C3=NC4=CC=C(C=C4[NH]3)C5=CC=C6C7=CC=C(C=C7C(F)(F)C6=C5)C8=CN=C([NH]8)C9CCC%10(CC%10)N9C(=O)C(NC(=O)OC)C(C)C,C49H54F2N8O6,S7579
21256,Abscisic Acid (Dormin),CC(/C=C/C1(O)C(=CC(=O)CC1(C)C)C)=C/C(O)=O,C15H20O4,S7594
21257,Filgotinib (GLPG0634),O=C(NC1=N[N]2C(=N1)C=CC=C2C3=CC=C(CN4CC[S](=O)(=O)CC4)C=C3)C5CC5,C21H23N5O3S,S7605
21258,Niraparib (MK-4827) tosylate,CC1=CC=C(C=C1)[S](O)(=O)=O.NC(=O)C2=CC=CC3=C[N](N=C23)C4=CC=C(C=C4)C5CCCNC5,C19H20N4O.C7H8O3S,S7625
21259,Lomitapide Mesylate,C[S](O)(=O)=O.FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C3=C(C=CC=C3)C4=CC=C(C=C4)C(F)(F)F)C5=C(C=CC=C5)C6=C1C=CC=C6,C40H41F6N3O5S,S7633
21260,Lomitapide,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C3=C(C=CC=C3)C4=CC=C(C=C4)C(F)(F)F)C5=C(C=CC=C5)C6=C1C=CC=C6,C39H37F6N3O2,S7635
21261,Peficitinib (ASP015K),NC(=O)C1=C(N[CH]2C3C[CH]4CC2C[C](O)(C4)C3)C5=C([NH]C=C5)N=C1,C18H22N4O2,S7650
21262,Obeticholic Acid,CCC1C(O)C2C3CCC(C(C)CCC(O)=O)C3(C)CCC2C4(C)CCC(O)CC14,C26H44O4,S7660
21263,Ruboxistaurin (LY333531) HCl,Cl.CN(C)CC1CC[N]2C=C(C3=C2C=CC=C3)C4=C(C(=O)NC4=O)C5=C[N](CCO1)C6=C5C=CC=C6,C28H28N4O3.HCl,S7663
21264,Picropodophyllin (PPP),COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(O)C4=CC5=C(OCO5)C=C24,C22H22O8,S7668
21265,Omaveloxolone (RTA-408),CC1(C)CCC2(CCC3(C)C(C2C1)C(=O)C=C4C3(C)CCC5C(C)(C)C(=O)C(=CC45C)C#N)NC(=O)C(C)(F)F,C33H44F2N2O3,S7672
21266,Savolitinib (AZD6094),CC([N]1N=NC2=NC=C(N=C12)C3=C[N](C)N=C3)C4=C[N]5C=CN=C5C=C4,C17H15N9,S7674
21267,Sacubitril/valsartan (LCZ696),[Na+].[Na+].[Na+].CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[NH]3)C(C(C)C)C(O)=O.CCOC(=O)C(C)CC(CC4=CC=C(C=C4)C5=CC=CC=C5)NC(=O)CCC(O)=O,C24H29N5O3.C24H29NO5.5/2H2O.3Na,S7678
21268,Monomethyl auristatin E (MMAE),CCC(C)C(C(CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(C)C(O)C2=CC=CC=C2)OC)N(C)C(=O)C(NC(=O)C(NC)C(C)C)C(C)C,C39H67N5O7,S7721
21269,Gilteritinib (ASP2215),CCC1=NC(=C(NC2=CC=C(N3CCC(CC3)N4CCN(C)CC4)C(=C2)OC)N=C1NC5CCOCC5)C(N)=O,C29H44N8O3,S7754
21270,Cabotegravir (GSK1265744),CC1COC2CN3C=C(C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)C(=C3C(=O)N12)O,C19H17F2N3O5,S7766
21271,Sunitinib (SU11248),CCN(CC)CCNC(=O)C1=C(C)[NH]C(=C1C)/C=C/2C(=O)NC3=C2C=C(F)C=C3,C22H27FN4O2,S7781
21272,Dasatinib Monohydrate,O.CC1=NC(=CC(=N1)NC2=NC=C(S2)C(=O)NC3=C(C)C=CC=C3Cl)N4CCN(CCO)CC4,C22H28ClN7O3S,S7782
21273,Combretastatin A4,COC1=C(O)C=C(\C=C/C2=CC(=C(OC)C(=C2)OC)OC)C=C1,C18H20O5,S7783
21274,Fumagillin,COC1C(CCC2(CO2)C1C3(C)OC3CC=C(C)C)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O,C26H34O7,S7784
21275,Erlotinib (OSI-774),COCCOC1=C(OCCOC)C=C2C(=NC=NC2=C1)NC3=CC=CC(=C3)C#C,C22H23N3O4,S7786
21276,Docetaxel Trihydrate,O.O.O.CC(=O)OC12COC1CC(O)C3(C)C2C(OC(=O)C4=CC=CC=C4)C5(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(=C(C(O)C3=O)C5(C)C)C,C43H53NO14.3H2O,S7787
21277,Afatinib (BIBW2992) Dimaleate,CN(C)C/C=C/C(=O)NC1=C(OC2CCOC2)C=C3N=CN=C(NC4=CC=C(F)C(=C4)Cl)C3=C1.OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O,C24H25ClFN5O3.2C4H4O4,S7810
21278,Pexidartinib (PLX3397),FC(F)(F)C1=NC=C(CNC2=NC=C(CC3=C[NH]C4=NC=C(Cl)C=C34)C=C2)C=C1,C20H15ClF3N5,S7818
21279,Cyclo (-RGDfK),NCCCCC1NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(O)=O)NC(=O)CNC(=O)C(CCCNC(N)=N)NC1=O.OC(=O)C(F)(F)F,C29H42F3N9O9,S7834
21280,Cyclo(RGDyK),NCCCCC1NC(=O)C(CC2=CC=C(O)C=C2)NC(=O)C(CC(O)=O)NC(=O)CNC(=O)C(CCCNC(N)=N)NC1=O.OC=O.OC(=O)C(F)(F)F.FC(F)F,C31H43F6N9O12,S7844
21281,Eliglustat,CCCCCCCC(=O)NC(CN1CCCC1)C(O)C2=CC=C3OCCOC3=C2,C23H36N2O4,S7852
21282,Tenofovir Alafenamide (GS-7340),CC(C)OC(=O)C(C)N[P](=O)(COC(C)C[N]1C=NC2=C1N=CN=C2N)OC3=CC=CC=C3,C21H29N6O5P,S7856
21283,Dibutyryl-cAMP (Bucladesine),CCCC(=O)NC1=NC=NC2=C1N=C[N]2C3OC4CO[P](=O)(O[Na])OC4C3OC(=O)CCC,C18H23N5NaO8P,S7858
21284,Oleuropein,COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)\C(=C\C)C1CC(=O)OCCC3=CC(=C(O)C=C3)O,C25H32O13,S7867
21285,Y-39983 HCl,Cl.Cl.CC(N)C1=CC=C(C=C1)C(=O)NC2=C3C=C[NH]C3=NC=C2,C16H16N4O.2HCl,S7935
21286,Belumosudil (KD025),CC(C)NC(=O)COC1=CC(=CC=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C([NH]N=C5)C=C4,C26H24N6O2,S7936
21287,Ozanimod (RPC1063),CC(C)OC1=CC=C(C=C1C#N)C2=NC(=NO2)C3=CC=CC4=C3CCC4NCCO,C23H24N4O3,S7952
21288,ETC-1002,CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O,C19H36O5,S7953
21289,CP21R7 (CP21),C[N]1C=C(C2=C1C=CC=C2)C3=C(C(=O)NC3=O)C4=CC=CC(=C4)N,C19H15N3O2,S7954
21290,Larotrectinib (LOXO-101) sulfate,OC1CCN(C1)C(=O)NC2=C3N=C(C=C[N]3N=C2)N4CCCC4C5=CC(=CC=C5F)F.O[S](O)(=O)=O,C21H22F2N6O2.H2SO4,S7960
21291,Favipiravir (T-705),NC(=O)C1=NC(=CN=C1O)F,C5H4FN3O2,S7975
21292,Ripasudil (K-115) hydrochloride dihydrate,O.O.Cl.CC1CNCCCN1[S](=O)(=O)C2=CC=CC3=CN=CC(=C23)F,C15H18FN3O2S.ClH.2H2O,S7995
21293,Entrectinib (RXDX-101),CN1CCN(CC1)C2=CC=C(C(=O)NC3=N[NH]C4=C3C=C(CC5=CC(=CC(=C5)F)F)C=C4)C(=C2)NC6CCOCC6,C31H34F2N6O2,S7998
21294,Vonoprazan Fumarate (TAK-438),CNCC1=C[N](C(=C1)C2=CC=CC=C2F)[S](=O)(=O)C3=CC=CN=C3.OC(=O)\C=C\C(O)=O,C17H16FN3O2S.C4H4O4,S8016
21295,Nirogacestat (PF-03084014),CCCC(NC1CCC2=CC(=CC(=C2C1)F)F)C(=O)NC3=C[N](C=N3)C(C)(C)CNCC(C)(C)C,C27H41F2N5O,S8018
21296,Capivasertib (AZD5363),NC1(CCN(CC1)C2=NC=NC3=C2C=C[NH]3)C(=O)NC(CCO)C4=CC=C(Cl)C=C4,C21H25ClN6O2,S8019
21297,Empagliflozin (BI 10773),OCC1OC(C(O)C(O)C1O)C2=CC(=C(Cl)C=C2)CC3=CC=C(OC4CCOC4)C=C3,C23H27ClO7,S8022
21298,Apremilast (CC-10004),CCOC1=C(OC)C=CC(=C1)C(C[S](C)(=O)=O)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(C)=O,C22H24N2O7S,S8034
21299,Cobimetinib (GDC-0973),OC1(CN(C1)C(=O)C2=C(NC3=CC=C(I)C=C3F)C(=C(F)C=C2)F)C4CCCCN4,C21H21F3IN3O2,S8041
21300,Venetoclax (ABT-199),CC1(C)CCC(=C(C1)C2=CC=C(Cl)C=C2)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)N[S](=O)(=O)C5=CC=C(NCC6CCOCC6)C(=C5)[N+]([O-])=O)OC7=CN=C8[NH]C=CC8=C7,C45H50ClN7O7S,S8048
21301,Macitentan (ACT 064992),CCCN[S](=O)(=O)NC1=NC=NC(=C1C2=CC=C(Br)C=C2)OCCOC3=NC=C(Br)C=N3,C19H20Br2N6O4S,S8051
21302,Pacritinib (SB1518),C1CCN(C1)CCOC2=CC=C3NC4=NC=CC(=N4)C5=CC(=CC=C5)COC\C=C\COCC2=C3,C28H32N4O3,S8057
21303,Vorapaxar (MK-5348),CCOC(=O)NC1CCC2C(C1)CC3C(C(C)OC3=O)C2\C=C\C4=CC=C(C=N4)C5=CC=CC(=C5)F,C29H33FN2O4,S8067
21304,Bardoxolone Methyl,COC(=O)C12CCC(C)(C)CC1C3C(=O)C=C4C(C)(CCC5C(C)(C)C(=O)C(=CC45C)C#N)C3(C)CC2,C32H43NO4,S8078
21305,CB-5083,CC1=CC2=C(C=CC=C2C(N)=O)[N]1C3=NC4=C(COCC4)C(=N3)NCC5=CC=CC=C5,C24H23N5O2,S8101
21306,Sotagliflozin (LX4211),CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)C3OC(SC)C(O)C(O)C3O)C=C1,C21H25ClO5S,S8103
21307,Acalabrutinib (ACP-196),CC#CC(=O)N1CCCC1C2=NC(=C3[N]2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=NC=CC=C5,C26H23N7O2,S8116
21308,Resiquimod (R-848),CCOCC1=NC2=C([N]1CC(C)(C)O)C3=C(C=CC=C3)N=C2N,C17H22N4O2,S8133
21309,Radotinib,CC1=C[N](C=N1)C2=CC(=CC(=C2)C(F)(F)F)NC(=O)C3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=NC=CN=C5,C27H21F3N8O,S8134
21310,Riociguat (BAY 63-2521),COC(=O)N(C)C1=C(N)N=C(N=C1N)C2=N[N](CC3=CC=CC=C3F)C4=NC=CC=C24,C20H19FN8O2,S8135
21311,Sivelestat (ONO-5046),CC(C)(C)C(=O)OC1=CC=C(C=C1)[S](=O)(=O)NC2=CC=CC=C2C(=O)NCC(O)=O,C20H22N2O7S,S8136
21312,Halofuginone,OC1CCCNC1CC(=O)CN2C=NC3=CC(=C(Cl)C=C3C2=O)Br,C16H17BrClN3O3,S8144
21313,tirabrutinib(ONO-4059) hydrochloride,Cl.CC#CC(=O)N1CCC(C1)N2C(=O)N(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C25,C25H22N6O3.HCl,S8166
21314,Daprodustat (GSK1278863),OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C3CCCCC3)C1=O,C19H27N3O6,S8171
21315,Pimavanserin tartrate,CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C3CCN(C)CC3)C=C1.CC(C)COC4=CC=C(CNC(=O)N(CC5=CC=C(F)C=C5)C6CCN(C)CC6)C=C4.OC(C(O)C(O)=O)C(O)=O,C50H68F2N6O4.C4H6O6,S8183
21316,umbralisib (TGR-1202),CC(C)OC1=C(F)C=C(C=C1)C2=N[N](C(C)C3=C(C4=CC(=CC=C4)F)C(=O)C5=CC(=CC=C5O3)F)C6=C2C(=NC=N6)N,C31H24F3N5O3,S8194
21317,Oclacitinib maleate,CN[S](=O)(=O)CC1CCC(CC1)N(C)C2=C3C=C[NH]C3=NC=N2.OC(=O)\C=C/C(O)=O,C15H23N5O2S.C4H4O4,S8195
21318,Enasidenib (AG-221),CC(C)(O)CNC1=NC(=NC(=N1)NC2=CC=NC(=C2)C(F)(F)F)C3=NC(=CC=C3)C(F)(F)F,C19H17F6N7O,S8205
21319,Ivosidenib (AG-120),FC1=CN=CC(=C1)N(C(C(=O)NC2CC(F)(F)C2)C3=C(Cl)C=CC=C3)C(=O)C4CCC(=O)N4C5=NC=CC(=C5)C#N,C28H22ClF3N6O3,S8206
21320,Ponesimod,CCCN=C1S\C(=C/C2=CC=C(OCC(O)CO)C(=C2)Cl)C(=O)N1C3=CC=CC=C3C,C23H25ClN2O4S,S8241
21321,Olmutinib (BI 1482694),CN1CCN(CC1)C2=CC=C(NC3=NC(=C4SC=CC4=N3)OC5=CC=CC(=C5)NC(=O)C=C)C=C2,C26H26N6O2S,S8294
21322,Tucatinib,CC1=CC(=CC=C1OC2=CC3=NC=N[N]3C=C2)NC4=NC=NC5=CC=C(NC6=NC(C)(C)CO6)C=C45,C26H24N8O2,S8362
21323,Erdafitinib (JNJ-42756493),COC1=CC(=CC(=C1)N(CCNC(C)C)C2=CC3=NC(=CN=C3C=C2)C4=C[N](C)N=C4)OC,C25H30N6O2,S8401
21324,Troglitazone (CS-045),CC1=C(O)C(=C2CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)OC2=C1C)C,C24H27NO5S,S8432
21325,Ritlecitinib (PF-06651600),CC1CCC(CN1C(=O)C=C)NC2=C3C=C[NH]C3=NC=N2,C15H19N5O,S8538
21326,TAS-102,Cl.OCC1OC(CC1O)N2C=C(C(=O)NC2=O)C(F)(F)F.OCC3OC(CC3O)N4C=C(C(=O)NC4=O)C(F)(F)F.ClC5=C(CN6CCCC6=N)NC(=O)NC5=O,C10H11F3N2O5.0.5C9H11ClN4O2.0.5HCl,S8539
21327,Voxelotor (GBT440),CC(C)[N]1N=CC=C1C2=NC=CC=C2COC3=CC=CC(=C3C=O)O,C19H19N3O3,S8540
21328,Asciminib (ABL001),OC1CCN(C1)C2=C(C=C(C=N2)C(=O)NC3=CC=C(OC(F)(F)Cl)C=C3)C4=CC=N[NH]4,C20H18ClF2N5O3,S8555
21329,Tofogliflozin(CSG 452),O.CCC1=CC=C(CC2=CC3=C(COC34OC(CO)C(O)C(O)C4O)C=C2)C=C1,C22H26O6.H2O,S8558
21330,Omarigliptin (MK-3102),C[S](=O)(=O)[N]1C=C2CN(CC2=N1)C3COC(C(N)C3)C4=C(F)C=CC(=C4)F,C17H20F2N4O3S,S8565
21331,Tucidinostat (Chidamide),NC1=C(NC(=O)C2=CC=C(CNC(=O)\C=C\C3=CC=CN=C3)C=C2)C=C(F)C=C1,C22H19FN4O2,S8567
21332,Repotrectinib (TPX-0005),CC1CNC(=O)C2=C3N=C(NC(C)C4=C(O1)C=CC(=C4)F)C=C[N]3N=C2,C18H18FN5O2,S8583
21333,Pamiparib (BGB-290),CC12CCCN1CC3=NNC(=O)C4=CC(=CC5=C4C3=C2[NH]5)F,C16H15FN4O,S8592
21334,Tirofiban Hydrochloride,O.Cl.CCCC[S](=O)(=O)NC(CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O,C22H36N2O5S.HCl.H2O,S8594
21335,Sodium dichloroacetate (DCA),[Na]OC(=O)C(Cl)Cl,C2HCl2O2.Na,S8615
21336,Ipragliflozin (ASP1941),OCC1OC(C(O)C(O)C1O)C2=CC(=C(F)C=C2)CC3=CC4=C(S3)C=CC=C4,C21H21FOS,S8637
21337,Anlotinib (AL3818) dihydrochloride,Cl.Cl.COC1=C(OCC2(N)CC2)C=C3N=CC=C(OC4=C(F)C5=C([NH]C(=C5)C)C=C4)C3=C1,C23H22FN3O3.2HCl,S8726
21338,leniolisib (CDZ 173),CCC(=O)N1CCC(C1)NC2=NC=NC3=C2CN(CC3)C4=CC(=C(OC)N=C4)C(F)(F)F,C21H25F3N6O2,S8752
21339,Ripretinib (DCC-2618),CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C3=C(Br)C=C(F)C(=C3)NC(=O)NC4=CC=CC=C4,C24H21BrFN5O2,S8757
21340,Abrocitinib (PF-04965842),CCC[S](=O)(=O)NC1CC(C1)N(C)C2=C3C=C[NH]C3=NC=N2,C14H21N5O2S,S8765
21341,Zanubrutinib (BGB-3111),NC(=O)C1=C2NCCC(C3CCN(CC3)C(=O)C=C)[N]2N=C1C4=CC=C(OC5=CC=CC=C5)C=C4,C27H29N5O3,S8791
21342,Almonertinib (HS-10296),COC1=C(NC2=NC(=CC=N2)C3=C[N](C4CC4)C5=C3C=CC=C5)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C,C30H35N7O2,S8817
21343,Omadacycline tosylate,CN(C)C1C2CC3CC4=C(C=C(CNCC(C)(C)C)C(=C4C(=O)C3=C(O)C2(O)C(=O)C(=C1O)C(N)=O)O)N(C)C.CC5=CC=C(C=C5)[S](O)(=O)=O,C36H48N4O10S,S8871
21344,Letermovir (AIC246),COC1=CC(=CC=C1)N2CCN(CC2)C3=NC4=C(C=CC=C4F)C(CC(O)=O)N3C5=CC(=CC=C5OC)C(F)(F)F,C29H28F4N4O4,S8873
21345,Malic acid,OC(CC(O)=O)C(O)=O,C4H6O5,S9001
21346,L-Fucose,CC(O)C(O)C(O)C(O)C=O,C6H12O5,S9002
21347,Rhamnose,CC(O)C(O)C(O)C(O)C=O,C6H12O5,E0245
21348,(R)-(-)-Mandelic acid,OC(C(O)=O)C1=CC=CC=C1,C8H8O3,S9003
21349,2'-Deoxyguanosine monohydrate,NC1=NC2=C(N=C[N]2C3CC(O)C(CO)O3)C(=O)N1,C10H13N5O4,S9007
21350,Sanguinarine,C[N+]1=CC2=C3OCOC3=CC=C2C4=C1C5=CC6=C(OCO6)C=C5C=C4,C20H14NO4,S9032
21351,Wedelolactone,COC1=CC2=C(C(=C1)O)C3=C(C(=O)O2)C4=C(O3)C=C(O)C(=C4)O,C16H10O7,S9042
21352,Berberine,COC1=C(OC)C2=C(C=C1)C=C3C4=C(CC[N+]3=C2)C=C5OCOC5=C4,C20H18NO4,S9046
21353,Harringtonine,COC(=O)CC(O)(CCC(C)(C)O)C(=O)OC1C2C3=CC4=C(OCO4)C=C3CCN5CCCC25C=C1OC,C28H37NO9,S9063
21354,Ingenol,CC1CC2C(C3C=C(CO)C(O)C4(O)C(O)C(=CC14C3=O)C)C2(C)C,C20H28O5,S9101
21355,Pulegone,CC1CCC(=C(C)C)C(=O)C1,C10H16O,S9140
21356,Berbamine,COC1=C2OC3=C4C(CC5=CC=C(O)C(=C5)OC6=CC=C(CC7N(C)CCC(=C1)C7=C2)C=C6)N(C)CCC4=CC(=C3OC)OC,C37H40N2O6,S9141
21357,Sparteine,C1CCN2CC3CC(CN4CCCCC34)C2C1,C15H26N2,S9142
21358,Catharanthine hemitartrate,CCC1=CC2CN3CCC4=C([NH]C5=C4C=CC=C5)C(C2)(C13)C(=O)OC.OC(C(O)C(O)=O)C(O)=O,C46H54N4O10,S9179
21359,Aristolochic acid A,COC1=CC=CC2=C3C4=C(OCO4)C=C(C(O)=O)C3=C(C=C12)[N+]([O-])=O,C17H11NO7,S9193
21360,Melamine,NC1=NC(=NC(=N1)N)N,C3H6N6,S9212
21361,Dipotassium glycyrrhizinate,[K+].[K+].CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(O)=O)OC6OC(C(O)C(O)C6OC7OC(C(O)C(O)C7O)C([O-])=O)C([O-])=O,C42H60K2O16,S9222
21362,Sinensetin,COC1=CC=C(C=C1OC)C2=CC(=O)C3=C(O2)C=C(OC)C(=C3OC)OC,C20H20O7,S9227
21363,Isofraxidin,COC1=CC2=C(OC(=O)C=C2)C(=C1O)OC,C11H10O5,S9240
21364,Securinine,O=C1OC23CC(C=CC2=C1)N4CCCCC34,C13H15NO2,S9249
21365,Corydaline,COC1=CC2=C(C=C1OC)C3C(C)C4=C(CN3CC2)C(=C(OC)C=C4)OC,C22H27NO4,S9252
21366,3-n-Butylphathlide,CCCCC1OC(=O)C2=C1C=CC=C2,C12H14O2,S9263
21367,Germacrone,CC(C)=C1C\C=C(C)\CC/C=C(C)/CC1=O,C15H22O,S9311
21368,Topotecan,CCC1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC(=C(CN(C)C)C5=C4)O)C2=O,C23H23N3O5,S9321
21369,Scopolamine,CN1C2CC(CC1C3OC23)OC(=O)C(CO)C4=CC=CC=C4,C17H21NO4,S9326
21370,Carboprost,CCCCCC(C)(O)/C=C/C1C(O)CC(O)C1C\C=C/CCCC(O)=O,C21H36O5,S9327
21371,Orcinol,CC1=CC(=CC(=C1)O)O,C7H8O2,S9329
21372,Octyl gallate,CCCCCCCCOC(=O)C1=CC(=C(O)C(=C1)O)O,C15H22O5,S9338
21373,1-Indanone,O=C1CCC2=C1C=CC=C2,C9H8O,S9346
21374,D-(+)-Raffinose pentahydrate,O.O.O.O.O.OCC1OC(OCC2OC(OC3(CO)OC(CO)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O,C18H42O21,S9349
21375,2'-Deoxyadenosine monohydrate,O.NC1=NC=NC2=C1N=C[N]2C3CC(O)C(CO)O3,C10H15N5O4,S9351
21376,Oxalic acid,OC(=O)C(O)=O,C2H2O4,S9354
21377,ADP,NC1=NC=NC2=C1N=C[N]2C3OC(CO[P](O)(=O)O[P](O)(O)=O)C(O)C3O,C10H15N5O10P2,S9368
21378,Neryl acetate,CC(=O)OC\C=C(C)/CCC=C(C)C,C12H20O2,S9373
21379,"5,7-Dihydroxy-4-methylcoumarin",CC1=CC(=O)OC2=C1C(=CC(=C2)O)O,C10H8O4,S9380
21380,Thymine,CC1=CNC(=O)NC1=O,C5H6N2O2,S9382
21381,Rhynchophylline,CCC1CN2CCC3(C2CC1\C(=C/OC)C(=O)OC)C(=O)NC4=CC=CC=C34,C22H28N2O4,S9400
21382,Yangonin,COC1=CC=C(C=C1)/C=C/C2=CC(=CC(=O)O2)OC,C15H14O4,S9413
21383,Uridine 5'-monophosphate,OC1C(O)C(OC1CO[P](O)(O)=O)N2C=CC(=O)NC2=O,C9H13N2O9P,S9451
21384,10-Undecenoic acid,OC(=O)CCCCCCCCC=C,C11H20O2,S9452
21385,Undecanoic acid,CCCCCCCCCCC(O)=O,C11H22O2,S9454
21386,Phensuximide,CN1C(=O)CC(C1=O)C2=CC=CC=C2,C11H11NO2,S9457
21387,Ergoloid Mesylates,CC(C)C1(NC(=O)C2CC3C(CC4=C[NH]C5=CC=CC3=C45)N(C)C2)OC6(O)C7CCCN7C(=O)C(N6C1=O)[R].C[S](O)(=O)=O,C33H45N5O5,S9458
21388,Mecamylamine Hydrochloride,Cl.CNC1(C)C2CCC(C2)C1(C)C,C11H21N · HCl,S9459
21389,Ethotoin,CCN1C(=O)NC(C1=O)C2=CC=CC=C2,C11H12N2O2,S9460
21390,Benzonatate,CCCCNC1=CC=C(C=C1)C(=O)OCCOC,(C2H4O)nC12H17NO2,S9461
21391,Demecarium Bromide,[Br-].[Br-].CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C,C32H52Br2N4O4,S9463
21392,Methenamine Hippurate,OC(=O)CNC(=O)C1=CC=CC=C1.C2N3CN4CN2CN(C3)C4,C15H21N5O3,S9466
21393,Thiothixene,CN1CCN(CC\C=C/2C3=C(SC4=C2C=C(C=C4)[S](=O)(=O)N(C)C)C=CC=C3)CC1,C23H29N3O2S2,S9467
21394,Haloperidol Decanoate,CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3,C31H41ClFNO3,S9469
21395,Penbutolol Sulfate,CC(C)(C)NCC(O)COC1=C(C=CC=C1)C2CCCC2.CC(C)(C)NCC(O)COC3=C(C=CC=C3)C4CCCC4.O[S](O)(=O)=O,C18H29NO2.1/2H2O4S,S9470
21396,Oxtriphylline,CN1C(=O)N(C)C2=C([N-]C=N2)C1=O.C[N+](C)(C)CCO,C12H21N5O3,S9472
21397,Valbenazine tosylate,COC1=C(OC)C=C2C3CC(OC(=O)C(N)C(C)C)C(CC(C)C)CN3CCC2=C1.CC4=CC=C(C=C4)[S](O)(=O)=O.CC5=CC=C(C=C5)[S](O)(=O)=O,C38H54N2O10S2,S9500
21398,Madecassic acid,CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(CO)C5C(O)CC34C)C2C1C)C(O)=O,C30H48O6,S9502
21399,(−)-Norepinephrine,NCC(O)C1=CC(=C(O)C=C1)O,C8H11NO3,S9507
21400,Brimonidine,BrC1=C(NC2=NCCN2)C=CC3=C1N=CC=N3,C11H10BrN5,S9508
21401,Tiapride Hydrochloride,Cl.CCN(CC)CCNC(=O)C1=CC(=CC=C1OC)[S](C)(=O)=O,C15H25ClN2O4S,S9509
21402,Protriptyline hydrochloride,Cl.CNCCCC1C2=C(C=CC=C2)C=CC3=C1C=CC=C3,C19H22ClN,S9510
21403,Farrerol,CC1=C(O)C2=C(OC(CC2=O)C3=CC=C(O)C=C3)C(=C1O)C,C17H16O5,S9552
21404,Anisodamine Hydrobromide,Br.CN1C2CC(O)C1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,C17H24BrNO4,S9560
21405,Bepridil hydrochloride,O.Cl.CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3,C24H37ClN2O2,S9566
21406,Indinavir Sulfate,CC(C)(C)NC(=O)C1CN(CCN1CC(O)CC(CC2=CC=CC=C2)C(=O)NC3C(O)CC4=C3C=CC=C4)CC5=CN=CC=C5.O[S](O)(=O)=O,C36H49N5O8S,S9567
21407,Sapropterin Dihydrochloride,Cl.Cl.CC(O)C(O)C1CNC2=C(N1)C(=O)NC(=N2)N,C9H17Cl2N5O3,S9568
21408,Ensartinib (X-396) dihydrochloride,Cl.Cl.CC1CN(CC(C)N1)C(=O)C2=CC=C(NC(=O)C3=NN=C(N)C(=C3)OC(C)C4=C(Cl)C(=CC=C4Cl)F)C=C2,C26H29Cl4FN6O3,S2934
21409,Josamycin,COC1C(CC(=O)OC(C)C/C=C/C=C/C(O)C(C)CC(CC=O)C1OC2OC(C)C(OC3CC(C)(O)C(OC(=O)CC(C)C)C(C)O3)C(C2O)N(C)C)OC(C)=O,C42H69NO15,S4421
21410,Trifluoperazine,CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1,C21H24F3N3S,S5856
21411,(-)-Fenchone,CC1(C)C2CCC(C)(C2)C1=O,C10H16O,S5934
21412,Vadadustat,OC(=O)CNC(=O)C1=NC=C(C=C1O)C2=CC=CC(=C2)Cl,C14H11ClN2O4,S6490
21413,Fosamprenavir calcium salt,[Ca++].CC(C)CN(CC(O[P]([O-])([O-])=O)C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)[S](=O)(=O)C3=CC=C(N)C=C3,C25H34CaN3O9PS,S6581
21414,Ozenoxacin,CNC1=NC=C(C=C1C)C2=C(C)C3=C(C=C2)C(=O)C(=CN3C4CC4)C(O)=O,C21H21N3O3,S6582
21415,Apraclonidine HCl,Cl.NC1=CC(=C(NC2=NCCN2)C(=C1)Cl)Cl,C9H11Cl3N4,S6583
21416,Norethisterone Enanthate,CCCCCCC(=O)OC1(CCC2C3CCC4=CC(=O)CCC4C3CCC12C)C#C,C27H38O3,S6589
21417,Methylprednisolone sodium succinate,[Na+].CC1CC2C3CCC(O)(C(=O)COC(=O)CCC([O-])=O)C3(C)CC(O)C2C4(C)C=CC(=O)C=C14,C26H33NaO8,S6593
21418,Avatrombopag,OC(=O)C1CCN(CC1)C2=C(Cl)C=C(C=N2)C(=O)NC3=NC(=C(S3)N4CCN(CC4)C5CCCCC5)C6=CC(=CS6)Cl,C29H34Cl2N6O3S2,S6624
21419,Brequinar (DUP785),CC1=C(N=C2C=CC(=CC2=C1C(O)=O)F)C3=CC=C(C=C3)C4=C(F)C=CC=C4,C23H15F2NO2,S6626
21420,Belotecan (CKD-602) hydrochloride,Cl.CCC1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC=CC5=C4CCNC(C)C)C2=O,C25H28ClN3O4,S6631
21421,Besifovir,NC1=NC=C2N=C[N](CC3(CC3)OC[P](O)(O)=O)C2=N1,C10H14N5O4P,S6729
21422,Etofenamate,OCCOCCOC(=O)C1=C(NC2=CC=CC(=C2)C(F)(F)F)C=CC=C1,C18H18F3NO4,S6742
21423,Pimitespib (TAS-116),CCC1=C(C=CC(=C1)C(N)=O)[N]2N=C(C(C)C)C3=C(C=CN=C23)[N]4C=NC(=C4)C5=C[N](C)N=C5,C25H26N8O,S7716
21424,Selpercatinib (LOXO-292),COC1=NC=C(CN2C3CC2CN(C3)C4=NC=C(C=C4)C5=CC(=C[N]6N=CC(=C56)C#N)OCC(C)(C)O)C=C1,C29H31N7O3,S8781
21425,Futibatinib (TAS-120),COC1=CC(=CC(=C1)C#CC2=N[N](C3CCN(C3)C(=O)C=C)C4=NC=NC(=C24)N)OC,C22H22N6O3,S8848
21426,Mavacamten (MYK-461),CC(C)N1C(=O)NC(=CC1=O)NC(C)C2=CC=CC=C2,C15H19N3O2,S8861
21427,Homoharringtonine (CGX-635),COC(=O)CC(O)(CCCC(C)(C)O)C(=O)OC1C2C3=CC4=C(OCO4)C=C3CCN5CCCC25C=C1OC,C29H39NO9,S9015
21428,Quillaic acid,CC1(C)CCC2(C(O)CC3(C)C(=CCC4C5(C)CCC(O)C(C)(C=O)C5CCC34C)C2C1)C(O)=O,C30H46O5,S9019
21429,3-O-Acetyl-11-keto-β-boswellic acid (AKBA),CC1CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(OC(C)=O)C(C)(C5CCC34C)C(O)=O)C2C1C,C32H48O5,S9024
21430,Cimifugin,COC1=C2CC(OC2=CC3=C1C(=O)C=C(CO)O3)C(C)(C)O,C16H18O6,S9028
21431,Boldine,COC1=C(O)C=C2CC3N(C)CCC4=CC(=C(OC)C(=C34)C2=C1)O,C19H21NO4,S9050
21432,Irisflorentin,COC1=CC(=CC(=C1OC)OC)C2=COC3=CC4=C(OCO4)C(=C3C2=O)OC,C20H18O8,S9053
21433,Dihydrocapsaicin,COC1=C(O)C=CC(=C1)CNC(=O)CCCCCCC(C)C,C18H29NO3,S9086
21434,Magnolin,COC1=C(OC)C=C(C=C1)C2OCC3C2COC3C4=CC(=C(OC)C(=C4)OC)OC,C23H28O7,S9102
21435,Morin,OC1=CC(=C(C=C1)C2=C(O)C(=O)C3=C(O2)C=C(O)C=C3O)O,C15H10O7,S9110
21436,Isorhamnetin,COC1=C(O)C=CC(=C1)C2=C(O)C(=O)C3=C(O2)C=C(O)C=C3O,C16H12O7,S9111
21437,Eriodictyol,OC1=CC2=C(C(=O)CC(O2)C3=CC(=C(O)C=C3)O)C(=C1)O,C15H12O6,S9123
21438,Harpagoside,CC1(CC(O)C2(O)C=COC(OC3OC(CO)C(O)C(O)C3O)C12)OC(=O)\C=C\C4=CC=CC=C4,C24H30O11,S9171
21439,Ruscogenin,CC1CCC2(OC1)OC3CC4C5CC=C6CC(O)CC(O)C6(C)C5CCC4(C)C3C2C,C27H42O4,S9183
21440,Vitexin,OCC1OC(C(O)C(O)C1O)C2=C(O)C=C(O)C3=C2OC(=CC3=O)C4=CC=C(O)C=C4,C21H20O10,S9192
21441,Pneumocandin B0,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(O)C(O)NC(=O)C2C(O)CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(O)CN3C(=O)C(NC1=O)C(C)O)C(O)C(O)C4=CC=C(O)C=C4)C(O)CC(N)=O,C50H80N8O17,S9200
21442,Dehydroandrographolide Succinate,CC1(COC(=O)CCC(O)=O)C(CCC2(C)C1CCC(=C)C2\C=C\C3=CCOC3=O)OC(=O)CCC(O)=O,C28H36O10,S9224
21443,Homoorientin,OCC1OC(C(O)C(O)C1O)C2=C(O)C3=C(OC(=CC3=O)C4=CC(=C(O)C=C4)O)C=C2O,C21H20O11,S9248
21444,Dracohodin perochlorate,COC1=C(C)C(=CC2=C1C=CC(=[O+]2)C3=CC=CC=C3)O.[O-][Cl](=O)(=O)=O,C17H15ClO7,S9270
21445,Peimine,CC1CCC2N(C1)CC3C4CC5C(CC(O)C6CC(O)CCC56C)C4CCC3C2(C)O,C27H45NO3,S9281
21446,Fargesin,COC1=CC=C(C=C1OC)C2OCC3C2COC3C4=CC5=C(OCO5)C=C4,C21H22O6,S9285
21447,Casticin,COC1=C(O)C=C(C=C1)C2=C(OC)C(=O)C3=C(O2)C=C(OC)C(=C3O)OC,C19H18O8,S9288
21448,Gelsemine,CN1CC2(C=C)C3CC4OCC3C1C2C45C(=O)NC6=CC=CC=C56,C20H22N2O2,S9294
21449,Triptonide,CC(C)C12OC1C3OC34C5(C)CCC6=C(COC6=O)C5CC7OC47C2=O,C20H22O6,S9416
21450,Fadrozole (CGS16949A),N#CC1=CC=C(C=C1)C2CCCC3=CN=C[N]23,C14H13N3,S9519
21451,Lasofoxifene Tartrate,OC(C(O)C(O)=O)C(O)=O.OC1=CC2=C(C=C1)C(C(CC2)C3=CC=CC=C3)C4=CC=C(OCCN5CCCC5)C=C4,C32H37NO8,S9520
21452,Temocapril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CSC(CN(CC(O)=O)C2=O)C3=CC=CS3,C23H28N2O5S2,S2100
21453,Roquinimex,CN(C1=CC=CC=C1)C(=O)C2=C(O)C3=C(C=CC=C3)N(C)C2=O,C18H16N2O3,S2307
21454,Tirapazamine,NC1=[N+]([O-])C2=CC=CC=C2[N+](=N1)[O-],C7H6N4O2,S2426
21455,Isopropyl myristate,CCCCCCCCCCCCCC(=O)OC(C)C,C17H34O2,S2428
21456,Fabomotizole hydrochloride,Cl.CCOC1=CC2=C([NH]C(=N2)SCCN3CCOCC3)C=C1,C15H22ClN3O2S,S2474
21457,Fexinidazole,CSC1=CC=C(OCC2=NC=C([N]2C)[N+]([O-])=O)C=C1,C12H13N3O3S,S2600
21458,2-Aminoethyl Diphenylborinate (2-APB),NCCOB(C1=CC=CC=C1)C2=CC=CC=C2,C14H16BNO,S6657
21459,Rimegepant (BMS-927711),NC1C(CCC(OC(=O)N2CCC(CC2)N3C(=O)NC4=NC=CC=C34)C5=NC=CC=C15)C6=CC=CC(=C6F)F,C28H28F2N6O3,S6659
21460,Resmetirom (MGL-3196),CC(C)C1=CC(=NNC1=O)OC2=C(Cl)C=C(C=C2Cl)N3N=C(C#N)C(=O)NC3=O,C17H12Cl2N6O4,S6663
21461,"Sparsentan (PS-433540, RE-021)",CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C(=C3)COCC)C4=CC=CC=C4[S](=O)(=O)NC5=NOC(=C5C)C,C32H40N4O5S,S6665
21462,Ebselen,O=C1N([Se]C2=C1C=CC=C2)C3=CC=CC=C3,C13H9NOSe,S6676
21463,Olutasidenib (FT-2102),CC(NC1=CC=C(C#N)N(C)C1=O)C2=CC3=C(NC2=O)C=CC(=C3)Cl,C18H15ClN4O2,S8949
21464,Myristic Acid,CCCCCCCCCCCCCC(O)=O,C14H28O2,S5617
21465,Pleconaril,CC1=NOC(=C1)CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F,C18H18F3N3O3,S0436
21466,Sulfatinib,CN(C)CCN[S](=O)(=O)CC1=CC(=CC=C1)NC2=NC=CC(=N2)OC3=CC4=C([NH]C(=C4)C)C=C3,C24H28N6O3S,S0487
21467,Rubitecan,CCC1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC=C(C5=C4)[N+]([O-])=O)C2=O,C20H15N3O6,S2288
21468,"Ansamitocin p-3 (Maytansinol isobutyrate, NSC292222)",COC1\C=C\C=C(C)\CC2=CC(=C(Cl)C(=C2)OC)N(C)C(=O)CC(OC(=O)C(C)C)C3(C)OC3C(C)C4CC1(O)NC(=O)O4,C32H43ClN2O9,S2447
21469,Mobocertinib (TAK788),COC1=C(NC2=NC=C(C(=O)OC(C)C)C(=N2)C3=C[N](C)C4=CC=CC=C34)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C,C32H39N7O4,S6813
21470,Dithiothreitol (DTT),OC(CS)C(O)CS,C4H10O2S2,S6829
21471,o-Phenanthroline,C1=CN=C2C(=C1)C=CC3=CC=CN=C23,C12H8N2,S6830
21472,3'-Fluoro-3'-deoxythymidine (Alovudine),CC1=CN(C2CC(F)C(CO)O2)C(=O)NC1=O,C10H13FN2O4,S6848
21473,Molnupiravir (EIDD-2801),CC(C)C(=O)OCC1OC(C(O)C1O)N2C=C\C(NC2=O)=N/O,C13H19N3O7,S8969
21474,Relebactam,O[S](=O)(=O)ON1C2CCC(N(C2)C1=O)C(=O)NC3CCNCC3,C12H20N4O6S,S0074
21475,Pemigatinib (INCB054828),CCN1C(=O)N(CC2=C1C3=C([NH]C(=C3)CN4CCOCC4)N=C2)C5=C(F)C(=CC(=C5F)OC)OC,C24H27F2N5O4,S0088
21476,Treprostinil sodium,CCCCCC(O)CCC1C(O)CC2CC3=C(OCC(=O)O[Na])C=CC=C3CC12,C23H33NaO5,S0325
21477,Astemizole,COC1=CC=C(CCN2CCC(CC2)NC3=NC4=CC=CC=C4[N]3CC5=CC=C(F)C=C5)C=C1,C28H31FN4O,S0398
21478,Ipragliflozin L-Proline,OCC1OC(C(O)C(O)C1O)C2=CC(=C(F)C=C2)CC3=CC4=CC=CC=C4S3.OC(=O)C5CCCN5,C26H30FNO7S,S0994
21479,Vindesine sulfate,CCC1(O)CC2CN(CCC3=C([NH]C4=CC=CC=C34)C(C2)(C(=O)OC)C5=C(OC)C=C6N(C)C7C(O)(C(O)C8(CC)C=CCN9CCC7(C89)C6=C5)C(N)=O)C1.O[S](O)(=O)=O,C43H57N5O11S,S2440
21480,Brilliant Blue G,[Na+].CCOC1=CC=C(NC2=CC=C(C=C2)\C(C3=CC=C(C=C3C)N(CC)CC4=CC=CC(=C4)[S]([O-])(=O)=O)=C/5C=CC(/C=C5C)=[N+](/CC)CC6=CC=CC(=C6)[S]([O-])(=O)=O)C=C1,C47H48N3NaO7S2,S3217
21481,Trigonelline,C[N+]1=CC(=CC=C1)C([O-])=O,C7H7NO2,S3220
21482,Hypericin,CC1=C2C3=C(C)C=C(O)C4=C3C5=C6C2=C(C(=C1)O)C(=O)C7=C6C(=C(O)C=C7O)C8=C(O)C=C(O)C(=C58)C4=O,C30H16O8,S3273
21483,Cynarin,OC1CC(CC(OC(=O)/C=C/C2=CC=C(O)C(=C2)O)C1O)(OC(=O)\C=C\C3=CC=C(O)C(=C3)O)C(O)=O,C25H24O12,S3301
21484,Gefapixant,COC1=CC(=C(OC2=CN=C(N)N=C2N)C=C1[S](N)(=O)=O)C(C)C,C14H19N5O4S,S6664
21485,Gossypol,CC(C)C1=C(O)C(=C(C=O)C2=C1C=C(C)C(=C2O)C3=C(O)C4=C(C=C3C)C(=C(O)C(=C4C=O)O)C(C)C)O,C30H30O8,S6852
21486,Monomethyl Fumarate,COC(=O)\C=C\C(O)=O,C5H6O4,S6889
21487,Clascoterone,CCC(=O)OC1(CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C)C(=O)CO,C24H34O5,S6896
21488,Capric acid,CCCCCCCCCC(O)=O,C10H20O2,S6906
21489,Orelabrutinib (ICP-022),NC(=O)C1=C(N=C(C=C1)C2CCN(CC2)C(=O)C=C)C3=CC=C(OC4=CC=CC=C4)C=C3,C26H25N3O3,S9600
21490,Pibrentasvir (ABT-530),COC(C)C(NC(=O)OC)C(=O)N1CCCC1C2=NC3=C([NH]2)C=C(C4CCC(N4C5=CC(=C(N6CCC(CC6)C7=CC=C(F)C=C7)C(=C5)F)F)C8=CC9=C(C=C8F)N=C([NH]9)C%10CCCN%10C(=O)C(NC(=O)OC)C(C)OC)C(=C3)F,C57H65F5N10O8,S9641
21491,Ampalex (CX-516),O=C(N1CCCCC1)C2=CC3=NC=CN=C3C=C2,C14H15N3O,S0165
21492,Antineoplaston A10,O=C1CCC(NC(=O)CC2=CC=CC=C2)C(=O)N1,C13H14N2O3,S0323
21493,Avacopan (CCX168),CC1=C(C=C(NC(=O)C2CCCN(C2C3=CC=C(NC4CCCC4)C=C3)C(=O)C5=C(C)C=CC=C5F)C=C1)C(F)(F)F,C33H35F4N3O2,S0474
21494,Ticlopidine,ClC1=CC=CC=C1CN2CCC3=C(C2)C=CS3,C14H14ClNS,S0721
21495,Carbetapentane,CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2,C20H31NO3,S0869
21496,Barnidipine,COC(=O)C1=C(C)NC(=C(C1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC3CCN(C3)CC4=CC=CC=C4)C,C27H29N3O6,S0870
21497,Irinotecan (CPT-11),CCC1=C2C=C(OC(=O)N3CCC(CC3)N4CCCCC4)C=CC2=NC5=C1CN6C(=O)C7=C(C=C56)C(O)(CC)C(=O)OC7,C33H38N4O6,S1198
21498,Staurosporine (AM-2282),CNC1CC2OC(C)(C1OC)[N]3C4=C(C=CC=C4)C5=C6CNC(=O)C6=C7C8=CC=CC=C8[N]2C7=C35,C28H26N4O3,S1421
21499,Adenine,NC1=NC=NC2=C1N=C[NH]2,C5H5N5,S1981
21500,Menthone,CC(C)C1CCC(C)CC1=O,C10H18O,S3009
21501,(-)-Menthone,CC(C)C1CCC(C)CC1=O,C10H18O,E4118
21502,Malonic acid,OC(=O)CC(O)=O,C3H4O4,S3029
21503,Deoxycholic acid sodium salt,[Na+].CC(CCC([O-])=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C,C24H39NaO4,S3069
21504,Maleic acid,OC(=O)\C=C/C(O)=O,C4H4O4,S3086
21505,Pyrazole,[NH]1C=CC=N1,C3H4N2,S3093
21506,2-Deoxy-D-ribose,OCC(O)C(O)CC=O,C5H10O4,S3101
21507,Pyridoxal hydrochloride,Cl.CC1=NC=C(CO)C(=C1O)C=O,C8H10ClNO3,S3111
21508,Maleimide,O=C1NC(=O)C=C1,C4H3NO2,S3141
21509,Pyruvic acid,CC(=O)C(O)=O,C3H4O3,S3143
21510,Glutaric acid,OC(=O)CCCC(O)=O,C5H8O4,S3152
21511,Amiloxate,COC1=CC=C(C=CC(=O)OCCC(C)C)C=C1,C15H20O3,S3218
21512,Myosmine,C1CN=C(C1)C2=CN=CC=C2,C9H10N2,S3311
21513,2-Methylpentanoic acid,CCCC(C)C(O)=O,C6H12O2,S3314
21514,D-Mannosamine hydrochloride,Cl.NC(C=O)C(O)C(O)C(O)CO,C6H14ClNO5,S3332
21515,Palmitoleic acid,CCCCCC\C=C/CCCCCCCC(O)=O,C16H30O2,S3341
21516,Bis(2-ethylhexyl) phthalate,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC,C24H38O4,S3360
21517,N-Acetyl-D-mannosamine,CC(=O)NC1C(O)OC(CO)C(O)C1O,C8H15NO6,S3371
21518,Oxiglutatione,NC(CCC(=O)NC(CSSCC(NC(=O)CCC(N)C(O)=O)C(=O)NCC(O)=O)C(=O)NCC(O)=O)C(O)=O,C20H32N6O12S2,S3743
21519,Ceftaroline Fosamil,CCO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(O)=O)SC3=NC(=CS3)C4=CC=[N+](C)C=C4)C5=NSC(=N5)N[P](O)(O)=O.CC([O-])=O,C24H25N8O10PS4,S4417
21520,Apatinib,O=C(NC1=CC=C(C=C1)C2(CCCC2)C#N)C3=C(NCC4=CC=NC=C4)N=CC=C3,C24H23N5O,S5248
21521,Hemin,CC1=C(CCC(O)=O)C\2=N\C1=C/C3=C(C=C)C(=C4\C=C5/N=C(/C=C6\N([Fe](Cl)[N]34)\C(=C2)C(=C6C)CCC(O)=O)C(=C5C=C)C)C,C34H32ClFeN4O4,S5645
21522,Indole,[NH]1C=CC2=C1C=CC=C2,C8H7N,S6358
21523,3-Hydroxybenzoic acid,OC(=O)C1=CC=CC(=C1)O,C7H6O3,S6367
21524,Trypan Blue,[Na+].[Na+].[Na+].[Na+].CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(O)C4=C(N)C=C(C=C4C=C3[S]([O-])(=O)=O)[S]([O-])(=O)=O)C)N=NC5=C(O)C6=C(N)C=C(C=C6C=C5[S]([O-])(=O)=O)[S]([O-])(=O)=O,C34H24N6Na4O14S4,S6890
21525,DOTAP chloride,[Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC,C42H80ClNO4,S6908
21526,Lanreotide,CC(C)C1NC(=O)C(CCCCN)NC(=O)C(CC2=C[NH]C3=C2C=CC=C3)NC(=O)C(CC4=CC=C(O)C=C4)NC(=O)C(CSSCC(NC1=O)C(=O)NC(C(C)O)C(N)=O)NC(=O)C(N)CC5=CC6=CC=CC=C6C=C5,C54H69N11O10S2,S6948
21527,β-Elemene,CC(=C)C1CCC(C)(C=C)C(C1)C(C)=C,C15H24,S6957
21528,Treosulfan,C[S](=O)(=O)OCC(O)C(O)CO[S](C)(=O)=O,C6H14O8S2,S6958
21529,Perhexiline maleate,OC(=O)\C=C/C(O)=O.C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,C23H39NO4,S6959
21530,Ginsenoside Ro,CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C(O)=O)C(C)(C)C5CCC34C)C2C1)C(=O)OC8OC(CO)C(O)C(O)C8O,C48H76O19,S9103
21531,Pentostatin,OCC1OC(CC1O)[N]2C=NC3=C2NC=NCC3O,C11H16N4O4,S9521
21532,Enarodustat (JTZ-951),OC(=O)CNC(=O)C1=C(O)C=C(CCC2=CC=CC=C2)[N]3N=CN=C13,C17H16N4O4,S9656
21533,Saroglitazar,CCOC(CC1=CC=C(OCC[N]2C(=CC=C2C3=CC=C(SC)C=C3)C)C=C1)C(O)=O,C25H29NO4S,S9674
21534,Tapinarof,CC(C)C1=C(O)C=C(\C=C\C2=CC=CC=C2)C=C1O,C17H18O2,S9700
21535,Fluzoparib (SHR-3162),FC1=CC=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1C(=O)N4CC[N]5N=C(N=C5C4)C(F)(F)F,C22H16F4N6O2,S9712
21536,Varenicline (CP 526555) dihydrochloride,Cl.Cl.C1NCC2CC1C3=CC4=NC=CN=C4C=C23,C13H15Cl2N3,S0717
21537,Crotamiton,CCN(C(=O)\C=C\C)C1=CC=CC=C1C,C13H17NO,S1711
21538,Indocyanine green,[Na+].CC1(C)C(=C/C=C/C=C/C=C/C2=[N+](CCCC[S]([O-])(=O)=O)C3=C(C4=C(C=CC=C4)C=C3)C2(C)C)/N(CCCC[S]([O-])(=O)=O)C5=C1C6=C(C=CC=C6)C=C5,C43H47N2NaO6S2,S1924
21539,Liranaftate,COC1=NC(=CC=C1)N(C)C(=S)OC2=CC3=C(CCCC3)C=C2,C18H20N2O2S,S1997
21540,Tecovirimat,FC(F)(F)C1=CC=C(C=C1)C(=O)NN2C(=O)C3C4C=CC(C5CC45)C3C2=O,C19H15F3N2O3,S3380
21541,Lefamulin acetate (Xenleta),CC1CCC23CCC(=O)C2C1(C)C(CC(C)(C=C)C(O)C3C)OC(=O)CSC4CCC(N)CC4O.CC(O)=O,C30H49NO7S,S3496
21542,Ecamsule.2Na,[Na+].[Na+].CC1(C)C2CCC1(C[S]([O-])(=O)=O)C(=O)C2=CC3=CC=C(C=C3)C=C4C5CCC(C[S]([O-])(=O)=O)(C4=O)C5(C)C,C28H32Na2O8S2,S3498
21543,Perflubron,FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br,C8BrF17,S3501
21544,Rhodamine 123,Cl.COC(=O)C1=CC=CC=C1C2=C3C=CC(=N)C=C3OC4=C2C=CC(=C4)N,C21H17ClN2O3,S3577
21545,Mebrofenin,CC1=C(Br)C(=C(NC(=O)CN(CC(O)=O)CC(O)=O)C(=C1)C)C,C15H19BrN2O5,S3587
21546,Hexylene glycol,CC(O)CC(C)(C)O,C6H14O2,S3588
21547,Bendazol,C(C1=NC2=CC=CC=C2[NH]1)C3=CC=CC=C3,C14H12N2,S3589
21548,Triolein,CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCCCC,C57H104O6,S3590
21549,4-Phenylbutyric acid (4-PBA),OC(=O)CCCC1=CC=CC=C1,C10H12O2,S3592
21550,Rhodamine 6G,[Cl-].CCNC1=CC2=C(C=C1C)C(=C3C=C(C)C(C=C3O2)=[NH+]CC)C4=CC=CC=C4C(=O)OCC,C28H31ClN2O3,S3593
21551,Adipic acid,OC(=O)CCCCC(O)=O,C6H10O4,S3594
21552,D-Gluconic acid,OCC(O)C(O)C(O)C(O)C(O)=O,C6H12O7,S3595
21553,3-Phenoxybenzoic acid,OC(=O)C1=CC(=CC=C1)OC2=CC=CC=C2,C13H10O3,S3597
21554,Resazurin sodium,[Na+].[O-]C1=CC2=C(C=C1)[N+](=C3C=CC(=O)C=C3O2)[O-],C12H6NNaO4,S3599
21555,Pimethixene maleate,CN1CCC(CC1)=C2C3=CC=CC=C3SC4=CC=CC=C24.OC(=O)\C=C/C(O)=O,C23H23NO4S,S3913
21556,Dydrogesterone,CC(=O)C1CCC2C3C=CC4=CC(=O)CCC4(C)C3CCC12C,C21H28O2,S4097
21557,Phenol Red sodium salt,[Na+].OC1=CC=C(C=C1)C2(O[S](=O)(=O)C3=CC=CC=C23)C4=CC=C([O-])C=C4,C19H13NaO5S,S4418
21558,Ensulizole,O[S](=O)(=O)C1=CC2=C(C=C1)N=C([NH]2)C3=CC=CC=C3,C13H10N2O3S,S4419
21559,Emamectin Benzoate,CCC(C)C1OC2(CC3CC(C\C=C(C)\C(OC4CC(OC)C(OC5CC(OC)C(NC)C(C)O5)C(C)O4)C(C)/C=C/C=C/6COC7C(O)C(=CC(C(=O)O3)C67O)C)O2)C=CC1C.OC(=O)C8=CC=CC=C8,C56H81NO15,S4423
21560,Rifamycin S,COC1\C=C\OC2(C)OC3=C(C2=O)C4=C(C(=C3C)O)C(=O)C(=CC4=O)NC(=O)\C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C,C37H45NO12,S4425
21561,Sacubitril hemicalcium salt,[Ca++].CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC([O-])=O.CCOC(=O)C(C)CC(CC3=CC=C(C=C3)C4=CC=CC=C4)NC(=O)CCC([O-])=O,C48H56CaN2O10,S4426
21562,Tenofovir alafenamide hemifumarate,CC(C)OC(=O)C(C)N[P](=O)(COC(C)C[N]1C=NC2=C(N)N=CN=C12)OC3=CC=CC=C3.CC(C)OC(=O)C(C)N[P](=O)(COC(C)C[N]4C=NC5=C(N)N=CN=C45)OC6=CC=CC=C6.OC(=O)\C=C\C(O)=O,C46H62N12O14P2,S4427
21563,Tenofovir alafenamide fumarate,CC(C)OC(=O)C(C)N[P](=O)(COC(C)C[N]1C=NC2=C(N)N=CN=C12)OC3=CC=CC=C3.OC(=O)\C=C\C(O)=O,C25H33N6O9P,S4428
21564,Edoxaban,CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(Cl)C=C4)C(=O)N(C)C,C24H30ClN7O4S,S4429
21565,Ertugliflozin L-pyroglutamic acid,CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)C34OCC(CO)(O3)C(O)C(O)C4O)C=C1.OC(=O)C5CCC(=O)N5,C27H32ClNO10,S4431
21566,Ixazomib Citrate (MLN9708),CC(C)CC(NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B2OC(=O)C(CC(O)=O)(CC(O)=O)O2,C20H23BCl2N2O9,S4432
21567,Eliglustat hemitartrate,CCCCCCCC(=O)NC(CN1CCCC1)C(O)C2=CC3=C(OCCO3)C=C2.CCCCCCCC(=O)NC(CN4CCCC4)C(O)C5=CC6=C(OCCO6)C=C5.OC(C(O)C(O)=O)C(O)=O,C50H78N4O14,S4433
21568,Ledipasvir acetone,COC(=O)NC(C(C)C)C(=O)N1CC2(CC2)CC1C3=NC=C([NH]3)C4=CC5=C(C=C4)C6=C(C=C(C=C6)C7=CC8=C(C=C7)N=C([NH]8)C9C%10CCC(C%10)N9C(=O)C(NC(=O)OC)C(C)C)C5(F)F.CC(C)=O,C52H60F2N8O7,S4434
21569,Metamizole sodium hydrate,O.[Na+].CN(C[S]([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2,C13H18N3NaO5S,S4435
21570,Pleuromutilin,CC1CCC23CCC(=O)C2C1(C)C(CC(C)(C=C)C(O)C3C)OC(=O)CO,C22H34O5,S4436
21571,Benzophenone,O=C(C1=CC=CC=C1)C2=CC=CC=C2,C13H10O,S4438
21572,Almitrine mesylate,C[S](O)(=O)=O.C[S](O)(=O)=O.FC1=CC=C(C=C1)C(N2CCN(CC2)C3=NC(=NC(=N3)NCC=C)NCC=C)C4=CC=C(F)C=C4,C28H37F2N7O6S2,S4439
21573,2-Phenylacetamide,NC(=O)CC1=CC=CC=C1,C8H9NO,S4440
21574,Isomalt,OCC(O)C(O)C(O)C(O)COC1OC(CO)C(O)C(O)C1O,C12H24O11,S4441
21575,Neotame,COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(O)=O)NCCC(C)(C)C,C20H30N2O5,S4442
21576,Dimercaprol,OCC(S)CS,C3H8OS2,S4446
21577,Pipobroman,BrCCC(=O)N1CCN(CC1)C(=O)CCBr,C10H16Br2N2O2,S4447
21578,Guanabenz,NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl,C8H8Cl2N4,S4481
21579,Iproniazid phosphate,CC(C)NNC(=O)C1=CC=NC=C1.O[P](O)(O)=O,C9H16N3O5P,S4483
21580,Trametinib DMSO solvate,CN1C(=O)C(=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC4=C(F)C=C(I)C=C4)C5=CC=CC(=C5)NC(C)=O)C.C[S](C)=O,C28H29FIN5O5S,S4484
21581,Thiamine monochloride,[Cl-].CC1=NC=C(C[N+]2=CSC(=C2C)CCO)C(=N1)N,C12H17ClN4OS,S4486
21582,Delafloxacin Meglumine,CNCC(O)C(O)C(O)C(O)CO.NC1=NC(=C(F)C=C1F)N2C=C(C(O)=O)C(=O)C3=CC(=C(N4CC(O)C4)C(=C23)Cl)F,C25H29ClF3N5O9,S4488
21583,Tetraethylammonium chloride,[Cl-].CC[N+](CC)(CC)CC,C8H20ClN,S4489
21584,Tetracycline,CN(C)C1C2CC3C(=C(O)C4=C(C=CC=C4O)C3(C)O)C(=O)C2(O)C(=C(C(N)=O)C1=O)O,C22H24N2O8,S4490
21585,Cetylpyridinium chloride monohydrate,O.[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1,C21H40ClNO,S4491
21586,Sodium nitroprusside,[Na+].[Na+].[Fe++](|[C-]#N)(|[C-]#N)(|[C-]#N)(|[C-]#N)(|[C-]#N)|N#[O+],C5FeN6O2Na,S4493
21587,Quinine,COC1=CC2=C(C=CN=C2C=C1)C(O)C3CC4CCN3CC4C=C,C20H24N2O2,S4495
21588,Maltose monohydrate,O.OCC(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)C(O)C=O,C12H24O12,S4496
21589,Iohexol,CC(=O)N(CC(O)CO)C1=C(I)C(=C(I)C(=C1I)C(=O)NCC(O)CO)C(=O)NCC(O)CO,C19H26I3N3O9,S4531
21590,Homosalate,CC1CC(CC(C)(C)C1)OC(=O)C2=C(O)C=CC=C2,C16H22O3,S4572
21591,Quinidine hydrochloride monohydrate,O.Cl.COC1=CC2=C(C=CN=C2C=C1)C(O)C3CC4CCN3CC4C=C,C20H27ClN2O3,S4681
21592,Pyrithioxin Dihydrochloride,Cl.Cl.CC1=NC=C(CSSCC2=CN=C(C)C(=C2CO)O)C(=C1O)CO,C16H22Cl2N2O4S2,S4730
21593,Balsalazide,OC(=O)CCNC(=O)C1=CC=C(C=C1)N=NC2=CC(=C(O)C=C2)C(O)=O,C17H15N3O6,S4842
21594,Nilotinib hydrochloride monohydrate,O.Cl.CC1=C[N](C=N1)C2=CC(=CC(=C2)NC(=O)C3=CC(=C(C)C=C3)NC4=NC=CC(=N4)C5=CN=CC=C5)C(F)(F)F,C28H25ClF3N7O2,S4895
21595,Enasidenib Mesylate,CC(C)(O)CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F.C[S](O)(=O)=O,C20H21F6N7O4S,S4929
21596,Fostamatinib disodium hexahydrate,O.O.O.O.O.O.[Na+].[Na+].COC1=CC(=CC(=C1OC)OC)NC2=NC=C(F)C(=N2)NC3=NC4=C(OC(C)(C)C(=O)N4CO[P]([O-])([O-])=O)C=C3,C23H36FN6Na2O15P,S4944
21597,Ethacridine lactate,CCOC1=CC2=C(N)C3=C(C=C(N)C=C3)N=C2C=C1.CC(O)C(O)=O,C18H21N3O4,S4945
21598,Regorafenib Hydrochloride,Cl.CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)F,C21H16Cl2F4N4O3,S4947
21599,Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)[NH]2,C19H18FN3O,S4948
21600,Ceritinib dihydrochloride,Cl.Cl.CC(C)OC1=C(NC2=NC=C(Cl)C(=N2)NC3=CC=CC=C3[S](=O)(=O)C(C)C)C=C(C)C(=C1)C4CCNCC4,C28H38Cl3N5O3S,S4967
21601,Oxacillin sodium,[Na+].CC1=C(C(=O)NC2C3SC(C)(C)C(N3C2=O)C([O-])=O)C(=NO1)C4=CC=CC=C4,C19H18N3NaO5S,S4974
21602,Procaine penicillin G,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.CC2(C)SC3C(NC(=O)CC4=CC=CC=C4)C(=O)N3C2C(O)=O,C29H38N4O6S,S4979
21603,Ciprofloxacin hydrochloride,Cl.OC(=O)C1=CN(C2CC2)C3=CC(=C(F)C=C3C1=O)N4CCNCC4,C17H19ClFN3O3,S5008
21604,Irinotecan hydrochloride,Cl.CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=C1C=C(OC(=O)N6CCC(CC6)N7CCCCC7)C=C5)C(O)(CC)C(=O)OC4,C33H39ClN4O6,S5026
21605,Neticonazole,CCCCCOC1=CC=CC=C1C(=C\SC)/[N]2C=CN=C2,C17H22N2OS,S5080
21606,Levobupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C)C=CC=C2C,C18H28N2O,S5181
21607,Dexamethasone palmitate,CCCCCCCCCCCCCCCC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,C38H59FO6,S5184
21608,Perospirone,O=C1C2CCCCC2C(=O)N1CCCCN3CCN(CC3)C4=NSC5=CC=CC=C45,C23H30N4O2S,S5185
21609,Cefpiramide,C[N]1N=NN=C1SCC2=C(N3C(SC2)C(NC(=O)C(NC(=O)C4=CNC(=CC4=O)C)C5=CC=C(O)C=C5)C3=O)C(O)=O,C25H24N8O7S2,S5186
21610,Ribociclib hydrochloride,Cl.CN(C)C(=O)C1=CC2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2[N]1C5CCCC5,C23H31ClN8O,S5187
21611,Ribociclib succinate,CN(C)C(=O)C1=CC2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2[N]1C5CCCC5.OC(=O)CCC(O)=O,C27H36N8O5,S5188
21612,Lesinurad sodium,[Na+].[O-]C(=O)CSC1=NN=C(Br)[N]1C2=CC=C(C3CC3)C4=CC=CC=C24,C17H13BrN3NaO2S,S5189
21613,Crizotinib hydrochloride,Cl.CC(OC1=C(N)N=CC(=C1)C2=C[N](N=C2)C3CCNCC3)C4=C(Cl)C=CC(=C4Cl)F,C21H23Cl3FN5O,S5190
21614,Cinacalcet,CC(NCCCC1=CC(=CC=C1)C(F)(F)F)C2=CC=CC3=CC=CC=C23,C22H22F3N,S5191
21615,L-Thyroxine sodium salt pentahydrate,O.O.O.O.O.[Na+].NC(CC1=CC(=C(OC2=CC(=C(O)C(=C2)I)I)C(=C1)I)I)C([O-])=O,C15H20I4NNaO9,S5193
21616,Furosemide sodium,[Na+].N[S](=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C([O-])=O,C12H10ClN2NaO5S,S5194
21617,Rucaparib Camsylate,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)[NH]2.CC5(C)C6CCC5(C[S](O)(=O)=O)C(=O)C6,C29H34FN3O5S,S5195
21618,Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C13)N(C)C,C17H20N2S,S5196
21619,Oxytetracycline hydrochloride,Cl.CN(C)C1C2C(O)C3C(=C(O)C4=C(C=CC=C4O)C3(C)O)C(=O)C2(O)C(=C(C(N)=O)C1=O)O,C22H25ClN2O9,S5199
21620,Allylestrenol,CC12CCC3C(CCC4=CCCCC34)C1CCC2(O)CC=C,C21H32O,S5219
21621,Cefodizime,CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(O)=O)CSC3=NC(=C(CC(O)=O)S3)C)C4=CSC(=N4)N,C20H20N6O7S4,S5235
21622,Trometamol hydrochloride,Cl.NC(CO)(CO)CO,C4H12ClNO3,S5300
21623,Spectinomycin dihydrochloride pentahydrate,O.O.O.O.O.Cl.Cl.CNC1C(O)C(NC)C2OC3(O)C(OC(C)CC3=O)OC2C1O,C14H36Cl2N2O12,S5417
21624,Prednisone acetate,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC12C,C23H28O6,S5489
21625,Ceftiofur sodium,[Na+].CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C([O-])=O)CSC(=O)C3=CC=CO3)C4=CSC(=N4)N,C19H16N5NaO7S3,S5495
21626,Pantoprazole sodium hydrate,O.O.O.[Na+].[Na+].COC1=C(OC)C(=NC=C1)C[S](=O)C2=NC3=C([N-]2)C=CC(=C3)OC(F)F.COC4=C(OC)C(=NC=C4)C[S](=O)C5=NC6=C([N-]5)C=CC(=C6)OC(F)F,C32H34F4N6Na2O11S2,S5608
21627,Ceftriaxone Sodium,[Na+].[Na+].CO/N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C([O-])=O)CSC3=NC(=O)C(=NN3C)[O-])C4=CSC(=N4)N,C18H16N8Na2O7S3,S5644
21628,Amcinonide,CC(=O)OCC(=O)C12OC3(CCCC3)OC1CC4C5CCC6=CC(=O)C=CC6(C)C5(F)C(O)CC24C,C28H35FO7,S5671
21629,Megestrol,CC(=O)C1(O)CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC12C,C22H30O3,S5738
21630,Pizotifen,CN1CCC(CC1)=C2C3=C(CCC4=CC=CC=C24)SC=C3,C19H21NS,S5770
21631,Ipratropium bromide monohydrate,O.[Br-].CC(C)[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,C20H32BrNO4,S5777
21632,Norethindrone acetate,CC(=O)OC1(CCC2C3CCC4=CC(=O)CCC4C3CCC12C)C#C,C22H28O3,S5785
21633,Bromfenac sodium hydrate,O.O.O.[Na+].[Na+].NC1=C(CC([O-])=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2.NC3=C(CC([O-])=O)C=CC=C3C(=O)C4=CC=C(Br)C=C4,C30H28Br2N2Na2O9,S5786
21634,Larotrectinib,OC1CCN(C1)C(=O)NC2=C3N=C(C=C[N]3N=C2)N4CCCC4C5=CC(=CC=C5F)F,C21H22F2N6O2,S5860
21635,Levocetirizine,OC(=O)COCCN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3,C21H25ClN2O3,S5864
21636,Beclamide,ClCCC(=O)NCC1=CC=CC=C1,C10H12ClNO,S5888
21637,Efonidipine hydrochloride monoethanolate,Cl.CCO.CC1=C(C(C2=CC(=CC=C2)[N+]([O-])=O)C(=C(C)N1)[P]3(=O)OCC(C)(C)CO3)C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5,C36H45ClN3O8P,S5898
21638,Bisoprolol,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,C18H31NO4,S5942
21639,Alverine,CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2,C20H27N,S5945
21640,Amitriptyline,CN(C)CC\C=C1/C2=C(CCC3=CC=CC=C13)C=CC=C2,C20H23N,S5947
21641,Metoclopramide hydrochloride hydrate,O.Cl.CCN(CC)CCNC(=O)C1=CC(=C(N)C=C1OC)Cl,C14H25Cl2N3O3,S5949
21642,Menadione bisulfite sodium,[Na+].CC1(CC(=O)C2=CC=CC=C2C1=O)[S]([O-])(=O)=O,C11H9NaO5S,S5953
21643,L-(-)-α-Methyldopa hydrate,O.O.O.CC(N)(CC1=CC(=C(O)C=C1)O)C(O)=O.CC(N)(CC2=CC(=C(O)C=C2)O)C(O)=O,C20H32N2O11,S5954
21644,Thiamine nitrate,CC1=NC=C(C[N+]2=CSC(=C2C)CCO)C(=N1)N.[O-][N+]([O-])=O,C12H17N5O4S,S5955
21645,Vardenafil hydrochloride,Cl.CCCC1=NC(=C2[N]1NC(=NC2=O)C3=C(OCC)C=CC(=C3)[S](=O)(=O)N4CCN(CC)CC4)C,C23H33ClN6O4S,S5957
21646,Metformin,CN(C)C(=N)NC(N)=N,C4H11N5,S5958
21647,Tenofovir Disoproxil,CC(C)OC(=O)OCO[P](=O)(COC(C)C[N]1C=NC2=C(N)N=CN=C12)OCOC(=O)OC(C)C,C19H30N5O10P,S5959
21648,Dabigatran etexilate mesylate,CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)[N]2C)C=C1.C[S](O)(=O)=O,C35H45N7O8S,S5960
21649,Sulfathiazole sodium,NC1=CC=C(C=C1)[S](=O)(=O)N([Na])C2=NC=CS2,C9H8N3NaO2S2,S5963
21650,Urapidil,COC1=CC=CC=C1N2CCN(CCCNC3=CC(=O)N(C)C(=O)N3C)CC2,C20H29N5O3,S5965
21651,Amlodipine maleate,CCOC(=O)C1=C(COCCN)NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C.OC(=O)\C=C/C(O)=O,C24H29ClN2O9,S5966
21652,Dicloxacillin Sodium hydrate,O.[Na+].CC1=C(C(=O)NC2C3SC(C)(C)C(N3C2=O)C([O-])=O)C(=NO1)C4=C(Cl)C=CC=C4Cl,C19H18Cl2N3NaO6S,S5969
21653,Pemetrexed,NC1=NC(=O)C2=C([NH]C=C2CCC3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O)N1,C20H21N5O6,S5971
21654,Hydrocortisone hemisuccinate,CC12CCC(=O)C=C1CCC3C4CCC(O)(C(=O)COC(=O)CCC(O)=O)C4(C)CC(O)C23,C25H34O8,S5972
21655,Methylprednisolone Acetate,CC1CC2C3CCC(O)(C(=O)COC(C)=O)C3(C)CC(O)C2C4(C)C=CC(=O)C=C14,C24H32O6,S5973
21656,Purine,[NH]1C=NC2=C1N=CN=C2,C5H4N4,S6359
21657,Oxolamine Citrate,CCN(CC)CCC1=NC(=NO1)C2=CC=CC=C2.OC(=O)CC(O)(CC(O)=O)C(O)=O,C20H27N3O8,S6437
21658,Sodium tauroglycocholate,[Na+].CC(CCC(=O)NCC(=O)NCC[S]([O-])(=O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,C28H47N2NaO8S,S6463
21659,Eicosapentaenoic acid ethyl ester,CCOC(=O)CCC\C=C/C/C=C\C\C=C/C/C=C\C\C=C/CC,C22H34O2,S6466
21660,Amdinocillin,CC1(C)SC2C(N=CN3CCCCCC3)C(=O)N2C1C(O)=O,C15H23N3O3S,S6584
21661,Lusutrombopag,CCCCCCOC(C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(\C=C(/C)C(O)=O)C(=C3)Cl)Cl,C29H32Cl2N2O5S,S6988
21662,Chloroquine (NSC-187208),CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,C18H26ClN3,S6999
21663,Fostemsavir,COC1=CN=C([N]2C=NC(=N2)C)C3=C1C(=C[N]3CO[P](O)(O)=O)C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5,C25H26N7O8P,S7220
21664,Remdesivir (GS-5734),CCC(CC)COC(=O)C(C)N[P](=O)(OCC1OC(C#N)(C(O)C1O)C2=CC=C3[N]2N=CN=C3N)OC4=CC=CC=C4,C27H35N6O8P,S8932
21665,Puromycin aminonucleoside,CN(C)C1=C2N=C[N](C3OC(CO)C(N)C3O)C2=NC=N1,C12H18N6O3,S9631
21666,Vericiguat,COC(=O)NC1=C(N)N=C(N=C1N)C2=N[N](CC3=CC=CC=C3F)C4=NC=C(F)C=C24,C19H16F2N8O2,S9693
21667,Lanraplenib (GS-9876),NC1=CN=CC(=N1)C2=C[N]3C=CN=C3C(=N2)NC4=CC=C(C=C4)N5CCN(CC5)C6COC6,C23H25N9O,S9715
21668,6-Aminonicotinamide,NC(=O)C1=CC=C(N)N=C1,C6H7N3O,S9783
21669,Iodoacetamide,NC(=O)CI,C2H4INO,S9827
21670,Remogliflozin etabonate (GSK189075),CCOC(=O)OCC1OC(OC2=N[N](C(C)C)C(=C2CC3=CC=C(OC(C)C)C=C3)C)C(O)C(O)C1O,C26H38N2O9,S0993
21671,Olodaterol (BI 1744),COC1=CC=C(CC(C)(C)NCC(O)C2=C3OCC(=O)NC3=CC(=C2)O)C=C1,C21H26N2O5,S4485
21672,Levomefolic acid,CN1C(CNC2=CC=C(C=C2)C(=O)NC(CCC(O)=O)C(O)=O)CNC3=C1C(=O)N=C(N)N3,C20H25N7O6,S6909
21673,Glycerol phenylbutyrate,O=C(CCCC1=CC=CC=C1)OCC(COC(=O)CCCC2=CC=CC=C2)OC(=O)CCCC3=CC=CC=C3,C33H38O6,S6981
21674,Varenicline,C1NCC2CC1C3=CC4=NC=CN=C4C=C23,C13H13N3,S6985
21675,Iron Dextran,[Fe].O[S](O)(=O)=O,FeH2O4S,S6987
21676,Gadoteridol,[Gd+3].CC(O)CN1CCN(CCN(CCN(CC1)CC([O-])=O)CC([O-])=O)CC([O-])=O,C17H29GdN4O7,E0006
21677,Isosulfan Blue,[Na+].CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(C=C2)=[N+](CC)CC)C3=C(C=CC(=C3)[S]([O-])(=O)=O)[S]([O-])(=O)=O,C27H31N2NaO6S2,E0007
21678,Dipivefrin Hydrochloride,Cl.CNCC(O)C1=CC(=C(OC(=O)C(C)(C)C)C=C1)OC(=O)C(C)(C)C,C19H30ClNO5,E0019
21679,Cyclizine,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3,C18H22N2,S0897
21680,Propidium Iodide,[I-].[I-].CC[N+](C)(CC)CCC[N+]1=C2C=C(N)C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N,C27H34N4.2I,S6874
21681,Saquinavir (Ro 31-8959),CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(CC3=CC=CC=C3)NC(=O)C(CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4,C38H50N6O5,S9625
21682,Imeglimin (EMD 387008) Hydrochloride,Cl.CC1N=C(N)NC(=N1)N(C)C,C6H13N5.ClH,S9925
21683,Bradykinin,NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(O)=O,C50H73N15O11,E0037
21684,β-Cyclodextrin,OCC1OC2OC3C(O)C(O)C(OC3CO)OC4C(O)C(O)C(OC4CO)OC5C(O)C(O)C(OC5CO)OC6C(O)C(O)C(OC6CO)OC7C(O)C(O)C(OC7CO)OC8C(O)C(O)C(OC8CO)OC1C(O)C2O,C42H70O35,E0046
21685,Tegoprazan,CN(C)C(=O)C1=CC2=C(N=C(C)[NH]2)C(=C1)OC3CCOC4=C3C(=CC(=C4)F)F,C20H19F2N3O3,E0054
21686,Baloxavir,OC1=C2N(C=CC1=O)N(C3COCCN3C2=O)C4C5=C(CSC6=CC=CC=C46)C(=C(F)C=C5)F,C24H19F2N3O4S,E0110
21687,Vernakalant (RSD1235) Hydrochloride,Cl.COC1=C(OC)C=C(CCOC2CCCCC2N3CCC(O)C3)C=C1,C20H31NO4.ClH,E0144
21688,Linalyl Acetate,CC(C)=CCCC(C)(OC(C)=O)C=C,C12H20O2,E0148
21689,Lithium Chloride,[Li+].[Cl-],ClLi,E0153
21690,Thioacetamide,CC(N)=S,C2H5NS,E0156
21691,Hexaminolevulinate hydrochloride,Cl.CCCCCCOC(=O)CCC(=O)CN,C11H21NO3.ClH,E0160
21692,Phenelzine sulfate,NNCCC1=CC=CC=C1.O[S](O)(=O)=O,C8H12N2.H2O4S,E0165
21693,Tazobactam Sodium,[NaH].CC1(C[N]2C=CN=N2)C(N3C(CC3=O)[S]1(=O)=O)C(O)=O,C10H12N4O5S.Na,E0167
21694,Zinc acetate,CC(=O)O[Zn]OC(C)=O,C4H6O4Zn,E0169
21695,Imidacloprid,[O-][N+](=O)\N=C1/NCCN1CC2=CC=C(Cl)N=C2,C9H10ClN5O2,E0172
21696,Betamethasone sodium phosphate,[Na+].[Na+].CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO[P]([O-])([O-])=O,C22H28FO8P.2Na,E0174
21697,Dexamethasone Sodium Phosphate,[Na+].[Na+].CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO[P]([O-])([O-])=O,C22H30FO8P.2Na,S4028
21698,Dexamethasone phosphate disodium,[Na+].[Na+].CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO[P]([O-])([O-])=O,C22H28FNa2O8P,S5956
21699,Hydrocortisone sodium succinate,[Na+].CC12CCC(=O)C=C1CCC3C4CCC(O)(C(=O)COC(=O)CCC([O-])=O)C4(C)CC(O)C23,C25H33O8.Na,E0177
21700,Zinc acetate dihydrate,O.O.[Zn++].CC([O-])=O.CC([O-])=O,C4H10O6Zn,E0181
21701,Magnesium chloride,[Mg++].[Cl-].[Cl-],Cl2Mg,E0183
21702,Enclomiphene Citrate,CCN(CC)CCOC1=CC=C(C=C1)\C(=C(\Cl)C2=CC=CC=C2)C3=CC=CC=C3.OC(=O)CC(O)(CC(O)=O)C(O)=O,C26H28ClNO.C6H8O7,E0361
21703,Setmelanotide (RM-493),CC1NC(=O)C(CSSCC(NC(=O)C(CC2=C[NH]C3=CC=CC=C23)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CN=C[NH]5)NC1=O)C(N)=O)NC(=O)C(CCCN=C(N)N)NC(C)=O,C49H68N18O9S2,E1002
21704,Miglustat,CCCCN1CC(O)C(O)C(O)C1CO,C10H21NO4,E1029
21705,Abaloparatide (BA058),nan,C176H304N56O51,P1092
21706,Colistin,nan,C52H98N16O13,E0525
21707,Spinosad,nan,C41H65NO10,E0524
21708,Cycloguanil hydrochloride,Cl.CC1(C)N=C(N)N=C(N)N1C2=CC=C(Cl)C=C2,C11H14ClN5.ClH,S0320
21709,Euquinine,CCOC(=O)OC(C1CC2CCN1CC2C=C)C3=C4C=C(OC)C=CC4=NC=C3,C23H28N2O4,S0846
21710,Fenoldopam,OC1=CC=C(C=C1)C2CNCCC3=C(Cl)C(=C(O)C=C23)O,C16H16ClNO3,S2089
21711,Hydroxyflutamide (Hydroxyniphtholide),CC(C)(O)C(=O)NC1=CC=C(C(=C1)C(F)(F)F)[N+]([O-])=O,C11H11F3N2O4,S2174
21712,DLinDMA,CCCCC/C=C\C\C=C/CCCCCCCCOCC(CN(C)C)OCCCCCCCC\C=C/C/C=C\CCCCC,C41H77NO2,S3561
21713,Deserpidine,COC1C(CC2CN3CCC4=C([NH]C5=CC=CC=C45)C3CC2C1C(=O)OC)OC(=O)C6=CC(=C(OC)C(=C6)OC)OC,C32H38N2O8,S3562
21714,Mirodenafil Dihydrochloride,Cl.Cl.CCCOC1=C(C=C(C=C1)[S;v6](=O)(=O)N2CCN(CCO)CC2)C3=NC(=O)C4=C(N3)C(=C[N]4CC)CCC,C26H37N5O5S.2ClH,S5894
21715,Isavuconazonium sulfate,CNCC(=O)OCC1=C(N=CC=C1)N(C)C(=O)OC(C)[N+]2=C[N](CC(O)(C(C)C3=NC(=CS3)C4=CC=C(C=C4)C#N)C5=C(F)C=CC(=C5)F)N=C2.O[S]([O-])(=O)=O,C35H35F2N8O5S.HO4S,S6458
21716,Flumatinib (HH-GV-678),CN1CCN(CC1)CC2=CC=C(C=C2C(F)(F)F)C(=O)NC3=CN=C(C)C(=C3)NC4=NC(=CC=N4)C5=CN=CC=C5,C29H29F3N8O,S9973
21717,Raclopride,CCN1CCCC1CNC(=O)C2=C(OC)C(=CC(=C2O)Cl)Cl,C15H20Cl2N2O3,E0125
21718,Invert sugar,OCC(O)C(O)C(O)C(O)C=O.OCC(O)C(O)C(O)C(=O)CO,C12H24O12,E0190
21719,Mometasone Furoate Hydrate,O.CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(CC2(C)C1(OC(=O)C5=CC=CO5)C(=O)CCl)OC(=O)C6=CC=CO6,C27H30Cl2O6.H2O,E0193
21720,(R)-Avanafil,COC1=C(Cl)C=C(CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCCC4CO)C=C1,C23H26ClN7O3,E0423
21721,Metrizoic acid,CN(C(C)=O)C1=C(I)C(=C(I)C(=C1I)NC(C)=O)C(O)=O,C12H11I3N2O4,E0502
21722,Norgestimate,CCC12CCC3C(CCC4=C/C(CCC34)=N/O)C1CCC2(OC(C)=O)C#C,C23H31NO3,E0527
21723,Flecainide,FC(F)(F)COC1=CC=C(OCC(F)(F)F)C(=C1)C(=O)NCC2CCCCN2,C17H20F6N2O3,E0528
21724,Metipranolol,CC(C)NCC(O)COC1=CC(=C(OC(C)=O)C(=C1C)C)C,C17H27NO4,E0529
21725,Prednicarbate,CCOC(=O)OC1(CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C)C(=O)COC(=O)CC,C27H36O8,E0530
21726,Methyl methanesulfonate,CO[S](C)(=O)=O,C2H6O3S,E0609
21727,γ-Terpinene,CC(C)C1=CCC(=CC1)C,C10H16,E0650
21728,Esaxerenone (CS-3150),CC1=C([N](CCO)C=C1C(=O)NC2=CC=C(C=C2)[S](C)(=O)=O)C3=CC=CC=C3C(F)(F)F,C22H21F3N2O4S,E0704
21729,Gemifloxacin mesylate,CO\N=C\1CN(CC1CN)C2=C(F)C=C3C(=O)C(=CN(C4CC4)C3=N2)C(O)=O.C[S](O)(=O)=O,C18H20FN5O4.CH4O3S,E0706
21730,Nomegestrol Acetate,CC(=O)OC1(CCC2C3C=C(C)C4=CC(=O)CCC4C3CCC12C)C(C)=O,C23H30O4,E0707
21731,Masitinib mesylate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC(=CS4)C5=CN=CC=C5.C[S](O)(=O)=O,C28H30N6OS.CH4O3S,E0814
21732,Rilpivirine Hydrochloride,Cl.CC1=C(NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C(=CC(=C1)\C=C\C#N)C,C22H18N6.ClH,E0815
21733,Oritavancin Diphosphate,CNC(CC(C)C)C(=O)NC1C(O)C2=CC(=C(OC3=C(OC4OC(CO)C(O)C(O)C4OC5CC(C)(NCC6=CC=C(C=C6)C7=CC=C(Cl)C=C7)C(O)C(C)O5)C8=CC(=C3)C(NC(=O)C(CC(N)=O)NC1=O)C(=O)NC9C(=O)NC(C(OC%10CC(C)(N)C(O)C(C)O%10)C%11=CC(=C(O8)C=C%11)Cl)C(=O)NC(C(O)=O)C%12=C(C(=CC(=C%12)O)O)C%13=C(O)C=CC9=C%13)C=C2)Cl.O[P](O)(O)=O.O[P](O)(O)=O,C86H97Cl3N10O26.2H3O4P,E0816
21734,Segesterone acetate,CC(=O)OC1(C(C)=O)C(=C)CC2C3CCC4=CC(=O)CCC4C3CCC12C,C23H30O4,E0937
21735,p-Nitrobenzyl mesylate,C[S;v6](=O)(=O)OCC1=CC=C(C=C1)[N;v5](=O)=O,C8H9NO5S,E1248
21736,Dotinurad,OC1=C(Cl)C=C(C=C1Cl)C(=O)N2C[S;v6](=O)(=O)C3=CC=CC=C23,C14H9Cl2NO4S,E2355
21737,Tandospirone,O=C1C2C3CCC(C3)C2C(=O)N1CCCCN4CCN(CC4)C5=NC=CC=N5,C21H29N5O2,E2356
21738,Azosemide,N[S](=O)(=O)C1=CC(=C(NCC2=CC=CS2)C=C1Cl)C3=N[NH]N=N3,C12H11ClN6O2S2,E2358
21739,Doxorubicin,COC1=C2C(=O)C3=C(C(=C4CC(O)(CC(OC5CC(N)C(O)C(C)O5)C4=C3O)C(=O)CO)O)C(=O)C2=CC=C1,C27H29NO11,E2516
21740,H-Leu-Leu-OMe Hydrochloride,Cl.COC(=O)C(CC(C)C)NC(=O)C(N)CC(C)C,C13H26N2O3.ClH,E2634
21741,Ursodeoxycholic acid sodium,[Na+].CC(CCC([O-])=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C,C24H40O4.Na,E2683
21742,"3,3'-Diaminobenzidine tetrahydrochloride",O.Cl.Cl.Cl.Cl.NC1=C(N)C=C(C=C1)C2=CC(=C(N)C=C2)N,C12H14N4.4ClH.H2O,E2690
21743,Hematein,OC1=CC2=C(C=C1O)C3=C4C=CC(=O)C(=C4OCC3(O)C2)O,C16H12O6,E2826
21744,Carbetocin Acetate,CCC(C)C1NC(=O)C(CC2=CC=C(OC)C=C2)NC(=O)CCCSCC(NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC1=O)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(N)=O.CC(O)=O,C45H69N11O12S,P1008
21745,Bremelanotide Acetate,CCCCC(NC(C)=O)C(=O)NC1CC(=O)NCCCCC(NC(=O)C(CC2=C[NH]C3=CC=CC=C23)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CN=C[NH]5)NC1=O)C(O)=O.CC(O)=O,C50H68N14O10.C2H4O2,P1108
21746,Etelcalcetide HCl,Cl.CC(NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CC(S)C(N)(S)C(O)=O)NC(C)=O)C(=O)NC(CCCN=C(N)N)C(N)=O,C38H74ClN21O10S2,P1110
21747,Dasiglucagon,CC(C)CC(NC(=O)C(CC1=C[NH]C2=CC=CC=C12)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(O)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C)NC(=O)C(CCCNC(N)=N)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C(CC(O)=O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(O)C=C4)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(O)C=C5)NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC6=CC=CC=C6)NC(=O)C(NC(=O)CNC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C(N)CC7=CN=C[NH]7)C(C)O)C(C)O)C(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CO)C(=O)NC(C(C)O)C(O)=O,C152H222N38O50,P1114
21748,Gastrin Tetrapeptide,CSCCC(NC(=O)C(N)CC1=C[NH]C2=CC=CC=C12)C(=O)NC(CC(O)=O)C(=O)NC(CC3=CC=CC=C3)C(N)=O,C29H36N6O6S,P1135
21749,Calcifediol,CC(CCCC(C)(C)O)C1CCC2/C(CCCC12C)=C/C=C3/CC(O)CCC3=C,C27H44O2,S1469
21750,Talazoparib (BMN 673),C[N]1N=CN=C1C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(F)C=C5,C19H14F2N6O,S7048
21751,Encorafenib (LGX818),COC(=O)NC(C)CNC1=NC=CC(=N1)C2=C[N](N=C2C3=C(F)C(=CC(=C3)Cl)N[S;v6](C)(=O)=O)C(C)C,C22 H27 Cl F N7 O4 S,S7108
21752,Upadacitinib (ABT-494),CCC1CN(CC1C2=CN=C3C=NC4=C(C=C[NH]4)[N]23)C(=O)NCC(F)(F)F,C17H19F3N6O,S8162
21753,Avapritinib (BLU-285),C[N]1C=C(C=N1)C2=C[N]3N=CN=C(N4CCN(CC4)C5=NC=C(C=N5)C(C)(N)C6=CC=C(F)C=C6)C3=C2,C26H27FN10,S8553
21754,Deucravacitinib (BMS-986165),C(NC(=O)C1=C(NC2=CC=CC(=C2OC)C3=N[N](C)C=N3)C=C(NC(=O)C4CC4)N=N1)([2H])([2H])[2H],C20H19D3N8O3,S8879
21755,Deslanoside,CC1OC(CC(O)C1OC2CC(O)C(OC3CC(O)C(OC4OC(CO)C(O)C(O)C4O)C(C)O3)C(C)O2)OC5CCC6(C)C(CCC7C6CC(O)C8(C)C(CCC78O)C9=CC(=O)OC9)C5,C47H74O19,E0680
21756,Danicopan (ACH-4471),CC(=O)C1=N[N](CC(=O)N2CC(F)CC2C(=O)NC3=NC(=CC=C3)Br)C4=C1C=C(C=C4)C5=CN=C(C)N=C5,C26H23BrFN7O3,S0803
21757,Laninamivir Octanoate,CCCCCCCC(=O)OCC(O)C(OC)C1OC(=CC(N=C(N)N)C1NC(C)=O)C(O)=O,C21H36N4O8,S0861
21758,Cyclophosphamide,ClCCN(CCCl)[P]1(=O)NCCCO1,C7H15Cl2N2O2P,S1217
21759,Apatinib (YN968D1) mesylate,C[S](O)(=O)=O.O=C(NC1=CC=C(C=C1)C2(CCCC2)C#N)C3=CC=CN=C3NCC4=CC=NC=C4,C25H27N5O4S,S2221
21760,Podophyllotoxin (Podofilox),COC1=C(OC)C(=CC(=C1)C2C3C(COC3=O)C(O)C4=CC5=C(OCO5)C=C24)OC,C22H22O8,S2345
21761,Romidepsin,C\C=C1/NC(=O)C2CSSCC/C=C/C(CC(=O)NC(C(C)C)C(=O)N2)OC(=O)C(NC1=O)C(C)C,C24H36N4O6S2,S3020
21762,Iodixanol,CC(=O)N(CC(O)CN(C(C)=O)C1=C(I)C(=C(I)C(=C1I)C(=O)NCC(O)CO)C(=O)NCC(O)CO)C2=C(I)C(=C(I)C(=C2I)C(=O)NCC(O)CO)C(=O)NCC(O)CO,C35H44I6N6O15,S5218
21763,Liarozole dihydrochloride,Cl.Cl.ClC1=CC=CC(=C1)C([N]2C=CN=C2)C3=CC4=C(C=C3)N=C[NH]4,C₁₇H₁₅Cl₃N₄,S6594
21764,Dianhydrogalactitol (VAL-083),OC(C(O)C1CO1)C2CO2,C6H10O4,S6984
21765,Ixabepilone (BMS-247550),CC1CCCC2(C)OC2CC(NC(=O)CC(O)C(C)(C)C(=O)C(C)C1O)C(/C)=C/C3=CSC(=N3)C,C27H42N2O5S,S7930
21766,Midostaurin (PKC412),COC1C(CC2OC1(C)[N]3C4=C(C=CC=C4)C5=C3C6=C(C7=C(C=CC=C7)[N]26)C8=C5CNC8=O)N(C)C(=O)C9=CC=CC=C9,C35H30N4O4,S8064
21767,Pralsetinib (BLU-667),COC1(CCC(CC1)C2=NC(=CC(=N2)NC3=N[NH]C(=C3)C)C)C(=O)NC(C)C4=CN=C(C=C4)[N]5C=C(F)C=N5,C27H32FN9O2,S8716
21768,Sotorasib (AMG510),CC(C)C1=C(N2C(=O)N=C(N3CCN(CC3C)C(=O)C=C)C4=CC(=C(N=C24)C5=C(F)C=CC=C5O)F)C(=CC=N1)C,C30H30F2N6O3,S8830
21769,Sotorasib (AMG510) racemate,CC(C)C1=C(N2C(=O)N=C(N3CCN(CC3C)C(=O)C=C)C4=CC(=C(N=C24)C5=C(F)C=CC=C5O)F)C(=CC=N1)C,C30H30F2N6O3,S8955
21770,Elexacaftor (VX-445),CC1CN(C2=C(C=CC(=N2)[N]3C=CC(=N3)OCC(C)(C)C(F)(F)F)C(=O)N[S](=O)(=O)C4=C[N](C)N=C4C)C(C)(C)C1,C26H34F3N7O4S,S8851
21771,Adagrasib (MRTX849),CN1CCCC1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN(C(CC#N)C6)C(=O)C(F)=C,C32H35ClFN7O2,S8884
21772,Valemetostat (DS-3201),CN(C)C1CCC(CC1)C2(C)OC3=C(Cl)C=C(C(=O)NCC4=C(C)C=C(C)NC4=O)C(=C3O2)C,C26H34ClN3O4,S8926
21773,Suramin sodium salt,CC1=C(NC(=O)C2=CC(=CC=C2)NC(=O)NC3=CC(=CC=C3)C(=O)NC4=CC(=CC=C4C)C(=O)NC5=CC=C(C6=C5C(=CC(=C6)[S;v6](=O)(=O)O[Na])[S;v6](=O)(=O)O[Na])[S;v6](=O)(=O)O[Na])C=C(C=C1)C(=O)NC7=CC=C(C8=C7C(=CC(=C8)[S;v6](=O)(=O)O[Na])[S;v6](=O)(=O)O[Na])[S;v6](=O)(=O)O[Na],C51H40N6O23S6.6Na,S8942
21774,Exatecan Mesylate,CCC1(O)C(=O)OCC2=C1C=C3N(CC4=C5C(N)CCC6=C5C(=CC(=C6C)F)N=C34)C2=O.C[S](O)(=O)=O,C24H22FN3O4.CH4O3S,S8999
21775,Valrubicin,CCCCC(=O)OCC(=O)C1(O)CC(OC2CC(NC(=O)C(F)(F)F)C(O)C(C)O2)C3=C(C1)C(=C4C(=O)C5=C(C(=O)C4=C3O)C(=CC=C5)OC)O,C34H36F3NO13,S9522
21776,Finerenone,CCOC1=NC=C(C)C2=C1C(C3=CC=C(C=C3OC)C#N)C(=C(C)N2)C(N)=O,C21H22N4O3,S9702
21777,Rimiducid (AP1903),CCC(C(=O)N1CCCCC1C(=O)OC(CCC2=CC(=C(OC)C=C2)OC)C3=CC(=CC=C3)OCC(=O)NCCNC(=O)COC4=CC=CC(=C4)C(CCC5=CC(=C(OC)C=C5)OC)OC(=O)C6CCCCN6C(=O)C(CC)C7=CC(=C(OC)C(=C7)OC)OC)C8=CC(=C(OC)C(=C8)OC)OC,C78H98N4O20,S9726
21778,Pirtobrutinib (LOXO-305),COC1=CC=C(F)C=C1C(=O)NCC2=CC=C(C=C2)C3=N[N](C(C)C(F)(F)F)C(=C3C(N)=O)N,C22H21F4N5O3,S9825
21779,Nirmatrelvir (PF-07321332),CC(C)(C)C(NC(=O)C(F)(F)F)C(=O)N1CC2C(C1C(=O)NC(CC3CCNC3=O)C#N)C2(C)C,C23H32F3N5O4,S9866
21780,Antazoline Phosphate,O[P](O)(O)=O.C1CN=C(CN(CC2=CC=CC=C2)C3=CC=CC=C3)N1,C17H19N3.H3O4P,E0164
21781,Melengestrol Acetate,CC(=O)OC1(C(C)=O)C(=C)CC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC12C,C25H32O4,E0742
21782,Quinupristin,CCC1NC(=O)C(NC(=O)C2=C(O)C=CC=N2)C(C)OC(=O)C(NC(=O)C3CC(=O)C(CSC4CN5CCC4CC5)CN3C(=O)C(CC6=CC=C(C=C6)N(C)C)N(C)C(=O)C7CCCN7C1=O)C8=CC=CC=C8,C53H67N9O10S,E0818
21783,Ginsenoside Rg3,CC(C)=CCCC(C)(O)C1CCC2(C)C1C(O)CC3C4(C)CCC(OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(C)(C)C4CCC23C,C42H72O13,E2438
21784,Tafenoquine,COC1=NC2=C(C(=C1)C)C(=C(OC)C=C2NC(C)CCCN)OC3=CC(=CC=C3)C(F)(F)F,C24H28F3N3O3,E2665
21785,Afoxolaner,FC(F)(F)CNC(=O)CNC(=O)C1=CC=C(C2=NOC(C2)(C3=CC(=CC(=C3)Cl)C(F)(F)F)C(F)(F)F)C4=C1C=CC=C4,C26H17ClF9N3O3,E2848
21786,Abarelix Acetate,CC(C)CC(NC(=O)C(CC(N)=O)NC(=O)C(CC1=CC=C(O)C=C1)N(C)C(=O)C(CO)NC(=O)C(CC2=CN=CC=C2)NC(=O)C(CC3=CC=C(Cl)C=C3)NC(=O)C(CC4=CC5=C(C=CC=C5)C=C4)NC(C)=O)C(=O)NC(CCCCNC(C)C)C(=O)N6CCCC6C(=O)NC(C)C(N)=O.CC(O)=O,C74H99ClN14O16,P1005
21787,CCK Octapeptide (Sincalide),CSCCC(NC(=O)C(CC1=CC=C(O[S](O)(=O)=O)C=C1)NC(=O)C(N)CC(O)=O)C(=O)NCC(=O)NC(CC2=C[NH]C3=CC=CC=C23)C(=O)NC(CCSC)C(=O)NC(CC(O)=O)C(=O)NC(CC4=CC=CC=C4)C(N)=O,C49H62N10O16S3,P1032
21788,Ganirelix acetate (Antagon),CCNC(NCC)=NCCCCC(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC2=CN=CC=C2)NC(=O)C(CC3=CC=C(Cl)C=C3)NC(=O)C(CC4=CC5=C(C=CC=C5)C=C4)NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN=C(NCC)NCC)C(=O)N6CCCC6C(=O)NC(C)C(N)=O.CC(O)=O.CC(O)=O,C80H113ClN18O13.2C2H4O2,P1069
21789,Linaclotide,CC(O)C1NC(=O)C2CSSCC3NC(=O)C(N)CSSCC(NC(=O)C(CSSCC(NC(=O)CNC1=O)C(=O)NC(CC4=CC=C(O)C=C4)C(O)=O)NC(=O)C(CC5=CC=C(O)C=C5)NC(=O)C(CCC(O)=O)NC3=O)C(=O)NC(CC(N)=O)C(=O)N6CCCC6C(=O)NC(C)C(=O)N2,C59H79N15O21S6,P1109
21790,Difelikefalin,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(N)CC2=CC=CC=C2)C(=O)NC(CCCCN)C(=O)N3CCC(N)(CC3)C(O)=O,C36H53N7O6,P1151
21791,p-Toluic acid,CC1=CC=C(C=C1)C(O)=O,C8H8O2,E4074
21792,Testosterone acetate,CC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C21H30O3,E4421
21793,DL-Adrenaline Hydrochloride,Cl.CNCC(O)C1=CC(=C(O)C=C1)O,C9H13NO3·HCl,E4422
21794,Phenylephrine,CNCC(O)C1=CC(=CC=C1)O,C9H13NO2,E4434
21795,Tyramine hydrochloride,Cl.NCCC1=CC=C(O)C=C1,C8H12ClNO,E4029
21796,Citric acid hydrate,O.OC(=O)CC(O)(CC(O)=O)C(O)=O,C6H10O8,E2164
21797,Gallic acid (hydrate),O.OC(=O)C1=CC(=C(O)C(=C1)O)O,C7H8O6,E4084
21798,7-Ketolithocholic acid,CC(CCC(O)=O)C1CCC2C3C(CCC12C)C4(C)CCC(O)CC4CC3=O,C24H38O4,E4226
21799,1-Naphthol,OC1=CC=CC2=C1C=CC=C2,C10H8O,E4271
21800,Ethyl linoleate,CCCCC/C=C\C\C=C/CCCCCCCC(=O)OCC,C20H36O2,E4419
21801,Evocalcet,CC(NC1CCN(C1)C2=CC=C(CC(O)=O)C=C2)C3=CC=CC4=C3C=CC=C4,C24H26N2O2,E0359
21802,DPCPX,CCCN1C(=O)N(CCC)C2=C([NH]C(=N2)C3CCCC3)C1=O,C16H24N4O2,E1310
21803,Digitonin,CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9O)C8OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C,C56H92O29,E1321
21804,Fluspirilene,FC1=CC=C(C=C1)C(CCCN2CCC3(CC2)N(CNC3=O)C4=CC=CC=C4)C5=CC=C(F)C=C5,C29H31F2N3O,E1410
21805,Taurodeoxycholic acid sodium hydrate,O.[Na;v0].CC(CCC(=O)NCC[S](O)(=O)=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C,C26H45NO6S.H2O.Na,E2411
21806,Sodium tetradecyl sulfate,[Na;v0].CCCCCCCCCCCCCCO[S](O)(=O)=O,C14H30O4S.Na,E2866
21807,Naloxegol Oxalate,COCCOCCOCCOCCOCCOCCOCCOC1CCC2(O)C3CC4=C5C(=C(O)C=C4)OC1C25CCN3CC=C.OC(=O)C(O)=O,C34H53NO11.C2H2O4,E2868
21808,Trovafloxacin Mesylate,C[S](O)(=O)=O.NC1C2CN(CC12)C3=C(F)C=C4C(=O)C(=CN(C5=C(F)C=C(F)C=C5)C4=N3)C(O)=O,C20H15F3N4O3.CH4O3S,E2871
21809,Clocortolone Pivalate,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1C(=O)COC(=O)C(C)(C)C,C27H36CIFO5,E2872
21810,Laropiprant,C[S](=O)(=O)C1=C2[N](CC3=CC=C(Cl)C=C3)C4=C(CCC4CC(O)=O)C2=CC(=C1)F,C21H19CIFNO4S,E2873
21811,Sofpironium bromide,[Br-].CCOC(=O)C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)C3=CC=CC=C3,C22H32NO5.Br,E2874
21812,Levobunolol(l-Bunolol) hydrochloride,Cl.CC(C)(C)NCC(O)COC1=C2CCCC(=O)C2=CC=C1,C17H25NO3.ClH,E2875
21813,pemafibrate,CCC(OC1=CC=CC(=C1)CN(CCCOC2=CC=C(OC)C=C2)C3=NC4=CC=CC=C4O3)C(O)=O,C28H30N2O6,E2876
21814,iothalamate sodium,[Na;v0].CNC(=O)C1=C(I)C(=C(I)C(=C1I)NC(C)=O)C(O)=O,C11H9I3N2O4.Na,E2878
21815,methylnaltrexone bromide,[Br-].C[N+]1(CCC23C4OC5=C(O)C=CC(=C25)CC1C3(O)CCC4=O)CC6CC6,C21H26NO4.Br,E2880
21816,(-)-Isoproterenol hydrochloride,Cl.CC(C)NCC(O)C1=CC(=C(O)C=C1)O,C11H17NO3.CIH,E2901
21817,Sodium Pyruvate,[Na;v0].CC(=O)C(O)=O,C3H4O3.Na,E2902
21818,Toluidine Blue O,[Cl-].CN(C)C1=CC2=C(C=C1)N=C3C=C(C)C(=CC3=[S+]2)N,C15H16N3S.Cl,E2958
21819,Norepinephrine tartrate,NCC(O)C1=CC(=C(O)C=C1)O.OC(C(O)C(O)=O)C(O)=O,C8H11NO3.C4H6O6,E2964
21820,Zinc sulfate heptahydrate,O.[Zn].O[S](O)(=O)=O,H2O4S.7H2O.Zn,E2968
21821,"L-3,4-Dihydroxyphenylalanine methyl ester hydrochloride",Cl.COC(=O)C(N)CC1=CC(=C(O)C=C1)O,C10H13NO4.ClH,E4010
21822,Calcium chloride dihydrate,O.Cl[Ca]Cl,CaCl2.2H2O,E4017
21823,Dobutamine HCl,Cl.CC(CCC1=CC=C(O)C=C1)NCCC2=CC(=C(O)C=C2)O,C18H23NO3&middot;HCl,S1423
21824,CB-5339,CC1=CC2=C(C=CC=C2[N]1C3=NC(=C4CCCN=C4N3)NCC5=CC=CC=C5)C(N)=O,C24H24N6O,S9865
21825,Fezolinetant,CC1N(CC[N]2C1=NN=C2C3=NC(=NS3)C)C(=O)C4=CC=C(F)C=C4,C₁₆H₁₅FN₆OS,E0109
21826,Etrasimod(APD334),OC(=O)CC1CCC2=C1[NH]C3=CC=C(OCC4=CC(=C(C=C4)C5CCCC5)C(F)(F)F)C=C23,C26H26F3NO3,E2363
21827,Propiolactone,O=C1CCO1,C3H4O2,E2869
21828,S-(5'-Adenosyl)-L-methionine p-toluenesulfonate salt,C[S+](CCC(N)C(O)=O)CC1OC(C(O)C1O)[N]2C=NC3=C(N)N=CN=C23.CC4=CC=C(C=C4)[S]([O-])(=O)=O,C15H23N6O5S.C7H7O3S,E4446
21829,Hexythiazox,CC1C(SC(=O)N1C(=O)NC2CCCCC2)C3=CC=C(Cl)C=C3,C17H21ClN2O2S,E4464
21830,Saquinavir Mesylate,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(CC3=CC=CC=C3)NC(=O)C(CC(N)=O)NC(=O)C4=NC5=C(C=CC=C5)C=C4.C[S](O)(=O)=O,C38H50N6O5.CH4O3S,E4466
21831,Temozolomide Acid,CN1N=NC2=C(N=C[N]2C1=O)C(O)=O,C6H5N5O3,E4467
21832,Clavulanic acid,OC\C=C\1OC2CC(=O)N2C1C(O)=O,C8H9NO5,E4472
21833,Infigratinib Phosphate,CCN1CCN(CC1)C2=CC=C(NC3=CC(=NC=N3)N(C)C(=O)NC4=C(Cl)C(=CC(=C4Cl)OC)OC)C=C2.O[P](O)(O)=O,C26H31Cl2N7O3.H3O4P,E4474
21834,Lumateperone,CN1CCN2C3CCN(CCCC(=O)C4=CC=C(F)C=C4)CC3C5=CC=CC1=C25,C24H28FN3O,E4477
21835,Acetrizoic acid,CC(=O)NC1=C(I)C(=C(I)C=C1I)C(O)=O,C9H6I3NO3,E4478
21836,Cariprazine hydrochloride,Cl.CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(Cl)C(=CC=C3)Cl,C21H32Cl2N4O.HCl,S7236
21837,Ubrogepant,CC1C(CC(NC(=O)C2=CN=C3CC4(CC3=C2)C(=O)NC5=NC=CC=C45)C(=O)N1CC(F)(F)F)C6=CC=CC=C6,C29H26F3N5O3,E1280
21838,Palovarotene,CC1(C)CCC(C)(C)C2=CC(=C(C[N]3C=CC=N3)C=C12)\C=C\C4=CC=C(C=C4)C(O)=O,C27H30N2O2,E1445
21839,Pasireotide,NCCCCC1NC(=O)C(CC2=C[NH]C3=CC=CC=C23)NC(=O)C(NC(=O)C4CC(CN4C(=O)C(CC5=CC=CC=C5)NC(=O)C(CC6=CC=C(OCC7=CC=CC=C7)C=C6)NC1=O)OC(=O)NCCN)C8=CC=CC=C8,C58H66N10O9,P1127
21840,Sildenafil,CCCC1=N[N](C)C2=C1N=C(NC2=O)C3=CC(=CC=C3OCC)[S](=O)(=O)N4CCN(C)CC4,C22H30N6O4S,S4684
21841,AG-120 (racemic),Fc1cncc(c1)N(C(C(=O)NC2CC(F)(F)C2)c3ccccc3Cl)C(=O)C4CCC(=O)N4c5cc(ccn5)C#N,C28H22ClF3N6O3,S0718
21842,Azvudine,[NH2:20][C:16]1=[N:15][C:14](=[O:19])[N:13]([CH:18]=[CH:17]1)[CH:4]2[O:5][C:1]([CH2:6][OH:11])([N:7]=[N+:8]=[N-:9])[CH:2]([OH:10])[CH:3]2[F:12],C9H11FN6O4,E1243
21843,Dimethindene maleate,[CH3:2][CH:1]([C:17]1=[CH:18][CH:20]=[CH:22][CH:21]=[N:19]1)[C:8]2=[C:10]([CH2:3][CH2:4][N:5]([CH3:6])[CH3:7])[CH2:13][C:11]3=[CH:14][CH:16]=[CH:15][CH:12]=[C:9]23.[OH:27][C:25](=[O:28])\[CH:23]=[CH:24]/[C:26]([OH:29])=[O:30],C20H24N2.C4H4O4,E1796
21844,Idarubicin HCl,[ClH:37].[CH3:11][CH:35]1[O:33][CH:31]([CH2:32][CH:34]([NH2:10])[CH:36]1[OH:12])[O:1][CH:15]2[CH2:19][C:22]([OH:7])([CH2:18][C:14]3=[C:13]2[C:16](=[C:20]4[C:23](=[O:8])[C:25]5=[CH:27][CH:29]=[CH:30][CH:28]=[C:26]5[C:24](=[O:9])[C:21]4=[C:17]3[OH:3])[OH:2])[C:4]([CH3:5])=[O:6],C26H27NO9.HCl,S1228
21845,Opicapone,[CH3:1][C:17]1=[C:19]([Cl:3])[C:21](=[N:20](=[O:4])[C:18](=[C:16]1[C:11]2=[N:13][O:15][C:14](=[N:12]2)[C:22]3=[CH:23][C:25](=[C:27]([OH:10])[C:26](=[CH:24]3)[OH:9])[N:6](=[O:7])=[O:8])[Cl:2])[CH3:5],C15H10Cl2N4O6,S6938
21846,Degarelix acetate,[CH3:19][CH:15]([CH3:20])[CH2:12][CH:8]([NH:11][C:14](=[O:18])[CH:17]([CH2:22][C:78]1=[CH:79][CH:81]=[C:83]([NH:63][C:64]([NH2:65])=[O:66])[CH:82]=[CH:80]1)[NH:23][C:26](=[O:28])[CH:27]([CH2:29][C:84]2=[CH:85][CH:87]=[C:89]([NH:67][C:68](=[O:69])[CH:90]3[CH2:91][C:93](=[O:70])[NH:95][C:94](=[O:71])[NH:92]3)[CH:88]=[CH:86]2)[NH:30][C:31](=[O:33])[CH:32]([CH2:35][OH:37])[NH:34][C:36](=[O:39])[CH:38]([CH2:40][C:96]4=[CH:98][N:100]=[CH:101][CH:99]=[CH:97]4)[NH:41][C:42](=[O:44])[CH:43]([CH2:45][C:102]5=[CH:103][CH:105]=[C:107]([Cl:72])[CH:106]=[CH:104]5)[NH:46][C:47](=[O:49])[CH:48]([CH2:50][C:108]6=[CH:109][C:111]7=[C:113]([CH:115]=[CH:117][CH:116]=[CH:114]7)[CH:112]=[CH:110]6)[NH:51][C:52]([CH3:53])=[O:54])[C:6](=[O:9])[NH:4][CH:2]([CH2:5][CH2:7][CH2:10][CH2:13][NH:16][CH:21]([CH3:24])[CH3:25])[C:1](=[O:3])[N:73]8[CH2:75][CH2:77][CH2:76][CH:74]8[C:55](=[O:57])[NH:56][CH:58]([CH3:60])[C:59]([NH2:61])=[O:62],C82H103ClN18O16.C2H4O2,P1094
21847,Minoxidil,[NH2:1][C:7]1=[CH:5][C:4](=[N:6][C:8](=[N:9]1=[O:3])[NH2:2])[N:10]2[CH2:11][CH2:13][CH2:15][CH2:14][CH2:12]2,C9H15N5O,S1383
21848,Perifosine (KRX-0401),CCCCCCCCCCCCCCCCCCO[P]([O-])(=O)OC1CC[N+](C)(C)CC1,C25H52NO4P,S1037
21849,Palbociclib (PD-0332991) HCl,Cl.CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2N(C5CCCC5)C1=O,C24H29N7O2.HCl,S1116
21850,Pemetrexed (LY-231514) disodium,[Na+].[Na+].NC1=NC(=O)C2=C([NH]C=C2CCC3=CC=C(C=C3)C(=O)NC(CCC([O-])=O)C([O-])=O)N1,C20H19N5Na2O6,S1135
21851,Gemcitabine (LY-188011) HCl,Cl.NC1=NC(=O)N(C=C1)C2OC(CO)C(O)C2(F)F,C9H11F2N3O4.HCI,S1149
21852,Pamidronate Disodium,[Na+].[Na+].NCCC(O)([P](O)([O-])=O)[P](O)([O-])=O,C3H9NNa2O7P2,S1311
21853,Gabapentin HCl,Cl.NCC1(CCCCC1)CC(O)=O,C9H17NO2.HCl,S1338
21854,Galanthamine HBr,Br.COC1=CC=C2CN(C)CCC34C=CC(O)CC3OC1=C24,C17H21NO3.HBr,S1339
21855,Granisetron HCl,Cl.CN1C2CCCC1CC(C2)NC(=O)C3=N[N](C)C4=CC=CC=C34,C18H24N4O.HCl,S1345
21856,Biapenem,CC(O)C1C2C(C)C(=C(N2C1=O)C([O-])=O)SC3C[N]4C=NC=[N+]4C3,C15H18N4O4S,S1370
21857,Dorzolamide HCl,Cl.CCNC1CC(C)[S](=O)(=O)C2=C1C=C(S2)[S](N)(=O)=O,C10H16N2O4S3.HCl,S1375
21858,Mizoribine,NC(=O)C1=C(O)[N](C=N1)C2OC(CO)C(O)C2O,C9H13N3O6,S1384
21859,Polymyxin B sulphate,CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCN)NC1=O)C(C)O.O[S](O)(=O)=O,C56H98N16O13.H2SO4,S1395
21860,Teicoplanin,CCCCCCCCCC(C)=O.CCCCC\C=C\CCC(C)=O.CCC(C)CCCCCCC(C)=O.CC(C)CCCCCCCC(C)=O.CC(C)CCCCCCC(C)=O.CC(=O)NC1C(O)C(O)C(CO)OC1OC2C3NC(=O)C(NC(=O)C4NC(=O)C5NC(=O)C(CC6=CC=C(OC7=C(OC8OC(CO)C(O)C(O)C8N[R])C(=CC4=C7)OC9=C(Cl)C=C2C=C9)C(=C6)Cl)NC(=O)C(N)C%10=CC(=C(O)C=C%10)OC%11=CC5=CC(=C%11)O)C%12=CC(=C(O)C=C%12)C%13=C(OC%14OC(CO)C(O)C(O)C%14O)C=C(O)C=C%13C(NC3=O)C(O)=O,C77H77N9O31Cl2.R,S1399
21861,Varenicline Tartrate (CP 526555-18),OC(C(O)C(O)=O)C(O)=O.C1NCC2CC1C3=C2C=C4N=CC=NC4=C3,C13H13N3.C4H6O6,S1440
21862,Perindopril Erbumine,CCCC(NC(C)C(=O)N1C2CCCCC2CC1C(O)=O)C(=O)OCC.CC(C)(C)N,C19H32N2O5.C4H11N,S1506
21863,Cidofovir,NC1=NC(=O)N(CC(CO)OC[P](O)(O)=O)C=C1,C8H14N3O6P,S1516
21864,Ibuprofen Lysine,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O.NCCCCC(N)C(O)=O,C19H32N2O4,S1518
21865,Palbociclib (PD0332991) Isethionate,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2N(C5CCCC5)C1=O.OCC[S](O)(=O)=O,C24H29N7O2.C2H6O4S,S1579
21866,Alendronate sodium trihydrate,O.O.O.NCCCC(O)([P](O)(O)=O)[P](O)(=O)O[Na],C4H13NO7P2.3H2O.Na,S1624
21867,L-Glutamine,NC(CCC(N)=O)C(O)=O,C5H10N2O3,S1749
21868,DL-Glutamine,NC(CCC(N)=O)C(O)=O,C5H10N2O3,S3963
21869,Gadodiamide Hydrate,O.[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,C16H28GdN5O9C16H28GdN5O9.xH2O,S1751
21870,Penicillamine,CC(C)(S)C(N)C(O)=O,C5H11NO2S,S1853
21871,DL-Penicillamine,CC(C)(S)C(N)C(O)=O,C5H11NO2S,S5962
21872,Etidronate,CC(O)([P](O)(O)=O)[P](O)(O)=O,C2H8O7P2,S1857
21873,Tranexamic Acid,NCC1CCC(CC1)C(O)=O,C8H15NO2,S1875
21874,Levamisole hydrochloride,Cl.C1CN2CC(N=C2S1)C3=CC=CC=C3,C11H12N2S.HCl,S1939
21875,Tetramisole HCl,Cl.C1CN2CC(N=C2S1)C3=CC=CC=C3,C11H12N2S.HCl,S4094
21876,Ticlopidine HCl,Cl.ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1,C14H14ClNS.HCl,S1984
21877,ATP disodium,[Na+].[Na+].NC1=NC=NC2=C1N=C[N]2C3OC(CO[P](O)(=O)O[P]([O-])(=O)O[P](O)([O-])=O)C(O)C3O,C10H14N5O13P3.2Na,S1985
21878,Procarbazine HCl,Cl.CNNCC1=CC=C(C=C1)C(=O)NC(C)C,C12H19N3O.HCl,S1995
21879,Sodium butyrate,[Na+].CCCC([O-])=O,C4H7NaO2,S1999
21880,Taurine,NCC[S](O)(=O)=O,C2H7NO3S,S2008
21881,Clindamycin Phosphate,CCCC1CC(N(C)C1)C(=O)NC(C(C)Cl)C2OC(SC)C(O[P](O)(O)=O)C(O)C2O,C18H34ClN2O8PS,S2048
21882,Lisinopril dihydrate,NCCCCC(NC(CCC1=CC=CC=C1)C(O)=O)C(=O)N2CCCC2C(O)=O,C21H35N3O7,S2076
21883,Fudosteine,NC(CSCCCO)C(O)=O,C6H13NO3S,S2129
21884,Gabapentin,NCC1(CCCCC1)CC(O)=O,C9H17NO2,S2133
21885,Kanamycin sulfate,NCC1OC(OC2C(N)CC(N)C(OC3OC(CO)C(O)C(N)C3O)C2O)C(O)C(O)C1O.O[S](O)(=O)=O,C18H38N4O15S,S2315
21886,Chondroitin sulfate,COC1OC(CO[S](O)(=O)=O)C(O)C(OC2OC(C(C)C(O)C2O)C(O)=O)C1NC(C)=O,(C14H21NO14S)n,S2416
21887,Donepezil HCl,Cl.COC1=C(OC)C=C2C(=O)C(CC3CCN(CC3)CC4=CC=CC=C4)CC2=C1,C24H29NO3.HCl,S2462
21888,Neostigmine Bromide,[Br-].CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,C12H19N2O2.Br,S2490
21889,Salbutamol Sulfate,CC(C)(C)NCC(O)C1=CC=C(O)C(=C1)CO.O[S](O)(=O)=O,C13H21NO3.H2SO4,S2507
21890,Tobramycin,NCC1OC(OC2C(N)CC(N)C(OC3OC(CO)C(O)C(N)C3O)C2O)C(N)CC1O,C18H37N5O9,S2514
21891,NAD+,NC(=O)C1=CC=C[N+](=C1)C2OC(CO[P]([O-])(=O)O[P](O)(=O)OCC3OC(C(O)C3O)[N]4C=NC5=C(N)N=CN=C45)C(O)C2O,C21H27N7O14P2,S2518
21892,Methacycline HCl,Cl.CN(C)C1C2C(O)C3C(=C)C4=CC=CC(=C4C(=O)C3=C(O)C2(O)C(=O)C(=C1O)C(N)=O)O,C22H22N2O8.HCl,S2527
21893,Lomefloxacin HCl,Cl.CCN1C=C(C(O)=O)C(=O)C2=CC(=C(N3CCNC(C)C3)C(=C12)F)F,C17H19F2N3O3.HCl,S2539
21894,Amiloride HCl dihydrate,O.O.Cl.NC(=N)NC(=O)C1=NC(=C(N)N=C1N)Cl,C6H8ClN7O.HCl.2H2O,S2560
21895,Oxacillin sodium monohydrate,O.[Na+].CC1=C(C(=O)NC2C3SC(C)(C)C(N3C2=O)C([O-])=O)C(=NO1)C4=CC=CC=C4,C19H18N3O5S.Na.H2O,S2563
21896,Neomycin sulfate,NCC1OC(OC2C(N)CC(N)C(O)C2OC3OC(CO)C(OC4OC(CN)C(O)C(O)C4N)C3O)C(N)C(O)C1O.O[S](O)(=O)=O,C23H46N6O13.H2SO4,S2568
21897,Framycetin sulphate,NCC1OC(OC2C(N)CC(N)C(O)C2OC3OC(CO)C(OC4OC(CN)C(O)C(O)C4N)C3O)C(N)C(O)C1O.O[S](O)(=O)=O,C23H48N6O17S,E0511
21898,Streptomycin sulfate,CNC1C(O)C(O)C(CO)OC1OC2C(OC(C)C2(O)C=O)OC3C(O)C(O)C(NC(N)=N)C(O)C3NC(N)=N.CNC4C(O)C(O)C(CO)OC4OC5C(OC(C)C5(O)C=O)OC6C(O)C(O)C(NC(N)=N)C(O)C6NC(N)=N.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O,2C21H39N7O12.3H2SO4,S2572
21899,Vancomycin HCl,Cl.CNC(CC(C)C)C(=O)NC1C(O)C2=CC=C(OC3=CC4=CC(=C3OC5OC(CO)C(O)C(O)C5OC6CC(C)(N)C(O)C(C)O6)OC7=CC=C(C=C7Cl)C(O)C8NC(=O)C(NC(=O)C4NC(=O)C(CC(N)=O)NC1=O)C9=CC(=C(O)C=C9)C%10=C(C=C(O)C=C%10O)C(NC8=O)C(O)=O)C(=C2)Cl,C66H75Cl2N9O24.HCl,S2575
21900,Hygromycin B,CNC1CC(N)C(O)C(OC2OC(CO)C(O)C3OC4(OC(C(N)CO)C(O)C(O)C4O)OC23)C1O,C20H37N3O13,S2908
21901,Zanamivir,CC(=O)NC1C(NC(N)=N)C=C(OC1C(O)C(O)CO)C(O)=O,C12H20N4O7,S3007
21902,Plerixafor (AMD3100) 8HCl,Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.C1CNCCNCCCN(CCNC1)CC2=CC=C(CN3CCCNCCNCCCNCC3)C=C2,C28H54N8.8HCl,S3013
21903,Geneticin (G418 Sulfate),CNC1C(O)C(OCC1(C)O)OC2C(N)CC(N)C(OC3OC(C(C)O)C(O)C(O)C3N)C2O.O[S](O)(=O)=O.O[S](O)(=O)=O,C20H40N4O10.2H2SO4,S3028
21904,Solifenacin succinate,OC(=O)CCC(O)=O.O=C(OC1CN2CCC1CC2)N3CCC4=C(C=CC=C4)C3C5=CC=CC=C5,C23H26N2O.C4H6O4,S3048
21905,Palonosetron HCl,Cl.O=C1N(CC2CCCC3=CC=CC1=C23)C4CN5CCC4CC5,C19H24N2O.HCl,S3050
21906,Miltefosine,CCCCCCCCCCCCCCCCO[P]([O-])(=O)OCC[N+](C)(C)C,C21H46NO4P,S3056
21907,Danofloxacin Mesylate,CN1CC2CC1CN2C3=CC4=C(C=C3F)C(=O)C(=CN4C5CC5)C(O)=O.C[S](O)(=O)=O,C19H20FN3O3.CH4O3S,S3058
21908,Amikacin disulfate,NCCC(O)C(=O)NC1CC(N)C(OC2OC(CN)C(O)C(O)C2O)C(O)C1OC3OC(CO)C(O)C(N)C3O.O[S](O)(=O)=O.O[S](O)(=O)=O,C22H43N5O13.2H2SO4,S3065
21909,(R)-baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,C10H12ClNO2,S3072
21910,Caspofungin (MK-0991) Acetate,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(O)C(NCCN)NC(=O)C2C(O)CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(O)CN3C(=O)C(NC1=O)C(C)O)C(O)C(O)C4=CC=C(O)C=C4)C(O)CCN.CC(O)=O.CC(O)=O,C52H88N10O15.2C2H4O2,S3073
21911,Creatinine,CN1CC(=O)NC1=N,C4H7N3O,S3102
21912,Amikacin hydrate,O.NCCC(O)C(=O)NC1CC(N)C(OC2OC(CN)C(O)C(O)C2O)C(O)C1OC3OC(CO)C(O)C(N)C3O,C22H43N5O13.xH2O,S3122
21913,Tripelennamine HCl,Cl.CN(C)CCN(CC1=CC=CC=C1)C2=NC=CC=C2,C16H21N3.HCl,S3146
21914,Ibandronate sodium monohydrate,O.[NaH].CCCCCN(C)CCC(O)([P](O)(O)=O)[P](O)(O)=O,C9H23NO7P2.Na.H2O,S3148
21915,Abacavir sulfate,NC1=NC2=C(N=C[N]2C3CC(CO)C=C3)C(=N1)NC4CC4.NC5=NC6=C(N=C[N]6C7CC(CO)C=C7)C(=N5)NC8CC8.O[S](O)(=O)=O,C14H18N6O.1/2H2SO4,S3165
21916,L-Arginine HCl (L-Arg),Cl.NC(CCCNC(N)=N)C(O)=O,C6H14N4O2.HCl,S3174
21917,Thiamine HCl (Vitamin B1),Cl.[Cl-].CC1=NC=C(C[N+]2=CSC(=C2C)CCO)C(=N1)N,C12H17N4OS.HCl,S3211
21918,Cesium chloride,Cl[Cs],CsCl,S3642
21919,Ceftazidime,CC(C)(O\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C([O-])=O)C[N+]3=CC=CC=C3)C4=CSC(=N4)N)C(O)=O,C22H22N6O7S2,S3649
21920,Penicillin V potassium salt,[K+].CC1(C)SC2C(NC(=O)COC3=CC=CC=C3)C(=O)N2C1C([O-])=O,C16H17N2O5S.K,S3650
21921,Pirenzepine dihydrochloride,Cl.Cl.CN1CCN(CC1)CC(=O)N2C3=C(C=CC=C3)C(=O)NC4=CC=CN=C24,C19H21N5O2.2HCl,S3662
21922,Imipenem,O.CC(O)C1C2CC(=C(N2C1=O)C(O)=O)SCCNC=N,C12H17N3O4S.H2O,S3667
21923,Cangrelor Tetrasodium,CSCCNC1=NC(=NC2=C1N=C[N]2C3OC(CO[P](=O)(O[Na])O[P](=O)(O[Na])C(Cl)(Cl)[P](=O)(O[Na])O[Na])C(O)C3O)SCCC(F)(F)F,21Cl2F3N5O12P3S2.4Na,S3737
21924,Acamprosate Calcium,CC(=O)NCCC[S]([O-])(=O)=O,C5H11NO4S.1/2Ca,S3748
21925,isoleucine,CCC(C)C(N)C(O)=O,C6H13NO2,S3752
21926,L-Leucine,CC(C)CC(N)C(O)=O,C6H13NO2,S3753
21927,L-Citrulline,NC(CCCNC(N)=O)C(O)=O,C6H13N3O3,S3798
21928,DL-Citrulline,NC(CCCNC(N)=O)C(O)=O,C6H13N3O3,S5124
21929,L-Theanine,CCNC(=O)CCC(N)C(O)=O,C7H14N2O3,S3852
21930,Sodium Demethylcantharidate,OC(=O)C1C2CCC(O2)C1C(=O)O[Na],C8H9O5.Na,S3861
21931,L-Lysine hydrochloride,Cl.NCCCCC(N)C(O)=O,C6H14N2O2.HCl,S3953
21932,L-SelenoMethionine,C[Se]CCC(N)C(O)=O,C5H11NO2Se,S3973
21933,Pemirolast potassium,[K+].CC1=CC=CN2C(=O)C(=CN=C12)C3=NN=N[N-]3,C10H7N6O.K,S4008
21934,Sodium Monofluorophosphate,[Na+].[Na+].[O-][P]([O-])(F)=O,FNa2O3P,S4013
21935,Flavoxate HCl,Cl.CC1=C(OC2=C(C=CC=C2C(=O)OCCN3CCCCC3)C1=O)C4=CC=CC=C4,C24H25NO4.HCl,S4027
21936,Colistin Sulfate,CCC(C)CCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O)C(C)O.CCC(C)CCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC2CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC2=O)C(C)O.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O,C52H98N16O13.5/2H2SO4,S4029
21937,Gentamicin Sulfate,CCN.CNC(C)C.CNC1C(O)C(OCC1(C)O)OC2C(N)CC(N)C(OC3OC(CCC3N)[R])C2O.CC(C)N.O[S](O)(=O)=O,H2SO4.xUnspecified,S4030
21938,Netilmicin Sulfate,CCNC1CC(N)C(OC2OC(=CCC2N)CN)C(O)C1OC3OCC(C)(O)C(NC)C3O.CCNC4CC(N)C(OC5OC(=CCC5N)CN)C(O)C4OC6OCC(C)(O)C(NC)C6O.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O,C21H41N5O7.2.5H2SO4,S4052
21939,Bismuth Subcitrate Potassium,[K+].[K+].[K+].[K+].[K+].[BiH6+3].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,C12H8BiK5O14,S4093
21940,Clodronate Disodium,[Na+].[Na+].O[P]([O-])(=O)C(Cl)(Cl)[P](O)([O-])=O,CH4Cl2O6P0.2Na,S4108
21941,Histamine Phosphate,NCCC1=C[NH]C=N1.O[P](O)(O)=O.O[P](O)(O)=O,C5H9N.2H3O4P,S4117
21942,Succinylcholine Chloride Dihydrate,O.O.[Cl-].[Cl-].C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,C14H30N2O4.2Cl.2H2O,S4121
21943,Terbutaline Sulfate,CC(C)(C)NCC(O)C1=CC(=CC(=C1)O)O.CC(C)(C)NCC(O)C2=CC(=CC(=C2)O)O.O[S](O)(=O)=O,C24H38N2O6.H2SO4,S4127
21944,Mildronate,C[N+](C)(C)NCCC(O)=O,C6H14N2O2,S4130
21945,Eprazinone 2HCl,Cl.Cl.CCOC(CN1CCN(CC1)CC(C)C(=O)C2=CC=CC=C2)C3=CC=CC=C3,C24H32N2O2.2HCl,S4137
21946,Amprolium HCl,Cl.[Cl-].CCCC1=NC=C(C[N+]2=C(C)C=CC=C2)C(=N1)N,C14H19N4.HCl.Cl,S4144
21947,Bacitracin,CCC(C)C(NC(=O)C(CCC(O)=O)NC(=O)C(CC(C)C)NC(=O)C1CN=C(S1)C(N)C(C)C)C(=O)NC2CCCCNC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(CC3=C[NH]C=N3)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(NC(=O)C(CCCN)NC2=O)C(C)CC,C65H101N17O16S,S4146
21948,Chloroquine diphosphate,CCN(CC)CCCC(C)NC1=CC=NC2=C1C=CC(=C2)Cl.O[P](O)(O)=O.O[P](O)(O)=O,C18H26ClN3.2H3O4P,S4157
21949,Ceftriaxone disodium salt hemi (heptahydrate),O.[Na;v0].CO\N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(O)=O)CSC3=NC(=O)C(=O)NN3C)C4=CSC(=N4)N,C18H16N8O7S3.7/2H2O.2Na,S4158
21950,Sodium Gluconate,[Na+].OCC(O)C(O)C(O)C(O)C([O-])=O,C6H11O7.Na,S4174
21951,Nefopam HCl,Cl.CN1CCOC(C2=CC=CC=C2)C3=C(C1)C=CC=C3,C17H19NO.HCl,S4180
21952,Paromomycin Sulfate,NCC1OC(OC2C(O)C(OC2CO)OC3C(O)C(N)CC(N)C3OC4OC(CO)C(O)C(O)C4N)C(N)C(O)C1O.O[S](O)(=O)=O,C23H45N5O14.xH2SO4,S4183
21953,Ribostamycin Sulfate,NCC1OC(OC2C(N)CC(N)C(O)C2OC3OC(CO)C(O)C3O)C(N)C(O)C1O.O[S](O)(=O)=O,C17H34N4O10.H2SO4,S4215
21954,Capreomycin Sulfate,CC1NC(=O)C(N)CNC(=O)C(NC(=O)C(NC(=O)C(CNC(=O)CC(N)CCCN)NC1=O)=CNC(N)=O)C2CCNC(=N2)N.O[S](O)(=O)=O,C25H44N14O7.H2SO4,S4234
21955,Proflavine Hemisulfate,NC1=CC=C2C=C3C=CC(=CC3=NC2=C1)N.NC4=CC=C5C=C6C=CC(=CC6=NC5=C4)N.O[S](O)(=O)=O,C13H11N3.1/2H2SO4,S4236
21956,Sodium ascorbate,[NaH].OCC(O)C1OC(=O)C(O)C1O,C6H7NaO6,S4245
21957,Apramycin Sulfate,CNC1C(O)C2OC(OC3C(N)CC(N)C(O)C3O)C(N)CC2OC1OC4OC(CO)C(N)C(O)C4O.O[S](O)(=O)=O,C21H41N5O11.xH2SO4,S4254
21958,Isepamicin Sulphate,CNC1C(O)C(OCC1(C)O)OC2C(O)C(OC3OC(CN)C(O)C(O)C3O)C(N)CC2NC(=O)C(O)CN.O[S](O)(=O)=O,C22H45N5O16S,S4271
21959,Micafungin (FK 463) Sodium,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(O)C(O)NC(=O)C5C(O)C(C)CN5C(=O)C(NC(=O)C(NC(=O)C6CC(O)CN6C(=O)C(NC4=O)C(C)O)C(O)C(O)C7=CC(=C(O)C=C7)O[S](=O)(=O)O[Na])C(O)CC(N)=O,C56H70N9NaO23S,S4287
21960,Amifostine trihydrate,O.O.O.NCCCNCCS[P](O)(O)=O,C5H15N2O3PS.3H2O,S4298
21961,Calcium Gluceptate,OCC(O)C(O)C(O)C(O)C(O)C(=O)O[Ca]OC(=O)C(O)C(O)C(O)C(O)C(O)CO,C14H26CaO16,S4311
21962,Ceftazidime Pentahydrate,O.O.O.O.O.CC(C)(O/N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C([O-])=O)C[N+]3=CC=CC=C3)C4=CSC(=N4)N)C(O)=O,C22H32N6O12S2,S4314
21963,Guanethidine Sulfate,NC(=N)NCCN1CCCCCCC1.NC(=N)NCCN2CCCCCCC2.O[S](O)(=O)=O,C20H44N8.H2O4S,S4328
21964,Tolmetin Sodium,O.O.C[N]1C(=CC=C1C(=O)C2=CC=C(C)C=C2)CC(=O)O[Na],C15H14NO3.Na.2H2O,S4360
21965,Potassium Canrenoate,[K+].CC12CCC(=O)C=C1C=CC3C2CCC4(C)C3CCC4(O)CCC([O-])=O,C22H29KO4,S4392
21966,Hydroxychloroquine Sulfate (NSC 4375),CCN(CCO)CCCC(C)NC1=CC=NC2=CC(=CC=C12)Cl.O[S](O)(=O)=O,C18H28ClN3O5S,S4430
21967,Dihydrostreptomycin sulfate,CNC1C(O)C(O)C(CO)OC1OC2C(OC(C)C2(O)CO)OC3C(O)C(O)C(NC(N)=N)C(O)C3NC(N)=N.CNC4C(O)C(O)C(CO)OC4OC5C(OC(C)C5(O)CO)OC6C(O)C(O)C(NC(N)=N)C(O)C6NC(N)=N.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O,2C21H41N7O12.3H2SO4,S4523
21968,Sisomicin sulfate,CNC1C(O)C(OCC1(C)O)OC2C(N)CC(N)C(OC3OC(=CCC3N)CN)C2O.CNC4C(O)C(OCC4(C)O)OC5C(N)CC(N)C(OC6OC(=CCC6N)CN)C5O.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O,2C19H37N5O7.5H2SO4,S4540
21969,Eprodisate disodium,[Na+].[Na+].[O-][S](=O)(=O)CCC[S]([O-])(=O)=O,C3H8O6S2.2Na,S4567
21970,Pralidoxime chloride,[Cl-].C[N+]1=C(C=CC=C1)\C=N\O,C7H9N2O.Cl,S4575
21971,Eflornithine (MDL-71782) hydrochloride hydrate,O.Cl.NCCCC(N)(C(F)F)C(O)=O,C6H12F2N2O2.HCl.H2O,S4582
21972,Captisol (SBE-β-CD),[Na+].[Na+].OCC1OC2OC3C(O)C(O)C(OC3CO)OC4C(O)C(O)C(OC4CO)OC5C(O)C(OCCCC[S]([O-])(=O)=O)C(OC5COCCCC[S]([O-])(=O)=O)OC6=C(CO)OC(OC7C(O)C(O)C(OC7CO)OC8C(O)C(O)C(OC8CO)OC1C(O)C2O)C(O)C6O,C42H70-nO35.nNa.n(C4H8O3S),S4592
21973,Glutathione,NC(CCC(=O)NC(CS)C(=O)NCC(O)=O)C(O)=O,C10H17N3O6S,S4606
21974,L-Ornithine hydrochloride,Cl.NCCCC(N)C(O)=O,C5H13ClN2O2,S4653
21975,Cefradine,CC1=C(N2C(SC1)C(NC(=O)C(N)C3=CCC=CC3)C2=O)C(O)=O,C16H19N3O4S,S4671
21976,4-Aminobutyric acid (GABA),NCCCC(O)=O,C4H9NO2,S4700
21977,Choline bitartrate,C[N+](C)(C)CCO.OC(C(O)C([O-])=O)C(O)=O,C5H14NO.C4H5O6,S4703
21978,D-(+)-Cellobiose,OCC1OC(OC2C(O)C(O)C(O)OC2CO)C(O)C(O)C1O,C12H22O11,S4704
21979,L-Glutamic acid monosodium salt,NC(CCC(=O)O[Na])C(O)=O,C5H8NO4.Na,S4721
21980,Sodium ferulate,[Na+].COC1=CC(=CC=C1O)\C=C\C([O-])=O,C10H9O4.Na,S4740
21981,Danshensu,OC(CC1=CC=C(O)C(=C1)O)C(O)=O,C9H10O5,S4741
21982,Creatine phosphate disodium salt,[Na+].[Na+].CN(CC(O)=O)C(=N)N[P]([O-])([O-])=O,C4H8N3O5P.2Na,S4770
21983,Glycylglycine,NCC(=O)NCC(O)=O,C4H8N2O3,S4810
21984,VitaMin U,[Cl-].C[S+](C)CCC(N)C(O)=O,C6H14NO2.Cl,S4811
21985,Glycine,NCC(O)=O,C2H5NO2,S4821
21986,Manganese chloride,Cl[Mn]Cl,MnCl2,S4827
21987,Sodium carbonate,[Na]OC(=O)O[Na],Na2CO3,S4828
21988,L(+)-Asparagine monohydrate,O.NC(CC(N)=O)C(O)=O,C4H8N2O3.H2O,S4950
21989,L-Threonine,CC(O)C(N)C(O)=O,C4H9NO3,S4951
21990,Choline Glycerophosphate,C[N+](C)(C)CCO[P]([O-])(=O)OCC(O)CO,C8H20NO6P,S4972
21991,Timonacic,OC(=O)C1CSCN1,C4H7NO2S,S4993
21992,Fosfomycin Disodium,[Na+].[Na+].CC1OC1[P]([O-])([O-])=O,C3H5O4P.2Na,S5048
21993,Pipemidic acid,CCN1C=C(C(O)=O)C(=O)C2=CN=C(N=C12)N3CCNCC3,C14H17N5O3,S5051
21994,Methotrexate disodium,[Na+].[Na+].CN(CC1=NC2=C(N)N=C(N)N=C2N=C1)C3=CC=C(C=C3)C(=O)NC(CCC([O-])=O)C([O-])=O,C20H20N8O5.2Na,S5097
21995,Riboflavin phosphate sodium,[Na+].CC1=CC2=C(C=C1C)N(CC(O)C(O)C(O)CO[P](O)([O-])=O)C3=NC(=O)NC(=O)C3=N2,C17H20N4NaO9P,S5107
21996,Homotaurine,NCCC[S](O)(=O)=O,C3H9NO3S,S5131
21997,Calcium folinate,[Ca++].NC1=NC(=C2N(C=O)C(CNC3=CC=C(C=C3)C(=O)NC(CCC([O-])=O)C([O-])=O)CNC2=N1)O,C20H21N7O7.Ca,S5136
21998,D-Pantethine,CC(C)(CO)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO,C22H42N4O8S2,S5220
21999,Ozagrel sodium,[Na+].[O-]C(=O)\C=C\C1=CC=C(C[N]2C=CN=C2)C=C1,C13H11N2O2.Na,S5252
22000,Nylidrin Hydrochloride,Cl.CC(CCC1=CC=CC=C1)NC(C)C(O)C2=CC=C(O)C=C2,C19H25NO2.HCl,S5267
22001,Cephradine monohydrate,O.CC1=C(N2C(SC1)C(NC(=O)C(N)C3=CCC=CC3)C2=O)C(O)=O,C16H19N3O4S.H2O,S5296
22002,Citicoline,C[N+](C)(C)CCO[P]([O-])(=O)O[P](O)(=O)OCC1OC(C(O)C1O)N2C=CC(=NC2=O)N,C14H26N4O11P2,S5362
22003,UTP Trisodium Salt,[Na+].[Na+].[Na+].OC1C(O)C(OC1CO[P]([O-])(=O)O[P]([O-])(=O)O[P](O)([O-])=O)N2C=CC(=O)NC2=O,C9H15N2O15P3.3Na,S5384
22004,Loxoprofen Sodium,[Na+].CC(C([O-])=O)C1=CC=C(CC2CCCC2=O)C=C1,C15H17O3.Na,S5412
22005,Sodium succinate,[Na+].[Na+].[O-]C(=O)CCC([O-])=O,C4H4O4.2Na,S5433
22006,Guanethidine Monosulfate,NC(=N)NCCN1CCCCCCC1.O[S](O)(=O)=O,C10H22N4.H2SO4,S5496
22007,Spermine Tetrahydrochloride,Cl.Cl.Cl.Cl.NCCCNCCCCNCCCN,C10H26N4.4HCl,S5524
22008,β-Alanine,NCCC(O)=O,C3H7NO2,S5526
22009,Tobramycin sulfate,NCC1OC(OC2C(N)CC(N)C(OC3OC(CO)C(O)C(N)C3O)C2O)C(N)CC1O.NCC4OC(OC5C(N)CC(N)C(OC6OC(CO)C(O)C(N)C6O)C5O)C(N)CC4O.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O.O[S](O)(=O)=O,C36H84N10O38S5,S5533
22010,DL-Serine,NC(CO)C(O)=O,C3H7NO3,S5545
22011,(R)-Serine,NC(CO)C(O)=O,C3H7NO3,S6224
22012,L-serine,NC(CO)C(O)=O,C3H7NO3,S9353
22013,DL-Arginine,NC(CCCNC(N)=N)C(O)=O,C6H14N4O2,S5549
22014,L-arginine,NC(CCCNC(N)=N)C(O)=O,C6H14N4O2,S5634
22015,L-Asparagine,NC(CC(N)=O)C(O)=O,C4H8N2O3,S5571
22016,Creatine,CN(CC(O)=O)C(N)=N,C4H9N3O2,S5588
22017,L-Valine,CC(C)C(N)C(O)=O,C5H11NO2,S5628
22018,L-Proline,OC(=O)C1CCCN1,C5H9NO2,S5629
22019,L-lysine,NCCCCC(N)C(O)=O,C6H14N2O2,S5630
22020,L-Alanine,CC(N)C(O)=O,C3H7NO2,S5631
22021,D-Alanine,CC(N)C(O)=O,C3H7NO2,S3203
22022,L-aspartic Acid,NC(CC(O)=O)C(O)=O,C4H7NO4,S5632
22023,L-methionine,CSCCC(N)C(O)=O,C5H11NO2S,S5633
22024,DL-Methionine,CSCCC(N)C(O)=O,C5H11NO2S,S9344
22025,Methionine,CSCCC(N)C(O)=O,C5H11NO2S,S4494
22026,L-cysteine,NC(CS)C(O)=O,C3H7NO2S,S5635
22027,D-Cysteine,NC(CS)C(O)=O,C3H7NO2S,E4227
22028,Clodronate disodium tetrahydrate,O.O.O.O.[Na+].[Na+].O[P]([O-])(=O)C(Cl)(Cl)[P](O)([O-])=O,CH10Cl2Na2O10P2,S5660
22029,Lodoxamide Tromethamine,NC(CO)(CO)CO.NC(CO)(CO)CO.OC(=O)C(=O)NC1=C(Cl)C(=CC(=C1)C#N)NC(=O)C(O)=O,C19H28ClN5O12,S5674
22030,Edetate Trisodium,[Na+].[Na+].[Na+].OC(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,C10H13N2Na3O8,S5706
22031,Edetate calcium disodium,[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,C10H12CaN2Na2O8,S5721
22032,pentetate calcium trisodium hydrate,[Na+].[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O,C14H18CaN3Na3O10.xH2O,S5746
22033,Ala-Gln,CC(N)C(=O)NC(CCC(N)=O)C(O)=O,C8H15N3O4,S5801
22034,L-Hydroxyproline,OC1CNC(C1)C(O)=O,C5H9NO3,S5820
22035,Gastrodenol,[K+].[K+].[K+].[BiH6+3].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,C12H10BiK3O14,S5866
22036,Bendazac L-lysine,NCCCCC(N)C(O)=O.OC(=O)COC1=N[N](CC2=CC=CC=C2)C3=C1C=CC=C3,C22H28N4O5,S5867
22037,Creatine monohydrate,O.CN(CC(O)=O)C(N)=N,C4H11N3O3,S6023
22038,Thiamine pyrophosphate hydrochloride,[Cl-].CC1=NC=C(C[N+]2=CSC(=C2C)CCO[P](O)(=O)O[P](O)(O)=O)C(=N1)N,C12H19ClN4O7P2S,S6102
22039,Malachite green,CN(C)C1=CC=C(C=C1)C(C2=CC=CC=C2)=C3C=CC(C=C3)=[N+](C)C.CN(C)C4=CC=C(C=C4)C(C5=CC=CC=C5)=C6C=CC(C=C6)=[N+](C)C.OC(=O)C(O)=O.OC(=O)C([O-])=O.OC(=O)C([O-])=O,C52H54N4O12,S6201
22040,(S)-Glutamic acid,NC(CCC(O)=O)C(O)=O,C5H9NO4,S6266
22041,Sodium phytate hydrate,O[P](O)(=O)OC1C(O[P](O)(O)=O)C(O[P](O)(O)=O)C(O[P](O)(O)=O)C(O[P](O)(O)=O)C1O[P](O)(O)=O,C6H18O24P6.xNa.yH2O,S6315
22042,Chlorophyllin (sodium copper salt),[Na+].[Na+].[Na+].[Cu++]|1|2|3|[N-]4C5=C(C)C(=C4C=C6N|1=C(C=C7[N-]|2C(=C(CC([O-])=O)C8=N|3C(=C5)C(C)C8CCC([O-])=O)C(=C7C)C([O-])=O)C(=C6C)CC)C=C,C34H31CuN4Na3O6,S6445
22043,Sugammadex (sodium),[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OC1C(O)C2OC3OC(CSCCC([O-])=O)C(OC4OC(CSCCC([O-])=O)C(OC5OC(CSCCC([O-])=O)C(OC6OC(CSCCC([O-])=O)C(OC7OC(CSCCC([O-])=O)C(OC8OC(CSCCC([O-])=O)C(OC9OC(CSCCC([O-])=O)C(OC1OC2CSCCC([O-])=O)C(O)C9O)C(O)C8O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O,C72H104Na8O48S8,S6460
22044,Gadoxetate sodium,[Na+].[Na+].[Gd+3]|1|2|3|4|5|6|7|[O-]C(=O)CN|1(CCN|2(CC([O-]|3)=O)CC([O-]|4)=O)CC(CC8=CC=C(OCC)C=C8)N|5(CC([O-]|6)=O)CC([O-]|7)=O,C23H28GdN3Na2O11,S6488
22045,Diquafosol Tetrasodium,[Na+].[Na+].[Na+].[Na+].OC1C(O)C(OC1CO[P]([O-])(=O)O[P]([O-])(=O)O[P]([O-])(=O)O[P]([O-])(=O)OCC2OC(C(O)C2O)N3C=CC(=O)NC3=O)N4C=CC(=O)NC4=O,C18H22N4Na4O23P4,S6592
22046,Rilmenidine Phosphate,O[P](O)(O)=O.C1CN=C(NC(C2CC2)C3CC3)O1,C10H19N2O5P,S7548
22047,Pemetrexed Disodium Hydrate,NC1=NC(=O)C2=C([NH]C=C2CCC3=CC=C(C=C3)C(=O)NC(CCC(=O)O[Na])C(=O)O[Na])N1,C20H21N5O6.5/2H2O.2Na,S7785
22048,Adenosine disodium triphosphate hydrate,O[C@H]1([C@H](N2C3C(N=C2)=C(N)N=CN=3)O[C@H](CO[P](O[P](O[P](=O)(O)O)(=O)O)(=O)O)[C@@H](O)1).[Na].O,C10H14N5Na2O13P3.xH2O,S9367
22049,Bivalirudin Trifluoroacetate,CCC(C)C(NC(=O)C(CCC(O)=O)NC(=O)C(CCC(O)=O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(O)=O)NC(=O)CNC(=O)C(CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C2CCCN2C(=O)C(CCCNC(N)=N)NC(=O)C3CCCN3C(=O)C(N)CC4=CC=CC=C4)C(=O)N5CCCC5C(=O)NC(CCC(O)=O)C(=O)NC(CCC(O)=O)C(=O)NC(CC6=CC=C(O)C=C6)C(=O)NC(CC(C)C)C(O)=O,C98H138N24O33,P1004
22050,Eptifibatide Acetate,NC(=N)NCCCCC1NC(=O)CCSSCC(NC(=O)C2CCCN2C(=O)C(CC3=C[NH]C4=C3C=CC=C4)NC(=O)C(CC(O)=O)NC(=O)CNC1=O)C(N)=O,C35H49N11O9S2,P1011
22051,Octreotide (SMS 201-995) acetate,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)CC2=CC=CC=C2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=C[NH]C5=C4C=CC=C5)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,C49H66N10O10S2.xC2H4O2,P1017
22052,Atosiban Acetate,CCOC1=CC=C(CC2NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(NC2=O)C(C)CC)C(C)O)C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(N)=O)C=C1,C43H67N11O12S2,P1025
22053,Oxytocin (Syntocinon),CCC(C)C1NC(=O)C(CC2=CC=C(O)C=C2)NC(=O)C(N)CSSCC(NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC1=O)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(N)=O.CC(O)=O,C45H70N12O14S2,P1029
22054,Salmon Calcitonin Acetate,CC(C)CC(NNC(CCC(N)=O)C(=O)NC(C(C)O)C(=O)C(=O)C(CC1=CC=C(O)C=C1)NN2CCCC2C(=O)NC(CCCNC(N)=N)C(=O)NC(C(C)O)C(=O)NC(CC(N)=O)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N3CCCC3C(N)=O)C(=O)C(=O)C(CCCCN)NC(=O)C(CC4=CN=C[NH]4)NC(=O)C(CC(C)C)NC(=O)C(CCC(O)=O)NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(NC(=O)C5CSSCC(N)C(=O)NC(CO)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)N5)C(C)C,C145H240N44O48S2,P1030
22055,Terlipressin Acetate,NCCCCC(NC(=O)C1CCCN1C(=O)C2CSSCC(NC(=O)CNC(=O)CNC(=O)CN)C(=O)NC(CC3=CC=C(O)C=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N2)C(=O)NCC(N)=O,C52H74N16O15S2,P1034
22056,Somatostatin Acetate,CC(N)C(=O)NCC(=O)NC1CSSCC(NC(=O)C(CO)NC(=O)C(NC(=O)C(CC2=CC=CC=C2)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(CC3=C[NH]C4=CC=CC=C34)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(N)=O)NC(=O)C(CCCCN)NC1=O)C(C)O)C(C)O)C(O)=O.CC(O)=O,C76H104N18O19S2,P1039
22057,GHRP-2,CC(N)C(=O)NC(CC1=CC=C2C=CC=CC2=C1)C(=O)NC(CC3=C[NH]C4=C3C=CC=C4)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCCN)C(N)=O,C47H59N9O8,P1049
22058,Desmopressin Acetate,CC(O)=O.NC(=N)NCCCC(NC(=O)C1CCCN1C(=O)C2CSSCCC(=O)NC(CC3=CC=C(O)C=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N2)C(=O)NCC(N)=O,C46H64N14O12S2.C2H4O2,P1084
22059,Angiotensin II human Acetate,CCC(C)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(NC(=O)C(CCCNC(N)=N)NC(=O)C(N)CC(O)=O)C(C)C)C(=O)NC(CC2=C[NH]C=N2)C(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(O)=O.CC(O)=O,C52H75N13O14,P1085
22060,Carperitide Acetate,CCC(C)C1NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(O)=O)NC(=O)C(CCSC)NC(=O)C(CCCNC(N)=N)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)NC(=O)C(CSSCC(NC(=O)CNC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CO)NC(=O)C(CCC(N)=O)NC(=O)C(C)NC(=O)CNC1=O)C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC4=CC=C(O)C=C4)C(O)=O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCCNC(N)=N)NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(C)C)NC(=O)C(N)CO.CC(O)=O,C129H207N45O41S3,P1087
22061,(6-)ε-​Aminocaproic acid,NCCCCCC(O)=O,C6H13NO2,S1671
22062,Foscarnet Sodium,[Na+].[Na+].[Na+].[O-]C(=O)[P]([O-])([O-])=O,CNa3O5P,S3076
22063,Citric acid trilithium salt tetrahydrate,O.O.O.O.[Li]OC(=O)CC(O)(CC(=O)O[Li])C(=O)O[Li],C6H5Li3O7&bull;4H2O,S4519
22064,Hyaluronic acid,CC(=O)NC1C(O[*])C(O)C(CO)OC1OC2C(O)C(O)C(O[*])OC2C(O)=O,0,S5865
22065,Latamoxef sodium,[Na+].[Na+].COC1(NC(=O)C(C([O-])=O)C2=CC=C(O)C=C2)C3OCC(=C(N3C1=O)C([O-])=O)CSC4=NN=N[N]4C,C20H18N6Na2O9S,S4986
22066,Estramustine phosphate sodium,[Na+].[Na+].CC12CCC3C(CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl)C1CCC2O[P]([O-])([O-])=O,C23H30Cl2NNa2O6P,S2441
22067,Sodium stibogluconate,O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].OCC(O)C1O[Sb]2(O)(OC1C(O2)C([O-])=O)O[Sb]34([O-])OC(C(O)CO)C(O3)C(O4)C([O-])=O,C12H35Na3O26Sb2,S2435
22068,HEPES,OCCN1CCN(CC1)CC[S](O)(=O)=O,C8H18N2O4S,S6831
22069,Lithium carbonate,[LiH].[Li]OOC=O,CLi2O3,S4933
22070,Lanreotide acetate,CC(C)C1NC(=O)C(CCCCN)NC(=O)C(CC2=C[NH]C3=C2C=CC=C3)NC(=O)C(CC4=CC=C(O)C=C4)NC(=O)C(CSSCC(NC1=O)C(=O)NC(C(C)O)C(N)=O)NC(=O)C(N)CC5=CC6=CC=CC=C6C=C5.CC(O)=O,C56H73N11O12S2,P1088
22071,L-Histidine monohydrochloride monohydrate,O.Cl.NC(CC1=CN=C[NH]1)C(O)=O,C6H12ClN3O3,S3096
22072,Potassium sorbate,[K+].C/C=C/C=C/C([O-])=O,C6H7KO2,S3142
22073,Teriparatide Acetate,CCC(C)C(NC(=O)C(CCC(O)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C(N)CO)C(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CN=C[NH]1)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CN=C[NH]2)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NC(C(C)C)C(=O)NC(CCC(O)=O)C(=O)C(=O)C(CC3=C[NH]C4=C3C=CC=C4)NC(=O)C(CC(C)C)NNC(CCCNC(N)=N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(O)=O)C(=O)NC(C(C)C)C(=O)NC(CC5=CN=C[NH]5)C(=O)NC(CC(N)=O)C(=O)NC(CC6=CC=CC=C6)C(O)=O.CC(O)=O,C181H291N55O51S2,P1033
22074,Felypressin Acetate,NCCCCC(NC(=O)C1CCCN1C(=O)C2CSSCC(N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N2)C(=O)NCC(N)=O,C46H65N13O11S2,P1047
22075,Zoledronic acid (ZOL 446),OC(C[N]1C=CN=C1)([P](O)(O)=O)[P](O)(O)=O,C5H10N2O7P2,S1314
22076,Gadobutrol,[Gd+3].OCC(O)C(CO)N1CCN(CCN(CCN(CC1)CC([O-])=O)CC([O-])=O)CC([O-])=O,C18H31GdN4O9,S3497
22077,Bekanamycin,NCC1OC(OC2C(N)CC(N)C(OC3OC(CO)C(O)C(N)C3O)C2O)C(N)C(O)C1O,C18H37N5O10,S4383
22078,Piperazine adipate,OC(=O)CCCCC(O)=O.C1CNCCN1,C10H20N2O4,S4443
22079,L-Ornithine,NCCCC(N)C(O)=O,C5H12N2O2,S4857
22080,Tenofovir hydrate,O.CC(C[N]1C=NC2=C(N)N=CN=C12)OC[P](O)(O)=O,C9H16N5O5P,S4879
22081,Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,C16H26GdN5O8,S5000
22082,Varenicline Hydrochloride,Cl.C1NCC2CC1C3=CC4=NC=CN=C4C=C23,C13H14ClN3,S5022
22083,Sodium Etidronate,[Na+].[Na+].CC(O)([P](O)([O-])=O)[P](O)([O-])=O,C2H6Na2O7P2,S5198
22084,ATP,NC1=C2N=C[N](C3OC(CO[P](O)(=O)O[P](O)(=O)O[P](O)(O)=O)C(O)C3O)C2=NC=N1,C10H16N5O13P3,S5260
22085,Amikacin Sulfate Salt,NCCC(O)C(=O)NC1CC(N)C(OC2OC(CN)C(O)C(O)C2O)C(O)C1OC3OC(CO)C(O)C(N)C3O.O[S](O)(=O)=O,C22H45N5O17S,S5330
22086,Gatifloxacin hydrochloride,Cl.COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(=C1N3CCNC(C)C3)F)C4CC4,C19H23ClFN3O4,S5964
22087,Kasugamycin hydrochloride hydrate,O.Cl.CC1OC(OC2C(O)C(O)C(O)C(O)C2O)C(N)CC1NC(=N)C(O)=O,C14H28ClN3O10,S5968
22088,Sodium citrate dihydrate,O.O.[Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,C6H9Na3O9,S6446
22089,Melittin,CCC(C)C(NC(=O)CN)C(=O)NCC(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CO)C(=O)NC(CC2=C[NH]C3=C2C=CC=C3)C(=O)C(=O)C(NC(=O)C(CCCCN)NNC(CCCNC(N)=N)C(=O)NC(CCCCN)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(N)=O)C(C)CC,C131H229N39O31,S9794
22090,Sodium Acetate,[Na+].CC([O-])=O,CH3COONa,S6991
22091,Calcium chloride,[Cl-].[Cl-].[Ca++],CaCl2,S6992
22092,Sodium citrate,[Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,C6H5Na3O7,S9489
22093,Ammonium ferric citrate,[NH4+].[NH4+].[NH4+].[Fe+3].[Fe+3].[Fe+3].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,C24H32Fe3N3O28,E0375
22094,Glatiramer acetate,CC(N)C(O)=O.CC(O)=O.NCCCCC(N)C(O)=O.NC(CCC(O)=O)C(O)=O.NC(CC1=CC=C(O)C=C1)C(O)=O,C25H45N5O13,P1104
22095,Gentamicin,CNC(C)C1CCC(N)C(O1)OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O.CNC4C(O)C(OCC4(C)O)OC5C(N)CC(N)C(OC6OC(CN)CCC6N)C5O.CNC7C(O)C(OCC7(C)O)OC8C(N)CC(N)C(OC9OC(CCC9N)C(C)N)C8O,C60H123N15O21,S6289
22096,Merbromin,[NaH].[NaH].O[Hg]C1=C(O)C(=CC2=C1OC3=CC(=C(Br)C=C3C24OC(=O)C5=C4C=CC=C5)O)Br,C20H10Br2HgO6.2Na,S6872
22097,Cidofovir hydrate,O.O.NC1=NC(=O)N(CC(CO)OC[P;v5](O)(O)=O)C=C1,C8H14N3O6P.2H2O,E0510
22098,Menotropin,CC(C)(C)CCCCC=O,C9H18O,E0532
22099,Flavin Adenine Dinucleotide Disodium,[NaH].[NaH].CC1=C(C)C=C2N(CC(O)C(O)C(O)CO[P;v5](O)(=O)O[P;v5](O)(=O)OCC3OC(C(O)C3O)[N]4C=NC5=C(N)N=CN=C45)C6=NC(=O)NC(=O)C6=NC2=C1,C27H33N9O15P2.2Na,E0705
22100,Tricine,OCC(CO)(CO)NCC(O)=O,C6H13NO5,E2638
22101,Fondaparinux Sodium (Org 31540),[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].COC1OC(CO[S]([O-])(=O)=O)C(OC2OC(C(OC3OC(CO[S]([O-])(=O)=O)C(OC4OC(C(OC5OC(CO[S]([O-])(=O)=O)C(O)C(O)C5N[S]([O-])(=O)=O)C(O)C4O)C([O-])=O)C(O[S]([O-])(=O)=O)C3N[S]([O-])(=O)=O)C(O)C2O[S]([O-])(=O)=O)C([O-])=O)C(O)C1N[S]([O-])(=O)=O,C31H43N3O49S8.10Na,S3736
22102,Cetrorelix Acetate,CC(C)CC(NC(=O)C(CCCNC(N)=O)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC2=CN=CC=C2)NC(=O)C(CC3=CC=C(Cl)C=C3)NC(=O)C(CC4=CC5=CC=CC=C5C=C4)NC(C)=O)C(=O)NC(CCCN=C(N)N)C(=O)N6CCCC6C(=O)NC(C)C(N)=O.CC(O)=O.CC(O)=O,C70H92ClN17O14.2(C2H4O2),P1019
22103,Papain,NCCC(=O)NC(CC1=CN=C[NH]1)C(O)=O,C9H14N4O3,E0149
22104,Fosphenytoin (disodium),[Na+].[Na+].[O-][P]([O-])(=O)OCN1C(=O)NC(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3,C16H13N2Na2O6P,S6482
22105,Prednisolone disodium phosphate,[Na+].[Na+].CC12CC(O)C3C(CCC4=CC(=O)C=CC34C)C1CCC2(O)C(=O)CO[P]([O-])([O-])=O,C21H27Na2O8P,S5961
22106,Cysteamine bitartrate,NCCS.OC(C(O)C(O)=O)C(O)=O,C6H13NO6S,E0178
22107,Potassium D-gluconate,[K;v0].OCC(O)C(O)C(O)C(O)C(O)=O,C6H12O7.K,E4002
22108,Ammonium sulfate,N.O[S](O)(=O)=O,H3N.1/2H2O4S,E4018
22109,Sodium Bicarbonate,[Na;v0].OC(O)=O,CH2O3.Na,E2895
22110,Potassium Chloride,Cl[K],ClK,E4470
22111,Trilaciclib dihydrochloride,[ClH:34].[CH3:3][N:33]1[CH2:31][CH2:29][N:28]([CH2:30][CH2:32]1)[C:27]2=[CH:25][CH:23]=[C:22]([NH:2][C:20]3=[N:21][CH:19]=[C:14]4[CH:16]=[C:10]5[N:5]([C:9]4=[N:15]3)[C:4]6([CH2:7][CH2:12][CH2:18][CH2:13][CH2:8]6)[CH2:6][NH:11][C:17]5=[O:1])[N:24]=[CH:26]2,C24H30N8O.2ClH,E4578
22112,Phenformin (NSC-756501) HCl,Cl.NC(=N)NC(=N)NCCC1=CC=CC=C1,C10H15N5.HCl,S2542
22113,Erlotinib (OSI-774) HCl,Cl.COCCOC1=C(OCCOC)C=C2C(=NC=NC2=C1)NC3=CC=CC(=C3)C#C,C22H23N3O4.HCl,S1023
22114,Vandetanib (ZD6474),COC1=CC2=C(C=C1OCC3CCN(C)CC3)N=CN=C2NC4=C(F)C=C(Br)C=C4,C22H24BrFN4O2,S1046
22115,Imiquimod (R-837),CC(C)C[N]1C=NC2=C(N)N=C3C=CC=CC3=C12,C14H16N4,S1211
22116,Camptothecin (NSC-100880),CCC1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC=CC5=C4)C2=O,C20H16N2O4,S1288
22117,Ketoconazole (R 41400),CC(=O)N1CCN(CC1)C2=CC=C(OCC3COC(C[N]4C=CN=C4)(O3)C5=CC=C(Cl)C=C5Cl)C=C2,C26H28Cl2N4O4,S1353
22118,Cefoselis Sulfate,CO/N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(O)=O)CN3C=CC(=N)N3CCO)C4=CSC(=N4)N.O[S](O)(=O)=O,C19H22N8O6S2.H2SO4,S1371
22119,Prazosin HCl,Cl.COC1=CC2=C(C=C1OC)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N,C19H21N5O4.HCl,S1424
22120,Marbofloxacin,CN1CCN(CC1)C2=C(F)C=C3C(=O)C(=CN4N(C)COC2=C34)C(O)=O,C17H19FN4O4,S1464
22121,Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=N[NH]N=N5,C25H28N6O,S1507
22122,Norfloxacin,CCN1C=C(C(O)=O)C(=O)C2=CC(=C(C=C12)N3CCNCC3)F,C16H18FN3O3,S1509
22123,Risperidone,CC1=C(CCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)C(=O)N5CCCCC5=N1,C23H27FN4O2,S1615
22124,Sulfapyridine,NC1=CC=C(C=C1)[S](=O)(=O)NC2=NC=CC=C2,C11H11N3O2S,S1617
22125,Methyldopa,CC(N)(CC1=CC(=C(O)C=C1)O)C(O)=O,C10H13NO4,S1642
22126,Torsemide,CC(C)NC(=O)N[S](=O)(=O)C1=C(NC2=CC(=CC=C2)C)C=CN=C1,C16H20N4O3S,S1698
22127,Eplerenone (CGP 30083),COC(=O)C1CC2=CC(=O)CCC2(C)C34OC3CC5(C)C(CCC56CCC(=O)O6)C14,C24H30O6,S1707
22128,Paliperidone,CC1=C(CCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)C(=O)N5CCCC(O)C5=N1,C23H27FN4O3,S1724
22129,Flubendazole,COC(=O)NC1=NC2=C([NH]1)C=C(C=C2)C(=O)C3=CC=C(F)C=C3,C16H12FN3O3,S1837
22130,Oxibendazole,CCCOC1=CC=C2N=C(NC(=O)OC)[NH]C2=C1,C12H15N3O3,S1851
22131,Irsogladine,NC1=NC(=NC(=N1)C2=C(Cl)C=CC(=C2)Cl)N,C9H7Cl2N5,S1929
22132,Sarafloxacin HCl,Cl.OC(=O)C1=CN(C2=CC=C(F)C=C2)C3=C(C=C(F)C(=C3)N4CCNCC4)C1=O,C20H17F2N3O3.HCl,S1977
22133,Meclizine 2HCl,Cl.Cl.CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(Cl)C=C4,C25H27Cl2N2.2HCl,S1986
22134,Epalrestat (ONO-2235),CC(=C/C1=CC=CC=C1)\C=C2/SC(=S)N(CC(O)=O)C2=O,C15H13NO3S2,S2035
22135,Lornoxicam,CN1C(=C(O)C2=C(C=C(Cl)S2)[S]1(=O)=O)C(=O)NC3=NC=CC=C3,C13H10ClN3O4S2,S2047
22136,Vinpocetine,CCOC(=O)C1=CC2(CC)CCCN3CCC4=C(C23)[N]1C5=CC=CC=C45,C22H26N2O2,S2110
22137,Neratinib (HKI-272),CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(=C1)N=CC(=C2NC3=CC=C(OCC4=NC=CC=C4)C(=C3)Cl)C#N,C30H29ClN6O3,S2150
22138,Sitafloxacin Hydrate,O.O.O.NC1CN(CC12CC2)C3=C(Cl)C4=C(C=C3F)C(=O)C(=CN4C5CC5F)C(O)=O.NC6CN(CC67CC7)C8=C(Cl)C9=C(C=C8F)C(=O)C(=CN9C%10CC%10F)C(O)=O,C19H18ClF2N3O3.3/2H2O,S2152
22139,Fostamatinib (R788) disodium,[Na+].[Na+].COC1=C(OC)C(=CC(=C1)NC2=NC=C(F)C(=N2)NC3=CC=C4OC(C)(C)C(=O)N(CO[P]([O-])([O-])=O)C4=N3)OC,C23H24FN6O9P.2Na,S2206
22140,Ketanserin,FC1=CC=C(C=C1)C(=O)C2CCN(CC2)CCN3C(=O)NC4=CC=CC=C4C3=O,C22H22FN3O3,S2232
22141,(-)-Huperzine A (HupA),C\C=C/1C2CC3=C(C=CC(=O)N3)C1(N)CC(=C2)C,C15H18N2O,S2251
22142,Diosmin,COC1=C(O)C=C(C=C1)C2=CC(=O)C3=C(O2)C=C(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)C=C3O,C28H32O15,S2292
22143,Hypoxanthine,O=C1NC=NC2=C1[NH]C=N2,C5H4N4O,S2424
22144,Itraconazole (R 51211),CCC(C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(C[N]6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4,C35H38Cl2N8O4,S2476
22145,7-Aminocephalosporanic acid,CC(=O)OCC1=C(N2C(SC1)C(N)C2=O)C(O)=O,C10H12N2O5S,S2530
22146,Trazodone HCl,Cl.ClC1=CC(=CC=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2,C19H22ClN5O.HCl,S2582
22147,Oseltamivir Phosphate,CCOC(=O)C1=CC(OC(CC)CC)C(NC(C)=O)C(N)C1.O[P](O)(O)=O,C16H28N2O4.H3PO4,S2597
22148,Capmatinib (INCB28060),CNC(=O)C1=CC=C(C=C1F)C2=N[N]3C(=CN=C3N=C2)CC4=CC=C5N=CC=CC5=C4,C23H17FN6O,S2788
22149,Mozavaptan,CN(C)C1CCCN(C(=O)C2=CC=C(NC(=O)C3=C(C)C=CC=C3)C=C2)C4=C1C=CC=C4,C27H29N3O2,S2920
22150,Droxidopa,NC(C(O)C1=CC(=C(O)C=C1)O)C(O)=O,C9H11NO5,S3041
22151,Enrofloxacin,CCN1CCN(CC1)C2=CC3=C(C=C2F)C(=O)C(=CN3C4CC4)C(O)=O,C19H22FN3O3,S3059
22152,Ambroxol HCl,Cl.NC1=C(Br)C=C(Br)C=C1CNC2CCC(O)CC2,C13H18Br2N2O.HCl,S3064
22153,Cefadroxil hydrate,O.CC1=C(N2C(SC1)C(NC(=O)C(N)C3=CC=C(O)C=C3)C2=O)C(O)=O,C16H17N3O5S.H2O,S3636
22154,Bilastine,CCOCC[N]1C(=NC2=C1C=CC=C2)C3CCN(CC3)CCC4=CC=C(C=C4)C(C)(C)C(O)=O,C28H37N3O3,S3721
22155,Sodium Aescinate,CC(OC(C)=O)C(C)C(=O)OCC12C(O)C3OC1CC4(C)C(=CCC5C6(C)CCC(OC7OC(C(OC8OC(CO)C(O)C(O)C8O)C(O)C7OC9OCC(O)C(O)C9O)C(=O)O[Na])C(C)(CO)C6CCC45C)C2CC3(C)C,C54H83NaO23,S3770
22156,Sodium Houttuyfonate,[Na+].CCCCCCCCCCCCOC(=O)C[S]([O-])(=O)=O,C14H27O5S.Na,S3801
22157,Nuciferine,COC1=C(OC)C2=C3C(CC4=C2C=CC=C4)N(C)CCC3=C1,C19H21NO2,S3821
22158,Vincamine,CCC12CCCN3CCC4=C(C13)[N](C5=CC=CC=C45)C(O)(C2)C(=O)OC,C21H26N2O3,S3891
22159,Clopidol,CC1=C(Cl)C(=C(Cl)C(=N1)C)O,C7H7Cl2NO,S4142
22160,Chlortetracycline HCl (NSC 13252),Cl.CN(C)C1C2CC3C(=C(O)C2(O)C(=O)C(=C1O)C(N)=O)C(=O)C4=C(C(=CC=C4O)Cl)C3(C)O,C22H23ClN2O8.HCl,S4156
22161,Amoxapine,ClC1=CC2=C(OC3=C(C=CC=C3)N=C2N4CCNCC4)C=C1,C17H16ClN3O,S4218
22162,Ebastine,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4,C32H39NO2,S4262
22163,Folic acid,NC1=NC(=O)C2=C(N1)N=CC(=N2)CNC3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O,C19H19N7O6,S4605
22164,Dolutegravir Sodium,CC1CCOC2CN3C=C(C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)C(=C3C(=O)N12)O[Na],C20H19F2N3O5.Na,S4642
22165,Netupitant,CN1CCN(CC1)C2=CC(=C(C=N2)N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C4=CC=CC=C4C,C30H32F6N4O,S4654
22166,Cetilistat,CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C)C=C2)C(=O)O1,C25H39NO3,S4930
22167,Mebhydrolin napadisylate,CN1CCC2=C(C1)C3=C(C=CC=C3)[N]2CC4=CC=CC=C4.CN5CCC6=C(C5)C7=C(C=CC=C7)[N]6CC8=CC=CC=C8.O[S](=O)(=O)C9=C%10C=CC=C(C%10=CC=C9)[S](O)(=O)=O,C48H48N4O6S2,S5018
22168,6-Aminopenicillanic acid,CC1(C)SC2C(N)C(=O)N2C1C(O)=O,C8H12N2O3S,S5035
22169,Alectinib (CH5424802) hydrochloride,Cl.CCC1=C(C=C2C(=C1)C(=O)C3=C([NH]C4=C3C=CC(=C4)C#N)C2(C)C)N5CCC(CC5)N6CCOCC6,C30H34N4O2.HCl,S5232
22170,Toceranib phosphate,CC1=C(C(=C([NH]1)\C=C2/C(=O)NC3=C2C=C(F)C=C3)C)C(=O)NCCN4CCCC4.O[P](O)(O)=O,C22H25FN4O2.H3O4P,S5272
22171,Amantadine,N[C]12C[CH]3[CH2]C([CH2][CH](C3)C1)C2,C10H17N,S5499
22172,Balofloxacin Dihydrate,O.O.CNC1CCCN(C1)C2=C(F)C=C3C(=O)C(=CN(C4CC4)C3=C2OC)C(O)=O,C20H28FN3O6,S5601
22173,Xanthopterin Hydrate,O.NC1=NC(=C2N=C(O)C=NC2=N1)O,C6H7N5O3,S5677
22174,Zofenopril calcium,CC(CSC(=O)C1=CC=CC=C1)C(=O)N2CC(CC2C(=O)O[Ca]OC(=O)C3CC(CN3C(=O)C(C)CSC(=O)C4=CC=CC=C4)SC5=CC=CC=C5)SC6=CC=CC=C6,C44H44CaN2O8S4,S5712
22175,Garenoxacin,CC1NCC2=C1C=CC(=C2)C3=C(OC(F)F)C4=C(C=C3)C(=O)C(=CN4C5CC5)C(O)=O,C23H20F2N2O4,S5908
22176,Mirogabalin (DS-5565),CCC1=CC2C(C1)CC2(CN)CC(O)=O,C12H19NO2,S6632
22177,Tazemetostat (EPZ-6438),CCN(C1CCOCC1)C2=C(C)C(=CC(=C2)C3=CC=C(CN4CCOCC4)C=C3)C(=O)NCC5=C(C)C=C(C)NC5=O,C34H44N4O4,S7128
22178,Indoximod (NLG-8189）,C[N]1C=C(CC(N)C(O)=O)C2=CC=CC=C12,C12H14N2O2,S7756
22179,Brigatinib (AP26113),COC1=C(NC2=NC(=C(Cl)C=N2)NC3=CC=CC=C3[P](C)(C)=O)C=CC(=C1)N4CCC(CC4)N5CCN(C)CC5,C29H39ClN7O2P,S8229
22180,Lazertinib,COC1=CC(=C(NC(=O)C=C)C=C1NC2=NC=CC(=N2)[N]3C=C(CN(C)C)C(=N3)C4=CC=CC=C4)N5CCOCC5,C30H34N8O3,S8724
22181,Gefitinib hydrochloride,Cl.COC1=CC2=C(C=C1OCCCN3CCOCC3)C(=NC=N2)NC4=CC(=C(F)C=C4)Cl,C22H24ClFN4O3.HCl,S5098
22182,Sulfaquinoxaline sodium,NC1=CC=C(C=C1)[S](=O)(=O)N([Na])C2=CN=C3C=CC=CC3=N2,C14H11N4O2S.Na,S5031
22183,Cephalexin,CC1=C(N2C(SC1)C(NC(=O)C(N)C3=CC=CC=C3)C2=O)C(O)=O,C16H17N3O4S,S1502
22184,Palbociclib,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2N(C5CCCC5)C1=O,C24H29N7O2,S4482
22185,Potassium guaiacolsulfonate hemihydrate,O.[K+].[K+].COC1=C(O)C=CC(=C1)[S]([O-])(=O)=O.COC2=C(O)C=CC(=C2)[S]([O-])(=O)=O,C14H16K2O11S2,S5799
22186,Bictegravir Sodium,[NaH].OC1=C2N(CC3OC4CCC(C4)N3C2=O)C=C(C(=O)NCC5=C(F)C=C(F)C=C5F)C1=O,C21H18F3N3O5.Na,E0161
22187,Tranylcypromine Sulfate,NC1CC1C2=CC=CC=C2.NC3CC3C4=CC=CC=C4.O[S;v6](O)(=O)=O,C18H24N2O4S,S9464
22188,Glycyl-L-tyrosine,NCC(=O)NC(CC1=CC=C(O)C=C1)C(O)=O,C11H14N2O4,E4160
22189,Cabotegravir Sodium,[Na;v0].CC1COC2CN3C=C(C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)C(=C3C(=O)N12)O,C19H17F2N3O5.Na,E4468
22190,Cefprozil hydrate,[OH2:29].[CH3:12]/[CH:11]=[CH:10]/[C:20]1=[C:16]([N:14]2[CH:15]([S:19][CH2:21]1)[CH:18]([NH:5][C:6](=[O:8])[CH:7]([NH2:9])[C:22]3=[CH:23][CH:25]=[C:27]([OH:13])[CH:26]=[CH:24]3)[C:17]2=[O:4])[C:1]([OH:2])=[O:3],C18H19N3O5S.H2O,S2544
22191,Heparin sodium,CCC1CC(N[R])C(OC1CO[S]([O-])(=O)=O)OC2C(O)C(O)C(OC3C(CO[R])OC(OC4C(O)C(O[S]([O-])(=O)=O)C(OC5C(O)C(N[S]([O-])(=O)=O)C(C)OC5CO[S]([O-])(=O)=O)OC4C([O-])=O)C(N[S]([O-])(=O)=O)C3[S]([O-])(=O)=O)OC2C([O-])=O,(C12H16NS2Na3)20,S1346
22192,Risedronate Sodium,[Na+].OC(CC1=CC=CN=C1)([P](O)(O)=O)[P](O)([O-])=O,C7H10NNaO7P2,S1428
22193,Disodium Cromoglycate,[Na+].[Na+].OC(COC1=C2C(=O)C=C(OC2=CC=C1)C([O-])=O)COC3=CC=CC4=C3C(=O)C=C(O4)C([O-])=O,C23H14O11.2Na,S1911
22194,Adenine sulfate,NC1=NC=NC2=C1[NH]C=N2.NC3=NC=NC4=C3[NH]C=N4.O[S](O)(=O)=O,2(C5H5N5).H2SO4,S1982
22195,Azasetron HCl,Cl.CN1C(=O)COC2=C(C=C(Cl)C=C12)C(=O)NC3CN4CCC3CC4,C17H20ClN3O3.HCl,S2106
22196,Hydralazine HCl,Cl.N/N=C/1NN=CC2=C1C=CC=C2,C8H8N4.HCl,S2562
22197,Besifloxacin HCl,Cl.NC1CCCCN(C1)C2=C(Cl)C3=C(C=C2F)C(=O)C(=CN3C4CC4)C(O)=O,C19H21ClFN3O3.HCl,S3055
22198,Calcium gluconate monohydrate,O.[Ca++].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O,C12H22O14.Ca.H2O,S3749
22199,Deferiprone,CN1C=CC(=O)C(=C1C)O,C7H9NO2,S4067
22200,D-Phenylalanine,NC(CC1=CC=CC=C1)C(O)=O,C9H11NO2,S4153
22201,Minocycline (CL 59806) HCl,Cl.CN(C)C1C2CC3CC4=C(C(=CC=C4N(C)C)O)C(=O)C3=C(O)C2(O)C(=O)C(=C1O)C(N)=O,C23H27N3O7.HCl,S4226
22202,Alosetron Hydrochloride,Cl.C[N]1C2=C(C(=O)N(CC2)CC3=C(C)N=C[NH]3)C4=C1C=CC=C4,C17H18N4O.HCl,S4694
22203,Piperaquine phosphate,O[P](O)(O)=O.ClC1=CC=C2C(=C1)N=CC=C2N3CCN(CCCN4CCN(CC4)C5=C6C=CC(=CC6=NC=C5)Cl)CC3,C29H32Cl2N6.H3O4P,S5355
22204,Icatibant Acetate,CC(O)=O.NC(CCCNC(N)=N)C(=O)NC(CCCNC(N)=N)C(=O)N1CCCC1C(=O)N2CC(O)CC2C(=O)NCC(=O)NC(CC3=CC=CS3)C(=O)NC(CO)C(=O)N4CC5=C(CC4C(=O)N6C7CCCCC7CC6C(=O)NC(CCCNC(N)=N)C(O)=O)C=CC=C5,C61H93N19O15S,S5695
22205,Plerixafor (AMD3100),C1CNCCNCCCN(CCNC1)CC2=CC=C(CN3CCCNCCNCCCNCC3)C=C2,C28H54N8,S8030
22206,Sodium Hyaluronate,[Na+].CC(=O)NC1C(C(O)C(CO)OC1OC2C(O)C(O)C(O[*])OC2C([O-])=O)[*],C14H20NNaO11R,S5650
22207,Fosinopril Sodium,[Na+].CCC(=O)OC(O[P](=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C([O-])=O)C3CCCCC3)C(C)C,C30H45NO7P.Na,S2095
22208,Strontium Ranelate,O=C1CN(CC(=O)O[Sr]O1)C2=C(C#N)C3=C(S2)C(=O)O[Sr]OC(=O)C3,C12H6N2O8S.2Sr,S2050
22209,L-5-Methyltetrahydrofolate calcium,[Ca++].CN1C(CNC2=CC=C(C=C2)C(=O)NC(CCC([O-])=O)C([O-])=O)CNC3=C1C(=O)NC(=N3)N,C20H23N7O6.Ca,S5264
